data_1a24_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1a24 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.487 ' HB3' ' CE1' ' A' ' 9' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' ASP . 1.3 mt-10 -97.83 56.92 1.29 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -0.928 . . . . 0.0 110.083 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 40.99 80.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.609 -0.682 . . . . 0.0 110.041 179.39 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.9 -25.56 5.52 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.48 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -79.96 -69.5 0.58 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.94 -1.329 . . . . 0.0 108.852 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.515 ' HG2' ' NE2' ' A' ' 177' ' ' GLN . 0.3 OUTLIER -95.6 2.01 53.99 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.16 -0.963 . . . . 0.0 109.852 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.555 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.2 OUTLIER 177.19 129.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.098 -1.001 . . . . 0.0 109.239 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -106.89 179.61 4.22 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.573 -0.705 . . . . 0.0 109.469 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 158' ' ' LYS . 1.4 m -123.66 138.64 54.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.351 0.596 . . . . 0.0 109.599 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -99.22 158.2 15.86 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' C ' ' HD3' ' A' ' 15' ' ' PRO . 3.4 pt-20 -91.51 1.27 57.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 109.712 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.523 ' O ' ' CD1' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -120.73 78.07 29.82 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 0.0 109.321 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD3' ' C ' ' A' ' 13' ' ' GLU . 36.3 Cg_endo -78.19 164.58 26.76 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.717 2.278 . . . . 0.0 110.558 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 17' ' ' ALA . 18.8 t -127.53 92.66 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.176 -0.953 . . . . 0.0 109.557 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -42.76 125.96 3.56 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 96.05 -18.23 57.83 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.505 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -39.41 160.83 0.09 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.505 -0.997 . . . . 0.0 109.927 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 35.1 Cg_endo -77.67 135.83 14.8 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.741 2.294 . . . . 0.0 111.309 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 9.1 mt-30 -49.4 -21.02 0.79 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.561 -0.712 . . . . 0.0 109.802 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.49 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 73.2 t -151.45 80.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.978 -1.076 . . . . 0.0 109.103 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.73 126.99 32.07 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.541 ' N ' HD21 ' A' ' 23' ' ' LEU . 3.5 tt0 -108.49 120.97 43.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.001 -1.062 . . . . 0.0 109.97 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.639 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 8.2 m-85 -108.33 107.52 18.13 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.414 ' CE1' ' HG2' ' A' ' 58' ' ' LYS . 2.0 p90 -153.08 141.19 20.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.97 -1.081 . . . . 0.0 110.423 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -118.51 -178.21 3.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.067 179.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 5.8 m-30 -97.03 46.16 1.04 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 108.698 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.572 ' CE2' HG12 ' A' ' 96' ' ' VAL . 15.0 m-85 -146.41 13.27 1.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.289 -0.882 . . . . 0.0 109.837 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 3.7 m -105.39 161.16 23.62 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.649 -1.282 . . . . 0.0 109.534 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 33.2 Cg_endo -75.04 -32.93 4.92 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.106 1.871 . . . . 0.0 108.17 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' PHE . 39.7 m80 -84.5 -20.37 31.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.494 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 5.1 t -49.69 -55.21 14.66 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 3.4 t80 -73.35 -33.51 65.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.901 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 25.7 mt-30 -85.65 -16.02 40.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.856 -1.152 . . . . 0.0 111.186 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 32' ' ' HIS . 8.9 t80 -86.25 -28.2 23.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.841 -1.162 . . . . 0.0 111.377 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.3 mt-10 -127.14 50.53 1.97 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.594 -1.316 . . . . 0.0 110.728 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 1.2 mt-10 -168.34 -59.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.009 -1.057 . . . . 0.0 110.767 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.32 -49.35 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.976 -1.077 . . . . 0.0 110.848 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.484 ' HB3' HG13 ' A' ' 42' ' ' ILE . 6.7 mp -71.1 -2.19 14.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.096 -1.003 . . . . 0.0 110.297 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.458 ' C ' ' O ' ' A' ' 40' ' ' LEU . 58.0 m-70 39.39 29.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.838 . . . . 0.0 109.954 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.484 HG13 ' HB3' ' A' ' 40' ' ' LEU . 36.4 mt -74.62 -21.43 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.557 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.442 ' O ' HG11 ' A' ' 46' ' ' VAL . 2.5 p -76.97 -43.45 35.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 109.619 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.83 -48.28 15.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.519 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -52.96 -43.56 66.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 109.517 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.504 HG11 ' N ' ' A' ' 47' ' ' LYS . 9.8 p -69.87 -25.77 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.143 -0.973 . . . . 0.0 109.16 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 49.4 mttm -80.76 -27.58 36.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 110.133 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -29.45 70.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.052 . . . . 0.0 109.79 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.487 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 8.3 mmtt -109.27 24.79 12.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.534 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 11.9 mt -70.85 113.71 21.02 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.971 . . . . 0.0 109.933 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 36.2 Cg_endo -78.73 151.37 24.85 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.245 1.963 . . . . 0.0 109.247 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 3.7 tp10 -75.47 21.13 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.625 -1.297 . . . . 0.0 110.724 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.75 29.99 5.24 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 186' ' ' SER . 60.7 t -153.07 118.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -1.007 . . . . 0.0 109.338 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.26 109.37 20.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.678 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.49 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 1.9 ttp -92.58 100.82 13.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.719 -0.613 . . . . 0.0 109.595 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.454 ' HB ' HD22 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -96.72 149.67 21.56 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.801 -1.159 . . . . 0.0 109.898 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.414 ' HG2' ' CE1' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -123.77 117.12 24.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.466 -0.771 . . . . 0.0 109.378 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.569 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.3 m-85 -123.78 166.26 15.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.81 -1.181 . . . . 0.0 111.617 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.575 ' CD2' ' OG ' ' A' ' 27' ' ' SER . 14.4 t60 -102.26 149.51 24.25 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.523 HG13 ' CG1' ' A' ' 150' ' ' VAL . 1.3 m -95.31 159.79 2.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 O-C-N 121.663 -0.648 . . . . 0.0 110.356 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -128.11 49.41 2.16 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.312 -0.867 . . . . 0.0 109.193 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.593 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 10.8 p90 -152.4 64.65 0.82 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -0.961 . . . . 0.0 109.799 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -119.04 30.77 6.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.932 -1.105 . . . . 0.0 109.592 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' MET . . . 45.12 42.73 8.65 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . -149.05 85.43 0.16 Allowed Glycine 0 C--O 1.204 -1.731 0 N-CA-C 107.572 -2.211 . . . . 0.0 107.572 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -31.62 -46.52 0.11 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.058 -0.672 . . . . 0.0 111.548 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.581 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -61.46 -22.24 64.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.647 -1.283 . . . . 0.0 109.49 -179.01 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 66' ' ' GLY . . . -54.52 -46.99 71.86 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.41 ' O ' ' HB ' ' A' ' 73' ' ' THR . 27.8 mttt -52.32 -47.04 66.24 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.531 ' CB ' ' HB3' ' A' ' 105' ' ' ALA . 8.5 t0 -64.41 -29.2 70.27 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 75' ' ' ALA . 17.6 tp -61.26 -35.4 77.17 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 5.3 m -62.75 -40.73 98.14 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.494 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 0.5 OUTLIER -61.91 -20.9 64.26 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 177.175 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -67.96 -41.92 81.69 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.446 ' HB3' ' OE1' ' A' ' 138' ' ' GLN . 24.1 t-105 -67.01 -31.67 72.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 0.0 108.91 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' CB ' HG21 ' A' ' 135' ' ' VAL . . . -79.51 -60.37 2.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.28 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.588 ' CG2' ' CE1' ' A' ' 122' ' ' TYR . 71.5 t -54.92 -27.81 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 110.043 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.521 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.25 -62.85 1.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.907 -1.121 . . . . 0.0 108.621 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.405 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -47.01 -27.42 1.3 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.16 75.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.598 -0.689 . . . . 0.0 109.286 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.451 ' O ' HG11 ' A' ' 84' ' ' VAL . 67.5 mt -107.92 12.75 26.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.224 -0.923 . . . . 0.0 110.562 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 49.17 32.01 12.59 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 26.0 m -93.81 2.01 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.476 -1.014 . . . . 0.0 110.531 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.452 ' O ' ' HB ' ' A' ' 89' ' ' THR . 38.4 tt0 -48.9 -68.31 0.19 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.866 -1.146 . . . . 0.0 109.402 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -40.04 -34.89 0.32 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.878 . . . . 0.0 110.465 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.484 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 35.1 mttt -79.82 -55.4 5.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 111.031 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.529 HG22 ' CD1' ' A' ' 92' ' ' LEU . 1.2 m -82.14 -22.28 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.812 -1.18 . . . . 0.0 110.608 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.602 HG21 ' CG ' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -64.77 -43.57 92.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.723 -1.235 . . . . 0.0 108.983 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.92 -56.21 30.22 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.351 -1.468 . . . . 0.0 110.474 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.484 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 26.1 Cg_endo -72.43 -16.21 27.62 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 N-CA-C 109.812 -0.88 . . . . 0.0 109.812 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.529 ' CD1' HG22 ' A' ' 88' ' ' VAL . 15.1 mt -87.39 -44.13 11.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 108.844 178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.602 ' CG ' HG21 ' A' ' 89' ' ' THR . 5.4 m-30 -65.51 -46.84 78.07 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.987 -1.071 . . . . 0.0 108.835 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -16.62 60.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -0.968 . . . . 0.0 109.203 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.66 -33.39 51.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.572 HG12 ' CE2' ' A' ' 29' ' ' PHE . 2.3 t -100.83 -7.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 121.12 -1.224 . . . . 0.0 109.35 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -110.08 8.73 24.07 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 120.893 -1.129 . . . . 0.0 110.514 -179.288 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.556 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -176.18 68.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.67 -1.269 . . . . 0.0 109.333 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.556 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 163.08 -46.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.522 -0.736 . . . . 0.0 109.575 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 71.67 17.54 5.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.397 -0.814 . . . . 0.0 110.38 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 t -81.45 -4.96 57.36 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.527 ' CB ' HG23 ' A' ' 96' ' ' VAL . 4.2 mm -95.41 84.49 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.34 28.29 1.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 109.382 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 107' ' ' ASP . 59.6 p -157.55 131.54 8.15 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.321 -0.862 . . . . 0.0 109.658 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.531 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -48.99 -31.66 7.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 t -64.5 -33.28 75.53 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -67.64 -50.11 59.6 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.526 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 36.3 mt -51.27 -28.53 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -36.49 56.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.52 -0.737 . . . . 0.0 109.052 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.22 -48.4 78.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.517 ' CG2' HD22 ' A' ' 92' ' ' LEU . 21.3 t -68.82 -37.68 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.455 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.427 ' O ' HG12 ' A' ' 117' ' ' ILE . 1.3 m-85 -59.9 -48.26 82.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.108 -0.995 . . . . 0.0 109.469 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 mt -66.26 -25.39 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.963 . . . . 0.0 109.279 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 111' ' ' VAL . 15.5 m-20 -61.77 -16.94 53.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.916 . . . . 0.0 109.544 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.94 15.48 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.078 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.59 -0.94 89.39 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 117' ' ' ILE . 3.9 mm -71.77 55.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -1.14 . . . . 0.0 109.843 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -36.73 145.53 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.285 -0.885 . . . . 0.0 110.073 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -47.15 -31.71 6.22 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.484 ' O ' ' HB1' ' A' ' 124' ' ' ALA . 2.3 mt-10 -61.79 -49.25 77.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -1.121 . . . . 0.0 109.49 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.19 -58.05 6.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 110.003 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.588 ' CE1' ' CG2' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -61.22 -56.84 16.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.938 . . . . 0.0 109.617 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 14.5 t70 -45.15 -34.34 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.036 -1.04 . . . . 0.0 109.054 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 120' ' ' GLU . . . -77.48 -43.9 30.7 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.416 -0.802 . . . . 0.0 109.012 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.545 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -52.85 -51.66 60.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.494 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 11.4 t90 -62.62 -53.2 58.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -53.86 -16.13 1.66 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.511 -0.743 . . . . 0.0 110.027 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.2 t -78.76 -179.48 6.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.984 -1.073 . . . . 0.0 110.273 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -95.24 -36.59 11.38 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.806 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.04 -47.83 80.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.209 -1.396 . . . . 0.0 109.709 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.545 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 2.2 t -64.95 -39.8 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.97 -1.081 . . . . 0.0 108.333 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -66.61 -31.62 72.42 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.3 t -64.6 -35.48 81.14 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.83 -19.14 52.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.313 -0.867 . . . . 0.0 108.678 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.405 HG21 ' CB ' ' A' ' 77' ' ' ALA . 4.6 t -80.35 -47.45 21.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.61 -36.9 85.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -32.96 73.06 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.569 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -64.37 -66.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.306 -0.871 . . . . 0.0 109.092 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 0.4 OUTLIER -52.23 -32.87 38.75 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.46 ' O ' ' OD2' ' A' ' 144' ' ' ASP . 0.3 OUTLIER -74.19 -28.21 61.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.345 -0.847 . . . . 0.0 108.991 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.463 ' HA ' ' OD2' ' A' ' 144' ' ' ASP . . . -64.37 -60.88 2.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.062 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.481 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -72.37 -21.72 61.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.717 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -77.56 -29.09 51.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.079 -1.013 . . . . 0.0 109.776 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.531 ' OD1' ' CG1' ' A' ' 145' ' ' VAL . 2.8 p30 -81.22 -47.82 12.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.001 . . . . 0.0 108.419 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.577 HG22 ' CE2' ' A' ' 25' ' ' PHE . 28.2 m -84.07 -14.44 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.542 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 4.0 tt0 81.2 -48.05 0.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.587 -0.696 . . . . 0.0 109.837 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.472 HD23 HG13 ' A' ' 61' ' ' VAL . 49.0 tp 61.79 134.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.466 -0.771 . . . . 0.0 109.319 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.72 40.36 0.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.623 -1.298 . . . . 0.0 109.681 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 152' ' ' ALA . . . 169.64 104.73 0.18 Allowed Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.014 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.547 HG23 ' CZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -99.0 141.13 22.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.131 . . . . 0.0 109.587 179.151 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.417 ' C ' ' HA ' ' A' ' 150' ' ' VAL . 33.1 Cg_endo -75.32 153.87 98.92 Favored 'Cis proline' 0 C--N 1.314 -1.26 0 C-N-CA 123.598 -1.417 . . . . 0.0 110.452 0.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' A' ' 25' ' ' PHE . . . -132.86 146.85 52.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.33 -1.481 . . . . 0.0 109.54 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 18.7 ttm -136.54 133.9 36.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 109.813 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.593 ' CD2' ' HB2' ' A' ' 160' ' ' GLN . 75.4 m-85 -129.57 127.08 39.97 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.332 -0.855 . . . . 0.0 110.104 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 56.1 t -97.03 129.46 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.045 -1.034 . . . . 0.0 109.5 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 47.41 21.72 0.24 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.979 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.75 55.72 28.54 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.475 ' O ' HG21 ' A' ' 11' ' ' THR . 13.5 tttp -163.71 -37.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.478 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 75.0 m-85 -114.91 124.84 52.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.593 ' HB2' ' CD2' ' A' ' 154' ' ' PHE . 4.4 tt0 -124.44 127.43 47.5 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.942 -1.099 . . . . 0.0 109.852 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.73 -179.84 0.74 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.499 -0.751 . . . . 0.0 109.081 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.457 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 38.1 t30 -144.42 65.0 12.69 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 109.64 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 162' ' ' ASN . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.478 0 C-N-CA 122.675 2.25 . . . . 0.0 110.424 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 35.7 mtm . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.873 0.844 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -76.42 -46.48 26.97 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.44 -25.76 25.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.301 -0.874 . . . . 0.0 109.12 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -73.6 -40.8 63.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.579 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 32.6 t -73.11 -29.83 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -0.988 . . . . 0.0 109.248 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -51.7 7.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 108.951 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.515 ' NE2' ' HG2' ' A' ' 8' ' ' GLN . 6.7 tt0 -57.71 -44.8 86.17 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.207 -0.933 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.485 ' HA ' ' OG1' ' A' ' 181' ' ' THR . 4.9 t80 -60.11 -56.7 18.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.073 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 183' ' ' LYS . . . -49.44 -27.58 4.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.337 -0.852 . . . . 0.0 108.873 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -79.48 -46.17 17.96 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.436 -0.79 . . . . 0.0 109.315 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.519 ' O ' ' CD1' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -48.62 -45.95 39.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.06 -1.025 . . . . 0.0 109.396 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.454 HG12 HG22 ' A' ' 22' ' ' VAL . 22.9 t -75.24 -32.09 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.959 -1.088 . . . . 0.0 109.792 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 179' ' ' ALA . 5.5 tttt -68.28 -38.43 81.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.364 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -83.41 -44.26 14.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.958 -1.089 . . . . 0.0 109.888 -179.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.536 HD22 ' CE2' ' A' ' 184' ' ' TYR . 14.5 mt -60.69 -22.75 64.25 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.62 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.532 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 5.2 t -68.98 -14.43 63.04 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.622 -0.674 . . . . 0.0 109.204 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.58 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 26.8 p90 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -118.17 63.51 0.76 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 110.359 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t0 69.13 96.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 110.38 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.28 -10.19 75.07 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.587 ' O ' ' CG ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -99.63 28.72 4.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -1.094 . . . . 0.0 108.199 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.587 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER 152.83 -40.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.03 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' A' ' 9' ' ' TYR . 8.4 p90 -139.79 113.34 8.52 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.193 -0.942 . . . . 0.0 108.691 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.438 HG21 ' HG3' ' A' ' 160' ' ' GLN . 15.1 t -93.3 -179.97 5.23 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' A' ' 158' ' ' LYS . 90.5 m -137.1 145.81 44.35 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.615 0.722 . . . . 0.0 110.079 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.434 HD11 ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -100.5 171.61 7.63 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.526 -0.734 . . . . 0.0 109.271 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.41 13.45 30.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.434 ' O ' HD11 ' A' ' 12' ' ' LEU . 1.6 mmtp -127.17 95.27 36.89 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.543 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.39 169.33 20.19 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.594 2.196 . . . . 0.0 110.204 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' ALA . 1.9 t -144.26 113.24 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 110.101 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.06 128.21 18.41 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 77.21 5.69 85.54 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.526 ' O ' ' O ' ' A' ' 18' ' ' GLY . . . -38.18 165.88 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.6 -0.941 . . . . 0.0 110.71 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.527 ' HG3' ' CD1' ' A' ' 23' ' ' LEU . 32.8 Cg_endo -74.02 101.26 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.859 2.373 . . . . 0.0 111.58 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.495 ' HB2' ' CB ' ' A' ' 55' ' ' LYS . 1.9 mp0 -42.1 -28.04 0.16 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 40.2 t -158.57 79.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.527 ' CD1' ' HG3' ' A' ' 20' ' ' PRO . 1.3 tt -73.62 139.27 45.38 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.447 ' N ' HD21 ' A' ' 23' ' ' LEU . 1.5 tt0 -127.8 98.77 5.28 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.199 -0.938 . . . . 0.0 109.803 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.502 ' CD1' ' CD2' ' A' ' 147' ' ' LEU . 11.4 m-85 -81.61 127.0 32.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.204 -0.935 . . . . 0.0 108.913 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -161.73 128.69 3.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.346 -0.846 . . . . 0.0 109.705 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.565 ' HA ' ' ND1' ' A' ' 60' ' ' HIS . 11.6 p -112.45 145.66 39.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.403 -0.81 . . . . 0.0 109.131 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.604 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 8.6 m-30 -72.93 49.87 0.25 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.252 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.598 ' CG ' HG13 ' A' ' 96' ' ' VAL . 11.4 m-85 -152.24 9.85 0.5 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.577 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -107.26 167.03 10.0 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.725 -1.235 . . . . 0.0 109.949 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.01 -43.07 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.564 2.176 . . . . 0.0 108.691 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.457 ' HB3' ' HG3' ' A' ' 151' ' ' PRO . 0.1 OUTLIER -78.17 -21.71 49.79 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 5.7 t -45.19 -56.27 4.96 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.505 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 51.9 t80 -69.98 -27.33 64.62 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.591 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 3.2 mm-40 -84.87 -28.67 25.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.138 . . . . 0.0 111.002 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -87.69 -36.25 17.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.83 -1.169 . . . . 0.0 111.724 -178.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 1.2 mp0 -111.46 31.95 5.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.633 -1.292 . . . . 0.0 111.38 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.553 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 26.3 mm-40 -160.03 -58.15 0.06 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.801 -1.187 . . . . 0.0 110.846 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 41' ' ' HIS . 69.2 t -88.91 -74.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.844 -1.16 . . . . 0.0 110.903 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.498 ' HB3' ' CD1' ' A' ' 42' ' ' ILE . 51.0 mt -42.7 -25.29 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.004 . . . . 0.0 110.315 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER 55.8 21.61 4.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.009 -1.057 . . . . 0.0 108.898 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 40' ' ' LEU . 14.9 mt -70.35 -21.23 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.45 -0.781 . . . . 0.0 109.888 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.464 ' O ' HG11 ' A' ' 46' ' ' VAL . 79.3 p -86.16 -77.27 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.09 -1.006 . . . . 0.0 110.078 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.5 OUTLIER -41.68 -31.5 0.3 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.867 . . . . 0.0 110.486 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 3.0 m120 -75.85 -31.58 59.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.949 -1.094 . . . . 0.0 110.064 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 3.5 p -54.2 -36.47 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.079 -1.013 . . . . 0.0 109.577 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -72.44 -36.39 68.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.119 -0.988 . . . . 0.0 109.474 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -45.02 -24.78 0.25 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.514 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -133.36 50.66 2.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.274 -0.892 . . . . 0.0 110.004 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.565 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 9.8 mt -114.47 72.3 2.51 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.868 -1.145 . . . . 0.0 110.562 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.514 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 36.8 Cg_endo -78.59 139.35 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.33 2.02 . . . . 0.0 110.269 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 51' ' ' PRO . 19.3 tp10 61.99 134.79 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.374 -0.829 . . . . 0.0 108.849 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . 58.21 23.53 53.04 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.565 ' CG1' ' O ' ' A' ' 50' ' ' LEU . 1.6 t -61.26 77.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.712 -0.875 . . . . 0.0 109.258 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -136.96 97.25 3.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.417 ' SD ' ' HD2' ' A' ' 58' ' ' LYS . 2.7 tmm? -103.6 103.01 12.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 108.91 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.52 121.68 36.32 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.197 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.52 ' HB2' ' CE1' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -103.39 110.23 22.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 0.0 109.715 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.606 ' CD1' ' CG ' ' A' ' 138' ' ' GLN . 4.1 m-85 -113.68 177.96 4.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.851 -1.156 . . . . 0.0 110.942 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.651 ' CE1' ' CD2' ' A' ' 72' ' ' LEU . 2.0 t-160 -140.0 130.4 25.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.44 -0.787 . . . . 0.0 109.651 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.527 ' CG2' HG13 ' A' ' 150' ' ' VAL . 1.4 m -115.18 137.38 48.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 2.0 p-10 -40.72 -55.89 2.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.352 -0.843 . . . . 0.0 109.37 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.553 ' CD2' HG12 ' A' ' 150' ' ' VAL . 3.6 m-85 32.1 40.64 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.623 0.725 . . . . 0.0 110.952 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.507 ' SD ' ' CD2' ' A' ' 29' ' ' PHE . 5.8 ptm -161.02 47.61 0.21 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.574 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.53 -49.22 1.33 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.58 -3.53 49.96 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.714 -1.231 . . . . 0.0 111.241 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.46 -81.18 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.371 -1.664 . . . . 0.0 108.384 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -88.87 -26.24 21.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.947 -1.095 . . . . 0.0 109.49 178.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.59 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -57.31 -42.29 93.49 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -46.66 80.45 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.324 -1.104 . . . . 0.0 108.496 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.432 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 1.3 m-20 -66.3 -28.24 68.54 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.651 ' CD2' ' CE1' ' A' ' 60' ' ' HIS . 6.4 tt -61.03 -45.33 95.24 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 60' ' ' HIS . 1.5 m -59.68 -44.5 93.6 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.52 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 8.7 tm0? -50.98 -27.36 7.53 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.555 ' O ' HG21 ' A' ' 78' ' ' VAL . . . -81.17 -32.29 33.67 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.207 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' ALA . 4.4 t-105 -50.01 -29.14 8.08 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.488 ' HB2' HG11 ' A' ' 131' ' ' VAL . . . -85.24 -38.96 18.31 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.639 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.607 ' CG2' ' CZ ' ' A' ' 112' ' ' PHE . 3.3 m -63.71 -30.71 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 120.745 -1.222 . . . . 0.0 109.011 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.491 ' N ' HG21 ' A' ' 78' ' ' VAL . . . -81.77 -53.65 6.02 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.475 ' HG2' ' HG ' ' A' ' 134' ' ' LEU . 4.9 tpt -49.23 -29.32 5.55 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 125' ' ' ALA . . . -60.78 -45.05 95.87 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.483 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 3.3 mt -110.87 16.0 21.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.47 -0.769 . . . . 0.0 110.055 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.75 30.23 6.58 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.483 ' CG1' ' HB2' ' A' ' 82' ' ' LEU . 36.0 m -89.39 -5.32 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -1.178 . . . . 0.0 110.551 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -42.85 -61.24 1.32 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.107 -0.996 . . . . 0.0 109.607 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -43.2 -33.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 115' ' ' ALA . 4.4 mtpt -83.29 -50.7 8.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.298 -0.876 . . . . 0.0 111.214 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.1 m -82.4 -5.83 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.711 -1.243 . . . . 0.0 110.681 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.621 ' CG2' ' CZ ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -77.92 -45.51 23.84 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.302 178.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.473 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 2.1 t -51.8 -52.84 57.25 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.75 -1.219 . . . . 0.0 110.406 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 90' ' ' VAL . 25.5 Cg_endo -73.28 -17.36 24.31 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 N-CA-C 109.645 -0.944 . . . . 0.0 109.645 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.541 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 13.6 mt -86.48 -44.92 11.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.621 ' CZ ' ' CG2' ' A' ' 89' ' ' THR . 7.1 m-30 -61.51 -47.65 84.64 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.916 -1.115 . . . . 0.0 108.772 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 90' ' ' VAL . 13.0 pt-20 -71.7 -16.7 62.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.111 -0.993 . . . . 0.0 109.641 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.434 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -79.05 -32.32 40.07 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.598 HG13 ' CG ' ' A' ' 29' ' ' PHE . 1.7 t -106.79 0.54 10.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.997 -1.296 . . . . 0.0 110.026 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.472 ' OE1' ' HB3' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -106.93 6.17 28.98 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 120.769 -1.207 . . . . 0.0 110.679 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.556 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER 177.28 76.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.734 -1.229 . . . . 0.0 109.074 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.556 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 161.41 -48.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.3 OUTLIER 71.74 18.6 5.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.346 -0.846 . . . . 0.0 110.48 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.439 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 2.8 t -80.07 -4.47 52.9 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.532 ' CB ' HG23 ' A' ' 96' ' ' VAL . 4.6 mm -97.91 81.78 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.809 -0.557 . . . . 0.0 109.609 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -142.31 32.66 1.51 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.933 -1.105 . . . . 0.0 109.601 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 107' ' ' ASP . 4.0 p -158.38 134.87 9.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.068 -1.02 . . . . 0.0 109.749 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.529 ' HA ' ' CD1' ' A' ' 108' ' ' ILE . . . -49.95 -39.83 41.84 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.46 ' OG ' ' OG ' ' A' ' 104' ' ' SER . 97.5 p -56.38 -31.73 64.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -71.63 -51.02 25.36 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.58 ' CD1' HD21 ' A' ' 68' ' ' LEU . 22.5 mt -45.5 -29.92 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 0.0 108.984 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -78.61 -37.84 41.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.177 -0.952 . . . . 0.0 109.553 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -58.92 -46.14 88.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.541 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 13.2 t -68.94 -38.81 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.607 ' CZ ' ' CG2' ' A' ' 78' ' ' VAL . 0.4 OUTLIER -61.19 -42.35 98.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.568 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mt -69.81 -25.5 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.165 -0.959 . . . . 0.0 109.669 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -64.07 -16.73 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.678 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.447 ' O ' ' HE2' ' A' ' 87' ' ' LYS . . . -96.04 11.89 32.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 109.649 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.65 -5.26 85.24 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.519 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -80.69 56.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -1.106 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 117' ' ' ILE . 59.8 mttt -37.68 153.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.789 . . . . 0.0 110.153 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -47.9 -27.12 4.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -58.59 -46.98 85.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.878 -1.366 . . . . 0.0 109.473 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -77.96 -50.94 11.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.849 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.575 ' C ' ' CD1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -62.61 -58.27 8.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.978 . . . . 0.0 108.954 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 62.8 t0 -50.09 -48.93 52.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.038 -1.039 . . . . 0.0 109.292 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.32 81.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.304 -0.872 . . . . 0.0 109.43 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.54 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -56.41 -49.5 74.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.293 -0.88 . . . . 0.0 108.951 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.55 ' HA ' ' CG1' ' A' ' 131' ' ' VAL . 6.0 t90 -54.85 -56.46 19.25 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -15.13 62.02 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.595 -0.69 . . . . 0.0 110.016 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 125' ' ' ALA . 16.8 p -71.56 179.72 2.91 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.013 -1.054 . . . . 0.0 110.095 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -90.42 -33.63 15.94 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.83 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.5 t -64.34 -36.96 78.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 C-N-CA 118.124 -1.43 . . . . 0.0 109.878 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 126' ' ' TRP . 16.5 t -64.16 -38.73 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.878 -1.139 . . . . 0.0 108.941 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -66.6 -34.54 78.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 108.992 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.34 -33.15 75.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.278 -0.889 . . . . 0.0 109.399 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.475 ' HG ' ' HG2' ' A' ' 80' ' ' MET . 1.8 mm? -79.54 -26.55 41.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 108.846 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.457 HG21 ' HB1' ' A' ' 77' ' ' ALA . 6.0 t -79.11 -39.02 20.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.53 -49.15 61.75 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.443 -0.786 . . . . 0.0 109.184 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.467 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -61.73 -35.35 77.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.204 -0.935 . . . . 0.0 109.159 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.606 ' CG ' ' CD1' ' A' ' 59' ' ' TYR . 18.0 tm0? -62.78 -62.38 1.77 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.224 -0.922 . . . . 0.0 109.195 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -46.77 -35.61 6.38 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -30.86 67.38 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.554 ' CB ' ' CD2' ' A' ' 59' ' ' TYR . . . -60.74 -47.74 84.95 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.354 -0.841 . . . . 0.0 108.915 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -73.07 -39.83 65.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.411 -0.805 . . . . 0.0 110.236 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.62 -16.9 59.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.973 -1.079 . . . . 0.0 109.824 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.447 ' HB3' HG23 ' A' ' 16' ' ' VAL . 9.1 m-20 -82.06 -44.95 15.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.057 -1.027 . . . . 0.0 108.592 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.544 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 17.6 m -100.08 -8.36 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.346 -0.846 . . . . 0.0 108.927 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.544 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 12.2 tp60 80.95 -42.15 0.18 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.461 -0.774 . . . . 0.0 110.113 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.502 ' CD2' ' CD1' ' A' ' 25' ' ' PHE . 20.1 tp 62.11 140.19 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.288 -0.882 . . . . 0.0 108.981 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.54 31.26 0.23 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.613 -1.304 . . . . 0.0 110.106 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 152' ' ' ALA . . . 157.22 98.8 0.15 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.523 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.553 HG12 ' CD2' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -92.51 138.37 23.99 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.457 ' HG3' ' HB3' ' A' ' 32' ' ' HIS . 31.6 Cg_endo -71.75 155.83 97.63 Favored 'Cis proline' 0 C--N 1.316 -1.163 0 C-N-CA 124.157 -1.185 . . . . 0.0 111.753 2.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -146.91 151.09 36.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.805 -1.185 . . . . 0.0 108.525 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.501 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -128.49 118.31 22.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.901 -1.124 . . . . 0.0 110.022 -179.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.565 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 57.8 m-85 -114.42 142.39 46.42 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 159' ' ' TYR . 30.6 t -124.08 124.62 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.989 -1.07 . . . . 0.0 108.947 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.444 ' C ' ' HB2' ' A' ' 19' ' ' ALA . 1.3 m-80 56.14 22.89 6.41 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.187 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.501 ' N ' ' HB2' ' A' ' 19' ' ' ALA . . . 52.96 22.76 13.26 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.705 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.505 ' O ' ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -134.58 -11.35 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.752 -1.44 . . . . 0.0 109.738 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 155' ' ' VAL . 99.5 m-85 -144.22 124.46 13.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.021 -1.05 . . . . 0.0 108.749 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.565 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 2.3 pt20 -133.31 129.39 37.48 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.965 -1.084 . . . . 0.0 110.157 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.565 HD13 ' CE1' ' A' ' 178' ' ' TYR . 17.1 mt -61.27 168.58 2.56 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.67 150.68 44.23 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.084 -1.01 . . . . 0.0 109.786 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 C--N 1.31 -1.448 0 C-N-CA 122.683 2.255 . . . . 0.0 110.546 179.782 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 2.0 mtp . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.965 0.888 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.48 -65.05 0.94 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.428 HG12 ' HG2' ' A' ' 177' ' ' GLN . 20.1 t -70.15 -23.48 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.294 -0.879 . . . . 0.0 109.058 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -68.53 -39.87 80.98 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -0.909 . . . . 0.0 109.241 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.3 t -76.44 -32.3 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -74.97 -52.34 11.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 109.445 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.428 ' HG2' HG12 ' A' ' 173' ' ' VAL . 40.6 mm-40 -58.62 -40.44 83.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.437 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.565 ' CE1' HD13 ' A' ' 161' ' ' LEU . 10.0 t80 -61.13 -50.82 71.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.132 -0.98 . . . . 0.0 109.231 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.496 ' O ' ' NZ ' ' A' ' 183' ' ' LYS . . . -64.12 -24.37 67.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.988 -1.07 . . . . 0.0 108.839 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -77.43 -40.92 41.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 0.0 108.986 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.525 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -58.61 -54.83 42.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 109.056 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.414 ' HA ' ' HG ' ' A' ' 185' ' ' LEU . 93.3 t -61.06 -36.85 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 109.607 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.496 ' NZ ' ' O ' ' A' ' 179' ' ' ALA . 0.0 OUTLIER -53.55 -44.47 69.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 109.217 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -84.42 -25.47 28.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.358 -0.839 . . . . 0.0 110.07 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 181' ' ' THR . 1.1 mt -62.17 -23.45 66.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.446 -1.409 . . . . 0.0 108.435 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.8 t -75.57 -4.39 39.7 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.991 -1.068 . . . . 0.0 108.365 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.828 . . . . 0.0 109.452 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 5' ' ' ASP . 5.6 pm0 -133.18 64.65 1.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.163 -0.96 . . . . 0.0 109.976 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 4' ' ' GLU . 19.6 t70 71.16 93.5 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.518 -0.738 . . . . 0.0 110.759 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.57 3.79 90.38 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.586 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -101.91 28.41 5.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.962 -1.316 . . . . 0.0 108.937 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.586 ' CB ' ' O ' ' A' ' 7' ' ' LYS . 2.9 mm-40 144.54 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.582 ' CG ' ' O ' ' A' ' 9' ' ' TYR . 2.2 p90 -141.89 114.21 8.25 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.054 0.93 . . . . 0.0 109.015 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.506 HG21 ' CG ' ' A' ' 160' ' ' GLN . 15.2 t -100.32 -179.19 4.04 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.2 m -111.6 143.72 42.02 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.899 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.447 HD23 ' HB3' ' A' ' 160' ' ' GLN . 0.2 OUTLIER -96.16 163.95 12.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.376 -0.828 . . . . 0.0 109.549 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.439 ' HG2' ' HG2' ' A' ' 14' ' ' LYS . 1.6 pt-20 -87.52 -15.83 36.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.691 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.439 ' HG2' ' HG2' ' A' ' 13' ' ' GLU . 3.3 mmtp -112.56 97.51 40.75 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.148 -0.97 . . . . 0.0 109.849 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.419 ' O ' HG21 ' A' ' 16' ' ' VAL . 34.9 Cg_endo -77.23 158.92 33.48 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.467 2.111 . . . . 0.0 109.863 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.492 HG13 ' CB ' ' A' ' 19' ' ' ALA . 15.8 t -140.52 83.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.099 -1.001 . . . . 0.0 109.761 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.12 129.7 18.1 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.63 -19.73 52.95 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.516 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -41.9 164.61 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.41 -1.053 . . . . 0.0 109.556 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.559 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 34.7 Cg_endo -76.43 126.82 9.31 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.573 2.182 . . . . 0.0 110.955 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 4.3 mt-30 -40.01 -24.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.558 -0.714 . . . . 0.0 110.421 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 20' ' ' PRO . 59.1 t -149.09 79.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.764 -1.21 . . . . 0.0 109.044 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.566 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -73.98 112.79 10.45 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.546 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -94.23 149.19 21.47 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.778 -178.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.58 ' CD1' HD21 ' A' ' 147' ' ' LEU . 7.6 m-85 -135.13 103.46 5.55 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.483 -0.76 . . . . 0.0 109.267 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.451 ' HA ' HG13 ' A' ' 150' ' ' VAL . 5.7 p90 -148.42 140.64 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 109.891 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.584 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -118.16 179.45 4.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.09 179.345 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 7.1 m-30 -90.33 40.44 1.01 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.593 ' CG ' HG12 ' A' ' 96' ' ' VAL . 11.0 m-85 -137.91 16.82 2.85 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -113.8 164.81 14.96 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.544 -1.348 . . . . 0.0 109.878 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.74 -41.08 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.463 2.109 . . . . 0.0 108.092 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.588 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 9.6 m170 -75.34 -23.53 57.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 12.3 t -43.94 -57.71 3.17 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.438 ' HB2' ' CD ' ' A' ' 97' ' ' GLN . 89.4 t80 -71.48 -55.06 8.6 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.182 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.439 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 12.5 mt-30 -54.88 -16.96 3.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.228 -0.92 . . . . 0.0 110.527 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.588 ' CE1' ' HB3' ' A' ' 32' ' ' HIS . 4.0 m-30 -86.4 -38.96 16.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.08 -1.013 . . . . 0.0 110.831 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.02 -13.1 20.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.782 -1.199 . . . . 0.0 112.206 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -136.27 28.51 3.09 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.17 -1.581 . . . . 0.0 111.418 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 35' ' ' GLN . 91.1 t -151.56 -88.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.394 -1.441 . . . . 0.0 110.138 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 1.4 mt -68.99 -19.49 64.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.95 . . . . 0.0 109.747 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 2.4 m-70 60.06 18.85 8.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.005 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 40' ' ' LEU . 1.4 mt -46.98 -36.42 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.479 -0.763 . . . . 0.0 109.44 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.474 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -80.48 -34.34 35.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.991 . . . . 0.0 110.115 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.463 ' HA ' ' HG3' ' A' ' 47' ' ' LYS . 15.5 m-20 -82.7 -36.87 25.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.099 -1.001 . . . . 0.0 109.625 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -58.31 -34.21 70.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.84 . . . . 0.0 110.184 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.497 HG22 ' CE ' ' A' ' 56' ' ' MET . 31.5 m -65.92 -31.98 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.033 -1.042 . . . . 0.0 110.021 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.492 ' N ' HG21 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -54.51 -44.89 73.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.976 -1.078 . . . . 0.0 109.461 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -44.28 -28.34 0.52 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.119 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.451 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 10.1 mtmm -112.7 44.5 1.47 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.842 . . . . 0.0 109.24 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.54 ' CD2' ' CG1' ' A' ' 54' ' ' VAL . 11.0 mt -115.87 79.35 7.9 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.165 -0.96 . . . . 0.0 109.945 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HD2' HG22 ' A' ' 54' ' ' VAL . 35.3 Cg_endo -78.33 143.26 19.55 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.615 2.21 . . . . 0.0 110.119 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -39.45 120.77 1.1 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.312 1.054 . . . . 0.0 109.908 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.78 -26.74 5.06 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.54 ' CG1' ' CD2' ' A' ' 50' ' ' LEU . 98.1 t -89.71 85.37 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -1.192 . . . . 0.0 109.296 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.96 93.25 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.779 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.497 ' CE ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -92.73 101.44 13.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.833 . . . . 0.0 109.437 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 4.9 m -111.45 134.09 53.27 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.11 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.546 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -114.13 109.2 18.05 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.48 ' OH ' ' HB3' ' A' ' 137' ' ' GLN . 4.5 m-85 -106.55 177.85 4.73 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.954 -1.092 . . . . 0.0 111.623 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.584 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 49.4 t-80 -111.85 132.62 54.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.735 0.779 . . . . 0.0 108.977 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.555 ' CG1' ' CG1' ' A' ' 150' ' ' VAL . 3.0 m -72.36 156.68 6.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.416 0.627 . . . . 0.0 110.598 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.481 ' ND2' ' HE3' ' A' ' 70' ' ' LYS . 14.0 t30 -118.56 51.19 1.11 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.628 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -155.86 61.17 0.59 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.731 -1.23 . . . . 0.0 110.106 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.509 ' HE2' ' CG2' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -144.92 43.37 1.34 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.958 -1.089 . . . . 0.0 109.488 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.47 -36.17 0.55 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.94 -43.07 3.13 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -88.7 -79.0 0.32 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.169 . . . . 0.0 110.109 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.588 ' CD1' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -78.0 -21.87 50.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.092 -1.005 . . . . 0.0 109.205 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.588 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -53.51 -42.83 66.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HE3' ' ND2' ' A' ' 62' ' ' ASN . 2.1 tttt -68.78 -54.76 14.03 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.16 -1.2 . . . . 0.0 108.362 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.549 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 8.2 t70 -56.12 -25.18 44.89 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.548 ' CD2' ' NE2' ' A' ' 60' ' ' HIS . 44.4 tp -65.4 -39.68 92.5 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 m -59.48 -41.94 90.93 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.467 ' OE1' ' OH ' ' A' ' 122' ' ' TYR . 0.4 OUTLIER -60.13 -22.63 63.07 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -66.23 -40.06 90.01 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 46.7 t-105 -64.4 -31.58 72.84 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.41 ' HB2' HG21 ' A' ' 135' ' ' VAL . . . -84.39 -68.14 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.725 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.555 ' CG1' ' CD1' ' A' ' 122' ' ' TYR . 95.7 t -43.98 -26.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 109.761 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.489 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -82.93 -58.62 2.79 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.085 -1.009 . . . . 0.0 108.717 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.28 -27.38 2.46 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.84 -43.15 69.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.483 -0.761 . . . . 0.0 109.447 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.468 ' HB2' HG11 ' A' ' 84' ' ' VAL . 23.0 mt -107.12 14.59 26.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 48.39 24.84 3.98 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.521 ' CG1' HD13 ' A' ' 117' ' ' ILE . 35.2 m -83.67 -9.92 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.408 -1.054 . . . . 0.0 110.397 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.469 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.3 OUTLIER -42.73 -63.4 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.137 -0.977 . . . . 0.0 109.37 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.96 -34.68 1.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.458 -0.776 . . . . 0.0 110.601 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -79.72 -53.18 7.06 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.186 -0.947 . . . . 0.0 111.741 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.566 HG23 ' CE1' ' A' ' 112' ' ' PHE . 2.9 m -84.7 -8.42 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.717 -1.239 . . . . 0.0 110.705 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.613 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -72.88 -44.5 61.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.593 -1.317 . . . . 0.0 108.596 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -53.64 -54.13 49.48 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.467 -1.396 . . . . 0.0 110.817 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HD2' ' C ' ' A' ' 88' ' ' VAL . 25.0 Cg_endo -72.99 -18.65 23.96 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 N-CA-C 109.82 -0.877 . . . . 0.0 109.82 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.503 ' CG ' ' O ' ' A' ' 88' ' ' VAL . 28.8 mt -87.22 -42.63 12.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.043 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.613 ' CG ' HG21 ' A' ' 89' ' ' THR . 5.2 m-30 -63.78 -46.68 84.11 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.003 -1.06 . . . . 0.0 108.856 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -23.05 61.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.209 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.49 -33.39 61.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.593 HG12 ' CG ' ' A' ' 29' ' ' PHE . 2.3 t -102.32 -1.74 9.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.095 -1.238 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -110.37 8.71 23.42 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 120.956 -1.09 . . . . 0.0 110.543 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.56 ' O ' ' CG2' ' A' ' 99' ' ' THR . 2.4 mttp -179.91 64.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.634 -1.291 . . . . 0.0 109.277 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.56 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 169.0 -50.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 99' ' ' THR . 8.1 mp0 73.96 16.55 3.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.423 -0.798 . . . . 0.0 110.743 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 t -79.74 -9.05 59.6 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.517 ' CB ' HG23 ' A' ' 96' ' ' VAL . 9.0 mm -85.49 78.69 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.78 32.54 2.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.151 -0.968 . . . . 0.0 109.833 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 107' ' ' ASP . 24.1 p -157.96 132.0 8.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.994 -1.066 . . . . 0.0 110.208 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.2 -29.54 14.4 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -30.74 71.79 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.5 OUTLIER -70.61 -48.86 53.01 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.572 ' CD1' HD21 ' A' ' 68' ' ' LEU . 18.9 mt -53.53 -27.06 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -75.93 -39.79 55.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.808 . . . . 0.0 109.817 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.467 ' OD2' ' O ' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -62.49 -41.55 98.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.086 -1.009 . . . . 0.0 109.53 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.475 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 1.5 t -72.15 -39.35 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.108 -0.995 . . . . 0.0 109.352 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.566 ' CE1' HG23 ' A' ' 88' ' ' VAL . 2.7 m-30 -63.93 -48.41 76.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.863 . . . . 0.0 110.031 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.1 mt -66.68 -25.41 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.986 . . . . 0.0 109.64 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -67.8 -17.54 64.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 0.0 109.816 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.464 ' HB3' HG11 ' A' ' 88' ' ' VAL . . . -90.52 7.03 41.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.637 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.53 2.6 82.12 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.521 HD13 ' CG1' ' A' ' 84' ' ' VAL . 3.0 mm -79.14 59.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.313 -1.11 . . . . 0.0 109.692 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 117' ' ' ILE . 5.3 mmtt -34.86 132.02 0.35 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.323 -0.861 . . . . 0.0 110.319 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 118' ' ' LYS . . . -40.76 -33.79 0.67 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -59.23 -43.14 92.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -1.18 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 118' ' ' LYS . 20.9 mt-10 -75.29 -43.64 50.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.615 ' C ' ' CD1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -67.65 -61.97 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.213 -0.929 . . . . 0.0 108.976 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 122' ' ' TYR . 11.4 t0 -47.19 -42.71 20.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.0 108.731 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.72 -45.93 80.84 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.333 -0.854 . . . . 0.0 109.017 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -54.21 -49.05 70.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.435 -0.79 . . . . 0.0 109.146 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.502 ' CD1' ' C ' ' A' ' 126' ' ' TRP . 7.2 t90 -59.81 -54.53 45.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 0.0 108.496 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.07 -15.31 3.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.588 -0.695 . . . . 0.0 110.15 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 32.6 m -70.3 178.04 3.05 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.988 -1.07 . . . . 0.0 110.431 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 -37.67 13.23 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.362 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.65 -46.84 79.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.248 -1.381 . . . . 0.0 109.678 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 5.2 t -63.77 -32.63 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.872 -1.143 . . . . 0.0 108.519 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -71.56 -36.4 70.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 108.84 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -36.49 83.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.388 -0.82 . . . . 0.0 109.156 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.15 -24.72 40.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -0.891 . . . . 0.0 108.661 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 131' ' ' VAL . 17.6 t -73.97 -41.93 52.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.55 -52.87 55.44 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.48 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -54.8 -27.3 40.73 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.043 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.432 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -67.83 -65.3 0.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 2.9 tt0 -51.79 -37.28 50.91 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 144' ' ' ASP . 1.3 mtmt -64.39 -30.77 71.8 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.463 ' O ' ' OD2' ' A' ' 144' ' ' ASP . . . -66.01 -60.29 2.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.453 -0.78 . . . . 0.0 109.052 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.554 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -71.78 -23.11 61.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.898 . . . . 0.0 109.823 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -83.35 -26.5 30.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.038 -1.039 . . . . 0.0 110.325 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.522 ' OD1' ' CG1' ' A' ' 145' ' ' VAL . 1.3 p30 -81.56 -44.03 17.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.901 -1.124 . . . . 0.0 108.595 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.538 ' CG2' ' CE2' ' A' ' 25' ' ' PHE . 16.0 m -96.39 -10.68 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.879 . . . . 0.0 108.731 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.554 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.0 tt0 78.18 -49.48 0.48 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.447 -0.783 . . . . 0.0 110.26 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.58 HD21 ' CD1' ' A' ' 25' ' ' PHE . 16.2 tp 65.2 133.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 0.0 109.4 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -160.89 40.44 0.16 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.579 -1.326 . . . . 0.0 109.879 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.67 107.43 0.21 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.464 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.555 ' CG1' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.0 144.71 29.62 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.353 -1.086 . . . . 0.0 109.442 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.04 152.4 91.8 Favored 'Cis proline' 0 C--N 1.316 -1.138 0 C-N-CA 124.041 -1.233 . . . . 0.0 110.466 0.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . . . -128.75 156.03 44.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.393 -1.442 . . . . 0.0 109.364 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -150.87 133.76 15.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 109.682 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.521 ' N ' ' CD1' ' A' ' 154' ' ' PHE . 4.3 m-85 -132.41 125.65 31.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.373 -0.829 . . . . 0.0 109.913 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 73.5 t -96.94 132.12 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.926 . . . . 0.0 110.153 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 47.75 20.88 0.23 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.913 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.516 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 57.87 55.09 32.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -164.45 -39.96 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.205 -1.174 . . . . 0.0 108.121 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -110.86 124.09 51.38 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.749 -0.78 . . . . 0.0 108.948 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.516 ' HA ' ' O ' ' A' ' 153' ' ' MET . 15.4 pt20 -120.79 127.29 51.82 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.966 -1.084 . . . . 0.0 109.912 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 153' ' ' MET . 19.7 mt -64.5 174.12 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -156.09 76.62 4.63 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 109.716 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 C--N 1.308 -1.556 0 C-N-CA 122.752 2.301 . . . . 0.0 110.711 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.8 mtp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.824 0.821 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -55.09 8.55 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.681 -0.637 . . . . 0.0 109.657 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 177' ' ' GLN . 14.1 t -70.35 -28.59 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.121 -0.987 . . . . 0.0 109.533 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.453 ' CD1' ' O ' ' A' ' 174' ' ' PHE . 2.5 t80 -67.46 -46.04 74.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.032 -1.043 . . . . 0.0 109.437 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.466 ' O ' HG11 ' A' ' 175' ' ' VAL . 82.6 t -74.74 -24.27 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 1.4 mt-30 -81.81 -52.74 6.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.511 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.518 ' HB3' ' NE2' ' A' ' 8' ' ' GLN . 41.4 mt-30 -63.85 -32.3 73.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.192 -0.943 . . . . 0.0 109.569 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.481 ' O ' ' OG1' ' A' ' 181' ' ' THR . 17.8 t80 -74.11 -58.38 3.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.004 . . . . 0.0 109.429 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.35 -33.06 67.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.946 -1.096 . . . . 0.0 108.44 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 33.2 t0 -71.31 -42.61 68.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.493 -0.754 . . . . 0.0 109.342 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.527 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 0.6 OUTLIER -55.09 -57.07 13.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.093 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.454 HG12 ' CE ' ' A' ' 153' ' ' MET . 2.3 t -57.12 -35.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.823 -1.173 . . . . 0.0 109.71 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -48.33 82.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.967 . . . . 0.0 109.903 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.26 -21.2 39.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.96 -1.088 . . . . 0.0 110.337 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 181' ' ' THR . 68.6 mt -73.66 -18.54 61.01 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.744 -1.222 . . . . 0.0 109.002 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.5 m -74.14 -4.47 35.92 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.526 -0.733 . . . . 0.0 109.805 -179.69 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 5' ' ' ASP . 12.5 mt-10 -114.07 56.96 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.127 -0.983 . . . . 0.0 110.42 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER 42.61 82.19 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.511 -0.743 . . . . 0.0 110.359 179.063 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.81 -24.63 6.02 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.723 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -82.15 -68.31 0.71 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.0 -1.294 . . . . 0.0 109.178 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.607 ' NE2' ' CD1' ' A' ' 9' ' ' TYR . 2.1 pp0? -95.23 -1.92 50.64 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.607 ' CD1' ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER 179.64 130.45 0.09 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.873 -1.142 . . . . 0.0 109.721 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.2 t -112.87 179.95 3.82 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 158' ' ' LYS . 59.2 m -127.87 143.82 51.1 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.456 0.645 . . . . 0.0 109.581 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.456 HD21 ' HG2' ' A' ' 160' ' ' GLN . 0.2 OUTLIER -100.69 156.17 17.48 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.399 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -93.63 0.54 56.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.492 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -124.88 89.41 52.58 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.283 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.03 166.55 26.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.608 2.206 . . . . 0.0 110.111 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.578 ' CG1' ' CB ' ' A' ' 19' ' ' ALA . 7.2 p -120.78 109.22 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -0.975 . . . . 0.0 110.264 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.38 125.24 4.54 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.491 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 91.53 -10.63 74.28 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.578 ' CB ' ' CG1' ' A' ' 16' ' ' VAL . . . -33.87 148.11 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.787 -0.831 . . . . 0.0 109.906 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.561 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.4 Cg_endo -81.21 133.72 8.84 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.472 2.115 . . . . 0.0 111.383 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.518 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 1.5 mm-40 -51.11 -21.81 2.13 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 56' ' ' MET . 24.1 t -151.12 89.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 108.975 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.641 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -80.43 128.74 33.92 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.53 ' N ' HD21 ' A' ' 23' ' ' LEU . 8.7 tt0 -113.48 96.59 5.96 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.92 -1.113 . . . . 0.0 109.729 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.641 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 4.4 m-85 -84.76 115.71 22.85 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.448 -0.782 . . . . 0.0 109.458 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.538 ' CE1' ' OE1' ' A' ' 37' ' ' GLU . 2.6 p90 -160.35 142.01 12.54 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.268 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.572 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 94.0 p -125.64 -172.72 2.66 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.624 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -109.3 49.3 0.83 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.675 -1.266 . . . . 0.0 108.472 178.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 72' ' ' LEU . 7.1 m-85 -133.78 -3.92 2.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.592 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 4.5 m -109.41 173.23 3.06 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.203 . . . . 0.0 108.586 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.592 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.3 Cg_endo -76.19 -58.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.752 1.635 . . . . 0.0 109.316 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.498 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 69.5 m-70 -63.37 -20.09 65.22 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -52.58 -53.89 40.33 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.582 0.706 . . . . 0.0 109.286 179.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 8.8 t80 -80.49 -37.46 31.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.575 -0.703 . . . . 0.0 109.884 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.458 ' HA ' HG22 ' A' ' 39' ' ' VAL . 35.6 mm-40 -66.09 -26.07 67.31 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.184 -0.948 . . . . 0.0 109.954 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -70.66 -39.52 73.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.054 -1.029 . . . . 0.0 109.578 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.538 ' OE1' ' CE1' ' A' ' 26' ' ' PHE . 1.2 mt-10 -98.15 -10.06 24.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 0.0 111.898 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -138.3 27.69 2.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.266 -1.521 . . . . 0.0 111.819 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.508 ' O ' ' CD2' ' A' ' 41' ' ' HIS . 64.9 t -151.45 -83.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.432 -1.418 . . . . 0.0 110.026 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 171' ' ' MET . 18.0 mt -65.14 -14.33 60.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.868 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 23.1 m-70 56.57 18.37 3.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.187 -0.946 . . . . 0.0 109.146 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.9 mt -55.39 -18.59 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.5 m -82.63 -54.38 5.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.023 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -86.77 -33.0 20.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.72 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 41' ' ' HIS . 10.4 t-20 -51.68 -27.23 11.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.838 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 31.4 t -81.21 -17.2 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.302 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.532 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 1.7 mttm -76.11 -17.93 59.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.813 -1.179 . . . . 0.0 110.074 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -64.46 -16.24 62.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 109.615 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -143.59 36.23 1.31 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.532 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 5.2 mt -91.94 142.9 26.95 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.954 -1.091 . . . . 0.0 109.595 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HD2' HD22 ' A' ' 50' ' ' LEU . 35.8 Cg_endo -78.03 149.88 25.99 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.689 2.259 . . . . 0.0 110.051 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -79.09 21.38 0.45 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.93 -1.106 . . . . 0.0 110.469 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 54' ' ' VAL . . . -124.46 32.74 4.01 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.475 HG23 ' CB ' ' A' ' 186' ' ' SER . 44.6 t -154.32 131.85 2.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.645 -0.915 . . . . 0.0 108.702 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.5 137.61 51.89 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.178 0.989 . . . . 0.0 109.961 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.5 ' O ' ' CG ' ' A' ' 56' ' ' MET . 3.3 ptm -107.04 98.96 8.55 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.39 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 24' ' ' GLU . 86.7 m -82.24 142.86 31.77 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.742 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -116.1 111.13 19.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.365 -0.834 . . . . 0.0 110.028 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.571 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 1.7 m-85 -113.44 158.24 20.92 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.173 -0.954 . . . . 0.0 110.864 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.638 ' CE1' ' CD2' ' A' ' 72' ' ' LEU . 17.9 t60 -99.94 124.69 45.53 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.553 HG22 ' CD1' ' A' ' 63' ' ' PHE . 1.3 m -69.85 144.95 13.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.598 -0.689 . . . . 0.0 110.166 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.526 ' HB2' ' CE ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -113.57 49.23 0.99 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.652 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 2.9 p90 -145.37 80.12 1.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.17 0.986 . . . . 0.0 110.048 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.566 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -159.91 -59.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.872 -1.143 . . . . 0.0 109.735 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.566 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -87.98 -28.07 24.38 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 70' ' ' LYS . . . 86.3 -49.17 4.04 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.19 -78.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.562 -0.964 . . . . 0.0 110.008 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.596 ' CD1' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -73.79 -22.62 59.76 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.855 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.596 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -55.53 -43.32 85.63 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 107.434 -2.266 . . . . 0.0 107.434 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.526 ' CE ' ' HB2' ' A' ' 62' ' ' ASN . 8.6 mmmt -63.71 -47.8 79.68 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.517 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 13.3 t0 -64.04 -28.38 69.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.638 ' CD2' ' CE1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -58.16 -38.5 76.74 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 62' ' ' ASN . 6.7 m -66.24 -42.85 88.05 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.536 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 1.0 OUTLIER -60.99 -18.58 58.29 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 177.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -68.37 -47.49 67.28 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -58.99 -27.73 65.69 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.483 ' CB ' ' CG2' ' A' ' 135' ' ' VAL . . . -79.37 -52.46 8.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.432 -0.792 . . . . 0.0 109.967 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.551 HG22 ' CE1' ' A' ' 122' ' ' TYR . 39.2 t -60.77 -26.53 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.044 -1.035 . . . . 0.0 109.875 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.524 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -80.23 -63.43 1.41 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.038 -1.039 . . . . 0.0 109.003 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -45.9 -27.94 1.0 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.43 ' HB3' HG21 ' A' ' 131' ' ' VAL . . . -70.35 -46.15 64.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.437 -0.79 . . . . 0.0 109.463 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.448 ' HB2' HG23 ' A' ' 84' ' ' VAL . 21.6 mt -102.05 12.07 37.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.15 -0.969 . . . . 0.0 110.214 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 53.56 20.55 11.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 34.9 m -86.47 -7.93 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.431 -1.041 . . . . 0.0 110.669 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -40.82 -59.47 1.41 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.087 -1.008 . . . . 0.0 109.986 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.4 -34.19 10.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.449 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 mttt -82.74 -52.88 6.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.199 -0.938 . . . . 0.0 111.471 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -75.15 -6.81 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.633 -1.292 . . . . 0.0 110.505 -178.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.607 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -77.04 -44.77 29.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.948 -1.095 . . . . 0.0 108.513 178.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.44 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -52.32 -52.38 63.49 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.543 -1.348 . . . . 0.0 110.565 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.482 ' HG2' HG11 ' A' ' 111' ' ' VAL . 26.0 Cg_endo -73.68 -20.93 19.67 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 O-C-N 122.727 0.856 . . . . 0.0 110.022 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.521 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 13.1 mt -85.61 -41.9 14.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 108.967 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.624 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 5.6 m-30 -65.95 -45.71 80.81 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.071 -1.018 . . . . 0.0 108.862 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 90' ' ' VAL . 23.5 mt-10 -76.3 -26.75 56.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 109.556 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.413 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -65.56 -36.93 93.11 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.466 HG21 HG13 ' A' ' 102' ' ' ILE . 2.9 t -93.07 -12.78 8.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.151 -1.205 . . . . 0.0 108.594 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 1.3 mt-30 -104.98 4.12 31.39 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 121.103 -0.998 . . . . 0.0 111.051 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.541 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -160.15 61.11 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.404 -1.435 . . . . 0.0 109.963 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.11 -49.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 74.27 15.2 3.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -0.989 . . . . 0.0 110.628 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -86.69 -4.29 59.16 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.732 0.777 . . . . 0.0 108.988 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.466 HG13 HG21 ' A' ' 96' ' ' VAL . 6.5 mm -80.57 77.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.75 35.13 1.79 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 110.074 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 107' ' ' ASP . 54.9 p -157.26 133.74 9.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.856 -1.152 . . . . 0.0 109.968 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.468 ' HA ' HD13 ' A' ' 108' ' ' ILE . . . -50.71 -35.7 32.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 75.7 m -59.19 -28.86 67.02 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -75.39 -50.78 14.84 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.557 ' CD1' HD21 ' A' ' 68' ' ' LEU . 21.9 mt -47.25 -31.34 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.086 -1.009 . . . . 0.0 109.421 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 106' ' ' SER . 1.3 ptm180 -78.99 -37.27 39.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.945 -1.097 . . . . 0.0 109.349 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -54.64 -46.06 73.88 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.153 -0.967 . . . . 0.0 108.929 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.522 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 70.4 t -69.95 -39.91 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -0.942 . . . . 0.0 109.227 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -59.6 -53.79 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.717 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.1 mt -60.21 -25.96 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.107 -0.996 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.47 -16.97 64.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.164 -0.96 . . . . 0.0 109.378 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.469 ' HB1' HD11 ' A' ' 117' ' ' ILE . . . -100.44 -7.14 24.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.544 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.76 -5.27 25.99 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.548 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 2.2 mp -78.42 52.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -1.158 . . . . 0.0 109.278 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 117' ' ' ILE . 38.3 mttp -36.2 157.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.318 -0.864 . . . . 0.0 110.555 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -59.82 -50.58 66.19 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 119' ' ' GLY . 21.1 tt0 -43.29 -55.19 4.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.03 -1.276 . . . . 0.0 109.929 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -63.98 -63.22 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.976 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.551 ' CE1' HG22 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -46.27 -60.94 2.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.135 -0.978 . . . . 0.0 109.239 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 122' ' ' TYR . 1.2 m-20 -44.54 -34.25 2.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.152 -0.968 . . . . 0.0 109.062 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.63 -44.36 43.13 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.353 -0.842 . . . . 0.0 109.23 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.523 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -59.02 -48.08 82.9 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.409 -0.807 . . . . 0.0 109.17 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.536 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 10.8 t90 -59.44 -53.23 60.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.404 -0.81 . . . . 0.0 108.957 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.94 -15.72 2.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.642 -0.661 . . . . 0.0 110.236 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.41 178.1 7.44 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.976 -1.078 . . . . 0.0 109.971 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.449 ' O ' ' OG ' ' A' ' 133' ' ' SER . 0.9 OUTLIER -91.45 -36.6 13.68 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.566 -179.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.6 t -64.27 -47.3 90.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.205 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 21.3 t -64.39 -39.84 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.109 -0.994 . . . . 0.0 108.481 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -29.1 67.42 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 129' ' ' PHE . 50.4 m -66.27 -34.39 77.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.842 . . . . 0.0 109.019 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -28.5 54.92 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.483 ' CG2' ' CB ' ' A' ' 77' ' ' ALA . 6.8 t -75.1 -36.34 37.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -67.66 -46.15 73.23 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.593 -0.692 . . . . 0.0 109.405 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.425 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -68.83 -23.64 64.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.428 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.571 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 4.7 mt-30 -72.49 -69.41 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.083 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.76 -35.05 21.02 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.427 ' O ' ' CG ' ' A' ' 144' ' ' ASP . 12.1 mtpt -75.94 -29.9 58.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.321 -0.862 . . . . 0.0 108.874 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 138' ' ' GLN . . . -57.34 -56.26 24.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.213 -0.93 . . . . 0.0 108.751 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -75.54 -32.89 60.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.925 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.21 -22.15 61.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 109.46 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 140' ' ' LYS . 73.7 m-20 -82.45 -47.36 12.34 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 11.3 m -88.55 -5.49 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 2.6 tp60 80.8 -50.36 0.31 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.587 -0.696 . . . . 0.0 109.543 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.466 HD12 ' CG ' ' A' ' 25' ' ' PHE . 13.1 tp 61.51 137.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.228 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -161.02 33.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.544 -1.347 . . . . 0.0 110.339 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 160.14 109.69 0.26 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 118.905 -1.617 . . . . 0.0 111.208 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.518 ' CG1' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -87.93 144.35 34.65 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.586 -0.949 . . . . 0.0 109.057 178.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.79 152.65 92.86 Favored 'Cis proline' 0 C--N 1.315 -1.222 0 C-N-CA 123.923 -1.282 . . . . 0.0 110.526 0.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.503 ' CB ' ' HB2' ' A' ' 25' ' ' PHE . . . -123.54 141.8 51.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.361 -1.462 . . . . 0.0 109.139 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 1.6 ttp -130.27 130.94 45.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.126 -0.984 . . . . 0.0 109.71 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.581 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 8.3 m-85 -133.73 131.44 39.41 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 12.2 t -105.32 125.57 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.753 -1.217 . . . . 0.0 108.618 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.451 ' C ' ' HB2' ' A' ' 19' ' ' ALA . 18.6 t-20 48.08 26.39 1.0 Allowed 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.901 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 52.17 25.27 17.76 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.208 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.451 ' O ' HG21 ' A' ' 11' ' ' THR . 10.0 tttm -124.9 -19.2 5.32 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.835 -1.391 . . . . 0.0 108.894 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -141.66 125.08 16.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 108.92 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.581 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -128.79 134.78 48.49 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.877 -1.139 . . . . 0.0 109.632 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.514 HD13 ' CZ ' ' A' ' 178' ' ' TYR . 12.8 mt -68.02 177.14 2.3 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.627 -0.671 . . . . 0.0 109.287 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.64 82.7 5.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.888 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 C--N 1.31 -1.469 0 C-N-CA 122.666 2.244 . . . . 0.0 110.311 179.696 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.524 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 3.8 mtm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.589 0.709 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.45 -50.82 14.62 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.696 -0.628 . . . . 0.0 109.341 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.5 t -74.69 -29.56 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' A' ' 178' ' ' TYR . 33.4 t80 -69.07 -36.2 77.36 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.947 -1.095 . . . . 0.0 108.614 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 171' ' ' MET . 24.3 t -74.34 -28.71 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.363 -0.836 . . . . 0.0 108.916 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -81.53 -58.39 3.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.053 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.72 -36.53 36.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.203 -0.936 . . . . 0.0 109.074 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.514 ' CZ ' HD13 ' A' ' 161' ' ' LEU . 18.9 t80 -69.44 -47.15 64.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.193 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.59 -22.42 66.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.15 -0.969 . . . . 0.0 108.978 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -79.09 -45.3 20.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 109.305 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.557 ' O ' ' CG ' ' A' ' 185' ' ' LEU . 6.5 m -63.11 -31.78 73.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -0.958 . . . . 0.0 109.317 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.491 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 52.0 t -77.39 -39.59 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.747 -1.22 . . . . 0.0 109.357 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -56.96 -52.23 66.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.5 -24.41 50.08 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.557 ' CG ' ' O ' ' A' ' 181' ' ' THR . 0.2 OUTLIER -64.31 -20.71 66.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.875 -1.141 . . . . 0.0 108.839 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.475 ' CB ' HG23 ' A' ' 54' ' ' VAL . 63.0 p -87.3 7.54 28.25 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.865 -1.147 . . . . 0.0 108.273 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.392 -0.818 . . . . 0.0 109.542 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.608 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 4.9 mt-10 -128.17 66.04 1.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 110.34 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.6 m-20 61.3 91.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 110.407 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.98 68.56 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.092 -1.051 . . . . 0.0 110.59 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.581 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 9.1 tttp -95.64 26.07 4.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.991 -1.299 . . . . 0.0 108.561 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.581 ' CB ' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER 145.09 -34.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.575 ' CG ' ' O ' ' A' ' 9' ' ' TYR . 2.5 p90 -141.86 115.59 9.14 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.001 -1.062 . . . . 0.0 109.225 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t -105.25 179.62 4.22 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.332 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -104.32 157.85 16.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.746 -0.596 . . . . 0.0 109.713 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.436 HD13 ' CB ' ' A' ' 160' ' ' GLN . 1.6 mp -100.08 159.11 15.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.362 -0.836 . . . . 0.0 109.477 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -98.97 11.75 38.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 109.443 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -168.3 93.27 0.61 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.195 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.476 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 36.4 Cg_endo -77.85 161.79 30.02 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.536 2.157 . . . . 0.0 110.891 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.548 HG11 ' CB ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -113.23 96.79 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 109.437 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -41.66 126.96 3.1 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 94.02 -16.69 60.35 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.548 ' CB ' HG11 ' A' ' 16' ' ' VAL . . . -38.63 158.18 0.1 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.484 -1.01 . . . . 0.0 109.94 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.55 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.7 Cg_endo -80.42 138.75 12.53 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.827 2.351 . . . . 0.0 111.48 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 6.0 mt-30 -47.53 -22.34 0.46 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.476 -0.765 . . . . 0.0 109.653 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 8.4 t -150.36 80.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.04 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.613 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -75.58 129.49 37.28 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.536 ' N ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -112.73 129.76 56.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.947 -1.095 . . . . 0.0 109.827 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.613 ' CE2' HD11 ' A' ' 23' ' ' LEU . 8.4 m-85 -116.88 102.83 9.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.247 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -146.4 136.36 23.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.894 -1.129 . . . . 0.0 110.026 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.609 ' CB ' ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -110.06 171.79 7.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.404 -0.81 . . . . 0.0 109.522 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.558 ' N ' ' NE2' ' A' ' 60' ' ' HIS . 7.9 m-30 -87.59 43.58 1.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.453 ' CD1' ' O ' ' A' ' 28' ' ' PHE . 9.6 m-85 -143.23 12.32 1.78 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.371 -0.83 . . . . 0.0 110.127 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 4.7 m -106.88 160.52 26.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.778 -1.201 . . . . 0.0 109.378 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -75.65 -32.39 4.72 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.111 1.874 . . . . 0.0 107.928 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.8 t-160 -79.9 -25.52 40.55 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 37.1 t -45.05 -64.17 0.77 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.561 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 28.0 t80 -65.0 -44.71 88.38 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.294 0.569 . . . . 0.0 110.055 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.485 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 52.7 mt-30 -67.43 -16.42 64.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.917 . . . . 0.0 110.859 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 32' ' ' HIS . 12.7 t80 -76.72 -52.0 10.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.979 -1.076 . . . . 0.0 110.344 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -106.53 -4.62 19.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.789 -1.195 . . . . 0.0 112.072 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.561 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 10.6 mt-10 -124.4 19.76 8.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.213 -1.555 . . . . 0.0 111.332 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.517 ' CG2' ' CE2' ' A' ' 34' ' ' TYR . 64.1 t -151.76 -84.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.614 -1.304 . . . . 0.0 109.92 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 171' ' ' MET . 13.8 mt -63.96 -13.9 49.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 0.0 109.867 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.472 ' O ' ' N ' ' A' ' 44' ' ' ASP . 57.0 m-70 49.05 24.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.169 -0.957 . . . . 0.0 108.649 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 46' ' ' VAL . 1.8 mt -43.18 -27.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.544 -0.722 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.26 -16.62 39.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -0.971 . . . . 0.0 110.867 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 41' ' ' HIS . 35.3 t70 -87.15 -34.05 19.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.916 -1.115 . . . . 0.0 110.413 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -73.26 -44.15 59.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.215 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 42' ' ' ILE . 3.7 m -55.96 -25.13 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.127 -0.983 . . . . 0.0 110.021 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HE2' HD11 ' A' ' 50' ' ' LEU . 3.1 mttt -65.67 -27.35 68.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 109.343 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -55.3 -18.56 6.58 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.376 -0.827 . . . . 0.0 109.096 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.485 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -134.86 48.26 2.3 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 109.764 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.407 HD11 ' HE2' ' A' ' 47' ' ' LYS . 10.7 mt -104.08 102.86 34.71 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 34.2 Cg_endo -76.3 152.78 35.19 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.512 2.141 . . . . 0.0 109.273 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 52' ' ' GLU . 12.1 tt0 -72.15 23.2 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.637 -1.289 . . . . 0.0 111.243 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 21' ' ' GLN . . . -122.13 29.47 5.53 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 186' ' ' SER . 68.5 t -148.92 121.17 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.502 -0.999 . . . . 0.0 108.722 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.7 116.69 32.48 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 110.471 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.48 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.94 96.99 9.66 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.468 ' HB ' HD22 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -88.68 141.58 28.4 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.039 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.68 113.93 21.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.404 -0.81 . . . . 0.0 109.639 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 138' ' ' GLN . 2.2 m-85 -116.97 154.05 31.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.995 -1.066 . . . . 0.0 111.838 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.609 ' CE1' ' CB ' ' A' ' 27' ' ' SER . 37.2 t-80 -108.87 111.71 23.56 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.588 HG23 ' CE1' ' A' ' 63' ' ' PHE . 3.1 m -82.36 158.18 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.976 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 70' ' ' LYS . 1.6 p30 -108.99 48.24 0.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.37 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.588 ' CE1' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -119.94 45.72 2.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.923 -1.111 . . . . 0.0 110.219 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.515 ' HG3' ' CD1' ' A' ' 63' ' ' PHE . 34.9 mtp -159.65 47.66 0.28 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 159.32 58.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -33.37 -36.56 0.05 OUTLIER Glycine 0 N--CA 1.493 2.499 0 O-C-N 122.004 -0.704 . . . . 0.0 111.472 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -87.59 -79.31 0.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.767 -1.431 . . . . 0.0 110.762 -178.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.598 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.74 -19.61 30.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.94 -1.1 . . . . 0.0 110.261 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.52 ' N ' HD12 ' A' ' 68' ' ' LEU . . . -56.79 -39.65 87.86 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -65.09 -42.85 93.67 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.25 -24.49 64.9 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.566 HD22 ' CE1' ' A' ' 60' ' ' HIS . 41.7 tp -65.64 -47.73 74.61 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.543 ' CG2' ' NE2' ' A' ' 138' ' ' GLN . 2.0 m -58.58 -43.46 89.45 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.546 ' O ' ' CG2' ' A' ' 78' ' ' VAL . 5.7 tp60 -55.69 -27.45 50.34 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -63.58 -41.52 98.36 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.486 ' HB2' ' CB ' ' A' ' 60' ' ' HIS . 47.8 t-105 -61.47 -30.68 70.75 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.391 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.487 ' CB ' HG21 ' A' ' 135' ' ' VAL . . . -81.68 -39.31 24.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 110.057 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.59 ' CG1' ' CD2' ' A' ' 122' ' ' TYR . 1.3 t -77.07 -27.12 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 109.75 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.457 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -80.87 -54.37 5.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.295 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -48.67 -27.79 3.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.203 -0.936 . . . . 0.0 108.742 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.521 ' CB ' HG21 ' A' ' 131' ' ' VAL . . . -60.5 -56.03 26.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.432 -0.792 . . . . 0.0 110.119 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.465 ' HB2' HG12 ' A' ' 84' ' ' VAL . 3.2 mt -102.04 10.38 39.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.038 -1.038 . . . . 0.0 110.59 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.45 27.98 61.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 82' ' ' LEU . 19.7 m -81.98 -6.64 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.375 -1.073 . . . . 0.0 109.858 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' THR . 3.9 tt0 -43.88 -65.1 0.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.547 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -41.41 -34.02 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 109.852 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -80.71 -51.95 8.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.459 -0.776 . . . . 0.0 111.158 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.501 ' O ' ' CG ' ' A' ' 92' ' ' LEU . 1.6 m -86.61 -9.57 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.708 -1.245 . . . . 0.0 110.869 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.618 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.46 -44.03 46.3 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.819 -1.176 . . . . 0.0 108.717 179.241 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.429 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -53.19 -53.18 58.63 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.478 -1.389 . . . . 0.0 110.453 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.53 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 26.0 Cg_endo -73.47 -18.08 23.19 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 O-C-N 122.786 0.887 . . . . 0.0 109.844 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 89' ' ' THR . 19.6 mt -87.24 -43.39 12.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.011 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.618 ' CG ' HG21 ' A' ' 89' ' ' THR . 7.1 m-30 -64.98 -45.94 83.53 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.894 -1.129 . . . . 0.0 108.73 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -72.73 -27.42 62.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.309 -0.87 . . . . 0.0 109.17 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.434 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -65.17 -38.19 94.95 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.521 HG23 ' CB ' ' A' ' 102' ' ' ILE . 3.8 t -97.81 -1.55 10.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.299 -1.118 . . . . 0.0 108.629 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 93' ' ' PHE . 18.8 mm-40 -111.14 9.61 21.92 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.169 -0.957 . . . . 0.0 110.874 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.562 ' O ' ' CG2' ' A' ' 99' ' ' THR . 50.6 tttt -172.5 62.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.482 -1.387 . . . . 0.0 109.822 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.562 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 164.47 -50.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.704 -0.622 . . . . 0.0 109.324 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.3 mt-30 75.92 15.28 2.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.195 -0.941 . . . . 0.0 110.777 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 t -82.82 -6.63 59.51 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.403 -0.81 . . . . 0.0 108.818 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.521 ' CB ' HG23 ' A' ' 96' ' ' VAL . 10.5 mm -79.97 72.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.494 ' HA ' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -134.21 31.56 3.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.198 -0.939 . . . . 0.0 109.167 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 107' ' ' ASP . 1.4 p -151.21 126.48 9.95 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.256 -0.902 . . . . 0.0 109.861 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.547 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -50.63 -31.81 17.16 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.4 t -59.3 -31.42 69.11 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -71.54 -49.34 41.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.529 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 37.3 mt -50.58 -30.32 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.124 -0.985 . . . . 0.0 108.947 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.4 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 24.5 mtm180 -79.55 -32.33 42.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.207 -0.933 . . . . 0.0 109.227 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -58.79 -46.79 86.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.268 -0.895 . . . . 0.0 108.799 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.53 ' CG1' ' HG2' ' A' ' 91' ' ' PRO . 70.1 t -71.35 -38.27 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.209 -0.932 . . . . 0.0 109.009 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CE2' ' CE2' ' A' ' 122' ' ' TYR . 0.5 OUTLIER -56.95 -44.72 82.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.5 mt -73.58 -24.21 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.594 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -65.82 -16.71 64.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.421 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.35 -3.23 56.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 109.86 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.94 -8.93 63.55 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 2.6 mp -88.86 51.83 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -1.098 . . . . 0.0 109.362 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 117' ' ' ILE . 16.7 pttm -33.78 153.89 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.565 -0.709 . . . . 0.0 110.826 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.17 -29.3 2.29 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.464 ' HB3' ' CD ' ' A' ' 118' ' ' LYS . 17.3 tt0 -50.37 -58.09 6.47 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.064 -1.256 . . . . 0.0 109.042 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.38 -54.14 6.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.438 -0.788 . . . . 0.0 109.662 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.59 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 2.6 t80 -46.73 -55.56 7.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.119 -0.988 . . . . 0.0 109.218 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.439 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 47.1 t0 -56.66 -48.59 77.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 109.07 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.49 -49.86 54.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.25 -0.906 . . . . 0.0 109.076 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 131' ' ' VAL . . . -51.44 -49.27 62.01 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.456 -0.778 . . . . 0.0 109.188 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.53 ' HA ' ' CG1' ' A' ' 131' ' ' VAL . 11.4 t90 -60.27 -56.49 20.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 108.956 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -15.64 3.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.517 -0.739 . . . . 0.0 109.923 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 63.2 m -77.35 -177.71 4.78 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.05 -1.031 . . . . 0.0 110.156 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.34 -32.43 13.61 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.76 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.3 -42.75 97.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 117.916 -1.514 . . . . 0.0 109.401 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.53 ' CG1' ' HA ' ' A' ' 126' ' ' TRP . 42.6 t -65.72 -38.21 81.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.04 -1.038 . . . . 0.0 108.295 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -38.44 89.14 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.3 m -62.1 -39.77 93.6 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.34 -16.63 56.01 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.487 HG21 ' CB ' ' A' ' 77' ' ' ALA . 5.0 t -79.4 -44.75 23.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 140' ' ' LYS . . . -68.62 -44.64 73.82 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.457 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 7.1 tp-100 -62.81 -32.64 73.87 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -0.817 . . . . 0.0 109.041 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.543 ' NE2' ' CG2' ' A' ' 73' ' ' THR . 1.6 tm0? -79.43 -62.75 1.59 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.199 -0.938 . . . . 0.0 108.751 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -49.47 -34.5 17.06 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 6.8 ttmt -75.11 -29.07 60.47 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.485 ' HA ' ' OD2' ' A' ' 144' ' ' ASP . . . -59.25 -54.23 49.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.362 -0.836 . . . . 0.0 109.143 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -75.83 -31.52 59.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 110.356 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.28 54.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.23 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.503 ' OD1' ' CG1' ' A' ' 145' ' ' VAL . 1.2 p30 -84.21 -47.18 11.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.978 -1.076 . . . . 0.0 108.181 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.593 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 10.3 m -82.04 -21.86 9.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 82.1 -25.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.849 -0.532 . . . . 0.0 110.188 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.544 ' CD2' ' CG1' ' A' ' 61' ' ' VAL . 10.5 tp 61.4 142.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 109.537 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.15 33.66 0.14 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.691 -1.256 . . . . 0.0 110.139 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 153.05 113.33 0.53 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.325 -1.416 . . . . 0.0 110.519 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.414 HG12 ' CE1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -101.56 139.55 20.49 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.34 -1.094 . . . . 0.0 109.395 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.31 151.46 95.0 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 123.725 -1.365 . . . . 0.0 110.209 0.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -130.37 126.77 37.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.271 -1.518 . . . . 0.0 109.127 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.499 ' SD ' ' CD1' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -122.71 114.77 21.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.087 -1.008 . . . . 0.0 110.094 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 154' ' ' PHE . 3.2 m-30 -110.58 148.3 32.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 159' ' ' TYR . 29.7 t -107.61 133.47 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.731 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 155' ' ' VAL . 5.6 p-10 40.7 25.49 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.4 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.54 ' N ' ' HB2' ' A' ' 19' ' ' ALA . . . 58.2 60.07 9.63 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.455 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 6.8 tttt -167.74 -33.68 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.379 -1.071 . . . . 0.0 108.327 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.514 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 96.5 m-85 -116.49 121.44 41.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.056 -1.028 . . . . 0.0 108.926 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.49 ' HG3' ' CE1' ' A' ' 154' ' ' PHE . 19.8 tt0 -113.42 109.02 18.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 109.749 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.499 ' CD1' ' SD ' ' A' ' 153' ' ' MET . 15.5 mt -59.32 172.12 0.68 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 8' ' ' GLN . 62.9 t-20 -152.2 83.07 5.16 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 120.849 -1.157 . . . . 0.0 109.848 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--N 1.308 -1.566 0 C-N-CA 122.713 2.275 . . . . 0.0 110.432 179.734 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.477 ' HB3' HD23 ' A' ' 40' ' ' LEU . 13.0 mtt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.661 0.743 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.6 -62.24 1.75 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.693 -0.63 . . . . 0.0 109.672 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.56 -21.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.151 -0.968 . . . . 0.0 108.919 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.485 ' CD1' ' O ' ' A' ' 174' ' ' PHE . 2.4 t80 -74.78 -45.23 45.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.293 -0.88 . . . . 0.0 109.268 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.439 ' O ' HG11 ' A' ' 175' ' ' VAL . 39.8 t -71.39 -26.87 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.174 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.66 -53.11 6.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.569 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.55 -40.64 87.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 109.01 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -63.92 -47.5 80.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.321 -0.862 . . . . 0.0 108.909 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.61 -29.48 70.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.25 -0.906 . . . . 0.0 108.947 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -75.08 -38.29 61.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 109.277 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 185' ' ' LEU . 2.9 m -66.11 -26.47 67.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -0.871 . . . . 0.0 109.274 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.486 ' CG2' ' HE3' ' A' ' 153' ' ' MET . 52.8 t -87.13 -37.23 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 108.581 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -57.46 -48.47 79.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.406 -0.809 . . . . 0.0 108.885 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.44 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -80.92 -28.74 35.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.397 -0.815 . . . . 0.0 109.416 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.53 ' CG ' ' O ' ' A' ' 181' ' ' THR . 0.6 OUTLIER -63.77 -17.3 62.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.198 . . . . 0.0 109.358 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.46 ' HB2' HG23 ' A' ' 54' ' ' VAL . 1.4 t -82.56 5.54 20.53 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.665 -1.272 . . . . 0.0 107.999 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.439 -0.788 . . . . 0.0 109.415 -179.777 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 5' ' ' ASP . 0.4 OUTLIER -105.11 55.74 0.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 4' ' ' GLU . 7.0 p-10 39.77 79.86 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.812 -0.555 . . . . 0.0 109.891 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 126.79 -26.52 5.09 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.762 -1.208 . . . . 0.0 110.348 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 -69.52 0.6 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.063 -1.257 . . . . 0.0 109.385 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -91.41 2.72 56.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.229 -0.919 . . . . 0.0 109.611 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 6' ' ' GLY . 2.2 p90 178.91 132.85 0.08 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.09 -1.006 . . . . 0.0 109.189 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 t -119.11 176.34 5.35 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.691 -0.63 . . . . 0.0 109.494 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -100.24 152.1 20.68 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.357 0.599 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 mp -92.95 170.9 9.31 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.303 -0.873 . . . . 0.0 109.594 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.42 ' OE2' ' HG2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -91.56 -5.92 53.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.511 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.42 ' HG2' ' OE2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -166.06 110.67 0.73 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.444 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 36.0 Cg_endo -77.97 160.49 30.37 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.417 2.078 . . . . 0.0 110.153 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -119.03 102.67 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 109.8 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.22 127.07 6.73 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 92.37 -15.03 63.2 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.534 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -38.35 156.18 0.11 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.94 . . . . 0.0 109.618 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.5 Cg_endo -79.17 128.32 8.12 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.547 2.165 . . . . 0.0 111.308 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.516 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 37.0 mt-30 -42.38 -24.28 0.05 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.398 -0.813 . . . . 0.0 109.586 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 7.1 t -147.26 83.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.127 -0.983 . . . . 0.0 109.155 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.587 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -77.75 128.56 34.22 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.524 ' N ' HD21 ' A' ' 23' ' ' LEU . 3.4 mm-40 -109.68 131.93 54.61 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.088 -1.008 . . . . 0.0 109.723 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.587 ' CE2' HD11 ' A' ' 23' ' ' LEU . 5.0 m-85 -120.58 113.93 20.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -151.75 144.89 24.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.974 -1.079 . . . . 0.0 109.698 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.598 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -118.53 163.86 16.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 110.085 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.67 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 18.8 m-30 -88.13 39.17 0.89 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.526 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 5.2 m-85 -138.72 15.51 2.7 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 110.179 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 4.2 m -114.39 158.18 40.59 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.596 -1.315 . . . . 0.0 109.722 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -74.5 -25.42 12.98 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.196 1.931 . . . . 0.0 107.835 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' PHE . 98.5 m-70 -89.17 -16.43 31.38 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 5.7 t -54.92 -53.44 55.51 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 38' ' ' GLU . 29.3 t80 -71.58 -40.61 69.78 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.486 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 3.3 mt-30 -78.33 -19.02 54.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 111.181 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 32' ' ' HIS . 70.6 t80 -78.0 -20.3 52.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.924 -1.11 . . . . 0.0 110.466 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 41' ' ' HIS . 3.7 tm-20 -133.31 -72.06 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.885 -1.134 . . . . 0.0 110.826 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.636 ' CB ' ' CE1' ' A' ' 34' ' ' TYR . 56.8 mm-40 -46.02 -40.25 10.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.831 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 34' ' ' TYR . 5.0 t -92.4 -74.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.053 . . . . 0.0 110.548 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.557 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 0.4 OUTLIER -75.21 -10.9 59.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.0 110.652 -178.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 11.0 p-80 40.92 32.11 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.136 -0.977 . . . . 0.0 109.342 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.487 HG13 ' HB3' ' A' ' 40' ' ' LEU . 3.6 mt -54.38 -18.12 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 110.152 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.6 p -84.95 -38.56 19.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.943 -1.098 . . . . 0.0 110.563 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 2.7 m-20 -81.58 -36.91 28.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.02 -1.05 . . . . 0.0 110.428 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 46' ' ' VAL . 15.8 t30 -60.54 -53.34 58.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.033 -1.042 . . . . 0.0 110.171 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' ASN . 6.7 m -42.82 -38.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 110.183 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -46.86 -34.81 5.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.039 . . . . 0.0 109.867 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.411 ' HD3' ' HG2' ' A' ' 49' ' ' LYS . 3.4 tmtm? -45.46 -24.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.145 -0.972 . . . . 0.0 109.93 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.446 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -116.32 40.57 2.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.729 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.542 ' HG ' ' CG1' ' A' ' 54' ' ' VAL . 5.5 mp -129.47 68.19 79.96 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.182 -0.949 . . . . 0.0 109.587 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 52' ' ' GLU . 36.1 Cg_endo -80.31 77.97 3.86 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.697 2.265 . . . . 0.0 111.685 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 51' ' ' PRO . 25.5 tp10 58.92 136.85 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.616 0.722 . . . . 0.0 110.103 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.13 -6.52 69.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.542 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -116.06 100.52 10.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.28 -1.13 . . . . 0.0 108.645 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -100.51 109.39 21.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.259 -0.901 . . . . 0.0 110.427 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.476 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -102.46 95.52 6.32 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.559 HG23 ' CE1' ' A' ' 59' ' ' TYR . 4.2 m -84.16 133.6 34.6 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.724 -1.19 . . . . 0.0 110.042 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 8.5 tttt -106.72 117.95 35.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.484 -0.76 . . . . 0.0 109.582 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.559 ' CE1' HG23 ' A' ' 57' ' ' THR . 3.3 m-85 -120.88 177.02 5.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.014 -1.054 . . . . 0.0 110.5 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.604 ' CE1' ' CD2' ' A' ' 72' ' ' LEU . 3.2 t60 -109.16 159.89 16.53 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.84 0.828 . . . . 0.0 109.538 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.54 ' CG2' ' CE1' ' A' ' 63' ' ' PHE . 1.4 m -104.02 162.4 4.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.79 58.31 1.7 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.141 -0.975 . . . . 0.0 109.314 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' CE1' ' CG2' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -158.03 64.82 0.46 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.023 -1.048 . . . . 0.0 110.849 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.525 ' CA ' ' HE1' ' A' ' 64' ' ' MET . 0.0 OUTLIER -126.17 33.27 5.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.503 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 64' ' ' MET . . . 44.72 42.42 7.6 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . -148.5 80.97 0.2 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 66' ' ' GLY . 44.5 t0 -33.39 -45.35 0.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.021 -0.693 . . . . 0.0 111.366 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -55.4 -21.01 13.81 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.749 -1.219 . . . . 0.0 109.192 -179.258 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.574 ' N ' ' CD2' ' A' ' 68' ' ' LEU . . . -63.62 -51.3 55.2 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -50.97 -55.05 19.18 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -27.0 68.96 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.604 ' CD2' ' CE1' ' A' ' 60' ' ' HIS . 6.2 tt -65.32 -38.06 89.0 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.545 ' CG2' ' NE2' ' A' ' 138' ' ' GLN . 1.8 m -59.69 -42.17 92.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.52 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 1.2 tt0 -53.92 -29.31 41.62 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -63.72 -40.06 95.83 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.425 ' O ' ' HB2' ' A' ' 80' ' ' MET . 53.4 t-105 -60.24 -30.93 69.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 108.534 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB2' HG21 ' A' ' 135' ' ' VAL . . . -86.96 -60.46 1.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 109.642 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.589 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 2.0 t -53.66 -28.1 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 109.171 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.09 -55.74 4.04 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 2.7 ttt -50.67 -27.54 7.18 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.533 ' CB ' HG12 ' A' ' 131' ' ' VAL . . . -68.79 -42.25 77.64 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.489 -0.757 . . . . 0.0 109.49 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.402 ' HB2' HG12 ' A' ' 84' ' ' VAL . 14.9 mt -101.97 7.8 41.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.376 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.32 29.32 45.8 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 82' ' ' LEU . 26.8 m -94.21 7.82 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.433 -1.039 . . . . 0.0 109.684 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 86' ' ' ASP . 48.9 tt0 -47.72 -72.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.12 -0.988 . . . . 0.0 109.487 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -38.86 -34.59 0.16 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.556 -0.715 . . . . 0.0 110.224 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.534 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 10.4 mtpp -73.95 -55.22 6.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.819 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.558 HG22 ' CE1' ' A' ' 112' ' ' PHE . 1.1 m -87.16 -19.98 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.737 -1.227 . . . . 0.0 110.681 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.613 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -70.17 -42.27 72.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.625 -1.297 . . . . 0.0 108.13 179.004 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.52 -55.66 37.85 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.603 -1.311 . . . . 0.0 110.692 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 24.4 Cg_endo -72.17 -16.7 28.34 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 N-CA-C 109.669 -0.935 . . . . 0.0 109.669 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.542 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 30.6 mt -86.85 -47.06 9.36 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.67 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 6.5 m-30 -58.56 -49.18 78.37 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 120.928 -1.108 . . . . 0.0 108.98 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -69.07 -33.09 73.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.061 -1.024 . . . . 0.0 109.015 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.427 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -67.86 -30.16 74.17 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 92' ' ' LEU . 2.1 t -107.45 9.71 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 121.086 -1.243 . . . . 0.0 108.784 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.546 ' NE2' ' HB2' ' A' ' 34' ' ' TYR . 58.9 mt-30 -112.79 15.23 19.91 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.073 -1.017 . . . . 0.0 110.567 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 7.0 mttt 178.97 -49.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.591 -1.318 . . . . 0.0 110.913 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -67.7 -38.16 83.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.561 -1.337 . . . . 0.0 110.048 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 67.24 13.57 9.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -0.832 . . . . 0.0 109.55 -179.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.439 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 42.5 p -79.79 -9.91 59.72 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.811 0.815 . . . . 0.0 109.048 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.477 HG13 HG21 ' A' ' 96' ' ' VAL . 5.5 mm -86.99 75.65 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.699 -0.626 . . . . 0.0 109.574 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.53 ' CA ' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -132.27 27.25 4.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 109.308 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 107' ' ' ASP . 7.9 p -147.8 127.07 13.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 109.856 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.512 ' N ' ' HB2' ' A' ' 68' ' ' LEU . . . -49.23 -42.81 41.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.1 p -54.36 -31.34 54.34 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 104' ' ' SER . 14.2 m-20 -74.88 -38.02 62.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.236 -0.915 . . . . 0.0 108.969 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 68' ' ' LEU . 31.0 mt -55.98 -27.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -38.54 57.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.9 -49.68 70.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.0 109.197 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.542 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 47.2 t -68.25 -37.78 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.479 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.558 ' CE1' HG22 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -58.74 -37.57 76.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.917 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.9 mt -78.99 -27.0 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.157 -0.964 . . . . 0.0 110.313 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -65.55 -16.7 63.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.912 -1.118 . . . . 0.0 109.572 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 87' ' ' LYS . . . -87.94 -1.57 58.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.783 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.0 -3.91 65.01 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.3 mp -87.67 61.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 108.928 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -36.6 154.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.879 -1.138 . . . . 0.0 110.426 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.13 -22.25 35.28 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.16 -54.41 47.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -1.191 . . . . 0.0 109.439 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -42.19 55.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.922 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.589 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 7.1 t80 -59.68 -48.12 82.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.139 -0.975 . . . . 0.0 109.716 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.54 -39.91 94.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.115 -0.99 . . . . 0.0 109.182 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . . . -55.73 -53.36 57.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.364 -0.835 . . . . 0.0 109.408 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.526 ' O ' ' HB ' ' A' ' 131' ' ' VAL . . . -56.46 -55.47 33.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.42 -0.8 . . . . 0.0 108.856 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.567 ' O ' ' CE3' ' A' ' 126' ' ' TRP . 0.7 OUTLIER -48.77 -54.11 16.39 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -68.63 -14.82 63.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.686 -0.634 . . . . 0.0 109.845 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 67.7 m -68.9 -179.24 1.41 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.066 -1.021 . . . . 0.0 110.135 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.7 -35.71 13.33 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.555 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.76 -46.61 60.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.36 -1.336 . . . . 0.0 110.171 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.533 HG12 ' CB ' ' A' ' 81' ' ' ALA . 3.0 t -66.57 -35.37 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.732 -1.23 . . . . 0.0 108.63 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -67.1 -38.74 86.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -39.53 94.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 108.974 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 77' ' ' ALA . 4.8 tp -75.64 -25.13 56.58 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.517 HG13 ' CZ3' ' A' ' 126' ' ' TRP . 11.6 t -73.96 -41.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.84 -37.05 85.95 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.03 -31.27 71.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.446 -0.784 . . . . 0.0 108.886 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.545 ' NE2' ' CG2' ' A' ' 73' ' ' THR . 2.3 mt-30 -66.89 -61.41 1.96 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.415 -0.803 . . . . 0.0 108.852 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.437 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 1.8 mt-10 -51.92 -33.41 37.08 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -76.48 -28.34 56.45 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.604 -0.685 . . . . 0.0 109.335 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.54 -57.5 9.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -72.84 -31.31 64.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.887 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 139' ' ' GLU . . . -79.27 -23.24 43.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.165 -0.959 . . . . 0.0 110.222 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 140' ' ' LYS . 76.1 m-20 -81.12 -44.42 17.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.08 -1.012 . . . . 0.0 108.49 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.578 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 31.7 m -95.58 -8.35 9.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 1.1 mm-40 78.12 -52.5 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.449 -0.782 . . . . 0.0 109.397 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.493 HD23 ' CG1' ' A' ' 61' ' ' VAL . 27.1 tp 68.39 129.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.876 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.59 41.51 0.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.589 -1.319 . . . . 0.0 109.568 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 172.28 105.27 0.18 Allowed Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.068 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.533 ' CG1' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -105.05 141.55 22.81 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.391 -1.064 . . . . 0.0 109.817 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.52 152.74 96.18 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 123.572 -1.428 . . . . 0.0 110.208 0.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -134.68 159.38 41.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.241 -1.537 . . . . 0.0 109.394 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 2.1 ttm -154.0 131.22 11.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.942 . . . . 0.0 109.851 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 160' ' ' GLN . 6.1 m-85 -124.76 133.7 53.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.156 -0.965 . . . . 0.0 110.026 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 48.2 t -96.2 132.34 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.361 -0.837 . . . . 0.0 110.287 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 48.48 21.23 0.37 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.826 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.534 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 55.86 55.53 28.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -164.71 -34.87 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.357 -1.084 . . . . 0.0 108.355 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -114.57 118.25 33.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.221 179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 154' ' ' PHE . 23.6 tt0 -104.29 109.04 20.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.282 -0.886 . . . . 0.0 109.574 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.465 HD12 ' CE1' ' A' ' 178' ' ' TYR . 30.0 mt -59.89 169.78 1.36 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -151.78 87.29 4.43 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.055 -1.028 . . . . 0.0 109.463 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . 35.8 Cg_endo . . . . . 0 C--N 1.307 -1.613 0 C-N-CA 122.603 2.202 . . . . 0.0 110.502 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.7 mtt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.708 0.766 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -70.7 -44.46 66.91 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.633 -0.667 . . . . 0.0 109.223 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.436 ' O ' HG11 ' A' ' 173' ' ' VAL . 14.8 t -73.46 -25.04 20.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.217 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 163' ' ' PRO . 4.1 t80 -69.16 -46.48 67.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 0.0 109.063 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 45.5 t -71.55 -24.54 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.568 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -83.14 -55.36 4.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.423 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -39.17 93.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.95 -1.094 . . . . 0.0 108.786 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.465 ' CE1' HD12 ' A' ' 161' ' ' LEU . 63.4 t80 -65.2 -43.52 91.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.376 -0.827 . . . . 0.0 108.891 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.86 -31.77 65.14 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.021 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.61 -38.62 54.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.317 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 185' ' ' LEU . 0.2 OUTLIER -62.5 -30.34 71.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.239 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.426 HG21 HD13 ' A' ' 161' ' ' LEU . 58.1 t -86.03 -33.69 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.191 -0.943 . . . . 0.0 108.636 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.81 -48.55 81.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 108.885 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.76 -32.26 52.53 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.184 -0.947 . . . . 0.0 108.886 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.479 HD21 ' N ' ' A' ' 185' ' ' LEU . 0.9 OUTLIER -64.32 -17.06 63.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.877 -1.14 . . . . 0.0 109.138 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 24.9 p -74.02 -10.46 59.65 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.909 -1.119 . . . . 0.0 108.569 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.486 1.361 0 O-C-N 121.477 -0.764 . . . . 0.0 109.441 179.895 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -114.84 61.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.292 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.4 t70 53.72 86.0 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.506 -0.746 . . . . 0.0 109.6 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.62 -22.9 8.09 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.173 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -69.83 0.58 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.981 -1.305 . . . . 0.0 108.505 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.474 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 0.6 OUTLIER -114.8 19.02 16.23 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.333 -0.854 . . . . 0.0 109.432 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 9' ' ' TYR . 0.8 OUTLIER 177.94 129.92 0.06 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.225 -0.922 . . . . 0.0 109.063 179.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -126.14 176.66 6.89 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.53 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.425 HG21 ' O ' ' A' ' 158' ' ' LYS . 24.9 m -104.14 149.47 25.22 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.472 0.653 . . . . 0.0 109.71 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.461 ' HG ' ' HG2' ' A' ' 160' ' ' GLN . 0.4 OUTLIER -89.46 149.52 22.9 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.431 -0.793 . . . . 0.0 109.658 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -70.58 -23.19 62.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.009 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -122.62 102.16 39.2 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.82 164.54 29.9 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.474 2.116 . . . . 0.0 111.118 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.45 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 37.7 t -129.1 76.68 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 109.562 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.45 133.18 5.78 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.46 -25.06 26.39 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.52 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -41.09 162.87 0.11 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.521 -0.987 . . . . 0.0 109.627 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.555 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 33.0 Cg_endo -75.8 125.82 9.04 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.589 2.193 . . . . 0.0 111.449 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.526 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -37.95 -25.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.848 -0.532 . . . . 0.0 110.854 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' PRO . 17.5 t -147.75 79.82 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.709 -1.244 . . . . 0.0 109.139 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.642 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -82.14 124.82 30.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.522 ' N ' HD21 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -123.71 108.47 12.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.027 -1.046 . . . . 0.0 109.222 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.642 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 7.6 m-85 -88.27 126.53 35.21 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.411 0.624 . . . . 0.0 110.035 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -155.16 142.1 19.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 109.69 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.538 ' HB2' ' NE2' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -126.32 161.94 26.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.224 -0.922 . . . . 0.0 109.129 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.678 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -83.74 48.13 1.39 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 0.0 108.817 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.574 ' CE1' HD21 ' A' ' 72' ' ' LEU . 6.3 m-85 -135.47 5.77 3.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.373 -0.829 . . . . 0.0 110.016 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.511 ' HB3' ' NE2' ' A' ' 32' ' ' HIS . 90.9 m -108.69 155.38 40.71 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 118.688 -1.205 . . . . 0.0 109.23 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -73.68 -28.9 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.079 1.853 . . . . 0.0 108.192 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 36' ' ' PHE . 2.5 p-80 -86.15 -20.76 28.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 14.7 t -47.31 -63.29 1.08 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.538 ' CE2' ' CD ' ' A' ' 38' ' ' GLU . 35.6 t80 -59.62 -54.5 45.78 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.469 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 1.5 mt-30 -56.52 -25.51 51.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.22 -0.925 . . . . 0.0 109.786 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 32' ' ' HIS . 35.5 t80 -84.49 -25.43 28.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 110.672 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.531 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 3.6 tt0 -125.81 51.46 1.74 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.842 -1.161 . . . . 0.0 110.16 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.538 ' CD ' ' CE2' ' A' ' 34' ' ' TYR . 1.1 mt-10 -171.06 -57.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.083 -1.011 . . . . 0.0 110.706 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.1 t -102.07 -58.76 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.924 -1.11 . . . . 0.0 110.917 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 35' ' ' GLN . 64.4 mt -46.43 -22.75 0.29 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.034 -1.041 . . . . 0.0 110.408 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 17.9 m80 57.07 16.97 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.036 -1.04 . . . . 0.0 109.522 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 42' ' ' ILE . 23.0 mt -64.04 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 109.358 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.85 -31.68 35.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.447 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.31 -27.51 32.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.922 -1.111 . . . . 0.0 110.061 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 36.8 t30 -80.44 -40.05 27.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.965 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.426 HG12 ' CE ' ' A' ' 56' ' ' MET . 12.0 p -65.72 -25.32 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.528 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.446 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 1.0 OUTLIER -68.76 -20.41 64.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.637 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -76.8 -20.76 56.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.142 -0.974 . . . . 0.0 109.62 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.478 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 4.1 mttt -105.65 3.86 29.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 0.0 109.842 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' A' ' 47' ' ' LYS . 14.4 mt -42.73 102.61 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 109.692 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.552 ' HG2' ' CG2' ' A' ' 54' ' ' VAL . 34.6 Cg_endo -77.74 127.98 9.07 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.339 2.026 . . . . 0.0 110.605 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.89 116.97 2.03 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.139 0.971 . . . . 0.0 109.233 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.53 -20.28 10.29 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.552 ' CG2' ' HG2' ' A' ' 51' ' ' PRO . 2.6 t -93.39 91.8 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -1.204 . . . . 0.0 109.051 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -75.19 102.09 4.85 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.508 -0.745 . . . . 0.0 109.769 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.491 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 15.1 ttp -89.93 99.92 12.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.563 -0.711 . . . . 0.0 109.483 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.455 ' O ' ' CG ' ' A' ' 24' ' ' GLU . 7.4 m -96.28 139.12 32.88 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.402 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.499 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -113.55 109.77 19.18 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.49 -0.756 . . . . 0.0 109.054 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.558 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 3.2 m-85 -110.28 168.72 9.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.839 -1.163 . . . . 0.0 110.562 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.577 ' NE2' ' CD2' ' A' ' 72' ' ' LEU . 55.9 t-80 -97.99 153.25 18.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.503 HG13 ' CG1' ' A' ' 150' ' ' VAL . 2.1 m -90.62 155.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.606 0.717 . . . . 0.0 110.485 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -124.5 28.58 6.57 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.575 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 12.8 p90 -130.87 61.57 1.62 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.018 -1.051 . . . . 0.0 110.185 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.567 ' HG2' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -160.17 -61.43 0.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.567 ' N ' ' HG2' ' A' ' 64' ' ' MET . . . -87.4 82.11 1.61 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -39.94 -51.04 3.4 Favored Glycine 0 N--CA 1.489 2.22 0 O-C-N 121.473 -1.016 . . . . 0.0 110.916 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -87.74 -78.53 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.023 -1.28 . . . . 0.0 111.168 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.586 HD21 ' CD1' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -71.97 -23.88 61.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.854 -1.154 . . . . 0.0 110.026 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.567 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -50.34 -60.4 6.79 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -48.33 -45.17 34.85 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.958 -1.319 . . . . 0.0 108.31 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.439 ' OD1' HD11 ' A' ' 108' ' ' ILE . 10.5 t70 -65.37 -31.14 72.1 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.577 ' CD2' ' NE2' ' A' ' 60' ' ' HIS . 44.5 tp -57.72 -42.74 84.44 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.6 m -61.53 -41.4 97.27 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.57 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 0.6 OUTLIER -58.4 -21.07 49.21 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -70.22 -45.75 65.9 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 28.4 t-105 -55.31 -30.71 60.73 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 135' ' ' VAL . . . -86.5 -65.36 1.02 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 110.134 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.647 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 2.7 t -48.15 -28.16 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 109.945 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 75' ' ' ALA . . . -85.29 -59.3 2.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.83 -1.169 . . . . 0.0 108.982 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ALA . 8.0 tpt -47.11 -27.98 1.6 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.86 -38.33 64.49 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.54 -0.725 . . . . 0.0 109.443 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.502 ' CB ' HG12 ' A' ' 84' ' ' VAL . 52.3 mt -99.56 5.23 46.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.113 -0.992 . . . . 0.0 110.403 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.28 20.09 27.64 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.502 HG12 ' CB ' ' A' ' 82' ' ' LEU . 35.4 m -89.25 -4.1 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.391 -1.064 . . . . 0.0 110.432 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -45.38 -68.15 0.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.072 -1.018 . . . . 0.0 109.439 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.13 -34.57 0.18 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 110.21 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.521 ' HE2' ' CB ' ' A' ' 115' ' ' ALA . 12.1 mtpt -83.05 -51.22 7.74 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.264 -0.898 . . . . 0.0 110.969 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.2 m -80.97 -17.59 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.773 -1.204 . . . . 0.0 110.505 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.605 HG21 ' CD1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -69.43 -43.39 73.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 108.74 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.78 -55.39 38.82 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.548 -1.345 . . . . 0.0 110.531 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.52 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 25.8 Cg_endo -72.47 -18.07 26.33 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 N-CA-C 109.909 -0.843 . . . . 0.0 109.909 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 21.8 mt -87.05 -43.94 11.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 108.949 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.678 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 4.2 m-30 -63.68 -46.62 84.72 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.926 -1.109 . . . . 0.0 109.027 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -16.74 61.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.98 . . . . 0.0 109.238 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.427 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -76.44 -30.63 56.37 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.567 HG12 ' CD1' ' A' ' 29' ' ' PHE . 1.1 t -105.71 -2.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.068 -1.254 . . . . 0.0 109.444 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -113.33 10.98 18.49 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 120.827 -1.171 . . . . 0.0 111.073 -178.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.481 ' O ' ' OG1' ' A' ' 99' ' ' THR . 0.7 OUTLIER -177.39 58.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.496 -1.378 . . . . 0.0 109.992 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.596 ' CG2' ' CG2' ' A' ' 101' ' ' THR . 1.0 OUTLIER 168.13 -48.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 99' ' ' THR . 1.5 mt-30 80.11 20.97 0.54 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.752 -1.217 . . . . 0.0 111.366 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.596 ' CG2' ' CG2' ' A' ' 99' ' ' THR . 26.1 p -84.01 -8.91 59.01 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.303 -0.873 . . . . 0.0 109.107 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.507 ' HB ' HG23 ' A' ' 96' ' ' VAL . 5.2 mm -91.81 82.97 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.69 -0.631 . . . . 0.0 109.35 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.532 ' N ' ' HD3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -146.36 29.6 1.05 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 109.409 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 107' ' ' ASP . 1.1 p -155.43 132.38 10.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.943 . . . . 0.0 110.025 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.498 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -50.41 -32.56 17.97 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 m -62.9 -32.79 74.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -69.81 -50.3 44.24 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.586 ' CD1' HD21 ' A' ' 68' ' ' LEU . 27.0 mt -49.72 -29.36 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.614 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -78.5 -29.05 46.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.332 -0.855 . . . . 0.0 109.318 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -64.91 -46.32 82.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.238 -0.914 . . . . 0.0 109.302 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.515 ' CG1' ' HG2' ' A' ' 91' ' ' PRO . 61.4 t -71.87 -37.9 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.453 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.408 ' HA ' HG13 ' A' ' 88' ' ' VAL . 1.0 OUTLIER -61.03 -36.3 79.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.925 . . . . 0.0 109.655 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 109' ' ' ARG . 15.1 mt -79.67 -25.49 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.996 . . . . 0.0 110.227 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -64.09 -23.35 67.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.421 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.521 ' CB ' ' HE2' ' A' ' 87' ' ' LYS . . . -85.65 2.16 46.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 109.62 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.45 -2.24 62.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.606 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.4 mp -90.33 60.66 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.121 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.4 OUTLIER -34.18 152.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -0.964 . . . . 0.0 110.681 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.52 -27.37 41.31 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.7 -47.22 86.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -1.172 . . . . 0.0 109.081 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -75.94 -40.87 53.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 109.221 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.647 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 3.9 t80 -58.92 -47.36 85.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.851 . . . . 0.0 109.286 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.47 -34.51 77.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.244 -0.91 . . . . 0.0 109.013 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.68 -51.37 67.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.307 -0.871 . . . . 0.0 108.919 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.511 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -55.77 -49.36 73.35 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.385 -0.822 . . . . 0.0 108.955 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.57 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 12.7 t90 -57.49 -55.06 39.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.346 -0.846 . . . . 0.0 108.832 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -54.45 -16.16 2.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.474 -0.766 . . . . 0.0 109.821 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.472 ' OG ' HG22 ' A' ' 131' ' ' VAL . 1.0 OUTLIER -67.71 -179.21 1.07 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 109.571 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.9 -36.28 13.55 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.45 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.6 t -73.81 -47.9 41.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 118.225 -1.39 . . . . 0.0 110.057 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 3.1 t -61.82 -40.56 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.771 -1.206 . . . . 0.0 108.411 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 132' ' ' LYS . 2.6 ttmm -64.87 -28.13 69.33 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.514 -0.741 . . . . 0.0 109.131 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.5 t -69.79 -37.93 76.5 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.348 -0.845 . . . . 0.0 109.241 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.91 -17.13 59.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.187 -0.946 . . . . 0.0 108.485 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' ' 77' ' ' ALA . 3.2 t -75.28 -43.84 43.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -68.51 -46.98 68.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.411 ' O ' ' HB1' ' A' ' 141' ' ' ALA . 2.6 mt-30 -58.15 -33.33 69.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.082 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.558 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -69.74 -74.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 0.0 109.407 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.444 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 1.8 mt-10 -45.58 -36.39 4.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.822 . . . . 0.0 108.932 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -72.63 -35.53 67.82 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.259 -0.901 . . . . 0.0 108.668 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.478 ' O ' ' OD2' ' A' ' 144' ' ' ASP . . . -53.09 -62.6 1.55 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.487 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -60.93 -25.14 66.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.267 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 139' ' ' GLU . . . -78.67 -25.68 44.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.536 ' OD1' ' CG1' ' A' ' 145' ' ' VAL . 0.5 OUTLIER -78.85 -48.32 14.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.07 -1.019 . . . . 0.0 108.342 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.544 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 27.4 m -89.83 -11.43 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.544 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.4 OUTLIER 80.87 -47.27 0.26 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.494 -0.754 . . . . 0.0 109.827 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.474 HD23 HG13 ' A' ' 61' ' ' VAL . 36.0 tp 61.77 130.08 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.35 -0.843 . . . . 0.0 109.102 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -160.96 40.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.525 -1.36 . . . . 0.0 109.94 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 165.14 107.96 0.21 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.503 ' CG1' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -99.42 143.45 26.44 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.294 -1.121 . . . . 0.0 109.769 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.529 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 35.1 Cg_endo -76.71 152.01 95.02 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 123.997 -1.251 . . . . 0.0 110.136 0.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.584 ' HB2' ' CE1' ' A' ' 154' ' ' PHE . . . -132.84 137.62 46.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.225 -1.547 . . . . 0.0 109.416 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.514 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 2.8 ttp -129.14 130.59 46.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.112 -0.992 . . . . 0.0 110.18 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.584 ' CE1' ' HB2' ' A' ' 152' ' ' ALA . 8.5 m-85 -127.55 129.73 47.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.307 -0.871 . . . . 0.0 109.792 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 54.3 t -96.76 131.46 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 110.057 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 44.9 23.58 0.09 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.353 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.52 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 55.4 57.67 17.51 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.511 ' HB3' ' CD1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -164.72 -36.38 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.512 ' N ' ' CD1' ' A' ' 159' ' ' TYR . 11.7 m-85 -117.45 123.03 45.38 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.485 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -125.42 120.78 31.97 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.975 -1.078 . . . . 0.0 109.81 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.448 HD23 HG23 ' A' ' 181' ' ' THR . 17.2 mt -65.33 177.36 1.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.555 -0.716 . . . . 0.0 109.152 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.538 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 50.9 t-20 -137.58 60.27 24.78 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.723 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 162' ' ' ASN . 35.5 Cg_endo . . . . . 0 C--N 1.309 -1.528 0 C-N-CA 122.635 2.224 . . . . 0.0 110.397 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 34.6 mtt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.693 0.759 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.07 -46.76 89.34 Favored 'General case' 0 C--N 1.293 -1.891 0 O-C-N 121.639 -0.663 . . . . 0.0 109.499 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.3 t -67.0 -28.14 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.36 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -66.85 -40.41 87.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.216 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 39.6 t -75.27 -27.42 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.173 -0.955 . . . . 0.0 109.458 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.15 -56.16 4.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.972 . . . . 0.0 109.246 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.468 ' O ' ' OG1' ' A' ' 181' ' ' THR . 12.7 pt20 -55.74 -33.25 64.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.15 -0.969 . . . . 0.0 109.151 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.467 ' C ' ' CD1' ' A' ' 178' ' ' TYR . 13.5 t80 -70.5 -53.11 17.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -0.951 . . . . 0.0 109.479 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.5 -31.84 71.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.556 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -76.81 -50.25 13.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.499 ' O ' ' CD2' ' A' ' 185' ' ' LEU . 20.6 m -54.39 -24.15 18.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.246 -0.909 . . . . 0.0 109.527 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 25.0 t -86.16 -40.29 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.031 -1.043 . . . . 0.0 109.174 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -55.18 -45.6 75.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.178 -0.952 . . . . 0.0 109.094 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.516 ' CE2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -81.75 -36.66 28.3 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.34 -0.85 . . . . 0.0 109.233 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.539 HD21 ' N ' ' A' ' 185' ' ' LEU . 0.7 OUTLIER -54.05 -20.2 6.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.886 -1.133 . . . . 0.0 109.875 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.462 ' HB3' HG23 ' A' ' 54' ' ' VAL . 64.9 p -63.91 -13.49 45.98 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.709 -1.244 . . . . 0.0 108.054 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.553 -0.717 . . . . 0.0 109.31 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -111.3 59.16 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.012 -1.055 . . . . 0.0 109.593 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 45.64 83.92 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.509 -0.744 . . . . 0.0 109.893 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 136.74 -33.01 2.39 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.084 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.79 -72.63 0.45 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -1.18 . . . . 0.0 109.398 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.506 ' HB3' ' CG2' ' A' ' 181' ' ' THR . 8.5 mm-40 -87.88 -4.24 58.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.816 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 24.0 p90 177.15 130.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.236 -0.915 . . . . 0.0 109.14 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.518 HG21 ' CG ' ' A' ' 160' ' ' GLN . 10.1 t -106.31 -179.92 4.08 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.43 HG21 ' O ' ' A' ' 158' ' ' LYS . 2.4 m -103.13 159.61 15.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.639 -0.663 . . . . 0.0 109.533 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.515 HD22 ' NE2' ' A' ' 160' ' ' GLN . 15.3 mt -95.98 154.86 17.01 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.357 -0.839 . . . . 0.0 109.748 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.28 -12.67 40.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.448 -0.783 . . . . 0.0 108.982 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 100.74 3.98 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 109.222 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.19 160.9 35.86 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.39 2.06 . . . . 0.0 110.703 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -121.31 98.63 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 109.595 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.77 126.94 6.0 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 99.13 -21.57 45.13 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HB3' ' CG1' ' A' ' 16' ' ' VAL . . . -40.9 157.06 0.19 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.987 . . . . 0.0 109.513 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.546 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.8 Cg_endo -79.83 139.59 14.0 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.725 2.283 . . . . 0.0 111.659 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 2.8 mm-40 -51.65 -20.52 2.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.537 -0.727 . . . . 0.0 109.099 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 53.9 t -151.62 82.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.209 -0.932 . . . . 0.0 108.759 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.572 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.49 126.88 31.71 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.535 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -110.18 127.33 54.88 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.039 -1.038 . . . . 0.0 109.764 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE2' HD11 ' A' ' 23' ' ' LEU . 3.1 m-85 -124.79 108.84 12.37 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.478 -0.764 . . . . 0.0 109.428 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -152.67 145.3 24.22 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.343 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.588 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -128.72 -164.94 1.44 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.642 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -116.62 53.95 0.87 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.92 -1.112 . . . . 0.0 108.683 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.593 ' CE1' ' CD1' ' A' ' 72' ' ' LEU . 9.6 m-85 -133.88 -5.33 2.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.019 -1.05 . . . . 0.0 110.64 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 0.2 OUTLIER -106.28 171.8 4.48 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.8 -1.188 . . . . 0.0 109.433 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 30' ' ' CYS . 33.5 Cg_endo -75.15 -38.87 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.294 1.996 . . . . 0.0 109.113 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.528 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.5 m80 -84.61 -20.7 30.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -52.56 -40.52 62.64 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.563 ' CE2' ' OE1' ' A' ' 38' ' ' GLU . 40.2 t80 -87.25 -47.45 8.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.69 -0.632 . . . . 0.0 109.619 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -66.18 -21.75 66.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 109.905 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 32' ' ' HIS . 89.1 t80 -83.06 -16.74 45.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.592 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.552 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -132.79 50.77 2.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.77 -1.206 . . . . 0.0 110.636 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.563 ' OE1' ' CE2' ' A' ' 34' ' ' TYR . 1.0 OUTLIER -175.41 -59.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.192 -0.943 . . . . 0.0 110.216 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.6 t -89.99 -46.91 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.204 -0.935 . . . . 0.0 110.733 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 41' ' ' HIS . 77.8 mt -65.99 -6.0 11.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.022 -1.049 . . . . 0.0 110.561 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.446 ' HA ' ' OD1' ' A' ' 44' ' ' ASP . 50.5 m170 44.03 27.0 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.992 -1.067 . . . . 0.0 109.163 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.463 ' CG1' HG23 ' A' ' 175' ' ' VAL . 15.6 mt -78.43 -22.57 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.821 . . . . 0.0 109.957 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.42 ' OG ' ' HG2' ' A' ' 37' ' ' GLU . 47.2 m -80.65 -26.67 37.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.976 -1.078 . . . . 0.0 110.333 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.446 ' OD1' ' HA ' ' A' ' 41' ' ' HIS . 1.9 p-10 -87.44 -49.86 6.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.976 -1.078 . . . . 0.0 110.117 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 46' ' ' VAL . 39.1 p-10 -59.72 -25.26 64.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.214 -0.929 . . . . 0.0 110.028 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.455 HG23 ' SD ' ' A' ' 56' ' ' MET . 9.4 p -65.27 -26.75 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 109.958 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' N ' HG11 ' A' ' 46' ' ' VAL . 3.8 mttt -77.05 -38.29 53.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 109.969 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.48 -23.92 1.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.062 -1.023 . . . . 0.0 109.468 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.467 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.6 33.25 5.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.352 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.517 HD21 ' CG1' ' A' ' 54' ' ' VAL . 13.8 mt -114.79 81.79 7.62 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.872 . . . . 0.0 109.198 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD2' ' CG2' ' A' ' 54' ' ' VAL . 35.6 Cg_endo -77.5 143.85 22.1 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.584 2.189 . . . . 0.0 110.566 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 51' ' ' PRO . 3.5 tm-20 -40.61 120.88 1.34 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 122.361 1.077 . . . . 0.0 109.233 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.39 -28.5 4.76 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.517 ' CG1' HD21 ' A' ' 50' ' ' LEU . 31.9 t -86.37 79.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -1.076 . . . . 0.0 108.849 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -61.07 101.67 0.17 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.422 -0.799 . . . . 0.0 110.528 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.481 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 7.9 ttt -100.67 97.68 8.32 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 1.6 m -94.68 123.5 38.16 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.325 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.535 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 3.1 tppt? -99.63 121.65 41.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.398 -0.814 . . . . 0.0 109.546 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.588 ' CE1' ' HG2' ' A' ' 138' ' ' GLN . 2.0 m-85 -126.05 174.78 8.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.854 -1.154 . . . . 0.0 111.174 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.588 ' CE1' ' HA ' ' A' ' 27' ' ' SER . 22.4 t60 -112.04 145.86 38.95 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.841 0.829 . . . . 0.0 109.378 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.598 ' CG1' ' CG1' ' A' ' 150' ' ' VAL . 8.4 m -80.86 155.73 4.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.325 0.583 . . . . 0.0 109.985 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.444 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . 52.0 p30 -121.02 38.81 3.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.142 -0.973 . . . . 0.0 109.604 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.593 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 2.4 p90 -139.34 57.11 1.66 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.163 -0.96 . . . . 0.0 109.611 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.516 ' HE2' ' CG2' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -125.79 35.23 4.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.134 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.83 -30.83 1.23 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.379 -1.889 . . . . 0.0 108.379 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.46 -35.02 3.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.7 -79.45 0.29 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.74 -1.447 . . . . 0.0 109.939 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.597 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -76.6 -19.14 58.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 108.85 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.508 ' N ' HD12 ' A' ' 68' ' ' LEU . . . -53.48 -54.46 29.91 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -52.99 -41.91 65.06 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.431 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 45.5 t0 -65.76 -31.39 72.35 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.593 ' CD1' ' CE1' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -59.05 -36.08 74.43 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 45.7 m -66.64 -41.74 87.8 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -63.83 -16.43 61.27 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -71.28 -40.6 70.81 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 20.0 t-105 -68.85 -31.35 70.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.519 ' CB ' ' CG2' ' A' ' 135' ' ' VAL . . . -81.0 -62.48 1.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.577 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.641 ' CG1' ' CD2' ' A' ' 122' ' ' TYR . 59.9 t -48.33 -29.1 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.949 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 80' ' ' MET . . . -84.03 -60.52 2.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.885 -1.134 . . . . 0.0 108.875 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -44.5 -28.8 0.62 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.45 -44.48 64.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.805 . . . . 0.0 109.572 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.459 ' O ' HG11 ' A' ' 84' ' ' VAL . 5.8 mt -99.97 11.18 39.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.037 -1.04 . . . . 0.0 110.004 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.38 22.02 6.95 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.459 HG11 ' O ' ' A' ' 82' ' ' LEU . 34.0 m -85.19 -7.81 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -1.076 . . . . 0.0 110.138 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -41.17 -60.3 1.27 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -33.43 7.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 110.345 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -83.29 -52.53 6.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.171 -0.956 . . . . 0.0 111.696 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.526 HG21 ' CD1' ' A' ' 92' ' ' LEU . 1.2 m -77.68 -10.06 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.586 -1.321 . . . . 0.0 110.249 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.596 HG21 ' CG ' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -70.88 -44.69 65.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.851 -1.155 . . . . 0.0 108.889 179.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -53.17 -54.77 40.92 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.448 -1.408 . . . . 0.0 110.477 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.446 ' HD2' ' C ' ' A' ' 88' ' ' VAL . 24.7 Cg_endo -72.8 -18.63 24.68 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 122.639 0.81 . . . . 0.0 109.995 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.527 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 15.0 mt -86.16 -41.75 14.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.235 -0.916 . . . . 0.0 109.09 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.642 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 5.8 m-30 -66.25 -47.61 73.19 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.056 -1.027 . . . . 0.0 109.007 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -31.96 70.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.935 -1.103 . . . . 0.0 109.322 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.464 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -63.06 -32.7 85.04 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.551 HG13 ' CD1' ' A' ' 29' ' ' PHE . 2.0 t -107.19 5.76 9.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.105 -1.232 . . . . 0.0 109.206 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.533 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -107.78 10.69 28.71 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.981 -1.074 . . . . 0.0 110.579 -179.187 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER 176.08 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.519 -1.363 . . . . 0.0 110.144 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 43.0 p -56.62 -44.66 81.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.489 -1.382 . . . . 0.0 109.114 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 99' ' ' THR . 38.2 mt-30 70.42 10.83 7.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.425 -0.797 . . . . 0.0 110.085 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 t -83.27 -5.28 59.08 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.734 0.778 . . . . 0.0 109.143 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.425 HG13 ' C ' ' A' ' 95' ' ' GLY . 12.9 mm -84.57 80.51 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.69 33.38 1.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 110.021 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.544 ' O ' ' N ' ' A' ' 107' ' ' ASP . 1.7 p -161.47 133.78 5.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.953 -1.092 . . . . 0.0 109.893 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.585 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -51.51 -32.62 28.3 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 104' ' ' SER . 5.5 p -61.85 -31.46 71.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -72.02 -49.54 36.07 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.539 ' CD1' HD21 ' A' ' 68' ' ' LEU . 26.9 mt -52.01 -30.9 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.456 ' O ' HD13 ' A' ' 113' ' ' ILE . 19.6 mtt-85 -74.11 -28.54 61.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 109.069 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -66.61 -48.15 70.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.339 -0.851 . . . . 0.0 109.374 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.527 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 49.1 t -65.83 -40.26 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.991 . . . . 0.0 109.507 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.487 ' CE1' HG13 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -57.57 -43.84 84.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.946 -1.096 . . . . 0.0 109.379 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 109' ' ' ARG . 18.7 mt -68.35 -24.8 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 109.623 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -20.11 66.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 109.691 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.47 ' CB ' HD11 ' A' ' 117' ' ' ILE . . . -93.87 9.71 36.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.552 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.44 -5.57 84.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.6 mp -76.65 55.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -1.175 . . . . 0.0 109.032 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -33.01 149.17 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.347 -0.846 . . . . 0.0 110.743 -179.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.8 -28.41 23.36 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -58.8 -47.56 84.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -1.155 . . . . 0.0 108.849 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -80.41 -34.51 36.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.401 -0.812 . . . . 0.0 109.705 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.641 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 3.5 t80 -64.17 -50.22 69.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 109.511 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.62 -35.19 75.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.013 -1.054 . . . . 0.0 108.713 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.6 -51.65 67.65 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.519 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -54.91 -52.06 64.12 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.533 ' CD1' ' C ' ' A' ' 126' ' ' TRP . 6.8 t90 -52.75 -55.61 21.59 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.14 -15.74 2.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.677 -0.639 . . . . 0.0 110.435 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -72.55 176.64 5.27 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.909 -1.119 . . . . 0.0 109.845 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -87.33 -39.0 15.73 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.179 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.43 -44.86 83.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 C-N-CA 118.254 -1.378 . . . . 0.0 109.789 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 2.8 t -67.02 -38.87 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.809 -1.182 . . . . 0.0 108.685 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -67.93 -29.37 68.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.89 -34.47 71.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.428 -0.795 . . . . 0.0 109.235 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.12 -21.41 43.24 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.277 -0.889 . . . . 0.0 108.617 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.519 ' CG2' ' CB ' ' A' ' 77' ' ' ALA . 17.9 t -81.48 -45.6 20.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.26 83.87 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -32.83 74.28 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.588 ' HG2' ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -60.15 -69.56 0.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.436 -0.79 . . . . 0.0 109.073 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.465 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 6.3 tm-20 -48.61 -33.38 9.74 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.457 ' HA ' ' HB1' ' A' ' 143' ' ' ALA . 9.5 tttm -68.72 -40.78 79.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.426 -0.796 . . . . 0.0 109.038 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.472 ' O ' ' OD2' ' A' ' 144' ' ' ASP . . . -55.52 -55.32 33.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 108.618 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.53 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -70.15 -22.97 62.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.345 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 139' ' ' GLU . . . -78.5 -26.51 45.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.069 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.541 ' OD1' ' CG1' ' A' ' 145' ' ' VAL . 1.4 p30 -82.8 -47.73 11.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.939 -1.1 . . . . 0.0 108.271 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.543 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 14.7 m -85.82 -17.05 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.8 OUTLIER 81.92 -47.54 0.2 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.449 0.643 . . . . 0.0 109.643 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.472 HD12 ' HB3' ' A' ' 25' ' ' PHE . 14.3 tp 67.33 131.63 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.449 -0.782 . . . . 0.0 109.421 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 148' ' ' ARG . 2.7 ptt85 -161.46 39.04 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.565 -1.335 . . . . 0.0 110.02 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 161.06 108.28 0.23 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.38 -1.39 . . . . 0.0 110.37 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.598 ' CG1' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -91.88 144.72 29.73 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.371 -1.076 . . . . 0.0 109.792 179.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.461 ' HG2' ' HG2' ' A' ' 163' ' ' PRO . 33.6 Cg_endo -77.09 152.23 94.54 Favored 'Cis proline' 0 C--N 1.317 -1.124 0 C-N-CA 124.1 -1.208 . . . . 0.0 110.501 0.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -126.63 152.26 46.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.426 -1.421 . . . . 0.0 109.353 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 2.6 tmm? -151.21 135.61 16.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.123 -0.986 . . . . 0.0 109.656 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.503 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 51.0 m-85 -137.1 124.54 22.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.418 -0.801 . . . . 0.0 110.311 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.505 ' O ' ' ND2' ' A' ' 156' ' ' ASN . 52.0 t -92.34 130.48 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.747 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 155' ' ' VAL . 3.9 p30 45.55 22.42 0.1 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.046 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.523 ' N ' ' HB2' ' A' ' 19' ' ' ALA . . . 58.82 56.56 24.64 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.483 ' HB2' ' OD1' ' A' ' 156' ' ' ASN . 0.0 OUTLIER -165.77 -36.85 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.299 -1.118 . . . . 0.0 108.169 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.479 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 75.9 m-85 -115.34 123.44 48.73 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.518 ' CG ' HG21 ' A' ' 10' ' ' THR . 20.8 pt20 -123.3 134.74 54.03 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.94 -1.1 . . . . 0.0 109.877 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.9 mt -70.95 177.83 3.48 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.445 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -147.76 65.95 9.43 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 120.878 -1.139 . . . . 0.0 110.02 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.461 ' HG2' ' HG2' ' A' ' 151' ' ' PRO . 36.0 Cg_endo . . . . . 0 C--N 1.308 -1.56 0 C-N-CA 122.575 2.183 . . . . 0.0 109.988 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 3.5 mtt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.676 0.75 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 173' ' ' VAL . 0.0 OUTLIER -75.43 -60.56 2.25 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 172' ' ' ASP . 4.9 t -64.69 -30.69 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.318 -0.864 . . . . 0.0 109.473 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -67.22 -45.32 77.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.665 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.463 HG23 ' CG1' ' A' ' 42' ' ' ILE . 70.7 t -73.63 -25.17 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.444 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.87 -57.53 3.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.526 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.97 -47.51 74.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.108 -0.995 . . . . 0.0 109.299 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.408 ' HA ' ' OG1' ' A' ' 181' ' ' THR . 31.9 t80 -59.15 -57.24 13.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.962 . . . . 0.0 109.128 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 175' ' ' VAL . . . -51.13 -29.08 12.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.33 -0.856 . . . . 0.0 109.14 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -77.89 -47.0 19.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.334 -0.853 . . . . 0.0 109.202 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.506 ' CG2' ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -50.3 -32.83 18.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.349 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 1.4 t -85.74 -37.62 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.981 . . . . 0.0 108.952 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.45 ' O ' ' OG ' ' A' ' 186' ' ' SER . 16.6 ttpt -60.38 -46.13 91.06 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.281 -0.887 . . . . 0.0 109.037 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -78.93 -27.15 43.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.233 -0.917 . . . . 0.0 108.98 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.474 HD21 ' N ' ' A' ' 185' ' ' LEU . 0.3 OUTLIER -65.69 -19.59 65.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.863 -1.148 . . . . 0.0 108.925 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 183' ' ' LYS . 15.0 p -77.88 -13.04 60.02 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.834 -1.166 . . . . 0.0 108.745 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 O-C-N 121.307 -0.871 . . . . 0.0 109.329 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.577 ' HB3' ' HB2' ' A' ' 8' ' ' GLN . 4.3 p90 . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.432 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 4.7 mt-10 -114.94 64.57 0.68 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.826 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 4.0 m-20 70.18 96.74 0.07 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.307 -0.871 . . . . 0.0 110.473 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.15 -3.4 81.02 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -100.48 26.98 6.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -1.172 . . . . 0.0 108.533 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.582 ' CB ' ' O ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER 150.42 -35.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.598 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -156.98 131.25 8.49 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.669 -1.269 . . . . 0.0 109.796 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.44 HG21 ' HG3' ' A' ' 160' ' ' GLN . 4.5 t -114.44 174.99 5.68 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.59 152.28 20.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.653 -0.655 . . . . 0.0 109.707 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.485 ' HG ' ' HG2' ' A' ' 160' ' ' GLN . 1.4 mt -92.56 161.31 14.65 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.396 -0.815 . . . . 0.0 109.517 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -84.93 -18.72 33.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.171 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -140.34 110.17 6.93 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.366 -0.833 . . . . 0.0 108.899 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 36.2 Cg_endo -77.22 167.9 24.0 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.352 2.034 . . . . 0.0 111.29 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.448 HG12 ' HB3' ' A' ' 144' ' ' ASP . 7.7 t -128.19 93.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.93 127.54 16.61 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 97.63 -20.8 49.21 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.515 ' HB2' ' N ' ' A' ' 157' ' ' GLY . . . -40.01 159.52 0.13 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.928 . . . . 0.0 109.347 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.559 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 34.9 Cg_endo -77.52 128.26 9.42 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.459 2.106 . . . . 0.0 111.35 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.511 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 10.3 mp0 -41.4 -25.56 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.529 -0.732 . . . . 0.0 109.724 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 21' ' ' GLN . 8.6 t -149.21 84.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.068 -1.02 . . . . 0.0 108.872 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.559 ' HG ' ' CG ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -77.35 126.13 30.43 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.541 ' N ' HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -118.46 104.03 10.31 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.076 -1.015 . . . . 0.0 109.732 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 5.2 m-85 -90.05 123.46 33.95 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.304 -0.873 . . . . 0.0 109.609 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 1.0 OUTLIER -160.91 140.23 10.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.231 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.585 ' HB2' ' CD2' ' A' ' 29' ' ' PHE . 11.1 p -116.29 174.97 5.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 110.183 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 8.3 m-30 -89.3 37.6 0.87 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.501 -0.749 . . . . 0.0 109.021 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 3.2 m-85 -135.65 18.92 3.31 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.773 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.473 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 3.8 m -112.79 164.07 16.35 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.819 -1.176 . . . . 0.0 109.428 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.9 Cg_endo -74.74 -13.19 22.09 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.014 1.809 . . . . 0.0 108.321 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.572 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 36.5 m170 -100.2 -29.7 12.33 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 34' ' ' TYR . 6.1 p -44.58 -40.51 5.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.636 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 21.1 t80 -88.22 -45.49 10.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.789 -0.57 . . . . 0.0 110.259 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -68.54 -22.39 64.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 111.12 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 32' ' ' HIS . 1.6 m-85 -80.16 -25.0 40.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.801 -1.187 . . . . 0.0 110.588 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' O ' ' CD ' ' A' ' 38' ' ' GLU . 0.4 OUTLIER -117.94 32.46 6.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.899 -1.126 . . . . 0.0 110.073 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.447 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 67.6 mm-40 -146.52 -63.83 0.3 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -0.995 . . . . 0.0 110.566 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 40' ' ' LEU . 4.0 t -101.75 -66.8 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.034 -1.041 . . . . 0.0 110.741 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.44 HD11 HD13 ' A' ' 42' ' ' ILE . 58.0 mt -42.92 -34.21 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 31.8 m170 57.27 20.32 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.172 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.52 HG23 ' CE2' ' A' ' 36' ' ' PHE . 8.5 mt -58.92 -24.32 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.619 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.6 m -77.17 -60.88 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.927 . . . . 0.0 109.722 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -70.84 -33.6 70.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.0 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 45' ' ' ASN . 12.5 t-20 -60.79 -49.73 76.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.661 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.3 t -77.27 -16.89 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.898 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -27.74 58.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.045 -1.035 . . . . 0.0 109.646 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -72.28 -22.86 61.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -0.974 . . . . 0.0 109.516 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 24.0 mtmt -97.54 -3.27 40.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.871 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.457 HD21 ' HB ' ' A' ' 54' ' ' VAL . 13.1 mt -73.5 113.42 22.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 109.679 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 54' ' ' VAL . 36.7 Cg_endo -78.54 138.4 15.36 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.174 1.916 . . . . 0.0 110.599 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 51' ' ' PRO . 23.4 tt0 -40.79 119.64 1.16 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.086 0.946 . . . . 0.0 109.573 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.32 -25.77 5.08 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.532 ' CG2' ' HD2' ' A' ' 51' ' ' PRO . 4.5 t -85.33 88.29 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -1.187 . . . . 0.0 109.358 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HE3' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -69.77 99.91 1.43 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.956 -179.666 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.45 ' HG3' HG13 ' A' ' 22' ' ' VAL . 1.8 ttt -92.7 100.63 13.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.573 -0.704 . . . . 0.0 109.321 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.457 ' OG1' ' HE3' ' A' ' 55' ' ' LYS . 89.8 m -95.39 139.89 31.05 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.136 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.547 ' O ' ' NE1' ' A' ' 76' ' ' TRP . 1.4 mppt? -118.14 105.46 11.84 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.589 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.0 m-85 -103.59 164.36 11.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.597 -1.315 . . . . 0.0 111.109 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.587 ' CD2' ' CD2' ' A' ' 72' ' ' LEU . 6.8 t-80 -116.28 134.6 54.73 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.721 0.772 . . . . 0.0 109.141 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.582 ' O ' ' CE1' ' A' ' 60' ' ' HIS . 2.6 m -104.97 160.73 5.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 O-C-N 121.666 -0.646 . . . . 0.0 110.123 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.509 ' HB3' ' N ' ' A' ' 70' ' ' LYS . 1.7 p-10 -103.85 54.53 0.74 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.512 ' CE1' ' HB ' ' A' ' 61' ' ' VAL . 4.9 m-85 -100.73 61.55 1.0 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.671 -0.643 . . . . 0.0 109.764 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.585 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -161.65 -56.66 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.891 -1.124 . . . . 0.0 111.6 179.326 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.585 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -114.82 -18.37 6.48 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.44 -42.63 1.98 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.07 -77.69 0.35 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -1.152 . . . . 0.0 109.45 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.524 ' CD1' ' OD2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -62.13 -21.61 65.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.45 ' N ' ' CD2' ' A' ' 68' ' ' LEU . . . -60.85 -64.93 3.66 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.509 ' N ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -54.61 -42.47 71.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.249 -1.147 . . . . 0.0 108.502 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.535 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 21.7 t0 -64.93 -29.33 70.26 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.621 ' CD1' ' CZ ' ' A' ' 29' ' ' PHE . 3.5 tt -66.58 -35.4 80.12 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 1.6 m -59.16 -41.73 89.1 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 177.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -61.32 -24.51 66.49 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -65.28 -34.23 77.86 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.554 ' CH2' ' OE2' ' A' ' 85' ' ' GLU . 53.0 t-105 -71.15 -31.86 68.21 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.528 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -79.16 -58.95 2.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.337 -0.852 . . . . 0.0 109.411 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.633 ' CG2' ' CE1' ' A' ' 122' ' ' TYR . 93.9 t -53.65 -27.55 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 109.981 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 75' ' ' ALA . . . -81.97 -61.27 1.96 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.984 -1.073 . . . . 0.0 108.654 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 3.1 tpt -49.17 -26.28 2.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.473 ' HB1' HG12 ' A' ' 131' ' ' VAL . . . -77.46 -36.5 52.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.531 -0.731 . . . . 0.0 109.563 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.463 ' O ' HG11 ' A' ' 84' ' ' VAL . 83.1 mt -105.81 8.89 32.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 0.0 110.75 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 54.25 27.89 40.95 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.57 HG22 ' CE1' ' A' ' 112' ' ' PHE . 32.6 m -99.67 29.17 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.461 -1.023 . . . . 0.0 110.049 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.554 ' OE2' ' CH2' ' A' ' 76' ' ' TRP . 5.2 mt-10 -62.88 -79.57 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.133 -0.979 . . . . 0.0 109.641 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -36.41 -37.63 0.13 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.345 0.593 . . . . 0.0 110.805 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.529 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 5.1 mtpt -70.85 -56.72 5.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.402 -0.811 . . . . 0.0 111.459 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.496 ' O ' ' CG ' ' A' ' 92' ' ' LEU . 1.3 m -86.74 -15.11 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.613 -1.304 . . . . 0.0 110.592 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.608 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -74.62 -42.52 58.46 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.589 -1.319 . . . . 0.0 108.341 178.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.406 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -54.68 -53.75 56.85 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.701 -1.249 . . . . 0.0 110.615 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 25.9 Cg_endo -73.07 -19.89 22.39 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 N-CA-C 109.829 -0.873 . . . . 0.0 109.829 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.548 HD22 ' CG2' ' A' ' 111' ' ' VAL . 21.9 mt -83.78 -42.62 16.3 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.608 ' CG ' HG21 ' A' ' 89' ' ' THR . 7.4 m-30 -64.83 -45.74 84.88 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.029 -1.044 . . . . 0.0 108.649 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -72.47 -28.6 63.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.171 -0.956 . . . . 0.0 109.254 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.07 -32.07 82.9 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.536 HG23 ' CB ' ' A' ' 102' ' ' ILE . 2.5 t -99.8 -6.83 9.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.194 -1.18 . . . . 0.0 109.245 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.636 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -108.71 7.5 26.44 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 120.935 -1.103 . . . . 0.0 111.037 -179.279 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.541 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.9 OUTLIER -175.63 66.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.516 -1.365 . . . . 0.0 109.55 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.08 -48.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.8 -0.563 . . . . 0.0 109.639 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.6 mt-30 74.26 17.7 3.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.197 -0.939 . . . . 0.0 110.276 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.8 t -79.93 -6.53 57.65 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.536 ' CB ' HG23 ' A' ' 96' ' ' VAL . 11.1 mm -89.72 71.08 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.716 -0.615 . . . . 0.0 109.345 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.406 ' N ' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -136.87 16.19 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 109.235 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -142.64 126.88 17.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.402 -0.811 . . . . 0.0 109.402 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.432 ' N ' ' HB2' ' A' ' 68' ' ' LEU . . . -49.37 -37.32 24.47 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 p -55.86 -31.63 62.94 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -74.14 -47.76 33.91 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.911 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 71' ' ' ASP . 30.4 mt -48.41 -29.34 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.911 -1.118 . . . . 0.0 108.582 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -74.37 -47.41 34.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 109.614 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -51.98 -40.39 60.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 109.37 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.548 ' CG2' HD22 ' A' ' 92' ' ' LEU . 2.4 t -71.18 -40.1 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.164 -0.96 . . . . 0.0 109.532 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.57 ' CE1' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -65.47 -33.46 75.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.564 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mt -76.42 -25.4 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.917 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -65.39 -20.0 66.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.059 -1.026 . . . . 0.0 109.61 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.458 ' HB1' HG11 ' A' ' 88' ' ' VAL . . . -90.05 4.72 49.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 109.722 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.6 0.37 69.65 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.507 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.5 mm -79.5 60.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -1.149 . . . . 0.0 109.555 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 117' ' ' ILE . 64.7 mttt -34.85 153.17 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.257 -0.902 . . . . 0.0 110.45 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.459 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -59.69 -27.69 64.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -66.45 -43.92 84.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -1.17 . . . . 0.0 109.607 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.0 -50.05 45.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.327 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CE1' ' CG2' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -65.34 -56.35 13.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.369 -0.832 . . . . 0.0 108.845 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 27.5 t70 -45.56 -39.22 7.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.101 -0.999 . . . . 0.0 108.892 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.69 -44.36 61.89 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.302 -0.874 . . . . 0.0 108.791 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.496 ' O ' ' HB ' ' A' ' 131' ' ' VAL . . . -54.63 -49.09 71.34 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -59.27 -58.74 7.29 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -53.86 -15.97 1.58 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.585 -0.697 . . . . 0.0 110.119 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -70.74 175.47 4.95 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.96 -1.088 . . . . 0.0 109.766 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.58 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 41.4 p90 -94.09 -37.03 11.82 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.776 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.58 ' CG2' ' CE2' ' A' ' 129' ' ' PHE . 25.0 t -67.18 -47.91 80.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.13 -1.428 . . . . 0.0 109.578 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 125' ' ' ALA . 16.6 t -63.41 -40.24 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.977 -1.077 . . . . 0.0 108.561 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -37.71 85.18 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.456 -0.778 . . . . 0.0 109.056 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -29.5 70.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.057 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.443 ' O ' HD21 ' A' ' 134' ' ' LEU . 0.4 OUTLIER -77.12 -30.8 55.36 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.528 HG22 ' CB ' ' A' ' 77' ' ' ALA . 9.8 t -76.04 -41.15 38.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.6 -48.72 80.56 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -37.17 82.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 109.139 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.589 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 18.9 tm0? -55.87 -62.42 1.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.037 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.433 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 11.6 mt-10 -48.35 -33.57 9.2 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -72.46 -29.29 63.54 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.351 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.581 ' HB3' ' CE2' ' A' ' 59' ' ' TYR . . . -62.46 -57.19 12.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 108.712 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -68.55 -35.87 78.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.519 -0.738 . . . . 0.0 110.036 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 139' ' ' GLU . . . -77.81 -16.64 58.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.043 -1.035 . . . . 0.0 109.835 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.448 ' HB3' HG12 ' A' ' 16' ' ' VAL . 5.7 m-20 -81.49 -43.76 18.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -0.966 . . . . 0.0 108.95 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.54 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 29.7 m -105.03 -9.4 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 108.885 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.54 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.9 OUTLIER 82.24 -43.72 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.519 -0.738 . . . . 0.0 109.876 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.582 ' CD2' ' CG1' ' A' ' 61' ' ' VAL . 14.1 tp 64.5 134.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.35 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -160.75 32.85 0.15 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.533 -1.354 . . . . 0.0 110.002 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 151' ' ' PRO . . . 175.01 77.97 0.05 OUTLIER Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.995 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.481 HG13 HG12 ' A' ' 61' ' ' VAL . 3.8 m -80.15 135.91 54.13 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.119 -1.224 . . . . 0.0 107.92 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 149' ' ' GLY . 30.9 Cg_endo -71.18 152.85 96.04 Favored 'Cis proline' 0 C--N 1.317 -1.098 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.508 2.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . . . -140.29 159.84 41.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.689 -1.257 . . . . 0.0 109.026 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.53 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 30.3 tpp -142.65 138.18 30.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.024 -1.048 . . . . 0.0 110.369 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.561 ' N ' ' CD1' ' A' ' 154' ' ' PHE . 6.3 m-85 -143.22 127.34 17.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.436 -0.79 . . . . 0.0 109.577 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 54.9 t -103.95 130.59 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.026 . . . . 0.0 109.501 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 155' ' ' VAL . 1.9 t-20 45.62 26.39 0.33 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.515 ' N ' ' HB2' ' A' ' 19' ' ' ALA . . . 52.07 27.46 22.61 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.402 -1.38 . . . . 0.0 109.88 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.66 -15.96 4.35 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.735 -1.45 . . . . 0.0 109.308 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -143.1 125.6 15.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.001 . . . . 0.0 109.149 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 153' ' ' MET . 1.1 pt20 -119.7 139.4 52.31 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.03 -1.044 . . . . 0.0 109.778 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.444 ' HG ' ' HB3' ' A' ' 153' ' ' MET . 7.7 mt -75.78 173.41 11.17 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -158.6 87.08 2.32 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 109.758 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 C--N 1.31 -1.465 0 C-N-CA 122.872 2.381 . . . . 0.0 111.225 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.444 ' O ' HG22 ' A' ' 175' ' ' VAL . 4.9 mmt . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.662 0.744 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.11 -63.13 1.29 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.352 0.596 . . . . 0.0 109.474 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 4.0 t -67.3 -18.27 23.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.153 -0.967 . . . . 0.0 109.475 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -76.52 -47.16 23.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.101 -1.0 . . . . 0.0 109.663 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 171' ' ' MET . 15.2 t -70.91 -25.05 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 109.376 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -80.63 -61.01 2.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.263 -0.898 . . . . 0.0 109.257 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 173' ' ' VAL . 0.5 OUTLIER -55.12 -42.72 73.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.218 -0.927 . . . . 0.0 109.198 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.515 ' CE1' HG22 ' A' ' 182' ' ' VAL . 9.7 t80 -61.32 -48.65 80.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.281 -0.887 . . . . 0.0 109.364 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.67 -30.07 65.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.343 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -77.38 -43.47 32.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.495 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.502 ' O ' ' CG ' ' A' ' 185' ' ' LEU . 0.1 OUTLIER -57.75 -34.09 69.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.0 . . . . 0.0 109.465 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.515 HG22 ' CE1' ' A' ' 178' ' ' TYR . 51.7 t -78.45 -36.09 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.154 -0.966 . . . . 0.0 109.044 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -52.04 67.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.289 -0.882 . . . . 0.0 109.169 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -77.11 -32.0 56.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.296 -0.878 . . . . 0.0 109.263 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.532 HD21 ' N ' ' A' ' 185' ' ' LEU . 0.2 OUTLIER -62.67 -17.06 59.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.06 -1.025 . . . . 0.0 109.653 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.519 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 87.8 p -73.08 -12.3 60.86 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.856 -1.153 . . . . 0.0 108.709 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.423 -0.798 . . . . 0.0 109.386 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.41 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 1.6 pt-20 -105.84 54.96 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.588 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 4' ' ' GLU . 1.2 m-20 42.48 82.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.751 -0.593 . . . . 0.0 110.1 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 131.88 -29.22 3.42 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.701 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 5.4 tptt -83.18 -69.05 0.66 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.869 -1.371 . . . . 0.0 109.27 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 77.6 mm-40 -92.97 2.01 57.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.744 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 6' ' ' GLY . 1.1 p90 176.67 132.38 0.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.078 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.5 ' CG2' ' CD ' ' A' ' 160' ' ' GLN . 11.3 t -112.26 -179.63 3.73 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 m -116.62 139.61 50.32 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.487 0.66 . . . . 0.0 109.615 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.439 HD13 ' C ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -95.18 169.83 9.82 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.389 -0.819 . . . . 0.0 109.375 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 14.3 mp0 -98.19 12.35 34.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 109.82 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 5.4 mtmt -141.51 80.47 16.2 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.925 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -79.13 159.26 26.8 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.719 2.279 . . . . 0.0 109.986 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.537 ' CG2' ' OD1' ' A' ' 144' ' ' ASP . 3.4 t -126.72 97.86 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.093 -1.004 . . . . 0.0 110.154 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.79 128.54 8.82 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 93.03 -14.9 64.14 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.644 -1.783 . . . . 0.0 108.644 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.562 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -39.25 161.7 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.946 . . . . 0.0 110.095 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.558 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.2 Cg_endo -78.56 127.53 8.13 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.746 2.297 . . . . 0.0 111.201 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 2.0 mm-40 -42.35 -24.48 0.05 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.511 -0.743 . . . . 0.0 109.798 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 22' ' ' VAL . 8.1 t -147.14 86.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.009 -1.057 . . . . 0.0 108.75 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.645 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -79.88 125.55 29.87 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.516 ' N ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -105.55 97.95 7.71 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.175 -0.953 . . . . 0.0 110.438 -178.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.645 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 4.7 m-85 -89.58 106.41 18.44 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 3.2 p90 -153.32 143.6 22.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.044 -1.035 . . . . 0.0 109.946 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.593 ' HB3' ' CE1' ' A' ' 60' ' ' HIS . 2.3 p -126.44 -165.02 1.39 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.68 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -115.67 53.46 0.84 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.758 -1.213 . . . . 0.0 108.224 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.567 ' CE1' HD21 ' A' ' 72' ' ' LEU . 9.1 m-85 -137.71 0.35 2.22 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.411 -0.806 . . . . 0.0 110.645 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.574 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 5.1 m -111.27 169.11 6.65 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.782 -1.199 . . . . 0.0 108.604 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 30.7 Cg_endo -73.97 -54.73 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.712 1.608 . . . . 0.0 109.344 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -68.66 -19.08 64.38 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 177.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -50.49 -47.47 57.15 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.596 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 5.7 t80 -79.82 -37.04 35.97 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.515 -0.74 . . . . 0.0 109.748 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 8.4 mm-40 -70.85 -25.08 62.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 110.054 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -83.74 -15.68 47.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.166 -0.959 . . . . 0.0 110.943 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.7 mm-40 -131.22 44.28 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.728 -1.232 . . . . 0.0 111.202 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -174.07 -60.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.004 . . . . 0.0 110.984 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.4 t -90.18 -53.45 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.045 -1.034 . . . . 0.0 111.143 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.587 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 94.8 mt -59.4 -11.24 4.04 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.977 -1.077 . . . . 0.0 110.76 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 56.8 p-80 41.31 28.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 109.663 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.465 ' O ' HG21 ' A' ' 46' ' ' VAL . 19.4 mt -68.71 -33.23 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 109.272 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 43.7 p -72.87 -26.05 61.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 109.877 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.09 -54.41 4.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 0.0 109.83 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -52.09 -53.99 35.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.163 -0.961 . . . . 0.0 109.755 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 42' ' ' ILE . 19.1 m -57.53 -35.32 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.53 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.488 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -70.78 -39.33 73.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -60.26 -22.77 63.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -111.22 9.44 21.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 0.0 109.807 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.488 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 8.3 mt -78.65 130.14 71.84 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 110.042 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.45 ' C ' ' H ' ' A' ' 53' ' ' GLY . 35.3 Cg_endo -78.47 154.05 27.5 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.408 2.072 . . . . 0.0 108.863 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 52' ' ' GLU . 11.8 tt0 -69.84 21.66 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.473 -1.392 . . . . 0.0 111.54 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 51' ' ' PRO . . . -121.61 29.99 5.48 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.468 ' CG2' ' HB2' ' A' ' 186' ' ' SER . 43.9 t -145.6 117.21 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.09 107.35 19.15 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.415 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -91.39 96.36 10.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -91.78 140.22 29.91 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.961 -1.095 . . . . 0.0 110.342 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.32 112.15 21.13 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.484 -0.76 . . . . 0.0 109.594 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 1.9 m-85 -116.67 167.43 11.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -0.964 . . . . 0.0 110.678 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' A' ' 27' ' ' SER . 54.8 t-80 -108.23 131.41 54.71 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.544 ' CG1' ' CG1' ' A' ' 150' ' ' VAL . 1.8 m -69.48 151.47 9.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.648 -0.658 . . . . 0.0 110.033 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 4.4 p-10 -116.57 42.61 2.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.594 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 1.6 p90 -144.48 59.15 1.33 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.153 -0.967 . . . . 0.0 109.67 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.49 ' CE ' ' SG ' ' A' ' 30' ' ' CYS . 0.4 OUTLIER -129.98 36.5 4.03 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.402 -0.811 . . . . 0.0 109.126 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.58 -32.02 0.34 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.17 -40.26 3.09 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -88.34 -79.55 0.3 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.109 -1.23 . . . . 0.0 110.628 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.614 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -79.68 -18.29 51.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.866 -1.146 . . . . 0.0 109.564 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.427 ' H ' HD11 ' A' ' 68' ' ' LEU . . . -53.19 -46.62 62.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -44.35 94.98 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.76 -27.66 67.78 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.582 HD22 ' CE1' ' A' ' 60' ' ' HIS . 27.8 tp -60.97 -44.8 96.83 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.486 ' CG2' ' HB3' ' A' ' 138' ' ' GLN . 1.6 m -60.3 -42.9 96.5 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.556 ' O ' ' CG2' ' A' ' 78' ' ' VAL . 1.6 tt0 -55.61 -26.14 42.4 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -67.41 -42.07 83.86 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -58.43 -28.2 65.04 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.477 ' CB ' HG21 ' A' ' 135' ' ' VAL . . . -85.94 -43.15 13.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.525 -0.734 . . . . 0.0 110.274 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.645 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 1.2 t -68.74 -30.87 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.903 -1.123 . . . . 0.0 109.693 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -82.63 -55.78 4.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.01 -1.057 . . . . 0.0 108.374 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.412 ' SD ' HD23 ' A' ' 134' ' ' LEU . 3.0 ttt -49.67 -28.55 6.07 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.98 -39.0 66.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.501 -0.749 . . . . 0.0 109.183 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.413 ' O ' HG11 ' A' ' 84' ' ' VAL . 66.1 mt -101.28 8.64 42.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.262 -0.899 . . . . 0.0 110.23 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.97 24.05 7.96 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 85' ' ' GLU . 33.5 m -90.27 1.44 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -1.092 . . . . 0.0 110.173 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 89' ' ' THR . 2.5 mt-10 -44.68 -66.79 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.979 -1.076 . . . . 0.0 109.436 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -41.03 -34.16 0.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.432 -0.793 . . . . 0.0 110.109 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -80.99 -51.41 8.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.329 -0.857 . . . . 0.0 111.294 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.522 HG21 ' CD1' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -87.18 -11.46 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.622 -1.299 . . . . 0.0 110.896 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.597 HG21 ' CD1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -71.64 -43.94 65.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.731 -1.231 . . . . 0.0 108.893 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.404 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -54.1 -54.26 49.35 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.515 -1.366 . . . . 0.0 110.657 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.451 ' HD2' ' C ' ' A' ' 88' ' ' VAL . 27.1 Cg_endo -72.86 -18.1 24.93 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 N-CA-C 109.844 -0.868 . . . . 0.0 109.844 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.522 ' CD1' HG21 ' A' ' 88' ' ' VAL . 17.5 mt -86.62 -43.73 12.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.892 . . . . 0.0 108.874 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.68 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 5.1 m-30 -63.53 -48.1 78.9 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.043 -1.036 . . . . 0.0 108.486 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.84 -29.28 63.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 108.977 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.403 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -57.05 -39.0 88.96 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.525 HG23 ' CB ' ' A' ' 102' ' ' ILE . 1.9 t -100.36 -3.37 9.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.211 -1.17 . . . . 0.0 109.387 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.596 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -101.56 2.6 39.2 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 120.853 -1.154 . . . . 0.0 110.714 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.553 ' O ' ' CG2' ' A' ' 99' ' ' THR . 1.1 mmtp -175.18 72.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.692 -1.255 . . . . 0.0 109.387 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.553 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.28 -49.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 99' ' ' THR . 3.0 mt-30 72.8 15.0 4.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 110.597 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 t -82.93 -7.85 59.62 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.859 0.838 . . . . 0.0 108.797 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.525 ' CB ' HG23 ' A' ' 96' ' ' VAL . 9.1 mm -82.44 69.63 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 32.56 3.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.729 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.541 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 32.1 p -156.56 131.0 8.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.989 -1.069 . . . . 0.0 110.201 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.572 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -49.79 -34.21 18.8 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.83 -34.74 75.02 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -66.15 -50.71 63.02 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.535 HD13 ' HB2' ' A' ' 68' ' ' LEU . 24.6 mt -49.38 -28.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.771 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -39.03 47.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.926 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 1.1 p30 -59.84 -46.08 90.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.114 -0.991 . . . . 0.0 109.626 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 58.7 t -68.65 -39.74 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.936 -1.103 . . . . 0.0 109.25 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.425 ' O ' ' HB ' ' A' ' 117' ' ' ILE . 1.9 m-85 -59.9 -42.84 94.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.181 -0.95 . . . . 0.0 109.544 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.0 mt -69.85 -23.83 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 109.403 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 110' ' ' ASP . 1.9 m-80 -63.33 -17.99 63.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 109.592 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.467 ' CB ' HD11 ' A' ' 117' ' ' ILE . . . -99.08 11.51 38.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.912 . . . . 0.0 109.344 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.35 -7.71 81.42 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.563 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.8 mp -77.32 55.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -1.077 . . . . 0.0 109.252 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 117' ' ' ILE . 3.0 mtmp? -35.19 149.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.215 -0.928 . . . . 0.0 110.475 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 123' ' ' ASP . . . -53.57 -27.91 35.74 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -61.86 -59.06 5.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.034 -1.274 . . . . 0.0 109.363 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -64.76 -41.95 95.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 109.226 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.645 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 3.1 t80 -56.5 -48.9 76.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.008 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.2 OUTLIER -59.97 -30.87 69.4 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.887 . . . . 0.0 109.064 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.43 -51.36 60.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.344 -0.847 . . . . 0.0 108.852 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 131' ' ' VAL . . . -51.89 -52.8 47.26 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.405 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 3.7 t-105 -57.87 -56.49 21.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.81 -16.17 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 110.282 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 50.2 m -74.03 173.69 9.67 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.901 -1.124 . . . . 0.0 109.991 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -90.63 -38.62 13.0 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.463 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.467 ' O ' ' OG ' ' A' ' 133' ' ' SER . 41.1 t -64.77 -47.17 89.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.085 -1.446 . . . . 0.0 109.244 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 125' ' ' ALA . 15.6 t -62.56 -32.66 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -67.89 -39.41 83.65 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 130' ' ' VAL . 90.0 p -61.74 -34.59 76.09 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.412 HD23 ' SD ' ' A' ' 80' ' ' MET . 0.4 OUTLIER -79.18 -18.36 53.2 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.288 -0.882 . . . . 0.0 108.662 179.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.477 HG21 ' CB ' ' A' ' 77' ' ' ALA . 3.5 t -80.17 -47.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.43 -32.87 74.43 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.424 ' O ' ' HB1' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -71.58 -33.53 69.14 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.577 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 8.9 mt-30 -74.24 -66.98 0.66 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 108.955 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.456 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 1.8 tt0 -45.36 -43.96 11.38 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.472 ' O ' ' OD2' ' A' ' 144' ' ' ASP . 0.1 OUTLIER -69.78 -28.39 65.7 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -56.19 -63.5 1.17 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.37 -0.831 . . . . 0.0 108.874 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.54 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -73.57 -19.43 60.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 109.834 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 139' ' ' GLU . . . -79.31 -29.48 42.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.01 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.537 ' OD1' ' CG2' ' A' ' 16' ' ' VAL . 2.8 p30 -81.85 -45.04 16.08 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.613 ' CG2' ' CE2' ' A' ' 25' ' ' PHE . 24.7 m -87.26 -14.91 9.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.54 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.5 tp-100 79.65 -50.5 0.39 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.63 -0.669 . . . . 0.0 109.501 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.513 HD21 ' CD1' ' A' ' 25' ' ' PHE . 12.2 tp 62.09 134.46 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.482 -0.761 . . . . 0.0 109.281 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -160.77 27.76 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.573 -1.33 . . . . 0.0 109.725 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 179.56 102.93 0.17 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.331 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.544 ' CG1' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.92 144.06 27.87 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 0.0 109.175 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.405 ' O ' ' HG3' ' A' ' 163' ' ' PRO . 35.7 Cg_endo -77.65 153.07 93.75 Favored 'Cis proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.946 -1.272 . . . . 0.0 110.649 0.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.467 ' HB1' HD12 ' A' ' 147' ' ' LEU . . . -129.43 130.05 45.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.39 -1.444 . . . . 0.0 109.408 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -119.59 115.57 24.25 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.256 -0.903 . . . . 0.0 109.152 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.547 ' CD1' ' CB ' ' A' ' 160' ' ' GLN . 13.7 m-30 -115.01 127.5 55.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.207 -0.933 . . . . 0.0 110.804 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 24.4 t -96.81 131.99 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.918 . . . . 0.0 109.684 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.422 ' C ' ' HB1' ' A' ' 19' ' ' ALA . 2.8 t-20 45.32 22.3 0.08 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.407 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.562 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.16 58.04 16.17 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -166.52 -36.1 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.426 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 96.4 m-85 -116.34 123.19 47.02 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.547 ' CB ' ' CD1' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -117.89 112.97 21.05 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.296 -0.877 . . . . 0.0 109.873 -179.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.37 170.68 1.26 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 109.063 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 162' ' ' ASN . 26.3 p-10 -131.42 113.29 15.58 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.548 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.405 ' HG3' ' O ' ' A' ' 151' ' ' PRO . 36.2 Cg_endo . . . . . 0 C--N 1.309 -1.503 0 C-N-CA 122.407 2.071 . . . . 0.0 110.542 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.47 ' O ' ' CG2' ' A' ' 175' ' ' VAL . 3.1 mtt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.88 0.848 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.61 -65.79 0.97 Allowed 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.0 t -57.84 -25.2 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.251 -0.906 . . . . 0.0 108.827 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.491 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 50.8 t80 -74.12 -39.82 63.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 109.112 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 171' ' ' MET . 96.9 t -70.91 -27.77 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 108.95 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.66 -64.83 1.1 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.248 -0.907 . . . . 0.0 108.904 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -50.31 -42.31 52.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.187 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 178' ' ' TYR . 8.1 t80 -61.42 -53.77 52.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.513 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 175' ' ' VAL . . . -53.38 -24.11 11.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.922 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.41 -43.62 23.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.555 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.479 ' O ' HD21 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -59.63 -42.28 92.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 109.386 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.469 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 43.2 t -74.01 -37.3 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.056 -1.028 . . . . 0.0 109.226 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -52.28 65.91 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.89 . . . . 0.0 109.193 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -76.72 -33.64 58.16 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.263 -0.898 . . . . 0.0 109.061 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.517 HD21 ' N ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -58.17 -19.54 33.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.982 -1.074 . . . . 0.0 109.839 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.468 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 1.3 t -73.17 -12.65 60.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.81 -1.181 . . . . 0.0 108.71 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.84 . . . . 0.0 109.44 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.527 ' HB2' ' CE1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -108.35 62.36 0.61 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.796 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.2 t70 44.82 82.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.408 -0.807 . . . . 0.0 109.404 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 118.38 -22.74 9.39 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.462 ' HB3' ' OE1' ' A' ' 8' ' ' GLN . 3.0 tttp -80.13 -68.67 0.65 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.107 -1.231 . . . . 0.0 108.709 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 17.2 mp0 -103.94 9.1 36.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.285 -0.884 . . . . 0.0 109.773 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 3' ' ' TYR . 3.7 p90 177.33 134.73 0.07 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.129 -0.982 . . . . 0.0 109.171 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -117.68 178.83 4.26 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 m -115.19 145.59 42.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.706 -0.621 . . . . 0.0 109.681 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.01 165.87 12.43 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.424 -0.797 . . . . 0.0 109.567 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -80.48 -15.64 56.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.599 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.02 115.17 11.04 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.404 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.492 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 34.4 Cg_endo -77.3 162.7 30.89 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.401 2.067 . . . . 0.0 110.531 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.527 HG23 ' CG1' ' A' ' 145' ' ' VAL . 48.1 t -105.93 79.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -46.6 128.25 10.23 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 93.77 -13.15 68.1 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 18' ' ' GLY . . . -37.36 152.28 0.13 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.75 -0.853 . . . . 0.0 109.043 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.521 ' O ' ' O ' ' A' ' 55' ' ' LYS . 36.6 Cg_endo -78.94 40.77 0.97 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.244 1.962 . . . . 0.0 112.631 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER 67.04 -43.22 0.44 Allowed 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.376 -0.827 . . . . 0.0 110.575 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 21' ' ' GLN . 32.2 t -150.52 78.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.57 HD12 ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -70.66 127.49 32.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -178.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.54 ' N ' HD21 ' A' ' 23' ' ' LEU . 2.1 tt0 -111.1 149.3 31.02 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.119 -0.988 . . . . 0.0 109.625 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE1' HD12 ' A' ' 23' ' ' LEU . 15.0 m-85 -122.86 126.43 47.32 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.467 -0.771 . . . . 0.0 109.689 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 1.9 p90 -159.09 140.97 13.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.354 -0.842 . . . . 0.0 109.486 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.576 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 75.2 p -122.01 169.94 10.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -0.98 . . . . 0.0 110.574 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' A' ' 29' ' ' PHE . 7.5 m-30 -92.3 37.66 1.0 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.582 ' CD1' ' O ' ' A' ' 28' ' ' PHE . 2.6 m-85 -142.59 20.01 2.02 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.092 -1.005 . . . . 0.0 110.258 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.542 ' CB ' ' CE1' ' A' ' 32' ' ' HIS . 1.3 m -117.95 166.93 12.3 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.642 -1.286 . . . . 0.0 109.617 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 33.6 Cg_endo -75.54 -38.13 1.5 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.287 1.991 . . . . 0.0 108.628 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.556 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 14.6 p80 -73.9 -25.49 60.04 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 22.7 t -44.75 -62.9 1.04 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 8.4 t80 -65.54 -46.41 79.65 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.287 0.565 . . . . 0.0 109.989 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.515 ' HA ' ' CG2' ' A' ' 39' ' ' VAL . 2.1 mm-40 -61.01 -23.64 65.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 110.538 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.467 ' N ' ' O ' ' A' ' 32' ' ' HIS . 3.4 m-30 -78.37 -43.1 28.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -110.98 8.06 21.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.748 -1.22 . . . . 0.0 111.391 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 27.8 mm-40 -135.01 29.15 3.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.562 -1.336 . . . . 0.0 110.346 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.515 ' CG2' ' HA ' ' A' ' 35' ' ' GLN . 98.0 t -150.92 -76.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.812 -1.18 . . . . 0.0 109.522 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HB2' HG13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -106.22 20.09 19.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.178 -0.951 . . . . 0.0 109.932 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 45' ' ' ASN . 5.3 m170 43.13 31.36 0.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.14 -0.975 . . . . 0.0 110.066 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.454 ' CG1' HG23 ' A' ' 175' ' ' VAL . 22.4 mt -50.48 -25.02 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.003 -1.061 . . . . 0.0 109.416 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.25 -55.9 5.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 110.186 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.483 ' HA ' ' HG2' ' A' ' 47' ' ' LYS . 6.9 m-20 -87.09 -33.57 19.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.355 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 41' ' ' HIS . 0.2 OUTLIER -60.54 -27.68 67.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.5 -179.267 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.501 ' O ' ' CD1' ' A' ' 50' ' ' LEU . 9.1 p -84.46 -24.84 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.028 -1.045 . . . . 0.0 111.091 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.54 ' HG3' ' N ' ' A' ' 48' ' ' LYS . 4.7 ptpt -78.68 -25.29 44.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.737 -1.227 . . . . 0.0 110.416 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.54 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 1.7 mtpt -63.84 -32.76 74.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.953 -1.092 . . . . 0.0 109.311 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -82.82 9.66 9.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.865 . . . . 0.0 109.411 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.517 ' N ' HD11 ' A' ' 50' ' ' LEU . 8.6 mp -98.64 108.5 48.62 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.128 -0.983 . . . . 0.0 109.449 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.502 ' O ' ' C ' ' A' ' 52' ' ' GLU . 35.1 Cg_endo -77.06 145.9 25.12 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.4 2.067 . . . . 0.0 110.478 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 51' ' ' PRO . 1.2 tt0 -33.46 118.13 0.32 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.266 1.031 . . . . 0.0 110.127 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.36 -26.64 5.46 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.516 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 3.7 t -97.58 93.5 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -1.102 . . . . 0.0 108.645 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -84.44 118.25 24.16 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.962 0.887 . . . . 0.0 110.079 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.455 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.4 OUTLIER -111.82 98.91 7.72 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.068 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 20' ' ' PRO . 7.4 m -99.6 128.18 45.7 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.716 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 115.17 29.89 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 1.3 m-85 -112.62 175.98 5.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.852 -1.155 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.589 ' CE1' HD21 ' A' ' 72' ' ' LEU . 28.9 t-80 -104.41 150.73 24.27 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.032 0.92 . . . . 0.0 109.322 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.584 HG22 ' CD1' ' A' ' 63' ' ' PHE . 1.3 m -96.96 160.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.369 0.604 . . . . 0.0 110.015 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -125.09 56.69 1.32 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.41 -0.806 . . . . 0.0 108.866 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.584 ' CD1' HG22 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -133.81 52.1 2.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.99 . . . . 0.0 110.974 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.572 ' HE1' ' CE2' ' A' ' 29' ' ' PHE . 3.1 ppp? -128.92 34.0 4.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.395 -0.815 . . . . 0.0 108.818 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.76 -37.35 3.24 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.91 -13.19 66.71 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.761 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -79.3 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.666 -1.49 . . . . 0.0 109.381 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -86.14 -28.22 24.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.037 -1.04 . . . . 0.0 109.345 179.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.562 ' N ' ' CD2' ' A' ' 68' ' ' LEU . . . -59.08 -55.08 32.88 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.453 ' NZ ' ' OE2' ' A' ' 139' ' ' GLU . 0.9 OUTLIER -56.87 -47.2 81.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.305 -1.114 . . . . 0.0 108.695 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 23.8 t0 -67.35 -24.37 65.71 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.589 HD21 ' CE1' ' A' ' 60' ' ' HIS . 5.8 tt -71.48 -39.52 70.84 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.508 ' CG2' ' OE1' ' A' ' 138' ' ' GLN . 1.3 m -57.87 -43.58 86.08 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.515 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 4.0 tt0 -56.71 -29.0 62.0 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -62.3 -40.15 95.36 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -61.9 -30.4 70.86 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.41 -48.02 10.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -0.807 . . . . 0.0 109.968 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.636 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 1.5 t -63.3 -27.7 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 0.0 109.442 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.45 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -83.14 -55.72 4.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.212 -0.93 . . . . 0.0 109.138 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.41 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -45.26 -29.15 0.93 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.277 -0.889 . . . . 0.0 108.779 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.464 ' HB2' HG21 ' A' ' 131' ' ' VAL . . . -74.4 -38.37 63.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.396 -0.815 . . . . 0.0 109.509 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.475 ' CB ' HG11 ' A' ' 84' ' ' VAL . 44.3 mt -104.63 12.64 32.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 110.022 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.05 23.01 1.44 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.572 HG22 ' CE1' ' A' ' 112' ' ' PHE . 21.9 m -84.95 -10.35 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -1.204 . . . . 0.0 110.189 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 84' ' ' VAL . 5.4 pt-20 -43.01 -59.02 2.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.076 -1.015 . . . . 0.0 109.823 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -33.29 2.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.111 -0.993 . . . . 0.0 109.682 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 84' ' ' VAL . 44.2 mtpt -83.89 -51.6 7.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.557 -0.714 . . . . 0.0 111.133 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.4 m -80.48 -6.07 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.787 -1.196 . . . . 0.0 110.676 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.649 ' CG2' ' CE2' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -78.24 -44.33 25.86 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.805 -1.184 . . . . 0.0 108.513 178.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.456 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -52.16 -52.01 66.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.568 -1.333 . . . . 0.0 110.227 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.49 ' HG2' HG11 ' A' ' 111' ' ' VAL . 24.4 Cg_endo -73.43 -20.51 20.75 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 N-CA-C 109.906 -0.844 . . . . 0.0 109.906 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.542 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 12.7 mt -83.83 -41.88 17.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 108.646 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.649 ' CE2' ' CG2' ' A' ' 89' ' ' THR . 8.3 m-30 -67.3 -45.08 77.62 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.125 -0.984 . . . . 0.0 108.589 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -74.65 -33.35 62.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.56 -0.713 . . . . 0.0 109.428 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.435 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -61.24 -32.1 79.46 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.493 HG13 ' HA ' ' A' ' 29' ' ' PHE . 2.5 t -99.48 -9.55 8.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.344 -1.092 . . . . 0.0 109.278 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 2.4 mt-30 -112.41 9.7 19.75 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.891 -1.131 . . . . 0.0 110.92 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.553 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.6 OUTLIER -164.63 59.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.472 -1.393 . . . . 0.0 109.408 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.553 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 163.62 -49.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.472 -0.768 . . . . 0.0 109.119 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 99' ' ' THR . 4.1 mp0 73.71 14.98 4.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.26 -0.9 . . . . 0.0 110.737 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 t -82.97 -7.8 59.63 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.5 ' CG2' HD12 ' A' ' 68' ' ' LEU . 12.4 mm -77.5 67.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.486 ' NE ' ' O ' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -128.56 30.83 5.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 109.452 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 107' ' ' ASP . 5.2 p -153.48 127.73 9.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.072 . . . . 0.0 110.187 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.475 ' HA ' ' CD1' ' A' ' 108' ' ' ILE . . . -48.79 -36.38 16.52 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 p -55.82 -33.85 64.82 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.6 OUTLIER -71.79 -44.99 63.04 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.704 179.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 34.7 mt -49.71 -29.29 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.892 -1.13 . . . . 0.0 108.459 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -79.36 -32.83 43.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.438 -0.789 . . . . 0.0 109.678 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -62.01 -43.47 98.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.166 -0.959 . . . . 0.0 109.403 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.542 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 55.8 t -74.68 -37.55 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 109.235 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.572 ' CE1' HG22 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -62.37 -48.11 81.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.883 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.5 mt -69.56 -26.22 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 109.538 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -19.81 54.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.373 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.46 5.32 48.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.526 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.82 -4.46 72.02 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 117' ' ' ILE . 1.3 mm -74.73 57.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -1.088 . . . . 0.0 109.723 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 117' ' ' ILE . 60.4 mttt -37.37 147.82 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.202 -0.936 . . . . 0.0 110.291 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -52.3 -27.87 25.65 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.44 ' O ' ' HB1' ' A' ' 124' ' ' ALA . 3.2 tt0 -62.7 -51.65 66.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -1.191 . . . . 0.0 109.51 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -77.01 -37.7 54.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.636 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 3.4 t80 -66.77 -53.3 34.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 109.753 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -60.29 -43.99 95.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.983 -1.073 . . . . 0.0 109.197 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 120' ' ' GLU . . . -57.52 -50.91 71.53 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.299 -0.876 . . . . 0.0 109.237 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -50.45 -53.32 30.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.416 -0.803 . . . . 0.0 108.94 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.515 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 6.0 t90 -54.98 -58.12 8.93 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -52.47 -16.31 0.86 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 110.396 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 2.4 m -70.59 179.11 2.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.885 -1.135 . . . . 0.0 110.207 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -90.4 -38.21 13.46 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.318 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.27 -48.28 68.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.183 -1.407 . . . . 0.0 109.463 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 3.3 t -62.37 -36.26 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.921 -1.112 . . . . 0.0 108.288 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -66.34 -31.99 73.11 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.079 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.1 t -66.02 -34.74 78.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.412 ' HA ' HD21 ' A' ' 134' ' ' LEU . 40.6 mt -78.96 -18.3 53.98 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.7 t -79.49 -46.33 23.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.34 -38.87 85.56 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.3 -39.98 96.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 108.973 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.572 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -62.32 -62.65 1.61 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.912 . . . . 0.0 108.797 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.453 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 1.2 mt-10 -52.6 -30.61 32.11 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 5.2 mttt -72.57 -29.43 63.53 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.72 -54.67 17.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 109.236 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.15 86.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.663 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 139' ' ' GLU . . . -81.39 -16.16 53.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.315 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 140' ' ' LYS . 6.3 m-20 -80.81 -45.09 17.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.983 -1.073 . . . . 0.0 109.014 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.562 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 23.3 m -99.32 -9.4 8.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.271 -0.893 . . . . 0.0 108.856 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 25.4 tt0 83.5 -39.63 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.658 -0.651 . . . . 0.0 109.537 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.537 HD21 ' CE2' ' A' ' 25' ' ' PHE . 13.4 tp 66.93 138.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.397 -0.815 . . . . 0.0 109.47 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -160.8 26.77 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.751 -1.218 . . . . 0.0 109.856 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 158.63 98.72 0.14 Allowed Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.171 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.549 HG13 ' CG1' ' A' ' 61' ' ' VAL . 0.9 OUTLIER -89.72 138.95 27.79 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.556 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 32.6 Cg_endo -72.83 156.68 99.15 Favored 'Cis proline' 0 C--N 1.316 -1.147 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.865 2.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 25' ' ' PHE . . . -151.79 117.18 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.939 -1.101 . . . . 0.0 108.385 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.487 ' CE ' HG23 ' A' ' 182' ' ' VAL . 4.8 tmm? -113.93 136.57 52.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.996 -1.065 . . . . 0.0 110.334 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.577 ' N ' ' CD1' ' A' ' 154' ' ' PHE . 3.8 m-85 -123.92 135.81 53.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.476 -0.765 . . . . 0.0 109.208 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 92.2 t -100.65 131.94 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.94 . . . . 0.0 110.06 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.93 21.83 0.33 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.61 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 15' ' ' PRO . . . 58.27 55.9 28.17 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -165.21 -35.64 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.191 -1.182 . . . . 0.0 108.379 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 154' ' ' PHE . 2.4 m-85 -111.52 120.42 42.06 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.019 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.534 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 12.8 tt0 -116.27 113.51 23.1 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.288 -0.883 . . . . 0.0 109.264 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.485 ' CD1' ' HE2' ' A' ' 153' ' ' MET . 8.6 mt -61.33 -179.6 0.17 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.36 -0.837 . . . . 0.0 108.847 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -137.35 150.19 68.0 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.026 -1.046 . . . . 0.0 109.459 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 C--N 1.309 -1.543 0 C-N-CA 122.672 2.248 . . . . 0.0 110.648 -179.881 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.422 ' HE2' ' OE1' ' A' ' 35' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.818 0.818 . . . . 0.0 109.651 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 172' ' ' ASP . 0.6 OUTLIER -69.61 -45.37 68.69 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.1 t -68.86 -22.32 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 108.831 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.429 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 22.7 t80 -72.48 -36.8 68.53 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.23 -0.919 . . . . 0.0 108.576 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.454 HG23 ' CG1' ' A' ' 42' ' ' ILE . 44.0 t -75.75 -26.96 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 109.194 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -83.32 -52.99 6.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.218 -0.926 . . . . 0.0 108.951 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.453 ' O ' ' OG1' ' A' ' 181' ' ' THR . 0.4 OUTLIER -62.88 -33.03 74.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.492 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.429 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 31.6 t80 -75.66 -54.18 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.521 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 175' ' ' VAL . . . -60.49 -24.42 65.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 109.412 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -77.91 -50.09 12.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.328 -0.857 . . . . 0.0 109.299 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.505 ' O ' HD22 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -58.39 -28.58 65.32 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.197 -0.94 . . . . 0.0 109.001 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.487 HG23 ' CE ' ' A' ' 153' ' ' MET . 66.4 t -85.91 -34.63 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.32 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -60.5 -42.56 96.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 108.98 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.567 ' CD2' HD21 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -82.46 -44.03 16.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.297 -0.877 . . . . 0.0 108.999 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.567 HD21 ' CD2' ' A' ' 184' ' ' TYR . 3.9 mm? -53.68 -18.35 2.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.942 -1.099 . . . . 0.0 109.417 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.439 ' OG ' HG23 ' A' ' 54' ' ' VAL . 1.7 t -66.31 -26.06 67.13 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.859 -1.151 . . . . 0.0 108.328 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.573 ' HB3' ' CE1' ' A' ' 9' ' ' TYR . 1.9 m-85 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -101.55 56.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.99 . . . . 0.0 109.833 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 46.04 82.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.614 -0.679 . . . . 0.0 110.239 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 116.11 -20.45 12.8 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.267 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.52 -68.01 0.72 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.182 -1.187 . . . . 0.0 109.107 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 1.6 mp0 -97.53 6.2 48.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.375 -0.828 . . . . 0.0 109.606 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.573 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 8.3 p90 177.26 134.07 0.06 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.284 -0.885 . . . . 0.0 108.994 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -115.28 176.3 5.13 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.577 -0.702 . . . . 0.0 109.24 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.454 HG21 ' O ' ' A' ' 158' ' ' LYS . 1.0 OUTLIER -114.15 159.49 20.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.382 0.611 . . . . 0.0 109.612 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.3 162.08 13.37 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.405 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.46 -0.23 36.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.147 -0.971 . . . . 0.0 109.141 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.34 113.29 1.02 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.374 -0.829 . . . . 0.0 109.12 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 34.7 Cg_endo -77.02 159.11 34.18 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.45 2.1 . . . . 0.0 110.849 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 t -110.91 91.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.481 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.05 128.81 9.58 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.39 -21.9 41.77 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.543 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -40.46 160.67 0.12 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.986 . . . . 0.0 109.83 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.547 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.3 Cg_endo -79.22 128.83 8.38 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.726 2.284 . . . . 0.0 111.196 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.516 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 16.3 mp0 -41.71 -25.37 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.498 -0.751 . . . . 0.0 109.861 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.46 ' N ' ' O ' ' A' ' 20' ' ' PRO . 25.1 t -149.43 82.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.113 -0.992 . . . . 0.0 108.996 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.636 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.07 118.3 16.87 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.493 ' N ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -98.07 122.82 41.67 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.113 -0.992 . . . . 0.0 109.935 -179.066 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CE2' ' CG2' ' A' ' 145' ' ' VAL . 9.1 m-85 -110.2 104.26 13.07 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -150.95 143.21 24.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.129 -0.982 . . . . 0.0 110.044 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.571 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 4.5 p -123.78 -167.65 1.66 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.66 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -110.18 53.57 0.69 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.571 ' CE1' HD13 ' A' ' 72' ' ' LEU . 9.1 m-85 -138.01 -1.94 1.93 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.831 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.51 ' CB ' ' HB3' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -108.49 164.79 13.97 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.571 -1.331 . . . . 0.0 109.405 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.475 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 32.0 Cg_endo -74.58 -32.56 5.96 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.35 2.033 . . . . 0.0 108.861 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.486 ' NE2' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -89.67 -19.11 25.24 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.038 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HB3' ' CB ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -52.96 -41.75 64.84 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.504 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 70.3 t80 -85.29 -39.03 18.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.305 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.516 ' O ' ' CG ' ' A' ' 40' ' ' LEU . 3.9 mt-30 -74.85 -24.4 58.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.986 -1.071 . . . . 0.0 110.429 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.563 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 25.7 t80 -76.41 -21.99 55.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.038 -1.039 . . . . 0.0 110.97 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.55 ' OE2' ' CE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -127.77 42.03 3.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.707 -1.245 . . . . 0.0 110.888 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 15.9 mm-40 -159.49 -68.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.174 -0.954 . . . . 0.0 109.899 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.02 -48.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 0.0 110.414 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.516 ' CG ' ' O ' ' A' ' 35' ' ' GLN . 95.2 mt -54.03 -17.18 2.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.016 -1.052 . . . . 0.0 110.132 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.442 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 82.3 m-70 45.91 30.85 0.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.081 -1.012 . . . . 0.0 109.281 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.497 ' O ' ' CG1' ' A' ' 46' ' ' VAL . 19.6 mt -79.3 -21.46 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.998 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.454 ' HA ' HG23 ' A' ' 46' ' ' VAL . 17.2 m -80.44 -21.06 42.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.982 -1.074 . . . . 0.0 110.512 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 41' ' ' HIS . 2.0 p-10 -87.06 -50.5 6.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.899 -1.126 . . . . 0.0 110.356 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 46' ' ' VAL . 45.2 p-10 -64.46 -26.22 68.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.193 -0.942 . . . . 0.0 110.533 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.501 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 27.7 m -74.21 -24.66 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.987 -1.07 . . . . 0.0 109.976 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -73.65 -46.78 44.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.049 -1.032 . . . . 0.0 109.516 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.514 ' N ' ' HD3' ' A' ' 48' ' ' LYS . 24.3 mmtm -58.86 -16.78 18.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.211 -0.931 . . . . 0.0 109.067 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.486 ' CG ' ' HB2' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -101.83 22.66 12.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 109.946 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.569 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 7.9 mt -124.06 66.09 39.81 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.007 -1.058 . . . . 0.0 110.706 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 52' ' ' GLU . 37.2 Cg_endo -80.09 140.67 14.24 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.406 2.07 . . . . 0.0 110.13 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 51' ' ' PRO . 12.6 tm-20 61.87 132.88 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.386 -0.821 . . . . 0.0 108.822 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . 58.89 23.35 56.33 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.569 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 2.0 t -60.33 80.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.752 -0.852 . . . . 0.0 109.374 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -125.77 91.94 3.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.131 -0.98 . . . . 0.0 110.264 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.406 ' HE2' ' HG3' ' A' ' 24' ' ' GLU . 7.1 ttt -103.72 98.31 8.2 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -93.35 134.5 35.5 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.057 -179.269 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.409 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 3.9 mtmt -109.8 108.98 19.5 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.448 -0.782 . . . . 0.0 109.487 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 2.7 m-85 -109.8 169.42 8.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.865 -1.147 . . . . 0.0 111.083 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.571 ' CE1' ' HA ' ' A' ' 27' ' ' SER . 4.0 t60 -107.68 133.45 52.09 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.744 0.783 . . . . 0.0 108.995 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.589 ' CG1' ' CG1' ' A' ' 150' ' ' VAL . 3.2 m -71.98 157.4 6.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 O-C-N 121.738 -0.601 . . . . 0.0 109.536 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.415 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 2.9 p-10 -123.46 47.2 2.05 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 16.0 p90 -148.52 61.57 1.08 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.093 -1.004 . . . . 0.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.491 ' CE ' ' O ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER -133.13 38.0 3.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.288 -0.883 . . . . 0.0 109.051 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.49 -31.37 1.14 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.79 -35.83 3.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 -79.37 0.28 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.874 -1.368 . . . . 0.0 109.676 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.585 HD21 ' CD1' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -78.59 -19.18 53.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.974 -1.079 . . . . 0.0 109.197 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.581 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -58.73 -57.11 21.6 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.76 -49.04 74.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.286 -1.126 . . . . 0.0 108.048 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.532 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 49.9 t0 -59.94 -26.68 66.16 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.571 HD13 ' CE1' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -60.75 -36.24 78.41 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.412 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.442 ' O ' ' NE2' ' A' ' 138' ' ' GLN . 31.5 m -67.0 -41.17 87.18 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 7.8 tp60 -61.73 -17.43 55.78 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -71.49 -45.1 63.42 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.455 ' HB3' ' NE2' ' A' ' 138' ' ' GLN . 20.0 t-105 -64.58 -31.84 73.22 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.175 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.88 -54.43 6.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.87 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.65 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 88.8 t -59.71 -26.18 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.151 -0.968 . . . . 0.0 109.964 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.428 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -83.55 -60.77 2.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 109.243 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.453 ' HB3' HD23 ' A' ' 134' ' ' LEU . 0.8 OUTLIER -45.67 -28.87 1.09 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.171 -0.956 . . . . 0.0 108.53 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.536 ' CB ' ' CG2' ' A' ' 131' ' ' VAL . . . -72.57 -41.51 65.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.472 -0.768 . . . . 0.0 109.374 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.468 ' O ' HG11 ' A' ' 84' ' ' VAL . 20.9 mt -101.51 9.41 41.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -0.962 . . . . 0.0 110.381 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.76 24.23 7.77 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 82' ' ' LEU . 33.2 m -87.29 -9.2 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.427 -1.043 . . . . 0.0 110.759 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 89' ' ' THR . 2.8 pt-20 -42.08 -58.76 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.047 -1.033 . . . . 0.0 110.015 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.6 -33.75 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.237 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -83.6 -50.47 8.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.339 -0.851 . . . . 0.0 111.425 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.482 ' O ' ' CG ' ' A' ' 92' ' ' LEU . 1.3 m -83.25 -7.51 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.786 -1.196 . . . . 0.0 110.784 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.604 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.31 -44.38 45.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.703 -1.248 . . . . 0.0 108.728 179.034 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.428 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -53.49 -52.76 63.77 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.542 -1.349 . . . . 0.0 110.555 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.512 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 25.3 Cg_endo -73.7 -18.47 22.22 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 N-CA-C 109.877 -0.855 . . . . 0.0 109.877 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.539 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 21.8 mt -87.07 -43.59 12.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 108.863 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.66 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 5.4 m-30 -65.57 -45.77 81.99 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.008 -1.058 . . . . 0.0 108.984 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -73.44 -20.73 60.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.065 -1.022 . . . . 0.0 109.08 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.58 -36.29 62.44 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.532 HG23 ' CB ' ' A' ' 102' ' ' ILE . 1.5 t -102.09 -0.49 10.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.087 -1.243 . . . . 0.0 109.409 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.496 ' OE1' ' HB3' ' A' ' 93' ' ' PHE . 16.4 mt-30 -97.91 1.53 48.16 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 120.915 -1.116 . . . . 0.0 110.557 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 175.79 81.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.744 -1.222 . . . . 0.0 109.582 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.556 ' CB ' ' O ' ' A' ' 98' ' ' LYS . 1.2 m 157.71 -43.85 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.9 OUTLIER 69.09 16.26 8.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.867 -1.146 . . . . 0.0 110.735 178.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.549 ' HB ' ' CG2' ' A' ' 99' ' ' THR . 5.3 t -79.3 -7.61 58.44 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.532 ' CB ' HG23 ' A' ' 96' ' ' VAL . 12.6 mm -87.62 61.93 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -127.58 32.18 5.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.967 . . . . 0.0 109.48 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 107' ' ' ASP . 4.8 p -153.02 128.11 9.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.002 -1.061 . . . . 0.0 110.075 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.452 ' HA ' HD13 ' A' ' 108' ' ' ILE . . . -49.55 -31.03 9.5 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -34.14 74.72 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -68.51 -51.11 46.74 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.585 ' CD1' HD21 ' A' ' 68' ' ' LEU . 27.9 mt -48.16 -29.9 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 0.0 108.684 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.454 ' O ' HD13 ' A' ' 113' ' ' ILE . 4.6 mtt180 -76.86 -39.9 49.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 109.419 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -57.34 -41.18 79.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.405 -0.809 . . . . 0.0 109.646 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.539 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 19.9 t -73.88 -38.45 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.173 -0.954 . . . . 0.0 109.569 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.458 ' HA ' HG13 ' A' ' 88' ' ' VAL . 2.6 m-85 -64.52 -39.01 92.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.052 -1.03 . . . . 0.0 109.121 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 109' ' ' ARG . 15.4 mt -75.11 -22.38 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.342 -0.849 . . . . 0.0 109.548 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -16.98 62.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.315 -0.866 . . . . 0.0 109.876 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.481 ' HB2' HD11 ' A' ' 117' ' ' ILE . . . -91.04 6.4 45.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.725 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.68 2.56 75.6 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.4 mp -86.27 63.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -1.102 . . . . 0.0 109.074 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -31.75 149.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.199 -0.938 . . . . 0.0 110.859 -179.218 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.42 -32.92 58.14 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.03 -46.26 82.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.999 -1.295 . . . . 0.0 109.195 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -73.01 -43.72 61.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.65 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 4.3 t80 -57.99 -45.59 86.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.613 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -64.3 -37.8 88.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.147 -0.97 . . . . 0.0 108.979 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.03 -50.35 72.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.151 -0.968 . . . . 0.0 108.878 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.51 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -52.0 -49.3 63.58 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.453 ' CD1' ' C ' ' A' ' 126' ' ' TRP . 3.5 t90 -58.22 -59.65 4.99 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -15.35 6.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.633 -0.667 . . . . 0.0 110.253 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.465 ' OG ' HG22 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -69.6 172.93 6.63 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.056 -1.028 . . . . 0.0 110.086 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -89.5 -40.14 12.86 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.39 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.6 t -63.13 -46.15 96.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.105 -1.438 . . . . 0.0 109.341 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.536 ' CG2' ' CB ' ' A' ' 81' ' ' ALA . 2.1 t -69.58 -33.79 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.975 -1.078 . . . . 0.0 108.369 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 128' ' ' SER . 19.2 ttpt -63.64 -37.99 89.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.5 p -69.37 -32.42 71.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.415 -0.803 . . . . 0.0 108.91 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.453 HD23 ' HB3' ' A' ' 80' ' ' MET . 0.2 OUTLIER -79.66 -19.18 49.69 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.903 . . . . 0.0 108.781 179.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.68 -48.77 21.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -62.33 -38.9 91.27 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -35.8 82.22 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.4 -0.813 . . . . 0.0 109.29 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.577 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 3.7 mt-30 -67.55 -66.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 109.185 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.33 -37.61 17.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.185 -0.947 . . . . 0.0 108.66 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 9.3 mttm -71.53 -33.57 69.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.367 -0.833 . . . . 0.0 108.85 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.503 ' CB ' ' CD2' ' A' ' 59' ' ' TYR . . . -56.64 -62.22 1.88 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 109.128 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -69.09 -26.24 64.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.599 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.435 ' HB1' ' HA ' ' A' ' 140' ' ' LYS . . . -76.09 -26.01 56.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.887 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.527 ' OD1' ' CG1' ' A' ' 145' ' ' VAL . 0.6 OUTLIER -80.88 -49.92 10.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.993 . . . . 0.0 108.478 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.643 ' CG2' ' CE2' ' A' ' 25' ' ' PHE . 19.7 m -84.75 -13.27 11.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 2.7 mt-30 80.89 -47.14 0.26 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.682 . . . . 0.0 109.875 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.477 HD23 HG13 ' A' ' 61' ' ' VAL . 24.4 tp 65.06 137.9 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.7 ttt85 -160.5 27.74 0.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.457 -1.402 . . . . 0.0 110.161 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.97 106.47 0.2 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.314 -1.422 . . . . 0.0 110.619 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.589 ' CG1' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -83.13 144.46 47.23 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.41 -1.053 . . . . 0.0 108.934 178.635 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.48 151.73 89.64 Favored 'Cis proline' 0 C--N 1.315 -1.224 0 C-N-CA 124.176 -1.177 . . . . 0.0 110.854 0.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.84 153.12 46.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.41 -1.431 . . . . 0.0 109.103 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.488 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -148.11 130.07 15.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.899 -1.126 . . . . 0.0 110.424 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.584 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 24.5 m-85 -126.22 129.17 48.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.53 -0.731 . . . . 0.0 109.698 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 14.8 t -96.77 131.13 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 0.0 109.607 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.437 ' C ' ' HB1' ' A' ' 19' ' ' ALA . 5.7 t30 43.16 23.73 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.471 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.543 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.87 58.11 16.19 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.483 ' HE3' ' CE2' ' A' ' 159' ' ' TYR . 32.6 ttpt -166.27 -35.67 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.483 ' CE2' ' HE3' ' A' ' 158' ' ' LYS . 50.3 m-85 -119.6 120.93 38.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.892 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.584 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -119.42 120.55 37.19 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.171 -0.956 . . . . 0.0 109.714 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.488 HD23 ' CG2' ' A' ' 181' ' ' THR . 69.8 mt -61.85 175.38 0.67 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -149.86 114.5 3.44 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.947 -1.095 . . . . 0.0 109.384 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--N 1.313 -1.342 0 C-N-CA 122.598 2.199 . . . . 0.0 111.351 -179.849 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 14.3 mtt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.615 0.722 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.75 -49.17 66.81 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.37 -29.16 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.033 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -68.25 -31.38 70.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.113 -0.992 . . . . 0.0 108.85 179.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 53.3 t -79.28 -29.29 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.552 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -82.97 -53.02 6.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.001 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.46 ' O ' ' OG1' ' A' ' 181' ' ' THR . 1.0 OUTLIER -62.34 -47.27 84.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.458 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.474 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 4.2 t80 -61.83 -49.68 75.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.01 -34.69 68.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.102 -0.999 . . . . 0.0 108.998 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -73.77 -38.73 64.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.423 -0.798 . . . . 0.0 109.182 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.5 ' O ' ' CG ' ' A' ' 185' ' ' LEU . 0.2 OUTLIER -59.01 -29.68 67.43 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.433 ' O ' ' OG ' ' A' ' 186' ' ' SER . 2.5 t -83.95 -36.41 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.973 . . . . 0.0 109.28 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.486 ' HB2' ' CG ' ' A' ' 49' ' ' LYS . 16.9 tttt -60.77 -46.49 90.25 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.173 -0.955 . . . . 0.0 108.915 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.567 ' CD2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -81.63 -30.91 32.63 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.366 -0.834 . . . . 0.0 109.371 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.567 ' CD2' ' CD2' ' A' ' 184' ' ' TYR . 0.4 OUTLIER -61.01 -20.93 63.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.825 -1.172 . . . . 0.0 108.775 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.438 ' OG ' HD22 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -80.79 -4.57 55.06 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.98 -1.075 . . . . 0.0 108.471 178.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 108.867 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -99.63 58.2 1.04 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.07 -1.019 . . . . 0.0 110.011 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 t0 48.98 85.26 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.44 -0.788 . . . . 0.0 110.04 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 114.92 -21.91 13.13 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -81.27 -67.25 0.8 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -1.196 . . . . 0.0 108.696 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 15.7 mp0 -99.09 7.83 45.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.252 -0.905 . . . . 0.0 109.611 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 6' ' ' GLY . 4.4 p90 176.54 134.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 108.975 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.551 HG21 ' CG ' ' A' ' 160' ' ' GLN . 9.3 t -114.43 177.68 4.55 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.585 -0.697 . . . . 0.0 109.328 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.502 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 0.4 OUTLIER -88.41 160.67 17.46 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.542 0.686 . . . . 0.0 110.42 -179.151 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' A' ' 160' ' ' GLN . 7.4 mt -98.41 161.74 13.53 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.562 -0.711 . . . . 0.0 109.127 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.426 ' C ' ' HG2' ' A' ' 14' ' ' LYS . 5.0 pm0 -115.6 -3.98 12.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 109.611 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HG2' ' C ' ' A' ' 13' ' ' GLU . 3.7 mmtp -139.89 75.11 30.88 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.18 -0.95 . . . . 0.0 109.617 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 35.3 Cg_endo -77.99 159.62 30.6 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.561 2.174 . . . . 0.0 110.576 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 19' ' ' ALA . 1.7 t -134.36 129.74 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.369 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.52 126.57 15.66 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 74.65 6.45 77.19 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.542 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . . . -42.57 172.45 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.498 -1.001 . . . . 0.0 110.277 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 23' ' ' LEU . 30.8 Cg_endo -71.52 111.94 3.24 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.919 2.412 . . . . 0.0 111.74 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 27.0 mm-40 -52.85 -22.35 5.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.557 -0.715 . . . . 0.0 109.597 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 10.5 t -156.62 79.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.587 HD12 ' CE2' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -81.7 138.48 35.24 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.43 ' N ' HD21 ' A' ' 23' ' ' LEU . 10.5 tt0 -132.85 103.1 5.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.047 -1.033 . . . . 0.0 109.789 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.587 ' CE2' HD12 ' A' ' 23' ' ' LEU . 58.4 m-85 -86.01 126.4 34.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.179 -0.951 . . . . 0.0 109.031 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.4 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 2.6 p90 -157.14 133.15 9.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.231 -0.918 . . . . 0.0 109.791 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.546 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 70.1 m -104.33 -174.37 2.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.413 -0.805 . . . . 0.0 109.827 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.558 ' O ' ' CD1' ' A' ' 29' ' ' PHE . 16.0 m-30 -104.53 48.46 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.578 ' CG ' HG13 ' A' ' 96' ' ' VAL . 16.6 m-85 -146.91 14.32 1.17 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 110.338 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -104.51 162.5 19.65 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.675 -1.266 . . . . 0.0 109.67 -179.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.96 -36.14 2.76 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.212 1.941 . . . . 0.0 108.388 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' A' ' 36' ' ' PHE . 4.4 m-70 -82.98 -22.32 33.71 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 16.2 t -47.06 -52.95 13.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.534 ' CB ' ' NE2' ' A' ' 97' ' ' GLN . 11.3 t80 -75.18 -40.66 59.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.794 -0.566 . . . . 0.0 110.403 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -72.38 -16.92 61.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.057 -1.027 . . . . 0.0 110.417 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' HIS . 1.8 m-85 -82.58 -29.62 30.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.02 -1.05 . . . . 0.0 110.443 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.74 22.7 13.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.955 -1.09 . . . . 0.0 109.629 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.514 ' OE2' ' CZ ' ' A' ' 34' ' ' TYR . 5.5 mm-40 -132.09 -61.09 0.89 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 111.092 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.2 t -90.61 -75.56 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.899 -1.126 . . . . 0.0 111.708 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 0.7 OUTLIER -70.75 -24.39 62.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.954 -1.091 . . . . 0.0 110.679 -178.089 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 94.9 m-70 60.67 32.71 20.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.058 -1.026 . . . . 0.0 108.965 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.449 HD13 HG23 ' A' ' 175' ' ' VAL . 13.5 mm -42.22 -26.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.419 -0.8 . . . . 0.0 109.921 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 41' ' ' HIS . 0.9 OUTLIER -81.4 -43.39 19.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.92 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.45 ' HB2' ' HB3' ' A' ' 41' ' ' HIS . 84.1 m-20 -85.39 -36.59 20.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.952 . . . . 0.0 109.894 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -65.04 -38.64 91.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 109.556 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 43' ' ' SER . 9.8 p -68.54 -26.46 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.736 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HA ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -61.64 -39.23 90.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.476 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -51.17 -24.45 4.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.169 -0.957 . . . . 0.0 108.734 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.469 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 17.6 mmtm -91.05 25.04 2.58 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.517 -0.739 . . . . 0.0 109.423 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.525 HD21 ' CG1' ' A' ' 54' ' ' VAL . 14.2 mt -125.22 67.3 54.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.175 -0.953 . . . . 0.0 110.104 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 52' ' ' GLU . 36.6 Cg_endo -79.39 75.35 5.11 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.542 2.161 . . . . 0.0 110.937 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 51' ' ' PRO . 6.0 tm-20 58.82 131.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.395 0.617 . . . . 0.0 110.2 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.08 -11.63 60.44 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.525 ' CG1' HD21 ' A' ' 50' ' ' LEU . 1.1 t -114.61 98.43 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -1.185 . . . . 0.0 109.142 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.09 102.95 14.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.909 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.482 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 8.7 ttt -99.02 102.88 14.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.428 -0.795 . . . . 0.0 109.606 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.0 m -99.1 126.48 44.85 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.265 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 113.83 27.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.458 -0.777 . . . . 0.0 109.382 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.541 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.8 m-85 -115.33 163.75 15.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.029 -1.045 . . . . 0.0 111.404 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.579 ' CE1' HD23 ' A' ' 72' ' ' LEU . 3.5 t-160 -117.28 122.16 43.18 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.609 ' CG2' ' CD1' ' A' ' 63' ' ' PHE . 16.8 m -101.88 156.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 110.384 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.492 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 1.1 p-10 -83.92 42.65 0.87 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.402 -0.811 . . . . 0.0 109.536 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.609 ' CD1' ' CG2' ' A' ' 61' ' ' VAL . 3.7 m-85 -91.56 30.96 1.23 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.0 110.023 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.425 ' SD ' ' HB3' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -161.74 45.93 0.17 Allowed 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.65 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 161.73 60.03 0.02 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.507 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.52 -35.72 0.13 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 65' ' ' GLY . 92.3 m-20 -88.94 -78.64 0.34 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -1.173 . . . . 0.0 110.129 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.607 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -82.27 -21.62 36.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.769 -1.207 . . . . 0.0 110.088 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 65' ' ' GLY . . . -51.97 -39.93 49.63 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 2.9 ttmt -61.05 -41.58 96.87 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.79 -29.54 65.75 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.579 HD23 ' CE1' ' A' ' 60' ' ' HIS . 13.9 tp -58.17 -50.77 72.38 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -56.64 -43.2 80.05 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.594 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 3.1 tt0 -54.92 -27.17 41.24 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -63.51 -46.36 86.44 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.404 ' O ' ' HG3' ' A' ' 80' ' ' MET . 29.7 t-105 -53.97 -31.98 52.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.99 -66.31 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.408 -0.808 . . . . 0.0 110.012 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.624 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 2.2 t -47.55 -30.68 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.214 -0.929 . . . . 0.0 110.047 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.429 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.5 -63.48 1.41 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.824 -1.173 . . . . 0.0 109.188 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.416 ' C ' ' O ' ' A' ' 79' ' ' ALA . 21.7 mtp -46.21 -27.12 0.91 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.594 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.525 ' CB ' HG23 ' A' ' 131' ' ' VAL . . . -67.8 -46.86 70.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 109.591 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.8 mt -99.62 7.24 45.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.63 31.18 60.18 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.469 ' CG1' HD13 ' A' ' 117' ' ' ILE . 26.9 m -97.35 8.21 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.448 -1.031 . . . . 0.0 110.144 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' A' ' 86' ' ' ASP . 2.3 tt0 -52.76 -70.56 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.086 -1.009 . . . . 0.0 109.722 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -38.89 -33.78 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 0.0 110.282 -179.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.462 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 25.1 mtpp -80.91 -52.5 7.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.377 -0.827 . . . . 0.0 110.995 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.3 m -86.12 -13.89 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.684 -1.26 . . . . 0.0 110.803 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.604 HG21 ' CG ' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -73.68 -42.39 61.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.646 -1.284 . . . . 0.0 108.206 178.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.22 -54.67 45.21 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.63 -1.294 . . . . 0.0 110.353 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.462 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 25.9 Cg_endo -72.82 -21.1 21.79 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 N-CA-C 109.758 -0.901 . . . . 0.0 109.758 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 89' ' ' THR . 15.6 mt -81.09 -44.64 17.67 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.604 ' CG ' HG21 ' A' ' 89' ' ' THR . 7.6 m-30 -64.03 -44.87 91.21 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.107 -0.995 . . . . 0.0 108.62 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -72.97 -24.33 60.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.297 -0.877 . . . . 0.0 109.321 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.537 ' O ' ' CG2' ' A' ' 99' ' ' THR . . . -69.03 -36.09 80.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.578 HG13 ' CG ' ' A' ' 29' ' ' PHE . 2.2 t -98.95 -1.57 10.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.225 -1.162 . . . . 0.0 108.768 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.534 ' NE2' ' CB ' ' A' ' 34' ' ' TYR . 27.4 mm-40 -110.26 6.27 22.41 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 121.022 -1.048 . . . . 0.0 111.323 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.519 ' C ' ' CG2' ' A' ' 99' ' ' THR . 1.5 ttmm -164.57 52.2 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.476 -1.39 . . . . 0.0 109.402 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 95' ' ' GLY . 0.5 OUTLIER 175.15 -51.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.361 -0.837 . . . . 0.0 109.847 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.534 ' O ' ' CD ' ' A' ' 103' ' ' ARG . 1.1 mt-30 75.05 10.95 3.66 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.042 -1.036 . . . . 0.0 109.886 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.1 t -84.32 -8.33 59.04 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.608 0.718 . . . . 0.0 109.319 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.439 HG13 ' C ' ' A' ' 95' ' ' GLY . 10.2 mm -74.14 75.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.56 -0.712 . . . . 0.0 109.544 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.534 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -136.65 31.42 2.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.84 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.526 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 7.3 p -146.91 128.45 15.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.064 -1.022 . . . . 0.0 109.716 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.54 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -52.82 -30.17 31.94 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.6 t -65.83 -29.03 69.43 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 104' ' ' SER . 61.6 m-20 -77.21 -39.5 48.45 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.396 -0.922 . . . . 0.0 108.678 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.507 ' CD1' HD21 ' A' ' 68' ' ' LEU . 44.4 mt -59.51 -29.82 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.29 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 4.6 mtm180 -78.03 -32.07 50.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.528 -0.733 . . . . 0.0 109.275 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.4 OUTLIER -61.47 -48.02 83.02 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.246 -0.909 . . . . 0.0 109.2 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.526 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 53.1 t -68.39 -40.37 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.915 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.474 ' CE1' HG22 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -56.78 -37.59 71.32 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.242 -0.912 . . . . 0.0 109.28 179.442 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.8 mt -76.16 -24.79 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -0.805 . . . . 0.0 109.869 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -64.47 -18.78 65.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.027 -1.046 . . . . 0.0 109.371 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.33 6.42 48.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.534 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.96 -1.48 77.94 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -78.74 57.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -1.118 . . . . 0.0 109.442 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 117' ' ' ILE . 2.2 mttt -37.73 153.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.882 . . . . 0.0 110.134 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.99 -38.01 73.47 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.43 -49.18 55.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.945 -1.326 . . . . 0.0 109.571 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.22 -48.79 12.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 110.335 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.624 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 4.1 t80 -58.28 -52.3 66.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.017 -1.052 . . . . 0.0 109.622 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -62.0 -41.13 97.72 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.33 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.58 -50.4 73.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.102 -0.999 . . . . 0.0 108.928 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 128' ' ' SER . . . -55.28 -46.71 76.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 108.886 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.594 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 4.7 t90 -57.55 -57.08 14.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.231 -0.918 . . . . 0.0 108.53 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -60.7 -15.54 30.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.5 -0.75 . . . . 0.0 109.553 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 63.1 m -76.13 -172.93 2.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.141 -0.975 . . . . 0.0 109.83 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -95.55 -28.3 14.93 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.906 -0.496 . . . . 0.0 111.061 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.14 -41.88 93.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.405 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.554 ' CG1' ' HA ' ' A' ' 126' ' ' TRP . 49.9 t -70.86 -36.65 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 120.995 -1.066 . . . . 0.0 108.487 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -67.4 -27.46 67.1 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.23 -37.68 69.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 138' ' ' GLN . 0.5 OUTLIER -79.45 -22.19 44.48 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 131' ' ' VAL . 17.1 t -79.12 -40.96 22.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.511 ' O ' ' CG ' ' A' ' 140' ' ' LYS . . . -68.01 -48.55 65.39 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.495 -0.753 . . . . 0.0 109.038 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.475 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -61.29 -32.69 72.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.233 -0.917 . . . . 0.0 108.751 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.541 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 4.4 tm0? -66.06 -69.76 0.28 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.827 . . . . 0.0 109.093 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' GLN . 0.0 OUTLIER -46.87 -32.67 3.92 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -70.28 -35.05 73.48 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -57.05 -50.3 73.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -70.25 -33.17 71.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.433 -0.792 . . . . 0.0 109.8 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.25 -18.21 55.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 110.042 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.427 ' HB3' HG23 ' A' ' 16' ' ' VAL . 67.4 m-20 -82.84 -43.48 16.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.048 -1.032 . . . . 0.0 108.36 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.554 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 27.5 m -98.61 -12.65 8.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.2 OUTLIER 83.61 -40.9 0.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.69 -0.631 . . . . 0.0 109.564 -179.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.602 ' CD2' ' CG1' ' A' ' 61' ' ' VAL . 10.7 tp 67.85 134.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 0.0 109.329 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -144.29 11.45 1.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.557 -1.339 . . . . 0.0 110.746 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.31 93.74 0.1 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.678 -1.725 . . . . 0.0 111.575 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.491 ' CG1' HG22 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -81.64 139.45 47.38 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.423 ' C ' ' HA ' ' A' ' 150' ' ' VAL . 32.4 Cg_endo -72.23 156.32 98.25 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 124.198 -1.168 . . . . 0.0 112.101 2.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.72 152.07 21.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.059 -1.025 . . . . 0.0 108.259 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.518 ' O ' ' CD1' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -131.69 137.83 48.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.928 -1.108 . . . . 0.0 110.195 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 153' ' ' MET . 14.0 m-85 -133.32 136.23 45.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.399 -0.813 . . . . 0.0 109.524 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 12.1 t -110.78 119.59 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.046 -1.034 . . . . 0.0 108.352 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 20' ' ' PRO . 1.7 m-20 53.29 27.31 6.0 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 15' ' ' PRO . . . 50.18 21.66 4.29 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.232 -1.461 . . . . 0.0 109.614 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -118.79 -21.02 8.0 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.756 -1.438 . . . . 0.0 108.721 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.44 ' N ' HD13 ' A' ' 12' ' ' LEU . 17.9 m-85 -134.87 123.93 24.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 109.291 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.551 ' CG ' HG21 ' A' ' 10' ' ' THR . 25.4 pt20 -116.93 117.42 29.64 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.268 -0.895 . . . . 0.0 109.59 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.499 HD22 ' CB ' ' A' ' 9' ' ' TYR . 11.6 mt -60.83 179.47 0.17 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.502 -0.749 . . . . 0.0 108.98 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -155.17 117.92 2.43 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.037 -1.039 . . . . 0.0 109.529 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 C--N 1.312 -1.379 0 C-N-CA 122.328 2.019 . . . . 0.0 110.635 179.888 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 5.7 mmm . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.773 0.797 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -78.53 -56.56 4.34 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 6.9 t -64.09 -28.49 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 108.939 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.437 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 48.7 t80 -69.18 -43.16 74.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 0.0 109.229 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.449 HG23 HD13 ' A' ' 42' ' ' ILE . 61.3 t -70.05 -27.35 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.181 -0.949 . . . . 0.0 109.478 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -83.95 -58.71 2.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 109.251 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.463 ' O ' ' OG1' ' A' ' 181' ' ' THR . 0.0 OUTLIER -56.94 -41.73 78.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.397 -0.815 . . . . 0.0 109.197 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 69.2 t80 -65.54 -51.85 56.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.067 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.17 -25.28 67.68 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.241 -0.912 . . . . 0.0 109.26 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.28 -45.07 20.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.899 . . . . 0.0 109.348 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.485 ' O ' HD21 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -57.0 -42.32 80.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.221 -0.924 . . . . 0.0 109.14 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 2.4 t -74.49 -36.55 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 109.135 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.419 ' HG3' ' HB3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -57.55 -50.11 74.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.19 -0.944 . . . . 0.0 109.102 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -31.46 55.66 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.235 -0.916 . . . . 0.0 109.086 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.536 HD21 ' N ' ' A' ' 185' ' ' LEU . 0.4 OUTLIER -58.24 -21.3 47.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.841 -1.162 . . . . 0.0 109.171 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.2 p -74.39 -4.77 38.45 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.817 -1.177 . . . . 0.0 108.691 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.418 -0.802 . . . . 0.0 109.267 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.486 ' HB2' ' CE1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.2 58.41 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.79 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.0 t0 50.5 84.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.574 -0.704 . . . . 0.0 110.271 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 112.89 -19.73 20.65 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -66.62 0.86 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.057 -1.26 . . . . 0.0 108.684 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.473 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 40.6 mm-40 -102.62 10.61 38.62 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.321 -0.862 . . . . 0.0 109.678 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 3' ' ' TYR . 6.9 p90 179.1 136.09 0.09 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.07 -1.019 . . . . 0.0 109.426 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.51 HG21 ' CG ' ' A' ' 160' ' ' GLN . 2.3 t -123.55 171.9 9.17 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.487 HG21 ' N ' ' A' ' 12' ' ' LEU . 53.5 m -120.97 149.69 42.27 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.514 0.673 . . . . 0.0 110.199 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.487 ' N ' HG21 ' A' ' 11' ' ' THR . 1.3 mp -98.18 157.45 16.15 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.572 -0.705 . . . . 0.0 109.21 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.508 ' HG2' ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -84.7 -25.64 28.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 109.192 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.508 ' N ' ' HG2' ' A' ' 13' ' ' GLU . 7.4 mttp -116.24 96.44 47.51 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.359 -0.838 . . . . 0.0 109.046 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 34.3 Cg_endo -76.74 159.95 34.7 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.337 2.025 . . . . 0.0 110.481 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 16' ' ' VAL . 11.7 t -108.73 90.52 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.885 . . . . 0.0 109.762 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.96 131.5 12.12 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 95.18 -24.49 28.6 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.534 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -41.2 160.62 0.14 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.404 -1.056 . . . . 0.0 109.471 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.541 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.0 Cg_endo -78.13 129.26 9.55 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.563 2.175 . . . . 0.0 111.015 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.522 ' CB ' HG11 ' A' ' 54' ' ' VAL . 2.5 mp0 -46.68 -20.69 0.14 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 22' ' ' VAL . 3.1 t -148.35 79.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.873 -1.142 . . . . 0.0 108.73 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.599 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -73.76 127.47 32.9 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' N ' HD21 ' A' ' 23' ' ' LEU . 33.2 tt0 -114.64 118.08 32.65 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.99 -1.068 . . . . 0.0 109.564 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.599 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 7.5 m-85 -103.76 112.5 25.47 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.586 -0.696 . . . . 0.0 109.274 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -155.19 142.28 19.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.998 -1.064 . . . . 0.0 110.14 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.551 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 4.3 p -124.55 -168.63 1.84 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.627 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -116.47 52.54 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.857 -1.152 . . . . 0.0 108.036 178.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.572 ' CG ' HG13 ' A' ' 96' ' ' VAL . 7.6 m-85 -139.97 10.62 2.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.222 -0.924 . . . . 0.0 110.236 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.64 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 4.0 m -117.06 179.88 0.74 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.753 -1.217 . . . . 0.0 108.484 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.3 Cg_endo -76.02 -59.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.593 1.529 . . . . 0.0 110.169 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -69.4 -11.46 60.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.955 -1.09 . . . . 0.0 108.4 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 27' ' ' SER . 1.2 m -57.15 -37.93 72.78 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.587 ' CE1' ' HG3' ' A' ' 38' ' ' GLU . 18.6 t80 -81.22 -41.91 21.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.758 -0.589 . . . . 0.0 109.791 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.492 ' N ' ' OE1' ' A' ' 35' ' ' GLN . 11.7 mp0 -78.56 -21.26 48.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.945 . . . . 0.0 110.681 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.567 ' CE2' HG22 ' A' ' 42' ' ' ILE . 27.0 t80 -75.52 -18.03 59.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 0.0 110.521 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 2.2 mm-40 -128.28 32.34 4.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.928 -1.107 . . . . 0.0 110.419 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.587 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 4.5 mm-40 -145.18 -67.89 0.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.977 -1.077 . . . . 0.0 109.797 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.46 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 13.2 t -97.1 -56.79 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.057 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.481 ' HB3' HG13 ' A' ' 42' ' ' ILE . 61.2 mt -43.49 -27.9 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.118 -0.989 . . . . 0.0 109.93 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' A' ' 38' ' ' GLU . 29.7 m170 49.37 24.28 1.03 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.044 -1.035 . . . . 0.0 109.027 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.567 HG22 ' CE2' ' A' ' 36' ' ' PHE . 12.2 mt -59.51 -32.8 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.42 -0.8 . . . . 0.0 109.64 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -45.09 24.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.051 -1.031 . . . . 0.0 110.006 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -81.16 -36.45 30.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.921 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 41' ' ' HIS . 6.2 t-20 -67.47 -30.34 70.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.947 . . . . 0.0 109.907 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 42' ' ' ILE . 43.5 t -74.5 -17.65 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.182 -0.949 . . . . 0.0 109.523 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HA ' HD13 ' A' ' 50' ' ' LEU . 25.9 mttm -75.9 -34.39 59.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.451 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -57.7 -18.96 23.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.922 . . . . 0.0 109.583 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.81 17.76 14.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.439 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 47' ' ' LYS . 11.9 mt -93.62 118.65 67.51 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.751 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 53' ' ' GLY . 35.1 Cg_endo -77.32 151.99 30.18 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.301 2.001 . . . . 0.0 108.954 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 52' ' ' GLU . 11.0 tt0 -71.09 42.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.497 -1.377 . . . . 0.0 110.882 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.514 ' O ' ' CG2' ' A' ' 54' ' ' VAL . . . -140.77 37.29 1.68 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.522 HG11 ' CB ' ' A' ' 21' ' ' GLN . 21.4 t -159.43 128.5 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.554 -0.968 . . . . 0.0 109.035 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.471 ' N ' ' OE1' ' A' ' 21' ' ' GLN . 3.6 ttpp -100.01 112.29 24.58 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.828 0.823 . . . . 0.0 110.013 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.0 ttt -93.02 99.29 11.94 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 2.5 m -92.45 143.14 26.66 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.86 -1.136 . . . . 0.0 110.039 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -119.46 111.19 17.81 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.354 -0.841 . . . . 0.0 109.762 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CE2' ' HG3' ' A' ' 138' ' ' GLN . 5.2 m-85 -111.3 166.11 11.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.225 -0.922 . . . . 0.0 111.074 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.551 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 62.7 t-80 -103.97 135.54 45.3 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.837 0.827 . . . . 0.0 109.008 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.586 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 4.4 m -73.45 154.24 7.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-O 121.476 0.655 . . . . 0.0 110.406 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -121.74 27.61 8.08 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.607 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 19.5 p90 -125.75 69.47 1.18 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.112 -0.992 . . . . 0.0 110.234 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.58 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -160.91 -59.06 0.05 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.918 . . . . 0.0 109.764 178.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.58 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -95.86 80.77 0.8 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.54 -43.03 0.72 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.57 -78.3 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.904 -1.351 . . . . 0.0 110.825 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.596 ' CD1' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -80.49 -20.88 42.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.122 . . . . 0.0 110.265 -179.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.596 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -54.79 -38.68 65.07 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -47.32 63.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.427 -1.043 . . . . 0.0 108.523 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.527 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 12.2 t70 -65.44 -23.57 66.96 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.542 HD22 ' NE2' ' A' ' 60' ' ' HIS . 36.7 tp -65.09 -46.47 80.96 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 m -58.51 -42.73 88.33 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.498 ' O ' ' CG2' ' A' ' 78' ' ' VAL . 19.2 tt0 -57.72 -25.03 59.78 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 177.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -64.69 -40.21 94.99 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.447 ' O ' ' HB2' ' A' ' 80' ' ' MET . 25.3 t-105 -63.54 -29.09 70.4 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.449 ' CB ' HG21 ' A' ' 135' ' ' VAL . . . -81.6 -44.02 17.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 109.763 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.648 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 1.6 t -71.78 -27.39 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 109.401 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.507 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -78.75 -57.78 3.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.13 -0.982 . . . . 0.0 108.804 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -48.17 -27.68 2.53 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.155 -0.965 . . . . 0.0 108.578 179.429 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.419 ' CB ' HG21 ' A' ' 131' ' ' VAL . . . -69.25 -45.74 69.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.584 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.459 ' HB2' HG12 ' A' ' 84' ' ' VAL . 12.6 mt -105.2 14.28 29.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 49.1 25.52 5.51 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 33.8 m -82.98 -11.53 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -1.086 . . . . 0.0 110.298 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.431 ' HG2' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -42.84 -63.59 0.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -0.98 . . . . 0.0 109.875 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.47 -33.43 1.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.285 -0.885 . . . . 0.0 110.264 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -81.6 -50.76 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.37 -0.832 . . . . 0.0 111.436 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 92' ' ' LEU . 2.2 m -90.57 6.1 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.863 -1.148 . . . . 0.0 111.195 -178.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.601 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -83.02 -45.7 13.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.818 -1.177 . . . . 0.0 108.347 178.582 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.464 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -52.39 -51.46 72.37 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.596 -1.315 . . . . 0.0 110.61 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 90' ' ' VAL . 27.1 Cg_endo -73.79 -20.13 20.26 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 N-CA-C 109.736 -0.909 . . . . 0.0 109.736 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.527 ' CD1' HG22 ' A' ' 88' ' ' VAL . 18.5 mt -86.18 -43.21 13.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 108.87 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.627 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 5.2 m-30 -64.47 -45.77 85.96 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.094 -1.004 . . . . 0.0 108.945 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -76.36 -21.2 56.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.083 -1.011 . . . . 0.0 109.751 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.456 ' O ' HG12 ' A' ' 102' ' ' ILE . . . -72.75 -29.77 64.85 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.572 HG13 ' CG ' ' A' ' 29' ' ' PHE . 3.4 t -98.77 -15.29 7.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.012 -1.287 . . . . 0.0 109.669 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.525 ' NE2' ' HB2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -108.64 8.23 26.92 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 120.815 -1.178 . . . . 0.0 111.131 -178.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 99' ' ' THR . 16.8 mttt -163.72 63.39 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.517 -1.365 . . . . 0.0 109.472 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.546 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.1 m 160.41 -44.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 71.51 13.52 6.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.803 -1.186 . . . . 0.0 110.834 178.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.546 ' HB ' ' CG2' ' A' ' 99' ' ' THR . 4.5 t -79.67 -8.49 59.25 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.5 ' CB ' HG23 ' A' ' 96' ' ' VAL . 7.7 mm -83.14 74.11 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.71 32.72 2.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 0.0 109.757 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 107' ' ' ASP . 13.2 p -159.28 132.09 6.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.03 -1.044 . . . . 0.0 109.797 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.489 ' HA ' ' CD1' ' A' ' 108' ' ' ILE . . . -48.65 -36.43 15.92 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 110' ' ' ASP . 22.7 t -58.1 -34.1 69.83 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -66.67 -49.7 65.3 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.553 ' CD1' HD21 ' A' ' 68' ' ' LEU . 24.5 mt -50.02 -26.71 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.253 -0.904 . . . . 0.0 108.623 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 110' ' ' ASP . 0.9 OUTLIER -71.5 -64.65 0.88 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.476 -0.765 . . . . 0.0 109.614 -179.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.489 ' OD1' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -43.62 -42.27 5.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.33 -0.856 . . . . 0.0 110.195 -179.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.51 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 1.4 t -67.78 -40.16 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.794 -1.191 . . . . 0.0 109.452 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -68.35 -37.66 80.7 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.227 -0.92 . . . . 0.0 109.578 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 110' ' ' ASP . 15.7 mt -68.4 -23.51 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.0 108.99 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -63.68 -17.58 63.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.454 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.46 ' HB1' HG11 ' A' ' 88' ' ' VAL . . . -95.51 12.83 28.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.211 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.67 8.23 87.21 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.492 ' O ' ' C ' ' A' ' 118' ' ' LYS . 3.9 mm -89.0 62.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -1.073 . . . . 0.0 109.653 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.492 ' C ' ' O ' ' A' ' 117' ' ' ILE . 1.7 tptp -33.35 140.85 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.342 -0.849 . . . . 0.0 110.374 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.47 -23.76 6.69 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.418 ' O ' ' HB1' ' A' ' 124' ' ' ALA . 9.7 tt0 -63.07 -49.07 75.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.267 . . . . 0.0 109.593 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -76.23 -38.21 56.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.622 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.648 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 1.9 t80 -64.54 -50.66 66.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.299 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.16 -48.39 76.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.093 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 120' ' ' GLU . . . -50.97 -53.3 34.29 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.328 -0.857 . . . . 0.0 108.875 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.49 ' CB ' HG23 ' A' ' 131' ' ' VAL . . . -49.86 -52.66 31.0 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 8.7 t90 -52.28 -59.78 3.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -52.31 -16.75 0.91 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.615 -0.678 . . . . 0.0 110.038 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.2 m -72.2 -178.56 2.51 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.904 -1.123 . . . . 0.0 109.6 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -90.08 -35.29 15.54 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.888 -0.507 . . . . 0.0 110.424 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.43 -45.63 81.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 118.198 -1.401 . . . . 0.0 109.586 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.491 ' CG1' ' HA ' ' A' ' 78' ' ' VAL . 3.6 t -71.75 -35.62 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.958 -1.089 . . . . 0.0 108.632 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -69.97 -38.47 76.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.381 -0.824 . . . . 0.0 108.926 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -65.72 -29.89 70.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 108.977 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.59 -21.97 44.31 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.449 HG21 ' CB ' ' A' ' 77' ' ' ALA . 6.0 t -75.77 -45.59 37.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.76 88.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -62.45 -38.26 89.1 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 141' ' ' ALA . 4.8 mt-30 -62.2 -64.39 0.95 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 4.5 tm-20 -48.18 -31.05 5.23 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -73.41 -33.29 64.89 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -63.8 -63.01 1.28 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 108.886 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -62.1 -35.39 78.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.359 -0.838 . . . . 0.0 109.745 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -77.19 -16.64 59.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 109.719 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 140' ' ' LYS . 9.4 m-20 -79.94 -44.28 20.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.098 -1.001 . . . . 0.0 108.725 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.546 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 16.0 m -105.78 -5.2 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.372 -0.83 . . . . 0.0 109.004 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 81.32 -47.16 0.23 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.773 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 25' ' ' PHE . 17.2 tp 66.29 132.74 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 109.295 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.511 ' CD ' ' O ' ' A' ' 148' ' ' ARG . 6.3 tmm_? -160.79 38.42 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.59 -1.319 . . . . 0.0 109.94 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.46 108.0 0.21 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.251 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.533 ' CG1' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -93.32 141.8 24.44 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.404 -1.057 . . . . 0.0 109.573 179.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.477 ' HD3' ' CE1' ' A' ' 32' ' ' HIS . 35.7 Cg_endo -78.42 150.39 87.87 Favored 'Cis proline' 0 C--N 1.316 -1.176 0 C-N-CA 123.858 -1.309 . . . . 0.0 110.312 0.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . . . -122.83 148.33 45.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.169 -1.582 . . . . 0.0 108.456 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -135.47 130.65 35.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.969 -1.082 . . . . 0.0 110.053 -179.08 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.53 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 29.6 m-85 -129.58 127.75 41.32 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.279 -0.888 . . . . 0.0 110.087 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 34.8 t -97.07 125.82 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 109.431 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.444 ' O ' ' CG ' ' A' ' 156' ' ' ASN . 21.5 t-20 52.54 22.69 2.25 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.194 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.534 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 54.34 39.18 64.14 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.315 -1.422 . . . . 0.0 109.639 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -142.95 -32.85 0.47 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.313 -1.11 . . . . 0.0 108.279 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -116.34 125.42 52.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 108.644 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.53 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 6.3 pt20 -122.5 120.18 33.11 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.058 -1.026 . . . . 0.0 109.895 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.424 HD22 ' HB2' ' A' ' 9' ' ' TYR . 25.5 mt -62.47 -179.6 0.26 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -159.86 70.21 3.13 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.126 -0.984 . . . . 0.0 109.388 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 C--N 1.31 -1.48 0 C-N-CA 122.78 2.32 . . . . 0.0 110.547 -179.848 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.453 ' O ' HG22 ' A' ' 175' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.578 0.704 . . . . 0.0 110.038 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.44 -48.05 62.1 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.605 -0.685 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.452 HG11 ' OE1' ' A' ' 177' ' ' GLN . 4.9 t -73.16 -26.55 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.148 -0.97 . . . . 0.0 109.619 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.479 ' CE2' HD12 ' A' ' 42' ' ' ILE . 6.7 t80 -71.53 -44.43 64.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.033 -1.042 . . . . 0.0 109.582 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 171' ' ' MET . 86.9 t -71.55 -26.1 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.112 -0.993 . . . . 0.0 109.21 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -56.61 3.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.452 ' OE1' HG11 ' A' ' 173' ' ' VAL . 18.2 pt20 -60.08 -35.67 75.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.981 . . . . 0.0 108.983 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.553 ' CE1' ' CG2' ' A' ' 182' ' ' VAL . 4.0 t80 -66.55 -51.81 52.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 175' ' ' VAL . . . -54.1 -26.54 27.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -0.916 . . . . 0.0 108.917 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.66 -37.99 40.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.526 ' O ' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -62.63 -40.77 98.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.314 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.553 ' CG2' ' CE1' ' A' ' 178' ' ' TYR . 21.2 t -75.53 -34.8 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.033 -1.042 . . . . 0.0 109.19 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -58.7 -49.48 77.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.22 -0.925 . . . . 0.0 109.157 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.529 ' CD2' HD21 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -77.7 -40.25 41.96 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.28 -0.887 . . . . 0.0 108.716 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.572 HD21 ' N ' ' A' ' 185' ' ' LEU . 3.8 mm? -53.6 -19.13 3.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.08 -1.012 . . . . 0.0 109.434 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 12.3 t -87.01 8.67 22.37 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.761 -1.212 . . . . 0.0 107.989 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 184' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.529 -0.732 . . . . 0.0 109.715 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.458 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 1.2 tt0 -130.03 60.38 1.6 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.113 -0.992 . . . . 0.0 110.201 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 0.7 OUTLIER 70.02 94.63 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.427 -0.796 . . . . 0.0 110.538 178.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.52 ' HA2' ' ND2' ' A' ' 162' ' ' ASN . . . 79.71 5.45 89.39 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 1.2 tttp -106.86 31.37 5.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -1.193 . . . . 0.0 108.91 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.577 ' CB ' ' O ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER 147.8 -39.45 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.374 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.571 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 1.3 p90 -157.96 124.51 4.85 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.086 -1.009 . . . . 0.0 109.352 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 t -104.03 176.79 5.04 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -116.25 146.72 42.14 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.596 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.472 ' HG ' ' NE2' ' A' ' 160' ' ' GLN . 1.5 mp -98.52 160.95 13.94 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.363 -0.835 . . . . 0.0 109.703 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -89.99 -1.63 58.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.479 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -142.64 94.84 6.56 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.301 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 35.6 Cg_endo -77.84 167.0 24.48 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.589 2.193 . . . . 0.0 110.517 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 144' ' ' ASP . 25.2 t -119.6 95.67 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.754 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.19 129.47 10.15 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 92.18 -18.74 53.15 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.55 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -38.54 157.84 0.1 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.517 -0.99 . . . . 0.0 109.828 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.5 Cg_endo -79.85 133.56 10.26 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.573 2.182 . . . . 0.0 111.126 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 9.6 mm-40 -41.16 -25.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.53 -0.731 . . . . 0.0 109.935 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 22' ' ' VAL . 5.1 t -147.98 80.41 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.007 -1.058 . . . . 0.0 109.022 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.649 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.23 120.71 20.17 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.504 ' N ' HD21 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -104.64 122.66 46.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.182 -0.948 . . . . 0.0 109.42 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.649 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 2.9 m-30 -108.26 103.62 12.83 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.408 -0.808 . . . . 0.0 109.9 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -140.67 141.06 35.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.423 -0.798 . . . . 0.0 109.243 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.598 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 1.3 t -115.41 172.22 7.23 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.093 -1.005 . . . . 0.0 109.217 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.555 ' N ' ' NE2' ' A' ' 60' ' ' HIS . 8.0 m-30 -89.71 43.67 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 28' ' ' PHE . 22.2 m-85 -147.3 17.33 1.19 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.494 -0.754 . . . . 0.0 109.698 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -113.68 165.96 12.34 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.756 -1.215 . . . . 0.0 109.622 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 33.7 Cg_endo -75.95 -38.46 1.21 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.33 2.02 . . . . 0.0 108.183 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.482 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 1.8 m-70 -72.56 -28.16 62.65 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.491 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 28.8 t -44.57 -61.93 1.38 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.81 0.814 . . . . 0.0 108.826 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.618 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 27.5 t80 -78.09 -40.09 39.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.885 -0.51 . . . . 0.0 110.55 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.485 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 3.4 mm-40 -64.52 -27.35 68.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.188 -0.945 . . . . 0.0 111.079 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.557 ' CE1' HD11 ' A' ' 42' ' ' ILE . 3.9 m-30 -87.02 -34.36 19.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.806 -1.184 . . . . 0.0 111.212 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.14 -23.2 22.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.805 -1.184 . . . . 0.0 111.987 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -136.34 28.14 3.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.344 -1.472 . . . . 0.0 111.612 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.507 ' O ' ' CD2' ' A' ' 41' ' ' HIS . 53.3 t -150.98 -81.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.541 -1.349 . . . . 0.0 109.821 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.9 mt -67.78 -12.52 60.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.804 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 14.3 m-70 51.51 21.76 1.34 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.979 . . . . 0.0 109.337 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.557 HD11 ' CE1' ' A' ' 36' ' ' PHE . 22.1 mt -65.32 -20.09 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 109.45 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.517 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -81.64 -41.43 21.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.757 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 47' ' ' LYS . 7.4 p-10 -87.08 -45.14 10.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.995 . . . . 0.0 109.59 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -45.83 -31.48 2.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.866 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 43' ' ' SER . 8.4 m -74.26 -30.85 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.089 -1.007 . . . . 0.0 109.655 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 44' ' ' ASP . 8.6 mmmm -48.49 -39.62 23.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 0.0 109.223 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -58.45 -23.23 57.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.353 -0.842 . . . . 0.0 109.206 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 6.4 mttm -93.31 23.31 4.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.401 -0.812 . . . . 0.0 109.78 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.536 HD21 ' CB ' ' A' ' 54' ' ' VAL . 18.8 mt -118.92 76.27 14.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.024 -1.047 . . . . 0.0 109.824 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 52' ' ' GLU . 36.6 Cg_endo -78.69 63.34 8.53 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.417 2.078 . . . . 0.0 110.293 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 51' ' ' PRO . 23.3 tp10 58.46 131.57 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.448 0.642 . . . . 0.0 110.259 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.69 -18.35 44.12 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.536 ' CB ' HD21 ' A' ' 50' ' ' LEU . 2.4 t -95.89 89.36 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.082 -1.246 . . . . 0.0 109.193 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.97 96.79 2.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.412 -0.805 . . . . 0.0 109.846 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.423 ' HG2' ' CD1' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -92.18 100.75 13.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.272 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.2 m -98.61 119.18 36.9 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.864 -1.135 . . . . 0.0 110.581 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -97.63 108.53 21.27 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.466 -0.771 . . . . 0.0 109.654 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CD1' ' HG3' ' A' ' 138' ' ' GLN . 3.0 m-85 -111.56 154.18 25.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.166 -0.959 . . . . 0.0 111.624 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.598 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 18.2 t-80 -106.62 108.88 20.61 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.575 HG22 ' CD1' ' A' ' 63' ' ' PHE . 15.1 m -69.64 156.53 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.44 -0.787 . . . . 0.0 109.994 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.512 ' CB ' ' HA ' ' A' ' 70' ' ' LYS . 3.6 p30 -108.23 51.38 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 109.573 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.577 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -131.1 52.94 2.02 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.172 -0.955 . . . . 0.0 110.155 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.521 ' SD ' ' CB ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -134.02 38.79 3.16 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.32 -34.2 0.65 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.57 -34.86 2.88 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.757 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.27 -80.44 0.25 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.765 -1.432 . . . . 0.0 109.852 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.56 HD21 ' CD1' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -77.44 -23.79 50.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.794 -1.191 . . . . 0.0 108.723 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.54 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -48.18 -44.0 26.25 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.512 ' HA ' ' CB ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -64.58 -45.13 88.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -1.117 . . . . 0.0 108.572 179.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.531 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 22.7 t0 -67.72 -28.7 67.88 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.583 ' HG ' ' CE1' ' A' ' 60' ' ' HIS . 13.1 tp -62.69 -44.37 96.41 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.45 HG22 ' HG2' ' A' ' 138' ' ' GLN . 2.5 m -60.46 -42.32 95.93 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.483 ' O ' ' CG2' ' A' ' 78' ' ' VAL . 8.4 tt0 -59.7 -21.17 60.24 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -68.62 -43.52 76.2 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.503 ' CD1' ' OE1' ' A' ' 138' ' ' GLN . 69.7 t-105 -60.45 -32.13 71.09 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.538 ' CB ' ' CG2' ' A' ' 135' ' ' VAL . . . -79.89 -55.41 4.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.549 -0.719 . . . . 0.0 109.876 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.641 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 2.8 t -57.7 -28.29 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 109.96 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -79.54 -59.04 2.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.883 -1.136 . . . . 0.0 108.564 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -46.19 -29.52 1.61 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.442 ' HB3' ' CG2' ' A' ' 131' ' ' VAL . . . -68.35 -44.6 74.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.383 -0.823 . . . . 0.0 109.391 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.477 ' O ' HG11 ' A' ' 84' ' ' VAL . 7.7 mt -104.68 13.35 31.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.189 -0.944 . . . . 0.0 110.026 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.39 27.51 4.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 82' ' ' LEU . 33.1 m -85.28 -9.15 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.314 -1.109 . . . . 0.0 110.415 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.3 OUTLIER -41.31 -60.49 1.25 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.17 -0.956 . . . . 0.0 109.784 -179.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.16 -33.46 2.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.365 -0.835 . . . . 0.0 110.041 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -83.82 -49.83 8.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.329 -0.857 . . . . 0.0 111.411 -178.517 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.2 m -87.06 -4.72 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.775 -1.203 . . . . 0.0 110.504 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.614 HG21 ' CG ' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -77.41 -44.17 30.08 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.811 -1.181 . . . . 0.0 108.508 178.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.438 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -51.46 -52.72 57.18 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.634 -1.291 . . . . 0.0 110.334 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.522 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 27.2 Cg_endo -74.04 -17.63 22.0 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 N-CA-C 109.847 -0.866 . . . . 0.0 109.847 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 89' ' ' THR . 12.7 mt -86.84 -42.49 13.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 108.956 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.614 ' CG ' HG21 ' A' ' 89' ' ' THR . 7.4 m-30 -69.88 -46.73 64.84 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.877 -1.139 . . . . 0.0 108.472 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 1.0 OUTLIER -72.77 -27.75 62.19 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.194 -0.941 . . . . 0.0 108.975 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.468 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -70.1 -29.09 70.81 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' A' ' 29' ' ' PHE . 1.6 t -103.8 1.38 10.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.194 -1.18 . . . . 0.0 108.917 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.618 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER -107.54 10.75 29.19 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.975 -1.078 . . . . 0.0 110.763 -179.15 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -178.62 -51.82 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.576 -1.327 . . . . 0.0 110.423 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 68.6 p -59.79 -40.84 89.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.48 -1.388 . . . . 0.0 109.507 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 67.49 9.9 7.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.372 -0.83 . . . . 0.0 109.783 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 t -81.15 -7.85 59.64 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.827 0.822 . . . . 0.0 109.044 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.499 HG13 HG21 ' A' ' 96' ' ' VAL . 8.8 mm -85.4 80.74 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -145.05 34.51 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.39 -0.819 . . . . 0.0 109.699 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 107' ' ' ASP . 83.4 p -164.96 136.28 4.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.893 -1.13 . . . . 0.0 110.269 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.505 ' N ' ' HB2' ' A' ' 68' ' ' LEU . . . -49.22 -38.65 27.13 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 t -56.75 -32.5 65.65 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -70.0 -53.39 17.88 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.56 ' CD1' HD21 ' A' ' 68' ' ' LEU . 25.5 mt -45.68 -28.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.173 -0.955 . . . . 0.0 108.771 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -46.34 31.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 109.565 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 1.2 p30 -53.14 -41.8 65.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 109.606 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.522 ' CG1' ' HG2' ' A' ' 91' ' ' PRO . 13.6 t -71.49 -38.39 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.96 -1.088 . . . . 0.0 109.51 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.412 ' CE1' HG22 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -65.79 -54.71 23.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.3 mt -61.67 -24.02 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.131 -0.981 . . . . 0.0 109.709 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -72.4 -16.64 61.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.155 -0.966 . . . . 0.0 109.45 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.6 8.08 43.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 109.77 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.44 -3.3 79.0 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.6 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.4 mp -85.54 60.73 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -1.129 . . . . 0.0 109.114 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -37.28 157.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.828 -1.17 . . . . 0.0 110.239 -179.456 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.42 -23.57 64.78 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.47 -52.01 63.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.982 -1.305 . . . . 0.0 109.337 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -75.5 -36.82 60.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.934 . . . . 0.0 109.331 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.641 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 3.2 t80 -62.78 -48.51 78.84 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.247 -0.908 . . . . 0.0 109.005 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -62.12 -36.88 83.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 108.75 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.466 ' O ' ' OG ' ' A' ' 128' ' ' SER . . . -63.24 -49.76 72.88 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 108.92 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.528 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -52.54 -50.72 62.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.002 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.465 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 3.1 t90 -60.18 -55.53 32.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -52.66 -16.47 0.96 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.547 -0.721 . . . . 0.0 110.015 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 124' ' ' ALA . 0.9 OUTLIER -73.54 176.8 5.8 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.965 -1.084 . . . . 0.0 109.383 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 133' ' ' SER . 60.4 m-85 -91.94 -37.94 12.57 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.63 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.9 t -65.21 -47.14 88.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 118.056 -1.458 . . . . 0.0 109.266 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 3.7 t -64.03 -39.44 85.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.057 -1.027 . . . . 0.0 108.344 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -71.19 -27.63 63.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.835 . . . . 0.0 108.915 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -66.42 -41.82 88.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.151 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.45 -18.17 55.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 108.699 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.538 ' CG2' ' CB ' ' A' ' 77' ' ' ALA . 3.9 t -75.54 -40.36 41.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -71.81 -39.69 69.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -30.3 70.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.09 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.53 ' HG3' ' CD1' ' A' ' 59' ' ' TYR . 2.8 tt0 -71.17 -64.71 0.86 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.33 -0.857 . . . . 0.0 109.075 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 0.6 OUTLIER -50.09 -33.43 18.6 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 108.475 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 26.4 mttt -76.71 -29.91 56.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -57.27 -53.99 51.82 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.309 -0.87 . . . . 0.0 108.763 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -72.03 -40.53 68.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.366 -0.834 . . . . 0.0 110.495 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.55 -16.93 61.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.991 -1.068 . . . . 0.0 109.939 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.482 ' HB3' ' CG2' ' A' ' 16' ' ' VAL . 2.4 m-20 -84.71 -43.21 14.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 108.553 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.583 HG23 ' CE2' ' A' ' 25' ' ' PHE . 4.5 m -93.42 -12.09 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 1.0 OUTLIER 82.33 -43.79 0.14 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.65 -0.657 . . . . 0.0 109.513 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.528 HD21 ' CG1' ' A' ' 61' ' ' VAL . 33.7 tp 62.9 139.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.426 -0.797 . . . . 0.0 109.939 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.501 ' CD ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -161.22 38.73 0.14 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.764 -1.21 . . . . 0.0 109.563 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 160.42 109.93 0.26 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.438 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.37 140.59 21.76 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.35 -1.088 . . . . 0.0 108.743 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.76 150.87 87.65 Favored 'Cis proline' 0 C--N 1.313 -1.312 0 C-N-CA 123.993 -1.253 . . . . 0.0 110.396 0.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.461 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . . . -123.63 160.19 27.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.442 -1.411 . . . . 0.0 109.051 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.469 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 0.6 OUTLIER -144.7 129.11 17.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.074 -1.016 . . . . 0.0 109.871 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 8.9 m-85 -131.64 134.18 45.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.372 -0.83 . . . . 0.0 109.993 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 53.7 t -105.56 133.16 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.912 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.405 ' N ' HG11 ' A' ' 155' ' ' VAL . 0.7 OUTLIER 45.5 22.21 0.09 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.201 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.55 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.92 57.56 19.08 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -168.88 -34.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.234 -1.156 . . . . 0.0 108.454 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 51.6 m-85 -117.89 125.09 49.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.815 . . . . 0.0 108.971 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.472 ' NE2' ' HG ' ' A' ' 12' ' ' LEU . 20.9 pt20 -123.74 130.5 52.73 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.78 -1.2 . . . . 0.0 109.82 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.14 172.75 10.5 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.52 ' ND2' ' HA2' ' A' ' 6' ' ' GLY . 5.6 p30 -151.95 147.12 19.37 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.089 -1.007 . . . . 0.0 109.482 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.309 -1.546 0 C-N-CA 122.672 2.248 . . . . 0.0 110.776 179.871 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.456 ' HA ' ' CD2' ' A' ' 174' ' ' PHE . 4.3 mtt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.778 0.799 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -75.32 -62.42 1.57 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.7 t -55.86 -26.82 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.248 -0.908 . . . . 0.0 108.601 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 174' ' ' PHE . 7.0 m-30 -69.26 -38.13 78.25 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.195 -0.941 . . . . 0.0 108.962 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.459 ' O ' ' HB1' ' A' ' 179' ' ' ALA . 77.6 t -73.78 -24.97 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.229 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -83.14 -60.4 2.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.301 -0.874 . . . . 0.0 109.226 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -37.86 61.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.167 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 174' ' ' PHE . 16.5 t80 -69.58 -44.4 70.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.342 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 175' ' ' VAL . . . -65.31 -29.06 69.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 109.076 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.19 -37.95 60.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.1 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -64.05 -44.27 92.97 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.23 -0.919 . . . . 0.0 108.948 179.404 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.473 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 55.7 t -69.77 -38.62 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.176 -0.953 . . . . 0.0 109.186 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -55.13 38.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.126 -0.984 . . . . 0.0 109.385 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -75.92 -26.4 56.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.219 -0.926 . . . . 0.0 109.146 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.519 HD21 ' N ' ' A' ' 185' ' ' LEU . 0.3 OUTLIER -64.63 -18.86 65.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.965 -1.085 . . . . 0.0 109.267 -179.654 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 59.6 p -80.15 0.39 32.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 0.0 108.519 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.447 -0.783 . . . . 0.0 109.264 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 5' ' ' ASP . 5.4 mt-10 -99.65 54.87 0.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.81 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 4' ' ' GLU . 4.2 p-10 39.86 80.08 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.284 0.564 . . . . 0.0 110.036 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 127.81 -26.4 4.83 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.662 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -80.98 -68.53 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.844 -1.386 . . . . 0.0 109.289 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 11.9 mp0 -93.52 4.36 54.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 0.0 109.427 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.567 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 3.4 p90 179.1 131.68 0.08 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.169 -0.957 . . . . 0.0 109.35 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.442 HG22 ' HG3' ' A' ' 160' ' ' GLN . 8.7 t -119.65 175.83 5.67 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.661 -0.649 . . . . 0.0 109.26 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.59 157.59 15.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.686 -0.634 . . . . 0.0 109.617 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.475 ' HG ' ' HG2' ' A' ' 160' ' ' GLN . 7.4 mt -96.16 158.19 15.55 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.355 -0.84 . . . . 0.0 109.445 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -84.02 -12.06 55.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.096 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -151.82 104.74 2.85 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.1 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.36 166.87 26.78 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.449 2.099 . . . . 0.0 110.679 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 17' ' ' ALA . 10.2 t -132.14 89.87 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.852 . . . . 0.0 109.649 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.24 131.14 8.02 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 92.49 -19.7 48.92 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -40.29 163.24 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.563 -0.963 . . . . 0.0 109.917 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.542 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 35.0 Cg_endo -77.41 125.81 7.94 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.61 2.207 . . . . 0.0 111.047 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 5.3 mm100 -40.07 -24.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.523 -0.736 . . . . 0.0 110.012 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 20' ' ' PRO . 2.7 t -146.1 81.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.168 -0.958 . . . . 0.0 108.772 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.542 ' HG ' ' CG ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -75.34 124.97 28.04 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.518 ' N ' HD21 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -107.95 133.92 51.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.083 -1.011 . . . . 0.0 110.234 -179.027 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CE2' ' CG2' ' A' ' 145' ' ' VAL . 7.5 m-85 -123.55 100.74 6.95 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.496 ' HA ' HG13 ' A' ' 150' ' ' VAL . 3.3 p90 -150.76 140.29 21.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.048 -1.033 . . . . 0.0 110.458 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.481 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 1.3 p -115.15 177.44 4.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.345 -0.847 . . . . 0.0 109.123 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.576 ' CD2' HD23 ' A' ' 72' ' ' LEU . 8.4 m-30 -94.04 41.73 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CE2' HD13 ' A' ' 72' ' ' LEU . 9.9 m-85 -130.96 14.52 5.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.351 -0.843 . . . . 0.0 110.175 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.6 OUTLIER -110.5 158.46 35.36 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.706 -1.246 . . . . 0.0 109.554 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.506 ' HG2' ' CD2' ' A' ' 32' ' ' HIS . 33.8 Cg_endo -75.05 -38.38 1.59 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.189 1.926 . . . . 0.0 108.037 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.506 ' CD2' ' HG2' ' A' ' 31' ' ' PRO . 27.1 m-70 -76.06 -21.13 57.1 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 52.1 t -47.49 -65.1 0.62 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.55 ' HB2' ' CG ' ' A' ' 97' ' ' GLN . 7.3 t80 -60.66 -43.01 98.15 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.221 0.534 . . . . 0.0 110.037 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 32' ' ' HIS . 1.8 mt-30 -60.92 -22.98 64.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.194 -0.941 . . . . 0.0 109.976 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -82.9 -36.85 24.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.369 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.524 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -106.29 47.99 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.959 -1.088 . . . . 0.0 109.938 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -171.62 -52.23 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.223 -0.923 . . . . 0.0 111.902 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.0 t -89.28 -83.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.463 -1.398 . . . . 0.0 112.204 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.72 -10.48 59.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.973 -1.079 . . . . 0.0 110.765 -177.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 55.66 33.7 21.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 109.36 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.6 mm -48.58 -22.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 109.913 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.97 -41.57 18.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.2 -0.937 . . . . 0.0 110.341 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -86.15 -38.32 17.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.063 -1.023 . . . . 0.0 110.149 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.67 -33.79 4.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 109.907 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.499 HG21 ' N ' ' A' ' 47' ' ' LYS . 32.1 m -80.19 -26.52 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.013 -1.055 . . . . 0.0 110.338 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 2.1 mmtp -63.07 -40.78 98.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.898 -1.126 . . . . 0.0 109.737 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.04 -27.75 6.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.16 -0.963 . . . . 0.0 109.23 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.478 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 11.5 mttt -117.1 40.46 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.531 ' CD2' HG13 ' A' ' 54' ' ' VAL . 11.4 mt -113.27 88.62 12.98 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 35.8 Cg_endo -77.67 143.09 21.01 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.76 2.307 . . . . 0.0 110.528 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 51' ' ' PRO . 1.6 tm-20 -40.14 121.6 1.37 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 122.361 1.077 . . . . 0.0 109.562 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.95 -30.92 3.44 Favored Glycine 0 C--N 1.286 -2.2 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.531 HG13 ' CD2' ' A' ' 50' ' ' LEU . 2.6 t -86.35 82.91 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -1.065 . . . . 0.0 108.536 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.47 96.76 0.39 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.425 -0.797 . . . . 0.0 110.172 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.436 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -90.68 94.22 9.59 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 31.5 m -94.66 135.39 36.19 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.916 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.501 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -115.25 115.03 26.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.313 -0.867 . . . . 0.0 109.714 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.5 ' OH ' ' CG ' ' A' ' 137' ' ' GLN . 2.2 m-85 -112.58 166.46 11.31 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.071 -1.018 . . . . 0.0 111.631 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.64 ' CE1' ' CD2' ' A' ' 72' ' ' LEU . 2.1 t60 -108.86 125.66 52.22 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.734 0.778 . . . . 0.0 109.816 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.536 ' CG1' HD22 ' A' ' 147' ' ' LEU . 1.9 m -73.28 157.22 6.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.732 -0.605 . . . . 0.0 109.907 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -121.99 28.21 7.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.324 -0.86 . . . . 0.0 109.131 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.596 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 11.6 p90 -121.22 67.61 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 110.052 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.592 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -160.12 -59.1 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.396 -0.815 . . . . 0.0 109.222 178.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.592 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -96.21 78.03 0.76 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 178.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.67 -40.92 0.51 Allowed Glycine 0 N--CA 1.492 2.423 0 O-C-N 121.552 -0.969 . . . . 0.0 110.925 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.4 -79.23 0.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.909 -1.348 . . . . 0.0 110.64 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.59 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -80.13 -20.78 44.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.0 -1.062 . . . . 0.0 110.219 -179.145 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 65' ' ' GLY . . . -51.95 -47.1 54.8 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -46.55 88.25 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.469 -1.018 . . . . 0.0 108.316 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.512 ' CB ' ' HB3' ' A' ' 105' ' ' ALA . 0.3 OUTLIER -62.27 -26.04 68.18 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.344 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.64 ' CD2' ' CE1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -63.54 -37.4 87.16 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.428 HG22 ' OE1' ' A' ' 138' ' ' GLN . 5.9 m -65.01 -42.43 94.46 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.559 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 37.7 tt0 -61.59 -19.28 62.02 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -67.82 -43.0 80.65 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 22.8 t-105 -63.69 -31.95 73.28 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.846 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.403 ' HB2' HG22 ' A' ' 135' ' ' VAL . . . -79.87 -56.67 4.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 109.919 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.574 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 45.8 t -58.18 -27.03 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 0.0 110.015 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.535 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -82.16 -64.08 1.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.884 -1.135 . . . . 0.0 108.9 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.432 ' HB3' HD21 ' A' ' 134' ' ' LEU . 0.1 OUTLIER -46.85 -27.55 1.27 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.424 ' C ' HD22 ' A' ' 82' ' ' LEU . . . -66.15 -49.51 67.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.48 -0.763 . . . . 0.0 109.837 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.424 HD22 ' C ' ' A' ' 81' ' ' ALA . 7.1 mt -101.64 9.73 40.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.072 -1.017 . . . . 0.0 110.369 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.13 29.37 55.88 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.535 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 28.4 m -87.79 -0.08 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.34 -1.094 . . . . 0.0 110.054 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.481 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -44.74 -66.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.054 -1.029 . . . . 0.0 109.396 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -42.85 -33.67 0.81 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 110.082 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -79.48 -53.96 6.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.349 -0.844 . . . . 0.0 111.106 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.536 HG22 ' CD1' ' A' ' 92' ' ' LEU . 2.1 m -89.02 -10.45 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.719 -1.238 . . . . 0.0 111.226 -178.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.604 HG21 ' CD1' ' A' ' 93' ' ' PHE . 1.1 m -72.98 -42.9 62.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.57 -1.331 . . . . 0.0 108.795 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.402 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -58.1 -53.26 67.79 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.489 -1.382 . . . . 0.0 111.116 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.443 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 24.8 Cg_endo -72.66 -23.51 19.51 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 N-CA-C 110.087 -0.774 . . . . 0.0 110.087 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.536 ' CD1' HG22 ' A' ' 88' ' ' VAL . 79.4 mt -85.14 -42.99 14.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 108.862 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.604 ' CD1' HG21 ' A' ' 89' ' ' THR . 3.2 m-85 -62.56 -43.5 98.67 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.083 -1.01 . . . . 0.0 108.55 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -80.85 -16.67 53.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.405 -0.81 . . . . 0.0 109.82 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.43 ' HA2' ' OG1' ' A' ' 99' ' ' THR . . . -77.79 -34.82 37.55 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.493 HG12 ' CD1' ' A' ' 29' ' ' PHE . 2.2 t -95.58 -24.9 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.168 -1.196 . . . . 0.0 109.146 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.55 ' CG ' ' HB2' ' A' ' 34' ' ' TYR . 4.4 mp0 -102.38 5.07 39.57 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.016 -1.052 . . . . 0.0 110.622 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.547 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.3 OUTLIER -161.58 61.96 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.653 -1.28 . . . . 0.0 109.625 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 165.44 -50.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.492 -0.755 . . . . 0.0 109.358 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.485 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER 75.23 19.62 2.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.382 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.3 p -90.0 -6.89 55.14 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.658 0.742 . . . . 0.0 109.706 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.464 HG21 ' OD1' ' A' ' 107' ' ' ASP . 9.5 mm -84.77 81.57 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 121.568 -0.708 . . . . 0.0 109.574 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -135.32 36.88 2.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.052 -179.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 107' ' ' ASP . 83.6 p -166.01 132.2 2.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.854 -1.154 . . . . 0.0 110.499 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.57 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -50.79 -27.83 8.07 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -32.04 73.49 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.5 OUTLIER -70.76 -50.77 32.46 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.063 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.545 ' CD1' HD21 ' A' ' 68' ' ' LEU . 32.2 mt -54.25 -27.6 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 108.598 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -76.25 -32.49 58.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.499 -0.75 . . . . 0.0 109.13 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.462 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 2.8 m-20 -65.65 -45.17 84.01 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.318 -0.864 . . . . 0.0 109.32 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.505 ' CG2' HD22 ' A' ' 92' ' ' LEU . 2.4 t -68.32 -40.72 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.0 -1.063 . . . . 0.0 109.015 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.574 ' CZ ' ' HB ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -55.86 -54.34 45.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 109.149 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mt -62.38 -23.05 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 110' ' ' ASP . 11.0 m-80 -72.21 -16.28 61.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.412 ' HB2' ' CD1' ' A' ' 117' ' ' ILE . . . -96.67 14.87 23.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.445 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.12 9.28 84.34 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.8 mp -92.02 56.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -1.102 . . . . 0.0 109.374 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 117' ' ' ILE . 16.6 mttp -36.84 149.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.071 -1.018 . . . . 0.0 110.037 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 123' ' ' ASP . . . -50.71 -37.3 34.13 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.04 -52.32 58.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -1.181 . . . . 0.0 109.637 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -66.05 -60.94 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.397 -0.814 . . . . 0.0 109.843 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.57 ' CD1' HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -50.12 -60.19 3.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 109.524 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 7.6 m-20 -44.93 -43.29 8.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.992 -1.068 . . . . 0.0 109.871 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.465 ' O ' ' OG ' ' A' ' 128' ' ' SER . . . -68.57 -44.9 73.46 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 109.791 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.518 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -58.71 -49.22 78.39 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 108.977 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.559 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 4.9 t-105 -57.13 -54.82 42.38 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -63.42 -14.83 54.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.657 -0.652 . . . . 0.0 110.179 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 124' ' ' ALA . 70.2 m -71.16 -178.21 1.94 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.98 -1.075 . . . . 0.0 110.43 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.21 -34.68 14.19 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.633 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.12 -44.7 84.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.996 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 5.9 t -69.77 -31.97 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.863 -1.148 . . . . 0.0 108.771 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -71.59 -37.18 71.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -35.47 80.74 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.432 HD21 ' HB3' ' A' ' 80' ' ' MET . 0.0 OUTLIER -74.68 -29.41 61.21 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.032 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.458 HG23 ' CZ3' ' A' ' 126' ' ' TRP . 5.7 t -73.71 -24.3 19.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.05 -54.26 6.77 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.5 ' CG ' ' OH ' ' A' ' 59' ' ' TYR . 7.0 tp-100 -59.88 -33.05 71.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.296 -0.878 . . . . 0.0 109.136 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.428 ' OE1' HG22 ' A' ' 73' ' ' THR . 12.1 tm0? -66.95 -64.83 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 108.749 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.455 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 1.9 mt-10 -51.33 -35.38 37.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.7 mtmm -72.2 -28.95 63.52 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.465 ' O ' ' OD2' ' A' ' 144' ' ' ASP . . . -60.59 -53.08 61.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 108.795 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.468 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -75.04 -25.39 58.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 109.742 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 139' ' ' GLU . . . -80.15 -27.25 39.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.106 -0.996 . . . . 0.0 110.234 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.478 ' CG ' ' N ' ' A' ' 145' ' ' VAL . 1.4 p30 -82.21 -48.26 11.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.949 -1.094 . . . . 0.0 108.439 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.563 ' CG2' ' CE2' ' A' ' 25' ' ' PHE . 25.5 m -84.62 -18.54 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 9.6 tt0 82.6 -40.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.811 -0.555 . . . . 0.0 110.247 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.536 HD22 ' CG1' ' A' ' 61' ' ' VAL . 12.1 tp 66.75 144.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -159.61 28.4 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.478 -1.389 . . . . 0.0 110.887 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.39 110.89 0.55 Allowed Glycine 0 N--CA 1.49 2.233 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.109 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.568 HG23 ' CZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -84.04 145.16 45.74 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.353 -1.087 . . . . 0.0 109.147 178.409 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.62 150.96 84.67 Favored 'Cis proline' 0 C--N 1.315 -1.213 0 O-C-N 123.312 1.164 . . . . 0.0 110.583 0.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -129.66 134.86 47.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.403 -1.435 . . . . 0.0 109.069 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.478 ' HE2' HG12 ' A' ' 22' ' ' VAL . 5.7 tpp -131.09 124.61 31.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 109.773 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.451 ' CD1' ' HB3' ' A' ' 160' ' ' GLN . 10.6 m-85 -123.86 129.94 51.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 0.0 109.922 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 45.5 t -97.92 131.26 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.945 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 46.43 21.91 0.14 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.293 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.547 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 55.36 57.04 20.43 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.08 -34.98 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.28 -1.129 . . . . 0.0 108.273 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -121.51 126.36 49.04 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.925 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 160' ' ' GLN . 16.4 pt20 -116.72 119.97 37.12 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.955 -1.091 . . . . 0.0 110.307 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.59 174.32 3.57 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -150.44 74.34 8.9 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.971 -1.081 . . . . 0.0 109.692 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 C--N 1.309 -1.514 0 C-N-CA 122.683 2.255 . . . . 0.0 110.97 -179.9 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 19.8 mmt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.701 0.763 . . . . 0.0 109.668 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.02 -55.98 5.48 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.707 -0.621 . . . . 0.0 109.355 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.413 ' O ' ' HG2' ' A' ' 177' ' ' GLN . 4.5 t -68.3 -29.66 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.204 -0.935 . . . . 0.0 109.189 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.558 ' CD1' ' OE1' ' A' ' 177' ' ' GLN . 26.6 m-85 -68.24 -34.8 76.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.268 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 64.6 t -78.36 -26.1 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.069 -1.019 . . . . 0.0 109.37 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -55.52 4.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.986 . . . . 0.0 109.272 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.558 ' OE1' ' CD1' ' A' ' 174' ' ' PHE . 7.6 pt20 -57.29 -36.35 70.95 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.16 -0.963 . . . . 0.0 108.735 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.409 ' HA ' ' OG1' ' A' ' 181' ' ' THR . 6.0 t80 -68.06 -49.72 59.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.89 . . . . 0.0 108.81 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 183' ' ' LYS . . . -58.85 -29.27 66.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 108.984 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.96 -37.82 58.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.15 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -61.45 -46.43 90.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.172 179.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 55.1 t -72.03 -36.89 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.802 -1.186 . . . . 0.0 109.295 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 179' ' ' ALA . 0.4 OUTLIER -59.93 -52.61 64.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.147 -0.97 . . . . 0.0 109.269 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.34 -29.28 53.38 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.906 . . . . 0.0 109.107 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.531 ' CG ' ' O ' ' A' ' 181' ' ' THR . 0.2 OUTLIER -62.51 -20.31 64.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.964 -1.085 . . . . 0.0 108.977 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -22.87 63.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.853 -1.154 . . . . 0.0 108.083 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.242 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -125.11 62.4 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.68 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.7 t0 47.11 83.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.48 -0.762 . . . . 0.0 109.498 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 131.97 -29.69 3.33 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.284 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.82 -71.31 0.46 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.02 -1.282 . . . . 0.0 108.916 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.568 ' OE1' ' CD1' ' A' ' 3' ' ' TYR . 13.9 pt20 -100.11 6.59 44.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.086 -1.009 . . . . 0.0 109.686 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 1.4 p90 177.53 130.72 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 0.0 109.466 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 160' ' ' GLN . 5.7 t -111.36 179.78 3.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -96.37 157.09 16.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.69 . . . . 0.0 109.796 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.467 ' HA ' ' OE1' ' A' ' 160' ' ' GLN . 2.6 mt -91.5 145.24 24.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.434 -0.791 . . . . 0.0 109.75 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.91 -22.01 65.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.902 . . . . 0.0 108.736 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -135.08 108.15 10.48 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.539 -0.726 . . . . 0.0 109.16 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.54 157.74 36.25 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.323 2.015 . . . . 0.0 110.645 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.507 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 7.9 t -124.03 82.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.65 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -47.79 127.28 11.59 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.707 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 99.06 -20.94 48.22 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.521 ' HB2' ' N ' ' A' ' 157' ' ' GLY . . . -45.02 168.25 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.122 -1.223 . . . . 0.0 109.421 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.545 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.0 Cg_endo -79.22 136.73 12.98 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.87 2.38 . . . . 0.0 111.246 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 5.7 mt-30 -49.17 -20.35 0.58 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.376 -0.827 . . . . 0.0 109.772 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.496 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 3.2 t -149.49 81.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.21 -0.931 . . . . 0.0 108.602 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.643 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -77.45 126.57 31.11 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.294 -0.879 . . . . 0.0 108.786 -179.305 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.522 ' N ' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -110.06 119.18 38.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.129 -0.982 . . . . 0.0 109.83 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 4.4 m-85 -111.52 107.48 16.68 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.522 -0.736 . . . . 0.0 109.371 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -152.39 138.81 18.53 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.326 -0.859 . . . . 0.0 108.948 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.599 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 1.5 t -112.83 177.07 4.76 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.091 -1.005 . . . . 0.0 109.896 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.541 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 7.7 m-30 -88.4 38.84 0.88 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.572 ' CE2' HD13 ' A' ' 72' ' ' LEU . 10.1 m-85 -130.69 14.19 5.39 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.315 -0.865 . . . . 0.0 110.346 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.535 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -118.15 156.69 50.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.619 -1.301 . . . . 0.0 109.78 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -74.46 -25.15 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.022 1.815 . . . . 0.0 107.667 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.572 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 24.4 p80 -84.74 -25.34 28.36 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 18.6 t -45.73 -58.69 3.27 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.49 ' CB ' ' NE2' ' A' ' 97' ' ' GLN . 45.7 t80 -75.17 -49.88 18.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.883 -0.511 . . . . 0.0 110.359 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -61.31 -21.93 64.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.168 -0.957 . . . . 0.0 110.699 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 32' ' ' HIS . 3.7 t80 -82.04 -50.97 8.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.978 -1.076 . . . . 0.0 110.24 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.403 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 33.2 tt0 -103.52 -0.14 30.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.858 -1.151 . . . . 0.0 111.553 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 34' ' ' TYR . 60.1 mm-40 -127.74 21.32 6.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.364 -1.46 . . . . 0.0 111.172 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.1 t -152.13 -85.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.656 -1.277 . . . . 0.0 110.066 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.96 -12.19 17.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 110.148 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.454 ' CD2' ' OD1' ' A' ' 44' ' ' ASP . 4.4 m170 55.48 22.83 5.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.018 . . . . 0.0 108.998 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.526 HG21 ' CZ ' ' A' ' 36' ' ' PHE . 7.1 mt -56.81 -16.79 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.384 -0.823 . . . . 0.0 109.445 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.514 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -83.25 -48.69 10.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 0.0 110.205 -179.523 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.454 ' OD1' ' CD2' ' A' ' 41' ' ' HIS . 8.1 p-10 -84.29 -30.91 25.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.153 -0.967 . . . . 0.0 110.124 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -49.19 -33.76 13.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 109.73 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.514 ' CG2' ' O ' ' A' ' 43' ' ' SER . 2.8 m -69.56 -33.72 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.981 -1.075 . . . . 0.0 109.452 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.53 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 14.0 mttt -61.06 -28.95 69.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.379 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -45.91 -27.13 0.82 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.386 -0.821 . . . . 0.0 109.795 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -142.29 50.8 1.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 9.0 mt -99.13 134.4 21.39 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.837 -1.164 . . . . 0.0 110.119 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 53' ' ' GLY . 35.8 Cg_endo -79.56 152.54 23.03 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.584 2.189 . . . . 0.0 109.118 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.478 ' CG ' ' O ' ' A' ' 52' ' ' GLU . 28.2 tt0 -73.07 23.54 0.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.568 -1.333 . . . . 0.0 111.241 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.428 ' C ' HG21 ' A' ' 54' ' ' VAL . . . -121.38 29.31 5.74 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.428 HG21 ' C ' ' A' ' 53' ' ' GLY . 12.3 t -148.96 119.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.507 -0.996 . . . . 0.0 109.135 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -106.33 120.23 41.31 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.496 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 2.1 mtm -96.49 99.49 11.14 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.393 0.616 . . . . 0.0 109.574 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 24' ' ' GLU . 1.1 m -89.21 132.85 34.67 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.846 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -109.35 114.87 28.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.236 -0.915 . . . . 0.0 109.785 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 5.2 m-85 -114.41 171.65 7.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.088 -1.007 . . . . 0.0 111.15 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.599 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 66.8 t-80 -109.93 129.78 55.61 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.529 HG13 ' CG1' ' A' ' 150' ' ' VAL . 2.3 m -69.23 158.86 5.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.606 -0.684 . . . . 0.0 109.595 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -124.4 33.13 5.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.318 -0.864 . . . . 0.0 109.462 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 24.8 p90 -132.24 51.38 2.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.013 -1.054 . . . . 0.0 109.986 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.457 ' HE2' ' CG2' ' A' ' 150' ' ' VAL . 2.5 mtt -159.17 48.43 0.32 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 154.84 57.44 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -34.07 -38.41 0.1 Allowed Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.915 -0.756 . . . . 0.0 111.408 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.63 -80.06 0.27 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.754 -1.439 . . . . 0.0 110.697 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -80.02 -25.89 40.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.864 -1.148 . . . . 0.0 109.521 -179.594 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.578 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -47.61 -53.43 12.96 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -56.07 -49.01 74.99 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.264 -1.139 . . . . 0.0 108.331 179.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.543 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 53.1 t0 -59.98 -30.87 69.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.591 ' CD2' ' NE2' ' A' ' 60' ' ' HIS . 1.1 tt -57.46 -36.92 72.06 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.514 ' CG2' ' HB3' ' A' ' 138' ' ' GLN . 40.6 m -66.09 -41.59 90.45 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.483 ' O ' HG22 ' A' ' 78' ' ' VAL . 1.1 tt0 -59.28 -20.33 53.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 177.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -68.98 -47.51 65.42 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.419 ' NE1' ' O ' ' A' ' 58' ' ' LYS . 37.9 t-105 -55.91 -28.82 58.54 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.79 -69.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 109.537 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.642 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 3.1 t -45.27 -27.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.934 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.457 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -84.18 -62.13 1.64 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 108.987 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -46.08 -27.35 0.93 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.4 ' N ' ' C ' ' A' ' 79' ' ' ALA . . . -72.36 -41.02 66.86 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.447 -0.783 . . . . 0.0 109.63 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.434 ' O ' HG11 ' A' ' 84' ' ' VAL . 40.8 mt -104.87 11.83 33.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.146 -0.971 . . . . 0.0 110.135 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 49.28 32.44 14.0 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.558 HG22 ' CE1' ' A' ' 112' ' ' PHE . 28.1 m -96.54 19.64 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.474 -1.015 . . . . 0.0 109.77 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 86' ' ' ASP . 87.6 mt-10 -58.91 -75.18 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.937 . . . . 0.0 110.01 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.47 -34.35 0.21 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.47 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 27.7 mtpp -74.23 -54.34 7.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.858 . . . . 0.0 110.643 -178.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -86.54 -23.1 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.826 -1.171 . . . . 0.0 110.765 -179.099 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.595 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -67.13 -43.39 82.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.731 -1.231 . . . . 0.0 109.016 179.472 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -54.62 -55.23 40.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.432 -1.418 . . . . 0.0 110.523 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.47 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 24.2 Cg_endo -72.21 -18.87 26.55 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 122.77 0.879 . . . . 0.0 109.883 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.526 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 11.6 mt -86.49 -42.63 13.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.183 -0.948 . . . . 0.0 108.937 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.595 ' CG ' HG21 ' A' ' 89' ' ' THR . 5.2 m-30 -62.85 -48.23 79.93 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.943 -1.098 . . . . 0.0 108.802 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.38 -22.36 59.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.037 -1.039 . . . . 0.0 109.45 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.474 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -76.43 -33.04 49.5 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.532 ' CG1' ' CE1' ' A' ' 29' ' ' PHE . 2.7 t -101.82 1.75 10.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.006 -1.291 . . . . 0.0 109.228 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 2.0 mt-30 -91.69 -8.63 46.49 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.981 -1.074 . . . . 0.0 110.878 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.4 mtpt -167.81 -53.48 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.736 -1.227 . . . . 0.0 111.118 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 95' ' ' GLY . 80.8 p -47.93 -39.79 20.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.275 -1.516 . . . . 0.0 109.468 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 99' ' ' THR . 1.1 mt-30 67.7 11.21 8.26 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.8 t -79.44 -5.99 55.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.522 ' CB ' HG23 ' A' ' 96' ' ' VAL . 3.8 mm -91.28 80.36 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.92 27.66 2.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.181 -0.949 . . . . 0.0 109.68 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 107' ' ' ASP . 56.1 p -151.08 129.15 11.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.903 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.535 ' HA ' ' CD1' ' A' ' 108' ' ' ILE . . . -48.95 -39.63 27.08 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.84 -31.25 62.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 104' ' ' SER . 84.2 m-20 -78.05 -40.07 39.85 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.977 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.565 ' CD1' HD21 ' A' ' 68' ' ' LEU . 28.4 mt -52.45 -26.29 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.556 -1.34 . . . . 0.0 107.513 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -78.05 -39.51 41.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.682 -0.636 . . . . 0.0 109.44 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -55.99 -44.36 78.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.368 -0.832 . . . . 0.0 109.445 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.526 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 88.0 t -74.63 -37.26 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.033 . . . . 0.0 109.089 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.558 ' CE1' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -61.25 -31.03 70.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.286 179.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.448 HG21 ' O ' ' A' ' 113' ' ' ILE . 18.7 mt -85.47 -30.46 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -60.76 -16.53 41.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.775 -1.203 . . . . 0.0 109.35 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.449 ' HB2' ' HE3' ' A' ' 87' ' ' LYS . . . -88.06 -2.43 58.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.689 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.32 -5.22 52.05 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.6 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.6 mp -88.88 56.13 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -1.136 . . . . 0.0 109.292 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 117' ' ' ILE . 3.2 mttp -33.01 152.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.366 -0.833 . . . . 0.0 110.832 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 122' ' ' TYR . . . -53.84 -23.93 24.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.94 -52.14 66.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.054 -1.263 . . . . 0.0 109.083 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -75.76 -35.8 60.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.89 . . . . 0.0 109.412 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.642 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 2.7 t80 -62.91 -51.21 67.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.069 -1.02 . . . . 0.0 109.166 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.69 -45.65 91.46 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 108.822 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.38 -53.91 31.76 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.36 -0.838 . . . . 0.0 108.911 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 131' ' ' VAL . . . -51.85 -53.06 44.82 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.432 -0.792 . . . . 0.0 108.885 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -52.7 -58.05 8.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 108.628 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.29 -15.41 3.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.661 -0.65 . . . . 0.0 110.239 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.1 OUTLIER -69.22 179.54 1.92 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.958 -1.089 . . . . 0.0 110.17 -179.262 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER -92.79 -37.89 12.07 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.411 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.4 t -72.04 -50.05 39.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.786 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 125' ' ' ALA . 3.7 t -57.44 -38.09 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.811 -1.18 . . . . 0.0 108.569 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -66.42 -35.59 80.7 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 109.068 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -26.32 68.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.05 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.7 mt -81.77 -28.27 33.35 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.288 -0.883 . . . . 0.0 108.795 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.2 t -74.91 -39.51 45.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -68.22 -40.05 82.18 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.427 ' O ' ' HB1' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -68.03 -33.82 75.32 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -0.818 . . . . 0.0 108.875 179.535 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.514 ' HB3' ' CG2' ' A' ' 73' ' ' THR . 0.2 OUTLIER -64.16 -70.73 0.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.247 -0.908 . . . . 0.0 109.032 179.541 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -48.15 -37.19 14.98 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 108.928 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 0.3 OUTLIER -72.48 -25.88 61.59 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.362 -0.836 . . . . 0.0 109.24 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.466 ' HA ' ' OD2' ' A' ' 144' ' ' ASP . . . -68.47 -55.22 12.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.398 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -73.76 -29.18 62.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 109.949 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -75.85 -25.63 56.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.059 -1.026 . . . . 0.0 109.87 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.533 ' OD1' ' CG1' ' A' ' 145' ' ' VAL . 1.0 OUTLIER -81.94 -48.14 11.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.011 . . . . 0.0 108.35 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.57 ' CG2' ' CE2' ' A' ' 25' ' ' PHE . 13.4 m -83.01 -12.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 81.15 -49.09 0.27 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 0.0 109.414 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.51 HD12 ' HB3' ' A' ' 25' ' ' PHE . 15.0 tp 61.65 132.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.452 -0.78 . . . . 0.0 109.426 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 16.7 mtt180 -161.49 38.8 0.14 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.587 -1.32 . . . . 0.0 110.302 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 164.46 108.5 0.21 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.42 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -97.99 144.15 27.52 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.4 -1.059 . . . . 0.0 109.335 179.031 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.572 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 36.3 Cg_endo -78.31 150.94 89.2 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 C-N-CA 124.088 -1.213 . . . . 0.0 110.54 0.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -130.95 141.18 50.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.319 -1.488 . . . . 0.0 108.702 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.548 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 2.8 ttp -144.91 134.02 22.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 0.0 110.027 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.548 ' CD1' ' C ' ' A' ' 153' ' ' MET . 0.5 OUTLIER -134.49 155.58 50.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 110.008 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 30.8 t -112.07 130.66 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.332 -0.855 . . . . 0.0 108.958 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 51.75 23.24 1.94 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.521 ' N ' ' HB2' ' A' ' 19' ' ' ALA . . . 54.97 22.71 28.75 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.537 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -125.01 -22.97 4.33 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.825 -1.397 . . . . 0.0 109.113 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 154' ' ' PHE . 12.6 m-85 -121.46 127.69 51.36 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 11.5 pt20 -123.32 118.28 27.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.503 ' N ' HD22 ' A' ' 161' ' ' LEU . 5.8 mt -67.3 177.12 1.97 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.44 ' O ' ' ND2' ' A' ' 162' ' ' ASN . 0.4 OUTLIER -144.1 94.83 5.73 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 120.919 -1.113 . . . . 0.0 109.799 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--N 1.309 -1.523 0 C-N-CA 122.787 2.325 . . . . 0.0 110.637 179.823 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 20.8 mtt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.783 0.801 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -76.74 -59.3 2.83 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.736 -0.602 . . . . 0.0 109.397 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.29 -23.27 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.235 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 178' ' ' TYR . 32.7 t80 -73.71 -39.79 64.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.139 -0.976 . . . . 0.0 109.383 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 18.6 t -73.61 -29.5 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.996 -1.065 . . . . 0.0 109.233 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -82.49 -51.98 7.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 0.0 109.481 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.438 ' O ' ' OG1' ' A' ' 181' ' ' THR . 0.8 OUTLIER -65.45 -24.98 67.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 174' ' ' PHE . 20.3 t80 -78.54 -47.58 17.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.218 -0.926 . . . . 0.0 109.372 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.8 -29.92 71.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.982 . . . . 0.0 109.313 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.14 -47.26 18.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.671 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.469 ' O ' HD21 ' A' ' 185' ' ' LEU . 15.3 m -58.7 -26.82 64.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.004 . . . . 0.0 109.642 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.3 t -87.75 -41.14 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.048 -1.032 . . . . 0.0 109.049 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -57.01 -42.99 81.33 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.29 -0.882 . . . . 0.0 109.133 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.556 ' CE2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -82.09 -35.09 28.99 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.305 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.556 ' CD2' ' CE2' ' A' ' 184' ' ' TYR . 0.7 OUTLIER -57.29 -20.13 26.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.875 -1.14 . . . . 0.0 109.331 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.1 t -78.63 -0.87 31.65 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.778 -1.201 . . . . 0.0 108.503 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.423 -0.798 . . . . 0.0 109.379 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.54 ' HB3' ' CG ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -115.37 58.37 0.72 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.827 -1.171 . . . . 0.0 111.017 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 1.7 m-20 45.16 87.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.454 -0.779 . . . . 0.0 110.603 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.82 -35.37 1.93 Allowed Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.207 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.09 -70.31 0.69 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.11 -1.229 . . . . 0.0 108.951 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.637 ' HG2' ' CD2' ' A' ' 9' ' ' TYR . 4.7 pm0 -65.77 -27.07 68.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.29 -0.881 . . . . 0.0 108.811 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.637 ' CD2' ' HG2' ' A' ' 8' ' ' GLN . 2.2 p90 -176.18 138.73 0.34 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -103.99 -179.69 4.02 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.505 HG23 ' N ' ' A' ' 12' ' ' LEU . 47.4 m -103.32 160.25 14.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.547 -0.721 . . . . 0.0 110.102 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.505 ' N ' HG23 ' A' ' 11' ' ' THR . 0.7 OUTLIER -92.04 163.25 14.05 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.426 -0.796 . . . . 0.0 109.41 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.41 ' C ' ' HG3' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -97.73 -16.07 20.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.41 ' HG3' ' C ' ' A' ' 13' ' ' GLU . 5.3 mttt -148.71 112.36 3.65 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.7 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.82 161.08 33.73 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.447 2.098 . . . . 0.0 109.703 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.582 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 1.1 p -122.32 126.74 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.999 -1.063 . . . . 0.0 110.237 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -46.35 125.72 7.11 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 77.16 8.9 87.01 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.582 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . . . -36.25 161.73 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.685 -0.891 . . . . 0.0 111.189 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.576 ' CG ' ' HB2' ' A' ' 23' ' ' LEU . 36.5 Cg_endo -78.06 113.57 3.44 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 123.273 2.649 . . . . 0.0 111.953 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 33.1 mt-30 -51.89 -31.12 26.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.472 HG21 ' CG2' ' A' ' 155' ' ' VAL . 24.2 t -157.05 81.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.595 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 1.3 tt -83.92 137.6 33.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.363 -0.835 . . . . 0.0 110.116 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.435 ' N ' HD21 ' A' ' 23' ' ' LEU . 31.6 mt-10 -120.52 99.38 6.52 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.595 ' CZ ' ' CD1' ' A' ' 23' ' ' LEU . 88.0 m-85 -83.5 115.3 22.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.489 -0.757 . . . . 0.0 109.434 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 26' ' ' PHE . 0.4 OUTLIER -154.23 139.1 17.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 110.033 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.589 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 8.3 p -121.44 173.17 7.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.41 -0.806 . . . . 0.0 109.443 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 1.6 m-30 -85.2 43.54 1.02 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.869 . . . . 0.0 108.84 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.503 ' CG ' HG13 ' A' ' 96' ' ' VAL . 9.0 m-85 -143.11 14.19 1.86 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.909 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -105.02 160.99 24.1 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 120.84 -1.162 . . . . 0.0 109.357 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -76.03 -35.43 2.45 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.134 1.889 . . . . 0.0 108.064 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -82.26 -23.65 35.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 11.1 t -46.13 -52.91 11.31 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.469 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 85.8 t80 -80.6 -31.5 36.67 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.905 -0.497 . . . . 0.0 111.064 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.64 -27.46 31.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.841 -1.162 . . . . 0.0 111.298 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.564 ' CE1' HD11 ' A' ' 40' ' ' LEU . 2.3 m-30 -84.1 -17.31 40.61 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.873 -1.142 . . . . 0.0 110.767 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -116.64 20.99 13.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.837 -1.164 . . . . 0.0 110.637 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 16.1 mm-40 -143.36 -66.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.953 -1.092 . . . . 0.0 110.405 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 4.6 t -90.16 -69.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.141 -0.974 . . . . 0.0 110.465 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.592 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 94.6 mt -47.81 -20.97 0.34 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.286 -0.884 . . . . 0.0 110.759 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 28.7 p-80 40.97 34.38 0.28 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 109.429 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.403 HG13 ' HB3' ' A' ' 40' ' ' LEU . 20.8 mt -76.01 -26.17 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.48 -0.762 . . . . 0.0 109.754 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.523 ' O ' ' CG1' ' A' ' 46' ' ' VAL . 14.1 m -78.18 -33.05 50.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.108 -0.995 . . . . 0.0 110.148 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -84.12 -47.42 10.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.034 -1.041 . . . . 0.0 109.829 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -57.27 -37.79 72.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 43' ' ' SER . 14.5 p -55.4 -28.23 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.179 -0.951 . . . . 0.0 109.644 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -30.74 68.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.404 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.52 -38.6 69.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -92.15 18.53 8.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 109.468 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.513 ' CD1' ' HG2' ' A' ' 56' ' ' MET . 12.1 mt -105.18 102.6 37.45 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.869 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 53' ' ' GLY . 32.6 Cg_endo -75.49 151.55 37.5 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.343 2.028 . . . . 0.0 108.96 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -65.55 52.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.804 -1.185 . . . . 0.0 110.981 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.545 ' O ' ' CG2' ' A' ' 54' ' ' VAL . . . -144.3 37.82 1.36 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.545 ' CG2' ' O ' ' A' ' 53' ' ' GLY . 13.3 t -166.91 149.87 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -113.36 115.74 28.58 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.34 -0.85 . . . . 0.0 110.36 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.513 ' HG2' ' CD1' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -100.93 105.07 16.28 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.107 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -96.01 141.14 29.77 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.07 -178.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -117.94 105.02 11.47 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.225 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.492 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 4.4 m-85 -113.5 175.33 5.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.106 -0.996 . . . . 0.0 110.926 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.639 ' CD2' ' CD2' ' A' ' 72' ' ' LEU . 9.8 t-80 -125.44 123.9 40.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.553 -0.717 . . . . 0.0 109.648 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.611 HG23 ' CE1' ' A' ' 63' ' ' PHE . 35.6 m -91.86 153.75 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.433 -0.792 . . . . 0.0 109.952 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -110.24 54.61 0.66 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.173 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.611 ' CE1' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -134.61 56.04 1.87 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.087 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.48 ' HE1' ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -122.08 32.16 5.92 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.458 -0.777 . . . . 0.0 109.53 179.635 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.31 40.88 23.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . -148.08 80.71 0.21 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 66' ' ' GLY . 5.3 t0 -26.78 -45.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.449 -0.442 . . . . 0.0 111.209 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.551 ' CD2' ' OD2' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -46.02 -30.37 1.81 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.357 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.48 ' CA ' ' HE1' ' A' ' 64' ' ' MET . . . -48.03 -55.97 9.5 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -49.81 -46.39 51.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.278 . . . . 0.0 108.604 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.4 -18.25 60.69 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.031 -1.043 . . . . 0.0 108.368 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.639 ' CD2' ' CD2' ' A' ' 60' ' ' HIS . 2.3 tt -76.1 -37.38 58.18 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.421 ' CG2' ' OE1' ' A' ' 138' ' ' GLN . 1.6 m -65.62 -41.45 92.67 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 177.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.497 ' NE2' ' HB2' ' A' ' 126' ' ' TRP . 15.3 tp60 -63.17 -23.63 67.52 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.43 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -70.49 -39.13 74.36 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.443 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.573 ' CH2' ' OE1' ' A' ' 85' ' ' GLU . 37.6 t-105 -66.09 -30.03 70.47 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.821 . . . . 0.0 108.932 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.423 ' CB ' HG21 ' A' ' 135' ' ' VAL . . . -83.39 -59.96 2.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.664 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 92.2 t -57.55 -26.65 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 109.665 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.529 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.46 -65.57 0.98 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.073 -1.017 . . . . 0.0 108.745 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -47.03 -26.25 1.0 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.103 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.458 ' CB ' ' CG2' ' A' ' 131' ' ' VAL . . . -74.89 -38.95 61.74 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.448 -0.783 . . . . 0.0 109.28 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 79' ' ' ALA . 85.9 mt -106.33 10.48 31.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.202 -0.936 . . . . 0.0 110.715 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 54.77 19.52 14.58 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.585 HG22 ' CE1' ' A' ' 112' ' ' PHE . 31.6 m -84.44 -6.29 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.284 -1.127 . . . . 0.0 110.318 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.573 ' OE1' ' CH2' ' A' ' 76' ' ' TRP . 3.1 mt-10 -42.22 -71.56 0.08 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.155 -0.966 . . . . 0.0 110.052 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -39.33 -34.26 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.378 -0.827 . . . . 0.0 110.622 -179.591 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.489 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 27.5 mtpp -81.66 -49.87 9.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.284 -0.885 . . . . 0.0 111.189 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.505 ' O ' ' CG ' ' A' ' 92' ' ' LEU . 1.4 m -86.54 -14.26 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.882 -1.136 . . . . 0.0 110.681 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.608 HG21 ' CG ' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -74.3 -42.51 59.41 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.698 -1.251 . . . . 0.0 108.349 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.406 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -55.75 -54.05 56.08 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.723 -1.236 . . . . 0.0 110.875 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.489 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 27.1 Cg_endo -72.4 -19.46 25.21 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 N-CA-C 109.881 -0.854 . . . . 0.0 109.881 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.523 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 35.5 mt -87.19 -43.56 12.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.127 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.608 ' CG ' HG21 ' A' ' 89' ' ' THR . 5.1 m-30 -63.59 -44.02 95.23 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.037 -1.039 . . . . 0.0 108.697 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.52 -19.59 57.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 109.426 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.432 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -69.85 -40.51 74.87 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.503 HG13 ' CG ' ' A' ' 29' ' ' PHE . 1.6 t -92.79 -15.71 7.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 O-C-N 121.102 -1.234 . . . . 0.0 108.734 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.463 ' HG2' ' HB2' ' A' ' 34' ' ' TYR . 2.9 mp0 -113.02 10.75 18.85 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.933 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.538 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.8 OUTLIER -159.01 51.47 0.38 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.392 -1.442 . . . . 0.0 109.851 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 166.88 -49.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.405 -0.81 . . . . 0.0 109.898 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.8 OUTLIER 75.7 16.29 2.5 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.14 -0.975 . . . . 0.0 110.494 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.7 t -85.7 -4.05 59.06 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.829 0.823 . . . . 0.0 108.861 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.499 ' CG2' HD21 ' A' ' 68' ' ' LEU . 6.6 mm -82.67 71.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.766 -0.584 . . . . 0.0 109.543 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.441 ' C ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -116.83 -11.36 10.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.174 -0.954 . . . . 0.0 109.995 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 107' ' ' ASP . 1.5 p -110.67 117.21 32.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 109.77 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.51 ' N ' ' HG ' ' A' ' 68' ' ' LEU . . . -48.31 -39.01 20.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.59 -33.31 54.45 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 108' ' ' ILE . 1.2 p30 -68.64 -41.45 79.39 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.752 -1.179 . . . . 0.0 108.644 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.556 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 3.1 mt -48.57 -44.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.612 -1.305 . . . . 0.0 107.666 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -48.49 79.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.576 -0.703 . . . . 0.0 109.686 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 114' ' ' ASN . 1.1 m-20 -51.65 -42.85 62.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.814 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.523 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 3.2 t -64.83 -40.13 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.134 -0.979 . . . . 0.0 109.767 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.585 ' CE1' HG22 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -56.77 -50.89 70.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.018 -1.051 . . . . 0.0 109.552 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.8 mt -70.67 -22.74 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 109.597 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 110' ' ' ASP . 2.8 m120 -64.86 -15.91 62.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.409 ' HB1' HG13 ' A' ' 88' ' ' VAL . . . -73.37 -6.0 43.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 108.992 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.03 15.16 39.94 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.6 mm -95.62 168.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -1.196 . . . . 0.0 108.957 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -89.24 139.55 30.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.331 -1.481 . . . . 0.0 109.7 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.75 -50.42 67.77 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -57.99 -44.47 87.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.138 -1.213 . . . . 0.0 109.016 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -55.3 -44.34 75.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 108.852 179.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.664 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 2.3 t80 -55.13 -46.98 75.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.862 . . . . 0.0 108.845 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -56.6 -38.9 72.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 108.708 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.22 71.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.385 -0.822 . . . . 0.0 108.828 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.51 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -49.16 -50.47 37.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.268 -0.895 . . . . 0.0 108.605 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.497 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 12.8 t90 -58.32 -56.12 26.22 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -55.34 -15.91 2.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.583 -0.698 . . . . 0.0 109.923 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -71.23 166.62 21.15 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.972 -1.08 . . . . 0.0 109.45 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -86.77 -40.66 14.78 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.264 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.09 -45.08 97.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 C-N-CA 118.062 -1.455 . . . . 0.0 109.316 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 2.5 t -64.6 -41.23 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.001 -1.062 . . . . 0.0 108.413 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -37.29 86.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.365 -0.834 . . . . 0.0 108.992 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.0 m -62.53 -30.76 71.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 108.908 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.72 -21.98 43.91 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.426 ' HA ' ' OE1' ' A' ' 138' ' ' GLN . 4.9 t -77.05 -46.38 29.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.449 ' O ' ' HG2' ' A' ' 139' ' ' GLU . . . -64.04 -42.83 96.92 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.478 ' HG2' ' OH ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -62.97 -32.37 73.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.404 -0.81 . . . . 0.0 109.036 179.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.492 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 48.0 mt-30 -65.03 -62.84 1.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 108.92 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 136' ' ' ALA . 6.8 pt-20 -54.51 -42.42 70.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 108.838 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 29.1 mttt -67.49 -27.19 66.8 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.375 -0.828 . . . . 0.0 109.151 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.424 ' HB3' HD12 ' A' ' 23' ' ' LEU . . . -63.42 -49.07 75.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.024 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.21 -41.39 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.837 . . . . 0.0 110.148 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.18 -16.74 60.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.158 -0.964 . . . . 0.0 109.862 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 140' ' ' LYS . 22.8 m-20 -82.9 -44.21 15.64 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.592 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 3.8 m -91.17 -5.38 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 81.86 -46.75 0.2 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.595 -0.691 . . . . 0.0 109.804 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.531 HD23 ' CG1' ' A' ' 61' ' ' VAL . 13.0 tp 73.12 141.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.66 -0.65 . . . . 0.0 109.72 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.39 25.77 0.16 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.771 -1.206 . . . . 0.0 110.315 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.03 112.2 0.62 Allowed Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.108 -1.52 . . . . 0.0 111.081 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.529 HG23 ' CZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -90.48 140.31 26.81 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.503 -0.998 . . . . 0.0 108.962 178.158 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.25 152.2 95.95 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 123.785 -1.339 . . . . 0.0 110.816 0.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -128.22 159.97 33.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.393 -1.442 . . . . 0.0 109.233 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.524 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 3.0 ttm -142.02 121.82 13.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.101 -0.999 . . . . 0.0 109.88 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.581 ' CD2' ' HB2' ' A' ' 160' ' ' GLN . 23.5 m-85 -122.89 145.77 48.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.139 -0.975 . . . . 0.0 109.644 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 36.9 t -124.66 122.31 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.145 -0.972 . . . . 0.0 108.957 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER 50.95 24.99 2.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.804 -0.758 . . . . 0.0 108.989 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 51.3 20.84 5.38 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.466 -1.349 . . . . 0.0 110.325 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -121.83 -19.92 6.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.819 -1.4 . . . . 0.0 108.867 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.456 ' O ' ' N ' ' A' ' 155' ' ' VAL . 19.6 m-85 -141.7 123.83 15.52 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.318 -0.864 . . . . 0.0 108.945 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.581 ' HB2' ' CD2' ' A' ' 154' ' ' PHE . 1.3 tt0 -130.29 126.56 37.54 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.279 -0.888 . . . . 0.0 109.389 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.536 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 8.1 mt -59.46 179.26 0.12 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 162' ' ' ASN . 12.8 p-10 -153.22 107.67 2.62 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.071 -1.018 . . . . 0.0 109.777 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 C--N 1.309 -1.513 0 C-N-CA 122.306 2.004 . . . . 0.0 110.2 179.472 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.705 0.764 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.75 -49.22 78.58 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 121.577 -0.702 . . . . 0.0 109.686 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 12.5 t -69.57 -29.14 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 109.854 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.459 ' O ' ' HB3' ' A' ' 178' ' ' TYR . 4.6 t80 -65.59 -36.62 84.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.015 -1.053 . . . . 0.0 109.466 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 93.3 t -81.2 -24.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.05 -1.031 . . . . 0.0 109.772 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -53.48 6.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.025 -1.047 . . . . 0.0 109.402 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.91 -33.39 75.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.106 -0.996 . . . . 0.0 109.356 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.459 ' HB3' ' O ' ' A' ' 174' ' ' PHE . 2.5 t80 -70.13 -57.18 5.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 109.093 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.79 -29.92 69.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.341 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -73.27 -41.71 63.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.933 . . . . 0.0 109.387 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.564 ' CG2' ' CG ' ' A' ' 8' ' ' GLN . 1.0 OUTLIER -62.37 -60.01 4.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.163 -0.961 . . . . 0.0 109.283 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.3 t -53.75 -32.68 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.06 -1.025 . . . . 0.0 109.198 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -47.08 86.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 109.446 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -85.56 -25.66 26.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.203 -0.936 . . . . 0.0 110.426 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.594 HD22 ' CE2' ' A' ' 9' ' ' TYR . 4.1 mt -67.81 -20.64 65.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.489 -1.382 . . . . 0.0 108.856 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.452 ' HB2' HG23 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -69.95 -10.65 59.32 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 O-C-N 121.55 -0.718 . . . . 0.0 109.359 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.691 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' ASP . 3.0 tt0 -86.72 52.32 2.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 0.0 110.277 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLU . 64.7 t0 39.82 81.01 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.796 -0.565 . . . . 0.0 109.906 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 119.19 -18.91 10.19 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.541 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.71 -67.32 0.77 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.902 -1.352 . . . . 0.0 108.769 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.591 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -96.4 4.0 52.49 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.21 -0.932 . . . . 0.0 109.806 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.557 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -177.31 130.8 0.16 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.913 -1.117 . . . . 0.0 109.611 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -117.79 177.05 4.91 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.813 -0.555 . . . . 0.0 109.525 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -100.17 160.22 14.49 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.374 0.607 . . . . 0.0 109.552 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.4 mt -95.69 133.96 39.16 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.315 -0.866 . . . . 0.0 109.779 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -72.63 -19.42 61.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 108.694 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -135.69 107.32 9.91 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.437 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 34.8 Cg_endo -76.08 158.34 37.98 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.412 2.075 . . . . 0.0 110.968 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.487 HG11 ' O ' ' A' ' 16' ' ' VAL . 46.1 t -128.72 87.43 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.418 -0.801 . . . . 0.0 109.38 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.52 133.05 13.42 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 95.82 -25.56 24.52 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.517 ' HB2' ' N ' ' A' ' 157' ' ' GLY . . . -42.02 157.75 0.21 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.401 -1.058 . . . . 0.0 109.367 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.55 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 35.2 Cg_endo -78.4 135.42 13.31 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.504 2.136 . . . . 0.0 111.015 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.2 OUTLIER -44.25 -24.03 0.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.411 -0.806 . . . . 0.0 109.764 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.542 ' CG1' ' HG2' ' A' ' 56' ' ' MET . 42.4 t -149.83 80.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.022 -1.049 . . . . 0.0 108.896 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.643 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -72.06 124.94 26.03 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.526 ' N ' HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -106.5 125.29 50.81 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.614 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 6.3 m-85 -115.73 110.32 18.95 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -150.79 145.36 25.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.953 . . . . 0.0 109.639 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.59 ' CB ' ' NE2' ' A' ' 60' ' ' HIS . 32.8 p -126.03 -163.86 1.26 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.203 -0.935 . . . . 0.0 108.83 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.67 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -118.65 55.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.152 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CG ' HG13 ' A' ' 96' ' ' VAL . 12.2 m-85 -138.88 2.14 2.13 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.453 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.503 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -113.91 172.46 3.56 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.658 -1.276 . . . . 0.0 109.765 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 30' ' ' CYS . 32.8 Cg_endo -75.04 -49.84 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.481 2.12 . . . . 0.0 108.835 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 18.5 m80 -73.11 -25.63 60.94 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -46.85 -41.14 15.17 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.109 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.501 ' CG ' ' OE1' ' A' ' 97' ' ' GLN . 3.7 t80 -88.44 -44.13 10.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.601 -0.687 . . . . 0.0 110.171 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 46.0 mt-30 -72.43 -24.49 61.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.986 -1.071 . . . . 0.0 110.924 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 1.6 t80 -80.45 -16.76 53.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.938 -1.101 . . . . 0.0 110.388 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.51 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.6 tt0 -131.96 50.99 2.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.892 -1.13 . . . . 0.0 110.381 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.51 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -171.29 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 110.55 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 52.1 t -94.77 -53.58 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 110.575 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 35' ' ' GLN . 22.6 mt -48.86 -20.18 0.47 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.169 -0.957 . . . . 0.0 110.58 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 47.93 31.67 2.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.889 -1.132 . . . . 0.0 108.852 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.413 ' O ' ' CG1' ' A' ' 46' ' ' VAL . 4.3 mt -83.46 -41.84 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.53 -0.731 . . . . 0.0 109.993 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.442 ' HA ' HG23 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -80.0 -17.84 51.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.984 -1.073 . . . . 0.0 110.557 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 2.2 m-20 -87.3 -39.02 15.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.935 -1.103 . . . . 0.0 110.074 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -71.66 -33.76 69.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.994 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' ' 43' ' ' SER . 30.5 m -55.74 -35.84 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.771 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -54.38 -46.42 73.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 109.562 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -26.77 38.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 2.5 mmtm -89.27 20.61 3.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.834 . . . . 0.0 110.308 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.526 HD21 ' CB ' ' A' ' 54' ' ' VAL . 35.8 mt -114.02 87.37 12.78 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.987 -1.07 . . . . 0.0 109.714 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' GLU . 36.3 Cg_endo -78.19 64.36 8.38 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.599 2.199 . . . . 0.0 111.01 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER 56.85 130.74 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.638 0.732 . . . . 0.0 110.516 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.29 -21.18 31.5 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.526 ' CB ' HD21 ' A' ' 50' ' ' LEU . 1.2 t -91.03 87.72 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -1.048 . . . . 0.0 108.833 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -77.6 97.03 4.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.952 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.542 ' HG2' ' CG1' ' A' ' 22' ' ' VAL . 63.4 mtp -95.83 97.1 9.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.12 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -91.82 135.57 33.81 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.617 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HG3' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -109.19 116.88 32.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.382 -0.824 . . . . 0.0 110.271 -179.419 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.47 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 3.2 m-85 -117.18 175.15 5.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.132 -0.98 . . . . 0.0 110.787 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.59 ' NE2' ' CB ' ' A' ' 27' ' ' SER . 2.6 t60 -112.15 141.38 45.92 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.683 0.754 . . . . 0.0 109.203 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.599 ' CG1' ' CG1' ' A' ' 150' ' ' VAL . 3.2 m -77.09 155.71 5.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.3 0.571 . . . . 0.0 109.847 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.518 ' OD1' ' CB ' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -124.79 36.73 4.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 108.822 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.564 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 6.3 p90 -136.11 52.55 1.97 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -155.91 47.99 0.49 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 158.36 61.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -28.78 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 65' ' ' GLY . 71.2 m-20 -88.94 -78.26 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -1.125 . . . . 0.0 110.663 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -79.87 -22.36 42.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.957 -1.089 . . . . 0.0 110.51 -178.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.59 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -53.95 -43.75 71.8 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 1.8 tmtp? -64.86 -45.93 84.01 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.065 -1.256 . . . . 0.0 108.258 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.538 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 1.5 t70 -66.03 -31.65 72.67 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.531 HD22 ' NE2' ' A' ' 60' ' ' HIS . 15.5 tp -53.79 -49.66 67.81 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 61' ' ' VAL . 1.3 m -57.33 -43.71 83.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.473 ' O ' HG22 ' A' ' 78' ' ' VAL . 2.5 tm0? -57.07 -25.26 58.4 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -64.44 -44.07 92.31 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -57.46 -33.04 67.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.525 ' CB ' HG21 ' A' ' 135' ' ' VAL . . . -79.53 -51.05 9.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.395 -0.816 . . . . 0.0 110.159 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.64 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 1.7 t -62.74 -27.41 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.068 -1.02 . . . . 0.0 109.641 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.464 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -77.95 -61.88 1.85 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.043 -1.036 . . . . 0.0 109.36 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.518 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -44.71 -27.29 0.48 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.227 -0.921 . . . . 0.0 108.951 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.464 ' HB3' HG21 ' A' ' 131' ' ' VAL . . . -68.71 -44.46 73.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.365 -0.834 . . . . 0.0 109.4 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.443 ' O ' HG11 ' A' ' 84' ' ' VAL . 21.9 mt -108.49 16.29 23.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.09 29.83 4.95 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.465 HG13 HD13 ' A' ' 117' ' ' ILE . 34.8 m -85.73 -3.89 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -1.17 . . . . 0.0 110.066 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.452 ' OE2' ' HB2' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -45.1 -73.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.09 -1.006 . . . . 0.0 109.911 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.27 -35.12 0.23 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.598 -0.689 . . . . 0.0 110.603 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -80.54 -52.78 7.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.943 . . . . 0.0 111.301 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.531 HG22 ' CD1' ' A' ' 92' ' ' LEU . 2.6 m -84.28 -9.46 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.745 -1.222 . . . . 0.0 110.944 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.591 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -73.68 -45.37 52.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.758 -1.214 . . . . 0.0 108.455 178.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.421 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -51.93 -53.94 46.0 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.556 -1.34 . . . . 0.0 110.757 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.537 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 24.0 Cg_endo -72.96 -17.74 24.88 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 N-CA-C 109.65 -0.942 . . . . 0.0 109.65 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.531 ' CD1' HG22 ' A' ' 88' ' ' VAL . 6.4 mt -86.19 -44.4 12.22 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.67 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 7.2 m-30 -62.04 -47.52 84.34 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.906 -1.121 . . . . 0.0 108.674 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.03 -34.81 75.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.025 -1.047 . . . . 0.0 109.554 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.466 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -64.71 -31.99 82.72 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.568 HG13 ' CG ' ' A' ' 29' ' ' PHE . 1.9 t -107.8 8.12 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.984 -1.303 . . . . 0.0 109.568 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.501 ' OE1' ' CG ' ' A' ' 34' ' ' TYR . 11.5 mt-30 -97.75 5.75 48.79 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.915 -1.116 . . . . 0.0 110.296 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.01 -49.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.803 -1.186 . . . . 0.0 110.631 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 1.4 p -55.05 -42.05 72.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.299 -1.501 . . . . 0.0 109.544 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.6 mm-40 67.62 10.5 7.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 110.126 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.3 t -83.67 -8.29 59.31 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.744 0.783 . . . . 0.0 109.102 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.541 ' CB ' HG23 ' A' ' 96' ' ' VAL . 16.3 mm -79.55 66.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.489 ' HA ' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -127.25 31.75 5.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.585 -179.572 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 107' ' ' ASP . 16.8 p -147.94 127.77 13.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 110.146 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.436 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -49.56 -29.8 7.55 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 t -63.71 -34.29 77.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.7 OUTLIER -68.3 -46.41 70.37 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.564 ' CD1' HD21 ' A' ' 68' ' ' LEU . 19.0 mt -52.39 -29.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -73.24 -39.43 65.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 109.121 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 114' ' ' ASN . 14.5 m-20 -56.34 -45.4 80.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.317 -0.864 . . . . 0.0 109.406 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.537 ' CG1' ' HG2' ' A' ' 91' ' ' PRO . 15.4 t -70.96 -38.59 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CE2' ' HE2' ' A' ' 122' ' ' TYR . 2.9 m-85 -65.75 -32.36 73.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.445 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 109' ' ' ARG . 16.1 mt -79.4 -25.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.025 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 110' ' ' ASP . 17.5 m-20 -70.17 -23.65 63.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.974 -1.079 . . . . 0.0 109.697 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.21 2.57 43.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.78 8.99 61.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -94.4 58.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 109.549 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 117' ' ' ILE . 56.5 mttt -37.1 154.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.228 -0.92 . . . . 0.0 110.295 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -50.78 -27.71 13.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -67.7 -43.43 80.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -1.146 . . . . 0.0 109.369 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -46.99 19.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.536 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 5.8 t80 -63.52 -47.08 83.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.177 -0.952 . . . . 0.0 109.52 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 30.5 t0 -61.38 -53.18 59.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.148 -0.97 . . . . 0.0 109.176 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.407 ' O ' ' OG ' ' A' ' 128' ' ' SER . . . -48.21 -53.67 16.17 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.536 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -48.23 -55.75 9.7 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.426 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 8.5 t90 -53.29 -59.18 4.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.14 -15.81 2.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.573 -0.705 . . . . 0.0 109.985 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 7.7 m -69.67 176.97 3.21 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.071 -1.018 . . . . 0.0 109.891 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -89.57 -39.62 13.16 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.335 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.39 -47.16 78.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.752 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 2.8 t -62.95 -34.54 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.904 -1.123 . . . . 0.0 108.399 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -67.33 -28.3 67.86 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 137' ' ' GLN . 1.8 m -69.93 -35.51 74.59 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.518 ' CD1' ' HB3' ' A' ' 80' ' ' MET . 0.2 OUTLIER -79.09 -19.08 52.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.525 HG21 ' CB ' ' A' ' 77' ' ' ALA . 10.2 t -82.25 -47.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.33 -35.59 81.36 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.41 -0.806 . . . . 0.0 108.841 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.9 OUTLIER -69.88 -37.39 76.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 109.025 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.47 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -65.4 -68.38 0.37 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 108.988 179.519 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.4 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 1.4 tt0 -47.71 -36.41 11.24 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.219 -0.926 . . . . 0.0 108.586 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -71.91 -30.91 65.85 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -61.11 -59.74 4.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.361 -0.837 . . . . 0.0 108.846 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.537 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -67.47 -26.76 66.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.838 . . . . 0.0 109.508 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 139' ' ' GLU . . . -78.72 -22.79 46.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.963 . . . . 0.0 109.884 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -82.22 -43.73 17.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.104 -0.997 . . . . 0.0 108.475 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 146' ' ' GLN . 18.4 m -98.36 -5.6 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.537 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.1 tt0 75.21 -53.34 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.491 -0.756 . . . . 0.0 109.793 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.467 HD23 HG13 ' A' ' 61' ' ' VAL . 13.6 tp 69.57 135.03 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.7 ptt85 -160.18 35.7 0.17 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.457 -1.402 . . . . 0.0 110.219 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 161.93 108.56 0.23 Allowed Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.559 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.599 ' CG1' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -89.62 144.31 31.74 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.405 -1.056 . . . . 0.0 109.225 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.18 152.25 94.29 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 124.009 -1.246 . . . . 0.0 110.779 0.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . . . -129.4 139.46 51.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.453 -1.404 . . . . 0.0 108.983 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 19.9 ttt -140.97 128.05 20.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.98 -1.075 . . . . 0.0 110.179 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.607 ' N ' ' CD1' ' A' ' 154' ' ' PHE . 2.5 m-85 -126.28 137.12 53.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -0.918 . . . . 0.0 109.634 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 54.7 t -99.25 133.72 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . 0.412 ' N ' HG11 ' A' ' 155' ' ' VAL . 3.9 t30 42.45 24.47 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.16 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.517 ' N ' ' HB2' ' A' ' 19' ' ' ALA . . . 56.81 59.22 11.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.437 ' HG3' ' HB3' ' A' ' 15' ' ' PRO . 6.7 tttt -166.65 -36.23 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.439 -1.036 . . . . 0.0 108.294 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 154' ' ' PHE . 10.7 m-85 -114.59 122.83 47.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.105 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.592 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -113.34 109.59 18.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 0.0 109.963 -179.231 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.507 HD22 ' CB ' ' A' ' 9' ' ' TYR . 15.3 mt -60.25 -179.86 0.12 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.1 125.76 4.62 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.084 -1.01 . . . . 0.0 109.559 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 C--N 1.312 -1.361 0 C-N-CA 122.514 2.143 . . . . 0.0 110.688 -179.881 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' MET . . . . . 0.45 ' O ' HG22 ' A' ' 175' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.612 0.72 . . . . 0.0 110.025 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.26 -58.93 2.98 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 109.579 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.5 t -68.48 -30.58 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.374 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 0.6 OUTLIER -69.95 -30.83 68.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.139 -0.976 . . . . 0.0 109.018 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 171' ' ' MET . 7.7 t -76.15 -31.74 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 108.892 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -80.82 -64.65 1.14 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.212 -0.93 . . . . 0.0 109.052 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -49.8 -40.87 43.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.864 . . . . 0.0 109.41 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 56.4 t80 -63.61 -50.74 68.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.65 -24.73 15.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.382 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.96 -51.08 10.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.645 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.473 ' O ' HD21 ' A' ' 185' ' ' LEU . 90.5 m -55.17 -27.17 43.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.116 -0.99 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 43.0 t -87.52 -35.74 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.067 -1.021 . . . . 0.0 108.672 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -43.56 81.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.418 -0.801 . . . . 0.0 108.96 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.522 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -82.01 -39.62 23.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.357 -0.84 . . . . 0.0 109.057 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.518 HD21 ' N ' ' A' ' 185' ' ' LEU . 1.1 mm? -53.41 -20.67 4.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.092 . . . . 0.0 109.391 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.6 p -74.81 -8.01 55.14 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.65 -1.282 . . . . 0.0 108.352 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.411 -0.806 . . . . 0.0 109.091 179.654 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.588 ' CD1' ' OE1' ' A' ' 8' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -124.9 62.56 1.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.91 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 48.3 t0 45.23 84.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 109.403 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 136.06 -32.44 2.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -70.27 0.52 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.958 -1.319 . . . . 0.0 108.716 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . 0.588 ' OE1' ' CD1' ' A' ' 3' ' ' TYR . 9.3 pt20 -96.65 0.09 49.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.154 -0.966 . . . . 0.0 109.944 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.511 ' O ' ' N ' ' A' ' 6' ' ' GLY . 1.2 p90 178.93 133.34 0.08 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.831 -1.168 . . . . 0.0 109.772 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.422 HG21 ' HB3' ' A' ' 160' ' ' GLN . 4.7 t -110.54 179.15 4.15 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -115.65 144.46 43.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.341 -0.849 . . . . 0.0 109.778 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.9 mt -95.45 144.06 26.27 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.434 -0.791 . . . . 0.0 109.59 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.91 -22.26 65.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 108.857 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -127.57 102.13 23.39 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.429 -0.795 . . . . 0.0 109.026 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HB3' ' CG ' ' A' ' 158' ' ' LYS . 34.2 Cg_endo -76.43 163.23 32.49 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.503 2.135 . . . . 0.0 110.846 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.465 ' HB ' ' HA3' ' A' ' 157' ' ' GLY . 38.2 t -123.13 92.14 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.84 . . . . 0.0 109.826 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.4 132.74 51.99 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 96.77 -25.74 25.21 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.547 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -42.49 162.75 0.15 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.371 -1.076 . . . . 0.0 109.699 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.556 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.2 Cg_endo -77.86 137.38 15.8 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.758 2.305 . . . . 0.0 111.206 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 30.3 mm-40 -47.4 -22.36 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.913 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 55.7 t -151.41 82.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.014 -1.054 . . . . 0.0 108.968 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.566 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -76.66 121.33 23.09 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.11 -0.994 . . . . 0.0 108.341 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.544 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -98.27 139.54 33.91 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 110.025 -179.295 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.571 ' CE2' ' CG2' ' A' ' 145' ' ' VAL . 7.0 m-85 -127.76 101.96 6.59 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -143.11 143.24 31.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.032 -1.042 . . . . 0.0 109.779 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.607 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -120.43 -179.07 3.85 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.91 . . . . 0.0 109.599 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.543 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 12.1 m-30 -98.48 47.4 0.99 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.604 ' CD2' ' CG1' ' A' ' 96' ' ' VAL . 28.4 m-85 -142.22 13.75 2.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.433 -0.792 . . . . 0.0 109.967 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.503 ' O ' ' NE2' ' A' ' 97' ' ' GLN . 0.5 OUTLIER -105.29 157.28 34.74 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.728 -1.233 . . . . 0.0 109.459 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.7 -27.16 12.95 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.209 1.939 . . . . 0.0 108.252 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 36' ' ' PHE . 27.0 m80 -90.93 -22.66 20.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 13.0 t -47.04 -49.92 20.47 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 9.6 t80 -75.03 -33.65 61.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.838 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.3 mm-40 -83.36 -45.59 13.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.867 -1.146 . . . . 0.0 110.85 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.566 ' CE2' HG23 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -48.47 -24.63 1.34 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.104 -0.997 . . . . 0.0 110.578 -179.252 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -114.79 -51.26 2.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.919 -1.113 . . . . 0.0 112.334 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 63.3 mm-40 -90.15 0.32 57.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.689 -1.257 . . . . 0.0 111.534 -177.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' A' ' 35' ' ' GLN . 41.3 t -135.76 -74.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.676 -1.265 . . . . 0.0 109.581 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 35' ' ' GLN . 78.1 mt -64.06 -24.74 67.82 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.236 -0.915 . . . . 0.0 109.561 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.3 m80 51.18 21.55 1.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.988 -1.07 . . . . 0.0 109.201 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.566 HG23 ' CE2' ' A' ' 36' ' ' PHE . 37.6 mt -63.5 -21.27 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.858 . . . . 0.0 109.757 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -60.1 2.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 109.661 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -57.66 -30.5 65.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.804 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -66.59 -34.48 77.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.721 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 42' ' ' ILE . 42.7 t -72.25 -16.85 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.032 . . . . 0.0 109.191 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.406 ' HA ' HD13 ' A' ' 50' ' ' LEU . 3.5 mttp -82.46 -41.41 19.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.87 . . . . 0.0 110.088 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.18 -22.44 0.65 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.073 -1.017 . . . . 0.0 109.662 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.41 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 1.3 ptmm? -115.62 42.05 2.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 109.631 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 47' ' ' LYS . 10.9 mt -108.16 101.74 43.12 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.17 -0.956 . . . . 0.0 109.752 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 53' ' ' GLY . 33.5 Cg_endo -74.93 153.9 42.46 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.536 2.157 . . . . 0.0 109.408 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 73.2 tt0 -69.5 22.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.742 -1.223 . . . . 0.0 111.548 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.448 ' O ' HG21 ' A' ' 54' ' ' VAL . . . -122.45 32.11 4.61 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.521 ' CG1' ' HB3' ' A' ' 186' ' ' SER . 59.0 t -153.39 127.16 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.47 105.43 17.4 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 110.766 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.474 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -104.36 99.1 8.8 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.564 HG23 ' CE1' ' A' ' 59' ' ' TYR . 1.3 m -100.37 135.04 42.42 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.714 -1.195 . . . . 0.0 110.982 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.544 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 6.7 tttt -106.84 117.81 35.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.564 ' CE1' HG23 ' A' ' 57' ' ' THR . 2.6 m-85 -118.08 170.76 8.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.909 -1.12 . . . . 0.0 111.706 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.607 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 1.9 t-160 -111.09 136.4 50.18 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.727 0.775 . . . . 0.0 109.236 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.514 HG23 ' CB ' ' A' ' 27' ' ' SER . 3.1 m -78.9 155.55 4.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-O 121.398 0.618 . . . . 0.0 110.272 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.46 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 1.0 OUTLIER -124.4 35.82 4.74 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.031 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 9.7 p90 -135.77 55.73 1.86 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.295 -0.878 . . . . 0.0 109.608 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.457 ' SD ' HD21 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -130.36 37.11 3.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.162 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.21 -33.28 0.42 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.19 -37.07 2.72 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -87.84 -79.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.004 -1.292 . . . . 0.0 110.464 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.591 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -79.87 -18.5 50.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.106 . . . . 0.0 109.618 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 72' ' ' LEU . . . -54.95 -36.34 60.34 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.27 -45.65 79.76 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.325 -1.103 . . . . 0.0 108.36 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -66.9 -24.7 66.13 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.599 HD22 ' CD2' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -65.55 -46.86 77.89 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.888 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 62' ' ' ASN . 1.6 m -56.04 -41.71 75.44 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 6.0 tp60 -61.4 -23.78 66.04 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -63.65 -37.33 86.95 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.559 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 20.7 t-105 -71.29 -32.26 68.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.528 -0.733 . . . . 0.0 109.142 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.471 ' HB3' ' NE2' ' A' ' 138' ' ' GLN . . . -75.75 -40.34 55.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.467 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.569 ' CG2' ' CE1' ' A' ' 122' ' ' TYR . 35.6 t -74.55 -26.24 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.288 -0.882 . . . . 0.0 109.655 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.536 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.1 -57.87 3.52 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.944 -1.097 . . . . 0.0 108.776 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -26.59 10.33 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.492 ' HB3' ' CG2' ' A' ' 131' ' ' VAL . . . -68.14 -47.2 68.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.642 -0.661 . . . . 0.0 109.397 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.422 ' HA ' HD21 ' A' ' 82' ' ' LEU . 44.8 mt -106.12 14.02 28.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.104 -0.997 . . . . 0.0 110.373 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.24 24.89 7.42 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.536 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 28.2 m -86.25 -4.16 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -1.027 . . . . 0.0 110.482 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.472 ' O ' ' HB ' ' A' ' 89' ' ' THR . 2.7 pt-20 -42.44 -59.11 1.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.047 -1.033 . . . . 0.0 109.897 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.68 -31.41 11.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 109.828 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 84' ' ' VAL . 46.3 mttp -78.65 -52.88 7.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 111.478 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -85.92 -8.63 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.752 -1.217 . . . . 0.0 111.053 -178.111 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.605 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.07 -44.98 44.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.729 -1.232 . . . . 0.0 108.679 178.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.424 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -52.61 -53.27 55.74 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.472 -1.392 . . . . 0.0 110.627 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.517 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 27.2 Cg_endo -73.28 -18.63 23.21 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 109.737 -0.909 . . . . 0.0 109.737 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.52 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 14.9 mt -86.83 -42.97 12.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 108.982 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.605 ' CG ' HG21 ' A' ' 89' ' ' THR . 5.1 m-30 -64.81 -46.66 81.04 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.889 -1.132 . . . . 0.0 108.87 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -71.78 -22.24 61.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.314 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.442 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -78.98 -31.02 44.79 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.604 ' CG1' ' CD2' ' A' ' 29' ' ' PHE . 2.8 t -105.73 6.63 10.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.179 -1.189 . . . . 0.0 109.325 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 93' ' ' PHE . 40.5 mm-40 -105.21 9.13 34.17 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 120.974 -1.079 . . . . 0.0 110.514 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER 173.27 -49.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.654 -1.278 . . . . 0.0 110.443 179.643 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 59.7 p -55.32 -44.53 75.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.608 -1.308 . . . . 0.0 109.297 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 71.41 12.04 6.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 110.285 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 t -79.63 -7.78 58.77 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.545 ' CB ' HG23 ' A' ' 96' ' ' VAL . 7.7 mm -84.95 73.32 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.12 33.37 3.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.605 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 107' ' ' ASP . 14.7 p -160.45 133.24 6.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 0.0 110.056 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.514 ' N ' ' HB3' ' A' ' 68' ' ' LEU . . . -50.81 -34.76 28.96 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.9 p -61.59 -31.6 71.67 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -70.6 -51.24 29.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.506 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 52.5 mt -48.66 -29.94 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -38.54 53.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.485 -0.759 . . . . 0.0 109.551 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.18 -44.32 83.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.438 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.52 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 69.9 t -72.62 -38.17 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -42.74 98.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.5 mt -71.5 -24.29 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.099 -1.001 . . . . 0.0 109.271 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -67.29 -19.65 65.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.75 -12.03 35.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.366 -0.834 . . . . 0.0 109.253 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.98 -7.96 25.4 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.9 mp -76.93 52.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.315 -1.109 . . . . 0.0 109.478 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 117' ' ' ILE . 35.5 mttm -40.46 154.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.035 -1.041 . . . . 0.0 109.769 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.75 -35.7 39.24 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.48 -56.27 24.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.045 -1.268 . . . . 0.0 110.018 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -46.86 87.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 109.946 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.569 ' CE1' ' CG2' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -62.86 -62.64 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.561 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 122' ' ' TYR . 13.8 t70 -42.52 -35.08 0.97 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.768 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.95 -41.87 28.27 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.698 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ALA . . . . . 0.535 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -58.57 -48.29 81.43 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 108.795 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 126' ' ' TRP . 2.2 t90 -62.37 -56.85 14.32 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.12 -16.1 0.71 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.552 -0.718 . . . . 0.0 110.559 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.7 t -69.07 -175.59 0.76 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.853 -1.154 . . . . 0.0 110.073 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -90.29 -34.89 15.56 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.299 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.4 -46.92 62.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 118.415 -1.314 . . . . 0.0 110.11 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 6.5 t -72.14 -34.14 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.853 -1.154 . . . . 0.0 108.911 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -64.3 -44.04 92.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.383 -0.823 . . . . 0.0 109.016 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 11.4 t -65.12 -30.87 71.84 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.7 tp -78.91 -17.59 55.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.19 -47.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -64.46 -33.36 75.7 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.445 ' OE1' ' OH ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -66.46 -37.85 86.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.442 -0.786 . . . . 0.0 108.959 179.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLN . . . . . 0.506 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 8.4 mt-30 -67.46 -67.62 0.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 108.885 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 138' ' ' GLN . 8.4 tt0 -46.74 -36.85 7.66 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 10.2 mmtt -72.52 -29.12 63.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.429 -0.794 . . . . 0.0 108.996 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -61.99 -53.62 53.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 109.071 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -71.77 -35.35 70.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.4 -0.813 . . . . 0.0 109.927 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.79 -18.63 58.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.836 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . 0.449 ' HB3' HG23 ' A' ' 16' ' ' VAL . 7.5 m-20 -82.82 -45.04 14.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.114 -0.992 . . . . 0.0 108.753 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . 0.571 ' CG2' ' CE2' ' A' ' 25' ' ' PHE . 20.9 m -97.33 -11.96 8.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.545 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 3.4 mt-30 82.02 -44.84 0.17 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.57 -0.706 . . . . 0.0 109.75 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.554 HD22 ' CE1' ' A' ' 63' ' ' PHE . 14.6 tp 66.46 133.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.347 -0.845 . . . . 0.0 109.144 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.4 37.41 0.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.536 -1.353 . . . . 0.0 109.846 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 158.04 109.51 0.28 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.291 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.505 ' CG1' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -93.56 142.59 25.37 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.427 -1.043 . . . . 0.0 109.358 178.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.16 151.76 93.79 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.891 -1.296 . . . . 0.0 110.487 0.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . . . -126.83 153.53 45.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.306 -1.496 . . . . 0.0 109.264 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' MET . . . . . 0.531 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 3.2 ttm -145.32 136.44 24.84 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.118 -0.989 . . . . 0.0 109.818 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.572 ' CE2' ' HG3' ' A' ' 160' ' ' GLN . 3.0 m-85 -135.7 129.18 32.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.149 -0.97 . . . . 0.0 110.003 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 53.9 t -98.32 132.11 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 0.0 109.636 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.3 t30 46.46 22.69 0.18 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.219 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.547 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.36 56.42 24.51 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LYS . . . . . 0.428 ' CG ' ' HB3' ' A' ' 15' ' ' PRO . 10.9 tttt -164.95 -34.16 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.377 -1.073 . . . . 0.0 108.32 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.454 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 86.1 m-85 -115.27 116.37 28.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.204 -0.935 . . . . 0.0 109.207 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.572 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 0.5 OUTLIER -100.67 106.15 17.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.386 -0.821 . . . . 0.0 109.958 -179.259 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.468 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 16.4 mt -61.3 159.7 11.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.838 . . . . 0.0 109.028 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -129.71 117.59 18.52 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 0.0 109.271 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.313 -1.31 0 C-N-CA 122.561 2.174 . . . . 0.0 111.239 -179.748 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.67 0.747 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.33 -61.27 2.06 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.677 -0.639 . . . . 0.0 109.415 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.422 ' O ' HG11 ' A' ' 173' ' ' VAL . 4.4 t -65.9 -23.08 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.205 -0.934 . . . . 0.0 109.034 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -73.44 -42.25 62.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.197 -0.94 . . . . 0.0 109.216 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 55.9 t -73.27 -26.26 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.121 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -61.31 2.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.3 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -52.55 -32.54 41.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -74.52 -60.49 2.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 109.524 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.27 -20.77 7.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.066 -1.021 . . . . 0.0 108.784 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -82.59 -55.52 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.48 -0.763 . . . . 0.0 109.448 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.479 ' OG1' ' OE1' ' A' ' 8' ' ' GLN . 69.6 m -50.73 -27.11 6.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.413 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 54.0 t -87.86 -37.3 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.034 -1.042 . . . . 0.0 108.911 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -57.27 -44.23 83.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 108.863 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -83.43 -35.74 24.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.403 -0.811 . . . . 0.0 109.391 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.514 HD21 ' N ' ' A' ' 185' ' ' LEU . 0.9 OUTLIER -58.03 -18.43 24.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.797 -1.189 . . . . 0.0 109.712 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' SER . . . . . 0.521 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -78.7 -5.06 52.09 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.793 -1.192 . . . . 0.0 108.722 178.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.481 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.464 ' HB3' ' CE ' ' A' ' 7' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.403 ' C ' ' CD2' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -139.16 64.13 1.48 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.622 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.487 ' HB3' ' CE1' ' A' ' 9' ' ' TYR . 0.4 OUTLIER 50.45 84.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.373 -0.829 . . . . 0.0 109.202 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' ASP . 1.3 mt-10 -97.83 56.92 1.29 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -0.928 . . . . 0.0 110.083 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 40.99 80.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.609 -0.682 . . . . 0.0 110.041 179.39 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.9 -25.56 5.52 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.48 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.464 ' CE ' ' HB3' ' A' ' 1' ' ' ALA . 3.6 tttp -79.96 -69.5 0.58 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.94 -1.329 . . . . 0.0 108.852 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.515 ' HG2' ' NE2' ' A' ' 177' ' ' GLN . 0.3 OUTLIER -95.6 2.01 53.99 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.16 -0.963 . . . . 0.0 109.852 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.555 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.2 OUTLIER 177.19 129.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.098 -1.001 . . . . 0.0 109.239 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -106.89 179.61 4.22 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.573 -0.705 . . . . 0.0 109.469 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.475 HG21 ' O ' ' A' ' 158' ' ' LYS . 1.4 m -123.66 138.64 54.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.351 0.596 . . . . 0.0 109.599 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -99.22 158.2 15.86 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.409 ' C ' ' HD3' ' A' ' 15' ' ' PRO . 3.4 pt-20 -91.51 1.27 57.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 109.712 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.523 ' O ' ' CD1' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -120.73 78.07 29.82 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 0.0 109.321 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD3' ' C ' ' A' ' 13' ' ' GLU . 36.3 Cg_endo -78.19 164.58 26.76 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.717 2.278 . . . . 0.0 110.558 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.445 ' O ' ' C ' ' A' ' 17' ' ' ALA . 18.8 t -127.53 92.66 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.176 -0.953 . . . . 0.0 109.557 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -42.76 125.96 3.56 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 96.05 -18.23 57.83 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.505 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -39.41 160.83 0.09 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.505 -0.997 . . . . 0.0 109.927 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 35.1 Cg_endo -77.67 135.83 14.8 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.741 2.294 . . . . 0.0 111.309 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.531 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 9.1 mt-30 -49.4 -21.02 0.79 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.561 -0.712 . . . . 0.0 109.802 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.49 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 73.2 t -151.45 80.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.978 -1.076 . . . . 0.0 109.103 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.639 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.73 126.99 32.07 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.541 ' N ' HD21 ' A' ' 23' ' ' LEU . 3.5 tt0 -108.49 120.97 43.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.001 -1.062 . . . . 0.0 109.97 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.639 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 8.2 m-85 -108.33 107.52 18.13 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.414 ' CE1' ' HG2' ' A' ' 58' ' ' LYS . 2.0 p90 -153.08 141.19 20.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.97 -1.081 . . . . 0.0 110.423 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -118.51 -178.21 3.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.067 179.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 5.8 m-30 -97.03 46.16 1.04 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 108.698 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.572 ' CE2' HG12 ' A' ' 96' ' ' VAL . 15.0 m-85 -146.41 13.27 1.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.289 -0.882 . . . . 0.0 109.837 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 3.7 m -105.39 161.16 23.62 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.649 -1.282 . . . . 0.0 109.534 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 33.2 Cg_endo -75.04 -32.93 4.92 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.106 1.871 . . . . 0.0 108.17 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' PHE . 39.7 m80 -84.5 -20.37 31.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.494 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 5.1 t -49.69 -55.21 14.66 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 3.4 t80 -73.35 -33.51 65.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.901 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.479 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 25.7 mt-30 -85.65 -16.02 40.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.856 -1.152 . . . . 0.0 111.186 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 32' ' ' HIS . 8.9 t80 -86.25 -28.2 23.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.841 -1.162 . . . . 0.0 111.377 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.3 mt-10 -127.14 50.53 1.97 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.594 -1.316 . . . . 0.0 110.728 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 1.2 mt-10 -168.34 -59.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.009 -1.057 . . . . 0.0 110.767 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.32 -49.35 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.976 -1.077 . . . . 0.0 110.848 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.484 ' HB3' HG13 ' A' ' 42' ' ' ILE . 6.7 mp -71.1 -2.19 14.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.096 -1.003 . . . . 0.0 110.297 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.458 ' C ' ' O ' ' A' ' 40' ' ' LEU . 58.0 m-70 39.39 29.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.838 . . . . 0.0 109.954 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.484 HG13 ' HB3' ' A' ' 40' ' ' LEU . 36.4 mt -74.62 -21.43 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.557 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.442 ' O ' HG11 ' A' ' 46' ' ' VAL . 2.5 p -76.97 -43.45 35.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 109.619 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.83 -48.28 15.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.519 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -52.96 -43.56 66.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 109.517 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.504 HG11 ' N ' ' A' ' 47' ' ' LYS . 9.8 p -69.87 -25.77 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.143 -0.973 . . . . 0.0 109.16 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 49.4 mttm -80.76 -27.58 36.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 110.133 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.47 -29.45 70.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.052 . . . . 0.0 109.79 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.487 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 8.3 mmtt -109.27 24.79 12.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.534 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 11.9 mt -70.85 113.71 21.02 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.971 . . . . 0.0 109.933 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 36.2 Cg_endo -78.73 151.37 24.85 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.245 1.963 . . . . 0.0 109.247 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.467 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 3.7 tp10 -75.47 21.13 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.625 -1.297 . . . . 0.0 110.724 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -122.75 29.99 5.24 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.532 ' CG2' ' HB2' ' A' ' 186' ' ' SER . 60.7 t -153.07 118.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -1.007 . . . . 0.0 109.338 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.26 109.37 20.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.678 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.49 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 1.9 ttp -92.58 100.82 13.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.719 -0.613 . . . . 0.0 109.595 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.454 ' HB ' HD22 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -96.72 149.67 21.56 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.801 -1.159 . . . . 0.0 109.898 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.414 ' HG2' ' CE1' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -123.77 117.12 24.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.466 -0.771 . . . . 0.0 109.378 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.569 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.3 m-85 -123.78 166.26 15.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.81 -1.181 . . . . 0.0 111.617 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.575 ' CD2' ' OG ' ' A' ' 27' ' ' SER . 14.4 t60 -102.26 149.51 24.25 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.523 HG13 ' CG1' ' A' ' 150' ' ' VAL . 1.3 m -95.31 159.79 2.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 O-C-N 121.663 -0.648 . . . . 0.0 110.356 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -128.11 49.41 2.16 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.312 -0.867 . . . . 0.0 109.193 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.593 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 10.8 p90 -152.4 64.65 0.82 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -0.961 . . . . 0.0 109.799 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -119.04 30.77 6.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.932 -1.105 . . . . 0.0 109.592 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' MET . . . 45.12 42.73 8.65 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . -149.05 85.43 0.16 Allowed Glycine 0 C--O 1.204 -1.731 0 N-CA-C 107.572 -2.211 . . . . 0.0 107.572 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -31.62 -46.52 0.11 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.058 -0.672 . . . . 0.0 111.548 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.581 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -61.46 -22.24 64.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.647 -1.283 . . . . 0.0 109.49 -179.01 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' A' ' 66' ' ' GLY . . . -54.52 -46.99 71.86 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.41 ' O ' ' HB ' ' A' ' 73' ' ' THR . 27.8 mttt -52.32 -47.04 66.24 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.531 ' CB ' ' HB3' ' A' ' 105' ' ' ALA . 8.5 t0 -64.41 -29.2 70.27 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.506 ' O ' ' CB ' ' A' ' 75' ' ' ALA . 17.6 tp -61.26 -35.4 77.17 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 5.3 m -62.75 -40.73 98.14 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.494 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 0.5 OUTLIER -61.91 -20.9 64.26 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 177.175 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -67.96 -41.92 81.69 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.446 ' HB3' ' OE1' ' A' ' 138' ' ' GLN . 24.1 t-105 -67.01 -31.67 72.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 0.0 108.91 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' CB ' HG21 ' A' ' 135' ' ' VAL . . . -79.51 -60.37 2.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.28 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.588 ' CG2' ' CE1' ' A' ' 122' ' ' TYR . 71.5 t -54.92 -27.81 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 110.043 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.521 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.25 -62.85 1.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.907 -1.121 . . . . 0.0 108.621 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.405 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -47.01 -27.42 1.3 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -69.43 -42.16 75.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.598 -0.689 . . . . 0.0 109.286 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.451 ' O ' HG11 ' A' ' 84' ' ' VAL . 67.5 mt -107.92 12.75 26.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.224 -0.923 . . . . 0.0 110.562 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 49.17 32.01 12.59 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 26.0 m -93.81 2.01 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.476 -1.014 . . . . 0.0 110.531 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.452 ' O ' ' HB ' ' A' ' 89' ' ' THR . 38.4 tt0 -48.9 -68.31 0.19 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.866 -1.146 . . . . 0.0 109.402 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -40.04 -34.89 0.32 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.878 . . . . 0.0 110.465 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.484 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 35.1 mttt -79.82 -55.4 5.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 111.031 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.529 HG22 ' CD1' ' A' ' 92' ' ' LEU . 1.2 m -82.14 -22.28 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.812 -1.18 . . . . 0.0 110.608 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.602 HG21 ' CG ' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -64.77 -43.57 92.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.723 -1.235 . . . . 0.0 108.983 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.92 -56.21 30.22 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.351 -1.468 . . . . 0.0 110.474 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.484 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 26.1 Cg_endo -72.43 -16.21 27.62 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 N-CA-C 109.812 -0.88 . . . . 0.0 109.812 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.529 ' CD1' HG22 ' A' ' 88' ' ' VAL . 15.1 mt -87.39 -44.13 11.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 108.844 178.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.602 ' CG ' HG21 ' A' ' 89' ' ' THR . 5.4 m-30 -65.51 -46.84 78.07 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.987 -1.071 . . . . 0.0 108.835 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -16.62 60.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -0.968 . . . . 0.0 109.203 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.66 -33.39 51.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.572 HG12 ' CE2' ' A' ' 29' ' ' PHE . 2.3 t -100.83 -7.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 121.12 -1.224 . . . . 0.0 109.35 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -110.08 8.73 24.07 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 120.893 -1.129 . . . . 0.0 110.514 -179.288 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.556 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -176.18 68.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.67 -1.269 . . . . 0.0 109.333 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.556 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 163.08 -46.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.522 -0.736 . . . . 0.0 109.575 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 71.67 17.54 5.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.397 -0.814 . . . . 0.0 110.38 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 t -81.45 -4.96 57.36 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.527 ' CB ' HG23 ' A' ' 96' ' ' VAL . 4.2 mm -95.41 84.49 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.34 28.29 1.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 109.382 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 107' ' ' ASP . 59.6 p -157.55 131.54 8.15 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.321 -0.862 . . . . 0.0 109.658 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.531 ' HB3' ' CB ' ' A' ' 71' ' ' ASP . . . -48.99 -31.66 7.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 t -64.5 -33.28 75.53 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -67.64 -50.11 59.6 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.526 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 36.3 mt -51.27 -28.53 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -36.49 56.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.52 -0.737 . . . . 0.0 109.052 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.22 -48.4 78.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.517 ' CG2' HD22 ' A' ' 92' ' ' LEU . 21.3 t -68.82 -37.68 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.455 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.427 ' O ' HG12 ' A' ' 117' ' ' ILE . 1.3 m-85 -59.9 -48.26 82.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.108 -0.995 . . . . 0.0 109.469 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 mt -66.26 -25.39 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.963 . . . . 0.0 109.279 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 111' ' ' VAL . 15.5 m-20 -61.77 -16.94 53.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.916 . . . . 0.0 109.544 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -97.94 15.48 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.078 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.59 -0.94 89.39 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.533 HD12 ' N ' ' A' ' 117' ' ' ILE . 3.9 mm -71.77 55.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -1.14 . . . . 0.0 109.843 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -36.73 145.53 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.285 -0.885 . . . . 0.0 110.073 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -47.15 -31.71 6.22 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.484 ' O ' ' HB1' ' A' ' 124' ' ' ALA . 2.3 mt-10 -61.79 -49.25 77.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -1.121 . . . . 0.0 109.49 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.19 -58.05 6.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 110.003 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.588 ' CE1' ' CG2' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -61.22 -56.84 16.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.938 . . . . 0.0 109.617 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 14.5 t70 -45.15 -34.34 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.036 -1.04 . . . . 0.0 109.054 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 120' ' ' GLU . . . -77.48 -43.9 30.7 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.416 -0.802 . . . . 0.0 109.012 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.545 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -52.85 -51.66 60.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.494 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 11.4 t90 -62.62 -53.2 58.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -53.86 -16.13 1.66 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.511 -0.743 . . . . 0.0 110.027 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.2 t -78.76 -179.48 6.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.984 -1.073 . . . . 0.0 110.273 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -95.24 -36.59 11.38 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.806 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.04 -47.83 80.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.209 -1.396 . . . . 0.0 109.709 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.545 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 2.2 t -64.95 -39.8 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.97 -1.081 . . . . 0.0 108.333 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -66.61 -31.62 72.42 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.3 t -64.6 -35.48 81.14 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.83 -19.14 52.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.313 -0.867 . . . . 0.0 108.678 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.405 HG21 ' CB ' ' A' ' 77' ' ' ALA . 4.6 t -80.35 -47.45 21.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.61 -36.9 85.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -32.96 73.06 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.569 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -64.37 -66.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.306 -0.871 . . . . 0.0 109.092 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 0.4 OUTLIER -52.23 -32.87 38.75 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.46 ' O ' ' OD2' ' A' ' 144' ' ' ASP . 0.3 OUTLIER -74.19 -28.21 61.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.345 -0.847 . . . . 0.0 108.991 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.463 ' HA ' ' OD2' ' A' ' 144' ' ' ASP . . . -64.37 -60.88 2.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.062 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.481 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -72.37 -21.72 61.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.717 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -77.56 -29.09 51.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.079 -1.013 . . . . 0.0 109.776 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.531 ' OD1' ' CG1' ' A' ' 145' ' ' VAL . 2.8 p30 -81.22 -47.82 12.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.001 . . . . 0.0 108.419 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.577 HG22 ' CE2' ' A' ' 25' ' ' PHE . 28.2 m -84.07 -14.44 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.542 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 4.0 tt0 81.2 -48.05 0.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.587 -0.696 . . . . 0.0 109.837 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.472 HD23 HG13 ' A' ' 61' ' ' VAL . 49.0 tp 61.79 134.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.466 -0.771 . . . . 0.0 109.319 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.72 40.36 0.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.623 -1.298 . . . . 0.0 109.681 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 152' ' ' ALA . . . 169.64 104.73 0.18 Allowed Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.014 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.547 HG23 ' CZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -99.0 141.13 22.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.131 . . . . 0.0 109.587 179.151 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.417 ' C ' ' HA ' ' A' ' 150' ' ' VAL . 33.1 Cg_endo -75.32 153.87 98.92 Favored 'Cis proline' 0 C--N 1.314 -1.26 0 C-N-CA 123.598 -1.417 . . . . 0.0 110.452 0.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' A' ' 25' ' ' PHE . . . -132.86 146.85 52.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.33 -1.481 . . . . 0.0 109.54 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.497 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 18.7 ttm -136.54 133.9 36.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 109.813 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.593 ' CD2' ' HB2' ' A' ' 160' ' ' GLN . 75.4 m-85 -129.57 127.08 39.97 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.332 -0.855 . . . . 0.0 110.104 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 56.1 t -97.03 129.46 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.045 -1.034 . . . . 0.0 109.5 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 47.41 21.72 0.24 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.979 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.505 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.75 55.72 28.54 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.475 ' O ' HG21 ' A' ' 11' ' ' THR . 13.5 tttp -163.71 -37.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.539 ' CE2' ' HG3' ' A' ' 188' ' ' LYS . 75.0 m-85 -114.91 124.84 52.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.593 ' HB2' ' CD2' ' A' ' 154' ' ' PHE . 4.4 tt0 -124.44 127.43 47.5 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.942 -1.099 . . . . 0.0 109.852 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.73 -179.84 0.74 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.499 -0.751 . . . . 0.0 109.081 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.457 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 38.1 t30 -144.42 65.0 12.69 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 109.64 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 162' ' ' ASN . 35.1 Cg_endo -77.95 63.41 8.14 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.675 2.25 . . . . 0.0 110.424 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -98.94 60.99 1.25 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.895 . . . . 0.0 109.559 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 67.96 72.33 0.82 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.506 ' HB3' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -64.21 -46.9 81.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -1.135 . . . . 0.0 109.342 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.0 t70 58.3 35.94 25.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.224 -0.922 . . . . 0.0 109.853 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.506 ' CG2' ' HB3' ' A' ' 166' ' ' MET . 1.0 OUTLIER -73.15 -4.84 35.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.997 -1.064 . . . . 0.0 109.632 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.11 38.29 10.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 0.0 109.233 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -158.21 74.88 0.72 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 109.19 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 35.7 mtm -57.31 -18.53 17.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.473 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -76.42 -46.48 26.97 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.44 -25.76 25.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.301 -0.874 . . . . 0.0 109.12 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -73.6 -40.8 63.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.579 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 32.6 t -73.11 -29.83 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -0.988 . . . . 0.0 109.248 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -51.7 7.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 108.951 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.515 ' NE2' ' HG2' ' A' ' 8' ' ' GLN . 6.7 tt0 -57.71 -44.8 86.17 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.207 -0.933 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.485 ' HA ' ' OG1' ' A' ' 181' ' ' THR . 4.9 t80 -60.11 -56.7 18.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.073 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 183' ' ' LYS . . . -49.44 -27.58 4.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.337 -0.852 . . . . 0.0 108.873 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -79.48 -46.17 17.96 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.436 -0.79 . . . . 0.0 109.315 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.519 ' O ' ' CD1' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -48.62 -45.95 39.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.06 -1.025 . . . . 0.0 109.396 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.454 HG12 HG22 ' A' ' 22' ' ' VAL . 22.9 t -75.24 -32.09 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.959 -1.088 . . . . 0.0 109.792 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 179' ' ' ALA . 5.5 tttt -68.28 -38.43 81.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.364 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -83.41 -44.26 14.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.958 -1.089 . . . . 0.0 109.888 -179.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.536 HD22 ' CE2' ' A' ' 184' ' ' TYR . 14.5 mt -60.69 -22.75 64.25 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.62 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.532 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 5.2 t -68.98 -14.43 63.04 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -82.55 -9.91 59.21 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.622 -0.674 . . . . 0.0 109.204 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.539 ' HG3' ' CE2' ' A' ' 159' ' ' TYR . 17.7 mmtt -54.38 -41.78 69.61 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.225 -0.922 . . . . 0.0 109.298 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 188' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.473 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.203 0.525 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 33.8 mt-30 -132.62 57.86 1.78 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.27 -0.894 . . . . 0.0 109.22 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.58 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 26.8 p90 -179.78 96.23 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -118.17 63.51 0.76 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 110.359 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t0 69.13 96.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 110.38 178.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.28 -10.19 75.07 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.587 ' O ' ' CG ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -99.63 28.72 4.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -1.094 . . . . 0.0 108.199 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.587 ' CG ' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER 152.83 -40.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.03 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.59 ' CG ' ' O ' ' A' ' 9' ' ' TYR . 8.4 p90 -139.79 113.34 8.52 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.193 -0.942 . . . . 0.0 108.691 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.438 HG21 ' HG3' ' A' ' 160' ' ' GLN . 15.1 t -93.3 -179.97 5.23 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' A' ' 158' ' ' LYS . 90.5 m -137.1 145.81 44.35 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.615 0.722 . . . . 0.0 110.079 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.434 HD11 ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -100.5 171.61 7.63 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.526 -0.734 . . . . 0.0 109.271 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.41 13.45 30.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.434 ' O ' HD11 ' A' ' 12' ' ' LEU . 1.6 mmtp -127.17 95.27 36.89 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.543 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.39 169.33 20.19 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.594 2.196 . . . . 0.0 110.204 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' ALA . 1.9 t -144.26 113.24 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 110.101 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.06 128.21 18.41 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 77.21 5.69 85.54 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.526 ' O ' ' O ' ' A' ' 18' ' ' GLY . . . -38.18 165.88 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.6 -0.941 . . . . 0.0 110.71 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.527 ' HG3' ' CD1' ' A' ' 23' ' ' LEU . 32.8 Cg_endo -74.02 101.26 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.859 2.373 . . . . 0.0 111.58 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.495 ' HB2' ' CB ' ' A' ' 55' ' ' LYS . 1.9 mp0 -42.1 -28.04 0.16 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.47 ' HA ' ' O ' ' A' ' 154' ' ' PHE . 40.2 t -158.57 79.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.527 ' CD1' ' HG3' ' A' ' 20' ' ' PRO . 1.3 tt -73.62 139.27 45.38 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.447 ' N ' HD21 ' A' ' 23' ' ' LEU . 1.5 tt0 -127.8 98.77 5.28 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.199 -0.938 . . . . 0.0 109.803 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.502 ' CD1' ' CD2' ' A' ' 147' ' ' LEU . 11.4 m-85 -81.61 127.0 32.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.204 -0.935 . . . . 0.0 108.913 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -161.73 128.69 3.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.346 -0.846 . . . . 0.0 109.705 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.565 ' HA ' ' ND1' ' A' ' 60' ' ' HIS . 11.6 p -112.45 145.66 39.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.403 -0.81 . . . . 0.0 109.131 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.604 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 8.6 m-30 -72.93 49.87 0.25 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.252 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.598 ' CG ' HG13 ' A' ' 96' ' ' VAL . 11.4 m-85 -152.24 9.85 0.5 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.577 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -107.26 167.03 10.0 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.725 -1.235 . . . . 0.0 109.949 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.01 -43.07 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.564 2.176 . . . . 0.0 108.691 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.457 ' HB3' ' HG3' ' A' ' 151' ' ' PRO . 0.1 OUTLIER -78.17 -21.71 49.79 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 5.7 t -45.19 -56.27 4.96 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.505 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 51.9 t80 -69.98 -27.33 64.62 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.591 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 3.2 mm-40 -84.87 -28.67 25.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.138 . . . . 0.0 111.002 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -87.69 -36.25 17.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.83 -1.169 . . . . 0.0 111.724 -178.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 1.2 mp0 -111.46 31.95 5.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.633 -1.292 . . . . 0.0 111.38 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.553 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 26.3 mm-40 -160.03 -58.15 0.06 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.801 -1.187 . . . . 0.0 110.846 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 41' ' ' HIS . 69.2 t -88.91 -74.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.844 -1.16 . . . . 0.0 110.903 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.498 ' HB3' ' CD1' ' A' ' 42' ' ' ILE . 51.0 mt -42.7 -25.29 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.004 . . . . 0.0 110.315 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER 55.8 21.61 4.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.009 -1.057 . . . . 0.0 108.898 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.498 ' CD1' ' HB3' ' A' ' 40' ' ' LEU . 14.9 mt -70.35 -21.23 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.45 -0.781 . . . . 0.0 109.888 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.464 ' O ' HG11 ' A' ' 46' ' ' VAL . 79.3 p -86.16 -77.27 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.09 -1.006 . . . . 0.0 110.078 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.5 OUTLIER -41.68 -31.5 0.3 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.867 . . . . 0.0 110.486 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 3.0 m120 -75.85 -31.58 59.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.949 -1.094 . . . . 0.0 110.064 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.486 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 3.5 p -54.2 -36.47 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.079 -1.013 . . . . 0.0 109.577 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.497 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -72.44 -36.39 68.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.119 -0.988 . . . . 0.0 109.474 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -45.02 -24.78 0.25 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.514 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -133.36 50.66 2.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.274 -0.892 . . . . 0.0 110.004 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.565 ' O ' ' CG1' ' A' ' 54' ' ' VAL . 9.8 mt -114.47 72.3 2.51 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.868 -1.145 . . . . 0.0 110.562 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.514 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 36.8 Cg_endo -78.59 139.35 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.33 2.02 . . . . 0.0 110.269 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 51' ' ' PRO . 19.3 tp10 61.99 134.79 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.374 -0.829 . . . . 0.0 108.849 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . 58.21 23.53 53.04 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.565 ' CG1' ' O ' ' A' ' 50' ' ' LEU . 1.6 t -61.26 77.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.712 -0.875 . . . . 0.0 109.258 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -136.96 97.25 3.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.417 ' SD ' ' HD2' ' A' ' 58' ' ' LYS . 2.7 tmm? -103.6 103.01 12.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 108.91 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.52 121.68 36.32 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.197 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.52 ' HB2' ' CE1' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -103.39 110.23 22.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 0.0 109.715 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.606 ' CD1' ' CG ' ' A' ' 138' ' ' GLN . 4.1 m-85 -113.68 177.96 4.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.851 -1.156 . . . . 0.0 110.942 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.651 ' CE1' ' CD2' ' A' ' 72' ' ' LEU . 2.0 t-160 -140.0 130.4 25.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.44 -0.787 . . . . 0.0 109.651 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.527 ' CG2' HG13 ' A' ' 150' ' ' VAL . 1.4 m -115.18 137.38 48.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 2.0 p-10 -40.72 -55.89 2.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.352 -0.843 . . . . 0.0 109.37 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.553 ' CD2' HG12 ' A' ' 150' ' ' VAL . 3.6 m-85 32.1 40.64 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.623 0.725 . . . . 0.0 110.952 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.507 ' SD ' ' CD2' ' A' ' 29' ' ' PHE . 5.8 ptm -161.02 47.61 0.21 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.574 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.53 -49.22 1.33 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.58 -3.53 49.96 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.714 -1.231 . . . . 0.0 111.241 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.46 -81.18 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.371 -1.664 . . . . 0.0 108.384 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -88.87 -26.24 21.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.947 -1.095 . . . . 0.0 109.49 178.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.59 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -57.31 -42.29 93.49 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -46.66 80.45 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.324 -1.104 . . . . 0.0 108.496 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.432 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 1.3 m-20 -66.3 -28.24 68.54 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.651 ' CD2' ' CE1' ' A' ' 60' ' ' HIS . 6.4 tt -61.03 -45.33 95.24 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.462 ' OG1' ' O ' ' A' ' 60' ' ' HIS . 1.5 m -59.68 -44.5 93.6 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.52 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 8.7 tm0? -50.98 -27.36 7.53 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.555 ' O ' HG21 ' A' ' 78' ' ' VAL . . . -81.17 -32.29 33.67 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.207 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' ALA . 4.4 t-105 -50.01 -29.14 8.08 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.488 ' HB2' HG11 ' A' ' 131' ' ' VAL . . . -85.24 -38.96 18.31 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.639 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.607 ' CG2' ' CZ ' ' A' ' 112' ' ' PHE . 3.3 m -63.71 -30.71 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 120.745 -1.222 . . . . 0.0 109.011 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.491 ' N ' HG21 ' A' ' 78' ' ' VAL . . . -81.77 -53.65 6.02 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.475 ' HG2' ' HG ' ' A' ' 134' ' ' LEU . 4.9 tpt -49.23 -29.32 5.55 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 125' ' ' ALA . . . -60.78 -45.05 95.87 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.483 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 3.3 mt -110.87 16.0 21.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.47 -0.769 . . . . 0.0 110.055 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.75 30.23 6.58 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.483 ' CG1' ' HB2' ' A' ' 82' ' ' LEU . 36.0 m -89.39 -5.32 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -1.178 . . . . 0.0 110.551 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -42.85 -61.24 1.32 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.107 -0.996 . . . . 0.0 109.607 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -43.2 -33.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 115' ' ' ALA . 4.4 mtpt -83.29 -50.7 8.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.298 -0.876 . . . . 0.0 111.214 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.1 m -82.4 -5.83 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.711 -1.243 . . . . 0.0 110.681 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.621 ' CG2' ' CZ ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -77.92 -45.51 23.84 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.302 178.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.473 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 2.1 t -51.8 -52.84 57.25 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.75 -1.219 . . . . 0.0 110.406 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.425 ' CD ' ' N ' ' A' ' 90' ' ' VAL . 25.5 Cg_endo -73.28 -17.36 24.31 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 N-CA-C 109.645 -0.944 . . . . 0.0 109.645 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.541 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 13.6 mt -86.48 -44.92 11.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.621 ' CZ ' ' CG2' ' A' ' 89' ' ' THR . 7.1 m-30 -61.51 -47.65 84.64 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.916 -1.115 . . . . 0.0 108.772 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 90' ' ' VAL . 13.0 pt-20 -71.7 -16.7 62.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.111 -0.993 . . . . 0.0 109.641 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.434 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -79.05 -32.32 40.07 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.598 HG13 ' CG ' ' A' ' 29' ' ' PHE . 1.7 t -106.79 0.54 10.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.997 -1.296 . . . . 0.0 110.026 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.472 ' OE1' ' HB3' ' A' ' 93' ' ' PHE . 0.7 OUTLIER -106.93 6.17 28.98 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 120.769 -1.207 . . . . 0.0 110.679 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.556 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER 177.28 76.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.734 -1.229 . . . . 0.0 109.074 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.556 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 161.41 -48.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.3 OUTLIER 71.74 18.6 5.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.346 -0.846 . . . . 0.0 110.48 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.439 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 2.8 t -80.07 -4.47 52.9 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.532 ' CB ' HG23 ' A' ' 96' ' ' VAL . 4.6 mm -97.91 81.78 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.809 -0.557 . . . . 0.0 109.609 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -142.31 32.66 1.51 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.933 -1.105 . . . . 0.0 109.601 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 107' ' ' ASP . 4.0 p -158.38 134.87 9.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.068 -1.02 . . . . 0.0 109.749 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.529 ' HA ' ' CD1' ' A' ' 108' ' ' ILE . . . -49.95 -39.83 41.84 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.46 ' OG ' ' OG ' ' A' ' 104' ' ' SER . 97.5 p -56.38 -31.73 64.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.1 OUTLIER -71.63 -51.02 25.36 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.58 ' CD1' HD21 ' A' ' 68' ' ' LEU . 22.5 mt -45.5 -29.92 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 0.0 108.984 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -78.61 -37.84 41.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.177 -0.952 . . . . 0.0 109.553 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -58.92 -46.14 88.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.541 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 13.2 t -68.94 -38.81 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.607 ' CZ ' ' CG2' ' A' ' 78' ' ' VAL . 0.4 OUTLIER -61.19 -42.35 98.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.568 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mt -69.81 -25.5 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.165 -0.959 . . . . 0.0 109.669 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -64.07 -16.73 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.678 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.447 ' O ' ' HE2' ' A' ' 87' ' ' LYS . . . -96.04 11.89 32.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 109.649 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.65 -5.26 85.24 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.519 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -80.69 56.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -1.106 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 117' ' ' ILE . 59.8 mttt -37.68 153.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.789 . . . . 0.0 110.153 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -47.9 -27.12 4.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -58.59 -46.98 85.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.878 -1.366 . . . . 0.0 109.473 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -77.96 -50.94 11.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.849 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.575 ' C ' ' CD1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -62.61 -58.27 8.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.978 . . . . 0.0 108.954 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 62.8 t0 -50.09 -48.93 52.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.038 -1.039 . . . . 0.0 109.292 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.32 81.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.304 -0.872 . . . . 0.0 109.43 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.54 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -56.41 -49.5 74.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.293 -0.88 . . . . 0.0 108.951 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.55 ' HA ' ' CG1' ' A' ' 131' ' ' VAL . 6.0 t90 -54.85 -56.46 19.25 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -15.13 62.02 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.595 -0.69 . . . . 0.0 110.016 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 125' ' ' ALA . 16.8 p -71.56 179.72 2.91 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.013 -1.054 . . . . 0.0 110.095 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -90.42 -33.63 15.94 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.83 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.5 t -64.34 -36.96 78.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 C-N-CA 118.124 -1.43 . . . . 0.0 109.878 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 126' ' ' TRP . 16.5 t -64.16 -38.73 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.878 -1.139 . . . . 0.0 108.941 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -66.6 -34.54 78.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 108.992 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.34 -33.15 75.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.278 -0.889 . . . . 0.0 109.399 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.475 ' HG ' ' HG2' ' A' ' 80' ' ' MET . 1.8 mm? -79.54 -26.55 41.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 108.846 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.457 HG21 ' HB1' ' A' ' 77' ' ' ALA . 6.0 t -79.11 -39.02 20.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.53 -49.15 61.75 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.443 -0.786 . . . . 0.0 109.184 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.467 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -61.73 -35.35 77.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.204 -0.935 . . . . 0.0 109.159 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.606 ' CG ' ' CD1' ' A' ' 59' ' ' TYR . 18.0 tm0? -62.78 -62.38 1.77 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.224 -0.922 . . . . 0.0 109.195 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -46.77 -35.61 6.38 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -30.86 67.38 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.554 ' CB ' ' CD2' ' A' ' 59' ' ' TYR . . . -60.74 -47.74 84.95 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.354 -0.841 . . . . 0.0 108.915 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -73.07 -39.83 65.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.411 -0.805 . . . . 0.0 110.236 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.62 -16.9 59.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.973 -1.079 . . . . 0.0 109.824 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.447 ' HB3' HG23 ' A' ' 16' ' ' VAL . 9.1 m-20 -82.06 -44.95 15.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.057 -1.027 . . . . 0.0 108.592 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.544 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 17.6 m -100.08 -8.36 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.346 -0.846 . . . . 0.0 108.927 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.544 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 12.2 tp60 80.95 -42.15 0.18 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.461 -0.774 . . . . 0.0 110.113 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.502 ' CD2' ' CD1' ' A' ' 25' ' ' PHE . 20.1 tp 62.11 140.19 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.288 -0.882 . . . . 0.0 108.981 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.54 31.26 0.23 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.613 -1.304 . . . . 0.0 110.106 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 152' ' ' ALA . . . 157.22 98.8 0.15 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.523 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.553 HG12 ' CD2' ' A' ' 63' ' ' PHE . 0.8 OUTLIER -92.51 138.37 23.99 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.457 ' HG3' ' HB3' ' A' ' 32' ' ' HIS . 31.6 Cg_endo -71.75 155.83 97.63 Favored 'Cis proline' 0 C--N 1.316 -1.163 0 C-N-CA 124.157 -1.185 . . . . 0.0 111.753 2.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 149' ' ' GLY . . . -146.91 151.09 36.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.805 -1.185 . . . . 0.0 108.525 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.501 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -128.49 118.31 22.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.901 -1.124 . . . . 0.0 110.022 -179.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.565 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 57.8 m-85 -114.42 142.39 46.42 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.512 ' N ' ' O ' ' A' ' 159' ' ' TYR . 30.6 t -124.08 124.62 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.989 -1.07 . . . . 0.0 108.947 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.444 ' C ' ' HB2' ' A' ' 19' ' ' ALA . 1.3 m-80 56.14 22.89 6.41 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.187 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.501 ' N ' ' HB2' ' A' ' 19' ' ' ALA . . . 52.96 22.76 13.26 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.705 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.505 ' O ' ' CG2' ' A' ' 11' ' ' THR . 0.0 OUTLIER -134.58 -11.35 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.752 -1.44 . . . . 0.0 109.738 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.581 ' CZ ' ' HD2' ' A' ' 188' ' ' LYS . 99.5 m-85 -144.22 124.46 13.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.021 -1.05 . . . . 0.0 108.749 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.565 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 2.3 pt20 -133.31 129.39 37.48 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.965 -1.084 . . . . 0.0 110.157 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.565 HD13 ' CE1' ' A' ' 178' ' ' TYR . 17.1 mt -61.27 168.58 2.56 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.67 150.68 44.23 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.084 -1.01 . . . . 0.0 109.786 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 166' ' ' MET . 36.0 Cg_endo -78.19 -9.53 16.48 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.683 2.255 . . . . 0.0 110.546 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 48.67 23.63 0.67 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.0 109.509 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 93.23 -23.12 31.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -176.64 -71.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.376 -1.073 . . . . 0.0 109.237 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.0 t0 48.06 24.47 0.64 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.468 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 168' ' ' THR . 0.2 OUTLIER -117.25 41.16 2.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.285 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.28 -1.53 45.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.495 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -156.4 95.74 1.6 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.158 -0.964 . . . . 0.0 108.894 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 2.0 mtp -56.47 -18.85 12.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.177 -0.952 . . . . 0.0 109.398 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.48 -65.05 0.94 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.428 HG12 ' HG2' ' A' ' 177' ' ' GLN . 20.1 t -70.15 -23.48 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.294 -0.879 . . . . 0.0 109.058 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -68.53 -39.87 80.98 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -0.909 . . . . 0.0 109.241 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.3 t -76.44 -32.3 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -74.97 -52.34 11.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 109.445 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.428 ' HG2' HG12 ' A' ' 173' ' ' VAL . 40.6 mm-40 -58.62 -40.44 83.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.437 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.565 ' CE1' HD13 ' A' ' 161' ' ' LEU . 10.0 t80 -61.13 -50.82 71.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.132 -0.98 . . . . 0.0 109.231 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.496 ' O ' ' NZ ' ' A' ' 183' ' ' LYS . . . -64.12 -24.37 67.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.988 -1.07 . . . . 0.0 108.839 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -77.43 -40.92 41.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 0.0 108.986 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.525 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -58.61 -54.83 42.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 109.056 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.414 ' HA ' ' HG ' ' A' ' 185' ' ' LEU . 93.3 t -61.06 -36.85 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 109.607 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.496 ' NZ ' ' O ' ' A' ' 179' ' ' ALA . 0.0 OUTLIER -53.55 -44.47 69.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 109.217 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -84.42 -25.47 28.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.358 -0.839 . . . . 0.0 110.07 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 181' ' ' THR . 1.1 mt -62.17 -23.45 66.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.446 -1.409 . . . . 0.0 108.435 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.8 t -75.57 -4.39 39.7 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.991 -1.068 . . . . 0.0 108.365 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -104.57 0.87 29.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.828 . . . . 0.0 109.452 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.581 ' HD2' ' CZ ' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -61.52 -37.05 82.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.218 -0.926 . . . . 0.0 109.72 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.418 ' CG ' ' O ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.481 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.407 ' HB2' ' HE3' ' A' ' 7' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.372 0.606 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.543 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 5.7 tt0 -123.02 65.85 0.98 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.246 -0.909 . . . . 0.0 109.087 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.543 ' CG ' ' C ' ' A' ' 2' ' ' GLN . 0.6 OUTLIER 73.1 88.93 0.1 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.344 -0.848 . . . . 0.0 108.899 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 5' ' ' ASP . 5.6 pm0 -133.18 64.65 1.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.163 -0.96 . . . . 0.0 109.976 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.488 ' HB3' ' O ' ' A' ' 4' ' ' GLU . 19.6 t70 71.16 93.5 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.518 -0.738 . . . . 0.0 110.759 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.57 3.79 90.38 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.586 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -101.91 28.41 5.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.962 -1.316 . . . . 0.0 108.937 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.586 ' CB ' ' O ' ' A' ' 7' ' ' LYS . 2.9 mm-40 144.54 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.582 ' CG ' ' O ' ' A' ' 9' ' ' TYR . 2.2 p90 -141.89 114.21 8.25 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.054 0.93 . . . . 0.0 109.015 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.506 HG21 ' CG ' ' A' ' 160' ' ' GLN . 15.2 t -100.32 -179.19 4.04 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.2 m -111.6 143.72 42.02 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.899 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.447 HD23 ' HB3' ' A' ' 160' ' ' GLN . 0.2 OUTLIER -96.16 163.95 12.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.376 -0.828 . . . . 0.0 109.549 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.439 ' HG2' ' HG2' ' A' ' 14' ' ' LYS . 1.6 pt-20 -87.52 -15.83 36.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.691 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.439 ' HG2' ' HG2' ' A' ' 13' ' ' GLU . 3.3 mmtp -112.56 97.51 40.75 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.148 -0.97 . . . . 0.0 109.849 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' O ' HG21 ' A' ' 16' ' ' VAL . 34.9 Cg_endo -77.23 158.92 33.48 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.467 2.111 . . . . 0.0 109.863 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.492 HG13 ' CB ' ' A' ' 19' ' ' ALA . 15.8 t -140.52 83.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.099 -1.001 . . . . 0.0 109.761 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.12 129.7 18.1 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.63 -19.73 52.95 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.516 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -41.9 164.61 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.41 -1.053 . . . . 0.0 109.556 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.559 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 34.7 Cg_endo -76.43 126.82 9.31 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.573 2.182 . . . . 0.0 110.955 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.535 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 4.3 mt-30 -40.01 -24.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.558 -0.714 . . . . 0.0 110.421 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.513 ' N ' ' O ' ' A' ' 20' ' ' PRO . 59.1 t -149.09 79.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.764 -1.21 . . . . 0.0 109.044 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.566 HD12 ' CZ ' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -73.98 112.79 10.45 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.546 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -94.23 149.19 21.47 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.778 -178.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.58 ' CD1' HD21 ' A' ' 147' ' ' LEU . 7.6 m-85 -135.13 103.46 5.55 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.483 -0.76 . . . . 0.0 109.267 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.451 ' HA ' HG13 ' A' ' 150' ' ' VAL . 5.7 p90 -148.42 140.64 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 109.891 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.584 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 0.0 OUTLIER -118.16 179.45 4.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.09 179.345 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 7.1 m-30 -90.33 40.44 1.01 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.593 ' CG ' HG12 ' A' ' 96' ' ' VAL . 11.0 m-85 -137.91 16.82 2.85 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -113.8 164.81 14.96 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.544 -1.348 . . . . 0.0 109.878 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.74 -41.08 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.463 2.109 . . . . 0.0 108.092 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.588 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 9.6 m170 -75.34 -23.53 57.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 12.3 t -43.94 -57.71 3.17 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.438 ' HB2' ' CD ' ' A' ' 97' ' ' GLN . 89.4 t80 -71.48 -55.06 8.6 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.182 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.439 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 12.5 mt-30 -54.88 -16.96 3.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.228 -0.92 . . . . 0.0 110.527 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.588 ' CE1' ' HB3' ' A' ' 32' ' ' HIS . 4.0 m-30 -86.4 -38.96 16.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.08 -1.013 . . . . 0.0 110.831 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.02 -13.1 20.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.782 -1.199 . . . . 0.0 112.206 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -136.27 28.51 3.09 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.17 -1.581 . . . . 0.0 111.418 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 35' ' ' GLN . 91.1 t -151.56 -88.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.394 -1.441 . . . . 0.0 110.138 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 1.4 mt -68.99 -19.49 64.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.95 . . . . 0.0 109.747 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.44 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 2.4 m-70 60.06 18.85 8.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.005 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.435 HD11 ' HB2' ' A' ' 40' ' ' LEU . 1.4 mt -46.98 -36.42 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.479 -0.763 . . . . 0.0 109.44 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.474 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -80.48 -34.34 35.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.991 . . . . 0.0 110.115 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.463 ' HA ' ' HG3' ' A' ' 47' ' ' LYS . 15.5 m-20 -82.7 -36.87 25.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.099 -1.001 . . . . 0.0 109.625 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -58.31 -34.21 70.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.84 . . . . 0.0 110.184 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.497 HG22 ' CE ' ' A' ' 56' ' ' MET . 31.5 m -65.92 -31.98 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.033 -1.042 . . . . 0.0 110.021 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.492 ' N ' HG21 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -54.51 -44.89 73.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.976 -1.078 . . . . 0.0 109.461 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -44.28 -28.34 0.52 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.119 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.451 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 10.1 mtmm -112.7 44.5 1.47 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.842 . . . . 0.0 109.24 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.54 ' CD2' ' CG1' ' A' ' 54' ' ' VAL . 11.0 mt -115.87 79.35 7.9 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.165 -0.96 . . . . 0.0 109.945 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.459 ' HD2' HG22 ' A' ' 54' ' ' VAL . 35.3 Cg_endo -78.33 143.26 19.55 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.615 2.21 . . . . 0.0 110.119 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -39.45 120.77 1.1 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.312 1.054 . . . . 0.0 109.908 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.78 -26.74 5.06 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.54 ' CG1' ' CD2' ' A' ' 50' ' ' LEU . 98.1 t -89.71 85.37 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -1.192 . . . . 0.0 109.296 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.96 93.25 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.779 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.497 ' CE ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -92.73 101.44 13.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.833 . . . . 0.0 109.437 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 4.9 m -111.45 134.09 53.27 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.11 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.546 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -114.13 109.2 18.05 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.27 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.48 ' OH ' ' HB3' ' A' ' 137' ' ' GLN . 4.5 m-85 -106.55 177.85 4.73 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.954 -1.092 . . . . 0.0 111.623 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.584 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 49.4 t-80 -111.85 132.62 54.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.735 0.779 . . . . 0.0 108.977 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.555 ' CG1' ' CG1' ' A' ' 150' ' ' VAL . 3.0 m -72.36 156.68 6.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.416 0.627 . . . . 0.0 110.598 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.481 ' ND2' ' HE3' ' A' ' 70' ' ' LYS . 14.0 t30 -118.56 51.19 1.11 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.628 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -155.86 61.17 0.59 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.731 -1.23 . . . . 0.0 110.106 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.509 ' HE2' ' CG2' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -144.92 43.37 1.34 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.958 -1.089 . . . . 0.0 109.488 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.47 -36.17 0.55 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.94 -43.07 3.13 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -88.7 -79.0 0.32 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.169 . . . . 0.0 110.109 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.588 ' CD1' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -78.0 -21.87 50.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.092 -1.005 . . . . 0.0 109.205 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.588 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -53.51 -42.83 66.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HE3' ' ND2' ' A' ' 62' ' ' ASN . 2.1 tttt -68.78 -54.76 14.03 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.16 -1.2 . . . . 0.0 108.362 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.549 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 8.2 t70 -56.12 -25.18 44.89 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.548 ' CD2' ' NE2' ' A' ' 60' ' ' HIS . 44.4 tp -65.4 -39.68 92.5 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 m -59.48 -41.94 90.93 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.467 ' OE1' ' OH ' ' A' ' 122' ' ' TYR . 0.4 OUTLIER -60.13 -22.63 63.07 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -66.23 -40.06 90.01 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 46.7 t-105 -64.4 -31.58 72.84 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.41 ' HB2' HG21 ' A' ' 135' ' ' VAL . . . -84.39 -68.14 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.725 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.555 ' CG1' ' CD1' ' A' ' 122' ' ' TYR . 95.7 t -43.98 -26.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 109.761 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.489 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -82.93 -58.62 2.79 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.085 -1.009 . . . . 0.0 108.717 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.28 -27.38 2.46 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -70.84 -43.15 69.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.483 -0.761 . . . . 0.0 109.447 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.468 ' HB2' HG11 ' A' ' 84' ' ' VAL . 23.0 mt -107.12 14.59 26.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 48.39 24.84 3.98 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.521 ' CG1' HD13 ' A' ' 117' ' ' ILE . 35.2 m -83.67 -9.92 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.408 -1.054 . . . . 0.0 110.397 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.469 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.3 OUTLIER -42.73 -63.4 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.137 -0.977 . . . . 0.0 109.37 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.96 -34.68 1.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.458 -0.776 . . . . 0.0 110.601 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -79.72 -53.18 7.06 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.186 -0.947 . . . . 0.0 111.741 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.566 HG23 ' CE1' ' A' ' 112' ' ' PHE . 2.9 m -84.7 -8.42 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.717 -1.239 . . . . 0.0 110.705 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.613 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -72.88 -44.5 61.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.593 -1.317 . . . . 0.0 108.596 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -53.64 -54.13 49.48 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.467 -1.396 . . . . 0.0 110.817 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.438 ' HD2' ' C ' ' A' ' 88' ' ' VAL . 25.0 Cg_endo -72.99 -18.65 23.96 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 N-CA-C 109.82 -0.877 . . . . 0.0 109.82 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.503 ' CG ' ' O ' ' A' ' 88' ' ' VAL . 28.8 mt -87.22 -42.63 12.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.043 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.613 ' CG ' HG21 ' A' ' 89' ' ' THR . 5.2 m-30 -63.78 -46.68 84.11 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.003 -1.06 . . . . 0.0 108.856 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -23.05 61.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.209 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.49 -33.39 61.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.593 HG12 ' CG ' ' A' ' 29' ' ' PHE . 2.3 t -102.32 -1.74 9.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.095 -1.238 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -110.37 8.71 23.42 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 120.956 -1.09 . . . . 0.0 110.543 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.56 ' O ' ' CG2' ' A' ' 99' ' ' THR . 2.4 mttp -179.91 64.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.634 -1.291 . . . . 0.0 109.277 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.56 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 169.0 -50.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 99' ' ' THR . 8.1 mp0 73.96 16.55 3.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.423 -0.798 . . . . 0.0 110.743 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 t -79.74 -9.05 59.6 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.517 ' CB ' HG23 ' A' ' 96' ' ' VAL . 9.0 mm -85.49 78.69 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.78 32.54 2.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.151 -0.968 . . . . 0.0 109.833 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 107' ' ' ASP . 24.1 p -157.96 132.0 8.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.994 -1.066 . . . . 0.0 110.208 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -51.2 -29.54 14.4 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -30.74 71.79 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.5 OUTLIER -70.61 -48.86 53.01 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.572 ' CD1' HD21 ' A' ' 68' ' ' LEU . 18.9 mt -53.53 -27.06 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -75.93 -39.79 55.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.808 . . . . 0.0 109.817 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.467 ' OD2' ' O ' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -62.49 -41.55 98.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.086 -1.009 . . . . 0.0 109.53 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.475 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 1.5 t -72.15 -39.35 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.108 -0.995 . . . . 0.0 109.352 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.566 ' CE1' HG23 ' A' ' 88' ' ' VAL . 2.7 m-30 -63.93 -48.41 76.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.863 . . . . 0.0 110.031 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.1 mt -66.68 -25.41 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.986 . . . . 0.0 109.64 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -67.8 -17.54 64.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 0.0 109.816 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.464 ' HB3' HG11 ' A' ' 88' ' ' VAL . . . -90.52 7.03 41.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.637 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.53 2.6 82.12 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.521 HD13 ' CG1' ' A' ' 84' ' ' VAL . 3.0 mm -79.14 59.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.313 -1.11 . . . . 0.0 109.692 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 117' ' ' ILE . 5.3 mmtt -34.86 132.02 0.35 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.323 -0.861 . . . . 0.0 110.319 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 118' ' ' LYS . . . -40.76 -33.79 0.67 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -59.23 -43.14 92.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -1.18 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 118' ' ' LYS . 20.9 mt-10 -75.29 -43.64 50.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.615 ' C ' ' CD1' ' A' ' 122' ' ' TYR . 0.1 OUTLIER -67.65 -61.97 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.213 -0.929 . . . . 0.0 108.976 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 122' ' ' TYR . 11.4 t0 -47.19 -42.71 20.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.0 108.731 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.72 -45.93 80.84 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.333 -0.854 . . . . 0.0 109.017 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -54.21 -49.05 70.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.435 -0.79 . . . . 0.0 109.146 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.502 ' CD1' ' C ' ' A' ' 126' ' ' TRP . 7.2 t90 -59.81 -54.53 45.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 0.0 108.496 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.07 -15.31 3.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.588 -0.695 . . . . 0.0 110.15 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 32.6 m -70.3 178.04 3.05 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.988 -1.07 . . . . 0.0 110.431 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 -37.67 13.23 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.362 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.65 -46.84 79.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.248 -1.381 . . . . 0.0 109.678 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 5.2 t -63.77 -32.63 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.872 -1.143 . . . . 0.0 108.519 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -71.56 -36.4 70.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 108.84 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -36.49 83.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.388 -0.82 . . . . 0.0 109.156 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.15 -24.72 40.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -0.891 . . . . 0.0 108.661 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 131' ' ' VAL . 17.6 t -73.97 -41.93 52.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.55 -52.87 55.44 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.48 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -54.8 -27.3 40.73 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.043 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.432 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -67.83 -65.3 0.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 2.9 tt0 -51.79 -37.28 50.91 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.438 ' O ' ' HB3' ' A' ' 144' ' ' ASP . 1.3 mtmt -64.39 -30.77 71.8 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.463 ' O ' ' OD2' ' A' ' 144' ' ' ASP . . . -66.01 -60.29 2.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.453 -0.78 . . . . 0.0 109.052 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.554 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -71.78 -23.11 61.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.898 . . . . 0.0 109.823 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -83.35 -26.5 30.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.038 -1.039 . . . . 0.0 110.325 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.522 ' OD1' ' CG1' ' A' ' 145' ' ' VAL . 1.3 p30 -81.56 -44.03 17.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.901 -1.124 . . . . 0.0 108.595 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.538 ' CG2' ' CE2' ' A' ' 25' ' ' PHE . 16.0 m -96.39 -10.68 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.879 . . . . 0.0 108.731 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.554 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.0 tt0 78.18 -49.48 0.48 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.447 -0.783 . . . . 0.0 110.26 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.58 HD21 ' CD1' ' A' ' 25' ' ' PHE . 16.2 tp 65.2 133.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 0.0 109.4 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -160.89 40.44 0.16 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.579 -1.326 . . . . 0.0 109.879 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.67 107.43 0.21 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.464 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.555 ' CG1' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.0 144.71 29.62 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.353 -1.086 . . . . 0.0 109.442 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.04 152.4 91.8 Favored 'Cis proline' 0 C--N 1.316 -1.138 0 C-N-CA 124.041 -1.233 . . . . 0.0 110.466 0.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . . . -128.75 156.03 44.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.393 -1.442 . . . . 0.0 109.364 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -150.87 133.76 15.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 109.682 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.521 ' N ' ' CD1' ' A' ' 154' ' ' PHE . 4.3 m-85 -132.41 125.65 31.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.373 -0.829 . . . . 0.0 109.913 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 73.5 t -96.94 132.12 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.926 . . . . 0.0 110.153 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 47.75 20.88 0.23 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.913 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.516 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 57.87 55.09 32.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -164.45 -39.96 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.205 -1.174 . . . . 0.0 108.121 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -110.86 124.09 51.38 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.749 -0.78 . . . . 0.0 108.948 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.516 ' HA ' ' O ' ' A' ' 153' ' ' MET . 15.4 pt20 -120.79 127.29 51.82 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.966 -1.084 . . . . 0.0 109.912 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 153' ' ' MET . 19.7 mt -64.5 174.12 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -156.09 76.62 4.63 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 109.716 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.07 -18.5 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.752 2.301 . . . . 0.0 110.711 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -14.51 18.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.898 . . . . 0.0 109.716 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -113.58 38.64 3.12 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.458 ' O ' ' C ' ' A' ' 167' ' ' ASP . 0.6 OUTLIER -106.24 -77.02 0.6 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -1.179 . . . . 0.0 109.637 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' A' ' 166' ' ' MET . 10.4 t0 40.94 33.37 0.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.253 -0.904 . . . . 0.0 109.734 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.428 ' O ' ' CB ' ' A' ' 169' ' ' SER . 7.6 t -68.88 -7.12 31.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 109.667 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' A' ' 168' ' ' THR . 0.7 OUTLIER 69.81 40.47 1.31 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.383 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -159.73 93.5 1.09 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.24 -0.913 . . . . 0.0 109.181 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.8 mtp -59.74 -15.59 21.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 109.735 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -55.09 8.55 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.681 -0.637 . . . . 0.0 109.657 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.447 HG12 ' HG3' ' A' ' 177' ' ' GLN . 14.1 t -70.35 -28.59 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.121 -0.987 . . . . 0.0 109.533 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.453 ' CD1' ' O ' ' A' ' 174' ' ' PHE . 2.5 t80 -67.46 -46.04 74.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.032 -1.043 . . . . 0.0 109.437 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.466 ' O ' HG11 ' A' ' 175' ' ' VAL . 82.6 t -74.74 -24.27 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 1.4 mt-30 -81.81 -52.74 6.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.511 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.518 ' HB3' ' NE2' ' A' ' 8' ' ' GLN . 41.4 mt-30 -63.85 -32.3 73.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.192 -0.943 . . . . 0.0 109.569 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.481 ' O ' ' OG1' ' A' ' 181' ' ' THR . 17.8 t80 -74.11 -58.38 3.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.004 . . . . 0.0 109.429 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.35 -33.06 67.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.946 -1.096 . . . . 0.0 108.44 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 33.2 t0 -71.31 -42.61 68.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.493 -0.754 . . . . 0.0 109.342 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.527 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 0.6 OUTLIER -55.09 -57.07 13.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.093 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.454 HG12 ' CE ' ' A' ' 153' ' ' MET . 2.3 t -57.12 -35.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.823 -1.173 . . . . 0.0 109.71 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -48.33 82.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.967 . . . . 0.0 109.903 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.26 -21.2 39.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.96 -1.088 . . . . 0.0 110.337 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 181' ' ' THR . 68.6 mt -73.66 -18.54 61.01 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.744 -1.222 . . . . 0.0 109.002 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.5 m -74.14 -4.47 35.92 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.66 5.1 30.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.526 -0.733 . . . . 0.0 109.805 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -73.11 -5.89 42.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.957 -1.089 . . . . 0.0 109.709 -179.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.479 ' CG ' ' C ' ' A' ' 188' ' ' LYS . 4.5 pttt . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.04 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.21 0.529 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.473 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 95.4 mt-30 -91.48 54.22 2.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -153.58 85.04 1.18 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 5' ' ' ASP . 12.5 mt-10 -114.07 56.96 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.127 -0.983 . . . . 0.0 110.42 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER 42.61 82.19 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.511 -0.743 . . . . 0.0 110.359 179.063 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.81 -24.63 6.02 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.723 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -82.15 -68.31 0.71 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.0 -1.294 . . . . 0.0 109.178 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.607 ' NE2' ' CD1' ' A' ' 9' ' ' TYR . 2.1 pp0? -95.23 -1.92 50.64 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.607 ' CD1' ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER 179.64 130.45 0.09 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.873 -1.142 . . . . 0.0 109.721 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.2 t -112.87 179.95 3.82 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 158' ' ' LYS . 59.2 m -127.87 143.82 51.1 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.456 0.645 . . . . 0.0 109.581 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.456 HD21 ' HG2' ' A' ' 160' ' ' GLN . 0.2 OUTLIER -100.69 156.17 17.48 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.399 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -93.63 0.54 56.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.492 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 4.2 mtmt -124.88 89.41 52.58 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.283 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.03 166.55 26.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.608 2.206 . . . . 0.0 110.111 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.578 ' CG1' ' CB ' ' A' ' 19' ' ' ALA . 7.2 p -120.78 109.22 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -0.975 . . . . 0.0 110.264 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.38 125.24 4.54 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.491 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 91.53 -10.63 74.28 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.578 ' CB ' ' CG1' ' A' ' 16' ' ' VAL . . . -33.87 148.11 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.787 -0.831 . . . . 0.0 109.906 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.561 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.4 Cg_endo -81.21 133.72 8.84 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.472 2.115 . . . . 0.0 111.383 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.518 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 1.5 mm-40 -51.11 -21.81 2.13 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 56' ' ' MET . 24.1 t -151.12 89.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 108.975 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.641 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -80.43 128.74 33.92 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.53 ' N ' HD21 ' A' ' 23' ' ' LEU . 8.7 tt0 -113.48 96.59 5.96 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.92 -1.113 . . . . 0.0 109.729 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.641 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 4.4 m-85 -84.76 115.71 22.85 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.448 -0.782 . . . . 0.0 109.458 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.538 ' CE1' ' OE1' ' A' ' 37' ' ' GLU . 2.6 p90 -160.35 142.01 12.54 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.268 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.572 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 94.0 p -125.64 -172.72 2.66 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.624 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -109.3 49.3 0.83 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.675 -1.266 . . . . 0.0 108.472 178.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 72' ' ' LEU . 7.1 m-85 -133.78 -3.92 2.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.592 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 4.5 m -109.41 173.23 3.06 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.203 . . . . 0.0 108.586 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.592 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.3 Cg_endo -76.19 -58.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.752 1.635 . . . . 0.0 109.316 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.498 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 69.5 m-70 -63.37 -20.09 65.22 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -52.58 -53.89 40.33 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.582 0.706 . . . . 0.0 109.286 179.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 8.8 t80 -80.49 -37.46 31.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.575 -0.703 . . . . 0.0 109.884 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.458 ' HA ' HG22 ' A' ' 39' ' ' VAL . 35.6 mm-40 -66.09 -26.07 67.31 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.184 -0.948 . . . . 0.0 109.954 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -70.66 -39.52 73.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.054 -1.029 . . . . 0.0 109.578 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.538 ' OE1' ' CE1' ' A' ' 26' ' ' PHE . 1.2 mt-10 -98.15 -10.06 24.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 0.0 111.898 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -138.3 27.69 2.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.266 -1.521 . . . . 0.0 111.819 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.508 ' O ' ' CD2' ' A' ' 41' ' ' HIS . 64.9 t -151.45 -83.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.432 -1.418 . . . . 0.0 110.026 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 171' ' ' MET . 18.0 mt -65.14 -14.33 60.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.868 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 23.1 m-70 56.57 18.37 3.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.187 -0.946 . . . . 0.0 109.146 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.9 mt -55.39 -18.59 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.5 m -82.63 -54.38 5.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.023 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -86.77 -33.0 20.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.72 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 41' ' ' HIS . 10.4 t-20 -51.68 -27.23 11.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.838 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.467 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 31.4 t -81.21 -17.2 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.302 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.532 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 1.7 mttm -76.11 -17.93 59.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.813 -1.179 . . . . 0.0 110.074 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -64.46 -16.24 62.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 109.615 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -143.59 36.23 1.31 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.532 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 5.2 mt -91.94 142.9 26.95 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.954 -1.091 . . . . 0.0 109.595 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HD2' HD22 ' A' ' 50' ' ' LEU . 35.8 Cg_endo -78.03 149.88 25.99 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.689 2.259 . . . . 0.0 110.051 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -79.09 21.38 0.45 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.93 -1.106 . . . . 0.0 110.469 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.464 ' O ' HG21 ' A' ' 54' ' ' VAL . . . -124.46 32.74 4.01 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.475 HG23 ' CB ' ' A' ' 186' ' ' SER . 44.6 t -154.32 131.85 2.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.645 -0.915 . . . . 0.0 108.702 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.5 137.61 51.89 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.178 0.989 . . . . 0.0 109.961 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.5 ' O ' ' CG ' ' A' ' 56' ' ' MET . 3.3 ptm -107.04 98.96 8.55 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.39 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 24' ' ' GLU . 86.7 m -82.24 142.86 31.77 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.742 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -116.1 111.13 19.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.365 -0.834 . . . . 0.0 110.028 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.571 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 1.7 m-85 -113.44 158.24 20.92 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.173 -0.954 . . . . 0.0 110.864 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.638 ' CE1' ' CD2' ' A' ' 72' ' ' LEU . 17.9 t60 -99.94 124.69 45.53 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.553 HG22 ' CD1' ' A' ' 63' ' ' PHE . 1.3 m -69.85 144.95 13.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.598 -0.689 . . . . 0.0 110.166 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.526 ' HB2' ' CE ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -113.57 49.23 0.99 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.652 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 2.9 p90 -145.37 80.12 1.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.17 0.986 . . . . 0.0 110.048 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.566 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -159.91 -59.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.872 -1.143 . . . . 0.0 109.735 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.566 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -87.98 -28.07 24.38 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.448 ' O ' ' HG2' ' A' ' 70' ' ' LYS . . . 86.3 -49.17 4.04 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.19 -78.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.562 -0.964 . . . . 0.0 110.008 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.596 ' CD1' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -73.79 -22.62 59.76 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.855 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.596 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -55.53 -43.32 85.63 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 107.434 -2.266 . . . . 0.0 107.434 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.526 ' CE ' ' HB2' ' A' ' 62' ' ' ASN . 8.6 mmmt -63.71 -47.8 79.68 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.517 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 13.3 t0 -64.04 -28.38 69.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.638 ' CD2' ' CE1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -58.16 -38.5 76.74 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.473 ' OG1' ' HB3' ' A' ' 62' ' ' ASN . 6.7 m -66.24 -42.85 88.05 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.536 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 1.0 OUTLIER -60.99 -18.58 58.29 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 177.055 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.505 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -68.37 -47.49 67.28 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -58.99 -27.73 65.69 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.483 ' CB ' ' CG2' ' A' ' 135' ' ' VAL . . . -79.37 -52.46 8.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.432 -0.792 . . . . 0.0 109.967 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.551 HG22 ' CE1' ' A' ' 122' ' ' TYR . 39.2 t -60.77 -26.53 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.044 -1.035 . . . . 0.0 109.875 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.524 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -80.23 -63.43 1.41 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.038 -1.039 . . . . 0.0 109.003 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -45.9 -27.94 1.0 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.43 ' HB3' HG21 ' A' ' 131' ' ' VAL . . . -70.35 -46.15 64.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.437 -0.79 . . . . 0.0 109.463 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.448 ' HB2' HG23 ' A' ' 84' ' ' VAL . 21.6 mt -102.05 12.07 37.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.15 -0.969 . . . . 0.0 110.214 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 53.56 20.55 11.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 34.9 m -86.47 -7.93 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.431 -1.041 . . . . 0.0 110.669 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.456 ' C ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -40.82 -59.47 1.41 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.087 -1.008 . . . . 0.0 109.986 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.4 -34.19 10.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.449 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 mttt -82.74 -52.88 6.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.199 -0.938 . . . . 0.0 111.471 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -75.15 -6.81 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.633 -1.292 . . . . 0.0 110.505 -178.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.607 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -77.04 -44.77 29.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.948 -1.095 . . . . 0.0 108.513 178.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.44 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -52.32 -52.38 63.49 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.543 -1.348 . . . . 0.0 110.565 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.482 ' HG2' HG11 ' A' ' 111' ' ' VAL . 26.0 Cg_endo -73.68 -20.93 19.67 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 O-C-N 122.727 0.856 . . . . 0.0 110.022 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.521 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 13.1 mt -85.61 -41.9 14.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 108.967 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.624 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 5.6 m-30 -65.95 -45.71 80.81 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.071 -1.018 . . . . 0.0 108.862 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 90' ' ' VAL . 23.5 mt-10 -76.3 -26.75 56.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 109.556 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.413 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -65.56 -36.93 93.11 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.466 HG21 HG13 ' A' ' 102' ' ' ILE . 2.9 t -93.07 -12.78 8.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.151 -1.205 . . . . 0.0 108.594 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.467 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 1.3 mt-30 -104.98 4.12 31.39 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 121.103 -0.998 . . . . 0.0 111.051 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.541 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.0 OUTLIER -160.15 61.11 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.404 -1.435 . . . . 0.0 109.963 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.11 -49.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 74.27 15.2 3.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -0.989 . . . . 0.0 110.628 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -86.69 -4.29 59.16 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.732 0.777 . . . . 0.0 108.988 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.466 HG13 HG21 ' A' ' 96' ' ' VAL . 6.5 mm -80.57 77.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.75 35.13 1.79 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 110.074 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 107' ' ' ASP . 54.9 p -157.26 133.74 9.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.856 -1.152 . . . . 0.0 109.968 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.468 ' HA ' HD13 ' A' ' 108' ' ' ILE . . . -50.71 -35.7 32.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.484 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 75.7 m -59.19 -28.86 67.02 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -75.39 -50.78 14.84 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.557 ' CD1' HD21 ' A' ' 68' ' ' LEU . 21.9 mt -47.25 -31.34 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.086 -1.009 . . . . 0.0 109.421 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 106' ' ' SER . 1.3 ptm180 -78.99 -37.27 39.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.945 -1.097 . . . . 0.0 109.349 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -54.64 -46.06 73.88 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.153 -0.967 . . . . 0.0 108.929 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.522 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 70.4 t -69.95 -39.91 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -0.942 . . . . 0.0 109.227 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -59.6 -53.79 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.717 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.1 mt -60.21 -25.96 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.107 -0.996 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.47 -16.97 64.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.164 -0.96 . . . . 0.0 109.378 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.469 ' HB1' HD11 ' A' ' 117' ' ' ILE . . . -100.44 -7.14 24.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.544 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.76 -5.27 25.99 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.548 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 2.2 mp -78.42 52.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -1.158 . . . . 0.0 109.278 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 117' ' ' ILE . 38.3 mttp -36.2 157.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.318 -0.864 . . . . 0.0 110.555 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -59.82 -50.58 66.19 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 119' ' ' GLY . 21.1 tt0 -43.29 -55.19 4.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.03 -1.276 . . . . 0.0 109.929 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -63.98 -63.22 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.976 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.551 ' CE1' HG22 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -46.27 -60.94 2.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.135 -0.978 . . . . 0.0 109.239 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 122' ' ' TYR . 1.2 m-20 -44.54 -34.25 2.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.152 -0.968 . . . . 0.0 109.062 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -75.63 -44.36 43.13 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.353 -0.842 . . . . 0.0 109.23 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.523 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -59.02 -48.08 82.9 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.409 -0.807 . . . . 0.0 109.17 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.536 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 10.8 t90 -59.44 -53.23 60.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.404 -0.81 . . . . 0.0 108.957 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.94 -15.72 2.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.642 -0.661 . . . . 0.0 110.236 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.41 178.1 7.44 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.976 -1.078 . . . . 0.0 109.971 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.449 ' O ' ' OG ' ' A' ' 133' ' ' SER . 0.9 OUTLIER -91.45 -36.6 13.68 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.566 -179.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.6 t -64.27 -47.3 90.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.205 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 21.3 t -64.39 -39.84 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.109 -0.994 . . . . 0.0 108.481 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -29.1 67.42 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 129' ' ' PHE . 50.4 m -66.27 -34.39 77.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.842 . . . . 0.0 109.019 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -28.5 54.92 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.483 ' CG2' ' CB ' ' A' ' 77' ' ' ALA . 6.8 t -75.1 -36.34 37.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -67.66 -46.15 73.23 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.593 -0.692 . . . . 0.0 109.405 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.425 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -68.83 -23.64 64.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.428 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.571 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 4.7 mt-30 -72.49 -69.41 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.083 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.76 -35.05 21.02 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.427 ' O ' ' CG ' ' A' ' 144' ' ' ASP . 12.1 mtpt -75.94 -29.9 58.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.321 -0.862 . . . . 0.0 108.874 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 138' ' ' GLN . . . -57.34 -56.26 24.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.213 -0.93 . . . . 0.0 108.751 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -75.54 -32.89 60.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.925 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.21 -22.15 61.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 109.46 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 140' ' ' LYS . 73.7 m-20 -82.45 -47.36 12.34 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 11.3 m -88.55 -5.49 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 2.6 tp60 80.8 -50.36 0.31 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.587 -0.696 . . . . 0.0 109.543 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.466 HD12 ' CG ' ' A' ' 25' ' ' PHE . 13.1 tp 61.51 137.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.228 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -161.02 33.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.544 -1.347 . . . . 0.0 110.339 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 160.14 109.69 0.26 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 118.905 -1.617 . . . . 0.0 111.208 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.518 ' CG1' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -87.93 144.35 34.65 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.586 -0.949 . . . . 0.0 109.057 178.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.79 152.65 92.86 Favored 'Cis proline' 0 C--N 1.315 -1.222 0 C-N-CA 123.923 -1.282 . . . . 0.0 110.526 0.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.503 ' CB ' ' HB2' ' A' ' 25' ' ' PHE . . . -123.54 141.8 51.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.361 -1.462 . . . . 0.0 109.139 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 1.6 ttp -130.27 130.94 45.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.126 -0.984 . . . . 0.0 109.71 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.581 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 8.3 m-85 -133.73 131.44 39.41 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 12.2 t -105.32 125.57 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.753 -1.217 . . . . 0.0 108.618 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.451 ' C ' ' HB2' ' A' ' 19' ' ' ALA . 18.6 t-20 48.08 26.39 1.0 Allowed 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.901 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 52.17 25.27 17.76 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.208 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.451 ' O ' HG21 ' A' ' 11' ' ' THR . 10.0 tttm -124.9 -19.2 5.32 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.835 -1.391 . . . . 0.0 108.894 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.477 ' HB2' ' HE3' ' A' ' 188' ' ' LYS . 94.0 m-85 -141.66 125.08 16.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 108.92 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.581 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -128.79 134.78 48.49 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.877 -1.139 . . . . 0.0 109.632 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.514 HD13 ' CZ ' ' A' ' 178' ' ' TYR . 12.8 mt -68.02 177.14 2.3 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.627 -0.671 . . . . 0.0 109.287 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.64 82.7 5.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.888 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.86 50.28 3.22 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.666 2.244 . . . . 0.0 110.311 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.5 146.13 37.82 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.373 -0.829 . . . . 0.0 108.778 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.85 7.56 43.18 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -99.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.962 -1.316 . . . . 0.0 109.295 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 17.7 t0 60.64 35.38 19.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.84 -1.163 . . . . 0.0 109.709 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 169' ' ' SER . 17.2 p -69.57 -29.51 67.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.004 -1.06 . . . . 0.0 109.911 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 168' ' ' THR . 1.0 OUTLIER 77.68 38.93 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.333 -0.855 . . . . 0.0 109.26 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -153.35 80.59 1.18 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.524 ' HB3' ' CD2' ' A' ' 40' ' ' LEU . 3.8 mtm -58.69 -15.77 13.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.491 -0.756 . . . . 0.0 109.967 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.45 -50.82 14.62 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.696 -0.628 . . . . 0.0 109.341 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.5 t -74.69 -29.56 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' A' ' 178' ' ' TYR . 33.4 t80 -69.07 -36.2 77.36 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.947 -1.095 . . . . 0.0 108.614 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 171' ' ' MET . 24.3 t -74.34 -28.71 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.363 -0.836 . . . . 0.0 108.916 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -81.53 -58.39 3.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.053 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.72 -36.53 36.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.203 -0.936 . . . . 0.0 109.074 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.514 ' CZ ' HD13 ' A' ' 161' ' ' LEU . 18.9 t80 -69.44 -47.15 64.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.193 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.59 -22.42 66.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.15 -0.969 . . . . 0.0 108.978 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -79.09 -45.3 20.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 109.305 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.557 ' O ' ' CG ' ' A' ' 185' ' ' LEU . 6.5 m -63.11 -31.78 73.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -0.958 . . . . 0.0 109.317 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.491 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 52.0 t -77.39 -39.59 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.747 -1.22 . . . . 0.0 109.357 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -56.96 -52.23 66.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.5 -24.41 50.08 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.557 ' CG ' ' O ' ' A' ' 181' ' ' THR . 0.2 OUTLIER -64.31 -20.71 66.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.875 -1.141 . . . . 0.0 108.839 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.475 ' CB ' HG23 ' A' ' 54' ' ' VAL . 63.0 p -87.3 7.54 28.25 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.865 -1.147 . . . . 0.0 108.273 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 188' ' ' LYS . 0.1 OUTLIER -119.41 8.06 11.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.392 -0.818 . . . . 0.0 109.542 -179.662 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.516 ' CE ' HD12 ' A' ' 185' ' ' LEU . 0.4 OUTLIER -43.03 -54.68 4.18 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.391 -0.818 . . . . 0.0 109.318 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.316 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.312 0.577 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.529 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 1.4 tp60 -126.49 65.23 1.25 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.23 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.608 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.7 OUTLIER 75.95 98.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 4.9 mt-10 -128.17 66.04 1.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 110.34 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.6 m-20 61.3 91.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 110.407 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.98 68.56 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.092 -1.051 . . . . 0.0 110.59 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.581 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 9.1 tttp -95.64 26.07 4.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.991 -1.299 . . . . 0.0 108.561 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.581 ' CB ' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER 145.09 -34.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.575 ' CG ' ' O ' ' A' ' 9' ' ' TYR . 2.5 p90 -141.86 115.59 9.14 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.001 -1.062 . . . . 0.0 109.225 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t -105.25 179.62 4.22 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.332 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -104.32 157.85 16.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.746 -0.596 . . . . 0.0 109.713 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.436 HD13 ' CB ' ' A' ' 160' ' ' GLN . 1.6 mp -100.08 159.11 15.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.362 -0.836 . . . . 0.0 109.477 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -98.97 11.75 38.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 109.443 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -168.3 93.27 0.61 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.195 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.476 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 36.4 Cg_endo -77.85 161.79 30.02 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.536 2.157 . . . . 0.0 110.891 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.548 HG11 ' CB ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -113.23 96.79 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 109.437 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -41.66 126.96 3.1 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 94.02 -16.69 60.35 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.548 ' CB ' HG11 ' A' ' 16' ' ' VAL . . . -38.63 158.18 0.1 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.484 -1.01 . . . . 0.0 109.94 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.55 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.7 Cg_endo -80.42 138.75 12.53 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.827 2.351 . . . . 0.0 111.48 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 6.0 mt-30 -47.53 -22.34 0.46 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.476 -0.765 . . . . 0.0 109.653 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 8.4 t -150.36 80.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.04 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.613 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -75.58 129.49 37.28 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.536 ' N ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -112.73 129.76 56.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.947 -1.095 . . . . 0.0 109.827 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.613 ' CE2' HD11 ' A' ' 23' ' ' LEU . 8.4 m-85 -116.88 102.83 9.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.247 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -146.4 136.36 23.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.894 -1.129 . . . . 0.0 110.026 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.609 ' CB ' ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -110.06 171.79 7.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.404 -0.81 . . . . 0.0 109.522 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.558 ' N ' ' NE2' ' A' ' 60' ' ' HIS . 7.9 m-30 -87.59 43.58 1.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.453 ' CD1' ' O ' ' A' ' 28' ' ' PHE . 9.6 m-85 -143.23 12.32 1.78 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.371 -0.83 . . . . 0.0 110.127 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 4.7 m -106.88 160.52 26.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.778 -1.201 . . . . 0.0 109.378 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -75.65 -32.39 4.72 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.111 1.874 . . . . 0.0 107.928 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.8 t-160 -79.9 -25.52 40.55 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 37.1 t -45.05 -64.17 0.77 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.561 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 28.0 t80 -65.0 -44.71 88.38 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.294 0.569 . . . . 0.0 110.055 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.485 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 52.7 mt-30 -67.43 -16.42 64.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.917 . . . . 0.0 110.859 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 32' ' ' HIS . 12.7 t80 -76.72 -52.0 10.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.979 -1.076 . . . . 0.0 110.344 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -106.53 -4.62 19.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.789 -1.195 . . . . 0.0 112.072 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.561 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 10.6 mt-10 -124.4 19.76 8.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.213 -1.555 . . . . 0.0 111.332 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.517 ' CG2' ' CE2' ' A' ' 34' ' ' TYR . 64.1 t -151.76 -84.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.614 -1.304 . . . . 0.0 109.92 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 171' ' ' MET . 13.8 mt -63.96 -13.9 49.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 0.0 109.867 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.472 ' O ' ' N ' ' A' ' 44' ' ' ASP . 57.0 m-70 49.05 24.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.169 -0.957 . . . . 0.0 108.649 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 46' ' ' VAL . 1.8 mt -43.18 -27.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.544 -0.722 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.26 -16.62 39.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -0.971 . . . . 0.0 110.867 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.472 ' N ' ' O ' ' A' ' 41' ' ' HIS . 35.3 t70 -87.15 -34.05 19.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.916 -1.115 . . . . 0.0 110.413 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -73.26 -44.15 59.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.215 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 42' ' ' ILE . 3.7 m -55.96 -25.13 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.127 -0.983 . . . . 0.0 110.021 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HE2' HD11 ' A' ' 50' ' ' LEU . 3.1 mttt -65.67 -27.35 68.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 109.343 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.402 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -55.3 -18.56 6.58 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.376 -0.827 . . . . 0.0 109.096 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.485 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -134.86 48.26 2.3 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 109.764 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.407 HD11 ' HE2' ' A' ' 47' ' ' LYS . 10.7 mt -104.08 102.86 34.71 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 34.2 Cg_endo -76.3 152.78 35.19 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.512 2.141 . . . . 0.0 109.273 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 52' ' ' GLU . 12.1 tt0 -72.15 23.2 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.637 -1.289 . . . . 0.0 111.243 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 21' ' ' GLN . . . -122.13 29.47 5.53 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 186' ' ' SER . 68.5 t -148.92 121.17 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.502 -0.999 . . . . 0.0 108.722 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.7 116.69 32.48 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 110.471 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.48 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.94 96.99 9.66 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.468 ' HB ' HD22 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -88.68 141.58 28.4 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.039 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.68 113.93 21.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.404 -0.81 . . . . 0.0 109.639 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 138' ' ' GLN . 2.2 m-85 -116.97 154.05 31.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.995 -1.066 . . . . 0.0 111.838 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.609 ' CE1' ' CB ' ' A' ' 27' ' ' SER . 37.2 t-80 -108.87 111.71 23.56 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.588 HG23 ' CE1' ' A' ' 63' ' ' PHE . 3.1 m -82.36 158.18 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.976 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.452 ' HB2' ' HA ' ' A' ' 70' ' ' LYS . 1.6 p30 -108.99 48.24 0.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.37 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.588 ' CE1' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -119.94 45.72 2.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.923 -1.111 . . . . 0.0 110.219 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.515 ' HG3' ' CD1' ' A' ' 63' ' ' PHE . 34.9 mtp -159.65 47.66 0.28 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 159.32 58.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -33.37 -36.56 0.05 OUTLIER Glycine 0 N--CA 1.493 2.499 0 O-C-N 122.004 -0.704 . . . . 0.0 111.472 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -87.59 -79.31 0.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.767 -1.431 . . . . 0.0 110.762 -178.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.598 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.74 -19.61 30.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.94 -1.1 . . . . 0.0 110.261 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.52 ' N ' HD12 ' A' ' 68' ' ' LEU . . . -56.79 -39.65 87.86 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -65.09 -42.85 93.67 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.25 -24.49 64.9 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.566 HD22 ' CE1' ' A' ' 60' ' ' HIS . 41.7 tp -65.64 -47.73 74.61 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.543 ' CG2' ' NE2' ' A' ' 138' ' ' GLN . 2.0 m -58.58 -43.46 89.45 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.546 ' O ' ' CG2' ' A' ' 78' ' ' VAL . 5.7 tp60 -55.69 -27.45 50.34 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -63.58 -41.52 98.36 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.486 ' HB2' ' CB ' ' A' ' 60' ' ' HIS . 47.8 t-105 -61.47 -30.68 70.75 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.391 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.487 ' CB ' HG21 ' A' ' 135' ' ' VAL . . . -81.68 -39.31 24.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 110.057 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.59 ' CG1' ' CD2' ' A' ' 122' ' ' TYR . 1.3 t -77.07 -27.12 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 109.75 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.457 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -80.87 -54.37 5.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.295 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -48.67 -27.79 3.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.203 -0.936 . . . . 0.0 108.742 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.521 ' CB ' HG21 ' A' ' 131' ' ' VAL . . . -60.5 -56.03 26.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.432 -0.792 . . . . 0.0 110.119 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.465 ' HB2' HG12 ' A' ' 84' ' ' VAL . 3.2 mt -102.04 10.38 39.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.038 -1.038 . . . . 0.0 110.59 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.45 27.98 61.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.465 HG12 ' HB2' ' A' ' 82' ' ' LEU . 19.7 m -81.98 -6.64 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.375 -1.073 . . . . 0.0 109.858 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' THR . 3.9 tt0 -43.88 -65.1 0.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.547 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -41.41 -34.02 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 109.852 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -80.71 -51.95 8.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.459 -0.776 . . . . 0.0 111.158 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.501 ' O ' ' CG ' ' A' ' 92' ' ' LEU . 1.6 m -86.61 -9.57 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.708 -1.245 . . . . 0.0 110.869 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.618 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.46 -44.03 46.3 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.819 -1.176 . . . . 0.0 108.717 179.241 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.429 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -53.19 -53.18 58.63 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.478 -1.389 . . . . 0.0 110.453 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.53 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 26.0 Cg_endo -73.47 -18.08 23.19 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 O-C-N 122.786 0.887 . . . . 0.0 109.844 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 89' ' ' THR . 19.6 mt -87.24 -43.39 12.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.011 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.618 ' CG ' HG21 ' A' ' 89' ' ' THR . 7.1 m-30 -64.98 -45.94 83.53 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.894 -1.129 . . . . 0.0 108.73 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -72.73 -27.42 62.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.309 -0.87 . . . . 0.0 109.17 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.434 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -65.17 -38.19 94.95 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.521 HG23 ' CB ' ' A' ' 102' ' ' ILE . 3.8 t -97.81 -1.55 10.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.299 -1.118 . . . . 0.0 108.629 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 93' ' ' PHE . 18.8 mm-40 -111.14 9.61 21.92 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.169 -0.957 . . . . 0.0 110.874 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.562 ' O ' ' CG2' ' A' ' 99' ' ' THR . 50.6 tttt -172.5 62.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.482 -1.387 . . . . 0.0 109.822 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.562 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 164.47 -50.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.704 -0.622 . . . . 0.0 109.324 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.3 mt-30 75.92 15.28 2.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.195 -0.941 . . . . 0.0 110.777 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 t -82.82 -6.63 59.51 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.403 -0.81 . . . . 0.0 108.818 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.521 ' CB ' HG23 ' A' ' 96' ' ' VAL . 10.5 mm -79.97 72.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.494 ' HA ' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -134.21 31.56 3.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.198 -0.939 . . . . 0.0 109.167 179.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 107' ' ' ASP . 1.4 p -151.21 126.48 9.95 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.256 -0.902 . . . . 0.0 109.861 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.547 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -50.63 -31.81 17.16 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.4 t -59.3 -31.42 69.11 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -71.54 -49.34 41.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.529 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 37.3 mt -50.58 -30.32 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.124 -0.985 . . . . 0.0 108.947 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.4 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 24.5 mtm180 -79.55 -32.33 42.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.207 -0.933 . . . . 0.0 109.227 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -58.79 -46.79 86.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.268 -0.895 . . . . 0.0 108.799 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.53 ' CG1' ' HG2' ' A' ' 91' ' ' PRO . 70.1 t -71.35 -38.27 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.209 -0.932 . . . . 0.0 109.009 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CE2' ' CE2' ' A' ' 122' ' ' TYR . 0.5 OUTLIER -56.95 -44.72 82.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.5 mt -73.58 -24.21 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.594 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -65.82 -16.71 64.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.421 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.35 -3.23 56.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 109.86 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.94 -8.93 63.55 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.591 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 2.6 mp -88.86 51.83 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -1.098 . . . . 0.0 109.362 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' A' ' 117' ' ' ILE . 16.7 pttm -33.78 153.89 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.565 -0.709 . . . . 0.0 110.826 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.17 -29.3 2.29 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.464 ' HB3' ' CD ' ' A' ' 118' ' ' LYS . 17.3 tt0 -50.37 -58.09 6.47 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.064 -1.256 . . . . 0.0 109.042 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.38 -54.14 6.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.438 -0.788 . . . . 0.0 109.662 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.59 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 2.6 t80 -46.73 -55.56 7.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.119 -0.988 . . . . 0.0 109.218 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.439 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 47.1 t0 -56.66 -48.59 77.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 109.07 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.49 -49.86 54.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.25 -0.906 . . . . 0.0 109.076 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 131' ' ' VAL . . . -51.44 -49.27 62.01 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.456 -0.778 . . . . 0.0 109.188 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.53 ' HA ' ' CG1' ' A' ' 131' ' ' VAL . 11.4 t90 -60.27 -56.49 20.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 108.956 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -15.64 3.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.517 -0.739 . . . . 0.0 109.923 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 63.2 m -77.35 -177.71 4.78 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.05 -1.031 . . . . 0.0 110.156 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.34 -32.43 13.61 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.76 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.3 -42.75 97.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 117.916 -1.514 . . . . 0.0 109.401 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.53 ' CG1' ' HA ' ' A' ' 126' ' ' TRP . 42.6 t -65.72 -38.21 81.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.04 -1.038 . . . . 0.0 108.295 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -38.44 89.14 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.3 m -62.1 -39.77 93.6 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.34 -16.63 56.01 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.487 HG21 ' CB ' ' A' ' 77' ' ' ALA . 5.0 t -79.4 -44.75 23.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 140' ' ' LYS . . . -68.62 -44.64 73.82 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.457 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 7.1 tp-100 -62.81 -32.64 73.87 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -0.817 . . . . 0.0 109.041 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.543 ' NE2' ' CG2' ' A' ' 73' ' ' THR . 1.6 tm0? -79.43 -62.75 1.59 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.199 -0.938 . . . . 0.0 108.751 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -49.47 -34.5 17.06 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 6.8 ttmt -75.11 -29.07 60.47 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.485 ' HA ' ' OD2' ' A' ' 144' ' ' ASP . . . -59.25 -54.23 49.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.362 -0.836 . . . . 0.0 109.143 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.468 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -75.83 -31.52 59.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 110.356 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.28 54.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.23 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.503 ' OD1' ' CG1' ' A' ' 145' ' ' VAL . 1.2 p30 -84.21 -47.18 11.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.978 -1.076 . . . . 0.0 108.181 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.593 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 10.3 m -82.04 -21.86 9.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 82.1 -25.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.849 -0.532 . . . . 0.0 110.188 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.544 ' CD2' ' CG1' ' A' ' 61' ' ' VAL . 10.5 tp 61.4 142.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 109.537 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.15 33.66 0.14 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.691 -1.256 . . . . 0.0 110.139 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 153.05 113.33 0.53 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.325 -1.416 . . . . 0.0 110.519 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.414 HG12 ' CE1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -101.56 139.55 20.49 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.34 -1.094 . . . . 0.0 109.395 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.31 151.46 95.0 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 123.725 -1.365 . . . . 0.0 110.209 0.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.41 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -130.37 126.77 37.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.271 -1.518 . . . . 0.0 109.127 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.499 ' SD ' ' CD1' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -122.71 114.77 21.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.087 -1.008 . . . . 0.0 110.094 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.509 ' N ' ' CD1' ' A' ' 154' ' ' PHE . 3.2 m-30 -110.58 148.3 32.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.514 ' HB ' ' HB2' ' A' ' 159' ' ' TYR . 29.7 t -107.61 133.47 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.731 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.48 ' OD1' ' O ' ' A' ' 155' ' ' VAL . 5.6 p-10 40.7 25.49 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.4 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.54 ' N ' ' HB2' ' A' ' 19' ' ' ALA . . . 58.2 60.07 9.63 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.455 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 6.8 tttt -167.74 -33.68 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.379 -1.071 . . . . 0.0 108.327 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.524 ' CE2' ' HB3' ' A' ' 188' ' ' LYS . 96.5 m-85 -116.49 121.44 41.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.056 -1.028 . . . . 0.0 108.926 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.49 ' HG3' ' CE1' ' A' ' 154' ' ' PHE . 19.8 tt0 -113.42 109.02 18.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 109.749 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.499 ' CD1' ' SD ' ' A' ' 153' ' ' MET . 15.5 mt -59.32 172.12 0.68 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 8' ' ' GLN . 62.9 t-20 -152.2 83.07 5.16 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 120.849 -1.157 . . . . 0.0 109.848 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 164' ' ' GLN . 34.8 Cg_endo -78.27 -11.54 16.03 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.713 2.275 . . . . 0.0 110.432 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 163' ' ' PRO . 33.1 tt0 43.86 28.2 0.22 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.945 . . . . 0.0 109.575 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 92.79 -35.88 3.91 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 17.2 ttt -169.81 -72.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -1.152 . . . . 0.0 109.353 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 167' ' ' ASP . 33.3 t70 51.23 30.7 6.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.443 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 169' ' ' SER . 2.1 p -134.04 -55.75 0.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.756 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 168' ' ' THR . 1.0 OUTLIER 77.54 22.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 109.152 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -160.52 99.99 1.31 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.477 ' HB3' HD23 ' A' ' 40' ' ' LEU . 13.0 mtt -56.06 -17.43 6.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.952 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.6 -62.24 1.75 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.693 -0.63 . . . . 0.0 109.672 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.56 -21.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.151 -0.968 . . . . 0.0 108.919 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.485 ' CD1' ' O ' ' A' ' 174' ' ' PHE . 2.4 t80 -74.78 -45.23 45.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.293 -0.88 . . . . 0.0 109.268 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.439 ' O ' HG11 ' A' ' 175' ' ' VAL . 39.8 t -71.39 -26.87 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.174 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.66 -53.11 6.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.569 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.55 -40.64 87.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 109.01 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -63.92 -47.5 80.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.321 -0.862 . . . . 0.0 108.909 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.61 -29.48 70.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.25 -0.906 . . . . 0.0 108.947 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -75.08 -38.29 61.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 109.277 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 185' ' ' LEU . 2.9 m -66.11 -26.47 67.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -0.871 . . . . 0.0 109.274 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.486 ' CG2' ' HE3' ' A' ' 153' ' ' MET . 52.8 t -87.13 -37.23 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 108.581 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -57.46 -48.47 79.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.406 -0.809 . . . . 0.0 108.885 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.44 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -80.92 -28.74 35.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.397 -0.815 . . . . 0.0 109.416 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 188' ' ' LYS . 0.6 OUTLIER -63.77 -17.3 62.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.198 . . . . 0.0 109.358 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.46 ' HB2' HG23 ' A' ' 54' ' ' VAL . 1.4 t -82.56 5.54 20.53 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.665 -1.272 . . . . 0.0 107.999 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -122.33 26.6 8.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.439 -0.788 . . . . 0.0 109.415 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -56.65 -23.03 38.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.1 -1.0 . . . . 0.0 109.288 -179.518 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.464 ' OXT' ' CD ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.359 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.453 ' O ' ' C ' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 1' ' ' ALA . 16.6 mt-30 42.17 48.06 4.13 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.914 0.864 . . . . 0.0 108.916 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER 60.27 88.36 0.08 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 5' ' ' ASP . 0.4 OUTLIER -105.11 55.74 0.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 4' ' ' GLU . 7.0 p-10 39.77 79.86 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.812 -0.555 . . . . 0.0 109.891 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 126.79 -26.52 5.09 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.762 -1.208 . . . . 0.0 110.348 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 -69.52 0.6 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.063 -1.257 . . . . 0.0 109.385 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.471 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -91.41 2.72 56.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.229 -0.919 . . . . 0.0 109.611 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.502 ' O ' ' N ' ' A' ' 6' ' ' GLY . 2.2 p90 178.91 132.85 0.08 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.09 -1.006 . . . . 0.0 109.189 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 t -119.11 176.34 5.35 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.691 -0.63 . . . . 0.0 109.494 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -100.24 152.1 20.68 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.357 0.599 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 mp -92.95 170.9 9.31 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.303 -0.873 . . . . 0.0 109.594 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.42 ' OE2' ' HG2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -91.56 -5.92 53.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.511 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.42 ' HG2' ' OE2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -166.06 110.67 0.73 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.444 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 36.0 Cg_endo -77.97 160.49 30.37 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.417 2.078 . . . . 0.0 110.153 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -119.03 102.67 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 109.8 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.22 127.07 6.73 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 92.37 -15.03 63.2 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.534 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -38.35 156.18 0.11 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.94 . . . . 0.0 109.618 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.5 Cg_endo -79.17 128.32 8.12 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.547 2.165 . . . . 0.0 111.308 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.516 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 37.0 mt-30 -42.38 -24.28 0.05 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.398 -0.813 . . . . 0.0 109.586 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 7.1 t -147.26 83.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.127 -0.983 . . . . 0.0 109.155 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.587 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -77.75 128.56 34.22 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.524 ' N ' HD21 ' A' ' 23' ' ' LEU . 3.4 mm-40 -109.68 131.93 54.61 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.088 -1.008 . . . . 0.0 109.723 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.587 ' CE2' HD11 ' A' ' 23' ' ' LEU . 5.0 m-85 -120.58 113.93 20.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -151.75 144.89 24.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.974 -1.079 . . . . 0.0 109.698 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.598 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -118.53 163.86 16.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 110.085 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.67 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 18.8 m-30 -88.13 39.17 0.89 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.526 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 5.2 m-85 -138.72 15.51 2.7 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 110.179 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 4.2 m -114.39 158.18 40.59 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.596 -1.315 . . . . 0.0 109.722 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -74.5 -25.42 12.98 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.196 1.931 . . . . 0.0 107.835 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' PHE . 98.5 m-70 -89.17 -16.43 31.38 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.477 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 5.7 t -54.92 -53.44 55.51 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 38' ' ' GLU . 29.3 t80 -71.58 -40.61 69.78 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.486 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 3.3 mt-30 -78.33 -19.02 54.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 111.181 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 32' ' ' HIS . 70.6 t80 -78.0 -20.3 52.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.924 -1.11 . . . . 0.0 110.466 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 41' ' ' HIS . 3.7 tm-20 -133.31 -72.06 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.885 -1.134 . . . . 0.0 110.826 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.636 ' CB ' ' CE1' ' A' ' 34' ' ' TYR . 56.8 mm-40 -46.02 -40.25 10.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.831 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 34' ' ' TYR . 5.0 t -92.4 -74.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.053 . . . . 0.0 110.548 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.557 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 0.4 OUTLIER -75.21 -10.9 59.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.0 110.652 -178.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 11.0 p-80 40.92 32.11 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.136 -0.977 . . . . 0.0 109.342 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.487 HG13 ' HB3' ' A' ' 40' ' ' LEU . 3.6 mt -54.38 -18.12 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 110.152 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.6 p -84.95 -38.56 19.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.943 -1.098 . . . . 0.0 110.563 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 2.7 m-20 -81.58 -36.91 28.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.02 -1.05 . . . . 0.0 110.428 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 46' ' ' VAL . 15.8 t30 -60.54 -53.34 58.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.033 -1.042 . . . . 0.0 110.171 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' ASN . 6.7 m -42.82 -38.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 110.183 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 44' ' ' ASP . 0.0 OUTLIER -46.86 -34.81 5.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.039 . . . . 0.0 109.867 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.411 ' HD3' ' HG2' ' A' ' 49' ' ' LYS . 3.4 tmtm? -45.46 -24.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.145 -0.972 . . . . 0.0 109.93 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.446 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -116.32 40.57 2.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.729 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.542 ' HG ' ' CG1' ' A' ' 54' ' ' VAL . 5.5 mp -129.47 68.19 79.96 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.182 -0.949 . . . . 0.0 109.587 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 52' ' ' GLU . 36.1 Cg_endo -80.31 77.97 3.86 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.697 2.265 . . . . 0.0 111.685 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 51' ' ' PRO . 25.5 tp10 58.92 136.85 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.616 0.722 . . . . 0.0 110.103 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.13 -6.52 69.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.542 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -116.06 100.52 10.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.28 -1.13 . . . . 0.0 108.645 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -100.51 109.39 21.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.259 -0.901 . . . . 0.0 110.427 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.476 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -102.46 95.52 6.32 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.559 HG23 ' CE1' ' A' ' 59' ' ' TYR . 4.2 m -84.16 133.6 34.6 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.724 -1.19 . . . . 0.0 110.042 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 8.5 tttt -106.72 117.95 35.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.484 -0.76 . . . . 0.0 109.582 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.559 ' CE1' HG23 ' A' ' 57' ' ' THR . 3.3 m-85 -120.88 177.02 5.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.014 -1.054 . . . . 0.0 110.5 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.604 ' CE1' ' CD2' ' A' ' 72' ' ' LEU . 3.2 t60 -109.16 159.89 16.53 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.84 0.828 . . . . 0.0 109.538 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.54 ' CG2' ' CE1' ' A' ' 63' ' ' PHE . 1.4 m -104.02 162.4 4.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.79 58.31 1.7 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.141 -0.975 . . . . 0.0 109.314 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' CE1' ' CG2' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -158.03 64.82 0.46 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.023 -1.048 . . . . 0.0 110.849 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.525 ' CA ' ' HE1' ' A' ' 64' ' ' MET . 0.0 OUTLIER -126.17 33.27 5.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.503 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 64' ' ' MET . . . 44.72 42.42 7.6 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.553 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . -148.5 80.97 0.2 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 66' ' ' GLY . 44.5 t0 -33.39 -45.35 0.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.021 -0.693 . . . . 0.0 111.366 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -55.4 -21.01 13.81 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.749 -1.219 . . . . 0.0 109.192 -179.258 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.574 ' N ' ' CD2' ' A' ' 68' ' ' LEU . . . -63.62 -51.3 55.2 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -50.97 -55.05 19.18 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -27.0 68.96 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.604 ' CD2' ' CE1' ' A' ' 60' ' ' HIS . 6.2 tt -65.32 -38.06 89.0 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.545 ' CG2' ' NE2' ' A' ' 138' ' ' GLN . 1.8 m -59.69 -42.17 92.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.52 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 1.2 tt0 -53.92 -29.31 41.62 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -63.72 -40.06 95.83 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.425 ' O ' ' HB2' ' A' ' 80' ' ' MET . 53.4 t-105 -60.24 -30.93 69.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 108.534 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.462 ' HB2' HG21 ' A' ' 135' ' ' VAL . . . -86.96 -60.46 1.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 109.642 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.589 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 2.0 t -53.66 -28.1 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 109.171 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.09 -55.74 4.04 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.425 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 2.7 ttt -50.67 -27.54 7.18 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.533 ' CB ' HG12 ' A' ' 131' ' ' VAL . . . -68.79 -42.25 77.64 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.489 -0.757 . . . . 0.0 109.49 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.402 ' HB2' HG12 ' A' ' 84' ' ' VAL . 14.9 mt -101.97 7.8 41.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.376 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.32 29.32 45.8 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 82' ' ' LEU . 26.8 m -94.21 7.82 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.433 -1.039 . . . . 0.0 109.684 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 86' ' ' ASP . 48.9 tt0 -47.72 -72.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.12 -0.988 . . . . 0.0 109.487 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -38.86 -34.59 0.16 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.556 -0.715 . . . . 0.0 110.224 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.534 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 10.4 mtpp -73.95 -55.22 6.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.819 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.558 HG22 ' CE1' ' A' ' 112' ' ' PHE . 1.1 m -87.16 -19.98 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.737 -1.227 . . . . 0.0 110.681 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.613 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -70.17 -42.27 72.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.625 -1.297 . . . . 0.0 108.13 179.004 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.52 -55.66 37.85 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.603 -1.311 . . . . 0.0 110.692 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 24.4 Cg_endo -72.17 -16.7 28.34 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 N-CA-C 109.669 -0.935 . . . . 0.0 109.669 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.542 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 30.6 mt -86.85 -47.06 9.36 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.67 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 6.5 m-30 -58.56 -49.18 78.37 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 120.928 -1.108 . . . . 0.0 108.98 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -69.07 -33.09 73.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.061 -1.024 . . . . 0.0 109.015 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.427 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -67.86 -30.16 74.17 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.477 HG21 ' O ' ' A' ' 92' ' ' LEU . 2.1 t -107.45 9.71 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 121.086 -1.243 . . . . 0.0 108.784 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.546 ' NE2' ' HB2' ' A' ' 34' ' ' TYR . 58.9 mt-30 -112.79 15.23 19.91 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.073 -1.017 . . . . 0.0 110.567 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 7.0 mttt 178.97 -49.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.591 -1.318 . . . . 0.0 110.913 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -67.7 -38.16 83.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.561 -1.337 . . . . 0.0 110.048 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 67.24 13.57 9.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -0.832 . . . . 0.0 109.55 -179.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.439 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 42.5 p -79.79 -9.91 59.72 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.811 0.815 . . . . 0.0 109.048 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.477 HG13 HG21 ' A' ' 96' ' ' VAL . 5.5 mm -86.99 75.65 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.699 -0.626 . . . . 0.0 109.574 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.53 ' CA ' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -132.27 27.25 4.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 109.308 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 107' ' ' ASP . 7.9 p -147.8 127.07 13.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 109.856 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.512 ' N ' ' HB2' ' A' ' 68' ' ' LEU . . . -49.23 -42.81 41.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.1 p -54.36 -31.34 54.34 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 104' ' ' SER . 14.2 m-20 -74.88 -38.02 62.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.236 -0.915 . . . . 0.0 108.969 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' A' ' 68' ' ' LEU . 31.0 mt -55.98 -27.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -38.54 57.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.9 -49.68 70.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.0 109.197 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.542 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 47.2 t -68.25 -37.78 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.479 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.558 ' CE1' HG22 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -58.74 -37.57 76.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.917 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.9 mt -78.99 -27.0 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.157 -0.964 . . . . 0.0 110.313 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -65.55 -16.7 63.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.912 -1.118 . . . . 0.0 109.572 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' A' ' 87' ' ' LYS . . . -87.94 -1.57 58.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.783 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.0 -3.91 65.01 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.3 mp -87.67 61.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 108.928 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -36.6 154.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.879 -1.138 . . . . 0.0 110.426 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.13 -22.25 35.28 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.16 -54.41 47.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -1.191 . . . . 0.0 109.439 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -42.19 55.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.922 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.589 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 7.1 t80 -59.68 -48.12 82.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.139 -0.975 . . . . 0.0 109.716 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.54 -39.91 94.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.115 -0.99 . . . . 0.0 109.182 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.454 ' O ' ' OG ' ' A' ' 128' ' ' SER . . . -55.73 -53.36 57.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.364 -0.835 . . . . 0.0 109.408 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.526 ' O ' ' HB ' ' A' ' 131' ' ' VAL . . . -56.46 -55.47 33.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.42 -0.8 . . . . 0.0 108.856 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.567 ' O ' ' CE3' ' A' ' 126' ' ' TRP . 0.7 OUTLIER -48.77 -54.11 16.39 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -68.63 -14.82 63.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.686 -0.634 . . . . 0.0 109.845 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 67.7 m -68.9 -179.24 1.41 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.066 -1.021 . . . . 0.0 110.135 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.7 -35.71 13.33 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.555 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.76 -46.61 60.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.36 -1.336 . . . . 0.0 110.171 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.533 HG12 ' CB ' ' A' ' 81' ' ' ALA . 3.0 t -66.57 -35.37 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.732 -1.23 . . . . 0.0 108.63 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -67.1 -38.74 86.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -39.53 94.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 108.974 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.449 ' CD2' ' HA ' ' A' ' 77' ' ' ALA . 4.8 tp -75.64 -25.13 56.58 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.517 HG13 ' CZ3' ' A' ' 126' ' ' TRP . 11.6 t -73.96 -41.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.84 -37.05 85.95 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.03 -31.27 71.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.446 -0.784 . . . . 0.0 108.886 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.545 ' NE2' ' CG2' ' A' ' 73' ' ' THR . 2.3 mt-30 -66.89 -61.41 1.96 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.415 -0.803 . . . . 0.0 108.852 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.437 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 1.8 mt-10 -51.92 -33.41 37.08 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -76.48 -28.34 56.45 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.604 -0.685 . . . . 0.0 109.335 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.54 -57.5 9.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -72.84 -31.31 64.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.887 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 139' ' ' GLU . . . -79.27 -23.24 43.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.165 -0.959 . . . . 0.0 110.222 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 140' ' ' LYS . 76.1 m-20 -81.12 -44.42 17.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.08 -1.012 . . . . 0.0 108.49 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.578 HG23 ' CZ ' ' A' ' 25' ' ' PHE . 31.7 m -95.58 -8.35 9.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 1.1 mm-40 78.12 -52.5 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.449 -0.782 . . . . 0.0 109.397 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.493 HD23 ' CG1' ' A' ' 61' ' ' VAL . 27.1 tp 68.39 129.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.876 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.59 41.51 0.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.589 -1.319 . . . . 0.0 109.568 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 172.28 105.27 0.18 Allowed Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.068 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.533 ' CG1' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -105.05 141.55 22.81 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.391 -1.064 . . . . 0.0 109.817 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.52 152.74 96.18 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 123.572 -1.428 . . . . 0.0 110.208 0.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -134.68 159.38 41.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.241 -1.537 . . . . 0.0 109.394 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 2.1 ttm -154.0 131.22 11.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.942 . . . . 0.0 109.851 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.445 ' CD1' ' HB2' ' A' ' 160' ' ' GLN . 6.1 m-85 -124.76 133.7 53.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.156 -0.965 . . . . 0.0 110.026 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 48.2 t -96.2 132.34 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.361 -0.837 . . . . 0.0 110.287 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 48.48 21.23 0.37 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.826 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.534 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 55.86 55.53 28.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -164.71 -34.87 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.357 -1.084 . . . . 0.0 108.355 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.575 ' CE2' ' HE3' ' A' ' 188' ' ' LYS . 72.7 m-85 -114.57 118.25 33.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.221 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.445 ' HB2' ' CD1' ' A' ' 154' ' ' PHE . 23.6 tt0 -104.29 109.04 20.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.282 -0.886 . . . . 0.0 109.574 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.465 HD12 ' CE1' ' A' ' 178' ' ' TYR . 30.0 mt -59.89 169.78 1.36 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -151.78 87.29 4.43 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.055 -1.028 . . . . 0.0 109.463 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . 35.8 Cg_endo -77.61 56.43 5.58 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.603 2.202 . . . . 0.0 110.502 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -128.12 -2.54 5.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.681 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -92.65 7.17 77.49 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.465 ' HG3' ' CD1' ' A' ' 174' ' ' PHE . 0.0 OUTLIER -150.37 49.35 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -1.197 . . . . 0.0 109.552 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -104.53 22.34 15.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.521 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.6 t -166.07 66.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.557 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 89.5 p -168.32 -63.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 109.169 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -160.27 98.3 1.28 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.7 mtt -56.8 -16.87 7.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.866 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -70.7 -44.46 66.91 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.633 -0.667 . . . . 0.0 109.223 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.436 ' O ' HG11 ' A' ' 173' ' ' VAL . 14.8 t -73.46 -25.04 20.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.217 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.494 ' CZ ' ' HB3' ' A' ' 163' ' ' PRO . 4.1 t80 -69.16 -46.48 67.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 0.0 109.063 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 45.5 t -71.55 -24.54 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.568 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -83.14 -55.36 4.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.423 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -39.17 93.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.95 -1.094 . . . . 0.0 108.786 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.465 ' CE1' HD12 ' A' ' 161' ' ' LEU . 63.4 t80 -65.2 -43.52 91.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.376 -0.827 . . . . 0.0 108.891 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.86 -31.77 65.14 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.021 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.61 -38.62 54.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.317 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 185' ' ' LEU . 0.2 OUTLIER -62.5 -30.34 71.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.239 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.426 HG21 HD13 ' A' ' 161' ' ' LEU . 58.1 t -86.03 -33.69 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.191 -0.943 . . . . 0.0 108.636 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.81 -48.55 81.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 108.885 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.76 -32.26 52.53 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.184 -0.947 . . . . 0.0 108.886 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.479 HD21 ' N ' ' A' ' 185' ' ' LEU . 0.9 OUTLIER -64.32 -17.06 63.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.877 -1.14 . . . . 0.0 109.138 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 24.9 p -74.02 -10.46 59.65 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.909 -1.119 . . . . 0.0 108.569 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 188' ' ' LYS . 2.2 mt-10 -88.98 -10.05 49.1 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.477 -0.764 . . . . 0.0 109.441 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.575 ' HE3' ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -41.78 -37.98 1.37 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.518 -0.739 . . . . 0.0 109.293 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 188' ' ' LYS . 5.7 ptmt . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.745 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.557 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 1.8 mt-30 -116.23 61.87 0.71 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 0.0 109.408 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER 171.39 89.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.419 -0.801 . . . . 0.0 109.332 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -114.84 61.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.292 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.4 t70 53.72 86.0 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.506 -0.746 . . . . 0.0 109.6 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 120.62 -22.9 8.09 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.173 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -69.83 0.58 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.981 -1.305 . . . . 0.0 108.505 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.474 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 0.6 OUTLIER -114.8 19.02 16.23 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.333 -0.854 . . . . 0.0 109.432 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.521 ' C ' ' CD1' ' A' ' 9' ' ' TYR . 0.8 OUTLIER 177.94 129.92 0.06 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.225 -0.922 . . . . 0.0 109.063 179.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -126.14 176.66 6.89 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.53 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.425 HG21 ' O ' ' A' ' 158' ' ' LYS . 24.9 m -104.14 149.47 25.22 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.472 0.653 . . . . 0.0 109.71 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.461 ' HG ' ' HG2' ' A' ' 160' ' ' GLN . 0.4 OUTLIER -89.46 149.52 22.9 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.431 -0.793 . . . . 0.0 109.658 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -70.58 -23.19 62.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.009 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -122.62 102.16 39.2 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.82 164.54 29.9 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.474 2.116 . . . . 0.0 111.118 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.45 ' O ' ' CG1' ' A' ' 16' ' ' VAL . 37.7 t -129.1 76.68 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 109.562 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.45 133.18 5.78 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.46 -25.06 26.39 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.52 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -41.09 162.87 0.11 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.521 -0.987 . . . . 0.0 109.627 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.555 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 33.0 Cg_endo -75.8 125.82 9.04 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.589 2.193 . . . . 0.0 111.449 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.526 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER -37.95 -25.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.848 -0.532 . . . . 0.0 110.854 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.509 ' N ' ' O ' ' A' ' 20' ' ' PRO . 17.5 t -147.75 79.82 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.709 -1.244 . . . . 0.0 109.139 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.642 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -82.14 124.82 30.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.522 ' N ' HD21 ' A' ' 23' ' ' LEU . 0.6 OUTLIER -123.71 108.47 12.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.027 -1.046 . . . . 0.0 109.222 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.642 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 7.6 m-85 -88.27 126.53 35.21 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.411 0.624 . . . . 0.0 110.035 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -155.16 142.1 19.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 109.69 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.538 ' HB2' ' NE2' ' A' ' 60' ' ' HIS . 0.1 OUTLIER -126.32 161.94 26.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.224 -0.922 . . . . 0.0 109.129 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.678 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -83.74 48.13 1.39 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 0.0 108.817 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.574 ' CE1' HD21 ' A' ' 72' ' ' LEU . 6.3 m-85 -135.47 5.77 3.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.373 -0.829 . . . . 0.0 110.016 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.511 ' HB3' ' NE2' ' A' ' 32' ' ' HIS . 90.9 m -108.69 155.38 40.71 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 118.688 -1.205 . . . . 0.0 109.23 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -73.68 -28.9 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.079 1.853 . . . . 0.0 108.192 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 36' ' ' PHE . 2.5 p-80 -86.15 -20.76 28.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 14.7 t -47.31 -63.29 1.08 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.538 ' CE2' ' CD ' ' A' ' 38' ' ' GLU . 35.6 t80 -59.62 -54.5 45.78 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.469 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 1.5 mt-30 -56.52 -25.51 51.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.22 -0.925 . . . . 0.0 109.786 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 32' ' ' HIS . 35.5 t80 -84.49 -25.43 28.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 110.672 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.531 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 3.6 tt0 -125.81 51.46 1.74 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.842 -1.161 . . . . 0.0 110.16 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.538 ' CD ' ' CE2' ' A' ' 34' ' ' TYR . 1.1 mt-10 -171.06 -57.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.083 -1.011 . . . . 0.0 110.706 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.1 t -102.07 -58.76 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.924 -1.11 . . . . 0.0 110.917 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 35' ' ' GLN . 64.4 mt -46.43 -22.75 0.29 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.034 -1.041 . . . . 0.0 110.408 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 17.9 m80 57.07 16.97 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.036 -1.04 . . . . 0.0 109.522 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 42' ' ' ILE . 23.0 mt -64.04 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 109.358 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.85 -31.68 35.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.447 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.31 -27.51 32.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.922 -1.111 . . . . 0.0 110.061 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 36.8 t30 -80.44 -40.05 27.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.965 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.426 HG12 ' CE ' ' A' ' 56' ' ' MET . 12.0 p -65.72 -25.32 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.528 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.446 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 1.0 OUTLIER -68.76 -20.41 64.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.637 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -76.8 -20.76 56.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.142 -0.974 . . . . 0.0 109.62 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.478 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 4.1 mttt -105.65 3.86 29.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 0.0 109.842 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.446 ' HG ' ' HA ' ' A' ' 47' ' ' LYS . 14.4 mt -42.73 102.61 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 109.692 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.552 ' HG2' ' CG2' ' A' ' 54' ' ' VAL . 34.6 Cg_endo -77.74 127.98 9.07 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.339 2.026 . . . . 0.0 110.605 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.89 116.97 2.03 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.139 0.971 . . . . 0.0 109.233 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.53 -20.28 10.29 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.552 ' CG2' ' HG2' ' A' ' 51' ' ' PRO . 2.6 t -93.39 91.8 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -1.204 . . . . 0.0 109.051 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -75.19 102.09 4.85 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.508 -0.745 . . . . 0.0 109.769 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.491 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 15.1 ttp -89.93 99.92 12.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.563 -0.711 . . . . 0.0 109.483 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.455 ' O ' ' CG ' ' A' ' 24' ' ' GLU . 7.4 m -96.28 139.12 32.88 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.402 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.499 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -113.55 109.77 19.18 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.49 -0.756 . . . . 0.0 109.054 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.558 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 3.2 m-85 -110.28 168.72 9.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.839 -1.163 . . . . 0.0 110.562 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.577 ' NE2' ' CD2' ' A' ' 72' ' ' LEU . 55.9 t-80 -97.99 153.25 18.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.503 HG13 ' CG1' ' A' ' 150' ' ' VAL . 2.1 m -90.62 155.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.606 0.717 . . . . 0.0 110.485 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -124.5 28.58 6.57 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.575 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 12.8 p90 -130.87 61.57 1.62 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.018 -1.051 . . . . 0.0 110.185 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.567 ' HG2' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -160.17 -61.43 0.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.567 ' N ' ' HG2' ' A' ' 64' ' ' MET . . . -87.4 82.11 1.61 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -39.94 -51.04 3.4 Favored Glycine 0 N--CA 1.489 2.22 0 O-C-N 121.473 -1.016 . . . . 0.0 110.916 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -87.74 -78.53 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.023 -1.28 . . . . 0.0 111.168 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.586 HD21 ' CD1' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -71.97 -23.88 61.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.854 -1.154 . . . . 0.0 110.026 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.567 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -50.34 -60.4 6.79 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -48.33 -45.17 34.85 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.958 -1.319 . . . . 0.0 108.31 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.439 ' OD1' HD11 ' A' ' 108' ' ' ILE . 10.5 t70 -65.37 -31.14 72.1 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.577 ' CD2' ' NE2' ' A' ' 60' ' ' HIS . 44.5 tp -57.72 -42.74 84.44 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.6 m -61.53 -41.4 97.27 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.57 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 0.6 OUTLIER -58.4 -21.07 49.21 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -70.22 -45.75 65.9 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 28.4 t-105 -55.31 -30.71 60.73 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.46 ' HB2' HG21 ' A' ' 135' ' ' VAL . . . -86.5 -65.36 1.02 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 110.134 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.647 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 2.7 t -48.15 -28.16 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 109.945 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 75' ' ' ALA . . . -85.29 -59.3 2.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.83 -1.169 . . . . 0.0 108.982 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ALA . 8.0 tpt -47.11 -27.98 1.6 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -73.86 -38.33 64.49 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.54 -0.725 . . . . 0.0 109.443 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.502 ' CB ' HG12 ' A' ' 84' ' ' VAL . 52.3 mt -99.56 5.23 46.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.113 -0.992 . . . . 0.0 110.403 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.28 20.09 27.64 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.502 HG12 ' CB ' ' A' ' 82' ' ' LEU . 35.4 m -89.25 -4.1 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.391 -1.064 . . . . 0.0 110.432 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -45.38 -68.15 0.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.072 -1.018 . . . . 0.0 109.439 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.13 -34.57 0.18 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 110.21 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.521 ' HE2' ' CB ' ' A' ' 115' ' ' ALA . 12.1 mtpt -83.05 -51.22 7.74 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.264 -0.898 . . . . 0.0 110.969 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.2 m -80.97 -17.59 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.773 -1.204 . . . . 0.0 110.505 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.605 HG21 ' CD1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -69.43 -43.39 73.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 108.74 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.78 -55.39 38.82 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.548 -1.345 . . . . 0.0 110.531 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.52 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 25.8 Cg_endo -72.47 -18.07 26.33 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 N-CA-C 109.909 -0.843 . . . . 0.0 109.909 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 88' ' ' VAL . 21.8 mt -87.05 -43.94 11.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 108.949 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.678 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 4.2 m-30 -63.68 -46.62 84.72 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.926 -1.109 . . . . 0.0 109.027 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -16.74 61.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.98 . . . . 0.0 109.238 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.427 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -76.44 -30.63 56.37 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.567 HG12 ' CD1' ' A' ' 29' ' ' PHE . 1.1 t -105.71 -2.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.068 -1.254 . . . . 0.0 109.444 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -113.33 10.98 18.49 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 120.827 -1.171 . . . . 0.0 111.073 -178.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.481 ' O ' ' OG1' ' A' ' 99' ' ' THR . 0.7 OUTLIER -177.39 58.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.496 -1.378 . . . . 0.0 109.992 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.596 ' CG2' ' CG2' ' A' ' 101' ' ' THR . 1.0 OUTLIER 168.13 -48.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 99' ' ' THR . 1.5 mt-30 80.11 20.97 0.54 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.752 -1.217 . . . . 0.0 111.366 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.596 ' CG2' ' CG2' ' A' ' 99' ' ' THR . 26.1 p -84.01 -8.91 59.01 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.303 -0.873 . . . . 0.0 109.107 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.507 ' HB ' HG23 ' A' ' 96' ' ' VAL . 5.2 mm -91.81 82.97 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.69 -0.631 . . . . 0.0 109.35 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.532 ' N ' ' HD3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -146.36 29.6 1.05 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 109.409 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 107' ' ' ASP . 1.1 p -155.43 132.38 10.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.943 . . . . 0.0 110.025 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.498 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -50.41 -32.56 17.97 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 m -62.9 -32.79 74.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -69.81 -50.3 44.24 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.586 ' CD1' HD21 ' A' ' 68' ' ' LEU . 27.0 mt -49.72 -29.36 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.614 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -78.5 -29.05 46.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.332 -0.855 . . . . 0.0 109.318 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -64.91 -46.32 82.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.238 -0.914 . . . . 0.0 109.302 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.515 ' CG1' ' HG2' ' A' ' 91' ' ' PRO . 61.4 t -71.87 -37.9 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.453 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.408 ' HA ' HG13 ' A' ' 88' ' ' VAL . 1.0 OUTLIER -61.03 -36.3 79.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.925 . . . . 0.0 109.655 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 109' ' ' ARG . 15.1 mt -79.67 -25.49 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.996 . . . . 0.0 110.227 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -64.09 -23.35 67.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.421 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.521 ' CB ' ' HE2' ' A' ' 87' ' ' LYS . . . -85.65 2.16 46.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 109.62 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.45 -2.24 62.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.606 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.4 mp -90.33 60.66 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.121 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.491 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.4 OUTLIER -34.18 152.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -0.964 . . . . 0.0 110.681 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.52 -27.37 41.31 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.7 -47.22 86.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -1.172 . . . . 0.0 109.081 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -75.94 -40.87 53.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 109.221 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.647 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 3.9 t80 -58.92 -47.36 85.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.851 . . . . 0.0 109.286 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.47 -34.51 77.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.244 -0.91 . . . . 0.0 109.013 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.68 -51.37 67.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.307 -0.871 . . . . 0.0 108.919 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.511 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -55.77 -49.36 73.35 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.385 -0.822 . . . . 0.0 108.955 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.57 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 12.7 t90 -57.49 -55.06 39.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.346 -0.846 . . . . 0.0 108.832 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -54.45 -16.16 2.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.474 -0.766 . . . . 0.0 109.821 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.472 ' OG ' HG22 ' A' ' 131' ' ' VAL . 1.0 OUTLIER -67.71 -179.21 1.07 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 109.571 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.9 -36.28 13.55 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.45 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.6 t -73.81 -47.9 41.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 118.225 -1.39 . . . . 0.0 110.057 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 3.1 t -61.82 -40.56 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.771 -1.206 . . . . 0.0 108.411 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 132' ' ' LYS . 2.6 ttmm -64.87 -28.13 69.33 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.514 -0.741 . . . . 0.0 109.131 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.5 t -69.79 -37.93 76.5 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.348 -0.845 . . . . 0.0 109.241 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.91 -17.13 59.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.187 -0.946 . . . . 0.0 108.485 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.46 HG21 ' HB2' ' A' ' 77' ' ' ALA . 3.2 t -75.28 -43.84 43.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -68.51 -46.98 68.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.411 ' O ' ' HB1' ' A' ' 141' ' ' ALA . 2.6 mt-30 -58.15 -33.33 69.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.082 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.558 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -69.74 -74.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 0.0 109.407 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.444 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 1.8 mt-10 -45.58 -36.39 4.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.822 . . . . 0.0 108.932 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -72.63 -35.53 67.82 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.259 -0.901 . . . . 0.0 108.668 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.478 ' O ' ' OD2' ' A' ' 144' ' ' ASP . . . -53.09 -62.6 1.55 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.487 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -60.93 -25.14 66.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.267 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 139' ' ' GLU . . . -78.67 -25.68 44.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.536 ' OD1' ' CG1' ' A' ' 145' ' ' VAL . 0.5 OUTLIER -78.85 -48.32 14.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.07 -1.019 . . . . 0.0 108.342 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.544 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 27.4 m -89.83 -11.43 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.544 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.4 OUTLIER 80.87 -47.27 0.26 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.494 -0.754 . . . . 0.0 109.827 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.474 HD23 HG13 ' A' ' 61' ' ' VAL . 36.0 tp 61.77 130.08 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.35 -0.843 . . . . 0.0 109.102 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -160.96 40.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.525 -1.36 . . . . 0.0 109.94 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 165.14 107.96 0.21 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.503 ' CG1' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -99.42 143.45 26.44 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.294 -1.121 . . . . 0.0 109.769 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.529 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 35.1 Cg_endo -76.71 152.01 95.02 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 123.997 -1.251 . . . . 0.0 110.136 0.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.584 ' HB2' ' CE1' ' A' ' 154' ' ' PHE . . . -132.84 137.62 46.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.225 -1.547 . . . . 0.0 109.416 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.514 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 2.8 ttp -129.14 130.59 46.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.112 -0.992 . . . . 0.0 110.18 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.584 ' CE1' ' HB2' ' A' ' 152' ' ' ALA . 8.5 m-85 -127.55 129.73 47.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.307 -0.871 . . . . 0.0 109.792 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 54.3 t -96.76 131.46 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 110.057 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.526 ' HB2' ' CE ' ' A' ' 188' ' ' LYS . 0.9 OUTLIER 44.9 23.58 0.09 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.353 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.52 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 55.4 57.67 17.51 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.511 ' HB3' ' CD1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -164.72 -36.38 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.525 ' CE1' ' HG2' ' A' ' 188' ' ' LYS . 11.7 m-85 -117.45 123.03 45.38 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.485 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -125.42 120.78 31.97 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.975 -1.078 . . . . 0.0 109.81 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.448 HD23 HG23 ' A' ' 181' ' ' THR . 17.2 mt -65.33 177.36 1.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.555 -0.716 . . . . 0.0 109.152 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.538 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 50.9 t-20 -137.58 60.27 24.78 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.723 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 162' ' ' ASN . 35.5 Cg_endo -77.97 60.11 7.18 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.635 2.224 . . . . 0.0 110.397 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -51.03 -22.44 2.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.135 -0.978 . . . . 0.0 108.959 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 99.92 57.87 0.9 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.46 ' O ' ' C ' ' A' ' 167' ' ' ASP . 5.3 mtt -112.71 -119.32 0.3 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.191 -1.182 . . . . 0.0 108.746 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 166' ' ' MET . 25.6 t0 38.84 38.55 0.28 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.21 -0.931 . . . . 0.0 109.908 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 12.3 p -69.12 -8.27 43.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.946 -1.096 . . . . 0.0 109.751 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.3 m -73.67 -31.19 63.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.016 . . . . 0.0 108.978 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.58 95.78 1.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.364 -0.835 . . . . 0.0 109.017 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 34.6 mtt -58.86 -15.88 14.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 109.62 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.07 -46.76 89.34 Favored 'General case' 0 C--N 1.293 -1.891 0 O-C-N 121.639 -0.663 . . . . 0.0 109.499 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.3 t -67.0 -28.14 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.36 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -66.85 -40.41 87.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.216 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 39.6 t -75.27 -27.42 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.173 -0.955 . . . . 0.0 109.458 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.15 -56.16 4.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.972 . . . . 0.0 109.246 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.468 ' O ' ' OG1' ' A' ' 181' ' ' THR . 12.7 pt20 -55.74 -33.25 64.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.15 -0.969 . . . . 0.0 109.151 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.467 ' C ' ' CD1' ' A' ' 178' ' ' TYR . 13.5 t80 -70.5 -53.11 17.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -0.951 . . . . 0.0 109.479 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.5 -31.84 71.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.556 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -76.81 -50.25 13.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.499 ' O ' ' CD2' ' A' ' 185' ' ' LEU . 20.6 m -54.39 -24.15 18.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.246 -0.909 . . . . 0.0 109.527 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.45 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 25.0 t -86.16 -40.29 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.031 -1.043 . . . . 0.0 109.174 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -55.18 -45.6 75.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.178 -0.952 . . . . 0.0 109.094 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.516 ' CE2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -81.75 -36.66 28.3 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.34 -0.85 . . . . 0.0 109.233 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.539 HD21 ' N ' ' A' ' 185' ' ' LEU . 0.7 OUTLIER -54.05 -20.2 6.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.886 -1.133 . . . . 0.0 109.875 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.462 ' HB3' HG23 ' A' ' 54' ' ' VAL . 64.9 p -63.91 -13.49 45.98 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.709 -1.244 . . . . 0.0 108.054 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.25 33.97 5.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.553 -0.717 . . . . 0.0 109.31 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.526 ' CE ' ' HB2' ' A' ' 156' ' ' ASN . 0.0 OUTLIER -76.2 4.46 8.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.044 -1.035 . . . . 0.0 110.024 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.087 -1.008 . . . . 0.0 109.531 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.551 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 1.2 mt-30 -104.7 57.39 0.7 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -0.861 . . . . 0.0 109.615 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.551 ' CG ' ' C ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -160.99 81.72 0.64 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.507 -0.746 . . . . 0.0 109.311 179.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -111.3 59.16 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.012 -1.055 . . . . 0.0 109.593 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 45.64 83.92 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.509 -0.744 . . . . 0.0 109.893 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 136.74 -33.01 2.39 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.084 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.79 -72.63 0.45 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -1.18 . . . . 0.0 109.398 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.506 ' HB3' ' CG2' ' A' ' 181' ' ' THR . 8.5 mm-40 -87.88 -4.24 58.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.816 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 24.0 p90 177.15 130.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.236 -0.915 . . . . 0.0 109.14 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.518 HG21 ' CG ' ' A' ' 160' ' ' GLN . 10.1 t -106.31 -179.92 4.08 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.43 HG21 ' O ' ' A' ' 158' ' ' LYS . 2.4 m -103.13 159.61 15.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.639 -0.663 . . . . 0.0 109.533 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.515 HD22 ' NE2' ' A' ' 160' ' ' GLN . 15.3 mt -95.98 154.86 17.01 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.357 -0.839 . . . . 0.0 109.748 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.28 -12.67 40.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.448 -0.783 . . . . 0.0 108.982 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 100.74 3.98 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 109.222 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.19 160.9 35.86 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.39 2.06 . . . . 0.0 110.703 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.547 ' CG1' ' HB3' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -121.31 98.63 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 109.595 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.77 126.94 6.0 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 99.13 -21.57 45.13 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' HB3' ' CG1' ' A' ' 16' ' ' VAL . . . -40.9 157.06 0.19 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.987 . . . . 0.0 109.513 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.546 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.8 Cg_endo -79.83 139.59 14.0 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.725 2.283 . . . . 0.0 111.659 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 2.8 mm-40 -51.65 -20.52 2.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.537 -0.727 . . . . 0.0 109.099 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 53.9 t -151.62 82.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.209 -0.932 . . . . 0.0 108.759 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.572 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.49 126.88 31.71 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.535 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -110.18 127.33 54.88 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.039 -1.038 . . . . 0.0 109.764 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE2' HD11 ' A' ' 23' ' ' LEU . 3.1 m-85 -124.79 108.84 12.37 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.478 -0.764 . . . . 0.0 109.428 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -152.67 145.3 24.22 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.343 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.588 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -128.72 -164.94 1.44 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.642 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -116.62 53.95 0.87 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.92 -1.112 . . . . 0.0 108.683 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.593 ' CE1' ' CD1' ' A' ' 72' ' ' LEU . 9.6 m-85 -133.88 -5.33 2.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.019 -1.05 . . . . 0.0 110.64 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.478 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 0.2 OUTLIER -106.28 171.8 4.48 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.8 -1.188 . . . . 0.0 109.433 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 30' ' ' CYS . 33.5 Cg_endo -75.15 -38.87 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.294 1.996 . . . . 0.0 109.113 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.528 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.5 m80 -84.61 -20.7 30.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.478 ' SG ' ' HB2' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -52.56 -40.52 62.64 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.563 ' CE2' ' OE1' ' A' ' 38' ' ' GLU . 40.2 t80 -87.25 -47.45 8.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.69 -0.632 . . . . 0.0 109.619 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -66.18 -21.75 66.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 109.905 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 32' ' ' HIS . 89.1 t80 -83.06 -16.74 45.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.592 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.552 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -132.79 50.77 2.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.77 -1.206 . . . . 0.0 110.636 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.563 ' OE1' ' CE2' ' A' ' 34' ' ' TYR . 1.0 OUTLIER -175.41 -59.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.192 -0.943 . . . . 0.0 110.216 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.6 t -89.99 -46.91 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.204 -0.935 . . . . 0.0 110.733 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 41' ' ' HIS . 77.8 mt -65.99 -6.0 11.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.022 -1.049 . . . . 0.0 110.561 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.446 ' HA ' ' OD1' ' A' ' 44' ' ' ASP . 50.5 m170 44.03 27.0 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.992 -1.067 . . . . 0.0 109.163 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.463 ' CG1' HG23 ' A' ' 175' ' ' VAL . 15.6 mt -78.43 -22.57 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.821 . . . . 0.0 109.957 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.42 ' OG ' ' HG2' ' A' ' 37' ' ' GLU . 47.2 m -80.65 -26.67 37.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.976 -1.078 . . . . 0.0 110.333 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.446 ' OD1' ' HA ' ' A' ' 41' ' ' HIS . 1.9 p-10 -87.44 -49.86 6.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.976 -1.078 . . . . 0.0 110.117 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 46' ' ' VAL . 39.1 p-10 -59.72 -25.26 64.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.214 -0.929 . . . . 0.0 110.028 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.455 HG23 ' SD ' ' A' ' 56' ' ' MET . 9.4 p -65.27 -26.75 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 109.958 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' N ' HG11 ' A' ' 46' ' ' VAL . 3.8 mttt -77.05 -38.29 53.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 109.969 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.48 -23.92 1.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.062 -1.023 . . . . 0.0 109.468 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.467 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.6 33.25 5.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.352 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.517 HD21 ' CG1' ' A' ' 54' ' ' VAL . 13.8 mt -114.79 81.79 7.62 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.872 . . . . 0.0 109.198 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD2' ' CG2' ' A' ' 54' ' ' VAL . 35.6 Cg_endo -77.5 143.85 22.1 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.584 2.189 . . . . 0.0 110.566 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 51' ' ' PRO . 3.5 tm-20 -40.61 120.88 1.34 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 122.361 1.077 . . . . 0.0 109.233 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.39 -28.5 4.76 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.517 ' CG1' HD21 ' A' ' 50' ' ' LEU . 31.9 t -86.37 79.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -1.076 . . . . 0.0 108.849 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -61.07 101.67 0.17 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.422 -0.799 . . . . 0.0 110.528 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.481 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 7.9 ttt -100.67 97.68 8.32 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.466 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 1.6 m -94.68 123.5 38.16 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.325 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.535 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 3.1 tppt? -99.63 121.65 41.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.398 -0.814 . . . . 0.0 109.546 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.588 ' CE1' ' HG2' ' A' ' 138' ' ' GLN . 2.0 m-85 -126.05 174.78 8.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.854 -1.154 . . . . 0.0 111.174 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.588 ' CE1' ' HA ' ' A' ' 27' ' ' SER . 22.4 t60 -112.04 145.86 38.95 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.841 0.829 . . . . 0.0 109.378 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.598 ' CG1' ' CG1' ' A' ' 150' ' ' VAL . 8.4 m -80.86 155.73 4.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.325 0.583 . . . . 0.0 109.985 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.444 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . 52.0 p30 -121.02 38.81 3.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.142 -0.973 . . . . 0.0 109.604 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.593 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 2.4 p90 -139.34 57.11 1.66 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.163 -0.96 . . . . 0.0 109.611 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.516 ' HE2' ' CG2' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -125.79 35.23 4.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.134 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.83 -30.83 1.23 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.379 -1.889 . . . . 0.0 108.379 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.46 -35.02 3.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.7 -79.45 0.29 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.74 -1.447 . . . . 0.0 109.939 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.597 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -76.6 -19.14 58.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 108.85 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.508 ' N ' HD12 ' A' ' 68' ' ' LEU . . . -53.48 -54.46 29.91 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.459 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 0.4 OUTLIER -52.99 -41.91 65.06 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.431 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 45.5 t0 -65.76 -31.39 72.35 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.593 ' CD1' ' CE1' ' A' ' 29' ' ' PHE . 0.3 OUTLIER -59.05 -36.08 74.43 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 45.7 m -66.64 -41.74 87.8 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -63.83 -16.43 61.27 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.444 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -71.28 -40.6 70.81 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 20.0 t-105 -68.85 -31.35 70.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.519 ' CB ' ' CG2' ' A' ' 135' ' ' VAL . . . -81.0 -62.48 1.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.577 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.641 ' CG1' ' CD2' ' A' ' 122' ' ' TYR . 59.9 t -48.33 -29.1 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.949 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.429 ' O ' ' C ' ' A' ' 80' ' ' MET . . . -84.03 -60.52 2.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.885 -1.134 . . . . 0.0 108.875 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.429 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -44.5 -28.8 0.62 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -71.45 -44.48 64.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.805 . . . . 0.0 109.572 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.459 ' O ' HG11 ' A' ' 84' ' ' VAL . 5.8 mt -99.97 11.18 39.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.037 -1.04 . . . . 0.0 110.004 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.38 22.02 6.95 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.459 HG11 ' O ' ' A' ' 82' ' ' LEU . 34.0 m -85.19 -7.81 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -1.076 . . . . 0.0 110.138 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -41.17 -60.3 1.27 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -33.43 7.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 110.345 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -83.29 -52.53 6.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.171 -0.956 . . . . 0.0 111.696 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.526 HG21 ' CD1' ' A' ' 92' ' ' LEU . 1.2 m -77.68 -10.06 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.586 -1.321 . . . . 0.0 110.249 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.596 HG21 ' CG ' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -70.88 -44.69 65.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.851 -1.155 . . . . 0.0 108.889 179.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -53.17 -54.77 40.92 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.448 -1.408 . . . . 0.0 110.477 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.446 ' HD2' ' C ' ' A' ' 88' ' ' VAL . 24.7 Cg_endo -72.8 -18.63 24.68 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 122.639 0.81 . . . . 0.0 109.995 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.527 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 15.0 mt -86.16 -41.75 14.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.235 -0.916 . . . . 0.0 109.09 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.642 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 5.8 m-30 -66.25 -47.61 73.19 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.056 -1.027 . . . . 0.0 109.007 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -31.96 70.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.935 -1.103 . . . . 0.0 109.322 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.464 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -63.06 -32.7 85.04 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.551 HG13 ' CD1' ' A' ' 29' ' ' PHE . 2.0 t -107.19 5.76 9.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.105 -1.232 . . . . 0.0 109.206 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.533 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -107.78 10.69 28.71 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.981 -1.074 . . . . 0.0 110.579 -179.187 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER 176.08 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.519 -1.363 . . . . 0.0 110.144 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 43.0 p -56.62 -44.66 81.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.489 -1.382 . . . . 0.0 109.114 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 99' ' ' THR . 38.2 mt-30 70.42 10.83 7.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.425 -0.797 . . . . 0.0 110.085 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 t -83.27 -5.28 59.08 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.734 0.778 . . . . 0.0 109.143 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.425 HG13 ' C ' ' A' ' 95' ' ' GLY . 12.9 mm -84.57 80.51 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.69 33.38 1.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 110.021 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.544 ' O ' ' N ' ' A' ' 107' ' ' ASP . 1.7 p -161.47 133.78 5.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.953 -1.092 . . . . 0.0 109.893 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.585 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -51.51 -32.62 28.3 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 104' ' ' SER . 5.5 p -61.85 -31.46 71.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -72.02 -49.54 36.07 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.539 ' CD1' HD21 ' A' ' 68' ' ' LEU . 26.9 mt -52.01 -30.9 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.456 ' O ' HD13 ' A' ' 113' ' ' ILE . 19.6 mtt-85 -74.11 -28.54 61.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 109.069 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -66.61 -48.15 70.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.339 -0.851 . . . . 0.0 109.374 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.527 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 49.1 t -65.83 -40.26 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.991 . . . . 0.0 109.507 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.487 ' CE1' HG13 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -57.57 -43.84 84.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.946 -1.096 . . . . 0.0 109.379 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.456 HD13 ' O ' ' A' ' 109' ' ' ARG . 18.7 mt -68.35 -24.8 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 109.623 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -20.11 66.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 109.691 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.47 ' CB ' HD11 ' A' ' 117' ' ' ILE . . . -93.87 9.71 36.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.552 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.44 -5.57 84.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.574 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.6 mp -76.65 55.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -1.175 . . . . 0.0 109.032 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -33.01 149.17 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.347 -0.846 . . . . 0.0 110.743 -179.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.8 -28.41 23.36 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -58.8 -47.56 84.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -1.155 . . . . 0.0 108.849 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -80.41 -34.51 36.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.401 -0.812 . . . . 0.0 109.705 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.641 ' CD2' ' CG1' ' A' ' 78' ' ' VAL . 3.5 t80 -64.17 -50.22 69.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 109.511 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.62 -35.19 75.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.013 -1.054 . . . . 0.0 108.713 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.6 -51.65 67.65 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.519 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -54.91 -52.06 64.12 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.533 ' CD1' ' C ' ' A' ' 126' ' ' TRP . 6.8 t90 -52.75 -55.61 21.59 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.14 -15.74 2.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.677 -0.639 . . . . 0.0 110.435 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -72.55 176.64 5.27 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.909 -1.119 . . . . 0.0 109.845 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -87.33 -39.0 15.73 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.179 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.43 -44.86 83.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 C-N-CA 118.254 -1.378 . . . . 0.0 109.789 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 2.8 t -67.02 -38.87 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.809 -1.182 . . . . 0.0 108.685 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -67.93 -29.37 68.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -70.89 -34.47 71.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.428 -0.795 . . . . 0.0 109.235 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.12 -21.41 43.24 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.277 -0.889 . . . . 0.0 108.617 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.519 ' CG2' ' CB ' ' A' ' 77' ' ' ALA . 17.9 t -81.48 -45.6 20.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.26 83.87 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -32.83 74.28 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.588 ' HG2' ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -60.15 -69.56 0.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.436 -0.79 . . . . 0.0 109.073 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.465 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 6.3 tm-20 -48.61 -33.38 9.74 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.457 ' HA ' ' HB1' ' A' ' 143' ' ' ALA . 9.5 tttm -68.72 -40.78 79.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.426 -0.796 . . . . 0.0 109.038 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.472 ' O ' ' OD2' ' A' ' 144' ' ' ASP . . . -55.52 -55.32 33.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 108.618 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.53 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -70.15 -22.97 62.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.345 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 139' ' ' GLU . . . -78.5 -26.51 45.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.069 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.541 ' OD1' ' CG1' ' A' ' 145' ' ' VAL . 1.4 p30 -82.8 -47.73 11.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.939 -1.1 . . . . 0.0 108.271 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.543 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 14.7 m -85.82 -17.05 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.8 OUTLIER 81.92 -47.54 0.2 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.449 0.643 . . . . 0.0 109.643 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.472 HD12 ' HB3' ' A' ' 25' ' ' PHE . 14.3 tp 67.33 131.63 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.449 -0.782 . . . . 0.0 109.421 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' A' ' 148' ' ' ARG . 2.7 ptt85 -161.46 39.04 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.565 -1.335 . . . . 0.0 110.02 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 161.06 108.28 0.23 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.38 -1.39 . . . . 0.0 110.37 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.598 ' CG1' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -91.88 144.72 29.73 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.371 -1.076 . . . . 0.0 109.792 179.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.461 ' HG2' ' HG2' ' A' ' 163' ' ' PRO . 33.6 Cg_endo -77.09 152.23 94.54 Favored 'Cis proline' 0 C--N 1.317 -1.124 0 C-N-CA 124.1 -1.208 . . . . 0.0 110.501 0.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -126.63 152.26 46.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.426 -1.421 . . . . 0.0 109.353 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.494 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 2.6 tmm? -151.21 135.61 16.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.123 -0.986 . . . . 0.0 109.656 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.503 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 51.0 m-85 -137.1 124.54 22.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.418 -0.801 . . . . 0.0 110.311 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.505 ' O ' ' ND2' ' A' ' 156' ' ' ASN . 52.0 t -92.34 130.48 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.747 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 155' ' ' VAL . 3.9 p30 45.55 22.42 0.1 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.046 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.523 ' N ' ' HB2' ' A' ' 19' ' ' ALA . . . 58.82 56.56 24.64 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.483 ' HB2' ' OD1' ' A' ' 156' ' ' ASN . 0.0 OUTLIER -165.77 -36.85 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.299 -1.118 . . . . 0.0 108.169 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.479 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 75.9 m-85 -115.34 123.44 48.73 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.518 ' CG ' HG21 ' A' ' 10' ' ' THR . 20.8 pt20 -123.3 134.74 54.03 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.94 -1.1 . . . . 0.0 109.877 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.9 mt -70.95 177.83 3.48 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.445 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -147.76 65.95 9.43 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 120.878 -1.139 . . . . 0.0 110.02 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.461 ' HG2' ' HG2' ' A' ' 151' ' ' PRO . 36.0 Cg_endo -79.1 65.76 8.83 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.575 2.183 . . . . 0.0 109.988 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -14.77 38.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.842 . . . . 0.0 109.677 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.25 66.14 0.23 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 5.3 ptp -115.01 42.99 2.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -1.113 . . . . 0.0 109.193 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.567 ' HB2' ' CD2' ' A' ' 174' ' ' PHE . 44.5 t0 -107.19 24.61 12.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.567 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.4 p -97.06 20.71 10.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.464 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 66.5 p -120.32 -49.47 2.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.621 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.9 101.52 1.28 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 109.148 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.46 ' HA ' ' OD1' ' A' ' 167' ' ' ASP . 3.5 mtt -55.84 -17.09 5.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 109.689 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 173' ' ' VAL . 0.0 OUTLIER -75.43 -60.56 2.25 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 172' ' ' ASP . 4.9 t -64.69 -30.69 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.318 -0.864 . . . . 0.0 109.473 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.567 ' CD2' ' HB2' ' A' ' 167' ' ' ASP . 24.9 t80 -67.22 -45.32 77.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.665 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.463 HG23 ' CG1' ' A' ' 42' ' ' ILE . 70.7 t -73.63 -25.17 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.444 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.87 -57.53 3.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.526 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.97 -47.51 74.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.108 -0.995 . . . . 0.0 109.299 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.408 ' HA ' ' OG1' ' A' ' 181' ' ' THR . 31.9 t80 -59.15 -57.24 13.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.962 . . . . 0.0 109.128 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 175' ' ' VAL . . . -51.13 -29.08 12.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.33 -0.856 . . . . 0.0 109.14 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -77.89 -47.0 19.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.334 -0.853 . . . . 0.0 109.202 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.506 ' CG2' ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -50.3 -32.83 18.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.349 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 1.4 t -85.74 -37.62 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.981 . . . . 0.0 108.952 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.45 ' O ' ' OG ' ' A' ' 186' ' ' SER . 16.6 ttpt -60.38 -46.13 91.06 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.281 -0.887 . . . . 0.0 109.037 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -78.93 -27.15 43.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.233 -0.917 . . . . 0.0 108.98 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.474 HD21 ' N ' ' A' ' 185' ' ' LEU . 0.3 OUTLIER -65.69 -19.59 65.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.863 -1.148 . . . . 0.0 108.925 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 183' ' ' LYS . 15.0 p -77.88 -13.04 60.02 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.834 -1.166 . . . . 0.0 108.745 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.85 4.7 51.05 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.307 -0.871 . . . . 0.0 109.329 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 189' ' ' LYS . 1.2 tptp -51.35 -39.57 57.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.2 -0.938 . . . . 0.0 109.578 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 188' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.97 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.34 0.591 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.448 ' C ' ' CD2' ' A' ' 3' ' ' TYR . 26.0 mt-30 -112.39 62.3 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.872 . . . . 0.0 108.721 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.577 ' HB3' ' HB2' ' A' ' 8' ' ' GLN . 4.3 p90 -175.19 97.01 0.08 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.432 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 4.7 mt-10 -114.94 64.57 0.68 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.826 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 4.0 m-20 70.18 96.74 0.07 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.307 -0.871 . . . . 0.0 110.473 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.15 -3.4 81.02 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -100.48 26.98 6.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -1.172 . . . . 0.0 108.533 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.582 ' CB ' ' O ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER 150.42 -35.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.598 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -156.98 131.25 8.49 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.669 -1.269 . . . . 0.0 109.796 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.44 HG21 ' HG3' ' A' ' 160' ' ' GLN . 4.5 t -114.44 174.99 5.68 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.59 152.28 20.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.653 -0.655 . . . . 0.0 109.707 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.485 ' HG ' ' HG2' ' A' ' 160' ' ' GLN . 1.4 mt -92.56 161.31 14.65 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.396 -0.815 . . . . 0.0 109.517 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -84.93 -18.72 33.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.171 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -140.34 110.17 6.93 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.366 -0.833 . . . . 0.0 108.899 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 36.2 Cg_endo -77.22 167.9 24.0 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.352 2.034 . . . . 0.0 111.29 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.448 HG12 ' HB3' ' A' ' 144' ' ' ASP . 7.7 t -128.19 93.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.93 127.54 16.61 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 97.63 -20.8 49.21 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.515 ' HB2' ' N ' ' A' ' 157' ' ' GLY . . . -40.01 159.52 0.13 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.928 . . . . 0.0 109.347 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.559 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 34.9 Cg_endo -77.52 128.26 9.42 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.459 2.106 . . . . 0.0 111.35 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.511 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 10.3 mp0 -41.4 -25.56 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.529 -0.732 . . . . 0.0 109.724 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 21' ' ' GLN . 8.6 t -149.21 84.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.068 -1.02 . . . . 0.0 108.872 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.559 ' HG ' ' CG ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -77.35 126.13 30.43 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.541 ' N ' HD21 ' A' ' 23' ' ' LEU . 0.9 OUTLIER -118.46 104.03 10.31 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.076 -1.015 . . . . 0.0 109.732 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 5.2 m-85 -90.05 123.46 33.95 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.304 -0.873 . . . . 0.0 109.609 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 1.0 OUTLIER -160.91 140.23 10.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.231 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.585 ' HB2' ' CD2' ' A' ' 29' ' ' PHE . 11.1 p -116.29 174.97 5.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 110.183 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 8.3 m-30 -89.3 37.6 0.87 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.501 -0.749 . . . . 0.0 109.021 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.621 ' CZ ' ' CD1' ' A' ' 72' ' ' LEU . 3.2 m-85 -135.65 18.92 3.31 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.773 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.473 ' O ' ' SG ' ' A' ' 33' ' ' CYS . 3.8 m -112.79 164.07 16.35 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.819 -1.176 . . . . 0.0 109.428 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.9 Cg_endo -74.74 -13.19 22.09 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.014 1.809 . . . . 0.0 108.321 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.572 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 36.5 m170 -100.2 -29.7 12.33 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 34' ' ' TYR . 6.1 p -44.58 -40.51 5.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.636 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 21.1 t80 -88.22 -45.49 10.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.789 -0.57 . . . . 0.0 110.259 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -68.54 -22.39 64.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 111.12 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.572 ' CD1' ' HB3' ' A' ' 32' ' ' HIS . 1.6 m-85 -80.16 -25.0 40.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.801 -1.187 . . . . 0.0 110.588 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.418 ' O ' ' CD ' ' A' ' 38' ' ' GLU . 0.4 OUTLIER -117.94 32.46 6.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.899 -1.126 . . . . 0.0 110.073 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.447 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 67.6 mm-40 -146.52 -63.83 0.3 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -0.995 . . . . 0.0 110.566 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 40' ' ' LEU . 4.0 t -101.75 -66.8 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.034 -1.041 . . . . 0.0 110.741 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.44 HD11 HD13 ' A' ' 42' ' ' ILE . 58.0 mt -42.92 -34.21 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 31.8 m170 57.27 20.32 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.172 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.52 HG23 ' CE2' ' A' ' 36' ' ' PHE . 8.5 mt -58.92 -24.32 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.619 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.6 m -77.17 -60.88 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.927 . . . . 0.0 109.722 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -70.84 -33.6 70.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.0 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 45' ' ' ASN . 12.5 t-20 -60.79 -49.73 76.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.661 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 67.3 t -77.27 -16.89 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.898 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -75.8 -27.74 58.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.045 -1.035 . . . . 0.0 109.646 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -72.28 -22.86 61.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -0.974 . . . . 0.0 109.516 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.482 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 24.0 mtmt -97.54 -3.27 40.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.871 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.457 HD21 ' HB ' ' A' ' 54' ' ' VAL . 13.1 mt -73.5 113.42 22.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 109.679 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.532 ' HD2' ' CG2' ' A' ' 54' ' ' VAL . 36.7 Cg_endo -78.54 138.4 15.36 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.174 1.916 . . . . 0.0 110.599 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 51' ' ' PRO . 23.4 tt0 -40.79 119.64 1.16 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.086 0.946 . . . . 0.0 109.573 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.32 -25.77 5.08 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.532 ' CG2' ' HD2' ' A' ' 51' ' ' PRO . 4.5 t -85.33 88.29 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -1.187 . . . . 0.0 109.358 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HE3' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -69.77 99.91 1.43 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.956 -179.666 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.45 ' HG3' HG13 ' A' ' 22' ' ' VAL . 1.8 ttt -92.7 100.63 13.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.573 -0.704 . . . . 0.0 109.321 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.457 ' OG1' ' HE3' ' A' ' 55' ' ' LYS . 89.8 m -95.39 139.89 31.05 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.136 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.547 ' O ' ' NE1' ' A' ' 76' ' ' TRP . 1.4 mppt? -118.14 105.46 11.84 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.589 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.0 m-85 -103.59 164.36 11.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.597 -1.315 . . . . 0.0 111.109 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.587 ' CD2' ' CD2' ' A' ' 72' ' ' LEU . 6.8 t-80 -116.28 134.6 54.73 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.721 0.772 . . . . 0.0 109.141 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.582 ' O ' ' CE1' ' A' ' 60' ' ' HIS . 2.6 m -104.97 160.73 5.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 O-C-N 121.666 -0.646 . . . . 0.0 110.123 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.509 ' HB3' ' N ' ' A' ' 70' ' ' LYS . 1.7 p-10 -103.85 54.53 0.74 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.512 ' CE1' ' HB ' ' A' ' 61' ' ' VAL . 4.9 m-85 -100.73 61.55 1.0 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.671 -0.643 . . . . 0.0 109.764 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.585 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -161.65 -56.66 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.891 -1.124 . . . . 0.0 111.6 179.326 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.585 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -114.82 -18.37 6.48 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.44 -42.63 1.98 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.07 -77.69 0.35 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -1.152 . . . . 0.0 109.45 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.524 ' CD1' ' OD2' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -62.13 -21.61 65.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.45 ' N ' ' CD2' ' A' ' 68' ' ' LEU . . . -60.85 -64.93 3.66 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.509 ' N ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -54.61 -42.47 71.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.249 -1.147 . . . . 0.0 108.502 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.535 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 21.7 t0 -64.93 -29.33 70.26 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.621 ' CD1' ' CZ ' ' A' ' 29' ' ' PHE . 3.5 tt -66.58 -35.4 80.12 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 1.6 m -59.16 -41.73 89.1 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 177.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -61.32 -24.51 66.49 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.494 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -65.28 -34.23 77.86 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.554 ' CH2' ' OE2' ' A' ' 85' ' ' GLU . 53.0 t-105 -71.15 -31.86 68.21 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.528 ' CB ' HG22 ' A' ' 135' ' ' VAL . . . -79.16 -58.95 2.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.337 -0.852 . . . . 0.0 109.411 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.633 ' CG2' ' CE1' ' A' ' 122' ' ' TYR . 93.9 t -53.65 -27.55 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 109.981 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 75' ' ' ALA . . . -81.97 -61.27 1.96 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.984 -1.073 . . . . 0.0 108.654 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 3.1 tpt -49.17 -26.28 2.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.473 ' HB1' HG12 ' A' ' 131' ' ' VAL . . . -77.46 -36.5 52.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.531 -0.731 . . . . 0.0 109.563 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.463 ' O ' HG11 ' A' ' 84' ' ' VAL . 83.1 mt -105.81 8.89 32.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 0.0 110.75 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 54.25 27.89 40.95 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.57 HG22 ' CE1' ' A' ' 112' ' ' PHE . 32.6 m -99.67 29.17 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.461 -1.023 . . . . 0.0 110.049 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.554 ' OE2' ' CH2' ' A' ' 76' ' ' TRP . 5.2 mt-10 -62.88 -79.57 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.133 -0.979 . . . . 0.0 109.641 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -36.41 -37.63 0.13 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.345 0.593 . . . . 0.0 110.805 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.529 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 5.1 mtpt -70.85 -56.72 5.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.402 -0.811 . . . . 0.0 111.459 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.496 ' O ' ' CG ' ' A' ' 92' ' ' LEU . 1.3 m -86.74 -15.11 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.613 -1.304 . . . . 0.0 110.592 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.608 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -74.62 -42.52 58.46 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.589 -1.319 . . . . 0.0 108.341 178.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.406 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -54.68 -53.75 56.85 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.701 -1.249 . . . . 0.0 110.615 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 25.9 Cg_endo -73.07 -19.89 22.39 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 N-CA-C 109.829 -0.873 . . . . 0.0 109.829 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.548 HD22 ' CG2' ' A' ' 111' ' ' VAL . 21.9 mt -83.78 -42.62 16.3 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.608 ' CG ' HG21 ' A' ' 89' ' ' THR . 7.4 m-30 -64.83 -45.74 84.88 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.029 -1.044 . . . . 0.0 108.649 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -72.47 -28.6 63.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.171 -0.956 . . . . 0.0 109.254 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.07 -32.07 82.9 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.536 HG23 ' CB ' ' A' ' 102' ' ' ILE . 2.5 t -99.8 -6.83 9.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.194 -1.18 . . . . 0.0 109.245 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.636 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -108.71 7.5 26.44 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 120.935 -1.103 . . . . 0.0 111.037 -179.279 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.541 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.9 OUTLIER -175.63 66.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.516 -1.365 . . . . 0.0 109.55 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.541 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.08 -48.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.8 -0.563 . . . . 0.0 109.639 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.6 mt-30 74.26 17.7 3.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.197 -0.939 . . . . 0.0 110.276 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.8 t -79.93 -6.53 57.65 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.536 ' CB ' HG23 ' A' ' 96' ' ' VAL . 11.1 mm -89.72 71.08 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.716 -0.615 . . . . 0.0 109.345 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.406 ' N ' HD11 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -136.87 16.19 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 109.235 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -142.64 126.88 17.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.402 -0.811 . . . . 0.0 109.402 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.432 ' N ' ' HB2' ' A' ' 68' ' ' LEU . . . -49.37 -37.32 24.47 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 p -55.86 -31.63 62.94 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.553 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -74.14 -47.76 33.91 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.911 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 71' ' ' ASP . 30.4 mt -48.41 -29.34 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.911 -1.118 . . . . 0.0 108.582 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -74.37 -47.41 34.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 109.614 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -51.98 -40.39 60.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 109.37 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.548 ' CG2' HD22 ' A' ' 92' ' ' LEU . 2.4 t -71.18 -40.1 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.164 -0.96 . . . . 0.0 109.532 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.57 ' CE1' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -65.47 -33.46 75.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.564 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mt -76.42 -25.4 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.917 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -65.39 -20.0 66.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.059 -1.026 . . . . 0.0 109.61 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.458 ' HB1' HG11 ' A' ' 88' ' ' VAL . . . -90.05 4.72 49.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 109.722 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.6 0.37 69.65 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.507 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.5 mm -79.5 60.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -1.149 . . . . 0.0 109.555 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 117' ' ' ILE . 64.7 mttt -34.85 153.17 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.257 -0.902 . . . . 0.0 110.45 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.459 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -59.69 -27.69 64.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -66.45 -43.92 84.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -1.17 . . . . 0.0 109.607 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.0 -50.05 45.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.327 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CE1' ' CG2' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -65.34 -56.35 13.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.369 -0.832 . . . . 0.0 108.845 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 27.5 t70 -45.56 -39.22 7.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.101 -0.999 . . . . 0.0 108.892 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.69 -44.36 61.89 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.302 -0.874 . . . . 0.0 108.791 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.496 ' O ' ' HB ' ' A' ' 131' ' ' VAL . . . -54.63 -49.09 71.34 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -59.27 -58.74 7.29 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -53.86 -15.97 1.58 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.585 -0.697 . . . . 0.0 110.119 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -70.74 175.47 4.95 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.96 -1.088 . . . . 0.0 109.766 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.58 ' CE2' ' CG2' ' A' ' 130' ' ' VAL . 41.4 p90 -94.09 -37.03 11.82 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.776 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.58 ' CG2' ' CE2' ' A' ' 129' ' ' PHE . 25.0 t -67.18 -47.91 80.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.13 -1.428 . . . . 0.0 109.578 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 125' ' ' ALA . 16.6 t -63.41 -40.24 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.977 -1.077 . . . . 0.0 108.561 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -37.71 85.18 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.456 -0.778 . . . . 0.0 109.056 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -29.5 70.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.057 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.443 ' O ' HD21 ' A' ' 134' ' ' LEU . 0.4 OUTLIER -77.12 -30.8 55.36 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.528 HG22 ' CB ' ' A' ' 77' ' ' ALA . 9.8 t -76.04 -41.15 38.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.6 -48.72 80.56 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -37.17 82.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 109.139 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.589 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 18.9 tm0? -55.87 -62.42 1.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.037 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.433 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 11.6 mt-10 -48.35 -33.57 9.2 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -72.46 -29.29 63.54 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.351 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.581 ' HB3' ' CE2' ' A' ' 59' ' ' TYR . . . -62.46 -57.19 12.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 108.712 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -68.55 -35.87 78.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.519 -0.738 . . . . 0.0 110.036 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 139' ' ' GLU . . . -77.81 -16.64 58.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.043 -1.035 . . . . 0.0 109.835 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.448 ' HB3' HG12 ' A' ' 16' ' ' VAL . 5.7 m-20 -81.49 -43.76 18.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -0.966 . . . . 0.0 108.95 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.54 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 29.7 m -105.03 -9.4 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 108.885 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.54 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.9 OUTLIER 82.24 -43.72 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.519 -0.738 . . . . 0.0 109.876 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.582 ' CD2' ' CG1' ' A' ' 61' ' ' VAL . 14.1 tp 64.5 134.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.35 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -160.75 32.85 0.15 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.533 -1.354 . . . . 0.0 110.002 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 151' ' ' PRO . . . 175.01 77.97 0.05 OUTLIER Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.995 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.481 HG13 HG12 ' A' ' 61' ' ' VAL . 3.8 m -80.15 135.91 54.13 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.119 -1.224 . . . . 0.0 107.92 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 149' ' ' GLY . 30.9 Cg_endo -71.18 152.85 96.04 Favored 'Cis proline' 0 C--N 1.317 -1.098 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.508 2.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . . . -140.29 159.84 41.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.689 -1.257 . . . . 0.0 109.026 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.53 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 30.3 tpp -142.65 138.18 30.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.024 -1.048 . . . . 0.0 110.369 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.561 ' N ' ' CD1' ' A' ' 154' ' ' PHE . 6.3 m-85 -143.22 127.34 17.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.436 -0.79 . . . . 0.0 109.577 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 54.9 t -103.95 130.59 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.026 . . . . 0.0 109.501 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.424 ' C ' ' O ' ' A' ' 155' ' ' VAL . 1.9 t-20 45.62 26.39 0.33 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.515 ' N ' ' HB2' ' A' ' 19' ' ' ALA . . . 52.07 27.46 22.61 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.402 -1.38 . . . . 0.0 109.88 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.66 -15.96 4.35 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.735 -1.45 . . . . 0.0 109.308 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.558 ' CE2' ' HE3' ' A' ' 188' ' ' LYS . 65.2 m-85 -143.1 125.6 15.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.001 . . . . 0.0 109.149 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 153' ' ' MET . 1.1 pt20 -119.7 139.4 52.31 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.03 -1.044 . . . . 0.0 109.778 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.444 ' HG ' ' HB3' ' A' ' 153' ' ' MET . 7.7 mt -75.78 173.41 11.17 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -158.6 87.08 2.32 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 109.758 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.01 35.23 0.56 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.872 2.381 . . . . 0.0 111.225 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -91.08 154.86 19.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.991 -1.068 . . . . 0.0 108.7 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 89.63 -34.18 4.12 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.452 ' O ' ' N ' ' A' ' 168' ' ' THR . 0.0 OUTLIER -89.48 -112.77 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.987 -1.302 . . . . 0.0 109.345 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 166' ' ' MET . 25.9 t0 41.34 27.79 0.06 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.981 -1.074 . . . . 0.0 109.853 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 166' ' ' MET . 81.4 p -85.61 -70.39 0.59 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.557 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.451 ' O ' ' OG ' ' A' ' 169' ' ' SER . 3.3 t -171.89 58.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.88 . . . . 0.0 109.36 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -148.34 64.07 1.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.145 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.444 ' O ' HG22 ' A' ' 175' ' ' VAL . 4.9 mmt -64.92 -15.55 62.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.312 -0.867 . . . . 0.0 109.635 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.11 -63.13 1.29 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.352 0.596 . . . . 0.0 109.474 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.412 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 4.0 t -67.3 -18.27 23.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.153 -0.967 . . . . 0.0 109.475 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -76.52 -47.16 23.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.101 -1.0 . . . . 0.0 109.663 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 171' ' ' MET . 15.2 t -70.91 -25.05 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 109.376 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -80.63 -61.01 2.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.263 -0.898 . . . . 0.0 109.257 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 173' ' ' VAL . 0.5 OUTLIER -55.12 -42.72 73.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.218 -0.927 . . . . 0.0 109.198 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.515 ' CE1' HG22 ' A' ' 182' ' ' VAL . 9.7 t80 -61.32 -48.65 80.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.281 -0.887 . . . . 0.0 109.364 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.67 -30.07 65.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.343 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -77.38 -43.47 32.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.495 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.502 ' O ' ' CG ' ' A' ' 185' ' ' LEU . 0.1 OUTLIER -57.75 -34.09 69.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.0 . . . . 0.0 109.465 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.515 HG22 ' CE1' ' A' ' 178' ' ' TYR . 51.7 t -78.45 -36.09 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.154 -0.966 . . . . 0.0 109.044 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -52.04 67.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.289 -0.882 . . . . 0.0 109.169 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -77.11 -32.0 56.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.296 -0.878 . . . . 0.0 109.263 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.532 HD21 ' N ' ' A' ' 185' ' ' LEU . 0.2 OUTLIER -62.67 -17.06 59.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.06 -1.025 . . . . 0.0 109.653 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.519 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 87.8 p -73.08 -12.3 60.86 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.856 -1.153 . . . . 0.0 108.709 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.21 0.95 57.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.423 -0.798 . . . . 0.0 109.386 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.558 ' HE3' ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -60.75 -37.13 80.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.399 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 pttm . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.464 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.455 ' C ' ' CD2' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -105.67 59.09 0.66 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.328 -0.857 . . . . 0.0 109.031 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.455 ' CD2' ' C ' ' A' ' 2' ' ' GLN . 3.1 m-85 56.4 74.44 0.4 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.659 -0.651 . . . . 0.0 109.486 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.41 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 1.6 pt-20 -105.84 54.96 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.588 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 4' ' ' GLU . 1.2 m-20 42.48 82.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.751 -0.593 . . . . 0.0 110.1 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 131.88 -29.22 3.42 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.701 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.41 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 5.4 tptt -83.18 -69.05 0.66 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.869 -1.371 . . . . 0.0 109.27 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.495 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 77.6 mm-40 -92.97 2.01 57.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.744 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 6' ' ' GLY . 1.1 p90 176.67 132.38 0.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.078 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.5 ' CG2' ' CD ' ' A' ' 160' ' ' GLN . 11.3 t -112.26 -179.63 3.73 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 m -116.62 139.61 50.32 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.487 0.66 . . . . 0.0 109.615 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.439 HD13 ' C ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -95.18 169.83 9.82 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.389 -0.819 . . . . 0.0 109.375 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 14.3 mp0 -98.19 12.35 34.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 109.82 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 5.4 mtmt -141.51 80.47 16.2 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.925 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -79.13 159.26 26.8 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.719 2.279 . . . . 0.0 109.986 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.537 ' CG2' ' OD1' ' A' ' 144' ' ' ASP . 3.4 t -126.72 97.86 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.093 -1.004 . . . . 0.0 110.154 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.79 128.54 8.82 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 93.03 -14.9 64.14 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.644 -1.783 . . . . 0.0 108.644 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.562 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -39.25 161.7 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.946 . . . . 0.0 110.095 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.558 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.2 Cg_endo -78.56 127.53 8.13 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.746 2.297 . . . . 0.0 111.201 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 2.0 mm-40 -42.35 -24.48 0.05 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.511 -0.743 . . . . 0.0 109.798 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.462 HG13 ' O ' ' A' ' 22' ' ' VAL . 8.1 t -147.14 86.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.009 -1.057 . . . . 0.0 108.75 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.645 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -79.88 125.55 29.87 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.516 ' N ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -105.55 97.95 7.71 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.175 -0.953 . . . . 0.0 110.438 -178.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.645 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 4.7 m-85 -89.58 106.41 18.44 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 3.2 p90 -153.32 143.6 22.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.044 -1.035 . . . . 0.0 109.946 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.593 ' HB3' ' CE1' ' A' ' 60' ' ' HIS . 2.3 p -126.44 -165.02 1.39 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.68 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -115.67 53.46 0.84 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.758 -1.213 . . . . 0.0 108.224 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.567 ' CE1' HD21 ' A' ' 72' ' ' LEU . 9.1 m-85 -137.71 0.35 2.22 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.411 -0.806 . . . . 0.0 110.645 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.574 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 5.1 m -111.27 169.11 6.65 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.782 -1.199 . . . . 0.0 108.604 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 30.7 Cg_endo -73.97 -54.73 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.712 1.608 . . . . 0.0 109.344 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -68.66 -19.08 64.38 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 177.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -50.49 -47.47 57.15 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.596 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 5.7 t80 -79.82 -37.04 35.97 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.515 -0.74 . . . . 0.0 109.748 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 8.4 mm-40 -70.85 -25.08 62.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 110.054 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.469 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -83.74 -15.68 47.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.166 -0.959 . . . . 0.0 110.943 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.7 mm-40 -131.22 44.28 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.728 -1.232 . . . . 0.0 111.202 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -174.07 -60.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.004 . . . . 0.0 110.984 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.4 t -90.18 -53.45 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.045 -1.034 . . . . 0.0 111.143 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.587 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 94.8 mt -59.4 -11.24 4.04 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.977 -1.077 . . . . 0.0 110.76 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 56.8 p-80 41.31 28.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 109.663 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.465 ' O ' HG21 ' A' ' 46' ' ' VAL . 19.4 mt -68.71 -33.23 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 109.272 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 43.7 p -72.87 -26.05 61.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 109.877 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.09 -54.41 4.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 0.0 109.83 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -52.09 -53.99 35.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.163 -0.961 . . . . 0.0 109.755 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 42' ' ' ILE . 19.1 m -57.53 -35.32 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.53 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.488 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -70.78 -39.33 73.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -60.26 -22.77 63.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -111.22 9.44 21.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 0.0 109.807 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.488 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 8.3 mt -78.65 130.14 71.84 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 110.042 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.45 ' C ' ' H ' ' A' ' 53' ' ' GLY . 35.3 Cg_endo -78.47 154.05 27.5 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.408 2.072 . . . . 0.0 108.863 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' CG ' ' O ' ' A' ' 52' ' ' GLU . 11.8 tt0 -69.84 21.66 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.473 -1.392 . . . . 0.0 111.54 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 51' ' ' PRO . . . -121.61 29.99 5.48 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.468 ' CG2' ' HB2' ' A' ' 186' ' ' SER . 43.9 t -145.6 117.21 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.09 107.35 19.15 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.415 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -91.39 96.36 10.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.9 OUTLIER -91.78 140.22 29.91 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.961 -1.095 . . . . 0.0 110.342 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.32 112.15 21.13 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.484 -0.76 . . . . 0.0 109.594 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 1.9 m-85 -116.67 167.43 11.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -0.964 . . . . 0.0 110.678 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' A' ' 27' ' ' SER . 54.8 t-80 -108.23 131.41 54.71 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.544 ' CG1' ' CG1' ' A' ' 150' ' ' VAL . 1.8 m -69.48 151.47 9.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.648 -0.658 . . . . 0.0 110.033 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 4.4 p-10 -116.57 42.61 2.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.594 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 1.6 p90 -144.48 59.15 1.33 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.153 -0.967 . . . . 0.0 109.67 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.49 ' CE ' ' SG ' ' A' ' 30' ' ' CYS . 0.4 OUTLIER -129.98 36.5 4.03 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.402 -0.811 . . . . 0.0 109.126 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.58 -32.02 0.34 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.17 -40.26 3.09 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -88.34 -79.55 0.3 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.109 -1.23 . . . . 0.0 110.628 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.614 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -79.68 -18.29 51.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.866 -1.146 . . . . 0.0 109.564 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.427 ' H ' HD11 ' A' ' 68' ' ' LEU . . . -53.19 -46.62 62.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -44.35 94.98 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.76 -27.66 67.78 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.582 HD22 ' CE1' ' A' ' 60' ' ' HIS . 27.8 tp -60.97 -44.8 96.83 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.486 ' CG2' ' HB3' ' A' ' 138' ' ' GLN . 1.6 m -60.3 -42.9 96.5 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.556 ' O ' ' CG2' ' A' ' 78' ' ' VAL . 1.6 tt0 -55.61 -26.14 42.4 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -67.41 -42.07 83.86 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -58.43 -28.2 65.04 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.477 ' CB ' HG21 ' A' ' 135' ' ' VAL . . . -85.94 -43.15 13.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.525 -0.734 . . . . 0.0 110.274 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.645 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 1.2 t -68.74 -30.87 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.903 -1.123 . . . . 0.0 109.693 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.447 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -82.63 -55.78 4.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.01 -1.057 . . . . 0.0 108.374 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.412 ' SD ' HD23 ' A' ' 134' ' ' LEU . 3.0 ttt -49.67 -28.55 6.07 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -72.98 -39.0 66.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.501 -0.749 . . . . 0.0 109.183 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.413 ' O ' HG11 ' A' ' 84' ' ' VAL . 66.1 mt -101.28 8.64 42.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.262 -0.899 . . . . 0.0 110.23 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.97 24.05 7.96 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.425 ' O ' ' C ' ' A' ' 85' ' ' GLU . 33.5 m -90.27 1.44 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -1.092 . . . . 0.0 110.173 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 89' ' ' THR . 2.5 mt-10 -44.68 -66.79 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.979 -1.076 . . . . 0.0 109.436 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -41.03 -34.16 0.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.432 -0.793 . . . . 0.0 110.109 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -80.99 -51.41 8.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.329 -0.857 . . . . 0.0 111.294 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.522 HG21 ' CD1' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -87.18 -11.46 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.622 -1.299 . . . . 0.0 110.896 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.597 HG21 ' CD1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -71.64 -43.94 65.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.731 -1.231 . . . . 0.0 108.893 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.404 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -54.1 -54.26 49.35 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.515 -1.366 . . . . 0.0 110.657 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.451 ' HD2' ' C ' ' A' ' 88' ' ' VAL . 27.1 Cg_endo -72.86 -18.1 24.93 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 N-CA-C 109.844 -0.868 . . . . 0.0 109.844 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.522 ' CD1' HG21 ' A' ' 88' ' ' VAL . 17.5 mt -86.62 -43.73 12.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.892 . . . . 0.0 108.874 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.68 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 5.1 m-30 -63.53 -48.1 78.9 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.043 -1.036 . . . . 0.0 108.486 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.84 -29.28 63.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 108.977 179.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.403 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -57.05 -39.0 88.96 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.525 HG23 ' CB ' ' A' ' 102' ' ' ILE . 1.9 t -100.36 -3.37 9.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.211 -1.17 . . . . 0.0 109.387 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.596 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -101.56 2.6 39.2 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 120.853 -1.154 . . . . 0.0 110.714 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.553 ' O ' ' CG2' ' A' ' 99' ' ' THR . 1.1 mmtp -175.18 72.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.692 -1.255 . . . . 0.0 109.387 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.553 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.28 -49.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 99' ' ' THR . 3.0 mt-30 72.8 15.0 4.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 110.597 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 t -82.93 -7.85 59.62 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.859 0.838 . . . . 0.0 108.797 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.525 ' CB ' HG23 ' A' ' 96' ' ' VAL . 9.1 mm -82.44 69.63 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 32.56 3.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.729 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.541 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 32.1 p -156.56 131.0 8.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.989 -1.069 . . . . 0.0 110.201 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.572 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -49.79 -34.21 18.8 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.83 -34.74 75.02 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -66.15 -50.71 63.02 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.535 HD13 ' HB2' ' A' ' 68' ' ' LEU . 24.6 mt -49.38 -28.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.771 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -39.03 47.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.926 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 1.1 p30 -59.84 -46.08 90.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.114 -0.991 . . . . 0.0 109.626 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.525 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 58.7 t -68.65 -39.74 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.936 -1.103 . . . . 0.0 109.25 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.425 ' O ' ' HB ' ' A' ' 117' ' ' ILE . 1.9 m-85 -59.9 -42.84 94.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.181 -0.95 . . . . 0.0 109.544 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.0 mt -69.85 -23.83 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 109.403 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 110' ' ' ASP . 1.9 m-80 -63.33 -17.99 63.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 109.592 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.467 ' CB ' HD11 ' A' ' 117' ' ' ILE . . . -99.08 11.51 38.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.912 . . . . 0.0 109.344 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.35 -7.71 81.42 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.563 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.8 mp -77.32 55.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -1.077 . . . . 0.0 109.252 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.486 ' C ' ' O ' ' A' ' 117' ' ' ILE . 3.0 mtmp? -35.19 149.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.215 -0.928 . . . . 0.0 110.475 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 123' ' ' ASP . . . -53.57 -27.91 35.74 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -61.86 -59.06 5.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.034 -1.274 . . . . 0.0 109.363 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -64.76 -41.95 95.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 109.226 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.645 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 3.1 t80 -56.5 -48.9 76.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.008 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.2 OUTLIER -59.97 -30.87 69.4 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.887 . . . . 0.0 109.064 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.43 -51.36 60.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.344 -0.847 . . . . 0.0 108.852 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.5 ' O ' ' HB ' ' A' ' 131' ' ' VAL . . . -51.89 -52.8 47.26 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.405 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 3.7 t-105 -57.87 -56.49 21.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.81 -16.17 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 110.282 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 50.2 m -74.03 173.69 9.67 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.901 -1.124 . . . . 0.0 109.991 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -90.63 -38.62 13.0 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.463 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.467 ' O ' ' OG ' ' A' ' 133' ' ' SER . 41.1 t -64.77 -47.17 89.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.085 -1.446 . . . . 0.0 109.244 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' A' ' 125' ' ' ALA . 15.6 t -62.56 -32.66 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -67.89 -39.41 83.65 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.467 ' OG ' ' O ' ' A' ' 130' ' ' VAL . 90.0 p -61.74 -34.59 76.09 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.412 HD23 ' SD ' ' A' ' 80' ' ' MET . 0.4 OUTLIER -79.18 -18.36 53.2 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.288 -0.882 . . . . 0.0 108.662 179.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.477 HG21 ' CB ' ' A' ' 77' ' ' ALA . 3.5 t -80.17 -47.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.43 -32.87 74.43 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.424 ' O ' ' HB1' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -71.58 -33.53 69.14 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.577 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 8.9 mt-30 -74.24 -66.98 0.66 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 108.955 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.456 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 1.8 tt0 -45.36 -43.96 11.38 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.472 ' O ' ' OD2' ' A' ' 144' ' ' ASP . 0.1 OUTLIER -69.78 -28.39 65.7 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -56.19 -63.5 1.17 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.37 -0.831 . . . . 0.0 108.874 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.54 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -73.57 -19.43 60.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 109.834 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 139' ' ' GLU . . . -79.31 -29.48 42.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.01 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.537 ' OD1' ' CG2' ' A' ' 16' ' ' VAL . 2.8 p30 -81.85 -45.04 16.08 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.613 ' CG2' ' CE2' ' A' ' 25' ' ' PHE . 24.7 m -87.26 -14.91 9.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.54 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.5 tp-100 79.65 -50.5 0.39 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.63 -0.669 . . . . 0.0 109.501 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.513 HD21 ' CD1' ' A' ' 25' ' ' PHE . 12.2 tp 62.09 134.46 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.482 -0.761 . . . . 0.0 109.281 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -160.77 27.76 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.573 -1.33 . . . . 0.0 109.725 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 179.56 102.93 0.17 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.331 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.544 ' CG1' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.92 144.06 27.87 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 0.0 109.175 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.405 ' O ' ' HG3' ' A' ' 163' ' ' PRO . 35.7 Cg_endo -77.65 153.07 93.75 Favored 'Cis proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.946 -1.272 . . . . 0.0 110.649 0.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.467 ' HB1' HD12 ' A' ' 147' ' ' LEU . . . -129.43 130.05 45.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.39 -1.444 . . . . 0.0 109.408 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.523 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -119.59 115.57 24.25 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.256 -0.903 . . . . 0.0 109.152 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.547 ' CD1' ' CB ' ' A' ' 160' ' ' GLN . 13.7 m-30 -115.01 127.5 55.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.207 -0.933 . . . . 0.0 110.804 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 24.4 t -96.81 131.99 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.918 . . . . 0.0 109.684 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.422 ' C ' ' HB1' ' A' ' 19' ' ' ALA . 2.8 t-20 45.32 22.3 0.08 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.407 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.562 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.16 58.04 16.17 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -166.52 -36.1 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.634 ' CE2' ' CG ' ' A' ' 188' ' ' LYS . 96.4 m-85 -116.34 123.19 47.02 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.547 ' CB ' ' CD1' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -117.89 112.97 21.05 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.296 -0.877 . . . . 0.0 109.873 -179.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.1 mt -60.37 170.68 1.26 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 109.063 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 162' ' ' ASN . 26.3 p-10 -131.42 113.29 15.58 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.548 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.405 ' HG3' ' O ' ' A' ' 151' ' ' PRO . 36.2 Cg_endo -78.26 5.85 5.14 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.407 2.071 . . . . 0.0 110.542 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -81.59 4.81 20.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.627 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -80.38 -15.21 78.85 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 6.8 mtp -80.33 -94.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.974 -1.309 . . . . 0.0 109.584 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.402 ' O ' HG21 ' A' ' 168' ' ' THR . 11.7 t0 50.28 28.24 3.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.125 -0.984 . . . . 0.0 109.545 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.446 ' O ' ' CB ' ' A' ' 169' ' ' SER . 6.0 p -146.86 -87.56 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.568 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 168' ' ' THR . 1.9 t 167.04 71.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.937 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -139.68 58.97 1.6 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.277 -0.89 . . . . 0.0 109.45 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.47 ' O ' ' CG2' ' A' ' 175' ' ' VAL . 3.1 mtt -59.66 -17.45 34.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.397 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.61 -65.79 0.97 Allowed 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.0 t -57.84 -25.2 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.251 -0.906 . . . . 0.0 108.827 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.491 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 50.8 t80 -74.12 -39.82 63.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 109.112 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 171' ' ' MET . 96.9 t -70.91 -27.77 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 108.95 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.66 -64.83 1.1 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.248 -0.907 . . . . 0.0 108.904 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -50.31 -42.31 52.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.187 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.534 ' C ' ' CD1' ' A' ' 178' ' ' TYR . 8.1 t80 -61.42 -53.77 52.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.513 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 175' ' ' VAL . . . -53.38 -24.11 11.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.922 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.41 -43.62 23.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.555 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.479 ' O ' HD21 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -59.63 -42.28 92.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 109.386 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.469 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 43.2 t -74.01 -37.3 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.056 -1.028 . . . . 0.0 109.226 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -52.28 65.91 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.89 . . . . 0.0 109.193 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -76.72 -33.64 58.16 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.263 -0.898 . . . . 0.0 109.061 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.517 HD21 ' N ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -58.17 -19.54 33.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.982 -1.074 . . . . 0.0 109.839 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.468 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 1.3 t -73.17 -12.65 60.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.81 -1.181 . . . . 0.0 108.71 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.57 9.01 39.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.84 . . . . 0.0 109.44 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.634 ' CG ' ' CE2' ' A' ' 159' ' ' TYR . 6.1 tptm -78.1 -13.88 59.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.408 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.567 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 20.5 mt-30 -105.84 57.8 0.66 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.919 . . . . 0.0 109.101 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.567 ' CG ' ' C ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER 176.09 85.18 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.611 -0.68 . . . . 0.0 109.191 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -108.35 62.36 0.61 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.796 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.2 t70 44.82 82.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.408 -0.807 . . . . 0.0 109.404 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 118.38 -22.74 9.39 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.462 ' HB3' ' OE1' ' A' ' 8' ' ' GLN . 3.0 tttp -80.13 -68.67 0.65 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.107 -1.231 . . . . 0.0 108.709 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' A' ' 2' ' ' GLN . 17.2 mp0 -103.94 9.1 36.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.285 -0.884 . . . . 0.0 109.773 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.527 ' CE1' ' HB2' ' A' ' 3' ' ' TYR . 3.7 p90 177.33 134.73 0.07 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.129 -0.982 . . . . 0.0 109.171 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -117.68 178.83 4.26 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 m -115.19 145.59 42.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.706 -0.621 . . . . 0.0 109.681 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.01 165.87 12.43 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.424 -0.797 . . . . 0.0 109.567 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -80.48 -15.64 56.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.599 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.02 115.17 11.04 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.404 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.492 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 34.4 Cg_endo -77.3 162.7 30.89 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.401 2.067 . . . . 0.0 110.531 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.527 HG23 ' CG1' ' A' ' 145' ' ' VAL . 48.1 t -105.93 79.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -46.6 128.25 10.23 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 93.77 -13.15 68.1 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 18' ' ' GLY . . . -37.36 152.28 0.13 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.75 -0.853 . . . . 0.0 109.043 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.521 ' O ' ' O ' ' A' ' 55' ' ' LYS . 36.6 Cg_endo -78.94 40.77 0.97 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.244 1.962 . . . . 0.0 112.631 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER 67.04 -43.22 0.44 Allowed 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.376 -0.827 . . . . 0.0 110.575 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 21' ' ' GLN . 32.2 t -150.52 78.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.57 HD12 ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -70.66 127.49 32.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -178.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.54 ' N ' HD21 ' A' ' 23' ' ' LEU . 2.1 tt0 -111.1 149.3 31.02 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.119 -0.988 . . . . 0.0 109.625 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.57 ' CE1' HD12 ' A' ' 23' ' ' LEU . 15.0 m-85 -122.86 126.43 47.32 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.467 -0.771 . . . . 0.0 109.689 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 1.9 p90 -159.09 140.97 13.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.354 -0.842 . . . . 0.0 109.486 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.576 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 75.2 p -122.01 169.94 10.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -0.98 . . . . 0.0 110.574 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' A' ' 29' ' ' PHE . 7.5 m-30 -92.3 37.66 1.0 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.582 ' CD1' ' O ' ' A' ' 28' ' ' PHE . 2.6 m-85 -142.59 20.01 2.02 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.092 -1.005 . . . . 0.0 110.258 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.542 ' CB ' ' CE1' ' A' ' 32' ' ' HIS . 1.3 m -117.95 166.93 12.3 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.642 -1.286 . . . . 0.0 109.617 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 33.6 Cg_endo -75.54 -38.13 1.5 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.287 1.991 . . . . 0.0 108.628 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.556 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 14.6 p80 -73.9 -25.49 60.04 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 22.7 t -44.75 -62.9 1.04 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 8.4 t80 -65.54 -46.41 79.65 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.287 0.565 . . . . 0.0 109.989 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.515 ' HA ' ' CG2' ' A' ' 39' ' ' VAL . 2.1 mm-40 -61.01 -23.64 65.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 110.538 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.467 ' N ' ' O ' ' A' ' 32' ' ' HIS . 3.4 m-30 -78.37 -43.1 28.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -110.98 8.06 21.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.748 -1.22 . . . . 0.0 111.391 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 27.8 mm-40 -135.01 29.15 3.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.562 -1.336 . . . . 0.0 110.346 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.515 ' CG2' ' HA ' ' A' ' 35' ' ' GLN . 98.0 t -150.92 -76.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.812 -1.18 . . . . 0.0 109.522 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HB2' HG13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -106.22 20.09 19.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.178 -0.951 . . . . 0.0 109.932 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 45' ' ' ASN . 5.3 m170 43.13 31.36 0.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.14 -0.975 . . . . 0.0 110.066 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.454 ' CG1' HG23 ' A' ' 175' ' ' VAL . 22.4 mt -50.48 -25.02 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.003 -1.061 . . . . 0.0 109.416 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.25 -55.9 5.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 110.186 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.483 ' HA ' ' HG2' ' A' ' 47' ' ' LYS . 6.9 m-20 -87.09 -33.57 19.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.355 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 41' ' ' HIS . 0.2 OUTLIER -60.54 -27.68 67.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.5 -179.267 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.501 ' O ' ' CD1' ' A' ' 50' ' ' LEU . 9.1 p -84.46 -24.84 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.028 -1.045 . . . . 0.0 111.091 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.54 ' HG3' ' N ' ' A' ' 48' ' ' LYS . 4.7 ptpt -78.68 -25.29 44.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.737 -1.227 . . . . 0.0 110.416 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.54 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 1.7 mtpt -63.84 -32.76 74.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.953 -1.092 . . . . 0.0 109.311 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -82.82 9.66 9.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.865 . . . . 0.0 109.411 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.517 ' N ' HD11 ' A' ' 50' ' ' LEU . 8.6 mp -98.64 108.5 48.62 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.128 -0.983 . . . . 0.0 109.449 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.502 ' O ' ' C ' ' A' ' 52' ' ' GLU . 35.1 Cg_endo -77.06 145.9 25.12 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.4 2.067 . . . . 0.0 110.478 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 51' ' ' PRO . 1.2 tt0 -33.46 118.13 0.32 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.266 1.031 . . . . 0.0 110.127 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.36 -26.64 5.46 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.516 ' CG1' ' HG ' ' A' ' 50' ' ' LEU . 3.7 t -97.58 93.5 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -1.102 . . . . 0.0 108.645 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -84.44 118.25 24.16 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.962 0.887 . . . . 0.0 110.079 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.455 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.4 OUTLIER -111.82 98.91 7.72 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.068 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 20' ' ' PRO . 7.4 m -99.6 128.18 45.7 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.716 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 115.17 29.89 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.572 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 1.3 m-85 -112.62 175.98 5.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.852 -1.155 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.589 ' CE1' HD21 ' A' ' 72' ' ' LEU . 28.9 t-80 -104.41 150.73 24.27 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.032 0.92 . . . . 0.0 109.322 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.584 HG22 ' CD1' ' A' ' 63' ' ' PHE . 1.3 m -96.96 160.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.369 0.604 . . . . 0.0 110.015 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -125.09 56.69 1.32 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.41 -0.806 . . . . 0.0 108.866 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.584 ' CD1' HG22 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -133.81 52.1 2.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.99 . . . . 0.0 110.974 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.572 ' HE1' ' CE2' ' A' ' 29' ' ' PHE . 3.1 ppp? -128.92 34.0 4.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.395 -0.815 . . . . 0.0 108.818 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.76 -37.35 3.24 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.91 -13.19 66.71 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.761 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -79.3 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.666 -1.49 . . . . 0.0 109.381 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -86.14 -28.22 24.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.037 -1.04 . . . . 0.0 109.345 179.469 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.562 ' N ' ' CD2' ' A' ' 68' ' ' LEU . . . -59.08 -55.08 32.88 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.453 ' NZ ' ' OE2' ' A' ' 139' ' ' GLU . 0.9 OUTLIER -56.87 -47.2 81.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.305 -1.114 . . . . 0.0 108.695 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 23.8 t0 -67.35 -24.37 65.71 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.589 HD21 ' CE1' ' A' ' 60' ' ' HIS . 5.8 tt -71.48 -39.52 70.84 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.508 ' CG2' ' OE1' ' A' ' 138' ' ' GLN . 1.3 m -57.87 -43.58 86.08 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.515 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 4.0 tt0 -56.71 -29.0 62.0 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -62.3 -40.15 95.36 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -61.9 -30.4 70.86 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.41 -48.02 10.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -0.807 . . . . 0.0 109.968 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.636 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 1.5 t -63.3 -27.7 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 0.0 109.442 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.45 ' HB3' HG21 ' A' ' 84' ' ' VAL . . . -83.14 -55.72 4.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.212 -0.93 . . . . 0.0 109.138 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.41 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -45.26 -29.15 0.93 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.277 -0.889 . . . . 0.0 108.779 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.464 ' HB2' HG21 ' A' ' 131' ' ' VAL . . . -74.4 -38.37 63.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.396 -0.815 . . . . 0.0 109.509 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.475 ' CB ' HG11 ' A' ' 84' ' ' VAL . 44.3 mt -104.63 12.64 32.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 110.022 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.05 23.01 1.44 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.572 HG22 ' CE1' ' A' ' 112' ' ' PHE . 21.9 m -84.95 -10.35 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -1.204 . . . . 0.0 110.189 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 84' ' ' VAL . 5.4 pt-20 -43.01 -59.02 2.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.076 -1.015 . . . . 0.0 109.823 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -33.29 2.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.111 -0.993 . . . . 0.0 109.682 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 84' ' ' VAL . 44.2 mtpt -83.89 -51.6 7.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.557 -0.714 . . . . 0.0 111.133 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.475 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.4 m -80.48 -6.07 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.787 -1.196 . . . . 0.0 110.676 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.649 ' CG2' ' CE2' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -78.24 -44.33 25.86 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.805 -1.184 . . . . 0.0 108.513 178.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.456 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -52.16 -52.01 66.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.568 -1.333 . . . . 0.0 110.227 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.49 ' HG2' HG11 ' A' ' 111' ' ' VAL . 24.4 Cg_endo -73.43 -20.51 20.75 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 N-CA-C 109.906 -0.844 . . . . 0.0 109.906 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.542 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 12.7 mt -83.83 -41.88 17.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 108.646 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.649 ' CE2' ' CG2' ' A' ' 89' ' ' THR . 8.3 m-30 -67.3 -45.08 77.62 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.125 -0.984 . . . . 0.0 108.589 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -74.65 -33.35 62.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.56 -0.713 . . . . 0.0 109.428 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.435 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -61.24 -32.1 79.46 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.493 HG13 ' HA ' ' A' ' 29' ' ' PHE . 2.5 t -99.48 -9.55 8.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.344 -1.092 . . . . 0.0 109.278 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 2.4 mt-30 -112.41 9.7 19.75 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.891 -1.131 . . . . 0.0 110.92 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.553 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.6 OUTLIER -164.63 59.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.472 -1.393 . . . . 0.0 109.408 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.553 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 163.62 -49.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.472 -0.768 . . . . 0.0 109.119 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 99' ' ' THR . 4.1 mp0 73.71 14.98 4.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.26 -0.9 . . . . 0.0 110.737 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 t -82.97 -7.8 59.63 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.5 ' CG2' HD12 ' A' ' 68' ' ' LEU . 12.4 mm -77.5 67.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.486 ' NE ' ' O ' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -128.56 30.83 5.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 109.452 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 107' ' ' ASP . 5.2 p -153.48 127.73 9.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.072 . . . . 0.0 110.187 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.475 ' HA ' ' CD1' ' A' ' 108' ' ' ILE . . . -48.79 -36.38 16.52 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 p -55.82 -33.85 64.82 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.6 OUTLIER -71.79 -44.99 63.04 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.704 179.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.528 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 34.7 mt -49.71 -29.29 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.892 -1.13 . . . . 0.0 108.459 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -79.36 -32.83 43.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.438 -0.789 . . . . 0.0 109.678 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -62.01 -43.47 98.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.166 -0.959 . . . . 0.0 109.403 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.542 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 55.8 t -74.68 -37.55 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 109.235 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.572 ' CE1' HG22 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -62.37 -48.11 81.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.883 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 22.5 mt -69.56 -26.22 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 109.538 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -19.81 54.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.373 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -90.46 5.32 48.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.526 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.82 -4.46 72.02 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.521 HD12 ' N ' ' A' ' 117' ' ' ILE . 1.3 mm -74.73 57.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -1.088 . . . . 0.0 109.723 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 117' ' ' ILE . 60.4 mttt -37.37 147.82 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.202 -0.936 . . . . 0.0 110.291 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -52.3 -27.87 25.65 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.44 ' O ' ' HB1' ' A' ' 124' ' ' ALA . 3.2 tt0 -62.7 -51.65 66.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -1.191 . . . . 0.0 109.51 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -77.01 -37.7 54.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.636 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 3.4 t80 -66.77 -53.3 34.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 109.753 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -60.29 -43.99 95.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.983 -1.073 . . . . 0.0 109.197 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.44 ' HB1' ' O ' ' A' ' 120' ' ' GLU . . . -57.52 -50.91 71.53 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.299 -0.876 . . . . 0.0 109.237 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -50.45 -53.32 30.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.416 -0.803 . . . . 0.0 108.94 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.515 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 6.0 t90 -54.98 -58.12 8.93 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -52.47 -16.31 0.86 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 110.396 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 2.4 m -70.59 179.11 2.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.885 -1.135 . . . . 0.0 110.207 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -90.4 -38.21 13.46 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.318 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.27 -48.28 68.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.183 -1.407 . . . . 0.0 109.463 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 3.3 t -62.37 -36.26 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.921 -1.112 . . . . 0.0 108.288 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -66.34 -31.99 73.11 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.079 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.1 t -66.02 -34.74 78.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.412 ' HA ' HD21 ' A' ' 134' ' ' LEU . 40.6 mt -78.96 -18.3 53.98 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.7 t -79.49 -46.33 23.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.34 -38.87 85.56 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.3 -39.98 96.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 108.973 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.572 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -62.32 -62.65 1.61 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.912 . . . . 0.0 108.797 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.453 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 1.2 mt-10 -52.6 -30.61 32.11 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 5.2 mttt -72.57 -29.43 63.53 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -67.72 -54.67 17.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 109.236 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.15 86.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.663 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 139' ' ' GLU . . . -81.39 -16.16 53.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.315 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 140' ' ' LYS . 6.3 m-20 -80.81 -45.09 17.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.983 -1.073 . . . . 0.0 109.014 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.562 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 23.3 m -99.32 -9.4 8.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.271 -0.893 . . . . 0.0 108.856 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 25.4 tt0 83.5 -39.63 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.658 -0.651 . . . . 0.0 109.537 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.537 HD21 ' CE2' ' A' ' 25' ' ' PHE . 13.4 tp 66.93 138.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.397 -0.815 . . . . 0.0 109.47 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -160.8 26.77 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.751 -1.218 . . . . 0.0 109.856 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 158.63 98.72 0.14 Allowed Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.171 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.549 HG13 ' CG1' ' A' ' 61' ' ' VAL . 0.9 OUTLIER -89.72 138.95 27.79 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.556 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 32.6 Cg_endo -72.83 156.68 99.15 Favored 'Cis proline' 0 C--N 1.316 -1.147 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.865 2.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 25' ' ' PHE . . . -151.79 117.18 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.939 -1.101 . . . . 0.0 108.385 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.487 ' CE ' HG23 ' A' ' 182' ' ' VAL . 4.8 tmm? -113.93 136.57 52.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.996 -1.065 . . . . 0.0 110.334 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.577 ' N ' ' CD1' ' A' ' 154' ' ' PHE . 3.8 m-85 -123.92 135.81 53.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.476 -0.765 . . . . 0.0 109.208 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 92.2 t -100.65 131.94 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.94 . . . . 0.0 110.06 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.93 21.83 0.33 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.61 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.492 ' O ' ' CB ' ' A' ' 15' ' ' PRO . . . 58.27 55.9 28.17 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -165.21 -35.64 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.191 -1.182 . . . . 0.0 108.379 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 154' ' ' PHE . 2.4 m-85 -111.52 120.42 42.06 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.019 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.534 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 12.8 tt0 -116.27 113.51 23.1 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.288 -0.883 . . . . 0.0 109.264 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.485 ' CD1' ' HE2' ' A' ' 153' ' ' MET . 8.6 mt -61.33 -179.6 0.17 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.36 -0.837 . . . . 0.0 108.847 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -137.35 150.19 68.0 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.026 -1.046 . . . . 0.0 109.459 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.74 8.12 3.89 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.672 2.248 . . . . 0.0 110.648 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.74 -22.65 0.84 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.71 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -89.8 8.94 78.84 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.96 1.56 26.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 0.0 109.596 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -124.87 33.12 5.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.145 -0.972 . . . . 0.0 109.577 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.8 t -85.75 -8.34 58.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.072 -1.018 . . . . 0.0 109.826 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.14 26.78 13.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.118 -0.989 . . . . 0.0 109.382 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -157.43 95.3 1.45 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.277 -0.89 . . . . 0.0 108.834 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.422 ' HE2' ' OE1' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -57.94 -16.86 13.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.17 -0.956 . . . . 0.0 109.651 -179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 172' ' ' ASP . 0.6 OUTLIER -69.61 -45.37 68.69 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.1 t -68.86 -22.32 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 108.831 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.429 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 22.7 t80 -72.48 -36.8 68.53 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.23 -0.919 . . . . 0.0 108.576 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.454 HG23 ' CG1' ' A' ' 42' ' ' ILE . 44.0 t -75.75 -26.96 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 109.194 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -83.32 -52.99 6.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.218 -0.926 . . . . 0.0 108.951 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.453 ' O ' ' OG1' ' A' ' 181' ' ' THR . 0.4 OUTLIER -62.88 -33.03 74.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.492 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.429 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 31.6 t80 -75.66 -54.18 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.521 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' HB1' ' O ' ' A' ' 175' ' ' VAL . . . -60.49 -24.42 65.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 109.412 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -77.91 -50.09 12.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.328 -0.857 . . . . 0.0 109.299 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.505 ' O ' HD22 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -58.39 -28.58 65.32 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.197 -0.94 . . . . 0.0 109.001 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.487 HG23 ' CE ' ' A' ' 153' ' ' MET . 66.4 t -85.91 -34.63 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.32 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -60.5 -42.56 96.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 108.98 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.567 ' CD2' HD21 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -82.46 -44.03 16.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.297 -0.877 . . . . 0.0 108.999 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.567 HD21 ' CD2' ' A' ' 184' ' ' TYR . 3.9 mm? -53.68 -18.35 2.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.942 -1.099 . . . . 0.0 109.417 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.439 ' OG ' HG23 ' A' ' 54' ' ' VAL . 1.7 t -66.31 -26.06 67.13 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.859 -1.151 . . . . 0.0 108.328 178.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.51 -71.98 0.38 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.63 23.42 13.72 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.828 0.823 . . . . 0.0 109.607 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.291 -1.939 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.487 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -136.06 66.45 1.5 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.345 -0.847 . . . . 0.0 109.447 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.573 ' HB3' ' CE1' ' A' ' 9' ' ' TYR . 1.9 m-85 50.18 80.08 0.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.355 -0.841 . . . . 0.0 109.39 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -101.55 56.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.99 . . . . 0.0 109.833 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 46.04 82.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.614 -0.679 . . . . 0.0 110.239 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 116.11 -20.45 12.8 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.267 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.52 -68.01 0.72 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.182 -1.187 . . . . 0.0 109.107 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 1.6 mp0 -97.53 6.2 48.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.375 -0.828 . . . . 0.0 109.606 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.573 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 8.3 p90 177.26 134.07 0.06 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.284 -0.885 . . . . 0.0 108.994 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -115.28 176.3 5.13 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.577 -0.702 . . . . 0.0 109.24 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.454 HG21 ' O ' ' A' ' 158' ' ' LYS . 1.0 OUTLIER -114.15 159.49 20.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.382 0.611 . . . . 0.0 109.612 -179.746 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.3 162.08 13.37 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.405 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.46 -0.23 36.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.147 -0.971 . . . . 0.0 109.141 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.34 113.29 1.02 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.374 -0.829 . . . . 0.0 109.12 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 34.7 Cg_endo -77.02 159.11 34.18 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.45 2.1 . . . . 0.0 110.849 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 t -110.91 91.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.481 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.05 128.81 9.58 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.39 -21.9 41.77 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.543 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -40.46 160.67 0.12 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.986 . . . . 0.0 109.83 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.547 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.3 Cg_endo -79.22 128.83 8.38 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.726 2.284 . . . . 0.0 111.196 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.516 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 16.3 mp0 -41.71 -25.37 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.498 -0.751 . . . . 0.0 109.861 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.46 ' N ' ' O ' ' A' ' 20' ' ' PRO . 25.1 t -149.43 82.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.113 -0.992 . . . . 0.0 108.996 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.636 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.07 118.3 16.87 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.493 ' N ' HD21 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -98.07 122.82 41.67 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.113 -0.992 . . . . 0.0 109.935 -179.066 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CE2' ' CG2' ' A' ' 145' ' ' VAL . 9.1 m-85 -110.2 104.26 13.07 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -150.95 143.21 24.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.129 -0.982 . . . . 0.0 110.044 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.571 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 4.5 p -123.78 -167.65 1.66 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.66 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -110.18 53.57 0.69 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.571 ' CE1' HD13 ' A' ' 72' ' ' LEU . 9.1 m-85 -138.01 -1.94 1.93 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.831 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.51 ' CB ' ' HB3' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -108.49 164.79 13.97 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.571 -1.331 . . . . 0.0 109.405 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.475 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 32.0 Cg_endo -74.58 -32.56 5.96 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.35 2.033 . . . . 0.0 108.861 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.486 ' NE2' HD12 ' A' ' 40' ' ' LEU . 0.3 OUTLIER -89.67 -19.11 25.24 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.038 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HB3' ' CB ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -52.96 -41.75 64.84 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.504 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 70.3 t80 -85.29 -39.03 18.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.305 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.516 ' O ' ' CG ' ' A' ' 40' ' ' LEU . 3.9 mt-30 -74.85 -24.4 58.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.986 -1.071 . . . . 0.0 110.429 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.563 ' O ' ' CD1' ' A' ' 36' ' ' PHE . 25.7 t80 -76.41 -21.99 55.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.038 -1.039 . . . . 0.0 110.97 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.55 ' OE2' ' CE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -127.77 42.03 3.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.707 -1.245 . . . . 0.0 110.888 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 15.9 mm-40 -159.49 -68.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.174 -0.954 . . . . 0.0 109.899 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.02 -48.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 0.0 110.414 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.516 ' CG ' ' O ' ' A' ' 35' ' ' GLN . 95.2 mt -54.03 -17.18 2.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.016 -1.052 . . . . 0.0 110.132 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.442 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 82.3 m-70 45.91 30.85 0.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.081 -1.012 . . . . 0.0 109.281 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.497 ' O ' ' CG1' ' A' ' 46' ' ' VAL . 19.6 mt -79.3 -21.46 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.998 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.454 ' HA ' HG23 ' A' ' 46' ' ' VAL . 17.2 m -80.44 -21.06 42.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.982 -1.074 . . . . 0.0 110.512 -179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 41' ' ' HIS . 2.0 p-10 -87.06 -50.5 6.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.899 -1.126 . . . . 0.0 110.356 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 46' ' ' VAL . 45.2 p-10 -64.46 -26.22 68.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.193 -0.942 . . . . 0.0 110.533 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.501 ' N ' ' OD1' ' A' ' 45' ' ' ASN . 27.7 m -74.21 -24.66 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.987 -1.07 . . . . 0.0 109.976 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -73.65 -46.78 44.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.049 -1.032 . . . . 0.0 109.516 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.514 ' N ' ' HD3' ' A' ' 48' ' ' LYS . 24.3 mmtm -58.86 -16.78 18.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.211 -0.931 . . . . 0.0 109.067 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.486 ' CG ' ' HB2' ' A' ' 183' ' ' LYS . 0.3 OUTLIER -101.83 22.66 12.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 109.946 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.569 ' O ' ' CG2' ' A' ' 54' ' ' VAL . 7.9 mt -124.06 66.09 39.81 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.007 -1.058 . . . . 0.0 110.706 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 52' ' ' GLU . 37.2 Cg_endo -80.09 140.67 14.24 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.406 2.07 . . . . 0.0 110.13 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 51' ' ' PRO . 12.6 tm-20 61.87 132.88 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.386 -0.821 . . . . 0.0 108.822 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . 58.89 23.35 56.33 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.569 ' CG2' ' O ' ' A' ' 50' ' ' LEU . 2.0 t -60.33 80.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.752 -0.852 . . . . 0.0 109.374 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -125.77 91.94 3.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.131 -0.98 . . . . 0.0 110.264 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.406 ' HE2' ' HG3' ' A' ' 24' ' ' GLU . 7.1 ttt -103.72 98.31 8.2 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -93.35 134.5 35.5 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.057 -179.269 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.409 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 3.9 mtmt -109.8 108.98 19.5 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.448 -0.782 . . . . 0.0 109.487 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 2.7 m-85 -109.8 169.42 8.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.865 -1.147 . . . . 0.0 111.083 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.571 ' CE1' ' HA ' ' A' ' 27' ' ' SER . 4.0 t60 -107.68 133.45 52.09 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.744 0.783 . . . . 0.0 108.995 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.589 ' CG1' ' CG1' ' A' ' 150' ' ' VAL . 3.2 m -71.98 157.4 6.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 O-C-N 121.738 -0.601 . . . . 0.0 109.536 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.415 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 2.9 p-10 -123.46 47.2 2.05 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 16.0 p90 -148.52 61.57 1.08 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.093 -1.004 . . . . 0.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.491 ' CE ' ' O ' ' A' ' 61' ' ' VAL . 0.5 OUTLIER -133.13 38.0 3.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.288 -0.883 . . . . 0.0 109.051 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.49 -31.37 1.14 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.79 -35.83 3.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 -79.37 0.28 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.874 -1.368 . . . . 0.0 109.676 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.585 HD21 ' CD1' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -78.59 -19.18 53.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.974 -1.079 . . . . 0.0 109.197 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.581 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -58.73 -57.11 21.6 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.76 -49.04 74.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.286 -1.126 . . . . 0.0 108.048 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.532 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 49.9 t0 -59.94 -26.68 66.16 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.571 HD13 ' CE1' ' A' ' 29' ' ' PHE . 0.6 OUTLIER -60.75 -36.24 78.41 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.412 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.442 ' O ' ' NE2' ' A' ' 138' ' ' GLN . 31.5 m -67.0 -41.17 87.18 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 7.8 tp60 -61.73 -17.43 55.78 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -71.49 -45.1 63.42 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.455 ' HB3' ' NE2' ' A' ' 138' ' ' GLN . 20.0 t-105 -64.58 -31.84 73.22 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.175 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.88 -54.43 6.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.87 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.65 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 88.8 t -59.71 -26.18 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.151 -0.968 . . . . 0.0 109.964 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.428 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -83.55 -60.77 2.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 109.243 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.453 ' HB3' HD23 ' A' ' 134' ' ' LEU . 0.8 OUTLIER -45.67 -28.87 1.09 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.171 -0.956 . . . . 0.0 108.53 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.536 ' CB ' ' CG2' ' A' ' 131' ' ' VAL . . . -72.57 -41.51 65.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.472 -0.768 . . . . 0.0 109.374 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.468 ' O ' HG11 ' A' ' 84' ' ' VAL . 20.9 mt -101.51 9.41 41.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -0.962 . . . . 0.0 110.381 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.76 24.23 7.77 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.468 HG11 ' O ' ' A' ' 82' ' ' LEU . 33.2 m -87.29 -9.2 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.427 -1.043 . . . . 0.0 110.759 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 89' ' ' THR . 2.8 pt-20 -42.08 -58.76 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.047 -1.033 . . . . 0.0 110.015 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.6 -33.75 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.237 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -83.6 -50.47 8.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.339 -0.851 . . . . 0.0 111.425 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.482 ' O ' ' CG ' ' A' ' 92' ' ' LEU . 1.3 m -83.25 -7.51 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.786 -1.196 . . . . 0.0 110.784 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.604 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.31 -44.38 45.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.703 -1.248 . . . . 0.0 108.728 179.034 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.428 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -53.49 -52.76 63.77 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.542 -1.349 . . . . 0.0 110.555 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.512 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 25.3 Cg_endo -73.7 -18.47 22.22 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 N-CA-C 109.877 -0.855 . . . . 0.0 109.877 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.539 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 21.8 mt -87.07 -43.59 12.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 108.863 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.66 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 5.4 m-30 -65.57 -45.77 81.99 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.008 -1.058 . . . . 0.0 108.984 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -73.44 -20.73 60.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.065 -1.022 . . . . 0.0 109.08 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.58 -36.29 62.44 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.532 HG23 ' CB ' ' A' ' 102' ' ' ILE . 1.5 t -102.09 -0.49 10.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.087 -1.243 . . . . 0.0 109.409 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.496 ' OE1' ' HB3' ' A' ' 93' ' ' PHE . 16.4 mt-30 -97.91 1.53 48.16 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 120.915 -1.116 . . . . 0.0 110.557 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 175.79 81.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.744 -1.222 . . . . 0.0 109.582 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.556 ' CB ' ' O ' ' A' ' 98' ' ' LYS . 1.2 m 157.71 -43.85 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.9 OUTLIER 69.09 16.26 8.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.867 -1.146 . . . . 0.0 110.735 178.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.549 ' HB ' ' CG2' ' A' ' 99' ' ' THR . 5.3 t -79.3 -7.61 58.44 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.532 ' CB ' HG23 ' A' ' 96' ' ' VAL . 12.6 mm -87.62 61.93 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -127.58 32.18 5.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.967 . . . . 0.0 109.48 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 107' ' ' ASP . 4.8 p -153.02 128.11 9.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.002 -1.061 . . . . 0.0 110.075 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.452 ' HA ' HD13 ' A' ' 108' ' ' ILE . . . -49.55 -31.03 9.5 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -34.14 74.72 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -68.51 -51.11 46.74 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.585 ' CD1' HD21 ' A' ' 68' ' ' LEU . 27.9 mt -48.16 -29.9 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 0.0 108.684 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.454 ' O ' HD13 ' A' ' 113' ' ' ILE . 4.6 mtt180 -76.86 -39.9 49.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 109.419 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -57.34 -41.18 79.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.405 -0.809 . . . . 0.0 109.646 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.539 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 19.9 t -73.88 -38.45 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.173 -0.954 . . . . 0.0 109.569 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.458 ' HA ' HG13 ' A' ' 88' ' ' VAL . 2.6 m-85 -64.52 -39.01 92.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.052 -1.03 . . . . 0.0 109.121 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.454 HD13 ' O ' ' A' ' 109' ' ' ARG . 15.4 mt -75.11 -22.38 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.342 -0.849 . . . . 0.0 109.548 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -16.98 62.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.315 -0.866 . . . . 0.0 109.876 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.481 ' HB2' HD11 ' A' ' 117' ' ' ILE . . . -91.04 6.4 45.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.725 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.68 2.56 75.6 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.602 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.4 mp -86.27 63.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -1.102 . . . . 0.0 109.074 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -31.75 149.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.199 -0.938 . . . . 0.0 110.859 -179.218 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.42 -32.92 58.14 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.03 -46.26 82.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.999 -1.295 . . . . 0.0 109.195 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -73.01 -43.72 61.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.65 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 4.3 t80 -57.99 -45.59 86.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.613 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -64.3 -37.8 88.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.147 -0.97 . . . . 0.0 108.979 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.03 -50.35 72.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.151 -0.968 . . . . 0.0 108.878 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.51 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -52.0 -49.3 63.58 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.453 ' CD1' ' C ' ' A' ' 126' ' ' TRP . 3.5 t90 -58.22 -59.65 4.99 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -15.35 6.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.633 -0.667 . . . . 0.0 110.253 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.465 ' OG ' HG22 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -69.6 172.93 6.63 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.056 -1.028 . . . . 0.0 110.086 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -89.5 -40.14 12.86 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.39 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.6 t -63.13 -46.15 96.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.105 -1.438 . . . . 0.0 109.341 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.536 ' CG2' ' CB ' ' A' ' 81' ' ' ALA . 2.1 t -69.58 -33.79 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.975 -1.078 . . . . 0.0 108.369 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 128' ' ' SER . 19.2 ttpt -63.64 -37.99 89.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.5 p -69.37 -32.42 71.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.415 -0.803 . . . . 0.0 108.91 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.453 HD23 ' HB3' ' A' ' 80' ' ' MET . 0.2 OUTLIER -79.66 -19.18 49.69 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.903 . . . . 0.0 108.781 179.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.0 t -78.68 -48.77 21.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -62.33 -38.9 91.27 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -35.8 82.22 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.4 -0.813 . . . . 0.0 109.29 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.577 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 3.7 mt-30 -67.55 -66.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 109.185 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.33 -37.61 17.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.185 -0.947 . . . . 0.0 108.66 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 9.3 mttm -71.53 -33.57 69.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.367 -0.833 . . . . 0.0 108.85 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.503 ' CB ' ' CD2' ' A' ' 59' ' ' TYR . . . -56.64 -62.22 1.88 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 109.128 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -69.09 -26.24 64.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.599 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.435 ' HB1' ' HA ' ' A' ' 140' ' ' LYS . . . -76.09 -26.01 56.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.887 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.527 ' OD1' ' CG1' ' A' ' 145' ' ' VAL . 0.6 OUTLIER -80.88 -49.92 10.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.993 . . . . 0.0 108.478 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.643 ' CG2' ' CE2' ' A' ' 25' ' ' PHE . 19.7 m -84.75 -13.27 11.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 2.7 mt-30 80.89 -47.14 0.26 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.682 . . . . 0.0 109.875 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.477 HD23 HG13 ' A' ' 61' ' ' VAL . 24.4 tp 65.06 137.9 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.7 ttt85 -160.5 27.74 0.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.457 -1.402 . . . . 0.0 110.161 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.97 106.47 0.2 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.314 -1.422 . . . . 0.0 110.619 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.589 ' CG1' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -83.13 144.46 47.23 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.41 -1.053 . . . . 0.0 108.934 178.635 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.48 151.73 89.64 Favored 'Cis proline' 0 C--N 1.315 -1.224 0 C-N-CA 124.176 -1.177 . . . . 0.0 110.854 0.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -127.84 153.12 46.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.41 -1.431 . . . . 0.0 109.103 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.488 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -148.11 130.07 15.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.899 -1.126 . . . . 0.0 110.424 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.584 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 24.5 m-85 -126.22 129.17 48.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.53 -0.731 . . . . 0.0 109.698 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 14.8 t -96.77 131.13 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 0.0 109.607 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.437 ' C ' ' HB1' ' A' ' 19' ' ' ALA . 5.7 t30 43.16 23.73 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.471 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.543 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.87 58.11 16.19 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.483 ' HE3' ' CE2' ' A' ' 159' ' ' TYR . 32.6 ttpt -166.27 -35.67 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.583 ' CD2' ' HE3' ' A' ' 188' ' ' LYS . 50.3 m-85 -119.6 120.93 38.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.892 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.584 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -119.42 120.55 37.19 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.171 -0.956 . . . . 0.0 109.714 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.488 HD23 ' CG2' ' A' ' 181' ' ' THR . 69.8 mt -61.85 175.38 0.67 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -149.86 114.5 3.44 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.947 -1.095 . . . . 0.0 109.384 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.62 26.21 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 122.598 2.199 . . . . 0.0 111.351 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -91.85 -13.65 31.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.891 -1.13 . . . . 0.0 109.355 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.67 20.33 42.46 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 8.9 ttp -81.46 49.73 1.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.192 -1.181 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -99.74 17.84 19.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.193 -0.942 . . . . 0.0 109.566 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 169' ' ' SER . 14.9 t -89.26 1.9 55.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -0.95 . . . . 0.0 109.625 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' A' ' 170' ' ' ASN . 0.5 OUTLIER 44.41 43.66 6.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.41 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 169' ' ' SER . 1.8 m120 -155.83 94.06 1.52 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.287 -0.883 . . . . 0.0 109.304 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 14.3 mtt -58.76 -15.74 13.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.602 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.75 -49.17 66.81 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.37 -29.16 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.033 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.474 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -68.25 -31.38 70.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.113 -0.992 . . . . 0.0 108.85 179.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 53.3 t -79.28 -29.29 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.552 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -82.97 -53.02 6.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.001 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.46 ' O ' ' OG1' ' A' ' 181' ' ' THR . 1.0 OUTLIER -62.34 -47.27 84.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.458 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.474 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 4.2 t80 -61.83 -49.68 75.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.01 -34.69 68.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.102 -0.999 . . . . 0.0 108.998 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -73.77 -38.73 64.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.423 -0.798 . . . . 0.0 109.182 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.5 ' O ' ' CG ' ' A' ' 185' ' ' LEU . 0.2 OUTLIER -59.01 -29.68 67.43 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.433 ' O ' ' OG ' ' A' ' 186' ' ' SER . 2.5 t -83.95 -36.41 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.973 . . . . 0.0 109.28 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.486 ' HB2' ' CG ' ' A' ' 49' ' ' LYS . 16.9 tttt -60.77 -46.49 90.25 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.173 -0.955 . . . . 0.0 108.915 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.567 ' CD2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -81.63 -30.91 32.63 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.366 -0.834 . . . . 0.0 109.371 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.567 ' CD2' ' CD2' ' A' ' 184' ' ' TYR . 0.4 OUTLIER -61.01 -20.93 63.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.825 -1.172 . . . . 0.0 108.775 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.438 ' OG ' HD22 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -80.79 -4.57 55.06 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.98 -1.075 . . . . 0.0 108.471 178.243 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.66 -76.52 0.61 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 108.867 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.583 ' HE3' ' CD2' ' A' ' 159' ' ' TYR . 1.0 OUTLIER 63.75 28.38 14.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.523 -0.736 . . . . 0.0 110.113 179.492 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 188' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.902 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.573 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -109.38 57.96 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 109.428 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER 166.84 86.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.517 -0.74 . . . . 0.0 109.262 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -99.63 58.2 1.04 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.07 -1.019 . . . . 0.0 110.011 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 t0 48.98 85.26 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.44 -0.788 . . . . 0.0 110.04 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 114.92 -21.91 13.13 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -81.27 -67.25 0.8 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -1.196 . . . . 0.0 108.696 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.496 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 15.7 mp0 -99.09 7.83 45.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.252 -0.905 . . . . 0.0 109.611 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 6' ' ' GLY . 4.4 p90 176.54 134.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 108.975 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.551 HG21 ' CG ' ' A' ' 160' ' ' GLN . 9.3 t -114.43 177.68 4.55 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.585 -0.697 . . . . 0.0 109.328 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.502 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 0.4 OUTLIER -88.41 160.67 17.46 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.542 0.686 . . . . 0.0 110.42 -179.151 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' A' ' 160' ' ' GLN . 7.4 mt -98.41 161.74 13.53 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.562 -0.711 . . . . 0.0 109.127 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.426 ' C ' ' HG2' ' A' ' 14' ' ' LYS . 5.0 pm0 -115.6 -3.98 12.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 109.611 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HG2' ' C ' ' A' ' 13' ' ' GLU . 3.7 mmtp -139.89 75.11 30.88 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.18 -0.95 . . . . 0.0 109.617 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 35.3 Cg_endo -77.99 159.62 30.6 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.561 2.174 . . . . 0.0 110.576 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 19' ' ' ALA . 1.7 t -134.36 129.74 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.369 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.52 126.57 15.66 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 74.65 6.45 77.19 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.542 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . . . -42.57 172.45 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.498 -1.001 . . . . 0.0 110.277 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.559 ' HG2' ' HB2' ' A' ' 23' ' ' LEU . 30.8 Cg_endo -71.52 111.94 3.24 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.919 2.412 . . . . 0.0 111.74 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.493 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 27.0 mm-40 -52.85 -22.35 5.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.557 -0.715 . . . . 0.0 109.597 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.482 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 10.5 t -156.62 79.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.587 HD12 ' CE2' ' A' ' 25' ' ' PHE . 0.6 OUTLIER -81.7 138.48 35.24 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.43 ' N ' HD21 ' A' ' 23' ' ' LEU . 10.5 tt0 -132.85 103.1 5.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.047 -1.033 . . . . 0.0 109.789 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.587 ' CE2' HD12 ' A' ' 23' ' ' LEU . 58.4 m-85 -86.01 126.4 34.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.179 -0.951 . . . . 0.0 109.031 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.4 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 2.6 p90 -157.14 133.15 9.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.231 -0.918 . . . . 0.0 109.791 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.546 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 70.1 m -104.33 -174.37 2.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.413 -0.805 . . . . 0.0 109.827 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.558 ' O ' ' CD1' ' A' ' 29' ' ' PHE . 16.0 m-30 -104.53 48.46 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.578 ' CG ' HG13 ' A' ' 96' ' ' VAL . 16.6 m-85 -146.91 14.32 1.17 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 110.338 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -104.51 162.5 19.65 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.675 -1.266 . . . . 0.0 109.67 -179.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.96 -36.14 2.76 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.212 1.941 . . . . 0.0 108.388 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' A' ' 36' ' ' PHE . 4.4 m-70 -82.98 -22.32 33.71 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 16.2 t -47.06 -52.95 13.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.534 ' CB ' ' NE2' ' A' ' 97' ' ' GLN . 11.3 t80 -75.18 -40.66 59.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.794 -0.566 . . . . 0.0 110.403 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -72.38 -16.92 61.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.057 -1.027 . . . . 0.0 110.417 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' HIS . 1.8 m-85 -82.58 -29.62 30.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.02 -1.05 . . . . 0.0 110.443 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.74 22.7 13.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.955 -1.09 . . . . 0.0 109.629 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.514 ' OE2' ' CZ ' ' A' ' 34' ' ' TYR . 5.5 mm-40 -132.09 -61.09 0.89 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 111.092 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.2 t -90.61 -75.56 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.899 -1.126 . . . . 0.0 111.708 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 0.7 OUTLIER -70.75 -24.39 62.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.954 -1.091 . . . . 0.0 110.679 -178.089 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 94.9 m-70 60.67 32.71 20.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.058 -1.026 . . . . 0.0 108.965 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.449 HD13 HG23 ' A' ' 175' ' ' VAL . 13.5 mm -42.22 -26.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.419 -0.8 . . . . 0.0 109.921 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 41' ' ' HIS . 0.9 OUTLIER -81.4 -43.39 19.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.92 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.45 ' HB2' ' HB3' ' A' ' 41' ' ' HIS . 84.1 m-20 -85.39 -36.59 20.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.952 . . . . 0.0 109.894 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -65.04 -38.64 91.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 109.556 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.411 HG11 ' O ' ' A' ' 43' ' ' SER . 9.8 p -68.54 -26.46 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.736 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.48 ' HA ' HD13 ' A' ' 50' ' ' LEU . 0.2 OUTLIER -61.64 -39.23 90.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.476 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -51.17 -24.45 4.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.169 -0.957 . . . . 0.0 108.734 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.469 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 17.6 mmtm -91.05 25.04 2.58 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.517 -0.739 . . . . 0.0 109.423 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.525 HD21 ' CG1' ' A' ' 54' ' ' VAL . 14.2 mt -125.22 67.3 54.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.175 -0.953 . . . . 0.0 110.104 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 52' ' ' GLU . 36.6 Cg_endo -79.39 75.35 5.11 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.542 2.161 . . . . 0.0 110.937 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 51' ' ' PRO . 6.0 tm-20 58.82 131.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.395 0.617 . . . . 0.0 110.2 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.08 -11.63 60.44 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.525 ' CG1' HD21 ' A' ' 50' ' ' LEU . 1.1 t -114.61 98.43 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -1.185 . . . . 0.0 109.142 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.09 102.95 14.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.909 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.482 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 8.7 ttt -99.02 102.88 14.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.428 -0.795 . . . . 0.0 109.606 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.0 m -99.1 126.48 44.85 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.265 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 113.83 27.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.458 -0.777 . . . . 0.0 109.382 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.541 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.8 m-85 -115.33 163.75 15.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.029 -1.045 . . . . 0.0 111.404 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.579 ' CE1' HD23 ' A' ' 72' ' ' LEU . 3.5 t-160 -117.28 122.16 43.18 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.609 ' CG2' ' CD1' ' A' ' 63' ' ' PHE . 16.8 m -101.88 156.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 110.384 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.492 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 1.1 p-10 -83.92 42.65 0.87 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.402 -0.811 . . . . 0.0 109.536 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.609 ' CD1' ' CG2' ' A' ' 61' ' ' VAL . 3.7 m-85 -91.56 30.96 1.23 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.0 110.023 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.425 ' SD ' ' HB3' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -161.74 45.93 0.17 Allowed 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.65 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 161.73 60.03 0.02 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.507 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.52 -35.72 0.13 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 65' ' ' GLY . 92.3 m-20 -88.94 -78.64 0.34 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -1.173 . . . . 0.0 110.129 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.607 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -82.27 -21.62 36.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.769 -1.207 . . . . 0.0 110.088 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 65' ' ' GLY . . . -51.97 -39.93 49.63 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 2.9 ttmt -61.05 -41.58 96.87 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.79 -29.54 65.75 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.579 HD23 ' CE1' ' A' ' 60' ' ' HIS . 13.9 tp -58.17 -50.77 72.38 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -56.64 -43.2 80.05 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.594 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 3.1 tt0 -54.92 -27.17 41.24 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -63.51 -46.36 86.44 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.404 ' O ' ' HG3' ' A' ' 80' ' ' MET . 29.7 t-105 -53.97 -31.98 52.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.99 -66.31 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.408 -0.808 . . . . 0.0 110.012 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.624 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 2.2 t -47.55 -30.68 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.214 -0.929 . . . . 0.0 110.047 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.429 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.5 -63.48 1.41 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.824 -1.173 . . . . 0.0 109.188 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.416 ' C ' ' O ' ' A' ' 79' ' ' ALA . 21.7 mtp -46.21 -27.12 0.91 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.594 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.525 ' CB ' HG23 ' A' ' 131' ' ' VAL . . . -67.8 -46.86 70.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 109.591 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.8 mt -99.62 7.24 45.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.63 31.18 60.18 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.469 ' CG1' HD13 ' A' ' 117' ' ' ILE . 26.9 m -97.35 8.21 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.448 -1.031 . . . . 0.0 110.144 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.454 ' O ' ' C ' ' A' ' 86' ' ' ASP . 2.3 tt0 -52.76 -70.56 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.086 -1.009 . . . . 0.0 109.722 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -38.89 -33.78 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 0.0 110.282 -179.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.462 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 25.1 mtpp -80.91 -52.5 7.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.377 -0.827 . . . . 0.0 110.995 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.488 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.3 m -86.12 -13.89 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.684 -1.26 . . . . 0.0 110.803 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.604 HG21 ' CG ' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -73.68 -42.39 61.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.646 -1.284 . . . . 0.0 108.206 178.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.22 -54.67 45.21 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.63 -1.294 . . . . 0.0 110.353 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.462 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 25.9 Cg_endo -72.82 -21.1 21.79 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 N-CA-C 109.758 -0.901 . . . . 0.0 109.758 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.501 ' HB2' ' HA ' ' A' ' 89' ' ' THR . 15.6 mt -81.09 -44.64 17.67 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.604 ' CG ' HG21 ' A' ' 89' ' ' THR . 7.6 m-30 -64.03 -44.87 91.21 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.107 -0.995 . . . . 0.0 108.62 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -72.97 -24.33 60.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.297 -0.877 . . . . 0.0 109.321 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.537 ' O ' ' CG2' ' A' ' 99' ' ' THR . . . -69.03 -36.09 80.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.578 HG13 ' CG ' ' A' ' 29' ' ' PHE . 2.2 t -98.95 -1.57 10.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.225 -1.162 . . . . 0.0 108.768 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.534 ' NE2' ' CB ' ' A' ' 34' ' ' TYR . 27.4 mm-40 -110.26 6.27 22.41 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 121.022 -1.048 . . . . 0.0 111.323 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.519 ' C ' ' CG2' ' A' ' 99' ' ' THR . 1.5 ttmm -164.57 52.2 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.476 -1.39 . . . . 0.0 109.402 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.537 ' CG2' ' O ' ' A' ' 95' ' ' GLY . 0.5 OUTLIER 175.15 -51.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.361 -0.837 . . . . 0.0 109.847 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.534 ' O ' ' CD ' ' A' ' 103' ' ' ARG . 1.1 mt-30 75.05 10.95 3.66 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.042 -1.036 . . . . 0.0 109.886 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.1 t -84.32 -8.33 59.04 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.608 0.718 . . . . 0.0 109.319 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.439 HG13 ' C ' ' A' ' 95' ' ' GLY . 10.2 mm -74.14 75.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.56 -0.712 . . . . 0.0 109.544 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.534 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -136.65 31.42 2.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.84 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.526 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 7.3 p -146.91 128.45 15.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.064 -1.022 . . . . 0.0 109.716 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.54 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -52.82 -30.17 31.94 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.6 t -65.83 -29.03 69.43 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 104' ' ' SER . 61.6 m-20 -77.21 -39.5 48.45 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.396 -0.922 . . . . 0.0 108.678 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.507 ' CD1' HD21 ' A' ' 68' ' ' LEU . 44.4 mt -59.51 -29.82 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.29 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 4.6 mtm180 -78.03 -32.07 50.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.528 -0.733 . . . . 0.0 109.275 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.4 OUTLIER -61.47 -48.02 83.02 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.246 -0.909 . . . . 0.0 109.2 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.526 ' N ' ' OD1' ' A' ' 110' ' ' ASP . 53.1 t -68.39 -40.37 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.915 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.474 ' CE1' HG22 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -56.78 -37.59 71.32 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.242 -0.912 . . . . 0.0 109.28 179.442 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.8 mt -76.16 -24.79 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -0.805 . . . . 0.0 109.869 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -64.47 -18.78 65.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.027 -1.046 . . . . 0.0 109.371 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.33 6.42 48.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.534 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.96 -1.48 77.94 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.528 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -78.74 57.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -1.118 . . . . 0.0 109.442 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 117' ' ' ILE . 2.2 mttt -37.73 153.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.882 . . . . 0.0 110.134 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.99 -38.01 73.47 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -50.43 -49.18 55.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.945 -1.326 . . . . 0.0 109.571 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.22 -48.79 12.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 110.335 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.624 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 4.1 t80 -58.28 -52.3 66.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.017 -1.052 . . . . 0.0 109.622 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -62.0 -41.13 97.72 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.33 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.58 -50.4 73.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.102 -0.999 . . . . 0.0 108.928 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 128' ' ' SER . . . -55.28 -46.71 76.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 108.886 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.594 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 4.7 t90 -57.55 -57.08 14.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.231 -0.918 . . . . 0.0 108.53 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -60.7 -15.54 30.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.5 -0.75 . . . . 0.0 109.553 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 63.1 m -76.13 -172.93 2.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.141 -0.975 . . . . 0.0 109.83 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -95.55 -28.3 14.93 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.906 -0.496 . . . . 0.0 111.061 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.14 -41.88 93.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.405 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.554 ' CG1' ' HA ' ' A' ' 126' ' ' TRP . 49.9 t -70.86 -36.65 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 120.995 -1.066 . . . . 0.0 108.487 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -67.4 -27.46 67.1 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.23 -37.68 69.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 138' ' ' GLN . 0.5 OUTLIER -79.45 -22.19 44.48 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 131' ' ' VAL . 17.1 t -79.12 -40.96 22.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.511 ' O ' ' CG ' ' A' ' 140' ' ' LYS . . . -68.01 -48.55 65.39 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.495 -0.753 . . . . 0.0 109.038 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.475 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -61.29 -32.69 72.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.233 -0.917 . . . . 0.0 108.751 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.541 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 4.4 tm0? -66.06 -69.76 0.28 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.827 . . . . 0.0 109.093 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' GLN . 0.0 OUTLIER -46.87 -32.67 3.92 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -70.28 -35.05 73.48 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.52 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -57.05 -50.3 73.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -70.25 -33.17 71.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.433 -0.792 . . . . 0.0 109.8 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.25 -18.21 55.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 110.042 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.427 ' HB3' HG23 ' A' ' 16' ' ' VAL . 67.4 m-20 -82.84 -43.48 16.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.048 -1.032 . . . . 0.0 108.36 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.554 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 27.5 m -98.61 -12.65 8.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.2 OUTLIER 83.61 -40.9 0.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.69 -0.631 . . . . 0.0 109.564 -179.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.602 ' CD2' ' CG1' ' A' ' 61' ' ' VAL . 10.7 tp 67.85 134.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 0.0 109.329 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -144.29 11.45 1.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.557 -1.339 . . . . 0.0 110.746 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.31 93.74 0.1 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.678 -1.725 . . . . 0.0 111.575 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.491 ' CG1' HG22 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -81.64 139.45 47.38 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.423 ' C ' ' HA ' ' A' ' 150' ' ' VAL . 32.4 Cg_endo -72.23 156.32 98.25 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 124.198 -1.168 . . . . 0.0 112.101 2.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.72 152.07 21.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.059 -1.025 . . . . 0.0 108.259 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.518 ' O ' ' CD1' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -131.69 137.83 48.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.928 -1.108 . . . . 0.0 110.195 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 153' ' ' MET . 14.0 m-85 -133.32 136.23 45.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.399 -0.813 . . . . 0.0 109.524 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 12.1 t -110.78 119.59 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.046 -1.034 . . . . 0.0 108.352 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 20' ' ' PRO . 1.7 m-20 53.29 27.31 6.0 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 15' ' ' PRO . . . 50.18 21.66 4.29 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.232 -1.461 . . . . 0.0 109.614 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -118.79 -21.02 8.0 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.756 -1.438 . . . . 0.0 108.721 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.44 ' N ' HD13 ' A' ' 12' ' ' LEU . 17.9 m-85 -134.87 123.93 24.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 109.291 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.551 ' CG ' HG21 ' A' ' 10' ' ' THR . 25.4 pt20 -116.93 117.42 29.64 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.268 -0.895 . . . . 0.0 109.59 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.499 HD22 ' CB ' ' A' ' 9' ' ' TYR . 11.6 mt -60.83 179.47 0.17 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.502 -0.749 . . . . 0.0 108.98 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -155.17 117.92 2.43 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.037 -1.039 . . . . 0.0 109.529 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.01 -23.43 9.22 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.328 2.019 . . . . 0.0 110.635 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.411 ' HB3' ' HG2' ' A' ' 166' ' ' MET . 2.5 tt0 61.23 20.62 11.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -0.938 . . . . 0.0 109.609 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 46.22 39.06 9.21 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.431 ' O ' ' C ' ' A' ' 167' ' ' ASP . 4.4 mmt -92.63 -95.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.12 -1.224 . . . . 0.0 109.39 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 166' ' ' MET . 22.0 t70 43.65 30.58 0.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.111 -0.993 . . . . 0.0 109.556 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 169' ' ' SER . 69.3 p -70.42 -72.45 0.2 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 109.769 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.429 ' N ' ' OG1' ' A' ' 168' ' ' THR . 0.5 OUTLIER -136.78 59.07 1.7 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.507 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.82 59.19 0.37 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.631 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 5.7 mmm -74.9 -16.57 60.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 109.479 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -78.53 -56.56 4.34 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 6.9 t -64.09 -28.49 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 108.939 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.437 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 48.7 t80 -69.18 -43.16 74.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 0.0 109.229 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.449 HG23 HD13 ' A' ' 42' ' ' ILE . 61.3 t -70.05 -27.35 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.181 -0.949 . . . . 0.0 109.478 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -83.95 -58.71 2.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 109.251 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.518 ' CG ' ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -56.94 -41.73 78.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.397 -0.815 . . . . 0.0 109.197 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 69.2 t80 -65.54 -51.85 56.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.067 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.17 -25.28 67.68 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.241 -0.912 . . . . 0.0 109.26 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.28 -45.07 20.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.899 . . . . 0.0 109.348 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.485 ' O ' HD21 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -57.0 -42.32 80.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.221 -0.924 . . . . 0.0 109.14 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.485 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 2.4 t -74.49 -36.55 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 109.135 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.419 ' HG3' ' HB3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -57.55 -50.11 74.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.19 -0.944 . . . . 0.0 109.102 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -31.46 55.66 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.235 -0.916 . . . . 0.0 109.086 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.536 HD21 ' N ' ' A' ' 185' ' ' LEU . 0.4 OUTLIER -58.24 -21.3 47.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.841 -1.162 . . . . 0.0 109.171 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 87.2 p -74.39 -4.77 38.45 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.817 -1.177 . . . . 0.0 108.691 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.43 10.68 19.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.418 -0.802 . . . . 0.0 109.267 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.409 ' HE2' ' HB2' ' A' ' 156' ' ' ASN . 0.6 OUTLIER -76.28 0.35 19.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.336 -179.314 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.004 -1.06 . . . . 0.0 109.55 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.57 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -111.36 58.62 0.62 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 109.58 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER 174.05 91.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.2 58.41 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.79 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.0 t0 50.5 84.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.574 -0.704 . . . . 0.0 110.271 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 112.89 -19.73 20.65 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -66.62 0.86 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.057 -1.26 . . . . 0.0 108.684 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.473 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 40.6 mm-40 -102.62 10.61 38.62 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.321 -0.862 . . . . 0.0 109.678 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 3' ' ' TYR . 6.9 p90 179.1 136.09 0.09 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.07 -1.019 . . . . 0.0 109.426 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.51 HG21 ' CG ' ' A' ' 160' ' ' GLN . 2.3 t -123.55 171.9 9.17 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.487 HG21 ' N ' ' A' ' 12' ' ' LEU . 53.5 m -120.97 149.69 42.27 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.514 0.673 . . . . 0.0 110.199 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.487 ' N ' HG21 ' A' ' 11' ' ' THR . 1.3 mp -98.18 157.45 16.15 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.572 -0.705 . . . . 0.0 109.21 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.508 ' HG2' ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -84.7 -25.64 28.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 109.192 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.508 ' N ' ' HG2' ' A' ' 13' ' ' GLU . 7.4 mttp -116.24 96.44 47.51 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.359 -0.838 . . . . 0.0 109.046 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 34.3 Cg_endo -76.74 159.95 34.7 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.337 2.025 . . . . 0.0 110.481 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.458 ' O ' HG13 ' A' ' 16' ' ' VAL . 11.7 t -108.73 90.52 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.885 . . . . 0.0 109.762 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.96 131.5 12.12 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 95.18 -24.49 28.6 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.534 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -41.2 160.62 0.14 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.404 -1.056 . . . . 0.0 109.471 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.541 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.0 Cg_endo -78.13 129.26 9.55 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.563 2.175 . . . . 0.0 111.015 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.522 ' CB ' HG11 ' A' ' 54' ' ' VAL . 2.5 mp0 -46.68 -20.69 0.14 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 22' ' ' VAL . 3.1 t -148.35 79.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.873 -1.142 . . . . 0.0 108.73 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.599 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -73.76 127.47 32.9 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' N ' HD21 ' A' ' 23' ' ' LEU . 33.2 tt0 -114.64 118.08 32.65 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.99 -1.068 . . . . 0.0 109.564 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.599 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 7.5 m-85 -103.76 112.5 25.47 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.586 -0.696 . . . . 0.0 109.274 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -155.19 142.28 19.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.998 -1.064 . . . . 0.0 110.14 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.551 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 4.3 p -124.55 -168.63 1.84 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.627 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -116.47 52.54 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.857 -1.152 . . . . 0.0 108.036 178.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.572 ' CG ' HG13 ' A' ' 96' ' ' VAL . 7.6 m-85 -139.97 10.62 2.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.222 -0.924 . . . . 0.0 110.236 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.64 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 4.0 m -117.06 179.88 0.74 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.753 -1.217 . . . . 0.0 108.484 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.64 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.3 Cg_endo -76.02 -59.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.593 1.529 . . . . 0.0 110.169 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -69.4 -11.46 60.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.955 -1.09 . . . . 0.0 108.4 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 27' ' ' SER . 1.2 m -57.15 -37.93 72.78 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.587 ' CE1' ' HG3' ' A' ' 38' ' ' GLU . 18.6 t80 -81.22 -41.91 21.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.758 -0.589 . . . . 0.0 109.791 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.492 ' N ' ' OE1' ' A' ' 35' ' ' GLN . 11.7 mp0 -78.56 -21.26 48.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.945 . . . . 0.0 110.681 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.567 ' CE2' HG22 ' A' ' 42' ' ' ILE . 27.0 t80 -75.52 -18.03 59.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 0.0 110.521 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.415 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 2.2 mm-40 -128.28 32.34 4.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.928 -1.107 . . . . 0.0 110.419 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.587 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 4.5 mm-40 -145.18 -67.89 0.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.977 -1.077 . . . . 0.0 109.797 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.46 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 13.2 t -97.1 -56.79 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.057 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.481 ' HB3' HG13 ' A' ' 42' ' ' ILE . 61.2 mt -43.49 -27.9 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.118 -0.989 . . . . 0.0 109.93 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' A' ' 38' ' ' GLU . 29.7 m170 49.37 24.28 1.03 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.044 -1.035 . . . . 0.0 109.027 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.567 HG22 ' CE2' ' A' ' 36' ' ' PHE . 12.2 mt -59.51 -32.8 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.42 -0.8 . . . . 0.0 109.64 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -45.09 24.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.051 -1.031 . . . . 0.0 110.006 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -81.16 -36.45 30.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.921 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 41' ' ' HIS . 6.2 t-20 -67.47 -30.34 70.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.947 . . . . 0.0 109.907 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 42' ' ' ILE . 43.5 t -74.5 -17.65 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.182 -0.949 . . . . 0.0 109.523 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' HA ' HD13 ' A' ' 50' ' ' LEU . 25.9 mttm -75.9 -34.39 59.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.451 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -57.7 -18.96 23.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.922 . . . . 0.0 109.583 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.81 17.76 14.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.439 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 47' ' ' LYS . 11.9 mt -93.62 118.65 67.51 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.751 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.41 ' C ' ' H ' ' A' ' 53' ' ' GLY . 35.1 Cg_endo -77.32 151.99 30.18 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.301 2.001 . . . . 0.0 108.954 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.493 ' CG ' ' O ' ' A' ' 52' ' ' GLU . 11.0 tt0 -71.09 42.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.497 -1.377 . . . . 0.0 110.882 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.514 ' O ' ' CG2' ' A' ' 54' ' ' VAL . . . -140.77 37.29 1.68 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.522 HG11 ' CB ' ' A' ' 21' ' ' GLN . 21.4 t -159.43 128.5 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.554 -0.968 . . . . 0.0 109.035 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.471 ' N ' ' OE1' ' A' ' 21' ' ' GLN . 3.6 ttpp -100.01 112.29 24.58 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.828 0.823 . . . . 0.0 110.013 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.0 ttt -93.02 99.29 11.94 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 2.5 m -92.45 143.14 26.66 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.86 -1.136 . . . . 0.0 110.039 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -119.46 111.19 17.81 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.354 -0.841 . . . . 0.0 109.762 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.446 ' CE2' ' HG3' ' A' ' 138' ' ' GLN . 5.2 m-85 -111.3 166.11 11.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.225 -0.922 . . . . 0.0 111.074 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.551 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 62.7 t-80 -103.97 135.54 45.3 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.837 0.827 . . . . 0.0 109.008 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.586 ' HB ' ' CE1' ' A' ' 63' ' ' PHE . 4.4 m -73.45 154.24 7.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-O 121.476 0.655 . . . . 0.0 110.406 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -121.74 27.61 8.08 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.607 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 19.5 p90 -125.75 69.47 1.18 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.112 -0.992 . . . . 0.0 110.234 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.58 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -160.91 -59.06 0.05 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.918 . . . . 0.0 109.764 178.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -95.86 80.77 0.8 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.54 -43.03 0.72 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.57 -78.3 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.904 -1.351 . . . . 0.0 110.825 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.596 ' CD1' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -80.49 -20.88 42.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.122 . . . . 0.0 110.265 -179.02 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.596 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -54.79 -38.68 65.07 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -47.32 63.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.427 -1.043 . . . . 0.0 108.523 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.527 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 12.2 t70 -65.44 -23.57 66.96 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.542 HD22 ' NE2' ' A' ' 60' ' ' HIS . 36.7 tp -65.09 -46.47 80.96 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 m -58.51 -42.73 88.33 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.498 ' O ' ' CG2' ' A' ' 78' ' ' VAL . 19.2 tt0 -57.72 -25.03 59.78 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 177.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -64.69 -40.21 94.99 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.447 ' O ' ' HB2' ' A' ' 80' ' ' MET . 25.3 t-105 -63.54 -29.09 70.4 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.449 ' CB ' HG21 ' A' ' 135' ' ' VAL . . . -81.6 -44.02 17.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 109.763 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.648 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 1.6 t -71.78 -27.39 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 109.401 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.507 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -78.75 -57.78 3.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.13 -0.982 . . . . 0.0 108.804 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -48.17 -27.68 2.53 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.155 -0.965 . . . . 0.0 108.578 179.429 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.419 ' CB ' HG21 ' A' ' 131' ' ' VAL . . . -69.25 -45.74 69.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.584 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.459 ' HB2' HG12 ' A' ' 84' ' ' VAL . 12.6 mt -105.2 14.28 29.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 49.1 25.52 5.51 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 33.8 m -82.98 -11.53 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -1.086 . . . . 0.0 110.298 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.431 ' HG2' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -42.84 -63.59 0.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -0.98 . . . . 0.0 109.875 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.47 -33.43 1.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.285 -0.885 . . . . 0.0 110.264 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -81.6 -50.76 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.37 -0.832 . . . . 0.0 111.436 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.527 HG22 ' CD1' ' A' ' 92' ' ' LEU . 2.2 m -90.57 6.1 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.863 -1.148 . . . . 0.0 111.195 -178.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.601 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -83.02 -45.7 13.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.818 -1.177 . . . . 0.0 108.347 178.582 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.464 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -52.39 -51.46 72.37 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.596 -1.315 . . . . 0.0 110.61 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 90' ' ' VAL . 27.1 Cg_endo -73.79 -20.13 20.26 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 N-CA-C 109.736 -0.909 . . . . 0.0 109.736 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.527 ' CD1' HG22 ' A' ' 88' ' ' VAL . 18.5 mt -86.18 -43.21 13.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 108.87 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.627 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 5.2 m-30 -64.47 -45.77 85.96 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.094 -1.004 . . . . 0.0 108.945 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -76.36 -21.2 56.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.083 -1.011 . . . . 0.0 109.751 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.456 ' O ' HG12 ' A' ' 102' ' ' ILE . . . -72.75 -29.77 64.85 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.572 HG13 ' CG ' ' A' ' 29' ' ' PHE . 3.4 t -98.77 -15.29 7.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.012 -1.287 . . . . 0.0 109.669 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.525 ' NE2' ' HB2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -108.64 8.23 26.92 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 120.815 -1.178 . . . . 0.0 111.131 -178.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 99' ' ' THR . 16.8 mttt -163.72 63.39 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.517 -1.365 . . . . 0.0 109.472 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.546 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 1.1 m 160.41 -44.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 71.51 13.52 6.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.803 -1.186 . . . . 0.0 110.834 178.915 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.546 ' HB ' ' CG2' ' A' ' 99' ' ' THR . 4.5 t -79.67 -8.49 59.25 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.5 ' CB ' HG23 ' A' ' 96' ' ' VAL . 7.7 mm -83.14 74.11 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.71 32.72 2.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 0.0 109.757 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 107' ' ' ASP . 13.2 p -159.28 132.09 6.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.03 -1.044 . . . . 0.0 109.797 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.489 ' HA ' ' CD1' ' A' ' 108' ' ' ILE . . . -48.65 -36.43 15.92 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 110' ' ' ASP . 22.7 t -58.1 -34.1 69.83 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -66.67 -49.7 65.3 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.553 ' CD1' HD21 ' A' ' 68' ' ' LEU . 24.5 mt -50.02 -26.71 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.253 -0.904 . . . . 0.0 108.623 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 110' ' ' ASP . 0.9 OUTLIER -71.5 -64.65 0.88 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.476 -0.765 . . . . 0.0 109.614 -179.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.489 ' OD1' ' HA ' ' A' ' 107' ' ' ASP . 0.0 OUTLIER -43.62 -42.27 5.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.33 -0.856 . . . . 0.0 110.195 -179.356 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.51 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 1.4 t -67.78 -40.16 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.794 -1.191 . . . . 0.0 109.452 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -68.35 -37.66 80.7 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.227 -0.92 . . . . 0.0 109.578 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.415 HD11 ' HA ' ' A' ' 110' ' ' ASP . 15.7 mt -68.4 -23.51 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.0 108.99 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -63.68 -17.58 63.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.454 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.46 ' HB1' HG11 ' A' ' 88' ' ' VAL . . . -95.51 12.83 28.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.211 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.67 8.23 87.21 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.492 ' O ' ' C ' ' A' ' 118' ' ' LYS . 3.9 mm -89.0 62.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -1.073 . . . . 0.0 109.653 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.492 ' C ' ' O ' ' A' ' 117' ' ' ILE . 1.7 tptp -33.35 140.85 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.342 -0.849 . . . . 0.0 110.374 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.47 -23.76 6.69 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.418 ' O ' ' HB1' ' A' ' 124' ' ' ALA . 9.7 tt0 -63.07 -49.07 75.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.267 . . . . 0.0 109.593 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -76.23 -38.21 56.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.622 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.648 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 1.9 t80 -64.54 -50.66 66.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.299 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.16 -48.39 76.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.093 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 120' ' ' GLU . . . -50.97 -53.3 34.29 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.328 -0.857 . . . . 0.0 108.875 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.49 ' CB ' HG23 ' A' ' 131' ' ' VAL . . . -49.86 -52.66 31.0 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 8.7 t90 -52.28 -59.78 3.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -52.31 -16.75 0.91 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.615 -0.678 . . . . 0.0 110.038 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.2 m -72.2 -178.56 2.51 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.904 -1.123 . . . . 0.0 109.6 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -90.08 -35.29 15.54 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.888 -0.507 . . . . 0.0 110.424 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.43 -45.63 81.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 118.198 -1.401 . . . . 0.0 109.586 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.491 ' CG1' ' HA ' ' A' ' 78' ' ' VAL . 3.6 t -71.75 -35.62 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.958 -1.089 . . . . 0.0 108.632 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -69.97 -38.47 76.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.381 -0.824 . . . . 0.0 108.926 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -65.72 -29.89 70.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 108.977 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.59 -21.97 44.31 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.449 HG21 ' CB ' ' A' ' 77' ' ' ALA . 6.0 t -75.77 -45.59 37.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.76 88.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -62.45 -38.26 89.1 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 141' ' ' ALA . 4.8 mt-30 -62.2 -64.39 0.95 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 4.5 tm-20 -48.18 -31.05 5.23 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -73.41 -33.29 64.89 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -63.8 -63.01 1.28 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 108.886 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -62.1 -35.39 78.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.359 -0.838 . . . . 0.0 109.745 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -77.19 -16.64 59.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 109.719 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 140' ' ' LYS . 9.4 m-20 -79.94 -44.28 20.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.098 -1.001 . . . . 0.0 108.725 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.546 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 16.0 m -105.78 -5.2 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.372 -0.83 . . . . 0.0 109.004 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 81.32 -47.16 0.23 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.773 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.571 HD11 ' CD2' ' A' ' 25' ' ' PHE . 17.2 tp 66.29 132.74 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 109.295 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.511 ' CD ' ' O ' ' A' ' 148' ' ' ARG . 6.3 tmm_? -160.79 38.42 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.59 -1.319 . . . . 0.0 109.94 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.46 108.0 0.21 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.251 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.533 ' CG1' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -93.32 141.8 24.44 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.404 -1.057 . . . . 0.0 109.573 179.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.477 ' HD3' ' CE1' ' A' ' 32' ' ' HIS . 35.7 Cg_endo -78.42 150.39 87.87 Favored 'Cis proline' 0 C--N 1.316 -1.176 0 C-N-CA 123.858 -1.309 . . . . 0.0 110.312 0.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.502 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . . . -122.83 148.33 45.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.169 -1.582 . . . . 0.0 108.456 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.509 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -135.47 130.65 35.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.969 -1.082 . . . . 0.0 110.053 -179.08 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.53 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 29.6 m-85 -129.58 127.75 41.32 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.279 -0.888 . . . . 0.0 110.087 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 34.8 t -97.07 125.82 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 109.431 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.444 ' O ' ' CG ' ' A' ' 156' ' ' ASN . 21.5 t-20 52.54 22.69 2.25 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.194 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.534 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 54.34 39.18 64.14 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.315 -1.422 . . . . 0.0 109.639 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 3.0 tttp -142.95 -32.85 0.47 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.313 -1.11 . . . . 0.0 108.279 179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.554 ' CD2' ' HD2' ' A' ' 188' ' ' LYS . 31.4 m-85 -116.34 125.42 52.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 108.644 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.53 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 6.3 pt20 -122.5 120.18 33.11 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.058 -1.026 . . . . 0.0 109.895 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.424 HD22 ' HB2' ' A' ' 9' ' ' TYR . 25.5 mt -62.47 -179.6 0.26 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -159.86 70.21 3.13 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.126 -0.984 . . . . 0.0 109.388 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.37 -22.28 11.05 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.78 2.32 . . . . 0.0 110.547 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.434 ' O ' ' C ' ' A' ' 165' ' ' GLY . 0.5 OUTLIER 57.22 16.5 3.07 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.275 -0.891 . . . . 0.0 109.418 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 164' ' ' GLN . . . 43.37 36.24 3.01 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.89 42.51 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -1.147 . . . . 0.0 109.825 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.446 ' OD2' ' HB2' ' A' ' 174' ' ' PHE . 10.8 t0 -136.04 37.74 2.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 109.88 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 69.7 p -77.7 -8.5 58.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.898 -1.126 . . . . 0.0 109.612 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.2 t -84.27 -17.35 39.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.309 -0.869 . . . . 0.0 109.381 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -148.35 67.08 1.07 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.053 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.453 ' O ' HG22 ' A' ' 175' ' ' VAL . 0.0 OUTLIER -59.02 -15.64 14.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -0.831 . . . . 0.0 110.038 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.44 -48.05 62.1 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.605 -0.685 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.452 HG11 ' OE1' ' A' ' 177' ' ' GLN . 4.9 t -73.16 -26.55 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.148 -0.97 . . . . 0.0 109.619 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.479 ' CE2' HD12 ' A' ' 42' ' ' ILE . 6.7 t80 -71.53 -44.43 64.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.033 -1.042 . . . . 0.0 109.582 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 171' ' ' MET . 86.9 t -71.55 -26.1 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.112 -0.993 . . . . 0.0 109.21 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -56.61 3.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.452 ' OE1' HG11 ' A' ' 173' ' ' VAL . 18.2 pt20 -60.08 -35.67 75.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.981 . . . . 0.0 108.983 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.553 ' CE1' ' CG2' ' A' ' 182' ' ' VAL . 4.0 t80 -66.55 -51.81 52.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 175' ' ' VAL . . . -54.1 -26.54 27.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -0.916 . . . . 0.0 108.917 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.66 -37.99 40.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.526 ' O ' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -62.63 -40.77 98.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.314 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.553 ' CG2' ' CE1' ' A' ' 178' ' ' TYR . 21.2 t -75.53 -34.8 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.033 -1.042 . . . . 0.0 109.19 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -58.7 -49.48 77.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.22 -0.925 . . . . 0.0 109.157 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.529 ' CD2' HD21 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -77.7 -40.25 41.96 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.28 -0.887 . . . . 0.0 108.716 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.572 HD21 ' N ' ' A' ' 185' ' ' LEU . 3.8 mm? -53.6 -19.13 3.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.08 -1.012 . . . . 0.0 109.434 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 12.3 t -87.01 8.67 22.37 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.761 -1.212 . . . . 0.0 107.989 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 184' ' ' TYR . 0.8 OUTLIER -117.19 0.8 12.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.529 -0.732 . . . . 0.0 109.715 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.554 ' HD2' ' CD2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -43.12 -58.07 2.63 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.176 -0.953 . . . . 0.0 109.097 -179.245 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.458 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.458 ' O ' ' C ' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.525 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER 40.74 49.52 2.83 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.838 0.827 . . . . 0.0 108.988 -179.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.7 OUTLIER 74.98 96.92 0.07 Allowed 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.458 ' CG ' ' O ' ' A' ' 4' ' ' GLU . 1.2 tt0 -130.03 60.38 1.6 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.113 -0.992 . . . . 0.0 110.201 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 0.7 OUTLIER 70.02 94.63 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.427 -0.796 . . . . 0.0 110.538 178.797 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.52 ' HA2' ' ND2' ' A' ' 162' ' ' ASN . . . 79.71 5.45 89.39 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 1.2 tttp -106.86 31.37 5.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -1.193 . . . . 0.0 108.91 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.577 ' CB ' ' O ' ' A' ' 7' ' ' LYS . 0.1 OUTLIER 147.8 -39.45 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.374 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.571 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 1.3 p90 -157.96 124.51 4.85 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.086 -1.009 . . . . 0.0 109.352 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 t -104.03 176.79 5.04 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -116.25 146.72 42.14 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.596 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.472 ' HG ' ' NE2' ' A' ' 160' ' ' GLN . 1.5 mp -98.52 160.95 13.94 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.363 -0.835 . . . . 0.0 109.703 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -89.99 -1.63 58.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.479 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -142.64 94.84 6.56 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.301 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 35.6 Cg_endo -77.84 167.0 24.48 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.589 2.193 . . . . 0.0 110.517 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 144' ' ' ASP . 25.2 t -119.6 95.67 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.754 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.19 129.47 10.15 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 92.18 -18.74 53.15 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.55 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -38.54 157.84 0.1 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.517 -0.99 . . . . 0.0 109.828 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.5 Cg_endo -79.85 133.56 10.26 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.573 2.182 . . . . 0.0 111.126 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 9.6 mm-40 -41.16 -25.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.53 -0.731 . . . . 0.0 109.935 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 22' ' ' VAL . 5.1 t -147.98 80.41 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.007 -1.058 . . . . 0.0 109.022 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.649 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.23 120.71 20.17 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.504 ' N ' HD21 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -104.64 122.66 46.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.182 -0.948 . . . . 0.0 109.42 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.649 ' CE1' ' CD1' ' A' ' 23' ' ' LEU . 2.9 m-30 -108.26 103.62 12.83 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.408 -0.808 . . . . 0.0 109.9 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -140.67 141.06 35.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.423 -0.798 . . . . 0.0 109.243 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.598 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 1.3 t -115.41 172.22 7.23 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.093 -1.005 . . . . 0.0 109.217 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.555 ' N ' ' NE2' ' A' ' 60' ' ' HIS . 8.0 m-30 -89.71 43.67 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.525 ' CD1' ' O ' ' A' ' 28' ' ' PHE . 22.2 m-85 -147.3 17.33 1.19 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.494 -0.754 . . . . 0.0 109.698 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -113.68 165.96 12.34 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.756 -1.215 . . . . 0.0 109.622 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 33.7 Cg_endo -75.95 -38.46 1.21 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.33 2.02 . . . . 0.0 108.183 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.482 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 1.8 m-70 -72.56 -28.16 62.65 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.491 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 28.8 t -44.57 -61.93 1.38 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.81 0.814 . . . . 0.0 108.826 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.618 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 27.5 t80 -78.09 -40.09 39.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.885 -0.51 . . . . 0.0 110.55 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.485 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 3.4 mm-40 -64.52 -27.35 68.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.188 -0.945 . . . . 0.0 111.079 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.557 ' CE1' HD11 ' A' ' 42' ' ' ILE . 3.9 m-30 -87.02 -34.36 19.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.806 -1.184 . . . . 0.0 111.212 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.14 -23.2 22.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.805 -1.184 . . . . 0.0 111.987 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -136.34 28.14 3.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.344 -1.472 . . . . 0.0 111.612 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.507 ' O ' ' CD2' ' A' ' 41' ' ' HIS . 53.3 t -150.98 -81.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.541 -1.349 . . . . 0.0 109.821 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 17.9 mt -67.78 -12.52 60.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.804 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 14.3 m-70 51.51 21.76 1.34 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.979 . . . . 0.0 109.337 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.557 HD11 ' CE1' ' A' ' 36' ' ' PHE . 22.1 mt -65.32 -20.09 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 109.45 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.517 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -81.64 -41.43 21.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.757 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 47' ' ' LYS . 7.4 p-10 -87.08 -45.14 10.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.995 . . . . 0.0 109.59 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -45.83 -31.48 2.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.866 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 43' ' ' SER . 8.4 m -74.26 -30.85 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.089 -1.007 . . . . 0.0 109.655 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 44' ' ' ASP . 8.6 mmmm -48.49 -39.62 23.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 0.0 109.223 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -58.45 -23.23 57.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.353 -0.842 . . . . 0.0 109.206 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 6.4 mttm -93.31 23.31 4.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.401 -0.812 . . . . 0.0 109.78 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.536 HD21 ' CB ' ' A' ' 54' ' ' VAL . 18.8 mt -118.92 76.27 14.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.024 -1.047 . . . . 0.0 109.824 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 52' ' ' GLU . 36.6 Cg_endo -78.69 63.34 8.53 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.417 2.078 . . . . 0.0 110.293 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 51' ' ' PRO . 23.3 tp10 58.46 131.57 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.448 0.642 . . . . 0.0 110.259 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.69 -18.35 44.12 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.536 ' CB ' HD21 ' A' ' 50' ' ' LEU . 2.4 t -95.89 89.36 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.082 -1.246 . . . . 0.0 109.193 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.97 96.79 2.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.412 -0.805 . . . . 0.0 109.846 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.423 ' HG2' ' CD1' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -92.18 100.75 13.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.272 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.2 m -98.61 119.18 36.9 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.864 -1.135 . . . . 0.0 110.581 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.495 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -97.63 108.53 21.27 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.466 -0.771 . . . . 0.0 109.654 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.53 ' CD1' ' HG3' ' A' ' 138' ' ' GLN . 3.0 m-85 -111.56 154.18 25.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.166 -0.959 . . . . 0.0 111.624 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.598 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 18.2 t-80 -106.62 108.88 20.61 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.575 HG22 ' CD1' ' A' ' 63' ' ' PHE . 15.1 m -69.64 156.53 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.44 -0.787 . . . . 0.0 109.994 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.512 ' CB ' ' HA ' ' A' ' 70' ' ' LYS . 3.6 p30 -108.23 51.38 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 109.573 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.577 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -131.1 52.94 2.02 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.172 -0.955 . . . . 0.0 110.155 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.521 ' SD ' ' CB ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -134.02 38.79 3.16 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.32 -34.2 0.65 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.57 -34.86 2.88 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.757 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.27 -80.44 0.25 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.765 -1.432 . . . . 0.0 109.852 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.56 HD21 ' CD1' ' A' ' 108' ' ' ILE . 0.0 OUTLIER -77.44 -23.79 50.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.794 -1.191 . . . . 0.0 108.723 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.54 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -48.18 -44.0 26.25 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.512 ' HA ' ' CB ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -64.58 -45.13 88.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -1.117 . . . . 0.0 108.572 179.281 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.531 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 22.7 t0 -67.72 -28.7 67.88 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.583 ' HG ' ' CE1' ' A' ' 60' ' ' HIS . 13.1 tp -62.69 -44.37 96.41 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.45 HG22 ' HG2' ' A' ' 138' ' ' GLN . 2.5 m -60.46 -42.32 95.93 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.483 ' O ' ' CG2' ' A' ' 78' ' ' VAL . 8.4 tt0 -59.7 -21.17 60.24 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.484 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -68.62 -43.52 76.2 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.503 ' CD1' ' OE1' ' A' ' 138' ' ' GLN . 69.7 t-105 -60.45 -32.13 71.09 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.538 ' CB ' ' CG2' ' A' ' 135' ' ' VAL . . . -79.89 -55.41 4.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.549 -0.719 . . . . 0.0 109.876 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.641 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 2.8 t -57.7 -28.29 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 109.96 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 83' ' ' GLY . . . -79.54 -59.04 2.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.883 -1.136 . . . . 0.0 108.564 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -46.19 -29.52 1.61 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.442 ' HB3' ' CG2' ' A' ' 131' ' ' VAL . . . -68.35 -44.6 74.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.383 -0.823 . . . . 0.0 109.391 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.477 ' O ' HG11 ' A' ' 84' ' ' VAL . 7.7 mt -104.68 13.35 31.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.189 -0.944 . . . . 0.0 110.026 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.39 27.51 4.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 82' ' ' LEU . 33.1 m -85.28 -9.15 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.314 -1.109 . . . . 0.0 110.415 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.466 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.3 OUTLIER -41.31 -60.49 1.25 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.17 -0.956 . . . . 0.0 109.784 -179.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.16 -33.46 2.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.365 -0.835 . . . . 0.0 110.041 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -83.82 -49.83 8.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.329 -0.857 . . . . 0.0 111.411 -178.517 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.2 m -87.06 -4.72 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.775 -1.203 . . . . 0.0 110.504 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.614 HG21 ' CG ' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -77.41 -44.17 30.08 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.811 -1.181 . . . . 0.0 108.508 178.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.438 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -51.46 -52.72 57.18 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.634 -1.291 . . . . 0.0 110.334 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.522 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 27.2 Cg_endo -74.04 -17.63 22.0 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 N-CA-C 109.847 -0.866 . . . . 0.0 109.847 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 89' ' ' THR . 12.7 mt -86.84 -42.49 13.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 108.956 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.614 ' CG ' HG21 ' A' ' 89' ' ' THR . 7.4 m-30 -69.88 -46.73 64.84 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.877 -1.139 . . . . 0.0 108.472 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 1.0 OUTLIER -72.77 -27.75 62.19 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.194 -0.941 . . . . 0.0 108.975 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.468 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -70.1 -29.09 70.81 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' A' ' 29' ' ' PHE . 1.6 t -103.8 1.38 10.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.194 -1.18 . . . . 0.0 108.917 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.618 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER -107.54 10.75 29.19 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.975 -1.078 . . . . 0.0 110.763 -179.15 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -178.62 -51.82 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.576 -1.327 . . . . 0.0 110.423 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 68.6 p -59.79 -40.84 89.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.48 -1.388 . . . . 0.0 109.507 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.472 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 67.49 9.9 7.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.372 -0.83 . . . . 0.0 109.783 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 t -81.15 -7.85 59.64 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.827 0.822 . . . . 0.0 109.044 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.499 HG13 HG21 ' A' ' 96' ' ' VAL . 8.8 mm -85.4 80.74 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -145.05 34.51 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.39 -0.819 . . . . 0.0 109.699 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 107' ' ' ASP . 83.4 p -164.96 136.28 4.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.893 -1.13 . . . . 0.0 110.269 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.505 ' N ' ' HB2' ' A' ' 68' ' ' LEU . . . -49.22 -38.65 27.13 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 t -56.75 -32.5 65.65 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -70.0 -53.39 17.88 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.56 ' CD1' HD21 ' A' ' 68' ' ' LEU . 25.5 mt -45.68 -28.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.173 -0.955 . . . . 0.0 108.771 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -46.34 31.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 109.565 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 1.2 p30 -53.14 -41.8 65.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 109.606 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.522 ' CG1' ' HG2' ' A' ' 91' ' ' PRO . 13.6 t -71.49 -38.39 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.96 -1.088 . . . . 0.0 109.51 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.412 ' CE1' HG22 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -65.79 -54.71 23.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.3 mt -61.67 -24.02 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.131 -0.981 . . . . 0.0 109.709 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -72.4 -16.64 61.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.155 -0.966 . . . . 0.0 109.45 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.6 8.08 43.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 109.77 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.44 -3.3 79.0 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.6 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.4 mp -85.54 60.73 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -1.129 . . . . 0.0 109.114 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -37.28 157.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.828 -1.17 . . . . 0.0 110.239 -179.456 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.42 -23.57 64.78 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.47 -52.01 63.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.982 -1.305 . . . . 0.0 109.337 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -75.5 -36.82 60.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.934 . . . . 0.0 109.331 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.641 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 3.2 t80 -62.78 -48.51 78.84 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.247 -0.908 . . . . 0.0 109.005 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -62.12 -36.88 83.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 108.75 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.466 ' O ' ' OG ' ' A' ' 128' ' ' SER . . . -63.24 -49.76 72.88 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 108.92 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.528 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -52.54 -50.72 62.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.002 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.465 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 3.1 t90 -60.18 -55.53 32.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -52.66 -16.47 0.96 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.547 -0.721 . . . . 0.0 110.015 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 124' ' ' ALA . 0.9 OUTLIER -73.54 176.8 5.8 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.965 -1.084 . . . . 0.0 109.383 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 133' ' ' SER . 60.4 m-85 -91.94 -37.94 12.57 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.63 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.9 t -65.21 -47.14 88.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 118.056 -1.458 . . . . 0.0 109.266 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 3.7 t -64.03 -39.44 85.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.057 -1.027 . . . . 0.0 108.344 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -71.19 -27.63 63.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.835 . . . . 0.0 108.915 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -66.42 -41.82 88.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.151 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.45 -18.17 55.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 108.699 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.538 ' CG2' ' CB ' ' A' ' 77' ' ' ALA . 3.9 t -75.54 -40.36 41.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -71.81 -39.69 69.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -30.3 70.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.09 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.53 ' HG3' ' CD1' ' A' ' 59' ' ' TYR . 2.8 tt0 -71.17 -64.71 0.86 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.33 -0.857 . . . . 0.0 109.075 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 0.6 OUTLIER -50.09 -33.43 18.6 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 108.475 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 26.4 mttt -76.71 -29.91 56.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -57.27 -53.99 51.82 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.309 -0.87 . . . . 0.0 108.763 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -72.03 -40.53 68.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.366 -0.834 . . . . 0.0 110.495 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.55 -16.93 61.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.991 -1.068 . . . . 0.0 109.939 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.482 ' HB3' ' CG2' ' A' ' 16' ' ' VAL . 2.4 m-20 -84.71 -43.21 14.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 108.553 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.583 HG23 ' CE2' ' A' ' 25' ' ' PHE . 4.5 m -93.42 -12.09 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 1.0 OUTLIER 82.33 -43.79 0.14 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.65 -0.657 . . . . 0.0 109.513 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.528 HD21 ' CG1' ' A' ' 61' ' ' VAL . 33.7 tp 62.9 139.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.426 -0.797 . . . . 0.0 109.939 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.501 ' CD ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -161.22 38.73 0.14 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.764 -1.21 . . . . 0.0 109.563 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 160.42 109.93 0.26 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.438 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.37 140.59 21.76 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.35 -1.088 . . . . 0.0 108.743 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.76 150.87 87.65 Favored 'Cis proline' 0 C--N 1.313 -1.312 0 C-N-CA 123.993 -1.253 . . . . 0.0 110.396 0.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.461 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . . . -123.63 160.19 27.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.442 -1.411 . . . . 0.0 109.051 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.469 ' HE3' ' CE2' ' A' ' 178' ' ' TYR . 0.6 OUTLIER -144.7 129.11 17.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.074 -1.016 . . . . 0.0 109.871 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 8.9 m-85 -131.64 134.18 45.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.372 -0.83 . . . . 0.0 109.993 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 53.7 t -105.56 133.16 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.912 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.405 ' N ' HG11 ' A' ' 155' ' ' VAL . 0.7 OUTLIER 45.5 22.21 0.09 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.201 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.55 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.92 57.56 19.08 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -168.88 -34.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.234 -1.156 . . . . 0.0 108.454 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.455 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 51.6 m-85 -117.89 125.09 49.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.815 . . . . 0.0 108.971 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.472 ' NE2' ' HG ' ' A' ' 12' ' ' LEU . 20.9 pt20 -123.74 130.5 52.73 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.78 -1.2 . . . . 0.0 109.82 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.14 172.75 10.5 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.52 ' ND2' ' HA2' ' A' ' 6' ' ' GLY . 5.6 p30 -151.95 147.12 19.37 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.089 -1.007 . . . . 0.0 109.482 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.43 39.66 0.88 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.672 2.248 . . . . 0.0 110.776 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 164' ' ' GLN . 1.1 tp60 -85.19 -20.91 29.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.987 -1.071 . . . . 0.0 109.547 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -100.16 37.48 3.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.473 ' CG ' ' O ' ' A' ' 166' ' ' MET . 9.3 ttt -123.91 34.54 5.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -1.112 . . . . 0.0 109.578 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -133.47 37.52 3.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.972 . . . . 0.0 109.783 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 169' ' ' SER . 62.0 p -121.01 0.17 10.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.979 -1.075 . . . . 0.0 109.657 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 168' ' ' THR . 1.2 t 72.36 58.79 0.13 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.224 -0.923 . . . . 0.0 109.359 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 174' ' ' PHE . 1.7 m-20 -159.68 72.27 0.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 0.0 109.4 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.456 ' HA ' ' CD2' ' A' ' 174' ' ' PHE . 4.3 mtt -59.62 -16.66 27.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -75.32 -62.42 1.57 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.7 t -55.86 -26.82 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.248 -0.908 . . . . 0.0 108.601 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 174' ' ' PHE . 7.0 m-30 -69.26 -38.13 78.25 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.195 -0.941 . . . . 0.0 108.962 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.459 ' O ' ' HB1' ' A' ' 179' ' ' ALA . 77.6 t -73.78 -24.97 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.229 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -83.14 -60.4 2.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.301 -0.874 . . . . 0.0 109.226 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -37.86 61.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.167 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 174' ' ' PHE . 16.5 t80 -69.58 -44.4 70.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.342 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 175' ' ' VAL . . . -65.31 -29.06 69.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 109.076 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.19 -37.95 60.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.1 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -64.05 -44.27 92.97 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.23 -0.919 . . . . 0.0 108.948 179.404 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.473 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 55.7 t -69.77 -38.62 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.176 -0.953 . . . . 0.0 109.186 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -55.13 38.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.126 -0.984 . . . . 0.0 109.385 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -75.92 -26.4 56.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.219 -0.926 . . . . 0.0 109.146 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.519 HD21 ' N ' ' A' ' 185' ' ' LEU . 0.3 OUTLIER -64.63 -18.86 65.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.965 -1.085 . . . . 0.0 109.267 -179.654 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 59.6 p -80.15 0.39 32.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 0.0 108.519 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.64 -75.86 0.58 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.447 -0.783 . . . . 0.0 109.264 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 189' ' ' LYS . 2.3 mmmp? 54.73 19.51 2.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.365 -0.835 . . . . 0.0 109.485 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.479 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.8 64.83 1.47 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.265 -0.897 . . . . 0.0 109.379 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.8 OUTLIER 52.05 86.05 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -0.835 . . . . 0.0 109.051 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 5' ' ' ASP . 5.4 mt-10 -99.65 54.87 0.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.81 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 4' ' ' GLU . 4.2 p-10 39.86 80.08 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.284 0.564 . . . . 0.0 110.036 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 127.81 -26.4 4.83 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.662 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -80.98 -68.53 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.844 -1.386 . . . . 0.0 109.289 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 11.9 mp0 -93.52 4.36 54.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 0.0 109.427 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.567 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 3.4 p90 179.1 131.68 0.08 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.169 -0.957 . . . . 0.0 109.35 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.442 HG22 ' HG3' ' A' ' 160' ' ' GLN . 8.7 t -119.65 175.83 5.67 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.661 -0.649 . . . . 0.0 109.26 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.59 157.59 15.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.686 -0.634 . . . . 0.0 109.617 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.475 ' HG ' ' HG2' ' A' ' 160' ' ' GLN . 7.4 mt -96.16 158.19 15.55 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.355 -0.84 . . . . 0.0 109.445 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -84.02 -12.06 55.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.096 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -151.82 104.74 2.85 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.1 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.36 166.87 26.78 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.449 2.099 . . . . 0.0 110.679 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 17' ' ' ALA . 10.2 t -132.14 89.87 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.852 . . . . 0.0 109.649 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.24 131.14 8.02 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 92.49 -19.7 48.92 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -40.29 163.24 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.563 -0.963 . . . . 0.0 109.917 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.542 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 35.0 Cg_endo -77.41 125.81 7.94 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.61 2.207 . . . . 0.0 111.047 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.529 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 5.3 mm100 -40.07 -24.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.523 -0.736 . . . . 0.0 110.012 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 20' ' ' PRO . 2.7 t -146.1 81.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.168 -0.958 . . . . 0.0 108.772 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.542 ' HG ' ' CG ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -75.34 124.97 28.04 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.518 ' N ' HD21 ' A' ' 23' ' ' LEU . 0.2 OUTLIER -107.95 133.92 51.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.083 -1.011 . . . . 0.0 110.234 -179.027 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CE2' ' CG2' ' A' ' 145' ' ' VAL . 7.5 m-85 -123.55 100.74 6.95 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.496 ' HA ' HG13 ' A' ' 150' ' ' VAL . 3.3 p90 -150.76 140.29 21.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.048 -1.033 . . . . 0.0 110.458 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.481 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 1.3 p -115.15 177.44 4.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.345 -0.847 . . . . 0.0 109.123 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.576 ' CD2' HD23 ' A' ' 72' ' ' LEU . 8.4 m-30 -94.04 41.73 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.515 ' CE2' HD13 ' A' ' 72' ' ' LEU . 9.9 m-85 -130.96 14.52 5.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.351 -0.843 . . . . 0.0 110.175 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.477 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.6 OUTLIER -110.5 158.46 35.36 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.706 -1.246 . . . . 0.0 109.554 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.506 ' HG2' ' CD2' ' A' ' 32' ' ' HIS . 33.8 Cg_endo -75.05 -38.38 1.59 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.189 1.926 . . . . 0.0 108.037 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.506 ' CD2' ' HG2' ' A' ' 31' ' ' PRO . 27.1 m-70 -76.06 -21.13 57.1 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 52.1 t -47.49 -65.1 0.62 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.55 ' HB2' ' CG ' ' A' ' 97' ' ' GLN . 7.3 t80 -60.66 -43.01 98.15 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.221 0.534 . . . . 0.0 110.037 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.469 ' HB2' ' HA ' ' A' ' 32' ' ' HIS . 1.8 mt-30 -60.92 -22.98 64.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.194 -0.941 . . . . 0.0 109.976 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -82.9 -36.85 24.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.369 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.524 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -106.29 47.99 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.959 -1.088 . . . . 0.0 109.938 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -171.62 -52.23 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.223 -0.923 . . . . 0.0 111.902 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.0 t -89.28 -83.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.463 -1.398 . . . . 0.0 112.204 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.72 -10.48 59.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.973 -1.079 . . . . 0.0 110.765 -177.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 55.66 33.7 21.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 109.36 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.6 mm -48.58 -22.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 109.913 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.97 -41.57 18.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.2 -0.937 . . . . 0.0 110.341 -179.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -86.15 -38.32 17.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.063 -1.023 . . . . 0.0 110.149 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.67 -33.79 4.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 109.907 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.499 HG21 ' N ' ' A' ' 47' ' ' LYS . 32.1 m -80.19 -26.52 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.013 -1.055 . . . . 0.0 110.338 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 2.1 mmtp -63.07 -40.78 98.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.898 -1.126 . . . . 0.0 109.737 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.04 -27.75 6.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.16 -0.963 . . . . 0.0 109.23 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.478 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 11.5 mttt -117.1 40.46 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.531 ' CD2' HG13 ' A' ' 54' ' ' VAL . 11.4 mt -113.27 88.62 12.98 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 35.8 Cg_endo -77.67 143.09 21.01 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.76 2.307 . . . . 0.0 110.528 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 51' ' ' PRO . 1.6 tm-20 -40.14 121.6 1.37 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 122.361 1.077 . . . . 0.0 109.562 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.95 -30.92 3.44 Favored Glycine 0 C--N 1.286 -2.2 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.531 HG13 ' CD2' ' A' ' 50' ' ' LEU . 2.6 t -86.35 82.91 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -1.065 . . . . 0.0 108.536 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.47 96.76 0.39 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.425 -0.797 . . . . 0.0 110.172 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.436 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -90.68 94.22 9.59 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 31.5 m -94.66 135.39 36.19 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.916 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.501 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -115.25 115.03 26.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.313 -0.867 . . . . 0.0 109.714 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.5 ' OH ' ' CG ' ' A' ' 137' ' ' GLN . 2.2 m-85 -112.58 166.46 11.31 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.071 -1.018 . . . . 0.0 111.631 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.64 ' CE1' ' CD2' ' A' ' 72' ' ' LEU . 2.1 t60 -108.86 125.66 52.22 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.734 0.778 . . . . 0.0 109.816 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.536 ' CG1' HD22 ' A' ' 147' ' ' LEU . 1.9 m -73.28 157.22 6.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.732 -0.605 . . . . 0.0 109.907 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -121.99 28.21 7.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.324 -0.86 . . . . 0.0 109.131 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.596 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 11.6 p90 -121.22 67.61 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 110.052 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.592 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -160.12 -59.1 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.396 -0.815 . . . . 0.0 109.222 178.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.592 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -96.21 78.03 0.76 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 178.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.67 -40.92 0.51 Allowed Glycine 0 N--CA 1.492 2.423 0 O-C-N 121.552 -0.969 . . . . 0.0 110.925 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.4 -79.23 0.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.909 -1.348 . . . . 0.0 110.64 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.59 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -80.13 -20.78 44.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.0 -1.062 . . . . 0.0 110.219 -179.145 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 65' ' ' GLY . . . -51.95 -47.1 54.8 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -46.55 88.25 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.469 -1.018 . . . . 0.0 108.316 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.512 ' CB ' ' HB3' ' A' ' 105' ' ' ALA . 0.3 OUTLIER -62.27 -26.04 68.18 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.344 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.64 ' CD2' ' CE1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -63.54 -37.4 87.16 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.428 HG22 ' OE1' ' A' ' 138' ' ' GLN . 5.9 m -65.01 -42.43 94.46 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.559 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 37.7 tt0 -61.59 -19.28 62.02 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.489 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -67.82 -43.0 80.65 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.462 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 22.8 t-105 -63.69 -31.95 73.28 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.846 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.403 ' HB2' HG22 ' A' ' 135' ' ' VAL . . . -79.87 -56.67 4.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 109.919 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.574 ' HB ' ' CZ ' ' A' ' 112' ' ' PHE . 45.8 t -58.18 -27.03 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 0.0 110.015 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.535 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -82.16 -64.08 1.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.884 -1.135 . . . . 0.0 108.9 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.432 ' HB3' HD21 ' A' ' 134' ' ' LEU . 0.1 OUTLIER -46.85 -27.55 1.27 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.424 ' C ' HD22 ' A' ' 82' ' ' LEU . . . -66.15 -49.51 67.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.48 -0.763 . . . . 0.0 109.837 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.424 HD22 ' C ' ' A' ' 81' ' ' ALA . 7.1 mt -101.64 9.73 40.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.072 -1.017 . . . . 0.0 110.369 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.13 29.37 55.88 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.535 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 28.4 m -87.79 -0.08 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.34 -1.094 . . . . 0.0 110.054 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.481 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -44.74 -66.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.054 -1.029 . . . . 0.0 109.396 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -42.85 -33.67 0.81 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 110.082 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -79.48 -53.96 6.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.349 -0.844 . . . . 0.0 111.106 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.536 HG22 ' CD1' ' A' ' 92' ' ' LEU . 2.1 m -89.02 -10.45 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.719 -1.238 . . . . 0.0 111.226 -178.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.604 HG21 ' CD1' ' A' ' 93' ' ' PHE . 1.1 m -72.98 -42.9 62.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.57 -1.331 . . . . 0.0 108.795 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.402 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -58.1 -53.26 67.79 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.489 -1.382 . . . . 0.0 111.116 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.443 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 24.8 Cg_endo -72.66 -23.51 19.51 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 N-CA-C 110.087 -0.774 . . . . 0.0 110.087 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.536 ' CD1' HG22 ' A' ' 88' ' ' VAL . 79.4 mt -85.14 -42.99 14.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 108.862 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.604 ' CD1' HG21 ' A' ' 89' ' ' THR . 3.2 m-85 -62.56 -43.5 98.67 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.083 -1.01 . . . . 0.0 108.55 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -80.85 -16.67 53.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.405 -0.81 . . . . 0.0 109.82 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.43 ' HA2' ' OG1' ' A' ' 99' ' ' THR . . . -77.79 -34.82 37.55 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.493 HG12 ' CD1' ' A' ' 29' ' ' PHE . 2.2 t -95.58 -24.9 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.168 -1.196 . . . . 0.0 109.146 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.55 ' CG ' ' HB2' ' A' ' 34' ' ' TYR . 4.4 mp0 -102.38 5.07 39.57 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.016 -1.052 . . . . 0.0 110.622 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.547 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.3 OUTLIER -161.58 61.96 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.653 -1.28 . . . . 0.0 109.625 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 165.44 -50.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.492 -0.755 . . . . 0.0 109.358 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.485 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER 75.23 19.62 2.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.382 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.3 p -90.0 -6.89 55.14 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.658 0.742 . . . . 0.0 109.706 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.464 HG21 ' OD1' ' A' ' 107' ' ' ASP . 9.5 mm -84.77 81.57 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 121.568 -0.708 . . . . 0.0 109.574 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.485 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -135.32 36.88 2.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.052 -179.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 107' ' ' ASP . 83.6 p -166.01 132.2 2.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.854 -1.154 . . . . 0.0 110.499 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.57 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -50.79 -27.83 8.07 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -32.04 73.49 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.5 OUTLIER -70.76 -50.77 32.46 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.063 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.545 ' CD1' HD21 ' A' ' 68' ' ' LEU . 32.2 mt -54.25 -27.6 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 108.598 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -76.25 -32.49 58.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.499 -0.75 . . . . 0.0 109.13 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.462 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 2.8 m-20 -65.65 -45.17 84.01 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.318 -0.864 . . . . 0.0 109.32 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.505 ' CG2' HD22 ' A' ' 92' ' ' LEU . 2.4 t -68.32 -40.72 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.0 -1.063 . . . . 0.0 109.015 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.574 ' CZ ' ' HB ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -55.86 -54.34 45.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 109.149 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mt -62.38 -23.05 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 110' ' ' ASP . 11.0 m-80 -72.21 -16.28 61.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.412 ' HB2' ' CD1' ' A' ' 117' ' ' ILE . . . -96.67 14.87 23.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.445 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.12 9.28 84.34 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.8 mp -92.02 56.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -1.102 . . . . 0.0 109.374 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 117' ' ' ILE . 16.6 mttp -36.84 149.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.071 -1.018 . . . . 0.0 110.037 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 123' ' ' ASP . . . -50.71 -37.3 34.13 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.04 -52.32 58.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -1.181 . . . . 0.0 109.637 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -66.05 -60.94 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.397 -0.814 . . . . 0.0 109.843 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.57 ' CD1' HG13 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -50.12 -60.19 3.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 109.524 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 7.6 m-20 -44.93 -43.29 8.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.992 -1.068 . . . . 0.0 109.871 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.465 ' O ' ' OG ' ' A' ' 128' ' ' SER . . . -68.57 -44.9 73.46 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 109.791 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.518 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -58.71 -49.22 78.39 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 108.977 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.559 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 4.9 t-105 -57.13 -54.82 42.38 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -63.42 -14.83 54.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.657 -0.652 . . . . 0.0 110.179 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 124' ' ' ALA . 70.2 m -71.16 -178.21 1.94 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.98 -1.075 . . . . 0.0 110.43 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.21 -34.68 14.19 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.633 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.12 -44.7 84.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.996 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 5.9 t -69.77 -31.97 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.863 -1.148 . . . . 0.0 108.771 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -71.59 -37.18 71.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -35.47 80.74 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.432 HD21 ' HB3' ' A' ' 80' ' ' MET . 0.0 OUTLIER -74.68 -29.41 61.21 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.032 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.458 HG23 ' CZ3' ' A' ' 126' ' ' TRP . 5.7 t -73.71 -24.3 19.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.05 -54.26 6.77 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.5 ' CG ' ' OH ' ' A' ' 59' ' ' TYR . 7.0 tp-100 -59.88 -33.05 71.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.296 -0.878 . . . . 0.0 109.136 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.428 ' OE1' HG22 ' A' ' 73' ' ' THR . 12.1 tm0? -66.95 -64.83 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 108.749 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.455 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 1.9 mt-10 -51.33 -35.38 37.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.7 mtmm -72.2 -28.95 63.52 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.465 ' O ' ' OD2' ' A' ' 144' ' ' ASP . . . -60.59 -53.08 61.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 108.795 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.468 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -75.04 -25.39 58.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 109.742 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 139' ' ' GLU . . . -80.15 -27.25 39.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.106 -0.996 . . . . 0.0 110.234 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.478 ' CG ' ' N ' ' A' ' 145' ' ' VAL . 1.4 p30 -82.21 -48.26 11.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.949 -1.094 . . . . 0.0 108.439 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.563 ' CG2' ' CE2' ' A' ' 25' ' ' PHE . 25.5 m -84.62 -18.54 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 9.6 tt0 82.6 -40.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.811 -0.555 . . . . 0.0 110.247 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.536 HD22 ' CG1' ' A' ' 61' ' ' VAL . 12.1 tp 66.75 144.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -159.61 28.4 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.478 -1.389 . . . . 0.0 110.887 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.39 110.89 0.55 Allowed Glycine 0 N--CA 1.49 2.233 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.109 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.568 HG23 ' CZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -84.04 145.16 45.74 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.353 -1.087 . . . . 0.0 109.147 178.409 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.62 150.96 84.67 Favored 'Cis proline' 0 C--N 1.315 -1.213 0 O-C-N 123.312 1.164 . . . . 0.0 110.583 0.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -129.66 134.86 47.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.403 -1.435 . . . . 0.0 109.069 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.478 ' HE2' HG12 ' A' ' 22' ' ' VAL . 5.7 tpp -131.09 124.61 31.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 109.773 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.451 ' CD1' ' HB3' ' A' ' 160' ' ' GLN . 10.6 m-85 -123.86 129.94 51.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 0.0 109.922 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 45.5 t -97.92 131.26 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.945 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 46.43 21.91 0.14 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.293 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.547 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 55.36 57.04 20.43 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.08 -34.98 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.28 -1.129 . . . . 0.0 108.273 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.563 ' CE1' ' HE2' ' A' ' 188' ' ' LYS . 8.8 m-85 -121.51 126.36 49.04 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.925 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 160' ' ' GLN . 16.4 pt20 -116.72 119.97 37.12 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.955 -1.091 . . . . 0.0 110.307 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.59 174.32 3.57 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -150.44 74.34 8.9 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.971 -1.081 . . . . 0.0 109.692 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.45 45.97 2.0 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.683 2.255 . . . . 0.0 110.97 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -129.99 -3.1 4.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.033 -1.042 . . . . 0.0 109.763 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -71.86 -45.17 44.48 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . 0.1 OUTLIER -121.23 -93.13 0.52 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -1.154 . . . . 0.0 109.468 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 31.3 t0 63.61 31.48 14.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.373 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -167.31 74.33 0.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 109.406 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 t 179.58 -36.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.759 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -158.8 83.04 0.8 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.29 -0.881 . . . . 0.0 109.33 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 19.8 mmt -59.44 -15.91 20.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.878 . . . . 0.0 109.668 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.02 -55.98 5.48 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.707 -0.621 . . . . 0.0 109.355 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.413 ' O ' ' HG2' ' A' ' 177' ' ' GLN . 4.5 t -68.3 -29.66 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.204 -0.935 . . . . 0.0 109.189 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.558 ' CD1' ' OE1' ' A' ' 177' ' ' GLN . 26.6 m-85 -68.24 -34.8 76.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.268 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 64.6 t -78.36 -26.1 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.069 -1.019 . . . . 0.0 109.37 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -55.52 4.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.986 . . . . 0.0 109.272 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.558 ' OE1' ' CD1' ' A' ' 174' ' ' PHE . 7.6 pt20 -57.29 -36.35 70.95 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.16 -0.963 . . . . 0.0 108.735 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.409 ' HA ' ' OG1' ' A' ' 181' ' ' THR . 6.0 t80 -68.06 -49.72 59.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.89 . . . . 0.0 108.81 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 183' ' ' LYS . . . -58.85 -29.27 66.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 108.984 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.96 -37.82 58.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.15 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -61.45 -46.43 90.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.172 179.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 55.1 t -72.03 -36.89 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.802 -1.186 . . . . 0.0 109.295 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 179' ' ' ALA . 0.4 OUTLIER -59.93 -52.61 64.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.147 -0.97 . . . . 0.0 109.269 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.34 -29.28 53.38 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.906 . . . . 0.0 109.107 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.531 ' CG ' ' O ' ' A' ' 181' ' ' THR . 0.2 OUTLIER -62.51 -20.31 64.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.964 -1.085 . . . . 0.0 108.977 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -22.87 63.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.853 -1.154 . . . . 0.0 108.083 178.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.569 ' O ' ' CB ' ' A' ' 188' ' ' LYS . 1.3 mp0 -94.13 -72.18 0.63 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.569 ' CB ' ' O ' ' A' ' 187' ' ' GLU . 29.6 tttm 83.78 -43.21 0.09 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.459 0.647 . . . . 0.0 109.546 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.598 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.677 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.536 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 3.7 pt20 32.5 50.2 0.18 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.764 0.793 . . . . 0.0 109.971 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.2 OUTLIER 69.12 86.17 0.13 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.427 ' OE1' ' CB ' ' A' ' 1' ' ' ALA . 69.5 tt0 -125.11 62.4 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.68 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.7 t0 47.11 83.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.48 -0.762 . . . . 0.0 109.498 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 131.97 -29.69 3.33 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.284 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.416 ' HG3' ' N ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -79.82 -71.31 0.46 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.02 -1.282 . . . . 0.0 108.916 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.568 ' OE1' ' CD1' ' A' ' 3' ' ' TYR . 13.9 pt20 -100.11 6.59 44.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.086 -1.009 . . . . 0.0 109.686 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 1.4 p90 177.53 130.72 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 0.0 109.466 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.448 ' O ' ' HG2' ' A' ' 160' ' ' GLN . 5.7 t -111.36 179.78 3.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -96.37 157.09 16.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.69 . . . . 0.0 109.796 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.467 ' HA ' ' OE1' ' A' ' 160' ' ' GLN . 2.6 mt -91.5 145.24 24.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.434 -0.791 . . . . 0.0 109.75 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.91 -22.01 65.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.902 . . . . 0.0 108.736 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -135.08 108.15 10.48 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.539 -0.726 . . . . 0.0 109.16 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.54 157.74 36.25 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.323 2.015 . . . . 0.0 110.645 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.507 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 7.9 t -124.03 82.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.65 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -47.79 127.28 11.59 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.707 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 99.06 -20.94 48.22 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.521 ' HB2' ' N ' ' A' ' 157' ' ' GLY . . . -45.02 168.25 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.122 -1.223 . . . . 0.0 109.421 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.545 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.0 Cg_endo -79.22 136.73 12.98 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.87 2.38 . . . . 0.0 111.246 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.551 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 5.7 mt-30 -49.17 -20.35 0.58 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.376 -0.827 . . . . 0.0 109.772 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.496 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 3.2 t -149.49 81.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.21 -0.931 . . . . 0.0 108.602 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.643 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -77.45 126.57 31.11 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.294 -0.879 . . . . 0.0 108.786 -179.305 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.522 ' N ' HD21 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -110.06 119.18 38.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.129 -0.982 . . . . 0.0 109.83 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 4.4 m-85 -111.52 107.48 16.68 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.522 -0.736 . . . . 0.0 109.371 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -152.39 138.81 18.53 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.326 -0.859 . . . . 0.0 108.948 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.599 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 1.5 t -112.83 177.07 4.76 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.091 -1.005 . . . . 0.0 109.896 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.541 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 7.7 m-30 -88.4 38.84 0.88 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.572 ' CE2' HD13 ' A' ' 72' ' ' LEU . 10.1 m-85 -130.69 14.19 5.39 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.315 -0.865 . . . . 0.0 110.346 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.535 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -118.15 156.69 50.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.619 -1.301 . . . . 0.0 109.78 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -74.46 -25.15 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.022 1.815 . . . . 0.0 107.667 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.572 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 24.4 p80 -84.74 -25.34 28.36 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 18.6 t -45.73 -58.69 3.27 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.49 ' CB ' ' NE2' ' A' ' 97' ' ' GLN . 45.7 t80 -75.17 -49.88 18.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.883 -0.511 . . . . 0.0 110.359 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -61.31 -21.93 64.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.168 -0.957 . . . . 0.0 110.699 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 32' ' ' HIS . 3.7 t80 -82.04 -50.97 8.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.978 -1.076 . . . . 0.0 110.24 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.403 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 33.2 tt0 -103.52 -0.14 30.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.858 -1.151 . . . . 0.0 111.553 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 34' ' ' TYR . 60.1 mm-40 -127.74 21.32 6.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.364 -1.46 . . . . 0.0 111.172 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.1 t -152.13 -85.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.656 -1.277 . . . . 0.0 110.066 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.96 -12.19 17.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 110.148 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.454 ' CD2' ' OD1' ' A' ' 44' ' ' ASP . 4.4 m170 55.48 22.83 5.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.018 . . . . 0.0 108.998 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.526 HG21 ' CZ ' ' A' ' 36' ' ' PHE . 7.1 mt -56.81 -16.79 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.384 -0.823 . . . . 0.0 109.445 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.514 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -83.25 -48.69 10.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 0.0 110.205 -179.523 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.454 ' OD1' ' CD2' ' A' ' 41' ' ' HIS . 8.1 p-10 -84.29 -30.91 25.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.153 -0.967 . . . . 0.0 110.124 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -49.19 -33.76 13.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 109.73 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.514 ' CG2' ' O ' ' A' ' 43' ' ' SER . 2.8 m -69.56 -33.72 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.981 -1.075 . . . . 0.0 109.452 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.53 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 14.0 mttt -61.06 -28.95 69.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.379 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -45.91 -27.13 0.82 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.386 -0.821 . . . . 0.0 109.795 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -142.29 50.8 1.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 9.0 mt -99.13 134.4 21.39 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.837 -1.164 . . . . 0.0 110.119 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 53' ' ' GLY . 35.8 Cg_endo -79.56 152.54 23.03 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.584 2.189 . . . . 0.0 109.118 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.478 ' CG ' ' O ' ' A' ' 52' ' ' GLU . 28.2 tt0 -73.07 23.54 0.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.568 -1.333 . . . . 0.0 111.241 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.428 ' C ' HG21 ' A' ' 54' ' ' VAL . . . -121.38 29.31 5.74 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 178.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.428 HG21 ' C ' ' A' ' 53' ' ' GLY . 12.3 t -148.96 119.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.507 -0.996 . . . . 0.0 109.135 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -106.33 120.23 41.31 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.496 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 2.1 mtm -96.49 99.49 11.14 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.393 0.616 . . . . 0.0 109.574 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 24' ' ' GLU . 1.1 m -89.21 132.85 34.67 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.846 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -109.35 114.87 28.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.236 -0.915 . . . . 0.0 109.785 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.418 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 5.2 m-85 -114.41 171.65 7.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.088 -1.007 . . . . 0.0 111.15 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.599 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 66.8 t-80 -109.93 129.78 55.61 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.529 HG13 ' CG1' ' A' ' 150' ' ' VAL . 2.3 m -69.23 158.86 5.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.606 -0.684 . . . . 0.0 109.595 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.498 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 1.0 OUTLIER -124.4 33.13 5.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.318 -0.864 . . . . 0.0 109.462 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 24.8 p90 -132.24 51.38 2.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.013 -1.054 . . . . 0.0 109.986 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.457 ' HE2' ' CG2' ' A' ' 150' ' ' VAL . 2.5 mtt -159.17 48.43 0.32 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 154.84 57.44 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -34.07 -38.41 0.1 Allowed Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.915 -0.756 . . . . 0.0 111.408 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.63 -80.06 0.27 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.754 -1.439 . . . . 0.0 110.697 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -80.02 -25.89 40.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.864 -1.148 . . . . 0.0 109.521 -179.594 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.578 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -47.61 -53.43 12.96 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -56.07 -49.01 74.99 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.264 -1.139 . . . . 0.0 108.331 179.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.543 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 53.1 t0 -59.98 -30.87 69.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.591 ' CD2' ' NE2' ' A' ' 60' ' ' HIS . 1.1 tt -57.46 -36.92 72.06 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.514 ' CG2' ' HB3' ' A' ' 138' ' ' GLN . 40.6 m -66.09 -41.59 90.45 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.483 ' O ' HG22 ' A' ' 78' ' ' VAL . 1.1 tt0 -59.28 -20.33 53.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 177.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -68.98 -47.51 65.42 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.419 ' NE1' ' O ' ' A' ' 58' ' ' LYS . 37.9 t-105 -55.91 -28.82 58.54 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -84.79 -69.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 109.537 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.642 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 3.1 t -45.27 -27.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.934 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.457 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -84.18 -62.13 1.64 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 108.987 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -46.08 -27.35 0.93 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.4 ' N ' ' C ' ' A' ' 79' ' ' ALA . . . -72.36 -41.02 66.86 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.447 -0.783 . . . . 0.0 109.63 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.434 ' O ' HG11 ' A' ' 84' ' ' VAL . 40.8 mt -104.87 11.83 33.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.146 -0.971 . . . . 0.0 110.135 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 49.28 32.44 14.0 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.558 HG22 ' CE1' ' A' ' 112' ' ' PHE . 28.1 m -96.54 19.64 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.474 -1.015 . . . . 0.0 109.77 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 86' ' ' ASP . 87.6 mt-10 -58.91 -75.18 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.937 . . . . 0.0 110.01 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.47 -34.35 0.21 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.47 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 27.7 mtpp -74.23 -54.34 7.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.858 . . . . 0.0 110.643 -178.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -86.54 -23.1 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.826 -1.171 . . . . 0.0 110.765 -179.099 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.595 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -67.13 -43.39 82.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.731 -1.231 . . . . 0.0 109.016 179.472 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -54.62 -55.23 40.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.432 -1.418 . . . . 0.0 110.523 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.47 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 24.2 Cg_endo -72.21 -18.87 26.55 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 122.77 0.879 . . . . 0.0 109.883 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.526 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 11.6 mt -86.49 -42.63 13.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.183 -0.948 . . . . 0.0 108.937 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.595 ' CG ' HG21 ' A' ' 89' ' ' THR . 5.2 m-30 -62.85 -48.23 79.93 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.943 -1.098 . . . . 0.0 108.802 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.38 -22.36 59.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.037 -1.039 . . . . 0.0 109.45 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.474 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -76.43 -33.04 49.5 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.532 ' CG1' ' CE1' ' A' ' 29' ' ' PHE . 2.7 t -101.82 1.75 10.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.006 -1.291 . . . . 0.0 109.228 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.501 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 2.0 mt-30 -91.69 -8.63 46.49 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.981 -1.074 . . . . 0.0 110.878 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.4 mtpt -167.81 -53.48 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.736 -1.227 . . . . 0.0 111.118 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 95' ' ' GLY . 80.8 p -47.93 -39.79 20.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.275 -1.516 . . . . 0.0 109.468 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 99' ' ' THR . 1.1 mt-30 67.7 11.21 8.26 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.8 t -79.44 -5.99 55.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.522 ' CB ' HG23 ' A' ' 96' ' ' VAL . 3.8 mm -91.28 80.36 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.92 27.66 2.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.181 -0.949 . . . . 0.0 109.68 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 107' ' ' ASP . 56.1 p -151.08 129.15 11.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.903 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.535 ' HA ' ' CD1' ' A' ' 108' ' ' ILE . . . -48.95 -39.63 27.08 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.84 -31.25 62.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.547 ' N ' ' O ' ' A' ' 104' ' ' SER . 84.2 m-20 -78.05 -40.07 39.85 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.977 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.565 ' CD1' HD21 ' A' ' 68' ' ' LEU . 28.4 mt -52.45 -26.29 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.556 -1.34 . . . . 0.0 107.513 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -78.05 -39.51 41.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.682 -0.636 . . . . 0.0 109.44 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -55.99 -44.36 78.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.368 -0.832 . . . . 0.0 109.445 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.526 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 88.0 t -74.63 -37.26 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.033 . . . . 0.0 109.089 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.558 ' CE1' HG22 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -61.25 -31.03 70.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.286 179.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.448 HG21 ' O ' ' A' ' 113' ' ' ILE . 18.7 mt -85.47 -30.46 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -60.76 -16.53 41.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.775 -1.203 . . . . 0.0 109.35 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.449 ' HB2' ' HE3' ' A' ' 87' ' ' LYS . . . -88.06 -2.43 58.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.689 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.32 -5.22 52.05 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.6 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.6 mp -88.88 56.13 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -1.136 . . . . 0.0 109.292 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.49 ' C ' ' O ' ' A' ' 117' ' ' ILE . 3.2 mttp -33.01 152.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.366 -0.833 . . . . 0.0 110.832 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.425 ' HA2' ' HB3' ' A' ' 122' ' ' TYR . . . -53.84 -23.93 24.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.94 -52.14 66.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.054 -1.263 . . . . 0.0 109.083 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -75.76 -35.8 60.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.89 . . . . 0.0 109.412 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.642 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 2.7 t80 -62.91 -51.21 67.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.069 -1.02 . . . . 0.0 109.166 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.69 -45.65 91.46 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 108.822 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.38 -53.91 31.76 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.36 -0.838 . . . . 0.0 108.911 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.486 ' O ' ' HB ' ' A' ' 131' ' ' VAL . . . -51.85 -53.06 44.82 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.432 -0.792 . . . . 0.0 108.885 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -52.7 -58.05 8.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 108.628 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.29 -15.41 3.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.661 -0.65 . . . . 0.0 110.239 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.1 OUTLIER -69.22 179.54 1.92 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.958 -1.089 . . . . 0.0 110.17 -179.262 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER -92.79 -37.89 12.07 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.411 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.4 t -72.04 -50.05 39.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.786 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 125' ' ' ALA . 3.7 t -57.44 -38.09 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.811 -1.18 . . . . 0.0 108.569 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -66.42 -35.59 80.7 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 109.068 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -26.32 68.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.05 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.7 mt -81.77 -28.27 33.35 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.288 -0.883 . . . . 0.0 108.795 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 11.2 t -74.91 -39.51 45.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -68.22 -40.05 82.18 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.427 ' O ' ' HB1' ' A' ' 141' ' ' ALA . 0.0 OUTLIER -68.03 -33.82 75.32 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -0.818 . . . . 0.0 108.875 179.535 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.514 ' HB3' ' CG2' ' A' ' 73' ' ' THR . 0.2 OUTLIER -64.16 -70.73 0.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.247 -0.908 . . . . 0.0 109.032 179.541 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -48.15 -37.19 14.98 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 108.928 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 0.3 OUTLIER -72.48 -25.88 61.59 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.362 -0.836 . . . . 0.0 109.24 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.466 ' HA ' ' OD2' ' A' ' 144' ' ' ASP . . . -68.47 -55.22 12.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.398 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -73.76 -29.18 62.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 109.949 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -75.85 -25.63 56.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.059 -1.026 . . . . 0.0 109.87 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.533 ' OD1' ' CG1' ' A' ' 145' ' ' VAL . 1.0 OUTLIER -81.94 -48.14 11.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.011 . . . . 0.0 108.35 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.57 ' CG2' ' CE2' ' A' ' 25' ' ' PHE . 13.4 m -83.01 -12.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 81.15 -49.09 0.27 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 0.0 109.414 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.51 HD12 ' HB3' ' A' ' 25' ' ' PHE . 15.0 tp 61.65 132.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.452 -0.78 . . . . 0.0 109.426 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 16.7 mtt180 -161.49 38.8 0.14 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.587 -1.32 . . . . 0.0 110.302 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 164.46 108.5 0.21 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.42 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.529 ' CG1' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -97.99 144.15 27.52 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.4 -1.059 . . . . 0.0 109.335 179.031 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.572 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 36.3 Cg_endo -78.31 150.94 89.2 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 C-N-CA 124.088 -1.213 . . . . 0.0 110.54 0.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 154' ' ' PHE . . . -130.95 141.18 50.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.319 -1.488 . . . . 0.0 108.702 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.548 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 2.8 ttp -144.91 134.02 22.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 0.0 110.027 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.548 ' CD1' ' C ' ' A' ' 153' ' ' MET . 0.5 OUTLIER -134.49 155.58 50.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 110.008 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 30.8 t -112.07 130.66 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.332 -0.855 . . . . 0.0 108.958 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 51.75 23.24 1.94 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.521 ' N ' ' HB2' ' A' ' 19' ' ' ALA . . . 54.97 22.71 28.75 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.537 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -125.01 -22.97 4.33 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.825 -1.397 . . . . 0.0 109.113 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.516 ' CZ ' ' HG2' ' A' ' 188' ' ' LYS . 12.6 m-85 -121.46 127.69 51.36 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 11.5 pt20 -123.32 118.28 27.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.503 ' N ' HD22 ' A' ' 161' ' ' LEU . 5.8 mt -67.3 177.12 1.97 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.44 ' O ' ' ND2' ' A' ' 162' ' ' ASN . 0.4 OUTLIER -144.1 94.83 5.73 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 120.919 -1.113 . . . . 0.0 109.799 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.08 40.33 0.95 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.787 2.325 . . . . 0.0 110.637 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -118.04 -6.73 10.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.022 . . . . 0.0 109.324 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.444 ' O ' ' HG2' ' A' ' 166' ' ' MET . . . -58.18 -45.59 93.83 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 165' ' ' GLY . 0.1 OUTLIER -150.34 -95.9 0.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.256 -1.144 . . . . 0.0 109.547 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.3 t70 64.54 32.57 11.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.116 -0.99 . . . . 0.0 109.677 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.4 p -112.34 -48.0 3.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.999 -1.063 . . . . 0.0 109.647 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.9 t -145.89 59.06 1.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.701 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -160.03 63.79 0.35 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.971 . . . . 0.0 109.463 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 20.8 mtt -72.64 -16.59 61.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -76.74 -59.3 2.83 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.736 -0.602 . . . . 0.0 109.397 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.29 -23.27 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.235 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 178' ' ' TYR . 32.7 t80 -73.71 -39.79 64.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.139 -0.976 . . . . 0.0 109.383 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 18.6 t -73.61 -29.5 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.996 -1.065 . . . . 0.0 109.233 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -82.49 -51.98 7.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 0.0 109.481 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.438 ' O ' ' OG1' ' A' ' 181' ' ' THR . 0.8 OUTLIER -65.45 -24.98 67.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 174' ' ' PHE . 20.3 t80 -78.54 -47.58 17.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.218 -0.926 . . . . 0.0 109.372 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.8 -29.92 71.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.982 . . . . 0.0 109.313 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.14 -47.26 18.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.671 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.469 ' O ' HD21 ' A' ' 185' ' ' LEU . 15.3 m -58.7 -26.82 64.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.004 . . . . 0.0 109.642 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.3 t -87.75 -41.14 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.048 -1.032 . . . . 0.0 109.049 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -57.01 -42.99 81.33 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.29 -0.882 . . . . 0.0 109.133 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.556 ' CE2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -82.09 -35.09 28.99 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.305 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.556 ' CD2' ' CE2' ' A' ' 184' ' ' TYR . 0.7 OUTLIER -57.29 -20.13 26.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.875 -1.14 . . . . 0.0 109.331 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.1 t -78.63 -0.87 31.65 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.778 -1.201 . . . . 0.0 108.503 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.46 7.31 14.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.423 -0.798 . . . . 0.0 109.379 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.516 ' HG2' ' CZ ' ' A' ' 159' ' ' TYR . 13.8 tptm -61.19 -46.86 88.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.922 . . . . 0.0 109.914 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.4 pttm . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.445 -179.865 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.593 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 12.2 mt-30 -114.02 60.33 0.67 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.548 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 2' ' ' GLN . 0.2 OUTLIER 173.96 102.29 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.43 -0.793 . . . . 0.0 108.986 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -115.37 58.37 0.72 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.827 -1.171 . . . . 0.0 111.017 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 5' ' ' ASP . 1.7 m-20 45.16 87.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.454 -0.779 . . . . 0.0 110.603 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.82 -35.37 1.93 Allowed Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.207 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.09 -70.31 0.69 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.11 -1.229 . . . . 0.0 108.951 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.637 ' HG2' ' CD2' ' A' ' 9' ' ' TYR . 4.7 pm0 -65.77 -27.07 68.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.29 -0.881 . . . . 0.0 108.811 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.637 ' CD2' ' HG2' ' A' ' 8' ' ' GLN . 2.2 p90 -176.18 138.73 0.34 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -103.99 -179.69 4.02 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.505 HG23 ' N ' ' A' ' 12' ' ' LEU . 47.4 m -103.32 160.25 14.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.547 -0.721 . . . . 0.0 110.102 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.505 ' N ' HG23 ' A' ' 11' ' ' THR . 0.7 OUTLIER -92.04 163.25 14.05 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.426 -0.796 . . . . 0.0 109.41 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.41 ' C ' ' HG3' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -97.73 -16.07 20.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.41 ' HG3' ' C ' ' A' ' 13' ' ' GLU . 5.3 mttt -148.71 112.36 3.65 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.7 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.82 161.08 33.73 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.447 2.098 . . . . 0.0 109.703 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.582 ' CG1' ' HA ' ' A' ' 19' ' ' ALA . 1.1 p -122.32 126.74 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.999 -1.063 . . . . 0.0 110.237 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -46.35 125.72 7.11 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 77.16 8.9 87.01 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.582 ' HA ' ' CG1' ' A' ' 16' ' ' VAL . . . -36.25 161.73 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.685 -0.891 . . . . 0.0 111.189 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.576 ' CG ' ' HB2' ' A' ' 23' ' ' LEU . 36.5 Cg_endo -78.06 113.57 3.44 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 123.273 2.649 . . . . 0.0 111.953 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.502 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 33.1 mt-30 -51.89 -31.12 26.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.472 HG21 ' CG2' ' A' ' 155' ' ' VAL . 24.2 t -157.05 81.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.595 ' CD1' ' CZ ' ' A' ' 25' ' ' PHE . 1.3 tt -83.92 137.6 33.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.363 -0.835 . . . . 0.0 110.116 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.435 ' N ' HD21 ' A' ' 23' ' ' LEU . 31.6 mt-10 -120.52 99.38 6.52 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.595 ' CZ ' ' CD1' ' A' ' 23' ' ' LEU . 88.0 m-85 -83.5 115.3 22.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.489 -0.757 . . . . 0.0 109.434 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 26' ' ' PHE . 0.4 OUTLIER -154.23 139.1 17.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 110.033 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.589 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 8.3 p -121.44 173.17 7.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.41 -0.806 . . . . 0.0 109.443 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 1.6 m-30 -85.2 43.54 1.02 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.869 . . . . 0.0 108.84 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.503 ' CG ' HG13 ' A' ' 96' ' ' VAL . 9.0 m-85 -143.11 14.19 1.86 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.909 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.489 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -105.02 160.99 24.1 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 120.84 -1.162 . . . . 0.0 109.357 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -76.03 -35.43 2.45 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.134 1.889 . . . . 0.0 108.064 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.468 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -82.26 -23.65 35.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 11.1 t -46.13 -52.91 11.31 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.469 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 85.8 t80 -80.6 -31.5 36.67 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.905 -0.497 . . . . 0.0 111.064 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.64 -27.46 31.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.841 -1.162 . . . . 0.0 111.298 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.564 ' CE1' HD11 ' A' ' 40' ' ' LEU . 2.3 m-30 -84.1 -17.31 40.61 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.873 -1.142 . . . . 0.0 110.767 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -116.64 20.99 13.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.837 -1.164 . . . . 0.0 110.637 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 16.1 mm-40 -143.36 -66.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.953 -1.092 . . . . 0.0 110.405 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 4.6 t -90.16 -69.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.141 -0.974 . . . . 0.0 110.465 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.592 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 94.6 mt -47.81 -20.97 0.34 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.286 -0.884 . . . . 0.0 110.759 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 28.7 p-80 40.97 34.38 0.28 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 109.429 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.403 HG13 ' HB3' ' A' ' 40' ' ' LEU . 20.8 mt -76.01 -26.17 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.48 -0.762 . . . . 0.0 109.754 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.523 ' O ' ' CG1' ' A' ' 46' ' ' VAL . 14.1 m -78.18 -33.05 50.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.108 -0.995 . . . . 0.0 110.148 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -84.12 -47.42 10.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.034 -1.041 . . . . 0.0 109.829 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -57.27 -37.79 72.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 43' ' ' SER . 14.5 p -55.4 -28.23 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.179 -0.951 . . . . 0.0 109.644 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -30.74 68.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.404 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.52 -38.6 69.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -92.15 18.53 8.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 109.468 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.513 ' CD1' ' HG2' ' A' ' 56' ' ' MET . 12.1 mt -105.18 102.6 37.45 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.869 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.498 ' O ' ' N ' ' A' ' 53' ' ' GLY . 32.6 Cg_endo -75.49 151.55 37.5 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.343 2.028 . . . . 0.0 108.96 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -65.55 52.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.804 -1.185 . . . . 0.0 110.981 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.545 ' O ' ' CG2' ' A' ' 54' ' ' VAL . . . -144.3 37.82 1.36 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.545 ' CG2' ' O ' ' A' ' 53' ' ' GLY . 13.3 t -166.91 149.87 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -113.36 115.74 28.58 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.34 -0.85 . . . . 0.0 110.36 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.513 ' HG2' ' CD1' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -100.93 105.07 16.28 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.107 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -96.01 141.14 29.77 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.07 -178.868 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -117.94 105.02 11.47 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.225 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.492 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 4.4 m-85 -113.5 175.33 5.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.106 -0.996 . . . . 0.0 110.926 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.639 ' CD2' ' CD2' ' A' ' 72' ' ' LEU . 9.8 t-80 -125.44 123.9 40.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.553 -0.717 . . . . 0.0 109.648 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.611 HG23 ' CE1' ' A' ' 63' ' ' PHE . 35.6 m -91.86 153.75 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.433 -0.792 . . . . 0.0 109.952 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -110.24 54.61 0.66 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.173 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.611 ' CE1' HG23 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -134.61 56.04 1.87 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.087 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.48 ' HE1' ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -122.08 32.16 5.92 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.458 -0.777 . . . . 0.0 109.53 179.635 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.31 40.88 23.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . -148.08 80.71 0.21 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 66' ' ' GLY . 5.3 t0 -26.78 -45.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.449 -0.442 . . . . 0.0 111.209 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.551 ' CD2' ' OD2' ' A' ' 107' ' ' ASP . 0.3 OUTLIER -46.02 -30.37 1.81 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.357 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.48 ' CA ' ' HE1' ' A' ' 64' ' ' MET . . . -48.03 -55.97 9.5 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 2.2 ttmt -49.81 -46.39 51.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.278 . . . . 0.0 108.604 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.4 -18.25 60.69 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.031 -1.043 . . . . 0.0 108.368 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.639 ' CD2' ' CD2' ' A' ' 60' ' ' HIS . 2.3 tt -76.1 -37.38 58.18 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.421 ' CG2' ' OE1' ' A' ' 138' ' ' GLN . 1.6 m -65.62 -41.45 92.67 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 177.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.497 ' NE2' ' HB2' ' A' ' 126' ' ' TRP . 15.3 tp60 -63.17 -23.63 67.52 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.43 ' O ' ' CB ' ' A' ' 79' ' ' ALA . . . -70.49 -39.13 74.36 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.443 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.573 ' CH2' ' OE1' ' A' ' 85' ' ' GLU . 37.6 t-105 -66.09 -30.03 70.47 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.821 . . . . 0.0 108.932 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.423 ' CB ' HG21 ' A' ' 135' ' ' VAL . . . -83.39 -59.96 2.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.664 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 92.2 t -57.55 -26.65 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 109.665 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.529 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.46 -65.57 0.98 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.073 -1.017 . . . . 0.0 108.745 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -47.03 -26.25 1.0 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.103 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.458 ' CB ' ' CG2' ' A' ' 131' ' ' VAL . . . -74.89 -38.95 61.74 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.448 -0.783 . . . . 0.0 109.28 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 79' ' ' ALA . 85.9 mt -106.33 10.48 31.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.202 -0.936 . . . . 0.0 110.715 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 54.77 19.52 14.58 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.585 HG22 ' CE1' ' A' ' 112' ' ' PHE . 31.6 m -84.44 -6.29 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.284 -1.127 . . . . 0.0 110.318 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.573 ' OE1' ' CH2' ' A' ' 76' ' ' TRP . 3.1 mt-10 -42.22 -71.56 0.08 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.155 -0.966 . . . . 0.0 110.052 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -39.33 -34.26 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.378 -0.827 . . . . 0.0 110.622 -179.591 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.489 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 27.5 mtpp -81.66 -49.87 9.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.284 -0.885 . . . . 0.0 111.189 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.505 ' O ' ' CG ' ' A' ' 92' ' ' LEU . 1.4 m -86.54 -14.26 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.882 -1.136 . . . . 0.0 110.681 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.608 HG21 ' CG ' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -74.3 -42.51 59.41 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.698 -1.251 . . . . 0.0 108.349 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.406 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -55.75 -54.05 56.08 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.723 -1.236 . . . . 0.0 110.875 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.489 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 27.1 Cg_endo -72.4 -19.46 25.21 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 N-CA-C 109.881 -0.854 . . . . 0.0 109.881 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.523 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 35.5 mt -87.19 -43.56 12.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.127 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.608 ' CG ' HG21 ' A' ' 89' ' ' THR . 5.1 m-30 -63.59 -44.02 95.23 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.037 -1.039 . . . . 0.0 108.697 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.52 -19.59 57.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 109.426 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.432 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -69.85 -40.51 74.87 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.503 HG13 ' CG ' ' A' ' 29' ' ' PHE . 1.6 t -92.79 -15.71 7.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 O-C-N 121.102 -1.234 . . . . 0.0 108.734 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.463 ' HG2' ' HB2' ' A' ' 34' ' ' TYR . 2.9 mp0 -113.02 10.75 18.85 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.933 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.538 ' O ' ' CG2' ' A' ' 99' ' ' THR . 0.8 OUTLIER -159.01 51.47 0.38 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.392 -1.442 . . . . 0.0 109.851 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 166.88 -49.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.405 -0.81 . . . . 0.0 109.898 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.8 OUTLIER 75.7 16.29 2.5 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.14 -0.975 . . . . 0.0 110.494 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.7 t -85.7 -4.05 59.06 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.829 0.823 . . . . 0.0 108.861 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.499 ' CG2' HD21 ' A' ' 68' ' ' LEU . 6.6 mm -82.67 71.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.766 -0.584 . . . . 0.0 109.543 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.441 ' C ' HD23 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -116.83 -11.36 10.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.174 -0.954 . . . . 0.0 109.995 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.554 ' O ' ' N ' ' A' ' 107' ' ' ASP . 1.5 p -110.67 117.21 32.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 109.77 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.51 ' N ' ' HG ' ' A' ' 68' ' ' LEU . . . -48.31 -39.01 20.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.59 -33.31 54.45 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 108' ' ' ILE . 1.2 p30 -68.64 -41.45 79.39 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.752 -1.179 . . . . 0.0 108.644 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.556 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 3.1 mt -48.57 -44.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.612 -1.305 . . . . 0.0 107.666 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -48.49 79.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.576 -0.703 . . . . 0.0 109.686 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 114' ' ' ASN . 1.1 m-20 -51.65 -42.85 62.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.814 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.523 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 3.2 t -64.83 -40.13 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.134 -0.979 . . . . 0.0 109.767 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.585 ' CE1' HG22 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -56.77 -50.89 70.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.018 -1.051 . . . . 0.0 109.552 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.8 mt -70.67 -22.74 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 109.597 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 110' ' ' ASP . 2.8 m120 -64.86 -15.91 62.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.409 ' HB1' HG13 ' A' ' 88' ' ' VAL . . . -73.37 -6.0 43.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 108.992 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.03 15.16 39.94 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.6 mm -95.62 168.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -1.196 . . . . 0.0 108.957 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -89.24 139.55 30.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.331 -1.481 . . . . 0.0 109.7 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.75 -50.42 67.77 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -57.99 -44.47 87.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.138 -1.213 . . . . 0.0 109.016 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -55.3 -44.34 75.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 108.852 179.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.664 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 2.3 t80 -55.13 -46.98 75.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.862 . . . . 0.0 108.845 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -56.6 -38.9 72.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 108.708 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.22 71.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.385 -0.822 . . . . 0.0 108.828 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.51 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -49.16 -50.47 37.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.268 -0.895 . . . . 0.0 108.605 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.497 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 12.8 t90 -58.32 -56.12 26.22 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -55.34 -15.91 2.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.583 -0.698 . . . . 0.0 109.923 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -71.23 166.62 21.15 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.972 -1.08 . . . . 0.0 109.45 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -86.77 -40.66 14.78 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.264 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.09 -45.08 97.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 C-N-CA 118.062 -1.455 . . . . 0.0 109.316 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 2.5 t -64.6 -41.23 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.001 -1.062 . . . . 0.0 108.413 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -37.29 86.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.365 -0.834 . . . . 0.0 108.992 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.0 m -62.53 -30.76 71.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 108.908 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.72 -21.98 43.91 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.426 ' HA ' ' OE1' ' A' ' 138' ' ' GLN . 4.9 t -77.05 -46.38 29.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.449 ' O ' ' HG2' ' A' ' 139' ' ' GLU . . . -64.04 -42.83 96.92 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.478 ' HG2' ' OH ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -62.97 -32.37 73.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.404 -0.81 . . . . 0.0 109.036 179.664 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.492 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 48.0 mt-30 -65.03 -62.84 1.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 108.92 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 136' ' ' ALA . 6.8 pt-20 -54.51 -42.42 70.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 108.838 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 29.1 mttt -67.49 -27.19 66.8 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.375 -0.828 . . . . 0.0 109.151 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.424 ' HB3' HD12 ' A' ' 23' ' ' LEU . . . -63.42 -49.07 75.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.024 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.21 -41.39 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.837 . . . . 0.0 110.148 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.18 -16.74 60.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.158 -0.964 . . . . 0.0 109.862 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 140' ' ' LYS . 22.8 m-20 -82.9 -44.21 15.64 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.592 ' CG2' ' CZ ' ' A' ' 25' ' ' PHE . 3.8 m -91.17 -5.38 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 81.86 -46.75 0.2 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.595 -0.691 . . . . 0.0 109.804 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.531 HD23 ' CG1' ' A' ' 61' ' ' VAL . 13.0 tp 73.12 141.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.66 -0.65 . . . . 0.0 109.72 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.39 25.77 0.16 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.771 -1.206 . . . . 0.0 110.315 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.03 112.2 0.62 Allowed Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.108 -1.52 . . . . 0.0 111.081 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.529 HG23 ' CZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -90.48 140.31 26.81 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.503 -0.998 . . . . 0.0 108.962 178.158 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.25 152.2 95.95 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 123.785 -1.339 . . . . 0.0 110.816 0.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -128.22 159.97 33.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.393 -1.442 . . . . 0.0 109.233 179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.524 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 3.0 ttm -142.02 121.82 13.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.101 -0.999 . . . . 0.0 109.88 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.581 ' CD2' ' HB2' ' A' ' 160' ' ' GLN . 23.5 m-85 -122.89 145.77 48.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.139 -0.975 . . . . 0.0 109.644 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 36.9 t -124.66 122.31 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.145 -0.972 . . . . 0.0 108.957 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER 50.95 24.99 2.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.804 -0.758 . . . . 0.0 108.989 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 51.3 20.84 5.38 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.466 -1.349 . . . . 0.0 110.325 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -121.83 -19.92 6.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.819 -1.4 . . . . 0.0 108.867 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.587 ' CD2' ' HG3' ' A' ' 188' ' ' LYS . 19.6 m-85 -141.7 123.83 15.52 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.318 -0.864 . . . . 0.0 108.945 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.581 ' HB2' ' CD2' ' A' ' 154' ' ' PHE . 1.3 tt0 -130.29 126.56 37.54 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.279 -0.888 . . . . 0.0 109.389 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.536 ' CD2' ' HB3' ' A' ' 9' ' ' TYR . 8.1 mt -59.46 179.26 0.12 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 162' ' ' ASN . 12.8 p-10 -153.22 107.67 2.62 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.071 -1.018 . . . . 0.0 109.777 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.03 50.08 3.19 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.306 2.004 . . . . 0.0 110.2 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -101.39 -5.96 24.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.415 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -123.53 39.12 2.27 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.62 4.43 13.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -1.096 . . . . 0.0 109.556 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -92.11 31.94 1.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.134 -0.979 . . . . 0.0 109.464 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 169' ' ' SER . 76.2 p -71.68 -20.49 61.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 109.825 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 168' ' ' THR . 1.6 t 76.47 14.11 2.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 0.0 109.457 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.442 ' OD1' ' HB ' ' A' ' 168' ' ' THR . 1.2 p30 -152.28 94.64 1.95 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.33 -0.857 . . . . 0.0 108.794 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 6.2 mtt -58.86 -15.36 12.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.361 -0.837 . . . . 0.0 109.882 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.75 -49.22 78.58 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 121.577 -0.702 . . . . 0.0 109.686 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 12.5 t -69.57 -29.14 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 109.854 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.459 ' O ' ' HB3' ' A' ' 178' ' ' TYR . 4.6 t80 -65.59 -36.62 84.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.015 -1.053 . . . . 0.0 109.466 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 93.3 t -81.2 -24.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.05 -1.031 . . . . 0.0 109.772 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -53.48 6.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.025 -1.047 . . . . 0.0 109.402 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 2' ' ' GLN . 0.3 OUTLIER -65.91 -33.39 75.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.106 -0.996 . . . . 0.0 109.356 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.459 ' HB3' ' O ' ' A' ' 174' ' ' PHE . 2.5 t80 -70.13 -57.18 5.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 109.093 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.79 -29.92 69.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.341 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -73.27 -41.71 63.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.933 . . . . 0.0 109.387 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.564 ' CG2' ' CG ' ' A' ' 8' ' ' GLN . 1.0 OUTLIER -62.37 -60.01 4.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.163 -0.961 . . . . 0.0 109.283 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 61.3 t -53.75 -32.68 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.06 -1.025 . . . . 0.0 109.198 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -47.08 86.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 109.446 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -85.56 -25.66 26.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.203 -0.936 . . . . 0.0 110.426 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.594 HD22 ' CE2' ' A' ' 9' ' ' TYR . 4.1 mt -67.81 -20.64 65.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.489 -1.382 . . . . 0.0 108.856 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.452 ' HB2' HG23 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -69.95 -10.65 59.32 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.61 -4.62 56.7 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.55 -0.718 . . . . 0.0 109.359 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.587 ' HG3' ' CD2' ' A' ' 159' ' ' TYR . 48.4 mmtt -55.56 -33.17 63.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.156 -0.965 . . . . 0.0 109.159 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 188' ' ' LYS . 3.3 pptp? . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.288 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.509 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 0.8 OUTLIER 40.96 48.27 2.77 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.967 0.889 . . . . 0.0 109.037 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.691 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER 72.32 98.13 0.07 Allowed 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.661 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' ASP . 3.0 tt0 -86.72 52.32 2.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 0.0 110.277 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLU . 64.7 t0 39.82 81.01 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.796 -0.565 . . . . 0.0 109.906 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 119.19 -18.91 10.19 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.541 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.71 -67.32 0.77 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.902 -1.352 . . . . 0.0 108.769 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.591 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -96.4 4.0 52.49 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.21 -0.932 . . . . 0.0 109.806 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.557 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -177.31 130.8 0.16 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.913 -1.117 . . . . 0.0 109.611 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -117.79 177.05 4.91 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.813 -0.555 . . . . 0.0 109.525 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -100.17 160.22 14.49 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.374 0.607 . . . . 0.0 109.552 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 17.4 mt -95.69 133.96 39.16 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.315 -0.866 . . . . 0.0 109.779 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -72.63 -19.42 61.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 108.694 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -135.69 107.32 9.91 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.437 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 34.8 Cg_endo -76.08 158.34 37.98 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.412 2.075 . . . . 0.0 110.968 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.487 HG11 ' O ' ' A' ' 16' ' ' VAL . 46.1 t -128.72 87.43 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.418 -0.801 . . . . 0.0 109.38 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.52 133.05 13.42 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 95.82 -25.56 24.52 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.517 ' HB2' ' N ' ' A' ' 157' ' ' GLY . . . -42.02 157.75 0.21 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.401 -1.058 . . . . 0.0 109.367 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.55 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 35.2 Cg_endo -78.4 135.42 13.31 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.504 2.136 . . . . 0.0 111.015 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 0.2 OUTLIER -44.25 -24.03 0.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.411 -0.806 . . . . 0.0 109.764 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.542 ' CG1' ' HG2' ' A' ' 56' ' ' MET . 42.4 t -149.83 80.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.022 -1.049 . . . . 0.0 108.896 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.643 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -72.06 124.94 26.03 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.526 ' N ' HD21 ' A' ' 23' ' ' LEU . 1.0 OUTLIER -106.5 125.29 50.81 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.614 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 6.3 m-85 -115.73 110.32 18.95 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.466 ' CD1' ' O ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -150.79 145.36 25.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.953 . . . . 0.0 109.639 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.59 ' CB ' ' NE2' ' A' ' 60' ' ' HIS . 32.8 p -126.03 -163.86 1.26 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.203 -0.935 . . . . 0.0 108.83 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.67 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -118.65 55.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.152 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CG ' HG13 ' A' ' 96' ' ' VAL . 12.2 m-85 -138.88 2.14 2.13 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.453 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.503 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -113.91 172.46 3.56 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.658 -1.276 . . . . 0.0 109.765 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 30' ' ' CYS . 32.8 Cg_endo -75.04 -49.84 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.481 2.12 . . . . 0.0 108.835 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 18.5 m80 -73.11 -25.63 60.94 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.469 ' SG ' ' HB2' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -46.85 -41.14 15.17 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.109 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.501 ' CG ' ' OE1' ' A' ' 97' ' ' GLN . 3.7 t80 -88.44 -44.13 10.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.601 -0.687 . . . . 0.0 110.171 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.474 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 46.0 mt-30 -72.43 -24.49 61.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.986 -1.071 . . . . 0.0 110.924 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 1.6 t80 -80.45 -16.76 53.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.938 -1.101 . . . . 0.0 110.388 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.51 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.6 tt0 -131.96 50.99 2.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.892 -1.13 . . . . 0.0 110.381 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.51 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -171.29 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 110.55 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 52.1 t -94.77 -53.58 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 110.575 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 35' ' ' GLN . 22.6 mt -48.86 -20.18 0.47 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.169 -0.957 . . . . 0.0 110.58 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 47.93 31.67 2.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.889 -1.132 . . . . 0.0 108.852 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.413 ' O ' ' CG1' ' A' ' 46' ' ' VAL . 4.3 mt -83.46 -41.84 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.53 -0.731 . . . . 0.0 109.993 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.442 ' HA ' HG23 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -80.0 -17.84 51.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.984 -1.073 . . . . 0.0 110.557 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 2.2 m-20 -87.3 -39.02 15.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.935 -1.103 . . . . 0.0 110.074 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -71.66 -33.76 69.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.994 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.442 HG23 ' HA ' ' A' ' 43' ' ' SER . 30.5 m -55.74 -35.84 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.771 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -54.38 -46.42 73.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 109.562 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -26.77 38.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.471 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 2.5 mmtm -89.27 20.61 3.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.834 . . . . 0.0 110.308 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.526 HD21 ' CB ' ' A' ' 54' ' ' VAL . 35.8 mt -114.02 87.37 12.78 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.987 -1.07 . . . . 0.0 109.714 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' GLU . 36.3 Cg_endo -78.19 64.36 8.38 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.599 2.199 . . . . 0.0 111.01 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER 56.85 130.74 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.638 0.732 . . . . 0.0 110.516 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.29 -21.18 31.5 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.526 ' CB ' HD21 ' A' ' 50' ' ' LEU . 1.2 t -91.03 87.72 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -1.048 . . . . 0.0 108.833 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -77.6 97.03 4.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.952 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.542 ' HG2' ' CG1' ' A' ' 22' ' ' VAL . 63.4 mtp -95.83 97.1 9.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.12 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -91.82 135.57 33.81 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.617 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' HG3' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -109.19 116.88 32.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.382 -0.824 . . . . 0.0 110.271 -179.419 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.47 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 3.2 m-85 -117.18 175.15 5.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.132 -0.98 . . . . 0.0 110.787 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.59 ' NE2' ' CB ' ' A' ' 27' ' ' SER . 2.6 t60 -112.15 141.38 45.92 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.683 0.754 . . . . 0.0 109.203 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.599 ' CG1' ' CG1' ' A' ' 150' ' ' VAL . 3.2 m -77.09 155.71 5.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.3 0.571 . . . . 0.0 109.847 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.518 ' OD1' ' CB ' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -124.79 36.73 4.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 108.822 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.564 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 6.3 p90 -136.11 52.55 1.97 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -155.91 47.99 0.49 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 158.36 61.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -28.78 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 65' ' ' GLY . 71.2 m-20 -88.94 -78.26 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -1.125 . . . . 0.0 110.663 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.59 ' CD1' ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -79.87 -22.36 42.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.957 -1.089 . . . . 0.0 110.51 -178.868 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.59 ' N ' ' CD1' ' A' ' 68' ' ' LEU . . . -53.95 -43.75 71.8 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 1.8 tmtp? -64.86 -45.93 84.01 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.065 -1.256 . . . . 0.0 108.258 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.538 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 1.5 t70 -66.03 -31.65 72.67 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.531 HD22 ' NE2' ' A' ' 60' ' ' HIS . 15.5 tp -53.79 -49.66 67.81 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 61' ' ' VAL . 1.3 m -57.33 -43.71 83.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.473 ' O ' HG22 ' A' ' 78' ' ' VAL . 2.5 tm0? -57.07 -25.26 58.4 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -64.44 -44.07 92.31 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -57.46 -33.04 67.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.525 ' CB ' HG21 ' A' ' 135' ' ' VAL . . . -79.53 -51.05 9.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.395 -0.816 . . . . 0.0 110.159 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.64 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 1.7 t -62.74 -27.41 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.068 -1.02 . . . . 0.0 109.641 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.464 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -77.95 -61.88 1.85 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.043 -1.036 . . . . 0.0 109.36 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.518 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -44.71 -27.29 0.48 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.227 -0.921 . . . . 0.0 108.951 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.464 ' HB3' HG21 ' A' ' 131' ' ' VAL . . . -68.71 -44.46 73.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.365 -0.834 . . . . 0.0 109.4 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.443 ' O ' HG11 ' A' ' 84' ' ' VAL . 21.9 mt -108.49 16.29 23.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.09 29.83 4.95 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.465 HG13 HD13 ' A' ' 117' ' ' ILE . 34.8 m -85.73 -3.89 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -1.17 . . . . 0.0 110.066 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.452 ' OE2' ' HB2' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -45.1 -73.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.09 -1.006 . . . . 0.0 109.911 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.27 -35.12 0.23 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.598 -0.689 . . . . 0.0 110.603 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -80.54 -52.78 7.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.943 . . . . 0.0 111.301 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.531 HG22 ' CD1' ' A' ' 92' ' ' LEU . 2.6 m -84.28 -9.46 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.745 -1.222 . . . . 0.0 110.944 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.591 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -73.68 -45.37 52.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.758 -1.214 . . . . 0.0 108.455 178.632 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.421 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -51.93 -53.94 46.0 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.556 -1.34 . . . . 0.0 110.757 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.537 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 24.0 Cg_endo -72.96 -17.74 24.88 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 N-CA-C 109.65 -0.942 . . . . 0.0 109.65 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.531 ' CD1' HG22 ' A' ' 88' ' ' VAL . 6.4 mt -86.19 -44.4 12.22 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.67 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 7.2 m-30 -62.04 -47.52 84.34 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.906 -1.121 . . . . 0.0 108.674 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -69.03 -34.81 75.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.025 -1.047 . . . . 0.0 109.554 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.466 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -64.71 -31.99 82.72 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.568 HG13 ' CG ' ' A' ' 29' ' ' PHE . 1.9 t -107.8 8.12 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.984 -1.303 . . . . 0.0 109.568 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.501 ' OE1' ' CG ' ' A' ' 34' ' ' TYR . 11.5 mt-30 -97.75 5.75 48.79 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.915 -1.116 . . . . 0.0 110.296 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.01 -49.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.803 -1.186 . . . . 0.0 110.631 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 1.4 p -55.05 -42.05 72.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.299 -1.501 . . . . 0.0 109.544 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.6 mm-40 67.62 10.5 7.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 110.126 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.3 t -83.67 -8.29 59.31 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.744 0.783 . . . . 0.0 109.102 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.541 ' CB ' HG23 ' A' ' 96' ' ' VAL . 16.3 mm -79.55 66.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.489 ' HA ' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -127.25 31.75 5.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.585 -179.572 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 107' ' ' ASP . 16.8 p -147.94 127.77 13.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 110.146 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.436 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -49.56 -29.8 7.55 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 t -63.71 -34.29 77.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.551 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.7 OUTLIER -68.3 -46.41 70.37 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.564 ' CD1' HD21 ' A' ' 68' ' ' LEU . 19.0 mt -52.39 -29.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -73.24 -39.43 65.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 109.121 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 114' ' ' ASN . 14.5 m-20 -56.34 -45.4 80.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.317 -0.864 . . . . 0.0 109.406 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.537 ' CG1' ' HG2' ' A' ' 91' ' ' PRO . 15.4 t -70.96 -38.59 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.407 ' CE2' ' HE2' ' A' ' 122' ' ' TYR . 2.9 m-85 -65.75 -32.36 73.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.445 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 109' ' ' ARG . 16.1 mt -79.4 -25.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.025 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 110' ' ' ASP . 17.5 m-20 -70.17 -23.65 63.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.974 -1.079 . . . . 0.0 109.697 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -85.21 2.57 43.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.78 8.99 61.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.487 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -94.4 58.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 109.549 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 117' ' ' ILE . 56.5 mttt -37.1 154.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.228 -0.92 . . . . 0.0 110.295 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.453 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -50.78 -27.71 13.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -67.7 -43.43 80.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -1.146 . . . . 0.0 109.369 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -46.99 19.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.536 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.64 ' CE2' ' CG1' ' A' ' 78' ' ' VAL . 5.8 t80 -63.52 -47.08 83.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.177 -0.952 . . . . 0.0 109.52 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 30.5 t0 -61.38 -53.18 59.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.148 -0.97 . . . . 0.0 109.176 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.407 ' O ' ' OG ' ' A' ' 128' ' ' SER . . . -48.21 -53.67 16.17 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.536 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -48.23 -55.75 9.7 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.426 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 8.5 t90 -53.29 -59.18 4.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.14 -15.81 2.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.573 -0.705 . . . . 0.0 109.985 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 7.7 m -69.67 176.97 3.21 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.071 -1.018 . . . . 0.0 109.891 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -89.57 -39.62 13.16 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.335 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.39 -47.16 78.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.752 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 2.8 t -62.95 -34.54 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.904 -1.123 . . . . 0.0 108.399 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -67.33 -28.3 67.86 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 137' ' ' GLN . 1.8 m -69.93 -35.51 74.59 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.518 ' CD1' ' HB3' ' A' ' 80' ' ' MET . 0.2 OUTLIER -79.09 -19.08 52.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.525 HG21 ' CB ' ' A' ' 77' ' ' ALA . 10.2 t -82.25 -47.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.33 -35.59 81.36 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.41 -0.806 . . . . 0.0 108.841 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.406 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.9 OUTLIER -69.88 -37.39 76.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 109.025 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.47 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -65.4 -68.38 0.37 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 108.988 179.519 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.4 ' O ' ' HB1' ' A' ' 143' ' ' ALA . 1.4 tt0 -47.71 -36.41 11.24 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.219 -0.926 . . . . 0.0 108.586 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.434 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -71.91 -30.91 65.85 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -61.11 -59.74 4.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.361 -0.837 . . . . 0.0 108.846 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.537 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -67.47 -26.76 66.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.838 . . . . 0.0 109.508 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 139' ' ' GLU . . . -78.72 -22.79 46.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.963 . . . . 0.0 109.884 -179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -82.22 -43.73 17.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.104 -0.997 . . . . 0.0 108.475 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 146' ' ' GLN . 18.4 m -98.36 -5.6 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.537 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.1 tt0 75.21 -53.34 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.491 -0.756 . . . . 0.0 109.793 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.467 HD23 HG13 ' A' ' 61' ' ' VAL . 13.6 tp 69.57 135.03 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.7 ptt85 -160.18 35.7 0.17 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.457 -1.402 . . . . 0.0 110.219 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 161.93 108.56 0.23 Allowed Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.559 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.599 ' CG1' ' CG1' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -89.62 144.31 31.74 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.405 -1.056 . . . . 0.0 109.225 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.18 152.25 94.29 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 124.009 -1.246 . . . . 0.0 110.779 0.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.482 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . . . -129.4 139.46 51.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.453 -1.404 . . . . 0.0 108.983 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 19.9 ttt -140.97 128.05 20.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.98 -1.075 . . . . 0.0 110.179 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.607 ' N ' ' CD1' ' A' ' 154' ' ' PHE . 2.5 m-85 -126.28 137.12 53.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -0.918 . . . . 0.0 109.634 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 54.7 t -99.25 133.72 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . 0.412 ' N ' HG11 ' A' ' 155' ' ' VAL . 3.9 t30 42.45 24.47 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.16 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.517 ' N ' ' HB2' ' A' ' 19' ' ' ALA . . . 56.81 59.22 11.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.437 ' HG3' ' HB3' ' A' ' 15' ' ' PRO . 6.7 tttt -166.65 -36.23 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.439 -1.036 . . . . 0.0 108.294 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 154' ' ' PHE . 10.7 m-85 -114.59 122.83 47.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.105 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.592 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -113.34 109.59 18.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 0.0 109.963 -179.231 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.507 HD22 ' CB ' ' A' ' 9' ' ' TYR . 15.3 mt -60.25 -179.86 0.12 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.1 125.76 4.62 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.084 -1.01 . . . . 0.0 109.559 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.505 ' C ' ' CG ' ' A' ' 164' ' ' GLN . 36.5 Cg_endo -79.4 -14.37 13.11 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.514 2.143 . . . . 0.0 110.688 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.505 ' CG ' ' C ' ' A' ' 163' ' ' PRO . 0.8 OUTLIER 41.89 27.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.301 -0.875 . . . . 0.0 109.617 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 163' ' ' PRO . . . 45.26 30.9 2.99 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' MET . . . . . 0.452 ' O ' HG23 ' A' ' 168' ' ' THR . 1.4 mmt -104.12 -110.39 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -1.213 . . . . 0.0 109.305 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 166' ' ' MET . 36.4 t70 44.03 30.25 0.4 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.812 -1.18 . . . . 0.0 109.72 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 166' ' ' MET . 0.5 OUTLIER -131.02 25.16 4.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.035 -1.04 . . . . 0.0 109.785 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 84.0 p -115.23 -37.57 4.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 109.463 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -160.23 90.72 0.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.351 -0.843 . . . . 0.0 108.953 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' MET . . . . . 0.45 ' O ' HG22 ' A' ' 175' ' ' VAL . 0.6 OUTLIER -58.41 -15.74 11.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.025 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.26 -58.93 2.98 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 109.579 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.5 t -68.48 -30.58 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.374 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 0.6 OUTLIER -69.95 -30.83 68.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.139 -0.976 . . . . 0.0 109.018 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 171' ' ' MET . 7.7 t -76.15 -31.74 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 108.892 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -80.82 -64.65 1.14 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.212 -0.93 . . . . 0.0 109.052 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -49.8 -40.87 43.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.864 . . . . 0.0 109.41 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 56.4 t80 -63.61 -50.74 68.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.65 -24.73 15.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.382 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.96 -51.08 10.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.645 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.473 ' O ' HD21 ' A' ' 185' ' ' LEU . 90.5 m -55.17 -27.17 43.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.116 -0.99 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 43.0 t -87.52 -35.74 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.067 -1.021 . . . . 0.0 108.672 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -43.56 81.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.418 -0.801 . . . . 0.0 108.96 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.522 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -82.01 -39.62 23.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.357 -0.84 . . . . 0.0 109.057 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.518 HD21 ' N ' ' A' ' 185' ' ' LEU . 1.1 mm? -53.41 -20.67 4.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.092 . . . . 0.0 109.391 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 19.6 p -74.81 -8.01 55.14 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.65 -1.282 . . . . 0.0 108.352 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . 0.467 ' O ' ' HG2' ' A' ' 189' ' ' LYS . 1.3 mm-40 -102.13 5.83 40.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.411 -0.806 . . . . 0.0 109.091 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.53 ' O ' ' CG ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -54.11 -36.84 63.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.259 -0.901 . . . . 0.0 109.656 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 188' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.731 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.452 ' O ' ' C ' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.493 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER 40.45 47.56 2.29 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.883 0.849 . . . . 0.0 109.248 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.588 ' CD1' ' OE1' ' A' ' 8' ' ' GLN . 0.9 OUTLIER 73.12 96.63 0.07 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.8 -0.562 . . . . 0.0 109.504 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 1' ' ' ALA . 2.0 tt0 -124.9 62.56 1.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.91 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 48.3 t0 45.23 84.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 109.403 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 136.06 -32.44 2.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -70.27 0.52 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.958 -1.319 . . . . 0.0 108.716 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.588 ' OE1' ' CD1' ' A' ' 3' ' ' TYR . 9.3 pt20 -96.65 0.09 49.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.154 -0.966 . . . . 0.0 109.944 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.511 ' O ' ' N ' ' A' ' 6' ' ' GLY . 1.2 p90 178.93 133.34 0.08 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.831 -1.168 . . . . 0.0 109.772 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.422 HG21 ' HB3' ' A' ' 160' ' ' GLN . 4.7 t -110.54 179.15 4.15 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -115.65 144.46 43.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.341 -0.849 . . . . 0.0 109.778 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.9 mt -95.45 144.06 26.27 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.434 -0.791 . . . . 0.0 109.59 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.91 -22.26 65.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 108.857 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -127.57 102.13 23.39 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.429 -0.795 . . . . 0.0 109.026 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HB3' ' CG ' ' A' ' 158' ' ' LYS . 34.2 Cg_endo -76.43 163.23 32.49 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.503 2.135 . . . . 0.0 110.846 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.465 ' HB ' ' HA3' ' A' ' 157' ' ' GLY . 38.2 t -123.13 92.14 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.84 . . . . 0.0 109.826 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.4 132.74 51.99 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 96.77 -25.74 25.21 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.547 ' CB ' ' HA3' ' A' ' 157' ' ' GLY . . . -42.49 162.75 0.15 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.371 -1.076 . . . . 0.0 109.699 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.556 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.2 Cg_endo -77.86 137.38 15.8 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.758 2.305 . . . . 0.0 111.206 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 155' ' ' VAL . 30.3 mm-40 -47.4 -22.36 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.913 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.474 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 55.7 t -151.41 82.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.014 -1.054 . . . . 0.0 108.968 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.566 HD11 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -76.66 121.33 23.09 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.11 -0.994 . . . . 0.0 108.341 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.544 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -98.27 139.54 33.91 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 110.025 -179.295 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.571 ' CE2' ' CG2' ' A' ' 145' ' ' VAL . 7.0 m-85 -127.76 101.96 6.59 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.467 ' CD1' ' O ' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -143.11 143.24 31.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.032 -1.042 . . . . 0.0 109.779 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.607 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -120.43 -179.07 3.85 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.91 . . . . 0.0 109.599 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.543 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 12.1 m-30 -98.48 47.4 0.99 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.604 ' CD2' ' CG1' ' A' ' 96' ' ' VAL . 28.4 m-85 -142.22 13.75 2.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.433 -0.792 . . . . 0.0 109.967 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.503 ' O ' ' NE2' ' A' ' 97' ' ' GLN . 0.5 OUTLIER -105.29 157.28 34.74 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.728 -1.233 . . . . 0.0 109.459 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.7 -27.16 12.95 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.209 1.939 . . . . 0.0 108.252 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.489 ' O ' ' N ' ' A' ' 36' ' ' PHE . 27.0 m80 -90.93 -22.66 20.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 13.0 t -47.04 -49.92 20.47 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 9.6 t80 -75.03 -33.65 61.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.838 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.3 mm-40 -83.36 -45.59 13.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.867 -1.146 . . . . 0.0 110.85 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.566 ' CE2' HG23 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -48.47 -24.63 1.34 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.104 -0.997 . . . . 0.0 110.578 -179.252 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -114.79 -51.26 2.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.919 -1.113 . . . . 0.0 112.334 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 63.3 mm-40 -90.15 0.32 57.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.689 -1.257 . . . . 0.0 111.534 -177.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' A' ' 35' ' ' GLN . 41.3 t -135.76 -74.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.676 -1.265 . . . . 0.0 109.581 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 35' ' ' GLN . 78.1 mt -64.06 -24.74 67.82 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.236 -0.915 . . . . 0.0 109.561 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.3 m80 51.18 21.55 1.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.988 -1.07 . . . . 0.0 109.201 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.566 HG23 ' CE2' ' A' ' 36' ' ' PHE . 37.6 mt -63.5 -21.27 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.858 . . . . 0.0 109.757 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -60.1 2.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 109.661 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -57.66 -30.5 65.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.804 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -66.59 -34.48 77.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.721 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 42' ' ' ILE . 42.7 t -72.25 -16.85 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.032 . . . . 0.0 109.191 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.406 ' HA ' HD13 ' A' ' 50' ' ' LEU . 3.5 mttp -82.46 -41.41 19.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.87 . . . . 0.0 110.088 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.18 -22.44 0.65 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.073 -1.017 . . . . 0.0 109.662 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.41 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 1.3 ptmm? -115.62 42.05 2.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 109.631 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 47' ' ' LYS . 10.9 mt -108.16 101.74 43.12 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.17 -0.956 . . . . 0.0 109.752 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 53' ' ' GLY . 33.5 Cg_endo -74.93 153.9 42.46 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.536 2.157 . . . . 0.0 109.408 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 73.2 tt0 -69.5 22.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.742 -1.223 . . . . 0.0 111.548 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.448 ' O ' HG21 ' A' ' 54' ' ' VAL . . . -122.45 32.11 4.61 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.521 ' CG1' ' HB3' ' A' ' 186' ' ' SER . 59.0 t -153.39 127.16 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.47 105.43 17.4 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 110.766 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.474 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -104.36 99.1 8.8 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.718 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.564 HG23 ' CE1' ' A' ' 59' ' ' TYR . 1.3 m -100.37 135.04 42.42 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.714 -1.195 . . . . 0.0 110.982 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.544 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 6.7 tttt -106.84 117.81 35.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.564 ' CE1' HG23 ' A' ' 57' ' ' THR . 2.6 m-85 -118.08 170.76 8.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.909 -1.12 . . . . 0.0 111.706 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.607 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 1.9 t-160 -111.09 136.4 50.18 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.727 0.775 . . . . 0.0 109.236 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.514 HG23 ' CB ' ' A' ' 27' ' ' SER . 3.1 m -78.9 155.55 4.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-O 121.398 0.618 . . . . 0.0 110.272 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.46 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 1.0 OUTLIER -124.4 35.82 4.74 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.031 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 63' ' ' PHE . 9.7 p90 -135.77 55.73 1.86 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.295 -0.878 . . . . 0.0 109.608 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.457 ' SD ' HD21 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -130.36 37.11 3.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.162 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.21 -33.28 0.42 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.19 -37.07 2.72 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -87.84 -79.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.004 -1.292 . . . . 0.0 110.464 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.591 ' C ' ' CD2' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -79.87 -18.5 50.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.106 . . . . 0.0 109.618 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 72' ' ' LEU . . . -54.95 -36.34 60.34 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.27 -45.65 79.76 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.325 -1.103 . . . . 0.0 108.36 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -66.9 -24.7 66.13 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.599 HD22 ' CD2' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -65.55 -46.86 77.89 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.888 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.46 ' OG1' ' HB3' ' A' ' 62' ' ' ASN . 1.6 m -56.04 -41.71 75.44 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 6.0 tp60 -61.4 -23.78 66.04 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 72' ' ' LEU . . . -63.65 -37.33 86.95 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.559 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 20.7 t-105 -71.29 -32.26 68.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.528 -0.733 . . . . 0.0 109.142 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.471 ' HB3' ' NE2' ' A' ' 138' ' ' GLN . . . -75.75 -40.34 55.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.467 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.569 ' CG2' ' CE1' ' A' ' 122' ' ' TYR . 35.6 t -74.55 -26.24 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.288 -0.882 . . . . 0.0 109.655 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.536 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.1 -57.87 3.52 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.944 -1.097 . . . . 0.0 108.776 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -26.59 10.33 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.492 ' HB3' ' CG2' ' A' ' 131' ' ' VAL . . . -68.14 -47.2 68.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.642 -0.661 . . . . 0.0 109.397 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.422 ' HA ' HD21 ' A' ' 82' ' ' LEU . 44.8 mt -106.12 14.02 28.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.104 -0.997 . . . . 0.0 110.373 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.24 24.89 7.42 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.536 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 28.2 m -86.25 -4.16 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -1.027 . . . . 0.0 110.482 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.472 ' O ' ' HB ' ' A' ' 89' ' ' THR . 2.7 pt-20 -42.44 -59.11 1.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.047 -1.033 . . . . 0.0 109.897 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.68 -31.41 11.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 109.828 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 84' ' ' VAL . 46.3 mttp -78.65 -52.88 7.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 111.478 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 92' ' ' LEU . 1.0 OUTLIER -85.92 -8.63 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.752 -1.217 . . . . 0.0 111.053 -178.111 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.605 HG21 ' CG ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.07 -44.98 44.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.729 -1.232 . . . . 0.0 108.679 178.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.424 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -52.61 -53.27 55.74 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.472 -1.392 . . . . 0.0 110.627 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.517 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 27.2 Cg_endo -73.28 -18.63 23.21 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 109.737 -0.909 . . . . 0.0 109.737 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.52 ' HG ' ' CG1' ' A' ' 111' ' ' VAL . 14.9 mt -86.83 -42.97 12.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 108.982 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.605 ' CG ' HG21 ' A' ' 89' ' ' THR . 5.1 m-30 -64.81 -46.66 81.04 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.889 -1.132 . . . . 0.0 108.87 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -71.78 -22.24 61.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.314 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.442 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -78.98 -31.02 44.79 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.604 ' CG1' ' CD2' ' A' ' 29' ' ' PHE . 2.8 t -105.73 6.63 10.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.179 -1.189 . . . . 0.0 109.325 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 93' ' ' PHE . 40.5 mm-40 -105.21 9.13 34.17 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 120.974 -1.079 . . . . 0.0 110.514 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER 173.27 -49.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.654 -1.278 . . . . 0.0 110.443 179.643 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 59.7 p -55.32 -44.53 75.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.608 -1.308 . . . . 0.0 109.297 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.446 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 71.41 12.04 6.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 110.285 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 t -79.63 -7.78 58.77 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.545 ' CB ' HG23 ' A' ' 96' ' ' VAL . 7.7 mm -84.95 73.32 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.12 33.37 3.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.605 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 107' ' ' ASP . 14.7 p -160.45 133.24 6.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 0.0 110.056 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.514 ' N ' ' HB3' ' A' ' 68' ' ' LEU . . . -50.81 -34.76 28.96 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.9 p -61.59 -31.6 71.67 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -70.6 -51.24 29.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.506 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 52.5 mt -48.66 -29.94 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -38.54 53.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.485 -0.759 . . . . 0.0 109.551 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.18 -44.32 83.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.438 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.52 ' CG1' ' HG ' ' A' ' 92' ' ' LEU . 69.9 t -72.62 -38.17 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -42.74 98.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.5 mt -71.5 -24.29 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.099 -1.001 . . . . 0.0 109.271 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -67.29 -19.65 65.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -91.75 -12.03 35.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.366 -0.834 . . . . 0.0 109.253 179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.98 -7.96 25.4 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.575 ' CD1' ' N ' ' A' ' 117' ' ' ILE . 1.9 mp -76.93 52.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.315 -1.109 . . . . 0.0 109.478 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 117' ' ' ILE . 35.5 mttm -40.46 154.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.035 -1.041 . . . . 0.0 109.769 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.75 -35.7 39.24 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.48 -56.27 24.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.045 -1.268 . . . . 0.0 110.018 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -46.86 87.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 109.946 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.569 ' CE1' ' CG2' ' A' ' 78' ' ' VAL . 0.1 OUTLIER -62.86 -62.64 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.561 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 122' ' ' TYR . 13.8 t70 -42.52 -35.08 0.97 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.768 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.95 -41.87 28.27 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.698 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . 0.535 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -58.57 -48.29 81.43 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 108.795 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 126' ' ' TRP . 2.2 t90 -62.37 -56.85 14.32 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.12 -16.1 0.71 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.552 -0.718 . . . . 0.0 110.559 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 4.7 t -69.07 -175.59 0.76 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.853 -1.154 . . . . 0.0 110.073 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -90.29 -34.89 15.56 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.299 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.4 -46.92 62.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 118.415 -1.314 . . . . 0.0 110.11 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 125' ' ' ALA . 6.5 t -72.14 -34.14 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.853 -1.154 . . . . 0.0 108.911 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -64.3 -44.04 92.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.383 -0.823 . . . . 0.0 109.016 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 11.4 t -65.12 -30.87 71.84 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.7 tp -78.91 -17.59 55.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.19 -47.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -64.46 -33.36 75.7 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.445 ' OE1' ' OH ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -66.46 -37.85 86.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.442 -0.786 . . . . 0.0 108.959 179.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.506 ' HA ' ' CE2' ' A' ' 59' ' ' TYR . 8.4 mt-30 -67.46 -67.62 0.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 108.885 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 138' ' ' GLN . 8.4 tt0 -46.74 -36.85 7.66 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 10.2 mmtt -72.52 -29.12 63.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.429 -0.794 . . . . 0.0 108.996 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -61.99 -53.62 53.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 109.071 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -71.77 -35.35 70.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.4 -0.813 . . . . 0.0 109.927 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.79 -18.63 58.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.836 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . 0.449 ' HB3' HG23 ' A' ' 16' ' ' VAL . 7.5 m-20 -82.82 -45.04 14.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.114 -0.992 . . . . 0.0 108.753 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . 0.571 ' CG2' ' CE2' ' A' ' 25' ' ' PHE . 20.9 m -97.33 -11.96 8.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.545 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 3.4 mt-30 82.02 -44.84 0.17 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.57 -0.706 . . . . 0.0 109.75 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.554 HD22 ' CE1' ' A' ' 63' ' ' PHE . 14.6 tp 66.46 133.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.347 -0.845 . . . . 0.0 109.144 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.4 37.41 0.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.536 -1.353 . . . . 0.0 109.846 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 158.04 109.51 0.28 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.291 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.505 ' CG1' HG13 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -93.56 142.59 25.37 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.427 -1.043 . . . . 0.0 109.358 178.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.16 151.76 93.79 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.891 -1.296 . . . . 0.0 110.487 0.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.496 ' HB2' ' HB2' ' A' ' 25' ' ' PHE . . . -126.83 153.53 45.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.306 -1.496 . . . . 0.0 109.264 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' MET . . . . . 0.531 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 3.2 ttm -145.32 136.44 24.84 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.118 -0.989 . . . . 0.0 109.818 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.572 ' CE2' ' HG3' ' A' ' 160' ' ' GLN . 3.0 m-85 -135.7 129.18 32.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.149 -0.97 . . . . 0.0 110.003 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 21' ' ' GLN . 53.9 t -98.32 132.11 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 0.0 109.636 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 4.3 t30 46.46 22.69 0.18 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.219 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.547 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.36 56.42 24.51 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LYS . . . . . 0.428 ' CG ' ' HB3' ' A' ' 15' ' ' PRO . 10.9 tttt -164.95 -34.16 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.377 -1.073 . . . . 0.0 108.32 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.581 ' CD2' ' HG2' ' A' ' 188' ' ' LYS . 86.1 m-85 -115.27 116.37 28.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.204 -0.935 . . . . 0.0 109.207 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.572 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 0.5 OUTLIER -100.67 106.15 17.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.386 -0.821 . . . . 0.0 109.958 -179.259 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.468 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 16.4 mt -61.3 159.7 11.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.838 . . . . 0.0 109.028 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -129.71 117.59 18.52 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 0.0 109.271 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.33 22.48 0.76 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.561 2.174 . . . . 0.0 111.239 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . 0.419 ' OE1' ' CA ' ' A' ' 164' ' ' GLN . 4.2 mm100 -83.96 -0.0 49.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.853 -1.154 . . . . 0.0 109.659 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 168' ' ' THR . . . -78.23 -1.07 79.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.84 -6.46 27.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.07 -1.253 . . . . 0.0 109.681 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -85.95 15.9 4.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.965 . . . . 0.0 109.576 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 169' ' ' SER . 3.7 t -81.43 -19.14 43.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.953 . . . . 0.0 109.527 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 168' ' ' THR . 4.2 m 70.55 42.75 0.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.865 . . . . 0.0 109.544 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -160.44 92.42 0.97 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.243 -0.91 . . . . 0.0 109.104 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.8 mmt -58.4 -16.19 13.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.916 . . . . 0.0 109.724 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.33 -61.27 2.06 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.677 -0.639 . . . . 0.0 109.415 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.422 ' O ' HG11 ' A' ' 173' ' ' VAL . 4.4 t -65.9 -23.08 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.205 -0.934 . . . . 0.0 109.034 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -73.44 -42.25 62.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.197 -0.94 . . . . 0.0 109.216 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 55.9 t -73.27 -26.26 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.121 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -61.31 2.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.3 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -52.55 -32.54 41.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -74.52 -60.49 2.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 109.524 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.27 -20.77 7.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.066 -1.021 . . . . 0.0 108.784 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -82.59 -55.52 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.48 -0.763 . . . . 0.0 109.448 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.479 ' OG1' ' OE1' ' A' ' 8' ' ' GLN . 69.6 m -50.73 -27.11 6.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.413 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 54.0 t -87.86 -37.3 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.034 -1.042 . . . . 0.0 108.911 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -57.27 -44.23 83.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 108.863 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -83.43 -35.74 24.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.403 -0.811 . . . . 0.0 109.391 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.514 HD21 ' N ' ' A' ' 185' ' ' LEU . 0.9 OUTLIER -58.03 -18.43 24.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.797 -1.189 . . . . 0.0 109.712 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' SER . . . . . 0.521 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -78.7 -5.06 52.09 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.793 -1.192 . . . . 0.0 108.722 178.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.22 9.07 40.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.481 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.581 ' HG2' ' CD2' ' A' ' 159' ' ' TYR . 2.4 tptp -56.37 -31.48 63.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.178 -0.951 . . . . 0.0 109.704 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.563 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.508 ' HB3' ' CE1' ' A' ' 9' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' ASP . 1.3 mt-10 -97.83 56.92 1.29 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -0.928 . . . . 0.0 110.083 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 40.99 80.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.609 -0.682 . . . . 0.0 110.041 179.39 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.9 -25.56 5.52 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.48 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -79.96 -69.5 0.58 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.94 -1.329 . . . . 0.0 108.852 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -95.6 2.01 53.99 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.16 -0.963 . . . . 0.0 109.852 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.555 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.2 OUTLIER 177.19 129.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.098 -1.001 . . . . 0.0 109.239 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -106.89 179.61 4.22 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.573 -0.705 . . . . 0.0 109.469 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 158' ' ' LYS . 1.4 m -123.66 138.64 54.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.351 0.596 . . . . 0.0 109.599 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -99.22 158.2 15.86 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.429 ' C ' ' HD3' ' A' ' 15' ' ' PRO . 3.4 pt-20 -91.51 1.27 57.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 109.712 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.559 ' C ' HD12 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -120.73 78.07 29.82 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 0.0 109.321 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 13' ' ' GLU . 36.3 Cg_endo -78.19 164.58 26.76 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.717 2.278 . . . . 0.0 110.558 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.746 HG21 ' OD1' ' A' ' 144' ' ' ASP . 18.8 t -127.53 92.66 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.176 -0.953 . . . . 0.0 109.557 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -42.76 125.96 3.56 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 96.05 -18.23 57.83 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.704 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -39.41 160.83 0.09 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.505 -0.997 . . . . 0.0 109.927 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.567 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 35.1 Cg_endo -77.67 135.83 14.8 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.741 2.294 . . . . 0.0 111.309 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.728 ' O ' HG13 ' A' ' 155' ' ' VAL . 9.1 mt-30 -49.4 -21.02 0.79 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.561 -0.712 . . . . 0.0 109.802 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 73.2 t -151.45 80.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.978 -1.076 . . . . 0.0 109.103 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.816 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.73 126.99 32.07 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.453 ' HB3' ' HG3' ' A' ' 58' ' ' LYS . 3.5 tt0 -108.49 120.97 43.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.001 -1.062 . . . . 0.0 109.97 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.002 ' CE2' HG21 ' A' ' 145' ' ' VAL . 8.2 m-85 -108.33 107.52 18.13 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.424 ' CE1' ' HG2' ' A' ' 58' ' ' LYS . 2.0 p90 -153.08 141.19 20.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.97 -1.081 . . . . 0.0 110.423 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.754 ' OG ' HG22 ' A' ' 61' ' ' VAL . 0.6 OUTLIER -118.51 -178.21 3.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.067 179.328 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 5.8 m-30 -97.03 46.16 1.04 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 108.698 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.609 ' CG ' HG11 ' A' ' 96' ' ' VAL . 15.0 m-85 -146.41 13.27 1.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.289 -0.882 . . . . 0.0 109.837 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 3.7 m -105.39 161.16 23.62 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.649 -1.282 . . . . 0.0 109.534 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 33.2 Cg_endo -75.04 -32.93 4.92 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.106 1.871 . . . . 0.0 108.17 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' PHE . 39.7 m80 -84.5 -20.37 31.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.502 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 5.1 t -49.69 -55.21 14.66 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 3.4 t80 -73.35 -33.51 65.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.901 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.605 ' O ' HD13 ' A' ' 40' ' ' LEU . 25.7 mt-30 -85.65 -16.02 40.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.856 -1.152 . . . . 0.0 111.186 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 32' ' ' HIS . 8.9 t80 -86.25 -28.2 23.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.841 -1.162 . . . . 0.0 111.377 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.3 mt-10 -127.14 50.53 1.97 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.594 -1.316 . . . . 0.0 110.728 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 1.2 mt-10 -168.34 -59.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.009 -1.057 . . . . 0.0 110.767 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.32 -49.35 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.976 -1.077 . . . . 0.0 110.848 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.605 HD13 ' O ' ' A' ' 35' ' ' GLN . 6.7 mp -71.1 -2.19 14.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.096 -1.003 . . . . 0.0 110.297 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.458 ' C ' ' O ' ' A' ' 40' ' ' LEU . 58.0 m-70 39.39 29.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.838 . . . . 0.0 109.954 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 40' ' ' LEU . 36.4 mt -74.62 -21.43 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.557 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.483 ' O ' HG12 ' A' ' 46' ' ' VAL . 2.5 p -76.97 -43.45 35.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 109.619 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.83 -48.28 15.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.519 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.458 ' ND2' HG11 ' A' ' 175' ' ' VAL . 56.2 t-20 -52.96 -43.56 66.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 109.517 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 43' ' ' SER . 9.8 p -69.87 -25.77 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.143 -0.973 . . . . 0.0 109.16 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.546 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 49.4 mttm -80.76 -27.58 36.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 110.133 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.421 ' NZ ' ' HE2' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -64.47 -29.45 70.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.052 . . . . 0.0 109.79 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 8.3 mmtt -109.27 24.79 12.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 11.9 mt -70.85 113.71 21.02 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.971 . . . . 0.0 109.933 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 36.2 Cg_endo -78.73 151.37 24.85 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.245 1.963 . . . . 0.0 109.247 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 3.7 tp10 -75.47 21.13 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.625 -1.297 . . . . 0.0 110.724 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.406 ' C ' HG23 ' A' ' 54' ' ' VAL . . . -122.75 29.99 5.24 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 186' ' ' SER . 60.7 t -153.07 118.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -1.007 . . . . 0.0 109.338 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.26 109.37 20.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.678 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.524 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 1.9 ttp -92.58 100.82 13.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.719 -0.613 . . . . 0.0 109.595 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 0.4 OUTLIER -96.72 149.67 21.56 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.801 -1.159 . . . . 0.0 109.898 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HG3' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -123.77 117.12 24.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.466 -0.771 . . . . 0.0 109.378 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.3 m-85 -123.78 166.26 15.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.81 -1.181 . . . . 0.0 111.617 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.636 ' CD2' ' HG ' ' A' ' 27' ' ' SER . 14.4 t60 -102.26 149.51 24.25 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.939 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.3 m -95.31 159.79 2.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 O-C-N 121.663 -0.648 . . . . 0.0 110.356 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.488 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 1.3 p-10 -128.11 49.41 2.16 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.312 -0.867 . . . . 0.0 109.193 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 10.8 p90 -152.4 64.65 0.82 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -0.961 . . . . 0.0 109.799 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -119.04 30.77 6.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.932 -1.105 . . . . 0.0 109.592 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' MET . . . 45.12 42.73 8.65 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . -149.05 85.43 0.16 Allowed Glycine 0 C--O 1.204 -1.731 0 N-CA-C 107.572 -2.211 . . . . 0.0 107.572 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -31.62 -46.52 0.11 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.058 -0.672 . . . . 0.0 111.548 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.866 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -61.46 -22.24 64.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.647 -1.283 . . . . 0.0 109.49 -179.01 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.828 ' N ' HD22 ' A' ' 68' ' ' LEU . . . -54.52 -46.99 71.86 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.421 ' O ' ' HB ' ' A' ' 73' ' ' THR . 27.8 mttt -52.32 -47.04 66.24 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.54 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 8.5 t0 -64.41 -29.2 70.27 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.79 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 17.6 tp -61.26 -35.4 77.17 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.645 HG23 ' CD ' ' A' ' 138' ' ' GLN . 5.3 m -62.75 -40.73 98.14 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.563 ' NE2' ' OH ' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -61.91 -20.9 64.26 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 177.175 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.79 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -67.96 -41.92 81.69 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.465 ' HB3' ' OE1' ' A' ' 138' ' ' GLN . 24.1 t-105 -67.01 -31.67 72.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 0.0 108.91 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -79.51 -60.37 2.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.28 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.884 HG21 ' CE1' ' A' ' 122' ' ' TYR . 71.5 t -54.92 -27.81 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 110.043 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.538 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.25 -62.85 1.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.907 -1.121 . . . . 0.0 108.621 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.405 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -47.01 -27.42 1.3 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.762 ' HB2' HG13 ' A' ' 131' ' ' VAL . . . -69.43 -42.16 75.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.598 -0.689 . . . . 0.0 109.286 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.5 mt -107.92 12.75 26.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.224 -0.923 . . . . 0.0 110.562 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 49.17 32.01 12.59 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.614 HG11 ' CD1' ' A' ' 117' ' ' ILE . 26.0 m -93.81 2.01 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.476 -1.014 . . . . 0.0 110.531 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.455 ' O ' ' HB ' ' A' ' 89' ' ' THR . 38.4 tt0 -48.9 -68.31 0.19 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.866 -1.146 . . . . 0.0 109.402 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -40.04 -34.89 0.32 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.878 . . . . 0.0 110.465 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.484 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 35.1 mttt -79.82 -55.4 5.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 111.031 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.857 HG23 HD12 ' A' ' 92' ' ' LEU . 1.2 m -82.14 -22.28 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.812 -1.18 . . . . 0.0 110.608 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.754 HG23 ' CE1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -64.77 -43.57 92.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.723 -1.235 . . . . 0.0 108.983 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.92 -56.21 30.22 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.351 -1.468 . . . . 0.0 110.474 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.484 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 26.1 Cg_endo -72.43 -16.21 27.62 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 N-CA-C 109.812 -0.88 . . . . 0.0 109.812 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.857 HD12 HG23 ' A' ' 88' ' ' VAL . 15.1 mt -87.39 -44.13 11.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 108.844 178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.754 ' CE1' HG23 ' A' ' 89' ' ' THR . 5.4 m-30 -65.51 -46.84 78.07 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.987 -1.071 . . . . 0.0 108.835 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -16.62 60.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -0.968 . . . . 0.0 109.203 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.66 -33.39 51.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.609 HG11 ' CG ' ' A' ' 29' ' ' PHE . 2.3 t -100.83 -7.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 121.12 -1.224 . . . . 0.0 109.35 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.491 ' O ' ' CG ' ' A' ' 98' ' ' LYS . 2.2 mp0 -110.08 8.73 24.07 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 120.893 -1.129 . . . . 0.0 110.514 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.786 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER -176.18 68.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.67 -1.269 . . . . 0.0 109.333 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 163.08 -46.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.522 -0.736 . . . . 0.0 109.575 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 71.67 17.54 5.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.397 -0.814 . . . . 0.0 110.38 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 t -81.45 -4.96 57.36 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.639 HG23 ' OD1' ' A' ' 107' ' ' ASP . 4.2 mm -95.41 84.49 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.34 28.29 1.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 109.382 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 107' ' ' ASP . 59.6 p -157.55 131.54 8.15 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.321 -0.862 . . . . 0.0 109.658 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.632 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -48.99 -31.66 7.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 t -64.5 -33.28 75.53 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.639 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -67.64 -50.11 59.6 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.743 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.731 HD11 HD23 ' A' ' 68' ' ' LEU . 36.3 mt -51.27 -28.53 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -36.49 56.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.52 -0.737 . . . . 0.0 109.052 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.22 -48.4 78.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.769 HG11 ' HG ' ' A' ' 92' ' ' LEU . 21.3 t -68.82 -37.68 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.455 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.435 ' O ' HG12 ' A' ' 117' ' ' ILE . 1.3 m-85 -59.9 -48.26 82.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.108 -0.995 . . . . 0.0 109.469 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 mt -66.26 -25.39 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.963 . . . . 0.0 109.279 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 111' ' ' VAL . 15.5 m-20 -61.77 -16.94 53.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.916 . . . . 0.0 109.544 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.585 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -97.94 15.48 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.078 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.59 -0.94 89.39 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.614 ' CD1' HG11 ' A' ' 84' ' ' VAL . 3.9 mm -71.77 55.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -1.14 . . . . 0.0 109.843 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -36.73 145.53 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.285 -0.885 . . . . 0.0 110.073 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -47.15 -31.71 6.22 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.79 -49.25 77.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -1.121 . . . . 0.0 109.49 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.19 -58.05 6.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 110.003 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.884 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -61.22 -56.84 16.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.938 . . . . 0.0 109.617 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 14.5 t70 -45.15 -34.34 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.036 -1.04 . . . . 0.0 109.054 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.48 -43.9 30.7 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.416 -0.802 . . . . 0.0 109.012 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.58 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -52.85 -51.66 60.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -62.62 -53.2 58.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -53.86 -16.13 1.66 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.511 -0.743 . . . . 0.0 110.027 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.2 t -78.76 -179.48 6.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.984 -1.073 . . . . 0.0 110.273 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -95.24 -36.59 11.38 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.806 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.04 -47.83 80.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.209 -1.396 . . . . 0.0 109.709 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' A' ' 81' ' ' ALA . 2.2 t -64.95 -39.8 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.97 -1.081 . . . . 0.0 108.333 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -66.61 -31.62 72.42 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.3 t -64.6 -35.48 81.14 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.83 -19.14 52.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.313 -0.867 . . . . 0.0 108.678 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.497 HG23 ' CB ' ' A' ' 77' ' ' ALA . 4.6 t -80.35 -47.45 21.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.61 -36.9 85.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -32.96 73.06 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.645 ' CD ' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -64.37 -66.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.306 -0.871 . . . . 0.0 109.092 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 0.4 OUTLIER -52.23 -32.87 38.75 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.46 ' O ' ' OD2' ' A' ' 144' ' ' ASP . 0.3 OUTLIER -74.19 -28.21 61.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.345 -0.847 . . . . 0.0 108.991 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -64.37 -60.88 2.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.062 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.481 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -72.37 -21.72 61.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.717 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -77.56 -29.09 51.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.079 -1.013 . . . . 0.0 109.776 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.95 ' OD1' HG13 ' A' ' 145' ' ' VAL . 2.8 p30 -81.22 -47.82 12.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.001 . . . . 0.0 108.419 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 1.002 HG21 ' CE2' ' A' ' 25' ' ' PHE . 28.2 m -84.07 -14.44 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.542 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 4.0 tt0 81.2 -48.05 0.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.587 -0.696 . . . . 0.0 109.837 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.662 HD22 ' CD1' ' A' ' 25' ' ' PHE . 49.0 tp 61.79 134.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.466 -0.771 . . . . 0.0 109.319 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.72 40.36 0.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.623 -1.298 . . . . 0.0 109.681 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 169.64 104.73 0.18 Allowed Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.014 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.939 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -99.0 141.13 22.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.131 . . . . 0.0 109.587 179.151 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 150' ' ' VAL . 33.1 Cg_endo -75.32 153.87 98.92 Favored 'Cis proline' 0 C--N 1.314 -1.26 0 C-N-CA 123.598 -1.417 . . . . 0.0 110.452 0.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -132.86 146.85 52.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.33 -1.481 . . . . 0.0 109.54 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.506 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 18.7 ttm -136.54 133.9 36.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 109.813 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.598 ' CD2' ' HB2' ' A' ' 160' ' ' GLN . 75.4 m-85 -129.57 127.08 39.97 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.332 -0.855 . . . . 0.0 110.104 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 21' ' ' GLN . 56.1 t -97.03 129.46 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.045 -1.034 . . . . 0.0 109.5 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.704 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 47.41 21.72 0.24 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.979 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.509 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.75 55.72 28.54 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.479 ' O ' HG23 ' A' ' 11' ' ' THR . 13.5 tttp -163.71 -37.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.497 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 75.0 m-85 -114.91 124.84 52.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.598 ' HB2' ' CD2' ' A' ' 154' ' ' PHE . 4.4 tt0 -124.44 127.43 47.5 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.942 -1.099 . . . . 0.0 109.852 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.73 -179.84 0.74 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.499 -0.751 . . . . 0.0 109.081 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.463 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 38.1 t30 -144.42 65.0 12.69 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 109.64 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 162' ' ' ASN . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.478 0 C-N-CA 122.675 2.25 . . . . 0.0 110.424 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 35.7 mtm . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.873 0.844 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -76.42 -46.48 26.97 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.44 -25.76 25.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.301 -0.874 . . . . 0.0 109.12 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -73.6 -40.8 63.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.579 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.458 HG11 ' ND2' ' A' ' 45' ' ' ASN . 32.6 t -73.11 -29.83 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -0.988 . . . . 0.0 109.248 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -51.7 7.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 108.951 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.459 ' NE2' ' OE1' ' A' ' 8' ' ' GLN . 4.5 tt0 -57.71 -44.8 86.17 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.207 -0.933 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.49 ' HA ' ' OG1' ' A' ' 181' ' ' THR . 4.9 t80 -60.11 -56.7 18.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.073 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 183' ' ' LYS . . . -49.44 -27.58 4.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.337 -0.852 . . . . 0.0 108.873 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -79.48 -46.17 17.96 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.436 -0.79 . . . . 0.0 109.315 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.598 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -48.62 -45.95 39.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.06 -1.025 . . . . 0.0 109.396 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.466 HG13 ' CG2' ' A' ' 22' ' ' VAL . 22.9 t -75.24 -32.09 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.959 -1.088 . . . . 0.0 109.792 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 179' ' ' ALA . 5.5 tttt -68.28 -38.43 81.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.364 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -83.41 -44.26 14.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.958 -1.089 . . . . 0.0 109.888 -179.468 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 181' ' ' THR . 14.5 mt -60.69 -22.75 64.25 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.62 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.527 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 5.2 t -68.98 -14.43 63.04 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.622 -0.674 . . . . 0.0 109.204 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.596 ' CB ' ' HB2' ' A' ' 8' ' ' GLN . 26.8 p90 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.41 ' H ' ' HB2' ' A' ' 7' ' ' LYS . 3.8 mm-40 -118.17 63.51 0.76 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 110.359 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 4' ' ' GLU . 8.8 t0 69.13 96.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 110.38 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.28 -10.19 75.07 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.587 ' O ' ' CG ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -99.63 28.72 4.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -1.094 . . . . 0.0 108.199 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.596 ' HB2' ' CB ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER 152.83 -40.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.03 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.59 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 8.4 p90 -139.79 113.34 8.52 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.193 -0.942 . . . . 0.0 108.691 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -93.3 -179.97 5.23 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 1.051 HG23 ' O ' ' A' ' 158' ' ' LYS . 90.5 m -137.1 145.81 44.35 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.615 0.722 . . . . 0.0 110.079 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.495 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -100.5 171.61 7.63 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.526 -0.734 . . . . 0.0 109.271 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.41 13.45 30.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.45 ' O ' HD12 ' A' ' 12' ' ' LEU . 1.6 mmtp -127.17 95.27 36.89 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.543 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.39 169.33 20.19 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.594 2.196 . . . . 0.0 110.204 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' ALA . 1.9 t -144.26 113.24 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 110.101 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.06 128.21 18.41 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 77.21 5.69 85.54 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.774 ' HB1' ' HD2' ' A' ' 20' ' ' PRO . . . -38.18 165.88 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.6 -0.941 . . . . 0.0 110.71 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.96 ' HG3' HD12 ' A' ' 23' ' ' LEU . 32.8 Cg_endo -74.02 101.26 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.859 2.373 . . . . 0.0 111.58 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.605 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.9 mp0 -42.1 -28.04 0.16 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 21' ' ' GLN . 40.2 t -158.57 79.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.96 HD12 ' HG3' ' A' ' 20' ' ' PRO . 1.3 tt -73.62 139.27 45.38 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.72 ' N ' HD23 ' A' ' 23' ' ' LEU . 1.5 tt0 -127.8 98.77 5.28 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.199 -0.938 . . . . 0.0 109.803 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.88 ' CD1' HD22 ' A' ' 147' ' ' LEU . 11.4 m-85 -81.61 127.0 32.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.204 -0.935 . . . . 0.0 108.913 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -161.73 128.69 3.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.346 -0.846 . . . . 0.0 109.705 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.779 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 11.6 p -112.45 145.66 39.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.403 -0.81 . . . . 0.0 109.131 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.604 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 8.6 m-30 -72.93 49.87 0.25 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.252 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.694 ' CG ' HG11 ' A' ' 96' ' ' VAL . 11.4 m-85 -152.24 9.85 0.5 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.577 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -107.26 167.03 10.0 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.725 -1.235 . . . . 0.0 109.949 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.01 -43.07 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.564 2.176 . . . . 0.0 108.691 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.479 ' HB3' ' HG3' ' A' ' 151' ' ' PRO . 0.1 OUTLIER -78.17 -21.71 49.79 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 5.7 t -45.19 -56.27 4.96 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.526 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 51.9 t80 -69.98 -27.33 64.62 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.591 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 3.2 mm-40 -84.87 -28.67 25.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.138 . . . . 0.0 111.002 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -87.69 -36.25 17.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.83 -1.169 . . . . 0.0 111.724 -178.287 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 1.2 mp0 -111.46 31.95 5.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.633 -1.292 . . . . 0.0 111.38 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.553 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 26.3 mm-40 -160.03 -58.15 0.06 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.801 -1.187 . . . . 0.0 110.846 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 41' ' ' HIS . 69.2 t -88.91 -74.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.844 -1.16 . . . . 0.0 110.903 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.52 ' HB3' ' CD1' ' A' ' 42' ' ' ILE . 51.0 mt -42.7 -25.29 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.004 . . . . 0.0 110.315 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER 55.8 21.61 4.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.009 -1.057 . . . . 0.0 108.898 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 40' ' ' LEU . 14.9 mt -70.35 -21.23 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.45 -0.781 . . . . 0.0 109.888 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.682 ' O ' HG12 ' A' ' 46' ' ' VAL . 79.3 p -86.16 -77.27 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.09 -1.006 . . . . 0.0 110.078 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.5 OUTLIER -41.68 -31.5 0.3 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.867 . . . . 0.0 110.486 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 3.0 m120 -75.85 -31.58 59.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.949 -1.094 . . . . 0.0 110.064 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 43' ' ' SER . 3.5 p -54.2 -36.47 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.079 -1.013 . . . . 0.0 109.577 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.937 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -72.44 -36.39 68.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.119 -0.988 . . . . 0.0 109.474 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -45.02 -24.78 0.25 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.548 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -133.36 50.66 2.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.274 -0.892 . . . . 0.0 110.004 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.937 HD12 ' HA ' ' A' ' 47' ' ' LYS . 9.8 mt -114.47 72.3 2.51 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.868 -1.145 . . . . 0.0 110.562 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.548 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 36.8 Cg_endo -78.59 139.35 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.33 2.02 . . . . 0.0 110.269 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 51' ' ' PRO . 19.3 tp10 61.99 134.79 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.374 -0.829 . . . . 0.0 108.849 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . 58.21 23.53 53.04 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.882 HG13 ' O ' ' A' ' 50' ' ' LEU . 1.6 t -61.26 77.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.712 -0.875 . . . . 0.0 109.258 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.499 ' CB ' ' HB2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -136.96 97.25 3.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.422 ' SD ' ' HD2' ' A' ' 58' ' ' LYS . 2.7 tmm? -103.6 103.01 12.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 108.91 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.52 121.68 36.32 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.197 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.526 ' HB2' ' CE1' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -103.39 110.23 22.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 0.0 109.715 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.606 ' CD1' ' CG ' ' A' ' 138' ' ' GLN . 4.1 m-85 -113.68 177.96 4.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.851 -1.156 . . . . 0.0 110.942 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.848 ' NE2' HD22 ' A' ' 72' ' ' LEU . 2.5 t-80 -140.0 130.4 25.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.44 -0.787 . . . . 0.0 109.651 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.677 HG11 HD23 ' A' ' 147' ' ' LEU . 1.4 m -115.18 137.38 48.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 2.0 p-10 -40.72 -55.89 2.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.352 -0.843 . . . . 0.0 109.37 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 62' ' ' ASN . 3.6 m-85 32.1 40.64 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.623 0.725 . . . . 0.0 110.952 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.507 ' SD ' ' CD2' ' A' ' 29' ' ' PHE . 5.8 ptm -161.02 47.61 0.21 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.574 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.53 -49.22 1.33 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.58 -3.53 49.96 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.714 -1.231 . . . . 0.0 111.241 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.46 -81.18 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.371 -1.664 . . . . 0.0 108.384 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.119 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -88.87 -26.24 21.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.947 -1.095 . . . . 0.0 109.49 178.627 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 1.119 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -57.31 -42.29 93.49 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -46.66 80.45 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.324 -1.104 . . . . 0.0 108.496 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.872 ' OD2' ' HB2' ' A' ' 105' ' ' ALA . 1.3 m-20 -66.3 -28.24 68.54 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.848 HD22 ' NE2' ' A' ' 60' ' ' HIS . 6.4 tt -61.03 -45.33 95.24 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 60' ' ' HIS . 1.5 m -59.68 -44.5 93.6 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.709 ' O ' HG13 ' A' ' 78' ' ' VAL . 8.7 tm0? -50.98 -27.36 7.53 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.715 ' HB1' ' CE2' ' A' ' 112' ' ' PHE . . . -81.17 -32.29 33.67 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.207 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' ALA . 4.4 t-105 -50.01 -29.14 8.08 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.769 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -85.24 -38.96 18.31 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.639 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 74' ' ' GLN . 3.3 m -63.71 -30.71 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 120.745 -1.222 . . . . 0.0 109.011 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.646 ' HB2' ' HZ ' ' A' ' 112' ' ' PHE . . . -81.77 -53.65 6.02 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.485 ' HB3' ' HG ' ' A' ' 134' ' ' LEU . 4.9 tpt -49.23 -29.32 5.55 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.651 ' HB2' ' CG2' ' A' ' 131' ' ' VAL . . . -60.78 -45.05 95.87 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.801 ' HB2' HG13 ' A' ' 84' ' ' VAL . 3.3 mt -110.87 16.0 21.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.47 -0.769 . . . . 0.0 110.055 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.75 30.23 6.58 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.801 HG13 ' HB2' ' A' ' 82' ' ' LEU . 36.0 m -89.39 -5.32 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -1.178 . . . . 0.0 110.551 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -42.85 -61.24 1.32 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.107 -0.996 . . . . 0.0 109.607 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -43.2 -33.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.455 ' CE ' ' HB1' ' A' ' 115' ' ' ALA . 4.4 mtpt -83.29 -50.7 8.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.298 -0.876 . . . . 0.0 111.214 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.749 HG23 HD12 ' A' ' 92' ' ' LEU . 1.1 m -82.4 -5.83 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.711 -1.243 . . . . 0.0 110.681 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.734 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -77.92 -45.51 23.84 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.302 178.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 2.1 t -51.8 -52.84 57.25 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.75 -1.219 . . . . 0.0 110.406 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 25.5 Cg_endo -73.28 -17.36 24.31 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 N-CA-C 109.645 -0.944 . . . . 0.0 109.645 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.749 HD12 HG23 ' A' ' 88' ' ' VAL . 13.6 mt -86.48 -44.92 11.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.734 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.1 m-30 -61.51 -47.65 84.64 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.916 -1.115 . . . . 0.0 108.772 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 90' ' ' VAL . 13.0 pt-20 -71.7 -16.7 62.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.111 -0.993 . . . . 0.0 109.641 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.46 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -79.05 -32.32 40.07 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.694 HG11 ' CG ' ' A' ' 29' ' ' PHE . 1.7 t -106.79 0.54 10.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.997 -1.296 . . . . 0.0 110.026 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.481 ' HG2' ' HB2' ' A' ' 34' ' ' TYR . 0.7 OUTLIER -106.93 6.17 28.98 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 120.769 -1.207 . . . . 0.0 110.679 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.786 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER 177.28 76.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.734 -1.229 . . . . 0.0 109.074 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 161.41 -48.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.3 OUTLIER 71.74 18.6 5.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.346 -0.846 . . . . 0.0 110.48 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.449 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 2.8 t -80.07 -4.47 52.9 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.603 HG23 ' OD1' ' A' ' 107' ' ' ASP . 4.6 mm -97.91 81.78 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.809 -0.557 . . . . 0.0 109.609 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.449 ' HD2' ' C ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -142.31 32.66 1.51 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.933 -1.105 . . . . 0.0 109.601 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 107' ' ' ASP . 4.0 p -158.38 134.87 9.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.068 -1.02 . . . . 0.0 109.749 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.873 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.95 -39.83 41.84 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.5 p -56.38 -31.73 64.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.603 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -71.63 -51.02 25.36 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.873 HD12 ' HA ' ' A' ' 105' ' ' ALA . 22.5 mt -45.5 -29.92 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 0.0 108.984 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.498 ' HG2' HD11 ' A' ' 113' ' ' ILE . 37.2 ttt180 -78.61 -37.84 41.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.177 -0.952 . . . . 0.0 109.553 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -58.92 -46.14 88.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.579 HG11 ' HG ' ' A' ' 92' ' ' LEU . 13.2 t -68.94 -38.81 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.715 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -61.19 -42.35 98.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.568 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.498 HD11 ' HG2' ' A' ' 109' ' ' ARG . 17.4 mt -69.81 -25.5 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.165 -0.959 . . . . 0.0 109.669 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -64.07 -16.73 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.678 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.597 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -96.04 11.89 32.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 109.649 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.65 -5.26 85.24 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.749 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -80.69 56.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -1.106 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.45 ' HA ' HG23 ' A' ' 113' ' ' ILE . 59.8 mttt -37.68 153.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.789 . . . . 0.0 110.153 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -47.9 -27.12 4.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -58.59 -46.98 85.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.878 -1.366 . . . . 0.0 109.473 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -77.96 -50.94 11.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.849 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.628 ' HE1' HG11 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -62.61 -58.27 8.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.978 . . . . 0.0 108.954 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 62.8 t0 -50.09 -48.93 52.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.038 -1.039 . . . . 0.0 109.292 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.32 81.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.304 -0.872 . . . . 0.0 109.43 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.682 ' C ' HG21 ' A' ' 131' ' ' VAL . . . -56.41 -49.5 74.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.293 -0.88 . . . . 0.0 108.951 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 1.01 ' HA ' HG11 ' A' ' 131' ' ' VAL . 6.0 t90 -54.85 -56.46 19.25 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -15.13 62.02 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.595 -0.69 . . . . 0.0 110.016 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 125' ' ' ALA . 16.8 p -71.56 179.72 2.91 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.013 -1.054 . . . . 0.0 110.095 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.421 ' CD1' HG23 ' A' ' 130' ' ' VAL . 4.4 p90 -90.42 -33.63 15.94 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.83 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.421 HG23 ' CD1' ' A' ' 129' ' ' PHE . 23.5 t -64.34 -36.96 78.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 C-N-CA 118.124 -1.43 . . . . 0.0 109.878 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 1.01 HG11 ' HA ' ' A' ' 126' ' ' TRP . 16.5 t -64.16 -38.73 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.878 -1.139 . . . . 0.0 108.941 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -66.6 -34.54 78.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 108.992 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.34 -33.15 75.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.278 -0.889 . . . . 0.0 109.399 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' A' ' 80' ' ' MET . 1.8 mm? -79.54 -26.55 41.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 108.846 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.769 HG23 ' CB ' ' A' ' 77' ' ' ALA . 6.0 t -79.11 -39.02 20.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.53 -49.15 61.75 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.443 -0.786 . . . . 0.0 109.184 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.481 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -61.73 -35.35 77.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.204 -0.935 . . . . 0.0 109.159 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.606 ' CG ' ' CD1' ' A' ' 59' ' ' TYR . 18.0 tm0? -62.78 -62.38 1.77 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.224 -0.922 . . . . 0.0 109.195 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -46.77 -35.61 6.38 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -30.86 67.38 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.614 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -60.74 -47.74 84.95 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.354 -0.841 . . . . 0.0 108.915 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -73.07 -39.83 65.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.411 -0.805 . . . . 0.0 110.236 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.62 -16.9 59.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.973 -1.079 . . . . 0.0 109.824 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.455 ' OD2' HG11 ' A' ' 16' ' ' VAL . 9.1 m-20 -82.06 -44.95 15.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.057 -1.027 . . . . 0.0 108.592 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 141' ' ' ALA . 17.6 m -100.08 -8.36 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.346 -0.846 . . . . 0.0 108.927 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.544 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 12.2 tp60 80.95 -42.15 0.18 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.461 -0.774 . . . . 0.0 110.113 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.88 HD22 ' CD1' ' A' ' 25' ' ' PHE . 20.1 tp 62.11 140.19 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.288 -0.882 . . . . 0.0 108.981 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.54 31.26 0.23 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.613 -1.304 . . . . 0.0 110.106 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 157.22 98.8 0.15 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.523 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.493 HG11 ' CG2' ' A' ' 61' ' ' VAL . 0.8 OUTLIER -92.51 138.37 23.99 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.914 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 31.6 Cg_endo -71.75 155.83 97.63 Favored 'Cis proline' 0 C--N 1.316 -1.163 0 C-N-CA 124.157 -1.185 . . . . 0.0 111.753 2.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -146.91 151.09 36.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.805 -1.185 . . . . 0.0 108.525 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -128.49 118.31 22.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.901 -1.124 . . . . 0.0 110.022 -179.673 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.579 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 57.8 m-85 -114.42 142.39 46.42 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.582 HG22 HG22 ' A' ' 22' ' ' VAL . 30.6 t -124.08 124.62 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.989 -1.07 . . . . 0.0 108.947 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.9 m120 56.14 22.89 6.41 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.187 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.407 ' O ' HD11 ' A' ' 12' ' ' LEU . . . 52.96 22.76 13.26 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.705 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 1.051 ' O ' HG23 ' A' ' 11' ' ' THR . 0.0 OUTLIER -134.58 -11.35 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.752 -1.44 . . . . 0.0 109.738 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 155' ' ' VAL . 99.5 m-85 -144.22 124.46 13.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.021 -1.05 . . . . 0.0 108.749 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.579 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 2.3 pt20 -133.31 129.39 37.48 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.965 -1.084 . . . . 0.0 110.157 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.009 HD12 ' CZ ' ' A' ' 178' ' ' TYR . 17.1 mt -61.27 168.58 2.56 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.67 150.68 44.23 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.084 -1.01 . . . . 0.0 109.786 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 C--N 1.31 -1.448 0 C-N-CA 122.683 2.255 . . . . 0.0 110.546 179.782 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 2.0 mtp . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.965 0.888 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.48 -65.05 0.94 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.464 HG13 ' HG2' ' A' ' 177' ' ' GLN . 20.1 t -70.15 -23.48 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.294 -0.879 . . . . 0.0 109.058 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -68.53 -39.87 80.98 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -0.909 . . . . 0.0 109.241 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.3 t -76.44 -32.3 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -74.97 -52.34 11.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 109.445 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.464 ' HG2' HG13 ' A' ' 173' ' ' VAL . 40.6 mm-40 -58.62 -40.44 83.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.437 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 1.009 ' CZ ' HD12 ' A' ' 161' ' ' LEU . 10.0 t80 -61.13 -50.82 71.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.132 -0.98 . . . . 0.0 109.231 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.432 ' O ' ' NZ ' ' A' ' 183' ' ' LYS . . . -64.12 -24.37 67.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.988 -1.07 . . . . 0.0 108.839 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -77.43 -40.92 41.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 0.0 108.986 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.558 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -58.61 -54.83 42.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 109.056 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.575 HG23 HD11 ' A' ' 161' ' ' LEU . 93.3 t -61.06 -36.85 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 109.607 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.474 ' HE3' ' CG ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -53.55 -44.47 69.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 109.217 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -84.42 -25.47 28.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.358 -0.839 . . . . 0.0 110.07 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 185' ' ' LEU . 1.1 mt -62.17 -23.45 66.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.446 -1.409 . . . . 0.0 108.435 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.8 t -75.57 -4.39 39.7 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.991 -1.068 . . . . 0.0 108.365 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.828 . . . . 0.0 109.452 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.497 ' O ' ' HB3' ' A' ' 5' ' ' ASP . 5.6 pm0 -133.18 64.65 1.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.163 -0.96 . . . . 0.0 109.976 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 4' ' ' GLU . 19.6 t70 71.16 93.5 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.518 -0.738 . . . . 0.0 110.759 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.57 3.79 90.38 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.586 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -101.91 28.41 5.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.962 -1.316 . . . . 0.0 108.937 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.586 ' CB ' ' O ' ' A' ' 7' ' ' LYS . 2.9 mm-40 144.54 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.582 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 2.2 p90 -141.89 114.21 8.25 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.054 0.93 . . . . 0.0 109.015 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -100.32 -179.19 4.04 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.2 m -111.6 143.72 42.02 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.899 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.784 HD12 ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -96.16 163.95 12.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.376 -0.828 . . . . 0.0 109.549 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 14' ' ' LYS . 1.6 pt-20 -87.52 -15.83 36.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.691 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.784 ' O ' HD12 ' A' ' 12' ' ' LEU . 3.3 mmtp -112.56 97.51 40.75 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.148 -0.97 . . . . 0.0 109.849 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.23 158.92 33.48 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.467 2.111 . . . . 0.0 109.863 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.671 ' O ' HG12 ' A' ' 16' ' ' VAL . 15.8 t -140.52 83.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.099 -1.001 . . . . 0.0 109.761 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.12 129.7 18.1 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.63 -19.73 52.95 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.77 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -41.9 164.61 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.41 -1.053 . . . . 0.0 109.556 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.661 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 34.7 Cg_endo -76.43 126.82 9.31 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.573 2.182 . . . . 0.0 110.955 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.818 ' O ' HG13 ' A' ' 155' ' ' VAL . 4.3 mt-30 -40.01 -24.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.558 -0.714 . . . . 0.0 110.421 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.687 HG13 ' HE2' ' A' ' 153' ' ' MET . 59.1 t -149.09 79.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.764 -1.21 . . . . 0.0 109.044 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.887 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -73.98 112.79 10.45 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.566 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -94.23 149.19 21.47 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.778 -178.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.943 ' CE2' HG21 ' A' ' 145' ' ' VAL . 7.6 m-85 -135.13 103.46 5.55 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.483 -0.76 . . . . 0.0 109.267 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -148.42 140.64 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 109.891 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.709 ' CB ' HG22 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -118.16 179.45 4.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.09 179.345 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 7.1 m-30 -90.33 40.44 1.01 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CG ' HG11 ' A' ' 96' ' ' VAL . 11.0 m-85 -137.91 16.82 2.85 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -113.8 164.81 14.96 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.544 -1.348 . . . . 0.0 109.878 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.74 -41.08 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.463 2.109 . . . . 0.0 108.092 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.598 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 9.6 m170 -75.34 -23.53 57.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 12.3 t -43.94 -57.71 3.17 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.455 ' HB2' ' CD ' ' A' ' 97' ' ' GLN . 89.4 t80 -71.48 -55.06 8.6 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.182 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 12.5 mt-30 -54.88 -16.96 3.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.228 -0.92 . . . . 0.0 110.527 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.598 ' CE1' ' HB3' ' A' ' 32' ' ' HIS . 4.0 m-30 -86.4 -38.96 16.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.08 -1.013 . . . . 0.0 110.831 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.02 -13.1 20.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.782 -1.199 . . . . 0.0 112.206 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.402 ' C ' HG23 ' A' ' 39' ' ' VAL . 3.0 mt-10 -136.27 28.51 3.09 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.17 -1.581 . . . . 0.0 111.418 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 35' ' ' GLN . 91.1 t -151.56 -88.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.394 -1.441 . . . . 0.0 110.138 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.807 ' HB2' HD12 ' A' ' 42' ' ' ILE . 1.4 mt -68.99 -19.49 64.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.95 . . . . 0.0 109.747 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 2.4 m-70 60.06 18.85 8.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.005 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.807 HD12 ' HB2' ' A' ' 40' ' ' LEU . 1.4 mt -46.98 -36.42 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.479 -0.763 . . . . 0.0 109.44 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.663 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -80.48 -34.34 35.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.991 . . . . 0.0 110.115 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.488 ' HA ' ' HG3' ' A' ' 47' ' ' LYS . 15.5 m-20 -82.7 -36.87 25.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.099 -1.001 . . . . 0.0 109.625 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -58.31 -34.21 70.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.84 . . . . 0.0 110.184 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 43' ' ' SER . 31.5 m -65.92 -31.98 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.033 -1.042 . . . . 0.0 110.021 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.61 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -54.51 -44.89 73.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.976 -1.078 . . . . 0.0 109.461 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -44.28 -28.34 0.52 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.119 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.472 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 10.1 mtmm -112.7 44.5 1.47 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.842 . . . . 0.0 109.24 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 47' ' ' LYS . 11.0 mt -115.87 79.35 7.9 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.165 -0.96 . . . . 0.0 109.945 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 35.3 Cg_endo -78.33 143.26 19.55 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.615 2.21 . . . . 0.0 110.119 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -39.45 120.77 1.1 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.312 1.054 . . . . 0.0 109.908 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.78 -26.74 5.06 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.54 ' CG1' ' CD2' ' A' ' 50' ' ' LEU . 98.1 t -89.71 85.37 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -1.192 . . . . 0.0 109.296 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.96 93.25 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.779 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.477 ' HG3' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -92.73 101.44 13.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.833 . . . . 0.0 109.437 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 4.9 m -111.45 134.09 53.27 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.11 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.566 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -114.13 109.2 18.05 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.27 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.482 ' OH ' ' HB3' ' A' ' 137' ' ' GLN . 4.5 m-85 -106.55 177.85 4.73 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.954 -1.092 . . . . 0.0 111.623 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.599 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 49.4 t-80 -111.85 132.62 54.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.735 0.779 . . . . 0.0 108.977 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.044 HG11 ' CG1' ' A' ' 150' ' ' VAL . 3.0 m -72.36 156.68 6.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.416 0.627 . . . . 0.0 110.598 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.492 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 14.0 t30 -118.56 51.19 1.11 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.628 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -155.86 61.17 0.59 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.731 -1.23 . . . . 0.0 110.106 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.693 ' HE1' ' CG2' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -144.92 43.37 1.34 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.958 -1.089 . . . . 0.0 109.488 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.47 -36.17 0.55 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.94 -43.07 3.13 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -88.7 -79.0 0.32 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.169 . . . . 0.0 110.109 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.115 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -78.0 -21.87 50.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.092 -1.005 . . . . 0.0 109.205 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 1.115 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -53.51 -42.83 66.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 2.1 tttt -68.78 -54.76 14.03 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.16 -1.2 . . . . 0.0 108.362 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.566 ' HB3' HD12 ' A' ' 108' ' ' ILE . 8.2 t70 -56.12 -25.18 44.89 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.782 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 44.4 tp -65.4 -39.68 92.5 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 m -59.48 -41.94 90.93 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.429 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 0.4 OUTLIER -60.13 -22.63 63.07 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.782 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -66.23 -40.06 90.01 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 46.7 t-105 -64.4 -31.58 72.84 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 78' ' ' VAL . . . -84.39 -68.14 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.725 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.85 HG21 ' CE1' ' A' ' 122' ' ' TYR . 95.7 t -43.98 -26.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 109.761 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.615 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -82.93 -58.62 2.79 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.085 -1.009 . . . . 0.0 108.717 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.28 -27.38 2.46 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.61 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -70.84 -43.15 69.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.483 -0.761 . . . . 0.0 109.447 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.671 ' HB2' HG13 ' A' ' 84' ' ' VAL . 23.0 mt -107.12 14.59 26.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 48.39 24.84 3.98 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.671 HG13 ' HB2' ' A' ' 82' ' ' LEU . 35.2 m -83.67 -9.92 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.408 -1.054 . . . . 0.0 110.397 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.467 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.3 OUTLIER -42.73 -63.4 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.137 -0.977 . . . . 0.0 109.37 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.96 -34.68 1.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.458 -0.776 . . . . 0.0 110.601 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -79.72 -53.18 7.06 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.186 -0.947 . . . . 0.0 111.741 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.781 HG23 HD12 ' A' ' 92' ' ' LEU . 2.9 m -84.7 -8.42 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.717 -1.239 . . . . 0.0 110.705 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.747 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -72.88 -44.5 61.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.593 -1.317 . . . . 0.0 108.596 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.402 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -53.64 -54.13 49.48 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.467 -1.396 . . . . 0.0 110.817 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.436 ' HD2' ' C ' ' A' ' 88' ' ' VAL . 25.0 Cg_endo -72.99 -18.65 23.96 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 N-CA-C 109.82 -0.877 . . . . 0.0 109.82 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.812 ' HG ' HG11 ' A' ' 111' ' ' VAL . 28.8 mt -87.22 -42.63 12.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.043 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.747 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.2 m-30 -63.78 -46.68 84.11 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.003 -1.06 . . . . 0.0 108.856 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -23.05 61.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.209 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.49 -33.39 61.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.661 HG11 ' CG ' ' A' ' 29' ' ' PHE . 2.3 t -102.32 -1.74 9.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.095 -1.238 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -110.37 8.71 23.42 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 120.956 -1.09 . . . . 0.0 110.543 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 99' ' ' THR . 2.4 mttp -179.91 64.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.634 -1.291 . . . . 0.0 109.277 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.871 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 169.0 -50.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 99' ' ' THR . 8.1 mp0 73.96 16.55 3.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.423 -0.798 . . . . 0.0 110.743 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 t -79.74 -9.05 59.6 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.585 ' CB ' HG22 ' A' ' 96' ' ' VAL . 9.0 mm -85.49 78.69 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.78 32.54 2.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.151 -0.968 . . . . 0.0 109.833 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 107' ' ' ASP . 24.1 p -157.96 132.0 8.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.994 -1.066 . . . . 0.0 110.208 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.536 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -51.2 -29.54 14.4 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -30.74 71.79 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.5 OUTLIER -70.61 -48.86 53.01 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.579 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 71' ' ' ASP . 18.9 mt -53.53 -27.06 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -75.93 -39.79 55.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.808 . . . . 0.0 109.817 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.467 ' OD2' ' O ' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -62.49 -41.55 98.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.086 -1.009 . . . . 0.0 109.53 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.812 HG11 ' HG ' ' A' ' 92' ' ' LEU . 1.5 t -72.15 -39.35 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.108 -0.995 . . . . 0.0 109.352 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.705 ' CE1' HG21 ' A' ' 88' ' ' VAL . 2.7 m-30 -63.93 -48.41 76.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.863 . . . . 0.0 110.031 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.1 mt -66.68 -25.41 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.986 . . . . 0.0 109.64 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -67.8 -17.54 64.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 0.0 109.816 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.64 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -90.52 7.03 41.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.637 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.53 2.6 82.12 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.64 HG12 ' HB3' ' A' ' 115' ' ' ALA . 3.0 mm -79.14 59.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.313 -1.11 . . . . 0.0 109.692 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 117' ' ' ILE . 5.3 mmtt -34.86 132.02 0.35 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.323 -0.861 . . . . 0.0 110.319 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 118' ' ' LYS . . . -40.76 -33.79 0.67 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -59.23 -43.14 92.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -1.18 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 118' ' ' LYS . 20.9 mt-10 -75.29 -43.64 50.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.85 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -67.65 -61.97 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.213 -0.929 . . . . 0.0 108.976 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 122' ' ' TYR . 11.4 t0 -47.19 -42.71 20.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.0 108.731 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.72 -45.93 80.84 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.333 -0.854 . . . . 0.0 109.017 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -54.21 -49.05 70.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.435 -0.79 . . . . 0.0 109.146 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.502 ' C ' ' CD1' ' A' ' 126' ' ' TRP . 7.2 t90 -59.81 -54.53 45.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 0.0 108.496 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.07 -15.31 3.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.588 -0.695 . . . . 0.0 110.15 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 32.6 m -70.3 178.04 3.05 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.988 -1.07 . . . . 0.0 110.431 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 -37.67 13.23 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.362 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.65 -46.84 79.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.248 -1.381 . . . . 0.0 109.678 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.61 HG22 ' HB1' ' A' ' 81' ' ' ALA . 5.2 t -63.77 -32.63 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.872 -1.143 . . . . 0.0 108.519 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -71.56 -36.4 70.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 108.84 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -36.49 83.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.388 -0.82 . . . . 0.0 109.156 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.15 -24.72 40.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -0.891 . . . . 0.0 108.661 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 131' ' ' VAL . 17.6 t -73.97 -41.93 52.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.55 -52.87 55.44 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.482 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -54.8 -27.3 40.73 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.043 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.43 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -67.83 -65.3 0.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 2.9 tt0 -51.79 -37.28 50.91 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 144' ' ' ASP . 1.3 mtmt -64.39 -30.77 71.8 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.639 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -66.01 -60.29 2.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.453 -0.78 . . . . 0.0 109.052 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.554 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -71.78 -23.11 61.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.898 . . . . 0.0 109.823 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -83.35 -26.5 30.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.038 -1.039 . . . . 0.0 110.325 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.811 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.3 p30 -81.56 -44.03 17.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.901 -1.124 . . . . 0.0 108.595 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.943 HG21 ' CE2' ' A' ' 25' ' ' PHE . 16.0 m -96.39 -10.68 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.879 . . . . 0.0 108.731 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.554 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.0 tt0 78.18 -49.48 0.48 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.447 -0.783 . . . . 0.0 110.26 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.976 HD21 HG12 ' A' ' 61' ' ' VAL . 16.2 tp 65.2 133.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 0.0 109.4 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -160.89 40.44 0.16 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.579 -1.326 . . . . 0.0 109.879 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.67 107.43 0.21 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.464 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 1.044 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.0 144.71 29.62 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.353 -1.086 . . . . 0.0 109.442 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.04 152.4 91.8 Favored 'Cis proline' 0 C--N 1.316 -1.138 0 C-N-CA 124.041 -1.233 . . . . 0.0 110.466 0.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.884 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -128.75 156.03 44.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.393 -1.442 . . . . 0.0 109.364 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.687 ' HE2' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -150.87 133.76 15.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 109.682 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.544 ' HE1' ' HB1' ' A' ' 152' ' ' ALA . 4.3 m-85 -132.41 125.65 31.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.373 -0.829 . . . . 0.0 109.913 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.818 HG13 ' O ' ' A' ' 21' ' ' GLN . 73.5 t -96.94 132.12 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.926 . . . . 0.0 110.153 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.77 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.9 OUTLIER 47.75 20.88 0.23 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.913 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.6 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 57.87 55.09 32.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -164.45 -39.96 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.205 -1.174 . . . . 0.0 108.121 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -110.86 124.09 51.38 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.749 -0.78 . . . . 0.0 108.948 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.527 ' HB3' HD22 ' A' ' 12' ' ' LEU . 15.4 pt20 -120.79 127.29 51.82 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.966 -1.084 . . . . 0.0 109.912 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.542 HD21 ' HB ' ' A' ' 181' ' ' THR . 19.7 mt -64.5 174.12 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -156.09 76.62 4.63 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 109.716 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 C--N 1.308 -1.556 0 C-N-CA 122.752 2.301 . . . . 0.0 110.711 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.8 mtp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.824 0.821 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -55.09 8.55 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.681 -0.637 . . . . 0.0 109.657 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.496 HG13 ' HG3' ' A' ' 177' ' ' GLN . 14.1 t -70.35 -28.59 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.121 -0.987 . . . . 0.0 109.533 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.453 ' O ' ' CD1' ' A' ' 174' ' ' PHE . 2.5 t80 -67.46 -46.04 74.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.032 -1.043 . . . . 0.0 109.437 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 82.6 t -74.74 -24.27 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 1.4 mt-30 -81.81 -52.74 6.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.511 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.545 ' HB3' ' NE2' ' A' ' 8' ' ' GLN . 41.4 mt-30 -63.85 -32.3 73.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.192 -0.943 . . . . 0.0 109.569 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 178' ' ' TYR . 17.8 t80 -74.11 -58.38 3.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.004 . . . . 0.0 109.429 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.35 -33.06 67.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.946 -1.096 . . . . 0.0 108.44 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 33.2 t0 -71.31 -42.61 68.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.493 -0.754 . . . . 0.0 109.342 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.542 ' HB ' HD21 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -55.09 -57.07 13.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.093 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.437 HG22 ' HE1' ' A' ' 153' ' ' MET . 2.3 t -57.12 -35.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.823 -1.173 . . . . 0.0 109.71 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -48.33 82.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.967 . . . . 0.0 109.903 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.26 -21.2 39.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.96 -1.088 . . . . 0.0 110.337 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 181' ' ' THR . 68.6 mt -73.66 -18.54 61.01 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.744 -1.222 . . . . 0.0 109.002 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.5 m -74.14 -4.47 35.92 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.526 -0.733 . . . . 0.0 109.805 -179.69 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 5' ' ' ASP . 12.5 mt-10 -114.07 56.96 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.127 -0.983 . . . . 0.0 110.42 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER 42.61 82.19 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.511 -0.743 . . . . 0.0 110.359 179.063 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.81 -24.63 6.02 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.723 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -82.15 -68.31 0.71 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.0 -1.294 . . . . 0.0 109.178 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.607 ' NE2' ' CD1' ' A' ' 9' ' ' TYR . 2.1 pp0? -95.23 -1.92 50.64 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.607 ' CD1' ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER 179.64 130.45 0.09 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.873 -1.142 . . . . 0.0 109.721 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.2 t -112.87 179.95 3.82 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.872 HG23 ' O ' ' A' ' 158' ' ' LYS . 59.2 m -127.87 143.82 51.1 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.456 0.645 . . . . 0.0 109.581 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -100.69 156.17 17.48 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.399 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -93.63 0.54 56.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.492 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.507 ' O ' HD12 ' A' ' 12' ' ' LEU . 4.2 mtmt -124.88 89.41 52.58 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.283 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.03 166.55 26.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.608 2.206 . . . . 0.0 110.111 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.918 HG13 ' HB2' ' A' ' 19' ' ' ALA . 7.2 p -120.78 109.22 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -0.975 . . . . 0.0 110.264 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.38 125.24 4.54 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.491 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 91.53 -10.63 74.28 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.918 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -33.87 148.11 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.787 -0.831 . . . . 0.0 109.906 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.588 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.4 Cg_endo -81.21 133.72 8.84 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.472 2.115 . . . . 0.0 111.383 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.842 ' OE1' HG22 ' A' ' 54' ' ' VAL . 1.5 mm-40 -51.11 -21.81 2.13 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.508 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 24.1 t -151.12 89.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 108.975 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.674 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -80.43 128.74 33.92 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 58' ' ' LYS . 8.7 tt0 -113.48 96.59 5.96 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.92 -1.113 . . . . 0.0 109.729 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.923 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 4.4 m-85 -84.76 115.71 22.85 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.448 -0.782 . . . . 0.0 109.458 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.538 ' CE1' ' OE1' ' A' ' 37' ' ' GLU . 2.6 p90 -160.35 142.01 12.54 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.268 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.593 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 94.0 p -125.64 -172.72 2.66 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.624 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -109.3 49.3 0.83 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.675 -1.266 . . . . 0.0 108.472 178.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.534 ' HB3' ' CE ' ' A' ' 64' ' ' MET . 7.1 m-85 -133.78 -3.92 2.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.637 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 4.5 m -109.41 173.23 3.06 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.203 . . . . 0.0 108.586 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.3 Cg_endo -76.19 -58.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.752 1.635 . . . . 0.0 109.316 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 69.5 m-70 -63.37 -20.09 65.22 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.536 ' HG ' ' CB ' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -52.58 -53.89 40.33 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.582 0.706 . . . . 0.0 109.286 179.53 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 8.8 t80 -80.49 -37.46 31.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.575 -0.703 . . . . 0.0 109.884 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.537 ' CD ' HG21 ' A' ' 39' ' ' VAL . 35.6 mm-40 -66.09 -26.07 67.31 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.184 -0.948 . . . . 0.0 109.954 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -70.66 -39.52 73.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.054 -1.029 . . . . 0.0 109.578 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.538 ' OE1' ' CE1' ' A' ' 26' ' ' PHE . 1.2 mt-10 -98.15 -10.06 24.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 0.0 111.898 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 1.8 mm-40 -138.3 27.69 2.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.266 -1.521 . . . . 0.0 111.819 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.537 HG21 ' CD ' ' A' ' 35' ' ' GLN . 64.9 t -151.45 -83.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.432 -1.418 . . . . 0.0 110.026 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.991 HD21 ' HB3' ' A' ' 171' ' ' MET . 18.0 mt -65.14 -14.33 60.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.868 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 23.1 m-70 56.57 18.37 3.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.187 -0.946 . . . . 0.0 109.146 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 46' ' ' VAL . 9.9 mt -55.39 -18.59 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.5 m -82.63 -54.38 5.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.023 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -86.77 -33.0 20.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.72 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 41' ' ' HIS . 10.4 t-20 -51.68 -27.23 11.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.838 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 42' ' ' ILE . 31.4 t -81.21 -17.2 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.302 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 1.036 ' HA ' HD12 ' A' ' 50' ' ' LEU . 1.7 mttm -76.11 -17.93 59.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.813 -1.179 . . . . 0.0 110.074 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -64.46 -16.24 62.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 109.615 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -143.59 36.23 1.31 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.036 HD12 ' HA ' ' A' ' 47' ' ' LYS . 5.2 mt -91.94 142.9 26.95 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.954 -1.091 . . . . 0.0 109.595 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.576 ' HD2' HD23 ' A' ' 50' ' ' LEU . 35.8 Cg_endo -78.03 149.88 25.99 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.689 2.259 . . . . 0.0 110.051 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -79.09 21.38 0.45 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.93 -1.106 . . . . 0.0 110.469 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -124.46 32.74 4.01 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.842 HG22 ' OE1' ' A' ' 21' ' ' GLN . 44.6 t -154.32 131.85 2.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.645 -0.915 . . . . 0.0 108.702 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.5 137.61 51.89 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.178 0.989 . . . . 0.0 109.961 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.508 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 3.3 ptm -107.04 98.96 8.55 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.39 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 24' ' ' GLU . 86.7 m -82.24 142.86 31.77 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.742 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -116.1 111.13 19.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.365 -0.834 . . . . 0.0 110.028 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.594 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 1.7 m-85 -113.44 158.24 20.92 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.173 -0.954 . . . . 0.0 110.864 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.951 ' CE1' HD22 ' A' ' 72' ' ' LEU . 17.9 t60 -99.94 124.69 45.53 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.01 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.3 m -69.85 144.95 13.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.598 -0.689 . . . . 0.0 110.166 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.541 ' HB2' ' CE ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -113.57 49.23 0.99 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.652 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 2.9 p90 -145.37 80.12 1.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.17 0.986 . . . . 0.0 110.048 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.566 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -159.91 -59.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.872 -1.143 . . . . 0.0 109.735 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.566 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -87.98 -28.07 24.38 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.472 ' O ' ' HG2' ' A' ' 70' ' ' LYS . . . 86.3 -49.17 4.04 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.19 -78.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.562 -0.964 . . . . 0.0 110.008 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.112 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -73.79 -22.62 59.76 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.855 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 1.112 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -55.53 -43.32 85.63 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 107.434 -2.266 . . . . 0.0 107.434 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.541 ' CE ' ' HB2' ' A' ' 62' ' ' ASN . 8.6 mmmt -63.71 -47.8 79.68 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.508 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 13.3 t0 -64.04 -28.38 69.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.951 HD22 ' CE1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -58.16 -38.5 76.74 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.571 HG23 ' OE1' ' A' ' 138' ' ' GLN . 6.7 m -66.24 -42.85 88.05 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.551 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -60.99 -18.58 58.29 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 177.055 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -68.37 -47.49 67.28 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -58.99 -27.73 65.69 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.736 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -79.37 -52.46 8.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.432 -0.792 . . . . 0.0 109.967 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.732 HG21 ' CE1' ' A' ' 122' ' ' TYR . 39.2 t -60.77 -26.53 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.044 -1.035 . . . . 0.0 109.875 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -80.23 -63.43 1.41 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.038 -1.039 . . . . 0.0 109.003 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -45.9 -27.94 1.0 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.682 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -70.35 -46.15 64.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.437 -0.79 . . . . 0.0 109.463 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.467 ' HB2' HG13 ' A' ' 84' ' ' VAL . 21.6 mt -102.05 12.07 37.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.15 -0.969 . . . . 0.0 110.214 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 53.56 20.55 11.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 79' ' ' ALA . 34.9 m -86.47 -7.93 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.431 -1.041 . . . . 0.0 110.669 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.474 ' CA ' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -40.82 -59.47 1.41 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.087 -1.008 . . . . 0.0 109.986 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.4 -34.19 10.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.449 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 mttt -82.74 -52.88 6.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.199 -0.938 . . . . 0.0 111.471 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.639 HG23 HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -75.15 -6.81 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.633 -1.292 . . . . 0.0 110.505 -178.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.675 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -77.04 -44.77 29.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.948 -1.095 . . . . 0.0 108.513 178.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.44 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -52.32 -52.38 63.49 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.543 -1.348 . . . . 0.0 110.565 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.677 ' HB2' HG13 ' A' ' 111' ' ' VAL . 26.0 Cg_endo -73.68 -20.93 19.67 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 O-C-N 122.727 0.856 . . . . 0.0 110.022 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.872 ' HG ' HG11 ' A' ' 111' ' ' VAL . 13.1 mt -85.61 -41.9 14.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 108.967 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.675 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.6 m-30 -65.95 -45.71 80.81 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.071 -1.018 . . . . 0.0 108.862 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 90' ' ' VAL . 23.5 mt-10 -76.3 -26.75 56.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 109.556 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.434 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -65.56 -36.93 93.11 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.9 t -93.07 -12.78 8.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.151 -1.205 . . . . 0.0 108.594 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 1.3 mt-30 -104.98 4.12 31.39 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 121.103 -0.998 . . . . 0.0 111.051 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.775 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER -160.15 61.11 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.404 -1.435 . . . . 0.0 109.963 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.11 -49.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 74.27 15.2 3.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -0.989 . . . . 0.0 110.628 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -86.69 -4.29 59.16 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.732 0.777 . . . . 0.0 108.988 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.488 HG23 ' OD1' ' A' ' 107' ' ' ASP . 6.5 mm -80.57 77.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HD3' ' C ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -140.75 35.13 1.79 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 110.074 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 107' ' ' ASP . 54.9 p -157.26 133.74 9.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.856 -1.152 . . . . 0.0 109.968 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.883 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -50.71 -35.7 32.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 75.7 m -59.19 -28.86 67.02 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -75.39 -50.78 14.84 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.883 HD12 ' HA ' ' A' ' 105' ' ' ALA . 21.9 mt -47.25 -31.34 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.086 -1.009 . . . . 0.0 109.421 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 106' ' ' SER . 1.3 ptm180 -78.99 -37.27 39.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.945 -1.097 . . . . 0.0 109.349 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -54.64 -46.06 73.88 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.153 -0.967 . . . . 0.0 108.929 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.872 HG11 ' HG ' ' A' ' 92' ' ' LEU . 70.4 t -69.95 -39.91 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -0.942 . . . . 0.0 109.227 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.61 ' HD2' HG21 ' A' ' 117' ' ' ILE . 1.4 m-85 -59.6 -53.79 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.717 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.1 mt -60.21 -25.96 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.107 -0.996 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.47 -16.97 64.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.164 -0.96 . . . . 0.0 109.378 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.622 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -100.44 -7.14 24.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.544 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.76 -5.27 25.99 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.783 HD12 ' N ' ' A' ' 117' ' ' ILE . 2.2 mp -78.42 52.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -1.158 . . . . 0.0 109.278 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 117' ' ' ILE . 38.3 mttp -36.2 157.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.318 -0.864 . . . . 0.0 110.555 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -59.82 -50.58 66.19 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 119' ' ' GLY . 21.1 tt0 -43.29 -55.19 4.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.03 -1.276 . . . . 0.0 109.929 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 1.3 tt0 -63.98 -63.22 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.976 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.732 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -46.27 -60.94 2.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.135 -0.978 . . . . 0.0 109.239 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 122' ' ' TYR . 1.2 m-20 -44.54 -34.25 2.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.152 -0.968 . . . . 0.0 109.062 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 121' ' ' GLU . . . -75.63 -44.36 43.13 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.353 -0.842 . . . . 0.0 109.23 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.688 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -59.02 -48.08 82.9 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.409 -0.807 . . . . 0.0 109.17 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.536 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 10.8 t90 -59.44 -53.23 60.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.404 -0.81 . . . . 0.0 108.957 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.94 -15.72 2.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.642 -0.661 . . . . 0.0 110.236 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.41 178.1 7.44 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.976 -1.078 . . . . 0.0 109.971 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -91.45 -36.6 13.68 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.566 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.6 t -64.27 -47.3 90.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.205 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.688 HG21 ' HB1' ' A' ' 125' ' ' ALA . 21.3 t -64.39 -39.84 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.109 -0.994 . . . . 0.0 108.481 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -29.1 67.42 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 50.4 m -66.27 -34.39 77.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.842 . . . . 0.0 109.019 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -28.5 54.92 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.736 HG23 ' CB ' ' A' ' 77' ' ' ALA . 6.8 t -75.1 -36.34 37.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -67.66 -46.15 73.23 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.593 -0.692 . . . . 0.0 109.405 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.444 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -68.83 -23.64 64.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.428 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.594 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 4.7 mt-30 -72.49 -69.41 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.083 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.76 -35.05 21.02 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.427 ' O ' ' CG ' ' A' ' 144' ' ' ASP . 12.1 mtpt -75.94 -29.9 58.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.321 -0.862 . . . . 0.0 108.874 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -57.34 -56.26 24.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.213 -0.93 . . . . 0.0 108.751 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -75.54 -32.89 60.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.925 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.21 -22.15 61.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 109.46 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 140' ' ' LYS . 73.7 m-20 -82.45 -47.36 12.34 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.853 HG21 ' HE2' ' A' ' 25' ' ' PHE . 11.3 m -88.55 -5.49 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 2.6 tp60 80.8 -50.36 0.31 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.587 -0.696 . . . . 0.0 109.543 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.643 HD13 ' CD2' ' A' ' 25' ' ' PHE . 13.1 tp 61.51 137.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.228 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -161.02 33.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.544 -1.347 . . . . 0.0 110.339 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 160.14 109.69 0.26 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 118.905 -1.617 . . . . 0.0 111.208 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 1.01 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -87.93 144.35 34.65 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.586 -0.949 . . . . 0.0 109.057 178.157 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.79 152.65 92.86 Favored 'Cis proline' 0 C--N 1.315 -1.222 0 C-N-CA 123.923 -1.282 . . . . 0.0 110.526 0.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.923 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -123.54 141.8 51.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.361 -1.462 . . . . 0.0 109.139 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.506 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 1.6 ttp -130.27 130.94 45.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.126 -0.984 . . . . 0.0 109.71 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.779 ' HE1' ' HB1' ' A' ' 152' ' ' ALA . 8.3 m-85 -133.73 131.44 39.41 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 21' ' ' GLN . 12.2 t -105.32 125.57 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.753 -1.217 . . . . 0.0 108.618 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 20' ' ' PRO . 18.6 t-20 48.08 26.39 1.0 Allowed 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.901 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 52.17 25.27 17.76 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.208 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.872 ' O ' HG23 ' A' ' 11' ' ' THR . 10.0 tttm -124.9 -19.2 5.32 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.835 -1.391 . . . . 0.0 108.894 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.407 ' O ' ' N ' ' A' ' 155' ' ' VAL . 94.0 m-85 -141.66 125.08 16.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 108.92 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.602 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 1.3 pt20 -128.79 134.78 48.49 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.877 -1.139 . . . . 0.0 109.632 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.519 HD12 ' CZ ' ' A' ' 178' ' ' TYR . 12.8 mt -68.02 177.14 2.3 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.627 -0.671 . . . . 0.0 109.287 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.64 82.7 5.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.888 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 C--N 1.31 -1.469 0 C-N-CA 122.666 2.244 . . . . 0.0 110.311 179.696 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.991 ' HB3' HD21 ' A' ' 40' ' ' LEU . 3.8 mtm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.589 0.709 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.45 -50.82 14.62 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.696 -0.628 . . . . 0.0 109.341 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.5 t -74.69 -29.56 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 178' ' ' TYR . 33.4 t80 -69.07 -36.2 77.36 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.947 -1.095 . . . . 0.0 108.614 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.784 ' CG2' HD22 ' A' ' 40' ' ' LEU . 24.3 t -74.34 -28.71 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.363 -0.836 . . . . 0.0 108.916 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -81.53 -58.39 3.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.053 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.72 -36.53 36.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.203 -0.936 . . . . 0.0 109.074 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.519 ' CZ ' HD12 ' A' ' 161' ' ' LEU . 18.9 t80 -69.44 -47.15 64.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.193 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.59 -22.42 66.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.15 -0.969 . . . . 0.0 108.978 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -79.09 -45.3 20.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 109.305 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.665 ' O ' HD23 ' A' ' 185' ' ' LEU . 6.5 m -63.11 -31.78 73.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -0.958 . . . . 0.0 109.317 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.505 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 52.0 t -77.39 -39.59 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.747 -1.22 . . . . 0.0 109.357 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -56.96 -52.23 66.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.5 -24.41 50.08 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.665 HD23 ' O ' ' A' ' 181' ' ' THR . 0.2 OUTLIER -64.31 -20.71 66.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.875 -1.141 . . . . 0.0 108.839 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.764 ' CB ' HG21 ' A' ' 54' ' ' VAL . 63.0 p -87.3 7.54 28.25 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.865 -1.147 . . . . 0.0 108.273 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.392 -0.818 . . . . 0.0 109.542 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.608 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 4.9 mt-10 -128.17 66.04 1.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 110.34 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.6 m-20 61.3 91.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 110.407 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.98 68.56 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.092 -1.051 . . . . 0.0 110.59 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.581 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 9.1 tttp -95.64 26.07 4.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.991 -1.299 . . . . 0.0 108.561 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.581 ' CB ' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER 145.09 -34.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.575 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 2.5 p90 -141.86 115.59 9.14 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.001 -1.062 . . . . 0.0 109.225 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t -105.25 179.62 4.22 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.332 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -104.32 157.85 16.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.746 -0.596 . . . . 0.0 109.713 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.783 HD11 ' HB2' ' A' ' 160' ' ' GLN . 1.6 mp -100.08 159.11 15.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.362 -0.836 . . . . 0.0 109.477 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -98.97 11.75 38.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 109.443 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -168.3 93.27 0.61 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.195 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HB3' ' O ' ' A' ' 157' ' ' GLY . 36.4 Cg_endo -77.85 161.79 30.02 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.536 2.157 . . . . 0.0 110.891 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.91 HG13 ' CB ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -113.23 96.79 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 109.437 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -41.66 126.96 3.1 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 94.02 -16.69 60.35 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.91 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -38.63 158.18 0.1 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.484 -1.01 . . . . 0.0 109.94 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.567 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.7 Cg_endo -80.42 138.75 12.53 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.827 2.351 . . . . 0.0 111.48 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.674 ' O ' HG13 ' A' ' 155' ' ' VAL . 6.0 mt-30 -47.53 -22.34 0.46 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.476 -0.765 . . . . 0.0 109.653 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.716 ' O ' HG12 ' A' ' 22' ' ' VAL . 8.4 t -150.36 80.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.04 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.628 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -75.58 129.49 37.28 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -112.73 129.76 56.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.947 -1.095 . . . . 0.0 109.827 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.062 ' CE2' HG21 ' A' ' 145' ' ' VAL . 8.4 m-85 -116.88 102.83 9.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.247 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -146.4 136.36 23.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.894 -1.129 . . . . 0.0 110.026 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.609 ' CB ' ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -110.06 171.79 7.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.404 -0.81 . . . . 0.0 109.522 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.605 ' HB2' HD21 ' A' ' 72' ' ' LEU . 7.9 m-30 -87.59 43.58 1.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.539 ' CE1' HD22 ' A' ' 72' ' ' LEU . 9.6 m-85 -143.23 12.32 1.78 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.371 -0.83 . . . . 0.0 110.127 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 4.7 m -106.88 160.52 26.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.778 -1.201 . . . . 0.0 109.378 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -75.65 -32.39 4.72 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.111 1.874 . . . . 0.0 107.928 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.8 t-160 -79.9 -25.52 40.55 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 37.1 t -45.05 -64.17 0.77 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.576 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 28.0 t80 -65.0 -44.71 88.38 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.294 0.569 . . . . 0.0 110.055 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.496 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 52.7 mt-30 -67.43 -16.42 64.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.917 . . . . 0.0 110.859 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 32' ' ' HIS . 12.7 t80 -76.72 -52.0 10.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.979 -1.076 . . . . 0.0 110.344 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -106.53 -4.62 19.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.789 -1.195 . . . . 0.0 112.072 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.576 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 10.6 mt-10 -124.4 19.76 8.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.213 -1.555 . . . . 0.0 111.332 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.517 ' CG2' ' CE2' ' A' ' 34' ' ' TYR . 64.1 t -151.76 -84.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.614 -1.304 . . . . 0.0 109.92 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.846 HD21 ' HB3' ' A' ' 171' ' ' MET . 13.8 mt -63.96 -13.9 49.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 0.0 109.867 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 44' ' ' ASP . 57.0 m-70 49.05 24.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.169 -0.957 . . . . 0.0 108.649 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.416 HD11 HD13 ' A' ' 40' ' ' LEU . 1.8 mt -43.18 -27.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.544 -0.722 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.26 -16.62 39.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -0.971 . . . . 0.0 110.867 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 41' ' ' HIS . 35.3 t70 -87.15 -34.05 19.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.916 -1.115 . . . . 0.0 110.413 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -73.26 -44.15 59.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.215 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.7 m -55.96 -25.13 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.127 -0.983 . . . . 0.0 110.021 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HG2' HD12 ' A' ' 50' ' ' LEU . 3.1 mttt -65.67 -27.35 68.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 109.343 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -55.3 -18.56 6.58 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.376 -0.827 . . . . 0.0 109.096 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -134.86 48.26 2.3 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 109.764 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.537 HD12 ' HG2' ' A' ' 47' ' ' LYS . 10.7 mt -104.08 102.86 34.71 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 34.2 Cg_endo -76.3 152.78 35.19 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.512 2.141 . . . . 0.0 109.273 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 52' ' ' GLU . 12.1 tt0 -72.15 23.2 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.637 -1.289 . . . . 0.0 111.243 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 21' ' ' GLN . . . -122.13 29.47 5.53 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 186' ' ' SER . 68.5 t -148.92 121.17 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.502 -0.999 . . . . 0.0 108.722 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.7 116.69 32.48 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 110.471 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.524 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.94 96.99 9.66 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.021 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -88.68 141.58 28.4 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.039 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.68 113.93 21.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.404 -0.81 . . . . 0.0 109.639 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 138' ' ' GLN . 2.2 m-85 -116.97 154.05 31.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.995 -1.066 . . . . 0.0 111.838 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.609 ' CE1' ' CB ' ' A' ' 27' ' ' SER . 37.2 t-80 -108.87 111.71 23.56 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.047 HG11 HD22 ' A' ' 147' ' ' LEU . 3.1 m -82.36 158.18 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.976 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 70' ' ' LYS . 1.5 p-10 -108.99 48.24 0.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.37 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.649 ' CE1' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -119.94 45.72 2.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.923 -1.111 . . . . 0.0 110.219 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.527 ' HG3' ' CD1' ' A' ' 63' ' ' PHE . 34.9 mtp -159.65 47.66 0.28 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 159.32 58.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -33.37 -36.56 0.05 OUTLIER Glycine 0 N--CA 1.493 2.499 0 O-C-N 122.004 -0.704 . . . . 0.0 111.472 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -87.59 -79.31 0.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.767 -1.431 . . . . 0.0 110.762 -178.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.9 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.74 -19.61 30.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.94 -1.1 . . . . 0.0 110.261 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.578 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -56.79 -39.65 87.86 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -65.09 -42.85 93.67 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.25 -24.49 64.9 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.769 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 41.7 tp -65.64 -47.73 74.61 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.437 ' OG1' ' C ' ' A' ' 61' ' ' VAL . 2.0 m -58.58 -43.46 89.45 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 1.053 ' O ' HG23 ' A' ' 78' ' ' VAL . 5.7 tp60 -55.69 -27.45 50.34 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.58 -41.52 98.36 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.497 ' HB2' ' CB ' ' A' ' 60' ' ' HIS . 47.8 t-105 -61.47 -30.68 70.75 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.391 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.674 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -81.68 -39.31 24.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 110.057 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.053 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.3 t -77.07 -27.12 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 109.75 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -80.87 -54.37 5.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.295 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -48.67 -27.79 3.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.203 -0.936 . . . . 0.0 108.742 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.927 ' HB2' HG22 ' A' ' 131' ' ' VAL . . . -60.5 -56.03 26.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.432 -0.792 . . . . 0.0 110.119 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.785 ' HB2' HG13 ' A' ' 84' ' ' VAL . 3.2 mt -102.04 10.38 39.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.038 -1.038 . . . . 0.0 110.59 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.45 27.98 61.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.919 HG11 HG12 ' A' ' 117' ' ' ILE . 19.7 m -81.98 -6.64 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.375 -1.073 . . . . 0.0 109.858 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' THR . 3.9 tt0 -43.88 -65.1 0.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.547 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -41.41 -34.02 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 109.852 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -80.71 -51.95 8.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.459 -0.776 . . . . 0.0 111.158 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.857 HG23 HD12 ' A' ' 92' ' ' LEU . 1.6 m -86.61 -9.57 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.708 -1.245 . . . . 0.0 110.869 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.689 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.46 -44.03 46.3 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.819 -1.176 . . . . 0.0 108.717 179.241 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.435 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -53.19 -53.18 58.63 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.478 -1.389 . . . . 0.0 110.453 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.544 ' HG2' HG13 ' A' ' 111' ' ' VAL . 26.0 Cg_endo -73.47 -18.08 23.19 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 O-C-N 122.786 0.887 . . . . 0.0 109.844 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.876 ' HG ' HG11 ' A' ' 111' ' ' VAL . 19.6 mt -87.24 -43.39 12.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.011 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.689 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.1 m-30 -64.98 -45.94 83.53 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.894 -1.129 . . . . 0.0 108.73 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 97' ' ' GLN . 7.2 tt0 -72.73 -27.42 62.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.309 -0.87 . . . . 0.0 109.17 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.461 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -65.17 -38.19 94.95 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.651 HG22 ' CB ' ' A' ' 102' ' ' ILE . 3.8 t -97.81 -1.55 10.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.299 -1.118 . . . . 0.0 108.629 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 93' ' ' PHE . 18.8 mm-40 -111.14 9.61 21.92 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.169 -0.957 . . . . 0.0 110.874 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.811 ' O ' HG23 ' A' ' 99' ' ' THR . 50.6 tttt -172.5 62.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.482 -1.387 . . . . 0.0 109.822 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 164.47 -50.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.704 -0.622 . . . . 0.0 109.324 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.3 mt-30 75.92 15.28 2.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.195 -0.941 . . . . 0.0 110.777 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 t -82.82 -6.63 59.51 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.403 -0.81 . . . . 0.0 108.818 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.651 ' CB ' HG22 ' A' ' 96' ' ' VAL . 10.5 mm -79.97 72.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.21 31.56 3.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.198 -0.939 . . . . 0.0 109.167 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 107' ' ' ASP . 1.4 p -151.21 126.48 9.95 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.256 -0.902 . . . . 0.0 109.861 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.657 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -50.63 -31.81 17.16 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.4 t -59.3 -31.42 69.11 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -71.54 -49.34 41.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' A' ' 105' ' ' ALA . 37.3 mt -50.58 -30.32 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.124 -0.985 . . . . 0.0 108.947 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.42 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 24.5 mtm180 -79.55 -32.33 42.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.207 -0.933 . . . . 0.0 109.227 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -58.79 -46.79 86.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.268 -0.895 . . . . 0.0 108.799 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.876 HG11 ' HG ' ' A' ' 92' ' ' LEU . 70.1 t -71.35 -38.27 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.209 -0.932 . . . . 0.0 109.009 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CE2' ' CE2' ' A' ' 122' ' ' TYR . 0.5 OUTLIER -56.95 -44.72 82.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.561 HG23 ' HA ' ' A' ' 118' ' ' LYS . 15.5 mt -73.58 -24.21 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.594 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -65.82 -16.71 64.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.421 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.571 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -91.35 -3.23 56.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 109.86 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.94 -8.93 63.55 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.919 HG12 HG11 ' A' ' 84' ' ' VAL . 2.6 mp -88.86 51.83 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -1.098 . . . . 0.0 109.362 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.561 ' HA ' HG23 ' A' ' 113' ' ' ILE . 16.7 pttm -33.78 153.89 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.565 -0.709 . . . . 0.0 110.826 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.17 -29.3 2.29 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.488 ' HB3' ' CD ' ' A' ' 118' ' ' LYS . 17.3 tt0 -50.37 -58.09 6.47 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.064 -1.256 . . . . 0.0 109.042 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.38 -54.14 6.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.438 -0.788 . . . . 0.0 109.662 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.787 ' CE2' HG11 ' A' ' 78' ' ' VAL . 2.6 t80 -46.73 -55.56 7.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.119 -0.988 . . . . 0.0 109.218 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.439 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 47.1 t0 -56.66 -48.59 77.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 109.07 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.49 -49.86 54.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.25 -0.906 . . . . 0.0 109.076 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 131' ' ' VAL . . . -51.44 -49.27 62.01 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.456 -0.778 . . . . 0.0 109.188 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.742 ' HA ' HG11 ' A' ' 131' ' ' VAL . 11.4 t90 -60.27 -56.49 20.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 108.956 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -56.09 -15.64 3.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.517 -0.739 . . . . 0.0 109.923 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 63.2 m -77.35 -177.71 4.78 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.05 -1.031 . . . . 0.0 110.156 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.34 -32.43 13.61 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.76 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.3 -42.75 97.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 117.916 -1.514 . . . . 0.0 109.401 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.927 HG22 ' HB2' ' A' ' 81' ' ' ALA . 42.6 t -65.72 -38.21 81.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.04 -1.038 . . . . 0.0 108.295 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -38.44 89.14 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.3 m -62.1 -39.77 93.6 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.34 -16.63 56.01 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.674 HG23 ' HB1' ' A' ' 77' ' ' ALA . 5.0 t -79.4 -44.75 23.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 140' ' ' LYS . . . -68.62 -44.64 73.82 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.449 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 7.1 tp-100 -62.81 -32.64 73.87 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -0.817 . . . . 0.0 109.041 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.492 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 12.9 tm0? -79.43 -62.75 1.59 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.199 -0.938 . . . . 0.0 108.751 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -49.47 -34.5 17.06 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 6.8 ttmt -75.11 -29.07 60.47 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.64 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -59.25 -54.23 49.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.362 -0.836 . . . . 0.0 109.143 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -75.83 -31.52 59.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 110.356 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.28 54.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.23 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.636 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.2 p30 -84.21 -47.18 11.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.978 -1.076 . . . . 0.0 108.181 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 1.062 HG21 ' CE2' ' A' ' 25' ' ' PHE . 10.3 m -82.04 -21.86 9.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 82.1 -25.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.849 -0.532 . . . . 0.0 110.188 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.047 HD22 HG11 ' A' ' 61' ' ' VAL . 10.5 tp 61.4 142.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 109.537 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.15 33.66 0.14 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.691 -1.256 . . . . 0.0 110.139 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.658 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 153.05 113.33 0.53 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.325 -1.416 . . . . 0.0 110.519 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.625 HG13 ' HZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -101.56 139.55 20.49 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.34 -1.094 . . . . 0.0 109.395 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.31 151.46 95.0 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 123.725 -1.365 . . . . 0.0 110.209 0.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -130.37 126.77 37.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.271 -1.518 . . . . 0.0 109.127 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.646 ' CE ' HG22 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -122.71 114.77 21.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.087 -1.008 . . . . 0.0 110.094 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.512 ' CE1' ' HB1' ' A' ' 152' ' ' ALA . 3.2 m-30 -110.58 148.3 32.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 21' ' ' GLN . 29.7 t -107.61 133.47 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.731 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.611 ' OD1' HG12 ' A' ' 155' ' ' VAL . 5.6 p-10 40.7 25.49 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.4 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 15' ' ' PRO . . . 58.2 60.07 9.63 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 6.8 tttt -167.74 -33.68 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.379 -1.071 . . . . 0.0 108.327 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.54 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 96.5 m-85 -116.49 121.44 41.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.056 -1.028 . . . . 0.0 108.926 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.783 ' HB2' HD11 ' A' ' 12' ' ' LEU . 19.8 tt0 -113.42 109.02 18.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 109.749 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 9' ' ' TYR . 15.5 mt -59.32 172.12 0.68 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 8' ' ' GLN . 62.9 t-20 -152.2 83.07 5.16 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 120.849 -1.157 . . . . 0.0 109.848 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--N 1.308 -1.566 0 C-N-CA 122.713 2.275 . . . . 0.0 110.432 179.734 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.846 ' HB3' HD21 ' A' ' 40' ' ' LEU . 13.0 mtt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.661 0.743 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.6 -62.24 1.75 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.693 -0.63 . . . . 0.0 109.672 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.56 -21.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.151 -0.968 . . . . 0.0 108.919 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.485 ' O ' ' CD1' ' A' ' 174' ' ' PHE . 2.4 t80 -74.78 -45.23 45.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.293 -0.88 . . . . 0.0 109.268 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.796 ' CG2' HD22 ' A' ' 40' ' ' LEU . 39.8 t -71.39 -26.87 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.174 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.66 -53.11 6.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.569 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.55 -40.64 87.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 109.01 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -63.92 -47.5 80.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.321 -0.862 . . . . 0.0 108.909 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.61 -29.48 70.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.25 -0.906 . . . . 0.0 108.947 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -75.08 -38.29 61.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 109.277 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.719 ' O ' HD23 ' A' ' 185' ' ' LEU . 2.9 m -66.11 -26.47 67.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -0.871 . . . . 0.0 109.274 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.646 HG22 ' CE ' ' A' ' 153' ' ' MET . 52.8 t -87.13 -37.23 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 108.581 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -57.46 -48.47 79.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.406 -0.809 . . . . 0.0 108.885 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.44 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -80.92 -28.74 35.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.397 -0.815 . . . . 0.0 109.416 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 181' ' ' THR . 0.6 OUTLIER -63.77 -17.3 62.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.198 . . . . 0.0 109.358 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.492 ' HB2' HG21 ' A' ' 54' ' ' VAL . 1.4 t -82.56 5.54 20.53 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.665 -1.272 . . . . 0.0 107.999 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.439 -0.788 . . . . 0.0 109.415 -179.777 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 5' ' ' ASP . 0.4 OUTLIER -105.11 55.74 0.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 4' ' ' GLU . 7.0 p-10 39.77 79.86 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.812 -0.555 . . . . 0.0 109.891 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 126.79 -26.52 5.09 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.762 -1.208 . . . . 0.0 110.348 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 -69.52 0.6 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.063 -1.257 . . . . 0.0 109.385 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -91.41 2.72 56.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.229 -0.919 . . . . 0.0 109.611 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 6' ' ' GLY . 2.2 p90 178.91 132.85 0.08 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.09 -1.006 . . . . 0.0 109.189 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 t -119.11 176.34 5.35 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.691 -0.63 . . . . 0.0 109.494 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -100.24 152.1 20.68 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.357 0.599 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 mp -92.95 170.9 9.31 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.303 -0.873 . . . . 0.0 109.594 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.428 ' OE2' ' HG2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -91.56 -5.92 53.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.511 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HG2' ' OE2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -166.06 110.67 0.73 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.444 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 36.0 Cg_endo -77.97 160.49 30.37 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.417 2.078 . . . . 0.0 110.153 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -119.03 102.67 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 109.8 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.22 127.07 6.73 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 92.37 -15.03 63.2 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.539 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -38.35 156.18 0.11 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.94 . . . . 0.0 109.618 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.569 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.5 Cg_endo -79.17 128.32 8.12 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.547 2.165 . . . . 0.0 111.308 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.765 ' O ' HG13 ' A' ' 155' ' ' VAL . 37.0 mt-30 -42.38 -24.28 0.05 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.398 -0.813 . . . . 0.0 109.586 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.684 ' O ' HG12 ' A' ' 22' ' ' VAL . 7.1 t -147.26 83.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.127 -0.983 . . . . 0.0 109.155 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.646 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -77.75 128.56 34.22 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 58' ' ' LYS . 3.4 mm-40 -109.68 131.93 54.61 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.088 -1.008 . . . . 0.0 109.723 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.03 ' CE2' HG21 ' A' ' 145' ' ' VAL . 5.0 m-85 -120.58 113.93 20.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -151.75 144.89 24.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.974 -1.079 . . . . 0.0 109.698 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.729 ' HB2' HG22 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -118.53 163.86 16.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 110.085 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.786 ' CD2' HD21 ' A' ' 72' ' ' LEU . 18.8 m-30 -88.13 39.17 0.89 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 1.009 ' CZ ' HD13 ' A' ' 72' ' ' LEU . 5.2 m-85 -138.72 15.51 2.7 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 110.179 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 4.2 m -114.39 158.18 40.59 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.596 -1.315 . . . . 0.0 109.722 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -74.5 -25.42 12.98 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.196 1.931 . . . . 0.0 107.835 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' PHE . 98.5 m-70 -89.17 -16.43 31.38 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 5.7 t -54.92 -53.44 55.51 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 38' ' ' GLU . 29.3 t80 -71.58 -40.61 69.78 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.486 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.483 ' HA ' ' CG2' ' A' ' 39' ' ' VAL . 3.3 mt-30 -78.33 -19.02 54.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 111.181 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 32' ' ' HIS . 70.6 t80 -78.0 -20.3 52.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.924 -1.11 . . . . 0.0 110.466 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 41' ' ' HIS . 3.7 tm-20 -133.31 -72.06 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.885 -1.134 . . . . 0.0 110.826 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.636 ' CB ' ' CE1' ' A' ' 34' ' ' TYR . 56.8 mm-40 -46.02 -40.25 10.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.831 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.483 ' CG2' ' HA ' ' A' ' 35' ' ' GLN . 5.0 t -92.4 -74.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.053 . . . . 0.0 110.548 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.557 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 0.4 OUTLIER -75.21 -10.9 59.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.0 110.652 -178.785 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 11.0 p-80 40.92 32.11 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.136 -0.977 . . . . 0.0 109.342 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.502 HG13 ' HB3' ' A' ' 40' ' ' LEU . 3.6 mt -54.38 -18.12 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 110.152 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.6 p -84.95 -38.56 19.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.943 -1.098 . . . . 0.0 110.563 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 2.7 m-20 -81.58 -36.91 28.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.02 -1.05 . . . . 0.0 110.428 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 46' ' ' VAL . 15.8 t30 -60.54 -53.34 58.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.033 -1.042 . . . . 0.0 110.171 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' ASN . 6.7 m -42.82 -38.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 110.183 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.797 ' HA ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -46.86 -34.81 5.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.039 . . . . 0.0 109.867 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.429 ' HD3' ' HG2' ' A' ' 49' ' ' LYS . 3.4 tmtm? -45.46 -24.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.145 -0.972 . . . . 0.0 109.93 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.519 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -116.32 40.57 2.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.729 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.797 HD13 ' HA ' ' A' ' 47' ' ' LYS . 5.5 mp -129.47 68.19 79.96 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.182 -0.949 . . . . 0.0 109.587 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 52' ' ' GLU . 36.1 Cg_endo -80.31 77.97 3.86 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.697 2.265 . . . . 0.0 111.685 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 51' ' ' PRO . 25.5 tp10 58.92 136.85 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.616 0.722 . . . . 0.0 110.103 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.13 -6.52 69.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.812 HG13 ' HB2' ' A' ' 186' ' ' SER . 0.9 OUTLIER -116.06 100.52 10.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.28 -1.13 . . . . 0.0 108.645 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -100.51 109.39 21.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.259 -0.901 . . . . 0.0 110.427 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.524 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -102.46 95.52 6.32 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.134 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 24' ' ' GLU . 4.2 m -84.16 133.6 34.6 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.724 -1.19 . . . . 0.0 110.042 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 8.5 tttt -106.72 117.95 35.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.484 -0.76 . . . . 0.0 109.582 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CE2' ' HG2' ' A' ' 138' ' ' GLN . 3.3 m-85 -120.88 177.02 5.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.014 -1.054 . . . . 0.0 110.5 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.607 ' CE1' ' HA ' ' A' ' 27' ' ' SER . 3.2 t60 -109.16 159.89 16.53 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.84 0.828 . . . . 0.0 109.538 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.049 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.4 m -104.02 162.4 4.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.79 58.31 1.7 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.141 -0.975 . . . . 0.0 109.314 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.702 ' HE1' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -158.03 64.82 0.46 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.023 -1.048 . . . . 0.0 110.849 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.671 ' HE1' ' O ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -126.17 33.27 5.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.503 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 64' ' ' MET . . . 44.72 42.42 7.6 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . -148.5 80.97 0.2 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 66' ' ' GLY . 44.5 t0 -33.39 -45.35 0.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.021 -0.693 . . . . 0.0 111.366 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.103 HD23 ' N ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -55.4 -21.01 13.81 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.749 -1.219 . . . . 0.0 109.192 -179.258 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 1.103 ' N ' HD23 ' A' ' 68' ' ' LEU . . . -63.62 -51.3 55.2 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -50.97 -55.05 19.18 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -27.0 68.96 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.009 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 6.2 tt -65.32 -38.06 89.0 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 m -59.69 -42.17 92.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.924 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.2 tt0 -53.92 -29.31 41.62 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.72 -40.06 95.83 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.446 ' O ' ' HB2' ' A' ' 80' ' ' MET . 53.4 t-105 -60.24 -30.93 69.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 108.534 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.546 ' HA ' HD21 ' A' ' 134' ' ' LEU . . . -86.96 -60.46 1.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 109.642 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 74' ' ' GLN . 2.0 t -53.66 -28.1 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 109.171 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.09 -55.74 4.04 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.521 ' SD ' HD22 ' A' ' 134' ' ' LEU . 2.7 ttt -50.67 -27.54 7.18 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.763 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -68.79 -42.25 77.64 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.489 -0.757 . . . . 0.0 109.49 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.505 ' HB2' HG13 ' A' ' 84' ' ' VAL . 14.9 mt -101.97 7.8 41.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.376 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.32 29.32 45.8 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.774 HG11 HG12 ' A' ' 117' ' ' ILE . 26.8 m -94.21 7.82 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.433 -1.039 . . . . 0.0 109.684 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 86' ' ' ASP . 48.9 tt0 -47.72 -72.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.12 -0.988 . . . . 0.0 109.487 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -38.86 -34.59 0.16 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.556 -0.715 . . . . 0.0 110.224 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.534 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 10.4 mtpp -73.95 -55.22 6.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.819 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.917 HG23 HD12 ' A' ' 92' ' ' LEU . 1.1 m -87.16 -19.98 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.737 -1.227 . . . . 0.0 110.681 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.717 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -70.17 -42.27 72.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.625 -1.297 . . . . 0.0 108.13 179.004 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.52 -55.66 37.85 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.603 -1.311 . . . . 0.0 110.692 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 24.4 Cg_endo -72.17 -16.7 28.34 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 N-CA-C 109.669 -0.935 . . . . 0.0 109.669 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.917 HD12 HG23 ' A' ' 88' ' ' VAL . 30.6 mt -86.85 -47.06 9.36 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.717 ' CE1' HG23 ' A' ' 89' ' ' THR . 6.5 m-30 -58.56 -49.18 78.37 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 120.928 -1.108 . . . . 0.0 108.98 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -69.07 -33.09 73.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.061 -1.024 . . . . 0.0 109.015 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.456 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -67.86 -30.16 74.17 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.795 HG11 ' HD1' ' A' ' 29' ' ' PHE . 2.1 t -107.45 9.71 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 121.086 -1.243 . . . . 0.0 108.784 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.482 ' CG ' ' O ' ' A' ' 93' ' ' PHE . 14.6 mt-30 -112.79 15.23 19.91 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.073 -1.017 . . . . 0.0 110.567 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 7.0 mttt 178.97 -49.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.591 -1.318 . . . . 0.0 110.913 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -67.7 -38.16 83.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.561 -1.337 . . . . 0.0 110.048 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 67.24 13.57 9.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -0.832 . . . . 0.0 109.55 -179.412 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.447 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 42.5 p -79.79 -9.91 59.72 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.811 0.815 . . . . 0.0 109.048 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.897 HG22 HD11 ' A' ' 68' ' ' LEU . 5.5 mm -86.99 75.65 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.699 -0.626 . . . . 0.0 109.574 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.564 ' CA ' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -132.27 27.25 4.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 109.308 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 107' ' ' ASP . 7.9 p -147.8 127.07 13.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 109.856 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.653 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.23 -42.81 41.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.1 p -54.36 -31.34 54.34 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 104' ' ' SER . 14.2 m-20 -74.88 -38.02 62.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.236 -0.915 . . . . 0.0 108.969 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.865 HD11 ' O ' ' A' ' 68' ' ' LEU . 31.0 mt -55.98 -27.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -38.54 57.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.9 -49.68 70.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.0 109.197 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.855 HG11 ' HG ' ' A' ' 92' ' ' LEU . 47.2 t -68.25 -37.78 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.479 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.677 ' CD1' HG11 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -58.74 -37.57 76.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.917 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.9 mt -78.99 -27.0 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.157 -0.964 . . . . 0.0 110.313 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -65.55 -16.7 63.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.912 -1.118 . . . . 0.0 109.572 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 87' ' ' LYS . . . -87.94 -1.57 58.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.783 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.0 -3.91 65.01 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.3 mp -87.67 61.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 108.928 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -36.6 154.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.879 -1.138 . . . . 0.0 110.426 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.13 -22.25 35.28 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.16 -54.41 47.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -1.191 . . . . 0.0 109.439 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -42.19 55.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.922 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.742 ' CE2' HG11 ' A' ' 78' ' ' VAL . 7.1 t80 -59.68 -48.12 82.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.139 -0.975 . . . . 0.0 109.716 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.54 -39.91 94.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.115 -0.99 . . . . 0.0 109.182 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 128' ' ' SER . . . -55.73 -53.36 57.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.364 -0.835 . . . . 0.0 109.408 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 1.026 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -56.46 -55.47 33.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.42 -0.8 . . . . 0.0 108.856 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.567 ' CE3' ' O ' ' A' ' 126' ' ' TRP . 0.7 OUTLIER -48.77 -54.11 16.39 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -14.82 63.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.686 -0.634 . . . . 0.0 109.845 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 67.7 m -68.9 -179.24 1.41 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.066 -1.021 . . . . 0.0 110.135 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.7 -35.71 13.33 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.555 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.76 -46.61 60.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.36 -1.336 . . . . 0.0 110.171 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 1.026 HG21 ' HB1' ' A' ' 125' ' ' ALA . 3.0 t -66.57 -35.37 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.732 -1.23 . . . . 0.0 108.63 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -67.1 -38.74 86.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -39.53 94.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 108.974 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 77' ' ' ALA . 4.8 tp -75.64 -25.13 56.58 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.513 HG11 ' CZ3' ' A' ' 126' ' ' TRP . 11.6 t -73.96 -41.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.84 -37.05 85.95 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.03 -31.27 71.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.446 -0.784 . . . . 0.0 108.886 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.515 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 2.6 mt-30 -66.89 -61.41 1.96 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.415 -0.803 . . . . 0.0 108.852 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.92 -33.41 37.08 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -76.48 -28.34 56.45 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.604 -0.685 . . . . 0.0 109.335 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.845 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -63.54 -57.5 9.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -72.84 -31.31 64.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.887 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.27 -23.24 43.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.165 -0.959 . . . . 0.0 110.222 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 140' ' ' LYS . 76.1 m-20 -81.12 -44.42 17.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.08 -1.012 . . . . 0.0 108.49 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 1.03 HG21 ' CE2' ' A' ' 25' ' ' PHE . 31.7 m -95.58 -8.35 9.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 1.1 mm-40 78.12 -52.5 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.449 -0.782 . . . . 0.0 109.397 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.605 HD13 ' CD2' ' A' ' 25' ' ' PHE . 27.1 tp 68.39 129.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.876 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.59 41.51 0.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.589 -1.319 . . . . 0.0 109.568 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 172.28 105.27 0.18 Allowed Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.068 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 1.049 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -105.05 141.55 22.81 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.391 -1.064 . . . . 0.0 109.817 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.52 152.74 96.18 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 123.572 -1.428 . . . . 0.0 110.208 0.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -134.68 159.38 41.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.241 -1.537 . . . . 0.0 109.394 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.514 ' SD ' HD12 ' A' ' 161' ' ' LEU . 2.1 ttm -154.0 131.22 11.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.942 . . . . 0.0 109.851 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 160' ' ' GLN . 6.1 m-85 -124.76 133.7 53.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.156 -0.965 . . . . 0.0 110.026 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 21' ' ' GLN . 48.2 t -96.2 132.34 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.361 -0.837 . . . . 0.0 110.287 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.539 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 1.2 m-20 48.48 21.23 0.37 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.826 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 55.86 55.53 28.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -164.71 -34.87 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.357 -1.084 . . . . 0.0 108.355 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.415 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 72.7 m-85 -114.57 118.25 33.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.221 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.431 ' HB2' ' CD1' ' A' ' 154' ' ' PHE . 23.6 tt0 -104.29 109.04 20.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.282 -0.886 . . . . 0.0 109.574 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.642 HD13 ' CZ ' ' A' ' 178' ' ' TYR . 30.0 mt -59.89 169.78 1.36 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -151.78 87.29 4.43 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.055 -1.028 . . . . 0.0 109.463 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . 35.8 Cg_endo . . . . . 0 C--N 1.307 -1.613 0 C-N-CA 122.603 2.202 . . . . 0.0 110.502 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.7 mtt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.708 0.766 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -70.7 -44.46 66.91 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.633 -0.667 . . . . 0.0 109.223 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.8 t -73.46 -25.04 20.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.217 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 163' ' ' PRO . 4.1 t80 -69.16 -46.48 67.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 0.0 109.063 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 42' ' ' ILE . 45.5 t -71.55 -24.54 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.568 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -83.14 -55.36 4.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.423 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -39.17 93.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.95 -1.094 . . . . 0.0 108.786 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.642 ' CZ ' HD13 ' A' ' 161' ' ' LEU . 63.4 t80 -65.2 -43.52 91.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.376 -0.827 . . . . 0.0 108.891 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.86 -31.77 65.14 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.021 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.61 -38.62 54.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.317 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.649 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -62.5 -30.34 71.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.239 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 58.1 t -86.03 -33.69 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.191 -0.943 . . . . 0.0 108.636 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.81 -48.55 81.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 108.885 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.76 -32.26 52.53 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.184 -0.947 . . . . 0.0 108.886 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 181' ' ' THR . 0.9 OUTLIER -64.32 -17.06 63.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.877 -1.14 . . . . 0.0 109.138 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.812 ' HB2' HG13 ' A' ' 54' ' ' VAL . 24.9 p -74.02 -10.46 59.65 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.909 -1.119 . . . . 0.0 108.569 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.486 1.361 0 O-C-N 121.477 -0.764 . . . . 0.0 109.441 179.895 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -114.84 61.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.292 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.4 t70 53.72 86.0 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.506 -0.746 . . . . 0.0 109.6 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 120.62 -22.9 8.09 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.173 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -69.83 0.58 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.981 -1.305 . . . . 0.0 108.505 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 1.6 mp0 -114.8 19.02 16.23 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.333 -0.854 . . . . 0.0 109.432 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.697 ' HB2' HD23 ' A' ' 161' ' ' LEU . 0.8 OUTLIER 177.94 129.92 0.06 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.225 -0.922 . . . . 0.0 109.063 179.287 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -126.14 176.66 6.89 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.53 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 158' ' ' LYS . 24.9 m -104.14 149.47 25.22 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.472 0.653 . . . . 0.0 109.71 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.4 OUTLIER -89.46 149.52 22.9 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.431 -0.793 . . . . 0.0 109.658 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -70.58 -23.19 62.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.009 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -122.62 102.16 39.2 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.82 164.54 29.9 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.474 2.116 . . . . 0.0 111.118 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.878 HG21 ' OD1' ' A' ' 144' ' ' ASP . 37.7 t -129.1 76.68 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 109.562 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.45 133.18 5.78 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.46 -25.06 26.39 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.669 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -41.09 162.87 0.11 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.521 -0.987 . . . . 0.0 109.627 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.607 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 33.0 Cg_endo -75.8 125.82 9.04 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.589 2.193 . . . . 0.0 111.449 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.762 ' O ' HG13 ' A' ' 155' ' ' VAL . 4.9 mm-40 -37.95 -25.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.848 -0.532 . . . . 0.0 110.854 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.674 ' O ' HG12 ' A' ' 22' ' ' VAL . 17.5 t -147.75 79.82 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.709 -1.244 . . . . 0.0 109.139 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.642 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -82.14 124.82 30.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.528 ' HG3' ' HA ' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -123.71 108.47 12.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.027 -1.046 . . . . 0.0 109.222 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.642 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 7.6 m-85 -88.27 126.53 35.21 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.411 0.624 . . . . 0.0 110.035 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -155.16 142.1 19.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 109.69 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.752 ' CB ' HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -126.32 161.94 26.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.224 -0.922 . . . . 0.0 109.129 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.678 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -83.74 48.13 1.39 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 0.0 108.817 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.723 ' CD1' ' HE3' ' A' ' 64' ' ' MET . 6.3 m-85 -135.47 5.77 3.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.373 -0.829 . . . . 0.0 110.016 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.524 ' HB3' ' NE2' ' A' ' 32' ' ' HIS . 90.9 m -108.69 155.38 40.71 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 118.688 -1.205 . . . . 0.0 109.23 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -73.68 -28.9 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.079 1.853 . . . . 0.0 108.192 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 36' ' ' PHE . 2.5 p-80 -86.15 -20.76 28.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 14.7 t -47.31 -63.29 1.08 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.538 ' CE2' ' CD ' ' A' ' 38' ' ' GLU . 35.6 t80 -59.62 -54.5 45.78 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.475 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 1.5 mt-30 -56.52 -25.51 51.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.22 -0.925 . . . . 0.0 109.786 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.639 ' CE1' HG21 ' A' ' 42' ' ' ILE . 35.5 t80 -84.49 -25.43 28.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 110.672 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.531 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 3.6 tt0 -125.81 51.46 1.74 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.842 -1.161 . . . . 0.0 110.16 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.538 ' CD ' ' CE2' ' A' ' 34' ' ' TYR . 1.1 mt-10 -171.06 -57.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.083 -1.011 . . . . 0.0 110.706 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.1 t -102.07 -58.76 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.924 -1.11 . . . . 0.0 110.917 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 35' ' ' GLN . 64.4 mt -46.43 -22.75 0.29 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.034 -1.041 . . . . 0.0 110.408 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 17.9 m80 57.07 16.97 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.036 -1.04 . . . . 0.0 109.522 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.639 HG21 ' CE1' ' A' ' 36' ' ' PHE . 23.0 mt -64.04 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 109.358 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.85 -31.68 35.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.447 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.31 -27.51 32.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.922 -1.111 . . . . 0.0 110.061 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 36.8 t30 -80.44 -40.05 27.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.965 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 p -65.72 -25.32 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.528 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.458 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 1.0 OUTLIER -68.76 -20.41 64.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.637 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -76.8 -20.76 56.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.142 -0.974 . . . . 0.0 109.62 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.454 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 4.1 mttt -105.65 3.86 29.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 0.0 109.842 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.458 ' HG ' ' HA ' ' A' ' 47' ' ' LYS . 14.4 mt -42.73 102.61 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 109.692 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' ' CG2' ' A' ' 54' ' ' VAL . 34.6 Cg_endo -77.74 127.98 9.07 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.339 2.026 . . . . 0.0 110.605 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.89 116.97 2.03 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.139 0.971 . . . . 0.0 109.233 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.53 -20.28 10.29 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.665 ' O ' HG12 ' A' ' 54' ' ' VAL . 2.6 t -93.39 91.8 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -1.204 . . . . 0.0 109.051 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -75.19 102.09 4.85 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.508 -0.745 . . . . 0.0 109.769 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.529 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 15.1 ttp -89.93 99.92 12.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.563 -0.711 . . . . 0.0 109.483 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.455 ' O ' ' CG ' ' A' ' 24' ' ' GLU . 7.4 m -96.28 139.12 32.88 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.402 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -113.55 109.77 19.18 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.49 -0.756 . . . . 0.0 109.054 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.574 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 3.2 m-85 -110.28 168.72 9.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.839 -1.163 . . . . 0.0 110.562 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.577 ' NE2' ' CD2' ' A' ' 72' ' ' LEU . 55.9 t-80 -97.99 153.25 18.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.899 HG11 HG11 ' A' ' 150' ' ' VAL . 2.1 m -90.62 155.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.606 0.717 . . . . 0.0 110.485 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -124.5 28.58 6.57 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.575 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 12.8 p90 -130.87 61.57 1.62 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.018 -1.051 . . . . 0.0 110.185 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.723 ' HE3' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -160.17 -61.43 0.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.58 ' N ' ' HG2' ' A' ' 64' ' ' MET . . . -87.4 82.11 1.61 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -39.94 -51.04 3.4 Favored Glycine 0 N--CA 1.489 2.22 0 O-C-N 121.473 -1.016 . . . . 0.0 110.916 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -87.74 -78.53 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.023 -1.28 . . . . 0.0 111.168 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.076 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -71.97 -23.88 61.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.854 -1.154 . . . . 0.0 110.026 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 1.076 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -50.34 -60.4 6.79 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -48.33 -45.17 34.85 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.958 -1.319 . . . . 0.0 108.31 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -65.37 -31.14 72.1 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.749 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 44.5 tp -57.72 -42.74 84.44 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.6 m -61.53 -41.4 97.27 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.97 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -58.4 -21.07 49.21 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -70.22 -45.75 65.9 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 28.4 t-105 -55.31 -30.71 60.73 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.555 ' HB2' ' OE1' ' A' ' 138' ' ' GLN . . . -86.5 -65.36 1.02 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 110.134 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.97 HG23 ' O ' ' A' ' 74' ' ' GLN . 2.7 t -48.15 -28.16 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 109.945 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.482 ' HB2' ' HZ ' ' A' ' 112' ' ' PHE . . . -85.29 -59.3 2.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.83 -1.169 . . . . 0.0 108.982 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ALA . 8.0 tpt -47.11 -27.98 1.6 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.854 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -73.86 -38.33 64.49 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.54 -0.725 . . . . 0.0 109.443 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 125' ' ' ALA . 52.3 mt -99.56 5.23 46.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.113 -0.992 . . . . 0.0 110.403 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.28 20.09 27.64 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.857 HG11 HG12 ' A' ' 117' ' ' ILE . 35.4 m -89.25 -4.1 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.391 -1.064 . . . . 0.0 110.432 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -45.38 -68.15 0.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.072 -1.018 . . . . 0.0 109.439 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.13 -34.57 0.18 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 110.21 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.943 ' HE2' ' HB1' ' A' ' 115' ' ' ALA . 12.1 mtpt -83.05 -51.22 7.74 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.264 -0.898 . . . . 0.0 110.969 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.867 HG23 HD12 ' A' ' 92' ' ' LEU . 1.2 m -80.97 -17.59 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.773 -1.204 . . . . 0.0 110.505 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.804 HG23 ' CD1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -69.43 -43.39 73.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 108.74 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.78 -55.39 38.82 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.548 -1.345 . . . . 0.0 110.531 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.521 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 25.8 Cg_endo -72.47 -18.07 26.33 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 N-CA-C 109.909 -0.843 . . . . 0.0 109.909 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.894 ' HG ' HG11 ' A' ' 111' ' ' VAL . 21.8 mt -87.05 -43.94 11.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 108.949 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.804 ' CD1' HG23 ' A' ' 89' ' ' THR . 4.2 m-30 -63.68 -46.62 84.72 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.926 -1.109 . . . . 0.0 109.027 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -16.74 61.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.98 . . . . 0.0 109.238 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.454 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -76.44 -30.63 56.37 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 92' ' ' LEU . 1.1 t -105.71 -2.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.068 -1.254 . . . . 0.0 109.444 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.49 ' HG2' ' HB2' ' A' ' 34' ' ' TYR . 2.0 mp0 -113.33 10.98 18.49 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 120.827 -1.171 . . . . 0.0 111.073 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 99' ' ' THR . 0.7 OUTLIER -177.39 58.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.496 -1.378 . . . . 0.0 109.992 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.933 ' CG2' HG23 ' A' ' 101' ' ' THR . 1.0 OUTLIER 168.13 -48.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 99' ' ' THR . 1.5 mt-30 80.11 20.97 0.54 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.752 -1.217 . . . . 0.0 111.366 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.933 HG23 ' CG2' ' A' ' 99' ' ' THR . 26.1 p -84.01 -8.91 59.01 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.303 -0.873 . . . . 0.0 109.107 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.6 ' CB ' HG22 ' A' ' 96' ' ' VAL . 5.2 mm -91.81 82.97 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.69 -0.631 . . . . 0.0 109.35 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.521 ' N ' ' HD3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -146.36 29.6 1.05 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 109.409 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.536 ' CA ' ' HB3' ' A' ' 68' ' ' LEU . 1.1 p -155.43 132.38 10.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.943 . . . . 0.0 110.025 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.776 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -50.41 -32.56 17.97 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 m -62.9 -32.79 74.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -69.81 -50.3 44.24 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.776 HD12 ' HA ' ' A' ' 105' ' ' ALA . 27.0 mt -49.72 -29.36 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.614 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.423 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -78.5 -29.05 46.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.332 -0.855 . . . . 0.0 109.318 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -64.91 -46.32 82.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.238 -0.914 . . . . 0.0 109.302 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.894 HG11 ' HG ' ' A' ' 92' ' ' LEU . 61.4 t -71.87 -37.9 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.453 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.482 ' HZ ' ' HB2' ' A' ' 79' ' ' ALA . 1.0 OUTLIER -61.03 -36.3 79.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.925 . . . . 0.0 109.655 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.842 HG23 ' HA ' ' A' ' 118' ' ' LYS . 15.1 mt -79.67 -25.49 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.996 . . . . 0.0 110.227 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -64.09 -23.35 67.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.421 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.943 ' HB1' ' HE2' ' A' ' 87' ' ' LYS . . . -85.65 2.16 46.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 109.62 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.431 ' C ' HD12 ' A' ' 117' ' ' ILE . . . 96.45 -2.24 62.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.857 HG12 HG11 ' A' ' 84' ' ' VAL . 1.4 mp -90.33 60.66 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.121 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.842 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.4 OUTLIER -34.18 152.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -0.964 . . . . 0.0 110.681 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.52 -27.37 41.31 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.7 -47.22 86.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -1.172 . . . . 0.0 109.081 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -75.94 -40.87 53.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 109.221 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.85 ' CE2' HG11 ' A' ' 78' ' ' VAL . 3.9 t80 -58.92 -47.36 85.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.851 . . . . 0.0 109.286 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.47 -34.51 77.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.244 -0.91 . . . . 0.0 109.013 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.68 -51.37 67.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.307 -0.871 . . . . 0.0 108.919 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.584 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -55.77 -49.36 73.35 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.385 -0.822 . . . . 0.0 108.955 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.42 ' CG ' ' OE1' ' A' ' 74' ' ' GLN . 12.7 t90 -57.49 -55.06 39.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.346 -0.846 . . . . 0.0 108.832 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -54.45 -16.16 2.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.474 -0.766 . . . . 0.0 109.821 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.419 ' OG ' HG23 ' A' ' 131' ' ' VAL . 1.0 OUTLIER -67.71 -179.21 1.07 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 109.571 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.9 -36.28 13.55 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.45 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.6 t -73.81 -47.9 41.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 118.225 -1.39 . . . . 0.0 110.057 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.854 HG22 ' HB1' ' A' ' 81' ' ' ALA . 3.1 t -61.82 -40.56 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.771 -1.206 . . . . 0.0 108.411 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 132' ' ' LYS . 2.6 ttmm -64.87 -28.13 69.33 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.514 -0.741 . . . . 0.0 109.131 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.5 t -69.79 -37.93 76.5 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.348 -0.845 . . . . 0.0 109.241 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.91 -17.13 59.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.187 -0.946 . . . . 0.0 108.485 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.28 -43.84 43.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -68.51 -46.98 68.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -58.15 -33.33 69.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.082 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.574 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -69.74 -74.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 0.0 109.407 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.8 mt-10 -45.58 -36.39 4.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.822 . . . . 0.0 108.932 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -72.63 -35.53 67.82 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.259 -0.901 . . . . 0.0 108.668 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.478 ' O ' ' OD2' ' A' ' 144' ' ' ASP . . . -53.09 -62.6 1.55 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.487 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -60.93 -25.14 66.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.267 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 140' ' ' LYS . . . -78.67 -25.68 44.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.878 ' OD1' HG21 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -78.85 -48.32 14.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.07 -1.019 . . . . 0.0 108.342 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.84 HG13 ' OD1' ' A' ' 144' ' ' ASP . 27.4 m -89.83 -11.43 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.544 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.4 OUTLIER 80.87 -47.27 0.26 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.494 -0.754 . . . . 0.0 109.827 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.553 HD21 HG12 ' A' ' 61' ' ' VAL . 36.0 tp 61.77 130.08 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.35 -0.843 . . . . 0.0 109.102 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -160.96 40.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.525 -1.36 . . . . 0.0 109.94 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 165.14 107.96 0.21 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.899 HG11 HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -99.42 143.45 26.44 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.294 -1.121 . . . . 0.0 109.769 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.521 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 35.1 Cg_endo -76.71 152.01 95.02 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 123.997 -1.251 . . . . 0.0 110.136 0.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -132.84 137.62 46.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.225 -1.547 . . . . 0.0 109.416 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.527 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 2.8 ttp -129.14 130.59 46.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.112 -0.992 . . . . 0.0 110.18 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.532 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 8.5 m-85 -127.55 129.73 47.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.307 -0.871 . . . . 0.0 109.792 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 21' ' ' GLN . 54.3 t -96.76 131.46 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 110.057 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.669 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.9 OUTLIER 44.9 23.58 0.09 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.353 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.576 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 55.4 57.67 17.51 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.528 ' HB3' ' CD1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -164.72 -36.38 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.528 ' CD1' ' HB3' ' A' ' 158' ' ' LYS . 11.7 m-85 -117.45 123.03 45.38 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.511 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -125.42 120.78 31.97 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.975 -1.078 . . . . 0.0 109.81 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.697 HD23 ' HB2' ' A' ' 9' ' ' TYR . 17.2 mt -65.33 177.36 1.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.555 -0.716 . . . . 0.0 109.152 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.549 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 50.9 t-20 -137.58 60.27 24.78 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.723 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 162' ' ' ASN . 35.5 Cg_endo . . . . . 0 C--N 1.309 -1.528 0 C-N-CA 122.635 2.224 . . . . 0.0 110.397 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 34.6 mtt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.693 0.759 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.07 -46.76 89.34 Favored 'General case' 0 C--N 1.293 -1.891 0 O-C-N 121.639 -0.663 . . . . 0.0 109.499 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.3 t -67.0 -28.14 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.36 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -66.85 -40.41 87.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.216 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.515 HG22 ' CG1' ' A' ' 42' ' ' ILE . 39.6 t -75.27 -27.42 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.173 -0.955 . . . . 0.0 109.458 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.15 -56.16 4.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.972 . . . . 0.0 109.246 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -55.74 -33.25 64.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.15 -0.969 . . . . 0.0 109.151 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 178' ' ' TYR . 13.5 t80 -70.5 -53.11 17.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -0.951 . . . . 0.0 109.479 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.5 -31.84 71.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.556 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -76.81 -50.25 13.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.746 ' O ' HD23 ' A' ' 185' ' ' LEU . 20.6 m -54.39 -24.15 18.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.246 -0.909 . . . . 0.0 109.527 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.463 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 25.0 t -86.16 -40.29 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.031 -1.043 . . . . 0.0 109.174 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -55.18 -45.6 75.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.178 -0.952 . . . . 0.0 109.094 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.516 ' CE2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -81.75 -36.66 28.3 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.34 -0.85 . . . . 0.0 109.233 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.746 HD23 ' O ' ' A' ' 181' ' ' THR . 0.7 OUTLIER -54.05 -20.2 6.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.886 -1.133 . . . . 0.0 109.875 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.619 ' HB3' HG21 ' A' ' 54' ' ' VAL . 64.9 p -63.91 -13.49 45.98 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.709 -1.244 . . . . 0.0 108.054 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.553 -0.717 . . . . 0.0 109.31 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -111.3 59.16 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.012 -1.055 . . . . 0.0 109.593 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 45.64 83.92 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.509 -0.744 . . . . 0.0 109.893 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 136.74 -33.01 2.39 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.084 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.79 -72.63 0.45 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -1.18 . . . . 0.0 109.398 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.783 ' HB3' HG21 ' A' ' 181' ' ' THR . 8.5 mm-40 -87.88 -4.24 58.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.816 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 24.0 p90 177.15 130.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.236 -0.915 . . . . 0.0 109.14 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -106.31 -179.92 4.08 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 m -103.13 159.61 15.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.639 -0.663 . . . . 0.0 109.533 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.777 HD21 ' CE2' ' A' ' 154' ' ' PHE . 15.3 mt -95.98 154.86 17.01 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.357 -0.839 . . . . 0.0 109.748 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.28 -12.67 40.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.448 -0.783 . . . . 0.0 108.982 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 100.74 3.98 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 109.222 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.19 160.9 35.86 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.39 2.06 . . . . 0.0 110.703 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.906 HG13 ' CB ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -121.31 98.63 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 109.595 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.77 126.94 6.0 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 99.13 -21.57 45.13 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.906 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -40.9 157.06 0.19 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.987 . . . . 0.0 109.513 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.572 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.8 Cg_endo -79.83 139.59 14.0 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.725 2.283 . . . . 0.0 111.659 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.801 ' O ' HG13 ' A' ' 155' ' ' VAL . 2.8 mm-40 -51.65 -20.52 2.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.537 -0.727 . . . . 0.0 109.099 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 53.9 t -151.62 82.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.209 -0.932 . . . . 0.0 108.759 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.716 HD12 HG11 ' A' ' 145' ' ' VAL . 0.0 OUTLIER -74.49 126.88 31.71 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.548 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -110.18 127.33 54.88 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.039 -1.038 . . . . 0.0 109.764 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.61 ' CE2' HD13 ' A' ' 23' ' ' LEU . 3.1 m-85 -124.79 108.84 12.37 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.478 -0.764 . . . . 0.0 109.428 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -152.67 145.3 24.22 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.343 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.607 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -128.72 -164.94 1.44 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.642 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -116.62 53.95 0.87 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.92 -1.112 . . . . 0.0 108.683 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' HD11 ' A' ' 72' ' ' LEU . 9.6 m-85 -133.88 -5.33 2.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.019 -1.05 . . . . 0.0 110.64 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.498 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 0.2 OUTLIER -106.28 171.8 4.48 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.8 -1.188 . . . . 0.0 109.433 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 30' ' ' CYS . 33.5 Cg_endo -75.15 -38.87 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.294 1.996 . . . . 0.0 109.113 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.528 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.5 m80 -84.61 -20.7 30.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -52.56 -40.52 62.64 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.563 ' CE2' ' OE1' ' A' ' 38' ' ' GLU . 40.2 t80 -87.25 -47.45 8.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.69 -0.632 . . . . 0.0 109.619 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -66.18 -21.75 66.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 109.905 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.576 ' CE1' HG21 ' A' ' 42' ' ' ILE . 89.1 t80 -83.06 -16.74 45.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.592 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.552 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -132.79 50.77 2.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.77 -1.206 . . . . 0.0 110.636 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.563 ' OE1' ' CE2' ' A' ' 34' ' ' TYR . 1.0 OUTLIER -175.41 -59.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.192 -0.943 . . . . 0.0 110.216 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.6 t -89.99 -46.91 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.204 -0.935 . . . . 0.0 110.733 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 41' ' ' HIS . 77.8 mt -65.99 -6.0 11.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.022 -1.049 . . . . 0.0 110.561 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.446 ' HA ' ' OD1' ' A' ' 44' ' ' ASP . 50.5 m170 44.03 27.0 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.992 -1.067 . . . . 0.0 109.163 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.576 HG21 ' CE1' ' A' ' 36' ' ' PHE . 15.6 mt -78.43 -22.57 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.821 . . . . 0.0 109.957 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.691 ' O ' HG12 ' A' ' 46' ' ' VAL . 47.2 m -80.65 -26.67 37.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.976 -1.078 . . . . 0.0 110.333 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.446 ' OD1' ' HA ' ' A' ' 41' ' ' HIS . 1.9 p-10 -87.44 -49.86 6.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.976 -1.078 . . . . 0.0 110.117 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 46' ' ' VAL . 39.1 p-10 -59.72 -25.26 64.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.214 -0.929 . . . . 0.0 110.028 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 43' ' ' SER . 9.4 p -65.27 -26.75 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 109.958 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.802 ' HA ' HD12 ' A' ' 50' ' ' LEU . 3.8 mttt -77.05 -38.29 53.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 109.969 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.48 -23.92 1.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.062 -1.023 . . . . 0.0 109.468 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.6 33.25 5.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.352 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.802 HD12 ' HA ' ' A' ' 47' ' ' LYS . 13.8 mt -114.79 81.79 7.62 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.872 . . . . 0.0 109.198 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.753 ' HD2' HG21 ' A' ' 54' ' ' VAL . 35.6 Cg_endo -77.5 143.85 22.1 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.584 2.189 . . . . 0.0 110.566 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 51' ' ' PRO . 3.5 tm-20 -40.61 120.88 1.34 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 122.361 1.077 . . . . 0.0 109.233 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.39 -28.5 4.76 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.753 HG21 ' HD2' ' A' ' 51' ' ' PRO . 31.9 t -86.37 79.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -1.076 . . . . 0.0 108.849 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -61.07 101.67 0.17 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.422 -0.799 . . . . 0.0 110.528 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.672 ' SD ' HD11 ' A' ' 50' ' ' LEU . 7.9 ttt -100.67 97.68 8.32 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.493 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 1.6 m -94.68 123.5 38.16 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.325 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.548 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 3.1 tppt? -99.63 121.65 41.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.398 -0.814 . . . . 0.0 109.546 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.593 ' CE1' ' HG2' ' A' ' 138' ' ' GLN . 2.0 m-85 -126.05 174.78 8.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.854 -1.154 . . . . 0.0 111.174 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.741 ' NE2' HD22 ' A' ' 72' ' ' LEU . 22.4 t60 -112.04 145.86 38.95 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.841 0.829 . . . . 0.0 109.378 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.078 HG11 ' CG1' ' A' ' 150' ' ' VAL . 8.4 m -80.86 155.73 4.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.325 0.583 . . . . 0.0 109.985 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . 52.0 p30 -121.02 38.81 3.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.142 -0.973 . . . . 0.0 109.604 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 2.4 p90 -139.34 57.11 1.66 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.163 -0.96 . . . . 0.0 109.611 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.515 ' CE ' ' CG2' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -125.79 35.23 4.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.134 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.83 -30.83 1.23 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.379 -1.889 . . . . 0.0 108.379 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.46 -35.02 3.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.7 -79.45 0.29 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.74 -1.447 . . . . 0.0 109.939 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.903 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -76.6 -19.14 58.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 108.85 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.564 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -53.48 -54.46 29.91 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -52.99 -41.91 65.06 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.602 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.77 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 45.5 t0 -65.76 -31.39 72.35 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.762 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -59.05 -36.08 74.43 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.665 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.582 HG23 ' OE1' ' A' ' 138' ' ' GLN . 45.7 m -66.64 -41.74 87.8 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -63.83 -16.43 61.27 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -71.28 -40.6 70.81 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 20.0 t-105 -68.85 -31.35 70.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.61 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -81.0 -62.48 1.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.577 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.146 HG11 ' CD2' ' A' ' 122' ' ' TYR . 59.9 t -48.33 -29.1 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.949 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.516 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -84.03 -60.52 2.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.885 -1.134 . . . . 0.0 108.875 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.584 ' HB3' HD22 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -44.5 -28.8 0.62 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.264 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.73 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -71.45 -44.48 64.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.805 . . . . 0.0 109.572 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.552 ' HB2' HG13 ' A' ' 84' ' ' VAL . 5.8 mt -99.97 11.18 39.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.037 -1.04 . . . . 0.0 110.004 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.38 22.02 6.95 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 82' ' ' LEU . 34.0 m -85.19 -7.81 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -1.076 . . . . 0.0 110.138 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -41.17 -60.3 1.27 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -33.43 7.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 110.345 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -83.29 -52.53 6.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.171 -0.956 . . . . 0.0 111.696 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.919 HG23 HD12 ' A' ' 92' ' ' LEU . 1.2 m -77.68 -10.06 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.586 -1.321 . . . . 0.0 110.249 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.713 HG23 ' CD1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -70.88 -44.69 65.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.851 -1.155 . . . . 0.0 108.889 179.233 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.403 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -53.17 -54.77 40.92 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.448 -1.408 . . . . 0.0 110.477 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.579 ' HB2' HG13 ' A' ' 111' ' ' VAL . 24.7 Cg_endo -72.8 -18.63 24.68 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 122.639 0.81 . . . . 0.0 109.995 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.919 HD12 HG23 ' A' ' 88' ' ' VAL . 15.0 mt -86.16 -41.75 14.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.235 -0.916 . . . . 0.0 109.09 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.713 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.8 m-30 -66.25 -47.61 73.19 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.056 -1.027 . . . . 0.0 109.007 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -31.96 70.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.935 -1.103 . . . . 0.0 109.322 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.464 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -63.06 -32.7 85.04 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.664 HG11 ' CD1' ' A' ' 29' ' ' PHE . 2.0 t -107.19 5.76 9.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.105 -1.232 . . . . 0.0 109.206 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.533 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -107.78 10.69 28.71 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.981 -1.074 . . . . 0.0 110.579 -179.187 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER 176.08 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.519 -1.363 . . . . 0.0 110.144 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 43.0 p -56.62 -44.66 81.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.489 -1.382 . . . . 0.0 109.114 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 99' ' ' THR . 38.2 mt-30 70.42 10.83 7.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.425 -0.797 . . . . 0.0 110.085 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 t -83.27 -5.28 59.08 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.734 0.778 . . . . 0.0 109.143 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.513 ' CB ' HG22 ' A' ' 96' ' ' VAL . 12.9 mm -84.57 80.51 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.69 33.38 1.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 110.021 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.544 ' O ' ' N ' ' A' ' 107' ' ' ASP . 1.7 p -161.47 133.78 5.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.953 -1.092 . . . . 0.0 109.893 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.77 ' HB1' ' OD2' ' A' ' 71' ' ' ASP . . . -51.51 -32.62 28.3 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 104' ' ' SER . 5.5 p -61.85 -31.46 71.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -72.02 -49.54 36.07 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.77 HD11 HD23 ' A' ' 68' ' ' LEU . 26.9 mt -52.01 -30.9 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.401 ' O ' HG13 ' A' ' 113' ' ' ILE . 19.6 mtt-85 -74.11 -28.54 61.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 109.069 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -66.61 -48.15 70.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.339 -0.851 . . . . 0.0 109.374 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.859 HG11 ' HG ' ' A' ' 92' ' ' LEU . 49.1 t -65.83 -40.26 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.991 . . . . 0.0 109.507 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CE1' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -57.57 -43.84 84.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.946 -1.096 . . . . 0.0 109.379 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 109' ' ' ARG . 18.7 mt -68.35 -24.8 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 109.623 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -20.11 66.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 109.691 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.83 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -93.87 9.71 36.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.552 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.44 -5.57 84.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.832 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.6 mp -76.65 55.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -1.175 . . . . 0.0 109.032 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -33.01 149.17 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.347 -0.846 . . . . 0.0 110.743 -179.497 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 122' ' ' TYR . . . -51.8 -28.41 23.36 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -58.8 -47.56 84.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -1.155 . . . . 0.0 108.849 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -80.41 -34.51 36.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.401 -0.812 . . . . 0.0 109.705 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 1.146 ' CD2' HG11 ' A' ' 78' ' ' VAL . 3.5 t80 -64.17 -50.22 69.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 109.511 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.62 -35.19 75.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.013 -1.054 . . . . 0.0 108.713 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.6 -51.65 67.65 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.634 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -54.91 -52.06 64.12 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.533 ' C ' ' CD1' ' A' ' 126' ' ' TRP . 6.8 t90 -52.75 -55.61 21.59 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.14 -15.74 2.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.677 -0.639 . . . . 0.0 110.435 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -72.55 176.64 5.27 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.909 -1.119 . . . . 0.0 109.845 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -87.33 -39.0 15.73 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.179 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.43 -44.86 83.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 C-N-CA 118.254 -1.378 . . . . 0.0 109.789 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.73 HG22 ' HB1' ' A' ' 81' ' ' ALA . 2.8 t -67.02 -38.87 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.809 -1.182 . . . . 0.0 108.685 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -67.93 -29.37 68.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 137' ' ' GLN . 0.4 OUTLIER -70.89 -34.47 71.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.428 -0.795 . . . . 0.0 109.235 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.584 HD22 ' HB3' ' A' ' 80' ' ' MET . 0.0 OUTLIER -80.12 -21.41 43.24 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.277 -0.889 . . . . 0.0 108.617 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.61 HG23 ' HB1' ' A' ' 77' ' ' ALA . 17.9 t -81.48 -45.6 20.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.26 83.87 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -63.01 -32.83 74.28 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.593 ' HG2' ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -60.15 -69.56 0.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.436 -0.79 . . . . 0.0 109.073 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.548 ' OE2' ' HB2' ' A' ' 143' ' ' ALA . 6.3 tm-20 -48.61 -33.38 9.74 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 9.5 tttm -68.72 -40.78 79.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.426 -0.796 . . . . 0.0 109.038 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.472 ' O ' ' OD2' ' A' ' 144' ' ' ASP . . . -55.52 -55.32 33.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 108.618 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.53 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -70.15 -22.97 62.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.345 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.548 ' HB2' ' OE2' ' A' ' 139' ' ' GLU . . . -78.5 -26.51 45.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.069 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.793 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.4 p30 -82.8 -47.73 11.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.939 -1.1 . . . . 0.0 108.271 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.793 HG13 ' OD1' ' A' ' 144' ' ' ASP . 14.7 m -85.82 -17.05 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.8 OUTLIER 81.92 -47.54 0.2 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.449 0.643 . . . . 0.0 109.643 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.04 HD21 HG12 ' A' ' 61' ' ' VAL . 14.3 tp 67.33 131.63 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.449 -0.782 . . . . 0.0 109.421 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 148' ' ' ARG . 2.7 ptt85 -161.46 39.04 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.565 -1.335 . . . . 0.0 110.02 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 161.06 108.28 0.23 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.38 -1.39 . . . . 0.0 110.37 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 1.078 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -91.88 144.72 29.73 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.371 -1.076 . . . . 0.0 109.792 179.111 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.462 ' HG2' ' HG2' ' A' ' 163' ' ' PRO . 33.6 Cg_endo -77.09 152.23 94.54 Favored 'Cis proline' 0 C--N 1.317 -1.124 0 C-N-CA 124.1 -1.208 . . . . 0.0 110.501 0.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -126.63 152.26 46.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.426 -1.421 . . . . 0.0 109.353 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 2.6 tmm? -151.21 135.61 16.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.123 -0.986 . . . . 0.0 109.656 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.777 ' CE2' HD21 ' A' ' 12' ' ' LEU . 51.0 m-85 -137.1 124.54 22.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.418 -0.801 . . . . 0.0 110.311 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 21' ' ' GLN . 52.0 t -92.34 130.48 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.747 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.683 HD22 HG12 ' A' ' 155' ' ' VAL . 3.9 p30 45.55 22.42 0.1 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.046 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.82 56.56 24.64 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.519 ' N ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -165.77 -36.85 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.299 -1.118 . . . . 0.0 108.169 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.499 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 75.9 m-85 -115.34 123.44 48.73 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.534 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 20.8 pt20 -123.3 134.74 54.03 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.94 -1.1 . . . . 0.0 109.877 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.9 mt -70.95 177.83 3.48 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.451 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -147.76 65.95 9.43 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 120.878 -1.139 . . . . 0.0 110.02 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.462 ' HG2' ' HG2' ' A' ' 151' ' ' PRO . 36.0 Cg_endo . . . . . 0 C--N 1.308 -1.56 0 C-N-CA 122.575 2.183 . . . . 0.0 109.988 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 3.5 mtt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.676 0.75 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 173' ' ' VAL . 0.0 OUTLIER -75.43 -60.56 2.25 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 172' ' ' ASP . 4.9 t -64.69 -30.69 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.318 -0.864 . . . . 0.0 109.473 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -67.22 -45.32 77.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.665 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.428 HG22 ' CG1' ' A' ' 42' ' ' ILE . 70.7 t -73.63 -25.17 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.444 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.87 -57.53 3.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.526 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.97 -47.51 74.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.108 -0.995 . . . . 0.0 109.299 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 182' ' ' VAL . 31.9 t80 -59.15 -57.24 13.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.962 . . . . 0.0 109.128 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.13 -29.08 12.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.33 -0.856 . . . . 0.0 109.14 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -77.89 -47.0 19.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.334 -0.853 . . . . 0.0 109.202 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.783 HG21 ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -50.3 -32.83 18.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.349 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 178' ' ' TYR . 1.4 t -85.74 -37.62 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.981 . . . . 0.0 108.952 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.45 ' O ' ' OG ' ' A' ' 186' ' ' SER . 16.6 ttpt -60.38 -46.13 91.06 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.281 -0.887 . . . . 0.0 109.037 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -78.93 -27.15 43.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.233 -0.917 . . . . 0.0 108.98 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.663 HD23 ' O ' ' A' ' 181' ' ' THR . 0.3 OUTLIER -65.69 -19.59 65.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.863 -1.148 . . . . 0.0 108.925 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.492 ' HB2' HG22 ' A' ' 54' ' ' VAL . 15.0 p -77.88 -13.04 60.02 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.834 -1.166 . . . . 0.0 108.745 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 O-C-N 121.307 -0.871 . . . . 0.0 109.329 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.633 ' HB3' ' HB2' ' A' ' 8' ' ' GLN . 4.3 p90 . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.432 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 4.7 mt-10 -114.94 64.57 0.68 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.826 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 4.0 m-20 70.18 96.74 0.07 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.307 -0.871 . . . . 0.0 110.473 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.15 -3.4 81.02 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -100.48 26.98 6.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -1.172 . . . . 0.0 108.533 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' A' ' 3' ' ' TYR . 0.9 OUTLIER 150.42 -35.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.598 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -156.98 131.25 8.49 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.669 -1.269 . . . . 0.0 109.796 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 t -114.44 174.99 5.68 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.59 152.28 20.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.653 -0.655 . . . . 0.0 109.707 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.496 ' HG ' ' HG2' ' A' ' 160' ' ' GLN . 1.4 mt -92.56 161.31 14.65 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.396 -0.815 . . . . 0.0 109.517 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -84.93 -18.72 33.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.171 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -140.34 110.17 6.93 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.366 -0.833 . . . . 0.0 108.899 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 36.2 Cg_endo -77.22 167.9 24.0 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.352 2.034 . . . . 0.0 111.29 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.692 HG21 ' HB3' ' A' ' 144' ' ' ASP . 7.7 t -128.19 93.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.93 127.54 16.61 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 97.63 -20.8 49.21 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -40.01 159.52 0.13 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.928 . . . . 0.0 109.347 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.587 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 34.9 Cg_endo -77.52 128.26 9.42 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.459 2.106 . . . . 0.0 111.35 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.859 ' O ' HG13 ' A' ' 155' ' ' VAL . 10.3 mp0 -41.4 -25.56 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.529 -0.732 . . . . 0.0 109.724 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.644 ' O ' HG12 ' A' ' 22' ' ' VAL . 8.6 t -149.21 84.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.068 -1.02 . . . . 0.0 108.872 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.587 ' HG ' ' CG ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -77.35 126.13 30.43 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.458 ' OE1' ' CD1' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -118.46 104.03 10.31 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.076 -1.015 . . . . 0.0 109.732 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.715 ' CD2' HD13 ' A' ' 147' ' ' LEU . 5.2 m-85 -90.05 123.46 33.95 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.304 -0.873 . . . . 0.0 109.609 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 1.0 OUTLIER -160.91 140.23 10.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.231 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.591 ' HB2' ' CD2' ' A' ' 29' ' ' PHE . 11.1 p -116.29 174.97 5.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 110.183 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.61 ' CD2' HD21 ' A' ' 72' ' ' LEU . 8.3 m-30 -89.3 37.6 0.87 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.501 -0.749 . . . . 0.0 109.021 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 1.14 ' CZ ' HD13 ' A' ' 72' ' ' LEU . 3.2 m-85 -135.65 18.92 3.31 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.773 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.436 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 3.8 m -112.79 164.07 16.35 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.819 -1.176 . . . . 0.0 109.428 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.9 Cg_endo -74.74 -13.19 22.09 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.014 1.809 . . . . 0.0 108.321 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.572 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 36.5 m170 -100.2 -29.7 12.33 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 34' ' ' TYR . 6.1 p -44.58 -40.51 5.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.517 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 21.1 t80 -88.22 -45.49 10.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.789 -0.57 . . . . 0.0 110.259 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -68.54 -22.39 64.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 111.12 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.661 ' CZ ' HD13 ' A' ' 42' ' ' ILE . 1.6 m-85 -80.16 -25.0 40.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.801 -1.187 . . . . 0.0 110.588 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' O ' ' CD ' ' A' ' 38' ' ' GLU . 0.4 OUTLIER -117.94 32.46 6.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.899 -1.126 . . . . 0.0 110.073 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 67.6 mm-40 -146.52 -63.83 0.3 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -0.995 . . . . 0.0 110.566 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 40' ' ' LEU . 4.0 t -101.75 -66.8 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.034 -1.041 . . . . 0.0 110.741 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 40' ' ' LEU . 58.0 mt -42.92 -34.21 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 31.8 m170 57.27 20.32 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.172 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.661 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 8.5 mt -58.92 -24.32 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.619 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.6 m -77.17 -60.88 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.927 . . . . 0.0 109.722 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 10.0 m-20 -70.84 -33.6 70.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.0 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 45' ' ' ASN . 12.5 t-20 -60.79 -49.73 76.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.661 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 67.3 t -77.27 -16.89 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.898 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -75.8 -27.74 58.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.045 -1.035 . . . . 0.0 109.646 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -72.28 -22.86 61.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -0.974 . . . . 0.0 109.516 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 24.0 mtmt -97.54 -3.27 40.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.871 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.545 HD22 ' HB ' ' A' ' 54' ' ' VAL . 13.1 mt -73.5 113.42 22.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 109.679 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.841 ' HD2' HG21 ' A' ' 54' ' ' VAL . 36.7 Cg_endo -78.54 138.4 15.36 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.174 1.916 . . . . 0.0 110.599 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 51' ' ' PRO . 23.4 tt0 -40.79 119.64 1.16 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.086 0.946 . . . . 0.0 109.573 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.32 -25.77 5.08 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.89 HG22 ' HB2' ' A' ' 186' ' ' SER . 4.5 t -85.33 88.29 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -1.187 . . . . 0.0 109.358 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HE3' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -69.77 99.91 1.43 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.956 -179.666 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.483 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 1.8 ttt -92.7 100.63 13.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.573 -0.704 . . . . 0.0 109.321 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.447 ' OG1' ' HE3' ' A' ' 55' ' ' LYS . 89.8 m -95.39 139.89 31.05 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.136 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.547 ' O ' ' NE1' ' A' ' 76' ' ' TRP . 1.4 mppt? -118.14 105.46 11.84 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.608 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.0 m-85 -103.59 164.36 11.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.597 -1.315 . . . . 0.0 111.109 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 1.022 ' NE2' HD22 ' A' ' 72' ' ' LEU . 6.8 t-80 -116.28 134.6 54.73 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.721 0.772 . . . . 0.0 109.141 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.043 HG21 HG11 ' A' ' 150' ' ' VAL . 2.6 m -104.97 160.73 5.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 O-C-N 121.666 -0.646 . . . . 0.0 110.123 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.535 ' HB3' ' N ' ' A' ' 70' ' ' LYS . 1.7 p-10 -103.85 54.53 0.74 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.524 ' CE1' ' HB ' ' A' ' 61' ' ' VAL . 4.9 m-85 -100.73 61.55 1.0 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.671 -0.643 . . . . 0.0 109.764 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.585 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -161.65 -56.66 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.891 -1.124 . . . . 0.0 111.6 179.326 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.585 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -114.82 -18.37 6.48 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.44 -42.63 1.98 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.07 -77.69 0.35 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -1.152 . . . . 0.0 109.45 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.07 HD11 HG22 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -62.13 -21.61 65.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.954 ' N ' HD23 ' A' ' 68' ' ' LEU . . . -60.85 -64.93 3.66 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.535 ' N ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -54.61 -42.47 71.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.249 -1.147 . . . . 0.0 108.502 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.706 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 21.7 t0 -64.93 -29.33 70.26 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.14 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 3.5 tt -66.58 -35.4 80.12 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 1.6 m -59.16 -41.73 89.1 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 177.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -61.32 -24.51 66.49 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -65.28 -34.23 77.86 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.554 ' CH2' ' OE2' ' A' ' 85' ' ' GLU . 53.0 t-105 -71.15 -31.86 68.21 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.644 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -79.16 -58.95 2.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.337 -0.852 . . . . 0.0 109.411 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.969 HG21 ' CE1' ' A' ' 122' ' ' TYR . 93.9 t -53.65 -27.55 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 109.981 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.583 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -81.97 -61.27 1.96 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.984 -1.073 . . . . 0.0 108.654 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 3.1 tpt -49.17 -26.28 2.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.883 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -77.46 -36.5 52.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.531 -0.731 . . . . 0.0 109.563 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 84' ' ' VAL . 83.1 mt -105.81 8.89 32.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 0.0 110.75 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 54.25 27.89 40.95 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.583 HG22 ' HA ' ' A' ' 79' ' ' ALA . 32.6 m -99.67 29.17 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.461 -1.023 . . . . 0.0 110.049 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.554 ' OE2' ' CH2' ' A' ' 76' ' ' TRP . 5.2 mt-10 -62.88 -79.57 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.133 -0.979 . . . . 0.0 109.641 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -36.41 -37.63 0.13 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.345 0.593 . . . . 0.0 110.805 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.529 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 5.1 mtpt -70.85 -56.72 5.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.402 -0.811 . . . . 0.0 111.459 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.746 HG23 HD12 ' A' ' 92' ' ' LEU . 1.3 m -86.74 -15.11 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.613 -1.304 . . . . 0.0 110.592 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.734 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -74.62 -42.52 58.46 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.589 -1.319 . . . . 0.0 108.341 178.7 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.417 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -54.68 -53.75 56.85 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.701 -1.249 . . . . 0.0 110.615 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 25.9 Cg_endo -73.07 -19.89 22.39 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 N-CA-C 109.829 -0.873 . . . . 0.0 109.829 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.746 HD12 HG23 ' A' ' 88' ' ' VAL . 21.9 mt -83.78 -42.62 16.3 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.734 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.4 m-30 -64.83 -45.74 84.88 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.029 -1.044 . . . . 0.0 108.649 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -72.47 -28.6 63.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.171 -0.956 . . . . 0.0 109.254 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.07 -32.07 82.9 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.623 HG11 ' HD1' ' A' ' 29' ' ' PHE . 2.5 t -99.8 -6.83 9.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.194 -1.18 . . . . 0.0 109.245 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.486 ' OE1' ' CG ' ' A' ' 34' ' ' TYR . 2.9 mt-30 -108.71 7.5 26.44 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 120.935 -1.103 . . . . 0.0 111.037 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.776 ' O ' HG23 ' A' ' 99' ' ' THR . 0.9 OUTLIER -175.63 66.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.516 -1.365 . . . . 0.0 109.55 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.08 -48.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.8 -0.563 . . . . 0.0 109.639 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.6 mt-30 74.26 17.7 3.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.197 -0.939 . . . . 0.0 110.276 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.8 t -79.93 -6.53 57.65 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 1.07 HG22 HD11 ' A' ' 68' ' ' LEU . 11.1 mm -89.72 71.08 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.716 -0.615 . . . . 0.0 109.345 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.541 ' CA ' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -136.87 16.19 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 109.235 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -142.64 126.88 17.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.402 -0.811 . . . . 0.0 109.402 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.706 ' HB1' ' OD2' ' A' ' 71' ' ' ASP . . . -49.37 -37.32 24.47 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 p -55.86 -31.63 62.94 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.769 ' OD2' HD12 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -74.14 -47.76 33.91 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.911 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.751 HD11 ' O ' ' A' ' 68' ' ' LEU . 30.4 mt -48.41 -29.34 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.911 -1.118 . . . . 0.0 108.582 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -74.37 -47.41 34.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 109.614 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -51.98 -40.39 60.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 109.37 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.692 HG11 ' HG ' ' A' ' 92' ' ' LEU . 2.4 t -71.18 -40.1 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.164 -0.96 . . . . 0.0 109.532 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.541 ' CE1' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -65.47 -33.46 75.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.564 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mt -76.42 -25.4 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.917 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -65.39 -20.0 66.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.059 -1.026 . . . . 0.0 109.61 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.505 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -90.05 4.72 49.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 109.722 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.6 0.37 69.65 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.719 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.5 mm -79.5 60.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -1.149 . . . . 0.0 109.555 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 117' ' ' ILE . 64.7 mttt -34.85 153.17 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.257 -0.902 . . . . 0.0 110.45 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.459 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -59.69 -27.69 64.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -66.45 -43.92 84.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -1.17 . . . . 0.0 109.607 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.0 -50.05 45.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.327 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.969 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -65.34 -56.35 13.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.369 -0.832 . . . . 0.0 108.845 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 27.5 t70 -45.56 -39.22 7.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.101 -0.999 . . . . 0.0 108.892 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.69 -44.36 61.89 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.302 -0.874 . . . . 0.0 108.791 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.575 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -54.63 -49.09 71.34 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -59.27 -58.74 7.29 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -53.86 -15.97 1.58 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.585 -0.697 . . . . 0.0 110.119 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -70.74 175.47 4.95 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.96 -1.088 . . . . 0.0 109.766 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.947 ' CE2' HG23 ' A' ' 130' ' ' VAL . 41.4 p90 -94.09 -37.03 11.82 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.776 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.947 HG23 ' CE2' ' A' ' 129' ' ' PHE . 25.0 t -67.18 -47.91 80.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.13 -1.428 . . . . 0.0 109.578 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.883 HG22 ' HB1' ' A' ' 81' ' ' ALA . 16.6 t -63.41 -40.24 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.977 -1.077 . . . . 0.0 108.561 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -37.71 85.18 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.456 -0.778 . . . . 0.0 109.056 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -29.5 70.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.057 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.12 -30.8 55.36 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.644 HG23 ' CB ' ' A' ' 77' ' ' ALA . 9.8 t -76.04 -41.15 38.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.6 -48.72 80.56 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -37.17 82.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 109.139 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.608 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 18.9 tm0? -55.87 -62.42 1.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.037 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -48.35 -33.57 9.2 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.427 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -72.46 -29.29 63.54 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.351 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.576 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . . . -62.46 -57.19 12.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 108.712 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -68.55 -35.87 78.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.519 -0.738 . . . . 0.0 110.036 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.81 -16.64 58.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.043 -1.035 . . . . 0.0 109.835 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.692 ' HB3' HG21 ' A' ' 16' ' ' VAL . 5.7 m-20 -81.49 -43.76 18.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -0.966 . . . . 0.0 108.95 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.54 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 29.7 m -105.03 -9.4 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 108.885 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.54 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.9 OUTLIER 82.24 -43.72 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.519 -0.738 . . . . 0.0 109.876 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.015 HD21 HG11 ' A' ' 61' ' ' VAL . 14.1 tp 64.5 134.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.35 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -160.75 32.85 0.15 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.533 -1.354 . . . . 0.0 110.002 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 151' ' ' PRO . . . 175.01 77.97 0.05 OUTLIER Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.995 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 1.043 HG11 HG21 ' A' ' 61' ' ' VAL . 3.8 m -80.15 135.91 54.13 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.119 -1.224 . . . . 0.0 107.92 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 149' ' ' GLY . 30.9 Cg_endo -71.18 152.85 96.04 Favored 'Cis proline' 0 C--N 1.317 -1.098 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.508 2.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -140.29 159.84 41.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.689 -1.257 . . . . 0.0 109.026 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.53 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 30.3 tpp -142.65 138.18 30.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.024 -1.048 . . . . 0.0 110.369 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 6.3 m-85 -143.22 127.34 17.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.436 -0.79 . . . . 0.0 109.577 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 21' ' ' GLN . 54.9 t -103.95 130.59 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.026 . . . . 0.0 109.501 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.512 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 1.9 t-20 45.62 26.39 0.33 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 15' ' ' PRO . . . 52.07 27.46 22.61 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.402 -1.38 . . . . 0.0 109.88 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.66 -15.96 4.35 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.735 -1.45 . . . . 0.0 109.308 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -143.1 125.6 15.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.001 . . . . 0.0 109.149 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.496 ' HG2' ' HG ' ' A' ' 12' ' ' LEU . 1.1 pt20 -119.7 139.4 52.31 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.03 -1.044 . . . . 0.0 109.778 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.445 ' HG ' ' HB3' ' A' ' 153' ' ' MET . 7.7 mt -75.78 173.41 11.17 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -158.6 87.08 2.32 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 109.758 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 C--N 1.31 -1.465 0 C-N-CA 122.872 2.381 . . . . 0.0 111.225 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.845 ' O ' HG23 ' A' ' 175' ' ' VAL . 4.9 mmt . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.662 0.744 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.11 -63.13 1.29 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.352 0.596 . . . . 0.0 109.474 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 4.0 t -67.3 -18.27 23.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.153 -0.967 . . . . 0.0 109.475 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -76.52 -47.16 23.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.101 -1.0 . . . . 0.0 109.663 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 171' ' ' MET . 15.2 t -70.91 -25.05 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 109.376 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -80.63 -61.01 2.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.263 -0.898 . . . . 0.0 109.257 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 173' ' ' VAL . 0.6 OUTLIER -55.12 -42.72 73.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.218 -0.927 . . . . 0.0 109.198 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 178' ' ' TYR . 9.7 t80 -61.32 -48.65 80.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.281 -0.887 . . . . 0.0 109.364 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.67 -30.07 65.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.343 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -77.38 -43.47 32.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.495 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.6 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.1 OUTLIER -57.75 -34.09 69.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.0 . . . . 0.0 109.465 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 51.7 t -78.45 -36.09 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.154 -0.966 . . . . 0.0 109.044 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -52.04 67.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.289 -0.882 . . . . 0.0 109.169 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -77.11 -32.0 56.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.296 -0.878 . . . . 0.0 109.263 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 181' ' ' THR . 0.2 OUTLIER -62.67 -17.06 59.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.06 -1.025 . . . . 0.0 109.653 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.89 ' HB2' HG22 ' A' ' 54' ' ' VAL . 87.8 p -73.08 -12.3 60.86 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.856 -1.153 . . . . 0.0 108.709 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.423 -0.798 . . . . 0.0 109.386 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.574 ' HE1' HG23 ' A' ' 181' ' ' THR . 3.1 m-85 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.449 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 1.6 pt-20 -105.84 54.96 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.588 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 4' ' ' GLU . 1.2 m-20 42.48 82.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.751 -0.593 . . . . 0.0 110.1 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 131.88 -29.22 3.42 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.701 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 5.4 tptt -83.18 -69.05 0.66 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.869 -1.371 . . . . 0.0 109.27 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 77.6 mm-40 -92.97 2.01 57.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.744 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 6' ' ' GLY . 1.1 p90 176.67 132.38 0.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.078 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.5 ' CG2' ' CD ' ' A' ' 160' ' ' GLN . 11.3 t -112.26 -179.63 3.73 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 m -116.62 139.61 50.32 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.487 0.66 . . . . 0.0 109.615 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.465 HD23 ' HG2' ' A' ' 160' ' ' GLN . 0.2 OUTLIER -95.18 169.83 9.82 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.389 -0.819 . . . . 0.0 109.375 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 14.3 mp0 -98.19 12.35 34.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 109.82 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 5.4 mtmt -141.51 80.47 16.2 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.925 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -79.13 159.26 26.8 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.719 2.279 . . . . 0.0 109.986 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.906 HG21 ' OD1' ' A' ' 144' ' ' ASP . 3.4 t -126.72 97.86 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.093 -1.004 . . . . 0.0 110.154 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.79 128.54 8.82 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 93.03 -14.9 64.14 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.644 -1.783 . . . . 0.0 108.644 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.792 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -39.25 161.7 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.946 . . . . 0.0 110.095 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.587 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.2 Cg_endo -78.56 127.53 8.13 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.746 2.297 . . . . 0.0 111.201 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.647 ' O ' HG22 ' A' ' 155' ' ' VAL . 2.0 mm-40 -42.35 -24.48 0.05 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.511 -0.743 . . . . 0.0 109.798 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.639 ' O ' HG12 ' A' ' 22' ' ' VAL . 8.1 t -147.14 86.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.009 -1.057 . . . . 0.0 108.75 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.715 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -79.88 125.55 29.87 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -105.55 97.95 7.71 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.175 -0.953 . . . . 0.0 110.438 -178.797 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.158 ' CE2' HG21 ' A' ' 145' ' ' VAL . 4.7 m-85 -89.58 106.41 18.44 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 3.2 p90 -153.32 143.6 22.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.044 -1.035 . . . . 0.0 109.946 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.613 ' HB3' ' CE1' ' A' ' 60' ' ' HIS . 2.3 p -126.44 -165.02 1.39 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.68 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -115.67 53.46 0.84 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.758 -1.213 . . . . 0.0 108.224 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.654 ' CE1' HD22 ' A' ' 72' ' ' LEU . 9.1 m-85 -137.71 0.35 2.22 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.411 -0.806 . . . . 0.0 110.645 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.62 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 5.1 m -111.27 169.11 6.65 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.782 -1.199 . . . . 0.0 108.604 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 30.7 Cg_endo -73.97 -54.73 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.712 1.608 . . . . 0.0 109.344 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -68.66 -19.08 64.38 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 177.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -50.49 -47.47 57.15 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.359 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.615 ' HB3' ' NE2' ' A' ' 97' ' ' GLN . 5.7 t80 -79.82 -37.04 35.97 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.515 -0.74 . . . . 0.0 109.748 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.486 ' O ' ' CG ' ' A' ' 40' ' ' LEU . 8.4 mm-40 -70.85 -25.08 62.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 110.054 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -83.74 -15.68 47.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.166 -0.959 . . . . 0.0 110.943 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.7 mm-40 -131.22 44.28 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.728 -1.232 . . . . 0.0 111.202 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -174.07 -60.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.004 . . . . 0.0 110.984 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.4 t -90.18 -53.45 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.045 -1.034 . . . . 0.0 111.143 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.587 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 94.8 mt -59.4 -11.24 4.04 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.977 -1.077 . . . . 0.0 110.76 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 56.8 p-80 41.31 28.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 109.663 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 46' ' ' VAL . 19.4 mt -68.71 -33.23 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 109.272 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 43.7 p -72.87 -26.05 61.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 109.877 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.09 -54.41 4.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 0.0 109.83 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -52.09 -53.99 35.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.163 -0.961 . . . . 0.0 109.755 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.741 HG22 ' O ' ' A' ' 42' ' ' ILE . 19.1 m -57.53 -35.32 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.53 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.967 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -70.78 -39.33 73.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -60.26 -22.77 63.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -111.22 9.44 21.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 0.0 109.807 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.967 HD12 ' HA ' ' A' ' 47' ' ' LYS . 8.3 mt -78.65 130.14 71.84 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 110.042 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD2' HD23 ' A' ' 50' ' ' LEU . 35.3 Cg_endo -78.47 154.05 27.5 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.408 2.072 . . . . 0.0 108.863 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' A' ' 52' ' ' GLU . 11.8 tt0 -69.84 21.66 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.473 -1.392 . . . . 0.0 111.54 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 51' ' ' PRO . . . -121.61 29.99 5.48 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 186' ' ' SER . 43.9 t -145.6 117.21 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.09 107.35 19.15 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.456 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -91.39 96.36 10.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -91.78 140.22 29.91 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.961 -1.095 . . . . 0.0 110.342 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.32 112.15 21.13 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.484 -0.76 . . . . 0.0 109.594 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.603 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 1.9 m-85 -116.67 167.43 11.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -0.964 . . . . 0.0 110.678 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.613 ' CE1' ' HB3' ' A' ' 27' ' ' SER . 54.8 t-80 -108.23 131.41 54.71 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.076 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.8 m -69.48 151.47 9.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.648 -0.658 . . . . 0.0 110.033 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 4.4 p-10 -116.57 42.61 2.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.594 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 1.6 p90 -144.48 59.15 1.33 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.153 -0.967 . . . . 0.0 109.67 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -129.98 36.5 4.03 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.402 -0.811 . . . . 0.0 109.126 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.58 -32.02 0.34 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.17 -40.26 3.09 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -88.34 -79.55 0.3 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.109 -1.23 . . . . 0.0 110.628 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.896 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -79.68 -18.29 51.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.866 -1.146 . . . . 0.0 109.564 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.633 ' N ' HD22 ' A' ' 68' ' ' LEU . . . -53.19 -46.62 62.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -44.35 94.98 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.76 -27.66 67.78 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.693 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 27.8 tp -60.97 -44.8 96.83 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 138' ' ' GLN . 1.6 m -60.3 -42.9 96.5 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 1.052 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.6 tt0 -55.61 -26.14 42.4 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -67.41 -42.07 83.86 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -58.43 -28.2 65.04 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HB2' ' NE2' ' A' ' 138' ' ' GLN . . . -85.94 -43.15 13.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.525 -0.734 . . . . 0.0 110.274 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.052 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.2 t -68.74 -30.87 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.903 -1.123 . . . . 0.0 109.693 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.581 ' HB1' ' HG2' ' A' ' 85' ' ' GLU . . . -82.63 -55.78 4.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.01 -1.057 . . . . 0.0 108.374 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 3.0 ttt -49.67 -28.55 6.07 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.864 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -72.98 -39.0 66.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.501 -0.749 . . . . 0.0 109.183 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.457 ' CB ' HG13 ' A' ' 84' ' ' VAL . 66.1 mt -101.28 8.64 42.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.262 -0.899 . . . . 0.0 110.23 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.97 24.05 7.96 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 79' ' ' ALA . 33.5 m -90.27 1.44 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -1.092 . . . . 0.0 110.173 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.581 ' HG2' ' HB1' ' A' ' 79' ' ' ALA . 2.5 mt-10 -44.68 -66.79 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.979 -1.076 . . . . 0.0 109.436 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -41.03 -34.16 0.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.432 -0.793 . . . . 0.0 110.109 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -80.99 -51.41 8.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.329 -0.857 . . . . 0.0 111.294 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.973 HG23 HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -87.18 -11.46 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.622 -1.299 . . . . 0.0 110.896 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.776 HG23 ' CE1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -71.64 -43.94 65.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.731 -1.231 . . . . 0.0 108.893 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.412 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -54.1 -54.26 49.35 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.515 -1.366 . . . . 0.0 110.657 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.601 ' HB2' HG13 ' A' ' 111' ' ' VAL . 27.1 Cg_endo -72.86 -18.1 24.93 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 N-CA-C 109.844 -0.868 . . . . 0.0 109.844 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.973 HD12 HG23 ' A' ' 88' ' ' VAL . 17.5 mt -86.62 -43.73 12.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.892 . . . . 0.0 108.874 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.776 ' CE1' HG23 ' A' ' 89' ' ' THR . 5.1 m-30 -63.53 -48.1 78.9 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.043 -1.036 . . . . 0.0 108.486 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -72.84 -29.28 63.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 108.977 179.083 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.426 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -57.05 -39.0 88.96 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.639 HG11 ' CG ' ' A' ' 29' ' ' PHE . 1.9 t -100.36 -3.37 9.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.211 -1.17 . . . . 0.0 109.387 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.615 ' NE2' ' HB3' ' A' ' 34' ' ' TYR . 2.0 mt-30 -101.56 2.6 39.2 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 120.853 -1.154 . . . . 0.0 110.714 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.783 ' O ' HG23 ' A' ' 99' ' ' THR . 1.1 mmtp -175.18 72.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.692 -1.255 . . . . 0.0 109.387 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.28 -49.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 99' ' ' THR . 3.0 mt-30 72.8 15.0 4.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 110.597 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 t -82.93 -7.85 59.62 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.859 0.838 . . . . 0.0 108.797 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.61 HG13 HG22 ' A' ' 96' ' ' VAL . 9.1 mm -82.44 69.63 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 32.56 3.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.729 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.55 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 32.1 p -156.56 131.0 8.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.989 -1.069 . . . . 0.0 110.201 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.904 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.79 -34.21 18.8 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.83 -34.74 75.02 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -66.15 -50.71 63.02 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.763 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 105' ' ' ALA . 24.6 mt -49.38 -28.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.771 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -39.03 47.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.926 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 1.1 p30 -59.84 -46.08 90.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.114 -0.991 . . . . 0.0 109.626 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.775 HG11 ' HG ' ' A' ' 92' ' ' LEU . 58.7 t -68.65 -39.74 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.936 -1.103 . . . . 0.0 109.25 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.434 ' O ' ' HB ' ' A' ' 117' ' ' ILE . 1.9 m-85 -59.9 -42.84 94.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.181 -0.95 . . . . 0.0 109.544 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.662 HG23 ' HA ' ' A' ' 118' ' ' LYS . 12.0 mt -69.85 -23.83 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 109.403 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 110' ' ' ASP . 1.9 m-80 -63.33 -17.99 63.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 109.592 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.858 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -99.08 11.51 38.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.912 . . . . 0.0 109.344 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.35 -7.71 81.42 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.858 HD13 ' HB3' ' A' ' 115' ' ' ALA . 1.8 mp -77.32 55.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -1.077 . . . . 0.0 109.252 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.662 ' HA ' HG23 ' A' ' 113' ' ' ILE . 3.0 mtmp? -35.19 149.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.215 -0.928 . . . . 0.0 110.475 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 123' ' ' ASP . . . -53.57 -27.91 35.74 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -61.86 -59.06 5.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.034 -1.274 . . . . 0.0 109.363 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -64.76 -41.95 95.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 109.226 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.955 ' CE2' HG11 ' A' ' 78' ' ' VAL . 3.1 t80 -56.5 -48.9 76.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.008 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.2 OUTLIER -59.97 -30.87 69.4 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.887 . . . . 0.0 109.064 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.43 -51.36 60.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.344 -0.847 . . . . 0.0 108.852 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.516 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -51.89 -52.8 47.26 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.406 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 3.7 t-105 -57.87 -56.49 21.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.81 -16.17 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 110.282 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 50.2 m -74.03 173.69 9.67 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.901 -1.124 . . . . 0.0 109.991 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -90.63 -38.62 13.0 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.463 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.77 -47.17 89.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.085 -1.446 . . . . 0.0 109.244 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.864 HG22 ' HB1' ' A' ' 81' ' ' ALA . 15.6 t -62.56 -32.66 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -67.89 -39.41 83.65 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 90.0 p -61.74 -34.59 76.09 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.18 -18.36 53.2 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.288 -0.882 . . . . 0.0 108.662 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.17 -47.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.43 -32.87 74.43 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -33.53 69.14 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.603 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 8.9 mt-30 -74.24 -66.98 0.66 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 108.955 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.8 tt0 -45.36 -43.96 11.38 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 0.1 OUTLIER -69.78 -28.39 65.7 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.916 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -56.19 -63.5 1.17 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.37 -0.831 . . . . 0.0 108.874 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.54 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -73.57 -19.43 60.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 109.834 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' A' ' 140' ' ' LYS . . . -79.31 -29.48 42.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.01 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 1.02 ' OD1' HG13 ' A' ' 145' ' ' VAL . 2.8 p30 -81.85 -45.04 16.08 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 1.158 HG21 ' CE2' ' A' ' 25' ' ' PHE . 24.7 m -87.26 -14.91 9.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.54 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.5 tp-100 79.65 -50.5 0.39 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.63 -0.669 . . . . 0.0 109.501 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.725 HD21 HG12 ' A' ' 61' ' ' VAL . 12.2 tp 62.09 134.46 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.482 -0.761 . . . . 0.0 109.281 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -160.77 27.76 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.573 -1.33 . . . . 0.0 109.725 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 179.56 102.93 0.17 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.331 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 1.076 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.92 144.06 27.87 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 0.0 109.175 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.429 ' O ' ' HG3' ' A' ' 163' ' ' PRO . 35.7 Cg_endo -77.65 153.07 93.75 Favored 'Cis proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.946 -1.272 . . . . 0.0 110.649 0.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -129.43 130.05 45.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.39 -1.444 . . . . 0.0 109.408 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -119.59 115.57 24.25 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.256 -0.903 . . . . 0.0 109.152 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.547 ' CD1' ' CB ' ' A' ' 160' ' ' GLN . 13.7 m-30 -115.01 127.5 55.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.207 -0.933 . . . . 0.0 110.804 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 21' ' ' GLN . 24.4 t -96.81 131.99 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.918 . . . . 0.0 109.684 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.792 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 2.8 t-20 45.32 22.3 0.08 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.407 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.563 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.16 58.04 16.17 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -166.52 -36.1 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.451 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 96.4 m-85 -116.34 123.19 47.02 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.547 ' CB ' ' CD1' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -117.89 112.97 21.05 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.296 -0.877 . . . . 0.0 109.873 -179.243 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 9' ' ' TYR . 11.1 mt -60.37 170.68 1.26 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 109.063 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 162' ' ' ASN . 26.3 p-10 -131.42 113.29 15.58 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.548 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.429 ' HG3' ' O ' ' A' ' 151' ' ' PRO . 36.2 Cg_endo . . . . . 0 C--N 1.309 -1.503 0 C-N-CA 122.407 2.071 . . . . 0.0 110.542 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.872 ' O ' HG23 ' A' ' 175' ' ' VAL . 3.1 mtt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.88 0.848 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.61 -65.79 0.97 Allowed 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.0 t -57.84 -25.2 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.251 -0.906 . . . . 0.0 108.827 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 178' ' ' TYR . 50.8 t80 -74.12 -39.82 63.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 109.112 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 171' ' ' MET . 96.9 t -70.91 -27.77 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 108.95 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.66 -64.83 1.1 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.248 -0.907 . . . . 0.0 108.904 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -50.31 -42.31 52.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.187 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 178' ' ' TYR . 8.1 t80 -61.42 -53.77 52.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.513 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.38 -24.11 11.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.922 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.41 -43.62 23.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.555 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.641 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -59.63 -42.28 92.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 109.386 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 43.2 t -74.01 -37.3 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.056 -1.028 . . . . 0.0 109.226 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -52.28 65.91 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.89 . . . . 0.0 109.193 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -76.72 -33.64 58.16 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.263 -0.898 . . . . 0.0 109.061 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 181' ' ' THR . 0.5 OUTLIER -58.17 -19.54 33.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.982 -1.074 . . . . 0.0 109.839 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.46 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 1.3 t -73.17 -12.65 60.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.81 -1.181 . . . . 0.0 108.71 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.84 . . . . 0.0 109.44 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.543 ' HB2' ' CE1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -108.35 62.36 0.61 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.796 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.2 t70 44.82 82.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.408 -0.807 . . . . 0.0 109.404 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 118.38 -22.74 9.39 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.457 ' HB3' ' OE1' ' A' ' 8' ' ' GLN . 3.0 tttp -80.13 -68.67 0.65 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.107 -1.231 . . . . 0.0 108.709 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 17.2 mp0 -103.94 9.1 36.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.285 -0.884 . . . . 0.0 109.773 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 3' ' ' TYR . 3.7 p90 177.33 134.73 0.07 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.129 -0.982 . . . . 0.0 109.171 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -117.68 178.83 4.26 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 m -115.19 145.59 42.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.706 -0.621 . . . . 0.0 109.681 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.418 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -94.01 165.87 12.43 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.424 -0.797 . . . . 0.0 109.567 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -80.48 -15.64 56.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.599 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.02 115.17 11.04 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.404 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.492 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 34.4 Cg_endo -77.3 162.7 30.89 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.401 2.067 . . . . 0.0 110.531 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.721 HG21 HG12 ' A' ' 145' ' ' VAL . 48.1 t -105.93 79.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -46.6 128.25 10.23 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 93.77 -13.15 68.1 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 18' ' ' GLY . . . -37.36 152.28 0.13 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.75 -0.853 . . . . 0.0 109.043 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.521 ' O ' ' O ' ' A' ' 55' ' ' LYS . 36.6 Cg_endo -78.94 40.77 0.97 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.244 1.962 . . . . 0.0 112.631 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER 67.04 -43.22 0.44 Allowed 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.376 -0.827 . . . . 0.0 110.575 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.615 ' O ' HG12 ' A' ' 22' ' ' VAL . 32.2 t -150.52 78.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.73 HD13 ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -70.66 127.49 32.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -178.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 57' ' ' THR . 2.1 tt0 -111.1 149.3 31.02 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.119 -0.988 . . . . 0.0 109.625 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.764 ' CD2' HD13 ' A' ' 147' ' ' LEU . 15.0 m-85 -122.86 126.43 47.32 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.467 -0.771 . . . . 0.0 109.689 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 1.9 p90 -159.09 140.97 13.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.354 -0.842 . . . . 0.0 109.486 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.996 ' HB3' HG22 ' A' ' 61' ' ' VAL . 75.2 p -122.01 169.94 10.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -0.98 . . . . 0.0 110.574 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' A' ' 29' ' ' PHE . 7.5 m-30 -92.3 37.66 1.0 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 1.037 ' CZ ' HD13 ' A' ' 72' ' ' LEU . 2.6 m-85 -142.59 20.01 2.02 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.092 -1.005 . . . . 0.0 110.258 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.542 ' CB ' ' CE1' ' A' ' 32' ' ' HIS . 1.3 m -117.95 166.93 12.3 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.642 -1.286 . . . . 0.0 109.617 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 33.6 Cg_endo -75.54 -38.13 1.5 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.287 1.991 . . . . 0.0 108.628 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.579 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 14.6 p80 -73.9 -25.49 60.04 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.509 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 22.7 t -44.75 -62.9 1.04 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 8.4 t80 -65.54 -46.41 79.65 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.287 0.565 . . . . 0.0 109.989 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.526 ' HA ' ' CG2' ' A' ' 39' ' ' VAL . 2.1 mm-40 -61.01 -23.64 65.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 110.538 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.467 ' N ' ' O ' ' A' ' 32' ' ' HIS . 3.4 m-30 -78.37 -43.1 28.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -110.98 8.06 21.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.748 -1.22 . . . . 0.0 111.391 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 27.8 mm-40 -135.01 29.15 3.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.562 -1.336 . . . . 0.0 110.346 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.831 HG12 ' HG ' ' A' ' 40' ' ' LEU . 98.0 t -150.92 -76.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.812 -1.18 . . . . 0.0 109.522 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.831 ' HG ' HG12 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -106.22 20.09 19.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.178 -0.951 . . . . 0.0 109.932 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 45' ' ' ASN . 5.3 m170 43.13 31.36 0.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.14 -0.975 . . . . 0.0 110.066 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.551 ' CG1' HG22 ' A' ' 175' ' ' VAL . 22.4 mt -50.48 -25.02 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.003 -1.061 . . . . 0.0 109.416 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.25 -55.9 5.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 110.186 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.509 ' HA ' ' HG2' ' A' ' 47' ' ' LYS . 6.9 m-20 -87.09 -33.57 19.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.355 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.507 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -60.54 -27.68 67.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.5 -179.267 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.833 ' O ' HD13 ' A' ' 50' ' ' LEU . 9.1 p -84.46 -24.84 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.028 -1.045 . . . . 0.0 111.091 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.54 ' HG3' ' N ' ' A' ' 48' ' ' LYS . 4.7 ptpt -78.68 -25.29 44.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.737 -1.227 . . . . 0.0 110.416 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.54 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 1.7 mtpt -63.84 -32.76 74.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.953 -1.092 . . . . 0.0 109.311 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -82.82 9.66 9.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.865 . . . . 0.0 109.411 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 46' ' ' VAL . 8.6 mp -98.64 108.5 48.62 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.128 -0.983 . . . . 0.0 109.449 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.615 ' HD2' HG21 ' A' ' 54' ' ' VAL . 35.1 Cg_endo -77.06 145.9 25.12 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.4 2.067 . . . . 0.0 110.478 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 51' ' ' PRO . 1.2 tt0 -33.46 118.13 0.32 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.266 1.031 . . . . 0.0 110.127 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.36 -26.64 5.46 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.615 HG21 ' HD2' ' A' ' 51' ' ' PRO . 3.7 t -97.58 93.5 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -1.102 . . . . 0.0 108.645 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -84.44 118.25 24.16 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.962 0.887 . . . . 0.0 110.079 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.489 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.4 OUTLIER -111.82 98.91 7.72 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.068 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 20' ' ' PRO . 7.4 m -99.6 128.18 45.7 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.716 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 115.17 29.89 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.585 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 1.3 m-85 -112.62 175.98 5.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.852 -1.155 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.622 ' CE1' HD22 ' A' ' 72' ' ' LEU . 28.9 t-80 -104.41 150.73 24.27 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.032 0.92 . . . . 0.0 109.322 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.996 HG22 ' HB3' ' A' ' 27' ' ' SER . 1.3 m -96.96 160.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.369 0.604 . . . . 0.0 110.015 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -125.09 56.69 1.32 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.41 -0.806 . . . . 0.0 108.866 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.57 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -133.81 52.1 2.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.99 . . . . 0.0 110.974 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.656 ' HE3' ' CE1' ' A' ' 29' ' ' PHE . 3.1 ppp? -128.92 34.0 4.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.395 -0.815 . . . . 0.0 108.818 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.76 -37.35 3.24 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.91 -13.19 66.71 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.761 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -79.3 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.666 -1.49 . . . . 0.0 109.381 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.066 HD23 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -86.14 -28.22 24.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.037 -1.04 . . . . 0.0 109.345 179.469 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 1.066 ' N ' HD23 ' A' ' 68' ' ' LEU . . . -59.08 -55.08 32.88 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -56.87 -47.2 81.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.305 -1.114 . . . . 0.0 108.695 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 23.8 t0 -67.35 -24.37 65.71 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.037 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 5.8 tt -71.48 -39.52 70.84 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.973 HG23 ' OE1' ' A' ' 138' ' ' GLN . 1.3 m -57.87 -43.58 86.08 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 1.028 ' O ' HG23 ' A' ' 78' ' ' VAL . 4.0 tt0 -56.71 -29.0 62.0 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -62.3 -40.15 95.36 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -61.9 -30.4 70.86 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.486 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -83.41 -48.02 10.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -0.807 . . . . 0.0 109.968 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.028 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.5 t -63.3 -27.7 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 0.0 109.442 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.535 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -83.14 -55.72 4.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.212 -0.93 . . . . 0.0 109.138 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.719 ' HG2' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -45.26 -29.15 0.93 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.277 -0.889 . . . . 0.0 108.779 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.817 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -74.4 -38.37 63.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.396 -0.815 . . . . 0.0 109.509 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.527 ' CB ' HG13 ' A' ' 84' ' ' VAL . 44.3 mt -104.63 12.64 32.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 110.022 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.05 23.01 1.44 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.597 HG21 ' CE1' ' A' ' 112' ' ' PHE . 21.9 m -84.95 -10.35 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -1.204 . . . . 0.0 110.189 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 84' ' ' VAL . 5.4 pt-20 -43.01 -59.02 2.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.076 -1.015 . . . . 0.0 109.823 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -33.29 2.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.111 -0.993 . . . . 0.0 109.682 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.571 ' HE2' ' HB1' ' A' ' 115' ' ' ALA . 44.2 mtpt -83.89 -51.6 7.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.557 -0.714 . . . . 0.0 111.133 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.723 HG23 HD12 ' A' ' 92' ' ' LEU . 1.4 m -80.48 -6.07 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.787 -1.196 . . . . 0.0 110.676 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.727 HG23 ' CZ ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -78.24 -44.33 25.86 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.805 -1.184 . . . . 0.0 108.513 178.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.456 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -52.16 -52.01 66.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.568 -1.333 . . . . 0.0 110.227 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.538 ' HB2' HG13 ' A' ' 111' ' ' VAL . 24.4 Cg_endo -73.43 -20.51 20.75 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 N-CA-C 109.906 -0.844 . . . . 0.0 109.906 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.841 ' HG ' HG11 ' A' ' 111' ' ' VAL . 12.7 mt -83.83 -41.88 17.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 108.646 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.727 ' CZ ' HG23 ' A' ' 89' ' ' THR . 8.3 m-30 -67.3 -45.08 77.62 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.125 -0.984 . . . . 0.0 108.589 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -74.65 -33.35 62.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.56 -0.713 . . . . 0.0 109.428 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.462 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -61.24 -32.1 79.46 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.5 t -99.48 -9.55 8.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.344 -1.092 . . . . 0.0 109.278 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 2.4 mt-30 -112.41 9.7 19.75 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.891 -1.131 . . . . 0.0 110.92 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.779 ' O ' HG23 ' A' ' 99' ' ' THR . 0.6 OUTLIER -164.63 59.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.472 -1.393 . . . . 0.0 109.408 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 163.62 -49.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.472 -0.768 . . . . 0.0 109.119 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.486 ' O ' ' NE ' ' A' ' 103' ' ' ARG . 4.1 mp0 73.71 14.98 4.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.26 -0.9 . . . . 0.0 110.737 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 t -82.97 -7.8 59.63 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 1.012 HG22 HD11 ' A' ' 68' ' ' LEU . 12.4 mm -77.5 67.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.486 ' NE ' ' O ' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -128.56 30.83 5.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 109.452 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 107' ' ' ASP . 5.2 p -153.48 127.73 9.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.072 . . . . 0.0 110.187 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.72 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -48.79 -36.38 16.52 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 p -55.82 -33.85 64.82 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.747 ' OD2' HD12 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -71.79 -44.99 63.04 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.704 179.047 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.779 HD11 ' O ' ' A' ' 68' ' ' LEU . 34.7 mt -49.71 -29.29 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.892 -1.13 . . . . 0.0 108.459 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -79.36 -32.83 43.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.438 -0.789 . . . . 0.0 109.678 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -62.01 -43.47 98.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.166 -0.959 . . . . 0.0 109.403 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.841 HG11 ' HG ' ' A' ' 92' ' ' LEU . 55.8 t -74.68 -37.55 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 109.235 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.597 ' CE1' HG21 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -62.37 -48.11 81.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.883 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.481 HG23 ' HA ' ' A' ' 118' ' ' LYS . 22.5 mt -69.56 -26.22 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 109.538 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -19.81 54.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.373 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.571 ' HB1' ' HE2' ' A' ' 87' ' ' LYS . . . -90.46 5.32 48.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.526 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.82 -4.46 72.02 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.74 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.3 mm -74.73 57.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -1.088 . . . . 0.0 109.723 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.481 ' HA ' HG23 ' A' ' 113' ' ' ILE . 60.4 mttt -37.37 147.82 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.202 -0.936 . . . . 0.0 110.291 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -52.3 -27.87 25.65 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.7 -51.65 66.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -1.191 . . . . 0.0 109.51 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -77.01 -37.7 54.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.911 ' CE2' HG11 ' A' ' 78' ' ' VAL . 3.4 t80 -66.77 -53.3 34.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 109.753 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -60.29 -43.99 95.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.983 -1.073 . . . . 0.0 109.197 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.91 71.53 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.299 -0.876 . . . . 0.0 109.237 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.567 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -50.45 -53.32 30.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.416 -0.803 . . . . 0.0 108.94 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.515 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 6.0 t90 -54.98 -58.12 8.93 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -52.47 -16.31 0.86 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 110.396 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 2.4 m -70.59 179.11 2.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.885 -1.135 . . . . 0.0 110.207 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -90.4 -38.21 13.46 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.318 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.27 -48.28 68.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.183 -1.407 . . . . 0.0 109.463 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.817 HG22 ' CB ' ' A' ' 81' ' ' ALA . 3.3 t -62.37 -36.26 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.921 -1.112 . . . . 0.0 108.288 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -66.34 -31.99 73.11 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.079 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.1 t -66.02 -34.74 78.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.719 HD13 ' HG2' ' A' ' 80' ' ' MET . 40.6 mt -78.96 -18.3 53.98 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.486 HG23 ' HB1' ' A' ' 77' ' ' ALA . 7.7 t -79.49 -46.33 23.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.34 -38.87 85.56 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.3 -39.98 96.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 108.973 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.973 ' OE1' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -62.32 -62.65 1.61 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.912 . . . . 0.0 108.797 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.453 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 1.2 mt-10 -52.6 -30.61 32.11 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 5.2 mttt -72.57 -29.43 63.53 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.438 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -67.72 -54.67 17.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 109.236 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.15 86.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.663 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.39 -16.16 53.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.315 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 140' ' ' LYS . 6.3 m-20 -80.81 -45.09 17.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.983 -1.073 . . . . 0.0 109.014 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.737 HG21 ' CE1' ' A' ' 25' ' ' PHE . 23.3 m -99.32 -9.4 8.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.271 -0.893 . . . . 0.0 108.856 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 25.4 tt0 83.5 -39.63 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.658 -0.651 . . . . 0.0 109.537 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.764 HD13 ' CD2' ' A' ' 25' ' ' PHE . 13.4 tp 66.93 138.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.397 -0.815 . . . . 0.0 109.47 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -160.8 26.77 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.751 -1.218 . . . . 0.0 109.856 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 158.63 98.72 0.14 Allowed Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.171 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.863 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -89.72 138.95 27.79 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.579 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 32.6 Cg_endo -72.83 156.68 99.15 Favored 'Cis proline' 0 C--N 1.316 -1.147 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.865 2.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -151.79 117.18 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.939 -1.101 . . . . 0.0 108.385 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.819 ' CE ' HG22 ' A' ' 182' ' ' VAL . 4.8 tmm? -113.93 136.57 52.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.996 -1.065 . . . . 0.0 110.334 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 3.8 m-85 -123.92 135.81 53.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.476 -0.765 . . . . 0.0 109.208 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.607 HG22 HG22 ' A' ' 22' ' ' VAL . 92.2 t -100.65 131.94 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.94 . . . . 0.0 110.06 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.93 21.83 0.33 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.61 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.516 ' HA3' ' HB ' ' A' ' 16' ' ' VAL . . . 58.27 55.9 28.17 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -165.21 -35.64 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.191 -1.182 . . . . 0.0 108.379 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 154' ' ' PHE . 2.4 m-85 -111.52 120.42 42.06 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.019 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.516 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 12.8 tt0 -116.27 113.51 23.1 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.288 -0.883 . . . . 0.0 109.264 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 161' ' ' LEU . 8.6 mt -61.33 -179.6 0.17 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.36 -0.837 . . . . 0.0 108.847 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 24.2 m120 -137.35 150.19 68.0 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.026 -1.046 . . . . 0.0 109.459 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 162' ' ' ASN . 36.0 Cg_endo . . . . . 0 C--N 1.309 -1.543 0 C-N-CA 122.672 2.248 . . . . 0.0 110.648 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.818 0.818 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 172' ' ' ASP . 0.6 OUTLIER -69.61 -45.37 68.69 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.1 t -68.86 -22.32 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 108.831 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.429 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 22.7 t80 -72.48 -36.8 68.53 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.23 -0.919 . . . . 0.0 108.576 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.551 HG22 ' CG1' ' A' ' 42' ' ' ILE . 44.0 t -75.75 -26.96 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 109.194 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -83.32 -52.99 6.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.218 -0.926 . . . . 0.0 108.951 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.453 ' O ' ' OG1' ' A' ' 181' ' ' THR . 0.4 OUTLIER -62.88 -33.03 74.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.492 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.429 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 31.6 t80 -75.66 -54.18 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.521 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.49 -24.42 65.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 109.412 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -77.91 -50.09 12.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.328 -0.857 . . . . 0.0 109.299 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.828 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -58.39 -28.58 65.32 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.197 -0.94 . . . . 0.0 109.001 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.819 HG22 ' CE ' ' A' ' 153' ' ' MET . 66.4 t -85.91 -34.63 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.32 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -60.5 -42.56 96.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 108.98 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.644 ' CE2' HD22 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -82.46 -44.03 16.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.297 -0.877 . . . . 0.0 108.999 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.828 HD23 ' O ' ' A' ' 181' ' ' THR . 3.9 mm? -53.68 -18.35 2.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.942 -1.099 . . . . 0.0 109.417 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.7 t -66.31 -26.06 67.13 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.859 -1.151 . . . . 0.0 108.328 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.591 ' HB3' ' CE1' ' A' ' 9' ' ' TYR . 1.9 m-85 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -101.55 56.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.99 . . . . 0.0 109.833 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 46.04 82.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.614 -0.679 . . . . 0.0 110.239 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 116.11 -20.45 12.8 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.267 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.52 -68.01 0.72 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.182 -1.187 . . . . 0.0 109.107 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 3' ' ' TYR . 1.6 mp0 -97.53 6.2 48.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.375 -0.828 . . . . 0.0 109.606 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 8.3 p90 177.26 134.07 0.06 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.284 -0.885 . . . . 0.0 108.994 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -115.28 176.3 5.13 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.577 -0.702 . . . . 0.0 109.24 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.15 159.49 20.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.382 0.611 . . . . 0.0 109.612 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.582 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.5 OUTLIER -98.3 162.08 13.37 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.405 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.46 -0.23 36.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.147 -0.971 . . . . 0.0 109.141 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.34 113.29 1.02 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.374 -0.829 . . . . 0.0 109.12 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 34.7 Cg_endo -77.02 159.11 34.18 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.45 2.1 . . . . 0.0 110.849 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.587 ' O ' HG12 ' A' ' 16' ' ' VAL . 5.0 t -110.91 91.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.481 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.05 128.81 9.58 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.39 -21.9 41.77 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.765 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -40.46 160.67 0.12 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.986 . . . . 0.0 109.83 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.569 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.3 Cg_endo -79.22 128.83 8.38 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.726 2.284 . . . . 0.0 111.196 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.664 ' O ' HG22 ' A' ' 155' ' ' VAL . 16.3 mp0 -41.71 -25.37 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.498 -0.751 . . . . 0.0 109.861 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 22' ' ' VAL . 25.1 t -149.43 82.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.113 -0.992 . . . . 0.0 108.996 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.939 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.07 118.3 16.87 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -98.07 122.82 41.67 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.113 -0.992 . . . . 0.0 109.935 -179.066 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.094 ' CE2' HG21 ' A' ' 145' ' ' VAL . 9.1 m-85 -110.2 104.26 13.07 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -150.95 143.21 24.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.129 -0.982 . . . . 0.0 110.044 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.833 ' HB3' HG22 ' A' ' 61' ' ' VAL . 4.5 p -123.78 -167.65 1.66 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.66 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -110.18 53.57 0.69 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.582 ' CG ' HG11 ' A' ' 96' ' ' VAL . 9.1 m-85 -138.01 -1.94 1.93 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.831 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' CB ' ' HB3' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -108.49 164.79 13.97 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.571 -1.331 . . . . 0.0 109.405 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.506 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 32.0 Cg_endo -74.58 -32.56 5.96 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.35 2.033 . . . . 0.0 108.861 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -89.67 -19.11 25.24 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.038 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -52.96 -41.75 64.84 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.504 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 70.3 t80 -85.29 -39.03 18.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.305 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.516 ' O ' ' CG ' ' A' ' 40' ' ' LEU . 3.2 mt-30 -74.85 -24.4 58.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.986 -1.071 . . . . 0.0 110.429 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.63 ' HA ' HD12 ' A' ' 40' ' ' LEU . 25.7 t80 -76.41 -21.99 55.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.038 -1.039 . . . . 0.0 110.97 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.55 ' OE2' ' CE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -127.77 42.03 3.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.707 -1.245 . . . . 0.0 110.888 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 15.9 mm-40 -159.49 -68.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.174 -0.954 . . . . 0.0 109.899 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.02 -48.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 0.0 110.414 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.63 HD12 ' HA ' ' A' ' 36' ' ' PHE . 95.2 mt -54.03 -17.18 2.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.016 -1.052 . . . . 0.0 110.132 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.442 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 36.8 m80 45.91 30.85 0.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.081 -1.012 . . . . 0.0 109.281 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.716 ' O ' HG13 ' A' ' 46' ' ' VAL . 19.6 mt -79.3 -21.46 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.998 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.2 m -80.44 -21.06 42.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.982 -1.074 . . . . 0.0 110.512 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 41' ' ' HIS . 2.0 p-10 -87.06 -50.5 6.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.899 -1.126 . . . . 0.0 110.356 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 46' ' ' VAL . 45.2 p-10 -64.46 -26.22 68.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.193 -0.942 . . . . 0.0 110.533 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 42' ' ' ILE . 27.7 m -74.21 -24.66 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.987 -1.07 . . . . 0.0 109.976 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -73.65 -46.78 44.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.049 -1.032 . . . . 0.0 109.516 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.512 ' N ' ' HD3' ' A' ' 48' ' ' LYS . 24.3 mmtm -58.86 -16.78 18.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.211 -0.931 . . . . 0.0 109.067 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.499 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -101.83 22.66 12.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 109.946 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.873 ' O ' HG22 ' A' ' 54' ' ' VAL . 7.9 mt -124.06 66.09 39.81 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.007 -1.058 . . . . 0.0 110.706 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 37.2 Cg_endo -80.09 140.67 14.24 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.406 2.07 . . . . 0.0 110.13 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 51' ' ' PRO . 12.6 tm-20 61.87 132.88 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.386 -0.821 . . . . 0.0 108.822 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . 58.89 23.35 56.33 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 50' ' ' LEU . 2.0 t -60.33 80.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.752 -0.852 . . . . 0.0 109.374 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -125.77 91.94 3.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.131 -0.98 . . . . 0.0 110.264 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.41 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 7.1 ttt -103.72 98.31 8.2 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -93.35 134.5 35.5 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.057 -179.269 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 3.9 mtmt -109.8 108.98 19.5 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.448 -0.782 . . . . 0.0 109.487 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.584 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 2.7 m-85 -109.8 169.42 8.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.865 -1.147 . . . . 0.0 111.083 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.804 ' NE2' HD22 ' A' ' 72' ' ' LEU . 4.0 t60 -107.68 133.45 52.09 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.744 0.783 . . . . 0.0 108.995 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.128 HG11 ' CG1' ' A' ' 150' ' ' VAL . 3.2 m -71.98 157.4 6.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 O-C-N 121.738 -0.601 . . . . 0.0 109.536 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.414 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 2.9 p-10 -123.46 47.2 2.05 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 16.0 p90 -148.52 61.57 1.08 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.093 -1.004 . . . . 0.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.688 ' HE1' HG23 ' A' ' 61' ' ' VAL . 0.5 OUTLIER -133.13 38.0 3.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.288 -0.883 . . . . 0.0 109.051 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.49 -31.37 1.14 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.79 -35.83 3.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 -79.37 0.28 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.874 -1.368 . . . . 0.0 109.676 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.108 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -78.59 -19.18 53.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.974 -1.079 . . . . 0.0 109.197 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 1.108 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -58.73 -57.11 21.6 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.76 -49.04 74.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.286 -1.126 . . . . 0.0 108.048 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.648 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 49.9 t0 -59.94 -26.68 66.16 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.804 HD22 ' NE2' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -60.75 -36.24 78.41 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.412 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.585 HG23 ' OE1' ' A' ' 138' ' ' GLN . 31.5 m -67.0 -41.17 87.18 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 7.8 tp60 -61.73 -17.43 55.78 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.803 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -71.49 -45.1 63.42 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 20.0 t-105 -64.58 -31.84 73.22 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.175 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.565 ' HB2' HE21 ' A' ' 138' ' ' GLN . . . -77.88 -54.43 6.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.87 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.107 HG11 ' CE2' ' A' ' 122' ' ' TYR . 88.8 t -59.71 -26.18 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.151 -0.968 . . . . 0.0 109.964 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.521 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -83.55 -60.77 2.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 109.243 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.421 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -45.67 -28.87 1.09 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.171 -0.956 . . . . 0.0 108.53 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.938 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -72.57 -41.51 65.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.472 -0.768 . . . . 0.0 109.374 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.491 ' CB ' HG13 ' A' ' 84' ' ' VAL . 20.9 mt -101.51 9.41 41.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -0.962 . . . . 0.0 110.381 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.76 24.23 7.77 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.618 HG11 HG12 ' A' ' 117' ' ' ILE . 33.2 m -87.29 -9.2 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.427 -1.043 . . . . 0.0 110.759 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.46 ' O ' ' HB ' ' A' ' 89' ' ' THR . 2.8 pt-20 -42.08 -58.76 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.047 -1.033 . . . . 0.0 110.015 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.6 -33.75 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.237 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.905 ' HE2' ' HB1' ' A' ' 115' ' ' ALA . 36.5 mtpt -83.6 -50.47 8.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.339 -0.851 . . . . 0.0 111.425 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.897 HG23 HD12 ' A' ' 92' ' ' LEU . 1.3 m -83.25 -7.51 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.786 -1.196 . . . . 0.0 110.784 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.675 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.31 -44.38 45.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.703 -1.248 . . . . 0.0 108.728 179.034 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.428 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -53.49 -52.76 63.77 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.542 -1.349 . . . . 0.0 110.555 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.572 ' HB2' HG13 ' A' ' 111' ' ' VAL . 25.3 Cg_endo -73.7 -18.47 22.22 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 N-CA-C 109.877 -0.855 . . . . 0.0 109.877 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.909 ' HG ' HG11 ' A' ' 111' ' ' VAL . 21.8 mt -87.07 -43.59 12.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 108.863 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.675 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.4 m-30 -65.57 -45.77 81.99 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.008 -1.058 . . . . 0.0 108.984 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -73.44 -20.73 60.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.065 -1.022 . . . . 0.0 109.08 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.58 -36.29 62.44 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.582 HG11 ' CG ' ' A' ' 29' ' ' PHE . 1.5 t -102.09 -0.49 10.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.087 -1.243 . . . . 0.0 109.409 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.493 ' OE1' ' HB3' ' A' ' 93' ' ' PHE . 16.4 mt-30 -97.91 1.53 48.16 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 120.915 -1.116 . . . . 0.0 110.557 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 175.79 81.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.744 -1.222 . . . . 0.0 109.582 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.904 HG22 ' H ' ' A' ' 101' ' ' THR . 1.2 m 157.71 -43.85 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.9 OUTLIER 69.09 16.26 8.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.867 -1.146 . . . . 0.0 110.735 178.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.904 ' H ' HG22 ' A' ' 99' ' ' THR . 5.3 t -79.3 -7.61 58.44 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.566 ' CB ' HG22 ' A' ' 96' ' ' VAL . 12.6 mm -87.62 61.93 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -127.58 32.18 5.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.967 . . . . 0.0 109.48 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 107' ' ' ASP . 4.8 p -153.02 128.11 9.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.002 -1.061 . . . . 0.0 110.075 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.745 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.55 -31.03 9.5 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -34.14 74.72 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -68.51 -51.11 46.74 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 105' ' ' ALA . 27.9 mt -48.16 -29.9 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 0.0 108.684 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -76.86 -39.9 49.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 109.419 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -57.34 -41.18 79.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.405 -0.809 . . . . 0.0 109.646 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.909 HG11 ' HG ' ' A' ' 92' ' ' LEU . 19.9 t -73.88 -38.45 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.173 -0.954 . . . . 0.0 109.569 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CD2' ' HD2' ' A' ' 122' ' ' TYR . 2.6 m-85 -64.52 -39.01 92.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.052 -1.03 . . . . 0.0 109.121 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.4 mt -75.11 -22.38 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.342 -0.849 . . . . 0.0 109.548 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -16.98 62.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.315 -0.866 . . . . 0.0 109.876 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.905 ' HB1' ' HE2' ' A' ' 87' ' ' LYS . . . -91.04 6.4 45.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.725 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.68 2.56 75.6 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.801 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.4 mp -86.27 63.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -1.102 . . . . 0.0 109.074 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -31.75 149.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.199 -0.938 . . . . 0.0 110.859 -179.218 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.42 -32.92 58.14 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.03 -46.26 82.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.999 -1.295 . . . . 0.0 109.195 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -73.01 -43.72 61.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 1.107 ' CE2' HG11 ' A' ' 78' ' ' VAL . 4.3 t80 -57.99 -45.59 86.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.613 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -64.3 -37.8 88.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.147 -0.97 . . . . 0.0 108.979 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.03 -50.35 72.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.151 -0.968 . . . . 0.0 108.878 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.51 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -52.0 -49.3 63.58 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.453 ' C ' ' CD1' ' A' ' 126' ' ' TRP . 3.5 t90 -58.22 -59.65 4.99 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -15.35 6.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.633 -0.667 . . . . 0.0 110.253 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.478 ' OG ' HG23 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -69.6 172.93 6.63 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.056 -1.028 . . . . 0.0 110.086 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -89.5 -40.14 12.86 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.39 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.6 t -63.13 -46.15 96.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.105 -1.438 . . . . 0.0 109.341 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.938 HG22 ' HB1' ' A' ' 81' ' ' ALA . 2.1 t -69.58 -33.79 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.975 -1.078 . . . . 0.0 108.369 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 128' ' ' SER . 19.2 ttpt -63.64 -37.99 89.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.5 p -69.37 -32.42 71.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.415 -0.803 . . . . 0.0 108.91 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -19.18 49.69 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.903 . . . . 0.0 108.781 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.515 HG23 ' HB1' ' A' ' 77' ' ' ALA . 3.0 t -78.68 -48.77 21.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -62.33 -38.9 91.27 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -35.8 82.22 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.4 -0.813 . . . . 0.0 109.29 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.585 ' OE1' HG23 ' A' ' 73' ' ' THR . 3.7 mt-30 -67.55 -66.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 109.185 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.33 -37.61 17.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.185 -0.947 . . . . 0.0 108.66 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 9.3 mttm -71.53 -33.57 69.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.367 -0.833 . . . . 0.0 108.85 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.503 ' CB ' ' CD2' ' A' ' 59' ' ' TYR . . . -56.64 -62.22 1.88 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 109.128 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -69.09 -26.24 64.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.599 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 140' ' ' LYS . . . -76.09 -26.01 56.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.887 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.752 ' OD1' HG13 ' A' ' 145' ' ' VAL . 0.6 OUTLIER -80.88 -49.92 10.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.993 . . . . 0.0 108.478 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 1.094 HG21 ' CE2' ' A' ' 25' ' ' PHE . 19.7 m -84.75 -13.27 11.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 2.7 mt-30 80.89 -47.14 0.26 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.682 . . . . 0.0 109.875 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.525 HD21 ' CG1' ' A' ' 61' ' ' VAL . 24.4 tp 65.06 137.9 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.7 ttt85 -160.5 27.74 0.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.457 -1.402 . . . . 0.0 110.161 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.97 106.47 0.2 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.314 -1.422 . . . . 0.0 110.619 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 1.128 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -83.13 144.46 47.23 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.41 -1.053 . . . . 0.0 108.934 178.635 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.48 151.73 89.64 Favored 'Cis proline' 0 C--N 1.315 -1.224 0 C-N-CA 124.176 -1.177 . . . . 0.0 110.854 0.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.797 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -127.84 153.12 46.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.41 -1.431 . . . . 0.0 109.103 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -148.11 130.07 15.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.899 -1.126 . . . . 0.0 110.424 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.607 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 24.5 m-85 -126.22 129.17 48.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.53 -0.731 . . . . 0.0 109.698 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 21' ' ' GLN . 14.8 t -96.77 131.13 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 0.0 109.607 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.765 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 5.7 t30 43.16 23.73 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.471 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.549 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.87 58.11 16.19 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.482 ' HE3' ' CE2' ' A' ' 159' ' ' TYR . 32.6 ttpt -166.27 -35.67 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.482 ' CE2' ' HE3' ' A' ' 158' ' ' LYS . 50.3 m-85 -119.6 120.93 38.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.892 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.607 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -119.42 120.55 37.19 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.171 -0.956 . . . . 0.0 109.714 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 9' ' ' TYR . 69.8 mt -61.85 175.38 0.67 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -149.86 114.5 3.44 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.947 -1.095 . . . . 0.0 109.384 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--N 1.313 -1.342 0 C-N-CA 122.598 2.199 . . . . 0.0 111.351 -179.849 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 14.3 mtt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.615 0.722 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.75 -49.17 66.81 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.37 -29.16 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.033 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -68.25 -31.38 70.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.113 -0.992 . . . . 0.0 108.85 179.656 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.417 HG22 HD11 ' A' ' 42' ' ' ILE . 53.3 t -79.28 -29.29 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.552 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -82.97 -53.02 6.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.001 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.46 ' O ' ' OG1' ' A' ' 181' ' ' THR . 1.0 OUTLIER -62.34 -47.27 84.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.458 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.604 ' O ' HG23 ' A' ' 182' ' ' VAL . 4.2 t80 -61.83 -49.68 75.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.01 -34.69 68.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.102 -0.999 . . . . 0.0 108.998 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -73.77 -38.73 64.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.423 -0.798 . . . . 0.0 109.182 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.662 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -59.01 -29.68 67.43 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 178' ' ' TYR . 2.5 t -83.95 -36.41 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.973 . . . . 0.0 109.28 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.477 ' HB2' ' CG ' ' A' ' 49' ' ' LYS . 16.9 tttt -60.77 -46.49 90.25 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.173 -0.955 . . . . 0.0 108.915 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.567 ' CD2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -81.63 -30.91 32.63 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.366 -0.834 . . . . 0.0 109.371 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 181' ' ' THR . 0.4 OUTLIER -61.01 -20.93 63.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.825 -1.172 . . . . 0.0 108.775 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.635 ' HB3' HD23 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -80.79 -4.57 55.06 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.98 -1.075 . . . . 0.0 108.471 178.243 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 108.867 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -99.63 58.2 1.04 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.07 -1.019 . . . . 0.0 110.011 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 t0 48.98 85.26 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.44 -0.788 . . . . 0.0 110.04 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 114.92 -21.91 13.13 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -81.27 -67.25 0.8 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -1.196 . . . . 0.0 108.696 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 3' ' ' TYR . 15.7 mp0 -99.09 7.83 45.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.252 -0.905 . . . . 0.0 109.611 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.669 ' CB ' HD23 ' A' ' 161' ' ' LEU . 4.4 p90 176.54 134.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 108.975 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.471 HG23 ' CG ' ' A' ' 160' ' ' GLN . 9.3 t -114.43 177.68 4.55 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.585 -0.697 . . . . 0.0 109.328 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.502 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 0.4 OUTLIER -88.41 160.67 17.46 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.542 0.686 . . . . 0.0 110.42 -179.151 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.452 ' HG ' ' HB3' ' A' ' 160' ' ' GLN . 7.4 mt -98.41 161.74 13.53 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.562 -0.711 . . . . 0.0 109.127 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.416 ' C ' ' HG2' ' A' ' 14' ' ' LYS . 5.0 pm0 -115.6 -3.98 12.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 109.611 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 13' ' ' GLU . 3.7 mmtp -139.89 75.11 30.88 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.18 -0.95 . . . . 0.0 109.617 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 157' ' ' GLY . 35.3 Cg_endo -77.99 159.62 30.6 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.561 2.174 . . . . 0.0 110.576 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.862 HG21 ' HB3' ' A' ' 144' ' ' ASP . 1.7 t -134.36 129.74 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.369 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.52 126.57 15.66 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 74.65 6.45 77.19 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.933 ' HB1' ' HD2' ' A' ' 20' ' ' PRO . . . -42.57 172.45 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.498 -1.001 . . . . 0.0 110.277 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.933 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 30.8 Cg_endo -71.52 111.94 3.24 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.919 2.412 . . . . 0.0 111.74 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.665 ' O ' HG22 ' A' ' 155' ' ' VAL . 27.0 mm-40 -52.85 -22.35 5.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.557 -0.715 . . . . 0.0 109.597 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.683 ' O ' HG12 ' A' ' 22' ' ' VAL . 10.5 t -156.62 79.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.655 HD12 ' HG3' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -81.7 138.48 35.24 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.586 ' H ' HD23 ' A' ' 23' ' ' LEU . 10.5 tt0 -132.85 103.1 5.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.047 -1.033 . . . . 0.0 109.789 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.912 ' HE2' HG21 ' A' ' 145' ' ' VAL . 58.4 m-85 -86.01 126.4 34.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.179 -0.951 . . . . 0.0 109.031 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.4 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 2.6 p90 -157.14 133.15 9.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.231 -0.918 . . . . 0.0 109.791 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.7 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 70.1 m -104.33 -174.37 2.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.413 -0.805 . . . . 0.0 109.827 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.558 ' O ' ' CD1' ' A' ' 29' ' ' PHE . 16.0 m-30 -104.53 48.46 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.665 ' CG ' HG11 ' A' ' 96' ' ' VAL . 16.6 m-85 -146.91 14.32 1.17 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 110.338 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -104.51 162.5 19.65 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.675 -1.266 . . . . 0.0 109.67 -179.768 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.96 -36.14 2.76 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.212 1.941 . . . . 0.0 108.388 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' A' ' 36' ' ' PHE . 4.4 m-70 -82.98 -22.32 33.71 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 16.2 t -47.06 -52.95 13.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.514 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 11.3 t80 -75.18 -40.66 59.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.794 -0.566 . . . . 0.0 110.403 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -72.38 -16.92 61.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.057 -1.027 . . . . 0.0 110.417 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' HIS . 1.8 m-85 -82.58 -29.62 30.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.02 -1.05 . . . . 0.0 110.443 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.74 22.7 13.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.955 -1.09 . . . . 0.0 109.629 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.514 ' OE2' ' CZ ' ' A' ' 34' ' ' TYR . 5.5 mm-40 -132.09 -61.09 0.89 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 111.092 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.2 t -90.61 -75.56 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.899 -1.126 . . . . 0.0 111.708 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 0.7 OUTLIER -70.75 -24.39 62.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.954 -1.091 . . . . 0.0 110.679 -178.089 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 44' ' ' ASP . 94.9 m-70 60.67 32.71 20.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.058 -1.026 . . . . 0.0 108.965 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' A' ' 41' ' ' HIS . 13.5 mm -42.22 -26.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.419 -0.8 . . . . 0.0 109.921 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 41' ' ' HIS . 0.9 OUTLIER -81.4 -43.39 19.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.92 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 41' ' ' HIS . 84.1 m-20 -85.39 -36.59 20.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.952 . . . . 0.0 109.894 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -65.04 -38.64 91.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 109.556 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 43' ' ' SER . 9.8 p -68.54 -26.46 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.736 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -61.64 -39.23 90.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.476 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -51.17 -24.45 4.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.169 -0.957 . . . . 0.0 108.734 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.867 ' O ' HD23 ' A' ' 50' ' ' LEU . 17.6 mmtm -91.05 25.04 2.58 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.517 -0.739 . . . . 0.0 109.423 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.867 HD23 ' O ' ' A' ' 49' ' ' LYS . 14.2 mt -125.22 67.3 54.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.175 -0.953 . . . . 0.0 110.104 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 36.6 Cg_endo -79.39 75.35 5.11 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.542 2.161 . . . . 0.0 110.937 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 51' ' ' PRO . 6.0 tm-20 58.82 131.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.395 0.617 . . . . 0.0 110.2 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.08 -11.63 60.44 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.814 ' CG1' HD22 ' A' ' 50' ' ' LEU . 1.1 t -114.61 98.43 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -1.185 . . . . 0.0 109.142 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -86.09 102.95 14.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.909 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.513 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 8.7 ttt -99.02 102.88 14.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.428 -0.795 . . . . 0.0 109.606 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.0 m -99.1 126.48 44.85 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.265 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 113.83 27.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.458 -0.777 . . . . 0.0 109.382 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.552 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.8 m-85 -115.33 163.75 15.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.029 -1.045 . . . . 0.0 111.404 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.818 ' CE1' HD21 ' A' ' 72' ' ' LEU . 2.6 t-80 -117.28 122.16 43.18 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.13 HG11 ' CD2' ' A' ' 147' ' ' LEU . 16.8 m -101.88 156.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 110.384 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 1.1 p-10 -83.92 42.65 0.87 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.402 -0.811 . . . . 0.0 109.536 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.609 ' CD1' ' CG2' ' A' ' 61' ' ' VAL . 3.7 m-85 -91.56 30.96 1.23 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.0 110.023 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.438 ' SD ' ' HB3' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -161.74 45.93 0.17 Allowed 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.65 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 161.73 60.03 0.02 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.507 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.52 -35.72 0.13 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 65' ' ' GLY . 92.3 m-20 -88.94 -78.64 0.34 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -1.173 . . . . 0.0 110.129 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.929 HD23 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -82.27 -21.62 36.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.769 -1.207 . . . . 0.0 110.088 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.732 ' N ' HD22 ' A' ' 68' ' ' LEU . . . -51.97 -39.93 49.63 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 2.9 ttmt -61.05 -41.58 96.87 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.473 ' OD1' ' NE2' ' A' ' 74' ' ' GLN . 0.6 OUTLIER -70.79 -29.54 65.75 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.145 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.818 HD21 ' CE1' ' A' ' 60' ' ' HIS . 13.9 tp -58.17 -50.77 72.38 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -56.64 -43.2 80.05 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.82 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -54.92 -27.17 41.24 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.828 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.51 -46.36 86.44 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 29.7 t-105 -53.97 -31.98 52.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.504 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -81.99 -66.31 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.408 -0.808 . . . . 0.0 110.012 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 74' ' ' GLN . 2.2 t -47.55 -30.68 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.214 -0.929 . . . . 0.0 110.047 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.439 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.5 -63.48 1.41 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.824 -1.173 . . . . 0.0 109.188 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.416 ' C ' ' O ' ' A' ' 79' ' ' ALA . 21.7 mtp -46.21 -27.12 0.91 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.594 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.647 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -67.8 -46.86 70.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 109.591 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.8 mt -99.62 7.24 45.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.63 31.18 60.18 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 26.9 m -97.35 8.21 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.448 -1.031 . . . . 0.0 110.144 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.475 ' HG2' ' OG1' ' A' ' 89' ' ' THR . 2.3 tt0 -52.76 -70.56 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.086 -1.009 . . . . 0.0 109.722 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -38.89 -33.78 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 0.0 110.282 -179.627 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.6 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 25.1 mtpp -80.91 -52.5 7.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.377 -0.827 . . . . 0.0 110.995 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.688 HG23 HD12 ' A' ' 92' ' ' LEU . 1.3 m -86.12 -13.89 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.684 -1.26 . . . . 0.0 110.803 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.77 HG23 ' CE1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -73.68 -42.39 61.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.646 -1.284 . . . . 0.0 108.206 178.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.403 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 2.1 t -54.22 -54.67 45.21 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.63 -1.294 . . . . 0.0 110.353 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.507 ' HB2' HG13 ' A' ' 111' ' ' VAL . 25.9 Cg_endo -72.82 -21.1 21.79 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 N-CA-C 109.758 -0.901 . . . . 0.0 109.758 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.688 HD12 HG23 ' A' ' 88' ' ' VAL . 15.6 mt -81.09 -44.64 17.67 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.77 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.6 m-30 -64.03 -44.87 91.21 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.107 -0.995 . . . . 0.0 108.62 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -72.97 -24.33 60.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.297 -0.877 . . . . 0.0 109.321 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.901 ' O ' HG23 ' A' ' 99' ' ' THR . . . -69.03 -36.09 80.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.665 HG11 ' CG ' ' A' ' 29' ' ' PHE . 2.2 t -98.95 -1.57 10.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.225 -1.162 . . . . 0.0 108.768 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.47 ' HG3' ' HB2' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -110.26 6.27 22.41 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 121.022 -1.048 . . . . 0.0 111.323 -179.092 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.754 ' C ' HG22 ' A' ' 99' ' ' THR . 1.5 ttmm -164.57 52.2 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.476 -1.39 . . . . 0.0 109.402 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.901 HG23 ' O ' ' A' ' 95' ' ' GLY . 0.5 OUTLIER 175.15 -51.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.361 -0.837 . . . . 0.0 109.847 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.534 ' O ' ' CD ' ' A' ' 103' ' ' ARG . 1.1 mt-30 75.05 10.95 3.66 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.042 -1.036 . . . . 0.0 109.886 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.1 t -84.32 -8.33 59.04 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.608 0.718 . . . . 0.0 109.319 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.468 HG13 ' C ' ' A' ' 95' ' ' GLY . 10.2 mm -74.14 75.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.56 -0.712 . . . . 0.0 109.544 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.534 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -136.65 31.42 2.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.84 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.533 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 7.3 p -146.91 128.45 15.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.064 -1.022 . . . . 0.0 109.716 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.54 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -52.82 -30.17 31.94 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.6 t -65.83 -29.03 69.43 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 104' ' ' SER . 61.6 m-20 -77.21 -39.5 48.45 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.396 -0.922 . . . . 0.0 108.678 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.929 HD11 HD23 ' A' ' 68' ' ' LEU . 44.4 mt -59.51 -29.82 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.29 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 4.6 mtm180 -78.03 -32.07 50.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.528 -0.733 . . . . 0.0 109.275 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.4 OUTLIER -61.47 -48.02 83.02 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.246 -0.909 . . . . 0.0 109.2 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.635 HG11 ' HG ' ' A' ' 92' ' ' LEU . 53.1 t -68.39 -40.37 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.915 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.579 ' CD1' HG11 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -56.78 -37.59 71.32 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.242 -0.912 . . . . 0.0 109.28 179.442 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.8 mt -76.16 -24.79 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -0.805 . . . . 0.0 109.869 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -64.47 -18.78 65.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.027 -1.046 . . . . 0.0 109.371 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.6 ' HB1' ' HE3' ' A' ' 87' ' ' LYS . . . -94.33 6.42 48.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.534 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.96 -1.48 77.94 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.732 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -78.74 57.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -1.118 . . . . 0.0 109.442 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 117' ' ' ILE . 2.2 mttt -37.73 153.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.882 . . . . 0.0 110.134 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.99 -38.01 73.47 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.431 ' HG3' ' HB2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -50.43 -49.18 55.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.945 -1.326 . . . . 0.0 109.571 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.22 -48.79 12.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 110.335 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.807 ' CE2' HG11 ' A' ' 78' ' ' VAL . 4.1 t80 -58.28 -52.3 66.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.017 -1.052 . . . . 0.0 109.622 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -62.0 -41.13 97.72 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.33 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.58 -50.4 73.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.102 -0.999 . . . . 0.0 108.928 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 128' ' ' SER . . . -55.28 -46.71 76.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 108.886 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.729 ' HA ' HG11 ' A' ' 131' ' ' VAL . 4.7 t90 -57.55 -57.08 14.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.231 -0.918 . . . . 0.0 108.53 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -60.7 -15.54 30.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.5 -0.75 . . . . 0.0 109.553 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 63.1 m -76.13 -172.93 2.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.141 -0.975 . . . . 0.0 109.83 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -95.55 -28.3 14.93 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.906 -0.496 . . . . 0.0 111.061 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.14 -41.88 93.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.405 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.729 HG11 ' HA ' ' A' ' 126' ' ' TRP . 49.9 t -70.86 -36.65 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 120.995 -1.066 . . . . 0.0 108.487 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -67.4 -27.46 67.1 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.23 -37.68 69.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 138' ' ' GLN . 0.5 OUTLIER -79.45 -22.19 44.48 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.504 HG23 ' CB ' ' A' ' 77' ' ' ALA . 17.1 t -79.12 -40.96 22.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.511 ' O ' ' CG ' ' A' ' 140' ' ' LYS . . . -68.01 -48.55 65.39 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.495 -0.753 . . . . 0.0 109.038 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.488 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -61.29 -32.69 72.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.233 -0.917 . . . . 0.0 108.751 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.552 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 4.4 tm0? -66.06 -69.76 0.28 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.827 . . . . 0.0 109.093 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' GLN . 0.0 OUTLIER -46.87 -32.67 3.92 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -70.28 -35.05 73.48 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.673 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -57.05 -50.3 73.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -70.25 -33.17 71.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.433 -0.792 . . . . 0.0 109.8 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.25 -18.21 55.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 110.042 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.862 ' HB3' HG21 ' A' ' 16' ' ' VAL . 67.4 m-20 -82.84 -43.48 16.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.048 -1.032 . . . . 0.0 108.36 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.912 HG21 ' HE2' ' A' ' 25' ' ' PHE . 27.5 m -98.61 -12.65 8.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.2 OUTLIER 83.61 -40.9 0.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.69 -0.631 . . . . 0.0 109.564 -179.507 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.13 ' CD2' HG11 ' A' ' 61' ' ' VAL . 10.7 tp 67.85 134.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 0.0 109.329 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -144.29 11.45 1.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.557 -1.339 . . . . 0.0 110.746 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.31 93.74 0.1 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.678 -1.725 . . . . 0.0 111.575 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 1.003 HG11 HG21 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -81.64 139.45 47.38 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 150' ' ' VAL . 32.4 Cg_endo -72.23 156.32 98.25 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 124.198 -1.168 . . . . 0.0 112.101 2.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.72 152.07 21.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.059 -1.025 . . . . 0.0 108.259 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.518 ' O ' ' CD1' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -131.69 137.83 48.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.928 -1.108 . . . . 0.0 110.195 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 153' ' ' MET . 14.0 m-85 -133.32 136.23 45.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.399 -0.813 . . . . 0.0 109.524 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 21' ' ' GLN . 12.1 t -110.78 119.59 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.046 -1.034 . . . . 0.0 108.352 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 20' ' ' PRO . 1.7 m-20 53.29 27.31 6.0 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 15' ' ' PRO . . . 50.18 21.66 4.29 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.232 -1.461 . . . . 0.0 109.614 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -118.79 -21.02 8.0 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.756 -1.438 . . . . 0.0 108.721 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.446 ' N ' HD12 ' A' ' 12' ' ' LEU . 17.9 m-85 -134.87 123.93 24.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 109.291 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 11' ' ' THR . 25.4 pt20 -116.93 117.42 29.64 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.268 -0.895 . . . . 0.0 109.59 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.669 HD23 ' CB ' ' A' ' 9' ' ' TYR . 11.6 mt -60.83 179.47 0.17 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.502 -0.749 . . . . 0.0 108.98 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -155.17 117.92 2.43 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.037 -1.039 . . . . 0.0 109.529 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 C--N 1.312 -1.379 0 C-N-CA 122.328 2.019 . . . . 0.0 110.635 179.888 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.433 ' O ' HG23 ' A' ' 175' ' ' VAL . 5.7 mmm . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.773 0.797 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -78.53 -56.56 4.34 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 6.9 t -64.09 -28.49 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 108.939 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.437 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 48.7 t80 -69.18 -43.16 74.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 0.0 109.229 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 171' ' ' MET . 61.3 t -70.05 -27.35 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.181 -0.949 . . . . 0.0 109.478 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -83.95 -58.71 2.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 109.251 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.457 ' O ' ' OG1' ' A' ' 181' ' ' THR . 0.0 OUTLIER -56.94 -41.73 78.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.397 -0.815 . . . . 0.0 109.197 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.647 ' O ' HG23 ' A' ' 182' ' ' VAL . 69.2 t80 -65.54 -51.85 56.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.067 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.17 -25.28 67.68 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.241 -0.912 . . . . 0.0 109.26 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.28 -45.07 20.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.899 . . . . 0.0 109.348 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.72 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -57.0 -42.32 80.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.221 -0.924 . . . . 0.0 109.14 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 178' ' ' TYR . 2.4 t -74.49 -36.55 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 109.135 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -57.55 -50.11 74.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.19 -0.944 . . . . 0.0 109.102 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -31.46 55.66 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.235 -0.916 . . . . 0.0 109.086 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.72 HD23 ' O ' ' A' ' 181' ' ' THR . 0.4 OUTLIER -58.24 -21.3 47.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.841 -1.162 . . . . 0.0 109.171 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.573 ' HB2' HG22 ' A' ' 54' ' ' VAL . 87.2 p -74.39 -4.77 38.45 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.817 -1.177 . . . . 0.0 108.691 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.418 -0.802 . . . . 0.0 109.267 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.506 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.2 58.41 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.79 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.0 t0 50.5 84.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.574 -0.704 . . . . 0.0 110.271 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 112.89 -19.73 20.65 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -66.62 0.86 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.057 -1.26 . . . . 0.0 108.684 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 3' ' ' TYR . 40.6 mm-40 -102.62 10.61 38.62 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.321 -0.862 . . . . 0.0 109.678 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.537 ' HB2' HD23 ' A' ' 161' ' ' LEU . 6.9 p90 179.1 136.09 0.09 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.07 -1.019 . . . . 0.0 109.426 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.495 HG23 ' CG ' ' A' ' 160' ' ' GLN . 2.3 t -123.55 171.9 9.17 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.5 m -120.97 149.69 42.27 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.514 0.673 . . . . 0.0 110.199 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 158' ' ' LYS . 1.3 mp -98.18 157.45 16.15 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.572 -0.705 . . . . 0.0 109.21 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.513 ' HG2' ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -84.7 -25.64 28.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 109.192 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.513 ' N ' ' HG2' ' A' ' 13' ' ' GLU . 7.4 mttp -116.24 96.44 47.51 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.359 -0.838 . . . . 0.0 109.046 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 34.3 Cg_endo -76.74 159.95 34.7 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.337 2.025 . . . . 0.0 110.481 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.73 HG21 ' HB3' ' A' ' 144' ' ' ASP . 11.7 t -108.73 90.52 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.885 . . . . 0.0 109.762 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.96 131.5 12.12 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 95.18 -24.49 28.6 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.719 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -41.2 160.62 0.14 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.404 -1.056 . . . . 0.0 109.471 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.572 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.0 Cg_endo -78.13 129.26 9.55 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.563 2.175 . . . . 0.0 111.015 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.649 ' O ' HG22 ' A' ' 155' ' ' VAL . 2.5 mp0 -46.68 -20.69 0.14 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.771 ' O ' HG12 ' A' ' 22' ' ' VAL . 3.1 t -148.35 79.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.873 -1.142 . . . . 0.0 108.73 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.761 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -73.76 127.47 32.9 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.5 ' HB3' ' HA ' ' A' ' 58' ' ' LYS . 33.2 tt0 -114.64 118.08 32.65 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.99 -1.068 . . . . 0.0 109.564 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.785 ' CD2' HD13 ' A' ' 147' ' ' LEU . 7.5 m-85 -103.76 112.5 25.47 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.586 -0.696 . . . . 0.0 109.274 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -155.19 142.28 19.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.998 -1.064 . . . . 0.0 110.14 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.807 ' HB3' HG22 ' A' ' 61' ' ' VAL . 4.3 p -124.55 -168.63 1.84 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.627 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -116.47 52.54 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.857 -1.152 . . . . 0.0 108.036 178.613 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.763 ' CD1' HG11 ' A' ' 96' ' ' VAL . 7.6 m-85 -139.97 10.62 2.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.222 -0.924 . . . . 0.0 110.236 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.717 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 4.0 m -117.06 179.88 0.74 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.753 -1.217 . . . . 0.0 108.484 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.3 Cg_endo -76.02 -59.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.593 1.529 . . . . 0.0 110.169 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -69.4 -11.46 60.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.955 -1.09 . . . . 0.0 108.4 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 27' ' ' SER . 1.2 m -57.15 -37.93 72.78 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.584 ' CE1' ' HG3' ' A' ' 38' ' ' GLU . 18.6 t80 -81.22 -41.91 21.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.758 -0.589 . . . . 0.0 109.791 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.492 ' N ' ' OE1' ' A' ' 35' ' ' GLN . 11.7 mp0 -78.56 -21.26 48.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.945 . . . . 0.0 110.681 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.77 ' CE2' HG21 ' A' ' 42' ' ' ILE . 27.0 t80 -75.52 -18.03 59.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 0.0 110.521 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 2.2 mm-40 -128.28 32.34 4.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.928 -1.107 . . . . 0.0 110.419 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.584 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 4.5 mm-40 -145.18 -67.89 0.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.977 -1.077 . . . . 0.0 109.797 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.46 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 13.2 t -97.1 -56.79 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.057 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.496 ' HB3' HG13 ' A' ' 42' ' ' ILE . 61.2 mt -43.49 -27.9 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.118 -0.989 . . . . 0.0 109.93 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' A' ' 38' ' ' GLU . 29.7 m170 49.37 24.28 1.03 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.044 -1.035 . . . . 0.0 109.027 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.77 HG21 ' CE2' ' A' ' 36' ' ' PHE . 12.2 mt -59.51 -32.8 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.42 -0.8 . . . . 0.0 109.64 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -45.09 24.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.051 -1.031 . . . . 0.0 110.006 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -81.16 -36.45 30.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.921 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 41' ' ' HIS . 6.2 t-20 -67.47 -30.34 70.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.947 . . . . 0.0 109.907 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 42' ' ' ILE . 43.5 t -74.5 -17.65 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.182 -0.949 . . . . 0.0 109.523 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.689 ' HA ' HD12 ' A' ' 50' ' ' LEU . 25.9 mttm -75.9 -34.39 59.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.451 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -57.7 -18.96 23.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.922 . . . . 0.0 109.583 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.81 17.76 14.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.439 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.689 HD12 ' HA ' ' A' ' 47' ' ' LYS . 11.9 mt -93.62 118.65 67.51 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.751 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.32 151.99 30.18 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.301 2.001 . . . . 0.0 108.954 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.493 ' O ' ' CG ' ' A' ' 52' ' ' GLU . 11.0 tt0 -71.09 42.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.497 -1.377 . . . . 0.0 110.882 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.514 ' O ' ' CG2' ' A' ' 54' ' ' VAL . . . -140.77 37.29 1.68 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.581 HG13 ' HB3' ' A' ' 21' ' ' GLN . 21.4 t -159.43 128.5 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.554 -0.968 . . . . 0.0 109.035 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.511 ' N ' ' OE1' ' A' ' 21' ' ' GLN . 3.6 ttpp -100.01 112.29 24.58 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.828 0.823 . . . . 0.0 110.013 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.0 ttt -93.02 99.29 11.94 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 2.5 m -92.45 143.14 26.66 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.86 -1.136 . . . . 0.0 110.039 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.5 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -119.46 111.19 17.81 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.354 -0.841 . . . . 0.0 109.762 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.467 ' CE2' ' HG3' ' A' ' 138' ' ' GLN . 5.2 m-85 -111.3 166.11 11.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.225 -0.922 . . . . 0.0 111.074 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.568 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 62.7 t-80 -103.97 135.54 45.3 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.837 0.827 . . . . 0.0 109.008 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.039 HG11 ' CG1' ' A' ' 150' ' ' VAL . 4.4 m -73.45 154.24 7.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-O 121.476 0.655 . . . . 0.0 110.406 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -121.74 27.61 8.08 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.607 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 19.5 p90 -125.75 69.47 1.18 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.112 -0.992 . . . . 0.0 110.234 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.583 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -160.91 -59.06 0.05 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.918 . . . . 0.0 109.764 178.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.583 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -95.86 80.77 0.8 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.54 -43.03 0.72 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.57 -78.3 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.904 -1.351 . . . . 0.0 110.825 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.128 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -80.49 -20.88 42.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.122 . . . . 0.0 110.265 -179.02 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 1.128 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -54.79 -38.68 65.07 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -47.32 63.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.427 -1.043 . . . . 0.0 108.523 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.524 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 12.2 t70 -65.44 -23.57 66.96 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.769 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 36.7 tp -65.09 -46.47 80.96 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 m -58.51 -42.73 88.33 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 1.04 ' O ' HG23 ' A' ' 78' ' ' VAL . 19.2 tt0 -57.72 -25.03 59.78 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 177.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -64.69 -40.21 94.99 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.457 ' O ' ' HB2' ' A' ' 80' ' ' MET . 25.3 t-105 -63.54 -29.09 70.4 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.63 ' HB2' HE22 ' A' ' 138' ' ' GLN . . . -81.6 -44.02 17.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 109.763 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.04 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.6 t -71.78 -27.39 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 109.401 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.604 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -78.75 -57.78 3.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.13 -0.982 . . . . 0.0 108.804 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -48.17 -27.68 2.53 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.155 -0.965 . . . . 0.0 108.578 179.429 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.752 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -69.25 -45.74 69.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.584 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.785 ' HB2' HG13 ' A' ' 84' ' ' VAL . 12.6 mt -105.2 14.28 29.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 49.1 25.52 5.51 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.785 HG13 ' HB2' ' A' ' 82' ' ' LEU . 33.8 m -82.98 -11.53 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -1.086 . . . . 0.0 110.298 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.45 ' HG2' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -42.84 -63.59 0.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -0.98 . . . . 0.0 109.875 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.47 -33.43 1.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.285 -0.885 . . . . 0.0 110.264 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -81.6 -50.76 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.37 -0.832 . . . . 0.0 111.436 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.762 HG23 HD12 ' A' ' 92' ' ' LEU . 2.2 m -90.57 6.1 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.863 -1.148 . . . . 0.0 111.195 -178.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.724 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -83.02 -45.7 13.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.818 -1.177 . . . . 0.0 108.347 178.582 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.464 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -52.39 -51.46 72.37 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.596 -1.315 . . . . 0.0 110.61 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 90' ' ' VAL . 27.1 Cg_endo -73.79 -20.13 20.26 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 N-CA-C 109.736 -0.909 . . . . 0.0 109.736 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.762 HD12 HG23 ' A' ' 88' ' ' VAL . 18.5 mt -86.18 -43.21 13.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 108.87 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.724 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.2 m-30 -64.47 -45.77 85.96 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.094 -1.004 . . . . 0.0 108.945 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -76.36 -21.2 56.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.083 -1.011 . . . . 0.0 109.751 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.479 ' O ' HG12 ' A' ' 102' ' ' ILE . . . -72.75 -29.77 64.85 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.763 HG11 ' CD1' ' A' ' 29' ' ' PHE . 3.4 t -98.77 -15.29 7.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.012 -1.287 . . . . 0.0 109.669 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.449 ' CD ' ' HB2' ' A' ' 34' ' ' TYR . 2.1 mp0 -108.64 8.23 26.92 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 120.815 -1.178 . . . . 0.0 111.131 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 99' ' ' THR . 16.8 mttt -163.72 63.39 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.517 -1.365 . . . . 0.0 109.472 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.924 HG22 ' H ' ' A' ' 101' ' ' THR . 1.1 m 160.41 -44.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 71.51 13.52 6.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.803 -1.186 . . . . 0.0 110.834 178.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.924 ' H ' HG22 ' A' ' 99' ' ' THR . 4.5 t -79.67 -8.49 59.25 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.586 ' CB ' HG22 ' A' ' 96' ' ' VAL . 7.7 mm -83.14 74.11 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.71 32.72 2.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 0.0 109.757 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 107' ' ' ASP . 13.2 p -159.28 132.09 6.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.03 -1.044 . . . . 0.0 109.797 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.94 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -48.65 -36.43 15.92 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 110' ' ' ASP . 22.7 t -58.1 -34.1 69.83 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -66.67 -49.7 65.3 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.835 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.94 HD12 ' HA ' ' A' ' 105' ' ' ALA . 24.5 mt -50.02 -26.71 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.253 -0.904 . . . . 0.0 108.623 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 110' ' ' ASP . 0.9 OUTLIER -71.5 -64.65 0.88 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.476 -0.765 . . . . 0.0 109.614 -179.673 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.522 ' HA ' HD12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -43.62 -42.27 5.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.33 -0.856 . . . . 0.0 110.195 -179.356 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 107' ' ' ASP . 1.4 t -67.78 -40.16 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.794 -1.191 . . . . 0.0 109.452 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -68.35 -37.66 80.7 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.227 -0.92 . . . . 0.0 109.578 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 110' ' ' ASP . 15.7 mt -68.4 -23.51 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.0 108.99 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -63.68 -17.58 63.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.454 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.669 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -95.51 12.83 28.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.211 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.67 8.23 87.21 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.669 HG12 ' HB3' ' A' ' 115' ' ' ALA . 3.9 mm -89.0 62.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -1.073 . . . . 0.0 109.653 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.492 ' C ' ' O ' ' A' ' 117' ' ' ILE . 1.7 tptp -33.35 140.85 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.342 -0.849 . . . . 0.0 110.374 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.47 -23.76 6.69 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -63.07 -49.07 75.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.267 . . . . 0.0 109.593 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -76.23 -38.21 56.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.622 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.855 ' CE2' HG11 ' A' ' 78' ' ' VAL . 1.9 t80 -64.54 -50.66 66.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.299 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.16 -48.39 76.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.093 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.97 -53.3 34.29 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.328 -0.857 . . . . 0.0 108.875 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.84 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -49.86 -52.66 31.0 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 8.7 t90 -52.28 -59.78 3.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -52.31 -16.75 0.91 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.615 -0.678 . . . . 0.0 110.038 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.2 m -72.2 -178.56 2.51 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.904 -1.123 . . . . 0.0 109.6 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -90.08 -35.29 15.54 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.888 -0.507 . . . . 0.0 110.424 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.43 -45.63 81.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 118.198 -1.401 . . . . 0.0 109.586 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.84 HG21 ' HB1' ' A' ' 125' ' ' ALA . 3.6 t -71.75 -35.62 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.958 -1.089 . . . . 0.0 108.632 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -69.97 -38.47 76.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.381 -0.824 . . . . 0.0 108.926 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -65.72 -29.89 70.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 108.977 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -79.59 -21.97 44.31 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.309 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.496 HG23 ' HB1' ' A' ' 77' ' ' ALA . 6.0 t -75.77 -45.59 37.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.78 -37.76 88.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -62.45 -38.26 89.1 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.63 HE22 ' HB2' ' A' ' 77' ' ' ALA . 4.8 mt-30 -62.2 -64.39 0.95 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 4.5 tm-20 -48.18 -31.05 5.23 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -73.41 -33.29 64.89 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -63.8 -63.01 1.28 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 108.886 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -62.1 -35.39 78.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.359 -0.838 . . . . 0.0 109.745 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -77.19 -16.64 59.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 109.719 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.73 ' HB3' HG21 ' A' ' 16' ' ' VAL . 9.4 m-20 -79.94 -44.28 20.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.098 -1.001 . . . . 0.0 108.725 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.6 HG21 ' HE2' ' A' ' 25' ' ' PHE . 16.0 m -105.78 -5.2 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.372 -0.83 . . . . 0.0 109.004 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 2.6 tt0 81.32 -47.16 0.23 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.773 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.785 HD13 ' CD2' ' A' ' 25' ' ' PHE . 17.2 tp 66.29 132.74 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 109.295 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.511 ' O ' ' CD ' ' A' ' 148' ' ' ARG . 6.3 tmm_? -160.79 38.42 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.59 -1.319 . . . . 0.0 109.94 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.46 108.0 0.21 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.251 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 1.039 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -93.32 141.8 24.44 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.404 -1.057 . . . . 0.0 109.573 179.26 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.489 ' HD3' ' CE1' ' A' ' 32' ' ' HIS . 35.7 Cg_endo -78.42 150.39 87.87 Favored 'Cis proline' 0 C--N 1.316 -1.176 0 C-N-CA 123.858 -1.309 . . . . 0.0 110.312 0.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.712 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -122.83 148.33 45.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.169 -1.582 . . . . 0.0 108.456 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -135.47 130.65 35.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.969 -1.082 . . . . 0.0 110.053 -179.08 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.555 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 29.6 m-85 -129.58 127.75 41.32 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.279 -0.888 . . . . 0.0 110.087 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 21' ' ' GLN . 34.8 t -97.07 125.82 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 109.431 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.719 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 21.5 t-20 52.54 22.69 2.25 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.194 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 54.34 39.18 64.14 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.315 -1.422 . . . . 0.0 109.639 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.409 ' O ' HD12 ' A' ' 12' ' ' LEU . 3.0 tttp -142.95 -32.85 0.47 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.313 -1.11 . . . . 0.0 108.279 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 154' ' ' PHE . 31.4 m-85 -116.34 125.42 52.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 108.644 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.555 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 6.3 pt20 -122.5 120.18 33.11 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.058 -1.026 . . . . 0.0 109.895 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' A' ' 9' ' ' TYR . 25.5 mt -62.47 -179.6 0.26 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -159.86 70.21 3.13 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.126 -0.984 . . . . 0.0 109.388 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 C--N 1.31 -1.48 0 C-N-CA 122.78 2.32 . . . . 0.0 110.547 -179.848 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.578 0.704 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.44 -48.05 62.1 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.605 -0.685 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.457 HG12 ' OE1' ' A' ' 177' ' ' GLN . 4.9 t -73.16 -26.55 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.148 -0.97 . . . . 0.0 109.619 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -71.53 -44.43 64.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.033 -1.042 . . . . 0.0 109.582 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.576 HG22 HG12 ' A' ' 42' ' ' ILE . 86.9 t -71.55 -26.1 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.112 -0.993 . . . . 0.0 109.21 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -56.61 3.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.457 ' OE1' HG12 ' A' ' 173' ' ' VAL . 18.2 pt20 -60.08 -35.67 75.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.981 . . . . 0.0 108.983 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.553 ' CE1' ' CG2' ' A' ' 182' ' ' VAL . 4.0 t80 -66.55 -51.81 52.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.1 -26.54 27.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -0.916 . . . . 0.0 108.917 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.66 -37.99 40.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.903 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -62.63 -40.77 98.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.314 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.553 ' CG2' ' CE1' ' A' ' 178' ' ' TYR . 21.2 t -75.53 -34.8 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.033 -1.042 . . . . 0.0 109.19 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -58.7 -49.48 77.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.22 -0.925 . . . . 0.0 109.157 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.588 ' CE2' HD22 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -77.7 -40.25 41.96 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.28 -0.887 . . . . 0.0 108.716 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.903 HD23 ' O ' ' A' ' 181' ' ' THR . 3.8 mm? -53.6 -19.13 3.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.08 -1.012 . . . . 0.0 109.434 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 12.3 t -87.01 8.67 22.37 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.761 -1.212 . . . . 0.0 107.989 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 184' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.529 -0.732 . . . . 0.0 109.715 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.458 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 1.2 tt0 -130.03 60.38 1.6 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.113 -0.992 . . . . 0.0 110.201 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 0.7 OUTLIER 70.02 94.63 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.427 -0.796 . . . . 0.0 110.538 178.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.517 ' HA2' ' ND2' ' A' ' 162' ' ' ASN . . . 79.71 5.45 89.39 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 1.2 tttp -106.86 31.37 5.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -1.193 . . . . 0.0 108.91 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.711 ' O ' HD23 ' A' ' 161' ' ' LEU . 0.1 OUTLIER 147.8 -39.45 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.374 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.571 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 1.3 p90 -157.96 124.51 4.85 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.086 -1.009 . . . . 0.0 109.352 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 t -104.03 176.79 5.04 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -116.25 146.72 42.14 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.596 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 160' ' ' GLN . 1.5 mp -98.52 160.95 13.94 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.363 -0.835 . . . . 0.0 109.703 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -89.99 -1.63 58.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.479 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -142.64 94.84 6.56 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.301 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 35.6 Cg_endo -77.84 167.0 24.48 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.589 2.193 . . . . 0.0 110.517 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 144' ' ' ASP . 25.2 t -119.6 95.67 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.754 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.19 129.47 10.15 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 92.18 -18.74 53.15 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.599 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -38.54 157.84 0.1 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.517 -0.99 . . . . 0.0 109.828 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.568 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.5 Cg_endo -79.85 133.56 10.26 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.573 2.182 . . . . 0.0 111.126 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.8 ' O ' HG13 ' A' ' 155' ' ' VAL . 9.6 mm-40 -41.16 -25.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.53 -0.731 . . . . 0.0 109.935 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.722 ' O ' HG12 ' A' ' 22' ' ' VAL . 5.1 t -147.98 80.41 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.007 -1.058 . . . . 0.0 109.022 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.649 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.23 120.71 20.17 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -104.64 122.66 46.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.182 -0.948 . . . . 0.0 109.42 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.876 ' HD2' HD13 ' A' ' 147' ' ' LEU . 2.9 m-30 -108.26 103.62 12.83 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.408 -0.808 . . . . 0.0 109.9 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -140.67 141.06 35.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.423 -0.798 . . . . 0.0 109.243 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.609 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 1.3 t -115.41 172.22 7.23 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.093 -1.005 . . . . 0.0 109.217 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.602 ' HB2' HD21 ' A' ' 72' ' ' LEU . 8.0 m-30 -89.71 43.67 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.748 ' HE1' HD22 ' A' ' 72' ' ' LEU . 22.2 m-85 -147.3 17.33 1.19 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.494 -0.754 . . . . 0.0 109.698 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -113.68 165.96 12.34 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.756 -1.215 . . . . 0.0 109.622 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 33.7 Cg_endo -75.95 -38.46 1.21 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.33 2.02 . . . . 0.0 108.183 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 1.8 m-70 -72.56 -28.16 62.65 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 28.8 t -44.57 -61.93 1.38 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.81 0.814 . . . . 0.0 108.826 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.46 ' CG ' ' OE1' ' A' ' 97' ' ' GLN . 27.5 t80 -78.09 -40.09 39.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.885 -0.51 . . . . 0.0 110.55 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.502 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 2.8 mm100 -64.52 -27.35 68.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.188 -0.945 . . . . 0.0 111.079 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 3.9 m-30 -87.02 -34.36 19.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.806 -1.184 . . . . 0.0 111.212 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.14 -23.2 22.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.805 -1.184 . . . . 0.0 111.987 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -136.34 28.14 3.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.344 -1.472 . . . . 0.0 111.612 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.507 ' O ' ' CD2' ' A' ' 41' ' ' HIS . 53.3 t -150.98 -81.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.541 -1.349 . . . . 0.0 109.821 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.403 ' N ' HG12 ' A' ' 39' ' ' VAL . 17.9 mt -67.78 -12.52 60.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.804 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 14.3 m-70 51.51 21.76 1.34 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.979 . . . . 0.0 109.337 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.425 HD12 ' CE1' ' A' ' 36' ' ' PHE . 22.1 mt -65.32 -20.09 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 109.45 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.517 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -81.64 -41.43 21.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.757 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 47' ' ' LYS . 7.4 p-10 -87.08 -45.14 10.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.995 . . . . 0.0 109.59 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -45.83 -31.48 2.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.866 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 43' ' ' SER . 8.4 m -74.26 -30.85 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.089 -1.007 . . . . 0.0 109.655 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 44' ' ' ASP . 8.6 mmmm -48.49 -39.62 23.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 0.0 109.223 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -58.45 -23.23 57.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.353 -0.842 . . . . 0.0 109.206 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 50' ' ' LEU . 6.4 mttm -93.31 23.31 4.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.401 -0.812 . . . . 0.0 109.78 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.682 HD22 ' CG1' ' A' ' 54' ' ' VAL . 18.8 mt -118.92 76.27 14.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.024 -1.047 . . . . 0.0 109.824 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 52' ' ' GLU . 36.6 Cg_endo -78.69 63.34 8.53 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.417 2.078 . . . . 0.0 110.293 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 51' ' ' PRO . 23.3 tp10 58.46 131.57 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.448 0.642 . . . . 0.0 110.259 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.69 -18.35 44.12 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.682 ' CG1' HD22 ' A' ' 50' ' ' LEU . 2.4 t -95.89 89.36 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.082 -1.246 . . . . 0.0 109.193 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.97 96.79 2.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.412 -0.805 . . . . 0.0 109.846 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.497 ' HG2' HD13 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -92.18 100.75 13.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.272 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.2 m -98.61 119.18 36.9 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.864 -1.135 . . . . 0.0 110.581 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -97.63 108.53 21.27 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.466 -0.771 . . . . 0.0 109.654 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.517 ' CD1' ' HG3' ' A' ' 138' ' ' GLN . 3.0 m-85 -111.56 154.18 25.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.166 -0.959 . . . . 0.0 111.624 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.609 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 18.2 t-80 -106.62 108.88 20.61 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.043 HG11 HD22 ' A' ' 147' ' ' LEU . 15.1 m -69.64 156.53 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.44 -0.787 . . . . 0.0 109.994 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.521 ' CB ' ' HA ' ' A' ' 70' ' ' LYS . 3.6 p30 -108.23 51.38 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 109.573 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.737 ' CE1' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -131.1 52.94 2.02 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.172 -0.955 . . . . 0.0 110.155 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.521 ' SD ' ' CB ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -134.02 38.79 3.16 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.32 -34.2 0.65 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.57 -34.86 2.88 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.757 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.27 -80.44 0.25 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.765 -1.432 . . . . 0.0 109.852 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.039 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -77.44 -23.79 50.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.794 -1.191 . . . . 0.0 108.723 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 1.039 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -48.18 -44.0 26.25 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HA ' ' CB ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -64.58 -45.13 88.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -1.117 . . . . 0.0 108.572 179.281 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.524 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 22.7 t0 -67.72 -28.7 67.88 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.748 HD22 ' HE1' ' A' ' 29' ' ' PHE . 13.1 tp -62.69 -44.37 96.41 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.474 HG23 ' CD ' ' A' ' 138' ' ' GLN . 2.5 m -60.46 -42.32 95.93 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 1.009 ' O ' HG23 ' A' ' 78' ' ' VAL . 8.4 tt0 -59.7 -21.17 60.24 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -68.62 -43.52 76.2 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.503 ' CD1' ' OE1' ' A' ' 138' ' ' GLN . 69.7 t-105 -60.45 -32.13 71.09 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -79.89 -55.41 4.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.549 -0.719 . . . . 0.0 109.876 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.025 HG11 ' CE2' ' A' ' 122' ' ' TYR . 2.8 t -57.7 -28.29 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 109.96 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.581 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -79.54 -59.04 2.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.883 -1.136 . . . . 0.0 108.564 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -46.19 -29.52 1.61 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.812 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -68.35 -44.6 74.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.383 -0.823 . . . . 0.0 109.391 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.792 ' HB2' HG13 ' A' ' 84' ' ' VAL . 7.7 mt -104.68 13.35 31.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.189 -0.944 . . . . 0.0 110.026 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.39 27.51 4.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 82' ' ' LEU . 33.1 m -85.28 -9.15 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.314 -1.109 . . . . 0.0 110.415 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.3 OUTLIER -41.31 -60.49 1.25 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.17 -0.956 . . . . 0.0 109.784 -179.563 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.16 -33.46 2.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.365 -0.835 . . . . 0.0 110.041 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -83.82 -49.83 8.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.329 -0.857 . . . . 0.0 111.411 -178.517 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.781 HG23 HD12 ' A' ' 92' ' ' LEU . 1.2 m -87.06 -4.72 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.775 -1.203 . . . . 0.0 110.504 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.66 HG23 ' CE1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -77.41 -44.17 30.08 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.811 -1.181 . . . . 0.0 108.508 178.669 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.438 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -51.46 -52.72 57.18 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.634 -1.291 . . . . 0.0 110.334 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.605 ' HB2' HG13 ' A' ' 111' ' ' VAL . 27.2 Cg_endo -74.04 -17.63 22.0 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 N-CA-C 109.847 -0.866 . . . . 0.0 109.847 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 1.041 ' O ' HG23 ' A' ' 96' ' ' VAL . 12.7 mt -86.84 -42.49 13.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 108.956 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.66 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.4 m-30 -69.88 -46.73 64.84 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.877 -1.139 . . . . 0.0 108.472 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 1.0 OUTLIER -72.77 -27.75 62.19 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.194 -0.941 . . . . 0.0 108.975 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -70.1 -29.09 70.81 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 1.041 HG23 ' O ' ' A' ' 92' ' ' LEU . 1.6 t -103.8 1.38 10.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.194 -1.18 . . . . 0.0 108.917 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.46 ' OE1' ' CG ' ' A' ' 34' ' ' TYR . 1.3 mt-30 -107.54 10.75 29.19 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.975 -1.078 . . . . 0.0 110.763 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -178.62 -51.82 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.576 -1.327 . . . . 0.0 110.423 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 68.6 p -59.79 -40.84 89.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.48 -1.388 . . . . 0.0 109.507 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.48 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER 67.49 9.9 7.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.372 -0.83 . . . . 0.0 109.783 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 t -81.15 -7.85 59.64 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.827 0.822 . . . . 0.0 109.044 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.464 HG23 ' OD1' ' A' ' 107' ' ' ASP . 8.8 mm -85.4 80.74 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.48 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -145.05 34.51 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.39 -0.819 . . . . 0.0 109.699 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 107' ' ' ASP . 83.4 p -164.96 136.28 4.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.893 -1.13 . . . . 0.0 110.269 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.881 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.22 -38.65 27.13 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 t -56.75 -32.5 65.65 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -70.0 -53.39 17.88 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.159 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.881 HD12 ' HA ' ' A' ' 105' ' ' ALA . 25.5 mt -45.68 -28.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.173 -0.955 . . . . 0.0 108.771 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -46.34 31.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 109.565 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 1.2 p30 -53.14 -41.8 65.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 109.606 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.835 HG11 ' HG ' ' A' ' 92' ' ' LEU . 13.6 t -71.49 -38.39 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.96 -1.088 . . . . 0.0 109.51 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.522 ' HE1' HG21 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -65.79 -54.71 23.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.3 mt -61.67 -24.02 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.131 -0.981 . . . . 0.0 109.709 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -72.4 -16.64 61.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.155 -0.966 . . . . 0.0 109.45 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.434 ' HB2' HG12 ' A' ' 88' ' ' VAL . . . -94.6 8.08 43.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 109.77 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.44 -3.3 79.0 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.836 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.4 mp -85.54 60.73 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -1.129 . . . . 0.0 109.114 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -37.28 157.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.828 -1.17 . . . . 0.0 110.239 -179.456 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.42 -23.57 64.78 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.47 -52.01 63.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.982 -1.305 . . . . 0.0 109.337 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -75.5 -36.82 60.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.934 . . . . 0.0 109.331 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 1.025 ' CE2' HG11 ' A' ' 78' ' ' VAL . 3.2 t80 -62.78 -48.51 78.84 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.247 -0.908 . . . . 0.0 109.005 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -62.12 -36.88 83.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 108.75 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.466 ' O ' ' OG ' ' A' ' 128' ' ' SER . . . -63.24 -49.76 72.88 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 108.92 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.528 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -52.54 -50.72 62.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.002 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.465 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 3.1 t90 -60.18 -55.53 32.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -52.66 -16.47 0.96 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.547 -0.721 . . . . 0.0 110.015 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 124' ' ' ALA . 0.9 OUTLIER -73.54 176.8 5.8 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.965 -1.084 . . . . 0.0 109.383 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 133' ' ' SER . 60.4 m-85 -91.94 -37.94 12.57 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.63 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.9 t -65.21 -47.14 88.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 118.056 -1.458 . . . . 0.0 109.266 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.812 HG22 ' CB ' ' A' ' 81' ' ' ALA . 3.7 t -64.03 -39.44 85.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.057 -1.027 . . . . 0.0 108.344 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -71.19 -27.63 63.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.835 . . . . 0.0 108.915 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -66.42 -41.82 88.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.151 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.45 -18.17 55.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 108.699 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.683 HG23 ' HB1' ' A' ' 77' ' ' ALA . 3.9 t -75.54 -40.36 41.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -71.81 -39.69 69.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -30.3 70.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.09 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.517 ' HG3' ' CD1' ' A' ' 59' ' ' TYR . 2.8 tt0 -71.17 -64.71 0.86 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.33 -0.857 . . . . 0.0 109.075 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 0.6 OUTLIER -50.09 -33.43 18.6 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 108.475 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 26.4 mttt -76.71 -29.91 56.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -57.27 -53.99 51.82 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.309 -0.87 . . . . 0.0 108.763 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -72.03 -40.53 68.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.366 -0.834 . . . . 0.0 110.495 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.55 -16.93 61.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.991 -1.068 . . . . 0.0 109.939 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.534 ' HB3' HG21 ' A' ' 16' ' ' VAL . 2.4 m-20 -84.71 -43.21 14.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 108.553 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.562 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 4.5 m -93.42 -12.09 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 1.0 OUTLIER 82.33 -43.79 0.14 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.65 -0.657 . . . . 0.0 109.513 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 1.043 HD22 HG11 ' A' ' 61' ' ' VAL . 33.7 tp 62.9 139.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.426 -0.797 . . . . 0.0 109.939 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.501 ' O ' ' CD ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -161.22 38.73 0.14 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.764 -1.21 . . . . 0.0 109.563 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 160.42 109.93 0.26 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.438 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.37 140.59 21.76 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.35 -1.088 . . . . 0.0 108.743 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.76 150.87 87.65 Favored 'Cis proline' 0 C--N 1.313 -1.312 0 C-N-CA 123.993 -1.253 . . . . 0.0 110.396 0.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -123.63 160.19 27.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.442 -1.411 . . . . 0.0 109.051 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.6 OUTLIER -144.7 129.11 17.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.074 -1.016 . . . . 0.0 109.871 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 8.9 m-85 -131.64 134.18 45.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.372 -0.83 . . . . 0.0 109.993 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 21' ' ' GLN . 53.7 t -105.56 133.16 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.912 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.599 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.9 OUTLIER 45.5 22.21 0.09 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.201 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.594 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 56.92 57.56 19.08 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -168.88 -34.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.234 -1.156 . . . . 0.0 108.454 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.468 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 51.6 m-85 -117.89 125.09 49.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.815 . . . . 0.0 108.971 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.728 ' HB3' HD11 ' A' ' 12' ' ' LEU . 5.7 pt20 -123.74 130.5 52.73 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.78 -1.2 . . . . 0.0 109.82 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.8 OUTLIER -73.14 172.75 10.5 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.517 ' ND2' ' HA2' ' A' ' 6' ' ' GLY . 5.6 p30 -151.95 147.12 19.37 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.089 -1.007 . . . . 0.0 109.482 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.309 -1.546 0 C-N-CA 122.672 2.248 . . . . 0.0 110.776 179.871 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.469 ' O ' HG23 ' A' ' 175' ' ' VAL . 4.3 mtt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.778 0.799 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -75.32 -62.42 1.57 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.7 t -55.86 -26.82 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.248 -0.908 . . . . 0.0 108.601 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 174' ' ' PHE . 7.0 m-30 -69.26 -38.13 78.25 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.195 -0.941 . . . . 0.0 108.962 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 171' ' ' MET . 77.6 t -73.78 -24.97 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.229 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -83.14 -60.4 2.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.301 -0.874 . . . . 0.0 109.226 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -52.96 -37.86 61.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.167 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' ' 174' ' ' PHE . 16.5 t80 -69.58 -44.4 70.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.342 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -65.31 -29.06 69.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 109.076 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.19 -37.95 60.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.1 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.647 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -64.05 -44.27 92.97 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.23 -0.919 . . . . 0.0 108.948 179.404 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.488 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 55.7 t -69.77 -38.62 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.176 -0.953 . . . . 0.0 109.186 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -55.13 38.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.126 -0.984 . . . . 0.0 109.385 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -75.92 -26.4 56.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.219 -0.926 . . . . 0.0 109.146 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.647 HD23 ' O ' ' A' ' 181' ' ' THR . 0.3 OUTLIER -64.63 -18.86 65.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.965 -1.085 . . . . 0.0 109.267 -179.654 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 59.6 p -80.15 0.39 32.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 0.0 108.519 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.447 -0.783 . . . . 0.0 109.264 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 5' ' ' ASP . 5.4 mt-10 -99.65 54.87 0.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.81 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 4' ' ' GLU . 4.2 p-10 39.86 80.08 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.284 0.564 . . . . 0.0 110.036 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 127.81 -26.4 4.83 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.662 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -80.98 -68.53 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.844 -1.386 . . . . 0.0 109.289 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 11.9 mp0 -93.52 4.36 54.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 0.0 109.427 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 3.4 p90 179.1 131.68 0.08 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.169 -0.957 . . . . 0.0 109.35 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.513 HG23 ' HG3' ' A' ' 160' ' ' GLN . 8.7 t -119.65 175.83 5.67 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.661 -0.649 . . . . 0.0 109.26 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.59 157.59 15.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.686 -0.634 . . . . 0.0 109.617 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.475 ' HG ' ' HG2' ' A' ' 160' ' ' GLN . 7.4 mt -96.16 158.19 15.55 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.355 -0.84 . . . . 0.0 109.445 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -84.02 -12.06 55.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.096 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -151.82 104.74 2.85 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.1 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.36 166.87 26.78 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.449 2.099 . . . . 0.0 110.679 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.706 HG21 ' OD1' ' A' ' 144' ' ' ASP . 10.2 t -132.14 89.87 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.852 . . . . 0.0 109.649 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.24 131.14 8.02 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 92.49 -19.7 48.92 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.739 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -40.29 163.24 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.563 -0.963 . . . . 0.0 109.917 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.633 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 35.0 Cg_endo -77.41 125.81 7.94 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.61 2.207 . . . . 0.0 111.047 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.593 ' O ' HG13 ' A' ' 155' ' ' VAL . 5.3 mm100 -40.07 -24.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.523 -0.736 . . . . 0.0 110.012 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.789 ' O ' HG12 ' A' ' 22' ' ' VAL . 2.7 t -146.1 81.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.168 -0.958 . . . . 0.0 108.772 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.753 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -75.34 124.97 28.04 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.515 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -107.95 133.92 51.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.083 -1.011 . . . . 0.0 110.234 -179.027 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.071 ' CE2' HG21 ' A' ' 145' ' ' VAL . 7.5 m-85 -123.55 100.74 6.95 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -150.76 140.29 21.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.048 -1.033 . . . . 0.0 110.458 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.53 ' HB3' HG22 ' A' ' 61' ' ' VAL . 1.3 p -115.15 177.44 4.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.345 -0.847 . . . . 0.0 109.123 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.695 ' CD2' HD21 ' A' ' 72' ' ' LEU . 8.4 m-30 -94.04 41.73 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.958 ' CE2' HD12 ' A' ' 72' ' ' LEU . 9.9 m-85 -130.96 14.52 5.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.351 -0.843 . . . . 0.0 110.175 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.6 OUTLIER -110.5 158.46 35.36 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.706 -1.246 . . . . 0.0 109.554 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.05 -38.38 1.59 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.189 1.926 . . . . 0.0 108.037 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.477 ' HA ' ' HB2' ' A' ' 35' ' ' GLN . 20.2 m80 -76.06 -21.13 57.1 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 52.1 t -47.49 -65.1 0.62 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.574 ' HB2' ' CG ' ' A' ' 97' ' ' GLN . 7.3 t80 -60.66 -43.01 98.15 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.221 0.534 . . . . 0.0 110.037 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 32' ' ' HIS . 1.8 mt-30 -60.92 -22.98 64.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.194 -0.941 . . . . 0.0 109.976 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -82.9 -36.85 24.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.369 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.524 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -106.29 47.99 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.959 -1.088 . . . . 0.0 109.938 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -171.62 -52.23 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.223 -0.923 . . . . 0.0 111.902 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.0 t -89.28 -83.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.463 -1.398 . . . . 0.0 112.204 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.72 -10.48 59.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.973 -1.079 . . . . 0.0 110.765 -177.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 55.66 33.7 21.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 109.36 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.6 mm -48.58 -22.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 109.913 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.433 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.6 OUTLIER -82.97 -41.57 18.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.2 -0.937 . . . . 0.0 110.341 -179.423 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -86.15 -38.32 17.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.063 -1.023 . . . . 0.0 110.149 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -46.67 -33.79 4.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 109.907 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 43' ' ' SER . 32.1 m -80.19 -26.52 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.013 -1.055 . . . . 0.0 110.338 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.909 ' HA ' HD12 ' A' ' 50' ' ' LEU . 2.1 mmtp -63.07 -40.78 98.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.898 -1.126 . . . . 0.0 109.737 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.04 -27.75 6.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.16 -0.963 . . . . 0.0 109.23 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 11.5 mttt -117.1 40.46 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.909 HD12 ' HA ' ' A' ' 47' ' ' LYS . 11.4 mt -113.27 88.62 12.98 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.652 ' HD2' HG21 ' A' ' 54' ' ' VAL . 35.8 Cg_endo -77.67 143.09 21.01 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.76 2.307 . . . . 0.0 110.528 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 51' ' ' PRO . 1.6 tm-20 -40.14 121.6 1.37 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 122.361 1.077 . . . . 0.0 109.562 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.95 -30.92 3.44 Favored Glycine 0 C--N 1.286 -2.2 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.652 HG21 ' HD2' ' A' ' 51' ' ' PRO . 2.6 t -86.35 82.91 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -1.065 . . . . 0.0 108.536 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.47 96.76 0.39 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.425 -0.797 . . . . 0.0 110.172 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.482 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -90.68 94.22 9.59 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 31.5 m -94.66 135.39 36.19 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.916 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.515 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -115.25 115.03 26.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.313 -0.867 . . . . 0.0 109.714 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.5 ' OH ' ' CG ' ' A' ' 137' ' ' GLN . 2.2 m-85 -112.58 166.46 11.31 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.071 -1.018 . . . . 0.0 111.631 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.949 ' CE1' HD22 ' A' ' 72' ' ' LEU . 2.1 t60 -108.86 125.66 52.22 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.734 0.778 . . . . 0.0 109.816 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.781 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.9 m -73.28 157.22 6.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.732 -0.605 . . . . 0.0 109.907 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -121.99 28.21 7.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.324 -0.86 . . . . 0.0 109.131 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.596 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 11.6 p90 -121.22 67.61 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 110.052 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.592 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -160.12 -59.1 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.396 -0.815 . . . . 0.0 109.222 178.885 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.592 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -96.21 78.03 0.76 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 178.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.67 -40.92 0.51 Allowed Glycine 0 N--CA 1.492 2.423 0 O-C-N 121.552 -0.969 . . . . 0.0 110.925 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.4 -79.23 0.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.909 -1.348 . . . . 0.0 110.64 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.919 HD23 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -80.13 -20.78 44.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.0 -1.062 . . . . 0.0 110.219 -179.145 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.627 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -51.95 -47.1 54.8 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -46.55 88.25 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.469 -1.018 . . . . 0.0 108.316 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.558 ' HB3' HD12 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -62.27 -26.04 68.18 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.344 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.958 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.9 OUTLIER -63.54 -37.4 87.16 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.885 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.428 HG21 ' OE1' ' A' ' 138' ' ' GLN . 5.9 m -65.01 -42.43 94.46 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.559 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 37.7 tt0 -61.59 -19.28 62.02 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -67.82 -43.0 80.65 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 22.8 t-105 -63.69 -31.95 73.28 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.846 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.479 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -79.87 -56.67 4.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 109.919 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.757 HG21 ' CE1' ' A' ' 122' ' ' TYR . 45.8 t -58.18 -27.03 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 0.0 110.015 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.593 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -82.16 -64.08 1.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.884 -1.135 . . . . 0.0 108.9 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.475 ' HB3' HD22 ' A' ' 134' ' ' LEU . 0.1 OUTLIER -46.85 -27.55 1.27 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.58 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -66.15 -49.51 67.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.48 -0.763 . . . . 0.0 109.837 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.686 ' HB2' HG13 ' A' ' 84' ' ' VAL . 7.1 mt -101.64 9.73 40.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.072 -1.017 . . . . 0.0 110.369 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.407 ' HA2' ' OE2' ' A' ' 85' ' ' GLU . . . 56.13 29.37 55.88 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.686 HG13 ' HB2' ' A' ' 82' ' ' LEU . 28.4 m -87.79 -0.08 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.34 -1.094 . . . . 0.0 110.054 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -44.74 -66.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.054 -1.029 . . . . 0.0 109.396 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -42.85 -33.67 0.81 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 110.082 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -79.48 -53.96 6.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.349 -0.844 . . . . 0.0 111.106 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.803 HG23 HD12 ' A' ' 92' ' ' LEU . 2.1 m -89.02 -10.45 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.719 -1.238 . . . . 0.0 111.226 -178.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.881 HG23 ' CD1' ' A' ' 93' ' ' PHE . 1.1 m -72.98 -42.9 62.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.57 -1.331 . . . . 0.0 108.795 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.402 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -58.1 -53.26 67.79 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.489 -1.382 . . . . 0.0 111.116 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.446 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 24.8 Cg_endo -72.66 -23.51 19.51 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 N-CA-C 110.087 -0.774 . . . . 0.0 110.087 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.838 ' HG ' HG11 ' A' ' 111' ' ' VAL . 79.4 mt -85.14 -42.99 14.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 108.862 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.881 ' CD1' HG23 ' A' ' 89' ' ' THR . 3.2 m-85 -62.56 -43.5 98.67 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.083 -1.01 . . . . 0.0 108.55 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -80.85 -16.67 53.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.405 -0.81 . . . . 0.0 109.82 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA2' ' OG1' ' A' ' 99' ' ' THR . . . -77.79 -34.82 37.55 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.2 t -95.58 -24.9 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.168 -1.196 . . . . 0.0 109.146 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.574 ' CG ' ' HB2' ' A' ' 34' ' ' TYR . 4.4 mp0 -102.38 5.07 39.57 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.016 -1.052 . . . . 0.0 110.622 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.803 ' O ' HG23 ' A' ' 99' ' ' THR . 0.3 OUTLIER -161.58 61.96 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.653 -1.28 . . . . 0.0 109.625 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 165.44 -50.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.492 -0.755 . . . . 0.0 109.358 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 75.23 19.62 2.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.382 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.3 p -90.0 -6.89 55.14 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.658 0.742 . . . . 0.0 109.706 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.756 HG23 ' OD1' ' A' ' 107' ' ' ASP . 9.5 mm -84.77 81.57 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 121.568 -0.708 . . . . 0.0 109.574 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -135.32 36.88 2.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.052 -179.766 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 107' ' ' ASP . 83.6 p -166.01 132.2 2.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.854 -1.154 . . . . 0.0 110.499 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.57 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -50.79 -27.83 8.07 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -32.04 73.49 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.756 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.5 OUTLIER -70.76 -50.77 32.46 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.063 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.919 HD11 HD23 ' A' ' 68' ' ' LEU . 32.2 mt -54.25 -27.6 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 108.598 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -76.25 -32.49 58.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.499 -0.75 . . . . 0.0 109.13 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.462 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 2.8 m-20 -65.65 -45.17 84.01 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.318 -0.864 . . . . 0.0 109.32 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.838 HG11 ' HG ' ' A' ' 92' ' ' LEU . 2.4 t -68.32 -40.72 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.0 -1.063 . . . . 0.0 109.015 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.578 ' CZ ' ' HB ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -55.86 -54.34 45.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 109.149 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mt -62.38 -23.05 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 110' ' ' ASP . 11.0 m-80 -72.21 -16.28 61.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.93 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -96.67 14.87 23.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.445 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.435 ' C ' HD12 ' A' ' 117' ' ' ILE . . . 83.12 9.28 84.34 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.93 HD13 ' HB3' ' A' ' 115' ' ' ALA . 1.8 mp -92.02 56.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -1.102 . . . . 0.0 109.374 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 117' ' ' ILE . 16.6 mttp -36.84 149.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.071 -1.018 . . . . 0.0 110.037 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 123' ' ' ASP . . . -50.71 -37.3 34.13 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.04 -52.32 58.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -1.181 . . . . 0.0 109.637 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -66.05 -60.94 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.397 -0.814 . . . . 0.0 109.843 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.757 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -50.12 -60.19 3.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 109.524 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 7.6 m-20 -44.93 -43.29 8.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.992 -1.068 . . . . 0.0 109.871 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.57 -44.9 73.46 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 109.791 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.774 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -58.71 -49.22 78.39 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 108.977 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.559 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 4.9 t-105 -57.13 -54.82 42.38 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -63.42 -14.83 54.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.657 -0.652 . . . . 0.0 110.179 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 70.2 m -71.16 -178.21 1.94 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.98 -1.075 . . . . 0.0 110.43 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.21 -34.68 14.19 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.633 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.12 -44.7 84.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.996 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.774 HG21 ' HB1' ' A' ' 125' ' ' ALA . 5.9 t -69.77 -31.97 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.863 -1.148 . . . . 0.0 108.771 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -71.59 -37.18 71.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -35.47 80.74 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.475 HD22 ' HB3' ' A' ' 80' ' ' MET . 0.0 OUTLIER -74.68 -29.41 61.21 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.032 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.479 HG23 ' HB1' ' A' ' 77' ' ' ALA . 5.7 t -73.71 -24.3 19.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.05 -54.26 6.77 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.5 ' CG ' ' OH ' ' A' ' 59' ' ' TYR . 7.0 tp-100 -59.88 -33.05 71.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.296 -0.878 . . . . 0.0 109.136 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.428 ' OE1' HG21 ' A' ' 73' ' ' THR . 12.1 tm0? -66.95 -64.83 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 108.749 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -51.33 -35.38 37.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.7 mtmm -72.2 -28.95 63.52 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.848 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -60.59 -53.08 61.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 108.795 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.468 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -75.04 -25.39 58.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 109.742 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -80.15 -27.25 39.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.106 -0.996 . . . . 0.0 110.234 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.716 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.4 p30 -82.21 -48.26 11.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.949 -1.094 . . . . 0.0 108.439 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 1.071 HG21 ' CE2' ' A' ' 25' ' ' PHE . 25.5 m -84.62 -18.54 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 9.6 tt0 82.6 -40.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.811 -0.555 . . . . 0.0 110.247 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.596 HD21 ' CG1' ' A' ' 61' ' ' VAL . 12.1 tp 66.75 144.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -159.61 28.4 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.478 -1.389 . . . . 0.0 110.887 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.39 110.89 0.55 Allowed Glycine 0 N--CA 1.49 2.233 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.109 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.781 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -84.04 145.16 45.74 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.353 -1.087 . . . . 0.0 109.147 178.409 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.62 150.96 84.67 Favored 'Cis proline' 0 C--N 1.315 -1.213 0 O-C-N 123.312 1.164 . . . . 0.0 110.583 0.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.814 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -129.66 134.86 47.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.403 -1.435 . . . . 0.0 109.069 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.51 ' SD ' HG13 ' A' ' 22' ' ' VAL . 5.7 tpp -131.09 124.61 31.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 109.773 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 160' ' ' GLN . 10.6 m-85 -123.86 129.94 51.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 0.0 109.922 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 21' ' ' GLN . 45.5 t -97.92 131.26 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.945 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.739 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 1.6 t-20 46.43 21.91 0.14 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.293 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.55 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 55.36 57.04 20.43 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.08 -34.98 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.28 -1.129 . . . . 0.0 108.273 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -121.51 126.36 49.04 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.925 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.513 ' HG3' HG23 ' A' ' 10' ' ' THR . 16.4 pt20 -116.72 119.97 37.12 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.955 -1.091 . . . . 0.0 110.307 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.59 174.32 3.57 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -150.44 74.34 8.9 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.971 -1.081 . . . . 0.0 109.692 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 C--N 1.309 -1.514 0 C-N-CA 122.683 2.255 . . . . 0.0 110.97 -179.9 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.784 ' O ' HG23 ' A' ' 175' ' ' VAL . 19.8 mmt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.701 0.763 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.02 -55.98 5.48 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.707 -0.621 . . . . 0.0 109.355 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 177' ' ' GLN . 4.5 t -68.3 -29.66 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.204 -0.935 . . . . 0.0 109.189 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.558 ' CD1' ' OE1' ' A' ' 177' ' ' GLN . 26.6 m-85 -68.24 -34.8 76.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.268 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 171' ' ' MET . 64.6 t -78.36 -26.1 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.069 -1.019 . . . . 0.0 109.37 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -55.52 4.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.986 . . . . 0.0 109.272 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.558 ' OE1' ' CD1' ' A' ' 174' ' ' PHE . 7.6 pt20 -57.29 -36.35 70.95 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.16 -0.963 . . . . 0.0 108.735 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.41 ' HA ' ' OG1' ' A' ' 181' ' ' THR . 6.0 t80 -68.06 -49.72 59.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.89 . . . . 0.0 108.81 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 183' ' ' LYS . . . -58.85 -29.27 66.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 108.984 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.96 -37.82 58.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.15 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.59 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -61.45 -46.43 90.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.172 179.69 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.47 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 55.1 t -72.03 -36.89 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.802 -1.186 . . . . 0.0 109.295 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 179' ' ' ALA . 0.4 OUTLIER -59.93 -52.61 64.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.147 -0.97 . . . . 0.0 109.269 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.34 -29.28 53.38 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.906 . . . . 0.0 109.107 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 181' ' ' THR . 0.2 OUTLIER -62.51 -20.31 64.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.964 -1.085 . . . . 0.0 108.977 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.497 ' HB3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -69.63 -22.87 63.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.853 -1.154 . . . . 0.0 108.083 178.265 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.242 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -125.11 62.4 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.68 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.7 t0 47.11 83.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.48 -0.762 . . . . 0.0 109.498 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 131.97 -29.69 3.33 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.284 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.82 -71.31 0.46 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.02 -1.282 . . . . 0.0 108.916 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.916 ' NE2' HG23 ' A' ' 181' ' ' THR . 13.9 pt20 -100.11 6.59 44.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.086 -1.009 . . . . 0.0 109.686 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.524 ' O ' ' N ' ' A' ' 6' ' ' GLY . 1.4 p90 177.53 130.72 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 0.0 109.466 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 160' ' ' GLN . 5.7 t -111.36 179.78 3.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -96.37 157.09 16.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.69 . . . . 0.0 109.796 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HA ' ' OE1' ' A' ' 160' ' ' GLN . 2.6 mt -91.5 145.24 24.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.434 -0.791 . . . . 0.0 109.75 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.91 -22.01 65.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.902 . . . . 0.0 108.736 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -135.08 108.15 10.48 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.539 -0.726 . . . . 0.0 109.16 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.54 157.74 36.25 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.323 2.015 . . . . 0.0 110.645 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.714 ' O ' HG12 ' A' ' 16' ' ' VAL . 7.9 t -124.03 82.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.65 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -47.79 127.28 11.59 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.707 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 99.06 -20.94 48.22 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.766 ' HB1' ' HD2' ' A' ' 20' ' ' PRO . . . -45.02 168.25 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.122 -1.223 . . . . 0.0 109.421 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.766 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 36.0 Cg_endo -79.22 136.73 12.98 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.87 2.38 . . . . 0.0 111.246 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.823 ' O ' HG22 ' A' ' 155' ' ' VAL . 5.7 mt-30 -49.17 -20.35 0.58 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.376 -0.827 . . . . 0.0 109.772 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.747 ' O ' HG12 ' A' ' 22' ' ' VAL . 3.2 t -149.49 81.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.21 -0.931 . . . . 0.0 108.602 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.713 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -77.45 126.57 31.11 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.294 -0.879 . . . . 0.0 108.786 -179.305 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -110.06 119.18 38.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.129 -0.982 . . . . 0.0 109.83 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.073 ' CE2' HG21 ' A' ' 145' ' ' VAL . 4.4 m-85 -111.52 107.48 16.68 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.522 -0.736 . . . . 0.0 109.371 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -152.39 138.81 18.53 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.326 -0.859 . . . . 0.0 108.948 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.864 ' HB2' HG22 ' A' ' 61' ' ' VAL . 1.5 t -112.83 177.07 4.76 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.091 -1.005 . . . . 0.0 109.896 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.71 ' HB2' HD11 ' A' ' 72' ' ' LEU . 7.7 m-30 -88.4 38.84 0.88 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.876 ' CE2' HD12 ' A' ' 72' ' ' LEU . 10.1 m-85 -130.69 14.19 5.39 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.315 -0.865 . . . . 0.0 110.346 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.539 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -118.15 156.69 50.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.619 -1.301 . . . . 0.0 109.78 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -74.46 -25.15 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.022 1.815 . . . . 0.0 107.667 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.563 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 24.4 p80 -84.74 -25.34 28.36 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 18.6 t -45.73 -58.69 3.27 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' A' ' 38' ' ' GLU . 45.7 t80 -75.17 -49.88 18.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.883 -0.511 . . . . 0.0 110.359 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -61.31 -21.93 64.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.168 -0.957 . . . . 0.0 110.699 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.568 ' CZ ' HG22 ' A' ' 42' ' ' ILE . 3.7 t80 -82.04 -50.97 8.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.978 -1.076 . . . . 0.0 110.24 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.403 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 33.2 tt0 -103.52 -0.14 30.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.858 -1.151 . . . . 0.0 111.553 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 34' ' ' TYR . 60.1 mm-40 -127.74 21.32 6.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.364 -1.46 . . . . 0.0 111.172 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.1 t -152.13 -85.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.656 -1.277 . . . . 0.0 110.066 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.96 -12.19 17.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 110.148 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 55.48 22.83 5.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.018 . . . . 0.0 108.998 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.633 HG12 HG22 ' A' ' 175' ' ' VAL . 7.1 mt -56.81 -16.79 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.384 -0.823 . . . . 0.0 109.445 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.514 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -83.25 -48.69 10.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 0.0 110.205 -179.523 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.29 -30.91 25.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.153 -0.967 . . . . 0.0 110.124 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -49.19 -33.76 13.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 109.73 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.514 ' CG2' ' O ' ' A' ' 43' ' ' SER . 2.8 m -69.56 -33.72 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.981 -1.075 . . . . 0.0 109.452 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.929 ' HA ' HD12 ' A' ' 50' ' ' LEU . 14.0 mttt -61.06 -28.95 69.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.379 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 3.9 tmtt? -45.91 -27.13 0.82 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.386 -0.821 . . . . 0.0 109.795 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -142.29 50.8 1.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.929 HD12 ' HA ' ' A' ' 47' ' ' LYS . 9.0 mt -99.13 134.4 21.39 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.837 -1.164 . . . . 0.0 110.119 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD2' HD23 ' A' ' 50' ' ' LEU . 35.8 Cg_endo -79.56 152.54 23.03 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.584 2.189 . . . . 0.0 109.118 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 28.2 tt0 -73.07 23.54 0.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.568 -1.333 . . . . 0.0 111.241 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.38 29.31 5.74 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 t -148.96 119.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.507 -0.996 . . . . 0.0 109.135 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -106.33 120.23 41.31 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.616 ' HE1' HD11 ' A' ' 50' ' ' LEU . 2.1 mtm -96.49 99.49 11.14 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.393 0.616 . . . . 0.0 109.574 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 24' ' ' GLU . 1.1 m -89.21 132.85 34.67 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.846 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -109.35 114.87 28.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.236 -0.915 . . . . 0.0 109.785 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 5.2 m-85 -114.41 171.65 7.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.088 -1.007 . . . . 0.0 111.15 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.864 ' NE2' HD22 ' A' ' 72' ' ' LEU . 66.8 t-80 -109.93 129.78 55.61 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.053 HG11 ' CG1' ' A' ' 150' ' ' VAL . 2.3 m -69.23 158.86 5.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.606 -0.684 . . . . 0.0 109.595 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.779 HD21 HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -124.4 33.13 5.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.318 -0.864 . . . . 0.0 109.462 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 24.8 p90 -132.24 51.38 2.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.013 -1.054 . . . . 0.0 109.986 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.5 mtt -159.17 48.43 0.32 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 154.84 57.44 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -34.07 -38.41 0.1 Allowed Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.915 -0.756 . . . . 0.0 111.408 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.63 -80.06 0.27 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.754 -1.439 . . . . 0.0 110.697 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.092 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -80.02 -25.89 40.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.864 -1.148 . . . . 0.0 109.521 -179.594 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 1.092 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -47.61 -53.43 12.96 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' O ' ' CE ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -56.07 -49.01 74.99 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.264 -1.139 . . . . 0.0 108.331 179.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.726 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 53.1 t0 -59.98 -30.87 69.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.876 HD12 ' CE2' ' A' ' 29' ' ' PHE . 1.1 tt -57.46 -36.92 72.06 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.779 HG21 HD21 ' A' ' 62' ' ' ASN . 40.6 m -66.09 -41.59 90.45 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.901 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.1 tt0 -59.28 -20.33 53.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 177.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -68.98 -47.51 65.42 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.419 ' NE1' ' O ' ' A' ' 58' ' ' LYS . 37.9 t-105 -55.91 -28.82 58.54 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.403 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -84.79 -69.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 109.537 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.03 HG11 ' CE2' ' A' ' 122' ' ' TYR . 3.1 t -45.27 -27.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.934 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.491 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -84.18 -62.13 1.64 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 108.987 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -46.08 -27.35 0.93 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.816 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -72.36 -41.02 66.86 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.447 -0.783 . . . . 0.0 109.63 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 84' ' ' VAL . 40.8 mt -104.87 11.83 33.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.146 -0.971 . . . . 0.0 110.135 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 49.28 32.44 14.0 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.944 HG11 HG12 ' A' ' 117' ' ' ILE . 28.1 m -96.54 19.64 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.474 -1.015 . . . . 0.0 109.77 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 86' ' ' ASP . 87.6 mt-10 -58.91 -75.18 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.937 . . . . 0.0 110.01 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.47 -34.35 0.21 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.53 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 27.7 mtpp -74.23 -54.34 7.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.858 . . . . 0.0 110.643 -178.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 84' ' ' VAL . 1.0 OUTLIER -86.54 -23.1 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.826 -1.171 . . . . 0.0 110.765 -179.099 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.746 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -67.13 -43.39 82.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.731 -1.231 . . . . 0.0 109.016 179.472 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.417 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.0 t -54.62 -55.23 40.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.432 -1.418 . . . . 0.0 110.523 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.47 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 24.2 Cg_endo -72.21 -18.87 26.55 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 122.77 0.879 . . . . 0.0 109.883 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.793 ' HG ' HG11 ' A' ' 111' ' ' VAL . 11.6 mt -86.49 -42.63 13.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.183 -0.948 . . . . 0.0 108.937 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.746 ' CE1' HG23 ' A' ' 89' ' ' THR . 5.2 m-30 -62.85 -48.23 79.93 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.943 -1.098 . . . . 0.0 108.802 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.38 -22.36 59.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.037 -1.039 . . . . 0.0 109.45 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.48 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -76.43 -33.04 49.5 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.7 t -101.82 1.75 10.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.006 -1.291 . . . . 0.0 109.228 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 3.8 mt-30 -91.69 -8.63 46.49 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.981 -1.074 . . . . 0.0 110.878 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.4 mtpt -167.81 -53.48 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.736 -1.227 . . . . 0.0 111.118 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 95' ' ' GLY . 80.8 p -47.93 -39.79 20.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.275 -1.516 . . . . 0.0 109.468 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 99' ' ' THR . 1.1 mt-30 67.7 11.21 8.26 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.8 t -79.44 -5.99 55.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.687 ' CB ' HG22 ' A' ' 96' ' ' VAL . 3.8 mm -91.28 80.36 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.92 27.66 2.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.181 -0.949 . . . . 0.0 109.68 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 107' ' ' ASP . 56.1 p -151.08 129.15 11.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.903 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.759 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -48.95 -39.63 27.08 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.84 -31.25 62.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 104' ' ' SER . 84.2 m-20 -78.05 -40.07 39.85 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.977 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 105' ' ' ALA . 28.4 mt -52.45 -26.29 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.556 -1.34 . . . . 0.0 107.513 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -78.05 -39.51 41.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.682 -0.636 . . . . 0.0 109.44 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -55.99 -44.36 78.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.368 -0.832 . . . . 0.0 109.445 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.793 HG11 ' HG ' ' A' ' 92' ' ' LEU . 88.0 t -74.63 -37.26 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.033 . . . . 0.0 109.089 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.737 ' CE1' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -61.25 -31.03 70.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.286 179.575 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.608 HG23 ' HA ' ' A' ' 118' ' ' LYS . 18.7 mt -85.47 -30.46 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -60.76 -16.53 41.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.775 -1.203 . . . . 0.0 109.35 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.53 ' HB1' ' HE3' ' A' ' 87' ' ' LYS . . . -88.06 -2.43 58.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.689 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.32 -5.22 52.05 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.944 HG12 HG11 ' A' ' 84' ' ' VAL . 1.6 mp -88.88 56.13 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -1.136 . . . . 0.0 109.292 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.608 ' HA ' HG23 ' A' ' 113' ' ' ILE . 3.2 mttp -33.01 152.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.366 -0.833 . . . . 0.0 110.832 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 122' ' ' TYR . . . -53.84 -23.93 24.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.94 -52.14 66.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.054 -1.263 . . . . 0.0 109.083 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -75.76 -35.8 60.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.89 . . . . 0.0 109.412 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 1.03 ' CE2' HG11 ' A' ' 78' ' ' VAL . 2.7 t80 -62.91 -51.21 67.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.069 -1.02 . . . . 0.0 109.166 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.69 -45.65 91.46 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 108.822 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.38 -53.91 31.76 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.36 -0.838 . . . . 0.0 108.911 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.737 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -51.85 -53.06 44.82 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.432 -0.792 . . . . 0.0 108.885 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -52.7 -58.05 8.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 108.628 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.29 -15.41 3.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.661 -0.65 . . . . 0.0 110.239 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.1 OUTLIER -69.22 179.54 1.92 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.958 -1.089 . . . . 0.0 110.17 -179.262 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER -92.79 -37.89 12.07 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.411 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.4 t -72.04 -50.05 39.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.786 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.816 HG22 ' HB1' ' A' ' 81' ' ' ALA . 3.7 t -57.44 -38.09 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.811 -1.18 . . . . 0.0 108.569 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -66.42 -35.59 80.7 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 109.068 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -26.32 68.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.05 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.7 mt -81.77 -28.27 33.35 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.288 -0.883 . . . . 0.0 108.795 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.403 HG23 ' CB ' ' A' ' 77' ' ' ALA . 11.2 t -74.91 -39.51 45.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -68.22 -40.05 82.18 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -33.82 75.32 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -0.818 . . . . 0.0 108.875 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.674 ' HG2' HG23 ' A' ' 73' ' ' THR . 0.2 OUTLIER -64.16 -70.73 0.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.247 -0.908 . . . . 0.0 109.032 179.541 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -48.15 -37.19 14.98 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 108.928 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 0.3 OUTLIER -72.48 -25.88 61.59 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.362 -0.836 . . . . 0.0 109.24 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.614 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -68.47 -55.22 12.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.398 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -73.76 -29.18 62.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 109.949 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -75.85 -25.63 56.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.059 -1.026 . . . . 0.0 109.87 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.702 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.0 OUTLIER -81.94 -48.14 11.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.011 . . . . 0.0 108.35 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 1.073 HG21 ' CE2' ' A' ' 25' ' ' PHE . 13.4 m -83.01 -12.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 81.15 -49.09 0.27 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 0.0 109.414 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.695 HD21 HG12 ' A' ' 61' ' ' VAL . 15.0 tp 61.65 132.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.452 -0.78 . . . . 0.0 109.426 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 16.7 mtt180 -161.49 38.8 0.14 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.587 -1.32 . . . . 0.0 110.302 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 164.46 108.5 0.21 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.42 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 1.053 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -97.99 144.15 27.52 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.4 -1.059 . . . . 0.0 109.335 179.031 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.563 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 36.3 Cg_endo -78.31 150.94 89.2 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 C-N-CA 124.088 -1.213 . . . . 0.0 110.54 0.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -130.95 141.18 50.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.319 -1.488 . . . . 0.0 108.702 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.548 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 2.8 ttp -144.91 134.02 22.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 0.0 110.027 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.548 ' CD1' ' C ' ' A' ' 153' ' ' MET . 0.5 OUTLIER -134.49 155.58 50.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 110.008 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.823 HG22 ' O ' ' A' ' 21' ' ' GLN . 30.8 t -112.07 130.66 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.332 -0.855 . . . . 0.0 108.958 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.538 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 51.75 23.24 1.94 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 54.97 22.71 28.75 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.537 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -125.01 -22.97 4.33 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.825 -1.397 . . . . 0.0 109.113 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 154' ' ' PHE . 12.6 m-85 -121.46 127.69 51.36 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 11.5 pt20 -123.32 118.28 27.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 161' ' ' LEU . 5.8 mt -67.3 177.12 1.97 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.44 ' O ' ' ND2' ' A' ' 162' ' ' ASN . 0.4 OUTLIER -144.1 94.83 5.73 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 120.919 -1.113 . . . . 0.0 109.799 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--N 1.309 -1.523 0 C-N-CA 122.787 2.325 . . . . 0.0 110.637 179.823 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 20.8 mtt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.783 0.801 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -76.74 -59.3 2.83 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.736 -0.602 . . . . 0.0 109.397 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.29 -23.27 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.235 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.503 ' O ' ' HB2' ' A' ' 178' ' ' TYR . 32.7 t80 -73.71 -39.79 64.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.139 -0.976 . . . . 0.0 109.383 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.633 HG22 HG12 ' A' ' 42' ' ' ILE . 18.6 t -73.61 -29.5 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.996 -1.065 . . . . 0.0 109.233 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -82.49 -51.98 7.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 0.0 109.481 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -24.98 67.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 174' ' ' PHE . 20.3 t80 -78.54 -47.58 17.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.218 -0.926 . . . . 0.0 109.372 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.8 -29.92 71.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.982 . . . . 0.0 109.313 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.14 -47.26 18.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.671 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.916 HG23 ' NE2' ' A' ' 8' ' ' GLN . 15.3 m -58.7 -26.82 64.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.004 . . . . 0.0 109.642 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.3 t -87.75 -41.14 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.048 -1.032 . . . . 0.0 109.049 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -57.01 -42.99 81.33 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.29 -0.882 . . . . 0.0 109.133 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.556 ' CE2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -82.09 -35.09 28.99 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.305 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.726 HD23 ' O ' ' A' ' 181' ' ' THR . 0.7 OUTLIER -57.29 -20.13 26.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.875 -1.14 . . . . 0.0 109.331 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.1 t -78.63 -0.87 31.65 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.778 -1.201 . . . . 0.0 108.503 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.423 -0.798 . . . . 0.0 109.379 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.567 ' HB3' ' CG ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -115.37 58.37 0.72 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.827 -1.171 . . . . 0.0 111.017 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 1.7 m-20 45.16 87.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.454 -0.779 . . . . 0.0 110.603 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.82 -35.37 1.93 Allowed Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.207 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.09 -70.31 0.69 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.11 -1.229 . . . . 0.0 108.951 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.671 ' HG2' ' CD2' ' A' ' 9' ' ' TYR . 4.7 pm0 -65.77 -27.07 68.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.29 -0.881 . . . . 0.0 108.811 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.671 ' CD2' ' HG2' ' A' ' 8' ' ' GLN . 2.2 p90 -176.18 138.73 0.34 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -103.99 -179.69 4.02 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 12' ' ' LEU . 47.4 m -103.32 160.25 14.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.547 -0.721 . . . . 0.0 110.102 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.528 HD11 ' HD2' ' A' ' 154' ' ' PHE . 0.7 OUTLIER -92.04 163.25 14.05 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.426 -0.796 . . . . 0.0 109.41 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.431 ' C ' ' HG3' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -97.73 -16.07 20.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.431 ' HG3' ' C ' ' A' ' 13' ' ' GLU . 5.3 mttt -148.71 112.36 3.65 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.7 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.82 161.08 33.73 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.447 2.098 . . . . 0.0 109.703 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.615 HG12 ' CB ' ' A' ' 19' ' ' ALA . 1.1 p -122.32 126.74 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.999 -1.063 . . . . 0.0 110.237 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -46.35 125.72 7.11 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 77.16 8.9 87.01 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 20' ' ' PRO . . . -36.25 161.73 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.685 -0.891 . . . . 0.0 111.189 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 1.086 ' HG3' HD12 ' A' ' 23' ' ' LEU . 36.5 Cg_endo -78.06 113.57 3.44 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 123.273 2.649 . . . . 0.0 111.953 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.795 ' O ' HG13 ' A' ' 155' ' ' VAL . 18.9 mt-30 -51.89 -31.12 26.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.71 HG22 HG22 ' A' ' 155' ' ' VAL . 24.2 t -157.05 81.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.086 HD12 ' HG3' ' A' ' 20' ' ' PRO . 1.3 tt -83.92 137.6 33.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.363 -0.835 . . . . 0.0 110.116 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.805 ' N ' HD23 ' A' ' 23' ' ' LEU . 31.6 mt-10 -120.52 99.38 6.52 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 1.036 ' CZ ' HD13 ' A' ' 23' ' ' LEU . 88.0 m-85 -83.5 115.3 22.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.489 -0.757 . . . . 0.0 109.434 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 0.4 OUTLIER -154.23 139.1 17.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 110.033 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.598 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 8.3 p -121.44 173.17 7.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.41 -0.806 . . . . 0.0 109.443 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.884 ' CD2' HD21 ' A' ' 72' ' ' LEU . 1.6 m-30 -85.2 43.54 1.02 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.869 . . . . 0.0 108.84 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.636 ' CG ' HG11 ' A' ' 96' ' ' VAL . 9.0 m-85 -143.11 14.19 1.86 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.909 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -105.02 160.99 24.1 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 120.84 -1.162 . . . . 0.0 109.357 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -76.03 -35.43 2.45 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.134 1.889 . . . . 0.0 108.064 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 12.2 m170 -82.26 -23.65 35.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 11.1 t -46.13 -52.91 11.31 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.47 ' HB2' ' HG2' ' A' ' 97' ' ' GLN . 85.8 t80 -80.6 -31.5 36.67 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.905 -0.497 . . . . 0.0 111.064 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.64 -27.46 31.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.841 -1.162 . . . . 0.0 111.298 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.642 ' CD1' HD12 ' A' ' 40' ' ' LEU . 2.3 m-30 -84.1 -17.31 40.61 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.873 -1.142 . . . . 0.0 110.767 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -116.64 20.99 13.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.837 -1.164 . . . . 0.0 110.637 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 16.1 mm-40 -143.36 -66.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.953 -1.092 . . . . 0.0 110.405 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 4.6 t -90.16 -69.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.141 -0.974 . . . . 0.0 110.465 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.642 HD12 ' CD1' ' A' ' 36' ' ' PHE . 94.6 mt -47.81 -20.97 0.34 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.286 -0.884 . . . . 0.0 110.759 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 28.7 p-80 40.97 34.38 0.28 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 109.429 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.415 HG13 ' HB3' ' A' ' 40' ' ' LEU . 20.8 mt -76.01 -26.17 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.48 -0.762 . . . . 0.0 109.754 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.764 ' O ' HG12 ' A' ' 46' ' ' VAL . 14.1 m -78.18 -33.05 50.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.108 -0.995 . . . . 0.0 110.148 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -84.12 -47.42 10.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.034 -1.041 . . . . 0.0 109.829 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -57.27 -37.79 72.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 43' ' ' SER . 14.5 p -55.4 -28.23 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.179 -0.951 . . . . 0.0 109.644 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.619 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -70.13 -30.74 68.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.404 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.52 -38.6 69.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.474 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -92.15 18.53 8.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 109.468 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.754 HD13 ' HG2' ' A' ' 56' ' ' MET . 12.1 mt -105.18 102.6 37.45 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.869 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.541 ' O ' ' N ' ' A' ' 53' ' ' GLY . 32.6 Cg_endo -75.49 151.55 37.5 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.343 2.028 . . . . 0.0 108.96 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -65.55 52.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.804 -1.185 . . . . 0.0 110.981 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.835 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -144.3 37.82 1.36 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.87 HG21 ' HB2' ' A' ' 186' ' ' SER . 13.3 t -166.91 149.87 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -113.36 115.74 28.58 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.34 -0.85 . . . . 0.0 110.36 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.754 ' HG2' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -100.93 105.07 16.28 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.107 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -96.01 141.14 29.77 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.07 -178.868 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.422 ' CD ' ' N ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -117.94 105.02 11.47 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.225 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.517 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 4.4 m-85 -113.5 175.33 5.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.106 -0.996 . . . . 0.0 110.926 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 1.169 ' CD2' HD22 ' A' ' 72' ' ' LEU . 9.8 t-80 -125.44 123.9 40.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.553 -0.717 . . . . 0.0 109.648 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.907 HG11 HD22 ' A' ' 147' ' ' LEU . 35.6 m -91.86 153.75 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.433 -0.792 . . . . 0.0 109.952 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 1.9 p-10 -110.24 54.61 0.66 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.173 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.72 ' CE1' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -134.61 56.04 1.87 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.087 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.719 ' HE1' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -122.08 32.16 5.92 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.458 -0.777 . . . . 0.0 109.53 179.635 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.31 40.88 23.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . -148.08 80.71 0.21 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 66' ' ' GLY . 5.3 t0 -26.78 -45.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.449 -0.442 . . . . 0.0 111.209 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.94 HD22 HG22 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -46.02 -30.37 1.81 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.357 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.719 ' HA2' ' HE1' ' A' ' 64' ' ' MET . . . -48.03 -55.97 9.5 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 2.2 ttmt -49.81 -46.39 51.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.278 . . . . 0.0 108.604 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.4 -18.25 60.69 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.031 -1.043 . . . . 0.0 108.368 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.169 HD22 ' CD2' ' A' ' 60' ' ' HIS . 2.3 tt -76.1 -37.38 58.18 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.421 ' CG2' ' OE1' ' A' ' 138' ' ' GLN . 1.6 m -65.62 -41.45 92.67 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 177.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.492 ' NE2' ' HB2' ' A' ' 126' ' ' TRP . 15.3 tp60 -63.17 -23.63 67.52 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -70.49 -39.13 74.36 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.443 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.573 ' CH2' ' OE1' ' A' ' 85' ' ' GLU . 37.6 t-105 -66.09 -30.03 70.47 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.821 . . . . 0.0 108.932 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.576 ' HB2' HE22 ' A' ' 138' ' ' GLN . . . -83.39 -59.96 2.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.138 HG11 ' CD2' ' A' ' 122' ' ' TYR . 92.2 t -57.55 -26.65 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 109.665 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.71 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -79.46 -65.57 0.98 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.073 -1.017 . . . . 0.0 108.745 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -47.03 -26.25 1.0 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.103 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.865 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -74.89 -38.95 61.74 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.448 -0.783 . . . . 0.0 109.28 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 79' ' ' ALA . 85.9 mt -106.33 10.48 31.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.202 -0.936 . . . . 0.0 110.715 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 54.77 19.52 14.58 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.949 HG21 ' CE1' ' A' ' 112' ' ' PHE . 31.6 m -84.44 -6.29 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.284 -1.127 . . . . 0.0 110.318 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.573 ' OE1' ' CH2' ' A' ' 76' ' ' TRP . 3.1 mt-10 -42.22 -71.56 0.08 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.155 -0.966 . . . . 0.0 110.052 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -39.33 -34.26 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.378 -0.827 . . . . 0.0 110.622 -179.591 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.535 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 27.5 mtpp -81.66 -49.87 9.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.284 -0.885 . . . . 0.0 111.189 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.826 HG23 HD12 ' A' ' 92' ' ' LEU . 1.4 m -86.54 -14.26 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.882 -1.136 . . . . 0.0 110.681 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.755 HG23 ' CD1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -74.3 -42.51 59.41 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.698 -1.251 . . . . 0.0 108.349 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.408 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -55.75 -54.05 56.08 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.723 -1.236 . . . . 0.0 110.875 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.489 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 27.1 Cg_endo -72.4 -19.46 25.21 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 N-CA-C 109.881 -0.854 . . . . 0.0 109.881 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.826 HD12 HG23 ' A' ' 88' ' ' VAL . 35.5 mt -87.19 -43.56 12.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.127 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.755 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.1 m-30 -63.59 -44.02 95.23 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.037 -1.039 . . . . 0.0 108.697 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.52 -19.59 57.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 109.426 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.456 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -69.85 -40.51 74.87 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.636 HG11 ' CG ' ' A' ' 29' ' ' PHE . 1.6 t -92.79 -15.71 7.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 O-C-N 121.102 -1.234 . . . . 0.0 108.734 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.47 ' HG2' ' HB2' ' A' ' 34' ' ' TYR . 2.9 mp0 -113.02 10.75 18.85 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.933 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.786 ' O ' HG23 ' A' ' 99' ' ' THR . 0.8 OUTLIER -159.01 51.47 0.38 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.392 -1.442 . . . . 0.0 109.851 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 166.88 -49.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.405 -0.81 . . . . 0.0 109.898 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 75.7 16.29 2.5 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.14 -0.975 . . . . 0.0 110.494 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.7 t -85.7 -4.05 59.06 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.829 0.823 . . . . 0.0 108.861 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.94 HG22 HD22 ' A' ' 68' ' ' LEU . 6.6 mm -82.67 71.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.766 -0.584 . . . . 0.0 109.543 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.501 ' C ' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -116.83 -11.36 10.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.174 -0.954 . . . . 0.0 109.995 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.678 ' N ' HD21 ' A' ' 68' ' ' LEU . 1.5 p -110.67 117.21 32.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 109.77 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . . . -48.31 -39.01 20.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.59 -33.31 54.45 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 108' ' ' ILE . 1.2 p30 -68.64 -41.45 79.39 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.752 -1.179 . . . . 0.0 108.644 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.556 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 3.1 mt -48.57 -44.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.612 -1.305 . . . . 0.0 107.666 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -48.49 79.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.576 -0.703 . . . . 0.0 109.686 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.65 -42.85 62.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.814 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.724 HG11 ' HG ' ' A' ' 92' ' ' LEU . 3.2 t -64.83 -40.13 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.134 -0.979 . . . . 0.0 109.767 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.949 ' CE1' HG21 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -56.77 -50.89 70.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.018 -1.051 . . . . 0.0 109.552 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.8 mt -70.67 -22.74 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 109.597 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -64.86 -15.91 62.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.801 ' HB2' HG12 ' A' ' 88' ' ' VAL . . . -73.37 -6.0 43.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 108.992 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.561 ' C ' HD13 ' A' ' 117' ' ' ILE . . . 97.03 15.16 39.94 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.684 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.6 mm -95.62 168.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -1.196 . . . . 0.0 108.957 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -89.24 139.55 30.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.331 -1.481 . . . . 0.0 109.7 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.75 -50.42 67.77 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -57.99 -44.47 87.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.138 -1.213 . . . . 0.0 109.016 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -55.3 -44.34 75.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 108.852 179.534 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 1.138 ' CD2' HG11 ' A' ' 78' ' ' VAL . 2.3 t80 -55.13 -46.98 75.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.862 . . . . 0.0 108.845 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -56.6 -38.9 72.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 108.708 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.22 71.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.385 -0.822 . . . . 0.0 108.828 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.51 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -49.16 -50.47 37.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.268 -0.895 . . . . 0.0 108.605 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.492 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 12.8 t90 -58.32 -56.12 26.22 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -55.34 -15.91 2.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.583 -0.698 . . . . 0.0 109.923 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -71.23 166.62 21.15 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.972 -1.08 . . . . 0.0 109.45 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -86.77 -40.66 14.78 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.264 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.09 -45.08 97.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 C-N-CA 118.062 -1.455 . . . . 0.0 109.316 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.865 HG22 ' HB1' ' A' ' 81' ' ' ALA . 2.5 t -64.6 -41.23 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.001 -1.062 . . . . 0.0 108.413 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -37.29 86.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.365 -0.834 . . . . 0.0 108.992 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.0 m -62.53 -30.76 71.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 108.908 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.72 -21.98 43.91 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.435 ' HA ' ' OE1' ' A' ' 138' ' ' GLN . 4.9 t -77.05 -46.38 29.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 139' ' ' GLU . . . -64.04 -42.83 96.92 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.479 ' HG2' ' OH ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -62.97 -32.37 73.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.404 -0.81 . . . . 0.0 109.036 179.664 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.576 HE22 ' HB2' ' A' ' 77' ' ' ALA . 48.0 mt-30 -65.03 -62.84 1.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 108.92 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 136' ' ' ALA . 6.8 pt-20 -54.51 -42.42 70.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 108.838 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 29.1 mttt -67.49 -27.19 66.8 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.375 -0.828 . . . . 0.0 109.151 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 23' ' ' LEU . . . -63.42 -49.07 75.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.024 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.512 ' HB2' HG12 ' A' ' 61' ' ' VAL . . . -73.21 -41.39 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.837 . . . . 0.0 110.148 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.18 -16.74 60.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.158 -0.964 . . . . 0.0 109.862 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.607 ' CG ' HG21 ' A' ' 16' ' ' VAL . 22.8 m-20 -82.9 -44.21 15.64 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.738 HG21 ' CE1' ' A' ' 25' ' ' PHE . 3.8 m -91.17 -5.38 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 147' ' ' LEU . 0.0 OUTLIER 81.86 -46.75 0.2 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.595 -0.691 . . . . 0.0 109.804 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.907 HD22 HG11 ' A' ' 61' ' ' VAL . 13.0 tp 73.12 141.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.66 -0.65 . . . . 0.0 109.72 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.39 25.77 0.16 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.771 -1.206 . . . . 0.0 110.315 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.03 112.2 0.62 Allowed Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.108 -1.52 . . . . 0.0 111.081 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.479 HG22 ' CZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -90.48 140.31 26.81 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.503 -0.998 . . . . 0.0 108.962 178.158 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.25 152.2 95.95 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 123.785 -1.339 . . . . 0.0 110.816 0.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -128.22 159.97 33.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.393 -1.442 . . . . 0.0 109.233 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.524 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 3.0 ttm -142.02 121.82 13.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.101 -0.999 . . . . 0.0 109.88 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 160' ' ' GLN . 23.5 m-85 -122.89 145.77 48.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.139 -0.975 . . . . 0.0 109.644 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.795 HG13 ' O ' ' A' ' 21' ' ' GLN . 36.9 t -124.66 122.31 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.145 -0.972 . . . . 0.0 108.957 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER 50.95 24.99 2.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.804 -0.758 . . . . 0.0 108.989 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.502 ' C ' HD13 ' A' ' 12' ' ' LEU . . . 51.3 20.84 5.38 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.466 -1.349 . . . . 0.0 110.325 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -121.83 -19.92 6.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.819 -1.4 . . . . 0.0 108.867 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.456 ' O ' ' N ' ' A' ' 155' ' ' VAL . 19.6 m-85 -141.7 123.83 15.52 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.318 -0.864 . . . . 0.0 108.945 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.59 ' HB2' ' CD2' ' A' ' 154' ' ' PHE . 1.3 tt0 -130.29 126.56 37.54 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.279 -0.888 . . . . 0.0 109.389 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.56 HD22 ' HB3' ' A' ' 9' ' ' TYR . 8.1 mt -59.46 179.26 0.12 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 162' ' ' ASN . 12.8 p-10 -153.22 107.67 2.62 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.071 -1.018 . . . . 0.0 109.777 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 C--N 1.309 -1.513 0 C-N-CA 122.306 2.004 . . . . 0.0 110.2 179.472 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.705 0.764 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.75 -49.22 78.58 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 121.577 -0.702 . . . . 0.0 109.686 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 12.5 t -69.57 -29.14 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 109.854 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.485 ' O ' ' HB3' ' A' ' 178' ' ' TYR . 4.6 t80 -65.59 -36.62 84.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.015 -1.053 . . . . 0.0 109.466 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 93.3 t -81.2 -24.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.05 -1.031 . . . . 0.0 109.772 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -53.48 6.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.025 -1.047 . . . . 0.0 109.402 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.91 -33.39 75.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.106 -0.996 . . . . 0.0 109.356 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 174' ' ' PHE . 2.5 t80 -70.13 -57.18 5.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 109.093 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.79 -29.92 69.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.341 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -73.27 -41.71 63.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.933 . . . . 0.0 109.387 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.564 ' CG2' ' CG ' ' A' ' 8' ' ' GLN . 1.0 OUTLIER -62.37 -60.01 4.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.163 -0.961 . . . . 0.0 109.283 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.434 HG21 ' CE1' ' A' ' 178' ' ' TYR . 61.3 t -53.75 -32.68 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.06 -1.025 . . . . 0.0 109.198 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -47.08 86.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 109.446 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -85.56 -25.66 26.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.203 -0.936 . . . . 0.0 110.426 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.624 HD21 ' CE2' ' A' ' 9' ' ' TYR . 4.1 mt -67.81 -20.64 65.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.489 -1.382 . . . . 0.0 108.856 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.87 ' HB2' HG21 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -69.95 -10.65 59.32 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.169 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 O-C-N 121.55 -0.718 . . . . 0.0 109.359 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.691 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' ASP . 3.0 tt0 -86.72 52.32 2.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 0.0 110.277 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLU . 64.7 t0 39.82 81.01 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.796 -0.565 . . . . 0.0 109.906 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 119.19 -18.91 10.19 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.541 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.71 -67.32 0.77 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.902 -1.352 . . . . 0.0 108.769 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.593 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -96.4 4.0 52.49 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.21 -0.932 . . . . 0.0 109.806 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.557 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -177.31 130.8 0.16 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.913 -1.117 . . . . 0.0 109.611 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -117.79 177.05 4.91 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.813 -0.555 . . . . 0.0 109.525 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -100.17 160.22 14.49 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.374 0.607 . . . . 0.0 109.552 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.773 HD11 ' HD2' ' A' ' 154' ' ' PHE . 17.4 mt -95.69 133.96 39.16 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.315 -0.866 . . . . 0.0 109.779 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -72.63 -19.42 61.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 108.694 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -135.69 107.32 9.91 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 34.8 Cg_endo -76.08 158.34 37.98 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.412 2.075 . . . . 0.0 110.968 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 16' ' ' VAL . 46.1 t -128.72 87.43 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.418 -0.801 . . . . 0.0 109.38 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.52 133.05 13.42 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 95.82 -25.56 24.52 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.741 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -42.02 157.75 0.21 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.401 -1.058 . . . . 0.0 109.367 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.571 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 35.2 Cg_endo -78.4 135.42 13.31 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.504 2.136 . . . . 0.0 111.015 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.804 ' O ' HG13 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -44.25 -24.03 0.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.411 -0.806 . . . . 0.0 109.764 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.766 HG13 ' CE ' ' A' ' 153' ' ' MET . 42.4 t -149.83 80.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.022 -1.049 . . . . 0.0 108.896 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.877 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -72.06 124.94 26.03 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.0 OUTLIER -106.5 125.29 50.81 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.614 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.877 ' CE2' HD13 ' A' ' 23' ' ' LEU . 6.3 m-85 -115.73 110.32 18.95 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.466 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -150.79 145.36 25.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.953 . . . . 0.0 109.639 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.986 ' HB3' HG22 ' A' ' 61' ' ' VAL . 32.8 p -126.03 -163.86 1.26 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.203 -0.935 . . . . 0.0 108.83 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.67 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -118.65 55.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.152 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.673 ' CE1' HD22 ' A' ' 72' ' ' LEU . 12.2 m-85 -138.88 2.14 2.13 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.453 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.516 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -113.91 172.46 3.56 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.658 -1.276 . . . . 0.0 109.765 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 30' ' ' CYS . 32.8 Cg_endo -75.04 -49.84 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.481 2.12 . . . . 0.0 108.835 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 18.5 m80 -73.11 -25.63 60.94 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -46.85 -41.14 15.17 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.109 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.501 ' CG ' ' OE1' ' A' ' 97' ' ' GLN . 3.7 t80 -88.44 -44.13 10.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.601 -0.687 . . . . 0.0 110.171 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 46.0 mt-30 -72.43 -24.49 61.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.986 -1.071 . . . . 0.0 110.924 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 1.6 t80 -80.45 -16.76 53.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.938 -1.101 . . . . 0.0 110.388 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.51 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.6 tt0 -131.96 50.99 2.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.892 -1.13 . . . . 0.0 110.381 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.51 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -171.29 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 110.55 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 52.1 t -94.77 -53.58 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 110.575 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 35' ' ' GLN . 22.6 mt -48.86 -20.18 0.47 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.169 -0.957 . . . . 0.0 110.58 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.4 m80 47.93 31.67 2.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.889 -1.132 . . . . 0.0 108.852 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.856 ' O ' HG13 ' A' ' 46' ' ' VAL . 4.3 mt -83.46 -41.84 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.53 -0.731 . . . . 0.0 109.993 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.461 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -80.0 -17.84 51.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.984 -1.073 . . . . 0.0 110.557 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 2.2 m-20 -87.3 -39.02 15.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.935 -1.103 . . . . 0.0 110.074 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -71.66 -33.76 69.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.994 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 42' ' ' ILE . 30.5 m -55.74 -35.84 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.771 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -54.38 -46.42 73.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 109.562 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -26.77 38.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.504 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 2.5 mmtm -89.27 20.61 3.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.834 . . . . 0.0 110.308 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.01 HD11 ' SD ' ' A' ' 56' ' ' MET . 35.8 mt -114.02 87.37 12.78 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.987 -1.07 . . . . 0.0 109.714 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 36.3 Cg_endo -78.19 64.36 8.38 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.599 2.199 . . . . 0.0 111.01 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER 56.85 130.74 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.638 0.732 . . . . 0.0 110.516 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.29 -21.18 31.5 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.996 HG11 HD22 ' A' ' 50' ' ' LEU . 1.2 t -91.03 87.72 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -1.048 . . . . 0.0 108.833 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -77.6 97.03 4.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.952 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' MET . . . . . 1.01 ' SD ' HD11 ' A' ' 50' ' ' LEU . 63.4 mtp -95.83 97.1 9.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.12 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -91.82 135.57 33.81 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.617 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.454 ' HG3' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -109.19 116.88 32.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.382 -0.824 . . . . 0.0 110.271 -179.419 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 3.2 m-85 -117.18 175.15 5.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.132 -0.98 . . . . 0.0 110.787 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.636 ' NE2' HD21 ' A' ' 72' ' ' LEU . 2.6 t60 -112.15 141.38 45.92 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.683 0.754 . . . . 0.0 109.203 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 1.072 HG11 ' CG1' ' A' ' 150' ' ' VAL . 3.2 m -77.09 155.71 5.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.3 0.571 . . . . 0.0 109.847 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.518 ' OD1' ' CB ' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -124.79 36.73 4.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 108.822 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.564 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 6.3 p90 -136.11 52.55 1.97 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -155.91 47.99 0.49 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 158.36 61.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -28.78 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 65' ' ' GLY . 71.2 m-20 -88.94 -78.26 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -1.125 . . . . 0.0 110.663 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.126 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -79.87 -22.36 42.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.957 -1.089 . . . . 0.0 110.51 -178.868 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 1.126 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -53.95 -43.75 71.8 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 1.8 tmtp? -64.86 -45.93 84.01 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.065 -1.256 . . . . 0.0 108.258 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.54 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 1.5 t70 -66.03 -31.65 72.67 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.754 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 15.5 tp -53.79 -49.66 67.81 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.514 HG23 ' CD ' ' A' ' 138' ' ' GLN . 1.3 m -57.33 -43.71 83.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 1.009 ' O ' HG23 ' A' ' 78' ' ' VAL . 2.5 tm0? -57.07 -25.26 58.4 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -64.44 -44.07 92.31 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -57.46 -33.04 67.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -79.53 -51.05 9.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.395 -0.816 . . . . 0.0 110.159 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 1.009 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.7 t -62.74 -27.41 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.068 -1.02 . . . . 0.0 109.641 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.606 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -77.95 -61.88 1.85 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.043 -1.036 . . . . 0.0 109.36 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.648 ' HB3' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -44.71 -27.29 0.48 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.227 -0.921 . . . . 0.0 108.951 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.624 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -68.71 -44.46 73.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.365 -0.834 . . . . 0.0 109.4 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.677 ' HB2' HG13 ' A' ' 84' ' ' VAL . 21.9 mt -108.49 16.29 23.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.09 29.83 4.95 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.677 HG13 ' HB2' ' A' ' 82' ' ' LEU . 34.8 m -85.73 -3.89 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -1.17 . . . . 0.0 110.066 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -45.1 -73.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.09 -1.006 . . . . 0.0 109.911 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.27 -35.12 0.23 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.598 -0.689 . . . . 0.0 110.603 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.789 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 25.7 mtpp -80.54 -52.78 7.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.943 . . . . 0.0 111.301 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.761 ' O ' HD12 ' A' ' 92' ' ' LEU . 2.6 m -84.28 -9.46 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.745 -1.222 . . . . 0.0 110.944 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.753 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -73.68 -45.37 52.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.758 -1.214 . . . . 0.0 108.455 178.632 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.424 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -51.93 -53.94 46.0 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.556 -1.34 . . . . 0.0 110.757 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.541 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 24.0 Cg_endo -72.96 -17.74 24.88 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 N-CA-C 109.65 -0.942 . . . . 0.0 109.65 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.848 ' HG ' HG11 ' A' ' 111' ' ' VAL . 6.4 mt -86.19 -44.4 12.22 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.753 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.2 m-30 -62.04 -47.52 84.34 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.906 -1.121 . . . . 0.0 108.674 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 97' ' ' GLN . 46.8 mt-10 -69.03 -34.81 75.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.025 -1.047 . . . . 0.0 109.554 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.457 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -64.71 -31.99 82.72 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 92' ' ' LEU . 1.9 t -107.8 8.12 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.984 -1.303 . . . . 0.0 109.568 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.501 ' OE1' ' CG ' ' A' ' 34' ' ' TYR . 11.5 mt-30 -97.75 5.75 48.79 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.915 -1.116 . . . . 0.0 110.296 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.01 -49.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.803 -1.186 . . . . 0.0 110.631 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 1.4 p -55.05 -42.05 72.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.299 -1.501 . . . . 0.0 109.544 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.6 mm-40 67.62 10.5 7.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 110.126 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.3 t -83.67 -8.29 59.31 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.744 0.783 . . . . 0.0 109.102 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.62 ' CB ' HG22 ' A' ' 96' ' ' VAL . 16.3 mm -79.55 66.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.457 ' HD3' ' C ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -127.25 31.75 5.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.585 -179.572 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 107' ' ' ASP . 16.8 p -147.94 127.77 13.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 110.146 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.48 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.56 -29.8 7.55 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 t -63.71 -34.29 77.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.597 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.7 OUTLIER -68.3 -46.41 70.37 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.556 ' CG1' HD23 ' A' ' 68' ' ' LEU . 19.0 mt -52.39 -29.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.448 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -73.24 -39.43 65.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 109.121 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 114' ' ' ASN . 14.5 m-20 -56.34 -45.4 80.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.317 -0.864 . . . . 0.0 109.406 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.848 HG11 ' HG ' ' A' ' 92' ' ' LEU . 15.4 t -70.96 -38.59 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.41 ' CE2' ' HE2' ' A' ' 122' ' ' TYR . 2.9 m-85 -65.75 -32.36 73.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.445 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 109' ' ' ARG . 16.1 mt -79.4 -25.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.025 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 110' ' ' ASP . 17.5 m-20 -70.17 -23.65 63.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.974 -1.079 . . . . 0.0 109.697 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.789 ' HB1' ' HE3' ' A' ' 87' ' ' LYS . . . -85.21 2.57 43.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . 0.551 ' C ' HD13 ' A' ' 117' ' ' ILE . . . 92.78 8.99 61.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.718 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -94.4 58.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 109.549 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 117' ' ' ILE . 56.5 mttt -37.1 154.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.228 -0.92 . . . . 0.0 110.295 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 123' ' ' ASP . . . -50.78 -27.71 13.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -67.7 -43.43 80.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -1.146 . . . . 0.0 109.369 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -46.99 19.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.536 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.895 ' CE2' HG11 ' A' ' 78' ' ' VAL . 5.8 t80 -63.52 -47.08 83.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.177 -0.952 . . . . 0.0 109.52 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 119' ' ' GLY . 30.5 t0 -61.38 -53.18 59.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.148 -0.97 . . . . 0.0 109.176 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.21 -53.67 16.17 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.623 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -48.23 -55.75 9.7 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.426 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 8.5 t90 -53.29 -59.18 4.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.14 -15.81 2.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.573 -0.705 . . . . 0.0 109.985 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 7.7 m -69.67 176.97 3.21 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.071 -1.018 . . . . 0.0 109.891 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -89.57 -39.62 13.16 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.335 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.39 -47.16 78.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.752 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.624 HG22 ' HB1' ' A' ' 81' ' ' ALA . 2.8 t -62.95 -34.54 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.904 -1.123 . . . . 0.0 108.399 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -67.33 -28.3 67.86 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 137' ' ' GLN . 1.8 m -69.93 -35.51 74.59 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.648 HD13 ' HB3' ' A' ' 80' ' ' MET . 0.2 OUTLIER -79.09 -19.08 52.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.568 HG23 ' HB1' ' A' ' 77' ' ' ALA . 10.2 t -82.25 -47.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.33 -35.59 81.36 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.41 -0.806 . . . . 0.0 108.841 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.9 OUTLIER -69.88 -37.39 76.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 109.025 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.514 ' CD ' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -65.4 -68.38 0.37 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 108.988 179.519 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.71 -36.41 11.24 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.219 -0.926 . . . . 0.0 108.586 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -71.91 -30.91 65.85 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -61.11 -59.74 4.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.361 -0.837 . . . . 0.0 108.846 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.537 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -67.47 -26.76 66.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.838 . . . . 0.0 109.508 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.72 -22.79 46.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.963 . . . . 0.0 109.884 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -82.22 -43.73 17.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.104 -0.997 . . . . 0.0 108.475 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.824 HG21 ' CE2' ' A' ' 25' ' ' PHE . 18.4 m -98.36 -5.6 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.537 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.1 tt0 75.21 -53.34 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.491 -0.756 . . . . 0.0 109.793 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.8 HD21 HG12 ' A' ' 61' ' ' VAL . 13.6 tp 69.57 135.03 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.7 ptt85 -160.18 35.7 0.17 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.457 -1.402 . . . . 0.0 110.219 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 161.93 108.56 0.23 Allowed Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.559 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 1.072 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -89.62 144.31 31.74 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.405 -1.056 . . . . 0.0 109.225 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.18 152.25 94.29 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 124.009 -1.246 . . . . 0.0 110.779 0.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -129.4 139.46 51.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.453 -1.404 . . . . 0.0 108.983 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.766 ' CE ' HG13 ' A' ' 22' ' ' VAL . 19.9 ttt -140.97 128.05 20.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.98 -1.075 . . . . 0.0 110.179 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.773 ' HD2' HD11 ' A' ' 12' ' ' LEU . 2.5 m-85 -126.28 137.12 53.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -0.918 . . . . 0.0 109.634 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' ' 21' ' ' GLN . 54.7 t -99.25 133.72 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.741 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 3.9 t30 42.45 24.47 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.16 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.532 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 56.81 59.22 11.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' N ' HD12 ' A' ' 12' ' ' LEU . 6.7 tttt -166.65 -36.23 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.439 -1.036 . . . . 0.0 108.294 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.495 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 10.7 m-85 -114.59 122.83 47.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.105 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.589 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 1.5 tt0 -113.34 109.59 18.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 0.0 109.963 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.692 HD12 ' SD ' ' A' ' 153' ' ' MET . 15.3 mt -60.25 -179.86 0.12 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.1 125.76 4.62 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.084 -1.01 . . . . 0.0 109.559 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 C--N 1.312 -1.361 0 C-N-CA 122.514 2.143 . . . . 0.0 110.688 -179.881 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 171' ' ' MET . . . . . 0.409 ' O ' HG23 ' A' ' 175' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.612 0.72 . . . . 0.0 110.025 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.26 -58.93 2.98 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 109.579 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.5 t -68.48 -30.58 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.374 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 0.6 OUTLIER -69.95 -30.83 68.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.139 -0.976 . . . . 0.0 109.018 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.782 HG22 HG12 ' A' ' 42' ' ' ILE . 7.7 t -76.15 -31.74 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 108.892 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -80.82 -64.65 1.14 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.212 -0.93 . . . . 0.0 109.052 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -49.8 -40.87 43.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.864 . . . . 0.0 109.41 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 56.4 t80 -63.61 -50.74 68.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.65 -24.73 15.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.382 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.96 -51.08 10.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.645 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.742 ' O ' HD23 ' A' ' 185' ' ' LEU . 90.5 m -55.17 -27.17 43.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.116 -0.99 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 43.0 t -87.52 -35.74 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.067 -1.021 . . . . 0.0 108.672 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -43.56 81.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.418 -0.801 . . . . 0.0 108.96 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.522 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -82.01 -39.62 23.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.357 -0.84 . . . . 0.0 109.057 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.77 HD12 HG21 ' A' ' 155' ' ' VAL . 1.1 mm? -53.41 -20.67 4.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.092 . . . . 0.0 109.391 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.728 ' CB ' HG13 ' A' ' 54' ' ' VAL . 19.6 p -74.81 -8.01 55.14 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.65 -1.282 . . . . 0.0 108.352 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.411 -0.806 . . . . 0.0 109.091 179.654 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.588 ' CD1' ' OE1' ' A' ' 8' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -124.9 62.56 1.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.91 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 48.3 t0 45.23 84.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 109.403 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 136.06 -32.44 2.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -70.27 0.52 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.958 -1.319 . . . . 0.0 108.716 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.588 ' OE1' ' CD1' ' A' ' 3' ' ' TYR . 9.3 pt20 -96.65 0.09 49.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.154 -0.966 . . . . 0.0 109.944 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.511 ' O ' ' N ' ' A' ' 6' ' ' GLY . 1.2 p90 178.93 133.34 0.08 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.831 -1.168 . . . . 0.0 109.772 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 t -110.54 179.15 4.15 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -115.65 144.46 43.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.341 -0.849 . . . . 0.0 109.778 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.546 HD11 ' HD2' ' A' ' 154' ' ' PHE . 1.9 mt -95.45 144.06 26.27 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.434 -0.791 . . . . 0.0 109.59 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.91 -22.26 65.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 108.857 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -127.57 102.13 23.39 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.429 -0.795 . . . . 0.0 109.026 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 34.2 Cg_endo -76.43 163.23 32.49 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.503 2.135 . . . . 0.0 110.846 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.498 ' HB ' ' HA3' ' A' ' 157' ' ' GLY . 38.2 t -123.13 92.14 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.84 . . . . 0.0 109.826 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.4 132.74 51.99 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 96.77 -25.74 25.21 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.735 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -42.49 162.75 0.15 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.371 -1.076 . . . . 0.0 109.699 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.608 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 36.2 Cg_endo -77.86 137.38 15.8 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.758 2.305 . . . . 0.0 111.206 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.781 ' O ' HG13 ' A' ' 155' ' ' VAL . 30.3 mm-40 -47.4 -22.36 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.913 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 55.7 t -151.41 82.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.014 -1.054 . . . . 0.0 108.968 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.771 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -76.66 121.33 23.09 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.11 -0.994 . . . . 0.0 108.341 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.558 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -98.27 139.54 33.91 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 110.025 -179.295 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.989 ' CE2' HG21 ' A' ' 145' ' ' VAL . 7.0 m-85 -127.76 101.96 6.59 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.467 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -143.11 143.24 31.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.032 -1.042 . . . . 0.0 109.779 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.993 ' HB2' HG22 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -120.43 -179.07 3.85 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.91 . . . . 0.0 109.599 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.543 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 12.1 m-30 -98.48 47.4 0.99 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.725 ' CG ' HG11 ' A' ' 96' ' ' VAL . 28.4 m-85 -142.22 13.75 2.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.433 -0.792 . . . . 0.0 109.967 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.503 ' O ' ' NE2' ' A' ' 97' ' ' GLN . 0.5 OUTLIER -105.29 157.28 34.74 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.728 -1.233 . . . . 0.0 109.459 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.7 -27.16 12.95 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.209 1.939 . . . . 0.0 108.252 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 27.0 m80 -90.93 -22.66 20.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 13.0 t -47.04 -49.92 20.47 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 9.6 t80 -75.03 -33.65 61.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.838 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.3 mm-40 -83.36 -45.59 13.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.867 -1.146 . . . . 0.0 110.85 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.624 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -48.47 -24.63 1.34 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.104 -0.997 . . . . 0.0 110.578 -179.252 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -114.79 -51.26 2.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.919 -1.113 . . . . 0.0 112.334 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 63.3 mm-40 -90.15 0.32 57.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.689 -1.257 . . . . 0.0 111.534 -177.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 35' ' ' GLN . 41.3 t -135.76 -74.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.676 -1.265 . . . . 0.0 109.581 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 35' ' ' GLN . 78.1 mt -64.06 -24.74 67.82 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.236 -0.915 . . . . 0.0 109.561 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.3 m80 51.18 21.55 1.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.988 -1.07 . . . . 0.0 109.201 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.624 HG21 ' CZ ' ' A' ' 36' ' ' PHE . 37.6 mt -63.5 -21.27 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.858 . . . . 0.0 109.757 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -60.1 2.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 109.661 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -57.66 -30.5 65.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.804 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -66.59 -34.48 77.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.721 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.7 t -72.25 -16.85 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.032 . . . . 0.0 109.191 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -82.46 -41.41 19.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.87 . . . . 0.0 110.088 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.18 -22.44 0.65 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.073 -1.017 . . . . 0.0 109.662 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 1.3 ptmm? -115.62 42.05 2.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 109.631 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 50' ' ' LEU . 10.9 mt -108.16 101.74 43.12 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.17 -0.956 . . . . 0.0 109.752 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 33.5 Cg_endo -74.93 153.9 42.46 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.536 2.157 . . . . 0.0 109.408 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 73.2 tt0 -69.5 22.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.742 -1.223 . . . . 0.0 111.548 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.416 ' C ' HG23 ' A' ' 54' ' ' VAL . . . -122.45 32.11 4.61 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.528 ' CG1' ' HB3' ' A' ' 186' ' ' SER . 59.0 t -153.39 127.16 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.47 105.43 17.4 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 110.766 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.512 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -104.36 99.1 8.8 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.718 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 1.3 m -100.37 135.04 42.42 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.714 -1.195 . . . . 0.0 110.982 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.558 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 6.7 tttt -106.84 117.81 35.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 2.6 m-85 -118.08 170.76 8.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.909 -1.12 . . . . 0.0 111.706 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.948 ' NE2' HD21 ' A' ' 72' ' ' LEU . 1.9 t-160 -111.09 136.4 50.18 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.727 0.775 . . . . 0.0 109.236 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.993 HG22 ' HB2' ' A' ' 27' ' ' SER . 3.1 m -78.9 155.55 4.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-O 121.398 0.618 . . . . 0.0 110.272 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.453 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 1.0 OUTLIER -124.4 35.82 4.74 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.031 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.563 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 9.7 p90 -135.77 55.73 1.86 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.295 -0.878 . . . . 0.0 109.608 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.629 ' CE ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -130.36 37.11 3.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.162 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.21 -33.28 0.42 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.19 -37.07 2.72 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -87.84 -79.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.004 -1.292 . . . . 0.0 110.464 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.888 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -79.87 -18.5 50.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.106 . . . . 0.0 109.618 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.652 ' N ' HD22 ' A' ' 68' ' ' LEU . . . -54.95 -36.34 60.34 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.27 -45.65 79.76 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.325 -1.103 . . . . 0.0 108.36 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.544 ' HB3' HD12 ' A' ' 108' ' ' ILE . 18.2 t0 -66.9 -24.7 66.13 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.948 HD21 ' NE2' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -65.55 -46.86 77.89 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.888 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.46 HG22 HE21 ' A' ' 138' ' ' GLN . 1.6 m -56.04 -41.71 75.44 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.575 ' O ' HG23 ' A' ' 78' ' ' VAL . 6.0 tp60 -61.4 -23.78 66.04 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.65 -37.33 86.95 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.593 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 20.7 t-105 -71.29 -32.26 68.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.528 -0.733 . . . . 0.0 109.142 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.53 ' HB2' ' NE2' ' A' ' 138' ' ' GLN . . . -75.75 -40.34 55.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.467 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.726 HG21 ' CE1' ' A' ' 122' ' ' TYR . 35.6 t -74.55 -26.24 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.288 -0.882 . . . . 0.0 109.655 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.553 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.1 -57.87 3.52 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.944 -1.097 . . . . 0.0 108.776 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -26.59 10.33 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.703 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -68.14 -47.2 68.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.642 -0.661 . . . . 0.0 109.397 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.535 ' HB2' HG13 ' A' ' 84' ' ' VAL . 44.8 mt -106.12 14.02 28.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.104 -0.997 . . . . 0.0 110.373 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.24 24.89 7.42 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 28.2 m -86.25 -4.16 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -1.027 . . . . 0.0 110.482 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 89' ' ' THR . 2.7 pt-20 -42.44 -59.11 1.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.047 -1.033 . . . . 0.0 109.897 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.68 -31.41 11.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 109.828 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 84' ' ' VAL . 46.3 mttp -78.65 -52.88 7.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 111.478 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.828 HG23 HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -85.92 -8.63 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.752 -1.217 . . . . 0.0 111.053 -178.111 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.744 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.07 -44.98 44.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.729 -1.232 . . . . 0.0 108.679 178.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.424 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -52.61 -53.27 55.74 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.472 -1.392 . . . . 0.0 110.627 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.651 ' HB2' HG13 ' A' ' 111' ' ' VAL . 27.2 Cg_endo -73.28 -18.63 23.21 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 109.737 -0.909 . . . . 0.0 109.737 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.857 ' HG ' HG11 ' A' ' 111' ' ' VAL . 14.9 mt -86.83 -42.97 12.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 108.982 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.744 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.1 m-30 -64.81 -46.66 81.04 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.889 -1.132 . . . . 0.0 108.87 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -71.78 -22.24 61.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.314 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.442 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -78.98 -31.02 44.79 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.725 HG11 ' CG ' ' A' ' 29' ' ' PHE . 2.8 t -105.73 6.63 10.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.179 -1.189 . . . . 0.0 109.325 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 93' ' ' PHE . 40.5 mm-40 -105.21 9.13 34.17 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 120.974 -1.079 . . . . 0.0 110.514 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER 173.27 -49.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.654 -1.278 . . . . 0.0 110.443 179.643 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 59.7 p -55.32 -44.53 75.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.608 -1.308 . . . . 0.0 109.297 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 71.41 12.04 6.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 110.285 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 t -79.63 -7.78 58.77 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.628 ' CB ' HG22 ' A' ' 96' ' ' VAL . 7.7 mm -84.95 73.32 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.12 33.37 3.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.605 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 107' ' ' ASP . 14.7 p -160.45 133.24 6.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 0.0 110.056 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.532 ' N ' ' HB3' ' A' ' 68' ' ' LEU . . . -50.81 -34.76 28.96 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.9 p -61.59 -31.6 71.67 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -70.6 -51.24 29.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.731 HD11 HD23 ' A' ' 68' ' ' LEU . 52.5 mt -48.66 -29.94 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -38.54 53.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.485 -0.759 . . . . 0.0 109.551 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.18 -44.32 83.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.438 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.857 HG11 ' HG ' ' A' ' 92' ' ' LEU . 69.9 t -72.62 -38.17 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -42.74 98.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.5 mt -71.5 -24.29 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.099 -1.001 . . . . 0.0 109.271 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -67.29 -19.65 65.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.672 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -91.75 -12.03 35.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.366 -0.834 . . . . 0.0 109.253 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.98 -7.96 25.4 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.823 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.9 mp -76.93 52.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.315 -1.109 . . . . 0.0 109.478 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 117' ' ' ILE . 35.5 mttm -40.46 154.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.035 -1.041 . . . . 0.0 109.769 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.75 -35.7 39.24 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.48 -56.27 24.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.045 -1.268 . . . . 0.0 110.018 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -46.86 87.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 109.946 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.726 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -62.86 -62.64 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.561 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 122' ' ' TYR . 13.8 t70 -42.52 -35.08 0.97 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.768 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.95 -41.87 28.27 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.698 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ALA . . . . . 0.535 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -58.57 -48.29 81.43 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 108.795 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 126' ' ' TRP . 2.2 t90 -62.37 -56.85 14.32 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.12 -16.1 0.71 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.552 -0.718 . . . . 0.0 110.559 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 4.7 t -69.07 -175.59 0.76 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.853 -1.154 . . . . 0.0 110.073 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -90.29 -34.89 15.56 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.299 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.4 -46.92 62.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 118.415 -1.314 . . . . 0.0 110.11 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.703 HG22 ' HB1' ' A' ' 81' ' ' ALA . 6.5 t -72.14 -34.14 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.853 -1.154 . . . . 0.0 108.911 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 128' ' ' SER . 1.3 tttm -64.3 -44.04 92.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.383 -0.823 . . . . 0.0 109.016 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 11.4 t -65.12 -30.87 71.84 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 77' ' ' ALA . 7.7 tp -78.91 -17.59 55.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.19 -47.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -64.46 -33.36 75.7 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.445 ' OE1' ' OH ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -66.46 -37.85 86.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.442 -0.786 . . . . 0.0 108.959 179.433 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLN . . . . . 0.53 ' NE2' ' HB2' ' A' ' 77' ' ' ALA . 8.4 mt-30 -67.46 -67.62 0.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 108.885 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 138' ' ' GLN . 8.4 tt0 -46.74 -36.85 7.66 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 10.2 mmtt -72.52 -29.12 63.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.429 -0.794 . . . . 0.0 108.996 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.58 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -61.99 -53.62 53.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 109.071 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -71.77 -35.35 70.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.4 -0.813 . . . . 0.0 109.927 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.79 -18.63 58.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.836 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 140' ' ' LYS . 7.5 m-20 -82.82 -45.04 14.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.114 -0.992 . . . . 0.0 108.753 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.989 HG21 ' CE2' ' A' ' 25' ' ' PHE . 20.9 m -97.33 -11.96 8.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.545 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 3.4 mt-30 82.02 -44.84 0.17 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.57 -0.706 . . . . 0.0 109.75 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.59 HD13 ' CG ' ' A' ' 25' ' ' PHE . 14.6 tp 66.46 133.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.347 -0.845 . . . . 0.0 109.144 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.4 37.41 0.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.536 -1.353 . . . . 0.0 109.846 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 158.04 109.51 0.28 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.291 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.965 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -93.56 142.59 25.37 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.427 -1.043 . . . . 0.0 109.358 178.838 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.16 151.76 93.79 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.891 -1.296 . . . . 0.0 110.487 0.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -126.83 153.53 45.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.306 -1.496 . . . . 0.0 109.264 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' MET . . . . . 0.531 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 3.2 ttm -145.32 136.44 24.84 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.118 -0.989 . . . . 0.0 109.818 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.6 ' CE2' ' HG3' ' A' ' 160' ' ' GLN . 3.0 m-85 -135.7 129.18 32.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.149 -0.97 . . . . 0.0 110.003 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 21' ' ' GLN . 53.9 t -98.32 132.11 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 0.0 109.636 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASN . . . . . 0.735 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 4.3 t30 46.46 22.69 0.18 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.219 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.651 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 56.36 56.42 24.51 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LYS . . . . . 0.465 ' HG3' ' HB3' ' A' ' 15' ' ' PRO . 10.9 tttt -164.95 -34.16 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.377 -1.073 . . . . 0.0 108.32 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.476 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 86.1 m-85 -115.27 116.37 28.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.204 -0.935 . . . . 0.0 109.207 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.6 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 0.5 OUTLIER -100.67 106.15 17.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.386 -0.821 . . . . 0.0 109.958 -179.259 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.468 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 16.4 mt -61.3 159.7 11.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.838 . . . . 0.0 109.028 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -129.71 117.59 18.52 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 0.0 109.271 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.313 -1.31 0 C-N-CA 122.561 2.174 . . . . 0.0 111.239 -179.748 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.67 0.747 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.33 -61.27 2.06 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.677 -0.639 . . . . 0.0 109.415 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.4 t -65.9 -23.08 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.205 -0.934 . . . . 0.0 109.034 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -73.44 -42.25 62.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.197 -0.94 . . . . 0.0 109.216 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 55.9 t -73.27 -26.26 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.121 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -61.31 2.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.3 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -52.55 -32.54 41.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -74.52 -60.49 2.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 109.524 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.27 -20.77 7.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.066 -1.021 . . . . 0.0 108.784 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -82.59 -55.52 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.48 -0.763 . . . . 0.0 109.448 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.679 ' O ' HD23 ' A' ' 185' ' ' LEU . 69.6 m -50.73 -27.11 6.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 54.0 t -87.86 -37.3 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.034 -1.042 . . . . 0.0 108.911 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -57.27 -44.23 83.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 108.863 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -83.43 -35.74 24.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.403 -0.811 . . . . 0.0 109.391 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 181' ' ' THR . 0.9 OUTLIER -58.03 -18.43 24.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.797 -1.189 . . . . 0.0 109.712 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 186' ' ' SER . . . . . 0.528 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -78.7 -5.06 52.09 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.793 -1.192 . . . . 0.0 108.722 178.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.481 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.595 ' HB1' ' HE3' ' A' ' 7' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.403 ' C ' ' CD2' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -139.16 64.13 1.48 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.622 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.508 ' HB3' ' CE1' ' A' ' 9' ' ' TYR . 0.4 OUTLIER 50.45 84.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.373 -0.829 . . . . 0.0 109.202 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' ASP . 1.3 mt-10 -97.83 56.92 1.29 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -0.928 . . . . 0.0 110.083 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 40.99 80.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.609 -0.682 . . . . 0.0 110.041 179.39 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.9 -25.56 5.52 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.48 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.595 ' HE3' ' HB1' ' A' ' 1' ' ' ALA . 3.6 tttp -79.96 -69.5 0.58 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.94 -1.329 . . . . 0.0 108.852 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.503 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -95.6 2.01 53.99 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.16 -0.963 . . . . 0.0 109.852 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.555 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.2 OUTLIER 177.19 129.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.098 -1.001 . . . . 0.0 109.239 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -106.89 179.61 4.22 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.573 -0.705 . . . . 0.0 109.469 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 158' ' ' LYS . 1.4 m -123.66 138.64 54.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.351 0.596 . . . . 0.0 109.599 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -99.22 158.2 15.86 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.429 ' C ' ' HD3' ' A' ' 15' ' ' PRO . 3.4 pt-20 -91.51 1.27 57.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 109.712 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.559 ' C ' HD12 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -120.73 78.07 29.82 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 0.0 109.321 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 13' ' ' GLU . 36.3 Cg_endo -78.19 164.58 26.76 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.717 2.278 . . . . 0.0 110.558 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.746 HG21 ' OD1' ' A' ' 144' ' ' ASP . 18.8 t -127.53 92.66 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.176 -0.953 . . . . 0.0 109.557 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -42.76 125.96 3.56 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 96.05 -18.23 57.83 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.704 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -39.41 160.83 0.09 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.505 -0.997 . . . . 0.0 109.927 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.567 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 35.1 Cg_endo -77.67 135.83 14.8 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.741 2.294 . . . . 0.0 111.309 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.728 ' O ' HG13 ' A' ' 155' ' ' VAL . 9.1 mt-30 -49.4 -21.02 0.79 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.561 -0.712 . . . . 0.0 109.802 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 73.2 t -151.45 80.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.978 -1.076 . . . . 0.0 109.103 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.816 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.73 126.99 32.07 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.453 ' HB3' ' HG3' ' A' ' 58' ' ' LYS . 3.5 tt0 -108.49 120.97 43.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.001 -1.062 . . . . 0.0 109.97 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.002 ' CE2' HG21 ' A' ' 145' ' ' VAL . 8.2 m-85 -108.33 107.52 18.13 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.424 ' CE1' ' HG2' ' A' ' 58' ' ' LYS . 2.0 p90 -153.08 141.19 20.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.97 -1.081 . . . . 0.0 110.423 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.754 ' OG ' HG22 ' A' ' 61' ' ' VAL . 0.6 OUTLIER -118.51 -178.21 3.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.067 179.328 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 5.8 m-30 -97.03 46.16 1.04 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 108.698 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.609 ' CG ' HG11 ' A' ' 96' ' ' VAL . 15.0 m-85 -146.41 13.27 1.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.289 -0.882 . . . . 0.0 109.837 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 3.7 m -105.39 161.16 23.62 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.649 -1.282 . . . . 0.0 109.534 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 33.2 Cg_endo -75.04 -32.93 4.92 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.106 1.871 . . . . 0.0 108.17 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' PHE . 39.7 m80 -84.5 -20.37 31.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.502 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 5.1 t -49.69 -55.21 14.66 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 3.4 t80 -73.35 -33.51 65.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.901 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.605 ' O ' HD13 ' A' ' 40' ' ' LEU . 25.7 mt-30 -85.65 -16.02 40.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.856 -1.152 . . . . 0.0 111.186 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 32' ' ' HIS . 8.9 t80 -86.25 -28.2 23.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.841 -1.162 . . . . 0.0 111.377 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.3 mt-10 -127.14 50.53 1.97 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.594 -1.316 . . . . 0.0 110.728 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 1.2 mt-10 -168.34 -59.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.009 -1.057 . . . . 0.0 110.767 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.32 -49.35 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.976 -1.077 . . . . 0.0 110.848 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.605 HD13 ' O ' ' A' ' 35' ' ' GLN . 6.7 mp -71.1 -2.19 14.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.096 -1.003 . . . . 0.0 110.297 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.458 ' C ' ' O ' ' A' ' 40' ' ' LEU . 58.0 m-70 39.39 29.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.838 . . . . 0.0 109.954 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 40' ' ' LEU . 36.4 mt -74.62 -21.43 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.557 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.483 ' O ' HG12 ' A' ' 46' ' ' VAL . 2.5 p -76.97 -43.45 35.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 109.619 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.83 -48.28 15.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.519 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.458 ' ND2' HG11 ' A' ' 175' ' ' VAL . 56.2 t-20 -52.96 -43.56 66.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 109.517 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 43' ' ' SER . 9.8 p -69.87 -25.77 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.143 -0.973 . . . . 0.0 109.16 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.546 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 49.4 mttm -80.76 -27.58 36.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 110.133 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.421 ' NZ ' ' HE2' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -64.47 -29.45 70.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.052 . . . . 0.0 109.79 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 8.3 mmtt -109.27 24.79 12.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 11.9 mt -70.85 113.71 21.02 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.971 . . . . 0.0 109.933 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 36.2 Cg_endo -78.73 151.37 24.85 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.245 1.963 . . . . 0.0 109.247 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 3.7 tp10 -75.47 21.13 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.625 -1.297 . . . . 0.0 110.724 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.406 ' C ' HG23 ' A' ' 54' ' ' VAL . . . -122.75 29.99 5.24 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 186' ' ' SER . 60.7 t -153.07 118.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -1.007 . . . . 0.0 109.338 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.26 109.37 20.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.678 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.524 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 1.9 ttp -92.58 100.82 13.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.719 -0.613 . . . . 0.0 109.595 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 0.4 OUTLIER -96.72 149.67 21.56 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.801 -1.159 . . . . 0.0 109.898 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HG3' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -123.77 117.12 24.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.466 -0.771 . . . . 0.0 109.378 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.3 m-85 -123.78 166.26 15.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.81 -1.181 . . . . 0.0 111.617 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.636 ' CD2' ' HG ' ' A' ' 27' ' ' SER . 14.4 t60 -102.26 149.51 24.25 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.939 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.3 m -95.31 159.79 2.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 O-C-N 121.663 -0.648 . . . . 0.0 110.356 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.488 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 1.3 p-10 -128.11 49.41 2.16 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.312 -0.867 . . . . 0.0 109.193 179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 10.8 p90 -152.4 64.65 0.82 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -0.961 . . . . 0.0 109.799 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -119.04 30.77 6.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.932 -1.105 . . . . 0.0 109.592 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' MET . . . 45.12 42.73 8.65 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . -149.05 85.43 0.16 Allowed Glycine 0 C--O 1.204 -1.731 0 N-CA-C 107.572 -2.211 . . . . 0.0 107.572 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -31.62 -46.52 0.11 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.058 -0.672 . . . . 0.0 111.548 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.866 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -61.46 -22.24 64.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.647 -1.283 . . . . 0.0 109.49 -179.01 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.828 ' N ' HD22 ' A' ' 68' ' ' LEU . . . -54.52 -46.99 71.86 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.421 ' O ' ' HB ' ' A' ' 73' ' ' THR . 27.8 mttt -52.32 -47.04 66.24 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.54 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 8.5 t0 -64.41 -29.2 70.27 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.79 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 17.6 tp -61.26 -35.4 77.17 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.645 HG23 ' CD ' ' A' ' 138' ' ' GLN . 5.3 m -62.75 -40.73 98.14 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.563 ' NE2' ' OH ' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -61.91 -20.9 64.26 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 177.175 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.79 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -67.96 -41.92 81.69 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.465 ' HB3' ' OE1' ' A' ' 138' ' ' GLN . 24.1 t-105 -67.01 -31.67 72.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 0.0 108.91 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -79.51 -60.37 2.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.28 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.884 HG21 ' CE1' ' A' ' 122' ' ' TYR . 71.5 t -54.92 -27.81 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 110.043 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.538 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.25 -62.85 1.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.907 -1.121 . . . . 0.0 108.621 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.405 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -47.01 -27.42 1.3 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.762 ' HB2' HG13 ' A' ' 131' ' ' VAL . . . -69.43 -42.16 75.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.598 -0.689 . . . . 0.0 109.286 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.5 mt -107.92 12.75 26.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.224 -0.923 . . . . 0.0 110.562 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 49.17 32.01 12.59 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.614 HG11 ' CD1' ' A' ' 117' ' ' ILE . 26.0 m -93.81 2.01 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.476 -1.014 . . . . 0.0 110.531 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.455 ' O ' ' HB ' ' A' ' 89' ' ' THR . 38.4 tt0 -48.9 -68.31 0.19 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.866 -1.146 . . . . 0.0 109.402 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -40.04 -34.89 0.32 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.878 . . . . 0.0 110.465 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.484 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 35.1 mttt -79.82 -55.4 5.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 111.031 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.857 HG23 HD12 ' A' ' 92' ' ' LEU . 1.2 m -82.14 -22.28 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.812 -1.18 . . . . 0.0 110.608 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.754 HG23 ' CE1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -64.77 -43.57 92.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.723 -1.235 . . . . 0.0 108.983 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.92 -56.21 30.22 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.351 -1.468 . . . . 0.0 110.474 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.484 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 26.1 Cg_endo -72.43 -16.21 27.62 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 N-CA-C 109.812 -0.88 . . . . 0.0 109.812 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.857 HD12 HG23 ' A' ' 88' ' ' VAL . 15.1 mt -87.39 -44.13 11.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 108.844 178.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.754 ' CE1' HG23 ' A' ' 89' ' ' THR . 5.4 m-30 -65.51 -46.84 78.07 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.987 -1.071 . . . . 0.0 108.835 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -16.62 60.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -0.968 . . . . 0.0 109.203 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.66 -33.39 51.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.609 HG11 ' CG ' ' A' ' 29' ' ' PHE . 2.3 t -100.83 -7.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 121.12 -1.224 . . . . 0.0 109.35 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.491 ' O ' ' CG ' ' A' ' 98' ' ' LYS . 2.2 mp0 -110.08 8.73 24.07 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 120.893 -1.129 . . . . 0.0 110.514 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.786 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER -176.18 68.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.67 -1.269 . . . . 0.0 109.333 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 163.08 -46.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.522 -0.736 . . . . 0.0 109.575 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 71.67 17.54 5.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.397 -0.814 . . . . 0.0 110.38 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 t -81.45 -4.96 57.36 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.639 HG23 ' OD1' ' A' ' 107' ' ' ASP . 4.2 mm -95.41 84.49 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.34 28.29 1.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 109.382 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 107' ' ' ASP . 59.6 p -157.55 131.54 8.15 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.321 -0.862 . . . . 0.0 109.658 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.632 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -48.99 -31.66 7.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 t -64.5 -33.28 75.53 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.639 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -67.64 -50.11 59.6 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.731 HD11 HD23 ' A' ' 68' ' ' LEU . 36.3 mt -51.27 -28.53 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -36.49 56.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.52 -0.737 . . . . 0.0 109.052 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.22 -48.4 78.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.769 HG11 ' HG ' ' A' ' 92' ' ' LEU . 21.3 t -68.82 -37.68 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.455 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.435 ' O ' HG12 ' A' ' 117' ' ' ILE . 1.3 m-85 -59.9 -48.26 82.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.108 -0.995 . . . . 0.0 109.469 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 mt -66.26 -25.39 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.963 . . . . 0.0 109.279 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 111' ' ' VAL . 15.5 m-20 -61.77 -16.94 53.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.916 . . . . 0.0 109.544 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.585 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -97.94 15.48 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.078 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.59 -0.94 89.39 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.614 ' CD1' HG11 ' A' ' 84' ' ' VAL . 3.9 mm -71.77 55.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -1.14 . . . . 0.0 109.843 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -36.73 145.53 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.285 -0.885 . . . . 0.0 110.073 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -47.15 -31.71 6.22 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.79 -49.25 77.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -1.121 . . . . 0.0 109.49 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.19 -58.05 6.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 110.003 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.884 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -61.22 -56.84 16.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.938 . . . . 0.0 109.617 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 14.5 t70 -45.15 -34.34 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.036 -1.04 . . . . 0.0 109.054 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.48 -43.9 30.7 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.416 -0.802 . . . . 0.0 109.012 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.58 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -52.85 -51.66 60.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -62.62 -53.2 58.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -53.86 -16.13 1.66 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.511 -0.743 . . . . 0.0 110.027 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.2 t -78.76 -179.48 6.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.984 -1.073 . . . . 0.0 110.273 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -95.24 -36.59 11.38 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.806 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.04 -47.83 80.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.209 -1.396 . . . . 0.0 109.709 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' A' ' 81' ' ' ALA . 2.2 t -64.95 -39.8 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.97 -1.081 . . . . 0.0 108.333 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -66.61 -31.62 72.42 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.3 t -64.6 -35.48 81.14 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.83 -19.14 52.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.313 -0.867 . . . . 0.0 108.678 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.497 HG23 ' CB ' ' A' ' 77' ' ' ALA . 4.6 t -80.35 -47.45 21.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.61 -36.9 85.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -32.96 73.06 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.645 ' CD ' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -64.37 -66.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.306 -0.871 . . . . 0.0 109.092 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 0.4 OUTLIER -52.23 -32.87 38.75 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.46 ' O ' ' OD2' ' A' ' 144' ' ' ASP . 0.3 OUTLIER -74.19 -28.21 61.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.345 -0.847 . . . . 0.0 108.991 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -64.37 -60.88 2.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.062 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.481 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -72.37 -21.72 61.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.717 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -77.56 -29.09 51.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.079 -1.013 . . . . 0.0 109.776 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.95 ' OD1' HG13 ' A' ' 145' ' ' VAL . 2.8 p30 -81.22 -47.82 12.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.001 . . . . 0.0 108.419 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 1.002 HG21 ' CE2' ' A' ' 25' ' ' PHE . 28.2 m -84.07 -14.44 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.542 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 4.0 tt0 81.2 -48.05 0.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.587 -0.696 . . . . 0.0 109.837 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.662 HD22 ' CD1' ' A' ' 25' ' ' PHE . 49.0 tp 61.79 134.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.466 -0.771 . . . . 0.0 109.319 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.72 40.36 0.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.623 -1.298 . . . . 0.0 109.681 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 169.64 104.73 0.18 Allowed Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.014 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.939 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -99.0 141.13 22.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.131 . . . . 0.0 109.587 179.151 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 150' ' ' VAL . 33.1 Cg_endo -75.32 153.87 98.92 Favored 'Cis proline' 0 C--N 1.314 -1.26 0 C-N-CA 123.598 -1.417 . . . . 0.0 110.452 0.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -132.86 146.85 52.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.33 -1.481 . . . . 0.0 109.54 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.506 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 18.7 ttm -136.54 133.9 36.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 109.813 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.598 ' CD2' ' HB2' ' A' ' 160' ' ' GLN . 75.4 m-85 -129.57 127.08 39.97 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.332 -0.855 . . . . 0.0 110.104 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 21' ' ' GLN . 56.1 t -97.03 129.46 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.045 -1.034 . . . . 0.0 109.5 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.704 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 47.41 21.72 0.24 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.979 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.509 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.75 55.72 28.54 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.479 ' O ' HG23 ' A' ' 11' ' ' THR . 13.5 tttp -163.71 -37.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.547 ' CZ ' ' HE3' ' A' ' 188' ' ' LYS . 75.0 m-85 -114.91 124.84 52.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.598 ' HB2' ' CD2' ' A' ' 154' ' ' PHE . 4.4 tt0 -124.44 127.43 47.5 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.942 -1.099 . . . . 0.0 109.852 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.73 -179.84 0.74 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.499 -0.751 . . . . 0.0 109.081 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.463 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 38.1 t30 -144.42 65.0 12.69 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 109.64 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 162' ' ' ASN . 35.1 Cg_endo -77.95 63.41 8.14 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.675 2.25 . . . . 0.0 110.424 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -98.94 60.99 1.25 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.895 . . . . 0.0 109.559 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 67.96 72.33 0.82 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.615 ' HB3' HG23 ' A' ' 168' ' ' THR . 0.0 OUTLIER -64.21 -46.9 81.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -1.135 . . . . 0.0 109.342 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.0 t70 58.3 35.94 25.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.224 -0.922 . . . . 0.0 109.853 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.615 HG23 ' HB3' ' A' ' 166' ' ' MET . 1.0 OUTLIER -73.15 -4.84 35.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.997 -1.064 . . . . 0.0 109.632 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.11 38.29 10.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 0.0 109.233 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -158.21 74.88 0.72 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 109.19 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 35.7 mtm -57.31 -18.53 17.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.473 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -76.42 -46.48 26.97 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.44 -25.76 25.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.301 -0.874 . . . . 0.0 109.12 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -73.6 -40.8 63.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.579 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.458 HG11 ' ND2' ' A' ' 45' ' ' ASN . 32.6 t -73.11 -29.83 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -0.988 . . . . 0.0 109.248 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -51.7 7.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 108.951 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.459 ' NE2' ' OE1' ' A' ' 8' ' ' GLN . 4.5 tt0 -57.71 -44.8 86.17 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.207 -0.933 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.49 ' HA ' ' OG1' ' A' ' 181' ' ' THR . 4.9 t80 -60.11 -56.7 18.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.073 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 183' ' ' LYS . . . -49.44 -27.58 4.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.337 -0.852 . . . . 0.0 108.873 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -79.48 -46.17 17.96 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.436 -0.79 . . . . 0.0 109.315 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.598 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -48.62 -45.95 39.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.06 -1.025 . . . . 0.0 109.396 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.466 HG13 ' CG2' ' A' ' 22' ' ' VAL . 22.9 t -75.24 -32.09 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.959 -1.088 . . . . 0.0 109.792 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 179' ' ' ALA . 5.5 tttt -68.28 -38.43 81.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.364 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -83.41 -44.26 14.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.958 -1.089 . . . . 0.0 109.888 -179.468 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 181' ' ' THR . 14.5 mt -60.69 -22.75 64.25 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.62 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.527 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 5.2 t -68.98 -14.43 63.04 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -82.55 -9.91 59.21 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.622 -0.674 . . . . 0.0 109.204 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.547 ' HE3' ' CZ ' ' A' ' 159' ' ' TYR . 17.7 mmtt -54.38 -41.78 69.61 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.225 -0.922 . . . . 0.0 109.298 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 188' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.473 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.203 0.525 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 33.8 mt-30 -132.62 57.86 1.78 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.27 -0.894 . . . . 0.0 109.22 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.596 ' CB ' ' HB2' ' A' ' 8' ' ' GLN . 26.8 p90 -179.78 96.23 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.41 ' H ' ' HB2' ' A' ' 7' ' ' LYS . 3.8 mm-40 -118.17 63.51 0.76 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 110.359 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 4' ' ' GLU . 8.8 t0 69.13 96.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 110.38 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.28 -10.19 75.07 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.587 ' O ' ' CG ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -99.63 28.72 4.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -1.094 . . . . 0.0 108.199 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.596 ' HB2' ' CB ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER 152.83 -40.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.03 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.59 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 8.4 p90 -139.79 113.34 8.52 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.193 -0.942 . . . . 0.0 108.691 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -93.3 -179.97 5.23 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 1.051 HG23 ' O ' ' A' ' 158' ' ' LYS . 90.5 m -137.1 145.81 44.35 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.615 0.722 . . . . 0.0 110.079 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.495 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -100.5 171.61 7.63 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.526 -0.734 . . . . 0.0 109.271 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.41 13.45 30.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.45 ' O ' HD12 ' A' ' 12' ' ' LEU . 1.6 mmtp -127.17 95.27 36.89 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.543 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.39 169.33 20.19 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.594 2.196 . . . . 0.0 110.204 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' ALA . 1.9 t -144.26 113.24 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 110.101 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.06 128.21 18.41 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 77.21 5.69 85.54 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.774 ' HB1' ' HD2' ' A' ' 20' ' ' PRO . . . -38.18 165.88 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.6 -0.941 . . . . 0.0 110.71 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.96 ' HG3' HD12 ' A' ' 23' ' ' LEU . 32.8 Cg_endo -74.02 101.26 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.859 2.373 . . . . 0.0 111.58 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.605 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.9 mp0 -42.1 -28.04 0.16 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 21' ' ' GLN . 40.2 t -158.57 79.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.96 HD12 ' HG3' ' A' ' 20' ' ' PRO . 1.3 tt -73.62 139.27 45.38 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.72 ' N ' HD23 ' A' ' 23' ' ' LEU . 1.5 tt0 -127.8 98.77 5.28 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.199 -0.938 . . . . 0.0 109.803 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.88 ' CD1' HD22 ' A' ' 147' ' ' LEU . 11.4 m-85 -81.61 127.0 32.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.204 -0.935 . . . . 0.0 108.913 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -161.73 128.69 3.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.346 -0.846 . . . . 0.0 109.705 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.779 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 11.6 p -112.45 145.66 39.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.403 -0.81 . . . . 0.0 109.131 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.604 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 8.6 m-30 -72.93 49.87 0.25 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.252 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.694 ' CG ' HG11 ' A' ' 96' ' ' VAL . 11.4 m-85 -152.24 9.85 0.5 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.577 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -107.26 167.03 10.0 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.725 -1.235 . . . . 0.0 109.949 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.01 -43.07 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.564 2.176 . . . . 0.0 108.691 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.479 ' HB3' ' HG3' ' A' ' 151' ' ' PRO . 0.1 OUTLIER -78.17 -21.71 49.79 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 5.7 t -45.19 -56.27 4.96 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.526 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 51.9 t80 -69.98 -27.33 64.62 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.591 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 3.2 mm-40 -84.87 -28.67 25.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.138 . . . . 0.0 111.002 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -87.69 -36.25 17.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.83 -1.169 . . . . 0.0 111.724 -178.287 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 1.2 mp0 -111.46 31.95 5.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.633 -1.292 . . . . 0.0 111.38 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.553 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 26.3 mm-40 -160.03 -58.15 0.06 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.801 -1.187 . . . . 0.0 110.846 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 41' ' ' HIS . 69.2 t -88.91 -74.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.844 -1.16 . . . . 0.0 110.903 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.52 ' HB3' ' CD1' ' A' ' 42' ' ' ILE . 51.0 mt -42.7 -25.29 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.004 . . . . 0.0 110.315 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER 55.8 21.61 4.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.009 -1.057 . . . . 0.0 108.898 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 40' ' ' LEU . 14.9 mt -70.35 -21.23 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.45 -0.781 . . . . 0.0 109.888 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.682 ' O ' HG12 ' A' ' 46' ' ' VAL . 79.3 p -86.16 -77.27 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.09 -1.006 . . . . 0.0 110.078 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.5 OUTLIER -41.68 -31.5 0.3 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.867 . . . . 0.0 110.486 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 3.0 m120 -75.85 -31.58 59.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.949 -1.094 . . . . 0.0 110.064 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 43' ' ' SER . 3.5 p -54.2 -36.47 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.079 -1.013 . . . . 0.0 109.577 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.937 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -72.44 -36.39 68.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.119 -0.988 . . . . 0.0 109.474 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -45.02 -24.78 0.25 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.548 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -133.36 50.66 2.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.274 -0.892 . . . . 0.0 110.004 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.937 HD12 ' HA ' ' A' ' 47' ' ' LYS . 9.8 mt -114.47 72.3 2.51 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.868 -1.145 . . . . 0.0 110.562 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.548 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 36.8 Cg_endo -78.59 139.35 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.33 2.02 . . . . 0.0 110.269 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 51' ' ' PRO . 19.3 tp10 61.99 134.79 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.374 -0.829 . . . . 0.0 108.849 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . 58.21 23.53 53.04 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.882 HG13 ' O ' ' A' ' 50' ' ' LEU . 1.6 t -61.26 77.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.712 -0.875 . . . . 0.0 109.258 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.499 ' CB ' ' HB2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -136.96 97.25 3.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.422 ' SD ' ' HD2' ' A' ' 58' ' ' LYS . 2.7 tmm? -103.6 103.01 12.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 108.91 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.52 121.68 36.32 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.197 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.526 ' HB2' ' CE1' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -103.39 110.23 22.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 0.0 109.715 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.606 ' CD1' ' CG ' ' A' ' 138' ' ' GLN . 4.1 m-85 -113.68 177.96 4.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.851 -1.156 . . . . 0.0 110.942 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.848 ' NE2' HD22 ' A' ' 72' ' ' LEU . 2.5 t-80 -140.0 130.4 25.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.44 -0.787 . . . . 0.0 109.651 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.677 HG11 HD23 ' A' ' 147' ' ' LEU . 1.4 m -115.18 137.38 48.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 2.0 p-10 -40.72 -55.89 2.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.352 -0.843 . . . . 0.0 109.37 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 62' ' ' ASN . 3.6 m-85 32.1 40.64 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.623 0.725 . . . . 0.0 110.952 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.507 ' SD ' ' CD2' ' A' ' 29' ' ' PHE . 5.8 ptm -161.02 47.61 0.21 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.574 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.53 -49.22 1.33 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.58 -3.53 49.96 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.714 -1.231 . . . . 0.0 111.241 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.46 -81.18 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.371 -1.664 . . . . 0.0 108.384 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.119 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -88.87 -26.24 21.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.947 -1.095 . . . . 0.0 109.49 178.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 1.119 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -57.31 -42.29 93.49 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -46.66 80.45 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.324 -1.104 . . . . 0.0 108.496 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.872 ' OD2' ' HB2' ' A' ' 105' ' ' ALA . 1.3 m-20 -66.3 -28.24 68.54 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.848 HD22 ' NE2' ' A' ' 60' ' ' HIS . 6.4 tt -61.03 -45.33 95.24 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 60' ' ' HIS . 1.5 m -59.68 -44.5 93.6 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.709 ' O ' HG13 ' A' ' 78' ' ' VAL . 8.7 tm0? -50.98 -27.36 7.53 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.715 ' HB1' ' CE2' ' A' ' 112' ' ' PHE . . . -81.17 -32.29 33.67 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.207 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' ALA . 4.4 t-105 -50.01 -29.14 8.08 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.769 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -85.24 -38.96 18.31 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.639 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 74' ' ' GLN . 3.3 m -63.71 -30.71 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 120.745 -1.222 . . . . 0.0 109.011 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.646 ' HB2' ' HZ ' ' A' ' 112' ' ' PHE . . . -81.77 -53.65 6.02 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.485 ' HB3' ' HG ' ' A' ' 134' ' ' LEU . 4.9 tpt -49.23 -29.32 5.55 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.651 ' HB2' ' CG2' ' A' ' 131' ' ' VAL . . . -60.78 -45.05 95.87 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.801 ' HB2' HG13 ' A' ' 84' ' ' VAL . 3.3 mt -110.87 16.0 21.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.47 -0.769 . . . . 0.0 110.055 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.75 30.23 6.58 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.801 HG13 ' HB2' ' A' ' 82' ' ' LEU . 36.0 m -89.39 -5.32 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -1.178 . . . . 0.0 110.551 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -42.85 -61.24 1.32 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.107 -0.996 . . . . 0.0 109.607 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -43.2 -33.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.455 ' CE ' ' HB1' ' A' ' 115' ' ' ALA . 4.4 mtpt -83.29 -50.7 8.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.298 -0.876 . . . . 0.0 111.214 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.749 HG23 HD12 ' A' ' 92' ' ' LEU . 1.1 m -82.4 -5.83 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.711 -1.243 . . . . 0.0 110.681 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.734 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -77.92 -45.51 23.84 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.302 178.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 2.1 t -51.8 -52.84 57.25 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.75 -1.219 . . . . 0.0 110.406 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 25.5 Cg_endo -73.28 -17.36 24.31 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 N-CA-C 109.645 -0.944 . . . . 0.0 109.645 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.749 HD12 HG23 ' A' ' 88' ' ' VAL . 13.6 mt -86.48 -44.92 11.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.734 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.1 m-30 -61.51 -47.65 84.64 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.916 -1.115 . . . . 0.0 108.772 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 90' ' ' VAL . 13.0 pt-20 -71.7 -16.7 62.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.111 -0.993 . . . . 0.0 109.641 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.46 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -79.05 -32.32 40.07 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.694 HG11 ' CG ' ' A' ' 29' ' ' PHE . 1.7 t -106.79 0.54 10.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.997 -1.296 . . . . 0.0 110.026 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.481 ' HG2' ' HB2' ' A' ' 34' ' ' TYR . 0.7 OUTLIER -106.93 6.17 28.98 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 120.769 -1.207 . . . . 0.0 110.679 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.786 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER 177.28 76.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.734 -1.229 . . . . 0.0 109.074 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 161.41 -48.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.3 OUTLIER 71.74 18.6 5.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.346 -0.846 . . . . 0.0 110.48 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.449 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 2.8 t -80.07 -4.47 52.9 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.603 HG23 ' OD1' ' A' ' 107' ' ' ASP . 4.6 mm -97.91 81.78 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.809 -0.557 . . . . 0.0 109.609 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.449 ' HD2' ' C ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -142.31 32.66 1.51 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.933 -1.105 . . . . 0.0 109.601 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 107' ' ' ASP . 4.0 p -158.38 134.87 9.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.068 -1.02 . . . . 0.0 109.749 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.873 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.95 -39.83 41.84 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.5 p -56.38 -31.73 64.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.603 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -71.63 -51.02 25.36 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.873 HD12 ' HA ' ' A' ' 105' ' ' ALA . 22.5 mt -45.5 -29.92 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 0.0 108.984 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.498 ' HG2' HD11 ' A' ' 113' ' ' ILE . 37.2 ttt180 -78.61 -37.84 41.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.177 -0.952 . . . . 0.0 109.553 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -58.92 -46.14 88.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.579 HG11 ' HG ' ' A' ' 92' ' ' LEU . 13.2 t -68.94 -38.81 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.715 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -61.19 -42.35 98.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.568 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.498 HD11 ' HG2' ' A' ' 109' ' ' ARG . 17.4 mt -69.81 -25.5 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.165 -0.959 . . . . 0.0 109.669 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -64.07 -16.73 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.678 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.597 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -96.04 11.89 32.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 109.649 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.65 -5.26 85.24 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.749 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -80.69 56.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -1.106 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.45 ' HA ' HG23 ' A' ' 113' ' ' ILE . 59.8 mttt -37.68 153.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.789 . . . . 0.0 110.153 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -47.9 -27.12 4.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -58.59 -46.98 85.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.878 -1.366 . . . . 0.0 109.473 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -77.96 -50.94 11.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.849 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.628 ' HE1' HG11 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -62.61 -58.27 8.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.978 . . . . 0.0 108.954 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 62.8 t0 -50.09 -48.93 52.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.038 -1.039 . . . . 0.0 109.292 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.32 81.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.304 -0.872 . . . . 0.0 109.43 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.682 ' C ' HG21 ' A' ' 131' ' ' VAL . . . -56.41 -49.5 74.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.293 -0.88 . . . . 0.0 108.951 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 1.01 ' HA ' HG11 ' A' ' 131' ' ' VAL . 6.0 t90 -54.85 -56.46 19.25 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -15.13 62.02 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.595 -0.69 . . . . 0.0 110.016 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 125' ' ' ALA . 16.8 p -71.56 179.72 2.91 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.013 -1.054 . . . . 0.0 110.095 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.421 ' CD1' HG23 ' A' ' 130' ' ' VAL . 4.4 p90 -90.42 -33.63 15.94 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.83 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.421 HG23 ' CD1' ' A' ' 129' ' ' PHE . 23.5 t -64.34 -36.96 78.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 C-N-CA 118.124 -1.43 . . . . 0.0 109.878 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 1.01 HG11 ' HA ' ' A' ' 126' ' ' TRP . 16.5 t -64.16 -38.73 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.878 -1.139 . . . . 0.0 108.941 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -66.6 -34.54 78.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 108.992 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.34 -33.15 75.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.278 -0.889 . . . . 0.0 109.399 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' A' ' 80' ' ' MET . 1.8 mm? -79.54 -26.55 41.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 108.846 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.769 HG23 ' CB ' ' A' ' 77' ' ' ALA . 6.0 t -79.11 -39.02 20.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.53 -49.15 61.75 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.443 -0.786 . . . . 0.0 109.184 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.481 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -61.73 -35.35 77.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.204 -0.935 . . . . 0.0 109.159 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.606 ' CG ' ' CD1' ' A' ' 59' ' ' TYR . 18.0 tm0? -62.78 -62.38 1.77 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.224 -0.922 . . . . 0.0 109.195 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -46.77 -35.61 6.38 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -30.86 67.38 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.614 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -60.74 -47.74 84.95 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.354 -0.841 . . . . 0.0 108.915 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -73.07 -39.83 65.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.411 -0.805 . . . . 0.0 110.236 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.62 -16.9 59.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.973 -1.079 . . . . 0.0 109.824 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.455 ' OD2' HG11 ' A' ' 16' ' ' VAL . 9.1 m-20 -82.06 -44.95 15.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.057 -1.027 . . . . 0.0 108.592 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 141' ' ' ALA . 17.6 m -100.08 -8.36 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.346 -0.846 . . . . 0.0 108.927 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.544 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 12.2 tp60 80.95 -42.15 0.18 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.461 -0.774 . . . . 0.0 110.113 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.88 HD22 ' CD1' ' A' ' 25' ' ' PHE . 20.1 tp 62.11 140.19 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.288 -0.882 . . . . 0.0 108.981 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.54 31.26 0.23 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.613 -1.304 . . . . 0.0 110.106 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 157.22 98.8 0.15 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.523 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.493 HG11 ' CG2' ' A' ' 61' ' ' VAL . 0.8 OUTLIER -92.51 138.37 23.99 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 31.6 Cg_endo -71.75 155.83 97.63 Favored 'Cis proline' 0 C--N 1.316 -1.163 0 C-N-CA 124.157 -1.185 . . . . 0.0 111.753 2.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -146.91 151.09 36.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.805 -1.185 . . . . 0.0 108.525 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -128.49 118.31 22.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.901 -1.124 . . . . 0.0 110.022 -179.673 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.579 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 57.8 m-85 -114.42 142.39 46.42 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.582 HG22 HG22 ' A' ' 22' ' ' VAL . 30.6 t -124.08 124.62 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.989 -1.07 . . . . 0.0 108.947 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.9 m120 56.14 22.89 6.41 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.187 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.407 ' O ' HD11 ' A' ' 12' ' ' LEU . . . 52.96 22.76 13.26 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.705 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 1.051 ' O ' HG23 ' A' ' 11' ' ' THR . 0.0 OUTLIER -134.58 -11.35 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.752 -1.44 . . . . 0.0 109.738 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.583 ' CE1' ' HE3' ' A' ' 188' ' ' LYS . 99.5 m-85 -144.22 124.46 13.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.021 -1.05 . . . . 0.0 108.749 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.579 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 2.3 pt20 -133.31 129.39 37.48 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.965 -1.084 . . . . 0.0 110.157 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.009 HD12 ' CZ ' ' A' ' 178' ' ' TYR . 17.1 mt -61.27 168.58 2.56 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.67 150.68 44.23 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.084 -1.01 . . . . 0.0 109.786 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 166' ' ' MET . 36.0 Cg_endo -78.19 -9.53 16.48 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.683 2.255 . . . . 0.0 110.546 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 48.67 23.63 0.67 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.0 109.509 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 93.23 -23.12 31.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -176.64 -71.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.376 -1.073 . . . . 0.0 109.237 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.0 t0 48.06 24.47 0.64 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.468 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.25 41.16 2.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.285 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.28 -1.53 45.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.495 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -156.4 95.74 1.6 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.158 -0.964 . . . . 0.0 108.894 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 2.0 mtp -56.47 -18.85 12.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.177 -0.952 . . . . 0.0 109.398 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.48 -65.05 0.94 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.464 HG13 ' HG2' ' A' ' 177' ' ' GLN . 20.1 t -70.15 -23.48 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.294 -0.879 . . . . 0.0 109.058 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -68.53 -39.87 80.98 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -0.909 . . . . 0.0 109.241 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.3 t -76.44 -32.3 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -74.97 -52.34 11.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 109.445 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.464 ' HG2' HG13 ' A' ' 173' ' ' VAL . 40.6 mm-40 -58.62 -40.44 83.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.437 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 1.009 ' CZ ' HD12 ' A' ' 161' ' ' LEU . 10.0 t80 -61.13 -50.82 71.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.132 -0.98 . . . . 0.0 109.231 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.432 ' O ' ' NZ ' ' A' ' 183' ' ' LYS . . . -64.12 -24.37 67.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.988 -1.07 . . . . 0.0 108.839 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -77.43 -40.92 41.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 0.0 108.986 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.558 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -58.61 -54.83 42.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 109.056 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.575 HG23 HD11 ' A' ' 161' ' ' LEU . 93.3 t -61.06 -36.85 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 109.607 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.474 ' HE3' ' CG ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -53.55 -44.47 69.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 109.217 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -84.42 -25.47 28.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.358 -0.839 . . . . 0.0 110.07 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 185' ' ' LEU . 1.1 mt -62.17 -23.45 66.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.446 -1.409 . . . . 0.0 108.435 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.8 t -75.57 -4.39 39.7 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.991 -1.068 . . . . 0.0 108.365 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -104.57 0.87 29.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.828 . . . . 0.0 109.452 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.583 ' HE3' ' CE1' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -61.52 -37.05 82.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.218 -0.926 . . . . 0.0 109.72 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.418 ' CG ' ' O ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.481 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.372 0.606 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.543 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 5.7 tt0 -123.02 65.85 0.98 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.246 -0.909 . . . . 0.0 109.087 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.543 ' CG ' ' C ' ' A' ' 2' ' ' GLN . 0.6 OUTLIER 73.1 88.93 0.1 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.344 -0.848 . . . . 0.0 108.899 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.497 ' O ' ' HB3' ' A' ' 5' ' ' ASP . 5.6 pm0 -133.18 64.65 1.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.163 -0.96 . . . . 0.0 109.976 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 4' ' ' GLU . 19.6 t70 71.16 93.5 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.518 -0.738 . . . . 0.0 110.759 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.57 3.79 90.38 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.586 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -101.91 28.41 5.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.962 -1.316 . . . . 0.0 108.937 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.586 ' CB ' ' O ' ' A' ' 7' ' ' LYS . 2.9 mm-40 144.54 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.582 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 2.2 p90 -141.89 114.21 8.25 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.054 0.93 . . . . 0.0 109.015 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -100.32 -179.19 4.04 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.2 m -111.6 143.72 42.02 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.899 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.784 HD12 ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -96.16 163.95 12.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.376 -0.828 . . . . 0.0 109.549 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 14' ' ' LYS . 1.6 pt-20 -87.52 -15.83 36.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.691 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.784 ' O ' HD12 ' A' ' 12' ' ' LEU . 3.3 mmtp -112.56 97.51 40.75 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.148 -0.97 . . . . 0.0 109.849 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.23 158.92 33.48 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.467 2.111 . . . . 0.0 109.863 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.671 ' O ' HG12 ' A' ' 16' ' ' VAL . 15.8 t -140.52 83.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.099 -1.001 . . . . 0.0 109.761 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.12 129.7 18.1 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.63 -19.73 52.95 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.77 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -41.9 164.61 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.41 -1.053 . . . . 0.0 109.556 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.661 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 34.7 Cg_endo -76.43 126.82 9.31 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.573 2.182 . . . . 0.0 110.955 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.818 ' O ' HG13 ' A' ' 155' ' ' VAL . 4.3 mt-30 -40.01 -24.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.558 -0.714 . . . . 0.0 110.421 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.687 HG13 ' HE2' ' A' ' 153' ' ' MET . 59.1 t -149.09 79.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.764 -1.21 . . . . 0.0 109.044 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.887 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -73.98 112.79 10.45 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.566 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -94.23 149.19 21.47 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.778 -178.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.943 ' CE2' HG21 ' A' ' 145' ' ' VAL . 7.6 m-85 -135.13 103.46 5.55 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.483 -0.76 . . . . 0.0 109.267 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -148.42 140.64 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 109.891 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.709 ' CB ' HG22 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -118.16 179.45 4.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.09 179.345 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 7.1 m-30 -90.33 40.44 1.01 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CG ' HG11 ' A' ' 96' ' ' VAL . 11.0 m-85 -137.91 16.82 2.85 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -113.8 164.81 14.96 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.544 -1.348 . . . . 0.0 109.878 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.74 -41.08 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.463 2.109 . . . . 0.0 108.092 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.598 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 9.6 m170 -75.34 -23.53 57.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 12.3 t -43.94 -57.71 3.17 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.455 ' HB2' ' CD ' ' A' ' 97' ' ' GLN . 89.4 t80 -71.48 -55.06 8.6 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.182 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 12.5 mt-30 -54.88 -16.96 3.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.228 -0.92 . . . . 0.0 110.527 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.598 ' CE1' ' HB3' ' A' ' 32' ' ' HIS . 4.0 m-30 -86.4 -38.96 16.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.08 -1.013 . . . . 0.0 110.831 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.02 -13.1 20.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.782 -1.199 . . . . 0.0 112.206 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' C ' HG23 ' A' ' 39' ' ' VAL . 3.0 mt-10 -136.27 28.51 3.09 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.17 -1.581 . . . . 0.0 111.418 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 35' ' ' GLN . 91.1 t -151.56 -88.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.394 -1.441 . . . . 0.0 110.138 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.807 ' HB2' HD12 ' A' ' 42' ' ' ILE . 1.4 mt -68.99 -19.49 64.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.95 . . . . 0.0 109.747 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 2.4 m-70 60.06 18.85 8.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.005 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.807 HD12 ' HB2' ' A' ' 40' ' ' LEU . 1.4 mt -46.98 -36.42 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.479 -0.763 . . . . 0.0 109.44 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.663 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -80.48 -34.34 35.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.991 . . . . 0.0 110.115 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.488 ' HA ' ' HG3' ' A' ' 47' ' ' LYS . 15.5 m-20 -82.7 -36.87 25.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.099 -1.001 . . . . 0.0 109.625 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -58.31 -34.21 70.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.84 . . . . 0.0 110.184 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 43' ' ' SER . 31.5 m -65.92 -31.98 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.033 -1.042 . . . . 0.0 110.021 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.61 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -54.51 -44.89 73.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.976 -1.078 . . . . 0.0 109.461 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -44.28 -28.34 0.52 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.119 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.472 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 10.1 mtmm -112.7 44.5 1.47 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.842 . . . . 0.0 109.24 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 47' ' ' LYS . 11.0 mt -115.87 79.35 7.9 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.165 -0.96 . . . . 0.0 109.945 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 35.3 Cg_endo -78.33 143.26 19.55 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.615 2.21 . . . . 0.0 110.119 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -39.45 120.77 1.1 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.312 1.054 . . . . 0.0 109.908 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.78 -26.74 5.06 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.54 ' CG1' ' CD2' ' A' ' 50' ' ' LEU . 98.1 t -89.71 85.37 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -1.192 . . . . 0.0 109.296 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.96 93.25 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.779 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.477 ' HG3' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -92.73 101.44 13.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.833 . . . . 0.0 109.437 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 4.9 m -111.45 134.09 53.27 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.11 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.566 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -114.13 109.2 18.05 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.27 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.482 ' OH ' ' HB3' ' A' ' 137' ' ' GLN . 4.5 m-85 -106.55 177.85 4.73 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.954 -1.092 . . . . 0.0 111.623 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.599 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 49.4 t-80 -111.85 132.62 54.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.735 0.779 . . . . 0.0 108.977 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.044 HG11 ' CG1' ' A' ' 150' ' ' VAL . 3.0 m -72.36 156.68 6.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.416 0.627 . . . . 0.0 110.598 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.492 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 14.0 t30 -118.56 51.19 1.11 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.628 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -155.86 61.17 0.59 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.731 -1.23 . . . . 0.0 110.106 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.693 ' HE1' ' CG2' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -144.92 43.37 1.34 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.958 -1.089 . . . . 0.0 109.488 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.47 -36.17 0.55 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.94 -43.07 3.13 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -88.7 -79.0 0.32 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.169 . . . . 0.0 110.109 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.115 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -78.0 -21.87 50.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.092 -1.005 . . . . 0.0 109.205 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 1.115 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -53.51 -42.83 66.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 2.1 tttt -68.78 -54.76 14.03 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.16 -1.2 . . . . 0.0 108.362 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.566 ' HB3' HD12 ' A' ' 108' ' ' ILE . 8.2 t70 -56.12 -25.18 44.89 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.782 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 44.4 tp -65.4 -39.68 92.5 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 m -59.48 -41.94 90.93 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.429 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 0.4 OUTLIER -60.13 -22.63 63.07 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.782 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -66.23 -40.06 90.01 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 46.7 t-105 -64.4 -31.58 72.84 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 78' ' ' VAL . . . -84.39 -68.14 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.725 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.85 HG21 ' CE1' ' A' ' 122' ' ' TYR . 95.7 t -43.98 -26.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 109.761 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.615 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -82.93 -58.62 2.79 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.085 -1.009 . . . . 0.0 108.717 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.28 -27.38 2.46 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.61 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -70.84 -43.15 69.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.483 -0.761 . . . . 0.0 109.447 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.671 ' HB2' HG13 ' A' ' 84' ' ' VAL . 23.0 mt -107.12 14.59 26.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 48.39 24.84 3.98 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.671 HG13 ' HB2' ' A' ' 82' ' ' LEU . 35.2 m -83.67 -9.92 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.408 -1.054 . . . . 0.0 110.397 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.467 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.3 OUTLIER -42.73 -63.4 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.137 -0.977 . . . . 0.0 109.37 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.96 -34.68 1.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.458 -0.776 . . . . 0.0 110.601 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -79.72 -53.18 7.06 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.186 -0.947 . . . . 0.0 111.741 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.781 HG23 HD12 ' A' ' 92' ' ' LEU . 2.9 m -84.7 -8.42 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.717 -1.239 . . . . 0.0 110.705 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.747 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -72.88 -44.5 61.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.593 -1.317 . . . . 0.0 108.596 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.402 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -53.64 -54.13 49.48 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.467 -1.396 . . . . 0.0 110.817 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.436 ' HD2' ' C ' ' A' ' 88' ' ' VAL . 25.0 Cg_endo -72.99 -18.65 23.96 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 N-CA-C 109.82 -0.877 . . . . 0.0 109.82 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.812 ' HG ' HG11 ' A' ' 111' ' ' VAL . 28.8 mt -87.22 -42.63 12.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.043 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.747 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.2 m-30 -63.78 -46.68 84.11 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.003 -1.06 . . . . 0.0 108.856 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -23.05 61.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.209 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.49 -33.39 61.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.661 HG11 ' CG ' ' A' ' 29' ' ' PHE . 2.3 t -102.32 -1.74 9.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.095 -1.238 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -110.37 8.71 23.42 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 120.956 -1.09 . . . . 0.0 110.543 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 99' ' ' THR . 2.4 mttp -179.91 64.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.634 -1.291 . . . . 0.0 109.277 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.871 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 169.0 -50.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 99' ' ' THR . 8.1 mp0 73.96 16.55 3.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.423 -0.798 . . . . 0.0 110.743 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 t -79.74 -9.05 59.6 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.585 ' CB ' HG22 ' A' ' 96' ' ' VAL . 9.0 mm -85.49 78.69 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.78 32.54 2.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.151 -0.968 . . . . 0.0 109.833 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 107' ' ' ASP . 24.1 p -157.96 132.0 8.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.994 -1.066 . . . . 0.0 110.208 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.536 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -51.2 -29.54 14.4 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -30.74 71.79 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.5 OUTLIER -70.61 -48.86 53.01 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.579 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 71' ' ' ASP . 18.9 mt -53.53 -27.06 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -75.93 -39.79 55.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.808 . . . . 0.0 109.817 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.467 ' OD2' ' O ' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -62.49 -41.55 98.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.086 -1.009 . . . . 0.0 109.53 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.812 HG11 ' HG ' ' A' ' 92' ' ' LEU . 1.5 t -72.15 -39.35 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.108 -0.995 . . . . 0.0 109.352 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.705 ' CE1' HG21 ' A' ' 88' ' ' VAL . 2.7 m-30 -63.93 -48.41 76.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.863 . . . . 0.0 110.031 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.1 mt -66.68 -25.41 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.986 . . . . 0.0 109.64 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -67.8 -17.54 64.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 0.0 109.816 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.64 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -90.52 7.03 41.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.637 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.53 2.6 82.12 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.64 HG12 ' HB3' ' A' ' 115' ' ' ALA . 3.0 mm -79.14 59.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.313 -1.11 . . . . 0.0 109.692 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 117' ' ' ILE . 5.3 mmtt -34.86 132.02 0.35 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.323 -0.861 . . . . 0.0 110.319 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 118' ' ' LYS . . . -40.76 -33.79 0.67 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -59.23 -43.14 92.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -1.18 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 118' ' ' LYS . 20.9 mt-10 -75.29 -43.64 50.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.85 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -67.65 -61.97 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.213 -0.929 . . . . 0.0 108.976 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 122' ' ' TYR . 11.4 t0 -47.19 -42.71 20.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.0 108.731 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.72 -45.93 80.84 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.333 -0.854 . . . . 0.0 109.017 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -54.21 -49.05 70.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.435 -0.79 . . . . 0.0 109.146 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.502 ' C ' ' CD1' ' A' ' 126' ' ' TRP . 7.2 t90 -59.81 -54.53 45.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 0.0 108.496 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.07 -15.31 3.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.588 -0.695 . . . . 0.0 110.15 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 32.6 m -70.3 178.04 3.05 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.988 -1.07 . . . . 0.0 110.431 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 -37.67 13.23 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.362 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.65 -46.84 79.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.248 -1.381 . . . . 0.0 109.678 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.61 HG22 ' HB1' ' A' ' 81' ' ' ALA . 5.2 t -63.77 -32.63 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.872 -1.143 . . . . 0.0 108.519 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -71.56 -36.4 70.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 108.84 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -36.49 83.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.388 -0.82 . . . . 0.0 109.156 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.15 -24.72 40.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -0.891 . . . . 0.0 108.661 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 131' ' ' VAL . 17.6 t -73.97 -41.93 52.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.55 -52.87 55.44 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.482 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -54.8 -27.3 40.73 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.043 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.43 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -67.83 -65.3 0.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 2.9 tt0 -51.79 -37.28 50.91 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 144' ' ' ASP . 1.3 mtmt -64.39 -30.77 71.8 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.639 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -66.01 -60.29 2.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.453 -0.78 . . . . 0.0 109.052 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.554 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -71.78 -23.11 61.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.898 . . . . 0.0 109.823 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -83.35 -26.5 30.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.038 -1.039 . . . . 0.0 110.325 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.811 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.3 p30 -81.56 -44.03 17.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.901 -1.124 . . . . 0.0 108.595 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.943 HG21 ' CE2' ' A' ' 25' ' ' PHE . 16.0 m -96.39 -10.68 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.879 . . . . 0.0 108.731 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.554 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.0 tt0 78.18 -49.48 0.48 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.447 -0.783 . . . . 0.0 110.26 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.976 HD21 HG12 ' A' ' 61' ' ' VAL . 16.2 tp 65.2 133.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 0.0 109.4 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -160.89 40.44 0.16 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.579 -1.326 . . . . 0.0 109.879 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.67 107.43 0.21 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.464 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 1.044 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.0 144.71 29.62 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.353 -1.086 . . . . 0.0 109.442 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.04 152.4 91.8 Favored 'Cis proline' 0 C--N 1.316 -1.138 0 C-N-CA 124.041 -1.233 . . . . 0.0 110.466 0.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.884 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -128.75 156.03 44.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.393 -1.442 . . . . 0.0 109.364 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.687 ' HE2' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -150.87 133.76 15.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 109.682 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.544 ' HE1' ' HB1' ' A' ' 152' ' ' ALA . 4.3 m-85 -132.41 125.65 31.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.373 -0.829 . . . . 0.0 109.913 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.818 HG13 ' O ' ' A' ' 21' ' ' GLN . 73.5 t -96.94 132.12 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.926 . . . . 0.0 110.153 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.77 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.9 OUTLIER 47.75 20.88 0.23 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.913 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.6 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 57.87 55.09 32.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -164.45 -39.96 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.205 -1.174 . . . . 0.0 108.121 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -110.86 124.09 51.38 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.749 -0.78 . . . . 0.0 108.948 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.527 ' HB3' HD22 ' A' ' 12' ' ' LEU . 15.4 pt20 -120.79 127.29 51.82 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.966 -1.084 . . . . 0.0 109.912 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.542 HD21 ' HB ' ' A' ' 181' ' ' THR . 19.7 mt -64.5 174.12 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -156.09 76.62 4.63 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 109.716 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.07 -18.5 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.752 2.301 . . . . 0.0 110.711 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -14.51 18.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.898 . . . . 0.0 109.716 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -113.58 38.64 3.12 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.458 ' O ' ' C ' ' A' ' 167' ' ' ASP . 0.6 OUTLIER -106.24 -77.02 0.6 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -1.179 . . . . 0.0 109.637 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' A' ' 166' ' ' MET . 10.4 t0 40.94 33.37 0.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.253 -0.904 . . . . 0.0 109.734 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.428 ' O ' ' CB ' ' A' ' 169' ' ' SER . 7.6 t -68.88 -7.12 31.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 109.667 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' A' ' 168' ' ' THR . 0.7 OUTLIER 69.81 40.47 1.31 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.383 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -159.73 93.5 1.09 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.24 -0.913 . . . . 0.0 109.181 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.8 mtp -59.74 -15.59 21.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 109.735 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -55.09 8.55 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.681 -0.637 . . . . 0.0 109.657 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.496 HG13 ' HG3' ' A' ' 177' ' ' GLN . 14.1 t -70.35 -28.59 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.121 -0.987 . . . . 0.0 109.533 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.453 ' O ' ' CD1' ' A' ' 174' ' ' PHE . 2.5 t80 -67.46 -46.04 74.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.032 -1.043 . . . . 0.0 109.437 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 82.6 t -74.74 -24.27 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 1.4 mt-30 -81.81 -52.74 6.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.511 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.545 ' HB3' ' NE2' ' A' ' 8' ' ' GLN . 41.4 mt-30 -63.85 -32.3 73.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.192 -0.943 . . . . 0.0 109.569 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 178' ' ' TYR . 17.8 t80 -74.11 -58.38 3.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.004 . . . . 0.0 109.429 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.35 -33.06 67.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.946 -1.096 . . . . 0.0 108.44 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 33.2 t0 -71.31 -42.61 68.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.493 -0.754 . . . . 0.0 109.342 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.542 ' HB ' HD21 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -55.09 -57.07 13.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.093 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.437 HG22 ' HE1' ' A' ' 153' ' ' MET . 2.3 t -57.12 -35.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.823 -1.173 . . . . 0.0 109.71 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -48.33 82.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.967 . . . . 0.0 109.903 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.26 -21.2 39.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.96 -1.088 . . . . 0.0 110.337 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 181' ' ' THR . 68.6 mt -73.66 -18.54 61.01 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.744 -1.222 . . . . 0.0 109.002 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.5 m -74.14 -4.47 35.92 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.66 5.1 30.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.526 -0.733 . . . . 0.0 109.805 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -73.11 -5.89 42.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.957 -1.089 . . . . 0.0 109.709 -179.347 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 188' ' ' LYS . 4.5 pttt . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.04 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.21 0.529 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.474 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 95.4 mt-30 -91.48 54.22 2.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -153.58 85.04 1.18 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 5' ' ' ASP . 12.5 mt-10 -114.07 56.96 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.127 -0.983 . . . . 0.0 110.42 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER 42.61 82.19 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.511 -0.743 . . . . 0.0 110.359 179.063 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.81 -24.63 6.02 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.723 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -82.15 -68.31 0.71 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.0 -1.294 . . . . 0.0 109.178 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.607 ' NE2' ' CD1' ' A' ' 9' ' ' TYR . 2.1 pp0? -95.23 -1.92 50.64 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.607 ' CD1' ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER 179.64 130.45 0.09 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.873 -1.142 . . . . 0.0 109.721 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.2 t -112.87 179.95 3.82 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.872 HG23 ' O ' ' A' ' 158' ' ' LYS . 59.2 m -127.87 143.82 51.1 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.456 0.645 . . . . 0.0 109.581 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -100.69 156.17 17.48 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.399 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -93.63 0.54 56.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.492 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.507 ' O ' HD12 ' A' ' 12' ' ' LEU . 4.2 mtmt -124.88 89.41 52.58 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.283 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.03 166.55 26.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.608 2.206 . . . . 0.0 110.111 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.918 HG13 ' HB2' ' A' ' 19' ' ' ALA . 7.2 p -120.78 109.22 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -0.975 . . . . 0.0 110.264 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.38 125.24 4.54 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.491 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 91.53 -10.63 74.28 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.918 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -33.87 148.11 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.787 -0.831 . . . . 0.0 109.906 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.588 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.4 Cg_endo -81.21 133.72 8.84 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.472 2.115 . . . . 0.0 111.383 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.842 ' OE1' HG22 ' A' ' 54' ' ' VAL . 1.5 mm-40 -51.11 -21.81 2.13 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.508 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 24.1 t -151.12 89.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 108.975 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.674 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -80.43 128.74 33.92 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 58' ' ' LYS . 8.7 tt0 -113.48 96.59 5.96 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.92 -1.113 . . . . 0.0 109.729 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.923 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 4.4 m-85 -84.76 115.71 22.85 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.448 -0.782 . . . . 0.0 109.458 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.538 ' CE1' ' OE1' ' A' ' 37' ' ' GLU . 2.6 p90 -160.35 142.01 12.54 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.268 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.593 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 94.0 p -125.64 -172.72 2.66 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.624 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -109.3 49.3 0.83 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.675 -1.266 . . . . 0.0 108.472 178.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.534 ' HB3' ' CE ' ' A' ' 64' ' ' MET . 7.1 m-85 -133.78 -3.92 2.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.637 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 4.5 m -109.41 173.23 3.06 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.203 . . . . 0.0 108.586 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.3 Cg_endo -76.19 -58.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.752 1.635 . . . . 0.0 109.316 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 69.5 m-70 -63.37 -20.09 65.22 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.536 ' HG ' ' CB ' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -52.58 -53.89 40.33 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.582 0.706 . . . . 0.0 109.286 179.53 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 8.8 t80 -80.49 -37.46 31.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.575 -0.703 . . . . 0.0 109.884 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.537 ' CD ' HG21 ' A' ' 39' ' ' VAL . 35.6 mm-40 -66.09 -26.07 67.31 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.184 -0.948 . . . . 0.0 109.954 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -70.66 -39.52 73.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.054 -1.029 . . . . 0.0 109.578 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.538 ' OE1' ' CE1' ' A' ' 26' ' ' PHE . 1.2 mt-10 -98.15 -10.06 24.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 0.0 111.898 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 1.8 mm-40 -138.3 27.69 2.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.266 -1.521 . . . . 0.0 111.819 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG21 ' CD ' ' A' ' 35' ' ' GLN . 64.9 t -151.45 -83.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.432 -1.418 . . . . 0.0 110.026 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.991 HD21 ' HB3' ' A' ' 171' ' ' MET . 18.0 mt -65.14 -14.33 60.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.868 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 23.1 m-70 56.57 18.37 3.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.187 -0.946 . . . . 0.0 109.146 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 46' ' ' VAL . 9.9 mt -55.39 -18.59 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.5 m -82.63 -54.38 5.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.023 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -86.77 -33.0 20.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.72 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 41' ' ' HIS . 10.4 t-20 -51.68 -27.23 11.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.838 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 42' ' ' ILE . 31.4 t -81.21 -17.2 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.302 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 1.036 ' HA ' HD12 ' A' ' 50' ' ' LEU . 1.7 mttm -76.11 -17.93 59.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.813 -1.179 . . . . 0.0 110.074 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -64.46 -16.24 62.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 109.615 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -143.59 36.23 1.31 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.036 HD12 ' HA ' ' A' ' 47' ' ' LYS . 5.2 mt -91.94 142.9 26.95 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.954 -1.091 . . . . 0.0 109.595 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.576 ' HD2' HD23 ' A' ' 50' ' ' LEU . 35.8 Cg_endo -78.03 149.88 25.99 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.689 2.259 . . . . 0.0 110.051 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -79.09 21.38 0.45 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.93 -1.106 . . . . 0.0 110.469 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -124.46 32.74 4.01 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.842 HG22 ' OE1' ' A' ' 21' ' ' GLN . 44.6 t -154.32 131.85 2.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.645 -0.915 . . . . 0.0 108.702 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.5 137.61 51.89 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.178 0.989 . . . . 0.0 109.961 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.508 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 3.3 ptm -107.04 98.96 8.55 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.39 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 24' ' ' GLU . 86.7 m -82.24 142.86 31.77 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.742 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -116.1 111.13 19.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.365 -0.834 . . . . 0.0 110.028 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.594 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 1.7 m-85 -113.44 158.24 20.92 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.173 -0.954 . . . . 0.0 110.864 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.951 ' CE1' HD22 ' A' ' 72' ' ' LEU . 17.9 t60 -99.94 124.69 45.53 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.01 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.3 m -69.85 144.95 13.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.598 -0.689 . . . . 0.0 110.166 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.541 ' HB2' ' CE ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -113.57 49.23 0.99 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.652 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 2.9 p90 -145.37 80.12 1.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.17 0.986 . . . . 0.0 110.048 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.566 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -159.91 -59.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.872 -1.143 . . . . 0.0 109.735 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.566 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -87.98 -28.07 24.38 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.472 ' O ' ' HG2' ' A' ' 70' ' ' LYS . . . 86.3 -49.17 4.04 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.19 -78.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.562 -0.964 . . . . 0.0 110.008 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.112 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -73.79 -22.62 59.76 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.855 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 1.112 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -55.53 -43.32 85.63 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 107.434 -2.266 . . . . 0.0 107.434 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.541 ' CE ' ' HB2' ' A' ' 62' ' ' ASN . 8.6 mmmt -63.71 -47.8 79.68 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.508 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 13.3 t0 -64.04 -28.38 69.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.951 HD22 ' CE1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -58.16 -38.5 76.74 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.571 HG23 ' OE1' ' A' ' 138' ' ' GLN . 6.7 m -66.24 -42.85 88.05 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.551 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -60.99 -18.58 58.29 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 177.055 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -68.37 -47.49 67.28 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -58.99 -27.73 65.69 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.736 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -79.37 -52.46 8.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.432 -0.792 . . . . 0.0 109.967 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.732 HG21 ' CE1' ' A' ' 122' ' ' TYR . 39.2 t -60.77 -26.53 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.044 -1.035 . . . . 0.0 109.875 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -80.23 -63.43 1.41 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.038 -1.039 . . . . 0.0 109.003 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -45.9 -27.94 1.0 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.682 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -70.35 -46.15 64.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.437 -0.79 . . . . 0.0 109.463 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.467 ' HB2' HG13 ' A' ' 84' ' ' VAL . 21.6 mt -102.05 12.07 37.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.15 -0.969 . . . . 0.0 110.214 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 53.56 20.55 11.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 79' ' ' ALA . 34.9 m -86.47 -7.93 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.431 -1.041 . . . . 0.0 110.669 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.474 ' CA ' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -40.82 -59.47 1.41 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.087 -1.008 . . . . 0.0 109.986 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.4 -34.19 10.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.449 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 mttt -82.74 -52.88 6.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.199 -0.938 . . . . 0.0 111.471 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.639 HG23 HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -75.15 -6.81 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.633 -1.292 . . . . 0.0 110.505 -178.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.675 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -77.04 -44.77 29.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.948 -1.095 . . . . 0.0 108.513 178.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.44 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -52.32 -52.38 63.49 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.543 -1.348 . . . . 0.0 110.565 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.677 ' HB2' HG13 ' A' ' 111' ' ' VAL . 26.0 Cg_endo -73.68 -20.93 19.67 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 O-C-N 122.727 0.856 . . . . 0.0 110.022 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.872 ' HG ' HG11 ' A' ' 111' ' ' VAL . 13.1 mt -85.61 -41.9 14.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 108.967 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.675 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.6 m-30 -65.95 -45.71 80.81 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.071 -1.018 . . . . 0.0 108.862 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 90' ' ' VAL . 23.5 mt-10 -76.3 -26.75 56.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 109.556 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.434 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -65.56 -36.93 93.11 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.9 t -93.07 -12.78 8.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.151 -1.205 . . . . 0.0 108.594 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 1.3 mt-30 -104.98 4.12 31.39 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 121.103 -0.998 . . . . 0.0 111.051 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.775 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER -160.15 61.11 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.404 -1.435 . . . . 0.0 109.963 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.11 -49.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 74.27 15.2 3.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -0.989 . . . . 0.0 110.628 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -86.69 -4.29 59.16 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.732 0.777 . . . . 0.0 108.988 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.488 HG23 ' OD1' ' A' ' 107' ' ' ASP . 6.5 mm -80.57 77.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HD3' ' C ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -140.75 35.13 1.79 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 110.074 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 107' ' ' ASP . 54.9 p -157.26 133.74 9.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.856 -1.152 . . . . 0.0 109.968 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.883 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -50.71 -35.7 32.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 75.7 m -59.19 -28.86 67.02 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -75.39 -50.78 14.84 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.883 HD12 ' HA ' ' A' ' 105' ' ' ALA . 21.9 mt -47.25 -31.34 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.086 -1.009 . . . . 0.0 109.421 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 106' ' ' SER . 1.3 ptm180 -78.99 -37.27 39.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.945 -1.097 . . . . 0.0 109.349 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -54.64 -46.06 73.88 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.153 -0.967 . . . . 0.0 108.929 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.872 HG11 ' HG ' ' A' ' 92' ' ' LEU . 70.4 t -69.95 -39.91 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -0.942 . . . . 0.0 109.227 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.61 ' HD2' HG21 ' A' ' 117' ' ' ILE . 1.4 m-85 -59.6 -53.79 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.717 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.1 mt -60.21 -25.96 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.107 -0.996 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.47 -16.97 64.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.164 -0.96 . . . . 0.0 109.378 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.622 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -100.44 -7.14 24.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.544 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.76 -5.27 25.99 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.783 HD12 ' N ' ' A' ' 117' ' ' ILE . 2.2 mp -78.42 52.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -1.158 . . . . 0.0 109.278 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 117' ' ' ILE . 38.3 mttp -36.2 157.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.318 -0.864 . . . . 0.0 110.555 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -59.82 -50.58 66.19 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 119' ' ' GLY . 21.1 tt0 -43.29 -55.19 4.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.03 -1.276 . . . . 0.0 109.929 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 1.3 tt0 -63.98 -63.22 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.976 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.732 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -46.27 -60.94 2.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.135 -0.978 . . . . 0.0 109.239 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 122' ' ' TYR . 1.2 m-20 -44.54 -34.25 2.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.152 -0.968 . . . . 0.0 109.062 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 121' ' ' GLU . . . -75.63 -44.36 43.13 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.353 -0.842 . . . . 0.0 109.23 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.688 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -59.02 -48.08 82.9 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.409 -0.807 . . . . 0.0 109.17 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.536 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 10.8 t90 -59.44 -53.23 60.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.404 -0.81 . . . . 0.0 108.957 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.94 -15.72 2.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.642 -0.661 . . . . 0.0 110.236 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.41 178.1 7.44 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.976 -1.078 . . . . 0.0 109.971 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -91.45 -36.6 13.68 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.566 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.6 t -64.27 -47.3 90.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.205 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.688 HG21 ' HB1' ' A' ' 125' ' ' ALA . 21.3 t -64.39 -39.84 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.109 -0.994 . . . . 0.0 108.481 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -29.1 67.42 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 50.4 m -66.27 -34.39 77.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.842 . . . . 0.0 109.019 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -28.5 54.92 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.736 HG23 ' CB ' ' A' ' 77' ' ' ALA . 6.8 t -75.1 -36.34 37.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -67.66 -46.15 73.23 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.593 -0.692 . . . . 0.0 109.405 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.444 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -68.83 -23.64 64.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.428 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.594 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 4.7 mt-30 -72.49 -69.41 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.083 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.76 -35.05 21.02 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.427 ' O ' ' CG ' ' A' ' 144' ' ' ASP . 12.1 mtpt -75.94 -29.9 58.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.321 -0.862 . . . . 0.0 108.874 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -57.34 -56.26 24.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.213 -0.93 . . . . 0.0 108.751 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -75.54 -32.89 60.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.925 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.21 -22.15 61.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 109.46 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 140' ' ' LYS . 73.7 m-20 -82.45 -47.36 12.34 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.853 HG21 ' HE2' ' A' ' 25' ' ' PHE . 11.3 m -88.55 -5.49 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 2.6 tp60 80.8 -50.36 0.31 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.587 -0.696 . . . . 0.0 109.543 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.643 HD13 ' CD2' ' A' ' 25' ' ' PHE . 13.1 tp 61.51 137.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.228 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -161.02 33.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.544 -1.347 . . . . 0.0 110.339 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 160.14 109.69 0.26 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 118.905 -1.617 . . . . 0.0 111.208 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 1.01 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -87.93 144.35 34.65 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.586 -0.949 . . . . 0.0 109.057 178.157 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.79 152.65 92.86 Favored 'Cis proline' 0 C--N 1.315 -1.222 0 C-N-CA 123.923 -1.282 . . . . 0.0 110.526 0.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.923 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -123.54 141.8 51.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.361 -1.462 . . . . 0.0 109.139 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.506 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 1.6 ttp -130.27 130.94 45.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.126 -0.984 . . . . 0.0 109.71 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.779 ' HE1' ' HB1' ' A' ' 152' ' ' ALA . 8.3 m-85 -133.73 131.44 39.41 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 21' ' ' GLN . 12.2 t -105.32 125.57 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.753 -1.217 . . . . 0.0 108.618 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 20' ' ' PRO . 18.6 t-20 48.08 26.39 1.0 Allowed 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.901 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 52.17 25.27 17.76 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.208 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.872 ' O ' HG23 ' A' ' 11' ' ' THR . 10.0 tttm -124.9 -19.2 5.32 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.835 -1.391 . . . . 0.0 108.894 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.497 ' HB2' ' HE3' ' A' ' 188' ' ' LYS . 94.0 m-85 -141.66 125.08 16.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 108.92 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.602 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 1.3 pt20 -128.79 134.78 48.49 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.877 -1.139 . . . . 0.0 109.632 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.519 HD12 ' CZ ' ' A' ' 178' ' ' TYR . 12.8 mt -68.02 177.14 2.3 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.627 -0.671 . . . . 0.0 109.287 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.64 82.7 5.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.888 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.86 50.28 3.22 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.666 2.244 . . . . 0.0 110.311 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.5 146.13 37.82 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.373 -0.829 . . . . 0.0 108.778 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.85 7.56 43.18 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -99.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.962 -1.316 . . . . 0.0 109.295 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 17.7 t0 60.64 35.38 19.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.84 -1.163 . . . . 0.0 109.709 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 169' ' ' SER . 17.2 p -69.57 -29.51 67.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.004 -1.06 . . . . 0.0 109.911 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 168' ' ' THR . 1.0 OUTLIER 77.68 38.93 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.333 -0.855 . . . . 0.0 109.26 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 169' ' ' SER . 4.2 m120 -153.35 80.59 1.18 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.991 ' HB3' HD21 ' A' ' 40' ' ' LEU . 3.8 mtm -58.69 -15.77 13.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.491 -0.756 . . . . 0.0 109.967 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.45 -50.82 14.62 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.696 -0.628 . . . . 0.0 109.341 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.5 t -74.69 -29.56 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 178' ' ' TYR . 33.4 t80 -69.07 -36.2 77.36 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.947 -1.095 . . . . 0.0 108.614 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.784 ' CG2' HD22 ' A' ' 40' ' ' LEU . 24.3 t -74.34 -28.71 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.363 -0.836 . . . . 0.0 108.916 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -81.53 -58.39 3.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.053 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.72 -36.53 36.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.203 -0.936 . . . . 0.0 109.074 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.519 ' CZ ' HD12 ' A' ' 161' ' ' LEU . 18.9 t80 -69.44 -47.15 64.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.193 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.59 -22.42 66.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.15 -0.969 . . . . 0.0 108.978 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -79.09 -45.3 20.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 109.305 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.665 ' O ' HD23 ' A' ' 185' ' ' LEU . 6.5 m -63.11 -31.78 73.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -0.958 . . . . 0.0 109.317 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.505 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 52.0 t -77.39 -39.59 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.747 -1.22 . . . . 0.0 109.357 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -56.96 -52.23 66.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.5 -24.41 50.08 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 1.059 HD13 ' CE ' ' A' ' 188' ' ' LYS . 0.2 OUTLIER -64.31 -20.71 66.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.875 -1.141 . . . . 0.0 108.839 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.764 ' CB ' HG21 ' A' ' 54' ' ' VAL . 63.0 p -87.3 7.54 28.25 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.865 -1.147 . . . . 0.0 108.273 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 188' ' ' LYS . 0.1 OUTLIER -119.41 8.06 11.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.392 -0.818 . . . . 0.0 109.542 -179.662 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 1.059 ' CE ' HD13 ' A' ' 185' ' ' LEU . 0.4 OUTLIER -43.03 -54.68 4.18 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.391 -0.818 . . . . 0.0 109.318 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.316 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.312 0.577 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.529 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 1.4 tp60 -126.49 65.23 1.25 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.23 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.608 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.7 OUTLIER 75.95 98.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 4.9 mt-10 -128.17 66.04 1.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 110.34 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.6 m-20 61.3 91.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 110.407 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.98 68.56 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.092 -1.051 . . . . 0.0 110.59 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.581 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 9.1 tttp -95.64 26.07 4.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.991 -1.299 . . . . 0.0 108.561 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.581 ' CB ' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER 145.09 -34.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.575 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 2.5 p90 -141.86 115.59 9.14 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.001 -1.062 . . . . 0.0 109.225 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t -105.25 179.62 4.22 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.332 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -104.32 157.85 16.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.746 -0.596 . . . . 0.0 109.713 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.783 HD11 ' HB2' ' A' ' 160' ' ' GLN . 1.6 mp -100.08 159.11 15.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.362 -0.836 . . . . 0.0 109.477 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -98.97 11.75 38.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 109.443 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -168.3 93.27 0.61 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.195 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HB3' ' O ' ' A' ' 157' ' ' GLY . 36.4 Cg_endo -77.85 161.79 30.02 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.536 2.157 . . . . 0.0 110.891 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.91 HG13 ' CB ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -113.23 96.79 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 109.437 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -41.66 126.96 3.1 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 94.02 -16.69 60.35 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.91 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -38.63 158.18 0.1 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.484 -1.01 . . . . 0.0 109.94 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.567 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.7 Cg_endo -80.42 138.75 12.53 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.827 2.351 . . . . 0.0 111.48 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.674 ' O ' HG13 ' A' ' 155' ' ' VAL . 6.0 mt-30 -47.53 -22.34 0.46 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.476 -0.765 . . . . 0.0 109.653 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.716 ' O ' HG12 ' A' ' 22' ' ' VAL . 8.4 t -150.36 80.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.04 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.628 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -75.58 129.49 37.28 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -112.73 129.76 56.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.947 -1.095 . . . . 0.0 109.827 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.062 ' CE2' HG21 ' A' ' 145' ' ' VAL . 8.4 m-85 -116.88 102.83 9.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.247 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -146.4 136.36 23.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.894 -1.129 . . . . 0.0 110.026 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.609 ' CB ' ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -110.06 171.79 7.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.404 -0.81 . . . . 0.0 109.522 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.605 ' HB2' HD21 ' A' ' 72' ' ' LEU . 7.9 m-30 -87.59 43.58 1.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.539 ' CE1' HD22 ' A' ' 72' ' ' LEU . 9.6 m-85 -143.23 12.32 1.78 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.371 -0.83 . . . . 0.0 110.127 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 4.7 m -106.88 160.52 26.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.778 -1.201 . . . . 0.0 109.378 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -75.65 -32.39 4.72 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.111 1.874 . . . . 0.0 107.928 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.8 t-160 -79.9 -25.52 40.55 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 37.1 t -45.05 -64.17 0.77 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.576 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 28.0 t80 -65.0 -44.71 88.38 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.294 0.569 . . . . 0.0 110.055 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.496 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 52.7 mt-30 -67.43 -16.42 64.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.917 . . . . 0.0 110.859 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 32' ' ' HIS . 12.7 t80 -76.72 -52.0 10.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.979 -1.076 . . . . 0.0 110.344 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -106.53 -4.62 19.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.789 -1.195 . . . . 0.0 112.072 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.576 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 10.6 mt-10 -124.4 19.76 8.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.213 -1.555 . . . . 0.0 111.332 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.517 ' CG2' ' CE2' ' A' ' 34' ' ' TYR . 64.1 t -151.76 -84.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.614 -1.304 . . . . 0.0 109.92 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.846 HD21 ' HB3' ' A' ' 171' ' ' MET . 13.8 mt -63.96 -13.9 49.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 0.0 109.867 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 44' ' ' ASP . 57.0 m-70 49.05 24.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.169 -0.957 . . . . 0.0 108.649 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.416 HD11 HD13 ' A' ' 40' ' ' LEU . 1.8 mt -43.18 -27.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.544 -0.722 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.26 -16.62 39.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -0.971 . . . . 0.0 110.867 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 41' ' ' HIS . 35.3 t70 -87.15 -34.05 19.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.916 -1.115 . . . . 0.0 110.413 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -73.26 -44.15 59.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.215 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.7 m -55.96 -25.13 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.127 -0.983 . . . . 0.0 110.021 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HG2' HD12 ' A' ' 50' ' ' LEU . 3.1 mttt -65.67 -27.35 68.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 109.343 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -55.3 -18.56 6.58 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.376 -0.827 . . . . 0.0 109.096 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -134.86 48.26 2.3 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 109.764 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.537 HD12 ' HG2' ' A' ' 47' ' ' LYS . 10.7 mt -104.08 102.86 34.71 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 34.2 Cg_endo -76.3 152.78 35.19 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.512 2.141 . . . . 0.0 109.273 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 52' ' ' GLU . 12.1 tt0 -72.15 23.2 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.637 -1.289 . . . . 0.0 111.243 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 21' ' ' GLN . . . -122.13 29.47 5.53 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 186' ' ' SER . 68.5 t -148.92 121.17 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.502 -0.999 . . . . 0.0 108.722 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.7 116.69 32.48 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 110.471 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.524 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.94 96.99 9.66 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.021 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -88.68 141.58 28.4 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.039 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.68 113.93 21.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.404 -0.81 . . . . 0.0 109.639 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 138' ' ' GLN . 2.2 m-85 -116.97 154.05 31.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.995 -1.066 . . . . 0.0 111.838 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.609 ' CE1' ' CB ' ' A' ' 27' ' ' SER . 37.2 t-80 -108.87 111.71 23.56 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.047 HG11 HD22 ' A' ' 147' ' ' LEU . 3.1 m -82.36 158.18 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.976 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 70' ' ' LYS . 1.5 p-10 -108.99 48.24 0.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.37 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.649 ' CE1' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -119.94 45.72 2.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.923 -1.111 . . . . 0.0 110.219 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.527 ' HG3' ' CD1' ' A' ' 63' ' ' PHE . 34.9 mtp -159.65 47.66 0.28 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 159.32 58.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -33.37 -36.56 0.05 OUTLIER Glycine 0 N--CA 1.493 2.499 0 O-C-N 122.004 -0.704 . . . . 0.0 111.472 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -87.59 -79.31 0.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.767 -1.431 . . . . 0.0 110.762 -178.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.9 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.74 -19.61 30.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.94 -1.1 . . . . 0.0 110.261 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.578 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -56.79 -39.65 87.86 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -65.09 -42.85 93.67 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.25 -24.49 64.9 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.769 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 41.7 tp -65.64 -47.73 74.61 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.437 ' OG1' ' C ' ' A' ' 61' ' ' VAL . 2.0 m -58.58 -43.46 89.45 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 1.053 ' O ' HG23 ' A' ' 78' ' ' VAL . 5.7 tp60 -55.69 -27.45 50.34 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.58 -41.52 98.36 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.497 ' HB2' ' CB ' ' A' ' 60' ' ' HIS . 47.8 t-105 -61.47 -30.68 70.75 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.391 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.674 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -81.68 -39.31 24.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 110.057 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.053 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.3 t -77.07 -27.12 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 109.75 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -80.87 -54.37 5.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.295 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -48.67 -27.79 3.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.203 -0.936 . . . . 0.0 108.742 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.927 ' HB2' HG22 ' A' ' 131' ' ' VAL . . . -60.5 -56.03 26.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.432 -0.792 . . . . 0.0 110.119 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.785 ' HB2' HG13 ' A' ' 84' ' ' VAL . 3.2 mt -102.04 10.38 39.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.038 -1.038 . . . . 0.0 110.59 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.45 27.98 61.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.919 HG11 HG12 ' A' ' 117' ' ' ILE . 19.7 m -81.98 -6.64 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.375 -1.073 . . . . 0.0 109.858 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' THR . 3.9 tt0 -43.88 -65.1 0.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.547 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -41.41 -34.02 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 109.852 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -80.71 -51.95 8.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.459 -0.776 . . . . 0.0 111.158 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.857 HG23 HD12 ' A' ' 92' ' ' LEU . 1.6 m -86.61 -9.57 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.708 -1.245 . . . . 0.0 110.869 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.689 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.46 -44.03 46.3 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.819 -1.176 . . . . 0.0 108.717 179.241 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.435 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -53.19 -53.18 58.63 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.478 -1.389 . . . . 0.0 110.453 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.544 ' HG2' HG13 ' A' ' 111' ' ' VAL . 26.0 Cg_endo -73.47 -18.08 23.19 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 O-C-N 122.786 0.887 . . . . 0.0 109.844 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.876 ' HG ' HG11 ' A' ' 111' ' ' VAL . 19.6 mt -87.24 -43.39 12.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.011 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.689 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.1 m-30 -64.98 -45.94 83.53 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.894 -1.129 . . . . 0.0 108.73 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 97' ' ' GLN . 7.2 tt0 -72.73 -27.42 62.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.309 -0.87 . . . . 0.0 109.17 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.461 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -65.17 -38.19 94.95 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.651 HG22 ' CB ' ' A' ' 102' ' ' ILE . 3.8 t -97.81 -1.55 10.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.299 -1.118 . . . . 0.0 108.629 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 93' ' ' PHE . 18.8 mm-40 -111.14 9.61 21.92 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.169 -0.957 . . . . 0.0 110.874 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.811 ' O ' HG23 ' A' ' 99' ' ' THR . 50.6 tttt -172.5 62.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.482 -1.387 . . . . 0.0 109.822 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 164.47 -50.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.704 -0.622 . . . . 0.0 109.324 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.3 mt-30 75.92 15.28 2.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.195 -0.941 . . . . 0.0 110.777 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 t -82.82 -6.63 59.51 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.403 -0.81 . . . . 0.0 108.818 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.651 ' CB ' HG22 ' A' ' 96' ' ' VAL . 10.5 mm -79.97 72.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.21 31.56 3.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.198 -0.939 . . . . 0.0 109.167 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 107' ' ' ASP . 1.4 p -151.21 126.48 9.95 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.256 -0.902 . . . . 0.0 109.861 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.657 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -50.63 -31.81 17.16 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.4 t -59.3 -31.42 69.11 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -71.54 -49.34 41.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' A' ' 105' ' ' ALA . 37.3 mt -50.58 -30.32 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.124 -0.985 . . . . 0.0 108.947 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.42 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 24.5 mtm180 -79.55 -32.33 42.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.207 -0.933 . . . . 0.0 109.227 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -58.79 -46.79 86.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.268 -0.895 . . . . 0.0 108.799 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.876 HG11 ' HG ' ' A' ' 92' ' ' LEU . 70.1 t -71.35 -38.27 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.209 -0.932 . . . . 0.0 109.009 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CE2' ' CE2' ' A' ' 122' ' ' TYR . 0.5 OUTLIER -56.95 -44.72 82.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.561 HG23 ' HA ' ' A' ' 118' ' ' LYS . 15.5 mt -73.58 -24.21 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.594 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -65.82 -16.71 64.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.421 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.571 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -91.35 -3.23 56.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 109.86 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.94 -8.93 63.55 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.919 HG12 HG11 ' A' ' 84' ' ' VAL . 2.6 mp -88.86 51.83 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -1.098 . . . . 0.0 109.362 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.561 ' HA ' HG23 ' A' ' 113' ' ' ILE . 16.7 pttm -33.78 153.89 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.565 -0.709 . . . . 0.0 110.826 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.17 -29.3 2.29 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.488 ' HB3' ' CD ' ' A' ' 118' ' ' LYS . 17.3 tt0 -50.37 -58.09 6.47 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.064 -1.256 . . . . 0.0 109.042 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.38 -54.14 6.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.438 -0.788 . . . . 0.0 109.662 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.787 ' CE2' HG11 ' A' ' 78' ' ' VAL . 2.6 t80 -46.73 -55.56 7.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.119 -0.988 . . . . 0.0 109.218 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.439 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 47.1 t0 -56.66 -48.59 77.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 109.07 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.49 -49.86 54.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.25 -0.906 . . . . 0.0 109.076 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 131' ' ' VAL . . . -51.44 -49.27 62.01 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.456 -0.778 . . . . 0.0 109.188 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.742 ' HA ' HG11 ' A' ' 131' ' ' VAL . 11.4 t90 -60.27 -56.49 20.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 108.956 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -56.09 -15.64 3.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.517 -0.739 . . . . 0.0 109.923 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 63.2 m -77.35 -177.71 4.78 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.05 -1.031 . . . . 0.0 110.156 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.34 -32.43 13.61 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.76 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.3 -42.75 97.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 117.916 -1.514 . . . . 0.0 109.401 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.927 HG22 ' HB2' ' A' ' 81' ' ' ALA . 42.6 t -65.72 -38.21 81.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.04 -1.038 . . . . 0.0 108.295 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -38.44 89.14 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.3 m -62.1 -39.77 93.6 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.34 -16.63 56.01 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.674 HG23 ' HB1' ' A' ' 77' ' ' ALA . 5.0 t -79.4 -44.75 23.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 140' ' ' LYS . . . -68.62 -44.64 73.82 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.449 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 7.1 tp-100 -62.81 -32.64 73.87 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -0.817 . . . . 0.0 109.041 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.492 ' HB2' ' CE1' ' A' ' 59' ' ' TYR . 12.9 tm0? -79.43 -62.75 1.59 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.199 -0.938 . . . . 0.0 108.751 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -49.47 -34.5 17.06 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 6.8 ttmt -75.11 -29.07 60.47 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.64 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -59.25 -54.23 49.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.362 -0.836 . . . . 0.0 109.143 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -75.83 -31.52 59.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 110.356 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.28 54.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.23 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.636 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.2 p30 -84.21 -47.18 11.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.978 -1.076 . . . . 0.0 108.181 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 1.062 HG21 ' CE2' ' A' ' 25' ' ' PHE . 10.3 m -82.04 -21.86 9.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 82.1 -25.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.849 -0.532 . . . . 0.0 110.188 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.047 HD22 HG11 ' A' ' 61' ' ' VAL . 10.5 tp 61.4 142.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 109.537 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.15 33.66 0.14 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.691 -1.256 . . . . 0.0 110.139 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.658 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 153.05 113.33 0.53 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.325 -1.416 . . . . 0.0 110.519 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.625 HG13 ' HZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -101.56 139.55 20.49 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.34 -1.094 . . . . 0.0 109.395 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.31 151.46 95.0 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 123.725 -1.365 . . . . 0.0 110.209 0.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -130.37 126.77 37.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.271 -1.518 . . . . 0.0 109.127 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.646 ' CE ' HG22 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -122.71 114.77 21.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.087 -1.008 . . . . 0.0 110.094 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.512 ' CE1' ' HB1' ' A' ' 152' ' ' ALA . 3.2 m-30 -110.58 148.3 32.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 21' ' ' GLN . 29.7 t -107.61 133.47 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.731 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.611 ' OD1' HG12 ' A' ' 155' ' ' VAL . 5.6 p-10 40.7 25.49 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.4 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 15' ' ' PRO . . . 58.2 60.07 9.63 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 6.8 tttt -167.74 -33.68 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.379 -1.071 . . . . 0.0 108.327 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.54 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 96.5 m-85 -116.49 121.44 41.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.056 -1.028 . . . . 0.0 108.926 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.783 ' HB2' HD11 ' A' ' 12' ' ' LEU . 19.8 tt0 -113.42 109.02 18.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 109.749 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 9' ' ' TYR . 15.5 mt -59.32 172.12 0.68 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 8' ' ' GLN . 62.9 t-20 -152.2 83.07 5.16 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 120.849 -1.157 . . . . 0.0 109.848 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 164' ' ' GLN . 34.8 Cg_endo -78.27 -11.54 16.03 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.713 2.275 . . . . 0.0 110.432 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 163' ' ' PRO . 33.1 tt0 43.86 28.2 0.22 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.945 . . . . 0.0 109.575 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 92.79 -35.88 3.91 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 17.2 ttt -169.81 -72.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -1.152 . . . . 0.0 109.353 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 167' ' ' ASP . 33.3 t70 51.23 30.7 6.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.443 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 169' ' ' SER . 2.1 p -134.04 -55.75 0.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.756 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 168' ' ' THR . 1.0 OUTLIER 77.54 22.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 109.152 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -160.52 99.99 1.31 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.846 ' HB3' HD21 ' A' ' 40' ' ' LEU . 13.0 mtt -56.06 -17.43 6.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.952 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.6 -62.24 1.75 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.693 -0.63 . . . . 0.0 109.672 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.56 -21.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.151 -0.968 . . . . 0.0 108.919 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.485 ' O ' ' CD1' ' A' ' 174' ' ' PHE . 2.4 t80 -74.78 -45.23 45.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.293 -0.88 . . . . 0.0 109.268 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.796 ' CG2' HD22 ' A' ' 40' ' ' LEU . 39.8 t -71.39 -26.87 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.174 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.66 -53.11 6.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.569 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.55 -40.64 87.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 109.01 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -63.92 -47.5 80.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.321 -0.862 . . . . 0.0 108.909 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.61 -29.48 70.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.25 -0.906 . . . . 0.0 108.947 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -75.08 -38.29 61.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 109.277 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.719 ' O ' HD23 ' A' ' 185' ' ' LEU . 2.9 m -66.11 -26.47 67.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -0.871 . . . . 0.0 109.274 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.646 HG22 ' CE ' ' A' ' 153' ' ' MET . 52.8 t -87.13 -37.23 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 108.581 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -57.46 -48.47 79.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.406 -0.809 . . . . 0.0 108.885 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.44 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -80.92 -28.74 35.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.397 -0.815 . . . . 0.0 109.416 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 181' ' ' THR . 0.6 OUTLIER -63.77 -17.3 62.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.198 . . . . 0.0 109.358 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.492 ' HB2' HG21 ' A' ' 54' ' ' VAL . 1.4 t -82.56 5.54 20.53 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.665 -1.272 . . . . 0.0 107.999 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -122.33 26.6 8.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.439 -0.788 . . . . 0.0 109.415 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -56.65 -23.03 38.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.1 -1.0 . . . . 0.0 109.288 -179.518 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.464 ' CD ' ' OXT' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.359 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 1' ' ' ALA . 16.6 mt-30 42.17 48.06 4.13 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.914 0.864 . . . . 0.0 108.916 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER 60.27 88.36 0.08 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -105.11 55.74 0.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 4' ' ' GLU . 7.0 p-10 39.77 79.86 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.812 -0.555 . . . . 0.0 109.891 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 126.79 -26.52 5.09 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.762 -1.208 . . . . 0.0 110.348 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 -69.52 0.6 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.063 -1.257 . . . . 0.0 109.385 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -91.41 2.72 56.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.229 -0.919 . . . . 0.0 109.611 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 6' ' ' GLY . 2.2 p90 178.91 132.85 0.08 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.09 -1.006 . . . . 0.0 109.189 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 t -119.11 176.34 5.35 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.691 -0.63 . . . . 0.0 109.494 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -100.24 152.1 20.68 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.357 0.599 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 mp -92.95 170.9 9.31 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.303 -0.873 . . . . 0.0 109.594 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.428 ' OE2' ' HG2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -91.56 -5.92 53.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.511 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HG2' ' OE2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -166.06 110.67 0.73 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.444 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 36.0 Cg_endo -77.97 160.49 30.37 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.417 2.078 . . . . 0.0 110.153 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -119.03 102.67 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 109.8 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.22 127.07 6.73 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 92.37 -15.03 63.2 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.539 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -38.35 156.18 0.11 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.94 . . . . 0.0 109.618 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.569 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.5 Cg_endo -79.17 128.32 8.12 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.547 2.165 . . . . 0.0 111.308 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.765 ' O ' HG13 ' A' ' 155' ' ' VAL . 37.0 mt-30 -42.38 -24.28 0.05 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.398 -0.813 . . . . 0.0 109.586 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.684 ' O ' HG12 ' A' ' 22' ' ' VAL . 7.1 t -147.26 83.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.127 -0.983 . . . . 0.0 109.155 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.646 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -77.75 128.56 34.22 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 58' ' ' LYS . 3.4 mm-40 -109.68 131.93 54.61 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.088 -1.008 . . . . 0.0 109.723 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.03 ' CE2' HG21 ' A' ' 145' ' ' VAL . 5.0 m-85 -120.58 113.93 20.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -151.75 144.89 24.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.974 -1.079 . . . . 0.0 109.698 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.729 ' HB2' HG22 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -118.53 163.86 16.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 110.085 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.786 ' CD2' HD21 ' A' ' 72' ' ' LEU . 18.8 m-30 -88.13 39.17 0.89 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 1.009 ' CZ ' HD13 ' A' ' 72' ' ' LEU . 5.2 m-85 -138.72 15.51 2.7 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 110.179 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 4.2 m -114.39 158.18 40.59 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.596 -1.315 . . . . 0.0 109.722 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -74.5 -25.42 12.98 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.196 1.931 . . . . 0.0 107.835 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' PHE . 98.5 m-70 -89.17 -16.43 31.38 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 5.7 t -54.92 -53.44 55.51 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 38' ' ' GLU . 29.3 t80 -71.58 -40.61 69.78 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.486 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.483 ' HA ' ' CG2' ' A' ' 39' ' ' VAL . 3.3 mt-30 -78.33 -19.02 54.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 111.181 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 32' ' ' HIS . 70.6 t80 -78.0 -20.3 52.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.924 -1.11 . . . . 0.0 110.466 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 41' ' ' HIS . 3.7 tm-20 -133.31 -72.06 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.885 -1.134 . . . . 0.0 110.826 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.636 ' CB ' ' CE1' ' A' ' 34' ' ' TYR . 56.8 mm-40 -46.02 -40.25 10.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.831 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.483 ' CG2' ' HA ' ' A' ' 35' ' ' GLN . 5.0 t -92.4 -74.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.053 . . . . 0.0 110.548 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.557 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 0.4 OUTLIER -75.21 -10.9 59.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.0 110.652 -178.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 11.0 p-80 40.92 32.11 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.136 -0.977 . . . . 0.0 109.342 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.502 HG13 ' HB3' ' A' ' 40' ' ' LEU . 3.6 mt -54.38 -18.12 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 110.152 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.6 p -84.95 -38.56 19.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.943 -1.098 . . . . 0.0 110.563 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 2.7 m-20 -81.58 -36.91 28.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.02 -1.05 . . . . 0.0 110.428 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 46' ' ' VAL . 15.8 t30 -60.54 -53.34 58.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.033 -1.042 . . . . 0.0 110.171 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' ASN . 6.7 m -42.82 -38.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 110.183 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.797 ' HA ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -46.86 -34.81 5.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.039 . . . . 0.0 109.867 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' HD3' ' HG2' ' A' ' 49' ' ' LYS . 3.4 tmtm? -45.46 -24.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.145 -0.972 . . . . 0.0 109.93 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -116.32 40.57 2.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.729 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.797 HD13 ' HA ' ' A' ' 47' ' ' LYS . 5.5 mp -129.47 68.19 79.96 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.182 -0.949 . . . . 0.0 109.587 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 52' ' ' GLU . 36.1 Cg_endo -80.31 77.97 3.86 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.697 2.265 . . . . 0.0 111.685 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 51' ' ' PRO . 25.5 tp10 58.92 136.85 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.616 0.722 . . . . 0.0 110.103 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.13 -6.52 69.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.812 HG13 ' HB2' ' A' ' 186' ' ' SER . 0.9 OUTLIER -116.06 100.52 10.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.28 -1.13 . . . . 0.0 108.645 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -100.51 109.39 21.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.259 -0.901 . . . . 0.0 110.427 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.524 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -102.46 95.52 6.32 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.134 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 24' ' ' GLU . 4.2 m -84.16 133.6 34.6 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.724 -1.19 . . . . 0.0 110.042 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 8.5 tttt -106.72 117.95 35.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.484 -0.76 . . . . 0.0 109.582 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CE2' ' HG2' ' A' ' 138' ' ' GLN . 3.3 m-85 -120.88 177.02 5.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.014 -1.054 . . . . 0.0 110.5 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.607 ' CE1' ' HA ' ' A' ' 27' ' ' SER . 3.2 t60 -109.16 159.89 16.53 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.84 0.828 . . . . 0.0 109.538 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.049 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.4 m -104.02 162.4 4.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.79 58.31 1.7 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.141 -0.975 . . . . 0.0 109.314 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.702 ' HE1' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -158.03 64.82 0.46 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.023 -1.048 . . . . 0.0 110.849 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.671 ' HE1' ' O ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -126.17 33.27 5.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.503 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 64' ' ' MET . . . 44.72 42.42 7.6 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . -148.5 80.97 0.2 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 66' ' ' GLY . 44.5 t0 -33.39 -45.35 0.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.021 -0.693 . . . . 0.0 111.366 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.103 HD23 ' N ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -55.4 -21.01 13.81 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.749 -1.219 . . . . 0.0 109.192 -179.258 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 1.103 ' N ' HD23 ' A' ' 68' ' ' LEU . . . -63.62 -51.3 55.2 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -50.97 -55.05 19.18 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -27.0 68.96 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.009 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 6.2 tt -65.32 -38.06 89.0 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 m -59.69 -42.17 92.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.924 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.2 tt0 -53.92 -29.31 41.62 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.72 -40.06 95.83 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.446 ' O ' ' HB2' ' A' ' 80' ' ' MET . 53.4 t-105 -60.24 -30.93 69.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 108.534 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.546 ' HA ' HD21 ' A' ' 134' ' ' LEU . . . -86.96 -60.46 1.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 109.642 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 74' ' ' GLN . 2.0 t -53.66 -28.1 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 109.171 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.09 -55.74 4.04 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.521 ' SD ' HD22 ' A' ' 134' ' ' LEU . 2.7 ttt -50.67 -27.54 7.18 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.763 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -68.79 -42.25 77.64 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.489 -0.757 . . . . 0.0 109.49 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.505 ' HB2' HG13 ' A' ' 84' ' ' VAL . 14.9 mt -101.97 7.8 41.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.376 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.32 29.32 45.8 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.774 HG11 HG12 ' A' ' 117' ' ' ILE . 26.8 m -94.21 7.82 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.433 -1.039 . . . . 0.0 109.684 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 86' ' ' ASP . 48.9 tt0 -47.72 -72.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.12 -0.988 . . . . 0.0 109.487 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -38.86 -34.59 0.16 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.556 -0.715 . . . . 0.0 110.224 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.534 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 10.4 mtpp -73.95 -55.22 6.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.819 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.917 HG23 HD12 ' A' ' 92' ' ' LEU . 1.1 m -87.16 -19.98 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.737 -1.227 . . . . 0.0 110.681 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.717 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -70.17 -42.27 72.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.625 -1.297 . . . . 0.0 108.13 179.004 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.52 -55.66 37.85 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.603 -1.311 . . . . 0.0 110.692 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 24.4 Cg_endo -72.17 -16.7 28.34 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 N-CA-C 109.669 -0.935 . . . . 0.0 109.669 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.917 HD12 HG23 ' A' ' 88' ' ' VAL . 30.6 mt -86.85 -47.06 9.36 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.717 ' CE1' HG23 ' A' ' 89' ' ' THR . 6.5 m-30 -58.56 -49.18 78.37 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 120.928 -1.108 . . . . 0.0 108.98 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -69.07 -33.09 73.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.061 -1.024 . . . . 0.0 109.015 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.456 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -67.86 -30.16 74.17 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.795 HG11 ' HD1' ' A' ' 29' ' ' PHE . 2.1 t -107.45 9.71 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 121.086 -1.243 . . . . 0.0 108.784 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.482 ' CG ' ' O ' ' A' ' 93' ' ' PHE . 14.6 mt-30 -112.79 15.23 19.91 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.073 -1.017 . . . . 0.0 110.567 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 7.0 mttt 178.97 -49.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.591 -1.318 . . . . 0.0 110.913 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -67.7 -38.16 83.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.561 -1.337 . . . . 0.0 110.048 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 67.24 13.57 9.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -0.832 . . . . 0.0 109.55 -179.412 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.447 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 42.5 p -79.79 -9.91 59.72 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.811 0.815 . . . . 0.0 109.048 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.897 HG22 HD11 ' A' ' 68' ' ' LEU . 5.5 mm -86.99 75.65 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.699 -0.626 . . . . 0.0 109.574 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.564 ' CA ' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -132.27 27.25 4.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 109.308 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 107' ' ' ASP . 7.9 p -147.8 127.07 13.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 109.856 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.653 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.23 -42.81 41.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.1 p -54.36 -31.34 54.34 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 104' ' ' SER . 14.2 m-20 -74.88 -38.02 62.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.236 -0.915 . . . . 0.0 108.969 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.865 HD11 ' O ' ' A' ' 68' ' ' LEU . 31.0 mt -55.98 -27.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -38.54 57.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.9 -49.68 70.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.0 109.197 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.855 HG11 ' HG ' ' A' ' 92' ' ' LEU . 47.2 t -68.25 -37.78 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.479 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.677 ' CD1' HG11 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -58.74 -37.57 76.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.917 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.9 mt -78.99 -27.0 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.157 -0.964 . . . . 0.0 110.313 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -65.55 -16.7 63.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.912 -1.118 . . . . 0.0 109.572 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 87' ' ' LYS . . . -87.94 -1.57 58.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.783 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.0 -3.91 65.01 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.3 mp -87.67 61.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 108.928 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -36.6 154.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.879 -1.138 . . . . 0.0 110.426 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.13 -22.25 35.28 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.16 -54.41 47.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -1.191 . . . . 0.0 109.439 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -42.19 55.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.922 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.742 ' CE2' HG11 ' A' ' 78' ' ' VAL . 7.1 t80 -59.68 -48.12 82.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.139 -0.975 . . . . 0.0 109.716 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.54 -39.91 94.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.115 -0.99 . . . . 0.0 109.182 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 128' ' ' SER . . . -55.73 -53.36 57.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.364 -0.835 . . . . 0.0 109.408 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 1.026 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -56.46 -55.47 33.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.42 -0.8 . . . . 0.0 108.856 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.567 ' CE3' ' O ' ' A' ' 126' ' ' TRP . 0.7 OUTLIER -48.77 -54.11 16.39 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.63 -14.82 63.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.686 -0.634 . . . . 0.0 109.845 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 67.7 m -68.9 -179.24 1.41 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.066 -1.021 . . . . 0.0 110.135 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.7 -35.71 13.33 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.555 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.76 -46.61 60.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.36 -1.336 . . . . 0.0 110.171 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 1.026 HG21 ' HB1' ' A' ' 125' ' ' ALA . 3.0 t -66.57 -35.37 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.732 -1.23 . . . . 0.0 108.63 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -67.1 -38.74 86.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -39.53 94.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 108.974 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 77' ' ' ALA . 4.8 tp -75.64 -25.13 56.58 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.513 HG11 ' CZ3' ' A' ' 126' ' ' TRP . 11.6 t -73.96 -41.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.84 -37.05 85.95 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.03 -31.27 71.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.446 -0.784 . . . . 0.0 108.886 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.515 ' HG2' ' CE2' ' A' ' 59' ' ' TYR . 2.6 mt-30 -66.89 -61.41 1.96 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.415 -0.803 . . . . 0.0 108.852 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.92 -33.41 37.08 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -76.48 -28.34 56.45 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.604 -0.685 . . . . 0.0 109.335 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.845 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -63.54 -57.5 9.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -72.84 -31.31 64.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.887 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.27 -23.24 43.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.165 -0.959 . . . . 0.0 110.222 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 140' ' ' LYS . 76.1 m-20 -81.12 -44.42 17.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.08 -1.012 . . . . 0.0 108.49 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 1.03 HG21 ' CE2' ' A' ' 25' ' ' PHE . 31.7 m -95.58 -8.35 9.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 1.1 mm-40 78.12 -52.5 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.449 -0.782 . . . . 0.0 109.397 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.605 HD13 ' CD2' ' A' ' 25' ' ' PHE . 27.1 tp 68.39 129.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.876 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.59 41.51 0.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.589 -1.319 . . . . 0.0 109.568 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 172.28 105.27 0.18 Allowed Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.068 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 1.049 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -105.05 141.55 22.81 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.391 -1.064 . . . . 0.0 109.817 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.52 152.74 96.18 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 123.572 -1.428 . . . . 0.0 110.208 0.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -134.68 159.38 41.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.241 -1.537 . . . . 0.0 109.394 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.514 ' SD ' HD12 ' A' ' 161' ' ' LEU . 2.1 ttm -154.0 131.22 11.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.942 . . . . 0.0 109.851 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 160' ' ' GLN . 6.1 m-85 -124.76 133.7 53.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.156 -0.965 . . . . 0.0 110.026 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 21' ' ' GLN . 48.2 t -96.2 132.34 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.361 -0.837 . . . . 0.0 110.287 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.539 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 1.2 m-20 48.48 21.23 0.37 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.826 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 55.86 55.53 28.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -164.71 -34.87 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.357 -1.084 . . . . 0.0 108.355 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.597 ' CE2' ' HE3' ' A' ' 188' ' ' LYS . 72.7 m-85 -114.57 118.25 33.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.221 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.431 ' HB2' ' CD1' ' A' ' 154' ' ' PHE . 23.6 tt0 -104.29 109.04 20.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.282 -0.886 . . . . 0.0 109.574 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.642 HD13 ' CZ ' ' A' ' 178' ' ' TYR . 30.0 mt -59.89 169.78 1.36 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -151.78 87.29 4.43 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.055 -1.028 . . . . 0.0 109.463 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . 35.8 Cg_endo -77.61 56.43 5.58 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.603 2.202 . . . . 0.0 110.502 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -128.12 -2.54 5.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.681 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -92.65 7.17 77.49 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.482 ' HG3' ' CD1' ' A' ' 174' ' ' PHE . 0.0 OUTLIER -150.37 49.35 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -1.197 . . . . 0.0 109.552 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -104.53 22.34 15.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.521 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 168' ' ' THR . 7.6 t -166.07 66.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.557 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 89.5 p -168.32 -63.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 109.169 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -160.27 98.3 1.28 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.7 mtt -56.8 -16.87 7.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.866 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -70.7 -44.46 66.91 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.633 -0.667 . . . . 0.0 109.223 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.8 t -73.46 -25.04 20.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.217 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 163' ' ' PRO . 4.1 t80 -69.16 -46.48 67.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 0.0 109.063 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 42' ' ' ILE . 45.5 t -71.55 -24.54 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.568 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -83.14 -55.36 4.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.423 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -39.17 93.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.95 -1.094 . . . . 0.0 108.786 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.642 ' CZ ' HD13 ' A' ' 161' ' ' LEU . 63.4 t80 -65.2 -43.52 91.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.376 -0.827 . . . . 0.0 108.891 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.86 -31.77 65.14 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.021 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.61 -38.62 54.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.317 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.649 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -62.5 -30.34 71.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.239 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 58.1 t -86.03 -33.69 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.191 -0.943 . . . . 0.0 108.636 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.81 -48.55 81.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 108.885 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.76 -32.26 52.53 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.184 -0.947 . . . . 0.0 108.886 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 181' ' ' THR . 0.9 OUTLIER -64.32 -17.06 63.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.877 -1.14 . . . . 0.0 109.138 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.812 ' HB2' HG13 ' A' ' 54' ' ' VAL . 24.9 p -74.02 -10.46 59.65 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.909 -1.119 . . . . 0.0 108.569 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 188' ' ' LYS . 2.2 mt-10 -88.98 -10.05 49.1 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.477 -0.764 . . . . 0.0 109.441 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.597 ' HE3' ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -41.78 -37.98 1.37 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.518 -0.739 . . . . 0.0 109.293 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 188' ' ' LYS . 5.7 ptmt . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.745 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.557 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 1.8 mt-30 -116.23 61.87 0.71 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 0.0 109.408 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER 171.39 89.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.419 -0.801 . . . . 0.0 109.332 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -114.84 61.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.292 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.4 t70 53.72 86.0 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.506 -0.746 . . . . 0.0 109.6 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 120.62 -22.9 8.09 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.173 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -69.83 0.58 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.981 -1.305 . . . . 0.0 108.505 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 0.6 OUTLIER -114.8 19.02 16.23 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.333 -0.854 . . . . 0.0 109.432 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.697 ' HB2' HD23 ' A' ' 161' ' ' LEU . 0.8 OUTLIER 177.94 129.92 0.06 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.225 -0.922 . . . . 0.0 109.063 179.287 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -126.14 176.66 6.89 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.53 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 158' ' ' LYS . 24.9 m -104.14 149.47 25.22 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.472 0.653 . . . . 0.0 109.71 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.4 OUTLIER -89.46 149.52 22.9 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.431 -0.793 . . . . 0.0 109.658 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -70.58 -23.19 62.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.009 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -122.62 102.16 39.2 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.82 164.54 29.9 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.474 2.116 . . . . 0.0 111.118 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.878 HG21 ' OD1' ' A' ' 144' ' ' ASP . 37.7 t -129.1 76.68 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 109.562 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.45 133.18 5.78 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.46 -25.06 26.39 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.669 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -41.09 162.87 0.11 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.521 -0.987 . . . . 0.0 109.627 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.607 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 33.0 Cg_endo -75.8 125.82 9.04 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.589 2.193 . . . . 0.0 111.449 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.762 ' O ' HG13 ' A' ' 155' ' ' VAL . 4.9 mm-40 -37.95 -25.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.848 -0.532 . . . . 0.0 110.854 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.674 ' O ' HG12 ' A' ' 22' ' ' VAL . 17.5 t -147.75 79.82 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.709 -1.244 . . . . 0.0 109.139 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.642 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -82.14 124.82 30.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.528 ' HG3' ' HA ' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -123.71 108.47 12.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.027 -1.046 . . . . 0.0 109.222 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.642 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 7.6 m-85 -88.27 126.53 35.21 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.411 0.624 . . . . 0.0 110.035 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -155.16 142.1 19.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 109.69 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.752 ' CB ' HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -126.32 161.94 26.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.224 -0.922 . . . . 0.0 109.129 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.678 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -83.74 48.13 1.39 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 0.0 108.817 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.723 ' CD1' ' HE3' ' A' ' 64' ' ' MET . 6.3 m-85 -135.47 5.77 3.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.373 -0.829 . . . . 0.0 110.016 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.524 ' HB3' ' NE2' ' A' ' 32' ' ' HIS . 90.9 m -108.69 155.38 40.71 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 118.688 -1.205 . . . . 0.0 109.23 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -73.68 -28.9 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.079 1.853 . . . . 0.0 108.192 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 36' ' ' PHE . 2.5 p-80 -86.15 -20.76 28.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 14.7 t -47.31 -63.29 1.08 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.538 ' CE2' ' CD ' ' A' ' 38' ' ' GLU . 35.6 t80 -59.62 -54.5 45.78 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.475 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 1.5 mt-30 -56.52 -25.51 51.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.22 -0.925 . . . . 0.0 109.786 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.639 ' CE1' HG21 ' A' ' 42' ' ' ILE . 35.5 t80 -84.49 -25.43 28.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 110.672 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.531 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 3.6 tt0 -125.81 51.46 1.74 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.842 -1.161 . . . . 0.0 110.16 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.538 ' CD ' ' CE2' ' A' ' 34' ' ' TYR . 1.1 mt-10 -171.06 -57.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.083 -1.011 . . . . 0.0 110.706 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.1 t -102.07 -58.76 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.924 -1.11 . . . . 0.0 110.917 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 35' ' ' GLN . 64.4 mt -46.43 -22.75 0.29 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.034 -1.041 . . . . 0.0 110.408 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 17.9 m80 57.07 16.97 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.036 -1.04 . . . . 0.0 109.522 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.639 HG21 ' CE1' ' A' ' 36' ' ' PHE . 23.0 mt -64.04 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 109.358 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.85 -31.68 35.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.447 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.31 -27.51 32.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.922 -1.111 . . . . 0.0 110.061 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 36.8 t30 -80.44 -40.05 27.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.965 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 p -65.72 -25.32 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.528 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.458 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 1.0 OUTLIER -68.76 -20.41 64.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.637 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -76.8 -20.76 56.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.142 -0.974 . . . . 0.0 109.62 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.454 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 4.1 mttt -105.65 3.86 29.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 0.0 109.842 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.458 ' HG ' ' HA ' ' A' ' 47' ' ' LYS . 14.4 mt -42.73 102.61 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 109.692 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' ' CG2' ' A' ' 54' ' ' VAL . 34.6 Cg_endo -77.74 127.98 9.07 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.339 2.026 . . . . 0.0 110.605 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.89 116.97 2.03 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.139 0.971 . . . . 0.0 109.233 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.53 -20.28 10.29 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.665 ' O ' HG12 ' A' ' 54' ' ' VAL . 2.6 t -93.39 91.8 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -1.204 . . . . 0.0 109.051 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -75.19 102.09 4.85 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.508 -0.745 . . . . 0.0 109.769 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.529 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 15.1 ttp -89.93 99.92 12.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.563 -0.711 . . . . 0.0 109.483 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.455 ' O ' ' CG ' ' A' ' 24' ' ' GLU . 7.4 m -96.28 139.12 32.88 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.402 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -113.55 109.77 19.18 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.49 -0.756 . . . . 0.0 109.054 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.574 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 3.2 m-85 -110.28 168.72 9.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.839 -1.163 . . . . 0.0 110.562 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.577 ' NE2' ' CD2' ' A' ' 72' ' ' LEU . 55.9 t-80 -97.99 153.25 18.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.899 HG11 HG11 ' A' ' 150' ' ' VAL . 2.1 m -90.62 155.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.606 0.717 . . . . 0.0 110.485 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -124.5 28.58 6.57 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.575 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 12.8 p90 -130.87 61.57 1.62 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.018 -1.051 . . . . 0.0 110.185 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.723 ' HE3' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -160.17 -61.43 0.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' N ' ' HG2' ' A' ' 64' ' ' MET . . . -87.4 82.11 1.61 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -39.94 -51.04 3.4 Favored Glycine 0 N--CA 1.489 2.22 0 O-C-N 121.473 -1.016 . . . . 0.0 110.916 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -87.74 -78.53 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.023 -1.28 . . . . 0.0 111.168 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.076 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -71.97 -23.88 61.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.854 -1.154 . . . . 0.0 110.026 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 1.076 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -50.34 -60.4 6.79 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -48.33 -45.17 34.85 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.958 -1.319 . . . . 0.0 108.31 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -65.37 -31.14 72.1 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.749 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 44.5 tp -57.72 -42.74 84.44 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.6 m -61.53 -41.4 97.27 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.97 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -58.4 -21.07 49.21 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -70.22 -45.75 65.9 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 28.4 t-105 -55.31 -30.71 60.73 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.555 ' HB2' ' OE1' ' A' ' 138' ' ' GLN . . . -86.5 -65.36 1.02 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 110.134 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.97 HG23 ' O ' ' A' ' 74' ' ' GLN . 2.7 t -48.15 -28.16 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 109.945 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.482 ' HB2' ' HZ ' ' A' ' 112' ' ' PHE . . . -85.29 -59.3 2.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.83 -1.169 . . . . 0.0 108.982 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ALA . 8.0 tpt -47.11 -27.98 1.6 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.854 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -73.86 -38.33 64.49 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.54 -0.725 . . . . 0.0 109.443 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 125' ' ' ALA . 52.3 mt -99.56 5.23 46.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.113 -0.992 . . . . 0.0 110.403 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.28 20.09 27.64 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.857 HG11 HG12 ' A' ' 117' ' ' ILE . 35.4 m -89.25 -4.1 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.391 -1.064 . . . . 0.0 110.432 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -45.38 -68.15 0.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.072 -1.018 . . . . 0.0 109.439 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.13 -34.57 0.18 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 110.21 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.943 ' HE2' ' HB1' ' A' ' 115' ' ' ALA . 12.1 mtpt -83.05 -51.22 7.74 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.264 -0.898 . . . . 0.0 110.969 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.867 HG23 HD12 ' A' ' 92' ' ' LEU . 1.2 m -80.97 -17.59 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.773 -1.204 . . . . 0.0 110.505 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.804 HG23 ' CD1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -69.43 -43.39 73.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 108.74 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.78 -55.39 38.82 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.548 -1.345 . . . . 0.0 110.531 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.521 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 25.8 Cg_endo -72.47 -18.07 26.33 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 N-CA-C 109.909 -0.843 . . . . 0.0 109.909 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.894 ' HG ' HG11 ' A' ' 111' ' ' VAL . 21.8 mt -87.05 -43.94 11.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 108.949 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.804 ' CD1' HG23 ' A' ' 89' ' ' THR . 4.2 m-30 -63.68 -46.62 84.72 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.926 -1.109 . . . . 0.0 109.027 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -16.74 61.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.98 . . . . 0.0 109.238 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.454 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -76.44 -30.63 56.37 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 92' ' ' LEU . 1.1 t -105.71 -2.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.068 -1.254 . . . . 0.0 109.444 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.49 ' HG2' ' HB2' ' A' ' 34' ' ' TYR . 2.0 mp0 -113.33 10.98 18.49 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 120.827 -1.171 . . . . 0.0 111.073 -178.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 99' ' ' THR . 0.7 OUTLIER -177.39 58.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.496 -1.378 . . . . 0.0 109.992 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.933 ' CG2' HG23 ' A' ' 101' ' ' THR . 1.0 OUTLIER 168.13 -48.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 99' ' ' THR . 1.5 mt-30 80.11 20.97 0.54 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.752 -1.217 . . . . 0.0 111.366 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.933 HG23 ' CG2' ' A' ' 99' ' ' THR . 26.1 p -84.01 -8.91 59.01 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.303 -0.873 . . . . 0.0 109.107 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.6 ' CB ' HG22 ' A' ' 96' ' ' VAL . 5.2 mm -91.81 82.97 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.69 -0.631 . . . . 0.0 109.35 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.521 ' N ' ' HD3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -146.36 29.6 1.05 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 109.409 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.536 ' CA ' ' HB3' ' A' ' 68' ' ' LEU . 1.1 p -155.43 132.38 10.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.943 . . . . 0.0 110.025 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.776 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -50.41 -32.56 17.97 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 m -62.9 -32.79 74.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -69.81 -50.3 44.24 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.776 HD12 ' HA ' ' A' ' 105' ' ' ALA . 27.0 mt -49.72 -29.36 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.614 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.423 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -78.5 -29.05 46.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.332 -0.855 . . . . 0.0 109.318 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -64.91 -46.32 82.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.238 -0.914 . . . . 0.0 109.302 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.894 HG11 ' HG ' ' A' ' 92' ' ' LEU . 61.4 t -71.87 -37.9 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.453 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.482 ' HZ ' ' HB2' ' A' ' 79' ' ' ALA . 1.0 OUTLIER -61.03 -36.3 79.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.925 . . . . 0.0 109.655 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.842 HG23 ' HA ' ' A' ' 118' ' ' LYS . 15.1 mt -79.67 -25.49 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.996 . . . . 0.0 110.227 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -64.09 -23.35 67.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.421 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.943 ' HB1' ' HE2' ' A' ' 87' ' ' LYS . . . -85.65 2.16 46.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 109.62 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.431 ' C ' HD12 ' A' ' 117' ' ' ILE . . . 96.45 -2.24 62.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.857 HG12 HG11 ' A' ' 84' ' ' VAL . 1.4 mp -90.33 60.66 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.121 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.842 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.4 OUTLIER -34.18 152.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -0.964 . . . . 0.0 110.681 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.52 -27.37 41.31 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.7 -47.22 86.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -1.172 . . . . 0.0 109.081 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -75.94 -40.87 53.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 109.221 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.85 ' CE2' HG11 ' A' ' 78' ' ' VAL . 3.9 t80 -58.92 -47.36 85.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.851 . . . . 0.0 109.286 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.47 -34.51 77.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.244 -0.91 . . . . 0.0 109.013 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.68 -51.37 67.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.307 -0.871 . . . . 0.0 108.919 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.584 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -55.77 -49.36 73.35 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.385 -0.822 . . . . 0.0 108.955 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.42 ' CG ' ' OE1' ' A' ' 74' ' ' GLN . 12.7 t90 -57.49 -55.06 39.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.346 -0.846 . . . . 0.0 108.832 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -54.45 -16.16 2.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.474 -0.766 . . . . 0.0 109.821 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.419 ' OG ' HG23 ' A' ' 131' ' ' VAL . 1.0 OUTLIER -67.71 -179.21 1.07 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 109.571 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.9 -36.28 13.55 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.45 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.6 t -73.81 -47.9 41.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 118.225 -1.39 . . . . 0.0 110.057 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.854 HG22 ' HB1' ' A' ' 81' ' ' ALA . 3.1 t -61.82 -40.56 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.771 -1.206 . . . . 0.0 108.411 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 132' ' ' LYS . 2.6 ttmm -64.87 -28.13 69.33 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.514 -0.741 . . . . 0.0 109.131 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.5 t -69.79 -37.93 76.5 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.348 -0.845 . . . . 0.0 109.241 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.91 -17.13 59.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.187 -0.946 . . . . 0.0 108.485 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.28 -43.84 43.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -68.51 -46.98 68.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -58.15 -33.33 69.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.082 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.574 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -69.74 -74.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 0.0 109.407 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.8 mt-10 -45.58 -36.39 4.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.822 . . . . 0.0 108.932 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -72.63 -35.53 67.82 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.259 -0.901 . . . . 0.0 108.668 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.478 ' O ' ' OD2' ' A' ' 144' ' ' ASP . . . -53.09 -62.6 1.55 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.487 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -60.93 -25.14 66.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.267 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 140' ' ' LYS . . . -78.67 -25.68 44.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.878 ' OD1' HG21 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -78.85 -48.32 14.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.07 -1.019 . . . . 0.0 108.342 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.84 HG13 ' OD1' ' A' ' 144' ' ' ASP . 27.4 m -89.83 -11.43 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.544 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.4 OUTLIER 80.87 -47.27 0.26 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.494 -0.754 . . . . 0.0 109.827 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.553 HD21 HG12 ' A' ' 61' ' ' VAL . 36.0 tp 61.77 130.08 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.35 -0.843 . . . . 0.0 109.102 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -160.96 40.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.525 -1.36 . . . . 0.0 109.94 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 165.14 107.96 0.21 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.899 HG11 HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -99.42 143.45 26.44 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.294 -1.121 . . . . 0.0 109.769 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.521 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 35.1 Cg_endo -76.71 152.01 95.02 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 123.997 -1.251 . . . . 0.0 110.136 0.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -132.84 137.62 46.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.225 -1.547 . . . . 0.0 109.416 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.527 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 2.8 ttp -129.14 130.59 46.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.112 -0.992 . . . . 0.0 110.18 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.532 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 8.5 m-85 -127.55 129.73 47.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.307 -0.871 . . . . 0.0 109.792 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 21' ' ' GLN . 54.3 t -96.76 131.46 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 110.057 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.669 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.9 OUTLIER 44.9 23.58 0.09 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.353 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.576 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 55.4 57.67 17.51 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.528 ' HB3' ' CD1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -164.72 -36.38 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.548 ' CE1' ' HG2' ' A' ' 188' ' ' LYS . 11.7 m-85 -117.45 123.03 45.38 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.511 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -125.42 120.78 31.97 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.975 -1.078 . . . . 0.0 109.81 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.697 HD23 ' HB2' ' A' ' 9' ' ' TYR . 17.2 mt -65.33 177.36 1.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.555 -0.716 . . . . 0.0 109.152 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.549 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 50.9 t-20 -137.58 60.27 24.78 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.723 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 162' ' ' ASN . 35.5 Cg_endo -77.97 60.11 7.18 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.635 2.224 . . . . 0.0 110.397 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -51.03 -22.44 2.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.135 -0.978 . . . . 0.0 108.959 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 99.92 57.87 0.9 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.46 ' O ' ' C ' ' A' ' 167' ' ' ASP . 5.3 mtt -112.71 -119.32 0.3 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.191 -1.182 . . . . 0.0 108.746 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 166' ' ' MET . 25.6 t0 38.84 38.55 0.28 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.21 -0.931 . . . . 0.0 109.908 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 12.3 p -69.12 -8.27 43.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.946 -1.096 . . . . 0.0 109.751 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.3 m -73.67 -31.19 63.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.016 . . . . 0.0 108.978 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -160.58 95.78 1.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.364 -0.835 . . . . 0.0 109.017 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 34.6 mtt -58.86 -15.88 14.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 109.62 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.07 -46.76 89.34 Favored 'General case' 0 C--N 1.293 -1.891 0 O-C-N 121.639 -0.663 . . . . 0.0 109.499 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.3 t -67.0 -28.14 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.36 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -66.85 -40.41 87.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.216 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.515 HG22 ' CG1' ' A' ' 42' ' ' ILE . 39.6 t -75.27 -27.42 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.173 -0.955 . . . . 0.0 109.458 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.15 -56.16 4.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.972 . . . . 0.0 109.246 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -55.74 -33.25 64.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.15 -0.969 . . . . 0.0 109.151 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 178' ' ' TYR . 13.5 t80 -70.5 -53.11 17.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -0.951 . . . . 0.0 109.479 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.5 -31.84 71.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.556 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -76.81 -50.25 13.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.746 ' O ' HD23 ' A' ' 185' ' ' LEU . 20.6 m -54.39 -24.15 18.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.246 -0.909 . . . . 0.0 109.527 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.463 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 25.0 t -86.16 -40.29 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.031 -1.043 . . . . 0.0 109.174 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -55.18 -45.6 75.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.178 -0.952 . . . . 0.0 109.094 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.516 ' CE2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -81.75 -36.66 28.3 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.34 -0.85 . . . . 0.0 109.233 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.746 HD23 ' O ' ' A' ' 181' ' ' THR . 0.7 OUTLIER -54.05 -20.2 6.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.886 -1.133 . . . . 0.0 109.875 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.619 ' HB3' HG21 ' A' ' 54' ' ' VAL . 64.9 p -63.91 -13.49 45.98 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.709 -1.244 . . . . 0.0 108.054 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.25 33.97 5.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.553 -0.717 . . . . 0.0 109.31 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.548 ' HG2' ' CE1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -76.2 4.46 8.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.044 -1.035 . . . . 0.0 110.024 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.087 -1.008 . . . . 0.0 109.531 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.551 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 1.2 mt-30 -104.7 57.39 0.7 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -0.861 . . . . 0.0 109.615 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.551 ' CG ' ' C ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -160.99 81.72 0.64 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.507 -0.746 . . . . 0.0 109.311 179.691 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -111.3 59.16 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.012 -1.055 . . . . 0.0 109.593 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 45.64 83.92 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.509 -0.744 . . . . 0.0 109.893 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 136.74 -33.01 2.39 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.084 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.79 -72.63 0.45 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -1.18 . . . . 0.0 109.398 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.783 ' HB3' HG21 ' A' ' 181' ' ' THR . 8.5 mm-40 -87.88 -4.24 58.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.816 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 24.0 p90 177.15 130.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.236 -0.915 . . . . 0.0 109.14 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -106.31 -179.92 4.08 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 m -103.13 159.61 15.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.639 -0.663 . . . . 0.0 109.533 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.777 HD21 ' CE2' ' A' ' 154' ' ' PHE . 15.3 mt -95.98 154.86 17.01 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.357 -0.839 . . . . 0.0 109.748 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.28 -12.67 40.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.448 -0.783 . . . . 0.0 108.982 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 100.74 3.98 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 109.222 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.19 160.9 35.86 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.39 2.06 . . . . 0.0 110.703 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.906 HG13 ' CB ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -121.31 98.63 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 109.595 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.77 126.94 6.0 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 99.13 -21.57 45.13 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.906 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -40.9 157.06 0.19 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.987 . . . . 0.0 109.513 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.572 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.8 Cg_endo -79.83 139.59 14.0 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.725 2.283 . . . . 0.0 111.659 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.801 ' O ' HG13 ' A' ' 155' ' ' VAL . 2.8 mm-40 -51.65 -20.52 2.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.537 -0.727 . . . . 0.0 109.099 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 53.9 t -151.62 82.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.209 -0.932 . . . . 0.0 108.759 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.716 HD12 HG11 ' A' ' 145' ' ' VAL . 0.0 OUTLIER -74.49 126.88 31.71 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.548 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -110.18 127.33 54.88 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.039 -1.038 . . . . 0.0 109.764 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.61 ' CE2' HD13 ' A' ' 23' ' ' LEU . 3.1 m-85 -124.79 108.84 12.37 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.478 -0.764 . . . . 0.0 109.428 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -152.67 145.3 24.22 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.343 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.607 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -128.72 -164.94 1.44 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.642 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -116.62 53.95 0.87 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.92 -1.112 . . . . 0.0 108.683 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' HD11 ' A' ' 72' ' ' LEU . 9.6 m-85 -133.88 -5.33 2.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.019 -1.05 . . . . 0.0 110.64 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.498 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 0.2 OUTLIER -106.28 171.8 4.48 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.8 -1.188 . . . . 0.0 109.433 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 30' ' ' CYS . 33.5 Cg_endo -75.15 -38.87 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.294 1.996 . . . . 0.0 109.113 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.528 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.5 m80 -84.61 -20.7 30.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -52.56 -40.52 62.64 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.563 ' CE2' ' OE1' ' A' ' 38' ' ' GLU . 40.2 t80 -87.25 -47.45 8.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.69 -0.632 . . . . 0.0 109.619 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -66.18 -21.75 66.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 109.905 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.576 ' CE1' HG21 ' A' ' 42' ' ' ILE . 89.1 t80 -83.06 -16.74 45.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.592 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.552 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -132.79 50.77 2.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.77 -1.206 . . . . 0.0 110.636 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.563 ' OE1' ' CE2' ' A' ' 34' ' ' TYR . 1.0 OUTLIER -175.41 -59.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.192 -0.943 . . . . 0.0 110.216 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.6 t -89.99 -46.91 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.204 -0.935 . . . . 0.0 110.733 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 41' ' ' HIS . 77.8 mt -65.99 -6.0 11.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.022 -1.049 . . . . 0.0 110.561 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.446 ' HA ' ' OD1' ' A' ' 44' ' ' ASP . 50.5 m170 44.03 27.0 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.992 -1.067 . . . . 0.0 109.163 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.576 HG21 ' CE1' ' A' ' 36' ' ' PHE . 15.6 mt -78.43 -22.57 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.821 . . . . 0.0 109.957 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.691 ' O ' HG12 ' A' ' 46' ' ' VAL . 47.2 m -80.65 -26.67 37.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.976 -1.078 . . . . 0.0 110.333 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.446 ' OD1' ' HA ' ' A' ' 41' ' ' HIS . 1.9 p-10 -87.44 -49.86 6.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.976 -1.078 . . . . 0.0 110.117 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 46' ' ' VAL . 39.1 p-10 -59.72 -25.26 64.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.214 -0.929 . . . . 0.0 110.028 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 43' ' ' SER . 9.4 p -65.27 -26.75 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 109.958 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.802 ' HA ' HD12 ' A' ' 50' ' ' LEU . 3.8 mttt -77.05 -38.29 53.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 109.969 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.48 -23.92 1.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.062 -1.023 . . . . 0.0 109.468 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.6 33.25 5.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.352 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.802 HD12 ' HA ' ' A' ' 47' ' ' LYS . 13.8 mt -114.79 81.79 7.62 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.872 . . . . 0.0 109.198 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.753 ' HD2' HG21 ' A' ' 54' ' ' VAL . 35.6 Cg_endo -77.5 143.85 22.1 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.584 2.189 . . . . 0.0 110.566 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 51' ' ' PRO . 3.5 tm-20 -40.61 120.88 1.34 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 122.361 1.077 . . . . 0.0 109.233 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.39 -28.5 4.76 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.753 HG21 ' HD2' ' A' ' 51' ' ' PRO . 31.9 t -86.37 79.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -1.076 . . . . 0.0 108.849 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -61.07 101.67 0.17 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.422 -0.799 . . . . 0.0 110.528 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.672 ' SD ' HD11 ' A' ' 50' ' ' LEU . 7.9 ttt -100.67 97.68 8.32 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.493 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 1.6 m -94.68 123.5 38.16 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.325 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.548 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 3.1 tppt? -99.63 121.65 41.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.398 -0.814 . . . . 0.0 109.546 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.593 ' CE1' ' HG2' ' A' ' 138' ' ' GLN . 2.0 m-85 -126.05 174.78 8.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.854 -1.154 . . . . 0.0 111.174 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.741 ' NE2' HD22 ' A' ' 72' ' ' LEU . 22.4 t60 -112.04 145.86 38.95 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.841 0.829 . . . . 0.0 109.378 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.078 HG11 ' CG1' ' A' ' 150' ' ' VAL . 8.4 m -80.86 155.73 4.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.325 0.583 . . . . 0.0 109.985 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . 52.0 p30 -121.02 38.81 3.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.142 -0.973 . . . . 0.0 109.604 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 2.4 p90 -139.34 57.11 1.66 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.163 -0.96 . . . . 0.0 109.611 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.515 ' CE ' ' CG2' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -125.79 35.23 4.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.134 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.83 -30.83 1.23 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.379 -1.889 . . . . 0.0 108.379 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.46 -35.02 3.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.7 -79.45 0.29 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.74 -1.447 . . . . 0.0 109.939 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.903 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -76.6 -19.14 58.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 108.85 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.564 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -53.48 -54.46 29.91 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -52.99 -41.91 65.06 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.77 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 45.5 t0 -65.76 -31.39 72.35 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.762 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -59.05 -36.08 74.43 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.582 HG23 ' OE1' ' A' ' 138' ' ' GLN . 45.7 m -66.64 -41.74 87.8 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -63.83 -16.43 61.27 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -71.28 -40.6 70.81 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 20.0 t-105 -68.85 -31.35 70.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.61 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -81.0 -62.48 1.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.577 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.146 HG11 ' CD2' ' A' ' 122' ' ' TYR . 59.9 t -48.33 -29.1 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.949 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.516 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -84.03 -60.52 2.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.885 -1.134 . . . . 0.0 108.875 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.584 ' HB3' HD22 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -44.5 -28.8 0.62 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.264 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.73 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -71.45 -44.48 64.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.805 . . . . 0.0 109.572 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.552 ' HB2' HG13 ' A' ' 84' ' ' VAL . 5.8 mt -99.97 11.18 39.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.037 -1.04 . . . . 0.0 110.004 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.38 22.02 6.95 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 82' ' ' LEU . 34.0 m -85.19 -7.81 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -1.076 . . . . 0.0 110.138 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -41.17 -60.3 1.27 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -33.43 7.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 110.345 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -83.29 -52.53 6.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.171 -0.956 . . . . 0.0 111.696 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.919 HG23 HD12 ' A' ' 92' ' ' LEU . 1.2 m -77.68 -10.06 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.586 -1.321 . . . . 0.0 110.249 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.713 HG23 ' CD1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -70.88 -44.69 65.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.851 -1.155 . . . . 0.0 108.889 179.233 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.403 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -53.17 -54.77 40.92 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.448 -1.408 . . . . 0.0 110.477 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.579 ' HB2' HG13 ' A' ' 111' ' ' VAL . 24.7 Cg_endo -72.8 -18.63 24.68 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 122.639 0.81 . . . . 0.0 109.995 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.919 HD12 HG23 ' A' ' 88' ' ' VAL . 15.0 mt -86.16 -41.75 14.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.235 -0.916 . . . . 0.0 109.09 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.713 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.8 m-30 -66.25 -47.61 73.19 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.056 -1.027 . . . . 0.0 109.007 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -31.96 70.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.935 -1.103 . . . . 0.0 109.322 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.464 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -63.06 -32.7 85.04 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.664 HG11 ' CD1' ' A' ' 29' ' ' PHE . 2.0 t -107.19 5.76 9.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.105 -1.232 . . . . 0.0 109.206 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.533 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -107.78 10.69 28.71 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.981 -1.074 . . . . 0.0 110.579 -179.187 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER 176.08 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.519 -1.363 . . . . 0.0 110.144 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 43.0 p -56.62 -44.66 81.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.489 -1.382 . . . . 0.0 109.114 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 99' ' ' THR . 38.2 mt-30 70.42 10.83 7.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.425 -0.797 . . . . 0.0 110.085 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 t -83.27 -5.28 59.08 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.734 0.778 . . . . 0.0 109.143 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.513 ' CB ' HG22 ' A' ' 96' ' ' VAL . 12.9 mm -84.57 80.51 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.69 33.38 1.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 110.021 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.544 ' O ' ' N ' ' A' ' 107' ' ' ASP . 1.7 p -161.47 133.78 5.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.953 -1.092 . . . . 0.0 109.893 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.77 ' HB1' ' OD2' ' A' ' 71' ' ' ASP . . . -51.51 -32.62 28.3 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 104' ' ' SER . 5.5 p -61.85 -31.46 71.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -72.02 -49.54 36.07 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.77 HD11 HD23 ' A' ' 68' ' ' LEU . 26.9 mt -52.01 -30.9 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.401 ' O ' HG13 ' A' ' 113' ' ' ILE . 19.6 mtt-85 -74.11 -28.54 61.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 109.069 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -66.61 -48.15 70.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.339 -0.851 . . . . 0.0 109.374 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.859 HG11 ' HG ' ' A' ' 92' ' ' LEU . 49.1 t -65.83 -40.26 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.991 . . . . 0.0 109.507 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CE1' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -57.57 -43.84 84.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.946 -1.096 . . . . 0.0 109.379 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 109' ' ' ARG . 18.7 mt -68.35 -24.8 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 109.623 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -20.11 66.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 109.691 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.83 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -93.87 9.71 36.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.552 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.44 -5.57 84.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.832 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.6 mp -76.65 55.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -1.175 . . . . 0.0 109.032 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -33.01 149.17 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.347 -0.846 . . . . 0.0 110.743 -179.497 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 122' ' ' TYR . . . -51.8 -28.41 23.36 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -58.8 -47.56 84.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -1.155 . . . . 0.0 108.849 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -80.41 -34.51 36.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.401 -0.812 . . . . 0.0 109.705 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 1.146 ' CD2' HG11 ' A' ' 78' ' ' VAL . 3.5 t80 -64.17 -50.22 69.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 109.511 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.62 -35.19 75.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.013 -1.054 . . . . 0.0 108.713 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.6 -51.65 67.65 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.634 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -54.91 -52.06 64.12 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.533 ' C ' ' CD1' ' A' ' 126' ' ' TRP . 6.8 t90 -52.75 -55.61 21.59 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.14 -15.74 2.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.677 -0.639 . . . . 0.0 110.435 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -72.55 176.64 5.27 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.909 -1.119 . . . . 0.0 109.845 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -87.33 -39.0 15.73 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.179 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.43 -44.86 83.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 C-N-CA 118.254 -1.378 . . . . 0.0 109.789 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.73 HG22 ' HB1' ' A' ' 81' ' ' ALA . 2.8 t -67.02 -38.87 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.809 -1.182 . . . . 0.0 108.685 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -67.93 -29.37 68.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 137' ' ' GLN . 0.4 OUTLIER -70.89 -34.47 71.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.428 -0.795 . . . . 0.0 109.235 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.584 HD22 ' HB3' ' A' ' 80' ' ' MET . 0.0 OUTLIER -80.12 -21.41 43.24 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.277 -0.889 . . . . 0.0 108.617 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.61 HG23 ' HB1' ' A' ' 77' ' ' ALA . 17.9 t -81.48 -45.6 20.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.26 83.87 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -63.01 -32.83 74.28 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.593 ' HG2' ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -60.15 -69.56 0.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.436 -0.79 . . . . 0.0 109.073 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.548 ' OE2' ' HB2' ' A' ' 143' ' ' ALA . 6.3 tm-20 -48.61 -33.38 9.74 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 9.5 tttm -68.72 -40.78 79.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.426 -0.796 . . . . 0.0 109.038 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.472 ' O ' ' OD2' ' A' ' 144' ' ' ASP . . . -55.52 -55.32 33.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 108.618 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.53 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -70.15 -22.97 62.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.345 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.548 ' HB2' ' OE2' ' A' ' 139' ' ' GLU . . . -78.5 -26.51 45.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.069 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.793 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.4 p30 -82.8 -47.73 11.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.939 -1.1 . . . . 0.0 108.271 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.793 HG13 ' OD1' ' A' ' 144' ' ' ASP . 14.7 m -85.82 -17.05 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.8 OUTLIER 81.92 -47.54 0.2 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.449 0.643 . . . . 0.0 109.643 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.04 HD21 HG12 ' A' ' 61' ' ' VAL . 14.3 tp 67.33 131.63 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.449 -0.782 . . . . 0.0 109.421 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 148' ' ' ARG . 2.7 ptt85 -161.46 39.04 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.565 -1.335 . . . . 0.0 110.02 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 161.06 108.28 0.23 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.38 -1.39 . . . . 0.0 110.37 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 1.078 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -91.88 144.72 29.73 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.371 -1.076 . . . . 0.0 109.792 179.111 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.462 ' HG2' ' HG2' ' A' ' 163' ' ' PRO . 33.6 Cg_endo -77.09 152.23 94.54 Favored 'Cis proline' 0 C--N 1.317 -1.124 0 C-N-CA 124.1 -1.208 . . . . 0.0 110.501 0.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -126.63 152.26 46.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.426 -1.421 . . . . 0.0 109.353 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 2.6 tmm? -151.21 135.61 16.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.123 -0.986 . . . . 0.0 109.656 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.777 ' CE2' HD21 ' A' ' 12' ' ' LEU . 51.0 m-85 -137.1 124.54 22.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.418 -0.801 . . . . 0.0 110.311 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 21' ' ' GLN . 52.0 t -92.34 130.48 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.747 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.683 HD22 HG12 ' A' ' 155' ' ' VAL . 3.9 p30 45.55 22.42 0.1 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.046 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.82 56.56 24.64 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.519 ' N ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -165.77 -36.85 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.299 -1.118 . . . . 0.0 108.169 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.499 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 75.9 m-85 -115.34 123.44 48.73 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.534 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 20.8 pt20 -123.3 134.74 54.03 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.94 -1.1 . . . . 0.0 109.877 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.9 mt -70.95 177.83 3.48 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.451 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -147.76 65.95 9.43 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 120.878 -1.139 . . . . 0.0 110.02 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.462 ' HG2' ' HG2' ' A' ' 151' ' ' PRO . 36.0 Cg_endo -79.1 65.76 8.83 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.575 2.183 . . . . 0.0 109.988 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -14.77 38.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.842 . . . . 0.0 109.677 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.25 66.14 0.23 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 5.3 ptp -115.01 42.99 2.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -1.113 . . . . 0.0 109.193 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.561 ' HB2' ' CD2' ' A' ' 174' ' ' PHE . 44.5 t0 -107.19 24.61 12.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.567 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.4 p -97.06 20.71 10.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.464 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 66.5 p -120.32 -49.47 2.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.621 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -160.9 101.52 1.28 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 109.148 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.48 ' HA ' ' OD1' ' A' ' 167' ' ' ASP . 3.5 mtt -55.84 -17.09 5.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 109.689 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 173' ' ' VAL . 0.0 OUTLIER -75.43 -60.56 2.25 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 172' ' ' ASP . 4.9 t -64.69 -30.69 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.318 -0.864 . . . . 0.0 109.473 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.561 ' CD2' ' HB2' ' A' ' 167' ' ' ASP . 24.9 t80 -67.22 -45.32 77.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.665 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.428 HG22 ' CG1' ' A' ' 42' ' ' ILE . 70.7 t -73.63 -25.17 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.444 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.87 -57.53 3.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.526 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.97 -47.51 74.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.108 -0.995 . . . . 0.0 109.299 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 182' ' ' VAL . 31.9 t80 -59.15 -57.24 13.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.962 . . . . 0.0 109.128 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.13 -29.08 12.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.33 -0.856 . . . . 0.0 109.14 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -77.89 -47.0 19.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.334 -0.853 . . . . 0.0 109.202 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.783 HG21 ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -50.3 -32.83 18.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.349 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 178' ' ' TYR . 1.4 t -85.74 -37.62 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.981 . . . . 0.0 108.952 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.45 ' O ' ' OG ' ' A' ' 186' ' ' SER . 16.6 ttpt -60.38 -46.13 91.06 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.281 -0.887 . . . . 0.0 109.037 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -78.93 -27.15 43.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.233 -0.917 . . . . 0.0 108.98 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.663 HD23 ' O ' ' A' ' 181' ' ' THR . 0.3 OUTLIER -65.69 -19.59 65.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.863 -1.148 . . . . 0.0 108.925 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.492 ' HB2' HG22 ' A' ' 54' ' ' VAL . 15.0 p -77.88 -13.04 60.02 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.834 -1.166 . . . . 0.0 108.745 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.85 4.7 51.05 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.307 -0.871 . . . . 0.0 109.329 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 189' ' ' LYS . 1.2 tptp -51.35 -39.57 57.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.2 -0.938 . . . . 0.0 109.578 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 188' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.97 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.34 0.591 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.448 ' C ' ' CD2' ' A' ' 3' ' ' TYR . 26.0 mt-30 -112.39 62.3 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.872 . . . . 0.0 108.721 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.633 ' HB3' ' HB2' ' A' ' 8' ' ' GLN . 4.3 p90 -175.19 97.01 0.08 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.432 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 4.7 mt-10 -114.94 64.57 0.68 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.826 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 4.0 m-20 70.18 96.74 0.07 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.307 -0.871 . . . . 0.0 110.473 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.15 -3.4 81.02 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -100.48 26.98 6.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -1.172 . . . . 0.0 108.533 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' A' ' 3' ' ' TYR . 0.9 OUTLIER 150.42 -35.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.598 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -156.98 131.25 8.49 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.669 -1.269 . . . . 0.0 109.796 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 t -114.44 174.99 5.68 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.59 152.28 20.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.653 -0.655 . . . . 0.0 109.707 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.496 ' HG ' ' HG2' ' A' ' 160' ' ' GLN . 1.4 mt -92.56 161.31 14.65 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.396 -0.815 . . . . 0.0 109.517 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -84.93 -18.72 33.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.171 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -140.34 110.17 6.93 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.366 -0.833 . . . . 0.0 108.899 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 36.2 Cg_endo -77.22 167.9 24.0 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.352 2.034 . . . . 0.0 111.29 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.692 HG21 ' HB3' ' A' ' 144' ' ' ASP . 7.7 t -128.19 93.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.93 127.54 16.61 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 97.63 -20.8 49.21 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -40.01 159.52 0.13 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.928 . . . . 0.0 109.347 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.587 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 34.9 Cg_endo -77.52 128.26 9.42 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.459 2.106 . . . . 0.0 111.35 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.859 ' O ' HG13 ' A' ' 155' ' ' VAL . 10.3 mp0 -41.4 -25.56 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.529 -0.732 . . . . 0.0 109.724 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.644 ' O ' HG12 ' A' ' 22' ' ' VAL . 8.6 t -149.21 84.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.068 -1.02 . . . . 0.0 108.872 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.587 ' HG ' ' CG ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -77.35 126.13 30.43 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' OE1' ' CD1' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -118.46 104.03 10.31 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.076 -1.015 . . . . 0.0 109.732 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.715 ' CD2' HD13 ' A' ' 147' ' ' LEU . 5.2 m-85 -90.05 123.46 33.95 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.304 -0.873 . . . . 0.0 109.609 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 1.0 OUTLIER -160.91 140.23 10.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.231 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.591 ' HB2' ' CD2' ' A' ' 29' ' ' PHE . 11.1 p -116.29 174.97 5.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 110.183 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.61 ' CD2' HD21 ' A' ' 72' ' ' LEU . 8.3 m-30 -89.3 37.6 0.87 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.501 -0.749 . . . . 0.0 109.021 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 1.14 ' CZ ' HD13 ' A' ' 72' ' ' LEU . 3.2 m-85 -135.65 18.92 3.31 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.773 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.436 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 3.8 m -112.79 164.07 16.35 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.819 -1.176 . . . . 0.0 109.428 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.9 Cg_endo -74.74 -13.19 22.09 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.014 1.809 . . . . 0.0 108.321 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.572 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 36.5 m170 -100.2 -29.7 12.33 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 34' ' ' TYR . 6.1 p -44.58 -40.51 5.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.517 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 21.1 t80 -88.22 -45.49 10.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.789 -0.57 . . . . 0.0 110.259 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -68.54 -22.39 64.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 111.12 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.661 ' CZ ' HD13 ' A' ' 42' ' ' ILE . 1.6 m-85 -80.16 -25.0 40.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.801 -1.187 . . . . 0.0 110.588 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.418 ' O ' ' CD ' ' A' ' 38' ' ' GLU . 0.4 OUTLIER -117.94 32.46 6.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.899 -1.126 . . . . 0.0 110.073 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 67.6 mm-40 -146.52 -63.83 0.3 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -0.995 . . . . 0.0 110.566 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 40' ' ' LEU . 4.0 t -101.75 -66.8 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.034 -1.041 . . . . 0.0 110.741 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 40' ' ' LEU . 58.0 mt -42.92 -34.21 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 31.8 m170 57.27 20.32 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.172 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.661 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 8.5 mt -58.92 -24.32 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.619 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.6 m -77.17 -60.88 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.927 . . . . 0.0 109.722 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 10.0 m-20 -70.84 -33.6 70.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.0 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 45' ' ' ASN . 12.5 t-20 -60.79 -49.73 76.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.661 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 67.3 t -77.27 -16.89 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.898 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -75.8 -27.74 58.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.045 -1.035 . . . . 0.0 109.646 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -72.28 -22.86 61.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -0.974 . . . . 0.0 109.516 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 24.0 mtmt -97.54 -3.27 40.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.871 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.545 HD22 ' HB ' ' A' ' 54' ' ' VAL . 13.1 mt -73.5 113.42 22.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 109.679 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.841 ' HD2' HG21 ' A' ' 54' ' ' VAL . 36.7 Cg_endo -78.54 138.4 15.36 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.174 1.916 . . . . 0.0 110.599 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 51' ' ' PRO . 23.4 tt0 -40.79 119.64 1.16 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.086 0.946 . . . . 0.0 109.573 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.32 -25.77 5.08 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.89 HG22 ' HB2' ' A' ' 186' ' ' SER . 4.5 t -85.33 88.29 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -1.187 . . . . 0.0 109.358 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HE3' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -69.77 99.91 1.43 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.956 -179.666 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.483 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 1.8 ttt -92.7 100.63 13.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.573 -0.704 . . . . 0.0 109.321 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.447 ' OG1' ' HE3' ' A' ' 55' ' ' LYS . 89.8 m -95.39 139.89 31.05 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.136 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.547 ' O ' ' NE1' ' A' ' 76' ' ' TRP . 1.4 mppt? -118.14 105.46 11.84 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.608 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.0 m-85 -103.59 164.36 11.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.597 -1.315 . . . . 0.0 111.109 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 1.022 ' NE2' HD22 ' A' ' 72' ' ' LEU . 6.8 t-80 -116.28 134.6 54.73 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.721 0.772 . . . . 0.0 109.141 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.043 HG21 HG11 ' A' ' 150' ' ' VAL . 2.6 m -104.97 160.73 5.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 O-C-N 121.666 -0.646 . . . . 0.0 110.123 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.535 ' HB3' ' N ' ' A' ' 70' ' ' LYS . 1.7 p-10 -103.85 54.53 0.74 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.524 ' CE1' ' HB ' ' A' ' 61' ' ' VAL . 4.9 m-85 -100.73 61.55 1.0 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.671 -0.643 . . . . 0.0 109.764 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.585 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -161.65 -56.66 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.891 -1.124 . . . . 0.0 111.6 179.326 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.585 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -114.82 -18.37 6.48 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.44 -42.63 1.98 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.07 -77.69 0.35 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -1.152 . . . . 0.0 109.45 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.07 HD11 HG22 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -62.13 -21.61 65.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.954 ' N ' HD23 ' A' ' 68' ' ' LEU . . . -60.85 -64.93 3.66 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.535 ' N ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -54.61 -42.47 71.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.249 -1.147 . . . . 0.0 108.502 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.706 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 21.7 t0 -64.93 -29.33 70.26 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.14 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 3.5 tt -66.58 -35.4 80.12 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 1.6 m -59.16 -41.73 89.1 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 177.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -61.32 -24.51 66.49 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -65.28 -34.23 77.86 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.554 ' CH2' ' OE2' ' A' ' 85' ' ' GLU . 53.0 t-105 -71.15 -31.86 68.21 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.644 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -79.16 -58.95 2.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.337 -0.852 . . . . 0.0 109.411 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.969 HG21 ' CE1' ' A' ' 122' ' ' TYR . 93.9 t -53.65 -27.55 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 109.981 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.583 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -81.97 -61.27 1.96 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.984 -1.073 . . . . 0.0 108.654 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 3.1 tpt -49.17 -26.28 2.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.883 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -77.46 -36.5 52.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.531 -0.731 . . . . 0.0 109.563 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 84' ' ' VAL . 83.1 mt -105.81 8.89 32.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 0.0 110.75 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 54.25 27.89 40.95 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.583 HG22 ' HA ' ' A' ' 79' ' ' ALA . 32.6 m -99.67 29.17 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.461 -1.023 . . . . 0.0 110.049 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.554 ' OE2' ' CH2' ' A' ' 76' ' ' TRP . 5.2 mt-10 -62.88 -79.57 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.133 -0.979 . . . . 0.0 109.641 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -36.41 -37.63 0.13 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.345 0.593 . . . . 0.0 110.805 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.529 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 5.1 mtpt -70.85 -56.72 5.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.402 -0.811 . . . . 0.0 111.459 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.746 HG23 HD12 ' A' ' 92' ' ' LEU . 1.3 m -86.74 -15.11 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.613 -1.304 . . . . 0.0 110.592 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.734 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -74.62 -42.52 58.46 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.589 -1.319 . . . . 0.0 108.341 178.7 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.417 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -54.68 -53.75 56.85 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.701 -1.249 . . . . 0.0 110.615 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 25.9 Cg_endo -73.07 -19.89 22.39 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 N-CA-C 109.829 -0.873 . . . . 0.0 109.829 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.746 HD12 HG23 ' A' ' 88' ' ' VAL . 21.9 mt -83.78 -42.62 16.3 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.734 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.4 m-30 -64.83 -45.74 84.88 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.029 -1.044 . . . . 0.0 108.649 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -72.47 -28.6 63.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.171 -0.956 . . . . 0.0 109.254 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.07 -32.07 82.9 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.623 HG11 ' HD1' ' A' ' 29' ' ' PHE . 2.5 t -99.8 -6.83 9.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.194 -1.18 . . . . 0.0 109.245 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.486 ' OE1' ' CG ' ' A' ' 34' ' ' TYR . 2.9 mt-30 -108.71 7.5 26.44 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 120.935 -1.103 . . . . 0.0 111.037 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.776 ' O ' HG23 ' A' ' 99' ' ' THR . 0.9 OUTLIER -175.63 66.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.516 -1.365 . . . . 0.0 109.55 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.08 -48.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.8 -0.563 . . . . 0.0 109.639 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.6 mt-30 74.26 17.7 3.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.197 -0.939 . . . . 0.0 110.276 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.8 t -79.93 -6.53 57.65 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 1.07 HG22 HD11 ' A' ' 68' ' ' LEU . 11.1 mm -89.72 71.08 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.716 -0.615 . . . . 0.0 109.345 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.541 ' CA ' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -136.87 16.19 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 109.235 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -142.64 126.88 17.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.402 -0.811 . . . . 0.0 109.402 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.706 ' HB1' ' OD2' ' A' ' 71' ' ' ASP . . . -49.37 -37.32 24.47 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 p -55.86 -31.63 62.94 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.769 ' OD2' HD12 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -74.14 -47.76 33.91 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.911 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.751 HD11 ' O ' ' A' ' 68' ' ' LEU . 30.4 mt -48.41 -29.34 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.911 -1.118 . . . . 0.0 108.582 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -74.37 -47.41 34.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 109.614 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -51.98 -40.39 60.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 109.37 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.692 HG11 ' HG ' ' A' ' 92' ' ' LEU . 2.4 t -71.18 -40.1 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.164 -0.96 . . . . 0.0 109.532 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.541 ' CE1' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -65.47 -33.46 75.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.564 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mt -76.42 -25.4 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.917 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -65.39 -20.0 66.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.059 -1.026 . . . . 0.0 109.61 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.505 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -90.05 4.72 49.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 109.722 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.6 0.37 69.65 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.719 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.5 mm -79.5 60.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -1.149 . . . . 0.0 109.555 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 117' ' ' ILE . 64.7 mttt -34.85 153.17 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.257 -0.902 . . . . 0.0 110.45 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.459 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -59.69 -27.69 64.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -66.45 -43.92 84.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -1.17 . . . . 0.0 109.607 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.0 -50.05 45.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.327 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.969 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -65.34 -56.35 13.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.369 -0.832 . . . . 0.0 108.845 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 27.5 t70 -45.56 -39.22 7.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.101 -0.999 . . . . 0.0 108.892 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.69 -44.36 61.89 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.302 -0.874 . . . . 0.0 108.791 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.575 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -54.63 -49.09 71.34 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -59.27 -58.74 7.29 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -53.86 -15.97 1.58 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.585 -0.697 . . . . 0.0 110.119 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -70.74 175.47 4.95 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.96 -1.088 . . . . 0.0 109.766 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.947 ' CE2' HG23 ' A' ' 130' ' ' VAL . 41.4 p90 -94.09 -37.03 11.82 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.776 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.947 HG23 ' CE2' ' A' ' 129' ' ' PHE . 25.0 t -67.18 -47.91 80.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.13 -1.428 . . . . 0.0 109.578 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.883 HG22 ' HB1' ' A' ' 81' ' ' ALA . 16.6 t -63.41 -40.24 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.977 -1.077 . . . . 0.0 108.561 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -37.71 85.18 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.456 -0.778 . . . . 0.0 109.056 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -29.5 70.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.057 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.12 -30.8 55.36 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.644 HG23 ' CB ' ' A' ' 77' ' ' ALA . 9.8 t -76.04 -41.15 38.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.6 -48.72 80.56 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -37.17 82.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 109.139 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.608 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 18.9 tm0? -55.87 -62.42 1.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.037 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -48.35 -33.57 9.2 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.427 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -72.46 -29.29 63.54 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.351 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.576 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . . . -62.46 -57.19 12.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 108.712 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -68.55 -35.87 78.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.519 -0.738 . . . . 0.0 110.036 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.81 -16.64 58.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.043 -1.035 . . . . 0.0 109.835 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.692 ' HB3' HG21 ' A' ' 16' ' ' VAL . 5.7 m-20 -81.49 -43.76 18.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -0.966 . . . . 0.0 108.95 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.54 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 29.7 m -105.03 -9.4 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 108.885 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.54 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.9 OUTLIER 82.24 -43.72 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.519 -0.738 . . . . 0.0 109.876 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.015 HD21 HG11 ' A' ' 61' ' ' VAL . 14.1 tp 64.5 134.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.35 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -160.75 32.85 0.15 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.533 -1.354 . . . . 0.0 110.002 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 151' ' ' PRO . . . 175.01 77.97 0.05 OUTLIER Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.995 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 1.043 HG11 HG21 ' A' ' 61' ' ' VAL . 3.8 m -80.15 135.91 54.13 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.119 -1.224 . . . . 0.0 107.92 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 149' ' ' GLY . 30.9 Cg_endo -71.18 152.85 96.04 Favored 'Cis proline' 0 C--N 1.317 -1.098 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.508 2.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -140.29 159.84 41.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.689 -1.257 . . . . 0.0 109.026 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.53 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 30.3 tpp -142.65 138.18 30.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.024 -1.048 . . . . 0.0 110.369 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 6.3 m-85 -143.22 127.34 17.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.436 -0.79 . . . . 0.0 109.577 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 21' ' ' GLN . 54.9 t -103.95 130.59 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.026 . . . . 0.0 109.501 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.512 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 1.9 t-20 45.62 26.39 0.33 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 15' ' ' PRO . . . 52.07 27.46 22.61 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.402 -1.38 . . . . 0.0 109.88 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.66 -15.96 4.35 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.735 -1.45 . . . . 0.0 109.308 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.576 ' CE2' ' HE3' ' A' ' 188' ' ' LYS . 65.2 m-85 -143.1 125.6 15.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.001 . . . . 0.0 109.149 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.496 ' HG2' ' HG ' ' A' ' 12' ' ' LEU . 1.1 pt20 -119.7 139.4 52.31 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.03 -1.044 . . . . 0.0 109.778 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.445 ' HG ' ' HB3' ' A' ' 153' ' ' MET . 7.7 mt -75.78 173.41 11.17 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -158.6 87.08 2.32 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 109.758 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.01 35.23 0.56 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.872 2.381 . . . . 0.0 111.225 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -91.08 154.86 19.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.991 -1.068 . . . . 0.0 108.7 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 89.63 -34.18 4.12 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.501 ' O ' HG23 ' A' ' 168' ' ' THR . 0.0 OUTLIER -89.48 -112.77 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.987 -1.302 . . . . 0.0 109.345 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 166' ' ' MET . 25.9 t0 41.34 27.79 0.06 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.981 -1.074 . . . . 0.0 109.853 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 166' ' ' MET . 81.4 p -85.61 -70.39 0.59 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.557 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 169' ' ' SER . 3.3 t -171.89 58.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.88 . . . . 0.0 109.36 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -148.34 64.07 1.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.145 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.845 ' O ' HG23 ' A' ' 175' ' ' VAL . 4.9 mmt -64.92 -15.55 62.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.312 -0.867 . . . . 0.0 109.635 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.11 -63.13 1.29 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.352 0.596 . . . . 0.0 109.474 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 4.0 t -67.3 -18.27 23.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.153 -0.967 . . . . 0.0 109.475 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -76.52 -47.16 23.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.101 -1.0 . . . . 0.0 109.663 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 171' ' ' MET . 15.2 t -70.91 -25.05 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 109.376 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -80.63 -61.01 2.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.263 -0.898 . . . . 0.0 109.257 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 173' ' ' VAL . 0.6 OUTLIER -55.12 -42.72 73.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.218 -0.927 . . . . 0.0 109.198 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 178' ' ' TYR . 9.7 t80 -61.32 -48.65 80.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.281 -0.887 . . . . 0.0 109.364 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.67 -30.07 65.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.343 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -77.38 -43.47 32.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.495 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.6 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.1 OUTLIER -57.75 -34.09 69.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.0 . . . . 0.0 109.465 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 51.7 t -78.45 -36.09 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.154 -0.966 . . . . 0.0 109.044 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -52.04 67.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.289 -0.882 . . . . 0.0 109.169 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -77.11 -32.0 56.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.296 -0.878 . . . . 0.0 109.263 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 181' ' ' THR . 0.2 OUTLIER -62.67 -17.06 59.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.06 -1.025 . . . . 0.0 109.653 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.89 ' HB2' HG22 ' A' ' 54' ' ' VAL . 87.8 p -73.08 -12.3 60.86 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.856 -1.153 . . . . 0.0 108.709 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.21 0.95 57.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.423 -0.798 . . . . 0.0 109.386 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.576 ' HE3' ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -60.75 -37.13 80.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.399 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 pttm . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.464 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.412 ' HB1' ' HG2' ' A' ' 7' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.455 ' C ' ' CD2' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -105.67 59.09 0.66 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.328 -0.857 . . . . 0.0 109.031 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.574 ' HE1' HG23 ' A' ' 181' ' ' THR . 3.1 m-85 56.4 74.44 0.4 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.659 -0.651 . . . . 0.0 109.486 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.449 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 1.6 pt-20 -105.84 54.96 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.588 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 4' ' ' GLU . 1.2 m-20 42.48 82.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.751 -0.593 . . . . 0.0 110.1 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 131.88 -29.22 3.42 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.701 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 5.4 tptt -83.18 -69.05 0.66 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.869 -1.371 . . . . 0.0 109.27 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 77.6 mm-40 -92.97 2.01 57.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.744 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 6' ' ' GLY . 1.1 p90 176.67 132.38 0.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.078 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.5 ' CG2' ' CD ' ' A' ' 160' ' ' GLN . 11.3 t -112.26 -179.63 3.73 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 m -116.62 139.61 50.32 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.487 0.66 . . . . 0.0 109.615 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.465 HD23 ' HG2' ' A' ' 160' ' ' GLN . 0.2 OUTLIER -95.18 169.83 9.82 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.389 -0.819 . . . . 0.0 109.375 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 14.3 mp0 -98.19 12.35 34.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 109.82 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 5.4 mtmt -141.51 80.47 16.2 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.925 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -79.13 159.26 26.8 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.719 2.279 . . . . 0.0 109.986 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.906 HG21 ' OD1' ' A' ' 144' ' ' ASP . 3.4 t -126.72 97.86 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.093 -1.004 . . . . 0.0 110.154 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.79 128.54 8.82 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 93.03 -14.9 64.14 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.644 -1.783 . . . . 0.0 108.644 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.792 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -39.25 161.7 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.946 . . . . 0.0 110.095 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.587 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.2 Cg_endo -78.56 127.53 8.13 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.746 2.297 . . . . 0.0 111.201 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.647 ' O ' HG22 ' A' ' 155' ' ' VAL . 2.0 mm-40 -42.35 -24.48 0.05 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.511 -0.743 . . . . 0.0 109.798 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.639 ' O ' HG12 ' A' ' 22' ' ' VAL . 8.1 t -147.14 86.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.009 -1.057 . . . . 0.0 108.75 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.715 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -79.88 125.55 29.87 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -105.55 97.95 7.71 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.175 -0.953 . . . . 0.0 110.438 -178.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.158 ' CE2' HG21 ' A' ' 145' ' ' VAL . 4.7 m-85 -89.58 106.41 18.44 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 3.2 p90 -153.32 143.6 22.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.044 -1.035 . . . . 0.0 109.946 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.613 ' HB3' ' CE1' ' A' ' 60' ' ' HIS . 2.3 p -126.44 -165.02 1.39 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.68 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -115.67 53.46 0.84 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.758 -1.213 . . . . 0.0 108.224 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.654 ' CE1' HD22 ' A' ' 72' ' ' LEU . 9.1 m-85 -137.71 0.35 2.22 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.411 -0.806 . . . . 0.0 110.645 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.62 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 5.1 m -111.27 169.11 6.65 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.782 -1.199 . . . . 0.0 108.604 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 30.7 Cg_endo -73.97 -54.73 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.712 1.608 . . . . 0.0 109.344 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -68.66 -19.08 64.38 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 177.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -50.49 -47.47 57.15 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.359 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.615 ' HB3' ' NE2' ' A' ' 97' ' ' GLN . 5.7 t80 -79.82 -37.04 35.97 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.515 -0.74 . . . . 0.0 109.748 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.486 ' O ' ' CG ' ' A' ' 40' ' ' LEU . 8.4 mm-40 -70.85 -25.08 62.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 110.054 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -83.74 -15.68 47.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.166 -0.959 . . . . 0.0 110.943 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.7 mm-40 -131.22 44.28 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.728 -1.232 . . . . 0.0 111.202 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -174.07 -60.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.004 . . . . 0.0 110.984 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.4 t -90.18 -53.45 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.045 -1.034 . . . . 0.0 111.143 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.587 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 94.8 mt -59.4 -11.24 4.04 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.977 -1.077 . . . . 0.0 110.76 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 56.8 p-80 41.31 28.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 109.663 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 46' ' ' VAL . 19.4 mt -68.71 -33.23 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 109.272 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 43.7 p -72.87 -26.05 61.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 109.877 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.09 -54.41 4.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 0.0 109.83 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -52.09 -53.99 35.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.163 -0.961 . . . . 0.0 109.755 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.741 HG22 ' O ' ' A' ' 42' ' ' ILE . 19.1 m -57.53 -35.32 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.53 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.967 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -70.78 -39.33 73.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -60.26 -22.77 63.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -111.22 9.44 21.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 0.0 109.807 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.967 HD12 ' HA ' ' A' ' 47' ' ' LYS . 8.3 mt -78.65 130.14 71.84 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 110.042 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD2' HD23 ' A' ' 50' ' ' LEU . 35.3 Cg_endo -78.47 154.05 27.5 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.408 2.072 . . . . 0.0 108.863 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' A' ' 52' ' ' GLU . 11.8 tt0 -69.84 21.66 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.473 -1.392 . . . . 0.0 111.54 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 51' ' ' PRO . . . -121.61 29.99 5.48 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 186' ' ' SER . 43.9 t -145.6 117.21 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.09 107.35 19.15 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.456 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -91.39 96.36 10.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -91.78 140.22 29.91 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.961 -1.095 . . . . 0.0 110.342 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.32 112.15 21.13 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.484 -0.76 . . . . 0.0 109.594 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.603 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 1.9 m-85 -116.67 167.43 11.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -0.964 . . . . 0.0 110.678 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.613 ' CE1' ' HB3' ' A' ' 27' ' ' SER . 54.8 t-80 -108.23 131.41 54.71 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.076 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.8 m -69.48 151.47 9.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.648 -0.658 . . . . 0.0 110.033 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 4.4 p-10 -116.57 42.61 2.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.594 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 1.6 p90 -144.48 59.15 1.33 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.153 -0.967 . . . . 0.0 109.67 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -129.98 36.5 4.03 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.402 -0.811 . . . . 0.0 109.126 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.58 -32.02 0.34 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.17 -40.26 3.09 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -88.34 -79.55 0.3 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.109 -1.23 . . . . 0.0 110.628 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.896 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -79.68 -18.29 51.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.866 -1.146 . . . . 0.0 109.564 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.633 ' N ' HD22 ' A' ' 68' ' ' LEU . . . -53.19 -46.62 62.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -44.35 94.98 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.76 -27.66 67.78 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.693 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 27.8 tp -60.97 -44.8 96.83 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 138' ' ' GLN . 1.6 m -60.3 -42.9 96.5 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 1.052 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.6 tt0 -55.61 -26.14 42.4 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -67.41 -42.07 83.86 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -58.43 -28.2 65.04 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HB2' ' NE2' ' A' ' 138' ' ' GLN . . . -85.94 -43.15 13.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.525 -0.734 . . . . 0.0 110.274 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.052 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.2 t -68.74 -30.87 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.903 -1.123 . . . . 0.0 109.693 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.581 ' HB1' ' HG2' ' A' ' 85' ' ' GLU . . . -82.63 -55.78 4.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.01 -1.057 . . . . 0.0 108.374 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 3.0 ttt -49.67 -28.55 6.07 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.864 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -72.98 -39.0 66.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.501 -0.749 . . . . 0.0 109.183 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.457 ' CB ' HG13 ' A' ' 84' ' ' VAL . 66.1 mt -101.28 8.64 42.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.262 -0.899 . . . . 0.0 110.23 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.97 24.05 7.96 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 79' ' ' ALA . 33.5 m -90.27 1.44 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -1.092 . . . . 0.0 110.173 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.581 ' HG2' ' HB1' ' A' ' 79' ' ' ALA . 2.5 mt-10 -44.68 -66.79 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.979 -1.076 . . . . 0.0 109.436 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -41.03 -34.16 0.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.432 -0.793 . . . . 0.0 110.109 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -80.99 -51.41 8.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.329 -0.857 . . . . 0.0 111.294 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.973 HG23 HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -87.18 -11.46 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.622 -1.299 . . . . 0.0 110.896 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.776 HG23 ' CE1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -71.64 -43.94 65.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.731 -1.231 . . . . 0.0 108.893 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.412 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -54.1 -54.26 49.35 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.515 -1.366 . . . . 0.0 110.657 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.601 ' HB2' HG13 ' A' ' 111' ' ' VAL . 27.1 Cg_endo -72.86 -18.1 24.93 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 N-CA-C 109.844 -0.868 . . . . 0.0 109.844 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.973 HD12 HG23 ' A' ' 88' ' ' VAL . 17.5 mt -86.62 -43.73 12.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.892 . . . . 0.0 108.874 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.776 ' CE1' HG23 ' A' ' 89' ' ' THR . 5.1 m-30 -63.53 -48.1 78.9 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.043 -1.036 . . . . 0.0 108.486 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -72.84 -29.28 63.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 108.977 179.083 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.426 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -57.05 -39.0 88.96 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.639 HG11 ' CG ' ' A' ' 29' ' ' PHE . 1.9 t -100.36 -3.37 9.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.211 -1.17 . . . . 0.0 109.387 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.615 ' NE2' ' HB3' ' A' ' 34' ' ' TYR . 2.0 mt-30 -101.56 2.6 39.2 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 120.853 -1.154 . . . . 0.0 110.714 -179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.783 ' O ' HG23 ' A' ' 99' ' ' THR . 1.1 mmtp -175.18 72.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.692 -1.255 . . . . 0.0 109.387 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.28 -49.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 99' ' ' THR . 3.0 mt-30 72.8 15.0 4.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 110.597 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 t -82.93 -7.85 59.62 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.859 0.838 . . . . 0.0 108.797 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.61 HG13 HG22 ' A' ' 96' ' ' VAL . 9.1 mm -82.44 69.63 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 32.56 3.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.729 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.55 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 32.1 p -156.56 131.0 8.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.989 -1.069 . . . . 0.0 110.201 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.904 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.79 -34.21 18.8 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.83 -34.74 75.02 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -66.15 -50.71 63.02 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 105' ' ' ALA . 24.6 mt -49.38 -28.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.771 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -39.03 47.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.926 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 1.1 p30 -59.84 -46.08 90.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.114 -0.991 . . . . 0.0 109.626 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.775 HG11 ' HG ' ' A' ' 92' ' ' LEU . 58.7 t -68.65 -39.74 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.936 -1.103 . . . . 0.0 109.25 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.434 ' O ' ' HB ' ' A' ' 117' ' ' ILE . 1.9 m-85 -59.9 -42.84 94.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.181 -0.95 . . . . 0.0 109.544 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.662 HG23 ' HA ' ' A' ' 118' ' ' LYS . 12.0 mt -69.85 -23.83 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 109.403 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 110' ' ' ASP . 1.9 m-80 -63.33 -17.99 63.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 109.592 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.858 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -99.08 11.51 38.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.912 . . . . 0.0 109.344 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.35 -7.71 81.42 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.858 HD13 ' HB3' ' A' ' 115' ' ' ALA . 1.8 mp -77.32 55.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -1.077 . . . . 0.0 109.252 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.662 ' HA ' HG23 ' A' ' 113' ' ' ILE . 3.0 mtmp? -35.19 149.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.215 -0.928 . . . . 0.0 110.475 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 123' ' ' ASP . . . -53.57 -27.91 35.74 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -61.86 -59.06 5.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.034 -1.274 . . . . 0.0 109.363 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -64.76 -41.95 95.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 109.226 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.955 ' CE2' HG11 ' A' ' 78' ' ' VAL . 3.1 t80 -56.5 -48.9 76.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.008 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.2 OUTLIER -59.97 -30.87 69.4 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.887 . . . . 0.0 109.064 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.43 -51.36 60.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.344 -0.847 . . . . 0.0 108.852 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.516 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -51.89 -52.8 47.26 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.406 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 3.7 t-105 -57.87 -56.49 21.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.81 -16.17 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 110.282 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 50.2 m -74.03 173.69 9.67 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.901 -1.124 . . . . 0.0 109.991 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -90.63 -38.62 13.0 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.463 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.77 -47.17 89.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.085 -1.446 . . . . 0.0 109.244 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.864 HG22 ' HB1' ' A' ' 81' ' ' ALA . 15.6 t -62.56 -32.66 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -67.89 -39.41 83.65 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 90.0 p -61.74 -34.59 76.09 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.18 -18.36 53.2 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.288 -0.882 . . . . 0.0 108.662 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.17 -47.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.43 -32.87 74.43 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -33.53 69.14 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.603 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 8.9 mt-30 -74.24 -66.98 0.66 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 108.955 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.8 tt0 -45.36 -43.96 11.38 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 0.1 OUTLIER -69.78 -28.39 65.7 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.916 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -56.19 -63.5 1.17 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.37 -0.831 . . . . 0.0 108.874 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.54 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -73.57 -19.43 60.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 109.834 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' A' ' 140' ' ' LYS . . . -79.31 -29.48 42.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.01 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 1.02 ' OD1' HG13 ' A' ' 145' ' ' VAL . 2.8 p30 -81.85 -45.04 16.08 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 1.158 HG21 ' CE2' ' A' ' 25' ' ' PHE . 24.7 m -87.26 -14.91 9.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.54 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.5 tp-100 79.65 -50.5 0.39 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.63 -0.669 . . . . 0.0 109.501 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.725 HD21 HG12 ' A' ' 61' ' ' VAL . 12.2 tp 62.09 134.46 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.482 -0.761 . . . . 0.0 109.281 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -160.77 27.76 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.573 -1.33 . . . . 0.0 109.725 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 179.56 102.93 0.17 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.331 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 1.076 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.92 144.06 27.87 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 0.0 109.175 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.429 ' O ' ' HG3' ' A' ' 163' ' ' PRO . 35.7 Cg_endo -77.65 153.07 93.75 Favored 'Cis proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.946 -1.272 . . . . 0.0 110.649 0.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -129.43 130.05 45.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.39 -1.444 . . . . 0.0 109.408 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -119.59 115.57 24.25 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.256 -0.903 . . . . 0.0 109.152 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.547 ' CD1' ' CB ' ' A' ' 160' ' ' GLN . 13.7 m-30 -115.01 127.5 55.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.207 -0.933 . . . . 0.0 110.804 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 21' ' ' GLN . 24.4 t -96.81 131.99 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.918 . . . . 0.0 109.684 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.792 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 2.8 t-20 45.32 22.3 0.08 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.407 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.563 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.16 58.04 16.17 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -166.52 -36.1 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.634 ' CE2' ' CG ' ' A' ' 188' ' ' LYS . 96.4 m-85 -116.34 123.19 47.02 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.547 ' CB ' ' CD1' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -117.89 112.97 21.05 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.296 -0.877 . . . . 0.0 109.873 -179.243 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 9' ' ' TYR . 11.1 mt -60.37 170.68 1.26 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 109.063 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 162' ' ' ASN . 26.3 p-10 -131.42 113.29 15.58 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.548 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.429 ' HG3' ' O ' ' A' ' 151' ' ' PRO . 36.2 Cg_endo -78.26 5.85 5.14 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.407 2.071 . . . . 0.0 110.542 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -81.59 4.81 20.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.627 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -80.38 -15.21 78.85 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.403 ' HG3' ' CD1' ' A' ' 174' ' ' PHE . 6.8 mtp -80.33 -94.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.974 -1.309 . . . . 0.0 109.584 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.7 t0 50.28 28.24 3.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.125 -0.984 . . . . 0.0 109.545 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.446 ' O ' ' CB ' ' A' ' 169' ' ' SER . 6.0 p -146.86 -87.56 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.568 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 168' ' ' THR . 1.9 t 167.04 71.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.937 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -139.68 58.97 1.6 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.277 -0.89 . . . . 0.0 109.45 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.872 ' O ' HG23 ' A' ' 175' ' ' VAL . 3.1 mtt -59.66 -17.45 34.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.397 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.61 -65.79 0.97 Allowed 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.0 t -57.84 -25.2 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.251 -0.906 . . . . 0.0 108.827 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 178' ' ' TYR . 50.8 t80 -74.12 -39.82 63.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 109.112 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 171' ' ' MET . 96.9 t -70.91 -27.77 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 108.95 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.66 -64.83 1.1 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.248 -0.907 . . . . 0.0 108.904 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -50.31 -42.31 52.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.187 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 178' ' ' TYR . 8.1 t80 -61.42 -53.77 52.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.513 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.38 -24.11 11.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.922 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.41 -43.62 23.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.555 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.641 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -59.63 -42.28 92.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 109.386 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 43.2 t -74.01 -37.3 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.056 -1.028 . . . . 0.0 109.226 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -52.28 65.91 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.89 . . . . 0.0 109.193 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -76.72 -33.64 58.16 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.263 -0.898 . . . . 0.0 109.061 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 181' ' ' THR . 0.5 OUTLIER -58.17 -19.54 33.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.982 -1.074 . . . . 0.0 109.839 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.46 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 1.3 t -73.17 -12.65 60.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.81 -1.181 . . . . 0.0 108.71 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.57 9.01 39.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.84 . . . . 0.0 109.44 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.634 ' CG ' ' CE2' ' A' ' 159' ' ' TYR . 6.1 tptm -78.1 -13.88 59.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.408 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.567 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 20.5 mt-30 -105.84 57.8 0.66 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.919 . . . . 0.0 109.101 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.567 ' CG ' ' C ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER 176.09 85.18 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.611 -0.68 . . . . 0.0 109.191 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -108.35 62.36 0.61 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.796 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.2 t70 44.82 82.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.408 -0.807 . . . . 0.0 109.404 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 118.38 -22.74 9.39 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.457 ' HB3' ' OE1' ' A' ' 8' ' ' GLN . 3.0 tttp -80.13 -68.67 0.65 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.107 -1.231 . . . . 0.0 108.709 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' A' ' 2' ' ' GLN . 17.2 mp0 -103.94 9.1 36.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.285 -0.884 . . . . 0.0 109.773 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 3' ' ' TYR . 3.7 p90 177.33 134.73 0.07 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.129 -0.982 . . . . 0.0 109.171 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -117.68 178.83 4.26 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 m -115.19 145.59 42.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.706 -0.621 . . . . 0.0 109.681 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.418 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -94.01 165.87 12.43 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.424 -0.797 . . . . 0.0 109.567 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -80.48 -15.64 56.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.599 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.02 115.17 11.04 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.404 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.492 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 34.4 Cg_endo -77.3 162.7 30.89 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.401 2.067 . . . . 0.0 110.531 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.721 HG21 HG12 ' A' ' 145' ' ' VAL . 48.1 t -105.93 79.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -46.6 128.25 10.23 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 93.77 -13.15 68.1 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 18' ' ' GLY . . . -37.36 152.28 0.13 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.75 -0.853 . . . . 0.0 109.043 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.521 ' O ' ' O ' ' A' ' 55' ' ' LYS . 36.6 Cg_endo -78.94 40.77 0.97 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.244 1.962 . . . . 0.0 112.631 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER 67.04 -43.22 0.44 Allowed 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.376 -0.827 . . . . 0.0 110.575 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.615 ' O ' HG12 ' A' ' 22' ' ' VAL . 32.2 t -150.52 78.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.73 HD13 ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -70.66 127.49 32.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -178.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 57' ' ' THR . 2.1 tt0 -111.1 149.3 31.02 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.119 -0.988 . . . . 0.0 109.625 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.764 ' CD2' HD13 ' A' ' 147' ' ' LEU . 15.0 m-85 -122.86 126.43 47.32 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.467 -0.771 . . . . 0.0 109.689 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 1.9 p90 -159.09 140.97 13.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.354 -0.842 . . . . 0.0 109.486 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.996 ' HB3' HG22 ' A' ' 61' ' ' VAL . 75.2 p -122.01 169.94 10.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -0.98 . . . . 0.0 110.574 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' A' ' 29' ' ' PHE . 7.5 m-30 -92.3 37.66 1.0 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 1.037 ' CZ ' HD13 ' A' ' 72' ' ' LEU . 2.6 m-85 -142.59 20.01 2.02 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.092 -1.005 . . . . 0.0 110.258 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.542 ' CB ' ' CE1' ' A' ' 32' ' ' HIS . 1.3 m -117.95 166.93 12.3 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.642 -1.286 . . . . 0.0 109.617 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 33.6 Cg_endo -75.54 -38.13 1.5 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.287 1.991 . . . . 0.0 108.628 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.579 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 14.6 p80 -73.9 -25.49 60.04 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.509 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 22.7 t -44.75 -62.9 1.04 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 8.4 t80 -65.54 -46.41 79.65 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.287 0.565 . . . . 0.0 109.989 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.526 ' HA ' ' CG2' ' A' ' 39' ' ' VAL . 2.1 mm-40 -61.01 -23.64 65.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 110.538 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.467 ' N ' ' O ' ' A' ' 32' ' ' HIS . 3.4 m-30 -78.37 -43.1 28.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -110.98 8.06 21.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.748 -1.22 . . . . 0.0 111.391 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 27.8 mm-40 -135.01 29.15 3.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.562 -1.336 . . . . 0.0 110.346 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.831 HG12 ' HG ' ' A' ' 40' ' ' LEU . 98.0 t -150.92 -76.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.812 -1.18 . . . . 0.0 109.522 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.831 ' HG ' HG12 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -106.22 20.09 19.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.178 -0.951 . . . . 0.0 109.932 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 45' ' ' ASN . 5.3 m170 43.13 31.36 0.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.14 -0.975 . . . . 0.0 110.066 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.551 ' CG1' HG22 ' A' ' 175' ' ' VAL . 22.4 mt -50.48 -25.02 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.003 -1.061 . . . . 0.0 109.416 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.25 -55.9 5.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 110.186 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.509 ' HA ' ' HG2' ' A' ' 47' ' ' LYS . 6.9 m-20 -87.09 -33.57 19.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.355 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.507 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -60.54 -27.68 67.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.5 -179.267 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.833 ' O ' HD13 ' A' ' 50' ' ' LEU . 9.1 p -84.46 -24.84 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.028 -1.045 . . . . 0.0 111.091 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.54 ' HG3' ' N ' ' A' ' 48' ' ' LYS . 4.7 ptpt -78.68 -25.29 44.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.737 -1.227 . . . . 0.0 110.416 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.54 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 1.7 mtpt -63.84 -32.76 74.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.953 -1.092 . . . . 0.0 109.311 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -82.82 9.66 9.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.865 . . . . 0.0 109.411 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 46' ' ' VAL . 8.6 mp -98.64 108.5 48.62 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.128 -0.983 . . . . 0.0 109.449 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.615 ' HD2' HG21 ' A' ' 54' ' ' VAL . 35.1 Cg_endo -77.06 145.9 25.12 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.4 2.067 . . . . 0.0 110.478 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 51' ' ' PRO . 1.2 tt0 -33.46 118.13 0.32 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.266 1.031 . . . . 0.0 110.127 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.36 -26.64 5.46 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.615 HG21 ' HD2' ' A' ' 51' ' ' PRO . 3.7 t -97.58 93.5 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -1.102 . . . . 0.0 108.645 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -84.44 118.25 24.16 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.962 0.887 . . . . 0.0 110.079 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.489 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.4 OUTLIER -111.82 98.91 7.72 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.068 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 20' ' ' PRO . 7.4 m -99.6 128.18 45.7 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.716 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 115.17 29.89 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.585 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 1.3 m-85 -112.62 175.98 5.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.852 -1.155 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.622 ' CE1' HD22 ' A' ' 72' ' ' LEU . 28.9 t-80 -104.41 150.73 24.27 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.032 0.92 . . . . 0.0 109.322 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.996 HG22 ' HB3' ' A' ' 27' ' ' SER . 1.3 m -96.96 160.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.369 0.604 . . . . 0.0 110.015 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -125.09 56.69 1.32 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.41 -0.806 . . . . 0.0 108.866 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.57 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -133.81 52.1 2.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.99 . . . . 0.0 110.974 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.656 ' HE3' ' CE1' ' A' ' 29' ' ' PHE . 3.1 ppp? -128.92 34.0 4.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.395 -0.815 . . . . 0.0 108.818 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.76 -37.35 3.24 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.91 -13.19 66.71 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.761 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -79.3 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.666 -1.49 . . . . 0.0 109.381 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.066 HD23 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -86.14 -28.22 24.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.037 -1.04 . . . . 0.0 109.345 179.469 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 1.066 ' N ' HD23 ' A' ' 68' ' ' LEU . . . -59.08 -55.08 32.88 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -56.87 -47.2 81.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.305 -1.114 . . . . 0.0 108.695 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 23.8 t0 -67.35 -24.37 65.71 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.037 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 5.8 tt -71.48 -39.52 70.84 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.973 HG23 ' OE1' ' A' ' 138' ' ' GLN . 1.3 m -57.87 -43.58 86.08 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 1.028 ' O ' HG23 ' A' ' 78' ' ' VAL . 4.0 tt0 -56.71 -29.0 62.0 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -62.3 -40.15 95.36 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -61.9 -30.4 70.86 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.486 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -83.41 -48.02 10.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -0.807 . . . . 0.0 109.968 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.028 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.5 t -63.3 -27.7 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 0.0 109.442 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.535 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -83.14 -55.72 4.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.212 -0.93 . . . . 0.0 109.138 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.719 ' HG2' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -45.26 -29.15 0.93 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.277 -0.889 . . . . 0.0 108.779 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.817 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -74.4 -38.37 63.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.396 -0.815 . . . . 0.0 109.509 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.527 ' CB ' HG13 ' A' ' 84' ' ' VAL . 44.3 mt -104.63 12.64 32.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 110.022 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.05 23.01 1.44 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.597 HG21 ' CE1' ' A' ' 112' ' ' PHE . 21.9 m -84.95 -10.35 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -1.204 . . . . 0.0 110.189 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 84' ' ' VAL . 5.4 pt-20 -43.01 -59.02 2.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.076 -1.015 . . . . 0.0 109.823 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -33.29 2.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.111 -0.993 . . . . 0.0 109.682 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.571 ' HE2' ' HB1' ' A' ' 115' ' ' ALA . 44.2 mtpt -83.89 -51.6 7.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.557 -0.714 . . . . 0.0 111.133 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.723 HG23 HD12 ' A' ' 92' ' ' LEU . 1.4 m -80.48 -6.07 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.787 -1.196 . . . . 0.0 110.676 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.727 HG23 ' CZ ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -78.24 -44.33 25.86 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.805 -1.184 . . . . 0.0 108.513 178.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.456 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -52.16 -52.01 66.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.568 -1.333 . . . . 0.0 110.227 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.538 ' HB2' HG13 ' A' ' 111' ' ' VAL . 24.4 Cg_endo -73.43 -20.51 20.75 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 N-CA-C 109.906 -0.844 . . . . 0.0 109.906 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.841 ' HG ' HG11 ' A' ' 111' ' ' VAL . 12.7 mt -83.83 -41.88 17.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 108.646 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.727 ' CZ ' HG23 ' A' ' 89' ' ' THR . 8.3 m-30 -67.3 -45.08 77.62 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.125 -0.984 . . . . 0.0 108.589 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -74.65 -33.35 62.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.56 -0.713 . . . . 0.0 109.428 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.462 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -61.24 -32.1 79.46 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.5 t -99.48 -9.55 8.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.344 -1.092 . . . . 0.0 109.278 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 2.4 mt-30 -112.41 9.7 19.75 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.891 -1.131 . . . . 0.0 110.92 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.779 ' O ' HG23 ' A' ' 99' ' ' THR . 0.6 OUTLIER -164.63 59.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.472 -1.393 . . . . 0.0 109.408 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 163.62 -49.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.472 -0.768 . . . . 0.0 109.119 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.486 ' O ' ' NE ' ' A' ' 103' ' ' ARG . 4.1 mp0 73.71 14.98 4.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.26 -0.9 . . . . 0.0 110.737 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 t -82.97 -7.8 59.63 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 1.012 HG22 HD11 ' A' ' 68' ' ' LEU . 12.4 mm -77.5 67.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.486 ' NE ' ' O ' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -128.56 30.83 5.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 109.452 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 107' ' ' ASP . 5.2 p -153.48 127.73 9.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.072 . . . . 0.0 110.187 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.72 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -48.79 -36.38 16.52 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 p -55.82 -33.85 64.82 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.747 ' OD2' HD12 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -71.79 -44.99 63.04 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.704 179.047 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.779 HD11 ' O ' ' A' ' 68' ' ' LEU . 34.7 mt -49.71 -29.29 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.892 -1.13 . . . . 0.0 108.459 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -79.36 -32.83 43.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.438 -0.789 . . . . 0.0 109.678 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -62.01 -43.47 98.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.166 -0.959 . . . . 0.0 109.403 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.841 HG11 ' HG ' ' A' ' 92' ' ' LEU . 55.8 t -74.68 -37.55 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 109.235 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.597 ' CE1' HG21 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -62.37 -48.11 81.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.883 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.481 HG23 ' HA ' ' A' ' 118' ' ' LYS . 22.5 mt -69.56 -26.22 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 109.538 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -19.81 54.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.373 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.571 ' HB1' ' HE2' ' A' ' 87' ' ' LYS . . . -90.46 5.32 48.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.526 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.82 -4.46 72.02 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.74 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.3 mm -74.73 57.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -1.088 . . . . 0.0 109.723 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.481 ' HA ' HG23 ' A' ' 113' ' ' ILE . 60.4 mttt -37.37 147.82 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.202 -0.936 . . . . 0.0 110.291 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -52.3 -27.87 25.65 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.7 -51.65 66.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -1.191 . . . . 0.0 109.51 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -77.01 -37.7 54.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.911 ' CE2' HG11 ' A' ' 78' ' ' VAL . 3.4 t80 -66.77 -53.3 34.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 109.753 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -60.29 -43.99 95.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.983 -1.073 . . . . 0.0 109.197 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.91 71.53 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.299 -0.876 . . . . 0.0 109.237 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.567 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -50.45 -53.32 30.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.416 -0.803 . . . . 0.0 108.94 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.515 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 6.0 t90 -54.98 -58.12 8.93 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -52.47 -16.31 0.86 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 110.396 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 2.4 m -70.59 179.11 2.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.885 -1.135 . . . . 0.0 110.207 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -90.4 -38.21 13.46 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.318 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.27 -48.28 68.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.183 -1.407 . . . . 0.0 109.463 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.817 HG22 ' CB ' ' A' ' 81' ' ' ALA . 3.3 t -62.37 -36.26 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.921 -1.112 . . . . 0.0 108.288 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -66.34 -31.99 73.11 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.079 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.1 t -66.02 -34.74 78.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.719 HD13 ' HG2' ' A' ' 80' ' ' MET . 40.6 mt -78.96 -18.3 53.98 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.486 HG23 ' HB1' ' A' ' 77' ' ' ALA . 7.7 t -79.49 -46.33 23.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.34 -38.87 85.56 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.3 -39.98 96.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 108.973 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.973 ' OE1' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -62.32 -62.65 1.61 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.912 . . . . 0.0 108.797 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.453 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 1.2 mt-10 -52.6 -30.61 32.11 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 5.2 mttt -72.57 -29.43 63.53 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.438 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -67.72 -54.67 17.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 109.236 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.15 86.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.663 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.39 -16.16 53.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.315 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 140' ' ' LYS . 6.3 m-20 -80.81 -45.09 17.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.983 -1.073 . . . . 0.0 109.014 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.737 HG21 ' CE1' ' A' ' 25' ' ' PHE . 23.3 m -99.32 -9.4 8.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.271 -0.893 . . . . 0.0 108.856 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 25.4 tt0 83.5 -39.63 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.658 -0.651 . . . . 0.0 109.537 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.764 HD13 ' CD2' ' A' ' 25' ' ' PHE . 13.4 tp 66.93 138.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.397 -0.815 . . . . 0.0 109.47 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -160.8 26.77 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.751 -1.218 . . . . 0.0 109.856 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 158.63 98.72 0.14 Allowed Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.171 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.863 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -89.72 138.95 27.79 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.579 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 32.6 Cg_endo -72.83 156.68 99.15 Favored 'Cis proline' 0 C--N 1.316 -1.147 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.865 2.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -151.79 117.18 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.939 -1.101 . . . . 0.0 108.385 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.819 ' CE ' HG22 ' A' ' 182' ' ' VAL . 4.8 tmm? -113.93 136.57 52.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.996 -1.065 . . . . 0.0 110.334 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 3.8 m-85 -123.92 135.81 53.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.476 -0.765 . . . . 0.0 109.208 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.607 HG22 HG22 ' A' ' 22' ' ' VAL . 92.2 t -100.65 131.94 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.94 . . . . 0.0 110.06 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.93 21.83 0.33 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.61 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.516 ' HA3' ' HB ' ' A' ' 16' ' ' VAL . . . 58.27 55.9 28.17 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -165.21 -35.64 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.191 -1.182 . . . . 0.0 108.379 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 154' ' ' PHE . 2.4 m-85 -111.52 120.42 42.06 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.019 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.516 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 12.8 tt0 -116.27 113.51 23.1 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.288 -0.883 . . . . 0.0 109.264 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 161' ' ' LEU . 8.6 mt -61.33 -179.6 0.17 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.36 -0.837 . . . . 0.0 108.847 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 24.2 m120 -137.35 150.19 68.0 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.026 -1.046 . . . . 0.0 109.459 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 162' ' ' ASN . 36.0 Cg_endo -78.74 8.12 3.89 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.672 2.248 . . . . 0.0 110.648 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.74 -22.65 0.84 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.71 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -89.8 8.94 78.84 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.96 1.56 26.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 0.0 109.596 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -124.87 33.12 5.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.145 -0.972 . . . . 0.0 109.577 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.622 HG23 ' H ' ' A' ' 170' ' ' ASN . 7.8 t -85.75 -8.34 58.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.072 -1.018 . . . . 0.0 109.826 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.14 26.78 13.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.118 -0.989 . . . . 0.0 109.382 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.622 ' H ' HG23 ' A' ' 168' ' ' THR . 0.8 OUTLIER -157.43 95.3 1.45 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.277 -0.89 . . . . 0.0 108.834 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -16.86 13.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.17 -0.956 . . . . 0.0 109.651 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 172' ' ' ASP . 0.6 OUTLIER -69.61 -45.37 68.69 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.1 t -68.86 -22.32 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 108.831 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.429 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 22.7 t80 -72.48 -36.8 68.53 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.23 -0.919 . . . . 0.0 108.576 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.551 HG22 ' CG1' ' A' ' 42' ' ' ILE . 44.0 t -75.75 -26.96 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 109.194 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -83.32 -52.99 6.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.218 -0.926 . . . . 0.0 108.951 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.453 ' O ' ' OG1' ' A' ' 181' ' ' THR . 0.4 OUTLIER -62.88 -33.03 74.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.492 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.429 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 31.6 t80 -75.66 -54.18 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.521 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.49 -24.42 65.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 109.412 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -77.91 -50.09 12.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.328 -0.857 . . . . 0.0 109.299 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.828 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -58.39 -28.58 65.32 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.197 -0.94 . . . . 0.0 109.001 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.819 HG22 ' CE ' ' A' ' 153' ' ' MET . 66.4 t -85.91 -34.63 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.32 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -60.5 -42.56 96.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 108.98 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.644 ' CE2' HD22 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -82.46 -44.03 16.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.297 -0.877 . . . . 0.0 108.999 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.828 HD23 ' O ' ' A' ' 181' ' ' THR . 3.9 mm? -53.68 -18.35 2.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.942 -1.099 . . . . 0.0 109.417 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.7 t -66.31 -26.06 67.13 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.859 -1.151 . . . . 0.0 108.328 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.51 -71.98 0.38 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.63 23.42 13.72 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.828 0.823 . . . . 0.0 109.607 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.291 -1.939 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.487 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.419 ' HB1' HE22 ' A' ' 8' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -136.06 66.45 1.5 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.345 -0.847 . . . . 0.0 109.447 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.591 ' HB3' ' CE1' ' A' ' 9' ' ' TYR . 1.9 m-85 50.18 80.08 0.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.355 -0.841 . . . . 0.0 109.39 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -101.55 56.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.99 . . . . 0.0 109.833 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 46.04 82.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.614 -0.679 . . . . 0.0 110.239 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 116.11 -20.45 12.8 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.267 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.52 -68.01 0.72 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.182 -1.187 . . . . 0.0 109.107 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 1.6 mp0 -97.53 6.2 48.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.375 -0.828 . . . . 0.0 109.606 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 8.3 p90 177.26 134.07 0.06 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.284 -0.885 . . . . 0.0 108.994 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -115.28 176.3 5.13 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.577 -0.702 . . . . 0.0 109.24 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.15 159.49 20.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.382 0.611 . . . . 0.0 109.612 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.582 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.5 OUTLIER -98.3 162.08 13.37 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.405 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.46 -0.23 36.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.147 -0.971 . . . . 0.0 109.141 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.34 113.29 1.02 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.374 -0.829 . . . . 0.0 109.12 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 34.7 Cg_endo -77.02 159.11 34.18 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.45 2.1 . . . . 0.0 110.849 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.587 ' O ' HG12 ' A' ' 16' ' ' VAL . 5.0 t -110.91 91.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.481 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.05 128.81 9.58 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.39 -21.9 41.77 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.765 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -40.46 160.67 0.12 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.986 . . . . 0.0 109.83 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.569 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.3 Cg_endo -79.22 128.83 8.38 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.726 2.284 . . . . 0.0 111.196 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.664 ' O ' HG22 ' A' ' 155' ' ' VAL . 16.3 mp0 -41.71 -25.37 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.498 -0.751 . . . . 0.0 109.861 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 22' ' ' VAL . 25.1 t -149.43 82.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.113 -0.992 . . . . 0.0 108.996 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.939 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.07 118.3 16.87 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -98.07 122.82 41.67 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.113 -0.992 . . . . 0.0 109.935 -179.066 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.094 ' CE2' HG21 ' A' ' 145' ' ' VAL . 9.1 m-85 -110.2 104.26 13.07 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -150.95 143.21 24.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.129 -0.982 . . . . 0.0 110.044 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.833 ' HB3' HG22 ' A' ' 61' ' ' VAL . 4.5 p -123.78 -167.65 1.66 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.66 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -110.18 53.57 0.69 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.582 ' CG ' HG11 ' A' ' 96' ' ' VAL . 9.1 m-85 -138.01 -1.94 1.93 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.831 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' CB ' ' HB3' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -108.49 164.79 13.97 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.571 -1.331 . . . . 0.0 109.405 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.506 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 32.0 Cg_endo -74.58 -32.56 5.96 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.35 2.033 . . . . 0.0 108.861 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -89.67 -19.11 25.24 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.038 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -52.96 -41.75 64.84 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.504 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 70.3 t80 -85.29 -39.03 18.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.305 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.516 ' O ' ' CG ' ' A' ' 40' ' ' LEU . 3.2 mt-30 -74.85 -24.4 58.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.986 -1.071 . . . . 0.0 110.429 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.63 ' HA ' HD12 ' A' ' 40' ' ' LEU . 25.7 t80 -76.41 -21.99 55.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.038 -1.039 . . . . 0.0 110.97 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.55 ' OE2' ' CE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -127.77 42.03 3.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.707 -1.245 . . . . 0.0 110.888 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 15.9 mm-40 -159.49 -68.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.174 -0.954 . . . . 0.0 109.899 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.02 -48.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 0.0 110.414 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.63 HD12 ' HA ' ' A' ' 36' ' ' PHE . 95.2 mt -54.03 -17.18 2.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.016 -1.052 . . . . 0.0 110.132 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.442 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 36.8 m80 45.91 30.85 0.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.081 -1.012 . . . . 0.0 109.281 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.716 ' O ' HG13 ' A' ' 46' ' ' VAL . 19.6 mt -79.3 -21.46 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.998 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.2 m -80.44 -21.06 42.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.982 -1.074 . . . . 0.0 110.512 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 41' ' ' HIS . 2.0 p-10 -87.06 -50.5 6.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.899 -1.126 . . . . 0.0 110.356 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 46' ' ' VAL . 45.2 p-10 -64.46 -26.22 68.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.193 -0.942 . . . . 0.0 110.533 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 42' ' ' ILE . 27.7 m -74.21 -24.66 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.987 -1.07 . . . . 0.0 109.976 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -73.65 -46.78 44.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.049 -1.032 . . . . 0.0 109.516 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.512 ' N ' ' HD3' ' A' ' 48' ' ' LYS . 24.3 mmtm -58.86 -16.78 18.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.211 -0.931 . . . . 0.0 109.067 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.499 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -101.83 22.66 12.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 109.946 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.873 ' O ' HG22 ' A' ' 54' ' ' VAL . 7.9 mt -124.06 66.09 39.81 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.007 -1.058 . . . . 0.0 110.706 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 37.2 Cg_endo -80.09 140.67 14.24 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.406 2.07 . . . . 0.0 110.13 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 51' ' ' PRO . 12.6 tm-20 61.87 132.88 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.386 -0.821 . . . . 0.0 108.822 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . 58.89 23.35 56.33 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 50' ' ' LEU . 2.0 t -60.33 80.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.752 -0.852 . . . . 0.0 109.374 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -125.77 91.94 3.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.131 -0.98 . . . . 0.0 110.264 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.41 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 7.1 ttt -103.72 98.31 8.2 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -93.35 134.5 35.5 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.057 -179.269 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 3.9 mtmt -109.8 108.98 19.5 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.448 -0.782 . . . . 0.0 109.487 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.584 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 2.7 m-85 -109.8 169.42 8.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.865 -1.147 . . . . 0.0 111.083 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.804 ' NE2' HD22 ' A' ' 72' ' ' LEU . 4.0 t60 -107.68 133.45 52.09 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.744 0.783 . . . . 0.0 108.995 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.128 HG11 ' CG1' ' A' ' 150' ' ' VAL . 3.2 m -71.98 157.4 6.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 O-C-N 121.738 -0.601 . . . . 0.0 109.536 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.414 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 2.9 p-10 -123.46 47.2 2.05 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 16.0 p90 -148.52 61.57 1.08 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.093 -1.004 . . . . 0.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.688 ' HE1' HG23 ' A' ' 61' ' ' VAL . 0.5 OUTLIER -133.13 38.0 3.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.288 -0.883 . . . . 0.0 109.051 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.49 -31.37 1.14 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.79 -35.83 3.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 -79.37 0.28 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.874 -1.368 . . . . 0.0 109.676 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.108 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -78.59 -19.18 53.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.974 -1.079 . . . . 0.0 109.197 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 1.108 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -58.73 -57.11 21.6 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.76 -49.04 74.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.286 -1.126 . . . . 0.0 108.048 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.648 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 49.9 t0 -59.94 -26.68 66.16 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.804 HD22 ' NE2' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -60.75 -36.24 78.41 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.412 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.585 HG23 ' OE1' ' A' ' 138' ' ' GLN . 31.5 m -67.0 -41.17 87.18 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 7.8 tp60 -61.73 -17.43 55.78 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.803 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -71.49 -45.1 63.42 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 20.0 t-105 -64.58 -31.84 73.22 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.175 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.565 ' HB2' HE21 ' A' ' 138' ' ' GLN . . . -77.88 -54.43 6.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.87 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.107 HG11 ' CE2' ' A' ' 122' ' ' TYR . 88.8 t -59.71 -26.18 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.151 -0.968 . . . . 0.0 109.964 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.521 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -83.55 -60.77 2.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 109.243 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.421 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -45.67 -28.87 1.09 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.171 -0.956 . . . . 0.0 108.53 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.938 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -72.57 -41.51 65.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.472 -0.768 . . . . 0.0 109.374 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.491 ' CB ' HG13 ' A' ' 84' ' ' VAL . 20.9 mt -101.51 9.41 41.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -0.962 . . . . 0.0 110.381 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.76 24.23 7.77 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.618 HG11 HG12 ' A' ' 117' ' ' ILE . 33.2 m -87.29 -9.2 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.427 -1.043 . . . . 0.0 110.759 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.46 ' O ' ' HB ' ' A' ' 89' ' ' THR . 2.8 pt-20 -42.08 -58.76 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.047 -1.033 . . . . 0.0 110.015 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.6 -33.75 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.237 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.905 ' HE2' ' HB1' ' A' ' 115' ' ' ALA . 36.5 mtpt -83.6 -50.47 8.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.339 -0.851 . . . . 0.0 111.425 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.897 HG23 HD12 ' A' ' 92' ' ' LEU . 1.3 m -83.25 -7.51 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.786 -1.196 . . . . 0.0 110.784 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.675 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.31 -44.38 45.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.703 -1.248 . . . . 0.0 108.728 179.034 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.428 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -53.49 -52.76 63.77 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.542 -1.349 . . . . 0.0 110.555 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.572 ' HB2' HG13 ' A' ' 111' ' ' VAL . 25.3 Cg_endo -73.7 -18.47 22.22 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 N-CA-C 109.877 -0.855 . . . . 0.0 109.877 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.909 ' HG ' HG11 ' A' ' 111' ' ' VAL . 21.8 mt -87.07 -43.59 12.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 108.863 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.675 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.4 m-30 -65.57 -45.77 81.99 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.008 -1.058 . . . . 0.0 108.984 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -73.44 -20.73 60.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.065 -1.022 . . . . 0.0 109.08 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.58 -36.29 62.44 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.582 HG11 ' CG ' ' A' ' 29' ' ' PHE . 1.5 t -102.09 -0.49 10.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.087 -1.243 . . . . 0.0 109.409 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.493 ' OE1' ' HB3' ' A' ' 93' ' ' PHE . 16.4 mt-30 -97.91 1.53 48.16 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 120.915 -1.116 . . . . 0.0 110.557 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 175.79 81.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.744 -1.222 . . . . 0.0 109.582 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.904 HG22 ' H ' ' A' ' 101' ' ' THR . 1.2 m 157.71 -43.85 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.9 OUTLIER 69.09 16.26 8.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.867 -1.146 . . . . 0.0 110.735 178.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.904 ' H ' HG22 ' A' ' 99' ' ' THR . 5.3 t -79.3 -7.61 58.44 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.566 ' CB ' HG22 ' A' ' 96' ' ' VAL . 12.6 mm -87.62 61.93 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -127.58 32.18 5.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.967 . . . . 0.0 109.48 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 107' ' ' ASP . 4.8 p -153.02 128.11 9.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.002 -1.061 . . . . 0.0 110.075 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.745 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.55 -31.03 9.5 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -34.14 74.72 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -68.51 -51.11 46.74 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 105' ' ' ALA . 27.9 mt -48.16 -29.9 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 0.0 108.684 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -76.86 -39.9 49.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 109.419 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -57.34 -41.18 79.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.405 -0.809 . . . . 0.0 109.646 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.909 HG11 ' HG ' ' A' ' 92' ' ' LEU . 19.9 t -73.88 -38.45 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.173 -0.954 . . . . 0.0 109.569 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CD2' ' HD2' ' A' ' 122' ' ' TYR . 2.6 m-85 -64.52 -39.01 92.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.052 -1.03 . . . . 0.0 109.121 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.4 mt -75.11 -22.38 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.342 -0.849 . . . . 0.0 109.548 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -16.98 62.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.315 -0.866 . . . . 0.0 109.876 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.905 ' HB1' ' HE2' ' A' ' 87' ' ' LYS . . . -91.04 6.4 45.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.725 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.68 2.56 75.6 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.801 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.4 mp -86.27 63.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -1.102 . . . . 0.0 109.074 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -31.75 149.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.199 -0.938 . . . . 0.0 110.859 -179.218 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.42 -32.92 58.14 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.03 -46.26 82.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.999 -1.295 . . . . 0.0 109.195 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -73.01 -43.72 61.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 1.107 ' CE2' HG11 ' A' ' 78' ' ' VAL . 4.3 t80 -57.99 -45.59 86.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.613 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -64.3 -37.8 88.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.147 -0.97 . . . . 0.0 108.979 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.03 -50.35 72.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.151 -0.968 . . . . 0.0 108.878 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.51 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -52.0 -49.3 63.58 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.453 ' C ' ' CD1' ' A' ' 126' ' ' TRP . 3.5 t90 -58.22 -59.65 4.99 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -15.35 6.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.633 -0.667 . . . . 0.0 110.253 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.478 ' OG ' HG23 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -69.6 172.93 6.63 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.056 -1.028 . . . . 0.0 110.086 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -89.5 -40.14 12.86 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.39 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.6 t -63.13 -46.15 96.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.105 -1.438 . . . . 0.0 109.341 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.938 HG22 ' HB1' ' A' ' 81' ' ' ALA . 2.1 t -69.58 -33.79 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.975 -1.078 . . . . 0.0 108.369 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 128' ' ' SER . 19.2 ttpt -63.64 -37.99 89.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.5 p -69.37 -32.42 71.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.415 -0.803 . . . . 0.0 108.91 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -19.18 49.69 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.903 . . . . 0.0 108.781 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.515 HG23 ' HB1' ' A' ' 77' ' ' ALA . 3.0 t -78.68 -48.77 21.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -62.33 -38.9 91.27 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -35.8 82.22 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.4 -0.813 . . . . 0.0 109.29 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.585 ' OE1' HG23 ' A' ' 73' ' ' THR . 3.7 mt-30 -67.55 -66.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 109.185 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.33 -37.61 17.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.185 -0.947 . . . . 0.0 108.66 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 9.3 mttm -71.53 -33.57 69.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.367 -0.833 . . . . 0.0 108.85 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.503 ' CB ' ' CD2' ' A' ' 59' ' ' TYR . . . -56.64 -62.22 1.88 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 109.128 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -69.09 -26.24 64.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.599 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 140' ' ' LYS . . . -76.09 -26.01 56.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.887 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.752 ' OD1' HG13 ' A' ' 145' ' ' VAL . 0.6 OUTLIER -80.88 -49.92 10.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.993 . . . . 0.0 108.478 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 1.094 HG21 ' CE2' ' A' ' 25' ' ' PHE . 19.7 m -84.75 -13.27 11.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 2.7 mt-30 80.89 -47.14 0.26 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.682 . . . . 0.0 109.875 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.525 HD21 ' CG1' ' A' ' 61' ' ' VAL . 24.4 tp 65.06 137.9 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.7 ttt85 -160.5 27.74 0.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.457 -1.402 . . . . 0.0 110.161 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.97 106.47 0.2 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.314 -1.422 . . . . 0.0 110.619 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 1.128 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -83.13 144.46 47.23 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.41 -1.053 . . . . 0.0 108.934 178.635 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.48 151.73 89.64 Favored 'Cis proline' 0 C--N 1.315 -1.224 0 C-N-CA 124.176 -1.177 . . . . 0.0 110.854 0.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.797 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -127.84 153.12 46.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.41 -1.431 . . . . 0.0 109.103 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -148.11 130.07 15.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.899 -1.126 . . . . 0.0 110.424 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.607 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 24.5 m-85 -126.22 129.17 48.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.53 -0.731 . . . . 0.0 109.698 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 21' ' ' GLN . 14.8 t -96.77 131.13 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 0.0 109.607 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.765 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 5.7 t30 43.16 23.73 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.471 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.549 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.87 58.11 16.19 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.482 ' HE3' ' CE2' ' A' ' 159' ' ' TYR . 32.6 ttpt -166.27 -35.67 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.588 ' CD2' ' HE3' ' A' ' 188' ' ' LYS . 50.3 m-85 -119.6 120.93 38.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.892 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.607 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -119.42 120.55 37.19 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.171 -0.956 . . . . 0.0 109.714 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 9' ' ' TYR . 69.8 mt -61.85 175.38 0.67 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -149.86 114.5 3.44 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.947 -1.095 . . . . 0.0 109.384 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.62 26.21 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 122.598 2.199 . . . . 0.0 111.351 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -91.85 -13.65 31.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.891 -1.13 . . . . 0.0 109.355 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.67 20.33 42.46 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 8.9 ttp -81.46 49.73 1.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.192 -1.181 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -99.74 17.84 19.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.193 -0.942 . . . . 0.0 109.566 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 169' ' ' SER . 14.9 t -89.26 1.9 55.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -0.95 . . . . 0.0 109.625 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' A' ' 170' ' ' ASN . 0.5 OUTLIER 44.41 43.66 6.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.41 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 169' ' ' SER . 1.8 m120 -155.83 94.06 1.52 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.287 -0.883 . . . . 0.0 109.304 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 14.3 mtt -58.76 -15.74 13.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.602 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.75 -49.17 66.81 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.37 -29.16 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.033 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -68.25 -31.38 70.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.113 -0.992 . . . . 0.0 108.85 179.656 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.417 HG22 HD11 ' A' ' 42' ' ' ILE . 53.3 t -79.28 -29.29 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.552 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -82.97 -53.02 6.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.001 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.46 ' O ' ' OG1' ' A' ' 181' ' ' THR . 1.0 OUTLIER -62.34 -47.27 84.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.458 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.604 ' O ' HG23 ' A' ' 182' ' ' VAL . 4.2 t80 -61.83 -49.68 75.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.01 -34.69 68.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.102 -0.999 . . . . 0.0 108.998 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -73.77 -38.73 64.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.423 -0.798 . . . . 0.0 109.182 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.662 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -59.01 -29.68 67.43 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 178' ' ' TYR . 2.5 t -83.95 -36.41 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.973 . . . . 0.0 109.28 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.477 ' HB2' ' CG ' ' A' ' 49' ' ' LYS . 16.9 tttt -60.77 -46.49 90.25 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.173 -0.955 . . . . 0.0 108.915 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.567 ' CD2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -81.63 -30.91 32.63 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.366 -0.834 . . . . 0.0 109.371 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.723 HD13 ' HE2' ' A' ' 188' ' ' LYS . 0.4 OUTLIER -61.01 -20.93 63.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.825 -1.172 . . . . 0.0 108.775 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.635 ' HB3' HD23 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -80.79 -4.57 55.06 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.98 -1.075 . . . . 0.0 108.471 178.243 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.66 -76.52 0.61 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 108.867 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.723 ' HE2' HD13 ' A' ' 185' ' ' LEU . 1.0 OUTLIER 63.75 28.38 14.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.523 -0.736 . . . . 0.0 110.113 179.492 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 188' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.902 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.573 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -109.38 57.96 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 109.428 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER 166.84 86.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.517 -0.74 . . . . 0.0 109.262 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -99.63 58.2 1.04 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.07 -1.019 . . . . 0.0 110.011 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 t0 48.98 85.26 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.44 -0.788 . . . . 0.0 110.04 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 114.92 -21.91 13.13 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -81.27 -67.25 0.8 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -1.196 . . . . 0.0 108.696 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 3' ' ' TYR . 15.7 mp0 -99.09 7.83 45.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.252 -0.905 . . . . 0.0 109.611 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.669 ' CB ' HD23 ' A' ' 161' ' ' LEU . 4.4 p90 176.54 134.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 108.975 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.471 HG23 ' CG ' ' A' ' 160' ' ' GLN . 9.3 t -114.43 177.68 4.55 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.585 -0.697 . . . . 0.0 109.328 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.502 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 0.4 OUTLIER -88.41 160.67 17.46 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.542 0.686 . . . . 0.0 110.42 -179.151 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.452 ' HG ' ' HB3' ' A' ' 160' ' ' GLN . 7.4 mt -98.41 161.74 13.53 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.562 -0.711 . . . . 0.0 109.127 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.416 ' C ' ' HG2' ' A' ' 14' ' ' LYS . 5.0 pm0 -115.6 -3.98 12.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 109.611 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 13' ' ' GLU . 3.7 mmtp -139.89 75.11 30.88 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.18 -0.95 . . . . 0.0 109.617 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 157' ' ' GLY . 35.3 Cg_endo -77.99 159.62 30.6 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.561 2.174 . . . . 0.0 110.576 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.862 HG21 ' HB3' ' A' ' 144' ' ' ASP . 1.7 t -134.36 129.74 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.369 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.52 126.57 15.66 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 74.65 6.45 77.19 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.933 ' HB1' ' HD2' ' A' ' 20' ' ' PRO . . . -42.57 172.45 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.498 -1.001 . . . . 0.0 110.277 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.933 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 30.8 Cg_endo -71.52 111.94 3.24 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.919 2.412 . . . . 0.0 111.74 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.665 ' O ' HG22 ' A' ' 155' ' ' VAL . 27.0 mm-40 -52.85 -22.35 5.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.557 -0.715 . . . . 0.0 109.597 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.683 ' O ' HG12 ' A' ' 22' ' ' VAL . 10.5 t -156.62 79.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.655 HD12 ' HG3' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -81.7 138.48 35.24 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.586 ' H ' HD23 ' A' ' 23' ' ' LEU . 10.5 tt0 -132.85 103.1 5.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.047 -1.033 . . . . 0.0 109.789 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.912 ' HE2' HG21 ' A' ' 145' ' ' VAL . 58.4 m-85 -86.01 126.4 34.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.179 -0.951 . . . . 0.0 109.031 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.4 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 2.6 p90 -157.14 133.15 9.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.231 -0.918 . . . . 0.0 109.791 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.7 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 70.1 m -104.33 -174.37 2.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.413 -0.805 . . . . 0.0 109.827 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.558 ' O ' ' CD1' ' A' ' 29' ' ' PHE . 16.0 m-30 -104.53 48.46 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.665 ' CG ' HG11 ' A' ' 96' ' ' VAL . 16.6 m-85 -146.91 14.32 1.17 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 110.338 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -104.51 162.5 19.65 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.675 -1.266 . . . . 0.0 109.67 -179.768 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.96 -36.14 2.76 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.212 1.941 . . . . 0.0 108.388 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' A' ' 36' ' ' PHE . 4.4 m-70 -82.98 -22.32 33.71 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 16.2 t -47.06 -52.95 13.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.514 ' CZ ' ' OE2' ' A' ' 38' ' ' GLU . 11.3 t80 -75.18 -40.66 59.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.794 -0.566 . . . . 0.0 110.403 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -72.38 -16.92 61.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.057 -1.027 . . . . 0.0 110.417 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' HIS . 1.8 m-85 -82.58 -29.62 30.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.02 -1.05 . . . . 0.0 110.443 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.74 22.7 13.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.955 -1.09 . . . . 0.0 109.629 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.514 ' OE2' ' CZ ' ' A' ' 34' ' ' TYR . 5.5 mm-40 -132.09 -61.09 0.89 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 111.092 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.2 t -90.61 -75.56 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.899 -1.126 . . . . 0.0 111.708 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 0.7 OUTLIER -70.75 -24.39 62.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.954 -1.091 . . . . 0.0 110.679 -178.089 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 44' ' ' ASP . 94.9 m-70 60.67 32.71 20.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.058 -1.026 . . . . 0.0 108.965 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' A' ' 41' ' ' HIS . 13.5 mm -42.22 -26.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.419 -0.8 . . . . 0.0 109.921 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 41' ' ' HIS . 0.9 OUTLIER -81.4 -43.39 19.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.92 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 41' ' ' HIS . 84.1 m-20 -85.39 -36.59 20.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.952 . . . . 0.0 109.894 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -65.04 -38.64 91.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 109.556 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 43' ' ' SER . 9.8 p -68.54 -26.46 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.736 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -61.64 -39.23 90.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.476 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -51.17 -24.45 4.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.169 -0.957 . . . . 0.0 108.734 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.867 ' O ' HD23 ' A' ' 50' ' ' LEU . 17.6 mmtm -91.05 25.04 2.58 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.517 -0.739 . . . . 0.0 109.423 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.867 HD23 ' O ' ' A' ' 49' ' ' LYS . 14.2 mt -125.22 67.3 54.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.175 -0.953 . . . . 0.0 110.104 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 36.6 Cg_endo -79.39 75.35 5.11 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.542 2.161 . . . . 0.0 110.937 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 51' ' ' PRO . 6.0 tm-20 58.82 131.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.395 0.617 . . . . 0.0 110.2 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.08 -11.63 60.44 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.814 ' CG1' HD22 ' A' ' 50' ' ' LEU . 1.1 t -114.61 98.43 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -1.185 . . . . 0.0 109.142 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -86.09 102.95 14.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.909 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.513 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 8.7 ttt -99.02 102.88 14.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.428 -0.795 . . . . 0.0 109.606 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.0 m -99.1 126.48 44.85 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.265 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 113.83 27.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.458 -0.777 . . . . 0.0 109.382 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.552 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.8 m-85 -115.33 163.75 15.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.029 -1.045 . . . . 0.0 111.404 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.818 ' CE1' HD21 ' A' ' 72' ' ' LEU . 2.6 t-80 -117.28 122.16 43.18 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.13 HG11 ' CD2' ' A' ' 147' ' ' LEU . 16.8 m -101.88 156.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 110.384 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 1.1 p-10 -83.92 42.65 0.87 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.402 -0.811 . . . . 0.0 109.536 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.609 ' CD1' ' CG2' ' A' ' 61' ' ' VAL . 3.7 m-85 -91.56 30.96 1.23 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.0 110.023 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.438 ' SD ' ' HB3' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -161.74 45.93 0.17 Allowed 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.65 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 161.73 60.03 0.02 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.507 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.52 -35.72 0.13 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 65' ' ' GLY . 92.3 m-20 -88.94 -78.64 0.34 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -1.173 . . . . 0.0 110.129 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.929 HD23 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -82.27 -21.62 36.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.769 -1.207 . . . . 0.0 110.088 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.732 ' N ' HD22 ' A' ' 68' ' ' LEU . . . -51.97 -39.93 49.63 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 2.9 ttmt -61.05 -41.58 96.87 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.473 ' OD1' ' NE2' ' A' ' 74' ' ' GLN . 0.6 OUTLIER -70.79 -29.54 65.75 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.145 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.818 HD21 ' CE1' ' A' ' 60' ' ' HIS . 13.9 tp -58.17 -50.77 72.38 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -56.64 -43.2 80.05 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.82 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -54.92 -27.17 41.24 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.828 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.51 -46.36 86.44 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 29.7 t-105 -53.97 -31.98 52.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.504 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -81.99 -66.31 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.408 -0.808 . . . . 0.0 110.012 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 74' ' ' GLN . 2.2 t -47.55 -30.68 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.214 -0.929 . . . . 0.0 110.047 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.439 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.5 -63.48 1.41 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.824 -1.173 . . . . 0.0 109.188 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.416 ' C ' ' O ' ' A' ' 79' ' ' ALA . 21.7 mtp -46.21 -27.12 0.91 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.594 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.647 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -67.8 -46.86 70.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 109.591 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.8 mt -99.62 7.24 45.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.63 31.18 60.18 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 26.9 m -97.35 8.21 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.448 -1.031 . . . . 0.0 110.144 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.475 ' HG2' ' OG1' ' A' ' 89' ' ' THR . 2.3 tt0 -52.76 -70.56 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.086 -1.009 . . . . 0.0 109.722 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -38.89 -33.78 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 0.0 110.282 -179.627 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.6 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 25.1 mtpp -80.91 -52.5 7.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.377 -0.827 . . . . 0.0 110.995 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.688 HG23 HD12 ' A' ' 92' ' ' LEU . 1.3 m -86.12 -13.89 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.684 -1.26 . . . . 0.0 110.803 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.77 HG23 ' CE1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -73.68 -42.39 61.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.646 -1.284 . . . . 0.0 108.206 178.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.403 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 2.1 t -54.22 -54.67 45.21 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.63 -1.294 . . . . 0.0 110.353 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.507 ' HB2' HG13 ' A' ' 111' ' ' VAL . 25.9 Cg_endo -72.82 -21.1 21.79 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 N-CA-C 109.758 -0.901 . . . . 0.0 109.758 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.688 HD12 HG23 ' A' ' 88' ' ' VAL . 15.6 mt -81.09 -44.64 17.67 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.77 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.6 m-30 -64.03 -44.87 91.21 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.107 -0.995 . . . . 0.0 108.62 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -72.97 -24.33 60.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.297 -0.877 . . . . 0.0 109.321 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.901 ' O ' HG23 ' A' ' 99' ' ' THR . . . -69.03 -36.09 80.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.665 HG11 ' CG ' ' A' ' 29' ' ' PHE . 2.2 t -98.95 -1.57 10.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.225 -1.162 . . . . 0.0 108.768 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.47 ' HG3' ' HB2' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -110.26 6.27 22.41 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 121.022 -1.048 . . . . 0.0 111.323 -179.092 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.754 ' C ' HG22 ' A' ' 99' ' ' THR . 1.5 ttmm -164.57 52.2 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.476 -1.39 . . . . 0.0 109.402 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.901 HG23 ' O ' ' A' ' 95' ' ' GLY . 0.5 OUTLIER 175.15 -51.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.361 -0.837 . . . . 0.0 109.847 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.534 ' O ' ' CD ' ' A' ' 103' ' ' ARG . 1.1 mt-30 75.05 10.95 3.66 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.042 -1.036 . . . . 0.0 109.886 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.1 t -84.32 -8.33 59.04 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.608 0.718 . . . . 0.0 109.319 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.468 HG13 ' C ' ' A' ' 95' ' ' GLY . 10.2 mm -74.14 75.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.56 -0.712 . . . . 0.0 109.544 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.534 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -136.65 31.42 2.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.84 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.533 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 7.3 p -146.91 128.45 15.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.064 -1.022 . . . . 0.0 109.716 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.54 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -52.82 -30.17 31.94 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.6 t -65.83 -29.03 69.43 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 104' ' ' SER . 61.6 m-20 -77.21 -39.5 48.45 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.396 -0.922 . . . . 0.0 108.678 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.929 HD11 HD23 ' A' ' 68' ' ' LEU . 44.4 mt -59.51 -29.82 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.29 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 4.6 mtm180 -78.03 -32.07 50.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.528 -0.733 . . . . 0.0 109.275 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.4 OUTLIER -61.47 -48.02 83.02 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.246 -0.909 . . . . 0.0 109.2 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.635 HG11 ' HG ' ' A' ' 92' ' ' LEU . 53.1 t -68.39 -40.37 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.915 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.579 ' CD1' HG11 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -56.78 -37.59 71.32 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.242 -0.912 . . . . 0.0 109.28 179.442 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.8 mt -76.16 -24.79 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -0.805 . . . . 0.0 109.869 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -64.47 -18.78 65.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.027 -1.046 . . . . 0.0 109.371 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.6 ' HB1' ' HE3' ' A' ' 87' ' ' LYS . . . -94.33 6.42 48.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.534 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.96 -1.48 77.94 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.732 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -78.74 57.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -1.118 . . . . 0.0 109.442 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 117' ' ' ILE . 2.2 mttt -37.73 153.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.882 . . . . 0.0 110.134 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.99 -38.01 73.47 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.431 ' HG3' ' HB2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -50.43 -49.18 55.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.945 -1.326 . . . . 0.0 109.571 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.22 -48.79 12.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 110.335 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.807 ' CE2' HG11 ' A' ' 78' ' ' VAL . 4.1 t80 -58.28 -52.3 66.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.017 -1.052 . . . . 0.0 109.622 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -62.0 -41.13 97.72 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.33 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.58 -50.4 73.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.102 -0.999 . . . . 0.0 108.928 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 128' ' ' SER . . . -55.28 -46.71 76.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 108.886 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.729 ' HA ' HG11 ' A' ' 131' ' ' VAL . 4.7 t90 -57.55 -57.08 14.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.231 -0.918 . . . . 0.0 108.53 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -60.7 -15.54 30.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.5 -0.75 . . . . 0.0 109.553 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 63.1 m -76.13 -172.93 2.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.141 -0.975 . . . . 0.0 109.83 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -95.55 -28.3 14.93 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.906 -0.496 . . . . 0.0 111.061 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.14 -41.88 93.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.405 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.729 HG11 ' HA ' ' A' ' 126' ' ' TRP . 49.9 t -70.86 -36.65 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 120.995 -1.066 . . . . 0.0 108.487 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -67.4 -27.46 67.1 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.23 -37.68 69.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 138' ' ' GLN . 0.5 OUTLIER -79.45 -22.19 44.48 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.504 HG23 ' CB ' ' A' ' 77' ' ' ALA . 17.1 t -79.12 -40.96 22.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.511 ' O ' ' CG ' ' A' ' 140' ' ' LYS . . . -68.01 -48.55 65.39 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.495 -0.753 . . . . 0.0 109.038 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.488 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -61.29 -32.69 72.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.233 -0.917 . . . . 0.0 108.751 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.552 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 4.4 tm0? -66.06 -69.76 0.28 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.827 . . . . 0.0 109.093 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' GLN . 0.0 OUTLIER -46.87 -32.67 3.92 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -70.28 -35.05 73.48 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.673 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -57.05 -50.3 73.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -70.25 -33.17 71.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.433 -0.792 . . . . 0.0 109.8 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.25 -18.21 55.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 110.042 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.862 ' HB3' HG21 ' A' ' 16' ' ' VAL . 67.4 m-20 -82.84 -43.48 16.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.048 -1.032 . . . . 0.0 108.36 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.912 HG21 ' HE2' ' A' ' 25' ' ' PHE . 27.5 m -98.61 -12.65 8.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.2 OUTLIER 83.61 -40.9 0.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.69 -0.631 . . . . 0.0 109.564 -179.507 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.13 ' CD2' HG11 ' A' ' 61' ' ' VAL . 10.7 tp 67.85 134.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 0.0 109.329 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -144.29 11.45 1.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.557 -1.339 . . . . 0.0 110.746 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.31 93.74 0.1 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.678 -1.725 . . . . 0.0 111.575 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 1.003 HG11 HG21 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -81.64 139.45 47.38 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 150' ' ' VAL . 32.4 Cg_endo -72.23 156.32 98.25 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 124.198 -1.168 . . . . 0.0 112.101 2.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.72 152.07 21.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.059 -1.025 . . . . 0.0 108.259 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.518 ' O ' ' CD1' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -131.69 137.83 48.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.928 -1.108 . . . . 0.0 110.195 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 153' ' ' MET . 14.0 m-85 -133.32 136.23 45.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.399 -0.813 . . . . 0.0 109.524 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 21' ' ' GLN . 12.1 t -110.78 119.59 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.046 -1.034 . . . . 0.0 108.352 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 20' ' ' PRO . 1.7 m-20 53.29 27.31 6.0 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 15' ' ' PRO . . . 50.18 21.66 4.29 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.232 -1.461 . . . . 0.0 109.614 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -118.79 -21.02 8.0 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.756 -1.438 . . . . 0.0 108.721 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.446 ' N ' HD12 ' A' ' 12' ' ' LEU . 17.9 m-85 -134.87 123.93 24.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 109.291 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 11' ' ' THR . 25.4 pt20 -116.93 117.42 29.64 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.268 -0.895 . . . . 0.0 109.59 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.669 HD23 ' CB ' ' A' ' 9' ' ' TYR . 11.6 mt -60.83 179.47 0.17 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.502 -0.749 . . . . 0.0 108.98 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -155.17 117.92 2.43 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.037 -1.039 . . . . 0.0 109.529 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.01 -23.43 9.22 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.328 2.019 . . . . 0.0 110.635 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.447 ' HB3' ' HG2' ' A' ' 166' ' ' MET . 2.5 tt0 61.23 20.62 11.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -0.938 . . . . 0.0 109.609 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 46.22 39.06 9.21 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.447 ' HG2' ' HB3' ' A' ' 164' ' ' GLN . 4.4 mmt -92.63 -95.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.12 -1.224 . . . . 0.0 109.39 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 166' ' ' MET . 22.0 t70 43.65 30.58 0.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.111 -0.993 . . . . 0.0 109.556 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 169' ' ' SER . 69.3 p -70.42 -72.45 0.2 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 109.769 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.429 ' N ' ' OG1' ' A' ' 168' ' ' THR . 0.5 OUTLIER -136.78 59.07 1.7 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.507 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.82 59.19 0.37 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.631 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.433 ' O ' HG23 ' A' ' 175' ' ' VAL . 5.7 mmm -74.9 -16.57 60.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 109.479 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -78.53 -56.56 4.34 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 6.9 t -64.09 -28.49 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 108.939 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.437 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 48.7 t80 -69.18 -43.16 74.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 0.0 109.229 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 171' ' ' MET . 61.3 t -70.05 -27.35 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.181 -0.949 . . . . 0.0 109.478 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -83.95 -58.71 2.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 109.251 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.532 ' CG ' ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -56.94 -41.73 78.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.397 -0.815 . . . . 0.0 109.197 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.647 ' O ' HG23 ' A' ' 182' ' ' VAL . 69.2 t80 -65.54 -51.85 56.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.067 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.17 -25.28 67.68 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.241 -0.912 . . . . 0.0 109.26 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.28 -45.07 20.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.899 . . . . 0.0 109.348 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.72 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -57.0 -42.32 80.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.221 -0.924 . . . . 0.0 109.14 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 178' ' ' TYR . 2.4 t -74.49 -36.55 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 109.135 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -57.55 -50.11 74.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.19 -0.944 . . . . 0.0 109.102 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -31.46 55.66 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.235 -0.916 . . . . 0.0 109.086 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.72 HD23 ' O ' ' A' ' 181' ' ' THR . 0.4 OUTLIER -58.24 -21.3 47.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.841 -1.162 . . . . 0.0 109.171 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.573 ' HB2' HG22 ' A' ' 54' ' ' VAL . 87.2 p -74.39 -4.77 38.45 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.817 -1.177 . . . . 0.0 108.691 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.43 10.68 19.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.418 -0.802 . . . . 0.0 109.267 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.443 ' HE2' ' HB2' ' A' ' 156' ' ' ASN . 0.6 OUTLIER -76.28 0.35 19.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.336 -179.314 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.004 -1.06 . . . . 0.0 109.55 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.57 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -111.36 58.62 0.62 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 109.58 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER 174.05 91.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.2 58.41 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.79 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.0 t0 50.5 84.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.574 -0.704 . . . . 0.0 110.271 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 112.89 -19.73 20.65 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -66.62 0.86 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.057 -1.26 . . . . 0.0 108.684 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 3' ' ' TYR . 40.6 mm-40 -102.62 10.61 38.62 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.321 -0.862 . . . . 0.0 109.678 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.537 ' HB2' HD23 ' A' ' 161' ' ' LEU . 6.9 p90 179.1 136.09 0.09 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.07 -1.019 . . . . 0.0 109.426 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.495 HG23 ' CG ' ' A' ' 160' ' ' GLN . 2.3 t -123.55 171.9 9.17 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.5 m -120.97 149.69 42.27 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.514 0.673 . . . . 0.0 110.199 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 158' ' ' LYS . 1.3 mp -98.18 157.45 16.15 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.572 -0.705 . . . . 0.0 109.21 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.513 ' HG2' ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -84.7 -25.64 28.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 109.192 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.513 ' N ' ' HG2' ' A' ' 13' ' ' GLU . 7.4 mttp -116.24 96.44 47.51 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.359 -0.838 . . . . 0.0 109.046 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 34.3 Cg_endo -76.74 159.95 34.7 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.337 2.025 . . . . 0.0 110.481 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.73 HG21 ' HB3' ' A' ' 144' ' ' ASP . 11.7 t -108.73 90.52 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.885 . . . . 0.0 109.762 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.96 131.5 12.12 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 95.18 -24.49 28.6 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.719 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -41.2 160.62 0.14 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.404 -1.056 . . . . 0.0 109.471 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.572 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.0 Cg_endo -78.13 129.26 9.55 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.563 2.175 . . . . 0.0 111.015 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.649 ' O ' HG22 ' A' ' 155' ' ' VAL . 2.5 mp0 -46.68 -20.69 0.14 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.771 ' O ' HG12 ' A' ' 22' ' ' VAL . 3.1 t -148.35 79.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.873 -1.142 . . . . 0.0 108.73 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.761 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -73.76 127.47 32.9 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.5 ' HB3' ' HA ' ' A' ' 58' ' ' LYS . 33.2 tt0 -114.64 118.08 32.65 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.99 -1.068 . . . . 0.0 109.564 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.785 ' CD2' HD13 ' A' ' 147' ' ' LEU . 7.5 m-85 -103.76 112.5 25.47 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.586 -0.696 . . . . 0.0 109.274 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -155.19 142.28 19.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.998 -1.064 . . . . 0.0 110.14 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.807 ' HB3' HG22 ' A' ' 61' ' ' VAL . 4.3 p -124.55 -168.63 1.84 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.627 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -116.47 52.54 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.857 -1.152 . . . . 0.0 108.036 178.613 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.763 ' CD1' HG11 ' A' ' 96' ' ' VAL . 7.6 m-85 -139.97 10.62 2.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.222 -0.924 . . . . 0.0 110.236 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.717 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 4.0 m -117.06 179.88 0.74 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.753 -1.217 . . . . 0.0 108.484 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.3 Cg_endo -76.02 -59.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.593 1.529 . . . . 0.0 110.169 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -69.4 -11.46 60.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.955 -1.09 . . . . 0.0 108.4 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 27' ' ' SER . 1.2 m -57.15 -37.93 72.78 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.584 ' CE1' ' HG3' ' A' ' 38' ' ' GLU . 18.6 t80 -81.22 -41.91 21.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.758 -0.589 . . . . 0.0 109.791 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.492 ' N ' ' OE1' ' A' ' 35' ' ' GLN . 11.7 mp0 -78.56 -21.26 48.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.945 . . . . 0.0 110.681 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.77 ' CE2' HG21 ' A' ' 42' ' ' ILE . 27.0 t80 -75.52 -18.03 59.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 0.0 110.521 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 2.2 mm-40 -128.28 32.34 4.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.928 -1.107 . . . . 0.0 110.419 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.584 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 4.5 mm-40 -145.18 -67.89 0.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.977 -1.077 . . . . 0.0 109.797 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.46 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 13.2 t -97.1 -56.79 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.057 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.496 ' HB3' HG13 ' A' ' 42' ' ' ILE . 61.2 mt -43.49 -27.9 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.118 -0.989 . . . . 0.0 109.93 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' A' ' 38' ' ' GLU . 29.7 m170 49.37 24.28 1.03 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.044 -1.035 . . . . 0.0 109.027 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.77 HG21 ' CE2' ' A' ' 36' ' ' PHE . 12.2 mt -59.51 -32.8 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.42 -0.8 . . . . 0.0 109.64 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -45.09 24.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.051 -1.031 . . . . 0.0 110.006 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -81.16 -36.45 30.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.921 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 41' ' ' HIS . 6.2 t-20 -67.47 -30.34 70.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.947 . . . . 0.0 109.907 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 42' ' ' ILE . 43.5 t -74.5 -17.65 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.182 -0.949 . . . . 0.0 109.523 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.689 ' HA ' HD12 ' A' ' 50' ' ' LEU . 25.9 mttm -75.9 -34.39 59.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.451 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -57.7 -18.96 23.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.922 . . . . 0.0 109.583 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.81 17.76 14.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.439 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.689 HD12 ' HA ' ' A' ' 47' ' ' LYS . 11.9 mt -93.62 118.65 67.51 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.751 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.32 151.99 30.18 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.301 2.001 . . . . 0.0 108.954 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.493 ' O ' ' CG ' ' A' ' 52' ' ' GLU . 11.0 tt0 -71.09 42.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.497 -1.377 . . . . 0.0 110.882 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.514 ' O ' ' CG2' ' A' ' 54' ' ' VAL . . . -140.77 37.29 1.68 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.581 HG13 ' HB3' ' A' ' 21' ' ' GLN . 21.4 t -159.43 128.5 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.554 -0.968 . . . . 0.0 109.035 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.511 ' N ' ' OE1' ' A' ' 21' ' ' GLN . 3.6 ttpp -100.01 112.29 24.58 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.828 0.823 . . . . 0.0 110.013 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.0 ttt -93.02 99.29 11.94 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 2.5 m -92.45 143.14 26.66 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.86 -1.136 . . . . 0.0 110.039 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.5 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -119.46 111.19 17.81 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.354 -0.841 . . . . 0.0 109.762 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.467 ' CE2' ' HG3' ' A' ' 138' ' ' GLN . 5.2 m-85 -111.3 166.11 11.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.225 -0.922 . . . . 0.0 111.074 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.568 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 62.7 t-80 -103.97 135.54 45.3 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.837 0.827 . . . . 0.0 109.008 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.039 HG11 ' CG1' ' A' ' 150' ' ' VAL . 4.4 m -73.45 154.24 7.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-O 121.476 0.655 . . . . 0.0 110.406 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -121.74 27.61 8.08 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.607 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 19.5 p90 -125.75 69.47 1.18 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.112 -0.992 . . . . 0.0 110.234 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.583 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -160.91 -59.06 0.05 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.918 . . . . 0.0 109.764 178.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.583 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -95.86 80.77 0.8 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.54 -43.03 0.72 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.57 -78.3 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.904 -1.351 . . . . 0.0 110.825 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.128 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -80.49 -20.88 42.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.122 . . . . 0.0 110.265 -179.02 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 1.128 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -54.79 -38.68 65.07 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -47.32 63.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.427 -1.043 . . . . 0.0 108.523 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.524 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 12.2 t70 -65.44 -23.57 66.96 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.769 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 36.7 tp -65.09 -46.47 80.96 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 m -58.51 -42.73 88.33 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 1.04 ' O ' HG23 ' A' ' 78' ' ' VAL . 19.2 tt0 -57.72 -25.03 59.78 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 177.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -64.69 -40.21 94.99 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.457 ' O ' ' HB2' ' A' ' 80' ' ' MET . 25.3 t-105 -63.54 -29.09 70.4 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.63 ' HB2' HE22 ' A' ' 138' ' ' GLN . . . -81.6 -44.02 17.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 109.763 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.04 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.6 t -71.78 -27.39 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 109.401 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.604 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -78.75 -57.78 3.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.13 -0.982 . . . . 0.0 108.804 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -48.17 -27.68 2.53 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.155 -0.965 . . . . 0.0 108.578 179.429 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.752 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -69.25 -45.74 69.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.584 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.785 ' HB2' HG13 ' A' ' 84' ' ' VAL . 12.6 mt -105.2 14.28 29.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 49.1 25.52 5.51 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.785 HG13 ' HB2' ' A' ' 82' ' ' LEU . 33.8 m -82.98 -11.53 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -1.086 . . . . 0.0 110.298 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.45 ' HG2' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -42.84 -63.59 0.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -0.98 . . . . 0.0 109.875 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.47 -33.43 1.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.285 -0.885 . . . . 0.0 110.264 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -81.6 -50.76 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.37 -0.832 . . . . 0.0 111.436 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.762 HG23 HD12 ' A' ' 92' ' ' LEU . 2.2 m -90.57 6.1 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.863 -1.148 . . . . 0.0 111.195 -178.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.724 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -83.02 -45.7 13.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.818 -1.177 . . . . 0.0 108.347 178.582 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.464 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -52.39 -51.46 72.37 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.596 -1.315 . . . . 0.0 110.61 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 90' ' ' VAL . 27.1 Cg_endo -73.79 -20.13 20.26 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 N-CA-C 109.736 -0.909 . . . . 0.0 109.736 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.762 HD12 HG23 ' A' ' 88' ' ' VAL . 18.5 mt -86.18 -43.21 13.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 108.87 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.724 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.2 m-30 -64.47 -45.77 85.96 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.094 -1.004 . . . . 0.0 108.945 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -76.36 -21.2 56.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.083 -1.011 . . . . 0.0 109.751 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.479 ' O ' HG12 ' A' ' 102' ' ' ILE . . . -72.75 -29.77 64.85 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.763 HG11 ' CD1' ' A' ' 29' ' ' PHE . 3.4 t -98.77 -15.29 7.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.012 -1.287 . . . . 0.0 109.669 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.449 ' CD ' ' HB2' ' A' ' 34' ' ' TYR . 2.1 mp0 -108.64 8.23 26.92 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 120.815 -1.178 . . . . 0.0 111.131 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 99' ' ' THR . 16.8 mttt -163.72 63.39 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.517 -1.365 . . . . 0.0 109.472 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.924 HG22 ' H ' ' A' ' 101' ' ' THR . 1.1 m 160.41 -44.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 71.51 13.52 6.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.803 -1.186 . . . . 0.0 110.834 178.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.924 ' H ' HG22 ' A' ' 99' ' ' THR . 4.5 t -79.67 -8.49 59.25 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.586 ' CB ' HG22 ' A' ' 96' ' ' VAL . 7.7 mm -83.14 74.11 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.71 32.72 2.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 0.0 109.757 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 107' ' ' ASP . 13.2 p -159.28 132.09 6.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.03 -1.044 . . . . 0.0 109.797 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.94 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -48.65 -36.43 15.92 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 110' ' ' ASP . 22.7 t -58.1 -34.1 69.83 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -66.67 -49.7 65.3 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.835 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.94 HD12 ' HA ' ' A' ' 105' ' ' ALA . 24.5 mt -50.02 -26.71 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.253 -0.904 . . . . 0.0 108.623 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 110' ' ' ASP . 0.9 OUTLIER -71.5 -64.65 0.88 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.476 -0.765 . . . . 0.0 109.614 -179.673 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.522 ' HA ' HD12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -43.62 -42.27 5.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.33 -0.856 . . . . 0.0 110.195 -179.356 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 107' ' ' ASP . 1.4 t -67.78 -40.16 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.794 -1.191 . . . . 0.0 109.452 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -68.35 -37.66 80.7 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.227 -0.92 . . . . 0.0 109.578 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 110' ' ' ASP . 15.7 mt -68.4 -23.51 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.0 108.99 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -63.68 -17.58 63.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.454 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.669 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -95.51 12.83 28.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.211 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.67 8.23 87.21 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.669 HG12 ' HB3' ' A' ' 115' ' ' ALA . 3.9 mm -89.0 62.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -1.073 . . . . 0.0 109.653 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.492 ' C ' ' O ' ' A' ' 117' ' ' ILE . 1.7 tptp -33.35 140.85 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.342 -0.849 . . . . 0.0 110.374 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.47 -23.76 6.69 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -63.07 -49.07 75.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.267 . . . . 0.0 109.593 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -76.23 -38.21 56.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.622 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.855 ' CE2' HG11 ' A' ' 78' ' ' VAL . 1.9 t80 -64.54 -50.66 66.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.299 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.16 -48.39 76.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.093 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.97 -53.3 34.29 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.328 -0.857 . . . . 0.0 108.875 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.84 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -49.86 -52.66 31.0 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 8.7 t90 -52.28 -59.78 3.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -52.31 -16.75 0.91 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.615 -0.678 . . . . 0.0 110.038 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.2 m -72.2 -178.56 2.51 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.904 -1.123 . . . . 0.0 109.6 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -90.08 -35.29 15.54 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.888 -0.507 . . . . 0.0 110.424 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.43 -45.63 81.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 118.198 -1.401 . . . . 0.0 109.586 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.84 HG21 ' HB1' ' A' ' 125' ' ' ALA . 3.6 t -71.75 -35.62 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.958 -1.089 . . . . 0.0 108.632 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -69.97 -38.47 76.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.381 -0.824 . . . . 0.0 108.926 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -65.72 -29.89 70.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 108.977 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -79.59 -21.97 44.31 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.309 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.496 HG23 ' HB1' ' A' ' 77' ' ' ALA . 6.0 t -75.77 -45.59 37.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.78 -37.76 88.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -62.45 -38.26 89.1 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.63 HE22 ' HB2' ' A' ' 77' ' ' ALA . 4.8 mt-30 -62.2 -64.39 0.95 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 4.5 tm-20 -48.18 -31.05 5.23 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -73.41 -33.29 64.89 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -63.8 -63.01 1.28 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 108.886 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -62.1 -35.39 78.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.359 -0.838 . . . . 0.0 109.745 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -77.19 -16.64 59.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 109.719 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.73 ' HB3' HG21 ' A' ' 16' ' ' VAL . 9.4 m-20 -79.94 -44.28 20.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.098 -1.001 . . . . 0.0 108.725 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.6 HG21 ' HE2' ' A' ' 25' ' ' PHE . 16.0 m -105.78 -5.2 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.372 -0.83 . . . . 0.0 109.004 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 2.6 tt0 81.32 -47.16 0.23 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.773 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.785 HD13 ' CD2' ' A' ' 25' ' ' PHE . 17.2 tp 66.29 132.74 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 109.295 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.511 ' O ' ' CD ' ' A' ' 148' ' ' ARG . 6.3 tmm_? -160.79 38.42 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.59 -1.319 . . . . 0.0 109.94 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.46 108.0 0.21 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.251 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 1.039 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -93.32 141.8 24.44 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.404 -1.057 . . . . 0.0 109.573 179.26 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.489 ' HD3' ' CE1' ' A' ' 32' ' ' HIS . 35.7 Cg_endo -78.42 150.39 87.87 Favored 'Cis proline' 0 C--N 1.316 -1.176 0 C-N-CA 123.858 -1.309 . . . . 0.0 110.312 0.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.712 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -122.83 148.33 45.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.169 -1.582 . . . . 0.0 108.456 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -135.47 130.65 35.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.969 -1.082 . . . . 0.0 110.053 -179.08 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.555 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 29.6 m-85 -129.58 127.75 41.32 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.279 -0.888 . . . . 0.0 110.087 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 21' ' ' GLN . 34.8 t -97.07 125.82 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 109.431 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.719 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 21.5 t-20 52.54 22.69 2.25 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.194 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 54.34 39.18 64.14 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.315 -1.422 . . . . 0.0 109.639 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.409 ' O ' HD12 ' A' ' 12' ' ' LEU . 3.0 tttp -142.95 -32.85 0.47 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.313 -1.11 . . . . 0.0 108.279 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.573 ' CD2' ' HD2' ' A' ' 188' ' ' LYS . 31.4 m-85 -116.34 125.42 52.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 108.644 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.555 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 6.3 pt20 -122.5 120.18 33.11 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.058 -1.026 . . . . 0.0 109.895 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' A' ' 9' ' ' TYR . 25.5 mt -62.47 -179.6 0.26 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -159.86 70.21 3.13 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.126 -0.984 . . . . 0.0 109.388 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.37 -22.28 11.05 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.78 2.32 . . . . 0.0 110.547 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.434 ' O ' ' C ' ' A' ' 165' ' ' GLY . 0.5 OUTLIER 57.22 16.5 3.07 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.275 -0.891 . . . . 0.0 109.418 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 164' ' ' GLN . . . 43.37 36.24 3.01 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.89 42.51 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -1.147 . . . . 0.0 109.825 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 174' ' ' PHE . 10.8 t0 -136.04 37.74 2.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 109.88 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 69.7 p -77.7 -8.5 58.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.898 -1.126 . . . . 0.0 109.612 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.2 t -84.27 -17.35 39.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.309 -0.869 . . . . 0.0 109.381 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -148.35 67.08 1.07 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.053 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -15.64 14.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -0.831 . . . . 0.0 110.038 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.44 -48.05 62.1 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.605 -0.685 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.457 HG12 ' OE1' ' A' ' 177' ' ' GLN . 4.9 t -73.16 -26.55 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.148 -0.97 . . . . 0.0 109.619 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.448 ' HB2' ' OD2' ' A' ' 167' ' ' ASP . 6.7 t80 -71.53 -44.43 64.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.033 -1.042 . . . . 0.0 109.582 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.576 HG22 HG12 ' A' ' 42' ' ' ILE . 86.9 t -71.55 -26.1 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.112 -0.993 . . . . 0.0 109.21 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -56.61 3.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.457 ' OE1' HG12 ' A' ' 173' ' ' VAL . 18.2 pt20 -60.08 -35.67 75.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.981 . . . . 0.0 108.983 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.553 ' CE1' ' CG2' ' A' ' 182' ' ' VAL . 4.0 t80 -66.55 -51.81 52.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.1 -26.54 27.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -0.916 . . . . 0.0 108.917 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.66 -37.99 40.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.903 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -62.63 -40.77 98.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.314 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.553 ' CG2' ' CE1' ' A' ' 178' ' ' TYR . 21.2 t -75.53 -34.8 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.033 -1.042 . . . . 0.0 109.19 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -58.7 -49.48 77.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.22 -0.925 . . . . 0.0 109.157 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.588 ' CE2' HD22 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -77.7 -40.25 41.96 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.28 -0.887 . . . . 0.0 108.716 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.903 HD23 ' O ' ' A' ' 181' ' ' THR . 3.8 mm? -53.6 -19.13 3.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.08 -1.012 . . . . 0.0 109.434 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 12.3 t -87.01 8.67 22.37 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.761 -1.212 . . . . 0.0 107.989 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 188' ' ' LYS . 0.8 OUTLIER -117.19 0.8 12.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.529 -0.732 . . . . 0.0 109.715 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.573 ' HD2' ' CD2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -43.12 -58.07 2.63 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.176 -0.953 . . . . 0.0 109.097 -179.245 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.458 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.525 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER 40.74 49.52 2.83 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.838 0.827 . . . . 0.0 108.988 -179.543 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.7 OUTLIER 74.98 96.92 0.07 Allowed 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 1' ' ' ALA . 1.2 tt0 -130.03 60.38 1.6 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.113 -0.992 . . . . 0.0 110.201 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 0.7 OUTLIER 70.02 94.63 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.427 -0.796 . . . . 0.0 110.538 178.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.517 ' HA2' ' ND2' ' A' ' 162' ' ' ASN . . . 79.71 5.45 89.39 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 1.2 tttp -106.86 31.37 5.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -1.193 . . . . 0.0 108.91 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.711 ' O ' HD23 ' A' ' 161' ' ' LEU . 0.1 OUTLIER 147.8 -39.45 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.374 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.571 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 1.3 p90 -157.96 124.51 4.85 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.086 -1.009 . . . . 0.0 109.352 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 t -104.03 176.79 5.04 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -116.25 146.72 42.14 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.596 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 160' ' ' GLN . 1.5 mp -98.52 160.95 13.94 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.363 -0.835 . . . . 0.0 109.703 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -89.99 -1.63 58.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.479 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -142.64 94.84 6.56 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.301 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 35.6 Cg_endo -77.84 167.0 24.48 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.589 2.193 . . . . 0.0 110.517 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 144' ' ' ASP . 25.2 t -119.6 95.67 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.754 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.19 129.47 10.15 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 92.18 -18.74 53.15 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.599 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -38.54 157.84 0.1 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.517 -0.99 . . . . 0.0 109.828 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.568 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.5 Cg_endo -79.85 133.56 10.26 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.573 2.182 . . . . 0.0 111.126 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.8 ' O ' HG13 ' A' ' 155' ' ' VAL . 9.6 mm-40 -41.16 -25.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.53 -0.731 . . . . 0.0 109.935 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.722 ' O ' HG12 ' A' ' 22' ' ' VAL . 5.1 t -147.98 80.41 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.007 -1.058 . . . . 0.0 109.022 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.649 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.23 120.71 20.17 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -104.64 122.66 46.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.182 -0.948 . . . . 0.0 109.42 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.876 ' HD2' HD13 ' A' ' 147' ' ' LEU . 2.9 m-30 -108.26 103.62 12.83 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.408 -0.808 . . . . 0.0 109.9 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -140.67 141.06 35.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.423 -0.798 . . . . 0.0 109.243 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.609 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 1.3 t -115.41 172.22 7.23 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.093 -1.005 . . . . 0.0 109.217 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.602 ' HB2' HD21 ' A' ' 72' ' ' LEU . 8.0 m-30 -89.71 43.67 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.748 ' HE1' HD22 ' A' ' 72' ' ' LEU . 22.2 m-85 -147.3 17.33 1.19 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.494 -0.754 . . . . 0.0 109.698 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -113.68 165.96 12.34 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.756 -1.215 . . . . 0.0 109.622 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 33.7 Cg_endo -75.95 -38.46 1.21 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.33 2.02 . . . . 0.0 108.183 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 1.8 m-70 -72.56 -28.16 62.65 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 28.8 t -44.57 -61.93 1.38 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.81 0.814 . . . . 0.0 108.826 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.46 ' CG ' ' OE1' ' A' ' 97' ' ' GLN . 27.5 t80 -78.09 -40.09 39.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.885 -0.51 . . . . 0.0 110.55 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.502 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 2.8 mm100 -64.52 -27.35 68.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.188 -0.945 . . . . 0.0 111.079 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 3.9 m-30 -87.02 -34.36 19.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.806 -1.184 . . . . 0.0 111.212 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.14 -23.2 22.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.805 -1.184 . . . . 0.0 111.987 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -136.34 28.14 3.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.344 -1.472 . . . . 0.0 111.612 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.507 ' O ' ' CD2' ' A' ' 41' ' ' HIS . 53.3 t -150.98 -81.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.541 -1.349 . . . . 0.0 109.821 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.403 ' N ' HG12 ' A' ' 39' ' ' VAL . 17.9 mt -67.78 -12.52 60.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.804 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 14.3 m-70 51.51 21.76 1.34 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.979 . . . . 0.0 109.337 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.425 HD12 ' CE1' ' A' ' 36' ' ' PHE . 22.1 mt -65.32 -20.09 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 109.45 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.517 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -81.64 -41.43 21.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.757 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 47' ' ' LYS . 7.4 p-10 -87.08 -45.14 10.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.995 . . . . 0.0 109.59 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -45.83 -31.48 2.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.866 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 43' ' ' SER . 8.4 m -74.26 -30.85 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.089 -1.007 . . . . 0.0 109.655 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 44' ' ' ASP . 8.6 mmmm -48.49 -39.62 23.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 0.0 109.223 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -58.45 -23.23 57.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.353 -0.842 . . . . 0.0 109.206 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 50' ' ' LEU . 6.4 mttm -93.31 23.31 4.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.401 -0.812 . . . . 0.0 109.78 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.682 HD22 ' CG1' ' A' ' 54' ' ' VAL . 18.8 mt -118.92 76.27 14.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.024 -1.047 . . . . 0.0 109.824 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 52' ' ' GLU . 36.6 Cg_endo -78.69 63.34 8.53 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.417 2.078 . . . . 0.0 110.293 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 51' ' ' PRO . 23.3 tp10 58.46 131.57 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.448 0.642 . . . . 0.0 110.259 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.69 -18.35 44.12 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.682 ' CG1' HD22 ' A' ' 50' ' ' LEU . 2.4 t -95.89 89.36 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.082 -1.246 . . . . 0.0 109.193 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.97 96.79 2.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.412 -0.805 . . . . 0.0 109.846 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.497 ' HG2' HD13 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -92.18 100.75 13.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.272 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.2 m -98.61 119.18 36.9 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.864 -1.135 . . . . 0.0 110.581 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -97.63 108.53 21.27 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.466 -0.771 . . . . 0.0 109.654 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.517 ' CD1' ' HG3' ' A' ' 138' ' ' GLN . 3.0 m-85 -111.56 154.18 25.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.166 -0.959 . . . . 0.0 111.624 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.609 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 18.2 t-80 -106.62 108.88 20.61 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.043 HG11 HD22 ' A' ' 147' ' ' LEU . 15.1 m -69.64 156.53 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.44 -0.787 . . . . 0.0 109.994 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.521 ' CB ' ' HA ' ' A' ' 70' ' ' LYS . 3.6 p30 -108.23 51.38 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 109.573 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.737 ' CE1' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -131.1 52.94 2.02 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.172 -0.955 . . . . 0.0 110.155 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.521 ' SD ' ' CB ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -134.02 38.79 3.16 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.32 -34.2 0.65 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.57 -34.86 2.88 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.757 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.27 -80.44 0.25 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.765 -1.432 . . . . 0.0 109.852 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.039 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -77.44 -23.79 50.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.794 -1.191 . . . . 0.0 108.723 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 1.039 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -48.18 -44.0 26.25 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HA ' ' CB ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -64.58 -45.13 88.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -1.117 . . . . 0.0 108.572 179.281 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.524 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 22.7 t0 -67.72 -28.7 67.88 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.748 HD22 ' HE1' ' A' ' 29' ' ' PHE . 13.1 tp -62.69 -44.37 96.41 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.474 HG23 ' CD ' ' A' ' 138' ' ' GLN . 2.5 m -60.46 -42.32 95.93 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 1.009 ' O ' HG23 ' A' ' 78' ' ' VAL . 8.4 tt0 -59.7 -21.17 60.24 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -68.62 -43.52 76.2 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.503 ' CD1' ' OE1' ' A' ' 138' ' ' GLN . 69.7 t-105 -60.45 -32.13 71.09 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -79.89 -55.41 4.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.549 -0.719 . . . . 0.0 109.876 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.025 HG11 ' CE2' ' A' ' 122' ' ' TYR . 2.8 t -57.7 -28.29 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 109.96 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.581 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -79.54 -59.04 2.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.883 -1.136 . . . . 0.0 108.564 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -46.19 -29.52 1.61 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.812 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -68.35 -44.6 74.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.383 -0.823 . . . . 0.0 109.391 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.792 ' HB2' HG13 ' A' ' 84' ' ' VAL . 7.7 mt -104.68 13.35 31.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.189 -0.944 . . . . 0.0 110.026 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.39 27.51 4.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 82' ' ' LEU . 33.1 m -85.28 -9.15 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.314 -1.109 . . . . 0.0 110.415 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.3 OUTLIER -41.31 -60.49 1.25 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.17 -0.956 . . . . 0.0 109.784 -179.563 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.16 -33.46 2.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.365 -0.835 . . . . 0.0 110.041 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -83.82 -49.83 8.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.329 -0.857 . . . . 0.0 111.411 -178.517 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.781 HG23 HD12 ' A' ' 92' ' ' LEU . 1.2 m -87.06 -4.72 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.775 -1.203 . . . . 0.0 110.504 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.66 HG23 ' CE1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -77.41 -44.17 30.08 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.811 -1.181 . . . . 0.0 108.508 178.669 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.438 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -51.46 -52.72 57.18 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.634 -1.291 . . . . 0.0 110.334 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.605 ' HB2' HG13 ' A' ' 111' ' ' VAL . 27.2 Cg_endo -74.04 -17.63 22.0 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 N-CA-C 109.847 -0.866 . . . . 0.0 109.847 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.041 ' O ' HG23 ' A' ' 96' ' ' VAL . 12.7 mt -86.84 -42.49 13.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 108.956 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.66 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.4 m-30 -69.88 -46.73 64.84 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.877 -1.139 . . . . 0.0 108.472 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 1.0 OUTLIER -72.77 -27.75 62.19 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.194 -0.941 . . . . 0.0 108.975 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -70.1 -29.09 70.81 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 1.041 HG23 ' O ' ' A' ' 92' ' ' LEU . 1.6 t -103.8 1.38 10.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.194 -1.18 . . . . 0.0 108.917 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.46 ' OE1' ' CG ' ' A' ' 34' ' ' TYR . 1.3 mt-30 -107.54 10.75 29.19 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.975 -1.078 . . . . 0.0 110.763 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -178.62 -51.82 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.576 -1.327 . . . . 0.0 110.423 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 68.6 p -59.79 -40.84 89.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.48 -1.388 . . . . 0.0 109.507 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.48 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER 67.49 9.9 7.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.372 -0.83 . . . . 0.0 109.783 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 t -81.15 -7.85 59.64 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.827 0.822 . . . . 0.0 109.044 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.464 HG23 ' OD1' ' A' ' 107' ' ' ASP . 8.8 mm -85.4 80.74 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.48 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -145.05 34.51 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.39 -0.819 . . . . 0.0 109.699 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 107' ' ' ASP . 83.4 p -164.96 136.28 4.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.893 -1.13 . . . . 0.0 110.269 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.881 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.22 -38.65 27.13 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 t -56.75 -32.5 65.65 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -70.0 -53.39 17.88 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.159 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.881 HD12 ' HA ' ' A' ' 105' ' ' ALA . 25.5 mt -45.68 -28.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.173 -0.955 . . . . 0.0 108.771 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -46.34 31.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 109.565 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 1.2 p30 -53.14 -41.8 65.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 109.606 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.835 HG11 ' HG ' ' A' ' 92' ' ' LEU . 13.6 t -71.49 -38.39 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.96 -1.088 . . . . 0.0 109.51 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.522 ' HE1' HG21 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -65.79 -54.71 23.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.3 mt -61.67 -24.02 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.131 -0.981 . . . . 0.0 109.709 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -72.4 -16.64 61.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.155 -0.966 . . . . 0.0 109.45 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.434 ' HB2' HG12 ' A' ' 88' ' ' VAL . . . -94.6 8.08 43.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 109.77 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.44 -3.3 79.0 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.836 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.4 mp -85.54 60.73 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -1.129 . . . . 0.0 109.114 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -37.28 157.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.828 -1.17 . . . . 0.0 110.239 -179.456 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.42 -23.57 64.78 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.47 -52.01 63.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.982 -1.305 . . . . 0.0 109.337 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -75.5 -36.82 60.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.934 . . . . 0.0 109.331 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 1.025 ' CE2' HG11 ' A' ' 78' ' ' VAL . 3.2 t80 -62.78 -48.51 78.84 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.247 -0.908 . . . . 0.0 109.005 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -62.12 -36.88 83.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 108.75 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.466 ' O ' ' OG ' ' A' ' 128' ' ' SER . . . -63.24 -49.76 72.88 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 108.92 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.528 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -52.54 -50.72 62.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.002 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.465 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 3.1 t90 -60.18 -55.53 32.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -52.66 -16.47 0.96 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.547 -0.721 . . . . 0.0 110.015 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 124' ' ' ALA . 0.9 OUTLIER -73.54 176.8 5.8 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.965 -1.084 . . . . 0.0 109.383 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 133' ' ' SER . 60.4 m-85 -91.94 -37.94 12.57 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.63 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.9 t -65.21 -47.14 88.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 118.056 -1.458 . . . . 0.0 109.266 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.812 HG22 ' CB ' ' A' ' 81' ' ' ALA . 3.7 t -64.03 -39.44 85.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.057 -1.027 . . . . 0.0 108.344 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -71.19 -27.63 63.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.835 . . . . 0.0 108.915 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -66.42 -41.82 88.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.151 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.45 -18.17 55.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 108.699 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.683 HG23 ' HB1' ' A' ' 77' ' ' ALA . 3.9 t -75.54 -40.36 41.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -71.81 -39.69 69.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -30.3 70.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.09 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.517 ' HG3' ' CD1' ' A' ' 59' ' ' TYR . 2.8 tt0 -71.17 -64.71 0.86 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.33 -0.857 . . . . 0.0 109.075 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 0.6 OUTLIER -50.09 -33.43 18.6 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 108.475 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 26.4 mttt -76.71 -29.91 56.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -57.27 -53.99 51.82 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.309 -0.87 . . . . 0.0 108.763 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -72.03 -40.53 68.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.366 -0.834 . . . . 0.0 110.495 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.55 -16.93 61.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.991 -1.068 . . . . 0.0 109.939 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.534 ' HB3' HG21 ' A' ' 16' ' ' VAL . 2.4 m-20 -84.71 -43.21 14.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 108.553 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.562 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 4.5 m -93.42 -12.09 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 1.0 OUTLIER 82.33 -43.79 0.14 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.65 -0.657 . . . . 0.0 109.513 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 1.043 HD22 HG11 ' A' ' 61' ' ' VAL . 33.7 tp 62.9 139.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.426 -0.797 . . . . 0.0 109.939 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.501 ' O ' ' CD ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -161.22 38.73 0.14 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.764 -1.21 . . . . 0.0 109.563 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 160.42 109.93 0.26 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.438 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.37 140.59 21.76 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.35 -1.088 . . . . 0.0 108.743 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.76 150.87 87.65 Favored 'Cis proline' 0 C--N 1.313 -1.312 0 C-N-CA 123.993 -1.253 . . . . 0.0 110.396 0.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -123.63 160.19 27.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.442 -1.411 . . . . 0.0 109.051 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.6 OUTLIER -144.7 129.11 17.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.074 -1.016 . . . . 0.0 109.871 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 8.9 m-85 -131.64 134.18 45.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.372 -0.83 . . . . 0.0 109.993 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 21' ' ' GLN . 53.7 t -105.56 133.16 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.912 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.599 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.9 OUTLIER 45.5 22.21 0.09 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.201 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.594 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 56.92 57.56 19.08 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -168.88 -34.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.234 -1.156 . . . . 0.0 108.454 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.468 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 51.6 m-85 -117.89 125.09 49.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.815 . . . . 0.0 108.971 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.728 ' HB3' HD11 ' A' ' 12' ' ' LEU . 5.7 pt20 -123.74 130.5 52.73 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.78 -1.2 . . . . 0.0 109.82 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.8 OUTLIER -73.14 172.75 10.5 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.517 ' ND2' ' HA2' ' A' ' 6' ' ' GLY . 5.6 p30 -151.95 147.12 19.37 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.089 -1.007 . . . . 0.0 109.482 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.43 39.66 0.88 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.672 2.248 . . . . 0.0 110.776 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 164' ' ' GLN . 1.1 tp60 -85.19 -20.91 29.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.987 -1.071 . . . . 0.0 109.547 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -100.16 37.48 3.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.473 ' O ' ' CG ' ' A' ' 166' ' ' MET . 9.3 ttt -123.91 34.54 5.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -1.112 . . . . 0.0 109.578 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -133.47 37.52 3.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.972 . . . . 0.0 109.783 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 169' ' ' SER . 62.0 p -121.01 0.17 10.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.979 -1.075 . . . . 0.0 109.657 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 168' ' ' THR . 1.2 t 72.36 58.79 0.13 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.224 -0.923 . . . . 0.0 109.359 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 174' ' ' PHE . 1.7 m-20 -159.68 72.27 0.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 0.0 109.4 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.469 ' O ' HG23 ' A' ' 175' ' ' VAL . 4.3 mtt -59.62 -16.66 27.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -75.32 -62.42 1.57 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.7 t -55.86 -26.82 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.248 -0.908 . . . . 0.0 108.601 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 174' ' ' PHE . 7.0 m-30 -69.26 -38.13 78.25 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.195 -0.941 . . . . 0.0 108.962 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 171' ' ' MET . 77.6 t -73.78 -24.97 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.229 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -83.14 -60.4 2.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.301 -0.874 . . . . 0.0 109.226 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -52.96 -37.86 61.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.167 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' ' 174' ' ' PHE . 16.5 t80 -69.58 -44.4 70.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.342 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -65.31 -29.06 69.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 109.076 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.19 -37.95 60.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.1 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.647 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -64.05 -44.27 92.97 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.23 -0.919 . . . . 0.0 108.948 179.404 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.488 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 55.7 t -69.77 -38.62 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.176 -0.953 . . . . 0.0 109.186 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -55.13 38.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.126 -0.984 . . . . 0.0 109.385 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -75.92 -26.4 56.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.219 -0.926 . . . . 0.0 109.146 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.647 HD23 ' O ' ' A' ' 181' ' ' THR . 0.3 OUTLIER -64.63 -18.86 65.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.965 -1.085 . . . . 0.0 109.267 -179.654 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 59.6 p -80.15 0.39 32.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 0.0 108.519 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.64 -75.86 0.58 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.447 -0.783 . . . . 0.0 109.264 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 189' ' ' LYS . 2.3 mmmp? 54.73 19.51 2.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.365 -0.835 . . . . 0.0 109.485 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.479 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.8 64.83 1.47 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.265 -0.897 . . . . 0.0 109.379 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.8 OUTLIER 52.05 86.05 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -0.835 . . . . 0.0 109.051 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 5' ' ' ASP . 5.4 mt-10 -99.65 54.87 0.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.81 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 4' ' ' GLU . 4.2 p-10 39.86 80.08 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.284 0.564 . . . . 0.0 110.036 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 127.81 -26.4 4.83 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.662 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -80.98 -68.53 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.844 -1.386 . . . . 0.0 109.289 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 11.9 mp0 -93.52 4.36 54.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 0.0 109.427 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 3.4 p90 179.1 131.68 0.08 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.169 -0.957 . . . . 0.0 109.35 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.513 HG23 ' HG3' ' A' ' 160' ' ' GLN . 8.7 t -119.65 175.83 5.67 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.661 -0.649 . . . . 0.0 109.26 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.59 157.59 15.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.686 -0.634 . . . . 0.0 109.617 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.475 ' HG ' ' HG2' ' A' ' 160' ' ' GLN . 7.4 mt -96.16 158.19 15.55 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.355 -0.84 . . . . 0.0 109.445 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -84.02 -12.06 55.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.096 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -151.82 104.74 2.85 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.1 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.36 166.87 26.78 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.449 2.099 . . . . 0.0 110.679 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.706 HG21 ' OD1' ' A' ' 144' ' ' ASP . 10.2 t -132.14 89.87 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.852 . . . . 0.0 109.649 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.24 131.14 8.02 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 92.49 -19.7 48.92 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.739 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -40.29 163.24 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.563 -0.963 . . . . 0.0 109.917 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.633 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 35.0 Cg_endo -77.41 125.81 7.94 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.61 2.207 . . . . 0.0 111.047 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.593 ' O ' HG13 ' A' ' 155' ' ' VAL . 5.3 mm100 -40.07 -24.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.523 -0.736 . . . . 0.0 110.012 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.789 ' O ' HG12 ' A' ' 22' ' ' VAL . 2.7 t -146.1 81.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.168 -0.958 . . . . 0.0 108.772 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.753 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -75.34 124.97 28.04 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.515 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -107.95 133.92 51.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.083 -1.011 . . . . 0.0 110.234 -179.027 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.071 ' CE2' HG21 ' A' ' 145' ' ' VAL . 7.5 m-85 -123.55 100.74 6.95 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -150.76 140.29 21.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.048 -1.033 . . . . 0.0 110.458 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.53 ' HB3' HG22 ' A' ' 61' ' ' VAL . 1.3 p -115.15 177.44 4.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.345 -0.847 . . . . 0.0 109.123 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.695 ' CD2' HD21 ' A' ' 72' ' ' LEU . 8.4 m-30 -94.04 41.73 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.958 ' CE2' HD12 ' A' ' 72' ' ' LEU . 9.9 m-85 -130.96 14.52 5.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.351 -0.843 . . . . 0.0 110.175 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.6 OUTLIER -110.5 158.46 35.36 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.706 -1.246 . . . . 0.0 109.554 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.05 -38.38 1.59 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.189 1.926 . . . . 0.0 108.037 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.477 ' HA ' ' HB2' ' A' ' 35' ' ' GLN . 20.2 m80 -76.06 -21.13 57.1 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 52.1 t -47.49 -65.1 0.62 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.574 ' HB2' ' CG ' ' A' ' 97' ' ' GLN . 7.3 t80 -60.66 -43.01 98.15 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.221 0.534 . . . . 0.0 110.037 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 32' ' ' HIS . 1.8 mt-30 -60.92 -22.98 64.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.194 -0.941 . . . . 0.0 109.976 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -82.9 -36.85 24.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.369 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.524 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -106.29 47.99 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.959 -1.088 . . . . 0.0 109.938 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -171.62 -52.23 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.223 -0.923 . . . . 0.0 111.902 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.0 t -89.28 -83.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.463 -1.398 . . . . 0.0 112.204 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.72 -10.48 59.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.973 -1.079 . . . . 0.0 110.765 -177.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 55.66 33.7 21.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 109.36 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.6 mm -48.58 -22.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 109.913 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.433 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.6 OUTLIER -82.97 -41.57 18.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.2 -0.937 . . . . 0.0 110.341 -179.423 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -86.15 -38.32 17.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.063 -1.023 . . . . 0.0 110.149 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -46.67 -33.79 4.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 109.907 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 43' ' ' SER . 32.1 m -80.19 -26.52 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.013 -1.055 . . . . 0.0 110.338 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.909 ' HA ' HD12 ' A' ' 50' ' ' LEU . 2.1 mmtp -63.07 -40.78 98.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.898 -1.126 . . . . 0.0 109.737 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.04 -27.75 6.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.16 -0.963 . . . . 0.0 109.23 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 11.5 mttt -117.1 40.46 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.909 HD12 ' HA ' ' A' ' 47' ' ' LYS . 11.4 mt -113.27 88.62 12.98 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.652 ' HD2' HG21 ' A' ' 54' ' ' VAL . 35.8 Cg_endo -77.67 143.09 21.01 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.76 2.307 . . . . 0.0 110.528 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 51' ' ' PRO . 1.6 tm-20 -40.14 121.6 1.37 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 122.361 1.077 . . . . 0.0 109.562 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.95 -30.92 3.44 Favored Glycine 0 C--N 1.286 -2.2 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.652 HG21 ' HD2' ' A' ' 51' ' ' PRO . 2.6 t -86.35 82.91 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -1.065 . . . . 0.0 108.536 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.47 96.76 0.39 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.425 -0.797 . . . . 0.0 110.172 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.482 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -90.68 94.22 9.59 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 31.5 m -94.66 135.39 36.19 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.916 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.515 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -115.25 115.03 26.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.313 -0.867 . . . . 0.0 109.714 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.5 ' OH ' ' CG ' ' A' ' 137' ' ' GLN . 2.2 m-85 -112.58 166.46 11.31 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.071 -1.018 . . . . 0.0 111.631 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.949 ' CE1' HD22 ' A' ' 72' ' ' LEU . 2.1 t60 -108.86 125.66 52.22 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.734 0.778 . . . . 0.0 109.816 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.781 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.9 m -73.28 157.22 6.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.732 -0.605 . . . . 0.0 109.907 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -121.99 28.21 7.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.324 -0.86 . . . . 0.0 109.131 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.596 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 11.6 p90 -121.22 67.61 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 110.052 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.592 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -160.12 -59.1 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.396 -0.815 . . . . 0.0 109.222 178.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.592 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -96.21 78.03 0.76 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 178.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.67 -40.92 0.51 Allowed Glycine 0 N--CA 1.492 2.423 0 O-C-N 121.552 -0.969 . . . . 0.0 110.925 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.4 -79.23 0.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.909 -1.348 . . . . 0.0 110.64 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.919 HD23 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -80.13 -20.78 44.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.0 -1.062 . . . . 0.0 110.219 -179.145 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.627 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -51.95 -47.1 54.8 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -46.55 88.25 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.469 -1.018 . . . . 0.0 108.316 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.558 ' HB3' HD12 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -62.27 -26.04 68.18 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.344 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.958 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.9 OUTLIER -63.54 -37.4 87.16 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.428 HG21 ' OE1' ' A' ' 138' ' ' GLN . 5.9 m -65.01 -42.43 94.46 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.559 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 37.7 tt0 -61.59 -19.28 62.02 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -67.82 -43.0 80.65 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 22.8 t-105 -63.69 -31.95 73.28 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.846 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.479 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -79.87 -56.67 4.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 109.919 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.757 HG21 ' CE1' ' A' ' 122' ' ' TYR . 45.8 t -58.18 -27.03 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 0.0 110.015 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.593 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -82.16 -64.08 1.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.884 -1.135 . . . . 0.0 108.9 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.475 ' HB3' HD22 ' A' ' 134' ' ' LEU . 0.1 OUTLIER -46.85 -27.55 1.27 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.58 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -66.15 -49.51 67.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.48 -0.763 . . . . 0.0 109.837 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.686 ' HB2' HG13 ' A' ' 84' ' ' VAL . 7.1 mt -101.64 9.73 40.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.072 -1.017 . . . . 0.0 110.369 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.407 ' HA2' ' OE2' ' A' ' 85' ' ' GLU . . . 56.13 29.37 55.88 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.686 HG13 ' HB2' ' A' ' 82' ' ' LEU . 28.4 m -87.79 -0.08 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.34 -1.094 . . . . 0.0 110.054 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -44.74 -66.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.054 -1.029 . . . . 0.0 109.396 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -42.85 -33.67 0.81 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 110.082 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -79.48 -53.96 6.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.349 -0.844 . . . . 0.0 111.106 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.803 HG23 HD12 ' A' ' 92' ' ' LEU . 2.1 m -89.02 -10.45 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.719 -1.238 . . . . 0.0 111.226 -178.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.881 HG23 ' CD1' ' A' ' 93' ' ' PHE . 1.1 m -72.98 -42.9 62.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.57 -1.331 . . . . 0.0 108.795 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.402 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -58.1 -53.26 67.79 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.489 -1.382 . . . . 0.0 111.116 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.446 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 24.8 Cg_endo -72.66 -23.51 19.51 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 N-CA-C 110.087 -0.774 . . . . 0.0 110.087 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.838 ' HG ' HG11 ' A' ' 111' ' ' VAL . 79.4 mt -85.14 -42.99 14.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 108.862 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.881 ' CD1' HG23 ' A' ' 89' ' ' THR . 3.2 m-85 -62.56 -43.5 98.67 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.083 -1.01 . . . . 0.0 108.55 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -80.85 -16.67 53.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.405 -0.81 . . . . 0.0 109.82 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA2' ' OG1' ' A' ' 99' ' ' THR . . . -77.79 -34.82 37.55 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.2 t -95.58 -24.9 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.168 -1.196 . . . . 0.0 109.146 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.574 ' CG ' ' HB2' ' A' ' 34' ' ' TYR . 4.4 mp0 -102.38 5.07 39.57 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.016 -1.052 . . . . 0.0 110.622 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.803 ' O ' HG23 ' A' ' 99' ' ' THR . 0.3 OUTLIER -161.58 61.96 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.653 -1.28 . . . . 0.0 109.625 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 165.44 -50.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.492 -0.755 . . . . 0.0 109.358 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 75.23 19.62 2.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.382 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.3 p -90.0 -6.89 55.14 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.658 0.742 . . . . 0.0 109.706 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.756 HG23 ' OD1' ' A' ' 107' ' ' ASP . 9.5 mm -84.77 81.57 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 121.568 -0.708 . . . . 0.0 109.574 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -135.32 36.88 2.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.052 -179.766 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 107' ' ' ASP . 83.6 p -166.01 132.2 2.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.854 -1.154 . . . . 0.0 110.499 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.57 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -50.79 -27.83 8.07 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -32.04 73.49 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.756 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.5 OUTLIER -70.76 -50.77 32.46 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.063 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.919 HD11 HD23 ' A' ' 68' ' ' LEU . 32.2 mt -54.25 -27.6 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 108.598 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -76.25 -32.49 58.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.499 -0.75 . . . . 0.0 109.13 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.462 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 2.8 m-20 -65.65 -45.17 84.01 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.318 -0.864 . . . . 0.0 109.32 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.838 HG11 ' HG ' ' A' ' 92' ' ' LEU . 2.4 t -68.32 -40.72 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.0 -1.063 . . . . 0.0 109.015 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.578 ' CZ ' ' HB ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -55.86 -54.34 45.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 109.149 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mt -62.38 -23.05 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 110' ' ' ASP . 11.0 m-80 -72.21 -16.28 61.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.93 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -96.67 14.87 23.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.445 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.435 ' C ' HD12 ' A' ' 117' ' ' ILE . . . 83.12 9.28 84.34 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.93 HD13 ' HB3' ' A' ' 115' ' ' ALA . 1.8 mp -92.02 56.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -1.102 . . . . 0.0 109.374 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 117' ' ' ILE . 16.6 mttp -36.84 149.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.071 -1.018 . . . . 0.0 110.037 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 123' ' ' ASP . . . -50.71 -37.3 34.13 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.04 -52.32 58.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -1.181 . . . . 0.0 109.637 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -66.05 -60.94 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.397 -0.814 . . . . 0.0 109.843 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.757 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -50.12 -60.19 3.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 109.524 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 7.6 m-20 -44.93 -43.29 8.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.992 -1.068 . . . . 0.0 109.871 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.57 -44.9 73.46 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 109.791 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.774 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -58.71 -49.22 78.39 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 108.977 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.559 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 4.9 t-105 -57.13 -54.82 42.38 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -63.42 -14.83 54.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.657 -0.652 . . . . 0.0 110.179 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 70.2 m -71.16 -178.21 1.94 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.98 -1.075 . . . . 0.0 110.43 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.21 -34.68 14.19 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.633 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.12 -44.7 84.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.996 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.774 HG21 ' HB1' ' A' ' 125' ' ' ALA . 5.9 t -69.77 -31.97 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.863 -1.148 . . . . 0.0 108.771 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -71.59 -37.18 71.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -35.47 80.74 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.475 HD22 ' HB3' ' A' ' 80' ' ' MET . 0.0 OUTLIER -74.68 -29.41 61.21 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.032 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.479 HG23 ' HB1' ' A' ' 77' ' ' ALA . 5.7 t -73.71 -24.3 19.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.05 -54.26 6.77 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.5 ' CG ' ' OH ' ' A' ' 59' ' ' TYR . 7.0 tp-100 -59.88 -33.05 71.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.296 -0.878 . . . . 0.0 109.136 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.428 ' OE1' HG21 ' A' ' 73' ' ' THR . 12.1 tm0? -66.95 -64.83 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 108.749 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -51.33 -35.38 37.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.7 mtmm -72.2 -28.95 63.52 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.848 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -60.59 -53.08 61.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 108.795 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.468 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -75.04 -25.39 58.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 109.742 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -80.15 -27.25 39.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.106 -0.996 . . . . 0.0 110.234 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.716 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.4 p30 -82.21 -48.26 11.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.949 -1.094 . . . . 0.0 108.439 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 1.071 HG21 ' CE2' ' A' ' 25' ' ' PHE . 25.5 m -84.62 -18.54 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 9.6 tt0 82.6 -40.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.811 -0.555 . . . . 0.0 110.247 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.596 HD21 ' CG1' ' A' ' 61' ' ' VAL . 12.1 tp 66.75 144.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -159.61 28.4 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.478 -1.389 . . . . 0.0 110.887 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.39 110.89 0.55 Allowed Glycine 0 N--CA 1.49 2.233 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.109 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.781 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -84.04 145.16 45.74 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.353 -1.087 . . . . 0.0 109.147 178.409 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.62 150.96 84.67 Favored 'Cis proline' 0 C--N 1.315 -1.213 0 O-C-N 123.312 1.164 . . . . 0.0 110.583 0.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.814 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -129.66 134.86 47.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.403 -1.435 . . . . 0.0 109.069 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.51 ' SD ' HG13 ' A' ' 22' ' ' VAL . 5.7 tpp -131.09 124.61 31.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 109.773 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 160' ' ' GLN . 10.6 m-85 -123.86 129.94 51.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 0.0 109.922 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 21' ' ' GLN . 45.5 t -97.92 131.26 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.945 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.739 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 1.6 t-20 46.43 21.91 0.14 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.293 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.55 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 55.36 57.04 20.43 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.08 -34.98 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.28 -1.129 . . . . 0.0 108.273 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.588 ' CE1' ' HE2' ' A' ' 188' ' ' LYS . 8.8 m-85 -121.51 126.36 49.04 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.925 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.513 ' HG3' HG23 ' A' ' 10' ' ' THR . 16.4 pt20 -116.72 119.97 37.12 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.955 -1.091 . . . . 0.0 110.307 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.59 174.32 3.57 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -150.44 74.34 8.9 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.971 -1.081 . . . . 0.0 109.692 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.45 45.97 2.0 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.683 2.255 . . . . 0.0 110.97 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -129.99 -3.1 4.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.033 -1.042 . . . . 0.0 109.763 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -71.86 -45.17 44.48 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . 0.1 OUTLIER -121.23 -93.13 0.52 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -1.154 . . . . 0.0 109.468 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 168' ' ' THR . 31.3 t0 63.61 31.48 14.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.373 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -167.31 74.33 0.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 109.406 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 t 179.58 -36.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.759 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -158.8 83.04 0.8 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.29 -0.881 . . . . 0.0 109.33 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.784 ' O ' HG23 ' A' ' 175' ' ' VAL . 19.8 mmt -59.44 -15.91 20.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.878 . . . . 0.0 109.668 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.02 -55.98 5.48 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.707 -0.621 . . . . 0.0 109.355 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 177' ' ' GLN . 4.5 t -68.3 -29.66 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.204 -0.935 . . . . 0.0 109.189 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.558 ' CD1' ' OE1' ' A' ' 177' ' ' GLN . 26.6 m-85 -68.24 -34.8 76.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.268 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 171' ' ' MET . 64.6 t -78.36 -26.1 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.069 -1.019 . . . . 0.0 109.37 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -55.52 4.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.986 . . . . 0.0 109.272 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.558 ' OE1' ' CD1' ' A' ' 174' ' ' PHE . 7.6 pt20 -57.29 -36.35 70.95 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.16 -0.963 . . . . 0.0 108.735 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.41 ' HA ' ' OG1' ' A' ' 181' ' ' THR . 6.0 t80 -68.06 -49.72 59.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.89 . . . . 0.0 108.81 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 183' ' ' LYS . . . -58.85 -29.27 66.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 108.984 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.96 -37.82 58.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.15 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.59 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -61.45 -46.43 90.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.172 179.69 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.47 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 55.1 t -72.03 -36.89 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.802 -1.186 . . . . 0.0 109.295 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 179' ' ' ALA . 0.4 OUTLIER -59.93 -52.61 64.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.147 -0.97 . . . . 0.0 109.269 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.34 -29.28 53.38 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.906 . . . . 0.0 109.107 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 181' ' ' THR . 0.2 OUTLIER -62.51 -20.31 64.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.964 -1.085 . . . . 0.0 108.977 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.497 ' HB3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -69.63 -22.87 63.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.853 -1.154 . . . . 0.0 108.083 178.265 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.569 ' O ' ' CB ' ' A' ' 188' ' ' LYS . 1.3 mp0 -94.13 -72.18 0.63 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.588 ' HE2' ' CE1' ' A' ' 159' ' ' TYR . 29.6 tttm 83.78 -43.21 0.09 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.459 0.647 . . . . 0.0 109.546 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.598 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.677 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.536 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 3.7 pt20 32.5 50.2 0.18 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.764 0.793 . . . . 0.0 109.971 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.2 OUTLIER 69.12 86.17 0.13 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 1' ' ' ALA . 69.5 tt0 -125.11 62.4 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.68 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.7 t0 47.11 83.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.48 -0.762 . . . . 0.0 109.498 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 131.97 -29.69 3.33 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.284 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -79.82 -71.31 0.46 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.02 -1.282 . . . . 0.0 108.916 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.916 ' NE2' HG23 ' A' ' 181' ' ' THR . 13.9 pt20 -100.11 6.59 44.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.086 -1.009 . . . . 0.0 109.686 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.524 ' O ' ' N ' ' A' ' 6' ' ' GLY . 1.4 p90 177.53 130.72 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 0.0 109.466 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 160' ' ' GLN . 5.7 t -111.36 179.78 3.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -96.37 157.09 16.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.69 . . . . 0.0 109.796 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HA ' ' OE1' ' A' ' 160' ' ' GLN . 2.6 mt -91.5 145.24 24.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.434 -0.791 . . . . 0.0 109.75 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.91 -22.01 65.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.902 . . . . 0.0 108.736 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -135.08 108.15 10.48 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.539 -0.726 . . . . 0.0 109.16 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.54 157.74 36.25 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.323 2.015 . . . . 0.0 110.645 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.714 ' O ' HG12 ' A' ' 16' ' ' VAL . 7.9 t -124.03 82.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.65 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -47.79 127.28 11.59 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.707 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 99.06 -20.94 48.22 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.766 ' HB1' ' HD2' ' A' ' 20' ' ' PRO . . . -45.02 168.25 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.122 -1.223 . . . . 0.0 109.421 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.766 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 36.0 Cg_endo -79.22 136.73 12.98 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.87 2.38 . . . . 0.0 111.246 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.823 ' O ' HG22 ' A' ' 155' ' ' VAL . 5.7 mt-30 -49.17 -20.35 0.58 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.376 -0.827 . . . . 0.0 109.772 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.747 ' O ' HG12 ' A' ' 22' ' ' VAL . 3.2 t -149.49 81.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.21 -0.931 . . . . 0.0 108.602 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.713 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -77.45 126.57 31.11 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.294 -0.879 . . . . 0.0 108.786 -179.305 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -110.06 119.18 38.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.129 -0.982 . . . . 0.0 109.83 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.073 ' CE2' HG21 ' A' ' 145' ' ' VAL . 4.4 m-85 -111.52 107.48 16.68 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.522 -0.736 . . . . 0.0 109.371 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -152.39 138.81 18.53 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.326 -0.859 . . . . 0.0 108.948 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.864 ' HB2' HG22 ' A' ' 61' ' ' VAL . 1.5 t -112.83 177.07 4.76 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.091 -1.005 . . . . 0.0 109.896 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.71 ' HB2' HD11 ' A' ' 72' ' ' LEU . 7.7 m-30 -88.4 38.84 0.88 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.876 ' CE2' HD12 ' A' ' 72' ' ' LEU . 10.1 m-85 -130.69 14.19 5.39 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.315 -0.865 . . . . 0.0 110.346 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.539 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -118.15 156.69 50.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.619 -1.301 . . . . 0.0 109.78 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -74.46 -25.15 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.022 1.815 . . . . 0.0 107.667 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.563 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 24.4 p80 -84.74 -25.34 28.36 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 18.6 t -45.73 -58.69 3.27 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' A' ' 38' ' ' GLU . 45.7 t80 -75.17 -49.88 18.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.883 -0.511 . . . . 0.0 110.359 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -61.31 -21.93 64.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.168 -0.957 . . . . 0.0 110.699 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.568 ' CZ ' HG22 ' A' ' 42' ' ' ILE . 3.7 t80 -82.04 -50.97 8.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.978 -1.076 . . . . 0.0 110.24 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.403 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 33.2 tt0 -103.52 -0.14 30.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.858 -1.151 . . . . 0.0 111.553 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 34' ' ' TYR . 60.1 mm-40 -127.74 21.32 6.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.364 -1.46 . . . . 0.0 111.172 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.1 t -152.13 -85.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.656 -1.277 . . . . 0.0 110.066 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.96 -12.19 17.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 110.148 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 5.9 m-70 55.48 22.83 5.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.018 . . . . 0.0 108.998 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.633 HG12 HG22 ' A' ' 175' ' ' VAL . 7.1 mt -56.81 -16.79 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.384 -0.823 . . . . 0.0 109.445 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.514 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -83.25 -48.69 10.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 0.0 110.205 -179.523 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -84.29 -30.91 25.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.153 -0.967 . . . . 0.0 110.124 -179.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -49.19 -33.76 13.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 109.73 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.514 ' CG2' ' O ' ' A' ' 43' ' ' SER . 2.8 m -69.56 -33.72 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.981 -1.075 . . . . 0.0 109.452 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.929 ' HA ' HD12 ' A' ' 50' ' ' LEU . 14.0 mttt -61.06 -28.95 69.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.379 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 3.9 tmtt? -45.91 -27.13 0.82 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.386 -0.821 . . . . 0.0 109.795 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -142.29 50.8 1.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.929 HD12 ' HA ' ' A' ' 47' ' ' LYS . 9.0 mt -99.13 134.4 21.39 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.837 -1.164 . . . . 0.0 110.119 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD2' HD23 ' A' ' 50' ' ' LEU . 35.8 Cg_endo -79.56 152.54 23.03 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.584 2.189 . . . . 0.0 109.118 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 28.2 tt0 -73.07 23.54 0.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.568 -1.333 . . . . 0.0 111.241 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.38 29.31 5.74 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 t -148.96 119.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.507 -0.996 . . . . 0.0 109.135 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -106.33 120.23 41.31 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.616 ' HE1' HD11 ' A' ' 50' ' ' LEU . 2.1 mtm -96.49 99.49 11.14 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.393 0.616 . . . . 0.0 109.574 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 24' ' ' GLU . 1.1 m -89.21 132.85 34.67 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.846 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -109.35 114.87 28.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.236 -0.915 . . . . 0.0 109.785 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 5.2 m-85 -114.41 171.65 7.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.088 -1.007 . . . . 0.0 111.15 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.864 ' NE2' HD22 ' A' ' 72' ' ' LEU . 66.8 t-80 -109.93 129.78 55.61 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.053 HG11 ' CG1' ' A' ' 150' ' ' VAL . 2.3 m -69.23 158.86 5.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.606 -0.684 . . . . 0.0 109.595 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.779 HD21 HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -124.4 33.13 5.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.318 -0.864 . . . . 0.0 109.462 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 24.8 p90 -132.24 51.38 2.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.013 -1.054 . . . . 0.0 109.986 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.5 mtt -159.17 48.43 0.32 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 154.84 57.44 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -34.07 -38.41 0.1 Allowed Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.915 -0.756 . . . . 0.0 111.408 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.63 -80.06 0.27 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.754 -1.439 . . . . 0.0 110.697 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.092 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -80.02 -25.89 40.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.864 -1.148 . . . . 0.0 109.521 -179.594 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 1.092 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -47.61 -53.43 12.96 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' O ' ' CE ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -56.07 -49.01 74.99 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.264 -1.139 . . . . 0.0 108.331 179.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.726 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 53.1 t0 -59.98 -30.87 69.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.876 HD12 ' CE2' ' A' ' 29' ' ' PHE . 1.1 tt -57.46 -36.92 72.06 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.779 HG21 HD21 ' A' ' 62' ' ' ASN . 40.6 m -66.09 -41.59 90.45 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.901 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.1 tt0 -59.28 -20.33 53.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 177.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -68.98 -47.51 65.42 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.419 ' NE1' ' O ' ' A' ' 58' ' ' LYS . 37.9 t-105 -55.91 -28.82 58.54 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.403 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -84.79 -69.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 109.537 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.03 HG11 ' CE2' ' A' ' 122' ' ' TYR . 3.1 t -45.27 -27.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.934 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.491 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -84.18 -62.13 1.64 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 108.987 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -46.08 -27.35 0.93 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.816 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -72.36 -41.02 66.86 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.447 -0.783 . . . . 0.0 109.63 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 84' ' ' VAL . 40.8 mt -104.87 11.83 33.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.146 -0.971 . . . . 0.0 110.135 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 49.28 32.44 14.0 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.944 HG11 HG12 ' A' ' 117' ' ' ILE . 28.1 m -96.54 19.64 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.474 -1.015 . . . . 0.0 109.77 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 86' ' ' ASP . 87.6 mt-10 -58.91 -75.18 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.937 . . . . 0.0 110.01 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.47 -34.35 0.21 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.53 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 27.7 mtpp -74.23 -54.34 7.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.858 . . . . 0.0 110.643 -178.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 84' ' ' VAL . 1.0 OUTLIER -86.54 -23.1 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.826 -1.171 . . . . 0.0 110.765 -179.099 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.746 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -67.13 -43.39 82.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.731 -1.231 . . . . 0.0 109.016 179.472 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.417 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.0 t -54.62 -55.23 40.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.432 -1.418 . . . . 0.0 110.523 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.47 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 24.2 Cg_endo -72.21 -18.87 26.55 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 122.77 0.879 . . . . 0.0 109.883 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.793 ' HG ' HG11 ' A' ' 111' ' ' VAL . 11.6 mt -86.49 -42.63 13.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.183 -0.948 . . . . 0.0 108.937 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.746 ' CE1' HG23 ' A' ' 89' ' ' THR . 5.2 m-30 -62.85 -48.23 79.93 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.943 -1.098 . . . . 0.0 108.802 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.38 -22.36 59.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.037 -1.039 . . . . 0.0 109.45 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.48 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -76.43 -33.04 49.5 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.7 t -101.82 1.75 10.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.006 -1.291 . . . . 0.0 109.228 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 3.8 mt-30 -91.69 -8.63 46.49 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.981 -1.074 . . . . 0.0 110.878 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.4 mtpt -167.81 -53.48 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.736 -1.227 . . . . 0.0 111.118 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 95' ' ' GLY . 80.8 p -47.93 -39.79 20.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.275 -1.516 . . . . 0.0 109.468 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 99' ' ' THR . 1.1 mt-30 67.7 11.21 8.26 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.8 t -79.44 -5.99 55.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.687 ' CB ' HG22 ' A' ' 96' ' ' VAL . 3.8 mm -91.28 80.36 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.92 27.66 2.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.181 -0.949 . . . . 0.0 109.68 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 107' ' ' ASP . 56.1 p -151.08 129.15 11.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.903 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.759 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -48.95 -39.63 27.08 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.84 -31.25 62.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 104' ' ' SER . 84.2 m-20 -78.05 -40.07 39.85 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.977 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 105' ' ' ALA . 28.4 mt -52.45 -26.29 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.556 -1.34 . . . . 0.0 107.513 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -78.05 -39.51 41.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.682 -0.636 . . . . 0.0 109.44 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -55.99 -44.36 78.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.368 -0.832 . . . . 0.0 109.445 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.793 HG11 ' HG ' ' A' ' 92' ' ' LEU . 88.0 t -74.63 -37.26 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.033 . . . . 0.0 109.089 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.737 ' CE1' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -61.25 -31.03 70.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.286 179.575 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.608 HG23 ' HA ' ' A' ' 118' ' ' LYS . 18.7 mt -85.47 -30.46 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -60.76 -16.53 41.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.775 -1.203 . . . . 0.0 109.35 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.53 ' HB1' ' HE3' ' A' ' 87' ' ' LYS . . . -88.06 -2.43 58.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.689 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.32 -5.22 52.05 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.944 HG12 HG11 ' A' ' 84' ' ' VAL . 1.6 mp -88.88 56.13 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -1.136 . . . . 0.0 109.292 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.608 ' HA ' HG23 ' A' ' 113' ' ' ILE . 3.2 mttp -33.01 152.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.366 -0.833 . . . . 0.0 110.832 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 122' ' ' TYR . . . -53.84 -23.93 24.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.94 -52.14 66.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.054 -1.263 . . . . 0.0 109.083 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -75.76 -35.8 60.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.89 . . . . 0.0 109.412 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 1.03 ' CE2' HG11 ' A' ' 78' ' ' VAL . 2.7 t80 -62.91 -51.21 67.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.069 -1.02 . . . . 0.0 109.166 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.69 -45.65 91.46 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 108.822 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.38 -53.91 31.76 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.36 -0.838 . . . . 0.0 108.911 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.737 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -51.85 -53.06 44.82 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.432 -0.792 . . . . 0.0 108.885 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -52.7 -58.05 8.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 108.628 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.29 -15.41 3.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.661 -0.65 . . . . 0.0 110.239 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.1 OUTLIER -69.22 179.54 1.92 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.958 -1.089 . . . . 0.0 110.17 -179.262 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER -92.79 -37.89 12.07 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.411 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.4 t -72.04 -50.05 39.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.786 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.816 HG22 ' HB1' ' A' ' 81' ' ' ALA . 3.7 t -57.44 -38.09 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.811 -1.18 . . . . 0.0 108.569 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -66.42 -35.59 80.7 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 109.068 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -26.32 68.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.05 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.7 mt -81.77 -28.27 33.35 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.288 -0.883 . . . . 0.0 108.795 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.403 HG23 ' CB ' ' A' ' 77' ' ' ALA . 11.2 t -74.91 -39.51 45.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -68.22 -40.05 82.18 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -33.82 75.32 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -0.818 . . . . 0.0 108.875 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.674 ' HG2' HG23 ' A' ' 73' ' ' THR . 0.2 OUTLIER -64.16 -70.73 0.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.247 -0.908 . . . . 0.0 109.032 179.541 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -48.15 -37.19 14.98 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 108.928 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 0.3 OUTLIER -72.48 -25.88 61.59 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.362 -0.836 . . . . 0.0 109.24 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.614 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -68.47 -55.22 12.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.398 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -73.76 -29.18 62.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 109.949 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -75.85 -25.63 56.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.059 -1.026 . . . . 0.0 109.87 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.702 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.0 OUTLIER -81.94 -48.14 11.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.011 . . . . 0.0 108.35 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 1.073 HG21 ' CE2' ' A' ' 25' ' ' PHE . 13.4 m -83.01 -12.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 81.15 -49.09 0.27 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 0.0 109.414 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.695 HD21 HG12 ' A' ' 61' ' ' VAL . 15.0 tp 61.65 132.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.452 -0.78 . . . . 0.0 109.426 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 16.7 mtt180 -161.49 38.8 0.14 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.587 -1.32 . . . . 0.0 110.302 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 164.46 108.5 0.21 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.42 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 1.053 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -97.99 144.15 27.52 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.4 -1.059 . . . . 0.0 109.335 179.031 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.563 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 36.3 Cg_endo -78.31 150.94 89.2 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 C-N-CA 124.088 -1.213 . . . . 0.0 110.54 0.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -130.95 141.18 50.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.319 -1.488 . . . . 0.0 108.702 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.548 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 2.8 ttp -144.91 134.02 22.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 0.0 110.027 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.548 ' CD1' ' C ' ' A' ' 153' ' ' MET . 0.5 OUTLIER -134.49 155.58 50.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 110.008 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.823 HG22 ' O ' ' A' ' 21' ' ' GLN . 30.8 t -112.07 130.66 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.332 -0.855 . . . . 0.0 108.958 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.538 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 51.75 23.24 1.94 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 54.97 22.71 28.75 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.537 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -125.01 -22.97 4.33 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.825 -1.397 . . . . 0.0 109.113 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.541 ' CZ ' ' HG2' ' A' ' 188' ' ' LYS . 12.6 m-85 -121.46 127.69 51.36 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 11.5 pt20 -123.32 118.28 27.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 161' ' ' LEU . 5.8 mt -67.3 177.12 1.97 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.44 ' O ' ' ND2' ' A' ' 162' ' ' ASN . 0.4 OUTLIER -144.1 94.83 5.73 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 120.919 -1.113 . . . . 0.0 109.799 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.08 40.33 0.95 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.787 2.325 . . . . 0.0 110.637 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -118.04 -6.73 10.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.022 . . . . 0.0 109.324 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 166' ' ' MET . . . -58.18 -45.59 93.83 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 165' ' ' GLY . 0.1 OUTLIER -150.34 -95.9 0.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.256 -1.144 . . . . 0.0 109.547 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.3 t70 64.54 32.57 11.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.116 -0.99 . . . . 0.0 109.677 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.4 p -112.34 -48.0 3.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.999 -1.063 . . . . 0.0 109.647 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.9 t -145.89 59.06 1.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.701 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -160.03 63.79 0.35 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.971 . . . . 0.0 109.463 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 20.8 mtt -72.64 -16.59 61.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -76.74 -59.3 2.83 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.736 -0.602 . . . . 0.0 109.397 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.29 -23.27 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.235 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.503 ' O ' ' HB2' ' A' ' 178' ' ' TYR . 32.7 t80 -73.71 -39.79 64.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.139 -0.976 . . . . 0.0 109.383 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.633 HG22 HG12 ' A' ' 42' ' ' ILE . 18.6 t -73.61 -29.5 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.996 -1.065 . . . . 0.0 109.233 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -82.49 -51.98 7.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 0.0 109.481 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -24.98 67.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 174' ' ' PHE . 20.3 t80 -78.54 -47.58 17.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.218 -0.926 . . . . 0.0 109.372 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.8 -29.92 71.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.982 . . . . 0.0 109.313 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.14 -47.26 18.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.671 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.916 HG23 ' NE2' ' A' ' 8' ' ' GLN . 15.3 m -58.7 -26.82 64.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.004 . . . . 0.0 109.642 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.3 t -87.75 -41.14 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.048 -1.032 . . . . 0.0 109.049 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -57.01 -42.99 81.33 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.29 -0.882 . . . . 0.0 109.133 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.556 ' CE2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -82.09 -35.09 28.99 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.305 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.726 HD23 ' O ' ' A' ' 181' ' ' THR . 0.7 OUTLIER -57.29 -20.13 26.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.875 -1.14 . . . . 0.0 109.331 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.1 t -78.63 -0.87 31.65 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.778 -1.201 . . . . 0.0 108.503 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.46 7.31 14.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.423 -0.798 . . . . 0.0 109.379 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.541 ' HG2' ' CZ ' ' A' ' 159' ' ' TYR . 13.8 tptm -61.19 -46.86 88.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.922 . . . . 0.0 109.914 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.4 pttm . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.445 -179.865 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.593 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 12.2 mt-30 -114.02 60.33 0.67 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.548 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 2' ' ' GLN . 0.2 OUTLIER 173.96 102.29 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.43 -0.793 . . . . 0.0 108.986 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -115.37 58.37 0.72 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.827 -1.171 . . . . 0.0 111.017 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 1.7 m-20 45.16 87.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.454 -0.779 . . . . 0.0 110.603 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.82 -35.37 1.93 Allowed Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.207 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.09 -70.31 0.69 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.11 -1.229 . . . . 0.0 108.951 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.671 ' HG2' ' CD2' ' A' ' 9' ' ' TYR . 4.7 pm0 -65.77 -27.07 68.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.29 -0.881 . . . . 0.0 108.811 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.671 ' CD2' ' HG2' ' A' ' 8' ' ' GLN . 2.2 p90 -176.18 138.73 0.34 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -103.99 -179.69 4.02 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 12' ' ' LEU . 47.4 m -103.32 160.25 14.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.547 -0.721 . . . . 0.0 110.102 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.528 HD11 ' HD2' ' A' ' 154' ' ' PHE . 0.7 OUTLIER -92.04 163.25 14.05 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.426 -0.796 . . . . 0.0 109.41 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.431 ' C ' ' HG3' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -97.73 -16.07 20.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' HG3' ' C ' ' A' ' 13' ' ' GLU . 5.3 mttt -148.71 112.36 3.65 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.7 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.82 161.08 33.73 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.447 2.098 . . . . 0.0 109.703 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.615 HG12 ' CB ' ' A' ' 19' ' ' ALA . 1.1 p -122.32 126.74 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.999 -1.063 . . . . 0.0 110.237 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -46.35 125.72 7.11 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 77.16 8.9 87.01 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 20' ' ' PRO . . . -36.25 161.73 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.685 -0.891 . . . . 0.0 111.189 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 1.086 ' HG3' HD12 ' A' ' 23' ' ' LEU . 36.5 Cg_endo -78.06 113.57 3.44 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 123.273 2.649 . . . . 0.0 111.953 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.795 ' O ' HG13 ' A' ' 155' ' ' VAL . 18.9 mt-30 -51.89 -31.12 26.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.71 HG22 HG22 ' A' ' 155' ' ' VAL . 24.2 t -157.05 81.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.086 HD12 ' HG3' ' A' ' 20' ' ' PRO . 1.3 tt -83.92 137.6 33.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.363 -0.835 . . . . 0.0 110.116 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.805 ' N ' HD23 ' A' ' 23' ' ' LEU . 31.6 mt-10 -120.52 99.38 6.52 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 1.036 ' CZ ' HD13 ' A' ' 23' ' ' LEU . 88.0 m-85 -83.5 115.3 22.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.489 -0.757 . . . . 0.0 109.434 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 0.4 OUTLIER -154.23 139.1 17.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 110.033 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.598 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 8.3 p -121.44 173.17 7.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.41 -0.806 . . . . 0.0 109.443 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.884 ' CD2' HD21 ' A' ' 72' ' ' LEU . 1.6 m-30 -85.2 43.54 1.02 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.869 . . . . 0.0 108.84 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.636 ' CG ' HG11 ' A' ' 96' ' ' VAL . 9.0 m-85 -143.11 14.19 1.86 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.909 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -105.02 160.99 24.1 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 120.84 -1.162 . . . . 0.0 109.357 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -76.03 -35.43 2.45 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.134 1.889 . . . . 0.0 108.064 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 12.2 m170 -82.26 -23.65 35.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 11.1 t -46.13 -52.91 11.31 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.47 ' HB2' ' HG2' ' A' ' 97' ' ' GLN . 85.8 t80 -80.6 -31.5 36.67 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.905 -0.497 . . . . 0.0 111.064 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.64 -27.46 31.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.841 -1.162 . . . . 0.0 111.298 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.642 ' CD1' HD12 ' A' ' 40' ' ' LEU . 2.3 m-30 -84.1 -17.31 40.61 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.873 -1.142 . . . . 0.0 110.767 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -116.64 20.99 13.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.837 -1.164 . . . . 0.0 110.637 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 16.1 mm-40 -143.36 -66.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.953 -1.092 . . . . 0.0 110.405 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 4.6 t -90.16 -69.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.141 -0.974 . . . . 0.0 110.465 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.642 HD12 ' CD1' ' A' ' 36' ' ' PHE . 94.6 mt -47.81 -20.97 0.34 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.286 -0.884 . . . . 0.0 110.759 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 28.7 p-80 40.97 34.38 0.28 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 109.429 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.415 HG13 ' HB3' ' A' ' 40' ' ' LEU . 20.8 mt -76.01 -26.17 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.48 -0.762 . . . . 0.0 109.754 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.764 ' O ' HG12 ' A' ' 46' ' ' VAL . 14.1 m -78.18 -33.05 50.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.108 -0.995 . . . . 0.0 110.148 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -84.12 -47.42 10.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.034 -1.041 . . . . 0.0 109.829 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -57.27 -37.79 72.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 43' ' ' SER . 14.5 p -55.4 -28.23 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.179 -0.951 . . . . 0.0 109.644 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.619 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -70.13 -30.74 68.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.404 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.52 -38.6 69.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.474 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -92.15 18.53 8.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 109.468 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.754 HD13 ' HG2' ' A' ' 56' ' ' MET . 12.1 mt -105.18 102.6 37.45 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.869 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.541 ' O ' ' N ' ' A' ' 53' ' ' GLY . 32.6 Cg_endo -75.49 151.55 37.5 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.343 2.028 . . . . 0.0 108.96 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -65.55 52.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.804 -1.185 . . . . 0.0 110.981 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.835 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -144.3 37.82 1.36 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.87 HG21 ' HB2' ' A' ' 186' ' ' SER . 13.3 t -166.91 149.87 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -113.36 115.74 28.58 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.34 -0.85 . . . . 0.0 110.36 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.754 ' HG2' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -100.93 105.07 16.28 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.107 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -96.01 141.14 29.77 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.07 -178.868 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.422 ' CD ' ' N ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -117.94 105.02 11.47 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.225 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.517 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 4.4 m-85 -113.5 175.33 5.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.106 -0.996 . . . . 0.0 110.926 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 1.169 ' CD2' HD22 ' A' ' 72' ' ' LEU . 9.8 t-80 -125.44 123.9 40.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.553 -0.717 . . . . 0.0 109.648 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.907 HG11 HD22 ' A' ' 147' ' ' LEU . 35.6 m -91.86 153.75 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.433 -0.792 . . . . 0.0 109.952 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 1.9 p-10 -110.24 54.61 0.66 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.173 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.72 ' CE1' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -134.61 56.04 1.87 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.087 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.719 ' HE1' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -122.08 32.16 5.92 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.458 -0.777 . . . . 0.0 109.53 179.635 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.31 40.88 23.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . -148.08 80.71 0.21 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 66' ' ' GLY . 5.3 t0 -26.78 -45.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.449 -0.442 . . . . 0.0 111.209 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.94 HD22 HG22 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -46.02 -30.37 1.81 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.357 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.719 ' HA2' ' HE1' ' A' ' 64' ' ' MET . . . -48.03 -55.97 9.5 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 2.2 ttmt -49.81 -46.39 51.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.278 . . . . 0.0 108.604 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.4 -18.25 60.69 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.031 -1.043 . . . . 0.0 108.368 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.169 HD22 ' CD2' ' A' ' 60' ' ' HIS . 2.3 tt -76.1 -37.38 58.18 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.421 ' CG2' ' OE1' ' A' ' 138' ' ' GLN . 1.6 m -65.62 -41.45 92.67 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 177.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.492 ' NE2' ' HB2' ' A' ' 126' ' ' TRP . 15.3 tp60 -63.17 -23.63 67.52 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -70.49 -39.13 74.36 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.443 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.573 ' CH2' ' OE1' ' A' ' 85' ' ' GLU . 37.6 t-105 -66.09 -30.03 70.47 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.821 . . . . 0.0 108.932 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.576 ' HB2' HE22 ' A' ' 138' ' ' GLN . . . -83.39 -59.96 2.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.138 HG11 ' CD2' ' A' ' 122' ' ' TYR . 92.2 t -57.55 -26.65 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 109.665 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.71 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -79.46 -65.57 0.98 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.073 -1.017 . . . . 0.0 108.745 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -47.03 -26.25 1.0 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.103 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.865 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -74.89 -38.95 61.74 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.448 -0.783 . . . . 0.0 109.28 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 79' ' ' ALA . 85.9 mt -106.33 10.48 31.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.202 -0.936 . . . . 0.0 110.715 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 54.77 19.52 14.58 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.949 HG21 ' CE1' ' A' ' 112' ' ' PHE . 31.6 m -84.44 -6.29 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.284 -1.127 . . . . 0.0 110.318 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.573 ' OE1' ' CH2' ' A' ' 76' ' ' TRP . 3.1 mt-10 -42.22 -71.56 0.08 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.155 -0.966 . . . . 0.0 110.052 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -39.33 -34.26 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.378 -0.827 . . . . 0.0 110.622 -179.591 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.535 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 27.5 mtpp -81.66 -49.87 9.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.284 -0.885 . . . . 0.0 111.189 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.826 HG23 HD12 ' A' ' 92' ' ' LEU . 1.4 m -86.54 -14.26 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.882 -1.136 . . . . 0.0 110.681 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.755 HG23 ' CD1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -74.3 -42.51 59.41 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.698 -1.251 . . . . 0.0 108.349 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.408 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -55.75 -54.05 56.08 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.723 -1.236 . . . . 0.0 110.875 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.489 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 27.1 Cg_endo -72.4 -19.46 25.21 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 N-CA-C 109.881 -0.854 . . . . 0.0 109.881 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.826 HD12 HG23 ' A' ' 88' ' ' VAL . 35.5 mt -87.19 -43.56 12.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.127 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.755 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.1 m-30 -63.59 -44.02 95.23 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.037 -1.039 . . . . 0.0 108.697 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.52 -19.59 57.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 109.426 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.456 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -69.85 -40.51 74.87 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.636 HG11 ' CG ' ' A' ' 29' ' ' PHE . 1.6 t -92.79 -15.71 7.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 O-C-N 121.102 -1.234 . . . . 0.0 108.734 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.47 ' HG2' ' HB2' ' A' ' 34' ' ' TYR . 2.9 mp0 -113.02 10.75 18.85 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.933 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.786 ' O ' HG23 ' A' ' 99' ' ' THR . 0.8 OUTLIER -159.01 51.47 0.38 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.392 -1.442 . . . . 0.0 109.851 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 166.88 -49.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.405 -0.81 . . . . 0.0 109.898 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 75.7 16.29 2.5 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.14 -0.975 . . . . 0.0 110.494 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.7 t -85.7 -4.05 59.06 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.829 0.823 . . . . 0.0 108.861 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.94 HG22 HD22 ' A' ' 68' ' ' LEU . 6.6 mm -82.67 71.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.766 -0.584 . . . . 0.0 109.543 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.501 ' C ' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -116.83 -11.36 10.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.174 -0.954 . . . . 0.0 109.995 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.678 ' N ' HD21 ' A' ' 68' ' ' LEU . 1.5 p -110.67 117.21 32.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 109.77 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . . . -48.31 -39.01 20.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.59 -33.31 54.45 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 108' ' ' ILE . 1.2 p30 -68.64 -41.45 79.39 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.752 -1.179 . . . . 0.0 108.644 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.556 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 3.1 mt -48.57 -44.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.612 -1.305 . . . . 0.0 107.666 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -48.49 79.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.576 -0.703 . . . . 0.0 109.686 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.65 -42.85 62.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.814 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.724 HG11 ' HG ' ' A' ' 92' ' ' LEU . 3.2 t -64.83 -40.13 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.134 -0.979 . . . . 0.0 109.767 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.949 ' CE1' HG21 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -56.77 -50.89 70.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.018 -1.051 . . . . 0.0 109.552 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.8 mt -70.67 -22.74 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 109.597 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -64.86 -15.91 62.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.801 ' HB2' HG12 ' A' ' 88' ' ' VAL . . . -73.37 -6.0 43.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 108.992 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.561 ' C ' HD13 ' A' ' 117' ' ' ILE . . . 97.03 15.16 39.94 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.684 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.6 mm -95.62 168.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -1.196 . . . . 0.0 108.957 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -89.24 139.55 30.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.331 -1.481 . . . . 0.0 109.7 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.75 -50.42 67.77 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -57.99 -44.47 87.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.138 -1.213 . . . . 0.0 109.016 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -55.3 -44.34 75.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 108.852 179.534 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 1.138 ' CD2' HG11 ' A' ' 78' ' ' VAL . 2.3 t80 -55.13 -46.98 75.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.862 . . . . 0.0 108.845 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -56.6 -38.9 72.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 108.708 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.22 71.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.385 -0.822 . . . . 0.0 108.828 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.51 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -49.16 -50.47 37.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.268 -0.895 . . . . 0.0 108.605 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.492 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 12.8 t90 -58.32 -56.12 26.22 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 -55.34 -15.91 2.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.583 -0.698 . . . . 0.0 109.923 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -71.23 166.62 21.15 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.972 -1.08 . . . . 0.0 109.45 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -86.77 -40.66 14.78 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.264 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.09 -45.08 97.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 C-N-CA 118.062 -1.455 . . . . 0.0 109.316 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.865 HG22 ' HB1' ' A' ' 81' ' ' ALA . 2.5 t -64.6 -41.23 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.001 -1.062 . . . . 0.0 108.413 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -37.29 86.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.365 -0.834 . . . . 0.0 108.992 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.0 m -62.53 -30.76 71.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 108.908 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.72 -21.98 43.91 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.435 ' HA ' ' OE1' ' A' ' 138' ' ' GLN . 4.9 t -77.05 -46.38 29.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 139' ' ' GLU . . . -64.04 -42.83 96.92 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.479 ' HG2' ' OH ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -62.97 -32.37 73.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.404 -0.81 . . . . 0.0 109.036 179.664 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.576 HE22 ' HB2' ' A' ' 77' ' ' ALA . 48.0 mt-30 -65.03 -62.84 1.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 108.92 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 136' ' ' ALA . 6.8 pt-20 -54.51 -42.42 70.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 108.838 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 29.1 mttt -67.49 -27.19 66.8 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.375 -0.828 . . . . 0.0 109.151 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 23' ' ' LEU . . . -63.42 -49.07 75.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.024 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.512 ' HB2' HG12 ' A' ' 61' ' ' VAL . . . -73.21 -41.39 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.837 . . . . 0.0 110.148 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.18 -16.74 60.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.158 -0.964 . . . . 0.0 109.862 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.607 ' CG ' HG21 ' A' ' 16' ' ' VAL . 22.8 m-20 -82.9 -44.21 15.64 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.738 HG21 ' CE1' ' A' ' 25' ' ' PHE . 3.8 m -91.17 -5.38 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 147' ' ' LEU . 0.0 OUTLIER 81.86 -46.75 0.2 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.595 -0.691 . . . . 0.0 109.804 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.907 HD22 HG11 ' A' ' 61' ' ' VAL . 13.0 tp 73.12 141.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.66 -0.65 . . . . 0.0 109.72 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.39 25.77 0.16 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.771 -1.206 . . . . 0.0 110.315 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.03 112.2 0.62 Allowed Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.108 -1.52 . . . . 0.0 111.081 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.479 HG22 ' CZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -90.48 140.31 26.81 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.503 -0.998 . . . . 0.0 108.962 178.158 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.25 152.2 95.95 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 123.785 -1.339 . . . . 0.0 110.816 0.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -128.22 159.97 33.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.393 -1.442 . . . . 0.0 109.233 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.524 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 3.0 ttm -142.02 121.82 13.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.101 -0.999 . . . . 0.0 109.88 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 160' ' ' GLN . 23.5 m-85 -122.89 145.77 48.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.139 -0.975 . . . . 0.0 109.644 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.795 HG13 ' O ' ' A' ' 21' ' ' GLN . 36.9 t -124.66 122.31 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.145 -0.972 . . . . 0.0 108.957 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER 50.95 24.99 2.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.804 -0.758 . . . . 0.0 108.989 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.502 ' C ' HD13 ' A' ' 12' ' ' LEU . . . 51.3 20.84 5.38 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.466 -1.349 . . . . 0.0 110.325 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -121.83 -19.92 6.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.819 -1.4 . . . . 0.0 108.867 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.586 ' CD2' ' HG3' ' A' ' 188' ' ' LYS . 19.6 m-85 -141.7 123.83 15.52 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.318 -0.864 . . . . 0.0 108.945 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.59 ' HB2' ' CD2' ' A' ' 154' ' ' PHE . 1.3 tt0 -130.29 126.56 37.54 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.279 -0.888 . . . . 0.0 109.389 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.56 HD22 ' HB3' ' A' ' 9' ' ' TYR . 8.1 mt -59.46 179.26 0.12 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 162' ' ' ASN . 12.8 p-10 -153.22 107.67 2.62 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.071 -1.018 . . . . 0.0 109.777 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.03 50.08 3.19 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.306 2.004 . . . . 0.0 110.2 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -101.39 -5.96 24.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.415 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 168' ' ' THR . . . -123.53 39.12 2.27 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.62 4.43 13.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -1.096 . . . . 0.0 109.556 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -92.11 31.94 1.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.134 -0.979 . . . . 0.0 109.464 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 169' ' ' SER . 76.2 p -71.68 -20.49 61.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 109.825 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 168' ' ' THR . 1.6 t 76.47 14.11 2.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 0.0 109.457 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.448 ' OD1' ' HB ' ' A' ' 168' ' ' THR . 1.2 p30 -152.28 94.64 1.95 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.33 -0.857 . . . . 0.0 108.794 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 6.2 mtt -58.86 -15.36 12.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.361 -0.837 . . . . 0.0 109.882 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.75 -49.22 78.58 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 121.577 -0.702 . . . . 0.0 109.686 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 12.5 t -69.57 -29.14 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 109.854 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.485 ' O ' ' HB3' ' A' ' 178' ' ' TYR . 4.6 t80 -65.59 -36.62 84.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.015 -1.053 . . . . 0.0 109.466 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 93.3 t -81.2 -24.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.05 -1.031 . . . . 0.0 109.772 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -53.48 6.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.025 -1.047 . . . . 0.0 109.402 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 2' ' ' GLN . 0.3 OUTLIER -65.91 -33.39 75.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.106 -0.996 . . . . 0.0 109.356 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 174' ' ' PHE . 2.5 t80 -70.13 -57.18 5.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 109.093 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.79 -29.92 69.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.341 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -73.27 -41.71 63.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.933 . . . . 0.0 109.387 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.564 ' CG2' ' CG ' ' A' ' 8' ' ' GLN . 1.0 OUTLIER -62.37 -60.01 4.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.163 -0.961 . . . . 0.0 109.283 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.434 HG21 ' CE1' ' A' ' 178' ' ' TYR . 61.3 t -53.75 -32.68 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.06 -1.025 . . . . 0.0 109.198 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -47.08 86.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 109.446 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -85.56 -25.66 26.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.203 -0.936 . . . . 0.0 110.426 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.624 HD21 ' CE2' ' A' ' 9' ' ' TYR . 4.1 mt -67.81 -20.64 65.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.489 -1.382 . . . . 0.0 108.856 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.87 ' HB2' HG21 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -69.95 -10.65 59.32 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.169 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.61 -4.62 56.7 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.55 -0.718 . . . . 0.0 109.359 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.586 ' HG3' ' CD2' ' A' ' 159' ' ' TYR . 48.4 mmtt -55.56 -33.17 63.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.156 -0.965 . . . . 0.0 109.159 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 188' ' ' LYS . 3.3 pptp? . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.288 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.509 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 0.8 OUTLIER 40.96 48.27 2.77 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.967 0.889 . . . . 0.0 109.037 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.691 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER 72.32 98.13 0.07 Allowed 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.661 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' ASP . 3.0 tt0 -86.72 52.32 2.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 0.0 110.277 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLU . 64.7 t0 39.82 81.01 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.796 -0.565 . . . . 0.0 109.906 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 119.19 -18.91 10.19 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.541 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.71 -67.32 0.77 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.902 -1.352 . . . . 0.0 108.769 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.593 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -96.4 4.0 52.49 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.21 -0.932 . . . . 0.0 109.806 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.557 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -177.31 130.8 0.16 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.913 -1.117 . . . . 0.0 109.611 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -117.79 177.05 4.91 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.813 -0.555 . . . . 0.0 109.525 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -100.17 160.22 14.49 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.374 0.607 . . . . 0.0 109.552 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.773 HD11 ' HD2' ' A' ' 154' ' ' PHE . 17.4 mt -95.69 133.96 39.16 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.315 -0.866 . . . . 0.0 109.779 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -72.63 -19.42 61.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 108.694 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -135.69 107.32 9.91 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 34.8 Cg_endo -76.08 158.34 37.98 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.412 2.075 . . . . 0.0 110.968 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 16' ' ' VAL . 46.1 t -128.72 87.43 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.418 -0.801 . . . . 0.0 109.38 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.52 133.05 13.42 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 95.82 -25.56 24.52 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.741 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -42.02 157.75 0.21 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.401 -1.058 . . . . 0.0 109.367 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.571 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 35.2 Cg_endo -78.4 135.42 13.31 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.504 2.136 . . . . 0.0 111.015 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.804 ' O ' HG13 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -44.25 -24.03 0.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.411 -0.806 . . . . 0.0 109.764 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.766 HG13 ' CE ' ' A' ' 153' ' ' MET . 42.4 t -149.83 80.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.022 -1.049 . . . . 0.0 108.896 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.877 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -72.06 124.94 26.03 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.0 OUTLIER -106.5 125.29 50.81 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.614 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.877 ' CE2' HD13 ' A' ' 23' ' ' LEU . 6.3 m-85 -115.73 110.32 18.95 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.466 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -150.79 145.36 25.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.953 . . . . 0.0 109.639 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.986 ' HB3' HG22 ' A' ' 61' ' ' VAL . 32.8 p -126.03 -163.86 1.26 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.203 -0.935 . . . . 0.0 108.83 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.67 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -118.65 55.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.152 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.673 ' CE1' HD22 ' A' ' 72' ' ' LEU . 12.2 m-85 -138.88 2.14 2.13 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.453 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.516 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -113.91 172.46 3.56 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.658 -1.276 . . . . 0.0 109.765 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 30' ' ' CYS . 32.8 Cg_endo -75.04 -49.84 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.481 2.12 . . . . 0.0 108.835 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 18.5 m80 -73.11 -25.63 60.94 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -46.85 -41.14 15.17 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.109 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.501 ' CG ' ' OE1' ' A' ' 97' ' ' GLN . 3.7 t80 -88.44 -44.13 10.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.601 -0.687 . . . . 0.0 110.171 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 46.0 mt-30 -72.43 -24.49 61.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.986 -1.071 . . . . 0.0 110.924 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 1.6 t80 -80.45 -16.76 53.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.938 -1.101 . . . . 0.0 110.388 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.51 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.6 tt0 -131.96 50.99 2.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.892 -1.13 . . . . 0.0 110.381 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.51 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -171.29 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 110.55 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 52.1 t -94.77 -53.58 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 110.575 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 35' ' ' GLN . 22.6 mt -48.86 -20.18 0.47 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.169 -0.957 . . . . 0.0 110.58 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 22.4 m80 47.93 31.67 2.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.889 -1.132 . . . . 0.0 108.852 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.856 ' O ' HG13 ' A' ' 46' ' ' VAL . 4.3 mt -83.46 -41.84 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.53 -0.731 . . . . 0.0 109.993 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.461 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -80.0 -17.84 51.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.984 -1.073 . . . . 0.0 110.557 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 2.2 m-20 -87.3 -39.02 15.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.935 -1.103 . . . . 0.0 110.074 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -71.66 -33.76 69.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.994 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 42' ' ' ILE . 30.5 m -55.74 -35.84 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.771 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -54.38 -46.42 73.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 109.562 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -26.77 38.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.504 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 2.5 mmtm -89.27 20.61 3.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.834 . . . . 0.0 110.308 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.01 HD11 ' SD ' ' A' ' 56' ' ' MET . 35.8 mt -114.02 87.37 12.78 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.987 -1.07 . . . . 0.0 109.714 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 36.3 Cg_endo -78.19 64.36 8.38 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.599 2.199 . . . . 0.0 111.01 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER 56.85 130.74 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.638 0.732 . . . . 0.0 110.516 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.29 -21.18 31.5 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.996 HG11 HD22 ' A' ' 50' ' ' LEU . 1.2 t -91.03 87.72 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -1.048 . . . . 0.0 108.833 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -77.6 97.03 4.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.952 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . 1.01 ' SD ' HD11 ' A' ' 50' ' ' LEU . 63.4 mtp -95.83 97.1 9.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.12 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -91.82 135.57 33.81 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.617 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.454 ' HG3' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -109.19 116.88 32.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.382 -0.824 . . . . 0.0 110.271 -179.419 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 3.2 m-85 -117.18 175.15 5.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.132 -0.98 . . . . 0.0 110.787 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.636 ' NE2' HD21 ' A' ' 72' ' ' LEU . 2.6 t60 -112.15 141.38 45.92 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.683 0.754 . . . . 0.0 109.203 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 1.072 HG11 ' CG1' ' A' ' 150' ' ' VAL . 3.2 m -77.09 155.71 5.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.3 0.571 . . . . 0.0 109.847 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.518 ' OD1' ' CB ' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -124.79 36.73 4.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 108.822 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.564 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 6.3 p90 -136.11 52.55 1.97 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -155.91 47.99 0.49 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 158.36 61.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -28.78 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 65' ' ' GLY . 71.2 m-20 -88.94 -78.26 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -1.125 . . . . 0.0 110.663 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.126 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -79.87 -22.36 42.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.957 -1.089 . . . . 0.0 110.51 -178.868 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 1.126 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -53.95 -43.75 71.8 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 1.8 tmtp? -64.86 -45.93 84.01 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.065 -1.256 . . . . 0.0 108.258 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.54 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 1.5 t70 -66.03 -31.65 72.67 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.754 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 15.5 tp -53.79 -49.66 67.81 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.514 HG23 ' CD ' ' A' ' 138' ' ' GLN . 1.3 m -57.33 -43.71 83.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 1.009 ' O ' HG23 ' A' ' 78' ' ' VAL . 2.5 tm0? -57.07 -25.26 58.4 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -64.44 -44.07 92.31 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -57.46 -33.04 67.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -79.53 -51.05 9.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.395 -0.816 . . . . 0.0 110.159 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 1.009 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.7 t -62.74 -27.41 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.068 -1.02 . . . . 0.0 109.641 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.606 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -77.95 -61.88 1.85 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.043 -1.036 . . . . 0.0 109.36 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.648 ' HB3' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -44.71 -27.29 0.48 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.227 -0.921 . . . . 0.0 108.951 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.624 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -68.71 -44.46 73.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.365 -0.834 . . . . 0.0 109.4 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.677 ' HB2' HG13 ' A' ' 84' ' ' VAL . 21.9 mt -108.49 16.29 23.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.09 29.83 4.95 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.677 HG13 ' HB2' ' A' ' 82' ' ' LEU . 34.8 m -85.73 -3.89 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -1.17 . . . . 0.0 110.066 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -45.1 -73.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.09 -1.006 . . . . 0.0 109.911 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.27 -35.12 0.23 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.598 -0.689 . . . . 0.0 110.603 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.789 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 25.7 mtpp -80.54 -52.78 7.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.943 . . . . 0.0 111.301 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.761 ' O ' HD12 ' A' ' 92' ' ' LEU . 2.6 m -84.28 -9.46 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.745 -1.222 . . . . 0.0 110.944 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.753 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -73.68 -45.37 52.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.758 -1.214 . . . . 0.0 108.455 178.632 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.424 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -51.93 -53.94 46.0 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.556 -1.34 . . . . 0.0 110.757 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.541 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 24.0 Cg_endo -72.96 -17.74 24.88 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 N-CA-C 109.65 -0.942 . . . . 0.0 109.65 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.848 ' HG ' HG11 ' A' ' 111' ' ' VAL . 6.4 mt -86.19 -44.4 12.22 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.753 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.2 m-30 -62.04 -47.52 84.34 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.906 -1.121 . . . . 0.0 108.674 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 97' ' ' GLN . 46.8 mt-10 -69.03 -34.81 75.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.025 -1.047 . . . . 0.0 109.554 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.457 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -64.71 -31.99 82.72 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 92' ' ' LEU . 1.9 t -107.8 8.12 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.984 -1.303 . . . . 0.0 109.568 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.501 ' OE1' ' CG ' ' A' ' 34' ' ' TYR . 11.5 mt-30 -97.75 5.75 48.79 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.915 -1.116 . . . . 0.0 110.296 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.01 -49.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.803 -1.186 . . . . 0.0 110.631 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 1.4 p -55.05 -42.05 72.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.299 -1.501 . . . . 0.0 109.544 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.6 mm-40 67.62 10.5 7.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 110.126 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.3 t -83.67 -8.29 59.31 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.744 0.783 . . . . 0.0 109.102 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.62 ' CB ' HG22 ' A' ' 96' ' ' VAL . 16.3 mm -79.55 66.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.457 ' HD3' ' C ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -127.25 31.75 5.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.585 -179.572 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 107' ' ' ASP . 16.8 p -147.94 127.77 13.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 110.146 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.48 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.56 -29.8 7.55 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 t -63.71 -34.29 77.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.597 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.7 OUTLIER -68.3 -46.41 70.37 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.556 ' CG1' HD23 ' A' ' 68' ' ' LEU . 19.0 mt -52.39 -29.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.448 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -73.24 -39.43 65.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 109.121 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 114' ' ' ASN . 14.5 m-20 -56.34 -45.4 80.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.317 -0.864 . . . . 0.0 109.406 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.848 HG11 ' HG ' ' A' ' 92' ' ' LEU . 15.4 t -70.96 -38.59 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.41 ' CE2' ' HE2' ' A' ' 122' ' ' TYR . 2.9 m-85 -65.75 -32.36 73.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.445 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 109' ' ' ARG . 16.1 mt -79.4 -25.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.025 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 110' ' ' ASP . 17.5 m-20 -70.17 -23.65 63.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.974 -1.079 . . . . 0.0 109.697 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.789 ' HB1' ' HE3' ' A' ' 87' ' ' LYS . . . -85.21 2.57 43.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.551 ' C ' HD13 ' A' ' 117' ' ' ILE . . . 92.78 8.99 61.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.718 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -94.4 58.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 109.549 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 117' ' ' ILE . 56.5 mttt -37.1 154.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.228 -0.92 . . . . 0.0 110.295 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 123' ' ' ASP . . . -50.78 -27.71 13.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -67.7 -43.43 80.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -1.146 . . . . 0.0 109.369 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -46.99 19.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.536 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.895 ' CE2' HG11 ' A' ' 78' ' ' VAL . 5.8 t80 -63.52 -47.08 83.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.177 -0.952 . . . . 0.0 109.52 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 119' ' ' GLY . 30.5 t0 -61.38 -53.18 59.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.148 -0.97 . . . . 0.0 109.176 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.21 -53.67 16.17 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.623 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -48.23 -55.75 9.7 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.426 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 8.5 t90 -53.29 -59.18 4.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.14 -15.81 2.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.573 -0.705 . . . . 0.0 109.985 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 7.7 m -69.67 176.97 3.21 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.071 -1.018 . . . . 0.0 109.891 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -89.57 -39.62 13.16 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.335 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.39 -47.16 78.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.752 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.624 HG22 ' HB1' ' A' ' 81' ' ' ALA . 2.8 t -62.95 -34.54 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.904 -1.123 . . . . 0.0 108.399 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -67.33 -28.3 67.86 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 137' ' ' GLN . 1.8 m -69.93 -35.51 74.59 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.648 HD13 ' HB3' ' A' ' 80' ' ' MET . 0.2 OUTLIER -79.09 -19.08 52.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.568 HG23 ' HB1' ' A' ' 77' ' ' ALA . 10.2 t -82.25 -47.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.33 -35.59 81.36 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.41 -0.806 . . . . 0.0 108.841 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.9 OUTLIER -69.88 -37.39 76.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 109.025 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.514 ' CD ' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -65.4 -68.38 0.37 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 108.988 179.519 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.71 -36.41 11.24 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.219 -0.926 . . . . 0.0 108.586 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -71.91 -30.91 65.85 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -61.11 -59.74 4.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.361 -0.837 . . . . 0.0 108.846 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.537 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -67.47 -26.76 66.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.838 . . . . 0.0 109.508 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.72 -22.79 46.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.963 . . . . 0.0 109.884 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -82.22 -43.73 17.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.104 -0.997 . . . . 0.0 108.475 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.824 HG21 ' CE2' ' A' ' 25' ' ' PHE . 18.4 m -98.36 -5.6 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.537 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.1 tt0 75.21 -53.34 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.491 -0.756 . . . . 0.0 109.793 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.8 HD21 HG12 ' A' ' 61' ' ' VAL . 13.6 tp 69.57 135.03 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.7 ptt85 -160.18 35.7 0.17 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.457 -1.402 . . . . 0.0 110.219 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 161.93 108.56 0.23 Allowed Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.559 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 1.072 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -89.62 144.31 31.74 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.405 -1.056 . . . . 0.0 109.225 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.18 152.25 94.29 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 124.009 -1.246 . . . . 0.0 110.779 0.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -129.4 139.46 51.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.453 -1.404 . . . . 0.0 108.983 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.766 ' CE ' HG13 ' A' ' 22' ' ' VAL . 19.9 ttt -140.97 128.05 20.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.98 -1.075 . . . . 0.0 110.179 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.773 ' HD2' HD11 ' A' ' 12' ' ' LEU . 2.5 m-85 -126.28 137.12 53.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -0.918 . . . . 0.0 109.634 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' ' 21' ' ' GLN . 54.7 t -99.25 133.72 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.741 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 3.9 t30 42.45 24.47 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.16 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.532 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 56.81 59.22 11.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' N ' HD12 ' A' ' 12' ' ' LEU . 6.7 tttt -166.65 -36.23 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.439 -1.036 . . . . 0.0 108.294 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.495 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 10.7 m-85 -114.59 122.83 47.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.105 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.589 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 1.5 tt0 -113.34 109.59 18.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 0.0 109.963 -179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.692 HD12 ' SD ' ' A' ' 153' ' ' MET . 15.3 mt -60.25 -179.86 0.12 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.1 125.76 4.62 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.084 -1.01 . . . . 0.0 109.559 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.505 ' C ' ' CG ' ' A' ' 164' ' ' GLN . 36.5 Cg_endo -79.4 -14.37 13.11 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.514 2.143 . . . . 0.0 110.688 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.505 ' CG ' ' C ' ' A' ' 163' ' ' PRO . 0.8 OUTLIER 41.89 27.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.301 -0.875 . . . . 0.0 109.617 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 163' ' ' PRO . . . 45.26 30.9 2.99 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' MET . . . . . 0.51 ' O ' HG22 ' A' ' 168' ' ' THR . 1.4 mmt -104.12 -110.39 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -1.213 . . . . 0.0 109.305 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 166' ' ' MET . 36.4 t70 44.03 30.25 0.4 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.812 -1.18 . . . . 0.0 109.72 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 166' ' ' MET . 0.5 OUTLIER -131.02 25.16 4.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.035 -1.04 . . . . 0.0 109.785 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 84.0 p -115.23 -37.57 4.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 109.463 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -160.23 90.72 0.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.351 -0.843 . . . . 0.0 108.953 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' MET . . . . . 0.409 ' O ' HG23 ' A' ' 175' ' ' VAL . 0.6 OUTLIER -58.41 -15.74 11.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.025 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.26 -58.93 2.98 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 109.579 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.5 t -68.48 -30.58 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.374 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 0.6 OUTLIER -69.95 -30.83 68.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.139 -0.976 . . . . 0.0 109.018 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.782 HG22 HG12 ' A' ' 42' ' ' ILE . 7.7 t -76.15 -31.74 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 108.892 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -80.82 -64.65 1.14 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.212 -0.93 . . . . 0.0 109.052 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -49.8 -40.87 43.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.864 . . . . 0.0 109.41 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 56.4 t80 -63.61 -50.74 68.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.65 -24.73 15.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.382 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.96 -51.08 10.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.645 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.742 ' O ' HD23 ' A' ' 185' ' ' LEU . 90.5 m -55.17 -27.17 43.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.116 -0.99 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 43.0 t -87.52 -35.74 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.067 -1.021 . . . . 0.0 108.672 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -43.56 81.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.418 -0.801 . . . . 0.0 108.96 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.522 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -82.01 -39.62 23.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.357 -0.84 . . . . 0.0 109.057 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.77 HD12 HG21 ' A' ' 155' ' ' VAL . 1.1 mm? -53.41 -20.67 4.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.092 . . . . 0.0 109.391 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.728 ' CB ' HG13 ' A' ' 54' ' ' VAL . 19.6 p -74.81 -8.01 55.14 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.65 -1.282 . . . . 0.0 108.352 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 189' ' ' LYS . 1.3 mm-40 -102.13 5.83 40.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.411 -0.806 . . . . 0.0 109.091 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.53 ' O ' ' CG ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -54.11 -36.84 63.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.259 -0.901 . . . . 0.0 109.656 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 188' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.731 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.772 ' HB3' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.493 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER 40.45 47.56 2.29 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.883 0.849 . . . . 0.0 109.248 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.588 ' CD1' ' OE1' ' A' ' 8' ' ' GLN . 0.9 OUTLIER 73.12 96.63 0.07 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.8 -0.562 . . . . 0.0 109.504 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.772 ' HB2' ' HB3' ' A' ' 1' ' ' ALA . 2.0 tt0 -124.9 62.56 1.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.91 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 48.3 t0 45.23 84.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 109.403 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 136.06 -32.44 2.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -70.27 0.52 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.958 -1.319 . . . . 0.0 108.716 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.588 ' OE1' ' CD1' ' A' ' 3' ' ' TYR . 9.3 pt20 -96.65 0.09 49.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.154 -0.966 . . . . 0.0 109.944 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.511 ' O ' ' N ' ' A' ' 6' ' ' GLY . 1.2 p90 178.93 133.34 0.08 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.831 -1.168 . . . . 0.0 109.772 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 t -110.54 179.15 4.15 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -115.65 144.46 43.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.341 -0.849 . . . . 0.0 109.778 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.546 HD11 ' HD2' ' A' ' 154' ' ' PHE . 1.9 mt -95.45 144.06 26.27 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.434 -0.791 . . . . 0.0 109.59 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.91 -22.26 65.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 108.857 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -127.57 102.13 23.39 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.429 -0.795 . . . . 0.0 109.026 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 34.2 Cg_endo -76.43 163.23 32.49 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.503 2.135 . . . . 0.0 110.846 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.498 ' HB ' ' HA3' ' A' ' 157' ' ' GLY . 38.2 t -123.13 92.14 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.84 . . . . 0.0 109.826 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.4 132.74 51.99 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 96.77 -25.74 25.21 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.735 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -42.49 162.75 0.15 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.371 -1.076 . . . . 0.0 109.699 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.608 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 36.2 Cg_endo -77.86 137.38 15.8 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.758 2.305 . . . . 0.0 111.206 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.781 ' O ' HG13 ' A' ' 155' ' ' VAL . 30.3 mm-40 -47.4 -22.36 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.913 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 55.7 t -151.41 82.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.014 -1.054 . . . . 0.0 108.968 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.771 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -76.66 121.33 23.09 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.11 -0.994 . . . . 0.0 108.341 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.558 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -98.27 139.54 33.91 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 110.025 -179.295 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.989 ' CE2' HG21 ' A' ' 145' ' ' VAL . 7.0 m-85 -127.76 101.96 6.59 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.467 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -143.11 143.24 31.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.032 -1.042 . . . . 0.0 109.779 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.993 ' HB2' HG22 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -120.43 -179.07 3.85 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.91 . . . . 0.0 109.599 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.543 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 12.1 m-30 -98.48 47.4 0.99 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.725 ' CG ' HG11 ' A' ' 96' ' ' VAL . 28.4 m-85 -142.22 13.75 2.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.433 -0.792 . . . . 0.0 109.967 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.503 ' O ' ' NE2' ' A' ' 97' ' ' GLN . 0.5 OUTLIER -105.29 157.28 34.74 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.728 -1.233 . . . . 0.0 109.459 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.7 -27.16 12.95 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.209 1.939 . . . . 0.0 108.252 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 27.0 m80 -90.93 -22.66 20.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 13.0 t -47.04 -49.92 20.47 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 9.6 t80 -75.03 -33.65 61.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.838 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.3 mm-40 -83.36 -45.59 13.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.867 -1.146 . . . . 0.0 110.85 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.624 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -48.47 -24.63 1.34 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.104 -0.997 . . . . 0.0 110.578 -179.252 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -114.79 -51.26 2.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.919 -1.113 . . . . 0.0 112.334 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 63.3 mm-40 -90.15 0.32 57.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.689 -1.257 . . . . 0.0 111.534 -177.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 35' ' ' GLN . 41.3 t -135.76 -74.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.676 -1.265 . . . . 0.0 109.581 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 35' ' ' GLN . 78.1 mt -64.06 -24.74 67.82 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.236 -0.915 . . . . 0.0 109.561 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.3 m80 51.18 21.55 1.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.988 -1.07 . . . . 0.0 109.201 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.624 HG21 ' CZ ' ' A' ' 36' ' ' PHE . 37.6 mt -63.5 -21.27 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.858 . . . . 0.0 109.757 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -60.1 2.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 109.661 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -57.66 -30.5 65.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.804 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -66.59 -34.48 77.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.721 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.7 t -72.25 -16.85 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.032 . . . . 0.0 109.191 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -82.46 -41.41 19.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.87 . . . . 0.0 110.088 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.18 -22.44 0.65 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.073 -1.017 . . . . 0.0 109.662 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 1.3 ptmm? -115.62 42.05 2.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 109.631 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 50' ' ' LEU . 10.9 mt -108.16 101.74 43.12 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.17 -0.956 . . . . 0.0 109.752 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 33.5 Cg_endo -74.93 153.9 42.46 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.536 2.157 . . . . 0.0 109.408 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 73.2 tt0 -69.5 22.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.742 -1.223 . . . . 0.0 111.548 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.416 ' C ' HG23 ' A' ' 54' ' ' VAL . . . -122.45 32.11 4.61 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.528 ' CG1' ' HB3' ' A' ' 186' ' ' SER . 59.0 t -153.39 127.16 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.47 105.43 17.4 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 110.766 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.512 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -104.36 99.1 8.8 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.718 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 1.3 m -100.37 135.04 42.42 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.714 -1.195 . . . . 0.0 110.982 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.558 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 6.7 tttt -106.84 117.81 35.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 2.6 m-85 -118.08 170.76 8.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.909 -1.12 . . . . 0.0 111.706 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.948 ' NE2' HD21 ' A' ' 72' ' ' LEU . 1.9 t-160 -111.09 136.4 50.18 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.727 0.775 . . . . 0.0 109.236 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.993 HG22 ' HB2' ' A' ' 27' ' ' SER . 3.1 m -78.9 155.55 4.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-O 121.398 0.618 . . . . 0.0 110.272 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.453 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 1.0 OUTLIER -124.4 35.82 4.74 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.031 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.563 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 9.7 p90 -135.77 55.73 1.86 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.295 -0.878 . . . . 0.0 109.608 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.629 ' CE ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -130.36 37.11 3.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.162 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.21 -33.28 0.42 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.19 -37.07 2.72 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -87.84 -79.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.004 -1.292 . . . . 0.0 110.464 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.888 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -79.87 -18.5 50.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.106 . . . . 0.0 109.618 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.652 ' N ' HD22 ' A' ' 68' ' ' LEU . . . -54.95 -36.34 60.34 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.27 -45.65 79.76 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.325 -1.103 . . . . 0.0 108.36 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.544 ' HB3' HD12 ' A' ' 108' ' ' ILE . 18.2 t0 -66.9 -24.7 66.13 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.948 HD21 ' NE2' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -65.55 -46.86 77.89 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.888 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.46 HG22 HE21 ' A' ' 138' ' ' GLN . 1.6 m -56.04 -41.71 75.44 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.575 ' O ' HG23 ' A' ' 78' ' ' VAL . 6.0 tp60 -61.4 -23.78 66.04 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.65 -37.33 86.95 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.593 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 20.7 t-105 -71.29 -32.26 68.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.528 -0.733 . . . . 0.0 109.142 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.53 ' HB2' ' NE2' ' A' ' 138' ' ' GLN . . . -75.75 -40.34 55.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.467 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.726 HG21 ' CE1' ' A' ' 122' ' ' TYR . 35.6 t -74.55 -26.24 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.288 -0.882 . . . . 0.0 109.655 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.553 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.1 -57.87 3.52 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.944 -1.097 . . . . 0.0 108.776 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -26.59 10.33 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.703 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -68.14 -47.2 68.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.642 -0.661 . . . . 0.0 109.397 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.535 ' HB2' HG13 ' A' ' 84' ' ' VAL . 44.8 mt -106.12 14.02 28.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.104 -0.997 . . . . 0.0 110.373 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.24 24.89 7.42 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 28.2 m -86.25 -4.16 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -1.027 . . . . 0.0 110.482 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 89' ' ' THR . 2.7 pt-20 -42.44 -59.11 1.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.047 -1.033 . . . . 0.0 109.897 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.68 -31.41 11.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 109.828 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 84' ' ' VAL . 46.3 mttp -78.65 -52.88 7.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 111.478 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.828 HG23 HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -85.92 -8.63 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.752 -1.217 . . . . 0.0 111.053 -178.111 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.744 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.07 -44.98 44.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.729 -1.232 . . . . 0.0 108.679 178.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.424 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -52.61 -53.27 55.74 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.472 -1.392 . . . . 0.0 110.627 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.651 ' HB2' HG13 ' A' ' 111' ' ' VAL . 27.2 Cg_endo -73.28 -18.63 23.21 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 109.737 -0.909 . . . . 0.0 109.737 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.857 ' HG ' HG11 ' A' ' 111' ' ' VAL . 14.9 mt -86.83 -42.97 12.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 108.982 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.744 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.1 m-30 -64.81 -46.66 81.04 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.889 -1.132 . . . . 0.0 108.87 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -71.78 -22.24 61.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.314 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.442 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -78.98 -31.02 44.79 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.725 HG11 ' CG ' ' A' ' 29' ' ' PHE . 2.8 t -105.73 6.63 10.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.179 -1.189 . . . . 0.0 109.325 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 93' ' ' PHE . 40.5 mm-40 -105.21 9.13 34.17 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 120.974 -1.079 . . . . 0.0 110.514 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER 173.27 -49.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.654 -1.278 . . . . 0.0 110.443 179.643 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 59.7 p -55.32 -44.53 75.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.608 -1.308 . . . . 0.0 109.297 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 71.41 12.04 6.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 110.285 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 t -79.63 -7.78 58.77 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.628 ' CB ' HG22 ' A' ' 96' ' ' VAL . 7.7 mm -84.95 73.32 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.12 33.37 3.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.605 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 107' ' ' ASP . 14.7 p -160.45 133.24 6.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 0.0 110.056 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.532 ' N ' ' HB3' ' A' ' 68' ' ' LEU . . . -50.81 -34.76 28.96 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.9 p -61.59 -31.6 71.67 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -70.6 -51.24 29.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.731 HD11 HD23 ' A' ' 68' ' ' LEU . 52.5 mt -48.66 -29.94 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -38.54 53.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.485 -0.759 . . . . 0.0 109.551 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.18 -44.32 83.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.438 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.857 HG11 ' HG ' ' A' ' 92' ' ' LEU . 69.9 t -72.62 -38.17 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -42.74 98.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.5 mt -71.5 -24.29 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.099 -1.001 . . . . 0.0 109.271 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -67.29 -19.65 65.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.672 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -91.75 -12.03 35.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.366 -0.834 . . . . 0.0 109.253 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.98 -7.96 25.4 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.823 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.9 mp -76.93 52.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.315 -1.109 . . . . 0.0 109.478 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 117' ' ' ILE . 35.5 mttm -40.46 154.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.035 -1.041 . . . . 0.0 109.769 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.75 -35.7 39.24 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.48 -56.27 24.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.045 -1.268 . . . . 0.0 110.018 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -46.86 87.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 109.946 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.726 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -62.86 -62.64 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.561 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 122' ' ' TYR . 13.8 t70 -42.52 -35.08 0.97 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.768 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.95 -41.87 28.27 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.698 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . 0.535 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -58.57 -48.29 81.43 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 108.795 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 126' ' ' TRP . 2.2 t90 -62.37 -56.85 14.32 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.12 -16.1 0.71 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.552 -0.718 . . . . 0.0 110.559 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 4.7 t -69.07 -175.59 0.76 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.853 -1.154 . . . . 0.0 110.073 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -90.29 -34.89 15.56 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.299 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.4 -46.92 62.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 118.415 -1.314 . . . . 0.0 110.11 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.703 HG22 ' HB1' ' A' ' 81' ' ' ALA . 6.5 t -72.14 -34.14 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.853 -1.154 . . . . 0.0 108.911 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 128' ' ' SER . 1.3 tttm -64.3 -44.04 92.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.383 -0.823 . . . . 0.0 109.016 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 11.4 t -65.12 -30.87 71.84 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 77' ' ' ALA . 7.7 tp -78.91 -17.59 55.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.19 -47.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -64.46 -33.36 75.7 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.445 ' OE1' ' OH ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -66.46 -37.85 86.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.442 -0.786 . . . . 0.0 108.959 179.433 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.53 ' NE2' ' HB2' ' A' ' 77' ' ' ALA . 8.4 mt-30 -67.46 -67.62 0.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 108.885 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 138' ' ' GLN . 8.4 tt0 -46.74 -36.85 7.66 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 10.2 mmtt -72.52 -29.12 63.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.429 -0.794 . . . . 0.0 108.996 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.58 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -61.99 -53.62 53.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 109.071 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -71.77 -35.35 70.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.4 -0.813 . . . . 0.0 109.927 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.79 -18.63 58.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.836 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 140' ' ' LYS . 7.5 m-20 -82.82 -45.04 14.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.114 -0.992 . . . . 0.0 108.753 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.989 HG21 ' CE2' ' A' ' 25' ' ' PHE . 20.9 m -97.33 -11.96 8.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.545 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 3.4 mt-30 82.02 -44.84 0.17 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.57 -0.706 . . . . 0.0 109.75 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.59 HD13 ' CG ' ' A' ' 25' ' ' PHE . 14.6 tp 66.46 133.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.347 -0.845 . . . . 0.0 109.144 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.4 37.41 0.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.536 -1.353 . . . . 0.0 109.846 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 158.04 109.51 0.28 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.291 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.965 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -93.56 142.59 25.37 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.427 -1.043 . . . . 0.0 109.358 178.838 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.16 151.76 93.79 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.891 -1.296 . . . . 0.0 110.487 0.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -126.83 153.53 45.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.306 -1.496 . . . . 0.0 109.264 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' MET . . . . . 0.531 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 3.2 ttm -145.32 136.44 24.84 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.118 -0.989 . . . . 0.0 109.818 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.6 ' CE2' ' HG3' ' A' ' 160' ' ' GLN . 3.0 m-85 -135.7 129.18 32.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.149 -0.97 . . . . 0.0 110.003 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 21' ' ' GLN . 53.9 t -98.32 132.11 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 0.0 109.636 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASN . . . . . 0.735 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 4.3 t30 46.46 22.69 0.18 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.219 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.651 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 56.36 56.42 24.51 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LYS . . . . . 0.465 ' HG3' ' HB3' ' A' ' 15' ' ' PRO . 10.9 tttt -164.95 -34.16 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.377 -1.073 . . . . 0.0 108.32 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.599 ' CD2' ' HG2' ' A' ' 188' ' ' LYS . 86.1 m-85 -115.27 116.37 28.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.204 -0.935 . . . . 0.0 109.207 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.6 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 0.5 OUTLIER -100.67 106.15 17.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.386 -0.821 . . . . 0.0 109.958 -179.259 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.468 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 16.4 mt -61.3 159.7 11.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.838 . . . . 0.0 109.028 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -129.71 117.59 18.52 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 0.0 109.271 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.33 22.48 0.76 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.561 2.174 . . . . 0.0 111.239 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLN . . . . . 0.419 ' OE1' ' CA ' ' A' ' 164' ' ' GLN . 4.2 mm100 -83.96 -0.0 49.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.853 -1.154 . . . . 0.0 109.659 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.23 -1.07 79.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.84 -6.46 27.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.07 -1.253 . . . . 0.0 109.681 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -85.95 15.9 4.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.965 . . . . 0.0 109.576 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 169' ' ' SER . 3.7 t -81.43 -19.14 43.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.953 . . . . 0.0 109.527 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 168' ' ' THR . 4.2 m 70.55 42.75 0.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.865 . . . . 0.0 109.544 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -160.44 92.42 0.97 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.243 -0.91 . . . . 0.0 109.104 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.8 mmt -58.4 -16.19 13.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.916 . . . . 0.0 109.724 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.33 -61.27 2.06 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.677 -0.639 . . . . 0.0 109.415 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.4 t -65.9 -23.08 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.205 -0.934 . . . . 0.0 109.034 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -73.44 -42.25 62.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.197 -0.94 . . . . 0.0 109.216 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 55.9 t -73.27 -26.26 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.121 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -61.31 2.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.3 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -52.55 -32.54 41.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -74.52 -60.49 2.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 109.524 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.27 -20.77 7.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.066 -1.021 . . . . 0.0 108.784 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -82.59 -55.52 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.48 -0.763 . . . . 0.0 109.448 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.679 ' O ' HD23 ' A' ' 185' ' ' LEU . 69.6 m -50.73 -27.11 6.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 54.0 t -87.86 -37.3 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.034 -1.042 . . . . 0.0 108.911 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -57.27 -44.23 83.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 108.863 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -83.43 -35.74 24.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.403 -0.811 . . . . 0.0 109.391 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 181' ' ' THR . 0.9 OUTLIER -58.03 -18.43 24.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.797 -1.189 . . . . 0.0 109.712 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 186' ' ' SER . . . . . 0.528 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -78.7 -5.06 52.09 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.793 -1.192 . . . . 0.0 108.722 178.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.22 9.07 40.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.481 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.599 ' HG2' ' CD2' ' A' ' 159' ' ' TYR . 2.4 tptp -56.37 -31.48 63.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.178 -0.951 . . . . 0.0 109.704 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.563 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.508 ' HB3' ' CE1' ' A' ' 9' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' ASP . 1.3 mt-10 -97.83 56.92 1.29 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -0.928 . . . . 0.0 110.083 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 40.99 80.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.609 -0.682 . . . . 0.0 110.041 179.39 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.9 -25.56 5.52 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.48 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -79.96 -69.5 0.58 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.94 -1.329 . . . . 0.0 108.852 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.526 ' HG2' ' NE2' ' A' ' 177' ' ' GLN . 0.3 OUTLIER -95.6 2.01 53.99 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.16 -0.963 . . . . 0.0 109.852 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.555 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.2 OUTLIER 177.19 129.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.098 -1.001 . . . . 0.0 109.239 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -106.89 179.61 4.22 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.573 -0.705 . . . . 0.0 109.469 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 158' ' ' LYS . 1.4 m -123.66 138.64 54.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.351 0.596 . . . . 0.0 109.599 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -99.22 158.2 15.86 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.429 ' C ' ' HD3' ' A' ' 15' ' ' PRO . 3.4 pt-20 -91.51 1.27 57.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 109.712 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.559 ' C ' HD12 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -120.73 78.07 29.82 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 0.0 109.321 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 13' ' ' GLU . 36.3 Cg_endo -78.19 164.58 26.76 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.717 2.278 . . . . 0.0 110.558 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.746 HG21 ' OD1' ' A' ' 144' ' ' ASP . 18.8 t -127.53 92.66 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.176 -0.953 . . . . 0.0 109.557 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -42.76 125.96 3.56 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 96.05 -18.23 57.83 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.704 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -39.41 160.83 0.09 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.505 -0.997 . . . . 0.0 109.927 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.567 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 35.1 Cg_endo -77.67 135.83 14.8 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.741 2.294 . . . . 0.0 111.309 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.728 ' O ' HG13 ' A' ' 155' ' ' VAL . 9.1 mt-30 -49.4 -21.02 0.79 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.561 -0.712 . . . . 0.0 109.802 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 73.2 t -151.45 80.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.978 -1.076 . . . . 0.0 109.103 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.816 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.73 126.99 32.07 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.453 ' HB3' ' HG3' ' A' ' 58' ' ' LYS . 3.5 tt0 -108.49 120.97 43.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.001 -1.062 . . . . 0.0 109.97 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.002 ' CE2' HG21 ' A' ' 145' ' ' VAL . 8.2 m-85 -108.33 107.52 18.13 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.424 ' CE1' ' HG2' ' A' ' 58' ' ' LYS . 2.0 p90 -153.08 141.19 20.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.97 -1.081 . . . . 0.0 110.423 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.754 ' OG ' HG22 ' A' ' 61' ' ' VAL . 0.6 OUTLIER -118.51 -178.21 3.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.067 179.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 5.8 m-30 -97.03 46.16 1.04 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 108.698 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.609 ' CG ' HG11 ' A' ' 96' ' ' VAL . 15.0 m-85 -146.41 13.27 1.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.289 -0.882 . . . . 0.0 109.837 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 3.7 m -105.39 161.16 23.62 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.649 -1.282 . . . . 0.0 109.534 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 33.2 Cg_endo -75.04 -32.93 4.92 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.106 1.871 . . . . 0.0 108.17 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' PHE . 39.7 m80 -84.5 -20.37 31.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.502 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 5.1 t -49.69 -55.21 14.66 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 3.4 t80 -73.35 -33.51 65.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.901 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.605 ' O ' HD13 ' A' ' 40' ' ' LEU . 25.7 mt-30 -85.65 -16.02 40.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.856 -1.152 . . . . 0.0 111.186 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 32' ' ' HIS . 8.9 t80 -86.25 -28.2 23.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.841 -1.162 . . . . 0.0 111.377 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.3 mt-10 -127.14 50.53 1.97 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.594 -1.316 . . . . 0.0 110.728 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 1.2 mt-10 -168.34 -59.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.009 -1.057 . . . . 0.0 110.767 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.32 -49.35 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.976 -1.077 . . . . 0.0 110.848 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.605 HD13 ' O ' ' A' ' 35' ' ' GLN . 6.7 mp -71.1 -2.19 14.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.096 -1.003 . . . . 0.0 110.297 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.458 ' C ' ' O ' ' A' ' 40' ' ' LEU . 58.0 m-70 39.39 29.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.838 . . . . 0.0 109.954 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 40' ' ' LEU . 36.4 mt -74.62 -21.43 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.557 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.483 ' O ' HG12 ' A' ' 46' ' ' VAL . 2.5 p -76.97 -43.45 35.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 109.619 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.83 -48.28 15.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.519 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.458 ' ND2' HG11 ' A' ' 175' ' ' VAL . 56.2 t-20 -52.96 -43.56 66.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 109.517 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 43' ' ' SER . 9.8 p -69.87 -25.77 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.143 -0.973 . . . . 0.0 109.16 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.546 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 49.4 mttm -80.76 -27.58 36.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 110.133 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.421 ' NZ ' ' HE2' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -64.47 -29.45 70.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.052 . . . . 0.0 109.79 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 8.3 mmtt -109.27 24.79 12.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 11.9 mt -70.85 113.71 21.02 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.971 . . . . 0.0 109.933 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 36.2 Cg_endo -78.73 151.37 24.85 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.245 1.963 . . . . 0.0 109.247 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 3.7 tp10 -75.47 21.13 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.625 -1.297 . . . . 0.0 110.724 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.406 ' C ' HG23 ' A' ' 54' ' ' VAL . . . -122.75 29.99 5.24 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 186' ' ' SER . 60.7 t -153.07 118.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -1.007 . . . . 0.0 109.338 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.26 109.37 20.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.678 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.524 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 1.9 ttp -92.58 100.82 13.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.719 -0.613 . . . . 0.0 109.595 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 0.4 OUTLIER -96.72 149.67 21.56 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.801 -1.159 . . . . 0.0 109.898 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HG3' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -123.77 117.12 24.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.466 -0.771 . . . . 0.0 109.378 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.3 m-85 -123.78 166.26 15.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.81 -1.181 . . . . 0.0 111.617 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.636 ' CD2' ' HG ' ' A' ' 27' ' ' SER . 14.4 t60 -102.26 149.51 24.25 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.939 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.3 m -95.31 159.79 2.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 O-C-N 121.663 -0.648 . . . . 0.0 110.356 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -128.11 49.41 2.16 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.312 -0.867 . . . . 0.0 109.193 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 10.8 p90 -152.4 64.65 0.82 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -0.961 . . . . 0.0 109.799 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -119.04 30.77 6.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.932 -1.105 . . . . 0.0 109.592 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' MET . . . 45.12 42.73 8.65 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . -149.05 85.43 0.16 Allowed Glycine 0 C--O 1.204 -1.731 0 N-CA-C 107.572 -2.211 . . . . 0.0 107.572 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -31.62 -46.52 0.11 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.058 -0.672 . . . . 0.0 111.548 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.866 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -61.46 -22.24 64.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.647 -1.283 . . . . 0.0 109.49 -179.01 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.828 ' N ' HD22 ' A' ' 68' ' ' LEU . . . -54.52 -46.99 71.86 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.421 ' O ' ' HB ' ' A' ' 73' ' ' THR . 27.8 mttt -52.32 -47.04 66.24 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.54 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 8.5 t0 -64.41 -29.2 70.27 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.79 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 17.6 tp -61.26 -35.4 77.17 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.645 HG23 ' CD ' ' A' ' 138' ' ' GLN . 5.3 m -62.75 -40.73 98.14 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.494 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 0.5 OUTLIER -61.91 -20.9 64.26 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 177.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.79 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -67.96 -41.92 81.69 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.465 ' HB3' ' OE1' ' A' ' 138' ' ' GLN . 24.1 t-105 -67.01 -31.67 72.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 0.0 108.91 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.497 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -79.51 -60.37 2.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.28 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.884 HG21 ' CE1' ' A' ' 122' ' ' TYR . 71.5 t -54.92 -27.81 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 110.043 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.538 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.25 -62.85 1.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.907 -1.121 . . . . 0.0 108.621 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.405 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -47.01 -27.42 1.3 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.762 ' HB2' HG13 ' A' ' 131' ' ' VAL . . . -69.43 -42.16 75.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.598 -0.689 . . . . 0.0 109.286 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.5 mt -107.92 12.75 26.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.224 -0.923 . . . . 0.0 110.562 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 49.17 32.01 12.59 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.614 HG11 ' CD1' ' A' ' 117' ' ' ILE . 26.0 m -93.81 2.01 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.476 -1.014 . . . . 0.0 110.531 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.455 ' O ' ' HB ' ' A' ' 89' ' ' THR . 38.4 tt0 -48.9 -68.31 0.19 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.866 -1.146 . . . . 0.0 109.402 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -40.04 -34.89 0.32 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.878 . . . . 0.0 110.465 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.484 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 35.1 mttt -79.82 -55.4 5.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 111.031 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.857 HG23 HD12 ' A' ' 92' ' ' LEU . 1.2 m -82.14 -22.28 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.812 -1.18 . . . . 0.0 110.608 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.754 HG23 ' CE1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -64.77 -43.57 92.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.723 -1.235 . . . . 0.0 108.983 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.92 -56.21 30.22 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.351 -1.468 . . . . 0.0 110.474 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.484 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 26.1 Cg_endo -72.43 -16.21 27.62 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 N-CA-C 109.812 -0.88 . . . . 0.0 109.812 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.857 HD12 HG23 ' A' ' 88' ' ' VAL . 15.1 mt -87.39 -44.13 11.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 108.844 178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.754 ' CE1' HG23 ' A' ' 89' ' ' THR . 5.4 m-30 -65.51 -46.84 78.07 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.987 -1.071 . . . . 0.0 108.835 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -16.62 60.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -0.968 . . . . 0.0 109.203 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.66 -33.39 51.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.609 HG11 ' CG ' ' A' ' 29' ' ' PHE . 2.3 t -100.83 -7.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 121.12 -1.224 . . . . 0.0 109.35 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -110.08 8.73 24.07 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 120.893 -1.129 . . . . 0.0 110.514 -179.288 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.786 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER -176.18 68.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.67 -1.269 . . . . 0.0 109.333 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 163.08 -46.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.522 -0.736 . . . . 0.0 109.575 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 71.67 17.54 5.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.397 -0.814 . . . . 0.0 110.38 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 t -81.45 -4.96 57.36 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.639 HG23 ' OD1' ' A' ' 107' ' ' ASP . 4.2 mm -95.41 84.49 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.34 28.29 1.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 109.382 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 107' ' ' ASP . 59.6 p -157.55 131.54 8.15 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.321 -0.862 . . . . 0.0 109.658 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.632 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -48.99 -31.66 7.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 t -64.5 -33.28 75.53 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.639 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -67.64 -50.11 59.6 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.731 HD11 HD23 ' A' ' 68' ' ' LEU . 36.3 mt -51.27 -28.53 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -36.49 56.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.52 -0.737 . . . . 0.0 109.052 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.22 -48.4 78.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.769 HG11 ' HG ' ' A' ' 92' ' ' LEU . 21.3 t -68.82 -37.68 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.455 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.435 ' O ' HG12 ' A' ' 117' ' ' ILE . 1.3 m-85 -59.9 -48.26 82.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.108 -0.995 . . . . 0.0 109.469 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 mt -66.26 -25.39 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.963 . . . . 0.0 109.279 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 111' ' ' VAL . 15.5 m-20 -61.77 -16.94 53.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.916 . . . . 0.0 109.544 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.585 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -97.94 15.48 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.078 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.59 -0.94 89.39 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.614 ' CD1' HG11 ' A' ' 84' ' ' VAL . 3.9 mm -71.77 55.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -1.14 . . . . 0.0 109.843 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -36.73 145.53 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.285 -0.885 . . . . 0.0 110.073 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -47.15 -31.71 6.22 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.79 -49.25 77.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -1.121 . . . . 0.0 109.49 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.19 -58.05 6.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 110.003 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.884 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -61.22 -56.84 16.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.938 . . . . 0.0 109.617 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 14.5 t70 -45.15 -34.34 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.036 -1.04 . . . . 0.0 109.054 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.48 -43.9 30.7 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.416 -0.802 . . . . 0.0 109.012 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.58 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -52.85 -51.66 60.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.494 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 11.4 t90 -62.62 -53.2 58.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -53.86 -16.13 1.66 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.511 -0.743 . . . . 0.0 110.027 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.2 t -78.76 -179.48 6.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.984 -1.073 . . . . 0.0 110.273 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -95.24 -36.59 11.38 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.806 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.04 -47.83 80.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.209 -1.396 . . . . 0.0 109.709 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' A' ' 81' ' ' ALA . 2.2 t -64.95 -39.8 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.97 -1.081 . . . . 0.0 108.333 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -66.61 -31.62 72.42 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.3 t -64.6 -35.48 81.14 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.83 -19.14 52.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.313 -0.867 . . . . 0.0 108.678 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.497 HG23 ' CB ' ' A' ' 77' ' ' ALA . 4.6 t -80.35 -47.45 21.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.61 -36.9 85.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -32.96 73.06 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.645 ' CD ' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -64.37 -66.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.306 -0.871 . . . . 0.0 109.092 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 0.4 OUTLIER -52.23 -32.87 38.75 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.46 ' O ' ' OD2' ' A' ' 144' ' ' ASP . 0.3 OUTLIER -74.19 -28.21 61.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.345 -0.847 . . . . 0.0 108.991 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -64.37 -60.88 2.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.062 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.481 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -72.37 -21.72 61.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.717 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -77.56 -29.09 51.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.079 -1.013 . . . . 0.0 109.776 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.95 ' OD1' HG13 ' A' ' 145' ' ' VAL . 2.8 p30 -81.22 -47.82 12.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.001 . . . . 0.0 108.419 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 1.002 HG21 ' CE2' ' A' ' 25' ' ' PHE . 28.2 m -84.07 -14.44 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.542 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 4.0 tt0 81.2 -48.05 0.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.587 -0.696 . . . . 0.0 109.837 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.662 HD22 ' CD1' ' A' ' 25' ' ' PHE . 49.0 tp 61.79 134.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.466 -0.771 . . . . 0.0 109.319 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.72 40.36 0.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.623 -1.298 . . . . 0.0 109.681 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 169.64 104.73 0.18 Allowed Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.014 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.939 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -99.0 141.13 22.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.131 . . . . 0.0 109.587 179.151 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 150' ' ' VAL . 33.1 Cg_endo -75.32 153.87 98.92 Favored 'Cis proline' 0 C--N 1.314 -1.26 0 C-N-CA 123.598 -1.417 . . . . 0.0 110.452 0.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -132.86 146.85 52.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.33 -1.481 . . . . 0.0 109.54 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.506 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 18.7 ttm -136.54 133.9 36.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 109.813 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.598 ' CD2' ' HB2' ' A' ' 160' ' ' GLN . 75.4 m-85 -129.57 127.08 39.97 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.332 -0.855 . . . . 0.0 110.104 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 21' ' ' GLN . 56.1 t -97.03 129.46 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.045 -1.034 . . . . 0.0 109.5 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.704 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 47.41 21.72 0.24 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.979 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.509 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.75 55.72 28.54 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.479 ' O ' HG23 ' A' ' 11' ' ' THR . 13.5 tttp -163.71 -37.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.497 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 75.0 m-85 -114.91 124.84 52.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.598 ' HB2' ' CD2' ' A' ' 154' ' ' PHE . 4.4 tt0 -124.44 127.43 47.5 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.942 -1.099 . . . . 0.0 109.852 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.73 -179.84 0.74 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.499 -0.751 . . . . 0.0 109.081 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.463 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 38.1 t30 -144.42 65.0 12.69 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 109.64 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 162' ' ' ASN . 35.1 Cg_endo . . . . . 0 C--N 1.31 -1.478 0 C-N-CA 122.675 2.25 . . . . 0.0 110.424 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 35.7 mtm . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.873 0.844 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -76.42 -46.48 26.97 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.44 -25.76 25.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.301 -0.874 . . . . 0.0 109.12 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -73.6 -40.8 63.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.579 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.458 HG11 ' ND2' ' A' ' 45' ' ' ASN . 32.6 t -73.11 -29.83 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -0.988 . . . . 0.0 109.248 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -51.7 7.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 108.951 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.526 ' NE2' ' HG2' ' A' ' 8' ' ' GLN . 6.7 tt0 -57.71 -44.8 86.17 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.207 -0.933 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.49 ' HA ' ' OG1' ' A' ' 181' ' ' THR . 4.9 t80 -60.11 -56.7 18.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.073 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 183' ' ' LYS . . . -49.44 -27.58 4.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.337 -0.852 . . . . 0.0 108.873 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -79.48 -46.17 17.96 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.436 -0.79 . . . . 0.0 109.315 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.598 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -48.62 -45.95 39.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.06 -1.025 . . . . 0.0 109.396 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.466 HG13 ' CG2' ' A' ' 22' ' ' VAL . 22.9 t -75.24 -32.09 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.959 -1.088 . . . . 0.0 109.792 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 179' ' ' ALA . 5.5 tttt -68.28 -38.43 81.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.364 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -83.41 -44.26 14.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.958 -1.089 . . . . 0.0 109.888 -179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 181' ' ' THR . 14.5 mt -60.69 -22.75 64.25 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.62 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.527 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 5.2 t -68.98 -14.43 63.04 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.442 0 O-C-N 121.622 -0.674 . . . . 0.0 109.204 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.596 ' CB ' ' HB2' ' A' ' 8' ' ' GLN . 26.8 p90 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.41 ' H ' ' HB2' ' A' ' 7' ' ' LYS . 3.8 mm-40 -118.17 63.51 0.76 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 110.359 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 4' ' ' GLU . 8.8 t0 69.13 96.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 110.38 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.28 -10.19 75.07 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.587 ' O ' ' CG ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -99.63 28.72 4.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -1.094 . . . . 0.0 108.199 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.596 ' HB2' ' CB ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER 152.83 -40.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.59 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 8.4 p90 -139.79 113.34 8.52 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.193 -0.942 . . . . 0.0 108.691 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -93.3 -179.97 5.23 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 1.051 HG23 ' O ' ' A' ' 158' ' ' LYS . 90.5 m -137.1 145.81 44.35 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.615 0.722 . . . . 0.0 110.079 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.495 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -100.5 171.61 7.63 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.526 -0.734 . . . . 0.0 109.271 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.41 13.45 30.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.45 ' O ' HD12 ' A' ' 12' ' ' LEU . 1.6 mmtp -127.17 95.27 36.89 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.543 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.39 169.33 20.19 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.594 2.196 . . . . 0.0 110.204 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' ALA . 1.9 t -144.26 113.24 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 110.101 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.06 128.21 18.41 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 77.21 5.69 85.54 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.774 ' HB1' ' HD2' ' A' ' 20' ' ' PRO . . . -38.18 165.88 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.6 -0.941 . . . . 0.0 110.71 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.96 ' HG3' HD12 ' A' ' 23' ' ' LEU . 32.8 Cg_endo -74.02 101.26 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.859 2.373 . . . . 0.0 111.58 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.605 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.9 mp0 -42.1 -28.04 0.16 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 21' ' ' GLN . 40.2 t -158.57 79.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.96 HD12 ' HG3' ' A' ' 20' ' ' PRO . 1.3 tt -73.62 139.27 45.38 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.72 ' N ' HD23 ' A' ' 23' ' ' LEU . 1.5 tt0 -127.8 98.77 5.28 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.199 -0.938 . . . . 0.0 109.803 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.88 ' CD1' HD22 ' A' ' 147' ' ' LEU . 11.4 m-85 -81.61 127.0 32.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.204 -0.935 . . . . 0.0 108.913 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -161.73 128.69 3.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.346 -0.846 . . . . 0.0 109.705 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.579 ' HA ' ' ND1' ' A' ' 60' ' ' HIS . 11.6 p -112.45 145.66 39.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.403 -0.81 . . . . 0.0 109.131 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.604 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 8.6 m-30 -72.93 49.87 0.25 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.252 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.694 ' CG ' HG11 ' A' ' 96' ' ' VAL . 11.4 m-85 -152.24 9.85 0.5 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.577 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -107.26 167.03 10.0 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.725 -1.235 . . . . 0.0 109.949 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.01 -43.07 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.564 2.176 . . . . 0.0 108.691 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.479 ' HB3' ' HG3' ' A' ' 151' ' ' PRO . 0.1 OUTLIER -78.17 -21.71 49.79 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 5.7 t -45.19 -56.27 4.96 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.526 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 51.9 t80 -69.98 -27.33 64.62 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.591 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 3.2 mm-40 -84.87 -28.67 25.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.138 . . . . 0.0 111.002 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -87.69 -36.25 17.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.83 -1.169 . . . . 0.0 111.724 -178.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 1.2 mp0 -111.46 31.95 5.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.633 -1.292 . . . . 0.0 111.38 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.553 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 26.3 mm-40 -160.03 -58.15 0.06 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.801 -1.187 . . . . 0.0 110.846 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 41' ' ' HIS . 69.2 t -88.91 -74.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.844 -1.16 . . . . 0.0 110.903 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.52 ' HB3' ' CD1' ' A' ' 42' ' ' ILE . 51.0 mt -42.7 -25.29 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.004 . . . . 0.0 110.315 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER 55.8 21.61 4.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.009 -1.057 . . . . 0.0 108.898 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 40' ' ' LEU . 14.9 mt -70.35 -21.23 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.45 -0.781 . . . . 0.0 109.888 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.682 ' O ' HG12 ' A' ' 46' ' ' VAL . 79.3 p -86.16 -77.27 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.09 -1.006 . . . . 0.0 110.078 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.5 OUTLIER -41.68 -31.5 0.3 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.867 . . . . 0.0 110.486 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 3.0 m120 -75.85 -31.58 59.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.949 -1.094 . . . . 0.0 110.064 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 43' ' ' SER . 3.5 p -54.2 -36.47 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.079 -1.013 . . . . 0.0 109.577 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.937 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -72.44 -36.39 68.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.119 -0.988 . . . . 0.0 109.474 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -45.02 -24.78 0.25 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.548 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -133.36 50.66 2.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.274 -0.892 . . . . 0.0 110.004 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.937 HD12 ' HA ' ' A' ' 47' ' ' LYS . 9.8 mt -114.47 72.3 2.51 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.868 -1.145 . . . . 0.0 110.562 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.548 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 36.8 Cg_endo -78.59 139.35 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.33 2.02 . . . . 0.0 110.269 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 51' ' ' PRO . 19.3 tp10 61.99 134.79 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.374 -0.829 . . . . 0.0 108.849 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . 58.21 23.53 53.04 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.882 HG13 ' O ' ' A' ' 50' ' ' LEU . 1.6 t -61.26 77.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.712 -0.875 . . . . 0.0 109.258 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.499 ' CB ' ' HB2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -136.96 97.25 3.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.422 ' SD ' ' HD2' ' A' ' 58' ' ' LYS . 2.7 tmm? -103.6 103.01 12.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 108.91 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.52 121.68 36.32 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.197 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.526 ' HB2' ' CE1' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -103.39 110.23 22.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 0.0 109.715 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.606 ' CD1' ' CG ' ' A' ' 138' ' ' GLN . 4.1 m-85 -113.68 177.96 4.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.851 -1.156 . . . . 0.0 110.942 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 1.048 ' CE1' HD22 ' A' ' 72' ' ' LEU . 2.0 t-160 -140.0 130.4 25.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.44 -0.787 . . . . 0.0 109.651 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.677 HG11 HD23 ' A' ' 147' ' ' LEU . 1.4 m -115.18 137.38 48.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 2.0 p-10 -40.72 -55.89 2.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.352 -0.843 . . . . 0.0 109.37 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 62' ' ' ASN . 3.6 m-85 32.1 40.64 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.623 0.725 . . . . 0.0 110.952 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.507 ' SD ' ' CD2' ' A' ' 29' ' ' PHE . 5.8 ptm -161.02 47.61 0.21 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.574 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.53 -49.22 1.33 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.58 -3.53 49.96 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.714 -1.231 . . . . 0.0 111.241 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.46 -81.18 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.371 -1.664 . . . . 0.0 108.384 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.119 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -88.87 -26.24 21.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.947 -1.095 . . . . 0.0 109.49 178.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 1.119 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -57.31 -42.29 93.49 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -46.66 80.45 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.324 -1.104 . . . . 0.0 108.496 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.872 ' OD2' ' HB2' ' A' ' 105' ' ' ALA . 1.3 m-20 -66.3 -28.24 68.54 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.048 HD22 ' CE1' ' A' ' 60' ' ' HIS . 6.4 tt -61.03 -45.33 95.24 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 60' ' ' HIS . 1.5 m -59.68 -44.5 93.6 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.709 ' O ' HG13 ' A' ' 78' ' ' VAL . 8.7 tm0? -50.98 -27.36 7.53 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.715 ' HB1' ' CE2' ' A' ' 112' ' ' PHE . . . -81.17 -32.29 33.67 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.207 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' ALA . 4.4 t-105 -50.01 -29.14 8.08 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.769 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -85.24 -38.96 18.31 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.639 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 74' ' ' GLN . 3.3 m -63.71 -30.71 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 120.745 -1.222 . . . . 0.0 109.011 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.646 ' HB2' ' HZ ' ' A' ' 112' ' ' PHE . . . -81.77 -53.65 6.02 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.485 ' HB3' ' HG ' ' A' ' 134' ' ' LEU . 4.9 tpt -49.23 -29.32 5.55 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.651 ' HB2' ' CG2' ' A' ' 131' ' ' VAL . . . -60.78 -45.05 95.87 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.801 ' HB2' HG13 ' A' ' 84' ' ' VAL . 3.3 mt -110.87 16.0 21.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.47 -0.769 . . . . 0.0 110.055 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.75 30.23 6.58 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.801 HG13 ' HB2' ' A' ' 82' ' ' LEU . 36.0 m -89.39 -5.32 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -1.178 . . . . 0.0 110.551 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -42.85 -61.24 1.32 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.107 -0.996 . . . . 0.0 109.607 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -43.2 -33.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.455 ' CE ' ' HB1' ' A' ' 115' ' ' ALA . 4.4 mtpt -83.29 -50.7 8.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.298 -0.876 . . . . 0.0 111.214 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.749 HG23 HD12 ' A' ' 92' ' ' LEU . 1.1 m -82.4 -5.83 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.711 -1.243 . . . . 0.0 110.681 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.734 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -77.92 -45.51 23.84 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.302 178.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 2.1 t -51.8 -52.84 57.25 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.75 -1.219 . . . . 0.0 110.406 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 25.5 Cg_endo -73.28 -17.36 24.31 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 N-CA-C 109.645 -0.944 . . . . 0.0 109.645 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.749 HD12 HG23 ' A' ' 88' ' ' VAL . 13.6 mt -86.48 -44.92 11.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.734 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.1 m-30 -61.51 -47.65 84.64 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.916 -1.115 . . . . 0.0 108.772 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 90' ' ' VAL . 13.0 pt-20 -71.7 -16.7 62.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.111 -0.993 . . . . 0.0 109.641 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.46 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -79.05 -32.32 40.07 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.694 HG11 ' CG ' ' A' ' 29' ' ' PHE . 1.7 t -106.79 0.54 10.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.997 -1.296 . . . . 0.0 110.026 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.481 ' HG2' ' HB2' ' A' ' 34' ' ' TYR . 0.7 OUTLIER -106.93 6.17 28.98 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 120.769 -1.207 . . . . 0.0 110.679 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.786 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER 177.28 76.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.734 -1.229 . . . . 0.0 109.074 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 161.41 -48.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.3 OUTLIER 71.74 18.6 5.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.346 -0.846 . . . . 0.0 110.48 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.449 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 2.8 t -80.07 -4.47 52.9 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.603 HG23 ' OD1' ' A' ' 107' ' ' ASP . 4.6 mm -97.91 81.78 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.809 -0.557 . . . . 0.0 109.609 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.449 ' HD2' ' C ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -142.31 32.66 1.51 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.933 -1.105 . . . . 0.0 109.601 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 107' ' ' ASP . 4.0 p -158.38 134.87 9.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.068 -1.02 . . . . 0.0 109.749 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.873 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.95 -39.83 41.84 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.5 p -56.38 -31.73 64.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.603 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -71.63 -51.02 25.36 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.873 HD12 ' HA ' ' A' ' 105' ' ' ALA . 22.5 mt -45.5 -29.92 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 0.0 108.984 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.498 ' HG2' HD11 ' A' ' 113' ' ' ILE . 37.2 ttt180 -78.61 -37.84 41.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.177 -0.952 . . . . 0.0 109.553 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -58.92 -46.14 88.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.579 HG11 ' HG ' ' A' ' 92' ' ' LEU . 13.2 t -68.94 -38.81 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.715 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -61.19 -42.35 98.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.568 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.498 HD11 ' HG2' ' A' ' 109' ' ' ARG . 17.4 mt -69.81 -25.5 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.165 -0.959 . . . . 0.0 109.669 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -64.07 -16.73 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.678 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.597 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -96.04 11.89 32.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 109.649 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.65 -5.26 85.24 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.749 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -80.69 56.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -1.106 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.45 ' HA ' HG23 ' A' ' 113' ' ' ILE . 59.8 mttt -37.68 153.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.789 . . . . 0.0 110.153 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -47.9 -27.12 4.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -58.59 -46.98 85.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.878 -1.366 . . . . 0.0 109.473 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -77.96 -50.94 11.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.849 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.628 ' HE1' HG11 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -62.61 -58.27 8.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.978 . . . . 0.0 108.954 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 62.8 t0 -50.09 -48.93 52.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.038 -1.039 . . . . 0.0 109.292 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.32 81.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.304 -0.872 . . . . 0.0 109.43 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.682 ' C ' HG21 ' A' ' 131' ' ' VAL . . . -56.41 -49.5 74.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.293 -0.88 . . . . 0.0 108.951 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 1.01 ' HA ' HG11 ' A' ' 131' ' ' VAL . 6.0 t90 -54.85 -56.46 19.25 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -15.13 62.02 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.595 -0.69 . . . . 0.0 110.016 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 125' ' ' ALA . 16.8 p -71.56 179.72 2.91 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.013 -1.054 . . . . 0.0 110.095 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.421 ' CD1' HG23 ' A' ' 130' ' ' VAL . 4.4 p90 -90.42 -33.63 15.94 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.83 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.421 HG23 ' CD1' ' A' ' 129' ' ' PHE . 23.5 t -64.34 -36.96 78.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 C-N-CA 118.124 -1.43 . . . . 0.0 109.878 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 1.01 HG11 ' HA ' ' A' ' 126' ' ' TRP . 16.5 t -64.16 -38.73 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.878 -1.139 . . . . 0.0 108.941 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -66.6 -34.54 78.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 108.992 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.34 -33.15 75.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.278 -0.889 . . . . 0.0 109.399 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' A' ' 80' ' ' MET . 1.8 mm? -79.54 -26.55 41.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 108.846 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.769 HG23 ' CB ' ' A' ' 77' ' ' ALA . 6.0 t -79.11 -39.02 20.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.53 -49.15 61.75 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.443 -0.786 . . . . 0.0 109.184 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.481 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -61.73 -35.35 77.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.204 -0.935 . . . . 0.0 109.159 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.606 ' CG ' ' CD1' ' A' ' 59' ' ' TYR . 18.0 tm0? -62.78 -62.38 1.77 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.224 -0.922 . . . . 0.0 109.195 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -46.77 -35.61 6.38 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -30.86 67.38 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.614 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -60.74 -47.74 84.95 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.354 -0.841 . . . . 0.0 108.915 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -73.07 -39.83 65.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.411 -0.805 . . . . 0.0 110.236 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.62 -16.9 59.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.973 -1.079 . . . . 0.0 109.824 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.455 ' OD2' HG11 ' A' ' 16' ' ' VAL . 9.1 m-20 -82.06 -44.95 15.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.057 -1.027 . . . . 0.0 108.592 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 141' ' ' ALA . 17.6 m -100.08 -8.36 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.346 -0.846 . . . . 0.0 108.927 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.544 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 12.2 tp60 80.95 -42.15 0.18 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.461 -0.774 . . . . 0.0 110.113 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.88 HD22 ' CD1' ' A' ' 25' ' ' PHE . 20.1 tp 62.11 140.19 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.288 -0.882 . . . . 0.0 108.981 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.54 31.26 0.23 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.613 -1.304 . . . . 0.0 110.106 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 157.22 98.8 0.15 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.523 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.493 HG11 ' CG2' ' A' ' 61' ' ' VAL . 0.8 OUTLIER -92.51 138.37 23.99 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 31.6 Cg_endo -71.75 155.83 97.63 Favored 'Cis proline' 0 C--N 1.316 -1.163 0 C-N-CA 124.157 -1.185 . . . . 0.0 111.753 2.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -146.91 151.09 36.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.805 -1.185 . . . . 0.0 108.525 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -128.49 118.31 22.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.901 -1.124 . . . . 0.0 110.022 -179.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.579 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 57.8 m-85 -114.42 142.39 46.42 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.582 HG22 HG22 ' A' ' 22' ' ' VAL . 30.6 t -124.08 124.62 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.989 -1.07 . . . . 0.0 108.947 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 56.14 22.89 6.41 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.187 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.407 ' O ' HD11 ' A' ' 12' ' ' LEU . . . 52.96 22.76 13.26 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.705 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 1.051 ' O ' HG23 ' A' ' 11' ' ' THR . 0.0 OUTLIER -134.58 -11.35 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.752 -1.44 . . . . 0.0 109.738 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.512 ' O ' ' N ' ' A' ' 155' ' ' VAL . 99.5 m-85 -144.22 124.46 13.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.021 -1.05 . . . . 0.0 108.749 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.579 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 2.3 pt20 -133.31 129.39 37.48 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.965 -1.084 . . . . 0.0 110.157 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.009 HD12 ' CZ ' ' A' ' 178' ' ' TYR . 17.1 mt -61.27 168.58 2.56 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.67 150.68 44.23 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.084 -1.01 . . . . 0.0 109.786 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo . . . . . 0 C--N 1.31 -1.448 0 C-N-CA 122.683 2.255 . . . . 0.0 110.546 179.782 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 2.0 mtp . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.965 0.888 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.48 -65.05 0.94 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.464 HG13 ' HG2' ' A' ' 177' ' ' GLN . 20.1 t -70.15 -23.48 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.294 -0.879 . . . . 0.0 109.058 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -68.53 -39.87 80.98 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -0.909 . . . . 0.0 109.241 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.3 t -76.44 -32.3 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -74.97 -52.34 11.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 109.445 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.464 ' HG2' HG13 ' A' ' 173' ' ' VAL . 40.6 mm-40 -58.62 -40.44 83.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.437 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 1.009 ' CZ ' HD12 ' A' ' 161' ' ' LEU . 10.0 t80 -61.13 -50.82 71.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.132 -0.98 . . . . 0.0 109.231 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.432 ' O ' ' NZ ' ' A' ' 183' ' ' LYS . . . -64.12 -24.37 67.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.988 -1.07 . . . . 0.0 108.839 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -77.43 -40.92 41.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 0.0 108.986 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.558 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -58.61 -54.83 42.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 109.056 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.575 HG23 HD11 ' A' ' 161' ' ' LEU . 93.3 t -61.06 -36.85 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 109.607 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.474 ' HE3' ' CG ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -53.55 -44.47 69.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 109.217 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -84.42 -25.47 28.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.358 -0.839 . . . . 0.0 110.07 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 185' ' ' LEU . 1.1 mt -62.17 -23.45 66.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.446 -1.409 . . . . 0.0 108.435 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.8 t -75.57 -4.39 39.7 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.991 -1.068 . . . . 0.0 108.365 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.828 . . . . 0.0 109.452 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.509 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.497 ' O ' ' HB3' ' A' ' 5' ' ' ASP . 5.6 pm0 -133.18 64.65 1.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.163 -0.96 . . . . 0.0 109.976 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 4' ' ' GLU . 19.6 t70 71.16 93.5 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.518 -0.738 . . . . 0.0 110.759 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.57 3.79 90.38 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.586 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -101.91 28.41 5.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.962 -1.316 . . . . 0.0 108.937 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.586 ' CB ' ' O ' ' A' ' 7' ' ' LYS . 2.9 mm-40 144.54 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.582 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 2.2 p90 -141.89 114.21 8.25 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.054 0.93 . . . . 0.0 109.015 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -100.32 -179.19 4.04 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.2 m -111.6 143.72 42.02 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.899 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.784 HD12 ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -96.16 163.95 12.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.376 -0.828 . . . . 0.0 109.549 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 14' ' ' LYS . 1.6 pt-20 -87.52 -15.83 36.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.691 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.784 ' O ' HD12 ' A' ' 12' ' ' LEU . 3.3 mmtp -112.56 97.51 40.75 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.148 -0.97 . . . . 0.0 109.849 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.23 158.92 33.48 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.467 2.111 . . . . 0.0 109.863 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.671 ' O ' HG12 ' A' ' 16' ' ' VAL . 15.8 t -140.52 83.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.099 -1.001 . . . . 0.0 109.761 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.12 129.7 18.1 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.63 -19.73 52.95 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.77 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -41.9 164.61 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.41 -1.053 . . . . 0.0 109.556 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.661 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 34.7 Cg_endo -76.43 126.82 9.31 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.573 2.182 . . . . 0.0 110.955 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.818 ' O ' HG13 ' A' ' 155' ' ' VAL . 4.3 mt-30 -40.01 -24.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.558 -0.714 . . . . 0.0 110.421 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.687 HG13 ' HE2' ' A' ' 153' ' ' MET . 59.1 t -149.09 79.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.764 -1.21 . . . . 0.0 109.044 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.887 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -73.98 112.79 10.45 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.566 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -94.23 149.19 21.47 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.778 -178.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.943 ' CE2' HG21 ' A' ' 145' ' ' VAL . 7.6 m-85 -135.13 103.46 5.55 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.483 -0.76 . . . . 0.0 109.267 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -148.42 140.64 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 109.891 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.709 ' CB ' HG22 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -118.16 179.45 4.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.09 179.345 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 7.1 m-30 -90.33 40.44 1.01 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CG ' HG11 ' A' ' 96' ' ' VAL . 11.0 m-85 -137.91 16.82 2.85 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -113.8 164.81 14.96 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.544 -1.348 . . . . 0.0 109.878 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.74 -41.08 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.463 2.109 . . . . 0.0 108.092 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.598 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 9.6 m170 -75.34 -23.53 57.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 12.3 t -43.94 -57.71 3.17 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.455 ' HB2' ' CD ' ' A' ' 97' ' ' GLN . 89.4 t80 -71.48 -55.06 8.6 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.182 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 12.5 mt-30 -54.88 -16.96 3.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.228 -0.92 . . . . 0.0 110.527 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.598 ' CE1' ' HB3' ' A' ' 32' ' ' HIS . 4.0 m-30 -86.4 -38.96 16.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.08 -1.013 . . . . 0.0 110.831 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.02 -13.1 20.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.782 -1.199 . . . . 0.0 112.206 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.402 ' C ' HG23 ' A' ' 39' ' ' VAL . 3.0 mt-10 -136.27 28.51 3.09 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.17 -1.581 . . . . 0.0 111.418 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 35' ' ' GLN . 91.1 t -151.56 -88.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.394 -1.441 . . . . 0.0 110.138 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.807 ' HB2' HD12 ' A' ' 42' ' ' ILE . 1.4 mt -68.99 -19.49 64.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.95 . . . . 0.0 109.747 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 2.4 m-70 60.06 18.85 8.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.005 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.807 HD12 ' HB2' ' A' ' 40' ' ' LEU . 1.4 mt -46.98 -36.42 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.479 -0.763 . . . . 0.0 109.44 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.663 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -80.48 -34.34 35.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.991 . . . . 0.0 110.115 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.488 ' HA ' ' HG3' ' A' ' 47' ' ' LYS . 15.5 m-20 -82.7 -36.87 25.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.099 -1.001 . . . . 0.0 109.625 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -58.31 -34.21 70.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.84 . . . . 0.0 110.184 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 43' ' ' SER . 31.5 m -65.92 -31.98 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.033 -1.042 . . . . 0.0 110.021 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.61 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -54.51 -44.89 73.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.976 -1.078 . . . . 0.0 109.461 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -44.28 -28.34 0.52 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.119 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.472 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 10.1 mtmm -112.7 44.5 1.47 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.842 . . . . 0.0 109.24 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 47' ' ' LYS . 11.0 mt -115.87 79.35 7.9 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.165 -0.96 . . . . 0.0 109.945 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 35.3 Cg_endo -78.33 143.26 19.55 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.615 2.21 . . . . 0.0 110.119 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -39.45 120.77 1.1 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.312 1.054 . . . . 0.0 109.908 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.78 -26.74 5.06 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.54 ' CG1' ' CD2' ' A' ' 50' ' ' LEU . 98.1 t -89.71 85.37 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -1.192 . . . . 0.0 109.296 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.96 93.25 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.779 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.477 ' HG3' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -92.73 101.44 13.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.833 . . . . 0.0 109.437 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 4.9 m -111.45 134.09 53.27 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.11 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.566 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -114.13 109.2 18.05 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.482 ' OH ' ' HB3' ' A' ' 137' ' ' GLN . 4.5 m-85 -106.55 177.85 4.73 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.954 -1.092 . . . . 0.0 111.623 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.599 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 49.4 t-80 -111.85 132.62 54.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.735 0.779 . . . . 0.0 108.977 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.044 HG11 ' CG1' ' A' ' 150' ' ' VAL . 3.0 m -72.36 156.68 6.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.416 0.627 . . . . 0.0 110.598 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.492 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 14.0 t30 -118.56 51.19 1.11 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.628 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -155.86 61.17 0.59 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.731 -1.23 . . . . 0.0 110.106 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.693 ' HE1' ' CG2' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -144.92 43.37 1.34 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.958 -1.089 . . . . 0.0 109.488 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.47 -36.17 0.55 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.94 -43.07 3.13 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -88.7 -79.0 0.32 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.169 . . . . 0.0 110.109 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.115 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -78.0 -21.87 50.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.092 -1.005 . . . . 0.0 109.205 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 1.115 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -53.51 -42.83 66.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 2.1 tttt -68.78 -54.76 14.03 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.16 -1.2 . . . . 0.0 108.362 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.566 ' HB3' HD12 ' A' ' 108' ' ' ILE . 8.2 t70 -56.12 -25.18 44.89 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.782 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 44.4 tp -65.4 -39.68 92.5 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 m -59.48 -41.94 90.93 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.429 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 0.4 OUTLIER -60.13 -22.63 63.07 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.782 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -66.23 -40.06 90.01 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 46.7 t-105 -64.4 -31.58 72.84 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 78' ' ' VAL . . . -84.39 -68.14 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.725 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.85 HG21 ' CE1' ' A' ' 122' ' ' TYR . 95.7 t -43.98 -26.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 109.761 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.615 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -82.93 -58.62 2.79 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.085 -1.009 . . . . 0.0 108.717 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.28 -27.38 2.46 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.61 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -70.84 -43.15 69.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.483 -0.761 . . . . 0.0 109.447 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.671 ' HB2' HG13 ' A' ' 84' ' ' VAL . 23.0 mt -107.12 14.59 26.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 48.39 24.84 3.98 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.671 HG13 ' HB2' ' A' ' 82' ' ' LEU . 35.2 m -83.67 -9.92 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.408 -1.054 . . . . 0.0 110.397 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.467 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.3 OUTLIER -42.73 -63.4 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.137 -0.977 . . . . 0.0 109.37 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.96 -34.68 1.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.458 -0.776 . . . . 0.0 110.601 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -79.72 -53.18 7.06 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.186 -0.947 . . . . 0.0 111.741 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.781 HG23 HD12 ' A' ' 92' ' ' LEU . 2.9 m -84.7 -8.42 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.717 -1.239 . . . . 0.0 110.705 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.747 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -72.88 -44.5 61.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.593 -1.317 . . . . 0.0 108.596 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.402 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -53.64 -54.13 49.48 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.467 -1.396 . . . . 0.0 110.817 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.436 ' HD2' ' C ' ' A' ' 88' ' ' VAL . 25.0 Cg_endo -72.99 -18.65 23.96 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 N-CA-C 109.82 -0.877 . . . . 0.0 109.82 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.812 ' HG ' HG11 ' A' ' 111' ' ' VAL . 28.8 mt -87.22 -42.63 12.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.043 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.747 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.2 m-30 -63.78 -46.68 84.11 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.003 -1.06 . . . . 0.0 108.856 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -23.05 61.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.209 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.49 -33.39 61.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.661 HG11 ' CG ' ' A' ' 29' ' ' PHE . 2.3 t -102.32 -1.74 9.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.095 -1.238 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -110.37 8.71 23.42 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 120.956 -1.09 . . . . 0.0 110.543 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 99' ' ' THR . 2.4 mttp -179.91 64.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.634 -1.291 . . . . 0.0 109.277 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.871 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 169.0 -50.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 99' ' ' THR . 8.1 mp0 73.96 16.55 3.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.423 -0.798 . . . . 0.0 110.743 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 t -79.74 -9.05 59.6 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.585 ' CB ' HG22 ' A' ' 96' ' ' VAL . 9.0 mm -85.49 78.69 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.78 32.54 2.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.151 -0.968 . . . . 0.0 109.833 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 107' ' ' ASP . 24.1 p -157.96 132.0 8.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.994 -1.066 . . . . 0.0 110.208 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.536 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -51.2 -29.54 14.4 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -30.74 71.79 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.5 OUTLIER -70.61 -48.86 53.01 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 71' ' ' ASP . 18.9 mt -53.53 -27.06 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -75.93 -39.79 55.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.808 . . . . 0.0 109.817 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.467 ' OD2' ' O ' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -62.49 -41.55 98.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.086 -1.009 . . . . 0.0 109.53 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.812 HG11 ' HG ' ' A' ' 92' ' ' LEU . 1.5 t -72.15 -39.35 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.108 -0.995 . . . . 0.0 109.352 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.705 ' CE1' HG21 ' A' ' 88' ' ' VAL . 2.7 m-30 -63.93 -48.41 76.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.863 . . . . 0.0 110.031 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.1 mt -66.68 -25.41 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.986 . . . . 0.0 109.64 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -67.8 -17.54 64.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 0.0 109.816 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.64 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -90.52 7.03 41.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.637 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.53 2.6 82.12 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.64 HG12 ' HB3' ' A' ' 115' ' ' ALA . 3.0 mm -79.14 59.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.313 -1.11 . . . . 0.0 109.692 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 117' ' ' ILE . 5.3 mmtt -34.86 132.02 0.35 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.323 -0.861 . . . . 0.0 110.319 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 118' ' ' LYS . . . -40.76 -33.79 0.67 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -59.23 -43.14 92.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -1.18 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 118' ' ' LYS . 20.9 mt-10 -75.29 -43.64 50.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.85 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -67.65 -61.97 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.213 -0.929 . . . . 0.0 108.976 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 122' ' ' TYR . 11.4 t0 -47.19 -42.71 20.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.0 108.731 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.72 -45.93 80.84 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.333 -0.854 . . . . 0.0 109.017 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -54.21 -49.05 70.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.435 -0.79 . . . . 0.0 109.146 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.502 ' C ' ' CD1' ' A' ' 126' ' ' TRP . 7.2 t90 -59.81 -54.53 45.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 0.0 108.496 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.07 -15.31 3.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.588 -0.695 . . . . 0.0 110.15 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 32.6 m -70.3 178.04 3.05 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.988 -1.07 . . . . 0.0 110.431 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 -37.67 13.23 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.362 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.65 -46.84 79.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.248 -1.381 . . . . 0.0 109.678 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.61 HG22 ' HB1' ' A' ' 81' ' ' ALA . 5.2 t -63.77 -32.63 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.872 -1.143 . . . . 0.0 108.519 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -71.56 -36.4 70.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 108.84 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -36.49 83.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.388 -0.82 . . . . 0.0 109.156 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.15 -24.72 40.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -0.891 . . . . 0.0 108.661 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 131' ' ' VAL . 17.6 t -73.97 -41.93 52.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.55 -52.87 55.44 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.482 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -54.8 -27.3 40.73 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.43 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -67.83 -65.3 0.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 2.9 tt0 -51.79 -37.28 50.91 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 144' ' ' ASP . 1.3 mtmt -64.39 -30.77 71.8 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.639 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -66.01 -60.29 2.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.453 -0.78 . . . . 0.0 109.052 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.554 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -71.78 -23.11 61.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.898 . . . . 0.0 109.823 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -83.35 -26.5 30.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.038 -1.039 . . . . 0.0 110.325 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.811 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.3 p30 -81.56 -44.03 17.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.901 -1.124 . . . . 0.0 108.595 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.943 HG21 ' CE2' ' A' ' 25' ' ' PHE . 16.0 m -96.39 -10.68 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.879 . . . . 0.0 108.731 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.554 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.0 tt0 78.18 -49.48 0.48 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.447 -0.783 . . . . 0.0 110.26 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.976 HD21 HG12 ' A' ' 61' ' ' VAL . 16.2 tp 65.2 133.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 0.0 109.4 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -160.89 40.44 0.16 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.579 -1.326 . . . . 0.0 109.879 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.67 107.43 0.21 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.464 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 1.044 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.0 144.71 29.62 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.353 -1.086 . . . . 0.0 109.442 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.04 152.4 91.8 Favored 'Cis proline' 0 C--N 1.316 -1.138 0 C-N-CA 124.041 -1.233 . . . . 0.0 110.466 0.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.884 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -128.75 156.03 44.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.393 -1.442 . . . . 0.0 109.364 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.687 ' HE2' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -150.87 133.76 15.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 109.682 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.544 ' HE1' ' HB1' ' A' ' 152' ' ' ALA . 4.3 m-85 -132.41 125.65 31.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.373 -0.829 . . . . 0.0 109.913 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.818 HG13 ' O ' ' A' ' 21' ' ' GLN . 73.5 t -96.94 132.12 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.926 . . . . 0.0 110.153 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.77 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.9 OUTLIER 47.75 20.88 0.23 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.913 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.6 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 57.87 55.09 32.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -164.45 -39.96 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.205 -1.174 . . . . 0.0 108.121 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -110.86 124.09 51.38 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.749 -0.78 . . . . 0.0 108.948 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.527 ' HB3' HD22 ' A' ' 12' ' ' LEU . 15.4 pt20 -120.79 127.29 51.82 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.966 -1.084 . . . . 0.0 109.912 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.542 HD21 ' HB ' ' A' ' 181' ' ' THR . 19.7 mt -64.5 174.12 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -156.09 76.62 4.63 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 109.716 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 C--N 1.308 -1.556 0 C-N-CA 122.752 2.301 . . . . 0.0 110.711 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.8 mtp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.824 0.821 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -55.09 8.55 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.681 -0.637 . . . . 0.0 109.657 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.496 HG13 ' HG3' ' A' ' 177' ' ' GLN . 14.1 t -70.35 -28.59 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.121 -0.987 . . . . 0.0 109.533 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.453 ' O ' ' CD1' ' A' ' 174' ' ' PHE . 2.5 t80 -67.46 -46.04 74.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.032 -1.043 . . . . 0.0 109.437 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 82.6 t -74.74 -24.27 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 1.4 mt-30 -81.81 -52.74 6.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.511 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.545 ' HB3' ' NE2' ' A' ' 8' ' ' GLN . 41.4 mt-30 -63.85 -32.3 73.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.192 -0.943 . . . . 0.0 109.569 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 178' ' ' TYR . 17.8 t80 -74.11 -58.38 3.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.004 . . . . 0.0 109.429 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.35 -33.06 67.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.946 -1.096 . . . . 0.0 108.44 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 33.2 t0 -71.31 -42.61 68.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.493 -0.754 . . . . 0.0 109.342 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.542 ' HB ' HD21 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -55.09 -57.07 13.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.093 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.437 HG22 ' HE1' ' A' ' 153' ' ' MET . 2.3 t -57.12 -35.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.823 -1.173 . . . . 0.0 109.71 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -48.33 82.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.967 . . . . 0.0 109.903 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.26 -21.2 39.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.96 -1.088 . . . . 0.0 110.337 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 181' ' ' THR . 68.6 mt -73.66 -18.54 61.01 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.744 -1.222 . . . . 0.0 109.002 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.5 m -74.14 -4.47 35.92 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.526 -0.733 . . . . 0.0 109.805 -179.69 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 5' ' ' ASP . 12.5 mt-10 -114.07 56.96 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.127 -0.983 . . . . 0.0 110.42 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER 42.61 82.19 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.511 -0.743 . . . . 0.0 110.359 179.063 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.81 -24.63 6.02 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.723 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -82.15 -68.31 0.71 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.0 -1.294 . . . . 0.0 109.178 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.607 ' NE2' ' CD1' ' A' ' 9' ' ' TYR . 2.1 pp0? -95.23 -1.92 50.64 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.607 ' CD1' ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER 179.64 130.45 0.09 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.873 -1.142 . . . . 0.0 109.721 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.2 t -112.87 179.95 3.82 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.872 HG23 ' O ' ' A' ' 158' ' ' LYS . 59.2 m -127.87 143.82 51.1 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.456 0.645 . . . . 0.0 109.581 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -100.69 156.17 17.48 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.399 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -93.63 0.54 56.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.492 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.507 ' O ' HD12 ' A' ' 12' ' ' LEU . 4.2 mtmt -124.88 89.41 52.58 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.283 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.03 166.55 26.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.608 2.206 . . . . 0.0 110.111 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.918 HG13 ' HB2' ' A' ' 19' ' ' ALA . 7.2 p -120.78 109.22 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -0.975 . . . . 0.0 110.264 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.38 125.24 4.54 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.491 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 91.53 -10.63 74.28 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.918 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -33.87 148.11 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.787 -0.831 . . . . 0.0 109.906 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.588 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.4 Cg_endo -81.21 133.72 8.84 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.472 2.115 . . . . 0.0 111.383 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.842 ' OE1' HG22 ' A' ' 54' ' ' VAL . 1.5 mm-40 -51.11 -21.81 2.13 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.508 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 24.1 t -151.12 89.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 108.975 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.674 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -80.43 128.74 33.92 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 58' ' ' LYS . 8.7 tt0 -113.48 96.59 5.96 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.92 -1.113 . . . . 0.0 109.729 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.923 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 4.4 m-85 -84.76 115.71 22.85 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.448 -0.782 . . . . 0.0 109.458 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.538 ' CE1' ' OE1' ' A' ' 37' ' ' GLU . 2.6 p90 -160.35 142.01 12.54 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.268 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.593 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 94.0 p -125.64 -172.72 2.66 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.624 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -109.3 49.3 0.83 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.675 -1.266 . . . . 0.0 108.472 178.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.534 ' HB3' ' CE ' ' A' ' 64' ' ' MET . 7.1 m-85 -133.78 -3.92 2.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.637 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 4.5 m -109.41 173.23 3.06 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.203 . . . . 0.0 108.586 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.3 Cg_endo -76.19 -58.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.752 1.635 . . . . 0.0 109.316 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 69.5 m-70 -63.37 -20.09 65.22 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.536 ' HG ' ' CB ' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -52.58 -53.89 40.33 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.582 0.706 . . . . 0.0 109.286 179.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 8.8 t80 -80.49 -37.46 31.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.575 -0.703 . . . . 0.0 109.884 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.537 ' CD ' HG21 ' A' ' 39' ' ' VAL . 35.6 mm-40 -66.09 -26.07 67.31 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.184 -0.948 . . . . 0.0 109.954 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -70.66 -39.52 73.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.054 -1.029 . . . . 0.0 109.578 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.538 ' OE1' ' CE1' ' A' ' 26' ' ' PHE . 1.2 mt-10 -98.15 -10.06 24.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 0.0 111.898 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 1.8 mm-40 -138.3 27.69 2.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.266 -1.521 . . . . 0.0 111.819 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.537 HG21 ' CD ' ' A' ' 35' ' ' GLN . 64.9 t -151.45 -83.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.432 -1.418 . . . . 0.0 110.026 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.991 HD21 ' HB3' ' A' ' 171' ' ' MET . 18.0 mt -65.14 -14.33 60.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.868 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 23.1 m-70 56.57 18.37 3.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.187 -0.946 . . . . 0.0 109.146 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 46' ' ' VAL . 9.9 mt -55.39 -18.59 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.5 m -82.63 -54.38 5.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.023 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -86.77 -33.0 20.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.72 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 41' ' ' HIS . 10.4 t-20 -51.68 -27.23 11.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.838 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 42' ' ' ILE . 31.4 t -81.21 -17.2 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.302 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 1.036 ' HA ' HD12 ' A' ' 50' ' ' LEU . 1.7 mttm -76.11 -17.93 59.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.813 -1.179 . . . . 0.0 110.074 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -64.46 -16.24 62.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 109.615 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -143.59 36.23 1.31 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.036 HD12 ' HA ' ' A' ' 47' ' ' LYS . 5.2 mt -91.94 142.9 26.95 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.954 -1.091 . . . . 0.0 109.595 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.576 ' HD2' HD23 ' A' ' 50' ' ' LEU . 35.8 Cg_endo -78.03 149.88 25.99 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.689 2.259 . . . . 0.0 110.051 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -79.09 21.38 0.45 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.93 -1.106 . . . . 0.0 110.469 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -124.46 32.74 4.01 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.842 HG22 ' OE1' ' A' ' 21' ' ' GLN . 44.6 t -154.32 131.85 2.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.645 -0.915 . . . . 0.0 108.702 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.5 137.61 51.89 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.178 0.989 . . . . 0.0 109.961 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.508 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 3.3 ptm -107.04 98.96 8.55 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.39 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 24' ' ' GLU . 86.7 m -82.24 142.86 31.77 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.742 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -116.1 111.13 19.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.365 -0.834 . . . . 0.0 110.028 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.594 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 1.7 m-85 -113.44 158.24 20.92 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.173 -0.954 . . . . 0.0 110.864 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.951 ' CE1' HD22 ' A' ' 72' ' ' LEU . 17.9 t60 -99.94 124.69 45.53 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.01 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.3 m -69.85 144.95 13.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.598 -0.689 . . . . 0.0 110.166 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.541 ' HB2' ' CE ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -113.57 49.23 0.99 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.652 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 2.9 p90 -145.37 80.12 1.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.17 0.986 . . . . 0.0 110.048 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.566 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -159.91 -59.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.872 -1.143 . . . . 0.0 109.735 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.566 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -87.98 -28.07 24.38 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.472 ' O ' ' HG2' ' A' ' 70' ' ' LYS . . . 86.3 -49.17 4.04 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.19 -78.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.562 -0.964 . . . . 0.0 110.008 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.112 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -73.79 -22.62 59.76 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.855 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 1.112 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -55.53 -43.32 85.63 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 107.434 -2.266 . . . . 0.0 107.434 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.541 ' CE ' ' HB2' ' A' ' 62' ' ' ASN . 8.6 mmmt -63.71 -47.8 79.68 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.508 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 13.3 t0 -64.04 -28.38 69.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.951 HD22 ' CE1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -58.16 -38.5 76.74 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.571 HG23 ' OE1' ' A' ' 138' ' ' GLN . 6.7 m -66.24 -42.85 88.05 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.551 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -60.99 -18.58 58.29 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 177.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -68.37 -47.49 67.28 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -58.99 -27.73 65.69 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.736 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -79.37 -52.46 8.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.432 -0.792 . . . . 0.0 109.967 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.732 HG21 ' CE1' ' A' ' 122' ' ' TYR . 39.2 t -60.77 -26.53 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.044 -1.035 . . . . 0.0 109.875 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -80.23 -63.43 1.41 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.038 -1.039 . . . . 0.0 109.003 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -45.9 -27.94 1.0 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.682 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -70.35 -46.15 64.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.437 -0.79 . . . . 0.0 109.463 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.467 ' HB2' HG13 ' A' ' 84' ' ' VAL . 21.6 mt -102.05 12.07 37.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.15 -0.969 . . . . 0.0 110.214 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 53.56 20.55 11.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 79' ' ' ALA . 34.9 m -86.47 -7.93 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.431 -1.041 . . . . 0.0 110.669 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.474 ' CA ' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -40.82 -59.47 1.41 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.087 -1.008 . . . . 0.0 109.986 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.4 -34.19 10.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.449 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 mttt -82.74 -52.88 6.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.199 -0.938 . . . . 0.0 111.471 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.639 HG23 HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -75.15 -6.81 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.633 -1.292 . . . . 0.0 110.505 -178.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.675 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -77.04 -44.77 29.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.948 -1.095 . . . . 0.0 108.513 178.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.44 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -52.32 -52.38 63.49 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.543 -1.348 . . . . 0.0 110.565 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.677 ' HB2' HG13 ' A' ' 111' ' ' VAL . 26.0 Cg_endo -73.68 -20.93 19.67 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 O-C-N 122.727 0.856 . . . . 0.0 110.022 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.872 ' HG ' HG11 ' A' ' 111' ' ' VAL . 13.1 mt -85.61 -41.9 14.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 108.967 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.675 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.6 m-30 -65.95 -45.71 80.81 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.071 -1.018 . . . . 0.0 108.862 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 90' ' ' VAL . 23.5 mt-10 -76.3 -26.75 56.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 109.556 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.434 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -65.56 -36.93 93.11 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.9 t -93.07 -12.78 8.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.151 -1.205 . . . . 0.0 108.594 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 1.3 mt-30 -104.98 4.12 31.39 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 121.103 -0.998 . . . . 0.0 111.051 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.775 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER -160.15 61.11 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.404 -1.435 . . . . 0.0 109.963 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.11 -49.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 74.27 15.2 3.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -0.989 . . . . 0.0 110.628 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -86.69 -4.29 59.16 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.732 0.777 . . . . 0.0 108.988 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.488 HG23 ' OD1' ' A' ' 107' ' ' ASP . 6.5 mm -80.57 77.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HD3' ' C ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -140.75 35.13 1.79 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 110.074 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 107' ' ' ASP . 54.9 p -157.26 133.74 9.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.856 -1.152 . . . . 0.0 109.968 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.883 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -50.71 -35.7 32.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 75.7 m -59.19 -28.86 67.02 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -75.39 -50.78 14.84 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.883 HD12 ' HA ' ' A' ' 105' ' ' ALA . 21.9 mt -47.25 -31.34 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.086 -1.009 . . . . 0.0 109.421 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 106' ' ' SER . 1.3 ptm180 -78.99 -37.27 39.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.945 -1.097 . . . . 0.0 109.349 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -54.64 -46.06 73.88 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.153 -0.967 . . . . 0.0 108.929 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.872 HG11 ' HG ' ' A' ' 92' ' ' LEU . 70.4 t -69.95 -39.91 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -0.942 . . . . 0.0 109.227 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.61 ' HD2' HG21 ' A' ' 117' ' ' ILE . 1.4 m-85 -59.6 -53.79 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.717 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.1 mt -60.21 -25.96 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.107 -0.996 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.47 -16.97 64.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.164 -0.96 . . . . 0.0 109.378 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.622 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -100.44 -7.14 24.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.544 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.76 -5.27 25.99 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.783 HD12 ' N ' ' A' ' 117' ' ' ILE . 2.2 mp -78.42 52.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -1.158 . . . . 0.0 109.278 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 117' ' ' ILE . 38.3 mttp -36.2 157.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.318 -0.864 . . . . 0.0 110.555 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -59.82 -50.58 66.19 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 119' ' ' GLY . 21.1 tt0 -43.29 -55.19 4.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.03 -1.276 . . . . 0.0 109.929 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 1.3 tt0 -63.98 -63.22 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.976 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.732 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -46.27 -60.94 2.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.135 -0.978 . . . . 0.0 109.239 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 122' ' ' TYR . 1.2 m-20 -44.54 -34.25 2.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.152 -0.968 . . . . 0.0 109.062 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 121' ' ' GLU . . . -75.63 -44.36 43.13 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.353 -0.842 . . . . 0.0 109.23 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.688 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -59.02 -48.08 82.9 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.409 -0.807 . . . . 0.0 109.17 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.536 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 10.8 t90 -59.44 -53.23 60.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.404 -0.81 . . . . 0.0 108.957 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.94 -15.72 2.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.642 -0.661 . . . . 0.0 110.236 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.41 178.1 7.44 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.976 -1.078 . . . . 0.0 109.971 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -91.45 -36.6 13.68 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.566 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.6 t -64.27 -47.3 90.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.205 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.688 HG21 ' HB1' ' A' ' 125' ' ' ALA . 21.3 t -64.39 -39.84 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.109 -0.994 . . . . 0.0 108.481 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -29.1 67.42 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 50.4 m -66.27 -34.39 77.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.842 . . . . 0.0 109.019 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -28.5 54.92 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.736 HG23 ' CB ' ' A' ' 77' ' ' ALA . 6.8 t -75.1 -36.34 37.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -67.66 -46.15 73.23 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.593 -0.692 . . . . 0.0 109.405 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.444 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -68.83 -23.64 64.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.428 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.594 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 4.7 mt-30 -72.49 -69.41 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.083 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.76 -35.05 21.02 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.427 ' O ' ' CG ' ' A' ' 144' ' ' ASP . 12.1 mtpt -75.94 -29.9 58.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.321 -0.862 . . . . 0.0 108.874 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -57.34 -56.26 24.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.213 -0.93 . . . . 0.0 108.751 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -75.54 -32.89 60.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.925 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.21 -22.15 61.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 109.46 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 140' ' ' LYS . 73.7 m-20 -82.45 -47.36 12.34 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.853 HG21 ' HE2' ' A' ' 25' ' ' PHE . 11.3 m -88.55 -5.49 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 2.6 tp60 80.8 -50.36 0.31 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.587 -0.696 . . . . 0.0 109.543 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.643 HD13 ' CD2' ' A' ' 25' ' ' PHE . 13.1 tp 61.51 137.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.228 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -161.02 33.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.544 -1.347 . . . . 0.0 110.339 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 160.14 109.69 0.26 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 118.905 -1.617 . . . . 0.0 111.208 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 1.01 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -87.93 144.35 34.65 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.586 -0.949 . . . . 0.0 109.057 178.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.79 152.65 92.86 Favored 'Cis proline' 0 C--N 1.315 -1.222 0 C-N-CA 123.923 -1.282 . . . . 0.0 110.526 0.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.923 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -123.54 141.8 51.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.361 -1.462 . . . . 0.0 109.139 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.506 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 1.6 ttp -130.27 130.94 45.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.126 -0.984 . . . . 0.0 109.71 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.779 ' HE1' ' HB1' ' A' ' 152' ' ' ALA . 8.3 m-85 -133.73 131.44 39.41 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 21' ' ' GLN . 12.2 t -105.32 125.57 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.753 -1.217 . . . . 0.0 108.618 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 20' ' ' PRO . 18.6 t-20 48.08 26.39 1.0 Allowed 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.901 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 52.17 25.27 17.76 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.208 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.872 ' O ' HG23 ' A' ' 11' ' ' THR . 10.0 tttm -124.9 -19.2 5.32 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.835 -1.391 . . . . 0.0 108.894 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.407 ' O ' ' N ' ' A' ' 155' ' ' VAL . 94.0 m-85 -141.66 125.08 16.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 108.92 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.602 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -128.79 134.78 48.49 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.877 -1.139 . . . . 0.0 109.632 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.519 HD12 ' CZ ' ' A' ' 178' ' ' TYR . 12.8 mt -68.02 177.14 2.3 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.627 -0.671 . . . . 0.0 109.287 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.64 82.7 5.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.888 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 C--N 1.31 -1.469 0 C-N-CA 122.666 2.244 . . . . 0.0 110.311 179.696 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.991 ' HB3' HD21 ' A' ' 40' ' ' LEU . 3.8 mtm . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.589 0.709 . . . . 0.0 109.967 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.45 -50.82 14.62 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.696 -0.628 . . . . 0.0 109.341 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.5 t -74.69 -29.56 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 178' ' ' TYR . 33.4 t80 -69.07 -36.2 77.36 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.947 -1.095 . . . . 0.0 108.614 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.784 ' CG2' HD22 ' A' ' 40' ' ' LEU . 24.3 t -74.34 -28.71 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.363 -0.836 . . . . 0.0 108.916 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -81.53 -58.39 3.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.053 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.72 -36.53 36.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.203 -0.936 . . . . 0.0 109.074 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.519 ' CZ ' HD12 ' A' ' 161' ' ' LEU . 18.9 t80 -69.44 -47.15 64.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.193 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.59 -22.42 66.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.15 -0.969 . . . . 0.0 108.978 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -79.09 -45.3 20.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 109.305 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.665 ' O ' HD23 ' A' ' 185' ' ' LEU . 6.5 m -63.11 -31.78 73.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -0.958 . . . . 0.0 109.317 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.505 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 52.0 t -77.39 -39.59 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.747 -1.22 . . . . 0.0 109.357 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -56.96 -52.23 66.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.5 -24.41 50.08 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.665 HD23 ' O ' ' A' ' 181' ' ' THR . 0.2 OUTLIER -64.31 -20.71 66.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.875 -1.141 . . . . 0.0 108.839 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.764 ' CB ' HG21 ' A' ' 54' ' ' VAL . 63.0 p -87.3 7.54 28.25 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.865 -1.147 . . . . 0.0 108.273 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.392 -0.818 . . . . 0.0 109.542 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.608 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 4.9 mt-10 -128.17 66.04 1.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 110.34 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.6 m-20 61.3 91.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 110.407 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.98 68.56 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.092 -1.051 . . . . 0.0 110.59 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.581 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 9.1 tttp -95.64 26.07 4.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.991 -1.299 . . . . 0.0 108.561 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.581 ' CB ' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER 145.09 -34.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.575 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 2.5 p90 -141.86 115.59 9.14 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.001 -1.062 . . . . 0.0 109.225 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t -105.25 179.62 4.22 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.332 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -104.32 157.85 16.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.746 -0.596 . . . . 0.0 109.713 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.783 HD11 ' HB2' ' A' ' 160' ' ' GLN . 1.6 mp -100.08 159.11 15.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.362 -0.836 . . . . 0.0 109.477 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -98.97 11.75 38.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 109.443 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -168.3 93.27 0.61 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.195 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HB3' ' O ' ' A' ' 157' ' ' GLY . 36.4 Cg_endo -77.85 161.79 30.02 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.536 2.157 . . . . 0.0 110.891 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.91 HG13 ' CB ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -113.23 96.79 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 109.437 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -41.66 126.96 3.1 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 94.02 -16.69 60.35 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.91 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -38.63 158.18 0.1 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.484 -1.01 . . . . 0.0 109.94 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.567 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.7 Cg_endo -80.42 138.75 12.53 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.827 2.351 . . . . 0.0 111.48 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.674 ' O ' HG13 ' A' ' 155' ' ' VAL . 6.0 mt-30 -47.53 -22.34 0.46 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.476 -0.765 . . . . 0.0 109.653 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.716 ' O ' HG12 ' A' ' 22' ' ' VAL . 8.4 t -150.36 80.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.04 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.628 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -75.58 129.49 37.28 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -112.73 129.76 56.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.947 -1.095 . . . . 0.0 109.827 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.062 ' CE2' HG21 ' A' ' 145' ' ' VAL . 8.4 m-85 -116.88 102.83 9.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.247 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -146.4 136.36 23.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.894 -1.129 . . . . 0.0 110.026 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.609 ' CB ' ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -110.06 171.79 7.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.404 -0.81 . . . . 0.0 109.522 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.605 ' HB2' HD21 ' A' ' 72' ' ' LEU . 7.9 m-30 -87.59 43.58 1.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.539 ' CE1' HD22 ' A' ' 72' ' ' LEU . 9.6 m-85 -143.23 12.32 1.78 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.371 -0.83 . . . . 0.0 110.127 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 4.7 m -106.88 160.52 26.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.778 -1.201 . . . . 0.0 109.378 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -75.65 -32.39 4.72 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.111 1.874 . . . . 0.0 107.928 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.8 t-160 -79.9 -25.52 40.55 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 37.1 t -45.05 -64.17 0.77 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.576 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 28.0 t80 -65.0 -44.71 88.38 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.294 0.569 . . . . 0.0 110.055 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.496 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 52.7 mt-30 -67.43 -16.42 64.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.917 . . . . 0.0 110.859 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 32' ' ' HIS . 12.7 t80 -76.72 -52.0 10.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.979 -1.076 . . . . 0.0 110.344 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -106.53 -4.62 19.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.789 -1.195 . . . . 0.0 112.072 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.576 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 10.6 mt-10 -124.4 19.76 8.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.213 -1.555 . . . . 0.0 111.332 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.517 ' CG2' ' CE2' ' A' ' 34' ' ' TYR . 64.1 t -151.76 -84.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.614 -1.304 . . . . 0.0 109.92 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.846 HD21 ' HB3' ' A' ' 171' ' ' MET . 13.8 mt -63.96 -13.9 49.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 0.0 109.867 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 44' ' ' ASP . 57.0 m-70 49.05 24.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.169 -0.957 . . . . 0.0 108.649 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.416 HD11 HD13 ' A' ' 40' ' ' LEU . 1.8 mt -43.18 -27.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.544 -0.722 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.26 -16.62 39.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -0.971 . . . . 0.0 110.867 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 41' ' ' HIS . 35.3 t70 -87.15 -34.05 19.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.916 -1.115 . . . . 0.0 110.413 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -73.26 -44.15 59.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.215 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.7 m -55.96 -25.13 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.127 -0.983 . . . . 0.0 110.021 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HG2' HD12 ' A' ' 50' ' ' LEU . 3.1 mttt -65.67 -27.35 68.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 109.343 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -55.3 -18.56 6.58 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.376 -0.827 . . . . 0.0 109.096 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -134.86 48.26 2.3 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 109.764 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.537 HD12 ' HG2' ' A' ' 47' ' ' LYS . 10.7 mt -104.08 102.86 34.71 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 34.2 Cg_endo -76.3 152.78 35.19 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.512 2.141 . . . . 0.0 109.273 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 52' ' ' GLU . 12.1 tt0 -72.15 23.2 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.637 -1.289 . . . . 0.0 111.243 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 21' ' ' GLN . . . -122.13 29.47 5.53 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 186' ' ' SER . 68.5 t -148.92 121.17 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.502 -0.999 . . . . 0.0 108.722 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.7 116.69 32.48 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 110.471 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.524 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.94 96.99 9.66 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -88.68 141.58 28.4 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.039 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.68 113.93 21.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.404 -0.81 . . . . 0.0 109.639 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 138' ' ' GLN . 2.2 m-85 -116.97 154.05 31.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.995 -1.066 . . . . 0.0 111.838 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.609 ' CE1' ' CB ' ' A' ' 27' ' ' SER . 37.2 t-80 -108.87 111.71 23.56 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.047 HG11 HD22 ' A' ' 147' ' ' LEU . 3.1 m -82.36 158.18 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.976 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 70' ' ' LYS . 1.6 p30 -108.99 48.24 0.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.37 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.649 ' CE1' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -119.94 45.72 2.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.923 -1.111 . . . . 0.0 110.219 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.527 ' HG3' ' CD1' ' A' ' 63' ' ' PHE . 34.9 mtp -159.65 47.66 0.28 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 159.32 58.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -33.37 -36.56 0.05 OUTLIER Glycine 0 N--CA 1.493 2.499 0 O-C-N 122.004 -0.704 . . . . 0.0 111.472 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -87.59 -79.31 0.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.767 -1.431 . . . . 0.0 110.762 -178.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.9 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.74 -19.61 30.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.94 -1.1 . . . . 0.0 110.261 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.578 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -56.79 -39.65 87.86 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -65.09 -42.85 93.67 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.25 -24.49 64.9 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.769 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 41.7 tp -65.64 -47.73 74.61 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.543 ' CG2' ' NE2' ' A' ' 138' ' ' GLN . 2.0 m -58.58 -43.46 89.45 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 1.053 ' O ' HG23 ' A' ' 78' ' ' VAL . 5.7 tp60 -55.69 -27.45 50.34 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.58 -41.52 98.36 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.497 ' HB2' ' CB ' ' A' ' 60' ' ' HIS . 47.8 t-105 -61.47 -30.68 70.75 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.391 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.674 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -81.68 -39.31 24.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 110.057 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.053 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.3 t -77.07 -27.12 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 109.75 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -80.87 -54.37 5.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.295 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -48.67 -27.79 3.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.203 -0.936 . . . . 0.0 108.742 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.927 ' HB2' HG22 ' A' ' 131' ' ' VAL . . . -60.5 -56.03 26.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.432 -0.792 . . . . 0.0 110.119 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.785 ' HB2' HG13 ' A' ' 84' ' ' VAL . 3.2 mt -102.04 10.38 39.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.038 -1.038 . . . . 0.0 110.59 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.45 27.98 61.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.919 HG11 HG12 ' A' ' 117' ' ' ILE . 19.7 m -81.98 -6.64 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.375 -1.073 . . . . 0.0 109.858 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' THR . 3.9 tt0 -43.88 -65.1 0.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.547 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -41.41 -34.02 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 109.852 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -80.71 -51.95 8.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.459 -0.776 . . . . 0.0 111.158 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.857 HG23 HD12 ' A' ' 92' ' ' LEU . 1.6 m -86.61 -9.57 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.708 -1.245 . . . . 0.0 110.869 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.689 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.46 -44.03 46.3 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.819 -1.176 . . . . 0.0 108.717 179.241 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.435 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -53.19 -53.18 58.63 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.478 -1.389 . . . . 0.0 110.453 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.544 ' HG2' HG13 ' A' ' 111' ' ' VAL . 26.0 Cg_endo -73.47 -18.08 23.19 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 O-C-N 122.786 0.887 . . . . 0.0 109.844 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.876 ' HG ' HG11 ' A' ' 111' ' ' VAL . 19.6 mt -87.24 -43.39 12.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.011 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.689 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.1 m-30 -64.98 -45.94 83.53 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.894 -1.129 . . . . 0.0 108.73 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 97' ' ' GLN . 7.2 tt0 -72.73 -27.42 62.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.309 -0.87 . . . . 0.0 109.17 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.461 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -65.17 -38.19 94.95 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.651 HG22 ' CB ' ' A' ' 102' ' ' ILE . 3.8 t -97.81 -1.55 10.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.299 -1.118 . . . . 0.0 108.629 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 93' ' ' PHE . 18.8 mm-40 -111.14 9.61 21.92 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.169 -0.957 . . . . 0.0 110.874 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.811 ' O ' HG23 ' A' ' 99' ' ' THR . 50.6 tttt -172.5 62.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.482 -1.387 . . . . 0.0 109.822 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 164.47 -50.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.704 -0.622 . . . . 0.0 109.324 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.3 mt-30 75.92 15.28 2.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.195 -0.941 . . . . 0.0 110.777 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 t -82.82 -6.63 59.51 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.403 -0.81 . . . . 0.0 108.818 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.651 ' CB ' HG22 ' A' ' 96' ' ' VAL . 10.5 mm -79.97 72.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.21 31.56 3.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.198 -0.939 . . . . 0.0 109.167 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 107' ' ' ASP . 1.4 p -151.21 126.48 9.95 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.256 -0.902 . . . . 0.0 109.861 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.657 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -50.63 -31.81 17.16 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.4 t -59.3 -31.42 69.11 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -71.54 -49.34 41.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' A' ' 105' ' ' ALA . 37.3 mt -50.58 -30.32 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.124 -0.985 . . . . 0.0 108.947 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.42 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 24.5 mtm180 -79.55 -32.33 42.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.207 -0.933 . . . . 0.0 109.227 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -58.79 -46.79 86.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.268 -0.895 . . . . 0.0 108.799 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.876 HG11 ' HG ' ' A' ' 92' ' ' LEU . 70.1 t -71.35 -38.27 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.209 -0.932 . . . . 0.0 109.009 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CE2' ' CE2' ' A' ' 122' ' ' TYR . 0.5 OUTLIER -56.95 -44.72 82.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.561 HG23 ' HA ' ' A' ' 118' ' ' LYS . 15.5 mt -73.58 -24.21 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.594 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -65.82 -16.71 64.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.421 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.571 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -91.35 -3.23 56.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 109.86 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.94 -8.93 63.55 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.919 HG12 HG11 ' A' ' 84' ' ' VAL . 2.6 mp -88.86 51.83 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -1.098 . . . . 0.0 109.362 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.561 ' HA ' HG23 ' A' ' 113' ' ' ILE . 16.7 pttm -33.78 153.89 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.565 -0.709 . . . . 0.0 110.826 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.17 -29.3 2.29 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.488 ' HB3' ' CD ' ' A' ' 118' ' ' LYS . 17.3 tt0 -50.37 -58.09 6.47 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.064 -1.256 . . . . 0.0 109.042 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.38 -54.14 6.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.438 -0.788 . . . . 0.0 109.662 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.787 ' CE2' HG11 ' A' ' 78' ' ' VAL . 2.6 t80 -46.73 -55.56 7.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.119 -0.988 . . . . 0.0 109.218 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.439 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 47.1 t0 -56.66 -48.59 77.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 109.07 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.49 -49.86 54.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.25 -0.906 . . . . 0.0 109.076 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 131' ' ' VAL . . . -51.44 -49.27 62.01 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.456 -0.778 . . . . 0.0 109.188 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.742 ' HA ' HG11 ' A' ' 131' ' ' VAL . 11.4 t90 -60.27 -56.49 20.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 108.956 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -15.64 3.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.517 -0.739 . . . . 0.0 109.923 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 63.2 m -77.35 -177.71 4.78 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.05 -1.031 . . . . 0.0 110.156 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.34 -32.43 13.61 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.76 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.3 -42.75 97.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 117.916 -1.514 . . . . 0.0 109.401 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.927 HG22 ' HB2' ' A' ' 81' ' ' ALA . 42.6 t -65.72 -38.21 81.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.04 -1.038 . . . . 0.0 108.295 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -38.44 89.14 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.3 m -62.1 -39.77 93.6 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.34 -16.63 56.01 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.674 HG23 ' HB1' ' A' ' 77' ' ' ALA . 5.0 t -79.4 -44.75 23.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 140' ' ' LYS . . . -68.62 -44.64 73.82 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.449 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 7.1 tp-100 -62.81 -32.64 73.87 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -0.817 . . . . 0.0 109.041 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.543 ' NE2' ' CG2' ' A' ' 73' ' ' THR . 1.6 tm0? -79.43 -62.75 1.59 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.199 -0.938 . . . . 0.0 108.751 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -49.47 -34.5 17.06 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 6.8 ttmt -75.11 -29.07 60.47 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.64 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -59.25 -54.23 49.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.362 -0.836 . . . . 0.0 109.143 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -75.83 -31.52 59.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 110.356 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.28 54.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.23 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.636 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.2 p30 -84.21 -47.18 11.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.978 -1.076 . . . . 0.0 108.181 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 1.062 HG21 ' CE2' ' A' ' 25' ' ' PHE . 10.3 m -82.04 -21.86 9.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 82.1 -25.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.849 -0.532 . . . . 0.0 110.188 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.047 HD22 HG11 ' A' ' 61' ' ' VAL . 10.5 tp 61.4 142.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 109.537 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.15 33.66 0.14 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.691 -1.256 . . . . 0.0 110.139 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.658 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 153.05 113.33 0.53 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.325 -1.416 . . . . 0.0 110.519 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.625 HG13 ' HZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -101.56 139.55 20.49 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.34 -1.094 . . . . 0.0 109.395 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.31 151.46 95.0 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 123.725 -1.365 . . . . 0.0 110.209 0.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -130.37 126.77 37.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.271 -1.518 . . . . 0.0 109.127 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.646 ' CE ' HG22 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -122.71 114.77 21.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.087 -1.008 . . . . 0.0 110.094 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.512 ' CE1' ' HB1' ' A' ' 152' ' ' ALA . 3.2 m-30 -110.58 148.3 32.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 21' ' ' GLN . 29.7 t -107.61 133.47 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.731 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.611 ' OD1' HG12 ' A' ' 155' ' ' VAL . 5.6 p-10 40.7 25.49 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.4 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 15' ' ' PRO . . . 58.2 60.07 9.63 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 6.8 tttt -167.74 -33.68 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.379 -1.071 . . . . 0.0 108.327 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.54 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 96.5 m-85 -116.49 121.44 41.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.056 -1.028 . . . . 0.0 108.926 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.783 ' HB2' HD11 ' A' ' 12' ' ' LEU . 19.8 tt0 -113.42 109.02 18.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 109.749 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 9' ' ' TYR . 15.5 mt -59.32 172.12 0.68 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 8' ' ' GLN . 62.9 t-20 -152.2 83.07 5.16 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 120.849 -1.157 . . . . 0.0 109.848 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 C--N 1.308 -1.566 0 C-N-CA 122.713 2.275 . . . . 0.0 110.432 179.734 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.846 ' HB3' HD21 ' A' ' 40' ' ' LEU . 13.0 mtt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.661 0.743 . . . . 0.0 109.952 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.6 -62.24 1.75 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.693 -0.63 . . . . 0.0 109.672 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.56 -21.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.151 -0.968 . . . . 0.0 108.919 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.485 ' O ' ' CD1' ' A' ' 174' ' ' PHE . 2.4 t80 -74.78 -45.23 45.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.293 -0.88 . . . . 0.0 109.268 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.796 ' CG2' HD22 ' A' ' 40' ' ' LEU . 39.8 t -71.39 -26.87 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.174 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.66 -53.11 6.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.569 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.55 -40.64 87.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 109.01 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -63.92 -47.5 80.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.321 -0.862 . . . . 0.0 108.909 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.61 -29.48 70.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.25 -0.906 . . . . 0.0 108.947 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -75.08 -38.29 61.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 109.277 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.719 ' O ' HD23 ' A' ' 185' ' ' LEU . 2.9 m -66.11 -26.47 67.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -0.871 . . . . 0.0 109.274 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.646 HG22 ' CE ' ' A' ' 153' ' ' MET . 52.8 t -87.13 -37.23 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 108.581 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -57.46 -48.47 79.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.406 -0.809 . . . . 0.0 108.885 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.44 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -80.92 -28.74 35.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.397 -0.815 . . . . 0.0 109.416 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 181' ' ' THR . 0.6 OUTLIER -63.77 -17.3 62.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.198 . . . . 0.0 109.358 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.492 ' HB2' HG21 ' A' ' 54' ' ' VAL . 1.4 t -82.56 5.54 20.53 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.665 -1.272 . . . . 0.0 107.999 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.439 -0.788 . . . . 0.0 109.415 -179.777 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 5' ' ' ASP . 0.4 OUTLIER -105.11 55.74 0.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 4' ' ' GLU . 7.0 p-10 39.77 79.86 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.812 -0.555 . . . . 0.0 109.891 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 126.79 -26.52 5.09 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.762 -1.208 . . . . 0.0 110.348 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 -69.52 0.6 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.063 -1.257 . . . . 0.0 109.385 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -91.41 2.72 56.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.229 -0.919 . . . . 0.0 109.611 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 6' ' ' GLY . 2.2 p90 178.91 132.85 0.08 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.09 -1.006 . . . . 0.0 109.189 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 t -119.11 176.34 5.35 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.691 -0.63 . . . . 0.0 109.494 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -100.24 152.1 20.68 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.357 0.599 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 mp -92.95 170.9 9.31 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.303 -0.873 . . . . 0.0 109.594 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.428 ' OE2' ' HG2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -91.56 -5.92 53.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.511 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HG2' ' OE2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -166.06 110.67 0.73 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.444 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.514 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 36.0 Cg_endo -77.97 160.49 30.37 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.417 2.078 . . . . 0.0 110.153 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -119.03 102.67 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 109.8 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.22 127.07 6.73 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 92.37 -15.03 63.2 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.539 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -38.35 156.18 0.11 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.94 . . . . 0.0 109.618 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.569 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.5 Cg_endo -79.17 128.32 8.12 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.547 2.165 . . . . 0.0 111.308 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.765 ' O ' HG13 ' A' ' 155' ' ' VAL . 37.0 mt-30 -42.38 -24.28 0.05 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.398 -0.813 . . . . 0.0 109.586 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.684 ' O ' HG12 ' A' ' 22' ' ' VAL . 7.1 t -147.26 83.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.127 -0.983 . . . . 0.0 109.155 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.646 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -77.75 128.56 34.22 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 58' ' ' LYS . 3.4 mm-40 -109.68 131.93 54.61 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.088 -1.008 . . . . 0.0 109.723 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.03 ' CE2' HG21 ' A' ' 145' ' ' VAL . 5.0 m-85 -120.58 113.93 20.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -151.75 144.89 24.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.974 -1.079 . . . . 0.0 109.698 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.729 ' HB2' HG22 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -118.53 163.86 16.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 110.085 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.786 ' CD2' HD21 ' A' ' 72' ' ' LEU . 18.8 m-30 -88.13 39.17 0.89 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 1.009 ' CZ ' HD13 ' A' ' 72' ' ' LEU . 5.2 m-85 -138.72 15.51 2.7 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 110.179 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 4.2 m -114.39 158.18 40.59 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.596 -1.315 . . . . 0.0 109.722 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -74.5 -25.42 12.98 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.196 1.931 . . . . 0.0 107.835 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' PHE . 98.5 m-70 -89.17 -16.43 31.38 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 5.7 t -54.92 -53.44 55.51 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 38' ' ' GLU . 29.3 t80 -71.58 -40.61 69.78 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.486 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.483 ' HA ' ' CG2' ' A' ' 39' ' ' VAL . 3.3 mt-30 -78.33 -19.02 54.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 111.181 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 32' ' ' HIS . 70.6 t80 -78.0 -20.3 52.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.924 -1.11 . . . . 0.0 110.466 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 41' ' ' HIS . 3.7 tm-20 -133.31 -72.06 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.885 -1.134 . . . . 0.0 110.826 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.636 ' CB ' ' CE1' ' A' ' 34' ' ' TYR . 56.8 mm-40 -46.02 -40.25 10.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.831 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.483 ' CG2' ' HA ' ' A' ' 35' ' ' GLN . 5.0 t -92.4 -74.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.053 . . . . 0.0 110.548 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.557 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 0.4 OUTLIER -75.21 -10.9 59.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.0 110.652 -178.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 11.0 p-80 40.92 32.11 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.136 -0.977 . . . . 0.0 109.342 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.502 HG13 ' HB3' ' A' ' 40' ' ' LEU . 3.6 mt -54.38 -18.12 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 110.152 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.6 p -84.95 -38.56 19.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.943 -1.098 . . . . 0.0 110.563 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 2.7 m-20 -81.58 -36.91 28.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.02 -1.05 . . . . 0.0 110.428 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 46' ' ' VAL . 15.8 t30 -60.54 -53.34 58.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.033 -1.042 . . . . 0.0 110.171 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' ASN . 6.7 m -42.82 -38.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 110.183 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.797 ' HA ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -46.86 -34.81 5.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.039 . . . . 0.0 109.867 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.429 ' HD3' ' HG2' ' A' ' 49' ' ' LYS . 3.4 tmtm? -45.46 -24.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.145 -0.972 . . . . 0.0 109.93 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.519 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -116.32 40.57 2.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.729 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.797 HD13 ' HA ' ' A' ' 47' ' ' LYS . 5.5 mp -129.47 68.19 79.96 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.182 -0.949 . . . . 0.0 109.587 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 52' ' ' GLU . 36.1 Cg_endo -80.31 77.97 3.86 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.697 2.265 . . . . 0.0 111.685 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 51' ' ' PRO . 25.5 tp10 58.92 136.85 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.616 0.722 . . . . 0.0 110.103 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.13 -6.52 69.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.812 HG13 ' HB2' ' A' ' 186' ' ' SER . 0.9 OUTLIER -116.06 100.52 10.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.28 -1.13 . . . . 0.0 108.645 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -100.51 109.39 21.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.259 -0.901 . . . . 0.0 110.427 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.524 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -102.46 95.52 6.32 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 24' ' ' GLU . 4.2 m -84.16 133.6 34.6 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.724 -1.19 . . . . 0.0 110.042 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 8.5 tttt -106.72 117.95 35.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.484 -0.76 . . . . 0.0 109.582 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CE2' ' HG2' ' A' ' 138' ' ' GLN . 3.3 m-85 -120.88 177.02 5.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.014 -1.054 . . . . 0.0 110.5 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.607 ' CE1' ' HA ' ' A' ' 27' ' ' SER . 3.2 t60 -109.16 159.89 16.53 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.84 0.828 . . . . 0.0 109.538 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.049 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.4 m -104.02 162.4 4.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.79 58.31 1.7 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.141 -0.975 . . . . 0.0 109.314 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.702 ' HE1' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -158.03 64.82 0.46 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.023 -1.048 . . . . 0.0 110.849 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.671 ' HE1' ' O ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -126.17 33.27 5.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.503 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 64' ' ' MET . . . 44.72 42.42 7.6 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . -148.5 80.97 0.2 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 66' ' ' GLY . 44.5 t0 -33.39 -45.35 0.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.021 -0.693 . . . . 0.0 111.366 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.103 HD23 ' N ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -55.4 -21.01 13.81 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.749 -1.219 . . . . 0.0 109.192 -179.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 1.103 ' N ' HD23 ' A' ' 68' ' ' LEU . . . -63.62 -51.3 55.2 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -50.97 -55.05 19.18 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -27.0 68.96 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.009 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 6.2 tt -65.32 -38.06 89.0 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.545 ' CG2' ' NE2' ' A' ' 138' ' ' GLN . 1.8 m -59.69 -42.17 92.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.924 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.2 tt0 -53.92 -29.31 41.62 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.72 -40.06 95.83 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.446 ' O ' ' HB2' ' A' ' 80' ' ' MET . 53.4 t-105 -60.24 -30.93 69.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 108.534 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.546 ' HA ' HD21 ' A' ' 134' ' ' LEU . . . -86.96 -60.46 1.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 109.642 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 74' ' ' GLN . 2.0 t -53.66 -28.1 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 109.171 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.09 -55.74 4.04 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.521 ' SD ' HD22 ' A' ' 134' ' ' LEU . 2.7 ttt -50.67 -27.54 7.18 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.763 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -68.79 -42.25 77.64 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.489 -0.757 . . . . 0.0 109.49 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.505 ' HB2' HG13 ' A' ' 84' ' ' VAL . 14.9 mt -101.97 7.8 41.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.376 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.32 29.32 45.8 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.774 HG11 HG12 ' A' ' 117' ' ' ILE . 26.8 m -94.21 7.82 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.433 -1.039 . . . . 0.0 109.684 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 86' ' ' ASP . 48.9 tt0 -47.72 -72.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.12 -0.988 . . . . 0.0 109.487 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -38.86 -34.59 0.16 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.556 -0.715 . . . . 0.0 110.224 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.534 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 10.4 mtpp -73.95 -55.22 6.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.819 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.917 HG23 HD12 ' A' ' 92' ' ' LEU . 1.1 m -87.16 -19.98 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.737 -1.227 . . . . 0.0 110.681 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.717 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -70.17 -42.27 72.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.625 -1.297 . . . . 0.0 108.13 179.004 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.52 -55.66 37.85 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.603 -1.311 . . . . 0.0 110.692 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 24.4 Cg_endo -72.17 -16.7 28.34 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 N-CA-C 109.669 -0.935 . . . . 0.0 109.669 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.917 HD12 HG23 ' A' ' 88' ' ' VAL . 30.6 mt -86.85 -47.06 9.36 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.717 ' CE1' HG23 ' A' ' 89' ' ' THR . 6.5 m-30 -58.56 -49.18 78.37 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 120.928 -1.108 . . . . 0.0 108.98 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -69.07 -33.09 73.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.061 -1.024 . . . . 0.0 109.015 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.456 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -67.86 -30.16 74.17 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.795 HG11 ' HD1' ' A' ' 29' ' ' PHE . 2.1 t -107.45 9.71 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 121.086 -1.243 . . . . 0.0 108.784 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.545 ' NE2' ' HB2' ' A' ' 34' ' ' TYR . 58.9 mt-30 -112.79 15.23 19.91 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.073 -1.017 . . . . 0.0 110.567 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 7.0 mttt 178.97 -49.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.591 -1.318 . . . . 0.0 110.913 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -67.7 -38.16 83.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.561 -1.337 . . . . 0.0 110.048 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 67.24 13.57 9.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -0.832 . . . . 0.0 109.55 -179.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.447 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 42.5 p -79.79 -9.91 59.72 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.811 0.815 . . . . 0.0 109.048 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.897 HG22 HD11 ' A' ' 68' ' ' LEU . 5.5 mm -86.99 75.65 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.699 -0.626 . . . . 0.0 109.574 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.564 ' CA ' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -132.27 27.25 4.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 109.308 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 107' ' ' ASP . 7.9 p -147.8 127.07 13.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 109.856 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.653 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.23 -42.81 41.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.1 p -54.36 -31.34 54.34 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 104' ' ' SER . 14.2 m-20 -74.88 -38.02 62.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.236 -0.915 . . . . 0.0 108.969 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.865 HD11 ' O ' ' A' ' 68' ' ' LEU . 31.0 mt -55.98 -27.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -38.54 57.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.9 -49.68 70.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.0 109.197 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.855 HG11 ' HG ' ' A' ' 92' ' ' LEU . 47.2 t -68.25 -37.78 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.479 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.677 ' CD1' HG11 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -58.74 -37.57 76.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.917 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.9 mt -78.99 -27.0 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.157 -0.964 . . . . 0.0 110.313 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -65.55 -16.7 63.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.912 -1.118 . . . . 0.0 109.572 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 87' ' ' LYS . . . -87.94 -1.57 58.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.783 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.0 -3.91 65.01 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.3 mp -87.67 61.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 108.928 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -36.6 154.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.879 -1.138 . . . . 0.0 110.426 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.13 -22.25 35.28 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.16 -54.41 47.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -1.191 . . . . 0.0 109.439 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -42.19 55.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.922 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.742 ' CE2' HG11 ' A' ' 78' ' ' VAL . 7.1 t80 -59.68 -48.12 82.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.139 -0.975 . . . . 0.0 109.716 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.54 -39.91 94.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.115 -0.99 . . . . 0.0 109.182 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 128' ' ' SER . . . -55.73 -53.36 57.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.364 -0.835 . . . . 0.0 109.408 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 1.026 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -56.46 -55.47 33.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.42 -0.8 . . . . 0.0 108.856 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.567 ' CE3' ' O ' ' A' ' 126' ' ' TRP . 0.7 OUTLIER -48.77 -54.11 16.39 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -68.63 -14.82 63.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.686 -0.634 . . . . 0.0 109.845 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 67.7 m -68.9 -179.24 1.41 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.066 -1.021 . . . . 0.0 110.135 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.7 -35.71 13.33 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.555 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.76 -46.61 60.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.36 -1.336 . . . . 0.0 110.171 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 1.026 HG21 ' HB1' ' A' ' 125' ' ' ALA . 3.0 t -66.57 -35.37 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.732 -1.23 . . . . 0.0 108.63 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -67.1 -38.74 86.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -39.53 94.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 108.974 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 77' ' ' ALA . 4.8 tp -75.64 -25.13 56.58 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.513 HG11 ' CZ3' ' A' ' 126' ' ' TRP . 11.6 t -73.96 -41.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.84 -37.05 85.95 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.03 -31.27 71.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.446 -0.784 . . . . 0.0 108.886 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.545 ' NE2' ' CG2' ' A' ' 73' ' ' THR . 2.3 mt-30 -66.89 -61.41 1.96 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.415 -0.803 . . . . 0.0 108.852 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.92 -33.41 37.08 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -76.48 -28.34 56.45 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.604 -0.685 . . . . 0.0 109.335 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.845 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -63.54 -57.5 9.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -72.84 -31.31 64.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.887 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.27 -23.24 43.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.165 -0.959 . . . . 0.0 110.222 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 140' ' ' LYS . 76.1 m-20 -81.12 -44.42 17.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.08 -1.012 . . . . 0.0 108.49 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 1.03 HG21 ' CE2' ' A' ' 25' ' ' PHE . 31.7 m -95.58 -8.35 9.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 1.1 mm-40 78.12 -52.5 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.449 -0.782 . . . . 0.0 109.397 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.605 HD13 ' CD2' ' A' ' 25' ' ' PHE . 27.1 tp 68.39 129.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.876 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.59 41.51 0.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.589 -1.319 . . . . 0.0 109.568 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 172.28 105.27 0.18 Allowed Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.068 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 1.049 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -105.05 141.55 22.81 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.391 -1.064 . . . . 0.0 109.817 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.52 152.74 96.18 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 123.572 -1.428 . . . . 0.0 110.208 0.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -134.68 159.38 41.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.241 -1.537 . . . . 0.0 109.394 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.514 ' SD ' HD12 ' A' ' 161' ' ' LEU . 2.1 ttm -154.0 131.22 11.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.942 . . . . 0.0 109.851 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 160' ' ' GLN . 6.1 m-85 -124.76 133.7 53.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.156 -0.965 . . . . 0.0 110.026 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 21' ' ' GLN . 48.2 t -96.2 132.34 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.361 -0.837 . . . . 0.0 110.287 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.539 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 1.2 m-20 48.48 21.23 0.37 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.826 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 55.86 55.53 28.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -164.71 -34.87 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.357 -1.084 . . . . 0.0 108.355 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.415 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 72.7 m-85 -114.57 118.25 33.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.221 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.431 ' HB2' ' CD1' ' A' ' 154' ' ' PHE . 23.6 tt0 -104.29 109.04 20.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.282 -0.886 . . . . 0.0 109.574 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.642 HD13 ' CZ ' ' A' ' 178' ' ' TYR . 30.0 mt -59.89 169.78 1.36 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -151.78 87.29 4.43 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.055 -1.028 . . . . 0.0 109.463 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . 35.8 Cg_endo . . . . . 0 C--N 1.307 -1.613 0 C-N-CA 122.603 2.202 . . . . 0.0 110.502 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.7 mtt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.708 0.766 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -70.7 -44.46 66.91 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.633 -0.667 . . . . 0.0 109.223 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.8 t -73.46 -25.04 20.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.217 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 163' ' ' PRO . 4.1 t80 -69.16 -46.48 67.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 0.0 109.063 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 42' ' ' ILE . 45.5 t -71.55 -24.54 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.568 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -83.14 -55.36 4.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.423 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -39.17 93.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.95 -1.094 . . . . 0.0 108.786 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.642 ' CZ ' HD13 ' A' ' 161' ' ' LEU . 63.4 t80 -65.2 -43.52 91.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.376 -0.827 . . . . 0.0 108.891 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.86 -31.77 65.14 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.021 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.61 -38.62 54.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.317 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.649 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -62.5 -30.34 71.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.239 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 58.1 t -86.03 -33.69 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.191 -0.943 . . . . 0.0 108.636 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.81 -48.55 81.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 108.885 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.76 -32.26 52.53 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.184 -0.947 . . . . 0.0 108.886 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 181' ' ' THR . 0.9 OUTLIER -64.32 -17.06 63.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.877 -1.14 . . . . 0.0 109.138 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.812 ' HB2' HG13 ' A' ' 54' ' ' VAL . 24.9 p -74.02 -10.46 59.65 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.909 -1.119 . . . . 0.0 108.569 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.486 1.361 0 O-C-N 121.477 -0.764 . . . . 0.0 109.441 179.895 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -114.84 61.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.292 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.4 t70 53.72 86.0 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.506 -0.746 . . . . 0.0 109.6 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 120.62 -22.9 8.09 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.173 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -69.83 0.58 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.981 -1.305 . . . . 0.0 108.505 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 0.6 OUTLIER -114.8 19.02 16.23 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.333 -0.854 . . . . 0.0 109.432 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.697 ' HB2' HD23 ' A' ' 161' ' ' LEU . 0.8 OUTLIER 177.94 129.92 0.06 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.225 -0.922 . . . . 0.0 109.063 179.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -126.14 176.66 6.89 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.53 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 158' ' ' LYS . 24.9 m -104.14 149.47 25.22 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.472 0.653 . . . . 0.0 109.71 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.4 OUTLIER -89.46 149.52 22.9 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.431 -0.793 . . . . 0.0 109.658 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -70.58 -23.19 62.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.009 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -122.62 102.16 39.2 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.82 164.54 29.9 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.474 2.116 . . . . 0.0 111.118 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.878 HG21 ' OD1' ' A' ' 144' ' ' ASP . 37.7 t -129.1 76.68 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 109.562 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.45 133.18 5.78 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.46 -25.06 26.39 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.669 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -41.09 162.87 0.11 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.521 -0.987 . . . . 0.0 109.627 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.607 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 33.0 Cg_endo -75.8 125.82 9.04 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.589 2.193 . . . . 0.0 111.449 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.762 ' O ' HG13 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -37.95 -25.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.848 -0.532 . . . . 0.0 110.854 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.674 ' O ' HG12 ' A' ' 22' ' ' VAL . 17.5 t -147.75 79.82 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.709 -1.244 . . . . 0.0 109.139 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.642 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -82.14 124.82 30.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.528 ' HG3' ' HA ' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -123.71 108.47 12.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.027 -1.046 . . . . 0.0 109.222 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.642 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 7.6 m-85 -88.27 126.53 35.21 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.411 0.624 . . . . 0.0 110.035 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -155.16 142.1 19.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 109.69 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.752 ' CB ' HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -126.32 161.94 26.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.224 -0.922 . . . . 0.0 109.129 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.678 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -83.74 48.13 1.39 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 0.0 108.817 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.723 ' CD1' ' HE3' ' A' ' 64' ' ' MET . 6.3 m-85 -135.47 5.77 3.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.373 -0.829 . . . . 0.0 110.016 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.524 ' HB3' ' NE2' ' A' ' 32' ' ' HIS . 90.9 m -108.69 155.38 40.71 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 118.688 -1.205 . . . . 0.0 109.23 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -73.68 -28.9 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.079 1.853 . . . . 0.0 108.192 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 36' ' ' PHE . 2.5 p-80 -86.15 -20.76 28.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 14.7 t -47.31 -63.29 1.08 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.538 ' CE2' ' CD ' ' A' ' 38' ' ' GLU . 35.6 t80 -59.62 -54.5 45.78 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.475 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 1.5 mt-30 -56.52 -25.51 51.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.22 -0.925 . . . . 0.0 109.786 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.639 ' CE1' HG21 ' A' ' 42' ' ' ILE . 35.5 t80 -84.49 -25.43 28.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 110.672 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.531 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 3.6 tt0 -125.81 51.46 1.74 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.842 -1.161 . . . . 0.0 110.16 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.538 ' CD ' ' CE2' ' A' ' 34' ' ' TYR . 1.1 mt-10 -171.06 -57.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.083 -1.011 . . . . 0.0 110.706 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.1 t -102.07 -58.76 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.924 -1.11 . . . . 0.0 110.917 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 35' ' ' GLN . 64.4 mt -46.43 -22.75 0.29 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.034 -1.041 . . . . 0.0 110.408 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 17.9 m80 57.07 16.97 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.036 -1.04 . . . . 0.0 109.522 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.639 HG21 ' CE1' ' A' ' 36' ' ' PHE . 23.0 mt -64.04 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 109.358 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.85 -31.68 35.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.447 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.31 -27.51 32.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.922 -1.111 . . . . 0.0 110.061 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 36.8 t30 -80.44 -40.05 27.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.965 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 p -65.72 -25.32 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.528 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.458 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 1.0 OUTLIER -68.76 -20.41 64.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.637 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -76.8 -20.76 56.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.142 -0.974 . . . . 0.0 109.62 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.454 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 4.1 mttt -105.65 3.86 29.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 0.0 109.842 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.458 ' HG ' ' HA ' ' A' ' 47' ' ' LYS . 14.4 mt -42.73 102.61 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 109.692 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' ' CG2' ' A' ' 54' ' ' VAL . 34.6 Cg_endo -77.74 127.98 9.07 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.339 2.026 . . . . 0.0 110.605 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.89 116.97 2.03 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.139 0.971 . . . . 0.0 109.233 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.53 -20.28 10.29 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.665 ' O ' HG12 ' A' ' 54' ' ' VAL . 2.6 t -93.39 91.8 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -1.204 . . . . 0.0 109.051 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -75.19 102.09 4.85 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.508 -0.745 . . . . 0.0 109.769 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.529 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 15.1 ttp -89.93 99.92 12.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.563 -0.711 . . . . 0.0 109.483 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.455 ' O ' ' CG ' ' A' ' 24' ' ' GLU . 7.4 m -96.28 139.12 32.88 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.402 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -113.55 109.77 19.18 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.49 -0.756 . . . . 0.0 109.054 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.574 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 3.2 m-85 -110.28 168.72 9.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.839 -1.163 . . . . 0.0 110.562 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.577 ' NE2' ' CD2' ' A' ' 72' ' ' LEU . 55.9 t-80 -97.99 153.25 18.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.899 HG11 HG11 ' A' ' 150' ' ' VAL . 2.1 m -90.62 155.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.606 0.717 . . . . 0.0 110.485 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -124.5 28.58 6.57 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.575 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 12.8 p90 -130.87 61.57 1.62 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.018 -1.051 . . . . 0.0 110.185 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.723 ' HE3' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -160.17 -61.43 0.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.58 ' N ' ' HG2' ' A' ' 64' ' ' MET . . . -87.4 82.11 1.61 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -39.94 -51.04 3.4 Favored Glycine 0 N--CA 1.489 2.22 0 O-C-N 121.473 -1.016 . . . . 0.0 110.916 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -87.74 -78.53 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.023 -1.28 . . . . 0.0 111.168 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.076 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -71.97 -23.88 61.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.854 -1.154 . . . . 0.0 110.026 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 1.076 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -50.34 -60.4 6.79 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -48.33 -45.17 34.85 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.958 -1.319 . . . . 0.0 108.31 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -65.37 -31.14 72.1 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.749 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 44.5 tp -57.72 -42.74 84.44 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.6 m -61.53 -41.4 97.27 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.97 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -58.4 -21.07 49.21 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -70.22 -45.75 65.9 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 28.4 t-105 -55.31 -30.71 60.73 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.555 ' HB2' ' OE1' ' A' ' 138' ' ' GLN . . . -86.5 -65.36 1.02 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 110.134 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.97 HG23 ' O ' ' A' ' 74' ' ' GLN . 2.7 t -48.15 -28.16 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 109.945 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.482 ' HB2' ' HZ ' ' A' ' 112' ' ' PHE . . . -85.29 -59.3 2.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.83 -1.169 . . . . 0.0 108.982 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ALA . 8.0 tpt -47.11 -27.98 1.6 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.854 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -73.86 -38.33 64.49 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.54 -0.725 . . . . 0.0 109.443 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 125' ' ' ALA . 52.3 mt -99.56 5.23 46.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.113 -0.992 . . . . 0.0 110.403 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.28 20.09 27.64 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.857 HG11 HG12 ' A' ' 117' ' ' ILE . 35.4 m -89.25 -4.1 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.391 -1.064 . . . . 0.0 110.432 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -45.38 -68.15 0.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.072 -1.018 . . . . 0.0 109.439 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.13 -34.57 0.18 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 110.21 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.943 ' HE2' ' HB1' ' A' ' 115' ' ' ALA . 12.1 mtpt -83.05 -51.22 7.74 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.264 -0.898 . . . . 0.0 110.969 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.867 HG23 HD12 ' A' ' 92' ' ' LEU . 1.2 m -80.97 -17.59 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.773 -1.204 . . . . 0.0 110.505 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.804 HG23 ' CD1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -69.43 -43.39 73.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 108.74 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.78 -55.39 38.82 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.548 -1.345 . . . . 0.0 110.531 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.521 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 25.8 Cg_endo -72.47 -18.07 26.33 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 N-CA-C 109.909 -0.843 . . . . 0.0 109.909 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.894 ' HG ' HG11 ' A' ' 111' ' ' VAL . 21.8 mt -87.05 -43.94 11.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 108.949 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.804 ' CD1' HG23 ' A' ' 89' ' ' THR . 4.2 m-30 -63.68 -46.62 84.72 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.926 -1.109 . . . . 0.0 109.027 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -16.74 61.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.98 . . . . 0.0 109.238 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.454 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -76.44 -30.63 56.37 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 92' ' ' LEU . 1.1 t -105.71 -2.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.068 -1.254 . . . . 0.0 109.444 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -113.33 10.98 18.49 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 120.827 -1.171 . . . . 0.0 111.073 -178.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 99' ' ' THR . 0.7 OUTLIER -177.39 58.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.496 -1.378 . . . . 0.0 109.992 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.933 ' CG2' HG23 ' A' ' 101' ' ' THR . 1.0 OUTLIER 168.13 -48.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 99' ' ' THR . 1.5 mt-30 80.11 20.97 0.54 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.752 -1.217 . . . . 0.0 111.366 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.933 HG23 ' CG2' ' A' ' 99' ' ' THR . 26.1 p -84.01 -8.91 59.01 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.303 -0.873 . . . . 0.0 109.107 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.6 ' CB ' HG22 ' A' ' 96' ' ' VAL . 5.2 mm -91.81 82.97 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.69 -0.631 . . . . 0.0 109.35 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.521 ' N ' ' HD3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -146.36 29.6 1.05 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 109.409 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.536 ' CA ' ' HB3' ' A' ' 68' ' ' LEU . 1.1 p -155.43 132.38 10.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.943 . . . . 0.0 110.025 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.776 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -50.41 -32.56 17.97 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 m -62.9 -32.79 74.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -69.81 -50.3 44.24 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.776 HD12 ' HA ' ' A' ' 105' ' ' ALA . 27.0 mt -49.72 -29.36 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.614 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.423 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -78.5 -29.05 46.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.332 -0.855 . . . . 0.0 109.318 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -64.91 -46.32 82.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.238 -0.914 . . . . 0.0 109.302 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.894 HG11 ' HG ' ' A' ' 92' ' ' LEU . 61.4 t -71.87 -37.9 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.453 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.482 ' HZ ' ' HB2' ' A' ' 79' ' ' ALA . 1.0 OUTLIER -61.03 -36.3 79.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.925 . . . . 0.0 109.655 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.842 HG23 ' HA ' ' A' ' 118' ' ' LYS . 15.1 mt -79.67 -25.49 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.996 . . . . 0.0 110.227 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -64.09 -23.35 67.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.421 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.943 ' HB1' ' HE2' ' A' ' 87' ' ' LYS . . . -85.65 2.16 46.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 109.62 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.431 ' C ' HD12 ' A' ' 117' ' ' ILE . . . 96.45 -2.24 62.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.857 HG12 HG11 ' A' ' 84' ' ' VAL . 1.4 mp -90.33 60.66 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.121 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.842 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.4 OUTLIER -34.18 152.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -0.964 . . . . 0.0 110.681 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.52 -27.37 41.31 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.7 -47.22 86.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -1.172 . . . . 0.0 109.081 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -75.94 -40.87 53.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 109.221 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.85 ' CE2' HG11 ' A' ' 78' ' ' VAL . 3.9 t80 -58.92 -47.36 85.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.851 . . . . 0.0 109.286 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.47 -34.51 77.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.244 -0.91 . . . . 0.0 109.013 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.68 -51.37 67.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.307 -0.871 . . . . 0.0 108.919 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.584 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -55.77 -49.36 73.35 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.385 -0.822 . . . . 0.0 108.955 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.57 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 12.7 t90 -57.49 -55.06 39.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.346 -0.846 . . . . 0.0 108.832 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -54.45 -16.16 2.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.474 -0.766 . . . . 0.0 109.821 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.419 ' OG ' HG23 ' A' ' 131' ' ' VAL . 1.0 OUTLIER -67.71 -179.21 1.07 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 109.571 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.9 -36.28 13.55 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.45 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.6 t -73.81 -47.9 41.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 118.225 -1.39 . . . . 0.0 110.057 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.854 HG22 ' HB1' ' A' ' 81' ' ' ALA . 3.1 t -61.82 -40.56 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.771 -1.206 . . . . 0.0 108.411 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 132' ' ' LYS . 2.6 ttmm -64.87 -28.13 69.33 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.514 -0.741 . . . . 0.0 109.131 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.5 t -69.79 -37.93 76.5 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.348 -0.845 . . . . 0.0 109.241 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.91 -17.13 59.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.187 -0.946 . . . . 0.0 108.485 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.28 -43.84 43.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -68.51 -46.98 68.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -58.15 -33.33 69.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.082 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.574 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -69.74 -74.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 0.0 109.407 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.8 mt-10 -45.58 -36.39 4.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.822 . . . . 0.0 108.932 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -72.63 -35.53 67.82 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.259 -0.901 . . . . 0.0 108.668 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.478 ' O ' ' OD2' ' A' ' 144' ' ' ASP . . . -53.09 -62.6 1.55 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.487 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -60.93 -25.14 66.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.267 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 140' ' ' LYS . . . -78.67 -25.68 44.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.878 ' OD1' HG21 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -78.85 -48.32 14.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.07 -1.019 . . . . 0.0 108.342 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.84 HG13 ' OD1' ' A' ' 144' ' ' ASP . 27.4 m -89.83 -11.43 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.544 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.4 OUTLIER 80.87 -47.27 0.26 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.494 -0.754 . . . . 0.0 109.827 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.553 HD21 HG12 ' A' ' 61' ' ' VAL . 36.0 tp 61.77 130.08 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.35 -0.843 . . . . 0.0 109.102 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -160.96 40.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.525 -1.36 . . . . 0.0 109.94 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 165.14 107.96 0.21 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.899 HG11 HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -99.42 143.45 26.44 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.294 -1.121 . . . . 0.0 109.769 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.521 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 35.1 Cg_endo -76.71 152.01 95.02 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 123.997 -1.251 . . . . 0.0 110.136 0.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -132.84 137.62 46.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.225 -1.547 . . . . 0.0 109.416 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.527 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 2.8 ttp -129.14 130.59 46.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.112 -0.992 . . . . 0.0 110.18 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.532 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 8.5 m-85 -127.55 129.73 47.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.307 -0.871 . . . . 0.0 109.792 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 21' ' ' GLN . 54.3 t -96.76 131.46 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 110.057 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.669 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.9 OUTLIER 44.9 23.58 0.09 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.353 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.576 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 55.4 57.67 17.51 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.528 ' HB3' ' CD1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -164.72 -36.38 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.528 ' CD1' ' HB3' ' A' ' 158' ' ' LYS . 11.7 m-85 -117.45 123.03 45.38 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.511 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -125.42 120.78 31.97 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.975 -1.078 . . . . 0.0 109.81 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.697 HD23 ' HB2' ' A' ' 9' ' ' TYR . 17.2 mt -65.33 177.36 1.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.555 -0.716 . . . . 0.0 109.152 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.549 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 50.9 t-20 -137.58 60.27 24.78 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.723 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 162' ' ' ASN . 35.5 Cg_endo . . . . . 0 C--N 1.309 -1.528 0 C-N-CA 122.635 2.224 . . . . 0.0 110.397 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 34.6 mtt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.693 0.759 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.07 -46.76 89.34 Favored 'General case' 0 C--N 1.293 -1.891 0 O-C-N 121.639 -0.663 . . . . 0.0 109.499 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.3 t -67.0 -28.14 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.36 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -66.85 -40.41 87.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.216 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.515 HG22 ' CG1' ' A' ' 42' ' ' ILE . 39.6 t -75.27 -27.42 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.173 -0.955 . . . . 0.0 109.458 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.15 -56.16 4.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.972 . . . . 0.0 109.246 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -55.74 -33.25 64.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.15 -0.969 . . . . 0.0 109.151 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 178' ' ' TYR . 13.5 t80 -70.5 -53.11 17.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -0.951 . . . . 0.0 109.479 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.5 -31.84 71.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.556 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -76.81 -50.25 13.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.746 ' O ' HD23 ' A' ' 185' ' ' LEU . 20.6 m -54.39 -24.15 18.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.246 -0.909 . . . . 0.0 109.527 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.463 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 25.0 t -86.16 -40.29 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.031 -1.043 . . . . 0.0 109.174 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -55.18 -45.6 75.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.178 -0.952 . . . . 0.0 109.094 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.516 ' CE2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -81.75 -36.66 28.3 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.34 -0.85 . . . . 0.0 109.233 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.746 HD23 ' O ' ' A' ' 181' ' ' THR . 0.7 OUTLIER -54.05 -20.2 6.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.886 -1.133 . . . . 0.0 109.875 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.619 ' HB3' HG21 ' A' ' 54' ' ' VAL . 64.9 p -63.91 -13.49 45.98 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.709 -1.244 . . . . 0.0 108.054 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.553 -0.717 . . . . 0.0 109.31 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -111.3 59.16 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.012 -1.055 . . . . 0.0 109.593 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 45.64 83.92 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.509 -0.744 . . . . 0.0 109.893 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 136.74 -33.01 2.39 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.084 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.79 -72.63 0.45 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -1.18 . . . . 0.0 109.398 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.783 ' HB3' HG21 ' A' ' 181' ' ' THR . 8.5 mm-40 -87.88 -4.24 58.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.816 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 24.0 p90 177.15 130.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.236 -0.915 . . . . 0.0 109.14 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -106.31 -179.92 4.08 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 m -103.13 159.61 15.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.639 -0.663 . . . . 0.0 109.533 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.777 HD21 ' CE2' ' A' ' 154' ' ' PHE . 15.3 mt -95.98 154.86 17.01 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.357 -0.839 . . . . 0.0 109.748 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.28 -12.67 40.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.448 -0.783 . . . . 0.0 108.982 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 100.74 3.98 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 109.222 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.19 160.9 35.86 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.39 2.06 . . . . 0.0 110.703 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.906 HG13 ' CB ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -121.31 98.63 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 109.595 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.77 126.94 6.0 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 99.13 -21.57 45.13 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.906 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -40.9 157.06 0.19 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.987 . . . . 0.0 109.513 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.572 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.8 Cg_endo -79.83 139.59 14.0 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.725 2.283 . . . . 0.0 111.659 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.801 ' O ' HG13 ' A' ' 155' ' ' VAL . 2.8 mm-40 -51.65 -20.52 2.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.537 -0.727 . . . . 0.0 109.099 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 53.9 t -151.62 82.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.209 -0.932 . . . . 0.0 108.759 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.716 HD12 HG11 ' A' ' 145' ' ' VAL . 0.0 OUTLIER -74.49 126.88 31.71 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.548 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -110.18 127.33 54.88 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.039 -1.038 . . . . 0.0 109.764 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.61 ' CE2' HD13 ' A' ' 23' ' ' LEU . 3.1 m-85 -124.79 108.84 12.37 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.478 -0.764 . . . . 0.0 109.428 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -152.67 145.3 24.22 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.343 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.607 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -128.72 -164.94 1.44 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.642 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -116.62 53.95 0.87 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.92 -1.112 . . . . 0.0 108.683 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' HD11 ' A' ' 72' ' ' LEU . 9.6 m-85 -133.88 -5.33 2.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.019 -1.05 . . . . 0.0 110.64 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.498 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 0.2 OUTLIER -106.28 171.8 4.48 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.8 -1.188 . . . . 0.0 109.433 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 30' ' ' CYS . 33.5 Cg_endo -75.15 -38.87 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.294 1.996 . . . . 0.0 109.113 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.528 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.5 m80 -84.61 -20.7 30.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -52.56 -40.52 62.64 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.563 ' CE2' ' OE1' ' A' ' 38' ' ' GLU . 40.2 t80 -87.25 -47.45 8.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.69 -0.632 . . . . 0.0 109.619 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -66.18 -21.75 66.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 109.905 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.576 ' CE1' HG21 ' A' ' 42' ' ' ILE . 89.1 t80 -83.06 -16.74 45.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.592 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.552 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -132.79 50.77 2.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.77 -1.206 . . . . 0.0 110.636 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.563 ' OE1' ' CE2' ' A' ' 34' ' ' TYR . 1.0 OUTLIER -175.41 -59.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.192 -0.943 . . . . 0.0 110.216 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.6 t -89.99 -46.91 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.204 -0.935 . . . . 0.0 110.733 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 41' ' ' HIS . 77.8 mt -65.99 -6.0 11.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.022 -1.049 . . . . 0.0 110.561 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.446 ' HA ' ' OD1' ' A' ' 44' ' ' ASP . 50.5 m170 44.03 27.0 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.992 -1.067 . . . . 0.0 109.163 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.576 HG21 ' CE1' ' A' ' 36' ' ' PHE . 15.6 mt -78.43 -22.57 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.821 . . . . 0.0 109.957 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.691 ' O ' HG12 ' A' ' 46' ' ' VAL . 47.2 m -80.65 -26.67 37.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.976 -1.078 . . . . 0.0 110.333 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.446 ' OD1' ' HA ' ' A' ' 41' ' ' HIS . 1.9 p-10 -87.44 -49.86 6.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.976 -1.078 . . . . 0.0 110.117 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 46' ' ' VAL . 39.1 p-10 -59.72 -25.26 64.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.214 -0.929 . . . . 0.0 110.028 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 43' ' ' SER . 9.4 p -65.27 -26.75 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 109.958 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.802 ' HA ' HD12 ' A' ' 50' ' ' LEU . 3.8 mttt -77.05 -38.29 53.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 109.969 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.48 -23.92 1.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.062 -1.023 . . . . 0.0 109.468 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.6 33.25 5.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.352 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.802 HD12 ' HA ' ' A' ' 47' ' ' LYS . 13.8 mt -114.79 81.79 7.62 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.872 . . . . 0.0 109.198 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.753 ' HD2' HG21 ' A' ' 54' ' ' VAL . 35.6 Cg_endo -77.5 143.85 22.1 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.584 2.189 . . . . 0.0 110.566 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 51' ' ' PRO . 3.5 tm-20 -40.61 120.88 1.34 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 122.361 1.077 . . . . 0.0 109.233 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.39 -28.5 4.76 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.753 HG21 ' HD2' ' A' ' 51' ' ' PRO . 31.9 t -86.37 79.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -1.076 . . . . 0.0 108.849 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -61.07 101.67 0.17 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.422 -0.799 . . . . 0.0 110.528 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.672 ' SD ' HD11 ' A' ' 50' ' ' LEU . 7.9 ttt -100.67 97.68 8.32 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.493 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 1.6 m -94.68 123.5 38.16 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.325 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.548 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 3.1 tppt? -99.63 121.65 41.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.398 -0.814 . . . . 0.0 109.546 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.593 ' CE1' ' HG2' ' A' ' 138' ' ' GLN . 2.0 m-85 -126.05 174.78 8.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.854 -1.154 . . . . 0.0 111.174 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.741 ' NE2' HD22 ' A' ' 72' ' ' LEU . 22.4 t60 -112.04 145.86 38.95 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.841 0.829 . . . . 0.0 109.378 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.078 HG11 ' CG1' ' A' ' 150' ' ' VAL . 8.4 m -80.86 155.73 4.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.325 0.583 . . . . 0.0 109.985 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . 52.0 p30 -121.02 38.81 3.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.142 -0.973 . . . . 0.0 109.604 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 2.4 p90 -139.34 57.11 1.66 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.163 -0.96 . . . . 0.0 109.611 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.515 ' CE ' ' CG2' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -125.79 35.23 4.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.134 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.83 -30.83 1.23 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.379 -1.889 . . . . 0.0 108.379 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.46 -35.02 3.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.7 -79.45 0.29 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.74 -1.447 . . . . 0.0 109.939 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.903 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -76.6 -19.14 58.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 108.85 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.564 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -53.48 -54.46 29.91 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -52.99 -41.91 65.06 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.77 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 45.5 t0 -65.76 -31.39 72.35 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.762 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -59.05 -36.08 74.43 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.582 HG23 ' OE1' ' A' ' 138' ' ' GLN . 45.7 m -66.64 -41.74 87.8 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -63.83 -16.43 61.27 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -71.28 -40.6 70.81 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 20.0 t-105 -68.85 -31.35 70.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.61 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -81.0 -62.48 1.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.577 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.146 HG11 ' CD2' ' A' ' 122' ' ' TYR . 59.9 t -48.33 -29.1 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.949 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.516 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -84.03 -60.52 2.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.885 -1.134 . . . . 0.0 108.875 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.584 ' HB3' HD22 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -44.5 -28.8 0.62 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.73 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -71.45 -44.48 64.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.805 . . . . 0.0 109.572 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.552 ' HB2' HG13 ' A' ' 84' ' ' VAL . 5.8 mt -99.97 11.18 39.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.037 -1.04 . . . . 0.0 110.004 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.38 22.02 6.95 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 82' ' ' LEU . 34.0 m -85.19 -7.81 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -1.076 . . . . 0.0 110.138 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -41.17 -60.3 1.27 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -33.43 7.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 110.345 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -83.29 -52.53 6.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.171 -0.956 . . . . 0.0 111.696 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.919 HG23 HD12 ' A' ' 92' ' ' LEU . 1.2 m -77.68 -10.06 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.586 -1.321 . . . . 0.0 110.249 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.713 HG23 ' CD1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -70.88 -44.69 65.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.851 -1.155 . . . . 0.0 108.889 179.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.403 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -53.17 -54.77 40.92 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.448 -1.408 . . . . 0.0 110.477 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.579 ' HB2' HG13 ' A' ' 111' ' ' VAL . 24.7 Cg_endo -72.8 -18.63 24.68 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 122.639 0.81 . . . . 0.0 109.995 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.919 HD12 HG23 ' A' ' 88' ' ' VAL . 15.0 mt -86.16 -41.75 14.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.235 -0.916 . . . . 0.0 109.09 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.713 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.8 m-30 -66.25 -47.61 73.19 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.056 -1.027 . . . . 0.0 109.007 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -31.96 70.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.935 -1.103 . . . . 0.0 109.322 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.464 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -63.06 -32.7 85.04 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.664 HG11 ' CD1' ' A' ' 29' ' ' PHE . 2.0 t -107.19 5.76 9.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.105 -1.232 . . . . 0.0 109.206 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.533 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -107.78 10.69 28.71 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.981 -1.074 . . . . 0.0 110.579 -179.187 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER 176.08 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.519 -1.363 . . . . 0.0 110.144 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 43.0 p -56.62 -44.66 81.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.489 -1.382 . . . . 0.0 109.114 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 99' ' ' THR . 38.2 mt-30 70.42 10.83 7.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.425 -0.797 . . . . 0.0 110.085 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 t -83.27 -5.28 59.08 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.734 0.778 . . . . 0.0 109.143 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.513 ' CB ' HG22 ' A' ' 96' ' ' VAL . 12.9 mm -84.57 80.51 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.69 33.38 1.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 110.021 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.544 ' O ' ' N ' ' A' ' 107' ' ' ASP . 1.7 p -161.47 133.78 5.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.953 -1.092 . . . . 0.0 109.893 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.77 ' HB1' ' OD2' ' A' ' 71' ' ' ASP . . . -51.51 -32.62 28.3 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 104' ' ' SER . 5.5 p -61.85 -31.46 71.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -72.02 -49.54 36.07 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.77 HD11 HD23 ' A' ' 68' ' ' LEU . 26.9 mt -52.01 -30.9 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.401 ' O ' HG13 ' A' ' 113' ' ' ILE . 19.6 mtt-85 -74.11 -28.54 61.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 109.069 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -66.61 -48.15 70.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.339 -0.851 . . . . 0.0 109.374 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.859 HG11 ' HG ' ' A' ' 92' ' ' LEU . 49.1 t -65.83 -40.26 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.991 . . . . 0.0 109.507 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CE1' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -57.57 -43.84 84.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.946 -1.096 . . . . 0.0 109.379 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 109' ' ' ARG . 18.7 mt -68.35 -24.8 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 109.623 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -20.11 66.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 109.691 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.83 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -93.87 9.71 36.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.552 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.44 -5.57 84.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.832 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.6 mp -76.65 55.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -1.175 . . . . 0.0 109.032 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -33.01 149.17 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.347 -0.846 . . . . 0.0 110.743 -179.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 122' ' ' TYR . . . -51.8 -28.41 23.36 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -58.8 -47.56 84.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -1.155 . . . . 0.0 108.849 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -80.41 -34.51 36.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.401 -0.812 . . . . 0.0 109.705 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 1.146 ' CD2' HG11 ' A' ' 78' ' ' VAL . 3.5 t80 -64.17 -50.22 69.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 109.511 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.62 -35.19 75.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.013 -1.054 . . . . 0.0 108.713 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.6 -51.65 67.65 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.634 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -54.91 -52.06 64.12 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.533 ' C ' ' CD1' ' A' ' 126' ' ' TRP . 6.8 t90 -52.75 -55.61 21.59 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.14 -15.74 2.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.677 -0.639 . . . . 0.0 110.435 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -72.55 176.64 5.27 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.909 -1.119 . . . . 0.0 109.845 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -87.33 -39.0 15.73 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.179 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.43 -44.86 83.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 C-N-CA 118.254 -1.378 . . . . 0.0 109.789 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.73 HG22 ' HB1' ' A' ' 81' ' ' ALA . 2.8 t -67.02 -38.87 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.809 -1.182 . . . . 0.0 108.685 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -67.93 -29.37 68.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 137' ' ' GLN . 0.4 OUTLIER -70.89 -34.47 71.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.428 -0.795 . . . . 0.0 109.235 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.584 HD22 ' HB3' ' A' ' 80' ' ' MET . 0.0 OUTLIER -80.12 -21.41 43.24 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.277 -0.889 . . . . 0.0 108.617 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.61 HG23 ' HB1' ' A' ' 77' ' ' ALA . 17.9 t -81.48 -45.6 20.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.26 83.87 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -63.01 -32.83 74.28 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.593 ' HG2' ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -60.15 -69.56 0.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.436 -0.79 . . . . 0.0 109.073 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.548 ' OE2' ' HB2' ' A' ' 143' ' ' ALA . 6.3 tm-20 -48.61 -33.38 9.74 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 9.5 tttm -68.72 -40.78 79.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.426 -0.796 . . . . 0.0 109.038 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.472 ' O ' ' OD2' ' A' ' 144' ' ' ASP . . . -55.52 -55.32 33.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 108.618 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.53 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -70.15 -22.97 62.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.345 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.548 ' HB2' ' OE2' ' A' ' 139' ' ' GLU . . . -78.5 -26.51 45.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.069 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.793 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.4 p30 -82.8 -47.73 11.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.939 -1.1 . . . . 0.0 108.271 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.793 HG13 ' OD1' ' A' ' 144' ' ' ASP . 14.7 m -85.82 -17.05 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.8 OUTLIER 81.92 -47.54 0.2 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.449 0.643 . . . . 0.0 109.643 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.04 HD21 HG12 ' A' ' 61' ' ' VAL . 14.3 tp 67.33 131.63 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.449 -0.782 . . . . 0.0 109.421 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 148' ' ' ARG . 2.7 ptt85 -161.46 39.04 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.565 -1.335 . . . . 0.0 110.02 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 161.06 108.28 0.23 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.38 -1.39 . . . . 0.0 110.37 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 1.078 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -91.88 144.72 29.73 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.371 -1.076 . . . . 0.0 109.792 179.111 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.462 ' HG2' ' HG2' ' A' ' 163' ' ' PRO . 33.6 Cg_endo -77.09 152.23 94.54 Favored 'Cis proline' 0 C--N 1.317 -1.124 0 C-N-CA 124.1 -1.208 . . . . 0.0 110.501 0.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -126.63 152.26 46.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.426 -1.421 . . . . 0.0 109.353 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 2.6 tmm? -151.21 135.61 16.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.123 -0.986 . . . . 0.0 109.656 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.777 ' CE2' HD21 ' A' ' 12' ' ' LEU . 51.0 m-85 -137.1 124.54 22.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.418 -0.801 . . . . 0.0 110.311 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 21' ' ' GLN . 52.0 t -92.34 130.48 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.747 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.683 HD22 HG12 ' A' ' 155' ' ' VAL . 3.9 p30 45.55 22.42 0.1 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.046 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.82 56.56 24.64 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.519 ' N ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -165.77 -36.85 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.299 -1.118 . . . . 0.0 108.169 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.499 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 75.9 m-85 -115.34 123.44 48.73 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.534 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 20.8 pt20 -123.3 134.74 54.03 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.94 -1.1 . . . . 0.0 109.877 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.9 mt -70.95 177.83 3.48 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.451 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -147.76 65.95 9.43 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 120.878 -1.139 . . . . 0.0 110.02 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.462 ' HG2' ' HG2' ' A' ' 151' ' ' PRO . 36.0 Cg_endo . . . . . 0 C--N 1.308 -1.56 0 C-N-CA 122.575 2.183 . . . . 0.0 109.988 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 3.5 mtt . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.676 0.75 . . . . 0.0 109.689 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 173' ' ' VAL . 0.0 OUTLIER -75.43 -60.56 2.25 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 172' ' ' ASP . 4.9 t -64.69 -30.69 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.318 -0.864 . . . . 0.0 109.473 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -67.22 -45.32 77.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.665 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.428 HG22 ' CG1' ' A' ' 42' ' ' ILE . 70.7 t -73.63 -25.17 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.444 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.87 -57.53 3.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.526 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.97 -47.51 74.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.108 -0.995 . . . . 0.0 109.299 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 182' ' ' VAL . 31.9 t80 -59.15 -57.24 13.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.962 . . . . 0.0 109.128 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.13 -29.08 12.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.33 -0.856 . . . . 0.0 109.14 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -77.89 -47.0 19.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.334 -0.853 . . . . 0.0 109.202 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.783 HG21 ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -50.3 -32.83 18.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.349 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 178' ' ' TYR . 1.4 t -85.74 -37.62 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.981 . . . . 0.0 108.952 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.45 ' O ' ' OG ' ' A' ' 186' ' ' SER . 16.6 ttpt -60.38 -46.13 91.06 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.281 -0.887 . . . . 0.0 109.037 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -78.93 -27.15 43.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.233 -0.917 . . . . 0.0 108.98 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.663 HD23 ' O ' ' A' ' 181' ' ' THR . 0.3 OUTLIER -65.69 -19.59 65.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.863 -1.148 . . . . 0.0 108.925 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.492 ' HB2' HG22 ' A' ' 54' ' ' VAL . 15.0 p -77.88 -13.04 60.02 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.834 -1.166 . . . . 0.0 108.745 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 O-C-N 121.307 -0.871 . . . . 0.0 109.329 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.633 ' HB3' ' HB2' ' A' ' 8' ' ' GLN . 4.3 p90 . . . . . 0 N--CA 1.488 1.44 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.432 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 4.7 mt-10 -114.94 64.57 0.68 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.826 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 4.0 m-20 70.18 96.74 0.07 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.307 -0.871 . . . . 0.0 110.473 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.15 -3.4 81.02 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -100.48 26.98 6.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -1.172 . . . . 0.0 108.533 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER 150.42 -35.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.598 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -156.98 131.25 8.49 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.669 -1.269 . . . . 0.0 109.796 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 t -114.44 174.99 5.68 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.59 152.28 20.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.653 -0.655 . . . . 0.0 109.707 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.496 ' HG ' ' HG2' ' A' ' 160' ' ' GLN . 1.4 mt -92.56 161.31 14.65 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.396 -0.815 . . . . 0.0 109.517 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -84.93 -18.72 33.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.171 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -140.34 110.17 6.93 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.366 -0.833 . . . . 0.0 108.899 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 36.2 Cg_endo -77.22 167.9 24.0 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.352 2.034 . . . . 0.0 111.29 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.692 HG21 ' HB3' ' A' ' 144' ' ' ASP . 7.7 t -128.19 93.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.93 127.54 16.61 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 97.63 -20.8 49.21 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -40.01 159.52 0.13 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.928 . . . . 0.0 109.347 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.587 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 34.9 Cg_endo -77.52 128.26 9.42 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.459 2.106 . . . . 0.0 111.35 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.859 ' O ' HG13 ' A' ' 155' ' ' VAL . 10.3 mp0 -41.4 -25.56 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.529 -0.732 . . . . 0.0 109.724 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.644 ' O ' HG12 ' A' ' 22' ' ' VAL . 8.6 t -149.21 84.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.068 -1.02 . . . . 0.0 108.872 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.587 ' HG ' ' CG ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -77.35 126.13 30.43 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.458 ' OE1' ' CD1' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -118.46 104.03 10.31 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.076 -1.015 . . . . 0.0 109.732 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.715 ' CD2' HD13 ' A' ' 147' ' ' LEU . 5.2 m-85 -90.05 123.46 33.95 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.304 -0.873 . . . . 0.0 109.609 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 1.0 OUTLIER -160.91 140.23 10.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.231 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.591 ' HB2' ' CD2' ' A' ' 29' ' ' PHE . 11.1 p -116.29 174.97 5.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 110.183 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.61 ' CD2' HD21 ' A' ' 72' ' ' LEU . 8.3 m-30 -89.3 37.6 0.87 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.501 -0.749 . . . . 0.0 109.021 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 1.14 ' CZ ' HD13 ' A' ' 72' ' ' LEU . 3.2 m-85 -135.65 18.92 3.31 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.773 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.436 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 3.8 m -112.79 164.07 16.35 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.819 -1.176 . . . . 0.0 109.428 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.9 Cg_endo -74.74 -13.19 22.09 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.014 1.809 . . . . 0.0 108.321 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.572 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 36.5 m170 -100.2 -29.7 12.33 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 34' ' ' TYR . 6.1 p -44.58 -40.51 5.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.636 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 21.1 t80 -88.22 -45.49 10.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.789 -0.57 . . . . 0.0 110.259 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -68.54 -22.39 64.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 111.12 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.661 ' CZ ' HD13 ' A' ' 42' ' ' ILE . 1.6 m-85 -80.16 -25.0 40.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.801 -1.187 . . . . 0.0 110.588 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' O ' ' CD ' ' A' ' 38' ' ' GLU . 0.4 OUTLIER -117.94 32.46 6.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.899 -1.126 . . . . 0.0 110.073 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 67.6 mm-40 -146.52 -63.83 0.3 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -0.995 . . . . 0.0 110.566 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 40' ' ' LEU . 4.0 t -101.75 -66.8 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.034 -1.041 . . . . 0.0 110.741 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 40' ' ' LEU . 58.0 mt -42.92 -34.21 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 31.8 m170 57.27 20.32 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.172 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.661 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 8.5 mt -58.92 -24.32 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.619 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.6 m -77.17 -60.88 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.927 . . . . 0.0 109.722 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 10.0 m-20 -70.84 -33.6 70.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.0 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 45' ' ' ASN . 12.5 t-20 -60.79 -49.73 76.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.661 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 67.3 t -77.27 -16.89 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.898 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -75.8 -27.74 58.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.045 -1.035 . . . . 0.0 109.646 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -72.28 -22.86 61.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -0.974 . . . . 0.0 109.516 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 24.0 mtmt -97.54 -3.27 40.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.871 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.545 HD22 ' HB ' ' A' ' 54' ' ' VAL . 13.1 mt -73.5 113.42 22.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 109.679 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.841 ' HD2' HG21 ' A' ' 54' ' ' VAL . 36.7 Cg_endo -78.54 138.4 15.36 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.174 1.916 . . . . 0.0 110.599 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 51' ' ' PRO . 23.4 tt0 -40.79 119.64 1.16 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.086 0.946 . . . . 0.0 109.573 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.32 -25.77 5.08 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.89 HG22 ' HB2' ' A' ' 186' ' ' SER . 4.5 t -85.33 88.29 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -1.187 . . . . 0.0 109.358 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HE3' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -69.77 99.91 1.43 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.956 -179.666 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.483 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 1.8 ttt -92.7 100.63 13.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.573 -0.704 . . . . 0.0 109.321 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.447 ' OG1' ' HE3' ' A' ' 55' ' ' LYS . 89.8 m -95.39 139.89 31.05 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.136 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.547 ' O ' ' NE1' ' A' ' 76' ' ' TRP . 1.4 mppt? -118.14 105.46 11.84 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.608 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.0 m-85 -103.59 164.36 11.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.597 -1.315 . . . . 0.0 111.109 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 1.022 ' NE2' HD22 ' A' ' 72' ' ' LEU . 6.8 t-80 -116.28 134.6 54.73 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.721 0.772 . . . . 0.0 109.141 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.043 HG21 HG11 ' A' ' 150' ' ' VAL . 2.6 m -104.97 160.73 5.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 O-C-N 121.666 -0.646 . . . . 0.0 110.123 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.535 ' HB3' ' N ' ' A' ' 70' ' ' LYS . 1.7 p-10 -103.85 54.53 0.74 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.524 ' CE1' ' HB ' ' A' ' 61' ' ' VAL . 4.9 m-85 -100.73 61.55 1.0 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.671 -0.643 . . . . 0.0 109.764 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.585 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -161.65 -56.66 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.891 -1.124 . . . . 0.0 111.6 179.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.585 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -114.82 -18.37 6.48 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.44 -42.63 1.98 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.07 -77.69 0.35 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -1.152 . . . . 0.0 109.45 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.07 HD11 HG22 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -62.13 -21.61 65.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.954 ' N ' HD23 ' A' ' 68' ' ' LEU . . . -60.85 -64.93 3.66 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.535 ' N ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -54.61 -42.47 71.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.249 -1.147 . . . . 0.0 108.502 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.706 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 21.7 t0 -64.93 -29.33 70.26 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.14 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 3.5 tt -66.58 -35.4 80.12 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 1.6 m -59.16 -41.73 89.1 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 177.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -61.32 -24.51 66.49 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -65.28 -34.23 77.86 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.554 ' CH2' ' OE2' ' A' ' 85' ' ' GLU . 53.0 t-105 -71.15 -31.86 68.21 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.644 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -79.16 -58.95 2.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.337 -0.852 . . . . 0.0 109.411 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.969 HG21 ' CE1' ' A' ' 122' ' ' TYR . 93.9 t -53.65 -27.55 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 109.981 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.583 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -81.97 -61.27 1.96 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.984 -1.073 . . . . 0.0 108.654 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 3.1 tpt -49.17 -26.28 2.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.883 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -77.46 -36.5 52.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.531 -0.731 . . . . 0.0 109.563 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 84' ' ' VAL . 83.1 mt -105.81 8.89 32.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 0.0 110.75 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 54.25 27.89 40.95 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.583 HG22 ' HA ' ' A' ' 79' ' ' ALA . 32.6 m -99.67 29.17 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.461 -1.023 . . . . 0.0 110.049 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.554 ' OE2' ' CH2' ' A' ' 76' ' ' TRP . 5.2 mt-10 -62.88 -79.57 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.133 -0.979 . . . . 0.0 109.641 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -36.41 -37.63 0.13 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.345 0.593 . . . . 0.0 110.805 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.529 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 5.1 mtpt -70.85 -56.72 5.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.402 -0.811 . . . . 0.0 111.459 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.746 HG23 HD12 ' A' ' 92' ' ' LEU . 1.3 m -86.74 -15.11 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.613 -1.304 . . . . 0.0 110.592 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.734 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -74.62 -42.52 58.46 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.589 -1.319 . . . . 0.0 108.341 178.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.417 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -54.68 -53.75 56.85 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.701 -1.249 . . . . 0.0 110.615 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 25.9 Cg_endo -73.07 -19.89 22.39 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 N-CA-C 109.829 -0.873 . . . . 0.0 109.829 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.746 HD12 HG23 ' A' ' 88' ' ' VAL . 21.9 mt -83.78 -42.62 16.3 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.734 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.4 m-30 -64.83 -45.74 84.88 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.029 -1.044 . . . . 0.0 108.649 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -72.47 -28.6 63.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.171 -0.956 . . . . 0.0 109.254 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.07 -32.07 82.9 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.623 HG11 ' HD1' ' A' ' 29' ' ' PHE . 2.5 t -99.8 -6.83 9.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.194 -1.18 . . . . 0.0 109.245 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.636 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -108.71 7.5 26.44 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 120.935 -1.103 . . . . 0.0 111.037 -179.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.776 ' O ' HG23 ' A' ' 99' ' ' THR . 0.9 OUTLIER -175.63 66.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.516 -1.365 . . . . 0.0 109.55 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.08 -48.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.8 -0.563 . . . . 0.0 109.639 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.6 mt-30 74.26 17.7 3.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.197 -0.939 . . . . 0.0 110.276 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.8 t -79.93 -6.53 57.65 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 1.07 HG22 HD11 ' A' ' 68' ' ' LEU . 11.1 mm -89.72 71.08 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.716 -0.615 . . . . 0.0 109.345 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.541 ' CA ' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -136.87 16.19 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 109.235 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -142.64 126.88 17.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.402 -0.811 . . . . 0.0 109.402 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.706 ' HB1' ' OD2' ' A' ' 71' ' ' ASP . . . -49.37 -37.32 24.47 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 p -55.86 -31.63 62.94 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.769 ' OD2' HD12 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -74.14 -47.76 33.91 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.911 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.751 HD11 ' O ' ' A' ' 68' ' ' LEU . 30.4 mt -48.41 -29.34 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.911 -1.118 . . . . 0.0 108.582 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -74.37 -47.41 34.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 109.614 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -51.98 -40.39 60.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 109.37 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.692 HG11 ' HG ' ' A' ' 92' ' ' LEU . 2.4 t -71.18 -40.1 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.164 -0.96 . . . . 0.0 109.532 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.541 ' CE1' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -65.47 -33.46 75.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.564 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mt -76.42 -25.4 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.917 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -65.39 -20.0 66.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.059 -1.026 . . . . 0.0 109.61 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.505 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -90.05 4.72 49.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 109.722 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.6 0.37 69.65 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.719 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.5 mm -79.5 60.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -1.149 . . . . 0.0 109.555 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 117' ' ' ILE . 64.7 mttt -34.85 153.17 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.257 -0.902 . . . . 0.0 110.45 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.459 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -59.69 -27.69 64.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -66.45 -43.92 84.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -1.17 . . . . 0.0 109.607 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.0 -50.05 45.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.327 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.969 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -65.34 -56.35 13.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.369 -0.832 . . . . 0.0 108.845 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 27.5 t70 -45.56 -39.22 7.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.101 -0.999 . . . . 0.0 108.892 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.69 -44.36 61.89 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.302 -0.874 . . . . 0.0 108.791 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.575 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -54.63 -49.09 71.34 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -59.27 -58.74 7.29 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -53.86 -15.97 1.58 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.585 -0.697 . . . . 0.0 110.119 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -70.74 175.47 4.95 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.96 -1.088 . . . . 0.0 109.766 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.947 ' CE2' HG23 ' A' ' 130' ' ' VAL . 41.4 p90 -94.09 -37.03 11.82 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.776 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.947 HG23 ' CE2' ' A' ' 129' ' ' PHE . 25.0 t -67.18 -47.91 80.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.13 -1.428 . . . . 0.0 109.578 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.883 HG22 ' HB1' ' A' ' 81' ' ' ALA . 16.6 t -63.41 -40.24 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.977 -1.077 . . . . 0.0 108.561 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -37.71 85.18 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.456 -0.778 . . . . 0.0 109.056 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -29.5 70.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.057 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.12 -30.8 55.36 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.644 HG23 ' CB ' ' A' ' 77' ' ' ALA . 9.8 t -76.04 -41.15 38.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.6 -48.72 80.56 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -37.17 82.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 109.139 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.608 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 18.9 tm0? -55.87 -62.42 1.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.037 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -48.35 -33.57 9.2 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.427 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -72.46 -29.29 63.54 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.576 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . . . -62.46 -57.19 12.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 108.712 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -68.55 -35.87 78.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.519 -0.738 . . . . 0.0 110.036 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.81 -16.64 58.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.043 -1.035 . . . . 0.0 109.835 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.692 ' HB3' HG21 ' A' ' 16' ' ' VAL . 5.7 m-20 -81.49 -43.76 18.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -0.966 . . . . 0.0 108.95 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.54 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 29.7 m -105.03 -9.4 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 108.885 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.54 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.9 OUTLIER 82.24 -43.72 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.519 -0.738 . . . . 0.0 109.876 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.015 HD21 HG11 ' A' ' 61' ' ' VAL . 14.1 tp 64.5 134.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.35 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -160.75 32.85 0.15 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.533 -1.354 . . . . 0.0 110.002 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 151' ' ' PRO . . . 175.01 77.97 0.05 OUTLIER Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.995 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 1.043 HG11 HG21 ' A' ' 61' ' ' VAL . 3.8 m -80.15 135.91 54.13 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.119 -1.224 . . . . 0.0 107.92 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 149' ' ' GLY . 30.9 Cg_endo -71.18 152.85 96.04 Favored 'Cis proline' 0 C--N 1.317 -1.098 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.508 2.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -140.29 159.84 41.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.689 -1.257 . . . . 0.0 109.026 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.53 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 30.3 tpp -142.65 138.18 30.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.024 -1.048 . . . . 0.0 110.369 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 6.3 m-85 -143.22 127.34 17.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.436 -0.79 . . . . 0.0 109.577 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 21' ' ' GLN . 54.9 t -103.95 130.59 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.026 . . . . 0.0 109.501 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.512 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 1.9 t-20 45.62 26.39 0.33 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 15' ' ' PRO . . . 52.07 27.46 22.61 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.402 -1.38 . . . . 0.0 109.88 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.66 -15.96 4.35 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.735 -1.45 . . . . 0.0 109.308 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -143.1 125.6 15.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.001 . . . . 0.0 109.149 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.496 ' HG2' ' HG ' ' A' ' 12' ' ' LEU . 1.1 pt20 -119.7 139.4 52.31 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.03 -1.044 . . . . 0.0 109.778 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.445 ' HG ' ' HB3' ' A' ' 153' ' ' MET . 7.7 mt -75.78 173.41 11.17 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -158.6 87.08 2.32 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 109.758 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 C--N 1.31 -1.465 0 C-N-CA 122.872 2.381 . . . . 0.0 111.225 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.845 ' O ' HG23 ' A' ' 175' ' ' VAL . 4.9 mmt . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 121.662 0.744 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.11 -63.13 1.29 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.352 0.596 . . . . 0.0 109.474 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 4.0 t -67.3 -18.27 23.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.153 -0.967 . . . . 0.0 109.475 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -76.52 -47.16 23.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.101 -1.0 . . . . 0.0 109.663 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 171' ' ' MET . 15.2 t -70.91 -25.05 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 109.376 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -80.63 -61.01 2.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.263 -0.898 . . . . 0.0 109.257 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 173' ' ' VAL . 0.5 OUTLIER -55.12 -42.72 73.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.218 -0.927 . . . . 0.0 109.198 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 178' ' ' TYR . 9.7 t80 -61.32 -48.65 80.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.281 -0.887 . . . . 0.0 109.364 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.67 -30.07 65.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.343 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -77.38 -43.47 32.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.495 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.6 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.1 OUTLIER -57.75 -34.09 69.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.0 . . . . 0.0 109.465 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 51.7 t -78.45 -36.09 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.154 -0.966 . . . . 0.0 109.044 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -52.04 67.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.289 -0.882 . . . . 0.0 109.169 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -77.11 -32.0 56.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.296 -0.878 . . . . 0.0 109.263 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 181' ' ' THR . 0.2 OUTLIER -62.67 -17.06 59.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.06 -1.025 . . . . 0.0 109.653 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.89 ' HB2' HG22 ' A' ' 54' ' ' VAL . 87.8 p -73.08 -12.3 60.86 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.856 -1.153 . . . . 0.0 108.709 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.423 -0.798 . . . . 0.0 109.386 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.574 ' HE1' HG23 ' A' ' 181' ' ' THR . 3.1 m-85 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.449 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 1.6 pt-20 -105.84 54.96 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.588 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 4' ' ' GLU . 1.2 m-20 42.48 82.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.751 -0.593 . . . . 0.0 110.1 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 131.88 -29.22 3.42 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.701 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 5.4 tptt -83.18 -69.05 0.66 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.869 -1.371 . . . . 0.0 109.27 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 77.6 mm-40 -92.97 2.01 57.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.744 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 6' ' ' GLY . 1.1 p90 176.67 132.38 0.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.078 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.5 ' CG2' ' CD ' ' A' ' 160' ' ' GLN . 11.3 t -112.26 -179.63 3.73 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 m -116.62 139.61 50.32 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.487 0.66 . . . . 0.0 109.615 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.465 HD23 ' HG2' ' A' ' 160' ' ' GLN . 0.2 OUTLIER -95.18 169.83 9.82 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.389 -0.819 . . . . 0.0 109.375 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 14.3 mp0 -98.19 12.35 34.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 109.82 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 5.4 mtmt -141.51 80.47 16.2 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.925 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -79.13 159.26 26.8 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.719 2.279 . . . . 0.0 109.986 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.906 HG21 ' OD1' ' A' ' 144' ' ' ASP . 3.4 t -126.72 97.86 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.093 -1.004 . . . . 0.0 110.154 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.79 128.54 8.82 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 93.03 -14.9 64.14 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.644 -1.783 . . . . 0.0 108.644 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.792 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -39.25 161.7 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.946 . . . . 0.0 110.095 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.587 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.2 Cg_endo -78.56 127.53 8.13 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.746 2.297 . . . . 0.0 111.201 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.647 ' O ' HG22 ' A' ' 155' ' ' VAL . 2.0 mm-40 -42.35 -24.48 0.05 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.511 -0.743 . . . . 0.0 109.798 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.639 ' O ' HG12 ' A' ' 22' ' ' VAL . 8.1 t -147.14 86.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.009 -1.057 . . . . 0.0 108.75 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.715 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -79.88 125.55 29.87 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -105.55 97.95 7.71 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.175 -0.953 . . . . 0.0 110.438 -178.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.158 ' CE2' HG21 ' A' ' 145' ' ' VAL . 4.7 m-85 -89.58 106.41 18.44 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 3.2 p90 -153.32 143.6 22.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.044 -1.035 . . . . 0.0 109.946 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.613 ' HB3' ' CE1' ' A' ' 60' ' ' HIS . 2.3 p -126.44 -165.02 1.39 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.68 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -115.67 53.46 0.84 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.758 -1.213 . . . . 0.0 108.224 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.654 ' CE1' HD22 ' A' ' 72' ' ' LEU . 9.1 m-85 -137.71 0.35 2.22 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.411 -0.806 . . . . 0.0 110.645 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.62 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 5.1 m -111.27 169.11 6.65 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.782 -1.199 . . . . 0.0 108.604 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 30.7 Cg_endo -73.97 -54.73 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.712 1.608 . . . . 0.0 109.344 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -68.66 -19.08 64.38 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 177.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -50.49 -47.47 57.15 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.596 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 5.7 t80 -79.82 -37.04 35.97 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.515 -0.74 . . . . 0.0 109.748 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.486 ' O ' ' CG ' ' A' ' 40' ' ' LEU . 8.4 mm-40 -70.85 -25.08 62.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 110.054 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -83.74 -15.68 47.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.166 -0.959 . . . . 0.0 110.943 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.7 mm-40 -131.22 44.28 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.728 -1.232 . . . . 0.0 111.202 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -174.07 -60.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.004 . . . . 0.0 110.984 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.4 t -90.18 -53.45 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.045 -1.034 . . . . 0.0 111.143 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.587 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 94.8 mt -59.4 -11.24 4.04 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.977 -1.077 . . . . 0.0 110.76 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 56.8 p-80 41.31 28.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 109.663 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 46' ' ' VAL . 19.4 mt -68.71 -33.23 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 109.272 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 43.7 p -72.87 -26.05 61.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 109.877 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.09 -54.41 4.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 0.0 109.83 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -52.09 -53.99 35.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.163 -0.961 . . . . 0.0 109.755 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.741 HG22 ' O ' ' A' ' 42' ' ' ILE . 19.1 m -57.53 -35.32 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.53 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.967 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -70.78 -39.33 73.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -60.26 -22.77 63.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -111.22 9.44 21.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 0.0 109.807 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.967 HD12 ' HA ' ' A' ' 47' ' ' LYS . 8.3 mt -78.65 130.14 71.84 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 110.042 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD2' HD23 ' A' ' 50' ' ' LEU . 35.3 Cg_endo -78.47 154.05 27.5 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.408 2.072 . . . . 0.0 108.863 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' A' ' 52' ' ' GLU . 11.8 tt0 -69.84 21.66 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.473 -1.392 . . . . 0.0 111.54 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 51' ' ' PRO . . . -121.61 29.99 5.48 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 186' ' ' SER . 43.9 t -145.6 117.21 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.09 107.35 19.15 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.456 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -91.39 96.36 10.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -91.78 140.22 29.91 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.961 -1.095 . . . . 0.0 110.342 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.32 112.15 21.13 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.484 -0.76 . . . . 0.0 109.594 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.603 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 1.9 m-85 -116.67 167.43 11.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -0.964 . . . . 0.0 110.678 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.613 ' CE1' ' HB3' ' A' ' 27' ' ' SER . 54.8 t-80 -108.23 131.41 54.71 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.076 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.8 m -69.48 151.47 9.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.648 -0.658 . . . . 0.0 110.033 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 4.4 p-10 -116.57 42.61 2.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.594 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 1.6 p90 -144.48 59.15 1.33 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.153 -0.967 . . . . 0.0 109.67 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -129.98 36.5 4.03 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.402 -0.811 . . . . 0.0 109.126 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.58 -32.02 0.34 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.17 -40.26 3.09 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -88.34 -79.55 0.3 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.109 -1.23 . . . . 0.0 110.628 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.896 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -79.68 -18.29 51.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.866 -1.146 . . . . 0.0 109.564 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.633 ' N ' HD22 ' A' ' 68' ' ' LEU . . . -53.19 -46.62 62.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -44.35 94.98 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.76 -27.66 67.78 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.693 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 27.8 tp -60.97 -44.8 96.83 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 138' ' ' GLN . 1.6 m -60.3 -42.9 96.5 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 1.052 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.6 tt0 -55.61 -26.14 42.4 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -67.41 -42.07 83.86 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -58.43 -28.2 65.04 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HB2' ' NE2' ' A' ' 138' ' ' GLN . . . -85.94 -43.15 13.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.525 -0.734 . . . . 0.0 110.274 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.052 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.2 t -68.74 -30.87 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.903 -1.123 . . . . 0.0 109.693 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.581 ' HB1' ' HG2' ' A' ' 85' ' ' GLU . . . -82.63 -55.78 4.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.01 -1.057 . . . . 0.0 108.374 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 3.0 ttt -49.67 -28.55 6.07 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.864 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -72.98 -39.0 66.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.501 -0.749 . . . . 0.0 109.183 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.457 ' CB ' HG13 ' A' ' 84' ' ' VAL . 66.1 mt -101.28 8.64 42.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.262 -0.899 . . . . 0.0 110.23 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.97 24.05 7.96 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 79' ' ' ALA . 33.5 m -90.27 1.44 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -1.092 . . . . 0.0 110.173 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.581 ' HG2' ' HB1' ' A' ' 79' ' ' ALA . 2.5 mt-10 -44.68 -66.79 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.979 -1.076 . . . . 0.0 109.436 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -41.03 -34.16 0.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.432 -0.793 . . . . 0.0 110.109 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -80.99 -51.41 8.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.329 -0.857 . . . . 0.0 111.294 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.973 HG23 HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -87.18 -11.46 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.622 -1.299 . . . . 0.0 110.896 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.776 HG23 ' CE1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -71.64 -43.94 65.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.731 -1.231 . . . . 0.0 108.893 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.412 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -54.1 -54.26 49.35 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.515 -1.366 . . . . 0.0 110.657 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.601 ' HB2' HG13 ' A' ' 111' ' ' VAL . 27.1 Cg_endo -72.86 -18.1 24.93 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 N-CA-C 109.844 -0.868 . . . . 0.0 109.844 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.973 HD12 HG23 ' A' ' 88' ' ' VAL . 17.5 mt -86.62 -43.73 12.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.892 . . . . 0.0 108.874 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.776 ' CE1' HG23 ' A' ' 89' ' ' THR . 5.1 m-30 -63.53 -48.1 78.9 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.043 -1.036 . . . . 0.0 108.486 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -72.84 -29.28 63.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 108.977 179.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.426 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -57.05 -39.0 88.96 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.639 HG11 ' CG ' ' A' ' 29' ' ' PHE . 1.9 t -100.36 -3.37 9.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.211 -1.17 . . . . 0.0 109.387 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.596 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -101.56 2.6 39.2 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 120.853 -1.154 . . . . 0.0 110.714 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.783 ' O ' HG23 ' A' ' 99' ' ' THR . 1.1 mmtp -175.18 72.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.692 -1.255 . . . . 0.0 109.387 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.28 -49.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 99' ' ' THR . 3.0 mt-30 72.8 15.0 4.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 110.597 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 t -82.93 -7.85 59.62 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.859 0.838 . . . . 0.0 108.797 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.61 HG13 HG22 ' A' ' 96' ' ' VAL . 9.1 mm -82.44 69.63 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 32.56 3.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.729 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.55 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 32.1 p -156.56 131.0 8.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.989 -1.069 . . . . 0.0 110.201 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.904 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.79 -34.21 18.8 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.83 -34.74 75.02 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -66.15 -50.71 63.02 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 105' ' ' ALA . 24.6 mt -49.38 -28.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.771 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -39.03 47.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.926 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 1.1 p30 -59.84 -46.08 90.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.114 -0.991 . . . . 0.0 109.626 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.775 HG11 ' HG ' ' A' ' 92' ' ' LEU . 58.7 t -68.65 -39.74 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.936 -1.103 . . . . 0.0 109.25 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.434 ' O ' ' HB ' ' A' ' 117' ' ' ILE . 1.9 m-85 -59.9 -42.84 94.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.181 -0.95 . . . . 0.0 109.544 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.662 HG23 ' HA ' ' A' ' 118' ' ' LYS . 12.0 mt -69.85 -23.83 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 109.403 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 110' ' ' ASP . 1.9 m-80 -63.33 -17.99 63.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 109.592 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.858 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -99.08 11.51 38.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.912 . . . . 0.0 109.344 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.35 -7.71 81.42 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.858 HD13 ' HB3' ' A' ' 115' ' ' ALA . 1.8 mp -77.32 55.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -1.077 . . . . 0.0 109.252 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.662 ' HA ' HG23 ' A' ' 113' ' ' ILE . 3.0 mtmp? -35.19 149.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.215 -0.928 . . . . 0.0 110.475 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 123' ' ' ASP . . . -53.57 -27.91 35.74 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -61.86 -59.06 5.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.034 -1.274 . . . . 0.0 109.363 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -64.76 -41.95 95.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 109.226 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.955 ' CE2' HG11 ' A' ' 78' ' ' VAL . 3.1 t80 -56.5 -48.9 76.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.008 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.2 OUTLIER -59.97 -30.87 69.4 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.887 . . . . 0.0 109.064 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.43 -51.36 60.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.344 -0.847 . . . . 0.0 108.852 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.516 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -51.89 -52.8 47.26 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.406 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 3.7 t-105 -57.87 -56.49 21.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.81 -16.17 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 110.282 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 50.2 m -74.03 173.69 9.67 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.901 -1.124 . . . . 0.0 109.991 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -90.63 -38.62 13.0 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.463 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.77 -47.17 89.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.085 -1.446 . . . . 0.0 109.244 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.864 HG22 ' HB1' ' A' ' 81' ' ' ALA . 15.6 t -62.56 -32.66 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -67.89 -39.41 83.65 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 90.0 p -61.74 -34.59 76.09 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.18 -18.36 53.2 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.288 -0.882 . . . . 0.0 108.662 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.17 -47.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.43 -32.87 74.43 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -33.53 69.14 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.603 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 8.9 mt-30 -74.24 -66.98 0.66 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 108.955 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.8 tt0 -45.36 -43.96 11.38 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 0.1 OUTLIER -69.78 -28.39 65.7 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.916 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -56.19 -63.5 1.17 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.37 -0.831 . . . . 0.0 108.874 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.54 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -73.57 -19.43 60.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 109.834 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' A' ' 140' ' ' LYS . . . -79.31 -29.48 42.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.01 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 1.02 ' OD1' HG13 ' A' ' 145' ' ' VAL . 2.8 p30 -81.85 -45.04 16.08 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 1.158 HG21 ' CE2' ' A' ' 25' ' ' PHE . 24.7 m -87.26 -14.91 9.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.54 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.5 tp-100 79.65 -50.5 0.39 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.63 -0.669 . . . . 0.0 109.501 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.725 HD21 HG12 ' A' ' 61' ' ' VAL . 12.2 tp 62.09 134.46 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.482 -0.761 . . . . 0.0 109.281 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -160.77 27.76 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.573 -1.33 . . . . 0.0 109.725 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 179.56 102.93 0.17 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.331 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 1.076 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.92 144.06 27.87 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 0.0 109.175 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.429 ' O ' ' HG3' ' A' ' 163' ' ' PRO . 35.7 Cg_endo -77.65 153.07 93.75 Favored 'Cis proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.946 -1.272 . . . . 0.0 110.649 0.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -129.43 130.05 45.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.39 -1.444 . . . . 0.0 109.408 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -119.59 115.57 24.25 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.256 -0.903 . . . . 0.0 109.152 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.547 ' CD1' ' CB ' ' A' ' 160' ' ' GLN . 13.7 m-30 -115.01 127.5 55.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.207 -0.933 . . . . 0.0 110.804 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 21' ' ' GLN . 24.4 t -96.81 131.99 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.918 . . . . 0.0 109.684 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.792 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 2.8 t-20 45.32 22.3 0.08 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.407 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.563 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.16 58.04 16.17 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -166.52 -36.1 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.451 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 96.4 m-85 -116.34 123.19 47.02 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.547 ' CB ' ' CD1' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -117.89 112.97 21.05 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.296 -0.877 . . . . 0.0 109.873 -179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 9' ' ' TYR . 11.1 mt -60.37 170.68 1.26 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 109.063 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 162' ' ' ASN . 26.3 p-10 -131.42 113.29 15.58 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.548 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.429 ' HG3' ' O ' ' A' ' 151' ' ' PRO . 36.2 Cg_endo . . . . . 0 C--N 1.309 -1.503 0 C-N-CA 122.407 2.071 . . . . 0.0 110.542 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.872 ' O ' HG23 ' A' ' 175' ' ' VAL . 3.1 mtt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.88 0.848 . . . . 0.0 109.397 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.61 -65.79 0.97 Allowed 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.0 t -57.84 -25.2 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.251 -0.906 . . . . 0.0 108.827 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 178' ' ' TYR . 50.8 t80 -74.12 -39.82 63.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 109.112 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 171' ' ' MET . 96.9 t -70.91 -27.77 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 108.95 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.66 -64.83 1.1 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.248 -0.907 . . . . 0.0 108.904 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -50.31 -42.31 52.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.187 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 178' ' ' TYR . 8.1 t80 -61.42 -53.77 52.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.513 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.38 -24.11 11.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.922 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.41 -43.62 23.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.555 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.641 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -59.63 -42.28 92.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 109.386 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 43.2 t -74.01 -37.3 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.056 -1.028 . . . . 0.0 109.226 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -52.28 65.91 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.89 . . . . 0.0 109.193 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -76.72 -33.64 58.16 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.263 -0.898 . . . . 0.0 109.061 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 181' ' ' THR . 0.5 OUTLIER -58.17 -19.54 33.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.982 -1.074 . . . . 0.0 109.839 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.46 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 1.3 t -73.17 -12.65 60.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.81 -1.181 . . . . 0.0 108.71 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.84 . . . . 0.0 109.44 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.543 ' HB2' ' CE1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -108.35 62.36 0.61 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.796 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.2 t70 44.82 82.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.408 -0.807 . . . . 0.0 109.404 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 118.38 -22.74 9.39 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.457 ' HB3' ' OE1' ' A' ' 8' ' ' GLN . 3.0 tttp -80.13 -68.67 0.65 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.107 -1.231 . . . . 0.0 108.709 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 17.2 mp0 -103.94 9.1 36.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.285 -0.884 . . . . 0.0 109.773 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 3' ' ' TYR . 3.7 p90 177.33 134.73 0.07 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.129 -0.982 . . . . 0.0 109.171 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -117.68 178.83 4.26 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 m -115.19 145.59 42.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.706 -0.621 . . . . 0.0 109.681 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.418 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -94.01 165.87 12.43 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.424 -0.797 . . . . 0.0 109.567 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -80.48 -15.64 56.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.599 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.02 115.17 11.04 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.404 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.492 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 34.4 Cg_endo -77.3 162.7 30.89 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.401 2.067 . . . . 0.0 110.531 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.721 HG21 HG12 ' A' ' 145' ' ' VAL . 48.1 t -105.93 79.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -46.6 128.25 10.23 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 93.77 -13.15 68.1 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 18' ' ' GLY . . . -37.36 152.28 0.13 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.75 -0.853 . . . . 0.0 109.043 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.521 ' O ' ' O ' ' A' ' 55' ' ' LYS . 36.6 Cg_endo -78.94 40.77 0.97 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.244 1.962 . . . . 0.0 112.631 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER 67.04 -43.22 0.44 Allowed 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.376 -0.827 . . . . 0.0 110.575 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.615 ' O ' HG12 ' A' ' 22' ' ' VAL . 32.2 t -150.52 78.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.73 HD13 ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -70.66 127.49 32.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -178.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 57' ' ' THR . 2.1 tt0 -111.1 149.3 31.02 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.119 -0.988 . . . . 0.0 109.625 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.764 ' CD2' HD13 ' A' ' 147' ' ' LEU . 15.0 m-85 -122.86 126.43 47.32 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.467 -0.771 . . . . 0.0 109.689 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 1.9 p90 -159.09 140.97 13.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.354 -0.842 . . . . 0.0 109.486 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.996 ' HB3' HG22 ' A' ' 61' ' ' VAL . 75.2 p -122.01 169.94 10.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -0.98 . . . . 0.0 110.574 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' A' ' 29' ' ' PHE . 7.5 m-30 -92.3 37.66 1.0 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 1.037 ' CZ ' HD13 ' A' ' 72' ' ' LEU . 2.6 m-85 -142.59 20.01 2.02 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.092 -1.005 . . . . 0.0 110.258 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.542 ' CB ' ' CE1' ' A' ' 32' ' ' HIS . 1.3 m -117.95 166.93 12.3 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.642 -1.286 . . . . 0.0 109.617 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 33.6 Cg_endo -75.54 -38.13 1.5 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.287 1.991 . . . . 0.0 108.628 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.579 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 14.6 p80 -73.9 -25.49 60.04 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.509 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 22.7 t -44.75 -62.9 1.04 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 8.4 t80 -65.54 -46.41 79.65 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.287 0.565 . . . . 0.0 109.989 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.526 ' HA ' ' CG2' ' A' ' 39' ' ' VAL . 2.1 mm-40 -61.01 -23.64 65.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 110.538 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.467 ' N ' ' O ' ' A' ' 32' ' ' HIS . 3.4 m-30 -78.37 -43.1 28.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -110.98 8.06 21.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.748 -1.22 . . . . 0.0 111.391 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 27.8 mm-40 -135.01 29.15 3.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.562 -1.336 . . . . 0.0 110.346 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.831 HG12 ' HG ' ' A' ' 40' ' ' LEU . 98.0 t -150.92 -76.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.812 -1.18 . . . . 0.0 109.522 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.831 ' HG ' HG12 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -106.22 20.09 19.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.178 -0.951 . . . . 0.0 109.932 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 45' ' ' ASN . 5.3 m170 43.13 31.36 0.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.14 -0.975 . . . . 0.0 110.066 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.551 ' CG1' HG22 ' A' ' 175' ' ' VAL . 22.4 mt -50.48 -25.02 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.003 -1.061 . . . . 0.0 109.416 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.25 -55.9 5.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 110.186 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.509 ' HA ' ' HG2' ' A' ' 47' ' ' LYS . 6.9 m-20 -87.09 -33.57 19.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.355 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.507 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -60.54 -27.68 67.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.5 -179.267 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.833 ' O ' HD13 ' A' ' 50' ' ' LEU . 9.1 p -84.46 -24.84 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.028 -1.045 . . . . 0.0 111.091 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.54 ' HG3' ' N ' ' A' ' 48' ' ' LYS . 4.7 ptpt -78.68 -25.29 44.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.737 -1.227 . . . . 0.0 110.416 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.54 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 1.7 mtpt -63.84 -32.76 74.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.953 -1.092 . . . . 0.0 109.311 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -82.82 9.66 9.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.865 . . . . 0.0 109.411 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 46' ' ' VAL . 8.6 mp -98.64 108.5 48.62 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.128 -0.983 . . . . 0.0 109.449 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.615 ' HD2' HG21 ' A' ' 54' ' ' VAL . 35.1 Cg_endo -77.06 145.9 25.12 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.4 2.067 . . . . 0.0 110.478 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 51' ' ' PRO . 1.2 tt0 -33.46 118.13 0.32 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.266 1.031 . . . . 0.0 110.127 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.36 -26.64 5.46 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.615 HG21 ' HD2' ' A' ' 51' ' ' PRO . 3.7 t -97.58 93.5 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -1.102 . . . . 0.0 108.645 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -84.44 118.25 24.16 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.962 0.887 . . . . 0.0 110.079 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.489 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.4 OUTLIER -111.82 98.91 7.72 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.068 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 20' ' ' PRO . 7.4 m -99.6 128.18 45.7 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.716 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 115.17 29.89 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.585 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 1.3 m-85 -112.62 175.98 5.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.852 -1.155 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.622 ' CE1' HD22 ' A' ' 72' ' ' LEU . 28.9 t-80 -104.41 150.73 24.27 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.032 0.92 . . . . 0.0 109.322 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.996 HG22 ' HB3' ' A' ' 27' ' ' SER . 1.3 m -96.96 160.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.369 0.604 . . . . 0.0 110.015 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -125.09 56.69 1.32 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.41 -0.806 . . . . 0.0 108.866 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.57 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -133.81 52.1 2.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.99 . . . . 0.0 110.974 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.656 ' HE3' ' CE1' ' A' ' 29' ' ' PHE . 3.1 ppp? -128.92 34.0 4.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.395 -0.815 . . . . 0.0 108.818 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.76 -37.35 3.24 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.91 -13.19 66.71 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.761 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -79.3 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.666 -1.49 . . . . 0.0 109.381 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.066 HD23 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -86.14 -28.22 24.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.037 -1.04 . . . . 0.0 109.345 179.469 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 1.066 ' N ' HD23 ' A' ' 68' ' ' LEU . . . -59.08 -55.08 32.88 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -56.87 -47.2 81.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.305 -1.114 . . . . 0.0 108.695 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 23.8 t0 -67.35 -24.37 65.71 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.037 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 5.8 tt -71.48 -39.52 70.84 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.973 HG23 ' OE1' ' A' ' 138' ' ' GLN . 1.3 m -57.87 -43.58 86.08 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 1.028 ' O ' HG23 ' A' ' 78' ' ' VAL . 4.0 tt0 -56.71 -29.0 62.0 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -62.3 -40.15 95.36 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -61.9 -30.4 70.86 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.486 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -83.41 -48.02 10.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -0.807 . . . . 0.0 109.968 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.028 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.5 t -63.3 -27.7 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 0.0 109.442 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.535 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -83.14 -55.72 4.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.212 -0.93 . . . . 0.0 109.138 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.719 ' HG2' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -45.26 -29.15 0.93 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.277 -0.889 . . . . 0.0 108.779 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.817 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -74.4 -38.37 63.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.396 -0.815 . . . . 0.0 109.509 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.527 ' CB ' HG13 ' A' ' 84' ' ' VAL . 44.3 mt -104.63 12.64 32.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 110.022 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.05 23.01 1.44 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.597 HG21 ' CE1' ' A' ' 112' ' ' PHE . 21.9 m -84.95 -10.35 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -1.204 . . . . 0.0 110.189 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 84' ' ' VAL . 5.4 pt-20 -43.01 -59.02 2.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.076 -1.015 . . . . 0.0 109.823 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -33.29 2.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.111 -0.993 . . . . 0.0 109.682 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.571 ' HE2' ' HB1' ' A' ' 115' ' ' ALA . 44.2 mtpt -83.89 -51.6 7.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.557 -0.714 . . . . 0.0 111.133 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.723 HG23 HD12 ' A' ' 92' ' ' LEU . 1.4 m -80.48 -6.07 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.787 -1.196 . . . . 0.0 110.676 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.727 HG23 ' CZ ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -78.24 -44.33 25.86 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.805 -1.184 . . . . 0.0 108.513 178.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.456 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -52.16 -52.01 66.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.568 -1.333 . . . . 0.0 110.227 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.538 ' HB2' HG13 ' A' ' 111' ' ' VAL . 24.4 Cg_endo -73.43 -20.51 20.75 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 N-CA-C 109.906 -0.844 . . . . 0.0 109.906 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.841 ' HG ' HG11 ' A' ' 111' ' ' VAL . 12.7 mt -83.83 -41.88 17.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 108.646 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.727 ' CZ ' HG23 ' A' ' 89' ' ' THR . 8.3 m-30 -67.3 -45.08 77.62 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.125 -0.984 . . . . 0.0 108.589 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -74.65 -33.35 62.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.56 -0.713 . . . . 0.0 109.428 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.462 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -61.24 -32.1 79.46 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.5 t -99.48 -9.55 8.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.344 -1.092 . . . . 0.0 109.278 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 2.4 mt-30 -112.41 9.7 19.75 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.891 -1.131 . . . . 0.0 110.92 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.779 ' O ' HG23 ' A' ' 99' ' ' THR . 0.6 OUTLIER -164.63 59.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.472 -1.393 . . . . 0.0 109.408 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 163.62 -49.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.472 -0.768 . . . . 0.0 109.119 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.486 ' O ' ' NE ' ' A' ' 103' ' ' ARG . 4.1 mp0 73.71 14.98 4.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.26 -0.9 . . . . 0.0 110.737 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 t -82.97 -7.8 59.63 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 1.012 HG22 HD11 ' A' ' 68' ' ' LEU . 12.4 mm -77.5 67.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.486 ' NE ' ' O ' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -128.56 30.83 5.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 109.452 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 107' ' ' ASP . 5.2 p -153.48 127.73 9.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.072 . . . . 0.0 110.187 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.72 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -48.79 -36.38 16.52 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 p -55.82 -33.85 64.82 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.747 ' OD2' HD12 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -71.79 -44.99 63.04 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.704 179.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.779 HD11 ' O ' ' A' ' 68' ' ' LEU . 34.7 mt -49.71 -29.29 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.892 -1.13 . . . . 0.0 108.459 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -79.36 -32.83 43.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.438 -0.789 . . . . 0.0 109.678 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -62.01 -43.47 98.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.166 -0.959 . . . . 0.0 109.403 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.841 HG11 ' HG ' ' A' ' 92' ' ' LEU . 55.8 t -74.68 -37.55 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 109.235 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.597 ' CE1' HG21 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -62.37 -48.11 81.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.883 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.481 HG23 ' HA ' ' A' ' 118' ' ' LYS . 22.5 mt -69.56 -26.22 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 109.538 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -19.81 54.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.373 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.571 ' HB1' ' HE2' ' A' ' 87' ' ' LYS . . . -90.46 5.32 48.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.526 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.82 -4.46 72.02 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.74 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.3 mm -74.73 57.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -1.088 . . . . 0.0 109.723 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.481 ' HA ' HG23 ' A' ' 113' ' ' ILE . 60.4 mttt -37.37 147.82 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.202 -0.936 . . . . 0.0 110.291 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -52.3 -27.87 25.65 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.7 -51.65 66.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -1.191 . . . . 0.0 109.51 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -77.01 -37.7 54.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.911 ' CE2' HG11 ' A' ' 78' ' ' VAL . 3.4 t80 -66.77 -53.3 34.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 109.753 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -60.29 -43.99 95.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.983 -1.073 . . . . 0.0 109.197 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.91 71.53 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.299 -0.876 . . . . 0.0 109.237 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.567 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -50.45 -53.32 30.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.416 -0.803 . . . . 0.0 108.94 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.515 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 6.0 t90 -54.98 -58.12 8.93 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -52.47 -16.31 0.86 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 110.396 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 2.4 m -70.59 179.11 2.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.885 -1.135 . . . . 0.0 110.207 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -90.4 -38.21 13.46 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.318 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.27 -48.28 68.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.183 -1.407 . . . . 0.0 109.463 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.817 HG22 ' CB ' ' A' ' 81' ' ' ALA . 3.3 t -62.37 -36.26 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.921 -1.112 . . . . 0.0 108.288 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -66.34 -31.99 73.11 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.079 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.1 t -66.02 -34.74 78.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.719 HD13 ' HG2' ' A' ' 80' ' ' MET . 40.6 mt -78.96 -18.3 53.98 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.486 HG23 ' HB1' ' A' ' 77' ' ' ALA . 7.7 t -79.49 -46.33 23.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.34 -38.87 85.56 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.3 -39.98 96.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 108.973 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.973 ' OE1' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -62.32 -62.65 1.61 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.912 . . . . 0.0 108.797 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.453 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 1.2 mt-10 -52.6 -30.61 32.11 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 5.2 mttt -72.57 -29.43 63.53 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.438 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -67.72 -54.67 17.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 109.236 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.15 86.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.663 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.39 -16.16 53.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.315 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 140' ' ' LYS . 6.3 m-20 -80.81 -45.09 17.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.983 -1.073 . . . . 0.0 109.014 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.737 HG21 ' CE1' ' A' ' 25' ' ' PHE . 23.3 m -99.32 -9.4 8.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.271 -0.893 . . . . 0.0 108.856 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 25.4 tt0 83.5 -39.63 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.658 -0.651 . . . . 0.0 109.537 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.764 HD13 ' CD2' ' A' ' 25' ' ' PHE . 13.4 tp 66.93 138.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.397 -0.815 . . . . 0.0 109.47 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -160.8 26.77 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.751 -1.218 . . . . 0.0 109.856 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 158.63 98.72 0.14 Allowed Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.171 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.863 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -89.72 138.95 27.79 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.579 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 32.6 Cg_endo -72.83 156.68 99.15 Favored 'Cis proline' 0 C--N 1.316 -1.147 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.865 2.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -151.79 117.18 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.939 -1.101 . . . . 0.0 108.385 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.819 ' CE ' HG22 ' A' ' 182' ' ' VAL . 4.8 tmm? -113.93 136.57 52.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.996 -1.065 . . . . 0.0 110.334 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 3.8 m-85 -123.92 135.81 53.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.476 -0.765 . . . . 0.0 109.208 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.607 HG22 HG22 ' A' ' 22' ' ' VAL . 92.2 t -100.65 131.94 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.94 . . . . 0.0 110.06 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.93 21.83 0.33 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.61 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.516 ' HA3' ' HB ' ' A' ' 16' ' ' VAL . . . 58.27 55.9 28.17 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -165.21 -35.64 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.191 -1.182 . . . . 0.0 108.379 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 154' ' ' PHE . 2.4 m-85 -111.52 120.42 42.06 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.019 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.516 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 12.8 tt0 -116.27 113.51 23.1 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.288 -0.883 . . . . 0.0 109.264 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 161' ' ' LEU . 8.6 mt -61.33 -179.6 0.17 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.36 -0.837 . . . . 0.0 108.847 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 24.2 m120 -137.35 150.19 68.0 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.026 -1.046 . . . . 0.0 109.459 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 162' ' ' ASN . 36.0 Cg_endo . . . . . 0 C--N 1.309 -1.543 0 C-N-CA 122.672 2.248 . . . . 0.0 110.648 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.818 0.818 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 172' ' ' ASP . 0.6 OUTLIER -69.61 -45.37 68.69 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.1 t -68.86 -22.32 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 108.831 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.429 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 22.7 t80 -72.48 -36.8 68.53 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.23 -0.919 . . . . 0.0 108.576 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.551 HG22 ' CG1' ' A' ' 42' ' ' ILE . 44.0 t -75.75 -26.96 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 109.194 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -83.32 -52.99 6.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.218 -0.926 . . . . 0.0 108.951 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.453 ' O ' ' OG1' ' A' ' 181' ' ' THR . 0.4 OUTLIER -62.88 -33.03 74.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.492 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.429 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 31.6 t80 -75.66 -54.18 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.521 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.49 -24.42 65.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 109.412 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -77.91 -50.09 12.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.328 -0.857 . . . . 0.0 109.299 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.828 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -58.39 -28.58 65.32 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.197 -0.94 . . . . 0.0 109.001 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.819 HG22 ' CE ' ' A' ' 153' ' ' MET . 66.4 t -85.91 -34.63 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.32 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -60.5 -42.56 96.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 108.98 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.644 ' CE2' HD22 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -82.46 -44.03 16.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.297 -0.877 . . . . 0.0 108.999 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.828 HD23 ' O ' ' A' ' 181' ' ' THR . 3.9 mm? -53.68 -18.35 2.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.942 -1.099 . . . . 0.0 109.417 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.7 t -66.31 -26.06 67.13 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.859 -1.151 . . . . 0.0 108.328 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.591 ' HB3' ' CE1' ' A' ' 9' ' ' TYR . 1.9 m-85 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -101.55 56.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.99 . . . . 0.0 109.833 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 46.04 82.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.614 -0.679 . . . . 0.0 110.239 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 116.11 -20.45 12.8 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.267 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.52 -68.01 0.72 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.182 -1.187 . . . . 0.0 109.107 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.491 ' OE1' ' N ' ' A' ' 3' ' ' TYR . 1.6 mp0 -97.53 6.2 48.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.375 -0.828 . . . . 0.0 109.606 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 8.3 p90 177.26 134.07 0.06 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.284 -0.885 . . . . 0.0 108.994 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -115.28 176.3 5.13 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.577 -0.702 . . . . 0.0 109.24 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.15 159.49 20.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.382 0.611 . . . . 0.0 109.612 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.582 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.5 OUTLIER -98.3 162.08 13.37 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.405 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.46 -0.23 36.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.147 -0.971 . . . . 0.0 109.141 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.34 113.29 1.02 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.374 -0.829 . . . . 0.0 109.12 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 34.7 Cg_endo -77.02 159.11 34.18 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.45 2.1 . . . . 0.0 110.849 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.587 ' O ' HG12 ' A' ' 16' ' ' VAL . 5.0 t -110.91 91.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.481 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.05 128.81 9.58 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.39 -21.9 41.77 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.765 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -40.46 160.67 0.12 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.986 . . . . 0.0 109.83 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.569 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.3 Cg_endo -79.22 128.83 8.38 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.726 2.284 . . . . 0.0 111.196 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.664 ' O ' HG22 ' A' ' 155' ' ' VAL . 16.3 mp0 -41.71 -25.37 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.498 -0.751 . . . . 0.0 109.861 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 22' ' ' VAL . 25.1 t -149.43 82.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.113 -0.992 . . . . 0.0 108.996 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.939 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.07 118.3 16.87 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -98.07 122.82 41.67 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.113 -0.992 . . . . 0.0 109.935 -179.066 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.094 ' CE2' HG21 ' A' ' 145' ' ' VAL . 9.1 m-85 -110.2 104.26 13.07 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -150.95 143.21 24.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.129 -0.982 . . . . 0.0 110.044 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.833 ' HB3' HG22 ' A' ' 61' ' ' VAL . 4.5 p -123.78 -167.65 1.66 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.66 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -110.18 53.57 0.69 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.582 ' CG ' HG11 ' A' ' 96' ' ' VAL . 9.1 m-85 -138.01 -1.94 1.93 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.831 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' CB ' ' HB3' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -108.49 164.79 13.97 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.571 -1.331 . . . . 0.0 109.405 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.506 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 32.0 Cg_endo -74.58 -32.56 5.96 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.35 2.033 . . . . 0.0 108.861 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -89.67 -19.11 25.24 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.038 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -52.96 -41.75 64.84 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.504 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 70.3 t80 -85.29 -39.03 18.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.305 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.516 ' O ' ' CG ' ' A' ' 40' ' ' LEU . 3.9 mt-30 -74.85 -24.4 58.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.986 -1.071 . . . . 0.0 110.429 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.63 ' HA ' HD12 ' A' ' 40' ' ' LEU . 25.7 t80 -76.41 -21.99 55.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.038 -1.039 . . . . 0.0 110.97 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.55 ' OE2' ' CE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -127.77 42.03 3.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.707 -1.245 . . . . 0.0 110.888 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 15.9 mm-40 -159.49 -68.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.174 -0.954 . . . . 0.0 109.899 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.02 -48.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 0.0 110.414 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.63 HD12 ' HA ' ' A' ' 36' ' ' PHE . 95.2 mt -54.03 -17.18 2.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.016 -1.052 . . . . 0.0 110.132 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.442 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 82.3 m-70 45.91 30.85 0.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.081 -1.012 . . . . 0.0 109.281 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.716 ' O ' HG13 ' A' ' 46' ' ' VAL . 19.6 mt -79.3 -21.46 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.998 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.2 m -80.44 -21.06 42.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.982 -1.074 . . . . 0.0 110.512 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 41' ' ' HIS . 2.0 p-10 -87.06 -50.5 6.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.899 -1.126 . . . . 0.0 110.356 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 46' ' ' VAL . 45.2 p-10 -64.46 -26.22 68.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.193 -0.942 . . . . 0.0 110.533 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 42' ' ' ILE . 27.7 m -74.21 -24.66 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.987 -1.07 . . . . 0.0 109.976 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -73.65 -46.78 44.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.049 -1.032 . . . . 0.0 109.516 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.512 ' N ' ' HD3' ' A' ' 48' ' ' LYS . 24.3 mmtm -58.86 -16.78 18.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.211 -0.931 . . . . 0.0 109.067 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.499 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -101.83 22.66 12.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 109.946 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.873 ' O ' HG22 ' A' ' 54' ' ' VAL . 7.9 mt -124.06 66.09 39.81 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.007 -1.058 . . . . 0.0 110.706 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 37.2 Cg_endo -80.09 140.67 14.24 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.406 2.07 . . . . 0.0 110.13 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 51' ' ' PRO . 12.6 tm-20 61.87 132.88 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.386 -0.821 . . . . 0.0 108.822 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . 58.89 23.35 56.33 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 50' ' ' LEU . 2.0 t -60.33 80.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.752 -0.852 . . . . 0.0 109.374 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -125.77 91.94 3.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.131 -0.98 . . . . 0.0 110.264 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.41 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 7.1 ttt -103.72 98.31 8.2 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -93.35 134.5 35.5 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.057 -179.269 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 3.9 mtmt -109.8 108.98 19.5 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.448 -0.782 . . . . 0.0 109.487 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.584 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 2.7 m-85 -109.8 169.42 8.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.865 -1.147 . . . . 0.0 111.083 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.804 ' NE2' HD22 ' A' ' 72' ' ' LEU . 4.0 t60 -107.68 133.45 52.09 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.744 0.783 . . . . 0.0 108.995 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.128 HG11 ' CG1' ' A' ' 150' ' ' VAL . 3.2 m -71.98 157.4 6.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 O-C-N 121.738 -0.601 . . . . 0.0 109.536 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.414 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 2.9 p-10 -123.46 47.2 2.05 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 16.0 p90 -148.52 61.57 1.08 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.093 -1.004 . . . . 0.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.688 ' HE1' HG23 ' A' ' 61' ' ' VAL . 0.5 OUTLIER -133.13 38.0 3.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.288 -0.883 . . . . 0.0 109.051 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.49 -31.37 1.14 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.79 -35.83 3.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 -79.37 0.28 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.874 -1.368 . . . . 0.0 109.676 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.108 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -78.59 -19.18 53.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.974 -1.079 . . . . 0.0 109.197 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 1.108 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -58.73 -57.11 21.6 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.76 -49.04 74.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.286 -1.126 . . . . 0.0 108.048 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.648 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 49.9 t0 -59.94 -26.68 66.16 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.804 HD22 ' NE2' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -60.75 -36.24 78.41 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.412 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.585 HG23 ' OE1' ' A' ' 138' ' ' GLN . 31.5 m -67.0 -41.17 87.18 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 7.8 tp60 -61.73 -17.43 55.78 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.803 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -71.49 -45.1 63.42 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 20.0 t-105 -64.58 -31.84 73.22 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.175 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.565 ' HB2' HE21 ' A' ' 138' ' ' GLN . . . -77.88 -54.43 6.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.87 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.107 HG11 ' CE2' ' A' ' 122' ' ' TYR . 88.8 t -59.71 -26.18 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.151 -0.968 . . . . 0.0 109.964 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.521 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -83.55 -60.77 2.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 109.243 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.421 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -45.67 -28.87 1.09 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.171 -0.956 . . . . 0.0 108.53 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.938 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -72.57 -41.51 65.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.472 -0.768 . . . . 0.0 109.374 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.491 ' CB ' HG13 ' A' ' 84' ' ' VAL . 20.9 mt -101.51 9.41 41.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -0.962 . . . . 0.0 110.381 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.76 24.23 7.77 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.618 HG11 HG12 ' A' ' 117' ' ' ILE . 33.2 m -87.29 -9.2 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.427 -1.043 . . . . 0.0 110.759 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.46 ' O ' ' HB ' ' A' ' 89' ' ' THR . 2.8 pt-20 -42.08 -58.76 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.047 -1.033 . . . . 0.0 110.015 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.6 -33.75 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.237 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.905 ' HE2' ' HB1' ' A' ' 115' ' ' ALA . 36.5 mtpt -83.6 -50.47 8.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.339 -0.851 . . . . 0.0 111.425 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.897 HG23 HD12 ' A' ' 92' ' ' LEU . 1.3 m -83.25 -7.51 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.786 -1.196 . . . . 0.0 110.784 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.675 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.31 -44.38 45.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.703 -1.248 . . . . 0.0 108.728 179.034 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.428 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -53.49 -52.76 63.77 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.542 -1.349 . . . . 0.0 110.555 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.572 ' HB2' HG13 ' A' ' 111' ' ' VAL . 25.3 Cg_endo -73.7 -18.47 22.22 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 N-CA-C 109.877 -0.855 . . . . 0.0 109.877 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.909 ' HG ' HG11 ' A' ' 111' ' ' VAL . 21.8 mt -87.07 -43.59 12.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 108.863 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.675 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.4 m-30 -65.57 -45.77 81.99 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.008 -1.058 . . . . 0.0 108.984 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -73.44 -20.73 60.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.065 -1.022 . . . . 0.0 109.08 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.58 -36.29 62.44 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.582 HG11 ' CG ' ' A' ' 29' ' ' PHE . 1.5 t -102.09 -0.49 10.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.087 -1.243 . . . . 0.0 109.409 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.493 ' OE1' ' HB3' ' A' ' 93' ' ' PHE . 16.4 mt-30 -97.91 1.53 48.16 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 120.915 -1.116 . . . . 0.0 110.557 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 175.79 81.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.744 -1.222 . . . . 0.0 109.582 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.904 HG22 ' H ' ' A' ' 101' ' ' THR . 1.2 m 157.71 -43.85 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.9 OUTLIER 69.09 16.26 8.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.867 -1.146 . . . . 0.0 110.735 178.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.904 ' H ' HG22 ' A' ' 99' ' ' THR . 5.3 t -79.3 -7.61 58.44 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.566 ' CB ' HG22 ' A' ' 96' ' ' VAL . 12.6 mm -87.62 61.93 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -127.58 32.18 5.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.967 . . . . 0.0 109.48 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 107' ' ' ASP . 4.8 p -153.02 128.11 9.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.002 -1.061 . . . . 0.0 110.075 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.745 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.55 -31.03 9.5 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -34.14 74.72 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -68.51 -51.11 46.74 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 105' ' ' ALA . 27.9 mt -48.16 -29.9 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 0.0 108.684 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -76.86 -39.9 49.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 109.419 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -57.34 -41.18 79.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.405 -0.809 . . . . 0.0 109.646 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.909 HG11 ' HG ' ' A' ' 92' ' ' LEU . 19.9 t -73.88 -38.45 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.173 -0.954 . . . . 0.0 109.569 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CD2' ' HD2' ' A' ' 122' ' ' TYR . 2.6 m-85 -64.52 -39.01 92.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.052 -1.03 . . . . 0.0 109.121 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.4 mt -75.11 -22.38 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.342 -0.849 . . . . 0.0 109.548 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -16.98 62.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.315 -0.866 . . . . 0.0 109.876 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.905 ' HB1' ' HE2' ' A' ' 87' ' ' LYS . . . -91.04 6.4 45.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.725 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.68 2.56 75.6 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.801 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.4 mp -86.27 63.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -1.102 . . . . 0.0 109.074 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -31.75 149.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.199 -0.938 . . . . 0.0 110.859 -179.218 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.42 -32.92 58.14 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.03 -46.26 82.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.999 -1.295 . . . . 0.0 109.195 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -73.01 -43.72 61.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 1.107 ' CE2' HG11 ' A' ' 78' ' ' VAL . 4.3 t80 -57.99 -45.59 86.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.613 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -64.3 -37.8 88.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.147 -0.97 . . . . 0.0 108.979 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.03 -50.35 72.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.151 -0.968 . . . . 0.0 108.878 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.51 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -52.0 -49.3 63.58 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.453 ' C ' ' CD1' ' A' ' 126' ' ' TRP . 3.5 t90 -58.22 -59.65 4.99 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -15.35 6.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.633 -0.667 . . . . 0.0 110.253 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.478 ' OG ' HG23 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -69.6 172.93 6.63 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.056 -1.028 . . . . 0.0 110.086 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -89.5 -40.14 12.86 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.39 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.6 t -63.13 -46.15 96.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.105 -1.438 . . . . 0.0 109.341 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.938 HG22 ' HB1' ' A' ' 81' ' ' ALA . 2.1 t -69.58 -33.79 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.975 -1.078 . . . . 0.0 108.369 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 128' ' ' SER . 19.2 ttpt -63.64 -37.99 89.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.5 p -69.37 -32.42 71.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.415 -0.803 . . . . 0.0 108.91 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -19.18 49.69 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.903 . . . . 0.0 108.781 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.515 HG23 ' HB1' ' A' ' 77' ' ' ALA . 3.0 t -78.68 -48.77 21.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -62.33 -38.9 91.27 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -35.8 82.22 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.4 -0.813 . . . . 0.0 109.29 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.585 ' OE1' HG23 ' A' ' 73' ' ' THR . 3.7 mt-30 -67.55 -66.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 109.185 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.33 -37.61 17.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.185 -0.947 . . . . 0.0 108.66 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 9.3 mttm -71.53 -33.57 69.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.367 -0.833 . . . . 0.0 108.85 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.503 ' CB ' ' CD2' ' A' ' 59' ' ' TYR . . . -56.64 -62.22 1.88 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 109.128 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -69.09 -26.24 64.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.599 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 140' ' ' LYS . . . -76.09 -26.01 56.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.887 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.752 ' OD1' HG13 ' A' ' 145' ' ' VAL . 0.6 OUTLIER -80.88 -49.92 10.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.993 . . . . 0.0 108.478 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 1.094 HG21 ' CE2' ' A' ' 25' ' ' PHE . 19.7 m -84.75 -13.27 11.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 2.7 mt-30 80.89 -47.14 0.26 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.682 . . . . 0.0 109.875 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.525 HD21 ' CG1' ' A' ' 61' ' ' VAL . 24.4 tp 65.06 137.9 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.7 ttt85 -160.5 27.74 0.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.457 -1.402 . . . . 0.0 110.161 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.97 106.47 0.2 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.314 -1.422 . . . . 0.0 110.619 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 1.128 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -83.13 144.46 47.23 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.41 -1.053 . . . . 0.0 108.934 178.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.48 151.73 89.64 Favored 'Cis proline' 0 C--N 1.315 -1.224 0 C-N-CA 124.176 -1.177 . . . . 0.0 110.854 0.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.797 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -127.84 153.12 46.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.41 -1.431 . . . . 0.0 109.103 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -148.11 130.07 15.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.899 -1.126 . . . . 0.0 110.424 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.607 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 24.5 m-85 -126.22 129.17 48.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.53 -0.731 . . . . 0.0 109.698 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 21' ' ' GLN . 14.8 t -96.77 131.13 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 0.0 109.607 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.765 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 5.7 t30 43.16 23.73 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.471 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.549 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.87 58.11 16.19 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.482 ' HE3' ' CE2' ' A' ' 159' ' ' TYR . 32.6 ttpt -166.27 -35.67 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.482 ' CE2' ' HE3' ' A' ' 158' ' ' LYS . 50.3 m-85 -119.6 120.93 38.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.892 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.607 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -119.42 120.55 37.19 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.171 -0.956 . . . . 0.0 109.714 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 9' ' ' TYR . 69.8 mt -61.85 175.38 0.67 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -149.86 114.5 3.44 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.947 -1.095 . . . . 0.0 109.384 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--N 1.313 -1.342 0 C-N-CA 122.598 2.199 . . . . 0.0 111.351 -179.849 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 14.3 mtt . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.615 0.722 . . . . 0.0 109.602 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.75 -49.17 66.81 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.37 -29.16 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.033 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -68.25 -31.38 70.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.113 -0.992 . . . . 0.0 108.85 179.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.417 HG22 HD11 ' A' ' 42' ' ' ILE . 53.3 t -79.28 -29.29 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.552 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -82.97 -53.02 6.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.001 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.46 ' O ' ' OG1' ' A' ' 181' ' ' THR . 1.0 OUTLIER -62.34 -47.27 84.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.458 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.604 ' O ' HG23 ' A' ' 182' ' ' VAL . 4.2 t80 -61.83 -49.68 75.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.01 -34.69 68.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.102 -0.999 . . . . 0.0 108.998 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -73.77 -38.73 64.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.423 -0.798 . . . . 0.0 109.182 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.662 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -59.01 -29.68 67.43 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 178' ' ' TYR . 2.5 t -83.95 -36.41 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.973 . . . . 0.0 109.28 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.477 ' HB2' ' CG ' ' A' ' 49' ' ' LYS . 16.9 tttt -60.77 -46.49 90.25 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.173 -0.955 . . . . 0.0 108.915 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.567 ' CD2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -81.63 -30.91 32.63 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.366 -0.834 . . . . 0.0 109.371 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 181' ' ' THR . 0.4 OUTLIER -61.01 -20.93 63.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.825 -1.172 . . . . 0.0 108.775 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.635 ' HB3' HD23 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -80.79 -4.57 55.06 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.98 -1.075 . . . . 0.0 108.471 178.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 108.867 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -99.63 58.2 1.04 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.07 -1.019 . . . . 0.0 110.011 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 t0 48.98 85.26 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.44 -0.788 . . . . 0.0 110.04 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 114.92 -21.91 13.13 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -81.27 -67.25 0.8 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -1.196 . . . . 0.0 108.696 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 3' ' ' TYR . 15.7 mp0 -99.09 7.83 45.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.252 -0.905 . . . . 0.0 109.611 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.669 ' CB ' HD23 ' A' ' 161' ' ' LEU . 4.4 p90 176.54 134.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 108.975 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.471 HG23 ' CG ' ' A' ' 160' ' ' GLN . 9.3 t -114.43 177.68 4.55 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.585 -0.697 . . . . 0.0 109.328 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.502 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 0.4 OUTLIER -88.41 160.67 17.46 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.542 0.686 . . . . 0.0 110.42 -179.151 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.452 ' HG ' ' HB3' ' A' ' 160' ' ' GLN . 7.4 mt -98.41 161.74 13.53 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.562 -0.711 . . . . 0.0 109.127 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.416 ' C ' ' HG2' ' A' ' 14' ' ' LYS . 5.0 pm0 -115.6 -3.98 12.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 109.611 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 13' ' ' GLU . 3.7 mmtp -139.89 75.11 30.88 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.18 -0.95 . . . . 0.0 109.617 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 157' ' ' GLY . 35.3 Cg_endo -77.99 159.62 30.6 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.561 2.174 . . . . 0.0 110.576 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.862 HG21 ' HB3' ' A' ' 144' ' ' ASP . 1.7 t -134.36 129.74 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.369 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.52 126.57 15.66 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 74.65 6.45 77.19 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.933 ' HB1' ' HD2' ' A' ' 20' ' ' PRO . . . -42.57 172.45 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.498 -1.001 . . . . 0.0 110.277 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.933 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 30.8 Cg_endo -71.52 111.94 3.24 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.919 2.412 . . . . 0.0 111.74 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.665 ' O ' HG22 ' A' ' 155' ' ' VAL . 27.0 mm-40 -52.85 -22.35 5.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.557 -0.715 . . . . 0.0 109.597 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.683 ' O ' HG12 ' A' ' 22' ' ' VAL . 10.5 t -156.62 79.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.655 HD12 ' HG3' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -81.7 138.48 35.24 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.586 ' H ' HD23 ' A' ' 23' ' ' LEU . 10.5 tt0 -132.85 103.1 5.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.047 -1.033 . . . . 0.0 109.789 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.912 ' HE2' HG21 ' A' ' 145' ' ' VAL . 58.4 m-85 -86.01 126.4 34.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.179 -0.951 . . . . 0.0 109.031 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.4 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 2.6 p90 -157.14 133.15 9.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.231 -0.918 . . . . 0.0 109.791 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.551 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 70.1 m -104.33 -174.37 2.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.413 -0.805 . . . . 0.0 109.827 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.558 ' O ' ' CD1' ' A' ' 29' ' ' PHE . 16.0 m-30 -104.53 48.46 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.665 ' CG ' HG11 ' A' ' 96' ' ' VAL . 16.6 m-85 -146.91 14.32 1.17 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 110.338 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -104.51 162.5 19.65 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.675 -1.266 . . . . 0.0 109.67 -179.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.96 -36.14 2.76 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.212 1.941 . . . . 0.0 108.388 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' A' ' 36' ' ' PHE . 4.4 m-70 -82.98 -22.32 33.71 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 16.2 t -47.06 -52.95 13.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.534 ' CB ' ' NE2' ' A' ' 97' ' ' GLN . 11.3 t80 -75.18 -40.66 59.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.794 -0.566 . . . . 0.0 110.403 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -72.38 -16.92 61.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.057 -1.027 . . . . 0.0 110.417 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' HIS . 1.8 m-85 -82.58 -29.62 30.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.02 -1.05 . . . . 0.0 110.443 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.74 22.7 13.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.955 -1.09 . . . . 0.0 109.629 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.514 ' OE2' ' CZ ' ' A' ' 34' ' ' TYR . 5.5 mm-40 -132.09 -61.09 0.89 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 111.092 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.2 t -90.61 -75.56 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.899 -1.126 . . . . 0.0 111.708 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 0.7 OUTLIER -70.75 -24.39 62.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.954 -1.091 . . . . 0.0 110.679 -178.089 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 44' ' ' ASP . 94.9 m-70 60.67 32.71 20.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.058 -1.026 . . . . 0.0 108.965 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' A' ' 41' ' ' HIS . 13.5 mm -42.22 -26.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.419 -0.8 . . . . 0.0 109.921 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 41' ' ' HIS . 0.9 OUTLIER -81.4 -43.39 19.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.92 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 41' ' ' HIS . 84.1 m-20 -85.39 -36.59 20.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.952 . . . . 0.0 109.894 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -65.04 -38.64 91.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 109.556 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 43' ' ' SER . 9.8 p -68.54 -26.46 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.736 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -61.64 -39.23 90.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.476 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -51.17 -24.45 4.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.169 -0.957 . . . . 0.0 108.734 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.867 ' O ' HD23 ' A' ' 50' ' ' LEU . 17.6 mmtm -91.05 25.04 2.58 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.517 -0.739 . . . . 0.0 109.423 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.867 HD23 ' O ' ' A' ' 49' ' ' LYS . 14.2 mt -125.22 67.3 54.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.175 -0.953 . . . . 0.0 110.104 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 36.6 Cg_endo -79.39 75.35 5.11 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.542 2.161 . . . . 0.0 110.937 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 51' ' ' PRO . 6.0 tm-20 58.82 131.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.395 0.617 . . . . 0.0 110.2 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.08 -11.63 60.44 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.814 ' CG1' HD22 ' A' ' 50' ' ' LEU . 1.1 t -114.61 98.43 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -1.185 . . . . 0.0 109.142 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -86.09 102.95 14.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.909 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.513 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 8.7 ttt -99.02 102.88 14.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.428 -0.795 . . . . 0.0 109.606 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.0 m -99.1 126.48 44.85 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.265 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 113.83 27.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.458 -0.777 . . . . 0.0 109.382 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.552 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.8 m-85 -115.33 163.75 15.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.029 -1.045 . . . . 0.0 111.404 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.658 ' CE1' HD21 ' A' ' 72' ' ' LEU . 3.5 t-160 -117.28 122.16 43.18 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.13 HG11 ' CD2' ' A' ' 147' ' ' LEU . 16.8 m -101.88 156.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 110.384 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 1.1 p-10 -83.92 42.65 0.87 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.402 -0.811 . . . . 0.0 109.536 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.609 ' CD1' ' CG2' ' A' ' 61' ' ' VAL . 3.7 m-85 -91.56 30.96 1.23 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.0 110.023 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.438 ' SD ' ' HB3' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -161.74 45.93 0.17 Allowed 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.65 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 161.73 60.03 0.02 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.507 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.52 -35.72 0.13 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 65' ' ' GLY . 92.3 m-20 -88.94 -78.64 0.34 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -1.173 . . . . 0.0 110.129 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.929 HD23 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -82.27 -21.62 36.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.769 -1.207 . . . . 0.0 110.088 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.732 ' N ' HD22 ' A' ' 68' ' ' LEU . . . -51.97 -39.93 49.63 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 2.9 ttmt -61.05 -41.58 96.87 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.79 -29.54 65.75 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.728 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 13.9 tp -58.17 -50.77 72.38 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -56.64 -43.2 80.05 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.82 ' O ' HG23 ' A' ' 78' ' ' VAL . 3.1 tt0 -54.92 -27.17 41.24 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.51 -46.36 86.44 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 29.7 t-105 -53.97 -31.98 52.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.504 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -81.99 -66.31 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.408 -0.808 . . . . 0.0 110.012 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 74' ' ' GLN . 2.2 t -47.55 -30.68 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.214 -0.929 . . . . 0.0 110.047 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.439 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.5 -63.48 1.41 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.824 -1.173 . . . . 0.0 109.188 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.416 ' C ' ' O ' ' A' ' 79' ' ' ALA . 21.7 mtp -46.21 -27.12 0.91 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.594 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.647 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -67.8 -46.86 70.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 109.591 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.8 mt -99.62 7.24 45.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.63 31.18 60.18 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 26.9 m -97.35 8.21 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.448 -1.031 . . . . 0.0 110.144 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.475 ' HG2' ' OG1' ' A' ' 89' ' ' THR . 2.3 tt0 -52.76 -70.56 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.086 -1.009 . . . . 0.0 109.722 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -38.89 -33.78 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 0.0 110.282 -179.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.6 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 25.1 mtpp -80.91 -52.5 7.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.377 -0.827 . . . . 0.0 110.995 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.688 HG23 HD12 ' A' ' 92' ' ' LEU . 1.3 m -86.12 -13.89 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.684 -1.26 . . . . 0.0 110.803 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.77 HG23 ' CE1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -73.68 -42.39 61.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.646 -1.284 . . . . 0.0 108.206 178.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.403 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 2.1 t -54.22 -54.67 45.21 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.63 -1.294 . . . . 0.0 110.353 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.507 ' HB2' HG13 ' A' ' 111' ' ' VAL . 25.9 Cg_endo -72.82 -21.1 21.79 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 N-CA-C 109.758 -0.901 . . . . 0.0 109.758 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.688 HD12 HG23 ' A' ' 88' ' ' VAL . 15.6 mt -81.09 -44.64 17.67 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.77 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.6 m-30 -64.03 -44.87 91.21 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.107 -0.995 . . . . 0.0 108.62 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -72.97 -24.33 60.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.297 -0.877 . . . . 0.0 109.321 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.901 ' O ' HG23 ' A' ' 99' ' ' THR . . . -69.03 -36.09 80.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.665 HG11 ' CG ' ' A' ' 29' ' ' PHE . 2.2 t -98.95 -1.57 10.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.225 -1.162 . . . . 0.0 108.768 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.534 ' NE2' ' CB ' ' A' ' 34' ' ' TYR . 27.4 mm-40 -110.26 6.27 22.41 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 121.022 -1.048 . . . . 0.0 111.323 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.754 ' C ' HG22 ' A' ' 99' ' ' THR . 1.5 ttmm -164.57 52.2 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.476 -1.39 . . . . 0.0 109.402 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.901 HG23 ' O ' ' A' ' 95' ' ' GLY . 0.5 OUTLIER 175.15 -51.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.361 -0.837 . . . . 0.0 109.847 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.534 ' O ' ' CD ' ' A' ' 103' ' ' ARG . 1.1 mt-30 75.05 10.95 3.66 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.042 -1.036 . . . . 0.0 109.886 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.1 t -84.32 -8.33 59.04 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.608 0.718 . . . . 0.0 109.319 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.468 HG13 ' C ' ' A' ' 95' ' ' GLY . 10.2 mm -74.14 75.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.56 -0.712 . . . . 0.0 109.544 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.534 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -136.65 31.42 2.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.84 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.533 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 7.3 p -146.91 128.45 15.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.064 -1.022 . . . . 0.0 109.716 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.54 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -52.82 -30.17 31.94 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.6 t -65.83 -29.03 69.43 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 104' ' ' SER . 61.6 m-20 -77.21 -39.5 48.45 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.396 -0.922 . . . . 0.0 108.678 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.929 HD11 HD23 ' A' ' 68' ' ' LEU . 44.4 mt -59.51 -29.82 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.29 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 4.6 mtm180 -78.03 -32.07 50.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.528 -0.733 . . . . 0.0 109.275 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.4 OUTLIER -61.47 -48.02 83.02 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.246 -0.909 . . . . 0.0 109.2 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.635 HG11 ' HG ' ' A' ' 92' ' ' LEU . 53.1 t -68.39 -40.37 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.915 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.579 ' CD1' HG11 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -56.78 -37.59 71.32 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.242 -0.912 . . . . 0.0 109.28 179.442 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.8 mt -76.16 -24.79 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -0.805 . . . . 0.0 109.869 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -64.47 -18.78 65.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.027 -1.046 . . . . 0.0 109.371 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.6 ' HB1' ' HE3' ' A' ' 87' ' ' LYS . . . -94.33 6.42 48.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.534 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.96 -1.48 77.94 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.732 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -78.74 57.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -1.118 . . . . 0.0 109.442 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 117' ' ' ILE . 2.2 mttt -37.73 153.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.882 . . . . 0.0 110.134 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.99 -38.01 73.47 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.431 ' HG3' ' HB2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -50.43 -49.18 55.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.945 -1.326 . . . . 0.0 109.571 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.22 -48.79 12.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 110.335 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.807 ' CE2' HG11 ' A' ' 78' ' ' VAL . 4.1 t80 -58.28 -52.3 66.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.017 -1.052 . . . . 0.0 109.622 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -62.0 -41.13 97.72 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.33 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.58 -50.4 73.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.102 -0.999 . . . . 0.0 108.928 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 128' ' ' SER . . . -55.28 -46.71 76.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 108.886 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.729 ' HA ' HG11 ' A' ' 131' ' ' VAL . 4.7 t90 -57.55 -57.08 14.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.231 -0.918 . . . . 0.0 108.53 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -60.7 -15.54 30.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.5 -0.75 . . . . 0.0 109.553 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 63.1 m -76.13 -172.93 2.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.141 -0.975 . . . . 0.0 109.83 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -95.55 -28.3 14.93 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.906 -0.496 . . . . 0.0 111.061 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.14 -41.88 93.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.405 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.729 HG11 ' HA ' ' A' ' 126' ' ' TRP . 49.9 t -70.86 -36.65 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 120.995 -1.066 . . . . 0.0 108.487 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -67.4 -27.46 67.1 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.23 -37.68 69.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 138' ' ' GLN . 0.5 OUTLIER -79.45 -22.19 44.48 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.504 HG23 ' CB ' ' A' ' 77' ' ' ALA . 17.1 t -79.12 -40.96 22.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.511 ' O ' ' CG ' ' A' ' 140' ' ' LYS . . . -68.01 -48.55 65.39 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.495 -0.753 . . . . 0.0 109.038 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.488 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -61.29 -32.69 72.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.233 -0.917 . . . . 0.0 108.751 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.552 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 4.4 tm0? -66.06 -69.76 0.28 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.827 . . . . 0.0 109.093 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' GLN . 0.0 OUTLIER -46.87 -32.67 3.92 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -70.28 -35.05 73.48 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.673 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -57.05 -50.3 73.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -70.25 -33.17 71.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.433 -0.792 . . . . 0.0 109.8 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.25 -18.21 55.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 110.042 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.862 ' HB3' HG21 ' A' ' 16' ' ' VAL . 67.4 m-20 -82.84 -43.48 16.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.048 -1.032 . . . . 0.0 108.36 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.912 HG21 ' HE2' ' A' ' 25' ' ' PHE . 27.5 m -98.61 -12.65 8.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.2 OUTLIER 83.61 -40.9 0.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.69 -0.631 . . . . 0.0 109.564 -179.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.13 ' CD2' HG11 ' A' ' 61' ' ' VAL . 10.7 tp 67.85 134.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 0.0 109.329 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -144.29 11.45 1.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.557 -1.339 . . . . 0.0 110.746 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.31 93.74 0.1 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.678 -1.725 . . . . 0.0 111.575 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 1.003 HG11 HG21 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -81.64 139.45 47.38 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 150' ' ' VAL . 32.4 Cg_endo -72.23 156.32 98.25 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 124.198 -1.168 . . . . 0.0 112.101 2.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.72 152.07 21.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.059 -1.025 . . . . 0.0 108.259 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.518 ' O ' ' CD1' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -131.69 137.83 48.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.928 -1.108 . . . . 0.0 110.195 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 153' ' ' MET . 14.0 m-85 -133.32 136.23 45.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.399 -0.813 . . . . 0.0 109.524 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 21' ' ' GLN . 12.1 t -110.78 119.59 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.046 -1.034 . . . . 0.0 108.352 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 20' ' ' PRO . 1.7 m-20 53.29 27.31 6.0 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 15' ' ' PRO . . . 50.18 21.66 4.29 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.232 -1.461 . . . . 0.0 109.614 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -118.79 -21.02 8.0 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.756 -1.438 . . . . 0.0 108.721 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.446 ' N ' HD12 ' A' ' 12' ' ' LEU . 17.9 m-85 -134.87 123.93 24.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 109.291 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 11' ' ' THR . 25.4 pt20 -116.93 117.42 29.64 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.268 -0.895 . . . . 0.0 109.59 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.669 HD23 ' CB ' ' A' ' 9' ' ' TYR . 11.6 mt -60.83 179.47 0.17 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.502 -0.749 . . . . 0.0 108.98 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -155.17 117.92 2.43 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.037 -1.039 . . . . 0.0 109.529 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo . . . . . 0 C--N 1.312 -1.379 0 C-N-CA 122.328 2.019 . . . . 0.0 110.635 179.888 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.433 ' O ' HG23 ' A' ' 175' ' ' VAL . 5.7 mmm . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.773 0.797 . . . . 0.0 109.479 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -78.53 -56.56 4.34 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 6.9 t -64.09 -28.49 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 108.939 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.437 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 48.7 t80 -69.18 -43.16 74.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 0.0 109.229 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 171' ' ' MET . 61.3 t -70.05 -27.35 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.181 -0.949 . . . . 0.0 109.478 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -83.95 -58.71 2.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 109.251 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.457 ' O ' ' OG1' ' A' ' 181' ' ' THR . 0.0 OUTLIER -56.94 -41.73 78.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.397 -0.815 . . . . 0.0 109.197 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.647 ' O ' HG23 ' A' ' 182' ' ' VAL . 69.2 t80 -65.54 -51.85 56.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.067 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.17 -25.28 67.68 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.241 -0.912 . . . . 0.0 109.26 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.28 -45.07 20.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.899 . . . . 0.0 109.348 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.72 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -57.0 -42.32 80.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.221 -0.924 . . . . 0.0 109.14 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 178' ' ' TYR . 2.4 t -74.49 -36.55 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 109.135 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -57.55 -50.11 74.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.19 -0.944 . . . . 0.0 109.102 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -31.46 55.66 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.235 -0.916 . . . . 0.0 109.086 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.72 HD23 ' O ' ' A' ' 181' ' ' THR . 0.4 OUTLIER -58.24 -21.3 47.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.841 -1.162 . . . . 0.0 109.171 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.573 ' HB2' HG22 ' A' ' 54' ' ' VAL . 87.2 p -74.39 -4.77 38.45 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.817 -1.177 . . . . 0.0 108.691 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.418 -0.802 . . . . 0.0 109.267 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.506 ' HB2' ' CD1' ' A' ' 9' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.2 58.41 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.79 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.0 t0 50.5 84.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.574 -0.704 . . . . 0.0 110.271 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 112.89 -19.73 20.65 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -66.62 0.86 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.057 -1.26 . . . . 0.0 108.684 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 3' ' ' TYR . 40.6 mm-40 -102.62 10.61 38.62 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.321 -0.862 . . . . 0.0 109.678 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.537 ' HB2' HD23 ' A' ' 161' ' ' LEU . 6.9 p90 179.1 136.09 0.09 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.07 -1.019 . . . . 0.0 109.426 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.495 HG23 ' CG ' ' A' ' 160' ' ' GLN . 2.3 t -123.55 171.9 9.17 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.5 m -120.97 149.69 42.27 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.514 0.673 . . . . 0.0 110.199 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 158' ' ' LYS . 1.3 mp -98.18 157.45 16.15 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.572 -0.705 . . . . 0.0 109.21 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.513 ' HG2' ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -84.7 -25.64 28.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 109.192 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.513 ' N ' ' HG2' ' A' ' 13' ' ' GLU . 7.4 mttp -116.24 96.44 47.51 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.359 -0.838 . . . . 0.0 109.046 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 34.3 Cg_endo -76.74 159.95 34.7 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.337 2.025 . . . . 0.0 110.481 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.73 HG21 ' HB3' ' A' ' 144' ' ' ASP . 11.7 t -108.73 90.52 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.885 . . . . 0.0 109.762 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.96 131.5 12.12 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 95.18 -24.49 28.6 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.719 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -41.2 160.62 0.14 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.404 -1.056 . . . . 0.0 109.471 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.572 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.0 Cg_endo -78.13 129.26 9.55 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.563 2.175 . . . . 0.0 111.015 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.649 ' O ' HG22 ' A' ' 155' ' ' VAL . 2.5 mp0 -46.68 -20.69 0.14 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.771 ' O ' HG12 ' A' ' 22' ' ' VAL . 3.1 t -148.35 79.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.873 -1.142 . . . . 0.0 108.73 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.761 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -73.76 127.47 32.9 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.5 ' HB3' ' HA ' ' A' ' 58' ' ' LYS . 33.2 tt0 -114.64 118.08 32.65 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.99 -1.068 . . . . 0.0 109.564 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.785 ' CD2' HD13 ' A' ' 147' ' ' LEU . 7.5 m-85 -103.76 112.5 25.47 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.586 -0.696 . . . . 0.0 109.274 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -155.19 142.28 19.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.998 -1.064 . . . . 0.0 110.14 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.807 ' HB3' HG22 ' A' ' 61' ' ' VAL . 4.3 p -124.55 -168.63 1.84 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.627 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -116.47 52.54 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.857 -1.152 . . . . 0.0 108.036 178.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.763 ' CD1' HG11 ' A' ' 96' ' ' VAL . 7.6 m-85 -139.97 10.62 2.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.222 -0.924 . . . . 0.0 110.236 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.717 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 4.0 m -117.06 179.88 0.74 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.753 -1.217 . . . . 0.0 108.484 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.3 Cg_endo -76.02 -59.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.593 1.529 . . . . 0.0 110.169 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -69.4 -11.46 60.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.955 -1.09 . . . . 0.0 108.4 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 27' ' ' SER . 1.2 m -57.15 -37.93 72.78 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.584 ' CE1' ' HG3' ' A' ' 38' ' ' GLU . 18.6 t80 -81.22 -41.91 21.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.758 -0.589 . . . . 0.0 109.791 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.492 ' N ' ' OE1' ' A' ' 35' ' ' GLN . 11.7 mp0 -78.56 -21.26 48.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.945 . . . . 0.0 110.681 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.77 ' CE2' HG21 ' A' ' 42' ' ' ILE . 27.0 t80 -75.52 -18.03 59.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 0.0 110.521 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 2.2 mm-40 -128.28 32.34 4.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.928 -1.107 . . . . 0.0 110.419 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.584 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 4.5 mm-40 -145.18 -67.89 0.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.977 -1.077 . . . . 0.0 109.797 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.46 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 13.2 t -97.1 -56.79 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.057 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.496 ' HB3' HG13 ' A' ' 42' ' ' ILE . 61.2 mt -43.49 -27.9 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.118 -0.989 . . . . 0.0 109.93 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' A' ' 38' ' ' GLU . 29.7 m170 49.37 24.28 1.03 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.044 -1.035 . . . . 0.0 109.027 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.77 HG21 ' CE2' ' A' ' 36' ' ' PHE . 12.2 mt -59.51 -32.8 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.42 -0.8 . . . . 0.0 109.64 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -45.09 24.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.051 -1.031 . . . . 0.0 110.006 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -81.16 -36.45 30.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.921 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 41' ' ' HIS . 6.2 t-20 -67.47 -30.34 70.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.947 . . . . 0.0 109.907 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 42' ' ' ILE . 43.5 t -74.5 -17.65 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.182 -0.949 . . . . 0.0 109.523 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.689 ' HA ' HD12 ' A' ' 50' ' ' LEU . 25.9 mttm -75.9 -34.39 59.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.451 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -57.7 -18.96 23.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.922 . . . . 0.0 109.583 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.81 17.76 14.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.439 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.689 HD12 ' HA ' ' A' ' 47' ' ' LYS . 11.9 mt -93.62 118.65 67.51 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.751 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.32 151.99 30.18 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.301 2.001 . . . . 0.0 108.954 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.493 ' O ' ' CG ' ' A' ' 52' ' ' GLU . 11.0 tt0 -71.09 42.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.497 -1.377 . . . . 0.0 110.882 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.514 ' O ' ' CG2' ' A' ' 54' ' ' VAL . . . -140.77 37.29 1.68 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.581 HG13 ' HB3' ' A' ' 21' ' ' GLN . 21.4 t -159.43 128.5 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.554 -0.968 . . . . 0.0 109.035 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.511 ' N ' ' OE1' ' A' ' 21' ' ' GLN . 3.6 ttpp -100.01 112.29 24.58 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.828 0.823 . . . . 0.0 110.013 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.0 ttt -93.02 99.29 11.94 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 2.5 m -92.45 143.14 26.66 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.86 -1.136 . . . . 0.0 110.039 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.5 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -119.46 111.19 17.81 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.354 -0.841 . . . . 0.0 109.762 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.467 ' CE2' ' HG3' ' A' ' 138' ' ' GLN . 5.2 m-85 -111.3 166.11 11.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.225 -0.922 . . . . 0.0 111.074 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.568 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 62.7 t-80 -103.97 135.54 45.3 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.837 0.827 . . . . 0.0 109.008 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.039 HG11 ' CG1' ' A' ' 150' ' ' VAL . 4.4 m -73.45 154.24 7.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-O 121.476 0.655 . . . . 0.0 110.406 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -121.74 27.61 8.08 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.607 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 19.5 p90 -125.75 69.47 1.18 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.112 -0.992 . . . . 0.0 110.234 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.583 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -160.91 -59.06 0.05 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.918 . . . . 0.0 109.764 178.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.583 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -95.86 80.77 0.8 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.54 -43.03 0.72 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.57 -78.3 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.904 -1.351 . . . . 0.0 110.825 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.128 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -80.49 -20.88 42.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.122 . . . . 0.0 110.265 -179.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 1.128 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -54.79 -38.68 65.07 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -47.32 63.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.427 -1.043 . . . . 0.0 108.523 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.524 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 12.2 t70 -65.44 -23.57 66.96 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.769 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 36.7 tp -65.09 -46.47 80.96 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 m -58.51 -42.73 88.33 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 1.04 ' O ' HG23 ' A' ' 78' ' ' VAL . 19.2 tt0 -57.72 -25.03 59.78 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 177.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -64.69 -40.21 94.99 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.457 ' O ' ' HB2' ' A' ' 80' ' ' MET . 25.3 t-105 -63.54 -29.09 70.4 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.63 ' HB2' HE22 ' A' ' 138' ' ' GLN . . . -81.6 -44.02 17.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 109.763 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.04 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.6 t -71.78 -27.39 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 109.401 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.604 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -78.75 -57.78 3.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.13 -0.982 . . . . 0.0 108.804 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -48.17 -27.68 2.53 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.155 -0.965 . . . . 0.0 108.578 179.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.752 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -69.25 -45.74 69.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.584 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.785 ' HB2' HG13 ' A' ' 84' ' ' VAL . 12.6 mt -105.2 14.28 29.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 49.1 25.52 5.51 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.785 HG13 ' HB2' ' A' ' 82' ' ' LEU . 33.8 m -82.98 -11.53 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -1.086 . . . . 0.0 110.298 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.45 ' HG2' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -42.84 -63.59 0.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -0.98 . . . . 0.0 109.875 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.47 -33.43 1.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.285 -0.885 . . . . 0.0 110.264 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -81.6 -50.76 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.37 -0.832 . . . . 0.0 111.436 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.762 HG23 HD12 ' A' ' 92' ' ' LEU . 2.2 m -90.57 6.1 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.863 -1.148 . . . . 0.0 111.195 -178.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.724 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -83.02 -45.7 13.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.818 -1.177 . . . . 0.0 108.347 178.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.464 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -52.39 -51.46 72.37 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.596 -1.315 . . . . 0.0 110.61 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 90' ' ' VAL . 27.1 Cg_endo -73.79 -20.13 20.26 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 N-CA-C 109.736 -0.909 . . . . 0.0 109.736 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.762 HD12 HG23 ' A' ' 88' ' ' VAL . 18.5 mt -86.18 -43.21 13.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 108.87 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.724 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.2 m-30 -64.47 -45.77 85.96 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.094 -1.004 . . . . 0.0 108.945 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -76.36 -21.2 56.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.083 -1.011 . . . . 0.0 109.751 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.479 ' O ' HG12 ' A' ' 102' ' ' ILE . . . -72.75 -29.77 64.85 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.763 HG11 ' CD1' ' A' ' 29' ' ' PHE . 3.4 t -98.77 -15.29 7.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.012 -1.287 . . . . 0.0 109.669 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.517 ' NE2' ' HB2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -108.64 8.23 26.92 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 120.815 -1.178 . . . . 0.0 111.131 -178.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 99' ' ' THR . 16.8 mttt -163.72 63.39 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.517 -1.365 . . . . 0.0 109.472 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.924 HG22 ' H ' ' A' ' 101' ' ' THR . 1.1 m 160.41 -44.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 71.51 13.52 6.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.803 -1.186 . . . . 0.0 110.834 178.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.924 ' H ' HG22 ' A' ' 99' ' ' THR . 4.5 t -79.67 -8.49 59.25 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.586 ' CB ' HG22 ' A' ' 96' ' ' VAL . 7.7 mm -83.14 74.11 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.71 32.72 2.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 0.0 109.757 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 107' ' ' ASP . 13.2 p -159.28 132.09 6.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.03 -1.044 . . . . 0.0 109.797 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.94 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -48.65 -36.43 15.92 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 110' ' ' ASP . 22.7 t -58.1 -34.1 69.83 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -66.67 -49.7 65.3 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.94 HD12 ' HA ' ' A' ' 105' ' ' ALA . 24.5 mt -50.02 -26.71 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.253 -0.904 . . . . 0.0 108.623 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 110' ' ' ASP . 0.9 OUTLIER -71.5 -64.65 0.88 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.476 -0.765 . . . . 0.0 109.614 -179.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.522 ' HA ' HD12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -43.62 -42.27 5.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.33 -0.856 . . . . 0.0 110.195 -179.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 107' ' ' ASP . 1.4 t -67.78 -40.16 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.794 -1.191 . . . . 0.0 109.452 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -68.35 -37.66 80.7 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.227 -0.92 . . . . 0.0 109.578 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 110' ' ' ASP . 15.7 mt -68.4 -23.51 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.0 108.99 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -63.68 -17.58 63.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.454 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.669 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -95.51 12.83 28.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.211 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.67 8.23 87.21 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.669 HG12 ' HB3' ' A' ' 115' ' ' ALA . 3.9 mm -89.0 62.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -1.073 . . . . 0.0 109.653 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.492 ' C ' ' O ' ' A' ' 117' ' ' ILE . 1.7 tptp -33.35 140.85 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.342 -0.849 . . . . 0.0 110.374 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.47 -23.76 6.69 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -63.07 -49.07 75.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.267 . . . . 0.0 109.593 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -76.23 -38.21 56.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.622 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.855 ' CE2' HG11 ' A' ' 78' ' ' VAL . 1.9 t80 -64.54 -50.66 66.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.299 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.16 -48.39 76.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.093 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.97 -53.3 34.29 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.328 -0.857 . . . . 0.0 108.875 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.84 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -49.86 -52.66 31.0 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 8.7 t90 -52.28 -59.78 3.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -52.31 -16.75 0.91 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.615 -0.678 . . . . 0.0 110.038 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.2 m -72.2 -178.56 2.51 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.904 -1.123 . . . . 0.0 109.6 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -90.08 -35.29 15.54 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.888 -0.507 . . . . 0.0 110.424 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.43 -45.63 81.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 118.198 -1.401 . . . . 0.0 109.586 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.84 HG21 ' HB1' ' A' ' 125' ' ' ALA . 3.6 t -71.75 -35.62 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.958 -1.089 . . . . 0.0 108.632 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -69.97 -38.47 76.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.381 -0.824 . . . . 0.0 108.926 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -65.72 -29.89 70.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 108.977 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -79.59 -21.97 44.31 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.309 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.496 HG23 ' HB1' ' A' ' 77' ' ' ALA . 6.0 t -75.77 -45.59 37.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.78 -37.76 88.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -62.45 -38.26 89.1 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.63 HE22 ' HB2' ' A' ' 77' ' ' ALA . 4.8 mt-30 -62.2 -64.39 0.95 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 4.5 tm-20 -48.18 -31.05 5.23 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -73.41 -33.29 64.89 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -63.8 -63.01 1.28 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 108.886 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -62.1 -35.39 78.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.359 -0.838 . . . . 0.0 109.745 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -77.19 -16.64 59.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 109.719 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.73 ' HB3' HG21 ' A' ' 16' ' ' VAL . 9.4 m-20 -79.94 -44.28 20.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.098 -1.001 . . . . 0.0 108.725 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.6 HG21 ' HE2' ' A' ' 25' ' ' PHE . 16.0 m -105.78 -5.2 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.372 -0.83 . . . . 0.0 109.004 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 81.32 -47.16 0.23 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.773 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.785 HD13 ' CD2' ' A' ' 25' ' ' PHE . 17.2 tp 66.29 132.74 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 109.295 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.511 ' O ' ' CD ' ' A' ' 148' ' ' ARG . 6.3 tmm_? -160.79 38.42 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.59 -1.319 . . . . 0.0 109.94 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.46 108.0 0.21 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.251 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 1.039 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -93.32 141.8 24.44 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.404 -1.057 . . . . 0.0 109.573 179.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.489 ' HD3' ' CE1' ' A' ' 32' ' ' HIS . 35.7 Cg_endo -78.42 150.39 87.87 Favored 'Cis proline' 0 C--N 1.316 -1.176 0 C-N-CA 123.858 -1.309 . . . . 0.0 110.312 0.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.712 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -122.83 148.33 45.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.169 -1.582 . . . . 0.0 108.456 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -135.47 130.65 35.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.969 -1.082 . . . . 0.0 110.053 -179.08 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.555 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 29.6 m-85 -129.58 127.75 41.32 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.279 -0.888 . . . . 0.0 110.087 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 21' ' ' GLN . 34.8 t -97.07 125.82 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 109.431 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.719 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 21.5 t-20 52.54 22.69 2.25 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.194 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 54.34 39.18 64.14 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.315 -1.422 . . . . 0.0 109.639 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.409 ' O ' HD12 ' A' ' 12' ' ' LEU . 3.0 tttp -142.95 -32.85 0.47 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.313 -1.11 . . . . 0.0 108.279 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.4 ' O ' ' HA ' ' A' ' 154' ' ' PHE . 31.4 m-85 -116.34 125.42 52.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 108.644 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.555 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 6.3 pt20 -122.5 120.18 33.11 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.058 -1.026 . . . . 0.0 109.895 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' A' ' 9' ' ' TYR . 25.5 mt -62.47 -179.6 0.26 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -159.86 70.21 3.13 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.126 -0.984 . . . . 0.0 109.388 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo . . . . . 0 C--N 1.31 -1.48 0 C-N-CA 122.78 2.32 . . . . 0.0 110.547 -179.848 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.578 0.704 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.44 -48.05 62.1 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.605 -0.685 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.457 HG12 ' OE1' ' A' ' 177' ' ' GLN . 4.9 t -73.16 -26.55 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.148 -0.97 . . . . 0.0 109.619 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -71.53 -44.43 64.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.033 -1.042 . . . . 0.0 109.582 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.576 HG22 HG12 ' A' ' 42' ' ' ILE . 86.9 t -71.55 -26.1 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.112 -0.993 . . . . 0.0 109.21 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -56.61 3.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.457 ' OE1' HG12 ' A' ' 173' ' ' VAL . 18.2 pt20 -60.08 -35.67 75.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.981 . . . . 0.0 108.983 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.553 ' CE1' ' CG2' ' A' ' 182' ' ' VAL . 4.0 t80 -66.55 -51.81 52.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.1 -26.54 27.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -0.916 . . . . 0.0 108.917 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.66 -37.99 40.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.903 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -62.63 -40.77 98.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.314 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.553 ' CG2' ' CE1' ' A' ' 178' ' ' TYR . 21.2 t -75.53 -34.8 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.033 -1.042 . . . . 0.0 109.19 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -58.7 -49.48 77.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.22 -0.925 . . . . 0.0 109.157 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.588 ' CE2' HD22 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -77.7 -40.25 41.96 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.28 -0.887 . . . . 0.0 108.716 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.903 HD23 ' O ' ' A' ' 181' ' ' THR . 3.8 mm? -53.6 -19.13 3.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.08 -1.012 . . . . 0.0 109.434 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 12.3 t -87.01 8.67 22.37 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.761 -1.212 . . . . 0.0 107.989 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . 0.42 ' N ' ' O ' ' A' ' 184' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.529 -0.732 . . . . 0.0 109.715 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.458 ' O ' ' CG ' ' A' ' 4' ' ' GLU . 1.2 tt0 -130.03 60.38 1.6 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.113 -0.992 . . . . 0.0 110.201 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 0.7 OUTLIER 70.02 94.63 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.427 -0.796 . . . . 0.0 110.538 178.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.517 ' HA2' ' ND2' ' A' ' 162' ' ' ASN . . . 79.71 5.45 89.39 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 1.2 tttp -106.86 31.37 5.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -1.193 . . . . 0.0 108.91 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.711 ' O ' HD23 ' A' ' 161' ' ' LEU . 0.1 OUTLIER 147.8 -39.45 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.374 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.571 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 1.3 p90 -157.96 124.51 4.85 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.086 -1.009 . . . . 0.0 109.352 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 t -104.03 176.79 5.04 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -116.25 146.72 42.14 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.596 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 160' ' ' GLN . 1.5 mp -98.52 160.95 13.94 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.363 -0.835 . . . . 0.0 109.703 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -89.99 -1.63 58.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.479 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -142.64 94.84 6.56 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.301 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 35.6 Cg_endo -77.84 167.0 24.48 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.589 2.193 . . . . 0.0 110.517 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 144' ' ' ASP . 25.2 t -119.6 95.67 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.754 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.19 129.47 10.15 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 92.18 -18.74 53.15 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.599 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -38.54 157.84 0.1 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.517 -0.99 . . . . 0.0 109.828 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.568 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.5 Cg_endo -79.85 133.56 10.26 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.573 2.182 . . . . 0.0 111.126 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.8 ' O ' HG13 ' A' ' 155' ' ' VAL . 9.6 mm-40 -41.16 -25.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.53 -0.731 . . . . 0.0 109.935 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.722 ' O ' HG12 ' A' ' 22' ' ' VAL . 5.1 t -147.98 80.41 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.007 -1.058 . . . . 0.0 109.022 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.649 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.23 120.71 20.17 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -104.64 122.66 46.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.182 -0.948 . . . . 0.0 109.42 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.876 ' HD2' HD13 ' A' ' 147' ' ' LEU . 2.9 m-30 -108.26 103.62 12.83 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.408 -0.808 . . . . 0.0 109.9 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -140.67 141.06 35.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.423 -0.798 . . . . 0.0 109.243 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.609 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 1.3 t -115.41 172.22 7.23 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.093 -1.005 . . . . 0.0 109.217 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.602 ' HB2' HD21 ' A' ' 72' ' ' LEU . 8.0 m-30 -89.71 43.67 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.748 ' HE1' HD22 ' A' ' 72' ' ' LEU . 22.2 m-85 -147.3 17.33 1.19 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.494 -0.754 . . . . 0.0 109.698 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -113.68 165.96 12.34 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.756 -1.215 . . . . 0.0 109.622 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 33.7 Cg_endo -75.95 -38.46 1.21 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.33 2.02 . . . . 0.0 108.183 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 1.8 m-70 -72.56 -28.16 62.65 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 28.8 t -44.57 -61.93 1.38 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.81 0.814 . . . . 0.0 108.826 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.618 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 27.5 t80 -78.09 -40.09 39.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.885 -0.51 . . . . 0.0 110.55 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.518 ' NE2' HG11 ' A' ' 39' ' ' VAL . 3.4 mm-40 -64.52 -27.35 68.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.188 -0.945 . . . . 0.0 111.079 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 3.9 m-30 -87.02 -34.36 19.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.806 -1.184 . . . . 0.0 111.212 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.14 -23.2 22.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.805 -1.184 . . . . 0.0 111.987 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -136.34 28.14 3.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.344 -1.472 . . . . 0.0 111.612 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.518 HG11 ' NE2' ' A' ' 35' ' ' GLN . 53.3 t -150.98 -81.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.541 -1.349 . . . . 0.0 109.821 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.403 ' N ' HG12 ' A' ' 39' ' ' VAL . 17.9 mt -67.78 -12.52 60.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.804 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 14.3 m-70 51.51 21.76 1.34 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.979 . . . . 0.0 109.337 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.425 HD12 ' CE1' ' A' ' 36' ' ' PHE . 22.1 mt -65.32 -20.09 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 109.45 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.517 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -81.64 -41.43 21.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.757 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 47' ' ' LYS . 7.4 p-10 -87.08 -45.14 10.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.995 . . . . 0.0 109.59 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -45.83 -31.48 2.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.866 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 43' ' ' SER . 8.4 m -74.26 -30.85 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.089 -1.007 . . . . 0.0 109.655 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 44' ' ' ASP . 8.6 mmmm -48.49 -39.62 23.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 0.0 109.223 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -58.45 -23.23 57.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.353 -0.842 . . . . 0.0 109.206 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 50' ' ' LEU . 6.4 mttm -93.31 23.31 4.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.401 -0.812 . . . . 0.0 109.78 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.682 HD22 ' CG1' ' A' ' 54' ' ' VAL . 18.8 mt -118.92 76.27 14.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.024 -1.047 . . . . 0.0 109.824 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 52' ' ' GLU . 36.6 Cg_endo -78.69 63.34 8.53 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.417 2.078 . . . . 0.0 110.293 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 51' ' ' PRO . 23.3 tp10 58.46 131.57 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.448 0.642 . . . . 0.0 110.259 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.69 -18.35 44.12 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.682 ' CG1' HD22 ' A' ' 50' ' ' LEU . 2.4 t -95.89 89.36 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.082 -1.246 . . . . 0.0 109.193 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.97 96.79 2.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.412 -0.805 . . . . 0.0 109.846 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.497 ' HG2' HD13 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -92.18 100.75 13.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.272 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.2 m -98.61 119.18 36.9 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.864 -1.135 . . . . 0.0 110.581 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -97.63 108.53 21.27 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.466 -0.771 . . . . 0.0 109.654 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.517 ' CD1' ' HG3' ' A' ' 138' ' ' GLN . 3.0 m-85 -111.56 154.18 25.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.166 -0.959 . . . . 0.0 111.624 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.609 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 18.2 t-80 -106.62 108.88 20.61 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.043 HG11 HD22 ' A' ' 147' ' ' LEU . 15.1 m -69.64 156.53 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.44 -0.787 . . . . 0.0 109.994 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.521 ' CB ' ' HA ' ' A' ' 70' ' ' LYS . 3.6 p30 -108.23 51.38 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 109.573 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.737 ' CE1' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -131.1 52.94 2.02 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.172 -0.955 . . . . 0.0 110.155 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.521 ' SD ' ' CB ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -134.02 38.79 3.16 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.32 -34.2 0.65 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.57 -34.86 2.88 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.757 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.27 -80.44 0.25 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.765 -1.432 . . . . 0.0 109.852 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.039 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -77.44 -23.79 50.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.794 -1.191 . . . . 0.0 108.723 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 1.039 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -48.18 -44.0 26.25 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HA ' ' CB ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -64.58 -45.13 88.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -1.117 . . . . 0.0 108.572 179.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.524 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 22.7 t0 -67.72 -28.7 67.88 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.748 HD22 ' HE1' ' A' ' 29' ' ' PHE . 13.1 tp -62.69 -44.37 96.41 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.474 HG23 ' CD ' ' A' ' 138' ' ' GLN . 2.5 m -60.46 -42.32 95.93 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 1.009 ' O ' HG23 ' A' ' 78' ' ' VAL . 8.4 tt0 -59.7 -21.17 60.24 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -68.62 -43.52 76.2 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.503 ' CD1' ' OE1' ' A' ' 138' ' ' GLN . 69.7 t-105 -60.45 -32.13 71.09 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -79.89 -55.41 4.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.549 -0.719 . . . . 0.0 109.876 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.025 HG11 ' CE2' ' A' ' 122' ' ' TYR . 2.8 t -57.7 -28.29 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 109.96 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.581 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -79.54 -59.04 2.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.883 -1.136 . . . . 0.0 108.564 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -46.19 -29.52 1.61 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.812 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -68.35 -44.6 74.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.383 -0.823 . . . . 0.0 109.391 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.792 ' HB2' HG13 ' A' ' 84' ' ' VAL . 7.7 mt -104.68 13.35 31.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.189 -0.944 . . . . 0.0 110.026 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.39 27.51 4.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 82' ' ' LEU . 33.1 m -85.28 -9.15 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.314 -1.109 . . . . 0.0 110.415 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.3 OUTLIER -41.31 -60.49 1.25 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.17 -0.956 . . . . 0.0 109.784 -179.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.16 -33.46 2.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.365 -0.835 . . . . 0.0 110.041 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -83.82 -49.83 8.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.329 -0.857 . . . . 0.0 111.411 -178.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.781 HG23 HD12 ' A' ' 92' ' ' LEU . 1.2 m -87.06 -4.72 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.775 -1.203 . . . . 0.0 110.504 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.66 HG23 ' CE1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -77.41 -44.17 30.08 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.811 -1.181 . . . . 0.0 108.508 178.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.438 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -51.46 -52.72 57.18 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.634 -1.291 . . . . 0.0 110.334 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.605 ' HB2' HG13 ' A' ' 111' ' ' VAL . 27.2 Cg_endo -74.04 -17.63 22.0 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 N-CA-C 109.847 -0.866 . . . . 0.0 109.847 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 1.041 ' O ' HG23 ' A' ' 96' ' ' VAL . 12.7 mt -86.84 -42.49 13.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 108.956 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.66 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.4 m-30 -69.88 -46.73 64.84 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.877 -1.139 . . . . 0.0 108.472 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 1.0 OUTLIER -72.77 -27.75 62.19 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.194 -0.941 . . . . 0.0 108.975 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -70.1 -29.09 70.81 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 1.041 HG23 ' O ' ' A' ' 92' ' ' LEU . 1.6 t -103.8 1.38 10.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.194 -1.18 . . . . 0.0 108.917 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.618 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER -107.54 10.75 29.19 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.975 -1.078 . . . . 0.0 110.763 -179.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -178.62 -51.82 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.576 -1.327 . . . . 0.0 110.423 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 68.6 p -59.79 -40.84 89.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.48 -1.388 . . . . 0.0 109.507 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.48 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER 67.49 9.9 7.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.372 -0.83 . . . . 0.0 109.783 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 t -81.15 -7.85 59.64 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.827 0.822 . . . . 0.0 109.044 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.464 HG23 ' OD1' ' A' ' 107' ' ' ASP . 8.8 mm -85.4 80.74 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.48 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -145.05 34.51 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.39 -0.819 . . . . 0.0 109.699 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 107' ' ' ASP . 83.4 p -164.96 136.28 4.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.893 -1.13 . . . . 0.0 110.269 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.881 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.22 -38.65 27.13 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 t -56.75 -32.5 65.65 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -70.0 -53.39 17.88 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.881 HD12 ' HA ' ' A' ' 105' ' ' ALA . 25.5 mt -45.68 -28.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.173 -0.955 . . . . 0.0 108.771 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -46.34 31.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 109.565 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 1.2 p30 -53.14 -41.8 65.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 109.606 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.835 HG11 ' HG ' ' A' ' 92' ' ' LEU . 13.6 t -71.49 -38.39 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.96 -1.088 . . . . 0.0 109.51 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.522 ' HE1' HG21 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -65.79 -54.71 23.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.3 mt -61.67 -24.02 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.131 -0.981 . . . . 0.0 109.709 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -72.4 -16.64 61.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.155 -0.966 . . . . 0.0 109.45 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.434 ' HB2' HG12 ' A' ' 88' ' ' VAL . . . -94.6 8.08 43.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 109.77 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.44 -3.3 79.0 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.836 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.4 mp -85.54 60.73 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -1.129 . . . . 0.0 109.114 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -37.28 157.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.828 -1.17 . . . . 0.0 110.239 -179.456 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.42 -23.57 64.78 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.47 -52.01 63.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.982 -1.305 . . . . 0.0 109.337 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -75.5 -36.82 60.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.934 . . . . 0.0 109.331 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 1.025 ' CE2' HG11 ' A' ' 78' ' ' VAL . 3.2 t80 -62.78 -48.51 78.84 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.247 -0.908 . . . . 0.0 109.005 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -62.12 -36.88 83.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 108.75 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.466 ' O ' ' OG ' ' A' ' 128' ' ' SER . . . -63.24 -49.76 72.88 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 108.92 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.528 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -52.54 -50.72 62.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.002 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.465 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 3.1 t90 -60.18 -55.53 32.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -52.66 -16.47 0.96 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.547 -0.721 . . . . 0.0 110.015 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 124' ' ' ALA . 0.9 OUTLIER -73.54 176.8 5.8 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.965 -1.084 . . . . 0.0 109.383 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 133' ' ' SER . 60.4 m-85 -91.94 -37.94 12.57 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.63 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.9 t -65.21 -47.14 88.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 118.056 -1.458 . . . . 0.0 109.266 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.812 HG22 ' CB ' ' A' ' 81' ' ' ALA . 3.7 t -64.03 -39.44 85.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.057 -1.027 . . . . 0.0 108.344 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -71.19 -27.63 63.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.835 . . . . 0.0 108.915 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -66.42 -41.82 88.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.151 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.45 -18.17 55.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 108.699 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.683 HG23 ' HB1' ' A' ' 77' ' ' ALA . 3.9 t -75.54 -40.36 41.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -71.81 -39.69 69.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -30.3 70.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.09 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.517 ' HG3' ' CD1' ' A' ' 59' ' ' TYR . 2.8 tt0 -71.17 -64.71 0.86 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.33 -0.857 . . . . 0.0 109.075 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 0.6 OUTLIER -50.09 -33.43 18.6 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 108.475 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 26.4 mttt -76.71 -29.91 56.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -57.27 -53.99 51.82 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.309 -0.87 . . . . 0.0 108.763 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -72.03 -40.53 68.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.366 -0.834 . . . . 0.0 110.495 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.55 -16.93 61.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.991 -1.068 . . . . 0.0 109.939 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.534 ' HB3' HG21 ' A' ' 16' ' ' VAL . 2.4 m-20 -84.71 -43.21 14.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 108.553 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.562 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 4.5 m -93.42 -12.09 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 1.0 OUTLIER 82.33 -43.79 0.14 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.65 -0.657 . . . . 0.0 109.513 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 1.043 HD22 HG11 ' A' ' 61' ' ' VAL . 33.7 tp 62.9 139.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.426 -0.797 . . . . 0.0 109.939 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.501 ' O ' ' CD ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -161.22 38.73 0.14 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.764 -1.21 . . . . 0.0 109.563 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 160.42 109.93 0.26 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.438 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.37 140.59 21.76 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.35 -1.088 . . . . 0.0 108.743 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.76 150.87 87.65 Favored 'Cis proline' 0 C--N 1.313 -1.312 0 C-N-CA 123.993 -1.253 . . . . 0.0 110.396 0.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -123.63 160.19 27.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.442 -1.411 . . . . 0.0 109.051 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.6 OUTLIER -144.7 129.11 17.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.074 -1.016 . . . . 0.0 109.871 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 8.9 m-85 -131.64 134.18 45.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.372 -0.83 . . . . 0.0 109.993 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 21' ' ' GLN . 53.7 t -105.56 133.16 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.912 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.599 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.7 OUTLIER 45.5 22.21 0.09 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.201 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.594 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 56.92 57.56 19.08 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -168.88 -34.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.234 -1.156 . . . . 0.0 108.454 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.468 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 51.6 m-85 -117.89 125.09 49.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.815 . . . . 0.0 108.971 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.728 ' HB3' HD11 ' A' ' 12' ' ' LEU . 20.9 pt20 -123.74 130.5 52.73 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.78 -1.2 . . . . 0.0 109.82 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.8 OUTLIER -73.14 172.75 10.5 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.517 ' ND2' ' HA2' ' A' ' 6' ' ' GLY . 5.6 p30 -151.95 147.12 19.37 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.089 -1.007 . . . . 0.0 109.482 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.309 -1.546 0 C-N-CA 122.672 2.248 . . . . 0.0 110.776 179.871 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.469 ' O ' HG23 ' A' ' 175' ' ' VAL . 4.3 mtt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.778 0.799 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -75.32 -62.42 1.57 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.7 t -55.86 -26.82 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.248 -0.908 . . . . 0.0 108.601 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 174' ' ' PHE . 7.0 m-30 -69.26 -38.13 78.25 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.195 -0.941 . . . . 0.0 108.962 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 171' ' ' MET . 77.6 t -73.78 -24.97 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.229 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -83.14 -60.4 2.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.301 -0.874 . . . . 0.0 109.226 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -37.86 61.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.167 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' ' 174' ' ' PHE . 16.5 t80 -69.58 -44.4 70.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.342 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -65.31 -29.06 69.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 109.076 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.19 -37.95 60.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.1 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.647 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -64.05 -44.27 92.97 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.23 -0.919 . . . . 0.0 108.948 179.404 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.488 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 55.7 t -69.77 -38.62 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.176 -0.953 . . . . 0.0 109.186 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -55.13 38.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.126 -0.984 . . . . 0.0 109.385 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -75.92 -26.4 56.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.219 -0.926 . . . . 0.0 109.146 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.647 HD23 ' O ' ' A' ' 181' ' ' THR . 0.3 OUTLIER -64.63 -18.86 65.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.965 -1.085 . . . . 0.0 109.267 -179.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 59.6 p -80.15 0.39 32.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 0.0 108.519 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.447 -0.783 . . . . 0.0 109.264 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 5' ' ' ASP . 5.4 mt-10 -99.65 54.87 0.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.81 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 4' ' ' GLU . 4.2 p-10 39.86 80.08 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.284 0.564 . . . . 0.0 110.036 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 127.81 -26.4 4.83 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.662 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -80.98 -68.53 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.844 -1.386 . . . . 0.0 109.289 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 11.9 mp0 -93.52 4.36 54.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 0.0 109.427 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 3.4 p90 179.1 131.68 0.08 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.169 -0.957 . . . . 0.0 109.35 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.513 HG23 ' HG3' ' A' ' 160' ' ' GLN . 8.7 t -119.65 175.83 5.67 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.661 -0.649 . . . . 0.0 109.26 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.59 157.59 15.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.686 -0.634 . . . . 0.0 109.617 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.475 ' HG ' ' HG2' ' A' ' 160' ' ' GLN . 7.4 mt -96.16 158.19 15.55 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.355 -0.84 . . . . 0.0 109.445 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -84.02 -12.06 55.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.096 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -151.82 104.74 2.85 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.1 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.36 166.87 26.78 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.449 2.099 . . . . 0.0 110.679 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.706 HG21 ' OD1' ' A' ' 144' ' ' ASP . 10.2 t -132.14 89.87 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.852 . . . . 0.0 109.649 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.24 131.14 8.02 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 92.49 -19.7 48.92 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.739 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -40.29 163.24 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.563 -0.963 . . . . 0.0 109.917 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.633 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 35.0 Cg_endo -77.41 125.81 7.94 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.61 2.207 . . . . 0.0 111.047 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.593 ' O ' HG13 ' A' ' 155' ' ' VAL . 5.3 mm100 -40.07 -24.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.523 -0.736 . . . . 0.0 110.012 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.789 ' O ' HG12 ' A' ' 22' ' ' VAL . 2.7 t -146.1 81.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.168 -0.958 . . . . 0.0 108.772 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.753 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -75.34 124.97 28.04 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.515 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -107.95 133.92 51.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.083 -1.011 . . . . 0.0 110.234 -179.027 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.071 ' CE2' HG21 ' A' ' 145' ' ' VAL . 7.5 m-85 -123.55 100.74 6.95 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -150.76 140.29 21.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.048 -1.033 . . . . 0.0 110.458 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.53 ' HB3' HG22 ' A' ' 61' ' ' VAL . 1.3 p -115.15 177.44 4.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.345 -0.847 . . . . 0.0 109.123 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.695 ' CD2' HD21 ' A' ' 72' ' ' LEU . 8.4 m-30 -94.04 41.73 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.958 ' CE2' HD12 ' A' ' 72' ' ' LEU . 9.9 m-85 -130.96 14.52 5.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.351 -0.843 . . . . 0.0 110.175 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.6 OUTLIER -110.5 158.46 35.36 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.706 -1.246 . . . . 0.0 109.554 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.505 ' HG2' ' CD2' ' A' ' 32' ' ' HIS . 33.8 Cg_endo -75.05 -38.38 1.59 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.189 1.926 . . . . 0.0 108.037 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.505 ' CD2' ' HG2' ' A' ' 31' ' ' PRO . 27.1 m-70 -76.06 -21.13 57.1 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 52.1 t -47.49 -65.1 0.62 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.574 ' HB2' ' CG ' ' A' ' 97' ' ' GLN . 7.3 t80 -60.66 -43.01 98.15 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.221 0.534 . . . . 0.0 110.037 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 32' ' ' HIS . 1.8 mt-30 -60.92 -22.98 64.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.194 -0.941 . . . . 0.0 109.976 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -82.9 -36.85 24.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.369 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.524 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -106.29 47.99 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.959 -1.088 . . . . 0.0 109.938 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -171.62 -52.23 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.223 -0.923 . . . . 0.0 111.902 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.0 t -89.28 -83.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.463 -1.398 . . . . 0.0 112.204 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.72 -10.48 59.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.973 -1.079 . . . . 0.0 110.765 -177.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 55.66 33.7 21.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 109.36 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.6 mm -48.58 -22.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 109.913 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.433 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.6 OUTLIER -82.97 -41.57 18.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.2 -0.937 . . . . 0.0 110.341 -179.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -86.15 -38.32 17.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.063 -1.023 . . . . 0.0 110.149 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.67 -33.79 4.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 109.907 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 43' ' ' SER . 32.1 m -80.19 -26.52 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.013 -1.055 . . . . 0.0 110.338 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.909 ' HA ' HD12 ' A' ' 50' ' ' LEU . 2.1 mmtp -63.07 -40.78 98.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.898 -1.126 . . . . 0.0 109.737 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.04 -27.75 6.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.16 -0.963 . . . . 0.0 109.23 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 11.5 mttt -117.1 40.46 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.909 HD12 ' HA ' ' A' ' 47' ' ' LYS . 11.4 mt -113.27 88.62 12.98 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.652 ' HD2' HG21 ' A' ' 54' ' ' VAL . 35.8 Cg_endo -77.67 143.09 21.01 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.76 2.307 . . . . 0.0 110.528 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 51' ' ' PRO . 1.6 tm-20 -40.14 121.6 1.37 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 122.361 1.077 . . . . 0.0 109.562 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.95 -30.92 3.44 Favored Glycine 0 C--N 1.286 -2.2 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.652 HG21 ' HD2' ' A' ' 51' ' ' PRO . 2.6 t -86.35 82.91 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -1.065 . . . . 0.0 108.536 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.47 96.76 0.39 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.425 -0.797 . . . . 0.0 110.172 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.482 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -90.68 94.22 9.59 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 31.5 m -94.66 135.39 36.19 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.916 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.515 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -115.25 115.03 26.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.313 -0.867 . . . . 0.0 109.714 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.5 ' OH ' ' CG ' ' A' ' 137' ' ' GLN . 2.2 m-85 -112.58 166.46 11.31 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.071 -1.018 . . . . 0.0 111.631 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.949 ' CE1' HD22 ' A' ' 72' ' ' LEU . 2.1 t60 -108.86 125.66 52.22 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.734 0.778 . . . . 0.0 109.816 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.781 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.9 m -73.28 157.22 6.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.732 -0.605 . . . . 0.0 109.907 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -121.99 28.21 7.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.324 -0.86 . . . . 0.0 109.131 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.596 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 11.6 p90 -121.22 67.61 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 110.052 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.592 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -160.12 -59.1 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.396 -0.815 . . . . 0.0 109.222 178.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.592 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -96.21 78.03 0.76 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 178.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.67 -40.92 0.51 Allowed Glycine 0 N--CA 1.492 2.423 0 O-C-N 121.552 -0.969 . . . . 0.0 110.925 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.4 -79.23 0.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.909 -1.348 . . . . 0.0 110.64 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.919 HD23 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -80.13 -20.78 44.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.0 -1.062 . . . . 0.0 110.219 -179.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.627 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -51.95 -47.1 54.8 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -46.55 88.25 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.469 -1.018 . . . . 0.0 108.316 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.558 ' HB3' HD12 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -62.27 -26.04 68.18 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.958 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.9 OUTLIER -63.54 -37.4 87.16 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.428 HG21 ' OE1' ' A' ' 138' ' ' GLN . 5.9 m -65.01 -42.43 94.46 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.559 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 37.7 tt0 -61.59 -19.28 62.02 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -67.82 -43.0 80.65 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 22.8 t-105 -63.69 -31.95 73.28 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.846 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.479 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -79.87 -56.67 4.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 109.919 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.757 HG21 ' CE1' ' A' ' 122' ' ' TYR . 45.8 t -58.18 -27.03 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 0.0 110.015 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.593 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -82.16 -64.08 1.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.884 -1.135 . . . . 0.0 108.9 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.475 ' HB3' HD22 ' A' ' 134' ' ' LEU . 0.1 OUTLIER -46.85 -27.55 1.27 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.58 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -66.15 -49.51 67.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.48 -0.763 . . . . 0.0 109.837 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.686 ' HB2' HG13 ' A' ' 84' ' ' VAL . 7.1 mt -101.64 9.73 40.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.072 -1.017 . . . . 0.0 110.369 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.407 ' HA2' ' OE2' ' A' ' 85' ' ' GLU . . . 56.13 29.37 55.88 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.686 HG13 ' HB2' ' A' ' 82' ' ' LEU . 28.4 m -87.79 -0.08 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.34 -1.094 . . . . 0.0 110.054 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -44.74 -66.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.054 -1.029 . . . . 0.0 109.396 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -42.85 -33.67 0.81 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 110.082 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -79.48 -53.96 6.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.349 -0.844 . . . . 0.0 111.106 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.803 HG23 HD12 ' A' ' 92' ' ' LEU . 2.1 m -89.02 -10.45 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.719 -1.238 . . . . 0.0 111.226 -178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.881 HG23 ' CD1' ' A' ' 93' ' ' PHE . 1.1 m -72.98 -42.9 62.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.57 -1.331 . . . . 0.0 108.795 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.402 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -58.1 -53.26 67.79 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.489 -1.382 . . . . 0.0 111.116 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.446 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 24.8 Cg_endo -72.66 -23.51 19.51 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 N-CA-C 110.087 -0.774 . . . . 0.0 110.087 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.838 ' HG ' HG11 ' A' ' 111' ' ' VAL . 79.4 mt -85.14 -42.99 14.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 108.862 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.881 ' CD1' HG23 ' A' ' 89' ' ' THR . 3.2 m-85 -62.56 -43.5 98.67 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.083 -1.01 . . . . 0.0 108.55 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -80.85 -16.67 53.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.405 -0.81 . . . . 0.0 109.82 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA2' ' OG1' ' A' ' 99' ' ' THR . . . -77.79 -34.82 37.55 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.2 t -95.58 -24.9 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.168 -1.196 . . . . 0.0 109.146 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.574 ' CG ' ' HB2' ' A' ' 34' ' ' TYR . 4.4 mp0 -102.38 5.07 39.57 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.016 -1.052 . . . . 0.0 110.622 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.803 ' O ' HG23 ' A' ' 99' ' ' THR . 0.3 OUTLIER -161.58 61.96 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.653 -1.28 . . . . 0.0 109.625 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 165.44 -50.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.492 -0.755 . . . . 0.0 109.358 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 75.23 19.62 2.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.382 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.3 p -90.0 -6.89 55.14 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.658 0.742 . . . . 0.0 109.706 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.756 HG23 ' OD1' ' A' ' 107' ' ' ASP . 9.5 mm -84.77 81.57 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 121.568 -0.708 . . . . 0.0 109.574 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -135.32 36.88 2.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.052 -179.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 107' ' ' ASP . 83.6 p -166.01 132.2 2.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.854 -1.154 . . . . 0.0 110.499 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.57 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -50.79 -27.83 8.07 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -32.04 73.49 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.756 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.5 OUTLIER -70.76 -50.77 32.46 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.063 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.919 HD11 HD23 ' A' ' 68' ' ' LEU . 32.2 mt -54.25 -27.6 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 108.598 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -76.25 -32.49 58.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.499 -0.75 . . . . 0.0 109.13 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.462 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 2.8 m-20 -65.65 -45.17 84.01 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.318 -0.864 . . . . 0.0 109.32 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.838 HG11 ' HG ' ' A' ' 92' ' ' LEU . 2.4 t -68.32 -40.72 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.0 -1.063 . . . . 0.0 109.015 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.578 ' CZ ' ' HB ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -55.86 -54.34 45.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 109.149 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mt -62.38 -23.05 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 110' ' ' ASP . 11.0 m-80 -72.21 -16.28 61.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.93 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -96.67 14.87 23.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.445 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.435 ' C ' HD12 ' A' ' 117' ' ' ILE . . . 83.12 9.28 84.34 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.93 HD13 ' HB3' ' A' ' 115' ' ' ALA . 1.8 mp -92.02 56.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -1.102 . . . . 0.0 109.374 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 117' ' ' ILE . 16.6 mttp -36.84 149.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.071 -1.018 . . . . 0.0 110.037 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 123' ' ' ASP . . . -50.71 -37.3 34.13 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.04 -52.32 58.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -1.181 . . . . 0.0 109.637 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -66.05 -60.94 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.397 -0.814 . . . . 0.0 109.843 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.757 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -50.12 -60.19 3.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 109.524 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 7.6 m-20 -44.93 -43.29 8.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.992 -1.068 . . . . 0.0 109.871 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.57 -44.9 73.46 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 109.791 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.774 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -58.71 -49.22 78.39 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 108.977 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.559 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 4.9 t-105 -57.13 -54.82 42.38 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -63.42 -14.83 54.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.657 -0.652 . . . . 0.0 110.179 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 70.2 m -71.16 -178.21 1.94 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.98 -1.075 . . . . 0.0 110.43 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.21 -34.68 14.19 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.633 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.12 -44.7 84.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.996 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.774 HG21 ' HB1' ' A' ' 125' ' ' ALA . 5.9 t -69.77 -31.97 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.863 -1.148 . . . . 0.0 108.771 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -71.59 -37.18 71.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -35.47 80.74 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.475 HD22 ' HB3' ' A' ' 80' ' ' MET . 0.0 OUTLIER -74.68 -29.41 61.21 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.479 HG23 ' HB1' ' A' ' 77' ' ' ALA . 5.7 t -73.71 -24.3 19.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.05 -54.26 6.77 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.5 ' CG ' ' OH ' ' A' ' 59' ' ' TYR . 7.0 tp-100 -59.88 -33.05 71.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.296 -0.878 . . . . 0.0 109.136 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.428 ' OE1' HG21 ' A' ' 73' ' ' THR . 12.1 tm0? -66.95 -64.83 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 108.749 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -51.33 -35.38 37.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.7 mtmm -72.2 -28.95 63.52 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.848 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -60.59 -53.08 61.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 108.795 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.468 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -75.04 -25.39 58.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 109.742 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -80.15 -27.25 39.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.106 -0.996 . . . . 0.0 110.234 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.716 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.4 p30 -82.21 -48.26 11.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.949 -1.094 . . . . 0.0 108.439 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 1.071 HG21 ' CE2' ' A' ' 25' ' ' PHE . 25.5 m -84.62 -18.54 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 9.6 tt0 82.6 -40.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.811 -0.555 . . . . 0.0 110.247 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.596 HD21 ' CG1' ' A' ' 61' ' ' VAL . 12.1 tp 66.75 144.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -159.61 28.4 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.478 -1.389 . . . . 0.0 110.887 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.39 110.89 0.55 Allowed Glycine 0 N--CA 1.49 2.233 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.109 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.781 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -84.04 145.16 45.74 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.353 -1.087 . . . . 0.0 109.147 178.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.62 150.96 84.67 Favored 'Cis proline' 0 C--N 1.315 -1.213 0 O-C-N 123.312 1.164 . . . . 0.0 110.583 0.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.814 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -129.66 134.86 47.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.403 -1.435 . . . . 0.0 109.069 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.51 ' SD ' HG13 ' A' ' 22' ' ' VAL . 5.7 tpp -131.09 124.61 31.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 109.773 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 160' ' ' GLN . 10.6 m-85 -123.86 129.94 51.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 0.0 109.922 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 21' ' ' GLN . 45.5 t -97.92 131.26 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.945 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.739 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.3 OUTLIER 46.43 21.91 0.14 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.293 179.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.55 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 55.36 57.04 20.43 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.08 -34.98 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.28 -1.129 . . . . 0.0 108.273 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -121.51 126.36 49.04 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.925 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.513 ' HG3' HG23 ' A' ' 10' ' ' THR . 16.4 pt20 -116.72 119.97 37.12 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.955 -1.091 . . . . 0.0 110.307 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.59 174.32 3.57 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -150.44 74.34 8.9 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.971 -1.081 . . . . 0.0 109.692 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 C--N 1.309 -1.514 0 C-N-CA 122.683 2.255 . . . . 0.0 110.97 -179.9 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.784 ' O ' HG23 ' A' ' 175' ' ' VAL . 19.8 mmt . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.701 0.763 . . . . 0.0 109.668 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.02 -55.98 5.48 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.707 -0.621 . . . . 0.0 109.355 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 177' ' ' GLN . 4.5 t -68.3 -29.66 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.204 -0.935 . . . . 0.0 109.189 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.558 ' CD1' ' OE1' ' A' ' 177' ' ' GLN . 26.6 m-85 -68.24 -34.8 76.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.268 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 171' ' ' MET . 64.6 t -78.36 -26.1 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.069 -1.019 . . . . 0.0 109.37 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -55.52 4.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.986 . . . . 0.0 109.272 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.558 ' OE1' ' CD1' ' A' ' 174' ' ' PHE . 7.6 pt20 -57.29 -36.35 70.95 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.16 -0.963 . . . . 0.0 108.735 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.41 ' HA ' ' OG1' ' A' ' 181' ' ' THR . 6.0 t80 -68.06 -49.72 59.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.89 . . . . 0.0 108.81 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 183' ' ' LYS . . . -58.85 -29.27 66.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 108.984 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.96 -37.82 58.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.15 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.59 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -61.45 -46.43 90.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.172 179.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.47 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 55.1 t -72.03 -36.89 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.802 -1.186 . . . . 0.0 109.295 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 179' ' ' ALA . 0.4 OUTLIER -59.93 -52.61 64.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.147 -0.97 . . . . 0.0 109.269 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.34 -29.28 53.38 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.906 . . . . 0.0 109.107 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 181' ' ' THR . 0.2 OUTLIER -62.51 -20.31 64.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.964 -1.085 . . . . 0.0 108.977 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.497 ' HB3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -69.63 -22.87 63.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.853 -1.154 . . . . 0.0 108.083 178.265 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 N--CA 1.487 1.423 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.242 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -125.11 62.4 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.68 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.7 t0 47.11 83.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.48 -0.762 . . . . 0.0 109.498 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 131.97 -29.69 3.33 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.284 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.82 -71.31 0.46 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.02 -1.282 . . . . 0.0 108.916 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.916 ' NE2' HG23 ' A' ' 181' ' ' THR . 13.9 pt20 -100.11 6.59 44.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.086 -1.009 . . . . 0.0 109.686 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.524 ' O ' ' N ' ' A' ' 6' ' ' GLY . 1.4 p90 177.53 130.72 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 0.0 109.466 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 160' ' ' GLN . 5.7 t -111.36 179.78 3.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -96.37 157.09 16.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.69 . . . . 0.0 109.796 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HA ' ' OE1' ' A' ' 160' ' ' GLN . 2.6 mt -91.5 145.24 24.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.434 -0.791 . . . . 0.0 109.75 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.91 -22.01 65.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.902 . . . . 0.0 108.736 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -135.08 108.15 10.48 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.539 -0.726 . . . . 0.0 109.16 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.54 157.74 36.25 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.323 2.015 . . . . 0.0 110.645 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.714 ' O ' HG12 ' A' ' 16' ' ' VAL . 7.9 t -124.03 82.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.65 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -47.79 127.28 11.59 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.707 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 99.06 -20.94 48.22 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.766 ' HB1' ' HD2' ' A' ' 20' ' ' PRO . . . -45.02 168.25 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.122 -1.223 . . . . 0.0 109.421 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.766 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 36.0 Cg_endo -79.22 136.73 12.98 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.87 2.38 . . . . 0.0 111.246 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.823 ' O ' HG22 ' A' ' 155' ' ' VAL . 5.7 mt-30 -49.17 -20.35 0.58 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.376 -0.827 . . . . 0.0 109.772 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.747 ' O ' HG12 ' A' ' 22' ' ' VAL . 3.2 t -149.49 81.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.21 -0.931 . . . . 0.0 108.602 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.713 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -77.45 126.57 31.11 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.294 -0.879 . . . . 0.0 108.786 -179.305 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -110.06 119.18 38.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.129 -0.982 . . . . 0.0 109.83 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.073 ' CE2' HG21 ' A' ' 145' ' ' VAL . 4.4 m-85 -111.52 107.48 16.68 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.522 -0.736 . . . . 0.0 109.371 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -152.39 138.81 18.53 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.326 -0.859 . . . . 0.0 108.948 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.864 ' HB2' HG22 ' A' ' 61' ' ' VAL . 1.5 t -112.83 177.07 4.76 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.091 -1.005 . . . . 0.0 109.896 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.71 ' HB2' HD11 ' A' ' 72' ' ' LEU . 7.7 m-30 -88.4 38.84 0.88 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.876 ' CE2' HD12 ' A' ' 72' ' ' LEU . 10.1 m-85 -130.69 14.19 5.39 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.315 -0.865 . . . . 0.0 110.346 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.539 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -118.15 156.69 50.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.619 -1.301 . . . . 0.0 109.78 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -74.46 -25.15 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.022 1.815 . . . . 0.0 107.667 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.563 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 24.4 p80 -84.74 -25.34 28.36 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 18.6 t -45.73 -58.69 3.27 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.49 ' CB ' ' NE2' ' A' ' 97' ' ' GLN . 45.7 t80 -75.17 -49.88 18.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.883 -0.511 . . . . 0.0 110.359 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -61.31 -21.93 64.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.168 -0.957 . . . . 0.0 110.699 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.568 ' CZ ' HG22 ' A' ' 42' ' ' ILE . 3.7 t80 -82.04 -50.97 8.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.978 -1.076 . . . . 0.0 110.24 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.403 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 33.2 tt0 -103.52 -0.14 30.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.858 -1.151 . . . . 0.0 111.553 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 34' ' ' TYR . 60.1 mm-40 -127.74 21.32 6.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.364 -1.46 . . . . 0.0 111.172 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.1 t -152.13 -85.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.656 -1.277 . . . . 0.0 110.066 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.96 -12.19 17.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 110.148 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.454 ' CD2' ' OD1' ' A' ' 44' ' ' ASP . 4.4 m170 55.48 22.83 5.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.018 . . . . 0.0 108.998 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.633 HG12 HG22 ' A' ' 175' ' ' VAL . 7.1 mt -56.81 -16.79 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.384 -0.823 . . . . 0.0 109.445 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.514 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -83.25 -48.69 10.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 0.0 110.205 -179.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.454 ' OD1' ' CD2' ' A' ' 41' ' ' HIS . 8.1 p-10 -84.29 -30.91 25.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.153 -0.967 . . . . 0.0 110.124 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -49.19 -33.76 13.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 109.73 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.514 ' CG2' ' O ' ' A' ' 43' ' ' SER . 2.8 m -69.56 -33.72 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.981 -1.075 . . . . 0.0 109.452 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.929 ' HA ' HD12 ' A' ' 50' ' ' LEU . 14.0 mttt -61.06 -28.95 69.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.379 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 3.9 tmtt? -45.91 -27.13 0.82 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.386 -0.821 . . . . 0.0 109.795 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -142.29 50.8 1.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.929 HD12 ' HA ' ' A' ' 47' ' ' LYS . 9.0 mt -99.13 134.4 21.39 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.837 -1.164 . . . . 0.0 110.119 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD2' HD23 ' A' ' 50' ' ' LEU . 35.8 Cg_endo -79.56 152.54 23.03 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.584 2.189 . . . . 0.0 109.118 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 28.2 tt0 -73.07 23.54 0.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.568 -1.333 . . . . 0.0 111.241 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.38 29.31 5.74 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 t -148.96 119.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.507 -0.996 . . . . 0.0 109.135 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -106.33 120.23 41.31 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.616 ' HE1' HD11 ' A' ' 50' ' ' LEU . 2.1 mtm -96.49 99.49 11.14 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.393 0.616 . . . . 0.0 109.574 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 24' ' ' GLU . 1.1 m -89.21 132.85 34.67 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.846 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -109.35 114.87 28.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.236 -0.915 . . . . 0.0 109.785 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 5.2 m-85 -114.41 171.65 7.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.088 -1.007 . . . . 0.0 111.15 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.864 ' NE2' HD22 ' A' ' 72' ' ' LEU . 66.8 t-80 -109.93 129.78 55.61 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.053 HG11 ' CG1' ' A' ' 150' ' ' VAL . 2.3 m -69.23 158.86 5.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.606 -0.684 . . . . 0.0 109.595 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.779 HD21 HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -124.4 33.13 5.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.318 -0.864 . . . . 0.0 109.462 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 24.8 p90 -132.24 51.38 2.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.013 -1.054 . . . . 0.0 109.986 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.5 mtt -159.17 48.43 0.32 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 154.84 57.44 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -34.07 -38.41 0.1 Allowed Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.915 -0.756 . . . . 0.0 111.408 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.63 -80.06 0.27 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.754 -1.439 . . . . 0.0 110.697 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.092 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -80.02 -25.89 40.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.864 -1.148 . . . . 0.0 109.521 -179.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 1.092 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -47.61 -53.43 12.96 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.524 ' O ' ' CE ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -56.07 -49.01 74.99 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.264 -1.139 . . . . 0.0 108.331 179.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.726 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 53.1 t0 -59.98 -30.87 69.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.876 HD12 ' CE2' ' A' ' 29' ' ' PHE . 1.1 tt -57.46 -36.92 72.06 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.779 HG21 HD21 ' A' ' 62' ' ' ASN . 40.6 m -66.09 -41.59 90.45 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.901 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.1 tt0 -59.28 -20.33 53.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 177.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -68.98 -47.51 65.42 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.419 ' NE1' ' O ' ' A' ' 58' ' ' LYS . 37.9 t-105 -55.91 -28.82 58.54 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.403 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -84.79 -69.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 109.537 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.03 HG11 ' CE2' ' A' ' 122' ' ' TYR . 3.1 t -45.27 -27.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.934 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.491 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -84.18 -62.13 1.64 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 108.987 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -46.08 -27.35 0.93 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.816 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -72.36 -41.02 66.86 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.447 -0.783 . . . . 0.0 109.63 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 84' ' ' VAL . 40.8 mt -104.87 11.83 33.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.146 -0.971 . . . . 0.0 110.135 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 49.28 32.44 14.0 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.944 HG11 HG12 ' A' ' 117' ' ' ILE . 28.1 m -96.54 19.64 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.474 -1.015 . . . . 0.0 109.77 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 86' ' ' ASP . 87.6 mt-10 -58.91 -75.18 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.937 . . . . 0.0 110.01 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.47 -34.35 0.21 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.53 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 27.7 mtpp -74.23 -54.34 7.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.858 . . . . 0.0 110.643 -178.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 84' ' ' VAL . 1.0 OUTLIER -86.54 -23.1 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.826 -1.171 . . . . 0.0 110.765 -179.099 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.746 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -67.13 -43.39 82.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.731 -1.231 . . . . 0.0 109.016 179.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.417 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.0 t -54.62 -55.23 40.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.432 -1.418 . . . . 0.0 110.523 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.47 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 24.2 Cg_endo -72.21 -18.87 26.55 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 122.77 0.879 . . . . 0.0 109.883 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.793 ' HG ' HG11 ' A' ' 111' ' ' VAL . 11.6 mt -86.49 -42.63 13.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.183 -0.948 . . . . 0.0 108.937 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.746 ' CE1' HG23 ' A' ' 89' ' ' THR . 5.2 m-30 -62.85 -48.23 79.93 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.943 -1.098 . . . . 0.0 108.802 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.38 -22.36 59.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.037 -1.039 . . . . 0.0 109.45 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.48 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -76.43 -33.04 49.5 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.7 t -101.82 1.75 10.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.006 -1.291 . . . . 0.0 109.228 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 2.0 mt-30 -91.69 -8.63 46.49 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.981 -1.074 . . . . 0.0 110.878 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.4 mtpt -167.81 -53.48 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.736 -1.227 . . . . 0.0 111.118 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 95' ' ' GLY . 80.8 p -47.93 -39.79 20.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.275 -1.516 . . . . 0.0 109.468 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 99' ' ' THR . 1.1 mt-30 67.7 11.21 8.26 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.8 t -79.44 -5.99 55.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.687 ' CB ' HG22 ' A' ' 96' ' ' VAL . 3.8 mm -91.28 80.36 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.92 27.66 2.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.181 -0.949 . . . . 0.0 109.68 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 107' ' ' ASP . 56.1 p -151.08 129.15 11.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.903 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.759 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -48.95 -39.63 27.08 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.84 -31.25 62.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 104' ' ' SER . 84.2 m-20 -78.05 -40.07 39.85 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.977 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 105' ' ' ALA . 28.4 mt -52.45 -26.29 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.556 -1.34 . . . . 0.0 107.513 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -78.05 -39.51 41.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.682 -0.636 . . . . 0.0 109.44 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -55.99 -44.36 78.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.368 -0.832 . . . . 0.0 109.445 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.793 HG11 ' HG ' ' A' ' 92' ' ' LEU . 88.0 t -74.63 -37.26 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.033 . . . . 0.0 109.089 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.737 ' CE1' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -61.25 -31.03 70.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.286 179.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.608 HG23 ' HA ' ' A' ' 118' ' ' LYS . 18.7 mt -85.47 -30.46 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -60.76 -16.53 41.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.775 -1.203 . . . . 0.0 109.35 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.53 ' HB1' ' HE3' ' A' ' 87' ' ' LYS . . . -88.06 -2.43 58.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.689 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.32 -5.22 52.05 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.944 HG12 HG11 ' A' ' 84' ' ' VAL . 1.6 mp -88.88 56.13 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -1.136 . . . . 0.0 109.292 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.608 ' HA ' HG23 ' A' ' 113' ' ' ILE . 3.2 mttp -33.01 152.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.366 -0.833 . . . . 0.0 110.832 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 122' ' ' TYR . . . -53.84 -23.93 24.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.94 -52.14 66.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.054 -1.263 . . . . 0.0 109.083 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -75.76 -35.8 60.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.89 . . . . 0.0 109.412 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 1.03 ' CE2' HG11 ' A' ' 78' ' ' VAL . 2.7 t80 -62.91 -51.21 67.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.069 -1.02 . . . . 0.0 109.166 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.69 -45.65 91.46 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 108.822 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.38 -53.91 31.76 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.36 -0.838 . . . . 0.0 108.911 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.737 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -51.85 -53.06 44.82 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.432 -0.792 . . . . 0.0 108.885 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -52.7 -58.05 8.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 108.628 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.29 -15.41 3.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.661 -0.65 . . . . 0.0 110.239 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.1 OUTLIER -69.22 179.54 1.92 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.958 -1.089 . . . . 0.0 110.17 -179.262 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER -92.79 -37.89 12.07 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.411 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.4 t -72.04 -50.05 39.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.786 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.816 HG22 ' HB1' ' A' ' 81' ' ' ALA . 3.7 t -57.44 -38.09 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.811 -1.18 . . . . 0.0 108.569 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -66.42 -35.59 80.7 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 109.068 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -26.32 68.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.05 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.7 mt -81.77 -28.27 33.35 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.288 -0.883 . . . . 0.0 108.795 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.403 HG23 ' CB ' ' A' ' 77' ' ' ALA . 11.2 t -74.91 -39.51 45.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -68.22 -40.05 82.18 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -33.82 75.32 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -0.818 . . . . 0.0 108.875 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.674 ' HG2' HG23 ' A' ' 73' ' ' THR . 0.2 OUTLIER -64.16 -70.73 0.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.247 -0.908 . . . . 0.0 109.032 179.541 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -48.15 -37.19 14.98 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 108.928 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 0.3 OUTLIER -72.48 -25.88 61.59 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.362 -0.836 . . . . 0.0 109.24 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.614 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -68.47 -55.22 12.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.398 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -73.76 -29.18 62.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 109.949 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -75.85 -25.63 56.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.059 -1.026 . . . . 0.0 109.87 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.702 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.0 OUTLIER -81.94 -48.14 11.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.011 . . . . 0.0 108.35 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 1.073 HG21 ' CE2' ' A' ' 25' ' ' PHE . 13.4 m -83.01 -12.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 81.15 -49.09 0.27 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 0.0 109.414 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.695 HD21 HG12 ' A' ' 61' ' ' VAL . 15.0 tp 61.65 132.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.452 -0.78 . . . . 0.0 109.426 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 16.7 mtt180 -161.49 38.8 0.14 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.587 -1.32 . . . . 0.0 110.302 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 164.46 108.5 0.21 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.42 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 1.053 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -97.99 144.15 27.52 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.4 -1.059 . . . . 0.0 109.335 179.031 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.563 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 36.3 Cg_endo -78.31 150.94 89.2 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 C-N-CA 124.088 -1.213 . . . . 0.0 110.54 0.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -130.95 141.18 50.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.319 -1.488 . . . . 0.0 108.702 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.548 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 2.8 ttp -144.91 134.02 22.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 0.0 110.027 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.548 ' CD1' ' C ' ' A' ' 153' ' ' MET . 0.5 OUTLIER -134.49 155.58 50.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 110.008 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.823 HG22 ' O ' ' A' ' 21' ' ' GLN . 30.8 t -112.07 130.66 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.332 -0.855 . . . . 0.0 108.958 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.538 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 51.75 23.24 1.94 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 54.97 22.71 28.75 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.537 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -125.01 -22.97 4.33 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.825 -1.397 . . . . 0.0 109.113 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.506 ' O ' ' HA ' ' A' ' 154' ' ' PHE . 12.6 m-85 -121.46 127.69 51.36 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 11.5 pt20 -123.32 118.28 27.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 161' ' ' LEU . 5.8 mt -67.3 177.12 1.97 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.44 ' O ' ' ND2' ' A' ' 162' ' ' ASN . 0.4 OUTLIER -144.1 94.83 5.73 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 120.919 -1.113 . . . . 0.0 109.799 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 C--N 1.309 -1.523 0 C-N-CA 122.787 2.325 . . . . 0.0 110.637 179.823 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 20.8 mtt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.783 0.801 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -76.74 -59.3 2.83 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.736 -0.602 . . . . 0.0 109.397 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.29 -23.27 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.235 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.503 ' O ' ' HB2' ' A' ' 178' ' ' TYR . 32.7 t80 -73.71 -39.79 64.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.139 -0.976 . . . . 0.0 109.383 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.633 HG22 HG12 ' A' ' 42' ' ' ILE . 18.6 t -73.61 -29.5 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.996 -1.065 . . . . 0.0 109.233 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -82.49 -51.98 7.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 0.0 109.481 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -24.98 67.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 174' ' ' PHE . 20.3 t80 -78.54 -47.58 17.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.218 -0.926 . . . . 0.0 109.372 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.8 -29.92 71.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.982 . . . . 0.0 109.313 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.14 -47.26 18.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.671 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.916 HG23 ' NE2' ' A' ' 8' ' ' GLN . 15.3 m -58.7 -26.82 64.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.004 . . . . 0.0 109.642 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.3 t -87.75 -41.14 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.048 -1.032 . . . . 0.0 109.049 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -57.01 -42.99 81.33 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.29 -0.882 . . . . 0.0 109.133 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.556 ' CE2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -82.09 -35.09 28.99 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.305 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.726 HD23 ' O ' ' A' ' 181' ' ' THR . 0.7 OUTLIER -57.29 -20.13 26.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.875 -1.14 . . . . 0.0 109.331 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.1 t -78.63 -0.87 31.65 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.778 -1.201 . . . . 0.0 108.503 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.423 -0.798 . . . . 0.0 109.379 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.567 ' HB3' ' CG ' ' A' ' 8' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -115.37 58.37 0.72 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.827 -1.171 . . . . 0.0 111.017 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 1.7 m-20 45.16 87.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.454 -0.779 . . . . 0.0 110.603 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.82 -35.37 1.93 Allowed Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.207 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.09 -70.31 0.69 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.11 -1.229 . . . . 0.0 108.951 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.671 ' HG2' ' CD2' ' A' ' 9' ' ' TYR . 4.7 pm0 -65.77 -27.07 68.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.29 -0.881 . . . . 0.0 108.811 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.671 ' CD2' ' HG2' ' A' ' 8' ' ' GLN . 2.2 p90 -176.18 138.73 0.34 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -103.99 -179.69 4.02 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 12' ' ' LEU . 47.4 m -103.32 160.25 14.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.547 -0.721 . . . . 0.0 110.102 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.528 HD11 ' HD2' ' A' ' 154' ' ' PHE . 0.7 OUTLIER -92.04 163.25 14.05 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.426 -0.796 . . . . 0.0 109.41 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.431 ' C ' ' HG3' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -97.73 -16.07 20.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.431 ' HG3' ' C ' ' A' ' 13' ' ' GLU . 5.3 mttt -148.71 112.36 3.65 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.7 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.82 161.08 33.73 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.447 2.098 . . . . 0.0 109.703 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.615 HG12 ' CB ' ' A' ' 19' ' ' ALA . 1.1 p -122.32 126.74 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.999 -1.063 . . . . 0.0 110.237 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -46.35 125.72 7.11 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 77.16 8.9 87.01 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 20' ' ' PRO . . . -36.25 161.73 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.685 -0.891 . . . . 0.0 111.189 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 1.086 ' HG3' HD12 ' A' ' 23' ' ' LEU . 36.5 Cg_endo -78.06 113.57 3.44 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 123.273 2.649 . . . . 0.0 111.953 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.795 ' O ' HG13 ' A' ' 155' ' ' VAL . 33.1 mt-30 -51.89 -31.12 26.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.71 HG22 HG22 ' A' ' 155' ' ' VAL . 24.2 t -157.05 81.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.086 HD12 ' HG3' ' A' ' 20' ' ' PRO . 1.3 tt -83.92 137.6 33.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.363 -0.835 . . . . 0.0 110.116 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.805 ' N ' HD23 ' A' ' 23' ' ' LEU . 31.6 mt-10 -120.52 99.38 6.52 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 1.036 ' CZ ' HD13 ' A' ' 23' ' ' LEU . 88.0 m-85 -83.5 115.3 22.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.489 -0.757 . . . . 0.0 109.434 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 0.4 OUTLIER -154.23 139.1 17.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 110.033 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.598 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 8.3 p -121.44 173.17 7.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.41 -0.806 . . . . 0.0 109.443 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.884 ' CD2' HD21 ' A' ' 72' ' ' LEU . 1.6 m-30 -85.2 43.54 1.02 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.869 . . . . 0.0 108.84 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.636 ' CG ' HG11 ' A' ' 96' ' ' VAL . 9.0 m-85 -143.11 14.19 1.86 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.909 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -105.02 160.99 24.1 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 120.84 -1.162 . . . . 0.0 109.357 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -76.03 -35.43 2.45 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.134 1.889 . . . . 0.0 108.064 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -82.26 -23.65 35.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 11.1 t -46.13 -52.91 11.31 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.47 ' HB2' ' HG2' ' A' ' 97' ' ' GLN . 85.8 t80 -80.6 -31.5 36.67 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.905 -0.497 . . . . 0.0 111.064 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.64 -27.46 31.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.841 -1.162 . . . . 0.0 111.298 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.642 ' CD1' HD12 ' A' ' 40' ' ' LEU . 2.3 m-30 -84.1 -17.31 40.61 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.873 -1.142 . . . . 0.0 110.767 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -116.64 20.99 13.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.837 -1.164 . . . . 0.0 110.637 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 16.1 mm-40 -143.36 -66.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.953 -1.092 . . . . 0.0 110.405 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 4.6 t -90.16 -69.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.141 -0.974 . . . . 0.0 110.465 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.642 HD12 ' CD1' ' A' ' 36' ' ' PHE . 94.6 mt -47.81 -20.97 0.34 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.286 -0.884 . . . . 0.0 110.759 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 28.7 p-80 40.97 34.38 0.28 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 109.429 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.415 HG13 ' HB3' ' A' ' 40' ' ' LEU . 20.8 mt -76.01 -26.17 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.48 -0.762 . . . . 0.0 109.754 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.764 ' O ' HG12 ' A' ' 46' ' ' VAL . 14.1 m -78.18 -33.05 50.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.108 -0.995 . . . . 0.0 110.148 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -84.12 -47.42 10.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.034 -1.041 . . . . 0.0 109.829 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -57.27 -37.79 72.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 43' ' ' SER . 14.5 p -55.4 -28.23 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.179 -0.951 . . . . 0.0 109.644 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.619 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -70.13 -30.74 68.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.404 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.52 -38.6 69.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.474 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -92.15 18.53 8.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 109.468 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.754 HD13 ' HG2' ' A' ' 56' ' ' MET . 12.1 mt -105.18 102.6 37.45 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.869 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.541 ' O ' ' N ' ' A' ' 53' ' ' GLY . 32.6 Cg_endo -75.49 151.55 37.5 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.343 2.028 . . . . 0.0 108.96 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -65.55 52.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.804 -1.185 . . . . 0.0 110.981 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.835 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -144.3 37.82 1.36 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.87 HG21 ' HB2' ' A' ' 186' ' ' SER . 13.3 t -166.91 149.87 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -113.36 115.74 28.58 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.34 -0.85 . . . . 0.0 110.36 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.754 ' HG2' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -100.93 105.07 16.28 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.107 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -96.01 141.14 29.77 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.07 -178.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.422 ' CD ' ' N ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -117.94 105.02 11.47 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.225 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.517 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 4.4 m-85 -113.5 175.33 5.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.106 -0.996 . . . . 0.0 110.926 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 1.169 ' CD2' HD22 ' A' ' 72' ' ' LEU . 9.8 t-80 -125.44 123.9 40.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.553 -0.717 . . . . 0.0 109.648 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.907 HG11 HD22 ' A' ' 147' ' ' LEU . 35.6 m -91.86 153.75 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.433 -0.792 . . . . 0.0 109.952 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 1.9 p-10 -110.24 54.61 0.66 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.173 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.72 ' CE1' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -134.61 56.04 1.87 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.087 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.719 ' HE1' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -122.08 32.16 5.92 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.458 -0.777 . . . . 0.0 109.53 179.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.31 40.88 23.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . -148.08 80.71 0.21 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 66' ' ' GLY . 5.3 t0 -26.78 -45.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.449 -0.442 . . . . 0.0 111.209 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.94 HD22 HG22 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -46.02 -30.37 1.81 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.357 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.719 ' HA2' ' HE1' ' A' ' 64' ' ' MET . . . -48.03 -55.97 9.5 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 2.2 ttmt -49.81 -46.39 51.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.278 . . . . 0.0 108.604 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.4 -18.25 60.69 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.031 -1.043 . . . . 0.0 108.368 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.169 HD22 ' CD2' ' A' ' 60' ' ' HIS . 2.3 tt -76.1 -37.38 58.18 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.421 ' CG2' ' OE1' ' A' ' 138' ' ' GLN . 1.6 m -65.62 -41.45 92.67 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 177.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.492 ' NE2' ' HB2' ' A' ' 126' ' ' TRP . 15.3 tp60 -63.17 -23.63 67.52 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -70.49 -39.13 74.36 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.443 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.573 ' CH2' ' OE1' ' A' ' 85' ' ' GLU . 37.6 t-105 -66.09 -30.03 70.47 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.821 . . . . 0.0 108.932 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.576 ' HB2' HE22 ' A' ' 138' ' ' GLN . . . -83.39 -59.96 2.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.138 HG11 ' CD2' ' A' ' 122' ' ' TYR . 92.2 t -57.55 -26.65 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 109.665 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.71 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -79.46 -65.57 0.98 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.073 -1.017 . . . . 0.0 108.745 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -47.03 -26.25 1.0 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.103 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.865 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -74.89 -38.95 61.74 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.448 -0.783 . . . . 0.0 109.28 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 79' ' ' ALA . 85.9 mt -106.33 10.48 31.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.202 -0.936 . . . . 0.0 110.715 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 54.77 19.52 14.58 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.949 HG21 ' CE1' ' A' ' 112' ' ' PHE . 31.6 m -84.44 -6.29 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.284 -1.127 . . . . 0.0 110.318 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.573 ' OE1' ' CH2' ' A' ' 76' ' ' TRP . 3.1 mt-10 -42.22 -71.56 0.08 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.155 -0.966 . . . . 0.0 110.052 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -39.33 -34.26 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.378 -0.827 . . . . 0.0 110.622 -179.591 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.535 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 27.5 mtpp -81.66 -49.87 9.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.284 -0.885 . . . . 0.0 111.189 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.826 HG23 HD12 ' A' ' 92' ' ' LEU . 1.4 m -86.54 -14.26 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.882 -1.136 . . . . 0.0 110.681 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.755 HG23 ' CD1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -74.3 -42.51 59.41 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.698 -1.251 . . . . 0.0 108.349 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.408 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -55.75 -54.05 56.08 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.723 -1.236 . . . . 0.0 110.875 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.489 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 27.1 Cg_endo -72.4 -19.46 25.21 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 N-CA-C 109.881 -0.854 . . . . 0.0 109.881 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.826 HD12 HG23 ' A' ' 88' ' ' VAL . 35.5 mt -87.19 -43.56 12.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.127 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.755 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.1 m-30 -63.59 -44.02 95.23 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.037 -1.039 . . . . 0.0 108.697 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.52 -19.59 57.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 109.426 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.456 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -69.85 -40.51 74.87 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.636 HG11 ' CG ' ' A' ' 29' ' ' PHE . 1.6 t -92.79 -15.71 7.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 O-C-N 121.102 -1.234 . . . . 0.0 108.734 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.47 ' HG2' ' HB2' ' A' ' 34' ' ' TYR . 2.9 mp0 -113.02 10.75 18.85 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.933 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.786 ' O ' HG23 ' A' ' 99' ' ' THR . 0.8 OUTLIER -159.01 51.47 0.38 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.392 -1.442 . . . . 0.0 109.851 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 166.88 -49.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.405 -0.81 . . . . 0.0 109.898 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.8 OUTLIER 75.7 16.29 2.5 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.14 -0.975 . . . . 0.0 110.494 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.7 t -85.7 -4.05 59.06 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.829 0.823 . . . . 0.0 108.861 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.94 HG22 HD22 ' A' ' 68' ' ' LEU . 6.6 mm -82.67 71.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.766 -0.584 . . . . 0.0 109.543 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.501 ' C ' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -116.83 -11.36 10.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.174 -0.954 . . . . 0.0 109.995 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.678 ' N ' HD21 ' A' ' 68' ' ' LEU . 1.5 p -110.67 117.21 32.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 109.77 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . . . -48.31 -39.01 20.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.59 -33.31 54.45 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 108' ' ' ILE . 1.2 p30 -68.64 -41.45 79.39 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.752 -1.179 . . . . 0.0 108.644 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.556 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 3.1 mt -48.57 -44.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.612 -1.305 . . . . 0.0 107.666 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -48.49 79.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.576 -0.703 . . . . 0.0 109.686 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 114' ' ' ASN . 1.1 m-20 -51.65 -42.85 62.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.814 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.724 HG11 ' HG ' ' A' ' 92' ' ' LEU . 3.2 t -64.83 -40.13 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.134 -0.979 . . . . 0.0 109.767 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.949 ' CE1' HG21 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -56.77 -50.89 70.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.018 -1.051 . . . . 0.0 109.552 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.8 mt -70.67 -22.74 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 109.597 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 110' ' ' ASP . 2.8 m120 -64.86 -15.91 62.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.801 ' HB2' HG12 ' A' ' 88' ' ' VAL . . . -73.37 -6.0 43.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 108.992 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.561 ' C ' HD13 ' A' ' 117' ' ' ILE . . . 97.03 15.16 39.94 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.684 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.6 mm -95.62 168.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -1.196 . . . . 0.0 108.957 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -89.24 139.55 30.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.331 -1.481 . . . . 0.0 109.7 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.75 -50.42 67.77 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -57.99 -44.47 87.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.138 -1.213 . . . . 0.0 109.016 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -55.3 -44.34 75.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 108.852 179.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 1.138 ' CD2' HG11 ' A' ' 78' ' ' VAL . 2.3 t80 -55.13 -46.98 75.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.862 . . . . 0.0 108.845 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -56.6 -38.9 72.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 108.708 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.22 71.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.385 -0.822 . . . . 0.0 108.828 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.51 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -49.16 -50.47 37.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.268 -0.895 . . . . 0.0 108.605 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.492 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 12.8 t90 -58.32 -56.12 26.22 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -55.34 -15.91 2.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.583 -0.698 . . . . 0.0 109.923 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -71.23 166.62 21.15 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.972 -1.08 . . . . 0.0 109.45 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -86.77 -40.66 14.78 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.264 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.09 -45.08 97.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 C-N-CA 118.062 -1.455 . . . . 0.0 109.316 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.865 HG22 ' HB1' ' A' ' 81' ' ' ALA . 2.5 t -64.6 -41.23 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.001 -1.062 . . . . 0.0 108.413 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -37.29 86.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.365 -0.834 . . . . 0.0 108.992 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.0 m -62.53 -30.76 71.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 108.908 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.72 -21.98 43.91 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.435 ' HA ' ' OE1' ' A' ' 138' ' ' GLN . 4.9 t -77.05 -46.38 29.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 139' ' ' GLU . . . -64.04 -42.83 96.92 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.479 ' HG2' ' OH ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -62.97 -32.37 73.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.404 -0.81 . . . . 0.0 109.036 179.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.576 HE22 ' HB2' ' A' ' 77' ' ' ALA . 48.0 mt-30 -65.03 -62.84 1.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 108.92 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 136' ' ' ALA . 6.8 pt-20 -54.51 -42.42 70.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 108.838 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 29.1 mttt -67.49 -27.19 66.8 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.375 -0.828 . . . . 0.0 109.151 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 23' ' ' LEU . . . -63.42 -49.07 75.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.024 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.512 ' HB2' HG12 ' A' ' 61' ' ' VAL . . . -73.21 -41.39 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.837 . . . . 0.0 110.148 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.18 -16.74 60.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.158 -0.964 . . . . 0.0 109.862 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.607 ' CG ' HG21 ' A' ' 16' ' ' VAL . 22.8 m-20 -82.9 -44.21 15.64 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.738 HG21 ' CE1' ' A' ' 25' ' ' PHE . 3.8 m -91.17 -5.38 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 147' ' ' LEU . 0.0 OUTLIER 81.86 -46.75 0.2 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.595 -0.691 . . . . 0.0 109.804 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.907 HD22 HG11 ' A' ' 61' ' ' VAL . 13.0 tp 73.12 141.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.66 -0.65 . . . . 0.0 109.72 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.39 25.77 0.16 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.771 -1.206 . . . . 0.0 110.315 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.03 112.2 0.62 Allowed Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.108 -1.52 . . . . 0.0 111.081 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.479 HG22 ' CZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -90.48 140.31 26.81 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.503 -0.998 . . . . 0.0 108.962 178.158 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.25 152.2 95.95 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 123.785 -1.339 . . . . 0.0 110.816 0.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -128.22 159.97 33.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.393 -1.442 . . . . 0.0 109.233 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.524 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 3.0 ttm -142.02 121.82 13.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.101 -0.999 . . . . 0.0 109.88 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 160' ' ' GLN . 23.5 m-85 -122.89 145.77 48.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.139 -0.975 . . . . 0.0 109.644 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.795 HG13 ' O ' ' A' ' 21' ' ' GLN . 36.9 t -124.66 122.31 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.145 -0.972 . . . . 0.0 108.957 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER 50.95 24.99 2.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.804 -0.758 . . . . 0.0 108.989 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.502 ' C ' HD13 ' A' ' 12' ' ' LEU . . . 51.3 20.84 5.38 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.466 -1.349 . . . . 0.0 110.325 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -121.83 -19.92 6.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.819 -1.4 . . . . 0.0 108.867 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.456 ' O ' ' N ' ' A' ' 155' ' ' VAL . 19.6 m-85 -141.7 123.83 15.52 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.318 -0.864 . . . . 0.0 108.945 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.59 ' HB2' ' CD2' ' A' ' 154' ' ' PHE . 1.3 tt0 -130.29 126.56 37.54 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.279 -0.888 . . . . 0.0 109.389 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.56 HD22 ' HB3' ' A' ' 9' ' ' TYR . 8.1 mt -59.46 179.26 0.12 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 162' ' ' ASN . 12.8 p-10 -153.22 107.67 2.62 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.071 -1.018 . . . . 0.0 109.777 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 C--N 1.309 -1.513 0 C-N-CA 122.306 2.004 . . . . 0.0 110.2 179.472 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 6.2 mtt . . . . . 0 N--CA 1.489 1.495 0 CA-C-O 121.705 0.764 . . . . 0.0 109.882 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.75 -49.22 78.58 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 121.577 -0.702 . . . . 0.0 109.686 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 12.5 t -69.57 -29.14 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 109.854 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.485 ' O ' ' HB3' ' A' ' 178' ' ' TYR . 4.6 t80 -65.59 -36.62 84.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.015 -1.053 . . . . 0.0 109.466 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 93.3 t -81.2 -24.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.05 -1.031 . . . . 0.0 109.772 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -53.48 6.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.025 -1.047 . . . . 0.0 109.402 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.91 -33.39 75.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.106 -0.996 . . . . 0.0 109.356 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 174' ' ' PHE . 2.5 t80 -70.13 -57.18 5.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 109.093 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.79 -29.92 69.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.341 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -73.27 -41.71 63.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.933 . . . . 0.0 109.387 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.564 ' CG2' ' CG ' ' A' ' 8' ' ' GLN . 1.0 OUTLIER -62.37 -60.01 4.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.163 -0.961 . . . . 0.0 109.283 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.434 HG21 ' CE1' ' A' ' 178' ' ' TYR . 61.3 t -53.75 -32.68 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.06 -1.025 . . . . 0.0 109.198 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -47.08 86.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 109.446 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -85.56 -25.66 26.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.203 -0.936 . . . . 0.0 110.426 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.624 HD21 ' CE2' ' A' ' 9' ' ' TYR . 4.1 mt -67.81 -20.64 65.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.489 -1.382 . . . . 0.0 108.856 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.87 ' HB2' HG21 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -69.95 -10.65 59.32 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 O-C-N 121.55 -0.718 . . . . 0.0 109.359 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.691 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.407 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' ASP . 3.0 tt0 -86.72 52.32 2.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 0.0 110.277 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLU . 64.7 t0 39.82 81.01 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.796 -0.565 . . . . 0.0 109.906 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 119.19 -18.91 10.19 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.541 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.71 -67.32 0.77 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.902 -1.352 . . . . 0.0 108.769 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.593 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -96.4 4.0 52.49 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.21 -0.932 . . . . 0.0 109.806 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.557 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -177.31 130.8 0.16 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.913 -1.117 . . . . 0.0 109.611 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -117.79 177.05 4.91 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.813 -0.555 . . . . 0.0 109.525 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -100.17 160.22 14.49 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.374 0.607 . . . . 0.0 109.552 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.773 HD11 ' HD2' ' A' ' 154' ' ' PHE . 17.4 mt -95.69 133.96 39.16 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.315 -0.866 . . . . 0.0 109.779 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -72.63 -19.42 61.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 108.694 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -135.69 107.32 9.91 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 34.8 Cg_endo -76.08 158.34 37.98 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.412 2.075 . . . . 0.0 110.968 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 16' ' ' VAL . 46.1 t -128.72 87.43 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.418 -0.801 . . . . 0.0 109.38 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.52 133.05 13.42 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 95.82 -25.56 24.52 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.741 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -42.02 157.75 0.21 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.401 -1.058 . . . . 0.0 109.367 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.571 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 35.2 Cg_endo -78.4 135.42 13.31 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.504 2.136 . . . . 0.0 111.015 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.804 ' O ' HG13 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -44.25 -24.03 0.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.411 -0.806 . . . . 0.0 109.764 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.766 HG13 ' CE ' ' A' ' 153' ' ' MET . 42.4 t -149.83 80.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.022 -1.049 . . . . 0.0 108.896 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.877 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -72.06 124.94 26.03 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.0 OUTLIER -106.5 125.29 50.81 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.614 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.877 ' CE2' HD13 ' A' ' 23' ' ' LEU . 6.3 m-85 -115.73 110.32 18.95 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.466 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -150.79 145.36 25.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.953 . . . . 0.0 109.639 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.986 ' HB3' HG22 ' A' ' 61' ' ' VAL . 32.8 p -126.03 -163.86 1.26 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.203 -0.935 . . . . 0.0 108.83 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.67 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -118.65 55.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.152 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.673 ' CE1' HD22 ' A' ' 72' ' ' LEU . 12.2 m-85 -138.88 2.14 2.13 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.453 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.516 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -113.91 172.46 3.56 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.658 -1.276 . . . . 0.0 109.765 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 30' ' ' CYS . 32.8 Cg_endo -75.04 -49.84 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.481 2.12 . . . . 0.0 108.835 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 18.5 m80 -73.11 -25.63 60.94 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -46.85 -41.14 15.17 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.501 ' CG ' ' OE1' ' A' ' 97' ' ' GLN . 3.7 t80 -88.44 -44.13 10.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.601 -0.687 . . . . 0.0 110.171 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 46.0 mt-30 -72.43 -24.49 61.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.986 -1.071 . . . . 0.0 110.924 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 1.6 t80 -80.45 -16.76 53.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.938 -1.101 . . . . 0.0 110.388 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.51 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.6 tt0 -131.96 50.99 2.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.892 -1.13 . . . . 0.0 110.381 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.51 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -171.29 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 110.55 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 52.1 t -94.77 -53.58 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 110.575 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 35' ' ' GLN . 22.6 mt -48.86 -20.18 0.47 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.169 -0.957 . . . . 0.0 110.58 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 47.93 31.67 2.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.889 -1.132 . . . . 0.0 108.852 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.856 ' O ' HG13 ' A' ' 46' ' ' VAL . 4.3 mt -83.46 -41.84 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.53 -0.731 . . . . 0.0 109.993 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.461 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -80.0 -17.84 51.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.984 -1.073 . . . . 0.0 110.557 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 2.2 m-20 -87.3 -39.02 15.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.935 -1.103 . . . . 0.0 110.074 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -71.66 -33.76 69.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.994 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 42' ' ' ILE . 30.5 m -55.74 -35.84 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.771 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -54.38 -46.42 73.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 109.562 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -26.77 38.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.504 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 2.5 mmtm -89.27 20.61 3.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.834 . . . . 0.0 110.308 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.01 HD11 ' SD ' ' A' ' 56' ' ' MET . 35.8 mt -114.02 87.37 12.78 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.987 -1.07 . . . . 0.0 109.714 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 36.3 Cg_endo -78.19 64.36 8.38 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.599 2.199 . . . . 0.0 111.01 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER 56.85 130.74 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.638 0.732 . . . . 0.0 110.516 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.29 -21.18 31.5 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.996 HG11 HD22 ' A' ' 50' ' ' LEU . 1.2 t -91.03 87.72 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -1.048 . . . . 0.0 108.833 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -77.6 97.03 4.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.952 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 1.01 ' SD ' HD11 ' A' ' 50' ' ' LEU . 63.4 mtp -95.83 97.1 9.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.12 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -91.82 135.57 33.81 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.617 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.454 ' HG3' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -109.19 116.88 32.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.382 -0.824 . . . . 0.0 110.271 -179.419 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 3.2 m-85 -117.18 175.15 5.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.132 -0.98 . . . . 0.0 110.787 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.636 ' NE2' HD21 ' A' ' 72' ' ' LEU . 2.6 t60 -112.15 141.38 45.92 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.683 0.754 . . . . 0.0 109.203 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 1.072 HG11 ' CG1' ' A' ' 150' ' ' VAL . 3.2 m -77.09 155.71 5.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.3 0.571 . . . . 0.0 109.847 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.518 ' OD1' ' CB ' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -124.79 36.73 4.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 108.822 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.564 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 6.3 p90 -136.11 52.55 1.97 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -155.91 47.99 0.49 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 158.36 61.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -28.78 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 65' ' ' GLY . 71.2 m-20 -88.94 -78.26 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -1.125 . . . . 0.0 110.663 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.126 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -79.87 -22.36 42.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.957 -1.089 . . . . 0.0 110.51 -178.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 1.126 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -53.95 -43.75 71.8 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 1.8 tmtp? -64.86 -45.93 84.01 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.065 -1.256 . . . . 0.0 108.258 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.54 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 1.5 t70 -66.03 -31.65 72.67 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.754 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 15.5 tp -53.79 -49.66 67.81 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.514 HG23 ' CD ' ' A' ' 138' ' ' GLN . 1.3 m -57.33 -43.71 83.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 1.009 ' O ' HG23 ' A' ' 78' ' ' VAL . 2.5 tm0? -57.07 -25.26 58.4 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -64.44 -44.07 92.31 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -57.46 -33.04 67.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -79.53 -51.05 9.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.395 -0.816 . . . . 0.0 110.159 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 1.009 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.7 t -62.74 -27.41 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.068 -1.02 . . . . 0.0 109.641 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.606 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -77.95 -61.88 1.85 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.043 -1.036 . . . . 0.0 109.36 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.648 ' HB3' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -44.71 -27.29 0.48 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.227 -0.921 . . . . 0.0 108.951 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.624 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -68.71 -44.46 73.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.365 -0.834 . . . . 0.0 109.4 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.677 ' HB2' HG13 ' A' ' 84' ' ' VAL . 21.9 mt -108.49 16.29 23.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.09 29.83 4.95 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.677 HG13 ' HB2' ' A' ' 82' ' ' LEU . 34.8 m -85.73 -3.89 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -1.17 . . . . 0.0 110.066 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -45.1 -73.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.09 -1.006 . . . . 0.0 109.911 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.27 -35.12 0.23 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.598 -0.689 . . . . 0.0 110.603 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.789 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 25.7 mtpp -80.54 -52.78 7.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.943 . . . . 0.0 111.301 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.761 ' O ' HD12 ' A' ' 92' ' ' LEU . 2.6 m -84.28 -9.46 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.745 -1.222 . . . . 0.0 110.944 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.753 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -73.68 -45.37 52.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.758 -1.214 . . . . 0.0 108.455 178.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.424 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -51.93 -53.94 46.0 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.556 -1.34 . . . . 0.0 110.757 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.541 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 24.0 Cg_endo -72.96 -17.74 24.88 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 N-CA-C 109.65 -0.942 . . . . 0.0 109.65 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.848 ' HG ' HG11 ' A' ' 111' ' ' VAL . 6.4 mt -86.19 -44.4 12.22 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.753 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.2 m-30 -62.04 -47.52 84.34 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.906 -1.121 . . . . 0.0 108.674 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 97' ' ' GLN . 46.8 mt-10 -69.03 -34.81 75.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.025 -1.047 . . . . 0.0 109.554 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.457 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -64.71 -31.99 82.72 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 92' ' ' LEU . 1.9 t -107.8 8.12 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.984 -1.303 . . . . 0.0 109.568 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.501 ' OE1' ' CG ' ' A' ' 34' ' ' TYR . 11.5 mt-30 -97.75 5.75 48.79 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.915 -1.116 . . . . 0.0 110.296 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.01 -49.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.803 -1.186 . . . . 0.0 110.631 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 1.4 p -55.05 -42.05 72.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.299 -1.501 . . . . 0.0 109.544 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.6 mm-40 67.62 10.5 7.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 110.126 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.3 t -83.67 -8.29 59.31 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.744 0.783 . . . . 0.0 109.102 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.62 ' CB ' HG22 ' A' ' 96' ' ' VAL . 16.3 mm -79.55 66.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.457 ' HD3' ' C ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -127.25 31.75 5.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.585 -179.572 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 107' ' ' ASP . 16.8 p -147.94 127.77 13.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 110.146 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.48 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.56 -29.8 7.55 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 t -63.71 -34.29 77.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.597 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.7 OUTLIER -68.3 -46.41 70.37 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.556 ' CG1' HD23 ' A' ' 68' ' ' LEU . 19.0 mt -52.39 -29.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.448 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -73.24 -39.43 65.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 109.121 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 114' ' ' ASN . 14.5 m-20 -56.34 -45.4 80.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.317 -0.864 . . . . 0.0 109.406 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.848 HG11 ' HG ' ' A' ' 92' ' ' LEU . 15.4 t -70.96 -38.59 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.41 ' CE2' ' HE2' ' A' ' 122' ' ' TYR . 2.9 m-85 -65.75 -32.36 73.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.445 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 109' ' ' ARG . 16.1 mt -79.4 -25.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.025 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 110' ' ' ASP . 17.5 m-20 -70.17 -23.65 63.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.974 -1.079 . . . . 0.0 109.697 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.789 ' HB1' ' HE3' ' A' ' 87' ' ' LYS . . . -85.21 2.57 43.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . 0.551 ' C ' HD13 ' A' ' 117' ' ' ILE . . . 92.78 8.99 61.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.718 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -94.4 58.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 109.549 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 117' ' ' ILE . 56.5 mttt -37.1 154.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.228 -0.92 . . . . 0.0 110.295 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 123' ' ' ASP . . . -50.78 -27.71 13.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -67.7 -43.43 80.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -1.146 . . . . 0.0 109.369 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -46.99 19.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.536 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.895 ' CE2' HG11 ' A' ' 78' ' ' VAL . 5.8 t80 -63.52 -47.08 83.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.177 -0.952 . . . . 0.0 109.52 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 119' ' ' GLY . 30.5 t0 -61.38 -53.18 59.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.148 -0.97 . . . . 0.0 109.176 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.21 -53.67 16.17 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.623 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -48.23 -55.75 9.7 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.426 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 8.5 t90 -53.29 -59.18 4.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.14 -15.81 2.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.573 -0.705 . . . . 0.0 109.985 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 7.7 m -69.67 176.97 3.21 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.071 -1.018 . . . . 0.0 109.891 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -89.57 -39.62 13.16 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.335 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.39 -47.16 78.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.752 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.624 HG22 ' HB1' ' A' ' 81' ' ' ALA . 2.8 t -62.95 -34.54 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.904 -1.123 . . . . 0.0 108.399 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -67.33 -28.3 67.86 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 137' ' ' GLN . 1.8 m -69.93 -35.51 74.59 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.648 HD13 ' HB3' ' A' ' 80' ' ' MET . 0.2 OUTLIER -79.09 -19.08 52.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.568 HG23 ' HB1' ' A' ' 77' ' ' ALA . 10.2 t -82.25 -47.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.33 -35.59 81.36 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.41 -0.806 . . . . 0.0 108.841 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.9 OUTLIER -69.88 -37.39 76.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 109.025 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.514 ' CD ' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -65.4 -68.38 0.37 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 108.988 179.519 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.71 -36.41 11.24 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.219 -0.926 . . . . 0.0 108.586 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -71.91 -30.91 65.85 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -61.11 -59.74 4.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.361 -0.837 . . . . 0.0 108.846 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.537 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -67.47 -26.76 66.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.838 . . . . 0.0 109.508 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.72 -22.79 46.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.963 . . . . 0.0 109.884 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -82.22 -43.73 17.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.104 -0.997 . . . . 0.0 108.475 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.824 HG21 ' CE2' ' A' ' 25' ' ' PHE . 18.4 m -98.36 -5.6 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.537 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.1 tt0 75.21 -53.34 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.491 -0.756 . . . . 0.0 109.793 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.8 HD21 HG12 ' A' ' 61' ' ' VAL . 13.6 tp 69.57 135.03 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.7 ptt85 -160.18 35.7 0.17 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.457 -1.402 . . . . 0.0 110.219 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 161.93 108.56 0.23 Allowed Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.559 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 1.072 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -89.62 144.31 31.74 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.405 -1.056 . . . . 0.0 109.225 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.18 152.25 94.29 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 124.009 -1.246 . . . . 0.0 110.779 0.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -129.4 139.46 51.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.453 -1.404 . . . . 0.0 108.983 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.766 ' CE ' HG13 ' A' ' 22' ' ' VAL . 19.9 ttt -140.97 128.05 20.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.98 -1.075 . . . . 0.0 110.179 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.773 ' HD2' HD11 ' A' ' 12' ' ' LEU . 2.5 m-85 -126.28 137.12 53.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -0.918 . . . . 0.0 109.634 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' ' 21' ' ' GLN . 54.7 t -99.25 133.72 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.741 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 3.9 t30 42.45 24.47 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.16 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.532 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 56.81 59.22 11.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.484 ' N ' HD12 ' A' ' 12' ' ' LEU . 6.7 tttt -166.65 -36.23 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.439 -1.036 . . . . 0.0 108.294 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.495 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 10.7 m-85 -114.59 122.83 47.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.105 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.589 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -113.34 109.59 18.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 0.0 109.963 -179.231 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.692 HD12 ' SD ' ' A' ' 153' ' ' MET . 15.3 mt -60.25 -179.86 0.12 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.1 125.76 4.62 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.084 -1.01 . . . . 0.0 109.559 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 C--N 1.312 -1.361 0 C-N-CA 122.514 2.143 . . . . 0.0 110.688 -179.881 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . 0.409 ' O ' HG23 ' A' ' 175' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.612 0.72 . . . . 0.0 110.025 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.26 -58.93 2.98 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 109.579 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.5 t -68.48 -30.58 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.374 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 0.6 OUTLIER -69.95 -30.83 68.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.139 -0.976 . . . . 0.0 109.018 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.782 HG22 HG12 ' A' ' 42' ' ' ILE . 7.7 t -76.15 -31.74 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 108.892 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -80.82 -64.65 1.14 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.212 -0.93 . . . . 0.0 109.052 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -49.8 -40.87 43.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.864 . . . . 0.0 109.41 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 56.4 t80 -63.61 -50.74 68.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.65 -24.73 15.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.382 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.96 -51.08 10.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.645 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.742 ' O ' HD23 ' A' ' 185' ' ' LEU . 90.5 m -55.17 -27.17 43.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.116 -0.99 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 43.0 t -87.52 -35.74 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.067 -1.021 . . . . 0.0 108.672 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -43.56 81.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.418 -0.801 . . . . 0.0 108.96 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.522 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -82.01 -39.62 23.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.357 -0.84 . . . . 0.0 109.057 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.77 HD12 HG21 ' A' ' 155' ' ' VAL . 1.1 mm? -53.41 -20.67 4.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.092 . . . . 0.0 109.391 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.728 ' CB ' HG13 ' A' ' 54' ' ' VAL . 19.6 p -74.81 -8.01 55.14 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.65 -1.282 . . . . 0.0 108.352 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.411 -0.806 . . . . 0.0 109.091 179.654 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.588 ' CD1' ' OE1' ' A' ' 8' ' ' GLN . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -124.9 62.56 1.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.91 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 48.3 t0 45.23 84.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 109.403 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 136.06 -32.44 2.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -70.27 0.52 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.958 -1.319 . . . . 0.0 108.716 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.588 ' OE1' ' CD1' ' A' ' 3' ' ' TYR . 9.3 pt20 -96.65 0.09 49.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.154 -0.966 . . . . 0.0 109.944 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.511 ' O ' ' N ' ' A' ' 6' ' ' GLY . 1.2 p90 178.93 133.34 0.08 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.831 -1.168 . . . . 0.0 109.772 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 t -110.54 179.15 4.15 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -115.65 144.46 43.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.341 -0.849 . . . . 0.0 109.778 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.546 HD11 ' HD2' ' A' ' 154' ' ' PHE . 1.9 mt -95.45 144.06 26.27 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.434 -0.791 . . . . 0.0 109.59 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.91 -22.26 65.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 108.857 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -127.57 102.13 23.39 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.429 -0.795 . . . . 0.0 109.026 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 34.2 Cg_endo -76.43 163.23 32.49 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.503 2.135 . . . . 0.0 110.846 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.498 ' HB ' ' HA3' ' A' ' 157' ' ' GLY . 38.2 t -123.13 92.14 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.84 . . . . 0.0 109.826 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.4 132.74 51.99 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 96.77 -25.74 25.21 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.735 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -42.49 162.75 0.15 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.371 -1.076 . . . . 0.0 109.699 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.608 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 36.2 Cg_endo -77.86 137.38 15.8 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.758 2.305 . . . . 0.0 111.206 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.781 ' O ' HG13 ' A' ' 155' ' ' VAL . 30.3 mm-40 -47.4 -22.36 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.913 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 55.7 t -151.41 82.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.014 -1.054 . . . . 0.0 108.968 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.771 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -76.66 121.33 23.09 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.11 -0.994 . . . . 0.0 108.341 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.558 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -98.27 139.54 33.91 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 110.025 -179.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.989 ' CE2' HG21 ' A' ' 145' ' ' VAL . 7.0 m-85 -127.76 101.96 6.59 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.467 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -143.11 143.24 31.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.032 -1.042 . . . . 0.0 109.779 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.993 ' HB2' HG22 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -120.43 -179.07 3.85 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.91 . . . . 0.0 109.599 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.543 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 12.1 m-30 -98.48 47.4 0.99 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.725 ' CG ' HG11 ' A' ' 96' ' ' VAL . 28.4 m-85 -142.22 13.75 2.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.433 -0.792 . . . . 0.0 109.967 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.503 ' O ' ' NE2' ' A' ' 97' ' ' GLN . 0.5 OUTLIER -105.29 157.28 34.74 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.728 -1.233 . . . . 0.0 109.459 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.7 -27.16 12.95 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.209 1.939 . . . . 0.0 108.252 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 27.0 m80 -90.93 -22.66 20.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 13.0 t -47.04 -49.92 20.47 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 9.6 t80 -75.03 -33.65 61.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.838 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.3 mm-40 -83.36 -45.59 13.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.867 -1.146 . . . . 0.0 110.85 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.624 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -48.47 -24.63 1.34 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.104 -0.997 . . . . 0.0 110.578 -179.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -114.79 -51.26 2.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.919 -1.113 . . . . 0.0 112.334 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 63.3 mm-40 -90.15 0.32 57.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.689 -1.257 . . . . 0.0 111.534 -177.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 35' ' ' GLN . 41.3 t -135.76 -74.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.676 -1.265 . . . . 0.0 109.581 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 35' ' ' GLN . 78.1 mt -64.06 -24.74 67.82 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.236 -0.915 . . . . 0.0 109.561 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.3 m80 51.18 21.55 1.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.988 -1.07 . . . . 0.0 109.201 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.624 HG21 ' CZ ' ' A' ' 36' ' ' PHE . 37.6 mt -63.5 -21.27 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.858 . . . . 0.0 109.757 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -60.1 2.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 109.661 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -57.66 -30.5 65.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.804 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -66.59 -34.48 77.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.721 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.7 t -72.25 -16.85 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.032 . . . . 0.0 109.191 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -82.46 -41.41 19.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.87 . . . . 0.0 110.088 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.18 -22.44 0.65 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.073 -1.017 . . . . 0.0 109.662 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 1.3 ptmm? -115.62 42.05 2.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 109.631 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 50' ' ' LEU . 10.9 mt -108.16 101.74 43.12 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.17 -0.956 . . . . 0.0 109.752 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 33.5 Cg_endo -74.93 153.9 42.46 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.536 2.157 . . . . 0.0 109.408 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 73.2 tt0 -69.5 22.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.742 -1.223 . . . . 0.0 111.548 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.416 ' C ' HG23 ' A' ' 54' ' ' VAL . . . -122.45 32.11 4.61 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.528 ' CG1' ' HB3' ' A' ' 186' ' ' SER . 59.0 t -153.39 127.16 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.47 105.43 17.4 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 110.766 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.512 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -104.36 99.1 8.8 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 1.3 m -100.37 135.04 42.42 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.714 -1.195 . . . . 0.0 110.982 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.558 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 6.7 tttt -106.84 117.81 35.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 2.6 m-85 -118.08 170.76 8.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.909 -1.12 . . . . 0.0 111.706 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.948 ' NE2' HD21 ' A' ' 72' ' ' LEU . 1.9 t-160 -111.09 136.4 50.18 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.727 0.775 . . . . 0.0 109.236 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.993 HG22 ' HB2' ' A' ' 27' ' ' SER . 3.1 m -78.9 155.55 4.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-O 121.398 0.618 . . . . 0.0 110.272 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.453 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 1.0 OUTLIER -124.4 35.82 4.74 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.031 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.563 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 9.7 p90 -135.77 55.73 1.86 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.295 -0.878 . . . . 0.0 109.608 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.629 ' CE ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -130.36 37.11 3.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.162 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.21 -33.28 0.42 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.19 -37.07 2.72 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -87.84 -79.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.004 -1.292 . . . . 0.0 110.464 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.888 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -79.87 -18.5 50.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.106 . . . . 0.0 109.618 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.652 ' N ' HD22 ' A' ' 68' ' ' LEU . . . -54.95 -36.34 60.34 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.27 -45.65 79.76 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.325 -1.103 . . . . 0.0 108.36 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.544 ' HB3' HD12 ' A' ' 108' ' ' ILE . 18.2 t0 -66.9 -24.7 66.13 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.948 HD21 ' NE2' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -65.55 -46.86 77.89 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.46 HG22 HE21 ' A' ' 138' ' ' GLN . 1.6 m -56.04 -41.71 75.44 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.575 ' O ' HG23 ' A' ' 78' ' ' VAL . 6.0 tp60 -61.4 -23.78 66.04 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.65 -37.33 86.95 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.593 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 20.7 t-105 -71.29 -32.26 68.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.528 -0.733 . . . . 0.0 109.142 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.53 ' HB2' ' NE2' ' A' ' 138' ' ' GLN . . . -75.75 -40.34 55.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.467 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.726 HG21 ' CE1' ' A' ' 122' ' ' TYR . 35.6 t -74.55 -26.24 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.288 -0.882 . . . . 0.0 109.655 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.553 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.1 -57.87 3.52 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.944 -1.097 . . . . 0.0 108.776 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -26.59 10.33 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.703 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -68.14 -47.2 68.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.642 -0.661 . . . . 0.0 109.397 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.535 ' HB2' HG13 ' A' ' 84' ' ' VAL . 44.8 mt -106.12 14.02 28.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.104 -0.997 . . . . 0.0 110.373 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.24 24.89 7.42 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 28.2 m -86.25 -4.16 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -1.027 . . . . 0.0 110.482 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 89' ' ' THR . 2.7 pt-20 -42.44 -59.11 1.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.047 -1.033 . . . . 0.0 109.897 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.68 -31.41 11.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 109.828 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 84' ' ' VAL . 46.3 mttp -78.65 -52.88 7.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 111.478 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.828 HG23 HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -85.92 -8.63 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.752 -1.217 . . . . 0.0 111.053 -178.111 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.744 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.07 -44.98 44.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.729 -1.232 . . . . 0.0 108.679 178.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.424 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -52.61 -53.27 55.74 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.472 -1.392 . . . . 0.0 110.627 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.651 ' HB2' HG13 ' A' ' 111' ' ' VAL . 27.2 Cg_endo -73.28 -18.63 23.21 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 109.737 -0.909 . . . . 0.0 109.737 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.857 ' HG ' HG11 ' A' ' 111' ' ' VAL . 14.9 mt -86.83 -42.97 12.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 108.982 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.744 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.1 m-30 -64.81 -46.66 81.04 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.889 -1.132 . . . . 0.0 108.87 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -71.78 -22.24 61.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.314 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.442 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -78.98 -31.02 44.79 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.725 HG11 ' CG ' ' A' ' 29' ' ' PHE . 2.8 t -105.73 6.63 10.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.179 -1.189 . . . . 0.0 109.325 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 93' ' ' PHE . 40.5 mm-40 -105.21 9.13 34.17 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 120.974 -1.079 . . . . 0.0 110.514 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER 173.27 -49.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.654 -1.278 . . . . 0.0 110.443 179.643 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 59.7 p -55.32 -44.53 75.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.608 -1.308 . . . . 0.0 109.297 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 71.41 12.04 6.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 110.285 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 t -79.63 -7.78 58.77 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.628 ' CB ' HG22 ' A' ' 96' ' ' VAL . 7.7 mm -84.95 73.32 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.12 33.37 3.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.605 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 107' ' ' ASP . 14.7 p -160.45 133.24 6.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 0.0 110.056 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.532 ' N ' ' HB3' ' A' ' 68' ' ' LEU . . . -50.81 -34.76 28.96 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.9 p -61.59 -31.6 71.67 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -70.6 -51.24 29.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.731 HD11 HD23 ' A' ' 68' ' ' LEU . 52.5 mt -48.66 -29.94 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -38.54 53.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.485 -0.759 . . . . 0.0 109.551 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.18 -44.32 83.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.438 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.857 HG11 ' HG ' ' A' ' 92' ' ' LEU . 69.9 t -72.62 -38.17 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -42.74 98.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.5 mt -71.5 -24.29 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.099 -1.001 . . . . 0.0 109.271 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -67.29 -19.65 65.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.672 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -91.75 -12.03 35.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.366 -0.834 . . . . 0.0 109.253 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.98 -7.96 25.4 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.823 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.9 mp -76.93 52.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.315 -1.109 . . . . 0.0 109.478 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 117' ' ' ILE . 35.5 mttm -40.46 154.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.035 -1.041 . . . . 0.0 109.769 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.75 -35.7 39.24 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.48 -56.27 24.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.045 -1.268 . . . . 0.0 110.018 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -46.86 87.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 109.946 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.726 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -62.86 -62.64 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.561 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 122' ' ' TYR . 13.8 t70 -42.52 -35.08 0.97 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.768 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.95 -41.87 28.27 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.698 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ALA . . . . . 0.535 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -58.57 -48.29 81.43 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 108.795 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 126' ' ' TRP . 2.2 t90 -62.37 -56.85 14.32 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.12 -16.1 0.71 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.552 -0.718 . . . . 0.0 110.559 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 4.7 t -69.07 -175.59 0.76 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.853 -1.154 . . . . 0.0 110.073 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -90.29 -34.89 15.56 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.299 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.4 -46.92 62.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 118.415 -1.314 . . . . 0.0 110.11 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.703 HG22 ' HB1' ' A' ' 81' ' ' ALA . 6.5 t -72.14 -34.14 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.853 -1.154 . . . . 0.0 108.911 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 128' ' ' SER . 1.3 tttm -64.3 -44.04 92.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.383 -0.823 . . . . 0.0 109.016 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 11.4 t -65.12 -30.87 71.84 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 77' ' ' ALA . 7.7 tp -78.91 -17.59 55.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.19 -47.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -64.46 -33.36 75.7 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.445 ' OE1' ' OH ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -66.46 -37.85 86.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.442 -0.786 . . . . 0.0 108.959 179.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLN . . . . . 0.53 ' NE2' ' HB2' ' A' ' 77' ' ' ALA . 8.4 mt-30 -67.46 -67.62 0.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 108.885 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 138' ' ' GLN . 8.4 tt0 -46.74 -36.85 7.66 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 10.2 mmtt -72.52 -29.12 63.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.429 -0.794 . . . . 0.0 108.996 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.58 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -61.99 -53.62 53.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 109.071 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -71.77 -35.35 70.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.4 -0.813 . . . . 0.0 109.927 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.79 -18.63 58.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.836 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 140' ' ' LYS . 7.5 m-20 -82.82 -45.04 14.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.114 -0.992 . . . . 0.0 108.753 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.989 HG21 ' CE2' ' A' ' 25' ' ' PHE . 20.9 m -97.33 -11.96 8.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.545 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 3.4 mt-30 82.02 -44.84 0.17 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.57 -0.706 . . . . 0.0 109.75 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.59 HD13 ' CG ' ' A' ' 25' ' ' PHE . 14.6 tp 66.46 133.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.347 -0.845 . . . . 0.0 109.144 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.4 37.41 0.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.536 -1.353 . . . . 0.0 109.846 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 158.04 109.51 0.28 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.291 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.965 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -93.56 142.59 25.37 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.427 -1.043 . . . . 0.0 109.358 178.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.16 151.76 93.79 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.891 -1.296 . . . . 0.0 110.487 0.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -126.83 153.53 45.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.306 -1.496 . . . . 0.0 109.264 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' MET . . . . . 0.531 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 3.2 ttm -145.32 136.44 24.84 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.118 -0.989 . . . . 0.0 109.818 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.6 ' CE2' ' HG3' ' A' ' 160' ' ' GLN . 3.0 m-85 -135.7 129.18 32.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.149 -0.97 . . . . 0.0 110.003 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 21' ' ' GLN . 53.9 t -98.32 132.11 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 0.0 109.636 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . 0.735 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 4.3 t30 46.46 22.69 0.18 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.219 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.651 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 56.36 56.42 24.51 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LYS . . . . . 0.465 ' HG3' ' HB3' ' A' ' 15' ' ' PRO . 10.9 tttt -164.95 -34.16 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.377 -1.073 . . . . 0.0 108.32 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.476 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 86.1 m-85 -115.27 116.37 28.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.204 -0.935 . . . . 0.0 109.207 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.6 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 0.5 OUTLIER -100.67 106.15 17.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.386 -0.821 . . . . 0.0 109.958 -179.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.468 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 16.4 mt -61.3 159.7 11.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.838 . . . . 0.0 109.028 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -129.71 117.59 18.52 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 0.0 109.271 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo . . . . . 0 C--N 1.313 -1.31 0 C-N-CA 122.561 2.174 . . . . 0.0 111.239 -179.748 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.8 mmt . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.67 0.747 . . . . 0.0 109.724 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.33 -61.27 2.06 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.677 -0.639 . . . . 0.0 109.415 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.4 t -65.9 -23.08 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.205 -0.934 . . . . 0.0 109.034 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -73.44 -42.25 62.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.197 -0.94 . . . . 0.0 109.216 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 55.9 t -73.27 -26.26 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.121 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -61.31 2.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.3 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -52.55 -32.54 41.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -74.52 -60.49 2.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 109.524 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.27 -20.77 7.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.066 -1.021 . . . . 0.0 108.784 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -82.59 -55.52 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.48 -0.763 . . . . 0.0 109.448 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.679 ' O ' HD23 ' A' ' 185' ' ' LEU . 69.6 m -50.73 -27.11 6.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 54.0 t -87.86 -37.3 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.034 -1.042 . . . . 0.0 108.911 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -57.27 -44.23 83.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 108.863 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -83.43 -35.74 24.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.403 -0.811 . . . . 0.0 109.391 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 181' ' ' THR . 0.9 OUTLIER -58.03 -18.43 24.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.797 -1.189 . . . . 0.0 109.712 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' SER . . . . . 0.528 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -78.7 -5.06 52.09 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.793 -1.192 . . . . 0.0 108.722 178.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.481 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.595 ' HB1' ' HE3' ' A' ' 7' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.403 ' C ' ' CD2' ' A' ' 3' ' ' TYR . 0.9 OUTLIER -139.16 64.13 1.48 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.622 -179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.508 ' HB3' ' CE1' ' A' ' 9' ' ' TYR . 0.4 OUTLIER 50.45 84.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.373 -0.829 . . . . 0.0 109.202 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 5' ' ' ASP . 1.3 mt-10 -97.83 56.92 1.29 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.215 -0.928 . . . . 0.0 110.083 -179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 4' ' ' GLU . 0.3 OUTLIER 40.99 80.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.609 -0.682 . . . . 0.0 110.041 179.39 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 125.9 -25.56 5.52 Favored Glycine 0 N--CA 1.493 2.434 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.48 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.595 ' HE3' ' HB1' ' A' ' 1' ' ' ALA . 3.6 tttp -79.96 -69.5 0.58 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.94 -1.329 . . . . 0.0 108.852 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.526 ' HG2' ' NE2' ' A' ' 177' ' ' GLN . 0.3 OUTLIER -95.6 2.01 53.99 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.16 -0.963 . . . . 0.0 109.852 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.555 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.2 OUTLIER 177.19 129.79 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.098 -1.001 . . . . 0.0 109.239 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -106.89 179.61 4.22 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.573 -0.705 . . . . 0.0 109.469 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 158' ' ' LYS . 1.4 m -123.66 138.64 54.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.351 0.596 . . . . 0.0 109.599 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 14' ' ' LYS . 0.5 OUTLIER -99.22 158.2 15.86 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.337 -0.852 . . . . 0.0 109.48 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.429 ' C ' ' HD3' ' A' ' 15' ' ' PRO . 3.4 pt-20 -91.51 1.27 57.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.176 -0.953 . . . . 0.0 109.712 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.559 ' C ' HD12 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -120.73 78.07 29.82 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.189 -0.944 . . . . 0.0 109.321 179.811 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 13' ' ' GLU . 36.3 Cg_endo -78.19 164.58 26.76 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.717 2.278 . . . . 0.0 110.558 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.746 HG21 ' OD1' ' A' ' 144' ' ' ASP . 18.8 t -127.53 92.66 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.176 -0.953 . . . . 0.0 109.557 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -42.76 125.96 3.56 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 96.05 -18.23 57.83 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.059 -1.617 . . . . 0.0 109.059 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.704 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -39.41 160.83 0.09 OUTLIER Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.505 -0.997 . . . . 0.0 109.927 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.567 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 35.1 Cg_endo -77.67 135.83 14.8 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.741 2.294 . . . . 0.0 111.309 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.728 ' O ' HG13 ' A' ' 155' ' ' VAL . 9.1 mt-30 -49.4 -21.02 0.79 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.561 -0.712 . . . . 0.0 109.802 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.524 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 73.2 t -151.45 80.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.978 -1.076 . . . . 0.0 109.103 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.816 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.73 126.99 32.07 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.453 ' HB3' ' HG3' ' A' ' 58' ' ' LYS . 3.5 tt0 -108.49 120.97 43.96 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.001 -1.062 . . . . 0.0 109.97 -179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.002 ' CE2' HG21 ' A' ' 145' ' ' VAL . 8.2 m-85 -108.33 107.52 18.13 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.424 ' CE1' ' HG2' ' A' ' 58' ' ' LYS . 2.0 p90 -153.08 141.19 20.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.97 -1.081 . . . . 0.0 110.423 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.754 ' OG ' HG22 ' A' ' 61' ' ' VAL . 0.6 OUTLIER -118.51 -178.21 3.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.326 -0.859 . . . . 0.0 109.067 179.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.522 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 5.8 m-30 -97.03 46.16 1.04 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.16 -0.962 . . . . 0.0 108.698 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.609 ' CG ' HG11 ' A' ' 96' ' ' VAL . 15.0 m-85 -146.41 13.27 1.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.289 -0.882 . . . . 0.0 109.837 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.495 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 3.7 m -105.39 161.16 23.62 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.649 -1.282 . . . . 0.0 109.534 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 33.2 Cg_endo -75.04 -32.93 4.92 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.106 1.871 . . . . 0.0 108.17 178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.53 ' O ' ' N ' ' A' ' 36' ' ' PHE . 39.7 m80 -84.5 -20.37 31.75 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.502 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 5.1 t -49.69 -55.21 14.66 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.577 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 3.4 t80 -73.35 -33.51 65.13 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.901 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.605 ' O ' HD13 ' A' ' 40' ' ' LEU . 25.7 mt-30 -85.65 -16.02 40.53 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.856 -1.152 . . . . 0.0 111.186 -178.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 32' ' ' HIS . 8.9 t80 -86.25 -28.2 23.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.841 -1.162 . . . . 0.0 111.377 -178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.3 mt-10 -127.14 50.53 1.97 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.594 -1.316 . . . . 0.0 110.728 -179.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.526 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 1.2 mt-10 -168.34 -59.54 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.009 -1.057 . . . . 0.0 110.767 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.32 -49.35 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.976 -1.077 . . . . 0.0 110.848 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.605 HD13 ' O ' ' A' ' 35' ' ' GLN . 6.7 mp -71.1 -2.19 14.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.096 -1.003 . . . . 0.0 110.297 -179.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.458 ' C ' ' O ' ' A' ' 40' ' ' LEU . 58.0 m-70 39.39 29.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.838 . . . . 0.0 109.954 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.509 HD11 HD23 ' A' ' 40' ' ' LEU . 36.4 mt -74.62 -21.43 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.932 . . . . 0.0 109.557 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.483 ' O ' HG12 ' A' ' 46' ' ' VAL . 2.5 p -76.97 -43.45 35.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 109.619 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.83 -48.28 15.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.178 -0.951 . . . . 0.0 109.519 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.458 ' ND2' HG11 ' A' ' 175' ' ' VAL . 56.2 t-20 -52.96 -43.56 66.45 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -0.948 . . . . 0.0 109.517 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 43' ' ' SER . 9.8 p -69.87 -25.77 28.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.143 -0.973 . . . . 0.0 109.16 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.546 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 49.4 mttm -80.76 -27.58 36.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.271 -0.893 . . . . 0.0 110.133 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.421 ' NZ ' ' HE2' ' A' ' 49' ' ' LYS . 0.1 OUTLIER -64.47 -29.45 70.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.016 -1.052 . . . . 0.0 109.79 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 8.3 mmtt -109.27 24.79 12.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.869 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD1' ' HA ' ' A' ' 47' ' ' LYS . 11.9 mt -70.85 113.71 21.02 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.146 -0.971 . . . . 0.0 109.933 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 36.2 Cg_endo -78.73 151.37 24.85 Favored 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.245 1.963 . . . . 0.0 109.247 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 52' ' ' GLU . 3.7 tp10 -75.47 21.13 0.14 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.625 -1.297 . . . . 0.0 110.724 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.406 ' C ' HG23 ' A' ' 54' ' ' VAL . . . -122.75 29.99 5.24 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.197 -1.961 . . . . 0.0 108.197 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 186' ' ' SER . 60.7 t -153.07 118.4 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.488 -1.007 . . . . 0.0 109.338 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.26 109.37 20.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.678 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.524 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 1.9 ttp -92.58 100.82 13.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.719 -0.613 . . . . 0.0 109.595 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.435 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 0.4 OUTLIER -96.72 149.67 21.56 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.801 -1.159 . . . . 0.0 109.898 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.453 ' HG3' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -123.77 117.12 24.19 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.466 -0.771 . . . . 0.0 109.378 -179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.577 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.3 m-85 -123.78 166.26 15.89 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.81 -1.181 . . . . 0.0 111.617 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.636 ' CD2' ' HG ' ' A' ' 27' ' ' SER . 14.4 t60 -102.26 149.51 24.25 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.939 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.3 m -95.31 159.79 2.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.007 0 O-C-N 121.663 -0.648 . . . . 0.0 110.356 -179.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -128.11 49.41 2.16 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.312 -0.867 . . . . 0.0 109.193 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 10.8 p90 -152.4 64.65 0.82 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.162 -0.961 . . . . 0.0 109.799 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.428 ' O ' ' C ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -119.04 30.77 6.98 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.932 -1.105 . . . . 0.0 109.592 179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 64' ' ' MET . . . 45.12 42.73 8.65 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.645 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . -149.05 85.43 0.16 Allowed Glycine 0 C--O 1.204 -1.731 0 N-CA-C 107.572 -2.211 . . . . 0.0 107.572 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' A' ' 66' ' ' GLY . 0.5 OUTLIER -31.62 -46.52 0.11 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 122.058 -0.672 . . . . 0.0 111.548 -178.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.866 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -61.46 -22.24 64.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.647 -1.283 . . . . 0.0 109.49 -179.01 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.828 ' N ' HD22 ' A' ' 68' ' ' LEU . . . -54.52 -46.99 71.86 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.421 ' O ' ' HB ' ' A' ' 73' ' ' THR . 27.8 mttt -52.32 -47.04 66.24 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.54 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 8.5 t0 -64.41 -29.2 70.27 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.79 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 17.6 tp -61.26 -35.4 77.17 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.645 HG23 ' CD ' ' A' ' 138' ' ' GLN . 5.3 m -62.75 -40.73 98.14 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 177.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.494 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 0.5 OUTLIER -61.91 -20.9 64.26 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 106.588 -1.634 . . . . 0.0 106.588 177.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.79 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -67.96 -41.92 81.69 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.465 ' HB3' ' OE1' ' A' ' 138' ' ' GLN . 24.1 t-105 -67.01 -31.67 72.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 0.0 108.91 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.497 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -79.51 -60.37 2.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -0.914 . . . . 0.0 109.28 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.884 HG21 ' CE1' ' A' ' 122' ' ' TYR . 71.5 t -54.92 -27.81 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -0.857 . . . . 0.0 110.043 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.538 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.25 -62.85 1.56 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.907 -1.121 . . . . 0.0 108.621 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.405 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -47.01 -27.42 1.3 Allowed 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.762 ' HB2' HG13 ' A' ' 131' ' ' VAL . . . -69.43 -42.16 75.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.598 -0.689 . . . . 0.0 109.286 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 67.5 mt -107.92 12.75 26.83 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.224 -0.923 . . . . 0.0 110.562 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 49.17 32.01 12.59 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.114 -1.594 . . . . 0.0 109.114 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.614 HG11 ' CD1' ' A' ' 117' ' ' ILE . 26.0 m -93.81 2.01 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.476 -1.014 . . . . 0.0 110.531 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.455 ' O ' ' HB ' ' A' ' 89' ' ' THR . 38.4 tt0 -48.9 -68.31 0.19 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.866 -1.146 . . . . 0.0 109.402 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -40.04 -34.89 0.32 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.296 -0.878 . . . . 0.0 110.465 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.484 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 35.1 mttt -79.82 -55.4 5.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.131 -0.98 . . . . 0.0 111.031 -178.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.857 HG23 HD12 ' A' ' 92' ' ' LEU . 1.2 m -82.14 -22.28 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 120.812 -1.18 . . . . 0.0 110.608 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.754 HG23 ' CE1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -64.77 -43.57 92.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.723 -1.235 . . . . 0.0 108.983 179.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.92 -56.21 30.22 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.351 -1.468 . . . . 0.0 110.474 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.484 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 26.1 Cg_endo -72.43 -16.21 27.62 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 N-CA-C 109.812 -0.88 . . . . 0.0 109.812 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.857 HD12 HG23 ' A' ' 88' ' ' VAL . 15.1 mt -87.39 -44.13 11.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.0 108.844 178.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.754 ' CE1' HG23 ' A' ' 89' ' ' THR . 5.4 m-30 -65.51 -46.84 78.07 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.987 -1.071 . . . . 0.0 108.835 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.26 -16.62 60.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.151 -0.968 . . . . 0.0 109.203 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -75.66 -33.39 51.98 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.609 HG11 ' CG ' ' A' ' 29' ' ' PHE . 2.3 t -100.83 -7.67 9.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 O-C-N 121.12 -1.224 . . . . 0.0 109.35 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.531 ' NE2' ' O ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -110.08 8.73 24.07 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 120.893 -1.129 . . . . 0.0 110.514 -179.288 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.786 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER -176.18 68.0 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.67 -1.269 . . . . 0.0 109.333 -179.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 163.08 -46.75 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.522 -0.736 . . . . 0.0 109.575 179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 71.67 17.54 5.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.397 -0.814 . . . . 0.0 110.38 179.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 t -81.45 -4.96 57.36 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.639 HG23 ' OD1' ' A' ' 107' ' ' ASP . 4.2 mm -95.41 84.49 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.34 28.29 1.35 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 109.382 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.558 ' O ' ' N ' ' A' ' 107' ' ' ASP . 59.6 p -157.55 131.54 8.15 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.321 -0.862 . . . . 0.0 109.658 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.632 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -48.99 -31.66 7.85 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.5 t -64.5 -33.28 75.53 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.639 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.4 OUTLIER -67.64 -50.11 59.6 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.731 HD11 HD23 ' A' ' 68' ' ' LEU . 36.3 mt -51.27 -28.53 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -36.49 56.66 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.52 -0.737 . . . . 0.0 109.052 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.22 -48.4 78.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.308 -0.87 . . . . 0.0 108.91 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.769 HG11 ' HG ' ' A' ' 92' ' ' LEU . 21.3 t -68.82 -37.68 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.234 -0.916 . . . . 0.0 109.455 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.435 ' O ' HG12 ' A' ' 117' ' ' ILE . 1.3 m-85 -59.9 -48.26 82.44 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.108 -0.995 . . . . 0.0 109.469 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 mt -66.26 -25.39 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.158 -0.963 . . . . 0.0 109.279 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 111' ' ' VAL . 15.5 m-20 -61.77 -16.94 53.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.916 . . . . 0.0 109.544 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.585 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -97.94 15.48 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.078 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 83.59 -0.94 89.39 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.614 ' CD1' HG11 ' A' ' 84' ' ' VAL . 3.9 mm -71.77 55.49 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.262 -1.14 . . . . 0.0 109.843 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.484 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -36.73 145.53 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.285 -0.885 . . . . 0.0 110.073 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -47.15 -31.71 6.22 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.79 -49.25 77.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.294 -1.121 . . . . 0.0 109.49 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.19 -58.05 6.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.252 -0.905 . . . . 0.0 110.003 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.884 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -61.22 -56.84 16.08 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.198 -0.938 . . . . 0.0 109.617 -179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.52 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 14.5 t70 -45.15 -34.34 2.64 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.036 -1.04 . . . . 0.0 109.054 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -77.48 -43.9 30.7 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.416 -0.802 . . . . 0.0 109.012 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.58 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -52.85 -51.66 60.16 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.494 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 11.4 t90 -62.62 -53.2 58.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -53.86 -16.13 1.66 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.511 -0.743 . . . . 0.0 110.027 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.2 t -78.76 -179.48 6.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.984 -1.073 . . . . 0.0 110.273 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -95.24 -36.59 11.38 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.806 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.04 -47.83 80.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 118.209 -1.396 . . . . 0.0 109.709 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.762 HG13 ' HB2' ' A' ' 81' ' ' ALA . 2.2 t -64.95 -39.8 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.97 -1.081 . . . . 0.0 108.333 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.9 ttmt -66.61 -31.62 72.42 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 10.3 t -64.6 -35.48 81.14 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.83 -19.14 52.78 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.313 -0.867 . . . . 0.0 108.678 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.497 HG23 ' CB ' ' A' ' 77' ' ' ALA . 4.6 t -80.35 -47.45 21.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.61 -36.9 85.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -32.96 73.06 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.645 ' CD ' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -64.37 -66.26 0.57 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.306 -0.871 . . . . 0.0 109.092 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.529 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 0.4 OUTLIER -52.23 -32.87 38.75 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.46 ' O ' ' OD2' ' A' ' 144' ' ' ASP . 0.3 OUTLIER -74.19 -28.21 61.17 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.345 -0.847 . . . . 0.0 108.991 179.339 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.607 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -64.37 -60.88 2.64 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.062 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.481 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -72.37 -21.72 61.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.717 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -77.56 -29.09 51.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.079 -1.013 . . . . 0.0 109.776 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.95 ' OD1' HG13 ' A' ' 145' ' ' VAL . 2.8 p30 -81.22 -47.82 12.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.001 . . . . 0.0 108.419 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 1.002 HG21 ' CE2' ' A' ' 25' ' ' PHE . 28.2 m -84.07 -14.44 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.542 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 4.0 tt0 81.2 -48.05 0.25 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.587 -0.696 . . . . 0.0 109.837 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.662 HD22 ' CD1' ' A' ' 25' ' ' PHE . 49.0 tp 61.79 134.88 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.466 -0.771 . . . . 0.0 109.319 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.72 40.36 0.16 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.623 -1.298 . . . . 0.0 109.681 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 169.64 104.73 0.18 Allowed Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.014 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.939 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -99.0 141.13 22.35 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.278 -1.131 . . . . 0.0 109.587 179.151 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.432 ' C ' ' HA ' ' A' ' 150' ' ' VAL . 33.1 Cg_endo -75.32 153.87 98.92 Favored 'Cis proline' 0 C--N 1.314 -1.26 0 C-N-CA 123.598 -1.417 . . . . 0.0 110.452 0.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.692 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -132.86 146.85 52.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.33 -1.481 . . . . 0.0 109.54 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.506 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 18.7 ttm -136.54 133.9 36.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.223 -0.923 . . . . 0.0 109.813 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.598 ' CD2' ' HB2' ' A' ' 160' ' ' GLN . 75.4 m-85 -129.57 127.08 39.97 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.332 -0.855 . . . . 0.0 110.104 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 21' ' ' GLN . 56.1 t -97.03 129.46 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.045 -1.034 . . . . 0.0 109.5 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.704 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 47.41 21.72 0.24 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.979 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.509 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.75 55.72 28.54 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.479 ' O ' HG23 ' A' ' 11' ' ' THR . 13.5 tttp -163.71 -37.84 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.547 ' CZ ' ' HE3' ' A' ' 188' ' ' LYS . 75.0 m-85 -114.91 124.84 52.74 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.598 ' HB2' ' CD2' ' A' ' 154' ' ' PHE . 4.4 tt0 -124.44 127.43 47.5 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 120.942 -1.099 . . . . 0.0 109.852 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.2 mt -65.73 -179.84 0.74 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.499 -0.751 . . . . 0.0 109.081 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.463 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 38.1 t30 -144.42 65.0 12.69 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.928 . . . . 0.0 109.64 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 162' ' ' ASN . 35.1 Cg_endo -77.95 63.41 8.14 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.675 2.25 . . . . 0.0 110.424 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -98.94 60.99 1.25 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.267 -0.895 . . . . 0.0 109.559 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 67.96 72.33 0.82 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.615 ' HB3' HG23 ' A' ' 168' ' ' THR . 0.0 OUTLIER -64.21 -46.9 81.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -1.135 . . . . 0.0 109.342 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 2.0 t70 58.3 35.94 25.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.224 -0.922 . . . . 0.0 109.853 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.615 HG23 ' HB3' ' A' ' 166' ' ' MET . 1.0 OUTLIER -73.15 -4.84 35.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.997 -1.064 . . . . 0.0 109.632 -179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 63.11 38.29 10.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.235 -0.915 . . . . 0.0 109.233 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -158.21 74.88 0.72 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.273 -0.892 . . . . 0.0 109.19 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 35.7 mtm -57.31 -18.53 17.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.188 -0.945 . . . . 0.0 109.473 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -76.42 -46.48 26.97 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.9 t -71.44 -25.76 25.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.301 -0.874 . . . . 0.0 109.12 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -73.6 -40.8 63.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.131 -0.981 . . . . 0.0 109.579 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.458 HG11 ' ND2' ' A' ' 45' ' ' ASN . 32.6 t -73.11 -29.83 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.12 -0.988 . . . . 0.0 109.248 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.69 -51.7 7.92 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 0.0 108.951 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.526 ' NE2' ' HG2' ' A' ' 8' ' ' GLN . 6.7 tt0 -57.71 -44.8 86.17 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.207 -0.933 . . . . 0.0 108.989 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.49 ' HA ' ' OG1' ' A' ' 181' ' ' THR . 4.9 t80 -60.11 -56.7 18.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.297 -0.877 . . . . 0.0 109.073 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 183' ' ' LYS . . . -49.44 -27.58 4.34 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.337 -0.852 . . . . 0.0 108.873 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -79.48 -46.17 17.96 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.436 -0.79 . . . . 0.0 109.315 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.598 ' O ' HD12 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -48.62 -45.95 39.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.06 -1.025 . . . . 0.0 109.396 179.893 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.466 HG13 ' CG2' ' A' ' 22' ' ' VAL . 22.9 t -75.24 -32.09 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.959 -1.088 . . . . 0.0 109.792 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 179' ' ' ALA . 5.5 tttt -68.28 -38.43 81.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 110.364 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.537 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -83.41 -44.26 14.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.958 -1.089 . . . . 0.0 109.888 -179.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 181' ' ' THR . 14.5 mt -60.69 -22.75 64.25 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.915 -1.114 . . . . 0.0 108.62 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.527 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 5.2 t -68.98 -14.43 63.04 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 177.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -82.55 -9.91 59.21 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.622 -0.674 . . . . 0.0 109.204 179.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.547 ' HE3' ' CZ ' ' A' ' 159' ' ' TYR . 17.7 mmtt -54.38 -41.78 69.61 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.225 -0.922 . . . . 0.0 109.298 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 188' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.473 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.203 0.525 . . . . 0.0 109.687 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 8' ' ' GLN . 33.8 mt-30 -132.62 57.86 1.78 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.27 -0.894 . . . . 0.0 109.22 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.596 ' CB ' ' HB2' ' A' ' 8' ' ' GLN . 26.8 p90 -179.78 96.23 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.41 ' H ' ' HB2' ' A' ' 7' ' ' LYS . 3.8 mm-40 -118.17 63.51 0.76 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.216 -0.928 . . . . 0.0 110.359 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 4' ' ' GLU . 8.8 t0 69.13 96.02 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.859 . . . . 0.0 110.38 178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.28 -10.19 75.07 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.587 ' O ' ' CG ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -99.63 28.72 4.48 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -1.094 . . . . 0.0 108.199 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.596 ' HB2' ' CB ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER 152.83 -40.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.59 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 8.4 p90 -139.79 113.34 8.52 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.193 -0.942 . . . . 0.0 108.691 178.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.1 t -93.3 -179.97 5.23 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 1.051 HG23 ' O ' ' A' ' 158' ' ' LYS . 90.5 m -137.1 145.81 44.35 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.615 0.722 . . . . 0.0 110.079 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.495 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -100.5 171.61 7.63 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.526 -0.734 . . . . 0.0 109.271 179.675 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.41 13.45 30.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.45 ' O ' HD12 ' A' ' 12' ' ' LEU . 1.6 mmtp -127.17 95.27 36.89 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 109.543 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.39 169.33 20.19 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.594 2.196 . . . . 0.0 110.204 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.508 ' O ' ' N ' ' A' ' 19' ' ' ALA . 1.9 t -144.26 113.24 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.18 -0.95 . . . . 0.0 110.101 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.06 128.21 18.41 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 77.21 5.69 85.54 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.774 ' HB1' ' HD2' ' A' ' 20' ' ' PRO . . . -38.18 165.88 0.04 OUTLIER Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.6 -0.941 . . . . 0.0 110.71 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.96 ' HG3' HD12 ' A' ' 23' ' ' LEU . 32.8 Cg_endo -74.02 101.26 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.859 2.373 . . . . 0.0 111.58 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.605 ' O ' HG23 ' A' ' 22' ' ' VAL . 1.9 mp0 -42.1 -28.04 0.16 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 21' ' ' GLN . 40.2 t -158.57 79.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.96 HD12 ' HG3' ' A' ' 20' ' ' PRO . 1.3 tt -73.62 139.27 45.38 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.72 ' N ' HD23 ' A' ' 23' ' ' LEU . 1.5 tt0 -127.8 98.77 5.28 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.199 -0.938 . . . . 0.0 109.803 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.88 ' CD1' HD22 ' A' ' 147' ' ' LEU . 11.4 m-85 -81.61 127.0 32.42 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.204 -0.935 . . . . 0.0 108.913 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -161.73 128.69 3.89 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.346 -0.846 . . . . 0.0 109.705 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.579 ' HA ' ' ND1' ' A' ' 60' ' ' HIS . 11.6 p -112.45 145.66 39.8 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.403 -0.81 . . . . 0.0 109.131 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.604 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 8.6 m-30 -72.93 49.87 0.25 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 0.0 109.252 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.694 ' CG ' HG11 ' A' ' 96' ' ' VAL . 11.4 m-85 -152.24 9.85 0.5 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.25 -0.906 . . . . 0.0 109.577 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 0.8 OUTLIER -107.26 167.03 10.0 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 120.725 -1.235 . . . . 0.0 109.949 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -77.01 -43.07 0.27 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.564 2.176 . . . . 0.0 108.691 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.479 ' HB3' ' HG3' ' A' ' 151' ' ' PRO . 0.1 OUTLIER -78.17 -21.71 49.79 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 177.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.51 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 5.7 t -45.19 -56.27 4.96 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.526 ' O ' ' HB2' ' A' ' 38' ' ' GLU . 51.9 t80 -69.98 -27.33 64.62 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.591 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 3.2 mm-40 -84.87 -28.67 25.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.88 -1.138 . . . . 0.0 111.002 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -87.69 -36.25 17.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.83 -1.169 . . . . 0.0 111.724 -178.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 1.2 mp0 -111.46 31.95 5.74 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.633 -1.292 . . . . 0.0 111.38 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.553 ' O ' ' CE1' ' A' ' 41' ' ' HIS . 26.3 mm-40 -160.03 -58.15 0.06 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.801 -1.187 . . . . 0.0 110.846 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.444 ' O ' ' N ' ' A' ' 41' ' ' HIS . 69.2 t -88.91 -74.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.844 -1.16 . . . . 0.0 110.903 -178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.52 ' HB3' ' CD1' ' A' ' 42' ' ' ILE . 51.0 mt -42.7 -25.29 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.093 -1.004 . . . . 0.0 110.315 -179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.553 ' CE1' ' O ' ' A' ' 38' ' ' GLU . 0.2 OUTLIER 55.8 21.61 4.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.009 -1.057 . . . . 0.0 108.898 -179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.52 ' CD1' ' HB3' ' A' ' 40' ' ' LEU . 14.9 mt -70.35 -21.23 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.45 -0.781 . . . . 0.0 109.888 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.682 ' O ' HG12 ' A' ' 46' ' ' VAL . 79.3 p -86.16 -77.27 0.31 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.09 -1.006 . . . . 0.0 110.078 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 43' ' ' SER . 0.5 OUTLIER -41.68 -31.5 0.3 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.867 . . . . 0.0 110.486 -179.396 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 3.0 m120 -75.85 -31.58 59.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.949 -1.094 . . . . 0.0 110.064 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 43' ' ' SER . 3.5 p -54.2 -36.47 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.079 -1.013 . . . . 0.0 109.577 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.937 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -72.44 -36.39 68.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.119 -0.988 . . . . 0.0 109.474 179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.404 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.8 OUTLIER -45.02 -24.78 0.25 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.278 -0.889 . . . . 0.0 109.226 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.548 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -133.36 50.66 2.2 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.274 -0.892 . . . . 0.0 110.004 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.937 HD12 ' HA ' ' A' ' 47' ' ' LYS . 9.8 mt -114.47 72.3 2.51 Favored Pre-proline 0 N--CA 1.495 1.802 0 O-C-N 120.868 -1.145 . . . . 0.0 110.562 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.548 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 36.8 Cg_endo -78.59 139.35 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.33 2.02 . . . . 0.0 110.269 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.466 ' O ' ' O ' ' A' ' 51' ' ' PRO . 19.3 tp10 61.99 134.79 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.374 -0.829 . . . . 0.0 108.849 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.497 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . 58.21 23.53 53.04 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 108.182 -1.967 . . . . 0.0 108.182 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.882 HG13 ' O ' ' A' ' 50' ' ' LEU . 1.6 t -61.26 77.7 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.712 -0.875 . . . . 0.0 109.258 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.499 ' CB ' ' HB2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -136.96 97.25 3.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.251 -0.906 . . . . 0.0 110.148 -179.887 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.422 ' SD ' ' HD2' ' A' ' 58' ' ' LYS . 2.7 tmm? -103.6 103.01 12.89 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.417 -0.802 . . . . 0.0 108.91 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.52 121.68 36.32 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.197 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.526 ' HB2' ' CE1' ' A' ' 26' ' ' PHE . 0.0 OUTLIER -103.39 110.23 22.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 0.0 109.715 -179.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.606 ' CD1' ' CG ' ' A' ' 138' ' ' GLN . 4.1 m-85 -113.68 177.96 4.45 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.851 -1.156 . . . . 0.0 110.942 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 1.048 ' CE1' HD22 ' A' ' 72' ' ' LEU . 2.0 t-160 -140.0 130.4 25.41 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.44 -0.787 . . . . 0.0 109.651 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.677 HG11 HD23 ' A' ' 147' ' ' LEU . 1.4 m -115.18 137.38 48.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.994 -1.114 . . . . 0.0 107.994 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 2.0 p-10 -40.72 -55.89 2.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.352 -0.843 . . . . 0.0 109.37 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.46 ' C ' ' O ' ' A' ' 62' ' ' ASN . 3.6 m-85 32.1 40.64 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 121.623 0.725 . . . . 0.0 110.952 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.507 ' SD ' ' CD2' ' A' ' 29' ' ' PHE . 5.8 ptm -161.02 47.61 0.21 Allowed 'General case' 0 C--N 1.294 -1.848 0 C-N-CA 119.824 -0.751 . . . . 0.0 110.574 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 98.53 -49.22 1.33 Allowed Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.58 -3.53 49.96 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.714 -1.231 . . . . 0.0 111.241 178.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -71.46 -81.18 0.05 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.371 -1.664 . . . . 0.0 108.384 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.119 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -88.87 -26.24 21.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.947 -1.095 . . . . 0.0 109.49 178.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 1.119 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -57.31 -42.29 93.49 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.706 -1.757 . . . . 0.0 108.706 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.02 -46.66 80.45 Favored 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.324 -1.104 . . . . 0.0 108.496 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.872 ' OD2' ' HB2' ' A' ' 105' ' ' ALA . 1.3 m-20 -66.3 -28.24 68.54 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.048 HD22 ' CE1' ' A' ' 60' ' ' HIS . 6.4 tt -61.03 -45.33 95.24 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 60' ' ' HIS . 1.5 m -59.68 -44.5 93.6 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.709 ' O ' HG13 ' A' ' 78' ' ' VAL . 8.7 tm0? -50.98 -27.36 7.53 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.205 -1.406 . . . . 0.0 107.205 178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.715 ' HB1' ' CE2' ' A' ' 112' ' ' PHE . . . -81.17 -32.29 33.67 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 118.832 -1.147 . . . . 0.0 109.207 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' ALA . 4.4 t-105 -50.01 -29.14 8.08 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 177.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.769 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -85.24 -38.96 18.31 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.639 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 74' ' ' GLN . 3.3 m -63.71 -30.71 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 120.745 -1.222 . . . . 0.0 109.011 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.646 ' HB2' ' HZ ' ' A' ' 112' ' ' PHE . . . -81.77 -53.65 6.02 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.485 ' HB3' ' HG ' ' A' ' 134' ' ' LEU . 4.9 tpt -49.23 -29.32 5.55 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.651 ' HB2' ' CG2' ' A' ' 131' ' ' VAL . . . -60.78 -45.05 95.87 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.801 ' HB2' HG13 ' A' ' 84' ' ' VAL . 3.3 mt -110.87 16.0 21.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.47 -0.769 . . . . 0.0 110.055 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.75 30.23 6.58 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.801 HG13 ' HB2' ' A' ' 82' ' ' LEU . 36.0 m -89.39 -5.32 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -1.178 . . . . 0.0 110.551 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -42.85 -61.24 1.32 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.107 -0.996 . . . . 0.0 109.607 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -43.2 -33.89 1.02 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.209 -0.932 . . . . 0.0 109.845 179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.455 ' CE ' ' HB1' ' A' ' 115' ' ' ALA . 4.4 mtpt -83.29 -50.7 8.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.298 -0.876 . . . . 0.0 111.214 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.749 HG23 HD12 ' A' ' 92' ' ' LEU . 1.1 m -82.4 -5.83 9.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.711 -1.243 . . . . 0.0 110.681 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.734 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -77.92 -45.51 23.84 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.302 178.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.465 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 2.1 t -51.8 -52.84 57.25 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 120.75 -1.219 . . . . 0.0 110.406 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 90' ' ' VAL . 25.5 Cg_endo -73.28 -17.36 24.31 Favored 'Trans proline' 0 C--N 1.3 -1.981 0 N-CA-C 109.645 -0.944 . . . . 0.0 109.645 179.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.749 HD12 HG23 ' A' ' 88' ' ' VAL . 13.6 mt -86.48 -44.92 11.6 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 177.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.734 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.1 m-30 -61.51 -47.65 84.64 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.916 -1.115 . . . . 0.0 108.772 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 90' ' ' VAL . 13.0 pt-20 -71.7 -16.7 62.24 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.111 -0.993 . . . . 0.0 109.641 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.46 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -79.05 -32.32 40.07 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.694 HG11 ' CG ' ' A' ' 29' ' ' PHE . 1.7 t -106.79 0.54 10.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.997 -1.296 . . . . 0.0 110.026 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.481 ' HG2' ' HB2' ' A' ' 34' ' ' TYR . 0.7 OUTLIER -106.93 6.17 28.98 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 120.769 -1.207 . . . . 0.0 110.679 -179.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.786 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER 177.28 76.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.734 -1.229 . . . . 0.0 109.074 179.828 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 161.41 -48.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.3 OUTLIER 71.74 18.6 5.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.346 -0.846 . . . . 0.0 110.48 179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.449 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 2.8 t -80.07 -4.47 52.9 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 177.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.603 HG23 ' OD1' ' A' ' 107' ' ' ASP . 4.6 mm -97.91 81.78 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.809 -0.557 . . . . 0.0 109.609 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.449 ' HD2' ' C ' ' A' ' 101' ' ' THR . 0.0 OUTLIER -142.31 32.66 1.51 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.933 -1.105 . . . . 0.0 109.601 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.552 ' O ' ' N ' ' A' ' 107' ' ' ASP . 4.0 p -158.38 134.87 9.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.068 -1.02 . . . . 0.0 109.749 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.873 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.95 -39.83 41.84 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 97.5 p -56.38 -31.73 64.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.603 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.1 OUTLIER -71.63 -51.02 25.36 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.873 HD12 ' HA ' ' A' ' 105' ' ' ALA . 22.5 mt -45.5 -29.92 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.094 -1.004 . . . . 0.0 108.984 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.498 ' HG2' HD11 ' A' ' 113' ' ' ILE . 37.2 ttt180 -78.61 -37.84 41.32 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.177 -0.952 . . . . 0.0 109.553 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -58.92 -46.14 88.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.296 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.579 HG11 ' HG ' ' A' ' 92' ' ' LEU . 13.2 t -68.94 -38.81 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.715 ' CE2' ' HB1' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -61.19 -42.35 98.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.061 -1.024 . . . . 0.0 109.568 179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.498 HD11 ' HG2' ' A' ' 109' ' ' ARG . 17.4 mt -69.81 -25.5 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.165 -0.959 . . . . 0.0 109.669 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -64.07 -16.73 62.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.678 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.597 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -96.04 11.89 32.49 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.137 -0.977 . . . . 0.0 109.649 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.65 -5.26 85.24 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.749 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -80.69 56.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.32 -1.106 . . . . 0.0 109.572 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.45 ' HA ' HG23 ' A' ' 113' ' ' ILE . 59.8 mttt -37.68 153.43 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.438 -0.789 . . . . 0.0 110.153 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -47.9 -27.12 4.69 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.139 -1.184 . . . . 0.0 110.139 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -58.59 -46.98 85.82 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.878 -1.366 . . . . 0.0 109.473 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -77.96 -50.94 11.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.243 -0.911 . . . . 0.0 109.849 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.628 ' HE1' HG11 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -62.61 -58.27 8.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.136 -0.978 . . . . 0.0 108.954 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.536 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 62.8 t0 -50.09 -48.93 52.98 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.038 -1.039 . . . . 0.0 109.292 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.42 -48.32 81.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.304 -0.872 . . . . 0.0 109.43 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.682 ' C ' HG21 ' A' ' 131' ' ' VAL . . . -56.41 -49.5 74.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.293 -0.88 . . . . 0.0 108.951 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 1.01 ' HA ' HG11 ' A' ' 131' ' ' VAL . 6.0 t90 -54.85 -56.46 19.25 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.07 -15.13 62.02 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.595 -0.69 . . . . 0.0 110.016 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 125' ' ' ALA . 16.8 p -71.56 179.72 2.91 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.013 -1.054 . . . . 0.0 110.095 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.421 ' CD1' HG23 ' A' ' 130' ' ' VAL . 4.4 p90 -90.42 -33.63 15.94 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.83 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.421 HG23 ' CD1' ' A' ' 129' ' ' PHE . 23.5 t -64.34 -36.96 78.71 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 C-N-CA 118.124 -1.43 . . . . 0.0 109.878 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 1.01 HG11 ' HA ' ' A' ' 126' ' ' TRP . 16.5 t -64.16 -38.73 83.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.878 -1.139 . . . . 0.0 108.941 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -66.6 -34.54 78.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 108.992 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.34 -33.15 75.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.278 -0.889 . . . . 0.0 109.399 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.485 ' HG ' ' HB3' ' A' ' 80' ' ' MET . 1.8 mm? -79.54 -26.55 41.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.22 -0.925 . . . . 0.0 108.846 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.769 HG23 ' CB ' ' A' ' 77' ' ' ALA . 6.0 t -79.11 -39.02 20.96 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -68.53 -49.15 61.75 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.443 -0.786 . . . . 0.0 109.184 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.481 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -61.73 -35.35 77.81 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.204 -0.935 . . . . 0.0 109.159 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.606 ' CG ' ' CD1' ' A' ' 59' ' ' TYR . 18.0 tm0? -62.78 -62.38 1.77 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.224 -0.922 . . . . 0.0 109.195 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -46.77 -35.61 6.38 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.85 -30.86 67.38 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.614 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -60.74 -47.74 84.95 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.354 -0.841 . . . . 0.0 108.915 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.518 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -73.07 -39.83 65.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.411 -0.805 . . . . 0.0 110.236 -179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.62 -16.9 59.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.973 -1.079 . . . . 0.0 109.824 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.455 ' OD2' HG11 ' A' ' 16' ' ' VAL . 9.1 m-20 -82.06 -44.95 15.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.057 -1.027 . . . . 0.0 108.592 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 141' ' ' ALA . 17.6 m -100.08 -8.36 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.346 -0.846 . . . . 0.0 108.927 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.544 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 12.2 tp60 80.95 -42.15 0.18 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.461 -0.774 . . . . 0.0 110.113 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.88 HD22 ' CD1' ' A' ' 25' ' ' PHE . 20.1 tp 62.11 140.19 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.288 -0.882 . . . . 0.0 108.981 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.54 31.26 0.23 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.613 -1.304 . . . . 0.0 110.106 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 157.22 98.8 0.15 Allowed Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.523 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.493 HG11 ' CG2' ' A' ' 61' ' ' VAL . 0.8 OUTLIER -92.51 138.37 23.99 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 178.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.5 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 31.6 Cg_endo -71.75 155.83 97.63 Favored 'Cis proline' 0 C--N 1.316 -1.163 0 C-N-CA 124.157 -1.185 . . . . 0.0 111.753 2.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -146.91 151.09 36.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.805 -1.185 . . . . 0.0 108.525 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.504 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -128.49 118.31 22.83 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.901 -1.124 . . . . 0.0 110.022 -179.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.579 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 57.8 m-85 -114.42 142.39 46.42 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.582 HG22 HG22 ' A' ' 22' ' ' VAL . 30.6 t -124.08 124.62 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.989 -1.07 . . . . 0.0 108.947 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 56.14 22.89 6.41 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 119.713 -0.795 . . . . 0.0 109.187 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.407 ' O ' HD11 ' A' ' 12' ' ' LEU . . . 52.96 22.76 13.26 Favored Glycine 0 N--CA 1.493 2.471 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.705 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 1.051 ' O ' HG23 ' A' ' 11' ' ' THR . 0.0 OUTLIER -134.58 -11.35 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.752 -1.44 . . . . 0.0 109.738 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.583 ' CE1' ' HE3' ' A' ' 188' ' ' LYS . 99.5 m-85 -144.22 124.46 13.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.021 -1.05 . . . . 0.0 108.749 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.579 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 2.3 pt20 -133.31 129.39 37.48 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.965 -1.084 . . . . 0.0 110.157 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.009 HD12 ' CZ ' ' A' ' 178' ' ' TYR . 17.1 mt -61.27 168.58 2.56 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.67 150.68 44.23 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.084 -1.01 . . . . 0.0 109.786 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.446 ' O ' ' N ' ' A' ' 166' ' ' MET . 36.0 Cg_endo -78.19 -9.53 16.48 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.683 2.255 . . . . 0.0 110.546 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 48.67 23.63 0.67 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.0 109.509 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 93.23 -23.12 31.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.446 ' N ' ' O ' ' A' ' 163' ' ' PRO . 0.2 OUTLIER -176.64 -71.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.376 -1.073 . . . . 0.0 109.237 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 7.0 t0 48.06 24.47 0.64 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.468 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.25 41.16 2.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.285 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.28 -1.53 45.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.495 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 33.2 m120 -156.4 95.74 1.6 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.158 -0.964 . . . . 0.0 108.894 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 2.0 mtp -56.47 -18.85 12.72 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.177 -0.952 . . . . 0.0 109.398 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -75.48 -65.05 0.94 Allowed 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.464 HG13 ' HG2' ' A' ' 177' ' ' GLN . 20.1 t -70.15 -23.48 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.294 -0.879 . . . . 0.0 109.058 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -68.53 -39.87 80.98 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.245 -0.909 . . . . 0.0 109.241 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 12.3 t -76.44 -32.3 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 11.0 tt0 -74.97 -52.34 11.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.116 -0.99 . . . . 0.0 109.445 179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.464 ' HG2' HG13 ' A' ' 173' ' ' VAL . 40.6 mm-40 -58.62 -40.44 83.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.437 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 1.009 ' CZ ' HD12 ' A' ' 161' ' ' LEU . 10.0 t80 -61.13 -50.82 71.66 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.132 -0.98 . . . . 0.0 109.231 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.432 ' O ' ' NZ ' ' A' ' 183' ' ' LYS . . . -64.12 -24.37 67.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.988 -1.07 . . . . 0.0 108.839 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -77.43 -40.92 41.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.274 -0.891 . . . . 0.0 108.986 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.558 ' O ' ' HG ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -58.61 -54.83 42.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.271 -0.893 . . . . 0.0 109.056 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.575 HG23 HD11 ' A' ' 161' ' ' LEU . 93.3 t -61.06 -36.85 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -0.892 . . . . 0.0 109.607 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.474 ' HE3' ' CG ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -53.55 -44.47 69.28 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 109.217 179.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.527 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -84.42 -25.47 28.98 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.358 -0.839 . . . . 0.0 110.07 -179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 185' ' ' LEU . 1.1 mt -62.17 -23.45 66.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.446 -1.409 . . . . 0.0 108.435 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 22.8 t -75.57 -4.39 39.7 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.991 -1.068 . . . . 0.0 108.365 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -104.57 0.87 29.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.828 . . . . 0.0 109.452 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.583 ' HE3' ' CE1' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -61.52 -37.05 82.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.218 -0.926 . . . . 0.0 109.72 -179.354 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.418 ' CG ' ' O ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.932 -1.032 . . . . 0.0 109.481 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.372 0.606 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.543 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 5.7 tt0 -123.02 65.85 0.98 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.246 -0.909 . . . . 0.0 109.087 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.543 ' CG ' ' C ' ' A' ' 2' ' ' GLN . 0.6 OUTLIER 73.1 88.93 0.1 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.344 -0.848 . . . . 0.0 108.899 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.497 ' O ' ' HB3' ' A' ' 5' ' ' ASP . 5.6 pm0 -133.18 64.65 1.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.163 -0.96 . . . . 0.0 109.976 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 4' ' ' GLU . 19.6 t70 71.16 93.5 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.518 -0.738 . . . . 0.0 110.759 179.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.57 3.79 90.38 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.537 -1.025 . . . . 0.0 110.537 178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.586 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 0.1 OUTLIER -101.91 28.41 5.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.962 -1.316 . . . . 0.0 108.937 179.611 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.586 ' CB ' ' O ' ' A' ' 7' ' ' LYS . 2.9 mm-40 144.54 -38.59 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.582 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 2.2 p90 -141.89 114.21 8.25 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-O 122.054 0.93 . . . . 0.0 109.015 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.2 t -100.32 -179.19 4.04 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 13.2 m -111.6 143.72 42.02 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 120.03 -0.668 . . . . 0.0 109.899 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.784 HD12 ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -96.16 163.95 12.89 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.376 -0.828 . . . . 0.0 109.549 179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.488 ' HG2' ' HG2' ' A' ' 14' ' ' LYS . 1.6 pt-20 -87.52 -15.83 36.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.691 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.784 ' O ' HD12 ' A' ' 12' ' ' LEU . 3.3 mmtp -112.56 97.51 40.75 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.148 -0.97 . . . . 0.0 109.849 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.23 158.92 33.48 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.467 2.111 . . . . 0.0 109.863 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.671 ' O ' HG12 ' A' ' 16' ' ' VAL . 15.8 t -140.52 83.27 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.099 -1.001 . . . . 0.0 109.761 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.12 129.7 18.1 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.63 -19.73 52.95 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.996 -1.641 . . . . 0.0 108.996 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.77 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -41.9 164.61 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.41 -1.053 . . . . 0.0 109.556 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.661 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 34.7 Cg_endo -76.43 126.82 9.31 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.573 2.182 . . . . 0.0 110.955 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.818 ' O ' HG13 ' A' ' 155' ' ' VAL . 4.3 mt-30 -40.01 -24.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.558 -0.714 . . . . 0.0 110.421 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.687 HG13 ' HE2' ' A' ' 153' ' ' MET . 59.1 t -149.09 79.12 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 O-C-N 120.764 -1.21 . . . . 0.0 109.044 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.887 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -73.98 112.79 10.45 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.566 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -94.23 149.19 21.47 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.149 -0.97 . . . . 0.0 109.778 -178.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.943 ' CE2' HG21 ' A' ' 145' ' ' VAL . 7.6 m-85 -135.13 103.46 5.55 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.483 -0.76 . . . . 0.0 109.267 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -148.42 140.64 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.891 . . . . 0.0 109.891 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.709 ' CB ' HG22 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -118.16 179.45 4.1 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.09 179.345 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 7.1 m-30 -90.33 40.44 1.01 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.661 ' CG ' HG11 ' A' ' 96' ' ' VAL . 11.0 m-85 -137.91 16.82 2.85 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 110.187 -178.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -113.8 164.81 14.96 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.544 -1.348 . . . . 0.0 109.878 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.74 -41.08 0.34 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.463 2.109 . . . . 0.0 108.092 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.598 ' HB3' ' CE1' ' A' ' 36' ' ' PHE . 9.6 m170 -75.34 -23.53 57.25 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.24 -1.393 . . . . 0.0 107.24 177.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 12.3 t -43.94 -57.71 3.17 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 178.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.455 ' HB2' ' CD ' ' A' ' 97' ' ' GLN . 89.4 t80 -71.48 -55.06 8.6 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.182 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 12.5 mt-30 -54.88 -16.96 3.04 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.228 -0.92 . . . . 0.0 110.527 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.598 ' CE1' ' HB3' ' A' ' 32' ' ' HIS . 4.0 m-30 -86.4 -38.96 16.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.08 -1.013 . . . . 0.0 110.831 -178.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.02 -13.1 20.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.782 -1.199 . . . . 0.0 112.206 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' C ' HG23 ' A' ' 39' ' ' VAL . 3.0 mt-10 -136.27 28.51 3.09 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.17 -1.581 . . . . 0.0 111.418 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.443 ' HB ' ' HA ' ' A' ' 35' ' ' GLN . 91.1 t -151.56 -88.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.394 -1.441 . . . . 0.0 110.138 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.807 ' HB2' HD12 ' A' ' 42' ' ' ILE . 1.4 mt -68.99 -19.49 64.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.181 -0.95 . . . . 0.0 109.747 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 40' ' ' LEU . 2.4 m-70 60.06 18.85 8.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.005 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.807 HD12 ' HB2' ' A' ' 40' ' ' LEU . 1.4 mt -46.98 -36.42 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.479 -0.763 . . . . 0.0 109.44 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.663 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -80.48 -34.34 35.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.991 . . . . 0.0 110.115 -179.555 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.488 ' HA ' ' HG3' ' A' ' 47' ' ' LYS . 15.5 m-20 -82.7 -36.87 25.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.099 -1.001 . . . . 0.0 109.625 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 15.0 t30 -58.31 -34.21 70.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.355 -0.84 . . . . 0.0 110.184 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.663 HG22 ' O ' ' A' ' 43' ' ' SER . 31.5 m -65.92 -31.98 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.033 -1.042 . . . . 0.0 110.021 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.61 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -54.51 -44.89 73.14 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.976 -1.078 . . . . 0.0 109.461 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -44.28 -28.34 0.52 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.119 179.712 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.472 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 10.1 mtmm -112.7 44.5 1.47 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.352 -0.842 . . . . 0.0 109.24 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 47' ' ' LYS . 11.0 mt -115.87 79.35 7.9 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.165 -0.96 . . . . 0.0 109.945 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 35.3 Cg_endo -78.33 143.26 19.55 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.615 2.21 . . . . 0.0 110.119 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -39.45 120.77 1.1 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 122.312 1.054 . . . . 0.0 109.908 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.78 -26.74 5.06 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.54 ' CG1' ' CD2' ' A' ' 50' ' ' LEU . 98.1 t -89.71 85.37 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.174 -1.192 . . . . 0.0 109.296 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.96 93.25 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.343 -0.848 . . . . 0.0 109.779 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.477 ' HG3' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -92.73 101.44 13.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.833 . . . . 0.0 109.437 179.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 4.9 m -111.45 134.09 53.27 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.11 -179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.566 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -114.13 109.2 18.05 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.27 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.482 ' OH ' ' HB3' ' A' ' 137' ' ' GLN . 4.5 m-85 -106.55 177.85 4.73 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.954 -1.092 . . . . 0.0 111.623 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.599 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 49.4 t-80 -111.85 132.62 54.59 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.735 0.779 . . . . 0.0 108.977 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.044 HG11 ' CG1' ' A' ' 150' ' ' VAL . 3.0 m -72.36 156.68 6.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-O 121.416 0.627 . . . . 0.0 110.598 -179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.492 ' OD1' ' HA ' ' A' ' 70' ' ' LYS . 14.0 t30 -118.56 51.19 1.11 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.628 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 1.0 OUTLIER -155.86 61.17 0.59 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.731 -1.23 . . . . 0.0 110.106 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.693 ' HE1' ' CG2' ' A' ' 150' ' ' VAL . 0.0 OUTLIER -144.92 43.37 1.34 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.958 -1.089 . . . . 0.0 109.488 179.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 157.47 -36.17 0.55 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.57 -1.812 . . . . 0.0 108.57 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.94 -43.07 3.13 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -88.7 -79.0 0.32 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.212 -1.169 . . . . 0.0 110.109 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.115 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -78.0 -21.87 50.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.092 -1.005 . . . . 0.0 109.205 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 1.115 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -53.51 -42.83 66.6 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.492 ' HA ' ' OD1' ' A' ' 62' ' ' ASN . 2.1 tttt -68.78 -54.76 14.03 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.16 -1.2 . . . . 0.0 108.362 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.566 ' HB3' HD12 ' A' ' 108' ' ' ILE . 8.2 t70 -56.12 -25.18 44.89 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.782 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 44.4 tp -65.4 -39.68 92.5 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.7 m -59.48 -41.94 90.93 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.429 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 0.4 OUTLIER -60.13 -22.63 63.07 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.782 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -66.23 -40.06 90.01 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 178.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.493 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 46.7 t-105 -64.4 -31.58 72.84 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' O ' ' C ' ' A' ' 78' ' ' VAL . . . -84.39 -68.14 0.74 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.725 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.85 HG21 ' CE1' ' A' ' 122' ' ' TYR . 95.7 t -43.98 -26.95 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.191 -0.943 . . . . 0.0 109.761 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.615 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -82.93 -58.62 2.79 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.085 -1.009 . . . . 0.0 108.717 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -48.28 -27.38 2.46 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.61 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -70.84 -43.15 69.12 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.483 -0.761 . . . . 0.0 109.447 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.671 ' HB2' HG13 ' A' ' 84' ' ' VAL . 23.0 mt -107.12 14.59 26.11 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.212 -0.93 . . . . 0.0 110.3 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 48.39 24.84 3.98 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.671 HG13 ' HB2' ' A' ' 82' ' ' LEU . 35.2 m -83.67 -9.92 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.408 -1.054 . . . . 0.0 110.397 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.467 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.3 OUTLIER -42.73 -63.4 0.79 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.137 -0.977 . . . . 0.0 109.37 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -43.96 -34.68 1.77 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.458 -0.776 . . . . 0.0 110.601 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.7 mttm -79.72 -53.18 7.06 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.186 -0.947 . . . . 0.0 111.741 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.781 HG23 HD12 ' A' ' 92' ' ' LEU . 2.9 m -84.7 -8.42 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.717 -1.239 . . . . 0.0 110.705 -178.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.747 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -72.88 -44.5 61.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.593 -1.317 . . . . 0.0 108.596 178.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.402 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -53.64 -54.13 49.48 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.467 -1.396 . . . . 0.0 110.817 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.436 ' HD2' ' C ' ' A' ' 88' ' ' VAL . 25.0 Cg_endo -72.99 -18.65 23.96 Favored 'Trans proline' 0 C--N 1.302 -1.884 0 N-CA-C 109.82 -0.877 . . . . 0.0 109.82 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.812 ' HG ' HG11 ' A' ' 111' ' ' VAL . 28.8 mt -87.22 -42.63 12.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.329 -0.857 . . . . 0.0 109.043 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.747 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.2 m-30 -63.78 -46.68 84.11 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.003 -1.06 . . . . 0.0 108.856 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -23.05 61.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.209 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -72.49 -33.39 61.16 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.661 HG11 ' CG ' ' A' ' 29' ' ' PHE . 2.3 t -102.32 -1.74 9.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.095 -1.238 . . . . 0.0 109.436 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -110.37 8.71 23.42 Favored 'General case' 0 C--N 1.309 -1.185 0 O-C-N 120.956 -1.09 . . . . 0.0 110.543 -179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.871 ' O ' HG23 ' A' ' 99' ' ' THR . 2.4 mttp -179.91 64.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.634 -1.291 . . . . 0.0 109.277 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.871 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 169.0 -50.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 99' ' ' THR . 8.1 mp0 73.96 16.55 3.63 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.423 -0.798 . . . . 0.0 110.743 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 t -79.74 -9.05 59.6 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.585 ' CB ' HG22 ' A' ' 96' ' ' VAL . 9.0 mm -85.49 78.69 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.78 32.54 2.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.151 -0.968 . . . . 0.0 109.833 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 107' ' ' ASP . 24.1 p -157.96 132.0 8.04 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.994 -1.066 . . . . 0.0 110.208 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.536 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -51.2 -29.54 14.4 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 178.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -64.09 -30.74 71.79 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.548 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.5 OUTLIER -70.61 -48.86 53.01 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.566 HD12 ' HB3' ' A' ' 71' ' ' ASP . 18.9 mt -53.53 -27.06 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -75.93 -39.79 55.49 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.808 . . . . 0.0 109.817 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.467 ' OD2' ' O ' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -62.49 -41.55 98.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.086 -1.009 . . . . 0.0 109.53 -179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.812 HG11 ' HG ' ' A' ' 92' ' ' LEU . 1.5 t -72.15 -39.35 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.108 -0.995 . . . . 0.0 109.352 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.705 ' CE1' HG21 ' A' ' 88' ' ' VAL . 2.7 m-30 -63.93 -48.41 76.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.318 -0.863 . . . . 0.0 110.031 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.1 mt -66.68 -25.41 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.122 -0.986 . . . . 0.0 109.64 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -67.8 -17.54 64.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.179 -0.951 . . . . 0.0 109.816 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.64 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -90.52 7.03 41.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.637 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.53 2.6 82.12 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.64 HG12 ' HB3' ' A' ' 115' ' ' ALA . 3.0 mm -79.14 59.52 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.313 -1.11 . . . . 0.0 109.692 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.473 ' C ' ' O ' ' A' ' 117' ' ' ILE . 5.3 mmtt -34.86 132.02 0.35 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.323 -0.861 . . . . 0.0 110.319 -179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 118' ' ' LYS . . . -40.76 -33.79 0.67 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 63.1 tt0 -59.23 -43.14 92.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -1.18 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.401 ' N ' ' O ' ' A' ' 118' ' ' LYS . 20.9 mt-10 -75.29 -43.64 50.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.243 -0.911 . . . . 0.0 109.653 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.85 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -67.65 -61.97 1.64 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.213 -0.929 . . . . 0.0 108.976 179.72 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 122' ' ' TYR . 11.4 t0 -47.19 -42.71 20.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.878 -1.139 . . . . 0.0 108.731 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.72 -45.93 80.84 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.333 -0.854 . . . . 0.0 109.017 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.524 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -54.21 -49.05 70.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.435 -0.79 . . . . 0.0 109.146 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.502 ' C ' ' CD1' ' A' ' 126' ' ' TRP . 7.2 t90 -59.81 -54.53 45.12 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.155 -0.965 . . . . 0.0 108.496 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.07 -15.31 3.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.588 -0.695 . . . . 0.0 110.15 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 32.6 m -70.3 178.04 3.05 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.988 -1.07 . . . . 0.0 110.431 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.14 -37.67 13.23 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.362 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.6 t -68.65 -46.84 79.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.248 -1.381 . . . . 0.0 109.678 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.61 HG22 ' HB1' ' A' ' 81' ' ' ALA . 5.2 t -63.77 -32.63 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.872 -1.143 . . . . 0.0 108.519 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -71.56 -36.4 70.92 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 108.84 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.59 -36.49 83.99 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.388 -0.82 . . . . 0.0 109.156 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 mt -80.15 -24.72 40.22 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -0.891 . . . . 0.0 108.661 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 131' ' ' VAL . 17.6 t -73.97 -41.93 52.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.55 -52.87 55.44 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.482 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.9 OUTLIER -54.8 -27.3 40.73 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.43 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -67.83 -65.3 0.71 Allowed 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.469 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 2.9 tt0 -51.79 -37.28 50.91 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 144' ' ' ASP . 1.3 mtmt -64.39 -30.77 71.8 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.639 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -66.01 -60.29 2.98 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.453 -0.78 . . . . 0.0 109.052 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.554 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -71.78 -23.11 61.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.262 -0.898 . . . . 0.0 109.823 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -83.35 -26.5 30.47 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.038 -1.039 . . . . 0.0 110.325 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.811 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.3 p30 -81.56 -44.03 17.88 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.901 -1.124 . . . . 0.0 108.595 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.943 HG21 ' CE2' ' A' ' 25' ' ' PHE . 16.0 m -96.39 -10.68 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.293 -0.879 . . . . 0.0 108.731 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.554 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.0 tt0 78.18 -49.48 0.48 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.447 -0.783 . . . . 0.0 110.26 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.976 HD21 HG12 ' A' ' 61' ' ' VAL . 16.2 tp 65.2 133.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.314 -0.866 . . . . 0.0 109.4 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -160.89 40.44 0.16 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.579 -1.326 . . . . 0.0 109.879 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.67 107.43 0.21 Allowed Glycine 0 N--CA 1.489 2.232 0 C-N-CA 119.442 -1.361 . . . . 0.0 110.464 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 1.044 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.0 144.71 29.62 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.353 -1.086 . . . . 0.0 109.442 178.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.04 152.4 91.8 Favored 'Cis proline' 0 C--N 1.316 -1.138 0 C-N-CA 124.041 -1.233 . . . . 0.0 110.466 0.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.884 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -128.75 156.03 44.18 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.393 -1.442 . . . . 0.0 109.364 179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.687 ' HE2' HG13 ' A' ' 22' ' ' VAL . 0.0 OUTLIER -150.87 133.76 15.87 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.205 -0.934 . . . . 0.0 109.682 -179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.544 ' HE1' ' HB1' ' A' ' 152' ' ' ALA . 4.3 m-85 -132.41 125.65 31.3 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.373 -0.829 . . . . 0.0 109.913 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.818 HG13 ' O ' ' A' ' 21' ' ' GLN . 73.5 t -96.94 132.12 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.219 -0.926 . . . . 0.0 110.153 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.77 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.9 OUTLIER 47.75 20.88 0.23 Allowed 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.913 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.6 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 57.87 55.09 32.43 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.2 mtmm -164.45 -39.96 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.205 -1.174 . . . . 0.0 108.121 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -110.86 124.09 51.38 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.749 -0.78 . . . . 0.0 108.948 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.527 ' HB3' HD22 ' A' ' 12' ' ' LEU . 15.4 pt20 -120.79 127.29 51.82 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.966 -1.084 . . . . 0.0 109.912 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.542 HD21 ' HB ' ' A' ' 181' ' ' THR . 19.7 mt -64.5 174.12 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -156.09 76.62 4.63 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.986 -1.071 . . . . 0.0 109.716 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.07 -18.5 11.29 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.752 2.301 . . . . 0.0 110.711 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.36 -14.51 18.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.898 . . . . 0.0 109.716 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -113.58 38.64 3.12 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.458 ' O ' ' C ' ' A' ' 167' ' ' ASP . 0.6 OUTLIER -106.24 -77.02 0.6 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.196 -1.179 . . . . 0.0 109.637 179.916 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.458 ' C ' ' O ' ' A' ' 166' ' ' MET . 10.4 t0 40.94 33.37 0.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.253 -0.904 . . . . 0.0 109.734 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.428 ' O ' ' CB ' ' A' ' 169' ' ' SER . 7.6 t -68.88 -7.12 31.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.145 -0.972 . . . . 0.0 109.667 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' A' ' 168' ' ' THR . 0.7 OUTLIER 69.81 40.47 1.31 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.383 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -159.73 93.5 1.09 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.24 -0.913 . . . . 0.0 109.181 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.8 mtp -59.74 -15.59 21.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 109.735 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.49 -55.09 8.55 Favored 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.681 -0.637 . . . . 0.0 109.657 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.496 HG13 ' HG3' ' A' ' 177' ' ' GLN . 14.1 t -70.35 -28.59 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.121 -0.987 . . . . 0.0 109.533 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.453 ' O ' ' CD1' ' A' ' 174' ' ' PHE . 2.5 t80 -67.46 -46.04 74.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.032 -1.043 . . . . 0.0 109.437 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 82.6 t -74.74 -24.27 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.267 -0.896 . . . . 0.0 109.683 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 180' ' ' ASP . 1.4 mt-30 -81.81 -52.74 6.81 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 109.511 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.545 ' HB3' ' NE2' ' A' ' 8' ' ' GLN . 41.4 mt-30 -63.85 -32.3 73.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.192 -0.943 . . . . 0.0 109.569 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.465 ' CD1' ' C ' ' A' ' 178' ' ' TYR . 17.8 t80 -74.11 -58.38 3.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.093 -1.004 . . . . 0.0 109.429 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.35 -33.06 67.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.946 -1.096 . . . . 0.0 108.44 179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 176' ' ' GLN . 33.2 t0 -71.31 -42.61 68.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.493 -0.754 . . . . 0.0 109.342 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.542 ' HB ' HD21 ' A' ' 161' ' ' LEU . 0.6 OUTLIER -55.09 -57.07 13.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.093 179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.437 HG22 ' HE1' ' A' ' 153' ' ' MET . 2.3 t -57.12 -35.76 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 120.823 -1.173 . . . . 0.0 109.71 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -48.33 82.2 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.154 -0.967 . . . . 0.0 109.903 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.26 -21.2 39.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.96 -1.088 . . . . 0.0 110.337 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 181' ' ' THR . 68.6 mt -73.66 -18.54 61.01 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.744 -1.222 . . . . 0.0 109.002 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 3.5 m -74.14 -4.47 35.92 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 176.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -105.66 5.1 30.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.526 -0.733 . . . . 0.0 109.805 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.533 ' HG2' ' O ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -73.11 -5.89 42.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.957 -1.089 . . . . 0.0 109.709 -179.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 188' ' ' LYS . 4.5 pttt . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.04 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.21 0.529 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.474 ' O ' ' HB3' ' A' ' 8' ' ' GLN . 95.4 mt-30 -91.48 54.22 2.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.461 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -153.58 85.04 1.18 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.413 ' O ' ' C ' ' A' ' 5' ' ' ASP . 12.5 mt-10 -114.07 56.96 0.7 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.127 -0.983 . . . . 0.0 110.42 -179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.413 ' C ' ' O ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER 42.61 82.19 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.511 -0.743 . . . . 0.0 110.359 179.063 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.81 -24.63 6.02 Favored Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.723 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -82.15 -68.31 0.71 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.0 -1.294 . . . . 0.0 109.178 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.607 ' NE2' ' CD1' ' A' ' 9' ' ' TYR . 2.1 pp0? -95.23 -1.92 50.64 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.248 -0.907 . . . . 0.0 110.305 -179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.607 ' CD1' ' NE2' ' A' ' 8' ' ' GLN . 0.2 OUTLIER 179.64 130.45 0.09 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.873 -1.142 . . . . 0.0 109.721 179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.2 t -112.87 179.95 3.82 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.872 HG23 ' O ' ' A' ' 158' ' ' LYS . 59.2 m -127.87 143.82 51.1 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.456 0.645 . . . . 0.0 109.581 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 14' ' ' LYS . 0.2 OUTLIER -100.69 156.17 17.48 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.399 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 -93.63 0.54 56.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.492 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.507 ' O ' HD12 ' A' ' 12' ' ' LEU . 4.2 mtmt -124.88 89.41 52.58 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.201 -0.937 . . . . 0.0 109.283 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.03 166.55 26.52 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.608 2.206 . . . . 0.0 110.111 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.918 HG13 ' HB2' ' A' ' 19' ' ' ALA . 7.2 p -120.78 109.22 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.14 -0.975 . . . . 0.0 110.264 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.38 125.24 4.54 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.491 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 91.53 -10.63 74.28 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.918 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -33.87 148.11 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.787 -0.831 . . . . 0.0 109.906 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.588 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.4 Cg_endo -81.21 133.72 8.84 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.472 2.115 . . . . 0.0 111.383 -179.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.842 ' OE1' HG22 ' A' ' 54' ' ' VAL . 1.5 mm-40 -51.11 -21.81 2.13 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.508 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 24.1 t -151.12 89.48 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.354 -0.841 . . . . 0.0 108.975 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.674 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -80.43 128.74 33.92 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.487 ' HB3' ' HA ' ' A' ' 58' ' ' LYS . 8.7 tt0 -113.48 96.59 5.96 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.92 -1.113 . . . . 0.0 109.729 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.923 ' HB2' ' HB3' ' A' ' 152' ' ' ALA . 4.4 m-85 -84.76 115.71 22.85 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.448 -0.782 . . . . 0.0 109.458 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.538 ' CE1' ' OE1' ' A' ' 37' ' ' GLU . 2.6 p90 -160.35 142.01 12.54 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.038 -1.065 . . . . 0.0 110.268 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.593 ' HB2' ' CE1' ' A' ' 60' ' ' HIS . 94.0 p -125.64 -172.72 2.66 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.624 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -109.3 49.3 0.83 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.675 -1.266 . . . . 0.0 108.472 178.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.534 ' HB3' ' CE ' ' A' ' 64' ' ' MET . 7.1 m-85 -133.78 -3.92 2.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.996 -1.065 . . . . 0.0 110.809 -178.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.637 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 4.5 m -109.41 173.23 3.06 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.776 -1.203 . . . . 0.0 108.586 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.3 Cg_endo -76.19 -58.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 121.752 1.635 . . . . 0.0 109.316 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.492 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 69.5 m-70 -63.37 -20.09 65.22 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 178.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.536 ' HG ' ' CB ' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -52.58 -53.89 40.33 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.582 0.706 . . . . 0.0 109.286 179.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 8.8 t80 -80.49 -37.46 31.69 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.575 -0.703 . . . . 0.0 109.884 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.537 ' CD ' HG21 ' A' ' 39' ' ' VAL . 35.6 mm-40 -66.09 -26.07 67.31 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.184 -0.948 . . . . 0.0 109.954 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.492 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -70.66 -39.52 73.56 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.054 -1.029 . . . . 0.0 109.578 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.538 ' OE1' ' CE1' ' A' ' 26' ' ' PHE . 1.2 mt-10 -98.15 -10.06 24.77 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 0.0 111.898 -178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' HB2' ' CE1' ' A' ' 34' ' ' TYR . 1.8 mm-40 -138.3 27.69 2.56 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.266 -1.521 . . . . 0.0 111.819 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG21 ' CD ' ' A' ' 35' ' ' GLN . 64.9 t -151.45 -83.28 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.432 -1.418 . . . . 0.0 110.026 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.991 HD21 ' HB3' ' A' ' 171' ' ' MET . 18.0 mt -65.14 -14.33 60.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.868 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.508 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 23.1 m-70 56.57 18.37 3.56 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.187 -0.946 . . . . 0.0 109.146 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 46' ' ' VAL . 9.9 mt -55.39 -18.59 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.367 -0.833 . . . . 0.0 109.393 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.5 m -82.63 -54.38 5.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 110.023 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -86.77 -33.0 20.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.124 -0.985 . . . . 0.0 109.72 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 41' ' ' HIS . 10.4 t-20 -51.68 -27.23 11.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.838 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 42' ' ' ILE . 31.4 t -81.21 -17.2 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.302 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 1.036 ' HA ' HD12 ' A' ' 50' ' ' LEU . 1.7 mttm -76.11 -17.93 59.39 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.813 -1.179 . . . . 0.0 110.074 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 mmtt -64.46 -16.24 62.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.234 -0.916 . . . . 0.0 109.615 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.2 mttt -143.59 36.23 1.31 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 110.262 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.036 HD12 ' HA ' ' A' ' 47' ' ' LYS . 5.2 mt -91.94 142.9 26.95 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.954 -1.091 . . . . 0.0 109.595 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.576 ' HD2' HD23 ' A' ' 50' ' ' LEU . 35.8 Cg_endo -78.03 149.88 25.99 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.689 2.259 . . . . 0.0 110.051 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -79.09 21.38 0.45 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.93 -1.106 . . . . 0.0 110.469 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.414 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -124.46 32.74 4.01 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.842 HG22 ' OE1' ' A' ' 21' ' ' GLN . 44.6 t -154.32 131.85 2.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 121.645 -0.915 . . . . 0.0 108.702 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -115.5 137.61 51.89 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 122.178 0.989 . . . . 0.0 109.961 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.508 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 3.3 ptm -107.04 98.96 8.55 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.39 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 24' ' ' GLU . 86.7 m -82.24 142.86 31.77 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.831 -1.148 . . . . 0.0 109.742 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -116.1 111.13 19.82 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.365 -0.834 . . . . 0.0 110.028 -179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.594 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 1.7 m-85 -113.44 158.24 20.92 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.173 -0.954 . . . . 0.0 110.864 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.951 ' CE1' HD22 ' A' ' 72' ' ' LEU . 17.9 t60 -99.94 124.69 45.53 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.01 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.3 m -69.85 144.95 13.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.598 -0.689 . . . . 0.0 110.166 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.541 ' HB2' ' CE ' ' A' ' 70' ' ' LYS . 0.2 OUTLIER -113.57 49.23 0.99 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.652 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 2.9 p90 -145.37 80.12 1.59 Allowed 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 122.17 0.986 . . . . 0.0 110.048 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.566 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -159.91 -59.17 0.06 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.872 -1.143 . . . . 0.0 109.735 179.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.566 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -87.98 -28.07 24.38 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 107.988 -2.045 . . . . 0.0 107.988 178.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.472 ' O ' ' HG2' ' A' ' 70' ' ' LYS . . . 86.3 -49.17 4.04 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.19 -78.72 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.562 -0.964 . . . . 0.0 110.008 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.112 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -73.79 -22.62 59.76 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.31 -0.956 . . . . 0.0 108.855 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 1.112 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -55.53 -43.32 85.63 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 107.434 -2.266 . . . . 0.0 107.434 177.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.541 ' CE ' ' HB2' ' A' ' 62' ' ' ASN . 8.6 mmmt -63.71 -47.8 79.68 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.508 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 13.3 t0 -64.04 -28.38 69.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.951 HD22 ' CE1' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -58.16 -38.5 76.74 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 178.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.571 HG23 ' OE1' ' A' ' 138' ' ' GLN . 6.7 m -66.24 -42.85 88.05 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.551 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.0 OUTLIER -60.99 -18.58 58.29 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 177.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -68.37 -47.49 67.28 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 25.9 t-105 -58.99 -27.73 65.69 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.736 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -79.37 -52.46 8.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.432 -0.792 . . . . 0.0 109.967 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.732 HG21 ' CE1' ' A' ' 122' ' ' TYR . 39.2 t -60.77 -26.53 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.044 -1.035 . . . . 0.0 109.875 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.552 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -80.23 -63.43 1.41 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.038 -1.039 . . . . 0.0 109.003 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.43 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -45.9 -27.94 1.0 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.197 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.682 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -70.35 -46.15 64.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.437 -0.79 . . . . 0.0 109.463 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.467 ' HB2' HG13 ' A' ' 84' ' ' VAL . 21.6 mt -102.05 12.07 37.42 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.15 -0.969 . . . . 0.0 110.214 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 53.56 20.55 11.94 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.552 HG22 ' HA ' ' A' ' 79' ' ' ALA . 34.9 m -86.47 -7.93 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.431 -1.041 . . . . 0.0 110.669 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.474 ' CA ' ' HB1' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -40.82 -59.47 1.41 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.087 -1.008 . . . . 0.0 109.986 -179.609 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -48.4 -34.19 10.42 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 110.273 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.449 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 mttt -82.74 -52.88 6.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.199 -0.938 . . . . 0.0 111.471 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.639 HG23 HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -75.15 -6.81 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.633 -1.292 . . . . 0.0 110.505 -178.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.675 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -77.04 -44.77 29.54 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 120.948 -1.095 . . . . 0.0 108.513 178.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.44 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -52.32 -52.38 63.49 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 120.543 -1.348 . . . . 0.0 110.565 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.677 ' HB2' HG13 ' A' ' 111' ' ' VAL . 26.0 Cg_endo -73.68 -20.93 19.67 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 O-C-N 122.727 0.856 . . . . 0.0 110.022 179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.872 ' HG ' HG11 ' A' ' 111' ' ' VAL . 13.1 mt -85.61 -41.9 14.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.234 -0.916 . . . . 0.0 108.967 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.675 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.6 m-30 -65.95 -45.71 80.81 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 121.071 -1.018 . . . . 0.0 108.862 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.401 ' HG3' ' O ' ' A' ' 90' ' ' VAL . 23.5 mt-10 -76.3 -26.75 56.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 0.0 109.556 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.434 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -65.56 -36.93 93.11 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.9 t -93.07 -12.78 8.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.151 -1.205 . . . . 0.0 108.594 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 1.3 mt-30 -104.98 4.12 31.39 Favored 'General case' 0 C--N 1.311 -1.095 0 O-C-N 121.103 -0.998 . . . . 0.0 111.051 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.775 ' O ' HG23 ' A' ' 99' ' ' THR . 0.0 OUTLIER -160.15 61.11 0.34 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.404 -1.435 . . . . 0.0 109.963 -179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.775 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.11 -49.71 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.464 -0.773 . . . . 0.0 109.384 179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 74.27 15.2 3.62 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.117 -0.989 . . . . 0.0 110.628 179.333 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.0 t -86.69 -4.29 59.16 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-O 121.732 0.777 . . . . 0.0 108.988 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.488 HG23 ' OD1' ' A' ' 107' ' ' ASP . 6.5 mm -80.57 77.36 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HD3' ' C ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -140.75 35.13 1.79 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.221 -0.924 . . . . 0.0 110.074 -179.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 107' ' ' ASP . 54.9 p -157.26 133.74 9.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.856 -1.152 . . . . 0.0 109.968 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.883 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -50.71 -35.7 32.57 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.481 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 75.7 m -59.19 -28.86 67.02 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.549 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -75.39 -50.78 14.84 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.883 HD12 ' HA ' ' A' ' 105' ' ' ALA . 21.9 mt -47.25 -31.34 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.086 -1.009 . . . . 0.0 109.421 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 106' ' ' SER . 1.3 ptm180 -78.99 -37.27 39.71 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.945 -1.097 . . . . 0.0 109.349 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -54.64 -46.06 73.88 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.153 -0.967 . . . . 0.0 108.929 179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.872 HG11 ' HG ' ' A' ' 92' ' ' LEU . 70.4 t -69.95 -39.91 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.193 -0.942 . . . . 0.0 109.227 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.61 ' HD2' HG21 ' A' ' 117' ' ' ILE . 1.4 m-85 -59.6 -53.79 53.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.717 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 19.1 mt -60.21 -25.96 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.107 -0.996 . . . . 0.0 109.426 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -66.47 -16.97 64.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.164 -0.96 . . . . 0.0 109.378 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.622 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -100.44 -7.14 24.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.335 -0.853 . . . . 0.0 109.544 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.76 -5.27 25.99 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.783 HD12 ' N ' ' A' ' 117' ' ' ILE . 2.2 mp -78.42 52.04 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.231 -1.158 . . . . 0.0 109.278 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.466 ' O ' ' O ' ' A' ' 117' ' ' ILE . 38.3 mttp -36.2 157.26 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.318 -0.864 . . . . 0.0 110.555 -179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 120' ' ' GLU . . . -59.82 -50.58 66.19 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 119' ' ' GLY . 21.1 tt0 -43.29 -55.19 4.16 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.03 -1.276 . . . . 0.0 109.929 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.431 ' O ' ' HB3' ' A' ' 124' ' ' ALA . 1.3 tt0 -63.98 -63.22 1.22 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.255 -0.903 . . . . 0.0 109.976 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.732 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -46.27 -60.94 2.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.135 -0.978 . . . . 0.0 109.239 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 122' ' ' TYR . 1.2 m-20 -44.54 -34.25 2.04 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.152 -0.968 . . . . 0.0 109.062 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 121' ' ' GLU . . . -75.63 -44.36 43.13 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.353 -0.842 . . . . 0.0 109.23 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.688 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -59.02 -48.08 82.9 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.409 -0.807 . . . . 0.0 109.17 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.536 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 10.8 t90 -59.44 -53.23 60.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.404 -0.81 . . . . 0.0 108.957 179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -54.94 -15.72 2.2 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.642 -0.661 . . . . 0.0 110.236 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.41 178.1 7.44 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.976 -1.078 . . . . 0.0 109.971 -179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -91.45 -36.6 13.68 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.566 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 23.6 t -64.27 -47.3 90.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.205 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.688 HG21 ' HB1' ' A' ' 125' ' ' ALA . 21.3 t -64.39 -39.84 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.109 -0.994 . . . . 0.0 108.481 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -29.1 67.42 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 50.4 m -66.27 -34.39 77.89 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.352 -0.842 . . . . 0.0 109.019 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -28.5 54.92 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.736 HG23 ' CB ' ' A' ' 77' ' ' ALA . 6.8 t -75.1 -36.34 37.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -67.66 -46.15 73.23 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.593 -0.692 . . . . 0.0 109.405 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.444 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 1.0 OUTLIER -68.83 -23.64 64.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.428 179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.594 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 4.7 mt-30 -72.49 -69.41 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.083 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.76 -35.05 21.02 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.427 ' O ' ' CG ' ' A' ' 144' ' ' ASP . 12.1 mtpt -75.94 -29.9 58.5 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.321 -0.862 . . . . 0.0 108.874 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -57.34 -56.26 24.08 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.213 -0.93 . . . . 0.0 108.751 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -75.54 -32.89 60.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.391 -0.818 . . . . 0.0 109.925 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.21 -22.15 61.31 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.105 -0.997 . . . . 0.0 109.46 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.427 ' CG ' ' O ' ' A' ' 140' ' ' LYS . 73.7 m-20 -82.45 -47.36 12.34 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.853 HG21 ' HE2' ' A' ' 25' ' ' PHE . 11.3 m -88.55 -5.49 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 2.6 tp60 80.8 -50.36 0.31 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.587 -0.696 . . . . 0.0 109.543 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.643 HD13 ' CD2' ' A' ' 25' ' ' PHE . 13.1 tp 61.51 137.92 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.423 -0.798 . . . . 0.0 109.228 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -161.02 33.42 0.14 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.544 -1.347 . . . . 0.0 110.339 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 160.14 109.69 0.26 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 118.905 -1.617 . . . . 0.0 111.208 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 1.01 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -87.93 144.35 34.65 Favored Pre-proline 0 N--CA 1.499 2.014 0 O-C-N 121.586 -0.949 . . . . 0.0 109.057 178.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.79 152.65 92.86 Favored 'Cis proline' 0 C--N 1.315 -1.222 0 C-N-CA 123.923 -1.282 . . . . 0.0 110.526 0.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.923 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -123.54 141.8 51.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.361 -1.462 . . . . 0.0 109.139 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.506 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 1.6 ttp -130.27 130.94 45.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.126 -0.984 . . . . 0.0 109.71 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.779 ' HE1' ' HB1' ' A' ' 152' ' ' ALA . 8.3 m-85 -133.73 131.44 39.41 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.425 -0.797 . . . . 0.0 109.764 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.731 HG22 ' O ' ' A' ' 21' ' ' GLN . 12.2 t -105.32 125.57 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.753 -1.217 . . . . 0.0 108.618 178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' A' ' 20' ' ' PRO . 18.6 t-20 48.08 26.39 1.0 Allowed 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.736 -0.786 . . . . 0.0 108.901 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 52.17 25.27 17.76 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.208 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.872 ' O ' HG23 ' A' ' 11' ' ' THR . 10.0 tttm -124.9 -19.2 5.32 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.835 -1.391 . . . . 0.0 108.894 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.497 ' HB2' ' HE3' ' A' ' 188' ' ' LYS . 94.0 m-85 -141.66 125.08 16.6 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 0.0 108.92 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.602 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -128.79 134.78 48.49 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 120.877 -1.139 . . . . 0.0 109.632 -179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.519 HD12 ' CZ ' ' A' ' 178' ' ' TYR . 12.8 mt -68.02 177.14 2.3 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.627 -0.671 . . . . 0.0 109.287 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -151.64 82.7 5.54 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.165 -0.959 . . . . 0.0 109.888 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.86 50.28 3.22 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.666 2.244 . . . . 0.0 110.311 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.5 146.13 37.82 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.373 -0.829 . . . . 0.0 108.778 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 66.85 7.56 43.18 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.986 -1.246 . . . . 0.0 109.986 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.81 -99.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.962 -1.316 . . . . 0.0 109.295 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 17.7 t0 60.64 35.38 19.9 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.84 -1.163 . . . . 0.0 109.709 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 169' ' ' SER . 17.2 p -69.57 -29.51 67.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.004 -1.06 . . . . 0.0 109.911 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.536 ' CB ' ' O ' ' A' ' 168' ' ' THR . 1.0 OUTLIER 77.68 38.93 0.19 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.333 -0.855 . . . . 0.0 109.26 -179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -153.35 80.59 1.18 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.991 ' HB3' HD21 ' A' ' 40' ' ' LEU . 3.8 mtm -58.69 -15.77 13.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.491 -0.756 . . . . 0.0 109.967 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -75.45 -50.82 14.62 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 121.696 -0.628 . . . . 0.0 109.341 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 16.5 t -74.69 -29.56 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.382 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 178' ' ' TYR . 33.4 t80 -69.07 -36.2 77.36 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.947 -1.095 . . . . 0.0 108.614 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.784 ' CG2' HD22 ' A' ' 40' ' ' LEU . 24.3 t -74.34 -28.71 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.363 -0.836 . . . . 0.0 108.916 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -81.53 -58.39 3.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.219 -0.926 . . . . 0.0 109.053 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.72 -36.53 36.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.203 -0.936 . . . . 0.0 109.074 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.519 ' CZ ' HD12 ' A' ' 161' ' ' LEU . 18.9 t80 -69.44 -47.15 64.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.193 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -66.59 -22.42 66.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.15 -0.969 . . . . 0.0 108.978 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -79.09 -45.3 20.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.37 -0.831 . . . . 0.0 109.305 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.665 ' O ' HD23 ' A' ' 185' ' ' LEU . 6.5 m -63.11 -31.78 73.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -0.958 . . . . 0.0 109.317 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.505 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 52.0 t -77.39 -39.59 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 120.747 -1.22 . . . . 0.0 109.357 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 26.8 tttt -56.96 -52.23 66.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.26 -0.9 . . . . 0.0 109.276 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.529 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.5 -24.41 50.08 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 1.059 HD13 ' CE ' ' A' ' 188' ' ' LYS . 0.2 OUTLIER -64.31 -20.71 66.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.875 -1.141 . . . . 0.0 108.839 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.764 ' CB ' HG21 ' A' ' 54' ' ' VAL . 63.0 p -87.3 7.54 28.25 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.865 -1.147 . . . . 0.0 108.273 177.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.421 ' O ' ' C ' ' A' ' 188' ' ' LYS . 0.1 OUTLIER -119.41 8.06 11.31 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.392 -0.818 . . . . 0.0 109.542 -179.662 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 1.059 ' CE ' HD13 ' A' ' 185' ' ' LEU . 0.4 OUTLIER -43.03 -54.68 4.18 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.391 -0.818 . . . . 0.0 109.318 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.316 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.312 0.577 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.529 ' O ' ' CB ' ' A' ' 3' ' ' TYR . 1.4 tp60 -126.49 65.23 1.25 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.934 . . . . 0.0 109.23 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.608 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.7 OUTLIER 75.95 98.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 5' ' ' ASP . 4.9 mt-10 -128.17 66.04 1.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.181 -0.949 . . . . 0.0 110.34 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' GLU . 1.6 m-20 61.3 91.77 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 110.407 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.98 68.56 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 120.092 -1.051 . . . . 0.0 110.59 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.581 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 9.1 tttp -95.64 26.07 4.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.991 -1.299 . . . . 0.0 108.561 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.581 ' CB ' ' O ' ' A' ' 7' ' ' LYS . 0.0 OUTLIER 145.09 -34.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.575 ' O ' ' CG ' ' A' ' 9' ' ' TYR . 2.5 p90 -141.86 115.59 9.14 Favored 'General case' 0 N--CA 1.485 1.276 0 O-C-N 121.001 -1.062 . . . . 0.0 109.225 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 t -105.25 179.62 4.22 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.332 -178.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.8 m -104.32 157.85 16.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.746 -0.596 . . . . 0.0 109.713 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.783 HD11 ' HB2' ' A' ' 160' ' ' GLN . 1.6 mp -100.08 159.11 15.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.362 -0.836 . . . . 0.0 109.477 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -98.97 11.75 38.03 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.936 . . . . 0.0 109.443 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -168.3 93.27 0.61 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 0.0 109.195 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.495 ' HB3' ' O ' ' A' ' 157' ' ' GLY . 36.4 Cg_endo -77.85 161.79 30.02 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.536 2.157 . . . . 0.0 110.891 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.91 HG13 ' CB ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER -113.23 96.79 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.0 109.437 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.456 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -41.66 126.96 3.1 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 94.02 -16.69 60.35 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.91 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -38.63 158.18 0.1 Allowed Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.484 -1.01 . . . . 0.0 109.94 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.567 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.7 Cg_endo -80.42 138.75 12.53 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.827 2.351 . . . . 0.0 111.48 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.674 ' O ' HG13 ' A' ' 155' ' ' VAL . 6.0 mt-30 -47.53 -22.34 0.46 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.476 -0.765 . . . . 0.0 109.653 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.716 ' O ' HG12 ' A' ' 22' ' ' VAL . 8.4 t -150.36 80.45 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.04 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.628 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -75.58 129.49 37.28 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -112.73 129.76 56.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.947 -1.095 . . . . 0.0 109.827 -179.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.062 ' CE2' HG21 ' A' ' 145' ' ' VAL . 8.4 m-85 -116.88 102.83 9.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.247 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -146.4 136.36 23.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.894 -1.129 . . . . 0.0 110.026 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.609 ' CB ' ' CE1' ' A' ' 60' ' ' HIS . 0.2 OUTLIER -110.06 171.79 7.24 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.404 -0.81 . . . . 0.0 109.522 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.605 ' HB2' HD21 ' A' ' 72' ' ' LEU . 7.9 m-30 -87.59 43.58 1.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.539 ' CE1' HD22 ' A' ' 72' ' ' LEU . 9.6 m-85 -143.23 12.32 1.78 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.371 -0.83 . . . . 0.0 110.127 -179.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 4.7 m -106.88 160.52 26.04 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 120.778 -1.201 . . . . 0.0 109.378 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -75.65 -32.39 4.72 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.111 1.874 . . . . 0.0 107.928 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.535 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.8 t-160 -79.9 -25.52 40.55 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 37.1 t -45.05 -64.17 0.77 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 178.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.576 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 28.0 t80 -65.0 -44.71 88.38 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-O 121.294 0.569 . . . . 0.0 110.055 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.496 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 52.7 mt-30 -67.43 -16.42 64.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.232 -0.917 . . . . 0.0 110.859 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.535 ' N ' ' O ' ' A' ' 32' ' ' HIS . 12.7 t80 -76.72 -52.0 10.41 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.979 -1.076 . . . . 0.0 110.344 -179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -106.53 -4.62 19.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.789 -1.195 . . . . 0.0 112.072 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.576 ' HB2' ' CD1' ' A' ' 34' ' ' TYR . 10.6 mt-10 -124.4 19.76 8.85 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.213 -1.555 . . . . 0.0 111.332 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.517 ' CG2' ' CE2' ' A' ' 34' ' ' TYR . 64.1 t -151.76 -84.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.614 -1.304 . . . . 0.0 109.92 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.846 HD21 ' HB3' ' A' ' 171' ' ' MET . 13.8 mt -63.96 -13.9 49.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.94 . . . . 0.0 109.867 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 44' ' ' ASP . 57.0 m-70 49.05 24.39 0.89 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.169 -0.957 . . . . 0.0 108.649 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.416 HD11 HD13 ' A' ' 40' ' ' LEU . 1.8 mt -43.18 -27.91 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.544 -0.722 . . . . 0.0 109.442 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -85.26 -16.62 39.58 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.146 -0.971 . . . . 0.0 110.867 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' A' ' 41' ' ' HIS . 35.3 t70 -87.15 -34.05 19.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.916 -1.115 . . . . 0.0 110.413 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -73.26 -44.15 59.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.119 -0.988 . . . . 0.0 110.215 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.7 m -55.96 -25.13 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.127 -0.983 . . . . 0.0 110.021 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.537 ' HG2' HD12 ' A' ' 50' ' ' LEU . 3.1 mttt -65.67 -27.35 68.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.101 -0.999 . . . . 0.0 109.343 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -55.3 -18.56 6.58 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.376 -0.827 . . . . 0.0 109.096 179.787 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.512 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.9 OUTLIER -134.86 48.26 2.3 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.223 -0.923 . . . . 0.0 109.764 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.537 HD12 ' HG2' ' A' ' 47' ' ' LYS . 10.7 mt -104.08 102.86 34.71 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.062 -1.024 . . . . 0.0 110.149 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 34.2 Cg_endo -76.3 152.78 35.19 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.512 2.141 . . . . 0.0 109.273 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 52' ' ' GLU . 12.1 tt0 -72.15 23.2 0.05 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.637 -1.289 . . . . 0.0 111.243 -179.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.484 ' O ' ' NE2' ' A' ' 21' ' ' GLN . . . -122.13 29.47 5.53 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 108.323 -1.911 . . . . 0.0 108.323 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 186' ' ' SER . 68.5 t -148.92 121.17 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.502 -0.999 . . . . 0.0 108.722 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -104.7 116.69 32.48 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.262 -0.899 . . . . 0.0 110.471 -179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.524 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -94.94 96.99 9.66 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.438 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -88.68 141.58 28.4 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.039 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.68 113.93 21.95 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.404 -0.81 . . . . 0.0 109.639 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 138' ' ' GLN . 2.2 m-85 -116.97 154.05 31.55 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.995 -1.066 . . . . 0.0 111.838 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.609 ' CE1' ' CB ' ' A' ' 27' ' ' SER . 37.2 t-80 -108.87 111.71 23.56 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.047 HG11 HD22 ' A' ' 147' ' ' LEU . 3.1 m -82.36 158.18 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 0.0 109.976 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 70' ' ' LYS . 1.6 p30 -108.99 48.24 0.87 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.282 -0.886 . . . . 0.0 110.37 -178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.649 ' CE1' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -119.94 45.72 2.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.923 -1.111 . . . . 0.0 110.219 179.468 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.527 ' HG3' ' CD1' ' A' ' 63' ' ' PHE . 34.9 mtp -159.65 47.66 0.28 Allowed 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.514 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 159.32 58.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 107.99 -2.044 . . . . 0.0 107.99 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.462 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -33.37 -36.56 0.05 OUTLIER Glycine 0 N--CA 1.493 2.499 0 O-C-N 122.004 -0.704 . . . . 0.0 111.472 -178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.433 ' N ' ' O ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -87.59 -79.31 0.29 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.767 -1.431 . . . . 0.0 110.762 -178.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.9 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -85.74 -19.61 30.54 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.94 -1.1 . . . . 0.0 110.261 -179.364 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.578 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -56.79 -39.65 87.86 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.233 -1.947 . . . . 0.0 108.233 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.48 ' HA ' ' HB2' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -65.09 -42.85 93.67 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.109 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.25 -24.49 64.9 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.769 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 41.7 tp -65.64 -47.73 74.61 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.543 ' CG2' ' NE2' ' A' ' 138' ' ' GLN . 2.0 m -58.58 -43.46 89.45 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 1.053 ' O ' HG23 ' A' ' 78' ' ' VAL . 5.7 tp60 -55.69 -27.45 50.34 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 177.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.58 -41.52 98.36 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.497 ' HB2' ' CB ' ' A' ' 60' ' ' HIS . 47.8 t-105 -61.47 -30.68 70.75 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.391 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.674 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -81.68 -39.31 24.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 110.057 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.053 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.3 t -77.07 -27.12 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.036 -1.04 . . . . 0.0 109.75 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.468 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -80.87 -54.37 5.65 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.14 -0.975 . . . . 0.0 109.295 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -48.67 -27.79 3.11 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.203 -0.936 . . . . 0.0 108.742 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.927 ' HB2' HG22 ' A' ' 131' ' ' VAL . . . -60.5 -56.03 26.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.432 -0.792 . . . . 0.0 110.119 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.785 ' HB2' HG13 ' A' ' 84' ' ' VAL . 3.2 mt -102.04 10.38 39.61 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.038 -1.038 . . . . 0.0 110.59 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 58.45 27.98 61.57 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.919 HG11 HG12 ' A' ' 117' ' ' ILE . 19.7 m -81.98 -6.64 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.375 -1.073 . . . . 0.0 109.858 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' O ' ' N ' ' A' ' 89' ' ' THR . 3.9 tt0 -43.88 -65.1 0.55 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.547 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -41.41 -34.02 0.48 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.412 -0.805 . . . . 0.0 109.852 179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -80.71 -51.95 8.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.459 -0.776 . . . . 0.0 111.158 -178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.857 HG23 HD12 ' A' ' 92' ' ' LEU . 1.6 m -86.61 -9.57 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 120.708 -1.245 . . . . 0.0 110.869 -178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.689 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.46 -44.03 46.3 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.819 -1.176 . . . . 0.0 108.717 179.241 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.435 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -53.19 -53.18 58.63 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 120.478 -1.389 . . . . 0.0 110.453 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.544 ' HG2' HG13 ' A' ' 111' ' ' VAL . 26.0 Cg_endo -73.47 -18.08 23.19 Favored 'Trans proline' 0 C--N 1.3 -1.979 0 O-C-N 122.786 0.887 . . . . 0.0 109.844 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.876 ' HG ' HG11 ' A' ' 111' ' ' VAL . 19.6 mt -87.24 -43.39 12.23 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.862 . . . . 0.0 109.011 178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.689 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.1 m-30 -64.98 -45.94 83.53 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.894 -1.129 . . . . 0.0 108.73 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.404 ' HA ' ' HB2' ' A' ' 97' ' ' GLN . 7.2 tt0 -72.73 -27.42 62.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.309 -0.87 . . . . 0.0 109.17 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.461 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -65.17 -38.19 94.95 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.651 HG22 ' CB ' ' A' ' 102' ' ' ILE . 3.8 t -97.81 -1.55 10.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 O-C-N 121.299 -1.118 . . . . 0.0 108.629 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.497 ' CG ' ' O ' ' A' ' 93' ' ' PHE . 18.8 mm-40 -111.14 9.61 21.92 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.169 -0.957 . . . . 0.0 110.874 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.811 ' O ' HG23 ' A' ' 99' ' ' THR . 50.6 tttt -172.5 62.47 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.482 -1.387 . . . . 0.0 109.822 -179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 164.47 -50.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.704 -0.622 . . . . 0.0 109.324 179.938 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.3 mt-30 75.92 15.28 2.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.195 -0.941 . . . . 0.0 110.777 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 t -82.82 -6.63 59.51 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.403 -0.81 . . . . 0.0 108.818 178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.651 ' CB ' HG22 ' A' ' 96' ' ' VAL . 10.5 mm -79.97 72.89 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.21 31.56 3.5 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.198 -0.939 . . . . 0.0 109.167 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.555 ' O ' ' N ' ' A' ' 107' ' ' ASP . 1.4 p -151.21 126.48 9.95 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.256 -0.902 . . . . 0.0 109.861 -179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.657 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -50.63 -31.81 17.16 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 26.4 t -59.3 -31.42 69.11 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.555 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -71.54 -49.34 41.8 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.038 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' A' ' 105' ' ' ALA . 37.3 mt -50.58 -30.32 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.124 -0.985 . . . . 0.0 108.947 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.42 ' HA ' ' HB2' ' A' ' 112' ' ' PHE . 24.5 mtm180 -79.55 -32.33 42.13 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.207 -0.933 . . . . 0.0 109.227 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -58.79 -46.79 86.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.268 -0.895 . . . . 0.0 108.799 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.876 HG11 ' HG ' ' A' ' 92' ' ' LEU . 70.1 t -71.35 -38.27 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.209 -0.932 . . . . 0.0 109.009 179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CE2' ' CE2' ' A' ' 122' ' ' TYR . 0.5 OUTLIER -56.95 -44.72 82.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.289 -0.882 . . . . 0.0 109.653 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.561 HG23 ' HA ' ' A' ' 118' ' ' LYS . 15.5 mt -73.58 -24.21 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.594 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -65.82 -16.71 64.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.421 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.571 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -91.35 -3.23 56.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.193 -0.942 . . . . 0.0 109.86 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 97.94 -8.93 63.55 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.919 HG12 HG11 ' A' ' 84' ' ' VAL . 2.6 mp -88.86 51.83 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -1.098 . . . . 0.0 109.362 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.561 ' HA ' HG23 ' A' ' 113' ' ' ILE . 16.7 pttm -33.78 153.89 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.565 -0.709 . . . . 0.0 110.826 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -45.17 -29.3 2.29 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.488 ' HB3' ' CD ' ' A' ' 118' ' ' LYS . 17.3 tt0 -50.37 -58.09 6.47 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.064 -1.256 . . . . 0.0 109.042 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.38 -54.14 6.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.438 -0.788 . . . . 0.0 109.662 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.787 ' CE2' HG11 ' A' ' 78' ' ' VAL . 2.6 t80 -46.73 -55.56 7.61 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.119 -0.988 . . . . 0.0 109.218 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.439 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 47.1 t0 -56.66 -48.59 77.25 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.101 -0.999 . . . . 0.0 109.07 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.49 -49.86 54.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.25 -0.906 . . . . 0.0 109.076 179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 131' ' ' VAL . . . -51.44 -49.27 62.01 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.456 -0.778 . . . . 0.0 109.188 179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.742 ' HA ' HG11 ' A' ' 131' ' ' VAL . 11.4 t90 -60.27 -56.49 20.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.314 -0.866 . . . . 0.0 108.956 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.09 -15.64 3.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.517 -0.739 . . . . 0.0 109.923 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.469 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 63.2 m -77.35 -177.71 4.78 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.05 -1.031 . . . . 0.0 110.156 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.34 -32.43 13.61 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.76 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 97.6 t -63.3 -42.75 97.52 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 C-N-CA 117.916 -1.514 . . . . 0.0 109.401 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.927 HG22 ' HB2' ' A' ' 81' ' ' ALA . 42.6 t -65.72 -38.21 81.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.04 -1.038 . . . . 0.0 108.295 179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -38.44 89.14 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.3 m -62.1 -39.77 93.6 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 mt -79.34 -16.63 56.01 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.674 HG23 ' HB1' ' A' ' 77' ' ' ALA . 5.0 t -79.4 -44.75 23.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.438 ' O ' ' CB ' ' A' ' 140' ' ' LYS . . . -68.62 -44.64 73.82 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.449 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 7.1 tp-100 -62.81 -32.64 73.87 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.393 -0.817 . . . . 0.0 109.041 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.543 ' NE2' ' CG2' ' A' ' 73' ' ' THR . 1.6 tm0? -79.43 -62.75 1.59 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.199 -0.938 . . . . 0.0 108.751 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -49.47 -34.5 17.06 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.438 ' CB ' ' O ' ' A' ' 136' ' ' ALA . 6.8 ttmt -75.11 -29.07 60.47 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.64 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -59.25 -54.23 49.29 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.362 -0.836 . . . . 0.0 109.143 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -75.83 -31.52 59.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 110.356 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.28 -23.28 54.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.026 -1.046 . . . . 0.0 110.23 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.636 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.2 p30 -84.21 -47.18 11.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.978 -1.076 . . . . 0.0 108.181 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 1.062 HG21 ' CE2' ' A' ' 25' ' ' PHE . 10.3 m -82.04 -21.86 9.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 82.1 -25.26 0.16 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.849 -0.532 . . . . 0.0 110.188 -179.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.047 HD22 HG11 ' A' ' 61' ' ' VAL . 10.5 tp 61.4 142.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 109.537 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -161.15 33.66 0.14 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.691 -1.256 . . . . 0.0 110.139 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.658 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 153.05 113.33 0.53 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.325 -1.416 . . . . 0.0 110.519 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.625 HG13 ' HZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -101.56 139.55 20.49 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.34 -1.094 . . . . 0.0 109.395 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -76.31 151.46 95.0 Favored 'Cis proline' 0 C--N 1.315 -1.231 0 C-N-CA 123.725 -1.365 . . . . 0.0 110.209 0.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.658 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -130.37 126.77 37.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.271 -1.518 . . . . 0.0 109.127 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.646 ' CE ' HG22 ' A' ' 182' ' ' VAL . 0.0 OUTLIER -122.71 114.77 21.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.087 -1.008 . . . . 0.0 110.094 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.512 ' CE1' ' HB1' ' A' ' 152' ' ' ALA . 3.2 m-30 -110.58 148.3 32.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.207 -0.933 . . . . 0.0 109.454 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.674 HG13 ' O ' ' A' ' 21' ' ' GLN . 29.7 t -107.61 133.47 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.127 -0.983 . . . . 0.0 109.731 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.611 ' OD1' HG12 ' A' ' 155' ' ' VAL . 5.6 p-10 40.7 25.49 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.4 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 15' ' ' PRO . . . 58.2 60.07 9.63 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.839 -1.704 . . . . 0.0 108.839 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' HB2' ' ND2' ' A' ' 156' ' ' ASN . 6.8 tttt -167.74 -33.68 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.379 -1.071 . . . . 0.0 108.327 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.54 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 96.5 m-85 -116.49 121.44 41.82 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.056 -1.028 . . . . 0.0 108.926 178.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.783 ' HB2' HD11 ' A' ' 12' ' ' LEU . 19.8 tt0 -113.42 109.02 18.01 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 109.749 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 9' ' ' TYR . 15.5 mt -59.32 172.12 0.68 Allowed 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.407 ' N ' ' O ' ' A' ' 8' ' ' GLN . 62.9 t-20 -152.2 83.07 5.16 Favored Pre-proline 0 C--N 1.303 -1.447 0 O-C-N 120.849 -1.157 . . . . 0.0 109.848 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 164' ' ' GLN . 34.8 Cg_endo -78.27 -11.54 16.03 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.713 2.275 . . . . 0.0 110.432 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 163' ' ' PRO . 33.1 tt0 43.86 28.2 0.22 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.945 . . . . 0.0 109.575 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 92.79 -35.88 3.91 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 17.2 ttt -169.81 -72.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.242 -1.152 . . . . 0.0 109.353 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.404 ' O ' ' CG ' ' A' ' 167' ' ' ASP . 33.3 t70 51.23 30.7 6.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.443 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.509 ' O ' ' CB ' ' A' ' 169' ' ' SER . 2.1 p -134.04 -55.75 0.87 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 0.0 109.756 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 168' ' ' THR . 1.0 OUTLIER 77.54 22.29 0.93 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.361 -0.837 . . . . 0.0 109.152 -179.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -160.52 99.99 1.31 Allowed 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.846 ' HB3' HD21 ' A' ' 40' ' ' LEU . 13.0 mtt -56.06 -17.43 6.95 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.881 . . . . 0.0 109.952 -179.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.6 -62.24 1.75 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.693 -0.63 . . . . 0.0 109.672 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.7 t -66.56 -21.12 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.151 -0.968 . . . . 0.0 108.919 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.485 ' O ' ' CD1' ' A' ' 174' ' ' PHE . 2.4 t80 -74.78 -45.23 45.07 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.293 -0.88 . . . . 0.0 109.268 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.796 ' CG2' HD22 ' A' ' 40' ' ' LEU . 39.8 t -71.39 -26.87 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 0.0 109.174 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.66 -53.11 6.5 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.569 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -59.55 -40.64 87.92 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.045 -1.034 . . . . 0.0 109.01 179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -63.92 -47.5 80.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.321 -0.862 . . . . 0.0 108.909 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.61 -29.48 70.63 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.25 -0.906 . . . . 0.0 108.947 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -75.08 -38.29 61.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.329 -0.857 . . . . 0.0 109.277 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.719 ' O ' HD23 ' A' ' 185' ' ' LEU . 2.9 m -66.11 -26.47 67.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.306 -0.871 . . . . 0.0 109.274 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.646 HG22 ' CE ' ' A' ' 153' ' ' MET . 52.8 t -87.13 -37.23 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.159 -0.963 . . . . 0.0 108.581 179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.7 tttt -57.46 -48.47 79.09 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.406 -0.809 . . . . 0.0 108.885 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.44 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -80.92 -28.74 35.7 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.397 -0.815 . . . . 0.0 109.416 179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 181' ' ' THR . 0.6 OUTLIER -63.77 -17.3 62.91 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.782 -1.198 . . . . 0.0 109.358 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.492 ' HB2' HG21 ' A' ' 54' ' ' VAL . 1.4 t -82.56 5.54 20.53 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 120.665 -1.272 . . . . 0.0 107.999 177.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -122.33 26.6 8.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.439 -0.788 . . . . 0.0 109.415 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -56.65 -23.03 38.56 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.1 -1.0 . . . . 0.0 109.288 -179.518 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.464 ' CD ' ' OXT' ' A' ' 189' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.359 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.571 ' HB3' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 1' ' ' ALA . 16.6 mt-30 42.17 48.06 4.13 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.914 0.864 . . . . 0.0 108.916 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER 60.27 88.36 0.08 Allowed 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 1' ' ' ALA . 0.4 OUTLIER -105.11 55.74 0.7 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.146 -0.971 . . . . 0.0 109.512 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 4' ' ' GLU . 7.0 p-10 39.77 79.86 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.812 -0.555 . . . . 0.0 109.891 179.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 126.79 -26.52 5.09 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.762 -1.208 . . . . 0.0 110.348 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.99 -69.52 0.6 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.063 -1.257 . . . . 0.0 109.385 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.469 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 0.0 OUTLIER -91.41 2.72 56.21 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.229 -0.919 . . . . 0.0 109.611 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.479 ' O ' ' N ' ' A' ' 6' ' ' GLY . 2.2 p90 178.91 132.85 0.08 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.09 -1.006 . . . . 0.0 109.189 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.3 t -119.11 176.34 5.35 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.691 -0.63 . . . . 0.0 109.494 -178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.3 m -100.24 152.1 20.68 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.357 0.599 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 mp -92.95 170.9 9.31 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.303 -0.873 . . . . 0.0 109.594 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.428 ' OE2' ' HG2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -91.56 -5.92 53.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.511 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.428 ' HG2' ' OE2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -166.06 110.67 0.73 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 0.0 109.444 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.514 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 36.0 Cg_endo -77.97 160.49 30.37 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.417 2.078 . . . . 0.0 110.153 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.438 ' O ' ' N ' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -119.03 102.67 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.19 -0.944 . . . . 0.0 109.8 -179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.22 127.07 6.73 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 92.37 -15.03 63.2 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 108.94 -1.664 . . . . 0.0 108.94 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.539 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -38.35 156.18 0.11 Allowed Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.601 -0.94 . . . . 0.0 109.618 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.569 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.5 Cg_endo -79.17 128.32 8.12 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.547 2.165 . . . . 0.0 111.308 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.765 ' O ' HG13 ' A' ' 155' ' ' VAL . 37.0 mt-30 -42.38 -24.28 0.05 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.398 -0.813 . . . . 0.0 109.586 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.684 ' O ' HG12 ' A' ' 22' ' ' VAL . 7.1 t -147.26 83.06 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.127 -0.983 . . . . 0.0 109.155 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.646 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -77.75 128.56 34.22 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.524 ' HB2' ' HA ' ' A' ' 58' ' ' LYS . 3.4 mm-40 -109.68 131.93 54.61 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.088 -1.008 . . . . 0.0 109.723 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.03 ' CE2' HG21 ' A' ' 145' ' ' VAL . 5.0 m-85 -120.58 113.93 20.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.429 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 0.9 OUTLIER -151.75 144.89 24.61 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.974 -1.079 . . . . 0.0 109.698 -179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.729 ' HB2' HG22 ' A' ' 61' ' ' VAL . 0.2 OUTLIER -118.53 163.86 16.15 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.243 -0.911 . . . . 0.0 110.085 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.786 ' CD2' HD21 ' A' ' 72' ' ' LEU . 18.8 m-30 -88.13 39.17 0.89 Allowed 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 1.009 ' CZ ' HD13 ' A' ' 72' ' ' LEU . 5.2 m-85 -138.72 15.51 2.7 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.26 -0.9 . . . . 0.0 110.179 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 4.2 m -114.39 158.18 40.59 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 120.596 -1.315 . . . . 0.0 109.722 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -74.5 -25.42 12.98 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.196 1.931 . . . . 0.0 107.835 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.523 ' O ' ' N ' ' A' ' 36' ' ' PHE . 98.5 m-70 -89.17 -16.43 31.38 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.487 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 5.7 t -54.92 -53.44 55.51 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.636 ' CE1' ' CB ' ' A' ' 38' ' ' GLU . 29.3 t80 -71.58 -40.61 69.78 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.486 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.483 ' HA ' ' CG2' ' A' ' 39' ' ' VAL . 3.3 mt-30 -78.33 -19.02 54.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.324 -0.86 . . . . 0.0 111.181 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 32' ' ' HIS . 70.6 t80 -78.0 -20.3 52.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.924 -1.11 . . . . 0.0 110.466 -179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.502 ' O ' ' N ' ' A' ' 41' ' ' HIS . 3.7 tm-20 -133.31 -72.06 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.885 -1.134 . . . . 0.0 110.826 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.636 ' CB ' ' CE1' ' A' ' 34' ' ' TYR . 56.8 mm-40 -46.02 -40.25 10.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.271 -0.893 . . . . 0.0 110.831 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.483 ' CG2' ' HA ' ' A' ' 35' ' ' GLN . 5.0 t -92.4 -74.09 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.015 -1.053 . . . . 0.0 110.548 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.557 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 0.4 OUTLIER -75.21 -10.9 59.89 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.096 -1.003 . . . . 0.0 110.652 -178.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.557 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 11.0 p-80 40.92 32.11 0.15 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.136 -0.977 . . . . 0.0 109.342 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.502 HG13 ' HB3' ' A' ' 40' ' ' LEU . 3.6 mt -54.38 -18.12 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.523 -0.736 . . . . 0.0 110.152 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.6 p -84.95 -38.56 19.17 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.943 -1.098 . . . . 0.0 110.563 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 2.7 m-20 -81.58 -36.91 28.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.02 -1.05 . . . . 0.0 110.428 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' A' ' 46' ' ' VAL . 15.8 t30 -60.54 -53.34 58.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.033 -1.042 . . . . 0.0 110.171 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' ASN . 6.7 m -42.82 -38.17 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.184 -0.948 . . . . 0.0 110.183 -179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.797 ' HA ' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -46.86 -34.81 5.71 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.038 -1.039 . . . . 0.0 109.867 -179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.429 ' HD3' ' HG2' ' A' ' 49' ' ' LYS . 3.4 tmtm? -45.46 -24.71 0.34 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.145 -0.972 . . . . 0.0 109.93 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' C ' HD12 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -116.32 40.57 2.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.077 -1.014 . . . . 0.0 109.729 -179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.797 HD13 ' HA ' ' A' ' 47' ' ' LYS . 5.5 mp -129.47 68.19 79.96 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.182 -0.949 . . . . 0.0 109.587 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.476 ' O ' ' O ' ' A' ' 52' ' ' GLU . 36.1 Cg_endo -80.31 77.97 3.86 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.697 2.265 . . . . 0.0 111.685 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.476 ' O ' ' O ' ' A' ' 51' ' ' PRO . 25.5 tp10 58.92 136.85 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.616 0.722 . . . . 0.0 110.103 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.13 -6.52 69.05 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.812 HG13 ' HB2' ' A' ' 186' ' ' SER . 0.9 OUTLIER -116.06 100.52 10.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.28 -1.13 . . . . 0.0 108.645 179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -100.51 109.39 21.51 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.259 -0.901 . . . . 0.0 110.427 -179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.524 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.0 OUTLIER -102.46 95.52 6.32 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.475 ' O ' ' N ' ' A' ' 24' ' ' GLU . 4.2 m -84.16 133.6 34.6 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 118.724 -1.19 . . . . 0.0 110.042 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.524 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 8.5 tttt -106.72 117.95 35.39 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.484 -0.76 . . . . 0.0 109.582 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CE2' ' HG2' ' A' ' 138' ' ' GLN . 3.3 m-85 -120.88 177.02 5.26 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.014 -1.054 . . . . 0.0 110.5 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.607 ' CE1' ' HA ' ' A' ' 27' ' ' SER . 3.2 t60 -109.16 159.89 16.53 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.84 0.828 . . . . 0.0 109.538 -178.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.049 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.4 m -104.02 162.4 4.26 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.79 58.31 1.7 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.141 -0.975 . . . . 0.0 109.314 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.702 ' HE1' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -158.03 64.82 0.46 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.023 -1.048 . . . . 0.0 110.849 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.671 ' HE1' ' O ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -126.17 33.27 5.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.503 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 64' ' ' MET . . . 44.72 42.42 7.6 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . -148.5 80.97 0.2 Allowed Glycine 0 N--CA 1.485 1.909 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.455 ' C ' ' O ' ' A' ' 66' ' ' GLY . 44.5 t0 -33.39 -45.35 0.16 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 122.021 -0.693 . . . . 0.0 111.366 -178.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.103 HD23 ' N ' ' A' ' 69' ' ' GLY . 0.1 OUTLIER -55.4 -21.01 13.81 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.749 -1.219 . . . . 0.0 109.192 -179.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 1.103 ' N ' HD23 ' A' ' 68' ' ' LEU . . . -63.62 -51.3 55.2 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -50.97 -55.05 19.18 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -27.0 68.96 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.009 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 6.2 tt -65.32 -38.06 89.0 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.545 ' CG2' ' NE2' ' A' ' 138' ' ' GLN . 1.8 m -59.69 -42.17 92.35 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.924 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.2 tt0 -53.92 -29.31 41.62 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 177.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.72 -40.06 95.83 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.446 ' O ' ' HB2' ' A' ' 80' ' ' MET . 53.4 t-105 -60.24 -30.93 69.74 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 108.534 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.546 ' HA ' HD21 ' A' ' 134' ' ' LEU . . . -86.96 -60.46 1.98 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 109.642 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.924 HG23 ' O ' ' A' ' 74' ' ' GLN . 2.0 t -53.66 -28.1 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 0.0 109.171 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -84.09 -55.74 4.04 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.521 ' SD ' HD22 ' A' ' 134' ' ' LEU . 2.7 ttt -50.67 -27.54 7.18 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.763 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -68.79 -42.25 77.64 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.489 -0.757 . . . . 0.0 109.49 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.505 ' HB2' HG13 ' A' ' 84' ' ' VAL . 14.9 mt -101.97 7.8 41.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.207 -0.933 . . . . 0.0 110.376 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 54.32 29.32 45.8 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.774 HG11 HG12 ' A' ' 117' ' ' ILE . 26.8 m -94.21 7.82 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.433 -1.039 . . . . 0.0 109.684 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.441 ' O ' ' C ' ' A' ' 86' ' ' ASP . 48.9 tt0 -47.72 -72.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.12 -0.988 . . . . 0.0 109.487 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.441 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -38.86 -34.59 0.16 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.556 -0.715 . . . . 0.0 110.224 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.534 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 10.4 mtpp -73.95 -55.22 6.42 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.241 -0.912 . . . . 0.0 110.819 -179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.917 HG23 HD12 ' A' ' 92' ' ' LEU . 1.1 m -87.16 -19.98 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.737 -1.227 . . . . 0.0 110.681 -179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.717 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -70.17 -42.27 72.67 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.625 -1.297 . . . . 0.0 108.13 179.004 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.52 -55.66 37.85 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.603 -1.311 . . . . 0.0 110.692 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.534 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 24.4 Cg_endo -72.17 -16.7 28.34 Favored 'Trans proline' 0 C--N 1.302 -1.87 0 N-CA-C 109.669 -0.935 . . . . 0.0 109.669 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.917 HD12 HG23 ' A' ' 88' ' ' VAL . 30.6 mt -86.85 -47.06 9.36 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.717 ' CE1' HG23 ' A' ' 89' ' ' THR . 6.5 m-30 -58.56 -49.18 78.37 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 120.928 -1.108 . . . . 0.0 108.98 179.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -69.07 -33.09 73.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.061 -1.024 . . . . 0.0 109.015 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.456 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -67.86 -30.16 74.17 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.795 HG11 ' HD1' ' A' ' 29' ' ' PHE . 2.1 t -107.45 9.71 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 O-C-N 121.086 -1.243 . . . . 0.0 108.784 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.545 ' NE2' ' HB2' ' A' ' 34' ' ' TYR . 58.9 mt-30 -112.79 15.23 19.91 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.073 -1.017 . . . . 0.0 110.567 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 7.0 mttt 178.97 -49.57 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.591 -1.318 . . . . 0.0 110.913 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 0.9 OUTLIER -67.7 -38.16 83.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.561 -1.337 . . . . 0.0 110.048 -179.275 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 67.24 13.57 9.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.368 -0.832 . . . . 0.0 109.55 -179.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.447 ' C ' ' HD2' ' A' ' 103' ' ' ARG . 42.5 p -79.79 -9.91 59.72 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.811 0.815 . . . . 0.0 109.048 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.897 HG22 HD11 ' A' ' 68' ' ' LEU . 5.5 mm -86.99 75.65 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 O-C-N 121.699 -0.626 . . . . 0.0 109.574 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.564 ' CA ' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -132.27 27.25 4.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.228 -0.92 . . . . 0.0 109.308 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 107' ' ' ASP . 7.9 p -147.8 127.07 13.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.154 -0.966 . . . . 0.0 109.856 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.653 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.23 -42.81 41.69 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 79.1 p -54.36 -31.34 54.34 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 104' ' ' SER . 14.2 m-20 -74.88 -38.02 62.01 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.236 -0.915 . . . . 0.0 108.969 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.865 HD11 ' O ' ' A' ' 68' ' ' LEU . 31.0 mt -55.98 -27.97 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.97 -38.54 57.37 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -54.9 -49.68 70.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.364 -0.835 . . . . 0.0 109.197 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.855 HG11 ' HG ' ' A' ' 92' ' ' LEU . 47.2 t -68.25 -37.78 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.479 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.677 ' CD1' HG11 ' A' ' 88' ' ' VAL . 0.4 OUTLIER -58.74 -37.57 76.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.252 -0.905 . . . . 0.0 109.917 179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.9 mt -78.99 -27.0 13.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.157 -0.964 . . . . 0.0 110.313 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -65.55 -16.7 63.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.912 -1.118 . . . . 0.0 109.572 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 87' ' ' LYS . . . -87.94 -1.57 58.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.229 -0.919 . . . . 0.0 109.783 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 96.0 -3.91 65.01 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.3 mp -87.67 61.13 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -1.134 . . . . 0.0 108.928 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER -36.6 154.86 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.879 -1.138 . . . . 0.0 110.426 -179.286 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -56.13 -22.25 35.28 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -59.16 -54.41 47.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.175 -1.191 . . . . 0.0 109.439 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -42.19 55.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.922 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.742 ' CE2' HG11 ' A' ' 78' ' ' VAL . 7.1 t80 -59.68 -48.12 82.91 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.139 -0.975 . . . . 0.0 109.716 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -64.54 -39.91 94.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.115 -0.99 . . . . 0.0 109.182 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 128' ' ' SER . . . -55.73 -53.36 57.59 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.364 -0.835 . . . . 0.0 109.408 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 1.026 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -56.46 -55.47 33.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.42 -0.8 . . . . 0.0 108.856 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.567 ' CE3' ' O ' ' A' ' 126' ' ' TRP . 0.7 OUTLIER -48.77 -54.11 16.39 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -68.63 -14.82 63.27 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.686 -0.634 . . . . 0.0 109.845 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 67.7 m -68.9 -179.24 1.41 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.066 -1.021 . . . . 0.0 110.135 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.7 -35.71 13.33 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.555 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.76 -46.61 60.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 C-N-CA 118.36 -1.336 . . . . 0.0 110.171 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 1.026 HG21 ' HB1' ' A' ' 125' ' ' ALA . 3.0 t -66.57 -35.37 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.732 -1.23 . . . . 0.0 108.63 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -67.1 -38.74 86.19 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.35 -0.844 . . . . 0.0 109.205 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -62.98 -39.53 94.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 108.974 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.546 HD21 ' HA ' ' A' ' 77' ' ' ALA . 4.8 tp -75.64 -25.13 56.58 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.513 HG11 ' CZ3' ' A' ' 126' ' ' TRP . 11.6 t -73.96 -41.04 53.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.84 -37.05 85.95 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -67.03 -31.27 71.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.446 -0.784 . . . . 0.0 108.886 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.545 ' NE2' ' CG2' ' A' ' 73' ' ' THR . 2.3 mt-30 -66.89 -61.41 1.96 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.415 -0.803 . . . . 0.0 108.852 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -51.92 -33.41 37.08 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -76.48 -28.34 56.45 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.604 -0.685 . . . . 0.0 109.335 179.479 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.845 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -63.54 -57.5 9.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.149 -0.969 . . . . 0.0 109.476 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -72.84 -31.31 64.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.887 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.27 -23.24 43.76 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.165 -0.959 . . . . 0.0 110.222 -179.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 140' ' ' LYS . 76.1 m-20 -81.12 -44.42 17.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.08 -1.012 . . . . 0.0 108.49 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 1.03 HG21 ' CE2' ' A' ' 25' ' ' PHE . 31.7 m -95.58 -8.35 9.54 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 1.1 mm-40 78.12 -52.5 0.5 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.449 -0.782 . . . . 0.0 109.397 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.605 HD13 ' CD2' ' A' ' 25' ' ' PHE . 27.1 tp 68.39 129.04 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.444 -0.785 . . . . 0.0 109.876 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.59 41.51 0.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.589 -1.319 . . . . 0.0 109.568 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.703 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 172.28 105.27 0.18 Allowed Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.502 -1.333 . . . . 0.0 110.068 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 1.049 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -105.05 141.55 22.81 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.391 -1.064 . . . . 0.0 109.817 179.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -76.52 152.74 96.18 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 123.572 -1.428 . . . . 0.0 110.208 0.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.703 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -134.68 159.38 41.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.241 -1.537 . . . . 0.0 109.394 179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.514 ' SD ' HD12 ' A' ' 161' ' ' LEU . 2.1 ttm -154.0 131.22 11.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.942 . . . . 0.0 109.851 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.431 ' CD1' ' HB2' ' A' ' 160' ' ' GLN . 6.1 m-85 -124.76 133.7 53.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.156 -0.965 . . . . 0.0 110.026 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.765 HG13 ' O ' ' A' ' 21' ' ' GLN . 48.2 t -96.2 132.34 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.361 -0.837 . . . . 0.0 110.287 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.539 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 1.2 m-20 48.48 21.23 0.37 Allowed 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.826 179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 55.86 55.53 28.56 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.1 tttt -164.71 -34.87 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.357 -1.084 . . . . 0.0 108.355 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.597 ' CE2' ' HE3' ' A' ' 188' ' ' LYS . 72.7 m-85 -114.57 118.25 33.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.325 -0.859 . . . . 0.0 109.221 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.431 ' HB2' ' CD1' ' A' ' 154' ' ' PHE . 23.6 tt0 -104.29 109.04 20.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.282 -0.886 . . . . 0.0 109.574 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.642 HD13 ' CZ ' ' A' ' 178' ' ' TYR . 30.0 mt -59.89 169.78 1.36 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -151.78 87.29 4.43 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.055 -1.028 . . . . 0.0 109.463 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.531 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . 35.8 Cg_endo -77.61 56.43 5.58 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.603 2.202 . . . . 0.0 110.502 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -128.12 -2.54 5.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 0.0 109.681 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -92.65 7.17 77.49 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.482 ' HG3' ' CD1' ' A' ' 174' ' ' PHE . 0.0 OUTLIER -150.37 49.35 0.89 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -1.197 . . . . 0.0 109.552 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 51.0 t0 -104.53 22.34 15.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.521 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 168' ' ' THR . 7.6 t -166.07 66.68 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.174 -0.954 . . . . 0.0 109.557 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 89.5 p -168.32 -63.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.897 . . . . 0.0 109.169 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -160.27 98.3 1.28 Allowed 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 51.7 mtt -56.8 -16.87 7.37 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.242 -0.911 . . . . 0.0 109.866 -179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -70.7 -44.46 66.91 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.633 -0.667 . . . . 0.0 109.223 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 14.8 t -73.46 -25.04 20.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.11 -1.036 . . . . 0.0 109.217 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.531 ' CZ ' ' HB3' ' A' ' 163' ' ' PRO . 4.1 t80 -69.16 -46.48 67.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.153 -0.967 . . . . 0.0 109.063 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.459 HG22 HG12 ' A' ' 42' ' ' ILE . 45.5 t -71.55 -24.54 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 0.0 109.568 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -83.14 -55.36 4.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.423 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.07 -39.17 93.94 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.95 -1.094 . . . . 0.0 108.786 179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.642 ' CZ ' HD13 ' A' ' 161' ' ' LEU . 63.4 t80 -65.2 -43.52 91.29 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.376 -0.827 . . . . 0.0 108.891 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -56.86 -31.77 65.14 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.358 -0.839 . . . . 0.0 109.021 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.61 -38.62 54.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.165 -0.959 . . . . 0.0 109.317 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.649 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -62.5 -30.34 71.2 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.239 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 58.1 t -86.03 -33.69 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.191 -0.943 . . . . 0.0 108.636 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.81 -48.55 81.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -0.796 . . . . 0.0 108.885 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.522 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.76 -32.26 52.53 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.184 -0.947 . . . . 0.0 108.886 179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.649 HD23 ' O ' ' A' ' 181' ' ' THR . 0.9 OUTLIER -64.32 -17.06 63.32 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.877 -1.14 . . . . 0.0 109.138 179.661 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.812 ' HB2' HG13 ' A' ' 54' ' ' VAL . 24.9 p -74.02 -10.46 59.65 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.909 -1.119 . . . . 0.0 108.569 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 188' ' ' LYS . 2.2 mt-10 -88.98 -10.05 49.1 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.477 -0.764 . . . . 0.0 109.441 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.597 ' HE3' ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -41.78 -37.98 1.37 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.518 -0.739 . . . . 0.0 109.293 -179.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.516 ' C ' ' O ' ' A' ' 188' ' ' LYS . 5.7 ptmt . . . . . 0 N--CA 1.499 2.011 0 CA-C-O 118.056 -0.973 . . . . 0.0 110.745 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.557 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 1.8 mt-30 -116.23 61.87 0.71 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.294 -0.879 . . . . 0.0 109.408 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER 171.39 89.68 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.419 -0.801 . . . . 0.0 109.332 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -114.84 61.83 0.68 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.281 -0.887 . . . . 0.0 109.292 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.4 t70 53.72 86.0 0.05 OUTLIER 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.506 -0.746 . . . . 0.0 109.6 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 120.62 -22.9 8.09 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 119.71 -1.233 . . . . 0.0 110.173 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.59 -69.83 0.58 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.981 -1.305 . . . . 0.0 108.505 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.475 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 0.6 OUTLIER -114.8 19.02 16.23 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.333 -0.854 . . . . 0.0 109.432 179.378 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.697 ' HB2' HD23 ' A' ' 161' ' ' LEU . 0.8 OUTLIER 177.94 129.92 0.06 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.225 -0.922 . . . . 0.0 109.063 179.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 5.2 t -126.14 176.66 6.89 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.966 -0.694 . . . . 0.0 109.53 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 158' ' ' LYS . 24.9 m -104.14 149.47 25.22 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.472 0.653 . . . . 0.0 109.71 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.483 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.4 OUTLIER -89.46 149.52 22.9 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.431 -0.793 . . . . 0.0 109.658 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -70.58 -23.19 62.54 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.204 -0.935 . . . . 0.0 109.009 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -122.62 102.16 39.2 Favored Pre-proline 0 N--CA 1.489 1.516 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.82 164.54 29.9 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.474 2.116 . . . . 0.0 111.118 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.878 HG21 ' OD1' ' A' ' 144' ' ' ASP . 37.7 t -129.1 76.68 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.383 -0.823 . . . . 0.0 109.562 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.45 133.18 5.78 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.46 -25.06 26.39 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.669 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -41.09 162.87 0.11 Allowed Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.521 -0.987 . . . . 0.0 109.627 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.607 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 33.0 Cg_endo -75.8 125.82 9.04 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.589 2.193 . . . . 0.0 111.449 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.762 ' O ' HG13 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -37.95 -25.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.848 -0.532 . . . . 0.0 110.854 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.674 ' O ' HG12 ' A' ' 22' ' ' VAL . 17.5 t -147.75 79.82 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.709 -1.244 . . . . 0.0 109.139 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.642 ' CD1' ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -82.14 124.82 30.21 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.528 ' HG3' ' HA ' ' A' ' 58' ' ' LYS . 0.6 OUTLIER -123.71 108.47 12.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.027 -1.046 . . . . 0.0 109.222 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.642 ' CE2' ' CD1' ' A' ' 23' ' ' LEU . 7.6 m-85 -88.27 126.53 35.21 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.411 0.624 . . . . 0.0 110.035 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -155.16 142.1 19.14 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 0.0 109.69 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.752 ' CB ' HG22 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -126.32 161.94 26.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.224 -0.922 . . . . 0.0 109.129 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.678 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.8 OUTLIER -83.74 48.13 1.39 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.312 -0.868 . . . . 0.0 108.817 179.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.723 ' CD1' ' HE3' ' A' ' 64' ' ' MET . 6.3 m-85 -135.47 5.77 3.22 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.373 -0.829 . . . . 0.0 110.016 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.524 ' HB3' ' NE2' ' A' ' 32' ' ' HIS . 90.9 m -108.69 155.38 40.71 Favored Pre-proline 0 N--CA 1.488 1.453 0 C-N-CA 118.688 -1.205 . . . . 0.0 109.23 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -73.68 -28.9 11.24 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.079 1.853 . . . . 0.0 108.192 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.534 ' O ' ' N ' ' A' ' 36' ' ' PHE . 2.5 p-80 -86.15 -20.76 28.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 14.7 t -47.31 -63.29 1.08 Allowed 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.538 ' CE2' ' CD ' ' A' ' 38' ' ' GLU . 35.6 t80 -59.62 -54.5 45.78 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.475 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 1.5 mt-30 -56.52 -25.51 51.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.22 -0.925 . . . . 0.0 109.786 -179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.639 ' CE1' HG21 ' A' ' 42' ' ' ILE . 35.5 t80 -84.49 -25.43 28.85 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 0.0 110.672 -179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.531 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 3.6 tt0 -125.81 51.46 1.74 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.842 -1.161 . . . . 0.0 110.16 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.538 ' CD ' ' CE2' ' A' ' 34' ' ' TYR . 1.1 mt-10 -171.06 -57.93 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.083 -1.011 . . . . 0.0 110.706 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.1 t -102.07 -58.76 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.924 -1.11 . . . . 0.0 110.917 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 35' ' ' GLN . 64.4 mt -46.43 -22.75 0.29 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.034 -1.041 . . . . 0.0 110.408 -178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 17.9 m80 57.07 16.97 3.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.036 -1.04 . . . . 0.0 109.522 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.639 HG21 ' CE1' ' A' ' 36' ' ' PHE . 23.0 mt -64.04 -40.79 90.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 0.0 109.358 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.85 -31.68 35.33 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.291 -0.881 . . . . 0.0 110.447 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.31 -27.51 32.23 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.922 -1.111 . . . . 0.0 110.061 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 41' ' ' HIS . 36.8 t30 -80.44 -40.05 27.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.11 -0.994 . . . . 0.0 109.965 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.0 p -65.72 -25.32 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.03 -1.044 . . . . 0.0 109.528 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.458 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 1.0 OUTLIER -68.76 -20.41 64.37 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.637 -179.766 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.436 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -76.8 -20.76 56.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.142 -0.974 . . . . 0.0 109.62 -179.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.454 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 4.1 mttt -105.65 3.86 29.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.146 -0.971 . . . . 0.0 109.842 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.458 ' HG ' ' HA ' ' A' ' 47' ' ' LYS . 14.4 mt -42.73 102.61 0.28 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 109.692 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG2' ' CG2' ' A' ' 54' ' ' VAL . 34.6 Cg_endo -77.74 127.98 9.07 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.339 2.026 . . . . 0.0 110.605 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -49.89 116.97 2.03 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 122.139 0.971 . . . . 0.0 109.233 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.53 -20.28 10.29 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.665 ' O ' HG12 ' A' ' 54' ' ' VAL . 2.6 t -93.39 91.8 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.153 -1.204 . . . . 0.0 109.051 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 7.8 mmmt -75.19 102.09 4.85 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.508 -0.745 . . . . 0.0 109.769 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.529 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 15.1 ttp -89.93 99.92 12.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.563 -0.711 . . . . 0.0 109.483 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.455 ' O ' ' CG ' ' A' ' 24' ' ' GLU . 7.4 m -96.28 139.12 32.88 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.124 -1.03 . . . . 0.0 110.402 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.528 ' HA ' ' HG3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -113.55 109.77 19.18 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.49 -0.756 . . . . 0.0 109.054 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.574 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 3.2 m-85 -110.28 168.72 9.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.839 -1.163 . . . . 0.0 110.562 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.577 ' NE2' ' CD2' ' A' ' 72' ' ' LEU . 55.9 t-80 -97.99 153.25 18.51 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.899 HG11 HG11 ' A' ' 150' ' ' VAL . 2.1 m -90.62 155.93 3.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.071 0 CA-C-O 121.606 0.717 . . . . 0.0 110.485 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -124.5 28.58 6.57 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.575 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 12.8 p90 -130.87 61.57 1.62 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.018 -1.051 . . . . 0.0 110.185 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.723 ' HE3' ' CD1' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -160.17 -61.43 0.06 Allowed 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' N ' ' HG2' ' A' ' 64' ' ' MET . . . -87.4 82.11 1.61 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.435 -1.866 . . . . 0.0 108.435 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -39.94 -51.04 3.4 Favored Glycine 0 N--CA 1.489 2.22 0 O-C-N 121.473 -1.016 . . . . 0.0 110.916 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 37.9 t0 -87.74 -78.53 0.31 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.023 -1.28 . . . . 0.0 111.168 -178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.076 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -71.97 -23.88 61.5 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.854 -1.154 . . . . 0.0 110.026 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 1.076 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -50.34 -60.4 6.79 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.412 ' C ' ' O ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -48.33 -45.17 34.85 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.958 -1.319 . . . . 0.0 108.31 179.259 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -65.37 -31.14 72.1 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.749 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 44.5 tp -57.72 -42.74 84.44 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 15.6 m -61.53 -41.4 97.27 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.97 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -58.4 -21.07 49.21 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.681 -1.599 . . . . 0.0 106.681 177.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.749 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -70.22 -45.75 65.9 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 28.4 t-105 -55.31 -30.71 60.73 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.555 ' HB2' ' OE1' ' A' ' 138' ' ' GLN . . . -86.5 -65.36 1.02 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.433 -0.792 . . . . 0.0 110.134 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.97 HG23 ' O ' ' A' ' 74' ' ' GLN . 2.7 t -48.15 -28.16 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.158 -0.964 . . . . 0.0 109.945 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.482 ' HB2' ' HZ ' ' A' ' 112' ' ' PHE . . . -85.29 -59.3 2.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.83 -1.169 . . . . 0.0 108.982 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.417 ' C ' ' O ' ' A' ' 79' ' ' ALA . 8.0 tpt -47.11 -27.98 1.6 Allowed 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.854 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -73.86 -38.33 64.49 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.54 -0.725 . . . . 0.0 109.443 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.554 HD21 ' HB2' ' A' ' 125' ' ' ALA . 52.3 mt -99.56 5.23 46.06 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.113 -0.992 . . . . 0.0 110.403 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.28 20.09 27.64 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.857 HG11 HG12 ' A' ' 117' ' ' ILE . 35.4 m -89.25 -4.1 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.391 -1.064 . . . . 0.0 110.432 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 86' ' ' ASP . 0.7 OUTLIER -45.38 -68.15 0.22 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.072 -1.018 . . . . 0.0 109.439 179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.13 -34.57 0.18 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.561 -0.712 . . . . 0.0 110.21 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.943 ' HE2' ' HB1' ' A' ' 115' ' ' ALA . 12.1 mtpt -83.05 -51.22 7.74 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.264 -0.898 . . . . 0.0 110.969 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.867 HG23 HD12 ' A' ' 92' ' ' LEU . 1.2 m -80.97 -17.59 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.773 -1.204 . . . . 0.0 110.505 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.804 HG23 ' CD1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -69.43 -43.39 73.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.774 -1.204 . . . . 0.0 108.74 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.78 -55.39 38.82 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 120.548 -1.345 . . . . 0.0 110.531 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.521 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 25.8 Cg_endo -72.47 -18.07 26.33 Favored 'Trans proline' 0 C--N 1.302 -1.895 0 N-CA-C 109.909 -0.843 . . . . 0.0 109.909 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.894 ' HG ' HG11 ' A' ' 111' ' ' VAL . 21.8 mt -87.05 -43.94 11.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 108.949 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.804 ' CD1' HG23 ' A' ' 89' ' ' THR . 4.2 m-30 -63.68 -46.62 84.72 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.926 -1.109 . . . . 0.0 109.027 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 -16.74 61.07 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.133 -0.98 . . . . 0.0 109.238 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.454 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -76.44 -30.63 56.37 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 92' ' ' LEU . 1.1 t -105.71 -2.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.068 -1.254 . . . . 0.0 109.444 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.501 ' NE2' ' O ' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -113.33 10.98 18.49 Favored 'General case' 0 C--N 1.309 -1.19 0 O-C-N 120.827 -1.171 . . . . 0.0 111.073 -178.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.475 ' O ' ' CB ' ' A' ' 99' ' ' THR . 0.7 OUTLIER -177.39 58.42 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.496 -1.378 . . . . 0.0 109.992 179.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.933 ' CG2' HG23 ' A' ' 101' ' ' THR . 1.0 OUTLIER 168.13 -48.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.364 -0.835 . . . . 0.0 109.468 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.532 ' CB ' ' O ' ' A' ' 99' ' ' THR . 1.5 mt-30 80.11 20.97 0.54 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.752 -1.217 . . . . 0.0 111.366 178.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.933 HG23 ' CG2' ' A' ' 99' ' ' THR . 26.1 p -84.01 -8.91 59.01 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.303 -0.873 . . . . 0.0 109.107 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.6 ' CB ' HG22 ' A' ' 96' ' ' VAL . 5.2 mm -91.81 82.97 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 O-C-N 121.69 -0.631 . . . . 0.0 109.35 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.521 ' N ' ' HD3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -146.36 29.6 1.05 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.179 -0.951 . . . . 0.0 109.409 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.536 ' CA ' ' HB3' ' A' ' 68' ' ' LEU . 1.1 p -155.43 132.38 10.71 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.19 -0.943 . . . . 0.0 110.025 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.776 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -50.41 -32.56 17.97 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.105 -1.443 . . . . 0.0 107.105 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 22.3 m -62.9 -32.79 74.13 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -69.81 -50.3 44.24 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 178.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.776 HD12 ' HA ' ' A' ' 105' ' ' ALA . 27.0 mt -49.72 -29.36 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.407 -0.917 . . . . 0.0 108.614 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.423 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -78.5 -29.05 46.43 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.332 -0.855 . . . . 0.0 109.318 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -64.91 -46.32 82.2 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.238 -0.914 . . . . 0.0 109.302 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.894 HG11 ' HG ' ' A' ' 92' ' ' LEU . 61.4 t -71.87 -37.9 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.209 -0.932 . . . . 0.0 109.453 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.482 ' HZ ' ' HB2' ' A' ' 79' ' ' ALA . 1.0 OUTLIER -61.03 -36.3 79.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.219 -0.925 . . . . 0.0 109.655 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.842 HG23 ' HA ' ' A' ' 118' ' ' LYS . 15.1 mt -79.67 -25.49 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.106 -0.996 . . . . 0.0 110.227 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -64.09 -23.35 67.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.421 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.943 ' HB1' ' HE2' ' A' ' 87' ' ' LYS . . . -85.65 2.16 46.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 109.62 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.431 ' C ' HD12 ' A' ' 117' ' ' ILE . . . 96.45 -2.24 62.74 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.857 HG12 HG11 ' A' ' 84' ' ' VAL . 1.4 mp -90.33 60.66 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.306 -1.114 . . . . 0.0 109.121 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.842 ' HA ' HG23 ' A' ' 113' ' ' ILE . 0.4 OUTLIER -34.18 152.67 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.158 -0.964 . . . . 0.0 110.681 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -54.52 -27.37 41.31 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -61.7 -47.22 86.26 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -1.172 . . . . 0.0 109.081 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -75.94 -40.87 53.21 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.367 -0.833 . . . . 0.0 109.221 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.85 ' CE2' HG11 ' A' ' 78' ' ' VAL . 3.9 t80 -58.92 -47.36 85.31 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.851 . . . . 0.0 109.286 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.47 -34.51 77.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.244 -0.91 . . . . 0.0 109.013 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.68 -51.37 67.47 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.307 -0.871 . . . . 0.0 108.919 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.584 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -55.77 -49.36 73.35 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.385 -0.822 . . . . 0.0 108.955 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.57 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 12.7 t90 -57.49 -55.06 39.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.346 -0.846 . . . . 0.0 108.832 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -54.45 -16.16 2.13 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.474 -0.766 . . . . 0.0 109.821 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.419 ' OG ' HG23 ' A' ' 131' ' ' VAL . 1.0 OUTLIER -67.71 -179.21 1.07 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 109.571 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -91.9 -36.28 13.55 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.45 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.6 t -73.81 -47.9 41.64 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 118.225 -1.39 . . . . 0.0 110.057 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.854 HG22 ' HB1' ' A' ' 81' ' ' ALA . 3.1 t -61.82 -40.56 87.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.771 -1.206 . . . . 0.0 108.411 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.41 ' O ' ' HG2' ' A' ' 132' ' ' LYS . 2.6 ttmm -64.87 -28.13 69.33 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.514 -0.741 . . . . 0.0 109.131 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 6.5 t -69.79 -37.93 76.5 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.348 -0.845 . . . . 0.0 109.241 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.91 -17.13 59.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.187 -0.946 . . . . 0.0 108.485 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.28 -43.84 43.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -68.51 -46.98 68.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -58.15 -33.33 69.08 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.254 -0.904 . . . . 0.0 109.082 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.574 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -69.74 -74.32 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 0.0 109.407 179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.8 mt-10 -45.58 -36.39 4.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.822 . . . . 0.0 108.932 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -72.63 -35.53 67.82 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.259 -0.901 . . . . 0.0 108.668 179.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.478 ' O ' ' OD2' ' A' ' 144' ' ' ASP . . . -53.09 -62.6 1.55 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.487 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -60.93 -25.14 66.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.4 -0.813 . . . . 0.0 109.267 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.423 ' HB3' ' HA ' ' A' ' 140' ' ' LYS . . . -78.67 -25.68 44.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -0.879 . . . . 0.0 110.205 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.878 ' OD1' HG21 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -78.85 -48.32 14.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.07 -1.019 . . . . 0.0 108.342 179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.84 HG13 ' OD1' ' A' ' 144' ' ' ASP . 27.4 m -89.83 -11.43 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.544 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.4 OUTLIER 80.87 -47.27 0.26 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.494 -0.754 . . . . 0.0 109.827 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.553 HD21 HG12 ' A' ' 61' ' ' VAL . 36.0 tp 61.77 130.08 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.35 -0.843 . . . . 0.0 109.102 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -160.96 40.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.525 -1.36 . . . . 0.0 109.94 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 165.14 107.96 0.21 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.899 HG11 HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -99.42 143.45 26.44 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.294 -1.121 . . . . 0.0 109.769 179.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.521 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 35.1 Cg_endo -76.71 152.01 95.02 Favored 'Cis proline' 0 C--N 1.315 -1.208 0 C-N-CA 123.997 -1.251 . . . . 0.0 110.136 0.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.547 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -132.84 137.62 46.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.225 -1.547 . . . . 0.0 109.416 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.527 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 2.8 ttp -129.14 130.59 46.62 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.112 -0.992 . . . . 0.0 110.18 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.532 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 8.5 m-85 -127.55 129.73 47.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.307 -0.871 . . . . 0.0 109.792 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 21' ' ' GLN . 54.3 t -96.76 131.46 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 110.057 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.669 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.9 OUTLIER 44.9 23.58 0.09 Allowed 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.353 179.61 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.576 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 55.4 57.67 17.51 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.507 -1.837 . . . . 0.0 108.507 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.528 ' HB3' ' CD1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -164.72 -36.38 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.975 -1.121 . . . . 0.0 107.975 -179.449 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.548 ' CE1' ' HG2' ' A' ' 188' ' ' LYS . 11.7 m-85 -117.45 123.03 45.38 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.511 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -125.42 120.78 31.97 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 120.975 -1.078 . . . . 0.0 109.81 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.697 HD23 ' HB2' ' A' ' 9' ' ' TYR . 17.2 mt -65.33 177.36 1.13 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.555 -0.716 . . . . 0.0 109.152 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.549 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 50.9 t-20 -137.58 60.27 24.78 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.196 -0.94 . . . . 0.0 109.723 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 162' ' ' ASN . 35.5 Cg_endo -77.97 60.11 7.18 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.635 2.224 . . . . 0.0 110.397 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -51.03 -22.44 2.34 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.135 -0.978 . . . . 0.0 108.959 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 99.92 57.87 0.9 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.46 ' O ' ' C ' ' A' ' 167' ' ' ASP . 5.3 mtt -112.71 -119.32 0.3 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.191 -1.182 . . . . 0.0 108.746 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 166' ' ' MET . 25.6 t0 38.84 38.55 0.28 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.21 -0.931 . . . . 0.0 109.908 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 12.3 p -69.12 -8.27 43.88 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.946 -1.096 . . . . 0.0 109.751 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.3 m -73.67 -31.19 63.33 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.075 -1.016 . . . . 0.0 108.978 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -160.58 95.78 1.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.364 -0.835 . . . . 0.0 109.017 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 34.6 mtt -58.86 -15.88 14.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.151 -0.968 . . . . 0.0 109.62 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.07 -46.76 89.34 Favored 'General case' 0 C--N 1.293 -1.891 0 O-C-N 121.639 -0.663 . . . . 0.0 109.499 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.3 t -67.0 -28.14 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.283 -0.886 . . . . 0.0 109.36 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -66.85 -40.41 87.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.089 -1.007 . . . . 0.0 109.216 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.515 HG22 ' CG1' ' A' ' 42' ' ' ILE . 39.6 t -75.27 -27.42 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.173 -0.955 . . . . 0.0 109.458 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -80.15 -56.16 4.42 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.146 -0.972 . . . . 0.0 109.246 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -55.74 -33.25 64.1 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.15 -0.969 . . . . 0.0 109.151 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.467 ' CD1' ' C ' ' A' ' 178' ' ' TYR . 13.5 t80 -70.5 -53.11 17.54 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.179 -0.951 . . . . 0.0 109.479 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -61.5 -31.84 71.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.556 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -76.81 -50.25 13.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.275 -0.891 . . . . 0.0 109.507 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.746 ' O ' HD23 ' A' ' 185' ' ' LEU . 20.6 m -54.39 -24.15 18.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.246 -0.909 . . . . 0.0 109.527 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.463 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 25.0 t -86.16 -40.29 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.031 -1.043 . . . . 0.0 109.174 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -55.18 -45.6 75.81 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.178 -0.952 . . . . 0.0 109.094 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.516 ' CE2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -81.75 -36.66 28.3 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.34 -0.85 . . . . 0.0 109.233 179.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.746 HD23 ' O ' ' A' ' 181' ' ' THR . 0.7 OUTLIER -54.05 -20.2 6.04 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.886 -1.133 . . . . 0.0 109.875 -179.532 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.619 ' HB3' HG21 ' A' ' 54' ' ' VAL . 64.9 p -63.91 -13.49 45.98 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.709 -1.244 . . . . 0.0 108.054 177.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -119.25 33.97 5.42 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.553 -0.717 . . . . 0.0 109.31 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.548 ' HG2' ' CE1' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -76.2 4.46 8.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.044 -1.035 . . . . 0.0 110.024 -179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.087 -1.008 . . . . 0.0 109.531 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.551 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 1.2 mt-30 -104.7 57.39 0.7 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.323 -0.861 . . . . 0.0 109.615 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.551 ' CG ' ' C ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -160.99 81.72 0.64 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.507 -0.746 . . . . 0.0 109.311 179.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -111.3 59.16 0.62 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.012 -1.055 . . . . 0.0 109.593 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 45.64 83.92 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.509 -0.744 . . . . 0.0 109.893 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 136.74 -33.01 2.39 Favored Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.084 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.79 -72.63 0.45 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.194 -1.18 . . . . 0.0 109.398 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.783 ' HB3' HG21 ' A' ' 181' ' ' THR . 8.5 mm-40 -87.88 -4.24 58.86 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.217 -0.927 . . . . 0.0 109.816 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.489 ' HB3' ' O ' ' A' ' 8' ' ' GLN . 24.0 p90 177.15 130.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.236 -0.915 . . . . 0.0 109.14 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.1 t -106.31 -179.92 4.08 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 m -103.13 159.61 15.38 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.639 -0.663 . . . . 0.0 109.533 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.777 HD21 ' CE2' ' A' ' 154' ' ' PHE . 15.3 mt -95.98 154.86 17.01 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.357 -0.839 . . . . 0.0 109.748 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -89.28 -12.67 40.0 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.448 -0.783 . . . . 0.0 108.982 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.77 100.74 3.98 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.336 -0.853 . . . . 0.0 109.222 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.19 160.9 35.86 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.39 2.06 . . . . 0.0 110.703 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.906 HG13 ' CB ' ' A' ' 19' ' ' ALA . 0.4 OUTLIER -121.31 98.63 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.386 -0.821 . . . . 0.0 109.595 -179.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -44.77 126.94 6.0 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 99.13 -21.57 45.13 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.906 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -40.9 157.06 0.19 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.522 -0.987 . . . . 0.0 109.513 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.572 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.8 Cg_endo -79.83 139.59 14.0 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.725 2.283 . . . . 0.0 111.659 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.801 ' O ' HG13 ' A' ' 155' ' ' VAL . 2.8 mm-40 -51.65 -20.52 2.08 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.537 -0.727 . . . . 0.0 109.099 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 53.9 t -151.62 82.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.209 -0.932 . . . . 0.0 108.759 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.716 HD12 HG11 ' A' ' 145' ' ' VAL . 0.0 OUTLIER -74.49 126.88 31.71 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.548 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -110.18 127.33 54.88 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.039 -1.038 . . . . 0.0 109.764 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.61 ' CE2' HD13 ' A' ' 23' ' ' LEU . 3.1 m-85 -124.79 108.84 12.37 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.478 -0.764 . . . . 0.0 109.428 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -152.67 145.3 24.22 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.53 -0.868 . . . . 0.0 109.343 -179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.607 ' HA ' ' CE1' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -128.72 -164.94 1.44 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.642 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.1 OUTLIER -116.62 53.95 0.87 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.92 -1.112 . . . . 0.0 108.683 179.25 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.676 ' CE1' HD11 ' A' ' 72' ' ' LEU . 9.6 m-85 -133.88 -5.33 2.79 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.019 -1.05 . . . . 0.0 110.64 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.498 ' HB2' ' SG ' ' A' ' 33' ' ' CYS . 0.2 OUTLIER -106.28 171.8 4.48 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 120.8 -1.188 . . . . 0.0 109.433 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 30' ' ' CYS . 33.5 Cg_endo -75.15 -38.87 1.34 Allowed 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.294 1.996 . . . . 0.0 109.113 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.528 ' O ' ' N ' ' A' ' 36' ' ' PHE . 3.5 m80 -84.61 -20.7 30.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -52.56 -40.52 62.64 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.294 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.563 ' CE2' ' OE1' ' A' ' 38' ' ' GLU . 40.2 t80 -87.25 -47.45 8.83 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.69 -0.632 . . . . 0.0 109.619 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -66.18 -21.75 66.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 0.0 109.905 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.576 ' CE1' HG21 ' A' ' 42' ' ' ILE . 89.1 t80 -83.06 -16.74 45.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.905 . . . . 0.0 110.592 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.552 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -132.79 50.77 2.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.77 -1.206 . . . . 0.0 110.636 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.563 ' OE1' ' CE2' ' A' ' 34' ' ' TYR . 1.0 OUTLIER -175.41 -59.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.192 -0.943 . . . . 0.0 110.216 179.416 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.6 t -89.99 -46.91 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.204 -0.935 . . . . 0.0 110.733 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.439 ' O ' ' C ' ' A' ' 41' ' ' HIS . 77.8 mt -65.99 -6.0 11.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.022 -1.049 . . . . 0.0 110.561 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.446 ' HA ' ' OD1' ' A' ' 44' ' ' ASP . 50.5 m170 44.03 27.0 0.17 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.992 -1.067 . . . . 0.0 109.163 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.576 HG21 ' CE1' ' A' ' 36' ' ' PHE . 15.6 mt -78.43 -22.57 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.387 -0.821 . . . . 0.0 109.957 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.691 ' O ' HG12 ' A' ' 46' ' ' VAL . 47.2 m -80.65 -26.67 37.52 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.976 -1.078 . . . . 0.0 110.333 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.446 ' OD1' ' HA ' ' A' ' 41' ' ' HIS . 1.9 p-10 -87.44 -49.86 6.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.976 -1.078 . . . . 0.0 110.117 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 46' ' ' VAL . 39.1 p-10 -59.72 -25.26 64.68 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.214 -0.929 . . . . 0.0 110.028 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.691 HG12 ' O ' ' A' ' 43' ' ' SER . 9.4 p -65.27 -26.75 40.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.19 -0.944 . . . . 0.0 109.958 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.802 ' HA ' HD12 ' A' ' 50' ' ' LEU . 3.8 mttt -77.05 -38.29 53.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.049 -1.032 . . . . 0.0 109.969 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -48.48 -23.92 1.12 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.062 -1.023 . . . . 0.0 109.468 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.5 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.6 33.25 5.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 109.352 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.802 HD12 ' HA ' ' A' ' 47' ' ' LYS . 13.8 mt -114.79 81.79 7.62 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.304 -0.872 . . . . 0.0 109.198 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.753 ' HD2' HG21 ' A' ' 54' ' ' VAL . 35.6 Cg_endo -77.5 143.85 22.1 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.584 2.189 . . . . 0.0 110.566 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 51' ' ' PRO . 3.5 tm-20 -40.61 120.88 1.34 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 122.361 1.077 . . . . 0.0 109.233 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 126.39 -28.5 4.76 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 -178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.753 HG21 ' HD2' ' A' ' 51' ' ' PRO . 31.9 t -86.37 79.52 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -1.076 . . . . 0.0 108.849 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -61.07 101.67 0.17 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.422 -0.799 . . . . 0.0 110.528 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.672 ' SD ' HD11 ' A' ' 50' ' ' LEU . 7.9 ttt -100.67 97.68 8.32 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 178.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.493 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 1.6 m -94.68 123.5 38.16 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.325 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.548 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 3.1 tppt? -99.63 121.65 41.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.398 -0.814 . . . . 0.0 109.546 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.593 ' CE1' ' HG2' ' A' ' 138' ' ' GLN . 2.0 m-85 -126.05 174.78 8.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.854 -1.154 . . . . 0.0 111.174 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.741 ' NE2' HD22 ' A' ' 72' ' ' LEU . 22.4 t60 -112.04 145.86 38.95 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 121.841 0.829 . . . . 0.0 109.378 -178.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.078 HG11 ' CG1' ' A' ' 150' ' ' VAL . 8.4 m -80.86 155.73 4.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 CA-C-O 121.325 0.583 . . . . 0.0 109.985 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' HB2' ' HE3' ' A' ' 70' ' ' LYS . 52.0 p30 -121.02 38.81 3.97 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.142 -0.973 . . . . 0.0 109.604 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.593 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 2.4 p90 -139.34 57.11 1.66 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.163 -0.96 . . . . 0.0 109.611 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.515 ' CE ' ' CG2' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -125.79 35.23 4.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.275 -0.891 . . . . 0.0 109.134 179.412 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 148.83 -30.83 1.23 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 108.379 -1.889 . . . . 0.0 108.379 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.46 -35.02 3.04 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.7 -79.45 0.29 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.74 -1.447 . . . . 0.0 109.939 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.903 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -76.6 -19.14 58.16 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.966 -1.084 . . . . 0.0 108.85 179.696 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.564 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -53.48 -54.46 29.91 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.026 -2.03 . . . . 0.0 108.026 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.468 ' HE3' ' HB2' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -52.99 -41.91 65.06 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 178.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.77 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 45.5 t0 -65.76 -31.39 72.35 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.762 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 0.3 OUTLIER -59.05 -36.08 74.43 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 178.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.582 HG23 ' OE1' ' A' ' 138' ' ' GLN . 45.7 m -66.64 -41.74 87.8 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -63.83 -16.43 61.27 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -71.28 -40.6 70.81 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 20.0 t-105 -68.85 -31.35 70.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.61 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -81.0 -62.48 1.65 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.339 -0.851 . . . . 0.0 109.577 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.146 HG11 ' CD2' ' A' ' 122' ' ' TYR . 59.9 t -48.33 -29.1 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.244 -0.91 . . . . 0.0 109.949 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.516 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -84.03 -60.52 2.07 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.885 -1.134 . . . . 0.0 108.875 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.584 ' HB3' HD22 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -44.5 -28.8 0.62 Allowed 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.73 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -71.45 -44.48 64.73 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.413 -0.805 . . . . 0.0 109.572 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.552 ' HB2' HG13 ' A' ' 84' ' ' VAL . 5.8 mt -99.97 11.18 39.94 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.037 -1.04 . . . . 0.0 110.004 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.38 22.02 6.95 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.552 HG13 ' HB2' ' A' ' 82' ' ' LEU . 34.0 m -85.19 -7.81 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -1.076 . . . . 0.0 110.138 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 84' ' ' VAL . 0.0 OUTLIER -41.17 -60.3 1.27 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -47.73 -33.43 7.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.249 -0.907 . . . . 0.0 110.345 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.2 mtpp -83.29 -52.53 6.48 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.171 -0.956 . . . . 0.0 111.696 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.919 HG23 HD12 ' A' ' 92' ' ' LEU . 1.2 m -77.68 -10.06 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.586 -1.321 . . . . 0.0 110.249 -178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.713 HG23 ' CD1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -70.88 -44.69 65.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.851 -1.155 . . . . 0.0 108.889 179.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.403 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -53.17 -54.77 40.92 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 120.448 -1.408 . . . . 0.0 110.477 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.579 ' HB2' HG13 ' A' ' 111' ' ' VAL . 24.7 Cg_endo -72.8 -18.63 24.68 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 122.639 0.81 . . . . 0.0 109.995 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.919 HD12 HG23 ' A' ' 88' ' ' VAL . 15.0 mt -86.16 -41.75 14.43 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.235 -0.916 . . . . 0.0 109.09 178.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.713 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.8 m-30 -66.25 -47.61 73.19 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.056 -1.027 . . . . 0.0 109.007 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -31.96 70.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.935 -1.103 . . . . 0.0 109.322 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.464 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -63.06 -32.7 85.04 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.664 HG11 ' CD1' ' A' ' 29' ' ' PHE . 2.0 t -107.19 5.76 9.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.105 -1.232 . . . . 0.0 109.206 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.533 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -107.78 10.69 28.71 Favored 'General case' 0 C--N 1.308 -1.2 0 O-C-N 120.981 -1.074 . . . . 0.0 110.579 -179.187 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 100' ' ' GLN . 0.1 OUTLIER 176.08 -50.39 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.519 -1.363 . . . . 0.0 110.144 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 43.0 p -56.62 -44.66 81.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.489 -1.382 . . . . 0.0 109.114 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 99' ' ' THR . 38.2 mt-30 70.42 10.83 7.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.425 -0.797 . . . . 0.0 110.085 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 t -83.27 -5.28 59.08 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-O 121.734 0.778 . . . . 0.0 109.143 178.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.513 ' CB ' HG22 ' A' ' 96' ' ' VAL . 12.9 mm -84.57 80.51 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.69 33.38 1.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 110.021 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.544 ' O ' ' N ' ' A' ' 107' ' ' ASP . 1.7 p -161.47 133.78 5.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.953 -1.092 . . . . 0.0 109.893 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.77 ' HB1' ' OD2' ' A' ' 71' ' ' ASP . . . -51.51 -32.62 28.3 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.465 ' OG ' ' HB2' ' A' ' 104' ' ' SER . 5.5 p -61.85 -31.46 71.73 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.544 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -72.02 -49.54 36.07 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.77 HD11 HD23 ' A' ' 68' ' ' LEU . 26.9 mt -52.01 -30.9 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.401 ' O ' HG13 ' A' ' 113' ' ' ILE . 19.6 mtt-85 -74.11 -28.54 61.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.433 -0.792 . . . . 0.0 109.069 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -66.61 -48.15 70.43 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.339 -0.851 . . . . 0.0 109.374 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.859 HG11 ' HG ' ' A' ' 92' ' ' LEU . 49.1 t -65.83 -40.26 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.115 -0.991 . . . . 0.0 109.507 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.4 ' CE1' HG12 ' A' ' 78' ' ' VAL . 0.5 OUTLIER -57.57 -43.84 84.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.946 -1.096 . . . . 0.0 109.379 179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 109' ' ' ARG . 18.7 mt -68.35 -24.8 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 0.0 109.623 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -20.11 66.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.217 -0.927 . . . . 0.0 109.691 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.83 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -93.87 9.71 36.2 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.552 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 87.44 -5.57 84.83 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.832 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.6 mp -76.65 55.24 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.202 -1.175 . . . . 0.0 109.032 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -33.01 149.17 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.347 -0.846 . . . . 0.0 110.743 -179.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.401 ' HA2' ' HB3' ' A' ' 122' ' ' TYR . . . -51.8 -28.41 23.36 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -58.8 -47.56 84.34 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.236 -1.155 . . . . 0.0 108.849 179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -80.41 -34.51 36.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.401 -0.812 . . . . 0.0 109.705 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 1.146 ' CD2' HG11 ' A' ' 78' ' ' VAL . 3.5 t80 -64.17 -50.22 69.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.993 -1.067 . . . . 0.0 109.511 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.62 -35.19 75.05 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.013 -1.054 . . . . 0.0 108.713 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -61.6 -51.65 67.65 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.634 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -54.91 -52.06 64.12 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.533 ' C ' ' CD1' ' A' ' 126' ' ' TRP . 6.8 t90 -52.75 -55.61 21.59 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -55.14 -15.74 2.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.677 -0.639 . . . . 0.0 110.435 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -72.55 176.64 5.27 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.909 -1.119 . . . . 0.0 109.845 -179.487 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -87.33 -39.0 15.73 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.179 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.43 -44.86 83.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 C-N-CA 118.254 -1.378 . . . . 0.0 109.789 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.73 HG22 ' HB1' ' A' ' 81' ' ' ALA . 2.8 t -67.02 -38.87 82.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.809 -1.182 . . . . 0.0 108.685 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 12.8 ttpp -67.93 -29.37 68.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 137' ' ' GLN . 0.4 OUTLIER -70.89 -34.47 71.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.428 -0.795 . . . . 0.0 109.235 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.584 HD22 ' HB3' ' A' ' 80' ' ' MET . 0.0 OUTLIER -80.12 -21.41 43.24 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.277 -0.889 . . . . 0.0 108.617 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.61 HG23 ' HB1' ' A' ' 77' ' ' ALA . 17.9 t -81.48 -45.6 20.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.26 83.87 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -63.01 -32.83 74.28 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.298 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.593 ' HG2' ' CE1' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -60.15 -69.56 0.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.436 -0.79 . . . . 0.0 109.073 179.448 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.548 ' OE2' ' HB2' ' A' ' 143' ' ' ALA . 6.3 tm-20 -48.61 -33.38 9.74 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 9.5 tttm -68.72 -40.78 79.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.426 -0.796 . . . . 0.0 109.038 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.472 ' O ' ' OD2' ' A' ' 144' ' ' ASP . . . -55.52 -55.32 33.19 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.273 -0.892 . . . . 0.0 108.618 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.53 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -70.15 -22.97 62.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.372 -0.83 . . . . 0.0 109.345 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.548 ' HB2' ' OE2' ' A' ' 139' ' ' GLU . . . -78.5 -26.51 45.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.223 -0.923 . . . . 0.0 110.069 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.793 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.4 p30 -82.8 -47.73 11.58 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.939 -1.1 . . . . 0.0 108.271 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.793 HG13 ' OD1' ' A' ' 144' ' ' ASP . 14.7 m -85.82 -17.05 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.543 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.8 OUTLIER 81.92 -47.54 0.2 Allowed 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.449 0.643 . . . . 0.0 109.643 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.04 HD21 HG12 ' A' ' 61' ' ' VAL . 14.3 tp 67.33 131.63 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.449 -0.782 . . . . 0.0 109.421 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 148' ' ' ARG . 2.7 ptt85 -161.46 39.04 0.14 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.565 -1.335 . . . . 0.0 110.02 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 161.06 108.28 0.23 Allowed Glycine 0 N--CA 1.49 2.3 0 C-N-CA 119.38 -1.39 . . . . 0.0 110.37 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 1.078 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -91.88 144.72 29.73 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.371 -1.076 . . . . 0.0 109.792 179.111 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.462 ' HG2' ' HG2' ' A' ' 163' ' ' PRO . 33.6 Cg_endo -77.09 152.23 94.54 Favored 'Cis proline' 0 C--N 1.317 -1.124 0 C-N-CA 124.1 -1.208 . . . . 0.0 110.501 0.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -126.63 152.26 46.93 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.426 -1.421 . . . . 0.0 109.353 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.502 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 2.6 tmm? -151.21 135.61 16.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.123 -0.986 . . . . 0.0 109.656 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.777 ' CE2' HD21 ' A' ' 12' ' ' LEU . 51.0 m-85 -137.1 124.54 22.06 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.418 -0.801 . . . . 0.0 110.311 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 21' ' ' GLN . 52.0 t -92.34 130.48 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.118 -0.989 . . . . 0.0 109.747 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.683 HD22 HG12 ' A' ' 155' ' ' VAL . 3.9 p30 45.55 22.42 0.1 Allowed 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.046 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.82 56.56 24.64 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.519 ' N ' HD12 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -165.77 -36.85 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.299 -1.118 . . . . 0.0 108.169 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.499 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 75.9 m-85 -115.34 123.44 48.73 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.534 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 20.8 pt20 -123.3 134.74 54.03 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.94 -1.1 . . . . 0.0 109.877 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.9 mt -70.95 177.83 3.48 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.451 ' N ' ' HD3' ' A' ' 163' ' ' PRO . 0.3 OUTLIER -147.76 65.95 9.43 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 120.878 -1.139 . . . . 0.0 110.02 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.462 ' HG2' ' HG2' ' A' ' 151' ' ' PRO . 36.0 Cg_endo -79.1 65.76 8.83 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.575 2.183 . . . . 0.0 109.988 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -14.77 38.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.354 -0.842 . . . . 0.0 109.677 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.25 66.14 0.23 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 5.3 ptp -115.01 42.99 2.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -1.113 . . . . 0.0 109.193 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.561 ' HB2' ' CD2' ' A' ' 174' ' ' PHE . 44.5 t0 -107.19 24.61 12.56 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.248 -0.908 . . . . 0.0 109.567 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.4 p -97.06 20.71 10.84 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.464 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 66.5 p -120.32 -49.47 2.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.199 -0.938 . . . . 0.0 109.621 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -160.9 101.52 1.28 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 109.148 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.48 ' HA ' ' OD1' ' A' ' 167' ' ' ASP . 3.5 mtt -55.84 -17.09 5.46 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 109.689 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.466 ' CG ' ' N ' ' A' ' 173' ' ' VAL . 0.0 OUTLIER -75.43 -60.56 2.25 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.466 ' N ' ' CG ' ' A' ' 172' ' ' ASP . 4.9 t -64.69 -30.69 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.318 -0.864 . . . . 0.0 109.473 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.561 ' CD2' ' HB2' ' A' ' 167' ' ' ASP . 24.9 t80 -67.22 -45.32 77.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.958 . . . . 0.0 109.665 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.428 HG22 ' CG1' ' A' ' 42' ' ' ILE . 70.7 t -73.63 -25.17 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.169 -0.957 . . . . 0.0 109.444 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -79.87 -57.53 3.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.228 -0.92 . . . . 0.0 109.526 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -54.97 -47.51 74.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.108 -0.995 . . . . 0.0 109.299 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 182' ' ' VAL . 31.9 t80 -59.15 -57.24 13.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.16 -0.962 . . . . 0.0 109.128 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -51.13 -29.08 12.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.33 -0.856 . . . . 0.0 109.14 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 20.0 t0 -77.89 -47.0 19.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.334 -0.853 . . . . 0.0 109.202 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.783 HG21 ' HB3' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -50.3 -32.83 18.06 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.349 179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 178' ' ' TYR . 1.4 t -85.74 -37.62 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.131 -0.981 . . . . 0.0 108.952 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.45 ' O ' ' OG ' ' A' ' 186' ' ' SER . 16.6 ttpt -60.38 -46.13 91.06 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.281 -0.887 . . . . 0.0 109.037 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.56 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -78.93 -27.15 43.65 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.233 -0.917 . . . . 0.0 108.98 179.787 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.663 HD23 ' O ' ' A' ' 181' ' ' THR . 0.3 OUTLIER -65.69 -19.59 65.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.863 -1.148 . . . . 0.0 108.925 179.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.492 ' HB2' HG22 ' A' ' 54' ' ' VAL . 15.0 p -77.88 -13.04 60.02 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.834 -1.166 . . . . 0.0 108.745 178.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.85 4.7 51.05 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.307 -0.871 . . . . 0.0 109.329 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.46 ' O ' ' C ' ' A' ' 189' ' ' LYS . 1.2 tptp -51.35 -39.57 57.33 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.2 -0.938 . . . . 0.0 109.578 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 188' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 117.965 -1.017 . . . . 0.0 109.97 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 121.34 0.591 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.448 ' C ' ' CD2' ' A' ' 3' ' ' TYR . 26.0 mt-30 -112.39 62.3 0.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -0.872 . . . . 0.0 108.721 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.633 ' HB3' ' HB2' ' A' ' 8' ' ' GLN . 4.3 p90 -175.19 97.01 0.08 Allowed 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.432 ' O ' ' CB ' ' A' ' 5' ' ' ASP . 4.7 mt-10 -114.94 64.57 0.68 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.165 -0.959 . . . . 0.0 110.826 -178.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.432 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 4.0 m-20 70.18 96.74 0.07 Allowed 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.307 -0.871 . . . . 0.0 110.473 178.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.15 -3.4 81.02 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.582 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 0.0 OUTLIER -100.48 26.98 6.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -1.172 . . . . 0.0 108.533 179.528 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' A' ' 3' ' ' TYR . 0.1 OUTLIER 150.42 -35.53 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.276 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.598 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -156.98 131.25 8.49 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 120.669 -1.269 . . . . 0.0 109.796 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.5 t -114.44 174.99 5.68 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.59 152.28 20.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.653 -0.655 . . . . 0.0 109.707 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.496 ' HG ' ' HG2' ' A' ' 160' ' ' GLN . 1.4 mt -92.56 161.31 14.65 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.396 -0.815 . . . . 0.0 109.517 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -84.93 -18.72 33.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.889 . . . . 0.0 109.171 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mtpt -140.34 110.17 6.93 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.366 -0.833 . . . . 0.0 108.899 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.52 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 36.2 Cg_endo -77.22 167.9 24.0 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.352 2.034 . . . . 0.0 111.29 -179.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.692 HG21 ' HB3' ' A' ' 144' ' ' ASP . 7.7 t -128.19 93.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 0.0 109.58 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -49.93 127.54 16.61 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 97.63 -20.8 49.21 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.818 -1.713 . . . . 0.0 108.818 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.512 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -40.01 159.52 0.13 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.623 -0.928 . . . . 0.0 109.347 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.587 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 34.9 Cg_endo -77.52 128.26 9.42 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.459 2.106 . . . . 0.0 111.35 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.859 ' O ' HG13 ' A' ' 155' ' ' VAL . 10.3 mp0 -41.4 -25.56 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.529 -0.732 . . . . 0.0 109.724 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.644 ' O ' HG12 ' A' ' 22' ' ' VAL . 8.6 t -149.21 84.88 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.068 -1.02 . . . . 0.0 108.872 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.587 ' HG ' ' CG ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -77.35 126.13 30.43 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' OE1' ' CD1' ' A' ' 26' ' ' PHE . 0.9 OUTLIER -118.46 104.03 10.31 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.076 -1.015 . . . . 0.0 109.732 -179.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.715 ' CD2' HD13 ' A' ' 147' ' ' LEU . 5.2 m-85 -90.05 123.46 33.95 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.304 -0.873 . . . . 0.0 109.609 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 1.0 OUTLIER -160.91 140.23 10.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.529 -0.732 . . . . 0.0 109.231 -179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.591 ' HB2' ' CD2' ' A' ' 29' ' ' PHE . 11.1 p -116.29 174.97 5.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.158 -0.964 . . . . 0.0 110.183 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.61 ' CD2' HD21 ' A' ' 72' ' ' LEU . 8.3 m-30 -89.3 37.6 0.87 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.501 -0.749 . . . . 0.0 109.021 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 1.14 ' CZ ' HD13 ' A' ' 72' ' ' LEU . 3.2 m-85 -135.65 18.92 3.31 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.18 -0.95 . . . . 0.0 109.773 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.436 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 3.8 m -112.79 164.07 16.35 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 120.819 -1.176 . . . . 0.0 109.428 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.9 Cg_endo -74.74 -13.19 22.09 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.014 1.809 . . . . 0.0 108.321 178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.572 ' HB3' ' CD1' ' A' ' 36' ' ' PHE . 36.5 m170 -100.2 -29.7 12.33 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.517 ' SG ' ' N ' ' A' ' 34' ' ' TYR . 6.1 p -44.58 -40.51 5.81 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.636 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 21.1 t80 -88.22 -45.49 10.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.789 -0.57 . . . . 0.0 110.259 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -68.54 -22.39 64.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.113 -0.992 . . . . 0.0 111.12 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.661 ' CZ ' HD13 ' A' ' 42' ' ' ILE . 1.6 m-85 -80.16 -25.0 40.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.801 -1.187 . . . . 0.0 110.588 -178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.418 ' O ' ' CD ' ' A' ' 38' ' ' GLU . 0.4 OUTLIER -117.94 32.46 6.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.899 -1.126 . . . . 0.0 110.073 -179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 38' ' ' GLU . 67.6 mm-40 -146.52 -63.83 0.3 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.107 -0.995 . . . . 0.0 110.566 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 40' ' ' LEU . 4.0 t -101.75 -66.8 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.034 -1.041 . . . . 0.0 110.741 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 40' ' ' LEU . 58.0 mt -42.92 -34.21 0.93 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.254 -0.904 . . . . 0.0 110.625 -178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.409 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 31.8 m170 57.27 20.32 5.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.047 -1.033 . . . . 0.0 109.172 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.661 HD13 ' CZ ' ' A' ' 36' ' ' PHE . 8.5 mt -58.92 -24.32 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.619 -179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 63.6 m -77.17 -60.88 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.216 -0.927 . . . . 0.0 109.722 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.41 ' HA ' ' HB2' ' A' ' 47' ' ' LYS . 10.0 m-20 -70.84 -33.6 70.82 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.209 -0.932 . . . . 0.0 110.0 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.423 ' OD1' ' C ' ' A' ' 45' ' ' ASN . 12.5 t-20 -60.79 -49.73 76.32 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.183 -0.948 . . . . 0.0 109.661 -179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.406 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 67.3 t -77.27 -16.89 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.898 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 44' ' ' ASP . 0.3 OUTLIER -75.8 -27.74 58.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.045 -1.035 . . . . 0.0 109.646 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -72.28 -22.86 61.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.142 -0.974 . . . . 0.0 109.516 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.476 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 24.0 mtmt -97.54 -3.27 40.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.871 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.545 HD22 ' HB ' ' A' ' 54' ' ' VAL . 13.1 mt -73.5 113.42 22.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 0.0 109.679 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.841 ' HD2' HG21 ' A' ' 54' ' ' VAL . 36.7 Cg_endo -78.54 138.4 15.36 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.174 1.916 . . . . 0.0 110.599 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' C ' ' O ' ' A' ' 51' ' ' PRO . 23.4 tt0 -40.79 119.64 1.16 Allowed 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.086 0.946 . . . . 0.0 109.573 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 127.32 -25.77 5.08 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.89 HG22 ' HB2' ' A' ' 186' ' ' SER . 4.5 t -85.33 88.29 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -1.187 . . . . 0.0 109.358 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.447 ' HE3' ' OG1' ' A' ' 57' ' ' THR . 0.0 OUTLIER -69.77 99.91 1.43 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.449 -0.782 . . . . 0.0 109.956 -179.666 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.483 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 1.8 ttt -92.7 100.63 13.09 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.573 -0.704 . . . . 0.0 109.321 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.447 ' OG1' ' HE3' ' A' ' 55' ' ' LYS . 89.8 m -95.39 139.89 31.05 Favored 'General case' 0 C--N 1.305 -1.34 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.136 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.547 ' O ' ' NE1' ' A' ' 76' ' ' TRP . 1.4 mppt? -118.14 105.46 11.84 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.608 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.0 m-85 -103.59 164.36 11.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.597 -1.315 . . . . 0.0 111.109 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 1.022 ' NE2' HD22 ' A' ' 72' ' ' LEU . 6.8 t-80 -116.28 134.6 54.73 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 121.721 0.772 . . . . 0.0 109.141 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.043 HG21 HG11 ' A' ' 150' ' ' VAL . 2.6 m -104.97 160.73 5.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 O-C-N 121.666 -0.646 . . . . 0.0 110.123 -179.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.535 ' HB3' ' N ' ' A' ' 70' ' ' LYS . 1.7 p-10 -103.85 54.53 0.74 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.524 ' CE1' ' HB ' ' A' ' 61' ' ' VAL . 4.9 m-85 -100.73 61.55 1.0 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.671 -0.643 . . . . 0.0 109.764 -179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.585 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -161.65 -56.66 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.891 -1.124 . . . . 0.0 111.6 179.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.585 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -114.82 -18.37 6.48 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.44 -42.63 1.98 Allowed Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.07 -77.69 0.35 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.242 -1.152 . . . . 0.0 109.45 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.07 HD11 HG22 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -62.13 -21.61 65.16 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.954 ' N ' HD23 ' A' ' 68' ' ' LEU . . . -60.85 -64.93 3.66 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.535 ' N ' ' HB3' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -54.61 -42.47 71.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.249 -1.147 . . . . 0.0 108.502 179.254 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.706 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 21.7 t0 -64.93 -29.33 70.26 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 178.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.14 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 3.5 tt -66.58 -35.4 80.12 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.433 ' HB ' ' O ' ' A' ' 70' ' ' LYS . 1.6 m -59.16 -41.73 89.1 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 177.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -61.32 -24.51 66.49 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.765 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -65.28 -34.23 77.86 Favored 'General case' 0 N--CA 1.482 1.172 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.554 ' CH2' ' OE2' ' A' ' 85' ' ' GLU . 53.0 t-105 -71.15 -31.86 68.21 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.644 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -79.16 -58.95 2.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.337 -0.852 . . . . 0.0 109.411 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.969 HG21 ' CE1' ' A' ' 122' ' ' TYR . 93.9 t -53.65 -27.55 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.39 -0.819 . . . . 0.0 109.981 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.583 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -81.97 -61.27 1.96 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.984 -1.073 . . . . 0.0 108.654 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 3.1 tpt -49.17 -26.28 2.74 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.883 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -77.46 -36.5 52.82 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.531 -0.731 . . . . 0.0 109.563 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 84' ' ' VAL . 83.1 mt -105.81 8.89 32.99 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 0.0 110.75 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 54.25 27.89 40.95 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.583 HG22 ' HA ' ' A' ' 79' ' ' ALA . 32.6 m -99.67 29.17 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.461 -1.023 . . . . 0.0 110.049 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.554 ' OE2' ' CH2' ' A' ' 76' ' ' TRP . 5.2 mt-10 -62.88 -79.57 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.133 -0.979 . . . . 0.0 109.641 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -36.41 -37.63 0.13 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 121.345 0.593 . . . . 0.0 110.805 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.529 ' O ' ' CD ' ' A' ' 91' ' ' PRO . 5.1 mtpt -70.85 -56.72 5.66 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.402 -0.811 . . . . 0.0 111.459 -178.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.746 HG23 HD12 ' A' ' 92' ' ' LEU . 1.3 m -86.74 -15.11 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.613 -1.304 . . . . 0.0 110.592 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.734 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -74.62 -42.52 58.46 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.589 -1.319 . . . . 0.0 108.341 178.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.417 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -54.68 -53.75 56.85 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 120.701 -1.249 . . . . 0.0 110.615 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 25.9 Cg_endo -73.07 -19.89 22.39 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 N-CA-C 109.829 -0.873 . . . . 0.0 109.829 178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.746 HD12 HG23 ' A' ' 88' ' ' VAL . 21.9 mt -83.78 -42.62 16.3 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.734 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.4 m-30 -64.83 -45.74 84.88 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.029 -1.044 . . . . 0.0 108.649 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -72.47 -28.6 63.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.171 -0.956 . . . . 0.0 109.254 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.07 -32.07 82.9 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.623 HG11 ' HD1' ' A' ' 29' ' ' PHE . 2.5 t -99.8 -6.83 9.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.194 -1.18 . . . . 0.0 109.245 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.636 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -108.71 7.5 26.44 Favored 'General case' 0 C--N 1.311 -1.108 0 O-C-N 120.935 -1.103 . . . . 0.0 111.037 -179.279 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.776 ' O ' HG23 ' A' ' 99' ' ' THR . 0.9 OUTLIER -175.63 66.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.516 -1.365 . . . . 0.0 109.55 -179.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.776 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.08 -48.11 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.8 -0.563 . . . . 0.0 109.639 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.6 mt-30 74.26 17.7 3.2 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.197 -0.939 . . . . 0.0 110.276 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.8 t -79.93 -6.53 57.65 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 1.07 HG22 HD11 ' A' ' 68' ' ' LEU . 11.1 mm -89.72 71.08 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.716 -0.615 . . . . 0.0 109.345 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.541 ' CA ' HD13 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -136.87 16.19 3.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 109.235 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.553 ' O ' ' N ' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -142.64 126.88 17.56 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.402 -0.811 . . . . 0.0 109.402 -179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.706 ' HB1' ' OD2' ' A' ' 71' ' ' ASP . . . -49.37 -37.32 24.47 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.3 p -55.86 -31.63 62.94 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.769 ' OD2' HD12 ' A' ' 68' ' ' LEU . 0.4 OUTLIER -74.14 -47.76 33.91 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.47 -0.892 . . . . 0.0 108.911 179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.751 HD11 ' O ' ' A' ' 68' ' ' LEU . 30.4 mt -48.41 -29.34 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.911 -1.118 . . . . 0.0 108.582 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -74.37 -47.41 34.33 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.333 -0.854 . . . . 0.0 109.614 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -51.98 -40.39 60.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.222 -0.924 . . . . 0.0 109.37 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.692 HG11 ' HG ' ' A' ' 92' ' ' LEU . 2.4 t -71.18 -40.1 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.164 -0.96 . . . . 0.0 109.532 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.541 ' CE1' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -65.47 -33.46 75.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.114 -0.991 . . . . 0.0 109.564 179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mt -76.42 -25.4 16.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.137 -0.977 . . . . 0.0 109.917 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -65.39 -20.0 66.19 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.059 -1.026 . . . . 0.0 109.61 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.505 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -90.05 4.72 49.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.242 -0.911 . . . . 0.0 109.722 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 92.6 0.37 69.65 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.719 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.5 mm -79.5 60.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -1.149 . . . . 0.0 109.555 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.489 ' C ' ' O ' ' A' ' 117' ' ' ILE . 64.7 mttt -34.85 153.17 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.257 -0.902 . . . . 0.0 110.45 -179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.459 ' O ' ' CB ' ' A' ' 123' ' ' ASP . . . -59.69 -27.69 64.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.709 -1.357 . . . . 0.0 109.709 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -66.45 -43.92 84.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -1.17 . . . . 0.0 109.607 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -70.0 -50.05 45.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.327 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.969 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -65.34 -56.35 13.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.369 -0.832 . . . . 0.0 108.845 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 119' ' ' GLY . 27.5 t70 -45.56 -39.22 7.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.101 -0.999 . . . . 0.0 108.892 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.69 -44.36 61.89 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.302 -0.874 . . . . 0.0 108.791 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.575 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -54.63 -49.09 71.34 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -59.27 -58.74 7.29 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -53.86 -15.97 1.58 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.585 -0.697 . . . . 0.0 110.119 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -70.74 175.47 4.95 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.96 -1.088 . . . . 0.0 109.766 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.947 ' CE2' HG23 ' A' ' 130' ' ' VAL . 41.4 p90 -94.09 -37.03 11.82 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.776 -179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.947 HG23 ' CE2' ' A' ' 129' ' ' PHE . 25.0 t -67.18 -47.91 80.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 C-N-CA 118.13 -1.428 . . . . 0.0 109.578 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.883 HG22 ' HB1' ' A' ' 81' ' ' ALA . 16.6 t -63.41 -40.24 88.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.977 -1.077 . . . . 0.0 108.561 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.75 -37.71 85.18 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.456 -0.778 . . . . 0.0 109.056 179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.25 -29.5 70.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 0.0 109.057 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.12 -30.8 55.36 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.644 HG23 ' CB ' ' A' ' 77' ' ' ALA . 9.8 t -76.04 -41.15 38.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -59.6 -48.72 80.56 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -37.17 82.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.254 -0.904 . . . . 0.0 109.139 179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.608 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 18.9 tm0? -55.87 -62.42 1.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.037 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 11.6 mt-10 -48.35 -33.57 9.2 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.427 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -72.46 -29.29 63.54 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.351 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.576 ' HB2' ' CE2' ' A' ' 59' ' ' TYR . . . -62.46 -57.19 12.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 108.712 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.535 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -68.55 -35.87 78.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.519 -0.738 . . . . 0.0 110.036 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -77.81 -16.64 58.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.043 -1.035 . . . . 0.0 109.835 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.692 ' HB3' HG21 ' A' ' 16' ' ' VAL . 5.7 m-20 -81.49 -43.76 18.36 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.155 -0.966 . . . . 0.0 108.95 179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.54 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 29.7 m -105.03 -9.4 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.428 -0.795 . . . . 0.0 108.885 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.54 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.9 OUTLIER 82.24 -43.72 0.15 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.519 -0.738 . . . . 0.0 109.876 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.015 HD21 HG11 ' A' ' 61' ' ' VAL . 14.1 tp 64.5 134.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.299 -0.876 . . . . 0.0 109.35 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.1 ttt180 -160.75 32.85 0.15 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.533 -1.354 . . . . 0.0 110.002 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 151' ' ' PRO . . . 175.01 77.97 0.05 OUTLIER Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.134 -1.508 . . . . 0.0 110.995 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 1.043 HG11 HG21 ' A' ' 61' ' ' VAL . 3.8 m -80.15 135.91 54.13 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.119 -1.224 . . . . 0.0 107.92 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 149' ' ' GLY . 30.9 Cg_endo -71.18 152.85 96.04 Favored 'Cis proline' 0 C--N 1.317 -1.098 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.508 2.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -140.29 159.84 41.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.689 -1.257 . . . . 0.0 109.026 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.53 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 30.3 tpp -142.65 138.18 30.48 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.024 -1.048 . . . . 0.0 110.369 -179.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.561 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 6.3 m-85 -143.22 127.34 17.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.436 -0.79 . . . . 0.0 109.577 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 21' ' ' GLN . 54.9 t -103.95 130.59 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.059 -1.026 . . . . 0.0 109.501 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.512 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 1.9 t-20 45.62 26.39 0.33 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 15' ' ' PRO . . . 52.07 27.46 22.61 Favored Glycine 0 N--CA 1.487 2.092 0 C-N-CA 119.402 -1.38 . . . . 0.0 109.88 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.66 -15.96 4.35 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.735 -1.45 . . . . 0.0 109.308 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.576 ' CE2' ' HE3' ' A' ' 188' ' ' LYS . 65.2 m-85 -143.1 125.6 15.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.001 . . . . 0.0 109.149 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.496 ' HG2' ' HG ' ' A' ' 12' ' ' LEU . 1.1 pt20 -119.7 139.4 52.31 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.03 -1.044 . . . . 0.0 109.778 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.445 ' HG ' ' HB3' ' A' ' 153' ' ' MET . 7.7 mt -75.78 173.41 11.17 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -158.6 87.08 2.32 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 120.973 -1.079 . . . . 0.0 109.758 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.01 35.23 0.56 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.872 2.381 . . . . 0.0 111.225 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -91.08 154.86 19.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.991 -1.068 . . . . 0.0 108.7 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 89.63 -34.18 4.12 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.501 ' O ' HG23 ' A' ' 168' ' ' THR . 0.0 OUTLIER -89.48 -112.77 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.987 -1.302 . . . . 0.0 109.345 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 166' ' ' MET . 25.9 t0 41.34 27.79 0.06 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.981 -1.074 . . . . 0.0 109.853 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 166' ' ' MET . 81.4 p -85.61 -70.39 0.59 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.161 -0.962 . . . . 0.0 109.557 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 169' ' ' SER . 3.3 t -171.89 58.67 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.291 -0.88 . . . . 0.0 109.36 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -148.34 64.07 1.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.145 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.845 ' O ' HG23 ' A' ' 175' ' ' VAL . 4.9 mmt -64.92 -15.55 62.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.312 -0.867 . . . . 0.0 109.635 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.11 -63.13 1.29 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.352 0.596 . . . . 0.0 109.474 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 4.0 t -67.3 -18.27 23.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.153 -0.967 . . . . 0.0 109.475 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -76.52 -47.16 23.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.101 -1.0 . . . . 0.0 109.663 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.845 HG23 ' O ' ' A' ' 171' ' ' MET . 15.2 t -70.91 -25.05 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 109.376 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 44.3 tt0 -80.63 -61.01 2.1 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.263 -0.898 . . . . 0.0 109.257 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.426 ' HB2' ' O ' ' A' ' 173' ' ' VAL . 0.5 OUTLIER -55.12 -42.72 73.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.218 -0.927 . . . . 0.0 109.198 179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.511 ' CD1' ' C ' ' A' ' 178' ' ' TYR . 9.7 t80 -61.32 -48.65 80.34 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.281 -0.887 . . . . 0.0 109.364 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.67 -30.07 65.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.864 . . . . 0.0 109.343 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -77.38 -43.47 32.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.495 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.6 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.1 OUTLIER -57.75 -34.09 69.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.099 -1.0 . . . . 0.0 109.465 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.448 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 51.7 t -78.45 -36.09 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.154 -0.966 . . . . 0.0 109.044 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.87 -52.04 67.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.289 -0.882 . . . . 0.0 109.169 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -77.11 -32.0 56.22 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.296 -0.878 . . . . 0.0 109.263 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 181' ' ' THR . 0.2 OUTLIER -62.67 -17.06 59.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.06 -1.025 . . . . 0.0 109.653 -179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.89 ' HB2' HG22 ' A' ' 54' ' ' VAL . 87.8 p -73.08 -12.3 60.86 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.856 -1.153 . . . . 0.0 108.709 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.21 0.95 57.26 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.423 -0.798 . . . . 0.0 109.386 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.576 ' HE3' ' CE2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -60.75 -37.13 80.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.252 -0.905 . . . . 0.0 109.399 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 pttm . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.464 179.992 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.412 ' HB1' ' HG2' ' A' ' 7' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.455 ' C ' ' CD2' ' A' ' 3' ' ' TYR . 0.3 OUTLIER -105.67 59.09 0.66 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.328 -0.857 . . . . 0.0 109.031 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.574 ' HE1' HG23 ' A' ' 181' ' ' THR . 3.1 m-85 56.4 74.44 0.4 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.659 -0.651 . . . . 0.0 109.486 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.449 ' HG3' ' HB2' ' A' ' 7' ' ' LYS . 1.6 pt-20 -105.84 54.96 0.69 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.155 -0.965 . . . . 0.0 109.588 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.405 ' C ' ' O ' ' A' ' 4' ' ' GLU . 1.2 m-20 42.48 82.84 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.751 -0.593 . . . . 0.0 110.1 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 131.88 -29.22 3.42 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.702 -1.237 . . . . 0.0 110.701 179.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.449 ' HB2' ' HG3' ' A' ' 4' ' ' GLU . 5.4 tptt -83.18 -69.05 0.66 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.869 -1.371 . . . . 0.0 109.27 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.493 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 77.6 mm-40 -92.97 2.01 57.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.172 -0.955 . . . . 0.0 109.744 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.504 ' O ' ' N ' ' A' ' 6' ' ' GLY . 1.1 p90 176.67 132.38 0.05 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.236 -0.915 . . . . 0.0 109.078 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.5 ' CG2' ' CD ' ' A' ' 160' ' ' GLN . 11.3 t -112.26 -179.63 3.73 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 25.6 m -116.62 139.61 50.32 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.487 0.66 . . . . 0.0 109.615 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.465 HD23 ' HG2' ' A' ' 160' ' ' GLN . 0.2 OUTLIER -95.18 169.83 9.82 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.389 -0.819 . . . . 0.0 109.375 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 14.3 mp0 -98.19 12.35 34.88 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.264 -0.898 . . . . 0.0 109.82 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 13' ' ' GLU . 5.4 mtmt -141.51 80.47 16.2 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.925 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -79.13 159.26 26.8 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.719 2.279 . . . . 0.0 109.986 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.906 HG21 ' OD1' ' A' ' 144' ' ' ASP . 3.4 t -126.72 97.86 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.093 -1.004 . . . . 0.0 110.154 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.79 128.54 8.82 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 93.03 -14.9 64.14 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.644 -1.783 . . . . 0.0 108.644 -179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.792 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -39.25 161.7 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 121.592 -0.946 . . . . 0.0 110.095 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.587 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.2 Cg_endo -78.56 127.53 8.13 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.746 2.297 . . . . 0.0 111.201 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.647 ' O ' HG22 ' A' ' 155' ' ' VAL . 2.0 mm-40 -42.35 -24.48 0.05 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.511 -0.743 . . . . 0.0 109.798 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.639 ' O ' HG12 ' A' ' 22' ' ' VAL . 8.1 t -147.14 86.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.009 -1.057 . . . . 0.0 108.75 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.715 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -79.88 125.55 29.87 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -105.55 97.95 7.71 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.175 -0.953 . . . . 0.0 110.438 -178.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.158 ' CE2' HG21 ' A' ' 145' ' ' VAL . 4.7 m-85 -89.58 106.41 18.44 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 3.2 p90 -153.32 143.6 22.36 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.044 -1.035 . . . . 0.0 109.946 -179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.613 ' HB3' ' CE1' ' A' ' 60' ' ' HIS . 2.3 p -126.44 -165.02 1.39 Allowed 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.68 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -115.67 53.46 0.84 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.758 -1.213 . . . . 0.0 108.224 179.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.654 ' CE1' HD22 ' A' ' 72' ' ' LEU . 9.1 m-85 -137.71 0.35 2.22 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.411 -0.806 . . . . 0.0 110.645 -178.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.62 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 5.1 m -111.27 169.11 6.65 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.782 -1.199 . . . . 0.0 108.604 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.62 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 30.7 Cg_endo -73.97 -54.73 0.1 OUTLIER 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 121.712 1.608 . . . . 0.0 109.344 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.479 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -68.66 -19.08 64.38 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 177.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 30' ' ' CYS . 0.2 OUTLIER -50.49 -47.47 57.15 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.596 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 5.7 t80 -79.82 -37.04 35.97 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.515 -0.74 . . . . 0.0 109.748 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.486 ' O ' ' CG ' ' A' ' 40' ' ' LEU . 8.4 mm-40 -70.85 -25.08 62.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.275 -0.89 . . . . 0.0 110.054 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.479 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 0.5 OUTLIER -83.74 -15.68 47.68 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.166 -0.959 . . . . 0.0 110.943 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.523 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.7 mm-40 -131.22 44.28 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.728 -1.232 . . . . 0.0 111.202 -178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -174.07 -60.88 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.093 -1.004 . . . . 0.0 110.984 179.251 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.4 t -90.18 -53.45 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.045 -1.034 . . . . 0.0 111.143 -178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.587 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 94.8 mt -59.4 -11.24 4.04 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.977 -1.077 . . . . 0.0 110.76 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 56.8 p-80 41.31 28.18 0.06 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 0.0 109.663 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.741 ' O ' HG22 ' A' ' 46' ' ' VAL . 19.4 mt -68.71 -33.23 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.287 -0.883 . . . . 0.0 109.272 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 47' ' ' LYS . 43.7 p -72.87 -26.05 61.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.206 -0.934 . . . . 0.0 109.877 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -87.09 -54.41 4.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 0.0 109.83 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -52.09 -53.99 35.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.163 -0.961 . . . . 0.0 109.755 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.741 HG22 ' O ' ' A' ' 42' ' ' ILE . 19.1 m -57.53 -35.32 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.9 . . . . 0.0 109.53 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.967 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -70.78 -39.33 73.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.248 -0.907 . . . . 0.0 109.813 -179.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.8 tmtt? -60.26 -22.77 63.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.211 -0.931 . . . . 0.0 109.816 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.2 mtpp -111.22 9.44 21.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.122 -0.986 . . . . 0.0 109.807 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.967 HD12 ' HA ' ' A' ' 47' ' ' LYS . 8.3 mt -78.65 130.14 71.84 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.959 . . . . 0.0 110.042 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD2' HD23 ' A' ' 50' ' ' LEU . 35.3 Cg_endo -78.47 154.05 27.5 Favored 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.408 2.072 . . . . 0.0 108.863 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.435 ' O ' ' CG ' ' A' ' 52' ' ' GLU . 11.8 tt0 -69.84 21.66 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.473 -1.392 . . . . 0.0 111.54 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.422 ' H ' ' C ' ' A' ' 51' ' ' PRO . . . -121.61 29.99 5.48 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.46 ' CG2' ' HB2' ' A' ' 186' ' ' SER . 43.9 t -145.6 117.21 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.09 107.35 19.15 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.254 -0.904 . . . . 0.0 110.219 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.456 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.3 OUTLIER -91.39 96.36 10.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.503 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -91.78 140.22 29.91 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.961 -1.095 . . . . 0.0 110.342 -179.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.32 112.15 21.13 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.484 -0.76 . . . . 0.0 109.594 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.603 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 1.9 m-85 -116.67 167.43 11.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.158 -0.964 . . . . 0.0 110.678 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.613 ' CE1' ' HB3' ' A' ' 27' ' ' SER . 54.8 t-80 -108.23 131.41 54.71 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.076 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.8 m -69.48 151.47 9.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 O-C-N 121.648 -0.658 . . . . 0.0 110.033 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 62' ' ' ASN . 4.4 p-10 -116.57 42.61 2.4 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.594 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 1.6 p90 -144.48 59.15 1.33 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.153 -0.967 . . . . 0.0 109.67 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.493 ' HG3' ' HB2' ' A' ' 29' ' ' PHE . 0.4 OUTLIER -129.98 36.5 4.03 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.402 -0.811 . . . . 0.0 109.126 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.58 -32.02 0.34 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.17 -40.26 3.09 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -88.34 -79.55 0.3 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.109 -1.23 . . . . 0.0 110.628 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.896 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -79.68 -18.29 51.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.866 -1.146 . . . . 0.0 109.564 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.633 ' N ' HD22 ' A' ' 68' ' ' LEU . . . -53.19 -46.62 62.54 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 107.955 -2.058 . . . . 0.0 107.955 179.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -44.35 94.98 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.76 -27.66 67.78 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.693 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 27.8 tp -60.97 -44.8 96.83 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 138' ' ' GLN . 1.6 m -60.3 -42.9 96.5 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 1.052 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.6 tt0 -55.61 -26.14 42.4 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -67.41 -42.07 83.86 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 38.2 t-105 -58.43 -28.2 65.04 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HB2' ' NE2' ' A' ' 138' ' ' GLN . . . -85.94 -43.15 13.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.525 -0.734 . . . . 0.0 110.274 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.052 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.2 t -68.74 -30.87 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.903 -1.123 . . . . 0.0 109.693 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.581 ' HB1' ' HG2' ' A' ' 85' ' ' GLU . . . -82.63 -55.78 4.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.01 -1.057 . . . . 0.0 108.374 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 3.0 ttt -49.67 -28.55 6.07 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.864 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -72.98 -39.0 66.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.501 -0.749 . . . . 0.0 109.183 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.457 ' CB ' HG13 ' A' ' 84' ' ' VAL . 66.1 mt -101.28 8.64 42.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.262 -0.899 . . . . 0.0 110.23 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.97 24.05 7.96 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.19 -1.564 . . . . 0.0 109.19 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG22 ' HA ' ' A' ' 79' ' ' ALA . 33.5 m -90.27 1.44 7.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.344 -1.092 . . . . 0.0 110.173 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.581 ' HG2' ' HB1' ' A' ' 79' ' ' ALA . 2.5 mt-10 -44.68 -66.79 0.35 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.979 -1.076 . . . . 0.0 109.436 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -41.03 -34.16 0.4 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.432 -0.793 . . . . 0.0 110.109 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -80.99 -51.41 8.56 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.329 -0.857 . . . . 0.0 111.294 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.973 HG23 HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -87.18 -11.46 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.622 -1.299 . . . . 0.0 110.896 -178.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.776 HG23 ' CE1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -71.64 -43.94 65.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.731 -1.231 . . . . 0.0 108.893 179.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.412 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -54.1 -54.26 49.35 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.515 -1.366 . . . . 0.0 110.657 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.601 ' HB2' HG13 ' A' ' 111' ' ' VAL . 27.1 Cg_endo -72.86 -18.1 24.93 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 N-CA-C 109.844 -0.868 . . . . 0.0 109.844 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.973 HD12 HG23 ' A' ' 88' ' ' VAL . 17.5 mt -86.62 -43.73 12.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.272 -0.892 . . . . 0.0 108.874 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.776 ' CE1' HG23 ' A' ' 89' ' ' THR . 5.1 m-30 -63.53 -48.1 78.9 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.043 -1.036 . . . . 0.0 108.486 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.403 ' HA ' ' HB2' ' A' ' 97' ' ' GLN . 0.3 OUTLIER -72.84 -29.28 63.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.237 -0.914 . . . . 0.0 108.977 179.083 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.426 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -57.05 -39.0 88.96 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.639 HG11 ' CG ' ' A' ' 29' ' ' PHE . 1.9 t -100.36 -3.37 9.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 O-C-N 121.211 -1.17 . . . . 0.0 109.387 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.596 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -101.56 2.6 39.2 Favored 'General case' 0 C--N 1.311 -1.092 0 O-C-N 120.853 -1.154 . . . . 0.0 110.714 -179.36 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.783 ' O ' HG23 ' A' ' 99' ' ' THR . 1.1 mmtp -175.18 72.69 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.692 -1.255 . . . . 0.0 109.387 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 164.28 -49.57 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 99' ' ' THR . 3.0 mt-30 72.8 15.0 4.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 0.0 110.597 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 t -82.93 -7.85 59.62 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.859 0.838 . . . . 0.0 108.797 178.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.61 HG13 HG22 ' A' ' 96' ' ' VAL . 9.1 mm -82.44 69.63 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.02 32.56 3.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.729 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.55 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 32.1 p -156.56 131.0 8.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.989 -1.069 . . . . 0.0 110.201 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.904 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.79 -34.21 18.8 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.046 -1.464 . . . . 0.0 107.046 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.83 -34.74 75.02 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.54 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.3 OUTLIER -66.15 -50.71 63.02 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.904 HD12 ' HA ' ' A' ' 105' ' ' ALA . 24.6 mt -49.38 -28.19 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 119.241 -0.984 . . . . 0.0 108.771 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.49 -39.03 47.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.335 -0.853 . . . . 0.0 109.926 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 1.1 p30 -59.84 -46.08 90.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.114 -0.991 . . . . 0.0 109.626 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.775 HG11 ' HG ' ' A' ' 92' ' ' LEU . 58.7 t -68.65 -39.74 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.936 -1.103 . . . . 0.0 109.25 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.434 ' O ' ' HB ' ' A' ' 117' ' ' ILE . 1.9 m-85 -59.9 -42.84 94.71 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.181 -0.95 . . . . 0.0 109.544 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.662 HG23 ' HA ' ' A' ' 118' ' ' LYS . 12.0 mt -69.85 -23.83 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.068 -1.02 . . . . 0.0 109.403 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.458 ' ND2' ' O ' ' A' ' 110' ' ' ASP . 1.9 m-80 -63.33 -17.99 63.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.247 -0.908 . . . . 0.0 109.592 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.858 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -99.08 11.51 38.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.24 -0.912 . . . . 0.0 109.344 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.35 -7.71 81.42 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.858 HD13 ' HB3' ' A' ' 115' ' ' ALA . 1.8 mp -77.32 55.28 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.368 -1.077 . . . . 0.0 109.252 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.662 ' HA ' HG23 ' A' ' 113' ' ' ILE . 3.0 mtmp? -35.19 149.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.215 -0.928 . . . . 0.0 110.475 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 123' ' ' ASP . . . -53.57 -27.91 35.74 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -61.86 -59.06 5.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.034 -1.274 . . . . 0.0 109.363 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -64.76 -41.95 95.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 109.226 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.955 ' CE2' HG11 ' A' ' 78' ' ' VAL . 3.1 t80 -56.5 -48.9 76.18 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.304 -0.873 . . . . 0.0 109.008 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 0.2 OUTLIER -59.97 -30.87 69.4 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.28 -0.887 . . . . 0.0 109.064 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.43 -51.36 60.79 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.344 -0.847 . . . . 0.0 108.852 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.516 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -51.89 -52.8 47.26 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.406 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 3.7 t-105 -57.87 -56.49 21.28 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.777 -0.824 . . . . 0.0 108.777 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -53.81 -16.17 1.63 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.508 -0.745 . . . . 0.0 110.282 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 50.2 m -74.03 173.69 9.67 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.901 -1.124 . . . . 0.0 109.991 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -90.63 -38.62 13.0 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.463 -179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 41.1 t -64.77 -47.17 89.72 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.786 0 C-N-CA 118.085 -1.446 . . . . 0.0 109.244 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.864 HG22 ' HB1' ' A' ' 81' ' ' ALA . 15.6 t -62.56 -32.66 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -67.89 -39.41 83.65 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 90.0 p -61.74 -34.59 76.09 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.18 -18.36 53.2 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.288 -0.882 . . . . 0.0 108.662 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 3.5 t -80.17 -47.6 21.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.43 -32.87 74.43 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.58 -33.53 69.14 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.603 ' HG3' ' CE1' ' A' ' 59' ' ' TYR . 8.9 mt-30 -74.24 -66.98 0.66 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.324 -0.86 . . . . 0.0 108.955 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 138' ' ' GLN . 1.8 tt0 -45.36 -43.96 11.38 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.565 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 0.1 OUTLIER -69.78 -28.39 65.7 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.296 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.916 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -56.19 -63.5 1.17 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.37 -0.831 . . . . 0.0 108.874 179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.54 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -73.57 -19.43 60.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.354 -0.841 . . . . 0.0 109.834 -179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.565 ' HB3' ' HA ' ' A' ' 140' ' ' LYS . . . -79.31 -29.48 42.39 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.02 -1.05 . . . . 0.0 110.01 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 1.02 ' OD1' HG13 ' A' ' 145' ' ' VAL . 2.8 p30 -81.85 -45.04 16.08 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 1.158 HG21 ' CE2' ' A' ' 25' ' ' PHE . 24.7 m -87.26 -14.91 9.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.54 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.5 tp-100 79.65 -50.5 0.39 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.63 -0.669 . . . . 0.0 109.501 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.725 HD21 HG12 ' A' ' 61' ' ' VAL . 12.2 tp 62.09 134.46 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.482 -0.761 . . . . 0.0 109.281 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -160.77 27.76 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.573 -1.33 . . . . 0.0 109.725 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 179.56 102.93 0.17 Allowed Glycine 0 N--CA 1.487 2.093 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.331 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 1.076 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -92.92 144.06 27.87 Favored Pre-proline 0 N--CA 1.495 1.821 0 O-C-N 121.408 -1.054 . . . . 0.0 109.175 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.429 ' O ' ' HG3' ' A' ' 163' ' ' PRO . 35.7 Cg_endo -77.65 153.07 93.75 Favored 'Cis proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.946 -1.272 . . . . 0.0 110.649 0.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -129.43 130.05 45.44 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.39 -1.444 . . . . 0.0 109.408 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.539 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -119.59 115.57 24.25 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.256 -0.903 . . . . 0.0 109.152 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.547 ' CD1' ' CB ' ' A' ' 160' ' ' GLN . 13.7 m-30 -115.01 127.5 55.7 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.207 -0.933 . . . . 0.0 110.804 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.647 HG22 ' O ' ' A' ' 21' ' ' GLN . 24.4 t -96.81 131.99 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.23 -0.918 . . . . 0.0 109.684 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.792 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 2.8 t-20 45.32 22.3 0.08 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.407 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.563 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.16 58.04 16.17 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.896 -1.681 . . . . 0.0 108.896 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 30.2 tttm -166.52 -36.1 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.634 ' CE2' ' CG ' ' A' ' 188' ' ' LYS . 96.4 m-85 -116.34 123.19 47.02 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.547 ' CB ' ' CD1' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -117.89 112.97 21.05 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.296 -0.877 . . . . 0.0 109.873 -179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.405 HD23 ' HB2' ' A' ' 9' ' ' TYR . 11.1 mt -60.37 170.68 1.26 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.363 -0.836 . . . . 0.0 109.063 179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 162' ' ' ASN . 26.3 p-10 -131.42 113.29 15.58 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.197 -0.939 . . . . 0.0 109.548 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.429 ' HG3' ' O ' ' A' ' 151' ' ' PRO . 36.2 Cg_endo -78.26 5.85 5.14 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.407 2.071 . . . . 0.0 110.542 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -81.59 4.81 20.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 109.627 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -80.38 -15.21 78.85 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.403 ' HG3' ' CD1' ' A' ' 174' ' ' PHE . 6.8 mtp -80.33 -94.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.974 -1.309 . . . . 0.0 109.584 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.7 t0 50.28 28.24 3.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.125 -0.984 . . . . 0.0 109.545 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.446 ' O ' ' CB ' ' A' ' 169' ' ' SER . 6.0 p -146.86 -87.56 0.1 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -0.927 . . . . 0.0 109.568 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 168' ' ' THR . 1.9 t 167.04 71.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.2 -0.937 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 20.1 p30 -139.68 58.97 1.6 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.277 -0.89 . . . . 0.0 109.45 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.872 ' O ' HG23 ' A' ' 175' ' ' VAL . 3.1 mtt -59.66 -17.45 34.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.228 -0.92 . . . . 0.0 109.397 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.61 -65.79 0.97 Allowed 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.0 t -57.84 -25.2 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.251 -0.906 . . . . 0.0 108.827 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 178' ' ' TYR . 50.8 t80 -74.12 -39.82 63.09 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.162 -0.961 . . . . 0.0 109.112 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.872 HG23 ' O ' ' A' ' 171' ' ' MET . 96.9 t -70.91 -27.77 31.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.14 -0.975 . . . . 0.0 108.95 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.66 -64.83 1.1 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.248 -0.907 . . . . 0.0 108.904 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -50.31 -42.31 52.39 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.187 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.534 ' CD1' ' C ' ' A' ' 178' ' ' TYR . 8.1 t80 -61.42 -53.77 52.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 0.0 109.513 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.38 -24.11 11.42 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.922 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.41 -43.62 23.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.116 -0.99 . . . . 0.0 109.555 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.641 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -59.63 -42.28 92.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 109.386 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.482 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 43.2 t -74.01 -37.3 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.056 -1.028 . . . . 0.0 109.226 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -52.28 65.91 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.89 . . . . 0.0 109.193 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -76.72 -33.64 58.16 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.263 -0.898 . . . . 0.0 109.061 179.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 181' ' ' THR . 0.5 OUTLIER -58.17 -19.54 33.93 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.982 -1.074 . . . . 0.0 109.839 -179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.46 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 1.3 t -73.17 -12.65 60.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.81 -1.181 . . . . 0.0 108.71 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.57 9.01 39.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.355 -0.84 . . . . 0.0 109.44 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.634 ' CG ' ' CE2' ' A' ' 159' ' ' TYR . 6.1 tptm -78.1 -13.88 59.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.246 -0.909 . . . . 0.0 110.171 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.408 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.567 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 20.5 mt-30 -105.84 57.8 0.66 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.919 . . . . 0.0 109.101 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.567 ' CG ' ' C ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER 176.09 85.18 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.611 -0.68 . . . . 0.0 109.191 -179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -108.35 62.36 0.61 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.796 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.2 t70 44.82 82.62 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.408 -0.807 . . . . 0.0 109.404 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 118.38 -22.74 9.39 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.457 ' HB3' ' OE1' ' A' ' 8' ' ' GLN . 3.0 tttp -80.13 -68.67 0.65 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.107 -1.231 . . . . 0.0 108.709 179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.507 ' CG ' ' O ' ' A' ' 2' ' ' GLN . 17.2 mp0 -103.94 9.1 36.83 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.285 -0.884 . . . . 0.0 109.773 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 3' ' ' TYR . 3.7 p90 177.33 134.73 0.07 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.129 -0.982 . . . . 0.0 109.171 179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -117.68 178.83 4.26 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 44.6 m -115.19 145.59 42.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.706 -0.621 . . . . 0.0 109.681 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.418 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -94.01 165.87 12.43 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.424 -0.797 . . . . 0.0 109.567 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -80.48 -15.64 56.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.166 -0.959 . . . . 0.0 109.599 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.02 115.17 11.04 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.404 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.492 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 34.4 Cg_endo -77.3 162.7 30.89 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.401 2.067 . . . . 0.0 110.531 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.721 HG21 HG12 ' A' ' 145' ' ' VAL . 48.1 t -105.93 79.03 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 0.0 109.923 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -46.6 128.25 10.23 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.471 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 93.77 -13.15 68.1 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.095 -1.602 . . . . 0.0 109.095 -179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.471 ' C ' ' O ' ' A' ' 18' ' ' GLY . . . -37.36 152.28 0.13 Allowed Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.75 -0.853 . . . . 0.0 109.043 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.521 ' O ' ' O ' ' A' ' 55' ' ' LYS . 36.6 Cg_endo -78.94 40.77 0.97 Allowed 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.244 1.962 . . . . 0.0 112.631 -177.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER 67.04 -43.22 0.44 Allowed 'General case' 0 C--N 1.292 -1.932 0 O-C-N 121.376 -0.827 . . . . 0.0 110.575 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.615 ' O ' HG12 ' A' ' 22' ' ' VAL . 32.2 t -150.52 78.65 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.73 HD13 ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -70.66 127.49 32.84 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -178.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.444 ' N ' ' O ' ' A' ' 57' ' ' THR . 2.1 tt0 -111.1 149.3 31.02 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.119 -0.988 . . . . 0.0 109.625 -179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.764 ' CD2' HD13 ' A' ' 147' ' ' LEU . 15.0 m-85 -122.86 126.43 47.32 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.467 -0.771 . . . . 0.0 109.689 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.484 ' O ' ' HA ' ' A' ' 60' ' ' HIS . 1.9 p90 -159.09 140.97 13.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.354 -0.842 . . . . 0.0 109.486 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.996 ' HB3' HG22 ' A' ' 61' ' ' VAL . 75.2 p -122.01 169.94 10.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -0.98 . . . . 0.0 110.574 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.582 ' O ' ' CD1' ' A' ' 29' ' ' PHE . 7.5 m-30 -92.3 37.66 1.0 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 1.037 ' CZ ' HD13 ' A' ' 72' ' ' LEU . 2.6 m-85 -142.59 20.01 2.02 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.092 -1.005 . . . . 0.0 110.258 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.542 ' CB ' ' CE1' ' A' ' 32' ' ' HIS . 1.3 m -117.95 166.93 12.3 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 120.642 -1.286 . . . . 0.0 109.617 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 33.6 Cg_endo -75.54 -38.13 1.5 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.287 1.991 . . . . 0.0 108.628 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.579 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 14.6 p80 -73.9 -25.49 60.04 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.509 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 22.7 t -44.75 -62.9 1.04 Allowed 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.493 ' C ' ' CD1' ' A' ' 34' ' ' TYR . 8.4 t80 -65.54 -46.41 79.65 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.287 0.565 . . . . 0.0 109.989 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.526 ' HA ' ' CG2' ' A' ' 39' ' ' VAL . 2.1 mm-40 -61.01 -23.64 65.56 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -0.936 . . . . 0.0 110.538 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.467 ' N ' ' O ' ' A' ' 32' ' ' HIS . 3.4 m-30 -78.37 -43.1 28.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.93 -1.106 . . . . 0.0 110.322 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -110.98 8.06 21.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.748 -1.22 . . . . 0.0 111.391 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 27.8 mm-40 -135.01 29.15 3.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.562 -1.336 . . . . 0.0 110.346 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.831 HG12 ' HG ' ' A' ' 40' ' ' LEU . 98.0 t -150.92 -76.41 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.812 -1.18 . . . . 0.0 109.522 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.831 ' HG ' HG12 ' A' ' 39' ' ' VAL . 0.2 OUTLIER -106.22 20.09 19.51 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.178 -0.951 . . . . 0.0 109.932 -179.646 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' A' ' 45' ' ' ASN . 5.3 m170 43.13 31.36 0.35 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.14 -0.975 . . . . 0.0 110.066 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.551 ' CG1' HG22 ' A' ' 175' ' ' VAL . 22.4 mt -50.48 -25.02 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.003 -1.061 . . . . 0.0 109.416 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.25 -55.9 5.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.198 -0.938 . . . . 0.0 110.186 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.509 ' HA ' ' HG2' ' A' ' 47' ' ' LYS . 6.9 m-20 -87.09 -33.57 19.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.209 -0.932 . . . . 0.0 110.355 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.507 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -60.54 -27.68 67.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.0 110.5 -179.267 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.833 ' O ' HD13 ' A' ' 50' ' ' LEU . 9.1 p -84.46 -24.84 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.028 -1.045 . . . . 0.0 111.091 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.54 ' HG3' ' N ' ' A' ' 48' ' ' LYS . 4.7 ptpt -78.68 -25.29 44.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.737 -1.227 . . . . 0.0 110.416 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.54 ' N ' ' HG3' ' A' ' 47' ' ' LYS . 1.7 mtpt -63.84 -32.76 74.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.953 -1.092 . . . . 0.0 109.311 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.7 OUTLIER -82.82 9.66 9.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.865 . . . . 0.0 109.411 179.801 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.833 HD13 ' O ' ' A' ' 46' ' ' VAL . 8.6 mp -98.64 108.5 48.62 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.128 -0.983 . . . . 0.0 109.449 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.615 ' HD2' HG21 ' A' ' 54' ' ' VAL . 35.1 Cg_endo -77.06 145.9 25.12 Favored 'Trans proline' 0 C--N 1.313 -1.33 0 C-N-CA 122.4 2.067 . . . . 0.0 110.478 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.502 ' C ' ' O ' ' A' ' 51' ' ' PRO . 1.2 tt0 -33.46 118.13 0.32 Allowed 'General case' 0 N--CA 1.487 1.379 0 CA-C-O 122.266 1.031 . . . . 0.0 110.127 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 125.36 -26.64 5.46 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.615 HG21 ' HD2' ' A' ' 51' ' ' PRO . 3.7 t -97.58 93.5 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -1.102 . . . . 0.0 108.645 179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.521 ' O ' ' O ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -84.44 118.25 24.16 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-O 121.962 0.887 . . . . 0.0 110.079 -179.159 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.489 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.4 OUTLIER -111.82 98.91 7.72 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 179.068 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 20' ' ' PRO . 7.4 m -99.6 128.18 45.7 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.863 -1.135 . . . . 0.0 110.716 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 115.17 29.89 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.585 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 1.3 m-85 -112.62 175.98 5.21 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.852 -1.155 . . . . 0.0 110.662 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.622 ' CE1' HD22 ' A' ' 72' ' ' LEU . 28.9 t-80 -104.41 150.73 24.27 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 122.032 0.92 . . . . 0.0 109.322 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.996 HG22 ' HB3' ' A' ' 27' ' ' SER . 1.3 m -96.96 160.03 2.96 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.102 0 CA-C-O 121.369 0.604 . . . . 0.0 110.015 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -125.09 56.69 1.32 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.41 -0.806 . . . . 0.0 108.866 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.57 ' O ' ' CD1' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -133.81 52.1 2.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.115 -0.99 . . . . 0.0 110.974 -179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.656 ' HE3' ' CE1' ' A' ' 29' ' ' PHE . 3.1 ppp? -128.92 34.0 4.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.395 -0.815 . . . . 0.0 108.818 178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 118.76 -37.35 3.24 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.454 -1.858 . . . . 0.0 108.454 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.91 -13.19 66.71 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 120.121 -1.038 . . . . 0.0 110.761 179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.14 -79.3 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.666 -1.49 . . . . 0.0 109.381 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.066 HD23 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -86.14 -28.22 24.12 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.037 -1.04 . . . . 0.0 109.345 179.469 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 1.066 ' N ' HD23 ' A' ' 68' ' ' LEU . . . -59.08 -55.08 32.88 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 0.9 OUTLIER -56.87 -47.2 81.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.305 -1.114 . . . . 0.0 108.695 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 71' ' ' ASP . 23.8 t0 -67.35 -24.37 65.71 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.037 HD13 ' CZ ' ' A' ' 29' ' ' PHE . 5.8 tt -71.48 -39.52 70.84 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.973 HG23 ' OE1' ' A' ' 138' ' ' GLN . 1.3 m -57.87 -43.58 86.08 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 1.028 ' O ' HG23 ' A' ' 78' ' ' VAL . 4.0 tt0 -56.71 -29.0 62.0 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 177.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.75 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -62.3 -40.15 95.36 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -61.9 -30.4 70.86 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.486 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -83.41 -48.02 10.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.409 -0.807 . . . . 0.0 109.968 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.028 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.5 t -63.3 -27.7 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.195 -0.941 . . . . 0.0 109.442 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.535 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -83.14 -55.72 4.2 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.212 -0.93 . . . . 0.0 109.138 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.719 ' HG2' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -45.26 -29.15 0.93 Allowed 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.277 -0.889 . . . . 0.0 108.779 179.497 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.817 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -74.4 -38.37 63.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.396 -0.815 . . . . 0.0 109.509 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.527 ' CB ' HG13 ' A' ' 84' ' ' VAL . 44.3 mt -104.63 12.64 32.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 0.0 110.022 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.428 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.05 23.01 1.44 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.704 -1.358 . . . . 0.0 109.704 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.597 HG21 ' CE1' ' A' ' 112' ' ' PHE . 21.9 m -84.95 -10.35 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -1.204 . . . . 0.0 110.189 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 84' ' ' VAL . 5.4 pt-20 -43.01 -59.02 2.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.076 -1.015 . . . . 0.0 109.823 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.11 -33.29 2.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.111 -0.993 . . . . 0.0 109.682 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.571 ' HE2' ' HB1' ' A' ' 115' ' ' ALA . 44.2 mtpt -83.89 -51.6 7.04 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.557 -0.714 . . . . 0.0 111.133 -178.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.723 HG23 HD12 ' A' ' 92' ' ' LEU . 1.4 m -80.48 -6.07 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.787 -1.196 . . . . 0.0 110.676 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.727 HG23 ' CZ ' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -78.24 -44.33 25.86 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.805 -1.184 . . . . 0.0 108.513 178.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.456 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -52.16 -52.01 66.33 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 120.568 -1.333 . . . . 0.0 110.227 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.538 ' HB2' HG13 ' A' ' 111' ' ' VAL . 24.4 Cg_endo -73.43 -20.51 20.75 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 N-CA-C 109.906 -0.844 . . . . 0.0 109.906 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.841 ' HG ' HG11 ' A' ' 111' ' ' VAL . 12.7 mt -83.83 -41.88 17.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.203 -0.935 . . . . 0.0 108.646 177.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.727 ' CZ ' HG23 ' A' ' 89' ' ' THR . 8.3 m-30 -67.3 -45.08 77.62 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 121.125 -0.984 . . . . 0.0 108.589 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -74.65 -33.35 62.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.56 -0.713 . . . . 0.0 109.428 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.462 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -61.24 -32.1 79.46 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.5 t -99.48 -9.55 8.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.344 -1.092 . . . . 0.0 109.278 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 93' ' ' PHE . 2.4 mt-30 -112.41 9.7 19.75 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 120.891 -1.131 . . . . 0.0 110.92 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.779 ' O ' HG23 ' A' ' 99' ' ' THR . 0.6 OUTLIER -164.63 59.63 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.472 -1.393 . . . . 0.0 109.408 -179.847 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.779 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 163.62 -49.38 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.472 -0.768 . . . . 0.0 109.119 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.486 ' O ' ' NE ' ' A' ' 103' ' ' ARG . 4.1 mp0 73.71 14.98 4.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.26 -0.9 . . . . 0.0 110.737 179.164 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.6 t -82.97 -7.8 59.63 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 1.012 HG22 HD11 ' A' ' 68' ' ' LEU . 12.4 mm -77.5 67.52 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.486 ' NE ' ' O ' ' A' ' 100' ' ' GLN . 0.7 OUTLIER -128.56 30.83 5.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.243 -0.911 . . . . 0.0 109.452 -179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 107' ' ' ASP . 5.2 p -153.48 127.73 9.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.986 -1.072 . . . . 0.0 110.187 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.72 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -48.79 -36.38 16.52 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.6 p -55.82 -33.85 64.82 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.747 ' OD2' HD12 ' A' ' 68' ' ' LEU . 0.6 OUTLIER -71.79 -44.99 63.04 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.283 -0.967 . . . . 0.0 108.704 179.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.779 HD11 ' O ' ' A' ' 68' ' ' LEU . 34.7 mt -49.71 -29.29 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.892 -1.13 . . . . 0.0 108.459 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -79.36 -32.83 43.29 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.438 -0.789 . . . . 0.0 109.678 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -62.01 -43.47 98.77 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.166 -0.959 . . . . 0.0 109.403 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.841 HG11 ' HG ' ' A' ' 92' ' ' LEU . 55.8 t -74.68 -37.55 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.157 -0.965 . . . . 0.0 109.235 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.597 ' CE1' HG21 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -62.37 -48.11 81.21 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.883 -179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.481 HG23 ' HA ' ' A' ' 118' ' ' LYS . 22.5 mt -69.56 -26.22 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.1 -1.0 . . . . 0.0 109.538 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.97 -19.81 54.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.373 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.571 ' HB1' ' HE2' ' A' ' 87' ' ' LYS . . . -90.46 5.32 48.07 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.526 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 93.82 -4.46 72.02 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.74 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.3 mm -74.73 57.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.351 -1.088 . . . . 0.0 109.723 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.481 ' HA ' HG23 ' A' ' 113' ' ' ILE . 60.4 mttt -37.37 147.82 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.202 -0.936 . . . . 0.0 110.291 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -52.3 -27.87 25.65 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -62.7 -51.65 66.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -1.191 . . . . 0.0 109.51 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -77.01 -37.7 54.51 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.308 -0.87 . . . . 0.0 109.767 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.911 ' CE2' HG11 ' A' ' 78' ' ' VAL . 3.4 t80 -66.77 -53.3 34.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.128 -0.982 . . . . 0.0 109.753 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -60.29 -43.99 95.77 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.983 -1.073 . . . . 0.0 109.197 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.52 -50.91 71.53 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.299 -0.876 . . . . 0.0 109.237 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.567 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -50.45 -53.32 30.53 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.416 -0.803 . . . . 0.0 108.94 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.515 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 6.0 t90 -54.98 -58.12 8.93 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -52.47 -16.31 0.86 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.555 -0.716 . . . . 0.0 110.396 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 2.4 m -70.59 179.11 2.69 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.885 -1.135 . . . . 0.0 110.207 -179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -90.4 -38.21 13.46 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.318 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.4 t -69.27 -48.28 68.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 C-N-CA 118.183 -1.407 . . . . 0.0 109.463 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.817 HG22 ' CB ' ' A' ' 81' ' ' ALA . 3.3 t -62.37 -36.26 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 120.921 -1.112 . . . . 0.0 108.288 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -66.34 -31.99 73.11 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.079 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.1 t -66.02 -34.74 78.77 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.719 HD13 ' HG2' ' A' ' 80' ' ' MET . 40.6 mt -78.96 -18.3 53.98 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.486 HG23 ' HB1' ' A' ' 77' ' ' ALA . 7.7 t -79.49 -46.33 23.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -67.34 -38.87 85.56 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.3 -39.98 96.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.423 -0.798 . . . . 0.0 108.973 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.973 ' OE1' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -62.32 -62.65 1.61 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.242 -0.912 . . . . 0.0 108.797 179.361 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.453 ' OE2' ' NZ ' ' A' ' 70' ' ' LYS . 1.2 mt-10 -52.6 -30.61 32.11 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.483 ' O ' ' CB ' ' A' ' 144' ' ' ASP . 5.2 mttt -72.57 -29.43 63.53 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.438 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -67.72 -54.67 17.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.231 -0.918 . . . . 0.0 109.236 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -65.35 -37.15 86.18 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.303 -0.873 . . . . 0.0 109.663 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.39 -16.16 53.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.317 -0.864 . . . . 0.0 110.315 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 140' ' ' LYS . 6.3 m-20 -80.81 -45.09 17.47 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.983 -1.073 . . . . 0.0 109.014 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.737 HG21 ' CE1' ' A' ' 25' ' ' PHE . 23.3 m -99.32 -9.4 8.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.271 -0.893 . . . . 0.0 108.856 179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 25.4 tt0 83.5 -39.63 0.08 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.658 -0.651 . . . . 0.0 109.537 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.764 HD13 ' CD2' ' A' ' 25' ' ' PHE . 13.4 tp 66.93 138.41 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.397 -0.815 . . . . 0.0 109.47 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.443 ' HD3' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -160.8 26.77 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.751 -1.218 . . . . 0.0 109.856 -179.937 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 152' ' ' ALA . . . 158.63 98.72 0.14 Allowed Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.546 -1.311 . . . . 0.0 110.171 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.863 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -89.72 138.95 27.79 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 178.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.579 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 32.6 Cg_endo -72.83 156.68 99.15 Favored 'Cis proline' 0 C--N 1.316 -1.147 0 C-N-CA 124.139 -1.192 . . . . 0.0 111.865 2.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 149' ' ' GLY . . . -151.79 117.18 5.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.939 -1.101 . . . . 0.0 108.385 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.819 ' CE ' HG22 ' A' ' 182' ' ' VAL . 4.8 tmm? -113.93 136.57 52.74 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.996 -1.065 . . . . 0.0 110.334 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.577 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 3.8 m-85 -123.92 135.81 53.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.476 -0.765 . . . . 0.0 109.208 179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.607 HG22 HG22 ' A' ' 22' ' ' VAL . 92.2 t -100.65 131.94 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.195 -0.94 . . . . 0.0 110.06 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.93 21.83 0.33 Allowed 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.61 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.516 ' HA3' ' HB ' ' A' ' 16' ' ' VAL . . . 58.27 55.9 28.17 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 108.927 -1.669 . . . . 0.0 108.927 -179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 1.6 tttm -165.21 -35.64 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.191 -1.182 . . . . 0.0 108.379 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.464 ' O ' ' HA ' ' A' ' 154' ' ' PHE . 2.4 m-85 -111.52 120.42 42.06 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.357 -0.937 . . . . 0.0 109.019 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.516 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 12.8 tt0 -116.27 113.51 23.1 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.288 -0.883 . . . . 0.0 109.264 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.436 ' N ' HD23 ' A' ' 161' ' ' LEU . 8.6 mt -61.33 -179.6 0.17 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.36 -0.837 . . . . 0.0 108.847 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.409 ' HA ' ' HD3' ' A' ' 163' ' ' PRO . 24.2 m120 -137.35 150.19 68.0 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.026 -1.046 . . . . 0.0 109.459 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 162' ' ' ASN . 36.0 Cg_endo -78.74 8.12 3.89 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.672 2.248 . . . . 0.0 110.648 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -48.74 -22.65 0.84 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.71 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -89.8 8.94 78.84 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.96 1.56 26.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -1.154 . . . . 0.0 109.596 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -124.87 33.12 5.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.145 -0.972 . . . . 0.0 109.577 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.622 HG23 ' H ' ' A' ' 170' ' ' ASN . 7.8 t -85.75 -8.34 58.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.072 -1.018 . . . . 0.0 109.826 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.14 26.78 13.97 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.118 -0.989 . . . . 0.0 109.382 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.622 ' H ' HG23 ' A' ' 168' ' ' THR . 0.8 OUTLIER -157.43 95.3 1.45 Allowed 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.277 -0.89 . . . . 0.0 108.834 179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.94 -16.86 13.64 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.17 -0.956 . . . . 0.0 109.651 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 172' ' ' ASP . 0.6 OUTLIER -69.61 -45.37 68.69 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 9.1 t -68.86 -22.32 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.198 -0.939 . . . . 0.0 108.831 179.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.429 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 22.7 t80 -72.48 -36.8 68.53 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.23 -0.919 . . . . 0.0 108.576 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.551 HG22 ' CG1' ' A' ' 42' ' ' ILE . 44.0 t -75.75 -26.96 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.26 -0.9 . . . . 0.0 109.194 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -83.32 -52.99 6.07 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.218 -0.926 . . . . 0.0 108.951 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.453 ' O ' ' OG1' ' A' ' 181' ' ' THR . 0.4 OUTLIER -62.88 -33.03 74.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.492 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.429 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 31.6 t80 -75.66 -54.18 7.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.252 -0.905 . . . . 0.0 109.521 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.49 -24.42 65.27 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.147 -0.971 . . . . 0.0 109.412 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -77.91 -50.09 12.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.328 -0.857 . . . . 0.0 109.299 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.828 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -58.39 -28.58 65.32 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.197 -0.94 . . . . 0.0 109.001 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.819 HG22 ' CE ' ' A' ' 153' ' ' MET . 66.4 t -85.91 -34.63 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.102 -0.999 . . . . 0.0 109.32 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.6 tttp -60.5 -42.56 96.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.229 -0.919 . . . . 0.0 108.98 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.644 ' CE2' HD22 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -82.46 -44.03 16.51 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.297 -0.877 . . . . 0.0 108.999 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.828 HD23 ' O ' ' A' ' 181' ' ' THR . 3.9 mm? -53.68 -18.35 2.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.942 -1.099 . . . . 0.0 109.417 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 1.7 t -66.31 -26.06 67.13 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.859 -1.151 . . . . 0.0 108.328 178.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.51 -71.98 0.38 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.63 23.42 13.72 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.828 0.823 . . . . 0.0 109.607 179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.291 -1.939 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.487 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.419 ' HB1' HE22 ' A' ' 8' ' ' GLN . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -136.06 66.45 1.5 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.345 -0.847 . . . . 0.0 109.447 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.591 ' HB3' ' CE1' ' A' ' 9' ' ' TYR . 1.9 m-85 50.18 80.08 0.08 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.355 -0.841 . . . . 0.0 109.39 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -101.55 56.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.115 -0.99 . . . . 0.0 109.833 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 46.04 82.12 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.614 -0.679 . . . . 0.0 110.239 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 116.11 -20.45 12.8 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.267 179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -80.52 -68.01 0.72 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.182 -1.187 . . . . 0.0 109.107 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.491 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 1.6 mp0 -97.53 6.2 48.46 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.375 -0.828 . . . . 0.0 109.606 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 8.3 p90 177.26 134.07 0.06 Allowed 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.284 -0.885 . . . . 0.0 108.994 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.0 t -115.28 176.3 5.13 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.577 -0.702 . . . . 0.0 109.24 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -114.15 159.49 20.01 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.382 0.611 . . . . 0.0 109.612 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.582 HD21 ' CE2' ' A' ' 154' ' ' PHE . 0.5 OUTLIER -98.3 162.08 13.37 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.366 -0.834 . . . . 0.0 109.405 -179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.46 -0.23 36.42 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.147 -0.971 . . . . 0.0 109.141 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.34 113.29 1.02 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.374 -0.829 . . . . 0.0 109.12 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 34.7 Cg_endo -77.02 159.11 34.18 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.45 2.1 . . . . 0.0 110.849 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.587 ' O ' HG12 ' A' ' 16' ' ' VAL . 5.0 t -110.91 91.24 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.325 -0.859 . . . . 0.0 109.481 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.05 128.81 9.58 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 95.39 -21.9 41.77 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.765 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -40.46 160.67 0.12 Allowed Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.986 . . . . 0.0 109.83 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.569 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.3 Cg_endo -79.22 128.83 8.38 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.726 2.284 . . . . 0.0 111.196 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.664 ' O ' HG22 ' A' ' 155' ' ' VAL . 16.3 mp0 -41.71 -25.37 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.498 -0.751 . . . . 0.0 109.861 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.605 ' O ' HG12 ' A' ' 22' ' ' VAL . 25.1 t -149.43 82.92 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 121.113 -0.992 . . . . 0.0 108.996 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.939 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.07 118.3 16.87 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 57' ' ' THR . 0.0 OUTLIER -98.07 122.82 41.67 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.113 -0.992 . . . . 0.0 109.935 -179.066 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.094 ' CE2' HG21 ' A' ' 145' ' ' VAL . 9.1 m-85 -110.2 104.26 13.07 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -150.95 143.21 24.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.129 -0.982 . . . . 0.0 110.044 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.833 ' HB3' HG22 ' A' ' 61' ' ' VAL . 4.5 p -123.78 -167.65 1.66 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.66 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -110.18 53.57 0.69 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.582 ' CG ' HG11 ' A' ' 96' ' ' VAL . 9.1 m-85 -138.01 -1.94 1.93 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.542 -0.863 . . . . 0.0 110.831 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' CB ' ' HB3' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -108.49 164.79 13.97 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 120.571 -1.331 . . . . 0.0 109.405 179.785 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.506 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 32.0 Cg_endo -74.58 -32.56 5.96 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.35 2.033 . . . . 0.0 108.861 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.434 ' O ' ' N ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -89.67 -19.11 25.24 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.038 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -52.96 -41.75 64.84 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.504 ' N ' ' SG ' ' A' ' 33' ' ' CYS . 70.3 t80 -85.29 -39.03 18.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.791 -0.568 . . . . 0.0 110.305 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.516 ' O ' ' CG ' ' A' ' 40' ' ' LEU . 3.9 mt-30 -74.85 -24.4 58.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.986 -1.071 . . . . 0.0 110.429 -179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.63 ' HA ' HD12 ' A' ' 40' ' ' LEU . 25.7 t80 -76.41 -21.99 55.28 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.038 -1.039 . . . . 0.0 110.97 -178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.55 ' OE2' ' CE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -127.77 42.03 3.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.707 -1.245 . . . . 0.0 110.888 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 15.9 mm-40 -159.49 -68.44 0.08 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.174 -0.954 . . . . 0.0 109.899 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 t -90.02 -48.84 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 0.0 110.414 -179.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.63 HD12 ' HA ' ' A' ' 36' ' ' PHE . 95.2 mt -54.03 -17.18 2.4 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.016 -1.052 . . . . 0.0 110.132 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.442 ' O ' ' OD1' ' A' ' 44' ' ' ASP . 82.3 m-70 45.91 30.85 0.95 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.081 -1.012 . . . . 0.0 109.281 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.716 ' O ' HG13 ' A' ' 46' ' ' VAL . 19.6 mt -79.3 -21.46 12.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 0.0 109.998 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.2 m -80.44 -21.06 42.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.982 -1.074 . . . . 0.0 110.512 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 41' ' ' HIS . 2.0 p-10 -87.06 -50.5 6.6 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.899 -1.126 . . . . 0.0 110.356 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.501 ' OD1' ' N ' ' A' ' 46' ' ' VAL . 45.2 p-10 -64.46 -26.22 68.35 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.193 -0.942 . . . . 0.0 110.533 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 42' ' ' ILE . 27.7 m -74.21 -24.66 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.987 -1.07 . . . . 0.0 109.976 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -73.65 -46.78 44.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.049 -1.032 . . . . 0.0 109.516 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.512 ' N ' ' HD3' ' A' ' 48' ' ' LYS . 24.3 mmtm -58.86 -16.78 18.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.211 -0.931 . . . . 0.0 109.067 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.499 ' C ' ' HD3' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -101.83 22.66 12.57 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.83 . . . . 0.0 109.946 -179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.873 ' O ' HG22 ' A' ' 54' ' ' VAL . 7.9 mt -124.06 66.09 39.81 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.007 -1.058 . . . . 0.0 110.706 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.499 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 37.2 Cg_endo -80.09 140.67 14.24 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.406 2.07 . . . . 0.0 110.13 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 51' ' ' PRO . 12.6 tm-20 61.87 132.88 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.386 -0.821 . . . . 0.0 108.822 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' A' ' 55' ' ' LYS . . . 58.89 23.35 56.33 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.022 -2.031 . . . . 0.0 108.022 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 50' ' ' LEU . 2.0 t -60.33 80.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.752 -0.852 . . . . 0.0 109.374 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 53' ' ' GLY . 0.0 OUTLIER -125.77 91.94 3.5 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.131 -0.98 . . . . 0.0 110.264 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.41 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 7.1 ttt -103.72 98.31 8.2 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -93.35 134.5 35.5 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.057 -179.269 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 3.9 mtmt -109.8 108.98 19.5 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.448 -0.782 . . . . 0.0 109.487 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.584 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 2.7 m-85 -109.8 169.42 8.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.865 -1.147 . . . . 0.0 111.083 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.804 ' NE2' HD22 ' A' ' 72' ' ' LEU . 4.0 t60 -107.68 133.45 52.09 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-O 121.744 0.783 . . . . 0.0 108.995 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.128 HG11 ' CG1' ' A' ' 150' ' ' VAL . 3.2 m -71.98 157.4 6.6 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 O-C-N 121.738 -0.601 . . . . 0.0 109.536 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.414 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 2.9 p-10 -123.46 47.2 2.05 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.151 -0.968 . . . . 0.0 109.39 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 16.0 p90 -148.52 61.57 1.08 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.093 -1.004 . . . . 0.0 109.836 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.688 ' HE1' HG23 ' A' ' 61' ' ' VAL . 0.5 OUTLIER -133.13 38.0 3.36 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.288 -0.883 . . . . 0.0 109.051 179.271 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 149.49 -31.37 1.14 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.767 -1.733 . . . . 0.0 108.767 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 84.79 -35.83 3.04 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.17 -79.37 0.28 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.874 -1.368 . . . . 0.0 109.676 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.108 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -78.59 -19.18 53.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.974 -1.079 . . . . 0.0 109.197 179.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 1.108 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -58.73 -57.11 21.6 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 178.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.76 -49.04 74.19 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.286 -1.126 . . . . 0.0 108.048 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.648 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 49.9 t0 -59.94 -26.68 66.16 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.804 HD22 ' NE2' ' A' ' 60' ' ' HIS . 0.6 OUTLIER -60.75 -36.24 78.41 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 178.412 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.585 HG23 ' OE1' ' A' ' 138' ' ' GLN . 31.5 m -67.0 -41.17 87.18 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.438 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 7.8 tp60 -61.73 -17.43 55.78 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 177.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.803 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -71.49 -45.1 63.42 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 20.0 t-105 -64.58 -31.84 73.22 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.644 -0.823 . . . . 0.0 109.175 179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.565 ' HB2' HE21 ' A' ' 138' ' ' GLN . . . -77.88 -54.43 6.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 0.0 109.87 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.107 HG11 ' CE2' ' A' ' 122' ' ' TYR . 88.8 t -59.71 -26.18 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.151 -0.968 . . . . 0.0 109.964 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.521 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -83.55 -60.77 2.02 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.055 -1.028 . . . . 0.0 109.243 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.421 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.8 OUTLIER -45.67 -28.87 1.09 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.171 -0.956 . . . . 0.0 108.53 179.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.938 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -72.57 -41.51 65.65 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.472 -0.768 . . . . 0.0 109.374 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.491 ' CB ' HG13 ' A' ' 84' ' ' VAL . 20.9 mt -101.51 9.41 41.34 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -0.962 . . . . 0.0 110.381 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.76 24.23 7.77 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.618 HG11 HG12 ' A' ' 117' ' ' ILE . 33.2 m -87.29 -9.2 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.427 -1.043 . . . . 0.0 110.759 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.46 ' O ' ' HB ' ' A' ' 89' ' ' THR . 2.8 pt-20 -42.08 -58.76 1.99 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.047 -1.033 . . . . 0.0 110.015 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -46.6 -33.75 4.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.166 -0.959 . . . . 0.0 110.237 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.905 ' HE2' ' HB1' ' A' ' 115' ' ' ALA . 36.5 mtpt -83.6 -50.47 8.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.339 -0.851 . . . . 0.0 111.425 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.897 HG23 HD12 ' A' ' 92' ' ' LEU . 1.3 m -83.25 -7.51 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.786 -1.196 . . . . 0.0 110.784 -178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.675 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.31 -44.38 45.83 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.703 -1.248 . . . . 0.0 108.728 179.034 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.428 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -53.49 -52.76 63.77 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 120.542 -1.349 . . . . 0.0 110.555 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.572 ' HB2' HG13 ' A' ' 111' ' ' VAL . 25.3 Cg_endo -73.7 -18.47 22.22 Favored 'Trans proline' 0 C--N 1.301 -1.932 0 N-CA-C 109.877 -0.855 . . . . 0.0 109.877 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.909 ' HG ' HG11 ' A' ' 111' ' ' VAL . 21.8 mt -87.07 -43.59 12.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.884 . . . . 0.0 108.863 178.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.675 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.4 m-30 -65.57 -45.77 81.99 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.008 -1.058 . . . . 0.0 108.984 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.1 mt-10 -73.44 -20.73 60.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.065 -1.022 . . . . 0.0 109.08 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -71.58 -36.29 62.44 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.582 HG11 ' CG ' ' A' ' 29' ' ' PHE . 1.5 t -102.09 -0.49 10.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.087 -1.243 . . . . 0.0 109.409 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.493 ' OE1' ' HB3' ' A' ' 93' ' ' PHE . 16.4 mt-30 -97.91 1.53 48.16 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 120.915 -1.116 . . . . 0.0 110.557 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.556 ' O ' ' CB ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 175.79 81.84 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.744 -1.222 . . . . 0.0 109.582 -179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.904 HG22 ' H ' ' A' ' 101' ' ' THR . 1.2 m 157.71 -43.85 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.9 OUTLIER 69.09 16.26 8.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.867 -1.146 . . . . 0.0 110.735 178.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.904 ' H ' HG22 ' A' ' 99' ' ' THR . 5.3 t -79.3 -7.61 58.44 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.566 ' CB ' HG22 ' A' ' 96' ' ' VAL . 12.6 mm -87.62 61.93 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -127.58 32.18 5.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.967 . . . . 0.0 109.48 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.557 ' O ' ' N ' ' A' ' 107' ' ' ASP . 4.8 p -153.02 128.11 9.72 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.002 -1.061 . . . . 0.0 110.075 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.745 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.55 -31.03 9.5 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.29 -34.14 74.72 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.4 OUTLIER -68.51 -51.11 46.74 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.745 HD12 ' HA ' ' A' ' 105' ' ' ALA . 27.9 mt -48.16 -29.9 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.123 -0.986 . . . . 0.0 108.684 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -76.86 -39.9 49.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.219 -0.926 . . . . 0.0 109.419 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -57.34 -41.18 79.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.405 -0.809 . . . . 0.0 109.646 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.909 HG11 ' HG ' ' A' ' 92' ' ' LEU . 19.9 t -73.88 -38.45 50.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.173 -0.954 . . . . 0.0 109.569 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.42 ' CD2' ' HD2' ' A' ' 122' ' ' TYR . 2.6 m-85 -64.52 -39.01 92.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.052 -1.03 . . . . 0.0 109.121 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.4 mt -75.11 -22.38 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.342 -0.849 . . . . 0.0 109.548 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.48 -16.98 62.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.315 -0.866 . . . . 0.0 109.876 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.905 ' HB1' ' HE2' ' A' ' 87' ' ' LYS . . . -91.04 6.4 45.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.177 -0.952 . . . . 0.0 109.725 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.68 2.56 75.6 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.801 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.4 mp -86.27 63.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -1.102 . . . . 0.0 109.074 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.498 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -31.75 149.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.199 -0.938 . . . . 0.0 110.859 -179.218 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.42 -32.92 58.14 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -57.03 -46.26 82.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.999 -1.295 . . . . 0.0 109.195 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -73.01 -43.72 61.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.9 . . . . 0.0 109.489 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 1.107 ' CE2' HG11 ' A' ' 78' ' ' VAL . 4.3 t80 -57.99 -45.59 86.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.613 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -64.3 -37.8 88.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.147 -0.97 . . . . 0.0 108.979 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -62.03 -50.35 72.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.151 -0.968 . . . . 0.0 108.878 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.51 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -52.0 -49.3 63.58 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.453 ' C ' ' CD1' ' A' ' 126' ' ' TRP . 3.5 t90 -58.22 -59.65 4.99 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -15.35 6.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.633 -0.667 . . . . 0.0 110.253 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.478 ' OG ' HG23 ' A' ' 131' ' ' VAL . 0.1 OUTLIER -69.6 172.93 6.63 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.056 -1.028 . . . . 0.0 110.086 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -89.5 -40.14 12.86 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.39 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.6 t -63.13 -46.15 96.75 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 C-N-CA 118.105 -1.438 . . . . 0.0 109.341 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.938 HG22 ' HB1' ' A' ' 81' ' ' ALA . 2.1 t -69.58 -33.79 58.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 120.975 -1.078 . . . . 0.0 108.369 179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 128' ' ' SER . 19.2 ttpt -63.64 -37.99 89.41 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 24.5 p -69.37 -32.42 71.47 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.415 -0.803 . . . . 0.0 108.91 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.66 -19.18 49.69 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.256 -0.903 . . . . 0.0 108.781 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.515 HG23 ' HB1' ' A' ' 77' ' ' ALA . 3.0 t -78.68 -48.77 21.65 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -62.33 -38.9 91.27 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -64.68 -35.8 82.22 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.4 -0.813 . . . . 0.0 109.29 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.585 ' OE1' HG23 ' A' ' 73' ' ' THR . 3.7 mt-30 -67.55 -66.59 0.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.202 -0.936 . . . . 0.0 109.185 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.33 -37.61 17.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.185 -0.947 . . . . 0.0 108.66 179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 9.3 mttm -71.53 -33.57 69.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.367 -0.833 . . . . 0.0 108.85 179.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.503 ' CB ' ' CD2' ' A' ' 59' ' ' TYR . . . -56.64 -62.22 1.88 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 0.0 109.128 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -69.09 -26.24 64.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -0.897 . . . . 0.0 109.599 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 140' ' ' LYS . . . -76.09 -26.01 56.04 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.193 -0.942 . . . . 0.0 109.887 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.752 ' OD1' HG13 ' A' ' 145' ' ' VAL . 0.6 OUTLIER -80.88 -49.92 10.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.112 -0.993 . . . . 0.0 108.478 179.647 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 1.094 HG21 ' CE2' ' A' ' 25' ' ' PHE . 19.7 m -84.75 -13.27 11.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 2.7 mt-30 80.89 -47.14 0.26 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.608 -0.682 . . . . 0.0 109.875 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.525 HD21 ' CG1' ' A' ' 61' ' ' VAL . 24.4 tp 65.06 137.9 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 13.7 ttt85 -160.5 27.74 0.16 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.457 -1.402 . . . . 0.0 110.161 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.97 106.47 0.2 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.314 -1.422 . . . . 0.0 110.619 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 1.128 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -83.13 144.46 47.23 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.41 -1.053 . . . . 0.0 108.934 178.635 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.48 151.73 89.64 Favored 'Cis proline' 0 C--N 1.315 -1.224 0 C-N-CA 124.176 -1.177 . . . . 0.0 110.854 0.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.797 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -127.84 153.12 46.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.41 -1.431 . . . . 0.0 109.103 179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.494 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -148.11 130.07 15.31 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.899 -1.126 . . . . 0.0 110.424 -179.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.607 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 24.5 m-85 -126.22 129.17 48.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.53 -0.731 . . . . 0.0 109.698 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 21' ' ' GLN . 14.8 t -96.77 131.13 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.183 -0.948 . . . . 0.0 109.607 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.765 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 5.7 t30 43.16 23.73 0.04 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.471 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.549 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 56.87 58.11 16.19 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.482 ' HE3' ' CE2' ' A' ' 159' ' ' TYR . 32.6 ttpt -166.27 -35.67 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.588 ' CD2' ' HE3' ' A' ' 188' ' ' LYS . 50.3 m-85 -119.6 120.93 38.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.892 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.607 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -119.42 120.55 37.19 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.171 -0.956 . . . . 0.0 109.714 -179.472 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 9' ' ' TYR . 69.8 mt -61.85 175.38 0.67 Allowed 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 16.4 p-10 -149.86 114.5 3.44 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.947 -1.095 . . . . 0.0 109.384 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.62 26.21 0.6 Allowed 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 122.598 2.199 . . . . 0.0 111.351 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.4 mm100 -91.85 -13.65 31.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.891 -1.13 . . . . 0.0 109.355 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -91.67 20.33 42.46 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 8.9 ttp -81.46 49.73 1.35 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.192 -1.181 . . . . 0.0 109.403 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -99.74 17.84 19.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.193 -0.942 . . . . 0.0 109.566 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 169' ' ' SER . 14.9 t -89.26 1.9 55.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.179 -0.95 . . . . 0.0 109.625 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.422 ' O ' ' OD1' ' A' ' 170' ' ' ASN . 0.5 OUTLIER 44.41 43.66 6.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.41 179.896 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 169' ' ' SER . 1.8 m120 -155.83 94.06 1.52 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.287 -0.883 . . . . 0.0 109.304 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 14.3 mtt -58.76 -15.74 13.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.28 -0.887 . . . . 0.0 109.602 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.75 -49.17 66.81 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.3 t -66.37 -29.16 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.314 -0.866 . . . . 0.0 109.033 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.476 ' O ' ' HB2' ' A' ' 178' ' ' TYR . 0.1 OUTLIER -68.25 -31.38 70.81 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.113 -0.992 . . . . 0.0 108.85 179.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.417 HG22 HD11 ' A' ' 42' ' ' ILE . 53.3 t -79.28 -29.29 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.214 -0.929 . . . . 0.0 109.552 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -82.97 -53.02 6.16 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.181 -0.949 . . . . 0.0 109.001 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.46 ' O ' ' OG1' ' A' ' 181' ' ' THR . 1.0 OUTLIER -62.34 -47.27 84.97 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.458 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.604 ' O ' HG23 ' A' ' 182' ' ' VAL . 4.2 t80 -61.83 -49.68 75.33 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.51 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -57.01 -34.69 68.41 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.102 -0.999 . . . . 0.0 108.998 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -73.77 -38.73 64.6 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.423 -0.798 . . . . 0.0 109.182 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.662 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.2 OUTLIER -59.01 -29.68 67.43 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 178' ' ' TYR . 2.5 t -83.95 -36.41 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.142 -0.973 . . . . 0.0 109.28 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.477 ' HB2' ' CG ' ' A' ' 49' ' ' LYS . 16.9 tttt -60.77 -46.49 90.25 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.173 -0.955 . . . . 0.0 108.915 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.567 ' CD2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -81.63 -30.91 32.63 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.366 -0.834 . . . . 0.0 109.371 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.723 HD13 ' HE2' ' A' ' 188' ' ' LYS . 0.4 OUTLIER -61.01 -20.93 63.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.825 -1.172 . . . . 0.0 108.775 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.635 ' HB3' HD23 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -80.79 -4.57 55.06 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.98 -1.075 . . . . 0.0 108.471 178.243 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -107.66 -76.52 0.61 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.354 -0.841 . . . . 0.0 108.867 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.723 ' HE2' HD13 ' A' ' 185' ' ' LEU . 1.0 OUTLIER 63.75 28.38 14.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.523 -0.736 . . . . 0.0 110.113 179.492 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 188' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.902 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.573 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER -109.38 57.96 0.61 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 109.428 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.611 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER 166.84 86.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.517 -0.74 . . . . 0.0 109.262 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.3 mm-40 -99.63 58.2 1.04 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.07 -1.019 . . . . 0.0 110.011 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 11.6 t0 48.98 85.26 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.44 -0.788 . . . . 0.0 110.04 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 114.92 -21.91 13.13 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 10.9 tttm -81.27 -67.25 0.8 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.166 -1.196 . . . . 0.0 108.696 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.511 ' HB2' ' HB3' ' A' ' 3' ' ' TYR . 15.7 mp0 -99.09 7.83 45.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.252 -0.905 . . . . 0.0 109.611 179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.669 ' CB ' HD23 ' A' ' 161' ' ' LEU . 4.4 p90 176.54 134.67 0.06 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 108.975 179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.471 HG23 ' CG ' ' A' ' 160' ' ' GLN . 9.3 t -114.43 177.68 4.55 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.585 -0.697 . . . . 0.0 109.328 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.502 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 0.4 OUTLIER -88.41 160.67 17.46 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.542 0.686 . . . . 0.0 110.42 -179.151 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.452 ' HG ' ' HB3' ' A' ' 160' ' ' GLN . 7.4 mt -98.41 161.74 13.53 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.562 -0.711 . . . . 0.0 109.127 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.416 ' C ' ' HG2' ' A' ' 14' ' ' LYS . 5.0 pm0 -115.6 -3.98 12.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.284 -0.885 . . . . 0.0 109.611 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 13' ' ' GLU . 3.7 mmtp -139.89 75.11 30.88 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.18 -0.95 . . . . 0.0 109.617 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 157' ' ' GLY . 35.3 Cg_endo -77.99 159.62 30.6 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.561 2.174 . . . . 0.0 110.576 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.862 HG21 ' HB3' ' A' ' 144' ' ' ASP . 1.7 t -134.36 129.74 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 0.0 110.369 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -50.52 126.57 15.66 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.526 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 74.65 6.45 77.19 Favored Glycine 0 N--CA 1.486 1.985 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.933 ' HB1' ' HD2' ' A' ' 20' ' ' PRO . . . -42.57 172.45 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.498 -1.001 . . . . 0.0 110.277 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.933 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 30.8 Cg_endo -71.52 111.94 3.24 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.919 2.412 . . . . 0.0 111.74 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.665 ' O ' HG22 ' A' ' 155' ' ' VAL . 27.0 mm-40 -52.85 -22.35 5.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.557 -0.715 . . . . 0.0 109.597 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.683 ' O ' HG12 ' A' ' 22' ' ' VAL . 10.5 t -156.62 79.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.655 HD12 ' HG3' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -81.7 138.48 35.24 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.385 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.586 ' H ' HD23 ' A' ' 23' ' ' LEU . 10.5 tt0 -132.85 103.1 5.92 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.047 -1.033 . . . . 0.0 109.789 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.912 ' HE2' HG21 ' A' ' 145' ' ' VAL . 58.4 m-85 -86.01 126.4 34.12 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.179 -0.951 . . . . 0.0 109.031 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.4 ' O ' ' CG ' ' A' ' 26' ' ' PHE . 2.6 p90 -157.14 133.15 9.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.231 -0.918 . . . . 0.0 109.791 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.551 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 70.1 m -104.33 -174.37 2.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.413 -0.805 . . . . 0.0 109.827 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.558 ' O ' ' CD1' ' A' ' 29' ' ' PHE . 16.0 m-30 -104.53 48.46 0.84 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.665 ' CG ' HG11 ' A' ' 96' ' ' VAL . 16.6 m-85 -146.91 14.32 1.17 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 110.338 -178.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.7 OUTLIER -104.51 162.5 19.65 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 120.675 -1.266 . . . . 0.0 109.67 -179.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.96 -36.14 2.76 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.212 1.941 . . . . 0.0 108.388 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.518 ' O ' ' N ' ' A' ' 36' ' ' PHE . 4.4 m-70 -82.98 -22.32 33.71 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 16.2 t -47.06 -52.95 13.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.534 ' CB ' ' NE2' ' A' ' 97' ' ' GLN . 11.3 t80 -75.18 -40.66 59.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.794 -0.566 . . . . 0.0 110.403 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 -72.38 -16.92 61.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.057 -1.027 . . . . 0.0 110.417 -179.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' HIS . 1.8 m-85 -82.58 -29.62 30.14 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.02 -1.05 . . . . 0.0 110.443 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.74 22.7 13.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.955 -1.09 . . . . 0.0 109.629 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.514 ' OE2' ' CZ ' ' A' ' 34' ' ' TYR . 5.5 mm-40 -132.09 -61.09 0.89 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.28 -0.887 . . . . 0.0 111.092 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 58.2 t -90.61 -75.56 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.899 -1.126 . . . . 0.0 111.708 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 41' ' ' HIS . 0.7 OUTLIER -70.75 -24.39 62.6 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.954 -1.091 . . . . 0.0 110.679 -178.089 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 44' ' ' ASP . 94.9 m-70 60.67 32.71 20.33 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.058 -1.026 . . . . 0.0 108.965 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.422 ' C ' ' O ' ' A' ' 41' ' ' HIS . 13.5 mm -42.22 -26.9 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.419 -0.8 . . . . 0.0 109.921 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 41' ' ' HIS . 0.9 OUTLIER -81.4 -43.39 19.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.201 -0.937 . . . . 0.0 109.92 -179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 41' ' ' HIS . 84.1 m-20 -85.39 -36.59 20.6 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.178 -0.952 . . . . 0.0 109.894 -179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -65.04 -38.64 91.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.118 -0.989 . . . . 0.0 109.556 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.412 HG12 ' O ' ' A' ' 43' ' ' SER . 9.8 p -68.54 -26.46 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.736 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.424 ' HA ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -61.64 -39.23 90.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.476 -179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -51.17 -24.45 4.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.169 -0.957 . . . . 0.0 108.734 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.867 ' O ' HD23 ' A' ' 50' ' ' LEU . 17.6 mmtm -91.05 25.04 2.58 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.517 -0.739 . . . . 0.0 109.423 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.867 HD23 ' O ' ' A' ' 49' ' ' LYS . 14.2 mt -125.22 67.3 54.95 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.175 -0.953 . . . . 0.0 110.104 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD3' ' C ' ' A' ' 49' ' ' LYS . 36.6 Cg_endo -79.39 75.35 5.11 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.542 2.161 . . . . 0.0 110.937 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 51' ' ' PRO . 6.0 tm-20 58.82 131.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 CA-C-O 121.395 0.617 . . . . 0.0 110.2 179.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.08 -11.63 60.44 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.814 ' CG1' HD22 ' A' ' 50' ' ' LEU . 1.1 t -114.61 98.43 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -1.185 . . . . 0.0 109.142 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.402 ' H ' ' HB2' ' A' ' 21' ' ' GLN . 0.0 OUTLIER -86.09 102.95 14.31 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.307 -0.871 . . . . 0.0 109.909 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.513 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 8.7 ttt -99.02 102.88 14.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.428 -0.795 . . . . 0.0 109.606 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.0 m -99.1 126.48 44.85 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.265 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.95 113.83 27.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.458 -0.777 . . . . 0.0 109.382 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.552 ' CD1' ' HG2' ' A' ' 138' ' ' GLN . 2.8 m-85 -115.33 163.75 15.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.029 -1.045 . . . . 0.0 111.404 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.658 ' CE1' HD21 ' A' ' 72' ' ' LEU . 3.5 t-160 -117.28 122.16 43.18 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.13 HG11 ' CD2' ' A' ' 147' ' ' LEU . 16.8 m -101.88 156.71 4.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 121.342 -0.849 . . . . 0.0 110.384 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 1.1 p-10 -83.92 42.65 0.87 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.402 -0.811 . . . . 0.0 109.536 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.609 ' CD1' ' CG2' ' A' ' 61' ' ' VAL . 3.7 m-85 -91.56 30.96 1.23 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.18 -0.95 . . . . 0.0 110.023 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.438 ' SD ' ' HB3' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -161.74 45.93 0.17 Allowed 'General case' 0 C--N 1.286 -2.157 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.65 179.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.587 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 161.73 60.03 0.02 OUTLIER Glycine 0 N--CA 1.483 1.821 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.507 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.52 -35.72 0.13 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 65' ' ' GLY . 92.3 m-20 -88.94 -78.64 0.34 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.206 -1.173 . . . . 0.0 110.129 179.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.929 HD23 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -82.27 -21.62 36.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.769 -1.207 . . . . 0.0 110.088 -179.508 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.732 ' N ' HD22 ' A' ' 68' ' ' LEU . . . -51.97 -39.93 49.63 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.134 -1.986 . . . . 0.0 108.134 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.522 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 2.9 ttmt -61.05 -41.58 96.87 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.79 -29.54 65.75 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.728 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 13.9 tp -58.17 -50.77 72.38 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -56.64 -43.2 80.05 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.82 ' O ' HG23 ' A' ' 78' ' ' VAL . 3.1 tt0 -54.92 -27.17 41.24 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 177.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.728 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.51 -46.36 86.44 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 29.7 t-105 -53.97 -31.98 52.42 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.504 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -81.99 -66.31 0.9 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.408 -0.808 . . . . 0.0 110.012 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 74' ' ' GLN . 2.2 t -47.55 -30.68 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.214 -0.929 . . . . 0.0 110.047 -179.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.439 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.5 -63.48 1.41 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.824 -1.173 . . . . 0.0 109.188 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.416 ' C ' ' O ' ' A' ' 79' ' ' ALA . 21.7 mtp -46.21 -27.12 0.91 Allowed 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.594 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.647 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -67.8 -46.86 70.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.388 -0.82 . . . . 0.0 109.591 179.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 61.8 mt -99.62 7.24 45.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.63 31.18 60.18 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 -179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.439 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 26.9 m -97.35 8.21 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.448 -1.031 . . . . 0.0 110.144 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.475 ' HG2' ' OG1' ' A' ' 89' ' ' THR . 2.3 tt0 -52.76 -70.56 0.09 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.086 -1.009 . . . . 0.0 109.722 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.454 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -38.89 -33.78 0.13 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.746 . . . . 0.0 110.282 -179.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.6 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 25.1 mtpp -80.91 -52.5 7.39 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.377 -0.827 . . . . 0.0 110.995 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.688 HG23 HD12 ' A' ' 92' ' ' LEU . 1.3 m -86.12 -13.89 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.684 -1.26 . . . . 0.0 110.803 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.77 HG23 ' CE1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -73.68 -42.39 61.37 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.646 -1.284 . . . . 0.0 108.206 178.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.403 ' HB ' ' HD3' ' A' ' 91' ' ' PRO . 2.1 t -54.22 -54.67 45.21 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.63 -1.294 . . . . 0.0 110.353 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.507 ' HB2' HG13 ' A' ' 111' ' ' VAL . 25.9 Cg_endo -72.82 -21.1 21.79 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 N-CA-C 109.758 -0.901 . . . . 0.0 109.758 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.688 HD12 HG23 ' A' ' 88' ' ' VAL . 15.6 mt -81.09 -44.64 17.67 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 177.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.77 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.6 m-30 -64.03 -44.87 91.21 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.107 -0.995 . . . . 0.0 108.62 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -72.97 -24.33 60.77 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.297 -0.877 . . . . 0.0 109.321 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.901 ' O ' HG23 ' A' ' 99' ' ' THR . . . -69.03 -36.09 80.14 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.093 -1.603 . . . . 0.0 109.093 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.665 HG11 ' CG ' ' A' ' 29' ' ' PHE . 2.2 t -98.95 -1.57 10.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.225 -1.162 . . . . 0.0 108.768 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.534 ' NE2' ' CB ' ' A' ' 34' ' ' TYR . 27.4 mm-40 -110.26 6.27 22.41 Favored 'General case' 0 C--N 1.31 -1.11 0 O-C-N 121.022 -1.048 . . . . 0.0 111.323 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.754 ' C ' HG22 ' A' ' 99' ' ' THR . 1.5 ttmm -164.57 52.2 0.13 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.476 -1.39 . . . . 0.0 109.402 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.901 HG23 ' O ' ' A' ' 95' ' ' GLY . 0.5 OUTLIER 175.15 -51.1 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.361 -0.837 . . . . 0.0 109.847 -179.91 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.534 ' O ' ' CD ' ' A' ' 103' ' ' ARG . 1.1 mt-30 75.05 10.95 3.66 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.042 -1.036 . . . . 0.0 109.886 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.1 t -84.32 -8.33 59.04 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.608 0.718 . . . . 0.0 109.319 178.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.468 HG13 ' C ' ' A' ' 95' ' ' GLY . 10.2 mm -74.14 75.75 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 121.56 -0.712 . . . . 0.0 109.544 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.534 ' CD ' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -136.65 31.42 2.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.84 -179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.533 ' N ' ' HG ' ' A' ' 68' ' ' LEU . 7.3 p -146.91 128.45 15.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.064 -1.022 . . . . 0.0 109.716 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.54 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -52.82 -30.17 31.94 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 19.6 t -65.83 -29.03 69.43 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 104' ' ' SER . 61.6 m-20 -77.21 -39.5 48.45 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.396 -0.922 . . . . 0.0 108.678 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.929 HD11 HD23 ' A' ' 68' ' ' LEU . 44.4 mt -59.51 -29.82 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.29 178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 105' ' ' ALA . 4.6 mtm180 -78.03 -32.07 50.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.528 -0.733 . . . . 0.0 109.275 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.4 OUTLIER -61.47 -48.02 83.02 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.246 -0.909 . . . . 0.0 109.2 179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.635 HG11 ' HG ' ' A' ' 92' ' ' LEU . 53.1 t -68.39 -40.37 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 119.284 -0.966 . . . . 0.0 108.915 179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.579 ' CD1' HG11 ' A' ' 88' ' ' VAL . 0.6 OUTLIER -56.78 -37.59 71.32 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.242 -0.912 . . . . 0.0 109.28 179.442 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 15.8 mt -76.16 -24.79 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -0.805 . . . . 0.0 109.869 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 16.5 m-20 -64.47 -18.78 65.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.027 -1.046 . . . . 0.0 109.371 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.6 ' HB1' ' HE3' ' A' ' 87' ' ' LYS . . . -94.33 6.42 48.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.534 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 90.96 -1.48 77.94 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.732 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -78.74 57.6 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.3 -1.118 . . . . 0.0 109.442 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.469 ' C ' ' O ' ' A' ' 117' ' ' ILE . 2.2 mttt -37.73 153.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.288 -0.882 . . . . 0.0 110.134 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -55.99 -38.01 73.47 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.431 ' HG3' ' HB2' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -50.43 -49.18 55.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.945 -1.326 . . . . 0.0 109.571 -179.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.22 -48.79 12.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.264 -0.898 . . . . 0.0 110.335 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.807 ' CE2' HG11 ' A' ' 78' ' ' VAL . 4.1 t80 -58.28 -52.3 66.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.017 -1.052 . . . . 0.0 109.622 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -62.0 -41.13 97.72 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.151 -0.968 . . . . 0.0 109.33 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.58 -50.4 73.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.102 -0.999 . . . . 0.0 108.928 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 128' ' ' SER . . . -55.28 -46.71 76.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.327 -0.858 . . . . 0.0 108.886 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.729 ' HA ' HG11 ' A' ' 131' ' ' VAL . 4.7 t90 -57.55 -57.08 14.27 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.231 -0.918 . . . . 0.0 108.53 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -60.7 -15.54 30.12 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.5 -0.75 . . . . 0.0 109.553 179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 63.1 m -76.13 -172.93 2.2 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.141 -0.975 . . . . 0.0 109.83 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -95.55 -28.3 14.93 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.906 -0.496 . . . . 0.0 111.061 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.14 -41.88 93.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 C-N-CA 117.972 -1.491 . . . . 0.0 109.405 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.729 HG11 ' HA ' ' A' ' 126' ' ' TRP . 49.9 t -70.86 -36.65 65.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 120.995 -1.066 . . . . 0.0 108.487 179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -67.4 -27.46 67.1 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.23 -37.68 69.11 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 138' ' ' GLN . 0.5 OUTLIER -79.45 -22.19 44.48 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.504 HG23 ' CB ' ' A' ' 77' ' ' ALA . 17.1 t -79.12 -40.96 22.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.511 ' O ' ' CG ' ' A' ' 140' ' ' LYS . . . -68.01 -48.55 65.39 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.495 -0.753 . . . . 0.0 109.038 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.488 ' HB3' ' OH ' ' A' ' 59' ' ' TYR . 0.0 OUTLIER -61.29 -32.69 72.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.233 -0.917 . . . . 0.0 108.751 179.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.552 ' HG2' ' CD1' ' A' ' 59' ' ' TYR . 4.4 tm0? -66.06 -69.76 0.28 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.827 . . . . 0.0 109.093 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 138' ' ' GLN . 0.0 OUTLIER -46.87 -32.67 3.92 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 136' ' ' ALA . 0.4 OUTLIER -70.28 -35.05 73.48 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 178.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.673 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -57.05 -50.3 73.17 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 179.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.527 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -70.25 -33.17 71.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.433 -0.792 . . . . 0.0 109.8 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.25 -18.21 55.66 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.208 -0.933 . . . . 0.0 110.042 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.862 ' HB3' HG21 ' A' ' 16' ' ' VAL . 67.4 m-20 -82.84 -43.48 16.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.048 -1.032 . . . . 0.0 108.36 179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.912 HG21 ' HE2' ' A' ' 25' ' ' PHE . 27.5 m -98.61 -12.65 8.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.2 OUTLIER 83.61 -40.9 0.08 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.69 -0.631 . . . . 0.0 109.564 -179.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.13 ' CD2' HG11 ' A' ' 61' ' ' VAL . 10.7 tp 67.85 134.8 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.395 -0.816 . . . . 0.0 109.329 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 18.2 ttp85 -144.29 11.45 1.52 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.557 -1.339 . . . . 0.0 110.746 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.31 93.74 0.1 OUTLIER Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.678 -1.725 . . . . 0.0 111.575 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 1.003 HG11 HG21 ' A' ' 61' ' ' VAL . 0.9 OUTLIER -81.64 139.45 47.38 Favored Pre-proline 0 N--CA 1.493 1.685 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 177.733 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 150' ' ' VAL . 32.4 Cg_endo -72.23 156.32 98.25 Favored 'Cis proline' 0 C--N 1.315 -1.205 0 C-N-CA 124.198 -1.168 . . . . 0.0 112.101 2.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -159.72 152.07 21.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.059 -1.025 . . . . 0.0 108.259 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.518 ' O ' ' CD1' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -131.69 137.83 48.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.928 -1.108 . . . . 0.0 110.195 -179.521 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.518 ' CD1' ' O ' ' A' ' 153' ' ' MET . 14.0 m-85 -133.32 136.23 45.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.399 -0.813 . . . . 0.0 109.524 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.665 HG22 ' O ' ' A' ' 21' ' ' GLN . 12.1 t -110.78 119.59 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.046 -1.034 . . . . 0.0 108.352 179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.496 ' N ' ' O ' ' A' ' 20' ' ' PRO . 1.7 m-20 53.29 27.31 6.0 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 15' ' ' PRO . . . 50.18 21.66 4.29 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.232 -1.461 . . . . 0.0 109.614 -179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 14.4 tttt -118.79 -21.02 8.0 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 120.756 -1.438 . . . . 0.0 108.721 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.446 ' N ' HD12 ' A' ' 12' ' ' LEU . 17.9 m-85 -134.87 123.93 24.23 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.419 -0.801 . . . . 0.0 109.291 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 11' ' ' THR . 25.4 pt20 -116.93 117.42 29.64 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.268 -0.895 . . . . 0.0 109.59 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.669 HD23 ' CB ' ' A' ' 9' ' ' TYR . 11.6 mt -60.83 179.47 0.17 Allowed 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.502 -0.749 . . . . 0.0 108.98 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -155.17 117.92 2.43 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.037 -1.039 . . . . 0.0 109.529 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.01 -23.43 9.22 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.328 2.019 . . . . 0.0 110.635 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.447 ' HB3' ' HG2' ' A' ' 166' ' ' MET . 2.5 tt0 61.23 20.62 11.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -0.938 . . . . 0.0 109.609 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 46.22 39.06 9.21 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.447 ' HG2' ' HB3' ' A' ' 164' ' ' GLN . 4.4 mmt -92.63 -95.22 0.14 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.12 -1.224 . . . . 0.0 109.39 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 166' ' ' MET . 22.0 t70 43.65 30.58 0.37 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.111 -0.993 . . . . 0.0 109.556 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.429 ' OG1' ' N ' ' A' ' 169' ' ' SER . 69.3 p -70.42 -72.45 0.2 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.238 -0.914 . . . . 0.0 109.769 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.429 ' N ' ' OG1' ' A' ' 168' ' ' THR . 0.5 OUTLIER -136.78 59.07 1.7 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.238 -0.914 . . . . 0.0 109.507 -179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -159.82 59.19 0.37 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.631 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.433 ' O ' HG23 ' A' ' 175' ' ' VAL . 5.7 mmm -74.9 -16.57 60.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.135 -0.978 . . . . 0.0 109.479 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -78.53 -56.56 4.34 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 177' ' ' GLN . 6.9 t -64.09 -28.49 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.18 -0.95 . . . . 0.0 108.939 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.437 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 48.7 t80 -69.18 -43.16 74.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.296 -0.878 . . . . 0.0 109.229 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 171' ' ' MET . 61.3 t -70.05 -27.35 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.181 -0.949 . . . . 0.0 109.478 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.9 tm0? -83.95 -58.71 2.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.153 -0.967 . . . . 0.0 109.251 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.532 ' CG ' ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -56.94 -41.73 78.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.397 -0.815 . . . . 0.0 109.197 179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.647 ' O ' HG23 ' A' ' 182' ' ' VAL . 69.2 t80 -65.54 -51.85 56.85 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.245 -0.909 . . . . 0.0 109.067 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -62.17 -25.28 67.68 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.241 -0.912 . . . . 0.0 109.26 179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -79.28 -45.07 20.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.261 -0.899 . . . . 0.0 109.348 179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.72 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -57.0 -42.32 80.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.221 -0.924 . . . . 0.0 109.14 179.675 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.647 HG23 ' O ' ' A' ' 178' ' ' TYR . 2.4 t -74.49 -36.55 42.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 109.135 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -57.55 -50.11 74.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.19 -0.944 . . . . 0.0 109.102 179.621 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -77.14 -31.46 55.66 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.235 -0.916 . . . . 0.0 109.086 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.72 HD23 ' O ' ' A' ' 181' ' ' THR . 0.4 OUTLIER -58.24 -21.3 47.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.841 -1.162 . . . . 0.0 109.171 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.573 ' HB2' HG22 ' A' ' 54' ' ' VAL . 87.2 p -74.39 -4.77 38.45 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.817 -1.177 . . . . 0.0 108.691 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.43 10.68 19.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.418 -0.802 . . . . 0.0 109.267 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.443 ' HE2' ' HB2' ' A' ' 156' ' ' ASN . 0.6 OUTLIER -76.28 0.35 19.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.269 -0.894 . . . . 0.0 110.336 -179.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.004 -1.06 . . . . 0.0 109.55 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.57 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 0.7 OUTLIER -111.36 58.62 0.62 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 0.0 109.58 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 2' ' ' GLN . 0.1 OUTLIER 174.05 91.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -98.2 58.41 1.31 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 109.79 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.0 t0 50.5 84.4 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.574 -0.704 . . . . 0.0 110.271 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 112.89 -19.73 20.65 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.019 -1.233 . . . . 0.0 110.019 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 -66.62 0.86 Allowed 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.057 -1.26 . . . . 0.0 108.684 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.482 ' HB2' ' HB3' ' A' ' 3' ' ' TYR . 40.6 mm-40 -102.62 10.61 38.62 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.321 -0.862 . . . . 0.0 109.678 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.537 ' HB2' HD23 ' A' ' 161' ' ' LEU . 6.9 p90 179.1 136.09 0.09 Allowed 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.07 -1.019 . . . . 0.0 109.426 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.495 HG23 ' CG ' ' A' ' 160' ' ' GLN . 2.3 t -123.55 171.9 9.17 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 53.5 m -120.97 149.69 42.27 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.514 0.673 . . . . 0.0 110.199 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 158' ' ' LYS . 1.3 mp -98.18 157.45 16.15 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.572 -0.705 . . . . 0.0 109.21 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.513 ' HG2' ' N ' ' A' ' 14' ' ' LYS . 0.3 OUTLIER -84.7 -25.64 28.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.116 -0.99 . . . . 0.0 109.192 179.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.513 ' N ' ' HG2' ' A' ' 13' ' ' GLU . 7.4 mttp -116.24 96.44 47.51 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.359 -0.838 . . . . 0.0 109.046 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 157' ' ' GLY . 34.3 Cg_endo -76.74 159.95 34.7 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.337 2.025 . . . . 0.0 110.481 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.73 HG21 ' HB3' ' A' ' 144' ' ' ASP . 11.7 t -108.73 90.52 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.285 -0.885 . . . . 0.0 109.762 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.96 131.5 12.12 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.45 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 95.18 -24.49 28.6 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.719 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -41.2 160.62 0.14 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.404 -1.056 . . . . 0.0 109.471 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.572 ' CG ' ' HG ' ' A' ' 23' ' ' LEU . 36.0 Cg_endo -78.13 129.26 9.55 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 C-N-CA 122.563 2.175 . . . . 0.0 111.015 -179.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.649 ' O ' HG22 ' A' ' 155' ' ' VAL . 2.5 mp0 -46.68 -20.69 0.14 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.433 -0.792 . . . . 0.0 109.792 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.771 ' O ' HG12 ' A' ' 22' ' ' VAL . 3.1 t -148.35 79.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.873 -1.142 . . . . 0.0 108.73 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.761 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -73.76 127.47 32.9 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.5 ' HB3' ' HA ' ' A' ' 58' ' ' LYS . 33.2 tt0 -114.64 118.08 32.65 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.99 -1.068 . . . . 0.0 109.564 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.785 ' CD2' HD13 ' A' ' 147' ' ' LEU . 7.5 m-85 -103.76 112.5 25.47 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.586 -0.696 . . . . 0.0 109.274 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -155.19 142.28 19.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.998 -1.064 . . . . 0.0 110.14 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.807 ' HB3' HG22 ' A' ' 61' ' ' VAL . 4.3 p -124.55 -168.63 1.84 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.627 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -116.47 52.54 0.92 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.857 -1.152 . . . . 0.0 108.036 178.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.763 ' CD1' HG11 ' A' ' 96' ' ' VAL . 7.6 m-85 -139.97 10.62 2.4 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.222 -0.924 . . . . 0.0 110.236 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.717 ' HB3' ' HD2' ' A' ' 31' ' ' PRO . 4.0 m -117.06 179.88 0.74 Allowed Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.753 -1.217 . . . . 0.0 108.484 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.717 ' HD2' ' HB3' ' A' ' 30' ' ' CYS . 32.3 Cg_endo -76.02 -59.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.337 0 C-N-CA 121.593 1.529 . . . . 0.0 110.169 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -69.4 -11.46 60.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.955 -1.09 . . . . 0.0 108.4 178.743 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.48 ' SG ' ' O ' ' A' ' 27' ' ' SER . 1.2 m -57.15 -37.93 72.78 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.584 ' CE1' ' HG3' ' A' ' 38' ' ' GLU . 18.6 t80 -81.22 -41.91 21.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.758 -0.589 . . . . 0.0 109.791 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.492 ' N ' ' OE1' ' A' ' 35' ' ' GLN . 11.7 mp0 -78.56 -21.26 48.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.187 -0.945 . . . . 0.0 110.681 -179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.77 ' CE2' HG21 ' A' ' 42' ' ' ILE . 27.0 t80 -75.52 -18.03 59.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.094 -1.004 . . . . 0.0 110.521 -179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 38' ' ' GLU . 2.2 mm-40 -128.28 32.34 4.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.928 -1.107 . . . . 0.0 110.419 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.584 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 4.5 mm-40 -145.18 -67.89 0.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.977 -1.077 . . . . 0.0 109.797 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.46 ' O ' ' CG ' ' A' ' 41' ' ' HIS . 13.2 t -97.1 -56.79 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.057 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.496 ' HB3' HG13 ' A' ' 42' ' ' ILE . 61.2 mt -43.49 -27.9 0.32 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.118 -0.989 . . . . 0.0 109.93 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' A' ' 38' ' ' GLU . 29.7 m170 49.37 24.28 1.03 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.044 -1.035 . . . . 0.0 109.027 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.77 HG21 ' CE2' ' A' ' 36' ' ' PHE . 12.2 mt -59.51 -32.8 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.42 -0.8 . . . . 0.0 109.64 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.04 -45.09 24.57 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.051 -1.031 . . . . 0.0 110.006 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -81.16 -36.45 30.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.921 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.453 ' N ' ' O ' ' A' ' 41' ' ' HIS . 6.2 t-20 -67.47 -30.34 70.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.947 . . . . 0.0 109.907 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 42' ' ' ILE . 43.5 t -74.5 -17.65 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.182 -0.949 . . . . 0.0 109.523 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.689 ' HA ' HD12 ' A' ' 50' ' ' LEU . 25.9 mttm -75.9 -34.39 59.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.451 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -57.7 -18.96 23.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -0.922 . . . . 0.0 109.583 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.81 17.76 14.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.224 -0.922 . . . . 0.0 109.439 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.689 HD12 ' HA ' ' A' ' 47' ' ' LYS . 11.9 mt -93.62 118.65 67.51 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.751 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.32 151.99 30.18 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.301 2.001 . . . . 0.0 108.954 179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.493 ' O ' ' CG ' ' A' ' 52' ' ' GLU . 11.0 tt0 -71.09 42.92 0.07 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.497 -1.377 . . . . 0.0 110.882 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.514 ' O ' ' CG2' ' A' ' 54' ' ' VAL . . . -140.77 37.29 1.68 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.768 -2.133 . . . . 0.0 107.768 178.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.581 HG13 ' HB3' ' A' ' 21' ' ' GLN . 21.4 t -159.43 128.5 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.554 -0.968 . . . . 0.0 109.035 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.511 ' N ' ' OE1' ' A' ' 21' ' ' GLN . 3.6 ttpp -100.01 112.29 24.58 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 121.828 0.823 . . . . 0.0 110.013 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 5.0 ttt -93.02 99.29 11.94 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.496 ' OG1' ' HB3' ' A' ' 20' ' ' PRO . 2.5 m -92.45 143.14 26.66 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.86 -1.136 . . . . 0.0 110.039 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.5 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -119.46 111.19 17.81 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.354 -0.841 . . . . 0.0 109.762 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.467 ' CE2' ' HG3' ' A' ' 138' ' ' GLN . 5.2 m-85 -111.3 166.11 11.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.225 -0.922 . . . . 0.0 111.074 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.568 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 62.7 t-80 -103.97 135.54 45.3 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-O 121.837 0.827 . . . . 0.0 109.008 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.039 HG11 ' CG1' ' A' ' 150' ' ' VAL . 4.4 m -73.45 154.24 7.07 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-O 121.476 0.655 . . . . 0.0 110.406 -179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.2 p30 -121.74 27.61 8.08 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.607 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 19.5 p90 -125.75 69.47 1.18 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.112 -0.992 . . . . 0.0 110.234 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.583 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -160.91 -59.06 0.05 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.232 -0.918 . . . . 0.0 109.764 178.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.583 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -95.86 80.77 0.8 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.413 -1.875 . . . . 0.0 108.413 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.54 -43.03 0.72 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -87.57 -78.3 0.32 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.904 -1.351 . . . . 0.0 110.825 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.128 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -80.49 -20.88 42.68 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.904 -1.122 . . . . 0.0 110.265 -179.02 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 1.128 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -54.79 -38.68 65.07 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 108.677 -1.769 . . . . 0.0 108.677 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.62 -47.32 63.82 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.427 -1.043 . . . . 0.0 108.523 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.524 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 12.2 t70 -65.44 -23.57 66.96 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.769 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 36.7 tp -65.09 -46.47 80.96 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.8 m -58.51 -42.73 88.33 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 1.04 ' O ' HG23 ' A' ' 78' ' ' VAL . 19.2 tt0 -57.72 -25.03 59.78 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 177.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.769 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -64.69 -40.21 94.99 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.457 ' O ' ' HB2' ' A' ' 80' ' ' MET . 25.3 t-105 -63.54 -29.09 70.4 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.63 ' HB2' HE22 ' A' ' 138' ' ' GLN . . . -81.6 -44.02 17.83 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.489 -0.757 . . . . 0.0 109.763 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.04 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.6 t -71.78 -27.39 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 0.0 109.401 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.604 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -78.75 -57.78 3.58 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.13 -0.982 . . . . 0.0 108.804 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.457 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -48.17 -27.68 2.53 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.155 -0.965 . . . . 0.0 108.578 179.429 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.752 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -69.25 -45.74 69.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.584 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.785 ' HB2' HG13 ' A' ' 84' ' ' VAL . 12.6 mt -105.2 14.28 29.31 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.232 -0.917 . . . . 0.0 110.173 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 49.1 25.52 5.51 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.785 HG13 ' HB2' ' A' ' 82' ' ' LEU . 33.8 m -82.98 -11.53 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.353 -1.086 . . . . 0.0 110.298 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.45 ' HG2' ' OG1' ' A' ' 89' ' ' THR . 0.1 OUTLIER -42.84 -63.59 0.76 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.132 -0.98 . . . . 0.0 109.875 -179.818 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.47 -33.43 1.71 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.285 -0.885 . . . . 0.0 110.264 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -81.6 -50.76 8.97 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.37 -0.832 . . . . 0.0 111.436 -178.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.762 HG23 HD12 ' A' ' 92' ' ' LEU . 2.2 m -90.57 6.1 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.863 -1.148 . . . . 0.0 111.195 -178.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.724 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -83.02 -45.7 13.73 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.818 -1.177 . . . . 0.0 108.347 178.582 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.464 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -52.39 -51.46 72.37 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 120.596 -1.315 . . . . 0.0 110.61 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 90' ' ' VAL . 27.1 Cg_endo -73.79 -20.13 20.26 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 N-CA-C 109.736 -0.909 . . . . 0.0 109.736 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.762 HD12 HG23 ' A' ' 88' ' ' VAL . 18.5 mt -86.18 -43.21 13.2 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.415 -0.803 . . . . 0.0 108.87 178.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.724 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.2 m-30 -64.47 -45.77 85.96 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 121.094 -1.004 . . . . 0.0 108.945 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -76.36 -21.2 56.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.083 -1.011 . . . . 0.0 109.751 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.479 ' O ' HG12 ' A' ' 102' ' ' ILE . . . -72.75 -29.77 64.85 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.763 HG11 ' CD1' ' A' ' 29' ' ' PHE . 3.4 t -98.77 -15.29 7.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 O-C-N 121.012 -1.287 . . . . 0.0 109.669 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.517 ' NE2' ' HB2' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -108.64 8.23 26.92 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 120.815 -1.178 . . . . 0.0 111.131 -178.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 99' ' ' THR . 16.8 mttt -163.72 63.39 0.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.517 -1.365 . . . . 0.0 109.472 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.924 HG22 ' H ' ' A' ' 101' ' ' THR . 1.1 m 160.41 -44.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 71.51 13.52 6.42 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.803 -1.186 . . . . 0.0 110.834 178.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.924 ' H ' HG22 ' A' ' 99' ' ' THR . 4.5 t -79.67 -8.49 59.25 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.586 ' CB ' HG22 ' A' ' 96' ' ' VAL . 7.7 mm -83.14 74.11 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.71 32.72 2.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 0.0 109.757 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 107' ' ' ASP . 13.2 p -159.28 132.09 6.88 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.03 -1.044 . . . . 0.0 109.797 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.94 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -48.65 -36.43 15.92 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.457 ' O ' ' OD1' ' A' ' 110' ' ' ASP . 22.7 t -58.1 -34.1 69.83 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 111' ' ' VAL . 0.3 OUTLIER -66.67 -49.7 65.3 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 178.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.94 HD12 ' HA ' ' A' ' 105' ' ' ALA . 24.5 mt -50.02 -26.71 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.253 -0.904 . . . . 0.0 108.623 179.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.403 ' O ' ' C ' ' A' ' 110' ' ' ASP . 0.9 OUTLIER -71.5 -64.65 0.88 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.476 -0.765 . . . . 0.0 109.614 -179.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.522 ' HA ' HD12 ' A' ' 113' ' ' ILE . 0.0 OUTLIER -43.62 -42.27 5.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.33 -0.856 . . . . 0.0 110.195 -179.356 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 107' ' ' ASP . 1.4 t -67.78 -40.16 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.794 -1.191 . . . . 0.0 109.452 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -68.35 -37.66 80.7 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.227 -0.92 . . . . 0.0 109.578 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.522 HD12 ' HA ' ' A' ' 110' ' ' ASP . 15.7 mt -68.4 -23.51 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.0 108.99 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -63.68 -17.58 63.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.371 -0.831 . . . . 0.0 109.454 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.669 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -95.51 12.83 28.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.211 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 77.67 8.23 87.21 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.669 HG12 ' HB3' ' A' ' 115' ' ' ALA . 3.9 mm -89.0 62.08 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.376 -1.073 . . . . 0.0 109.653 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.492 ' C ' ' O ' ' A' ' 117' ' ' ILE . 1.7 tptp -33.35 140.85 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.342 -0.849 . . . . 0.0 110.374 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -50.47 -23.76 6.69 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -63.07 -49.07 75.97 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.267 . . . . 0.0 109.593 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -76.23 -38.21 56.7 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.622 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.855 ' CE2' HG11 ' A' ' 78' ' ' VAL . 1.9 t80 -64.54 -50.66 66.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.247 -0.908 . . . . 0.0 109.299 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -64.16 -48.39 76.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.158 -0.964 . . . . 0.0 109.093 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -50.97 -53.3 34.29 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.328 -0.857 . . . . 0.0 108.875 179.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.84 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -49.86 -52.66 31.0 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.484 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 8.7 t90 -52.28 -59.78 3.99 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -52.31 -16.75 0.91 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.615 -0.678 . . . . 0.0 110.038 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 1.2 m -72.2 -178.56 2.51 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.904 -1.123 . . . . 0.0 109.6 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 2.8 m-30 -90.08 -35.29 15.54 Favored 'General case' 0 C--N 1.293 -1.874 0 O-C-N 121.888 -0.507 . . . . 0.0 110.424 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.8 t -68.43 -45.63 81.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 C-N-CA 118.198 -1.401 . . . . 0.0 109.586 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.84 HG21 ' HB1' ' A' ' 125' ' ' ALA . 3.6 t -71.75 -35.62 55.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.958 -1.089 . . . . 0.0 108.632 179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -69.97 -38.47 76.07 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.381 -0.824 . . . . 0.0 108.926 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.1 m -65.72 -29.89 70.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.341 -0.85 . . . . 0.0 108.977 179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.466 HD22 ' HA ' ' A' ' 77' ' ' ALA . 0.2 OUTLIER -79.59 -21.97 44.31 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.309 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.496 HG23 ' HB1' ' A' ' 77' ' ' ALA . 6.0 t -75.77 -45.59 37.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -63.78 -37.76 88.58 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -62.45 -38.26 89.1 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.63 HE22 ' HB2' ' A' ' 77' ' ' ALA . 4.8 mt-30 -62.2 -64.39 0.95 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.428 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 4.5 tm-20 -48.18 -31.05 5.23 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.424 ' O ' ' CG ' ' A' ' 144' ' ' ASP . 0.0 OUTLIER -73.41 -33.29 64.89 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.197 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -63.8 -63.01 1.28 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 108.886 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.528 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -62.1 -35.39 78.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.359 -0.838 . . . . 0.0 109.745 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.428 ' CB ' ' O ' ' A' ' 139' ' ' GLU . . . -77.19 -16.64 59.01 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 0.0 109.719 -179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.73 ' HB3' HG21 ' A' ' 16' ' ' VAL . 9.4 m-20 -79.94 -44.28 20.62 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.098 -1.001 . . . . 0.0 108.725 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.6 HG21 ' HE2' ' A' ' 25' ' ' PHE . 16.0 m -105.78 -5.2 9.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.372 -0.83 . . . . 0.0 109.004 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.546 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 81.32 -47.16 0.23 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.482 -0.761 . . . . 0.0 109.773 -179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.785 HD13 ' CD2' ' A' ' 25' ' ' PHE . 17.2 tp 66.29 132.74 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.403 -0.811 . . . . 0.0 109.295 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.511 ' O ' ' CD ' ' A' ' 148' ' ' ARG . 6.3 tmm_? -160.79 38.42 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.59 -1.319 . . . . 0.0 109.94 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 163.46 108.0 0.21 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.377 -1.392 . . . . 0.0 110.251 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 1.039 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -93.32 141.8 24.44 Favored Pre-proline 0 N--CA 1.495 1.817 0 O-C-N 121.404 -1.057 . . . . 0.0 109.573 179.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.489 ' HD3' ' CE1' ' A' ' 32' ' ' HIS . 35.7 Cg_endo -78.42 150.39 87.87 Favored 'Cis proline' 0 C--N 1.316 -1.176 0 C-N-CA 123.858 -1.309 . . . . 0.0 110.312 0.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.712 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -122.83 148.33 45.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.169 -1.582 . . . . 0.0 108.456 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.0 OUTLIER -135.47 130.65 35.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.969 -1.082 . . . . 0.0 110.053 -179.08 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.555 ' CD2' ' HB3' ' A' ' 160' ' ' GLN . 29.6 m-85 -129.58 127.75 41.32 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.279 -0.888 . . . . 0.0 110.087 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.649 HG22 ' O ' ' A' ' 21' ' ' GLN . 34.8 t -97.07 125.82 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.103 -0.998 . . . . 0.0 109.431 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.719 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 21.5 t-20 52.54 22.69 2.25 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.905 -0.718 . . . . 0.0 109.194 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 54.34 39.18 64.14 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.315 -1.422 . . . . 0.0 109.639 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.409 ' O ' HD12 ' A' ' 12' ' ' LEU . 3.0 tttp -142.95 -32.85 0.47 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.313 -1.11 . . . . 0.0 108.279 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.573 ' CD2' ' HD2' ' A' ' 188' ' ' LYS . 31.4 m-85 -116.34 125.42 52.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 108.644 179.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.555 ' HB3' ' CD2' ' A' ' 154' ' ' PHE . 6.3 pt20 -122.5 120.18 33.11 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.058 -1.026 . . . . 0.0 109.895 -179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' A' ' 9' ' ' TYR . 25.5 mt -62.47 -179.6 0.26 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 15.3 t30 -159.86 70.21 3.13 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.126 -0.984 . . . . 0.0 109.388 179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.37 -22.28 11.05 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.78 2.32 . . . . 0.0 110.547 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.434 ' O ' ' C ' ' A' ' 165' ' ' GLY . 0.5 OUTLIER 57.22 16.5 3.07 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.275 -0.891 . . . . 0.0 109.418 -179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 164' ' ' GLN . . . 43.37 36.24 3.01 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.89 42.51 1.4 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.25 -1.147 . . . . 0.0 109.825 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 174' ' ' PHE . 10.8 t0 -136.04 37.74 2.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.197 -0.939 . . . . 0.0 109.88 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 69.7 p -77.7 -8.5 58.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.898 -1.126 . . . . 0.0 109.612 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.2 t -84.27 -17.35 39.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.309 -0.869 . . . . 0.0 109.381 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -148.35 67.08 1.07 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.053 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -15.64 14.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.37 -0.831 . . . . 0.0 110.038 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -69.44 -48.05 62.1 Favored 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.605 -0.685 . . . . 0.0 109.814 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.457 HG12 ' OE1' ' A' ' 177' ' ' GLN . 4.9 t -73.16 -26.55 22.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.148 -0.97 . . . . 0.0 109.619 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.448 ' HB2' ' OD2' ' A' ' 167' ' ' ASP . 6.7 t80 -71.53 -44.43 64.64 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.033 -1.042 . . . . 0.0 109.582 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.576 HG22 HG12 ' A' ' 42' ' ' ILE . 86.9 t -71.55 -26.1 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.112 -0.993 . . . . 0.0 109.21 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.57 -56.61 3.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.954 . . . . 0.0 109.473 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.457 ' OE1' HG12 ' A' ' 173' ' ' VAL . 18.2 pt20 -60.08 -35.67 75.69 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.131 -0.981 . . . . 0.0 108.983 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.553 ' CE1' ' CG2' ' A' ' 182' ' ' VAL . 4.0 t80 -66.55 -51.81 52.47 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.318 -0.864 . . . . 0.0 109.073 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.1 -26.54 27.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.234 -0.916 . . . . 0.0 108.917 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.66 -37.99 40.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.903 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -62.63 -40.77 98.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.247 -0.908 . . . . 0.0 109.314 179.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.553 ' CG2' ' CE1' ' A' ' 178' ' ' TYR . 21.2 t -75.53 -34.8 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.033 -1.042 . . . . 0.0 109.19 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.1 tptp -58.7 -49.48 77.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.22 -0.925 . . . . 0.0 109.157 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.588 ' CE2' HD22 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -77.7 -40.25 41.96 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.28 -0.887 . . . . 0.0 108.716 179.613 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.903 HD23 ' O ' ' A' ' 181' ' ' THR . 3.8 mm? -53.6 -19.13 3.53 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.08 -1.012 . . . . 0.0 109.434 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 12.3 t -87.01 8.67 22.37 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 120.761 -1.212 . . . . 0.0 107.989 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 188' ' ' LYS . 0.8 OUTLIER -117.19 0.8 12.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.529 -0.732 . . . . 0.0 109.715 -179.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.573 ' HD2' ' CD2' ' A' ' 159' ' ' TYR . 0.0 OUTLIER -43.12 -58.07 2.63 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.176 -0.953 . . . . 0.0 109.097 -179.245 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.458 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.698 ' HB3' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.525 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER 40.74 49.52 2.83 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 121.838 0.827 . . . . 0.0 108.988 -179.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.576 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.7 OUTLIER 74.98 96.92 0.07 Allowed 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 -179.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.698 ' HB2' ' HB3' ' A' ' 1' ' ' ALA . 1.2 tt0 -130.03 60.38 1.6 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.113 -0.992 . . . . 0.0 110.201 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 4' ' ' GLU . 0.7 OUTLIER 70.02 94.63 0.07 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.427 -0.796 . . . . 0.0 110.538 178.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.517 ' HA2' ' ND2' ' A' ' 162' ' ' ASN . . . 79.71 5.45 89.39 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.577 ' O ' ' CB ' ' A' ' 8' ' ' GLN . 1.2 tttp -106.86 31.37 5.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -1.193 . . . . 0.0 108.91 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.711 ' O ' HD23 ' A' ' 161' ' ' LEU . 0.1 OUTLIER 147.8 -39.45 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 -179.374 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.571 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 1.3 p90 -157.96 124.51 4.85 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.086 -1.009 . . . . 0.0 109.352 179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.3 t -104.03 176.79 5.04 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -116.25 146.72 42.14 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.596 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.728 HD11 ' HB3' ' A' ' 160' ' ' GLN . 1.5 mp -98.52 160.95 13.94 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.363 -0.835 . . . . 0.0 109.703 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -89.99 -1.63 58.0 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.315 -0.866 . . . . 0.0 109.479 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.8 mttt -142.64 94.84 6.56 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.301 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.526 ' CB ' ' O ' ' A' ' 157' ' ' GLY . 35.6 Cg_endo -77.84 167.0 24.48 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.589 2.193 . . . . 0.0 110.517 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 144' ' ' ASP . 25.2 t -119.6 95.67 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.242 -0.911 . . . . 0.0 109.754 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.19 129.47 10.15 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.46 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 92.18 -18.74 53.15 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 -179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.599 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -38.54 157.84 0.1 Allowed Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.517 -0.99 . . . . 0.0 109.828 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.568 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 36.5 Cg_endo -79.85 133.56 10.26 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.573 2.182 . . . . 0.0 111.126 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.8 ' O ' HG13 ' A' ' 155' ' ' VAL . 9.6 mm-40 -41.16 -25.61 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.53 -0.731 . . . . 0.0 109.935 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.722 ' O ' HG12 ' A' ' 22' ' ' VAL . 5.1 t -147.98 80.41 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.007 -1.058 . . . . 0.0 109.022 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.649 ' CD1' ' CE1' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -74.23 120.71 20.17 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.532 ' HB3' ' HA ' ' A' ' 58' ' ' LYS . 0.3 OUTLIER -104.64 122.66 46.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.182 -0.948 . . . . 0.0 109.42 -179.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.876 ' HD2' HD13 ' A' ' 147' ' ' LEU . 2.9 m-30 -108.26 103.62 12.83 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.408 -0.808 . . . . 0.0 109.9 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -140.67 141.06 35.06 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.423 -0.798 . . . . 0.0 109.243 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.609 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 1.3 t -115.41 172.22 7.23 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.093 -1.005 . . . . 0.0 109.217 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.602 ' HB2' HD21 ' A' ' 72' ' ' LEU . 8.0 m-30 -89.71 43.67 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.748 ' HE1' HD22 ' A' ' 72' ' ' LEU . 22.2 m-85 -147.3 17.33 1.19 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.494 -0.754 . . . . 0.0 109.698 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.1 OUTLIER -113.68 165.96 12.34 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 120.756 -1.215 . . . . 0.0 109.622 -179.79 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD2' ' SG ' ' A' ' 30' ' ' CYS . 33.7 Cg_endo -75.95 -38.46 1.21 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.33 2.02 . . . . 0.0 108.183 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 1.8 m-70 -72.56 -28.16 62.65 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 28.8 t -44.57 -61.93 1.38 Allowed 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.81 0.814 . . . . 0.0 108.826 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.618 ' CG ' ' NE2' ' A' ' 97' ' ' GLN . 27.5 t80 -78.09 -40.09 39.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.885 -0.51 . . . . 0.0 110.55 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.518 ' NE2' HG11 ' A' ' 39' ' ' VAL . 3.4 mm-40 -64.52 -27.35 68.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.188 -0.945 . . . . 0.0 111.079 -178.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.475 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 3.9 m-30 -87.02 -34.36 19.25 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.806 -1.184 . . . . 0.0 111.212 -178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.14 -23.2 22.51 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.805 -1.184 . . . . 0.0 111.987 -178.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -136.34 28.14 3.09 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.344 -1.472 . . . . 0.0 111.612 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.518 HG11 ' NE2' ' A' ' 35' ' ' GLN . 53.3 t -150.98 -81.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.541 -1.349 . . . . 0.0 109.821 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.403 ' N ' HG12 ' A' ' 39' ' ' VAL . 17.9 mt -67.78 -12.52 60.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.804 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 39' ' ' VAL . 14.3 m-70 51.51 21.76 1.34 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.133 -0.979 . . . . 0.0 109.337 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.425 HD12 ' CE1' ' A' ' 36' ' ' PHE . 22.1 mt -65.32 -20.09 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 109.45 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.517 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -81.64 -41.43 21.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.757 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' A' ' 47' ' ' LYS . 7.4 p-10 -87.08 -45.14 10.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.995 . . . . 0.0 109.59 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -45.83 -31.48 2.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.241 -0.912 . . . . 0.0 109.866 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 43' ' ' SER . 8.4 m -74.26 -30.85 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.089 -1.007 . . . . 0.0 109.655 -179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 44' ' ' ASP . 8.6 mmmm -48.49 -39.62 23.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 0.0 109.223 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -58.45 -23.23 57.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.353 -0.842 . . . . 0.0 109.206 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.612 ' O ' HD23 ' A' ' 50' ' ' LEU . 6.4 mttm -93.31 23.31 4.53 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.401 -0.812 . . . . 0.0 109.78 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.682 HD22 ' CG1' ' A' ' 54' ' ' VAL . 18.8 mt -118.92 76.27 14.38 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.024 -1.047 . . . . 0.0 109.824 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.485 ' O ' ' O ' ' A' ' 52' ' ' GLU . 36.6 Cg_endo -78.69 63.34 8.53 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.417 2.078 . . . . 0.0 110.293 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.485 ' O ' ' O ' ' A' ' 51' ' ' PRO . 23.3 tp10 58.46 131.57 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.977 0 CA-C-O 121.448 0.642 . . . . 0.0 110.259 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.69 -18.35 44.12 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.682 ' CG1' HD22 ' A' ' 50' ' ' LEU . 2.4 t -95.89 89.36 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.082 -1.246 . . . . 0.0 109.193 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.97 96.79 2.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.412 -0.805 . . . . 0.0 109.846 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.497 ' HG2' HD13 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -92.18 100.75 13.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.516 -0.74 . . . . 0.0 109.272 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 4.2 m -98.61 119.18 36.9 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.864 -1.135 . . . . 0.0 110.581 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.532 ' HA ' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -97.63 108.53 21.27 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.466 -0.771 . . . . 0.0 109.654 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.517 ' CD1' ' HG3' ' A' ' 138' ' ' GLN . 3.0 m-85 -111.56 154.18 25.18 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.166 -0.959 . . . . 0.0 111.624 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.609 ' CD2' ' HA ' ' A' ' 27' ' ' SER . 18.2 t-80 -106.62 108.88 20.61 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.043 HG11 HD22 ' A' ' 147' ' ' LEU . 15.1 m -69.64 156.53 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.44 -0.787 . . . . 0.0 109.994 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.521 ' CB ' ' HA ' ' A' ' 70' ' ' LYS . 3.6 p30 -108.23 51.38 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.358 -0.839 . . . . 0.0 109.573 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.737 ' CE1' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -131.1 52.94 2.02 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.172 -0.955 . . . . 0.0 110.155 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.521 ' SD ' ' CB ' ' A' ' 29' ' ' PHE . 0.0 OUTLIER -134.02 38.79 3.16 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 155.32 -34.2 0.65 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.57 -34.86 2.88 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 120.2 -1.0 . . . . 0.0 110.757 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -87.27 -80.44 0.25 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.765 -1.432 . . . . 0.0 109.852 -179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.039 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -77.44 -23.79 50.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.794 -1.191 . . . . 0.0 108.723 179.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 1.039 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -48.18 -44.0 26.25 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.733 -1.747 . . . . 0.0 108.733 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.521 ' HA ' ' CB ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -64.58 -45.13 88.34 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.3 -1.117 . . . . 0.0 108.572 179.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.524 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 22.7 t0 -67.72 -28.7 67.88 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.748 HD22 ' HE1' ' A' ' 29' ' ' PHE . 13.1 tp -62.69 -44.37 96.41 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.474 HG23 ' CD ' ' A' ' 138' ' ' GLN . 2.5 m -60.46 -42.32 95.93 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 178.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 1.009 ' O ' HG23 ' A' ' 78' ' ' VAL . 8.4 tt0 -59.7 -21.17 60.24 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 177.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -68.62 -43.52 76.2 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.503 ' CD1' ' OE1' ' A' ' 138' ' ' GLN . 69.7 t-105 -60.45 -32.13 71.09 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.683 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -79.89 -55.41 4.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.549 -0.719 . . . . 0.0 109.876 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.025 HG11 ' CE2' ' A' ' 122' ' ' TYR . 2.8 t -57.7 -28.29 31.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.145 -0.972 . . . . 0.0 109.96 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.581 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -79.54 -59.04 2.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.883 -1.136 . . . . 0.0 108.564 179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.408 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -46.19 -29.52 1.61 Allowed 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.121 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.812 ' CB ' HG22 ' A' ' 131' ' ' VAL . . . -68.35 -44.6 74.93 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.383 -0.823 . . . . 0.0 109.391 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.792 ' HB2' HG13 ' A' ' 84' ' ' VAL . 7.7 mt -104.68 13.35 31.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.189 -0.944 . . . . 0.0 110.026 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 47.39 27.51 4.12 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.792 HG13 ' HB2' ' A' ' 82' ' ' LEU . 33.1 m -85.28 -9.15 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.314 -1.109 . . . . 0.0 110.415 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.463 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.3 OUTLIER -41.31 -60.49 1.25 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.17 -0.956 . . . . 0.0 109.784 -179.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -45.16 -33.46 2.26 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.365 -0.835 . . . . 0.0 110.041 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 84' ' ' VAL . 0.1 OUTLIER -83.82 -49.83 8.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.329 -0.857 . . . . 0.0 111.411 -178.517 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.781 HG23 HD12 ' A' ' 92' ' ' LEU . 1.2 m -87.06 -4.72 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.775 -1.203 . . . . 0.0 110.504 -178.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.66 HG23 ' CE1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -77.41 -44.17 30.08 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.811 -1.181 . . . . 0.0 108.508 178.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.438 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -51.46 -52.72 57.18 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.634 -1.291 . . . . 0.0 110.334 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.605 ' HB2' HG13 ' A' ' 111' ' ' VAL . 27.2 Cg_endo -74.04 -17.63 22.0 Favored 'Trans proline' 0 C--N 1.302 -1.907 0 N-CA-C 109.847 -0.866 . . . . 0.0 109.847 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.041 ' O ' HG23 ' A' ' 96' ' ' VAL . 12.7 mt -86.84 -42.49 13.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.276 -0.89 . . . . 0.0 108.956 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.66 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.4 m-30 -69.88 -46.73 64.84 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.877 -1.139 . . . . 0.0 108.472 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 90' ' ' VAL . 1.0 OUTLIER -72.77 -27.75 62.19 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.194 -0.941 . . . . 0.0 108.975 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.456 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -70.1 -29.09 70.81 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 109.053 -1.619 . . . . 0.0 109.053 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 1.041 HG23 ' O ' ' A' ' 92' ' ' LEU . 1.6 t -103.8 1.38 10.41 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.194 -1.18 . . . . 0.0 108.917 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.618 ' NE2' ' CG ' ' A' ' 34' ' ' TYR . 0.2 OUTLIER -107.54 10.75 29.19 Favored 'General case' 0 C--N 1.309 -1.162 0 O-C-N 120.975 -1.078 . . . . 0.0 110.763 -179.15 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -178.62 -51.82 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.576 -1.327 . . . . 0.0 110.423 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.476 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 68.6 p -59.79 -40.84 89.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.48 -1.388 . . . . 0.0 109.507 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.48 ' O ' ' HD2' ' A' ' 103' ' ' ARG . 0.0 OUTLIER 67.49 9.9 7.36 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.372 -0.83 . . . . 0.0 109.783 -179.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 t -81.15 -7.85 59.64 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 121.827 0.822 . . . . 0.0 109.044 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.464 HG23 ' OD1' ' A' ' 107' ' ' ASP . 8.8 mm -85.4 80.74 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.48 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -145.05 34.51 1.1 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.39 -0.819 . . . . 0.0 109.699 -179.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 107' ' ' ASP . 83.4 p -164.96 136.28 4.13 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.893 -1.13 . . . . 0.0 110.269 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.881 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.22 -38.65 27.13 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 8.1 t -56.75 -32.5 65.65 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -70.0 -53.39 17.88 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.881 HD12 ' HA ' ' A' ' 105' ' ' ALA . 25.5 mt -45.68 -28.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.173 -0.955 . . . . 0.0 108.771 179.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.79 -46.34 31.21 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 109.565 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.472 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 1.2 p30 -53.14 -41.8 65.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.098 -1.001 . . . . 0.0 109.606 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.835 HG11 ' HG ' ' A' ' 92' ' ' LEU . 13.6 t -71.49 -38.39 67.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.96 -1.088 . . . . 0.0 109.51 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.522 ' HE1' HG21 ' A' ' 84' ' ' VAL . 0.4 OUTLIER -65.79 -54.71 23.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.937 -179.943 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 14.3 mt -61.67 -24.02 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.131 -0.981 . . . . 0.0 109.709 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.1 t30 -72.4 -16.64 61.84 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.155 -0.966 . . . . 0.0 109.45 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.434 ' HB2' HG12 ' A' ' 88' ' ' VAL . . . -94.6 8.08 43.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.351 -0.843 . . . . 0.0 109.77 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 91.44 -3.3 79.0 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.836 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.4 mp -85.54 60.73 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -1.129 . . . . 0.0 109.114 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.472 ' C ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -37.28 157.55 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.828 -1.17 . . . . 0.0 110.239 -179.456 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -62.42 -23.57 64.78 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -63.47 -52.01 63.2 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.982 -1.305 . . . . 0.0 109.337 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -75.5 -36.82 60.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.934 . . . . 0.0 109.331 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 1.025 ' CE2' HG11 ' A' ' 78' ' ' VAL . 3.2 t80 -62.78 -48.51 78.84 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.247 -0.908 . . . . 0.0 109.005 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -62.12 -36.88 83.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.18 -0.95 . . . . 0.0 108.75 179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.466 ' O ' ' OG ' ' A' ' 128' ' ' SER . . . -63.24 -49.76 72.88 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 108.92 179.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.528 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -52.54 -50.72 62.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.002 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.465 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 3.1 t90 -60.18 -55.53 32.73 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -52.66 -16.47 0.96 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.547 -0.721 . . . . 0.0 110.015 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 124' ' ' ALA . 0.9 OUTLIER -73.54 176.8 5.8 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.965 -1.084 . . . . 0.0 109.383 -179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.428 ' O ' ' N ' ' A' ' 133' ' ' SER . 60.4 m-85 -91.94 -37.94 12.57 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.63 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.9 t -65.21 -47.14 88.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 C-N-CA 118.056 -1.458 . . . . 0.0 109.266 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.812 HG22 ' CB ' ' A' ' 81' ' ' ALA . 3.7 t -64.03 -39.44 85.46 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.057 -1.027 . . . . 0.0 108.344 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.2 OUTLIER -71.19 -27.63 63.65 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.835 . . . . 0.0 108.915 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.428 ' N ' ' O ' ' A' ' 129' ' ' PHE . 0.2 OUTLIER -66.42 -41.82 88.67 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.281 -0.887 . . . . 0.0 109.151 179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.45 -18.17 55.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 108.699 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.683 HG23 ' HB1' ' A' ' 77' ' ' ALA . 3.9 t -75.54 -40.36 41.15 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 108.058 -1.089 . . . . 0.0 108.058 179.428 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -71.81 -39.69 69.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.04 -30.3 70.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.09 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.517 ' HG3' ' CD1' ' A' ' 59' ' ' TYR . 2.8 tt0 -71.17 -64.71 0.86 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.33 -0.857 . . . . 0.0 109.075 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 0.6 OUTLIER -50.09 -33.43 18.6 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 108.475 179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 26.4 mttt -76.71 -29.91 56.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.414 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -57.27 -53.99 51.82 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.309 -0.87 . . . . 0.0 108.763 179.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -72.03 -40.53 68.35 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.366 -0.834 . . . . 0.0 110.495 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -72.55 -16.93 61.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.991 -1.068 . . . . 0.0 109.939 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.534 ' HB3' HG21 ' A' ' 16' ' ' VAL . 2.4 m-20 -84.71 -43.21 14.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 108.553 179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.562 ' O ' ' CB ' ' A' ' 146' ' ' GLN . 4.5 m -93.42 -12.09 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.562 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 1.0 OUTLIER 82.33 -43.79 0.14 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.65 -0.657 . . . . 0.0 109.513 -179.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 1.043 HD22 HG11 ' A' ' 61' ' ' VAL . 33.7 tp 62.9 139.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.426 -0.797 . . . . 0.0 109.939 179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.501 ' O ' ' CD ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER -161.22 38.73 0.14 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.764 -1.21 . . . . 0.0 109.563 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 160.42 109.93 0.26 Allowed Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.438 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -99.37 140.59 21.76 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.35 -1.088 . . . . 0.0 108.743 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.76 150.87 87.65 Favored 'Cis proline' 0 C--N 1.313 -1.312 0 C-N-CA 123.993 -1.253 . . . . 0.0 110.396 0.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.614 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -123.63 160.19 27.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.442 -1.411 . . . . 0.0 109.051 179.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 160' ' ' GLN . 0.6 OUTLIER -144.7 129.11 17.92 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.074 -1.016 . . . . 0.0 109.871 -179.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 154' ' ' PHE . 8.9 m-85 -131.64 134.18 45.71 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.372 -0.83 . . . . 0.0 109.993 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 21' ' ' GLN . 53.7 t -105.56 133.16 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.207 -0.933 . . . . 0.0 109.912 179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.599 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.7 OUTLIER 45.5 22.21 0.09 Allowed 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.201 179.824 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.594 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 56.92 57.56 19.08 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -168.88 -34.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.234 -1.156 . . . . 0.0 108.454 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.468 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 51.6 m-85 -117.89 125.09 49.84 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.815 . . . . 0.0 108.971 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.728 ' HB3' HD11 ' A' ' 12' ' ' LEU . 20.9 pt20 -123.74 130.5 52.73 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 120.78 -1.2 . . . . 0.0 109.82 -179.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.711 HD23 ' O ' ' A' ' 8' ' ' GLN . 0.8 OUTLIER -73.14 172.75 10.5 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.694 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.517 ' ND2' ' HA2' ' A' ' 6' ' ' GLY . 5.6 p30 -151.95 147.12 19.37 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.089 -1.007 . . . . 0.0 109.482 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.43 39.66 0.88 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.672 2.248 . . . . 0.0 110.776 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 164' ' ' GLN . 1.1 tp60 -85.19 -20.91 29.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.987 -1.071 . . . . 0.0 109.547 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -100.16 37.48 3.54 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.473 ' O ' ' CG ' ' A' ' 166' ' ' MET . 9.3 ttt -123.91 34.54 5.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.309 -1.112 . . . . 0.0 109.578 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -133.47 37.52 3.32 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.972 . . . . 0.0 109.783 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.456 ' O ' ' CB ' ' A' ' 169' ' ' SER . 62.0 p -121.01 0.17 10.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.979 -1.075 . . . . 0.0 109.657 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.456 ' CB ' ' O ' ' A' ' 168' ' ' THR . 1.2 t 72.36 58.79 0.13 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.224 -0.923 . . . . 0.0 109.359 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.453 ' O ' ' CG ' ' A' ' 174' ' ' PHE . 1.7 m-20 -159.68 72.27 0.52 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.356 -0.84 . . . . 0.0 109.4 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.469 ' O ' HG23 ' A' ' 175' ' ' VAL . 4.3 mtt -59.62 -16.66 27.52 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.533 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -75.32 -62.42 1.57 Allowed 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 2.7 t -55.86 -26.82 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.248 -0.908 . . . . 0.0 108.601 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 174' ' ' PHE . 7.0 m-30 -69.26 -38.13 78.25 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.195 -0.941 . . . . 0.0 108.962 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 171' ' ' MET . 77.6 t -73.78 -24.97 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 109.229 179.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -83.14 -60.4 2.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.301 -0.874 . . . . 0.0 109.226 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -37.86 61.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.22 -0.925 . . . . 0.0 109.167 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.493 ' HB2' ' O ' ' A' ' 174' ' ' PHE . 16.5 t80 -69.58 -44.4 70.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.342 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 49' ' ' LYS . . . -65.31 -29.06 69.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.247 -0.908 . . . . 0.0 109.076 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.19 -37.95 60.98 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.1 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.647 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -64.05 -44.27 92.97 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.23 -0.919 . . . . 0.0 108.948 179.404 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.488 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 55.7 t -69.77 -38.62 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.176 -0.953 . . . . 0.0 109.186 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.83 -55.13 38.89 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.126 -0.984 . . . . 0.0 109.385 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.465 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -75.92 -26.4 56.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.219 -0.926 . . . . 0.0 109.146 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.647 HD23 ' O ' ' A' ' 181' ' ' THR . 0.3 OUTLIER -64.63 -18.86 65.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.965 -1.085 . . . . 0.0 109.267 -179.654 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 59.6 p -80.15 0.39 32.46 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.948 -1.095 . . . . 0.0 108.519 178.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.64 -75.86 0.58 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.447 -0.783 . . . . 0.0 109.264 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.476 ' O ' ' HG2' ' A' ' 189' ' ' LYS . 2.3 mmmp? 54.73 19.51 2.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.365 -0.835 . . . . 0.0 109.485 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 188' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.499 2.001 0 CA-C-O 118.032 -0.985 . . . . 0.0 110.479 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.8 64.83 1.47 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.265 -0.897 . . . . 0.0 109.379 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.8 OUTLIER 52.05 86.05 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.363 -0.835 . . . . 0.0 109.051 -179.999 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.448 ' O ' ' C ' ' A' ' 5' ' ' ASP . 5.4 mt-10 -99.65 54.87 0.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.217 -0.927 . . . . 0.0 109.81 -179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.448 ' C ' ' O ' ' A' ' 4' ' ' GLU . 4.2 p-10 39.86 80.08 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.284 0.564 . . . . 0.0 110.036 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 127.81 -26.4 4.83 Favored Glycine 0 N--CA 1.493 2.449 0 C-N-CA 119.785 -1.198 . . . . 0.0 110.662 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 5.0 tttm -80.98 -68.53 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.844 -1.386 . . . . 0.0 109.289 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.472 ' O ' ' HB3' ' A' ' 9' ' ' TYR . 11.9 mp0 -93.52 4.36 54.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.23 -0.919 . . . . 0.0 109.427 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 3' ' ' TYR . 3.4 p90 179.1 131.68 0.08 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.169 -0.957 . . . . 0.0 109.35 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.513 HG23 ' HG3' ' A' ' 160' ' ' GLN . 8.7 t -119.65 175.83 5.67 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.661 -0.649 . . . . 0.0 109.26 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.59 157.59 15.83 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.686 -0.634 . . . . 0.0 109.617 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.475 ' HG ' ' HG2' ' A' ' 160' ' ' GLN . 7.4 mt -96.16 158.19 15.55 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.355 -0.84 . . . . 0.0 109.445 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -84.02 -12.06 55.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.219 -0.926 . . . . 0.0 109.096 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -151.82 104.74 2.85 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.311 -0.868 . . . . 0.0 109.1 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.36 166.87 26.78 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.449 2.099 . . . . 0.0 110.679 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.706 HG21 ' OD1' ' A' ' 144' ' ' ASP . 10.2 t -132.14 89.87 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.336 -0.852 . . . . 0.0 109.649 -179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -45.24 131.14 8.02 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 179.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 92.49 -19.7 48.92 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.739 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -40.29 163.24 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.563 -0.963 . . . . 0.0 109.917 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.633 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 35.0 Cg_endo -77.41 125.81 7.94 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.61 2.207 . . . . 0.0 111.047 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.593 ' O ' HG13 ' A' ' 155' ' ' VAL . 5.3 mm100 -40.07 -24.99 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.523 -0.736 . . . . 0.0 110.012 179.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.789 ' O ' HG12 ' A' ' 22' ' ' VAL . 2.7 t -146.1 81.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 121.168 -0.958 . . . . 0.0 108.772 179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.753 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -75.34 124.97 28.04 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.515 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.2 OUTLIER -107.95 133.92 51.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.083 -1.011 . . . . 0.0 110.234 -179.027 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.071 ' CE2' HG21 ' A' ' 145' ' ' VAL . 7.5 m-85 -123.55 100.74 6.95 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -150.76 140.29 21.55 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.048 -1.033 . . . . 0.0 110.458 -178.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.53 ' HB3' HG22 ' A' ' 61' ' ' VAL . 1.3 p -115.15 177.44 4.65 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.345 -0.847 . . . . 0.0 109.123 179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.695 ' CD2' HD21 ' A' ' 72' ' ' LEU . 8.4 m-30 -94.04 41.73 1.09 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.958 ' CE2' HD12 ' A' ' 72' ' ' LEU . 9.9 m-85 -130.96 14.52 5.25 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.351 -0.843 . . . . 0.0 110.175 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 33' ' ' CYS . 0.6 OUTLIER -110.5 158.46 35.36 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 120.706 -1.246 . . . . 0.0 109.554 179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.505 ' HG2' ' CD2' ' A' ' 32' ' ' HIS . 33.8 Cg_endo -75.05 -38.38 1.59 Allowed 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.189 1.926 . . . . 0.0 108.037 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.505 ' CD2' ' HG2' ' A' ' 31' ' ' PRO . 27.1 m-70 -76.06 -21.13 57.1 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 177.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 30' ' ' CYS . 52.1 t -47.49 -65.1 0.62 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.574 ' HB2' ' CG ' ' A' ' 97' ' ' GLN . 7.3 t80 -60.66 -43.01 98.15 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.221 0.534 . . . . 0.0 110.037 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.477 ' HB2' ' HA ' ' A' ' 32' ' ' HIS . 1.8 mt-30 -60.92 -22.98 64.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.194 -0.941 . . . . 0.0 109.976 -179.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -82.9 -36.85 24.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.163 -0.961 . . . . 0.0 110.369 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.524 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 0.0 OUTLIER -106.29 47.99 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.959 -1.088 . . . . 0.0 109.938 -179.327 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -171.62 -52.23 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.223 -0.923 . . . . 0.0 111.902 179.691 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.0 t -89.28 -83.85 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.463 -1.398 . . . . 0.0 112.204 -177.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.72 -10.48 59.83 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.973 -1.079 . . . . 0.0 110.765 -177.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 6.9 m-70 55.66 33.7 21.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.143 -0.973 . . . . 0.0 109.36 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.6 mm -48.58 -22.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.228 -0.92 . . . . 0.0 109.913 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.433 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.6 OUTLIER -82.97 -41.57 18.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.2 -0.937 . . . . 0.0 110.341 -179.423 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -86.15 -38.32 17.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.063 -1.023 . . . . 0.0 110.149 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -46.67 -33.79 4.55 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.097 -1.002 . . . . 0.0 109.907 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 43' ' ' SER . 32.1 m -80.19 -26.52 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.013 -1.055 . . . . 0.0 110.338 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.909 ' HA ' HD12 ' A' ' 50' ' ' LEU . 2.1 mmtp -63.07 -40.78 98.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.898 -1.126 . . . . 0.0 109.737 -179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -50.04 -27.75 6.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.16 -0.963 . . . . 0.0 109.23 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.513 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 11.5 mttt -117.1 40.46 3.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.428 -0.795 . . . . 0.0 109.73 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.909 HD12 ' HA ' ' A' ' 47' ' ' LYS . 11.4 mt -113.27 88.62 12.98 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 0.0 109.351 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.652 ' HD2' HG21 ' A' ' 54' ' ' VAL . 35.8 Cg_endo -77.67 143.09 21.01 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.76 2.307 . . . . 0.0 110.528 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 51' ' ' PRO . 1.6 tm-20 -40.14 121.6 1.37 Allowed 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 122.361 1.077 . . . . 0.0 109.562 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.95 -30.92 3.44 Favored Glycine 0 C--N 1.286 -2.2 0 N-CA-C 108.43 -1.868 . . . . 0.0 108.43 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.652 HG21 ' HD2' ' A' ' 51' ' ' PRO . 2.6 t -86.35 82.91 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.389 -1.065 . . . . 0.0 108.536 179.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -66.47 96.76 0.39 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.425 -0.797 . . . . 0.0 110.172 -179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.482 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -90.68 94.22 9.59 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.372 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 31.5 m -94.66 135.39 36.19 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.916 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.515 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -115.25 115.03 26.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.313 -0.867 . . . . 0.0 109.714 -179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.5 ' OH ' ' CG ' ' A' ' 137' ' ' GLN . 2.2 m-85 -112.58 166.46 11.31 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.071 -1.018 . . . . 0.0 111.631 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.949 ' CE1' HD22 ' A' ' 72' ' ' LEU . 2.1 t60 -108.86 125.66 52.22 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-O 121.734 0.778 . . . . 0.0 109.816 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.781 HG11 ' CG1' ' A' ' 150' ' ' VAL . 1.9 m -73.28 157.22 6.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 O-C-N 121.732 -0.605 . . . . 0.0 109.907 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -121.99 28.21 7.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.324 -0.86 . . . . 0.0 109.131 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.596 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 11.6 p90 -121.22 67.61 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.132 -0.98 . . . . 0.0 110.052 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.592 ' HG3' ' N ' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -160.12 -59.1 0.06 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.396 -0.815 . . . . 0.0 109.222 178.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.592 ' N ' ' HG3' ' A' ' 64' ' ' MET . . . -96.21 78.03 0.76 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 108.334 -1.906 . . . . 0.0 108.334 178.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -36.67 -40.92 0.51 Allowed Glycine 0 N--CA 1.492 2.423 0 O-C-N 121.552 -0.969 . . . . 0.0 110.925 -178.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.4 -79.23 0.31 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.909 -1.348 . . . . 0.0 110.64 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.919 HD23 HD11 ' A' ' 108' ' ' ILE . 0.0 OUTLIER -80.13 -20.78 44.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.0 -1.062 . . . . 0.0 110.219 -179.145 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.627 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -51.95 -47.1 54.8 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 108.165 -1.974 . . . . 0.0 108.165 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -46.55 88.25 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.469 -1.018 . . . . 0.0 108.316 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.558 ' HB3' HD12 ' A' ' 108' ' ' ILE . 0.3 OUTLIER -62.27 -26.04 68.18 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.958 HD12 ' CE2' ' A' ' 29' ' ' PHE . 0.9 OUTLIER -63.54 -37.4 87.16 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.428 HG21 ' OE1' ' A' ' 138' ' ' GLN . 5.9 m -65.01 -42.43 94.46 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.559 ' NE2' ' CG ' ' A' ' 126' ' ' TRP . 37.7 tt0 -61.59 -19.28 62.02 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.789 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -67.82 -43.0 80.65 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.488 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 22.8 t-105 -63.69 -31.95 73.28 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.538 -0.865 . . . . 0.0 108.846 179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.479 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -79.87 -56.67 4.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.225 -0.922 . . . . 0.0 109.919 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.757 HG21 ' CE1' ' A' ' 122' ' ' TYR . 45.8 t -58.18 -27.03 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 0.0 110.015 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.593 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -82.16 -64.08 1.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.884 -1.135 . . . . 0.0 108.9 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.475 ' HB3' HD22 ' A' ' 134' ' ' LEU . 0.1 OUTLIER -46.85 -27.55 1.27 Allowed 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.117 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.58 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -66.15 -49.51 67.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.48 -0.763 . . . . 0.0 109.837 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.686 ' HB2' HG13 ' A' ' 84' ' ' VAL . 7.1 mt -101.64 9.73 40.82 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.072 -1.017 . . . . 0.0 110.369 -179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.407 ' HA2' ' OE2' ' A' ' 85' ' ' GLU . . . 56.13 29.37 55.88 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.686 HG13 ' HB2' ' A' ' 82' ' ' LEU . 28.4 m -87.79 -0.08 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.34 -1.094 . . . . 0.0 110.054 -179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.477 ' O ' ' HB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -44.74 -66.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.054 -1.029 . . . . 0.0 109.396 -179.926 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -42.85 -33.67 0.81 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -0.883 . . . . 0.0 110.082 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.8 mttm -79.48 -53.96 6.37 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.349 -0.844 . . . . 0.0 111.106 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.803 HG23 HD12 ' A' ' 92' ' ' LEU . 2.1 m -89.02 -10.45 10.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.719 -1.238 . . . . 0.0 111.226 -178.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.881 HG23 ' CD1' ' A' ' 93' ' ' PHE . 1.1 m -72.98 -42.9 62.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.57 -1.331 . . . . 0.0 108.795 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.402 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.2 t -58.1 -53.26 67.79 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 120.489 -1.382 . . . . 0.0 111.116 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.446 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 24.8 Cg_endo -72.66 -23.51 19.51 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 N-CA-C 110.087 -0.774 . . . . 0.0 110.087 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.838 ' HG ' HG11 ' A' ' 111' ' ' VAL . 79.4 mt -85.14 -42.99 14.25 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -0.963 . . . . 0.0 108.862 178.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.881 ' CD1' HG23 ' A' ' 89' ' ' THR . 3.2 m-85 -62.56 -43.5 98.67 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.083 -1.01 . . . . 0.0 108.55 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -80.85 -16.67 53.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.405 -0.81 . . . . 0.0 109.82 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' HA2' ' OG1' ' A' ' 99' ' ' THR . . . -77.79 -34.82 37.55 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.2 t -95.58 -24.9 4.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.293 0 O-C-N 121.168 -1.196 . . . . 0.0 109.146 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.574 ' CG ' ' HB2' ' A' ' 34' ' ' TYR . 4.4 mp0 -102.38 5.07 39.57 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.016 -1.052 . . . . 0.0 110.622 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.803 ' O ' HG23 ' A' ' 99' ' ' THR . 0.3 OUTLIER -161.58 61.96 0.26 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.653 -1.28 . . . . 0.0 109.625 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.2 OUTLIER 165.44 -50.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.492 -0.755 . . . . 0.0 109.358 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.0 OUTLIER 75.23 19.62 2.21 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.183 -0.948 . . . . 0.0 110.382 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 40.3 p -90.0 -6.89 55.14 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.658 0.742 . . . . 0.0 109.706 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.756 HG23 ' OD1' ' A' ' 107' ' ' ASP . 9.5 mm -84.77 81.57 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 O-C-N 121.568 -0.708 . . . . 0.0 109.574 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.491 ' HD2' ' O ' ' A' ' 100' ' ' GLN . 0.0 OUTLIER -135.32 36.88 2.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 110.052 -179.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.564 ' O ' ' N ' ' A' ' 107' ' ' ASP . 83.6 p -166.01 132.2 2.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.854 -1.154 . . . . 0.0 110.499 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.57 ' N ' ' CB ' ' A' ' 68' ' ' LEU . . . -50.79 -27.83 8.07 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.41 -32.04 73.49 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.756 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.5 OUTLIER -70.76 -50.77 32.46 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.063 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.919 HD11 HD23 ' A' ' 68' ' ' LEU . 32.2 mt -54.25 -27.6 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 108.598 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 mtt-85 -76.25 -32.49 58.89 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.499 -0.75 . . . . 0.0 109.13 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.462 ' O ' ' ND2' ' A' ' 114' ' ' ASN . 2.8 m-20 -65.65 -45.17 84.01 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.318 -0.864 . . . . 0.0 109.32 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.838 HG11 ' HG ' ' A' ' 92' ' ' LEU . 2.4 t -68.32 -40.72 82.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.0 -1.063 . . . . 0.0 109.015 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.578 ' CZ ' ' HB ' ' A' ' 78' ' ' VAL . 0.3 OUTLIER -55.86 -54.34 45.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -0.972 . . . . 0.0 109.149 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.4 mt -62.38 -23.05 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.271 -0.893 . . . . 0.0 109.436 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 110' ' ' ASP . 11.0 m-80 -72.21 -16.28 61.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.361 -0.837 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.93 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -96.67 14.87 23.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.445 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.435 ' C ' HD12 ' A' ' 117' ' ' ILE . . . 83.12 9.28 84.34 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.93 HD13 ' HB3' ' A' ' 115' ' ' ALA . 1.8 mp -92.02 56.23 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -1.102 . . . . 0.0 109.374 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 117' ' ' ILE . 16.6 mttp -36.84 149.61 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.071 -1.018 . . . . 0.0 110.037 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 123' ' ' ASP . . . -50.71 -37.3 34.13 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.989 -1.244 . . . . 0.0 109.989 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.04 -52.32 58.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -1.181 . . . . 0.0 109.637 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -66.05 -60.94 2.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.397 -0.814 . . . . 0.0 109.843 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.757 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.2 OUTLIER -50.12 -60.19 3.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.204 -0.935 . . . . 0.0 109.524 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.446 ' HB2' ' O ' ' A' ' 119' ' ' GLY . 7.6 m-20 -44.93 -43.29 8.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.992 -1.068 . . . . 0.0 109.871 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.57 -44.9 73.46 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 109.791 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.774 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -58.71 -49.22 78.39 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.313 -0.867 . . . . 0.0 108.977 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.559 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 4.9 t-105 -57.13 -54.82 42.38 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -63.42 -14.83 54.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.657 -0.652 . . . . 0.0 110.179 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 70.2 m -71.16 -178.21 1.94 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.98 -1.075 . . . . 0.0 110.43 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -92.21 -34.68 14.19 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.633 -179.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 87.3 t -68.12 -44.7 84.23 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 C-N-CA 118.327 -1.349 . . . . 0.0 109.996 -179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.774 HG21 ' HB1' ' A' ' 125' ' ' ALA . 5.9 t -69.77 -31.97 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.863 -1.148 . . . . 0.0 108.771 179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -71.59 -37.18 71.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -63.85 -35.47 80.74 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.475 HD22 ' HB3' ' A' ' 80' ' ' MET . 0.0 OUTLIER -74.68 -29.41 61.21 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.479 HG23 ' HB1' ' A' ' 77' ' ' ALA . 5.7 t -73.71 -24.3 19.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -77.05 -54.26 6.77 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.5 ' CG ' ' OH ' ' A' ' 59' ' ' TYR . 7.0 tp-100 -59.88 -33.05 71.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.296 -0.878 . . . . 0.0 109.136 179.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.428 ' OE1' HG21 ' A' ' 73' ' ' THR . 12.1 tm0? -66.95 -64.83 0.77 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 108.749 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -51.33 -35.38 37.88 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.7 mtmm -72.2 -28.95 63.52 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.848 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -60.59 -53.08 61.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.3 -0.875 . . . . 0.0 108.795 179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.468 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -75.04 -25.39 58.68 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.337 -0.852 . . . . 0.0 109.742 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -80.15 -27.25 39.08 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.106 -0.996 . . . . 0.0 110.234 -179.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.716 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.4 p30 -82.21 -48.26 11.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.949 -1.094 . . . . 0.0 108.439 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 1.071 HG21 ' CE2' ' A' ' 25' ' ' PHE . 25.5 m -84.62 -18.54 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.551 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 9.6 tt0 82.6 -40.05 0.1 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.811 -0.555 . . . . 0.0 110.247 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.596 HD21 ' CG1' ' A' ' 61' ' ' VAL . 12.1 tp 66.75 144.17 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -159.61 28.4 0.19 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.478 -1.389 . . . . 0.0 110.887 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.39 110.89 0.55 Allowed Glycine 0 N--CA 1.49 2.233 0 C-N-CA 118.865 -1.636 . . . . 0.0 111.109 179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.781 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -84.04 145.16 45.74 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.353 -1.087 . . . . 0.0 109.147 178.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.62 150.96 84.67 Favored 'Cis proline' 0 C--N 1.315 -1.213 0 O-C-N 123.312 1.164 . . . . 0.0 110.583 0.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.814 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -129.66 134.86 47.91 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.403 -1.435 . . . . 0.0 109.069 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.51 ' SD ' HG13 ' A' ' 22' ' ' VAL . 5.7 tpp -131.09 124.61 31.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 109.773 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.471 ' CD1' ' HB3' ' A' ' 160' ' ' GLN . 10.6 m-85 -123.86 129.94 51.82 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.274 -0.891 . . . . 0.0 109.922 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 21' ' ' GLN . 45.5 t -97.92 131.26 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.945 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.739 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.3 OUTLIER 46.43 21.91 0.14 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.293 179.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.55 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 55.36 57.04 20.43 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.08 -34.98 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.28 -1.129 . . . . 0.0 108.273 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.588 ' CE1' ' HE2' ' A' ' 188' ' ' LYS . 8.8 m-85 -121.51 126.36 49.04 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.44 -0.904 . . . . 0.0 108.925 179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.513 ' HG3' HG23 ' A' ' 10' ' ' THR . 16.4 pt20 -116.72 119.97 37.12 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 120.955 -1.091 . . . . 0.0 110.307 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.8 mt -67.59 174.32 3.57 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -150.44 74.34 8.9 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.971 -1.081 . . . . 0.0 109.692 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.45 45.97 2.0 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.683 2.255 . . . . 0.0 110.97 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -129.99 -3.1 4.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.033 -1.042 . . . . 0.0 109.763 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -71.86 -45.17 44.48 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 174' ' ' PHE . 0.1 OUTLIER -121.23 -93.13 0.52 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.238 -1.154 . . . . 0.0 109.468 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 168' ' ' THR . 31.3 t0 63.61 31.48 14.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.373 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 167' ' ' ASP . 0.0 OUTLIER -167.31 74.33 0.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.236 -0.915 . . . . 0.0 109.406 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 t 179.58 -36.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.252 -0.905 . . . . 0.0 109.759 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -158.8 83.04 0.8 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.29 -0.881 . . . . 0.0 109.33 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.784 ' O ' HG23 ' A' ' 175' ' ' VAL . 19.8 mmt -59.44 -15.91 20.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.294 -0.878 . . . . 0.0 109.668 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -74.02 -55.98 5.48 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.707 -0.621 . . . . 0.0 109.355 179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.403 ' O ' ' HG2' ' A' ' 177' ' ' GLN . 4.5 t -68.3 -29.66 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.204 -0.935 . . . . 0.0 109.189 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.558 ' CD1' ' OE1' ' A' ' 177' ' ' GLN . 26.6 m-85 -68.24 -34.8 76.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.193 -0.942 . . . . 0.0 109.268 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.784 HG23 ' O ' ' A' ' 171' ' ' MET . 64.6 t -78.36 -26.1 14.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.069 -1.019 . . . . 0.0 109.37 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.16 -55.52 4.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.123 -0.986 . . . . 0.0 109.272 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.558 ' OE1' ' CD1' ' A' ' 174' ' ' PHE . 7.6 pt20 -57.29 -36.35 70.95 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.16 -0.963 . . . . 0.0 108.735 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.41 ' HA ' ' OG1' ' A' ' 181' ' ' THR . 6.0 t80 -68.06 -49.72 59.57 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.89 . . . . 0.0 108.81 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 183' ' ' LYS . . . -58.85 -29.27 66.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 108.984 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.96 -37.82 58.19 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.336 -0.853 . . . . 0.0 109.15 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.59 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -61.45 -46.43 90.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.178 -0.951 . . . . 0.0 109.172 179.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.47 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 55.1 t -72.03 -36.89 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.802 -1.186 . . . . 0.0 109.295 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 179' ' ' ALA . 0.4 OUTLIER -59.93 -52.61 64.68 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.147 -0.97 . . . . 0.0 109.269 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -77.34 -29.28 53.38 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.25 -0.906 . . . . 0.0 109.107 179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.59 HD23 ' O ' ' A' ' 181' ' ' THR . 0.2 OUTLIER -62.51 -20.31 64.48 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.964 -1.085 . . . . 0.0 108.977 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.497 ' HB3' HG22 ' A' ' 54' ' ' VAL . 0.0 OUTLIER -69.63 -22.87 63.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.853 -1.154 . . . . 0.0 108.083 178.265 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.569 ' O ' ' CB ' ' A' ' 188' ' ' LYS . 1.3 mp0 -94.13 -72.18 0.63 Allowed 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.588 ' HE2' ' CE1' ' A' ' 159' ' ' TYR . 29.6 tttm 83.78 -43.21 0.09 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.459 0.647 . . . . 0.0 109.546 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.598 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.677 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.536 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 3.7 pt20 32.5 50.2 0.18 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.764 0.793 . . . . 0.0 109.971 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.2 OUTLIER 69.12 86.17 0.13 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.489 ' HB2' ' HB3' ' A' ' 1' ' ' ALA . 69.5 tt0 -125.11 62.4 1.17 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.981 . . . . 0.0 109.68 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 2.7 t0 47.11 83.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.48 -0.762 . . . . 0.0 109.498 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 131.97 -29.69 3.33 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.284 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 1' ' ' ALA . 0.1 OUTLIER -79.82 -71.31 0.46 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.02 -1.282 . . . . 0.0 108.916 179.931 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.916 ' NE2' HG23 ' A' ' 181' ' ' THR . 13.9 pt20 -100.11 6.59 44.92 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.086 -1.009 . . . . 0.0 109.686 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.524 ' O ' ' N ' ' A' ' 6' ' ' GLY . 1.4 p90 177.53 130.72 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 0.0 109.466 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.464 ' O ' ' HG2' ' A' ' 160' ' ' GLN . 5.7 t -111.36 179.78 3.93 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -178.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.3 m -96.37 157.09 16.06 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.597 -0.69 . . . . 0.0 109.796 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.474 ' HA ' ' OE1' ' A' ' 160' ' ' GLN . 2.6 mt -91.5 145.24 24.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.434 -0.791 . . . . 0.0 109.75 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.91 -22.01 65.97 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.256 -0.902 . . . . 0.0 108.736 179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -135.08 108.15 10.48 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.539 -0.726 . . . . 0.0 109.16 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.54 157.74 36.25 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.323 2.015 . . . . 0.0 110.645 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.714 ' O ' HG12 ' A' ' 16' ' ' VAL . 7.9 t -124.03 82.86 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.238 -0.914 . . . . 0.0 109.65 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -47.79 127.28 11.59 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.562 -0.855 . . . . 0.0 108.707 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 99.06 -20.94 48.22 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.766 ' HB1' ' HD2' ' A' ' 20' ' ' PRO . . . -45.02 168.25 0.09 OUTLIER Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.122 -1.223 . . . . 0.0 109.421 179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.766 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 36.0 Cg_endo -79.22 136.73 12.98 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.87 2.38 . . . . 0.0 111.246 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.823 ' O ' HG22 ' A' ' 155' ' ' VAL . 5.7 mt-30 -49.17 -20.35 0.58 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.376 -0.827 . . . . 0.0 109.772 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.747 ' O ' HG12 ' A' ' 22' ' ' VAL . 3.2 t -149.49 81.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.21 -0.931 . . . . 0.0 108.602 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.713 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -77.45 126.57 31.11 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.294 -0.879 . . . . 0.0 108.786 -179.305 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 58' ' ' LYS . 0.1 OUTLIER -110.06 119.18 38.49 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.129 -0.982 . . . . 0.0 109.83 -179.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.073 ' CE2' HG21 ' A' ' 145' ' ' VAL . 4.4 m-85 -111.52 107.48 16.68 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.522 -0.736 . . . . 0.0 109.371 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -152.39 138.81 18.53 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.326 -0.859 . . . . 0.0 108.948 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.864 ' HB2' HG22 ' A' ' 61' ' ' VAL . 1.5 t -112.83 177.07 4.76 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.091 -1.005 . . . . 0.0 109.896 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.71 ' HB2' HD11 ' A' ' 72' ' ' LEU . 7.7 m-30 -88.4 38.84 0.88 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.876 ' CE2' HD12 ' A' ' 72' ' ' LEU . 10.1 m-85 -130.69 14.19 5.39 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.315 -0.865 . . . . 0.0 110.346 -178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.539 ' HB3' ' CD2' ' A' ' 32' ' ' HIS . 0.1 OUTLIER -118.15 156.69 50.26 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.619 -1.301 . . . . 0.0 109.78 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -74.46 -25.15 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.022 1.815 . . . . 0.0 107.667 178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.563 ' CD2' ' HD3' ' A' ' 151' ' ' PRO . 24.4 p80 -84.74 -25.34 28.36 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 177.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.512 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 18.6 t -45.73 -58.69 3.27 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.49 ' CB ' ' NE2' ' A' ' 97' ' ' GLN . 45.7 t80 -75.17 -49.88 18.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.883 -0.511 . . . . 0.0 110.359 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -61.31 -21.93 64.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.168 -0.957 . . . . 0.0 110.699 -178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.568 ' CZ ' HG22 ' A' ' 42' ' ' ILE . 3.7 t80 -82.04 -50.97 8.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.978 -1.076 . . . . 0.0 110.24 -179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.403 ' O ' ' OE2' ' A' ' 38' ' ' GLU . 33.2 tt0 -103.52 -0.14 30.22 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.858 -1.151 . . . . 0.0 111.553 -178.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 34' ' ' TYR . 60.1 mm-40 -127.74 21.32 6.47 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.364 -1.46 . . . . 0.0 111.172 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 85.1 t -152.13 -85.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.656 -1.277 . . . . 0.0 110.066 179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.1 mt -61.96 -12.19 17.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.457 -0.777 . . . . 0.0 110.148 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.454 ' CD2' ' OD1' ' A' ' 44' ' ' ASP . 4.4 m170 55.48 22.83 5.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.072 -1.018 . . . . 0.0 108.998 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.633 HG12 HG22 ' A' ' 175' ' ' VAL . 7.1 mt -56.81 -16.79 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.384 -0.823 . . . . 0.0 109.445 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.514 ' O ' ' CG2' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -83.25 -48.69 10.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.18 -0.95 . . . . 0.0 110.205 -179.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.454 ' OD1' ' CD2' ' A' ' 41' ' ' HIS . 8.1 p-10 -84.29 -30.91 25.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.153 -0.967 . . . . 0.0 110.124 -179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -49.19 -33.76 13.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.012 . . . . 0.0 109.73 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.514 ' CG2' ' O ' ' A' ' 43' ' ' SER . 2.8 m -69.56 -33.72 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.981 -1.075 . . . . 0.0 109.452 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.929 ' HA ' HD12 ' A' ' 50' ' ' LEU . 14.0 mttt -61.06 -28.95 69.44 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.379 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 3.9 tmtt? -45.91 -27.13 0.82 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.386 -0.821 . . . . 0.0 109.795 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -142.29 50.8 1.49 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 0.0 110.257 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.929 HD12 ' HA ' ' A' ' 47' ' ' LYS . 9.0 mt -99.13 134.4 21.39 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 120.837 -1.164 . . . . 0.0 110.119 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD2' HD23 ' A' ' 50' ' ' LEU . 35.8 Cg_endo -79.56 152.54 23.03 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.584 2.189 . . . . 0.0 109.118 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.48 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 28.2 tt0 -73.07 23.54 0.06 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.568 -1.333 . . . . 0.0 111.241 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -121.38 29.31 5.74 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 12.3 t -148.96 119.39 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.507 -0.996 . . . . 0.0 109.135 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -106.33 120.23 41.31 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.887 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.616 ' HE1' HD11 ' A' ' 50' ' ' LEU . 2.1 mtm -96.49 99.49 11.14 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.393 0.616 . . . . 0.0 109.574 179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.477 ' O ' ' N ' ' A' ' 24' ' ' GLU . 1.1 m -89.21 132.85 34.67 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.846 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.503 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -109.35 114.87 28.9 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.236 -0.915 . . . . 0.0 109.785 -179.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.429 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 5.2 m-85 -114.41 171.65 7.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.088 -1.007 . . . . 0.0 111.15 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.864 ' NE2' HD22 ' A' ' 72' ' ' LEU . 66.8 t-80 -109.93 129.78 55.61 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.053 HG11 ' CG1' ' A' ' 150' ' ' VAL . 2.3 m -69.23 158.86 5.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 O-C-N 121.606 -0.684 . . . . 0.0 109.595 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.779 HD21 HG21 ' A' ' 73' ' ' THR . 1.0 OUTLIER -124.4 33.13 5.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.318 -0.864 . . . . 0.0 109.462 179.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 63' ' ' PHE . 24.8 p90 -132.24 51.38 2.16 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.013 -1.054 . . . . 0.0 109.986 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.5 mtt -159.17 48.43 0.32 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.531 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 154.84 57.44 0.01 OUTLIER Glycine 0 N--CA 1.489 2.229 0 N-CA-C 107.963 -2.055 . . . . 0.0 107.963 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -34.07 -38.41 0.1 Allowed Glycine 0 N--CA 1.493 2.482 0 O-C-N 121.915 -0.756 . . . . 0.0 111.408 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -87.63 -80.06 0.27 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.754 -1.439 . . . . 0.0 110.697 -178.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.092 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -80.02 -25.89 40.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.864 -1.148 . . . . 0.0 109.521 -179.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 1.092 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -47.61 -53.43 12.96 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.358 -1.897 . . . . 0.0 108.358 178.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' O ' ' CE ' ' A' ' 70' ' ' LYS . 0.1 OUTLIER -56.07 -49.01 74.99 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.264 -1.139 . . . . 0.0 108.331 179.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.726 ' OD2' ' HB1' ' A' ' 105' ' ' ALA . 53.1 t0 -59.98 -30.87 69.4 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 178.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.876 HD12 ' CE2' ' A' ' 29' ' ' PHE . 1.1 tt -57.46 -36.92 72.06 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.779 HG21 HD21 ' A' ' 62' ' ' ASN . 40.6 m -66.09 -41.59 90.45 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 178.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.901 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.1 tt0 -59.28 -20.33 53.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 177.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -68.98 -47.51 65.42 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.419 ' NE1' ' O ' ' A' ' 58' ' ' LYS . 37.9 t-105 -55.91 -28.82 58.54 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.403 ' CB ' HG23 ' A' ' 135' ' ' VAL . . . -84.79 -69.07 0.67 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.49 -0.756 . . . . 0.0 109.537 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.03 HG11 ' CE2' ' A' ' 122' ' ' TYR . 3.1 t -45.27 -27.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.21 -0.931 . . . . 0.0 109.934 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.491 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -84.18 -62.13 1.64 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.934 -1.104 . . . . 0.0 108.987 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -46.08 -27.35 0.93 Allowed 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.408 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.816 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -72.36 -41.02 66.86 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.447 -0.783 . . . . 0.0 109.63 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 84' ' ' VAL . 40.8 mt -104.87 11.83 33.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.146 -0.971 . . . . 0.0 110.135 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 49.28 32.44 14.0 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.944 HG11 HG12 ' A' ' 117' ' ' ILE . 28.1 m -96.54 19.64 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.474 -1.015 . . . . 0.0 109.77 -179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 86' ' ' ASP . 87.6 mt-10 -58.91 -75.18 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.2 -0.937 . . . . 0.0 110.01 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.47 -34.35 0.21 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.408 -0.807 . . . . 0.0 110.536 -179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.53 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 27.7 mtpp -74.23 -54.34 7.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.328 -0.858 . . . . 0.0 110.643 -178.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.602 HG13 ' O ' ' A' ' 84' ' ' VAL . 1.0 OUTLIER -86.54 -23.1 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.826 -1.171 . . . . 0.0 110.765 -179.099 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.746 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -67.13 -43.39 82.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.731 -1.231 . . . . 0.0 109.016 179.472 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.417 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.0 t -54.62 -55.23 40.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 120.432 -1.418 . . . . 0.0 110.523 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.47 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 24.2 Cg_endo -72.21 -18.87 26.55 Favored 'Trans proline' 0 C--N 1.3 -2.007 0 O-C-N 122.77 0.879 . . . . 0.0 109.883 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.793 ' HG ' HG11 ' A' ' 111' ' ' VAL . 11.6 mt -86.49 -42.63 13.41 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.183 -0.948 . . . . 0.0 108.937 178.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.746 ' CE1' HG23 ' A' ' 89' ' ' THR . 5.2 m-30 -62.85 -48.23 79.93 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.943 -1.098 . . . . 0.0 108.802 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.38 -22.36 59.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.037 -1.039 . . . . 0.0 109.45 179.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.48 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -76.43 -33.04 49.5 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.701 HG23 ' O ' ' A' ' 92' ' ' LEU . 2.7 t -101.82 1.75 10.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 O-C-N 121.006 -1.291 . . . . 0.0 109.228 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.514 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 2.0 mt-30 -91.69 -8.63 46.49 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 120.981 -1.074 . . . . 0.0 110.878 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 97' ' ' GLN . 1.4 mtpt -167.81 -53.48 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.736 -1.227 . . . . 0.0 111.118 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 95' ' ' GLY . 80.8 p -47.93 -39.79 20.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.275 -1.516 . . . . 0.0 109.468 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 99' ' ' THR . 1.1 mt-30 67.7 11.21 8.26 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.263 -0.898 . . . . 0.0 109.829 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.8 t -79.44 -5.99 55.9 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.687 ' CB ' HG22 ' A' ' 96' ' ' VAL . 3.8 mm -91.28 80.36 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.92 27.66 2.39 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.181 -0.949 . . . . 0.0 109.68 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 107' ' ' ASP . 56.1 p -151.08 129.15 11.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.129 -0.982 . . . . 0.0 109.903 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.759 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -48.95 -39.63 27.08 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.84 -31.25 62.56 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 104' ' ' SER . 84.2 m-20 -78.05 -40.07 39.85 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.05 -1.06 . . . . 0.0 108.977 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.759 HD12 ' HA ' ' A' ' 105' ' ' ALA . 28.4 mt -52.45 -26.29 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.556 -1.34 . . . . 0.0 107.513 178.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.6 mtp180 -78.05 -39.51 41.64 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.682 -0.636 . . . . 0.0 109.44 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 111' ' ' VAL . 0.8 OUTLIER -55.99 -44.36 78.53 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.368 -0.832 . . . . 0.0 109.445 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.793 HG11 ' HG ' ' A' ' 92' ' ' LEU . 88.0 t -74.63 -37.26 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.033 . . . . 0.0 109.089 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.737 ' CE1' HG21 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -61.25 -31.03 70.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.286 179.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.608 HG23 ' HA ' ' A' ' 118' ' ' LYS . 18.7 mt -85.47 -30.46 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.318 -0.864 . . . . 0.0 110.697 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 111' ' ' VAL . 0.2 OUTLIER -60.76 -16.53 41.26 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.775 -1.203 . . . . 0.0 109.35 -179.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.53 ' HB1' ' HE3' ' A' ' 87' ' ' LYS . . . -88.06 -2.43 58.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.321 -0.862 . . . . 0.0 109.689 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 102.32 -5.22 52.05 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.944 HG12 HG11 ' A' ' 84' ' ' VAL . 1.6 mp -88.88 56.13 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.268 -1.136 . . . . 0.0 109.292 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.608 ' HA ' HG23 ' A' ' 113' ' ' ILE . 3.2 mttp -33.01 152.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.366 -0.833 . . . . 0.0 110.832 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 122' ' ' TYR . . . -53.84 -23.93 24.39 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.94 -52.14 66.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.054 -1.263 . . . . 0.0 109.083 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -75.76 -35.8 60.05 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.89 . . . . 0.0 109.412 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 1.03 ' CE2' HG11 ' A' ' 78' ' ' VAL . 2.7 t80 -62.91 -51.21 67.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.069 -1.02 . . . . 0.0 109.166 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -59.69 -45.65 91.46 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.201 -0.937 . . . . 0.0 108.822 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -51.38 -53.91 31.76 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.36 -0.838 . . . . 0.0 108.911 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.737 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -51.85 -53.06 44.82 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.432 -0.792 . . . . 0.0 108.885 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -52.7 -58.05 8.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.163 -0.961 . . . . 0.0 108.628 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -56.29 -15.41 3.89 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.661 -0.65 . . . . 0.0 110.239 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.1 OUTLIER -69.22 179.54 1.92 Allowed 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.958 -1.089 . . . . 0.0 110.17 -179.262 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 129' ' ' PHE . 1.0 OUTLIER -92.79 -37.89 12.07 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.411 -179.232 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 24.4 t -72.04 -50.05 39.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 C-N-CA 118.349 -1.34 . . . . 0.0 109.786 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.816 HG22 ' HB1' ' A' ' 81' ' ' ALA . 3.7 t -57.44 -38.09 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.811 -1.18 . . . . 0.0 108.569 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -66.42 -35.59 80.7 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.407 -0.808 . . . . 0.0 109.068 179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.96 -26.32 68.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.201 -0.937 . . . . 0.0 109.05 179.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.7 mt -81.77 -28.27 33.35 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.288 -0.883 . . . . 0.0 108.795 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.403 HG23 ' CB ' ' A' ' 77' ' ' ALA . 11.2 t -74.91 -39.51 45.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 140' ' ' LYS . . . -68.22 -40.05 82.18 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -33.82 75.32 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.392 -0.818 . . . . 0.0 108.875 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.674 ' HG2' HG23 ' A' ' 73' ' ' THR . 0.2 OUTLIER -64.16 -70.73 0.2 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.247 -0.908 . . . . 0.0 109.032 179.541 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -48.15 -37.19 14.98 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.367 -0.833 . . . . 0.0 108.928 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 136' ' ' ALA . 0.3 OUTLIER -72.48 -25.88 61.59 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.362 -0.836 . . . . 0.0 109.24 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.614 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -68.47 -55.22 12.55 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.251 -0.906 . . . . 0.0 109.398 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.442 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -73.76 -29.18 62.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.23 -0.919 . . . . 0.0 109.949 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -75.85 -25.63 56.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.059 -1.026 . . . . 0.0 109.87 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.702 ' OD1' HG13 ' A' ' 145' ' ' VAL . 1.0 OUTLIER -81.94 -48.14 11.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.011 . . . . 0.0 108.35 179.53 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 1.073 HG21 ' CE2' ' A' ' 25' ' ' PHE . 13.4 m -83.01 -12.95 12.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.509 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 0.0 OUTLIER 81.15 -49.09 0.27 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.61 -0.681 . . . . 0.0 109.414 -179.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.695 HD21 HG12 ' A' ' 61' ' ' VAL . 15.0 tp 61.65 132.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.452 -0.78 . . . . 0.0 109.426 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 147' ' ' LEU . 16.7 mtt180 -161.49 38.8 0.14 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.587 -1.32 . . . . 0.0 110.302 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 164.46 108.5 0.21 Allowed Glycine 0 N--CA 1.491 2.339 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.42 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 1.053 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -97.99 144.15 27.52 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.4 -1.059 . . . . 0.0 109.335 179.031 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.563 ' HD3' ' CD2' ' A' ' 32' ' ' HIS . 36.3 Cg_endo -78.31 150.94 89.2 Favored 'Cis proline' 0 C--N 1.315 -1.187 0 C-N-CA 124.088 -1.213 . . . . 0.0 110.54 0.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -130.95 141.18 50.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.319 -1.488 . . . . 0.0 108.702 179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.548 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 2.8 ttp -144.91 134.02 22.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.028 -1.045 . . . . 0.0 110.027 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.548 ' CD1' ' C ' ' A' ' 153' ' ' MET . 0.5 OUTLIER -134.49 155.58 50.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.183 -0.948 . . . . 0.0 110.008 179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.823 HG22 ' O ' ' A' ' 21' ' ' GLN . 30.8 t -112.07 130.66 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.332 -0.855 . . . . 0.0 108.958 179.681 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.538 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 51.75 23.24 1.94 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 19' ' ' ALA . . . 54.97 22.71 28.75 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.537 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -125.01 -22.97 4.33 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.825 -1.397 . . . . 0.0 109.113 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.541 ' CZ ' ' HG2' ' A' ' 188' ' ' LYS . 12.6 m-85 -121.46 127.69 51.36 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.541 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 11.5 pt20 -123.32 118.28 27.17 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.23 -0.919 . . . . 0.0 110.172 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 161' ' ' LEU . 5.8 mt -67.3 177.12 1.97 Allowed 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.44 ' O ' ' ND2' ' A' ' 162' ' ' ASN . 0.4 OUTLIER -144.1 94.83 5.73 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 120.919 -1.113 . . . . 0.0 109.799 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.08 40.33 0.95 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.787 2.325 . . . . 0.0 110.637 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -118.04 -6.73 10.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.064 -1.022 . . . . 0.0 109.324 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 166' ' ' MET . . . -58.18 -45.59 93.83 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 165' ' ' GLY . 0.1 OUTLIER -150.34 -95.9 0.07 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.256 -1.144 . . . . 0.0 109.547 179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.3 t70 64.54 32.57 11.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.116 -0.99 . . . . 0.0 109.677 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 14.4 p -112.34 -48.0 3.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.999 -1.063 . . . . 0.0 109.647 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 45.9 t -145.89 59.06 1.25 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.909 . . . . 0.0 109.701 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -160.03 63.79 0.35 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.147 -0.971 . . . . 0.0 109.463 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 20.8 mtt -72.64 -16.59 61.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -0.936 . . . . 0.0 109.564 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -76.74 -59.3 2.83 Favored 'General case' 0 C--N 1.295 -1.799 0 O-C-N 121.736 -0.602 . . . . 0.0 109.397 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.9 t -64.29 -23.27 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.235 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.503 ' O ' ' HB2' ' A' ' 178' ' ' TYR . 32.7 t80 -73.71 -39.79 64.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.139 -0.976 . . . . 0.0 109.383 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.633 HG22 HG12 ' A' ' 42' ' ' ILE . 18.6 t -73.61 -29.5 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.996 -1.065 . . . . 0.0 109.233 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -82.49 -51.98 7.29 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 0.0 109.481 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -65.45 -24.98 67.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.385 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 174' ' ' PHE . 20.3 t80 -78.54 -47.58 17.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.218 -0.926 . . . . 0.0 109.372 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -63.8 -29.92 71.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.128 -0.982 . . . . 0.0 109.313 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -78.14 -47.26 18.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.671 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.916 HG23 ' NE2' ' A' ' 8' ' ' GLN . 15.3 m -58.7 -26.82 64.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.093 -1.004 . . . . 0.0 109.642 -179.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 15.3 t -87.75 -41.14 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.048 -1.032 . . . . 0.0 109.049 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -57.01 -42.99 81.33 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.29 -0.882 . . . . 0.0 109.133 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.556 ' CE2' ' CD2' ' A' ' 185' ' ' LEU . 0.0 OUTLIER -82.09 -35.09 28.99 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.563 -0.855 . . . . 0.0 109.305 179.92 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.726 HD23 ' O ' ' A' ' 181' ' ' THR . 0.7 OUTLIER -57.29 -20.13 26.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.875 -1.14 . . . . 0.0 109.331 -179.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . . . . . . . . . 7.1 t -78.63 -0.87 31.65 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.778 -1.201 . . . . 0.0 108.503 178.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -115.46 7.31 14.96 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.423 -0.798 . . . . 0.0 109.379 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.541 ' HG2' ' CZ ' ' A' ' 159' ' ' TYR . 13.8 tptm -61.19 -46.86 88.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -0.922 . . . . 0.0 109.914 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.4 pttm . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.445 -179.865 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.593 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 12.2 mt-30 -114.02 60.33 0.67 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.548 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.593 ' CD2' ' O ' ' A' ' 2' ' ' GLN . 0.2 OUTLIER 173.96 102.29 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.43 -0.793 . . . . 0.0 108.986 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -115.37 58.37 0.72 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.827 -1.171 . . . . 0.0 111.017 -179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 5' ' ' ASP . 1.7 m-20 45.16 87.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.454 -0.779 . . . . 0.0 110.603 178.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.82 -35.37 1.93 Allowed Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.842 -1.171 . . . . 0.0 110.207 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.09 -70.31 0.69 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.11 -1.229 . . . . 0.0 108.951 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.671 ' HG2' ' CD2' ' A' ' 9' ' ' TYR . 4.7 pm0 -65.77 -27.07 68.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.29 -0.881 . . . . 0.0 108.811 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.671 ' CD2' ' HG2' ' A' ' 8' ' ' GLN . 2.2 p90 -176.18 138.73 0.34 Allowed 'General case' 0 N--CA 1.484 1.239 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -103.99 -179.69 4.02 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 12' ' ' LEU . 47.4 m -103.32 160.25 14.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.547 -0.721 . . . . 0.0 110.102 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.528 HD11 ' HD2' ' A' ' 154' ' ' PHE . 0.7 OUTLIER -92.04 163.25 14.05 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.426 -0.796 . . . . 0.0 109.41 179.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.431 ' C ' ' HG3' ' A' ' 14' ' ' LYS . 1.0 OUTLIER -97.73 -16.07 20.06 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.431 ' HG3' ' C ' ' A' ' 13' ' ' GLU . 5.3 mttt -148.71 112.36 3.65 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.7 -179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -76.82 161.08 33.73 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.447 2.098 . . . . 0.0 109.703 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.615 HG12 ' CB ' ' A' ' 19' ' ' ALA . 1.1 p -122.32 126.74 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 120.999 -1.063 . . . . 0.0 110.237 -179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 16' ' ' VAL . . . -46.35 125.72 7.11 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 77.16 8.9 87.01 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.666 ' HB1' ' HD2' ' A' ' 20' ' ' PRO . . . -36.25 161.73 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.685 -0.891 . . . . 0.0 111.189 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 1.086 ' HG3' HD12 ' A' ' 23' ' ' LEU . 36.5 Cg_endo -78.06 113.57 3.44 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 123.273 2.649 . . . . 0.0 111.953 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.795 ' O ' HG13 ' A' ' 155' ' ' VAL . 33.1 mt-30 -51.89 -31.12 26.93 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.71 HG22 HG22 ' A' ' 155' ' ' VAL . 24.2 t -157.05 81.12 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.086 HD12 ' HG3' ' A' ' 20' ' ' PRO . 1.3 tt -83.92 137.6 33.57 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.363 -0.835 . . . . 0.0 110.116 -177.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.805 ' N ' HD23 ' A' ' 23' ' ' LEU . 31.6 mt-10 -120.52 99.38 6.52 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 1.036 ' CZ ' HD13 ' A' ' 23' ' ' LEU . 88.0 m-85 -83.5 115.3 22.02 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.489 -0.757 . . . . 0.0 109.434 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.576 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 0.4 OUTLIER -154.23 139.1 17.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.068 -1.02 . . . . 0.0 110.033 179.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.598 ' HA ' ' CD2' ' A' ' 60' ' ' HIS . 8.3 p -121.44 173.17 7.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.41 -0.806 . . . . 0.0 109.443 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.884 ' CD2' HD21 ' A' ' 72' ' ' LEU . 1.6 m-30 -85.2 43.54 1.02 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.309 -0.869 . . . . 0.0 108.84 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.636 ' CG ' HG11 ' A' ' 96' ' ' VAL . 9.0 m-85 -143.11 14.19 1.86 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.909 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -105.02 160.99 24.1 Favored Pre-proline 0 N--CA 1.487 1.414 0 O-C-N 120.84 -1.162 . . . . 0.0 109.357 179.837 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -76.03 -35.43 2.45 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.134 1.889 . . . . 0.0 108.064 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -82.26 -23.65 35.17 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 30' ' ' CYS . 11.1 t -46.13 -52.91 11.31 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.47 ' HB2' ' HG2' ' A' ' 97' ' ' GLN . 85.8 t80 -80.6 -31.5 36.67 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.905 -0.497 . . . . 0.0 111.064 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.64 -27.46 31.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.841 -1.162 . . . . 0.0 111.298 -178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.642 ' CD1' HD12 ' A' ' 40' ' ' LEU . 2.3 m-30 -84.1 -17.31 40.61 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.873 -1.142 . . . . 0.0 110.767 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -116.64 20.99 13.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.837 -1.164 . . . . 0.0 110.637 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.47 ' HB2' ' O ' ' A' ' 34' ' ' TYR . 16.1 mm-40 -143.36 -66.08 0.37 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.953 -1.092 . . . . 0.0 110.405 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' O ' ' ND1' ' A' ' 41' ' ' HIS . 4.6 t -90.16 -69.51 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.141 -0.974 . . . . 0.0 110.465 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.642 HD12 ' CD1' ' A' ' 36' ' ' PHE . 94.6 mt -47.81 -20.97 0.34 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.286 -0.884 . . . . 0.0 110.759 -179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 40' ' ' LEU . 28.7 p-80 40.97 34.38 0.28 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.0 109.429 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.415 HG13 ' HB3' ' A' ' 40' ' ' LEU . 20.8 mt -76.01 -26.17 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.48 -0.762 . . . . 0.0 109.754 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.764 ' O ' HG12 ' A' ' 46' ' ' VAL . 14.1 m -78.18 -33.05 50.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.108 -0.995 . . . . 0.0 110.148 -179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -84.12 -47.42 10.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.034 -1.041 . . . . 0.0 109.829 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -57.27 -37.79 72.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.764 HG12 ' O ' ' A' ' 43' ' ' SER . 14.5 p -55.4 -28.23 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.179 -0.951 . . . . 0.0 109.644 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.619 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -70.13 -30.74 68.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.249 -0.907 . . . . 0.0 109.404 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.52 -38.6 69.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.345 -0.847 . . . . 0.0 109.444 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.474 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -92.15 18.53 8.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.282 -0.886 . . . . 0.0 109.468 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.754 HD13 ' HG2' ' A' ' 56' ' ' MET . 12.1 mt -105.18 102.6 37.45 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.869 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.541 ' O ' ' N ' ' A' ' 53' ' ' GLY . 32.6 Cg_endo -75.49 151.55 37.5 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.343 2.028 . . . . 0.0 108.96 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -65.55 52.47 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.804 -1.185 . . . . 0.0 110.981 -179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.835 ' O ' HG23 ' A' ' 54' ' ' VAL . . . -144.3 37.82 1.36 Allowed Glycine 0 N--CA 1.487 2.074 0 N-CA-C 107.997 -2.041 . . . . 0.0 107.997 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.87 HG21 ' HB2' ' A' ' 186' ' ' SER . 13.3 t -166.91 149.87 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 N-CA-C 107.95 -1.129 . . . . 0.0 107.95 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 6.1 mmtm -113.36 115.74 28.58 Favored 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.34 -0.85 . . . . 0.0 110.36 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.754 ' HG2' HD13 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -100.93 105.07 16.28 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.107 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 24' ' ' GLU . 0.2 OUTLIER -96.01 141.14 29.77 Favored 'General case' 0 C--N 1.303 -1.445 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.07 -178.868 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.422 ' CD ' ' N ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -117.94 105.02 11.47 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.225 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.517 ' CE1' ' HG3' ' A' ' 138' ' ' GLN . 4.4 m-85 -113.5 175.33 5.5 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.106 -0.996 . . . . 0.0 110.926 -179.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 1.169 ' CD2' HD22 ' A' ' 72' ' ' LEU . 9.8 t-80 -125.44 123.9 40.26 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.553 -0.717 . . . . 0.0 109.648 -179.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.907 HG11 HD22 ' A' ' 147' ' ' LEU . 35.6 m -91.86 153.75 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.433 -0.792 . . . . 0.0 109.952 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 70' ' ' LYS . 1.9 p-10 -110.24 54.61 0.66 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.322 -0.861 . . . . 0.0 109.173 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.72 ' CE1' HG21 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -134.61 56.04 1.87 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.362 -0.836 . . . . 0.0 110.087 -179.888 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.719 ' HE1' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -122.08 32.16 5.92 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.458 -0.777 . . . . 0.0 109.53 179.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 48.31 40.88 23.18 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.604 -1.798 . . . . 0.0 108.604 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 67' ' ' ASP . . . -148.08 80.71 0.21 Allowed Glycine 0 N--CA 1.486 1.97 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.501 ' C ' ' O ' ' A' ' 66' ' ' GLY . 5.3 t0 -26.78 -45.09 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.0 0 O-C-N 122.449 -0.442 . . . . 0.0 111.209 -178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.94 HD22 HG22 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -46.02 -30.37 1.81 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.11 -1.036 . . . . 0.0 108.357 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.719 ' HA2' ' HE1' ' A' ' 64' ' ' MET . . . -48.03 -55.97 9.5 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HA ' ' HB3' ' A' ' 62' ' ' ASN . 2.2 ttmt -49.81 -46.39 51.0 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.028 -1.278 . . . . 0.0 108.604 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.4 -18.25 60.69 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.031 -1.043 . . . . 0.0 108.368 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.169 HD22 ' CD2' ' A' ' 60' ' ' HIS . 2.3 tt -76.1 -37.38 58.18 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 107.937 -1.135 . . . . 0.0 107.937 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.421 ' CG2' ' OE1' ' A' ' 138' ' ' GLN . 1.6 m -65.62 -41.45 92.67 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 177.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.492 ' NE2' ' HB2' ' A' ' 126' ' ' TRP . 15.3 tp60 -63.17 -23.63 67.52 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 177.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.512 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -70.49 -39.13 74.36 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 119.084 -1.046 . . . . 0.0 108.443 178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.573 ' CH2' ' OE1' ' A' ' 85' ' ' GLU . 37.6 t-105 -66.09 -30.03 70.47 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.821 . . . . 0.0 108.932 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.576 ' HB2' HE22 ' A' ' 138' ' ' GLN . . . -83.39 -59.96 2.29 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 109.694 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.138 HG11 ' CD2' ' A' ' 122' ' ' TYR . 92.2 t -57.55 -26.65 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 109.665 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.71 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -79.46 -65.57 0.98 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.073 -1.017 . . . . 0.0 108.745 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.456 ' HB2' ' O ' ' A' ' 76' ' ' TRP . 0.0 OUTLIER -47.03 -26.25 1.0 Allowed 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.103 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.865 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -74.89 -38.95 61.74 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.448 -0.783 . . . . 0.0 109.28 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.414 ' N ' ' O ' ' A' ' 79' ' ' ALA . 85.9 mt -106.33 10.48 31.61 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.202 -0.936 . . . . 0.0 110.715 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 54.77 19.52 14.58 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.918 -1.273 . . . . 0.0 109.918 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.949 HG21 ' CE1' ' A' ' 112' ' ' PHE . 31.6 m -84.44 -6.29 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.284 -1.127 . . . . 0.0 110.318 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.573 ' OE1' ' CH2' ' A' ' 76' ' ' TRP . 3.1 mt-10 -42.22 -71.56 0.08 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.155 -0.966 . . . . 0.0 110.052 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -39.33 -34.26 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.378 -0.827 . . . . 0.0 110.622 -179.591 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.535 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 27.5 mtpp -81.66 -49.87 9.97 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.284 -0.885 . . . . 0.0 111.189 -178.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.826 HG23 HD12 ' A' ' 92' ' ' LEU . 1.4 m -86.54 -14.26 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.882 -1.136 . . . . 0.0 110.681 -178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.755 HG23 ' CD1' ' A' ' 93' ' ' PHE . 1.0 OUTLIER -74.3 -42.51 59.41 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.698 -1.251 . . . . 0.0 108.349 178.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.408 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -55.75 -54.05 56.08 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 120.723 -1.236 . . . . 0.0 110.875 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.489 ' CD ' ' O ' ' A' ' 87' ' ' LYS . 27.1 Cg_endo -72.4 -19.46 25.21 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 N-CA-C 109.881 -0.854 . . . . 0.0 109.881 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.826 HD12 HG23 ' A' ' 88' ' ' VAL . 35.5 mt -87.19 -43.56 12.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.335 -0.853 . . . . 0.0 109.127 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.755 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.1 m-30 -63.59 -44.02 95.23 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 121.037 -1.039 . . . . 0.0 108.697 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -76.52 -19.59 57.79 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 109.426 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.456 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -69.85 -40.51 74.87 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.636 HG11 ' CG ' ' A' ' 29' ' ' PHE . 1.6 t -92.79 -15.71 7.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 O-C-N 121.102 -1.234 . . . . 0.0 108.734 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.47 ' HG2' ' HB2' ' A' ' 34' ' ' TYR . 2.9 mp0 -113.02 10.75 18.85 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.933 -179.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.786 ' O ' HG23 ' A' ' 99' ' ' THR . 0.8 OUTLIER -159.01 51.47 0.38 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.392 -1.442 . . . . 0.0 109.851 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.786 HG23 ' O ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER 166.88 -49.03 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.405 -0.81 . . . . 0.0 109.898 179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.481 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.8 OUTLIER 75.7 16.29 2.5 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.14 -0.975 . . . . 0.0 110.494 179.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.7 t -85.7 -4.05 59.06 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.829 0.823 . . . . 0.0 108.861 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.94 HG22 HD22 ' A' ' 68' ' ' LEU . 6.6 mm -82.67 71.88 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.766 -0.584 . . . . 0.0 109.543 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.501 ' C ' HD21 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -116.83 -11.36 10.9 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.174 -0.954 . . . . 0.0 109.995 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.678 ' N ' HD21 ' A' ' 68' ' ' LEU . 1.5 p -110.67 117.21 32.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.177 -0.952 . . . . 0.0 109.77 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 68' ' ' LEU . . . -48.31 -39.01 20.41 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -53.59 -33.31 54.45 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.556 ' OD1' ' N ' ' A' ' 108' ' ' ILE . 1.2 p30 -68.64 -41.45 79.39 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.752 -1.179 . . . . 0.0 108.644 179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.556 ' N ' ' OD1' ' A' ' 107' ' ' ASP . 3.1 mt -48.57 -44.53 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.612 -1.305 . . . . 0.0 107.666 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.5 -48.49 79.12 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.576 -0.703 . . . . 0.0 109.686 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' A' ' 114' ' ' ASN . 1.1 m-20 -51.65 -42.85 62.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.274 -0.891 . . . . 0.0 109.814 -179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.724 HG11 ' HG ' ' A' ' 92' ' ' LEU . 3.2 t -64.83 -40.13 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.134 -0.979 . . . . 0.0 109.767 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.949 ' CE1' HG21 ' A' ' 84' ' ' VAL . 0.7 OUTLIER -56.77 -50.89 70.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.018 -1.051 . . . . 0.0 109.552 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.8 mt -70.67 -22.74 23.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.047 -1.033 . . . . 0.0 109.597 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 110' ' ' ASP . 2.8 m120 -64.86 -15.91 62.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.928 . . . . 0.0 109.57 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.801 ' HB2' HG12 ' A' ' 88' ' ' VAL . . . -73.37 -6.0 43.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.191 -0.943 . . . . 0.0 108.992 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.561 ' C ' HD13 ' A' ' 117' ' ' ILE . . . 97.03 15.16 39.94 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.684 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.6 mm -95.62 168.07 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.167 -1.196 . . . . 0.0 108.957 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 121' ' ' GLU . 0.1 OUTLIER -89.24 139.55 30.37 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.331 -1.481 . . . . 0.0 109.7 179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -60.75 -50.42 67.77 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -57.99 -44.47 87.18 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.138 -1.213 . . . . 0.0 109.016 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.46 ' HB2' ' HB3' ' A' ' 118' ' ' LYS . 0.0 OUTLIER -55.3 -44.34 75.66 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.299 -0.876 . . . . 0.0 108.852 179.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 1.138 ' CD2' HG11 ' A' ' 78' ' ' VAL . 2.3 t80 -55.13 -46.98 75.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.862 . . . . 0.0 108.845 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -56.6 -38.9 72.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.184 -0.947 . . . . 0.0 108.708 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -58.99 -51.22 71.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.385 -0.822 . . . . 0.0 108.828 179.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.51 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -49.16 -50.47 37.6 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.268 -0.895 . . . . 0.0 108.605 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.492 ' HB2' ' NE2' ' A' ' 74' ' ' GLN . 12.8 t90 -58.32 -56.12 26.22 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -55.34 -15.91 2.99 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.583 -0.698 . . . . 0.0 109.923 179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 125' ' ' ALA . 0.2 OUTLIER -71.23 166.62 21.15 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.972 -1.08 . . . . 0.0 109.45 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -86.77 -40.66 14.78 Favored 'General case' 0 C--N 1.291 -1.949 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.264 -179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 83.9 t -64.09 -45.08 97.57 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 C-N-CA 118.062 -1.455 . . . . 0.0 109.316 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.865 HG22 ' HB1' ' A' ' 81' ' ' ALA . 2.5 t -64.6 -41.23 91.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.001 -1.062 . . . . 0.0 108.413 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.46 -37.29 86.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.365 -0.834 . . . . 0.0 108.992 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.0 m -62.53 -30.76 71.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.369 -0.832 . . . . 0.0 108.908 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.72 -21.98 43.91 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.435 ' HA ' ' OE1' ' A' ' 138' ' ' GLN . 4.9 t -77.05 -46.38 29.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.474 ' O ' ' HG2' ' A' ' 139' ' ' GLU . . . -64.04 -42.83 96.92 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.479 ' HG2' ' OH ' ' A' ' 59' ' ' TYR . 0.3 OUTLIER -62.97 -32.37 73.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.404 -0.81 . . . . 0.0 109.036 179.664 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.576 HE22 ' HB2' ' A' ' 77' ' ' ALA . 48.0 mt-30 -65.03 -62.84 1.31 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 108.92 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 136' ' ' ALA . 6.8 pt-20 -54.51 -42.42 70.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.273 -0.892 . . . . 0.0 108.838 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 144' ' ' ASP . 29.1 mttt -67.49 -27.19 66.8 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.375 -0.828 . . . . 0.0 109.151 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 23' ' ' LEU . . . -63.42 -49.07 75.21 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.313 -0.867 . . . . 0.0 109.024 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.512 ' HB2' HG12 ' A' ' 61' ' ' VAL . . . -73.21 -41.39 63.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.837 . . . . 0.0 110.148 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.18 -16.74 60.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.158 -0.964 . . . . 0.0 109.862 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.607 ' CG ' HG21 ' A' ' 16' ' ' VAL . 22.8 m-20 -82.9 -44.21 15.64 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.738 HG21 ' CE1' ' A' ' 25' ' ' PHE . 3.8 m -91.17 -5.38 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.526 ' O ' ' HB3' ' A' ' 147' ' ' LEU . 0.0 OUTLIER 81.86 -46.75 0.2 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.595 -0.691 . . . . 0.0 109.804 -179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.907 HD22 HG11 ' A' ' 61' ' ' VAL . 13.0 tp 73.12 141.96 0.06 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.66 -0.65 . . . . 0.0 109.72 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.39 25.77 0.16 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.771 -1.206 . . . . 0.0 110.315 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 149.03 112.2 0.62 Allowed Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.108 -1.52 . . . . 0.0 111.081 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.479 HG22 ' CZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -90.48 140.31 26.81 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.503 -0.998 . . . . 0.0 108.962 178.158 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -76.25 152.2 95.95 Favored 'Cis proline' 0 C--N 1.313 -1.314 0 C-N-CA 123.785 -1.339 . . . . 0.0 110.816 0.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.501 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -128.22 159.97 33.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.393 -1.442 . . . . 0.0 109.233 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.524 ' O ' ' CG ' ' A' ' 160' ' ' GLN . 3.0 ttm -142.02 121.82 13.52 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.101 -0.999 . . . . 0.0 109.88 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.59 ' CD2' ' HB2' ' A' ' 160' ' ' GLN . 23.5 m-85 -122.89 145.77 48.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.139 -0.975 . . . . 0.0 109.644 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.795 HG13 ' O ' ' A' ' 21' ' ' GLN . 36.9 t -124.66 122.31 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.145 -0.972 . . . . 0.0 108.957 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.52 ' N ' ' O ' ' A' ' 20' ' ' PRO . 1.0 OUTLIER 50.95 24.99 2.02 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.804 -0.758 . . . . 0.0 108.989 -179.657 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.502 ' C ' HD13 ' A' ' 12' ' ' LEU . . . 51.3 20.84 5.38 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.466 -1.349 . . . . 0.0 110.325 -179.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -121.83 -19.92 6.58 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.819 -1.4 . . . . 0.0 108.867 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.586 ' CD2' ' HG3' ' A' ' 188' ' ' LYS . 19.6 m-85 -141.7 123.83 15.52 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.318 -0.864 . . . . 0.0 108.945 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.59 ' HB2' ' CD2' ' A' ' 154' ' ' PHE . 1.3 tt0 -130.29 126.56 37.54 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.279 -0.888 . . . . 0.0 109.389 -179.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.56 HD22 ' HB3' ' A' ' 9' ' ' TYR . 8.1 mt -59.46 179.26 0.12 Allowed 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . 0.481 ' OD1' ' N ' ' A' ' 162' ' ' ASN . 12.8 p-10 -153.22 107.67 2.62 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.071 -1.018 . . . . 0.0 109.777 -179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.03 50.08 3.19 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.306 2.004 . . . . 0.0 110.2 179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -101.39 -5.96 24.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.415 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 168' ' ' THR . . . -123.53 39.12 2.27 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.62 4.43 13.57 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.336 -1.096 . . . . 0.0 109.556 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -92.11 31.94 1.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.134 -0.979 . . . . 0.0 109.464 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 169' ' ' SER . 76.2 p -71.68 -20.49 61.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.938 . . . . 0.0 109.825 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 168' ' ' THR . 1.6 t 76.47 14.11 2.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -0.938 . . . . 0.0 109.457 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.448 ' OD1' ' HB ' ' A' ' 168' ' ' THR . 1.2 p30 -152.28 94.64 1.95 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.33 -0.857 . . . . 0.0 108.794 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 6.2 mtt -58.86 -15.36 12.2 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.361 -0.837 . . . . 0.0 109.882 -179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.75 -49.22 78.58 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 121.577 -0.702 . . . . 0.0 109.686 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 12.5 t -69.57 -29.14 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.188 -0.945 . . . . 0.0 109.854 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.485 ' O ' ' HB3' ' A' ' 178' ' ' TYR . 4.6 t80 -65.59 -36.62 84.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.015 -1.053 . . . . 0.0 109.466 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 93.3 t -81.2 -24.86 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.05 -1.031 . . . . 0.0 109.772 179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -53.48 6.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.025 -1.047 . . . . 0.0 109.402 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 2' ' ' GLN . 0.3 OUTLIER -65.91 -33.39 75.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.106 -0.996 . . . . 0.0 109.356 179.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 174' ' ' PHE . 2.5 t80 -70.13 -57.18 5.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 109.093 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -60.79 -29.92 69.74 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.301 -0.874 . . . . 0.0 109.341 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -73.27 -41.71 63.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.208 -0.933 . . . . 0.0 109.387 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.564 ' CG2' ' CG ' ' A' ' 8' ' ' GLN . 1.0 OUTLIER -62.37 -60.01 4.17 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.163 -0.961 . . . . 0.0 109.283 179.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.434 HG21 ' CE1' ' A' ' 178' ' ' TYR . 61.3 t -53.75 -32.68 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.06 -1.025 . . . . 0.0 109.198 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.0 -47.08 86.48 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.373 -0.829 . . . . 0.0 109.446 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.582 ' CD1' ' O ' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -85.56 -25.66 26.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.203 -0.936 . . . . 0.0 110.426 -179.293 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.624 HD21 ' CE2' ' A' ' 9' ' ' TYR . 4.1 mt -67.81 -20.64 65.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.489 -1.382 . . . . 0.0 108.856 179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.87 ' HB2' HG21 ' A' ' 54' ' ' VAL . 0.1 OUTLIER -69.95 -10.65 59.32 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -90.61 -4.62 56.7 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.55 -0.718 . . . . 0.0 109.359 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.586 ' HG3' ' CD2' ' A' ' 159' ' ' TYR . 48.4 mmtt -55.56 -33.17 63.63 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.156 -0.965 . . . . 0.0 109.159 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 188' ' ' LYS . 3.3 pptp? . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.288 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.463 ' O ' ' C ' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.509 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 0.8 OUTLIER 40.96 48.27 2.77 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.967 0.889 . . . . 0.0 109.037 -179.488 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.691 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 0.1 OUTLIER 72.32 98.13 0.07 Allowed 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -179.661 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 5' ' ' ASP . 3.0 tt0 -86.72 52.32 2.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 0.0 110.277 -179.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 4' ' ' GLU . 64.7 t0 39.82 81.01 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.796 -0.565 . . . . 0.0 109.906 179.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 119.19 -18.91 10.19 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 119.662 -1.256 . . . . 0.0 110.541 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.71 -67.32 0.77 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.902 -1.352 . . . . 0.0 108.769 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.593 ' HG2' ' CD1' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -96.4 4.0 52.49 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.21 -0.932 . . . . 0.0 109.806 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.557 ' O ' ' CD1' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -177.31 130.8 0.16 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 120.913 -1.117 . . . . 0.0 109.611 179.96 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.1 t -117.79 177.05 4.91 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.813 -0.555 . . . . 0.0 109.525 -178.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.7 m -100.17 160.22 14.49 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.374 0.607 . . . . 0.0 109.552 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.773 HD11 ' HD2' ' A' ' 154' ' ' PHE . 17.4 mt -95.69 133.96 39.16 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.315 -0.866 . . . . 0.0 109.779 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -72.63 -19.42 61.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 108.694 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -135.69 107.32 9.91 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 34.8 Cg_endo -76.08 158.34 37.98 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.412 2.075 . . . . 0.0 110.968 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 16' ' ' VAL . 46.1 t -128.72 87.43 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.418 -0.801 . . . . 0.0 109.38 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -47.52 133.05 13.42 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.453 ' O ' ' C ' ' A' ' 19' ' ' ALA . . . 95.82 -25.56 24.52 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 108.617 -1.793 . . . . 0.0 108.617 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.741 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -42.02 157.75 0.21 Allowed Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.401 -1.058 . . . . 0.0 109.367 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.571 ' HG2' ' CB ' ' A' ' 23' ' ' LEU . 35.2 Cg_endo -78.4 135.42 13.31 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.504 2.136 . . . . 0.0 111.015 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.804 ' O ' HG13 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -44.25 -24.03 0.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.411 -0.806 . . . . 0.0 109.764 179.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.766 HG13 ' CE ' ' A' ' 153' ' ' MET . 42.4 t -149.83 80.55 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.022 -1.049 . . . . 0.0 108.896 179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.877 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -72.06 124.94 26.03 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 57' ' ' THR . 1.0 OUTLIER -106.5 125.29 50.81 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.211 -0.931 . . . . 0.0 109.614 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.877 ' CE2' HD13 ' A' ' 23' ' ' LEU . 6.3 m-85 -115.73 110.32 18.95 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.466 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -150.79 145.36 25.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.176 -0.953 . . . . 0.0 109.639 -179.438 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.986 ' HB3' HG22 ' A' ' 61' ' ' VAL . 32.8 p -126.03 -163.86 1.26 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.203 -0.935 . . . . 0.0 108.83 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.67 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 0.4 OUTLIER -118.65 55.95 0.9 Allowed 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.152 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.673 ' CE1' HD22 ' A' ' 72' ' ' LEU . 12.2 m-85 -138.88 2.14 2.13 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.221 -0.991 . . . . 0.0 110.453 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.516 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.2 OUTLIER -113.91 172.46 3.56 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 120.658 -1.276 . . . . 0.0 109.765 -179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.516 ' HD2' ' CB ' ' A' ' 30' ' ' CYS . 32.8 Cg_endo -75.04 -49.84 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.481 2.12 . . . . 0.0 108.835 179.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 18.5 m80 -73.11 -25.63 60.94 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 177.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -46.85 -41.14 15.17 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.109 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.501 ' CG ' ' OE1' ' A' ' 97' ' ' GLN . 3.7 t80 -88.44 -44.13 10.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.601 -0.687 . . . . 0.0 110.171 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 40' ' ' LEU . 46.0 mt-30 -72.43 -24.49 61.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.986 -1.071 . . . . 0.0 110.924 -178.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 32' ' ' HIS . 1.6 t80 -80.45 -16.76 53.61 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.938 -1.101 . . . . 0.0 110.388 -179.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.51 ' O ' ' CG ' ' A' ' 38' ' ' GLU . 1.6 tt0 -131.96 50.99 2.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.892 -1.13 . . . . 0.0 110.381 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.51 ' CG ' ' O ' ' A' ' 37' ' ' GLU . 0.7 OUTLIER -171.29 -62.88 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.033 -1.042 . . . . 0.0 110.55 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 52.1 t -94.77 -53.58 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.024 -1.047 . . . . 0.0 110.575 -178.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 35' ' ' GLN . 22.6 mt -48.86 -20.18 0.47 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.169 -0.957 . . . . 0.0 110.58 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.6 m-70 47.93 31.67 2.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.889 -1.132 . . . . 0.0 108.852 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.856 ' O ' HG13 ' A' ' 46' ' ' VAL . 4.3 mt -83.46 -41.84 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.53 -0.731 . . . . 0.0 109.993 -179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.461 ' O ' HG22 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -80.0 -17.84 51.82 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.984 -1.073 . . . . 0.0 110.557 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 44' ' ' ASP . 2.2 m-20 -87.3 -39.02 15.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.935 -1.103 . . . . 0.0 110.074 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 -71.66 -33.76 69.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.118 -0.989 . . . . 0.0 109.994 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.856 HG13 ' O ' ' A' ' 42' ' ' ILE . 30.5 m -55.74 -35.84 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.22 -0.925 . . . . 0.0 109.771 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 9.1 mtpt -54.38 -46.42 73.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.198 -0.939 . . . . 0.0 109.562 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.96 -26.77 38.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.269 -0.895 . . . . 0.0 109.494 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.504 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 2.5 mmtm -89.27 20.61 3.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.365 -0.834 . . . . 0.0 110.308 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.01 HD11 ' SD ' ' A' ' 56' ' ' MET . 35.8 mt -114.02 87.37 12.78 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 120.987 -1.07 . . . . 0.0 109.714 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 36.3 Cg_endo -78.19 64.36 8.38 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.599 2.199 . . . . 0.0 111.01 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.503 ' O ' ' O ' ' A' ' 51' ' ' PRO . 0.7 OUTLIER 56.85 130.74 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.638 0.732 . . . . 0.0 110.516 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.29 -21.18 31.5 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.996 HG11 HD22 ' A' ' 50' ' ' LEU . 1.2 t -91.03 87.72 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.418 -1.048 . . . . 0.0 108.833 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.1 mttm -77.6 97.03 4.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.952 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 1.01 ' SD ' HD11 ' A' ' 50' ' ' LEU . 63.4 mtp -95.83 97.1 9.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.12 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.506 ' O ' ' N ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER -91.82 135.57 33.81 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.617 -179.663 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.454 ' HG3' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -109.19 116.88 32.75 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.382 -0.824 . . . . 0.0 110.271 -179.419 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 3.2 m-85 -117.18 175.15 5.73 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.132 -0.98 . . . . 0.0 110.787 179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.636 ' NE2' HD21 ' A' ' 72' ' ' LEU . 2.6 t60 -112.15 141.38 45.92 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.683 0.754 . . . . 0.0 109.203 -179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 1.072 HG11 ' CG1' ' A' ' 150' ' ' VAL . 3.2 m -77.09 155.71 5.49 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-O 121.3 0.571 . . . . 0.0 109.847 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.518 ' OD1' ' CB ' ' A' ' 142' ' ' ALA . 0.9 OUTLIER -124.79 36.73 4.54 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.403 -0.811 . . . . 0.0 108.822 179.391 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.564 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 6.3 p90 -136.11 52.55 1.97 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.172 -0.955 . . . . 0.0 109.817 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.477 ' HG2' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -155.91 47.99 0.49 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.58 ' O ' ' N ' ' A' ' 69' ' ' GLY . . . 158.36 61.33 0.01 OUTLIER Glycine 0 N--CA 1.485 1.916 0 N-CA-C 107.829 -2.108 . . . . 0.0 107.829 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.521 ' C ' ' O ' ' A' ' 65' ' ' GLY . . . -28.78 -40.57 0.02 OUTLIER Glycine 0 N--CA 1.498 2.792 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 65' ' ' GLY . 71.2 m-20 -88.94 -78.26 0.35 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -1.125 . . . . 0.0 110.663 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.126 HD13 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -79.87 -22.36 42.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.957 -1.089 . . . . 0.0 110.51 -178.868 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 1.126 ' N ' HD13 ' A' ' 68' ' ' LEU . . . -53.95 -43.75 71.8 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.719 -1.752 . . . . 0.0 108.719 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.479 ' HD3' ' O ' ' A' ' 70' ' ' LYS . 1.8 tmtp? -64.86 -45.93 84.01 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.065 -1.256 . . . . 0.0 108.258 179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.54 ' HB3' ' CD1' ' A' ' 108' ' ' ILE . 1.5 t70 -66.03 -31.65 72.67 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 178.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.754 ' O ' ' HB3' ' A' ' 75' ' ' ALA . 15.5 tp -53.79 -49.66 67.81 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.514 HG23 ' CD ' ' A' ' 138' ' ' GLN . 1.3 m -57.33 -43.71 83.61 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 1.009 ' O ' HG23 ' A' ' 78' ' ' VAL . 2.5 tm0? -57.07 -25.26 58.4 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 177.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.754 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -64.44 -44.07 92.31 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -57.46 -33.04 67.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.568 ' HB1' HG23 ' A' ' 135' ' ' VAL . . . -79.53 -51.05 9.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.395 -0.816 . . . . 0.0 110.159 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 1.009 HG23 ' O ' ' A' ' 74' ' ' GLN . 1.7 t -62.74 -27.41 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.068 -1.02 . . . . 0.0 109.641 -179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.606 ' HA ' HG22 ' A' ' 84' ' ' VAL . . . -77.95 -61.88 1.85 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.043 -1.036 . . . . 0.0 109.36 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.648 ' HB3' HD13 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -44.71 -27.29 0.48 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.227 -0.921 . . . . 0.0 108.951 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.624 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -68.71 -44.46 73.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.365 -0.834 . . . . 0.0 109.4 179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.677 ' HB2' HG13 ' A' ' 84' ' ' VAL . 21.9 mt -108.49 16.29 23.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.238 -0.914 . . . . 0.0 110.243 -179.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.09 29.83 4.95 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.677 HG13 ' HB2' ' A' ' 82' ' ' LEU . 34.8 m -85.73 -3.89 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -1.17 . . . . 0.0 110.066 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 86' ' ' ASP . 0.8 OUTLIER -45.1 -73.23 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.09 -1.006 . . . . 0.0 109.911 -179.806 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -39.27 -35.12 0.23 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.598 -0.689 . . . . 0.0 110.603 -179.615 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.789 ' HE3' ' HB1' ' A' ' 115' ' ' ALA . 25.7 mtpp -80.54 -52.78 7.21 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.943 . . . . 0.0 111.301 -178.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.761 ' O ' HD12 ' A' ' 92' ' ' LEU . 2.6 m -84.28 -9.46 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.745 -1.222 . . . . 0.0 110.944 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.753 HG23 ' CE1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -73.68 -45.37 52.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.758 -1.214 . . . . 0.0 108.455 178.632 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.424 ' N ' ' HD2' ' A' ' 91' ' ' PRO . 2.1 t -51.93 -53.94 46.0 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 120.556 -1.34 . . . . 0.0 110.757 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.541 ' HG2' ' CG1' ' A' ' 111' ' ' VAL . 24.0 Cg_endo -72.96 -17.74 24.88 Favored 'Trans proline' 0 C--N 1.3 -2.013 0 N-CA-C 109.65 -0.942 . . . . 0.0 109.65 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.848 ' HG ' HG11 ' A' ' 111' ' ' VAL . 6.4 mt -86.19 -44.4 12.22 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.753 ' CE1' HG23 ' A' ' 89' ' ' THR . 7.2 m-30 -62.04 -47.52 84.34 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 120.906 -1.121 . . . . 0.0 108.674 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.413 ' HA ' ' HB2' ' A' ' 97' ' ' GLN . 46.8 mt-10 -69.03 -34.81 75.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.025 -1.047 . . . . 0.0 109.554 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.457 ' C ' HG13 ' A' ' 102' ' ' ILE . . . -64.71 -31.99 82.72 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 92' ' ' LEU . 1.9 t -107.8 8.12 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.984 -1.303 . . . . 0.0 109.568 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.501 ' OE1' ' CG ' ' A' ' 34' ' ' TYR . 11.5 mt-30 -97.75 5.75 48.79 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.915 -1.116 . . . . 0.0 110.296 -179.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.01 -49.45 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.803 -1.186 . . . . 0.0 110.631 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.492 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 1.4 p -55.05 -42.05 72.22 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.299 -1.501 . . . . 0.0 109.544 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 99' ' ' THR . 2.6 mm-40 67.62 10.5 7.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.391 -0.818 . . . . 0.0 110.126 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.3 t -83.67 -8.29 59.31 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.744 0.783 . . . . 0.0 109.102 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.62 ' CB ' HG22 ' A' ' 96' ' ' VAL . 16.3 mm -79.55 66.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 108.993 -0.744 . . . . 0.0 108.993 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.457 ' HD3' ' C ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -127.25 31.75 5.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.274 -0.891 . . . . 0.0 109.585 -179.572 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.551 ' O ' ' N ' ' A' ' 107' ' ' ASP . 16.8 p -147.94 127.77 13.49 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.044 -1.035 . . . . 0.0 110.146 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.48 ' HA ' HD12 ' A' ' 108' ' ' ILE . . . -49.56 -29.8 7.55 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 27.8 t -63.71 -34.29 77.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.597 ' OD1' HG23 ' A' ' 102' ' ' ILE . 0.7 OUTLIER -68.3 -46.41 70.37 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.556 ' CG1' HD23 ' A' ' 68' ' ' LEU . 19.0 mt -52.39 -29.5 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.448 ' O ' HG13 ' A' ' 113' ' ' ILE . 0.1 OUTLIER -73.24 -39.43 65.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.583 -0.698 . . . . 0.0 109.121 179.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.422 ' O ' ' OD1' ' A' ' 114' ' ' ASN . 14.5 m-20 -56.34 -45.4 80.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.317 -0.864 . . . . 0.0 109.406 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.848 HG11 ' HG ' ' A' ' 92' ' ' LEU . 15.4 t -70.96 -38.59 72.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.41 ' CE2' ' HE2' ' A' ' 122' ' ' TYR . 2.9 m-85 -65.75 -32.36 73.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.445 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.448 HG13 ' O ' ' A' ' 109' ' ' ARG . 16.1 mt -79.4 -25.13 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.253 -0.905 . . . . 0.0 110.025 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.422 ' OD1' ' O ' ' A' ' 110' ' ' ASP . 17.5 m-20 -70.17 -23.65 63.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.974 -1.079 . . . . 0.0 109.697 -179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.789 ' HB1' ' HE3' ' A' ' 87' ' ' LYS . . . -85.21 2.57 43.22 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.271 -0.893 . . . . 0.0 109.482 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.551 ' C ' HD13 ' A' ' 117' ' ' ILE . . . 92.78 8.99 61.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.718 HD13 ' N ' ' A' ' 117' ' ' ILE . 1.4 mm -94.4 58.5 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.274 -1.133 . . . . 0.0 109.549 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 117' ' ' ILE . 56.5 mttt -37.1 154.99 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.228 -0.92 . . . . 0.0 110.295 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 123' ' ' ASP . . . -50.78 -27.71 13.95 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -67.7 -43.43 80.09 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -1.146 . . . . 0.0 109.369 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.17 -46.99 19.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.536 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.895 ' CE2' HG11 ' A' ' 78' ' ' VAL . 5.8 t80 -63.52 -47.08 83.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.177 -0.952 . . . . 0.0 109.52 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.472 ' HB3' ' O ' ' A' ' 119' ' ' GLY . 30.5 t0 -61.38 -53.18 59.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.148 -0.97 . . . . 0.0 109.176 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -48.21 -53.67 16.17 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.431 -0.793 . . . . 0.0 109.288 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.623 ' HB1' HG21 ' A' ' 131' ' ' VAL . . . -48.23 -55.75 9.7 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.426 ' CG ' ' NE2' ' A' ' 74' ' ' GLN . 8.5 t90 -53.29 -59.18 4.9 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -55.14 -15.81 2.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.573 -0.705 . . . . 0.0 109.985 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 7.7 m -69.67 176.97 3.21 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.071 -1.018 . . . . 0.0 109.891 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -89.57 -39.62 13.16 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.335 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.3 t -68.39 -47.16 78.93 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 C-N-CA 118.238 -1.385 . . . . 0.0 109.752 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.624 HG22 ' HB1' ' A' ' 81' ' ' ALA . 2.8 t -62.95 -34.54 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.904 -1.123 . . . . 0.0 108.399 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -67.33 -28.3 67.86 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.182 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.412 ' O ' ' HB2' ' A' ' 137' ' ' GLN . 1.8 m -69.93 -35.51 74.59 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.648 HD13 ' HB3' ' A' ' 80' ' ' MET . 0.2 OUTLIER -79.09 -19.08 52.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.175 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.568 HG23 ' HB1' ' A' ' 77' ' ' ALA . 10.2 t -82.25 -47.46 19.04 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.257 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.33 -35.59 81.36 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.41 -0.806 . . . . 0.0 108.841 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 133' ' ' SER . 0.9 OUTLIER -69.88 -37.39 76.04 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.401 -0.812 . . . . 0.0 109.025 179.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.514 ' CD ' HG23 ' A' ' 73' ' ' THR . 0.0 OUTLIER -65.4 -68.38 0.37 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.0 108.988 179.519 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -47.71 -36.41 11.24 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.219 -0.926 . . . . 0.0 108.586 179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.432 ' O ' ' HG2' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -71.91 -30.91 65.85 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.397 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 138' ' ' GLN . . . -61.11 -59.74 4.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.361 -0.837 . . . . 0.0 108.846 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.537 ' O ' ' CA ' ' A' ' 146' ' ' GLN . . . -67.47 -26.76 66.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.358 -0.838 . . . . 0.0 109.508 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.72 -22.79 46.05 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.16 -0.963 . . . . 0.0 109.884 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -82.22 -43.73 17.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.104 -0.997 . . . . 0.0 108.475 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.824 HG21 ' CE2' ' A' ' 25' ' ' PHE . 18.4 m -98.36 -5.6 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.537 ' CA ' ' O ' ' A' ' 142' ' ' ALA . 2.1 tt0 75.21 -53.34 0.66 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.491 -0.756 . . . . 0.0 109.793 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.8 HD21 HG12 ' A' ' 61' ' ' VAL . 13.6 tp 69.57 135.03 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 5.7 ptt85 -160.18 35.7 0.17 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.457 -1.402 . . . . 0.0 110.219 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 161.93 108.56 0.23 Allowed Glycine 0 N--CA 1.488 2.164 0 C-N-CA 119.192 -1.48 . . . . 0.0 110.559 179.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 1.072 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -89.62 144.31 31.74 Favored Pre-proline 0 N--CA 1.496 1.845 0 O-C-N 121.405 -1.056 . . . . 0.0 109.225 178.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.18 152.25 94.29 Favored 'Cis proline' 0 C--N 1.313 -1.304 0 C-N-CA 124.009 -1.246 . . . . 0.0 110.779 0.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -129.4 139.46 51.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.453 -1.404 . . . . 0.0 108.983 179.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.766 ' CE ' HG13 ' A' ' 22' ' ' VAL . 19.9 ttt -140.97 128.05 20.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.98 -1.075 . . . . 0.0 110.179 -179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.773 ' HD2' HD11 ' A' ' 12' ' ' LEU . 2.5 m-85 -126.28 137.12 53.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.232 -0.918 . . . . 0.0 109.634 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' ' 21' ' ' GLN . 54.7 t -99.25 133.72 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.159 -0.963 . . . . 0.0 110.263 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.741 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 3.9 t30 42.45 24.47 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.16 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.532 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 56.81 59.22 11.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.262 -1.935 . . . . 0.0 108.262 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.484 ' N ' HD12 ' A' ' 12' ' ' LEU . 6.7 tttt -166.65 -36.23 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.439 -1.036 . . . . 0.0 108.294 -179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.495 ' HB2' ' HB ' ' A' ' 155' ' ' VAL . 10.7 m-85 -114.59 122.83 47.73 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.224 -0.922 . . . . 0.0 109.105 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.589 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -113.34 109.59 18.97 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.26 -0.9 . . . . 0.0 109.963 -179.231 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.692 HD12 ' SD ' ' A' ' 153' ' ' MET . 15.3 mt -60.25 -179.86 0.12 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -151.1 125.76 4.62 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.084 -1.01 . . . . 0.0 109.559 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.505 ' C ' ' CG ' ' A' ' 164' ' ' GLN . 36.5 Cg_endo -79.4 -14.37 13.11 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.514 2.143 . . . . 0.0 110.688 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.505 ' CG ' ' C ' ' A' ' 163' ' ' PRO . 0.8 OUTLIER 41.89 27.71 0.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.301 -0.875 . . . . 0.0 109.617 -179.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 163' ' ' PRO . . . 45.26 30.9 2.99 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . 0.51 ' O ' HG22 ' A' ' 168' ' ' THR . 1.4 mmt -104.12 -110.39 0.26 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.137 -1.213 . . . . 0.0 109.305 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 166' ' ' MET . 36.4 t70 44.03 30.25 0.4 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.812 -1.18 . . . . 0.0 109.72 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 166' ' ' MET . 0.5 OUTLIER -131.02 25.16 4.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.035 -1.04 . . . . 0.0 109.785 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 84.0 p -115.23 -37.57 4.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 109.463 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -160.23 90.72 0.9 Allowed 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.351 -0.843 . . . . 0.0 108.953 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . 0.409 ' O ' HG23 ' A' ' 175' ' ' VAL . 0.6 OUTLIER -58.41 -15.74 11.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.292 -0.88 . . . . 0.0 110.025 -179.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.26 -58.93 2.98 Favored 'General case' 0 C--N 1.292 -1.904 0 O-C-N 121.63 -0.669 . . . . 0.0 109.579 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 6.5 t -68.48 -30.58 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.308 -0.87 . . . . 0.0 109.374 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.538 ' O ' ' CB ' ' A' ' 178' ' ' TYR . 0.6 OUTLIER -69.95 -30.83 68.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.139 -0.976 . . . . 0.0 109.018 179.595 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.782 HG22 HG12 ' A' ' 42' ' ' ILE . 7.7 t -76.15 -31.74 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.146 -0.971 . . . . 0.0 108.892 179.316 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 4.6 tp60 -80.82 -64.65 1.14 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.212 -0.93 . . . . 0.0 109.052 179.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 3.3 tm0? -49.8 -40.87 43.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.317 -0.864 . . . . 0.0 109.41 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 174' ' ' PHE . 56.4 t80 -63.61 -50.74 68.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.939 . . . . 0.0 109.369 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -53.65 -24.73 15.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.382 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -78.96 -51.08 10.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.645 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.742 ' O ' HD23 ' A' ' 185' ' ' LEU . 90.5 m -55.17 -27.17 43.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.116 -0.99 . . . . 0.0 109.454 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.404 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 43.0 t -87.52 -35.74 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.067 -1.021 . . . . 0.0 108.672 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -43.56 81.04 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.418 -0.801 . . . . 0.0 108.96 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.522 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -82.01 -39.62 23.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.357 -0.84 . . . . 0.0 109.057 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.77 HD12 HG21 ' A' ' 155' ' ' VAL . 1.1 mm? -53.41 -20.67 4.84 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.952 -1.092 . . . . 0.0 109.391 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.728 ' CB ' HG13 ' A' ' 54' ' ' VAL . 19.6 p -74.81 -8.01 55.14 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 120.65 -1.282 . . . . 0.0 108.352 178.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 189' ' ' LYS . 1.3 mm-40 -102.13 5.83 40.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.411 -0.806 . . . . 0.0 109.091 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.53 ' O ' ' CG ' ' A' ' 189' ' ' LYS . 0.0 OUTLIER -54.11 -36.84 63.66 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.259 -0.901 . . . . 0.0 109.656 -179.647 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.53 ' CG ' ' O ' ' A' ' 188' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.731 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.772 ' HB3' ' HB2' ' A' ' 4' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.493 ' C ' ' CG ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER 40.45 47.56 2.29 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.883 0.849 . . . . 0.0 109.248 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.588 ' CD1' ' OE1' ' A' ' 8' ' ' GLN . 0.9 OUTLIER 73.12 96.63 0.07 Allowed 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.8 -0.562 . . . . 0.0 109.504 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.772 ' HB2' ' HB3' ' A' ' 1' ' ' ALA . 2.0 tt0 -124.9 62.56 1.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.91 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 48.3 t0 45.23 84.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.424 -0.798 . . . . 0.0 109.403 179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 136.06 -32.44 2.5 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.997 -1.241 . . . . 0.0 109.997 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -70.27 0.52 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.958 -1.319 . . . . 0.0 108.716 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.588 ' OE1' ' CD1' ' A' ' 3' ' ' TYR . 9.3 pt20 -96.65 0.09 49.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.154 -0.966 . . . . 0.0 109.944 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.511 ' O ' ' N ' ' A' ' 6' ' ' GLY . 1.2 p90 178.93 133.34 0.08 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.831 -1.168 . . . . 0.0 109.772 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.7 t -110.54 179.15 4.15 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -115.65 144.46 43.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.341 -0.849 . . . . 0.0 109.778 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.546 HD11 ' HD2' ' A' ' 154' ' ' PHE . 1.9 mt -95.45 144.06 26.27 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.434 -0.791 . . . . 0.0 109.59 -179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -66.91 -22.26 65.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.887 . . . . 0.0 108.857 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -127.57 102.13 23.39 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.429 -0.795 . . . . 0.0 109.026 179.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HB3' ' HG3' ' A' ' 158' ' ' LYS . 34.2 Cg_endo -76.43 163.23 32.49 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.503 2.135 . . . . 0.0 110.846 -179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.498 ' HB ' ' HA3' ' A' ' 157' ' ' GLY . 38.2 t -123.13 92.14 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.357 -0.84 . . . . 0.0 109.826 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.4 132.74 51.99 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 19' ' ' ALA . . . 96.77 -25.74 25.21 Favored Glycine 0 N--CA 1.485 1.906 0 N-CA-C 108.736 -1.746 . . . . 0.0 108.736 -179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.735 ' HB3' ' C ' ' A' ' 156' ' ' ASN . . . -42.49 162.75 0.15 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.371 -1.076 . . . . 0.0 109.699 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.608 ' HD2' ' HB1' ' A' ' 19' ' ' ALA . 36.2 Cg_endo -77.86 137.38 15.8 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.758 2.305 . . . . 0.0 111.206 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.781 ' O ' HG13 ' A' ' 155' ' ' VAL . 30.3 mm-40 -47.4 -22.36 0.43 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.432 -0.792 . . . . 0.0 109.913 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 56' ' ' MET . 55.7 t -151.41 82.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.014 -1.054 . . . . 0.0 108.968 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.771 HD13 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -76.66 121.33 23.09 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.11 -0.994 . . . . 0.0 108.341 -179.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.558 ' CB ' ' HA ' ' A' ' 58' ' ' LYS . 0.0 OUTLIER -98.27 139.54 33.91 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.224 -0.923 . . . . 0.0 110.025 -179.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.989 ' CE2' HG21 ' A' ' 145' ' ' VAL . 7.0 m-85 -127.76 101.96 6.59 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.467 ' O ' ' CD1' ' A' ' 26' ' ' PHE . 0.7 OUTLIER -143.11 143.24 31.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.032 -1.042 . . . . 0.0 109.779 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.993 ' HB2' HG22 ' A' ' 61' ' ' VAL . 0.3 OUTLIER -120.43 -179.07 3.85 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.245 -0.91 . . . . 0.0 109.599 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.543 ' CD1' ' CE1' ' A' ' 93' ' ' PHE . 12.1 m-30 -98.48 47.4 0.99 Allowed 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.725 ' CG ' HG11 ' A' ' 96' ' ' VAL . 28.4 m-85 -142.22 13.75 2.02 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.433 -0.792 . . . . 0.0 109.967 -179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.503 ' O ' ' NE2' ' A' ' 97' ' ' GLN . 0.5 OUTLIER -105.29 157.28 34.74 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.728 -1.233 . . . . 0.0 109.459 179.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -73.7 -27.16 12.95 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.209 1.939 . . . . 0.0 108.252 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 36' ' ' PHE . 27.0 m80 -90.93 -22.66 20.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 177.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' A' ' 28' ' ' PHE . 13.0 t -47.04 -49.92 20.47 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.473 ' CD1' ' C ' ' A' ' 34' ' ' TYR . 9.6 t80 -75.03 -33.65 61.8 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.838 -179.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.522 ' O ' ' N ' ' A' ' 40' ' ' LEU . 1.3 mm-40 -83.36 -45.59 13.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.867 -1.146 . . . . 0.0 110.85 -178.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.624 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -48.47 -24.63 1.34 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.104 -0.997 . . . . 0.0 110.578 -179.252 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -114.79 -51.26 2.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.919 -1.113 . . . . 0.0 112.334 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.405 ' OE1' ' HA ' ' A' ' 38' ' ' GLU . 63.3 mm-40 -90.15 0.32 57.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.689 -1.257 . . . . 0.0 111.534 -177.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.457 ' HB ' ' HA ' ' A' ' 35' ' ' GLN . 41.3 t -135.76 -74.58 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.676 -1.265 . . . . 0.0 109.581 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.522 ' N ' ' O ' ' A' ' 35' ' ' GLN . 78.1 mt -64.06 -24.74 67.82 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.236 -0.915 . . . . 0.0 109.561 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 3.3 m80 51.18 21.55 1.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.988 -1.07 . . . . 0.0 109.201 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.624 HG21 ' CZ ' ' A' ' 36' ' ' PHE . 37.6 mt -63.5 -21.27 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.328 -0.858 . . . . 0.0 109.757 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -60.1 2.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -0.945 . . . . 0.0 109.661 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -57.66 -30.5 65.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.903 . . . . 0.0 109.804 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -66.59 -34.48 77.99 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.179 -0.951 . . . . 0.0 109.721 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.7 t -72.25 -16.85 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.048 -1.032 . . . . 0.0 109.191 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 mttp -82.46 -41.41 19.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.307 -0.87 . . . . 0.0 110.088 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.18 -22.44 0.65 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.073 -1.017 . . . . 0.0 109.662 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.433 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 1.3 ptmm? -115.62 42.05 2.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.224 -0.922 . . . . 0.0 109.631 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 50' ' ' LEU . 10.9 mt -108.16 101.74 43.12 Favored Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.17 -0.956 . . . . 0.0 109.752 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 49' ' ' LYS . 33.5 Cg_endo -74.93 153.9 42.46 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.536 2.157 . . . . 0.0 109.408 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 52' ' ' GLU . 73.2 tt0 -69.5 22.21 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.742 -1.223 . . . . 0.0 111.548 -179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.416 ' C ' HG23 ' A' ' 54' ' ' VAL . . . -122.45 32.11 4.61 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.47 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.528 ' CG1' ' HB3' ' A' ' 186' ' ' SER . 59.0 t -153.39 127.16 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.47 105.43 17.4 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.297 -0.877 . . . . 0.0 110.766 -178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.512 ' HA ' ' HB ' ' A' ' 22' ' ' VAL . 0.1 OUTLIER -104.36 99.1 8.8 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.718 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 1.3 m -100.37 135.04 42.42 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 118.714 -1.195 . . . . 0.0 110.982 -178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.558 ' HA ' ' CB ' ' A' ' 24' ' ' GLU . 6.7 tttt -106.84 117.81 35.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.515 ' CE2' ' HA ' ' A' ' 138' ' ' GLN . 2.6 m-85 -118.08 170.76 8.59 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.909 -1.12 . . . . 0.0 111.706 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.948 ' NE2' HD21 ' A' ' 72' ' ' LEU . 1.9 t-160 -111.09 136.4 50.18 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.727 0.775 . . . . 0.0 109.236 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.993 HG22 ' HB2' ' A' ' 27' ' ' SER . 3.1 m -78.9 155.55 4.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-O 121.398 0.618 . . . . 0.0 110.272 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.453 ' HB3' ' OG1' ' A' ' 73' ' ' THR . 1.0 OUTLIER -124.4 35.82 4.74 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.031 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.563 ' CG ' ' O ' ' A' ' 63' ' ' PHE . 9.7 p90 -135.77 55.73 1.86 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.295 -0.878 . . . . 0.0 109.608 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.629 ' CE ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -130.36 37.11 3.9 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.162 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.21 -33.28 0.42 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 107.982 -2.047 . . . . 0.0 107.982 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.19 -37.07 2.72 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.688 -0.965 . . . . 0.0 110.688 179.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -87.84 -79.35 0.29 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.004 -1.292 . . . . 0.0 110.464 -179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.888 HD22 ' C ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -79.87 -18.5 50.52 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.93 -1.106 . . . . 0.0 109.618 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.652 ' N ' HD22 ' A' ' 68' ' ' LEU . . . -54.95 -36.34 60.34 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.315 -1.914 . . . . 0.0 108.315 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.27 -45.65 79.76 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.325 -1.103 . . . . 0.0 108.36 179.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.544 ' HB3' HD12 ' A' ' 108' ' ' ILE . 18.2 t0 -66.9 -24.7 66.13 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.948 HD21 ' NE2' ' A' ' 60' ' ' HIS . 0.3 OUTLIER -65.55 -46.86 77.89 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.888 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.46 HG22 HE21 ' A' ' 138' ' ' GLN . 1.6 m -56.04 -41.71 75.44 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.575 ' O ' HG23 ' A' ' 78' ' ' VAL . 6.0 tp60 -61.4 -23.78 66.04 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 177.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 72' ' ' LEU . . . -63.65 -37.33 86.95 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.593 ' HB2' ' HB2' ' A' ' 60' ' ' HIS . 20.7 t-105 -71.29 -32.26 68.44 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.528 -0.733 . . . . 0.0 109.142 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.53 ' HB2' ' NE2' ' A' ' 138' ' ' GLN . . . -75.75 -40.34 55.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.178 -0.951 . . . . 0.0 109.467 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.726 HG21 ' CE1' ' A' ' 122' ' ' TYR . 35.6 t -74.55 -26.24 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.288 -0.882 . . . . 0.0 109.655 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.553 ' HA ' ' CG2' ' A' ' 84' ' ' VAL . . . -79.1 -57.87 3.52 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.944 -1.097 . . . . 0.0 108.776 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.85 -26.59 10.33 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.703 ' HB1' HG22 ' A' ' 131' ' ' VAL . . . -68.14 -47.2 68.72 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.642 -0.661 . . . . 0.0 109.397 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.535 ' HB2' HG13 ' A' ' 84' ' ' VAL . 44.8 mt -106.12 14.02 28.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.104 -0.997 . . . . 0.0 110.373 -179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 79' ' ' ALA . . . 50.24 24.89 7.42 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 79' ' ' ALA . 28.2 m -86.25 -4.16 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.454 -1.027 . . . . 0.0 110.482 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 89' ' ' THR . 2.7 pt-20 -42.44 -59.11 1.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.047 -1.033 . . . . 0.0 109.897 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.68 -31.41 11.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.169 -0.957 . . . . 0.0 109.828 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 84' ' ' VAL . 46.3 mttp -78.65 -52.88 7.79 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.53 -0.731 . . . . 0.0 111.478 -178.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.828 HG23 HD12 ' A' ' 92' ' ' LEU . 1.0 OUTLIER -85.92 -8.63 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.752 -1.217 . . . . 0.0 111.053 -178.111 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.744 HG23 ' CD1' ' A' ' 93' ' ' PHE . 0.9 OUTLIER -75.07 -44.98 44.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.729 -1.232 . . . . 0.0 108.679 178.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.424 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.1 t -52.61 -53.27 55.74 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 120.472 -1.392 . . . . 0.0 110.627 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.651 ' HB2' HG13 ' A' ' 111' ' ' VAL . 27.2 Cg_endo -73.28 -18.63 23.21 Favored 'Trans proline' 0 C--N 1.299 -2.032 0 N-CA-C 109.737 -0.909 . . . . 0.0 109.737 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.857 ' HG ' HG11 ' A' ' 111' ' ' VAL . 14.9 mt -86.83 -42.97 12.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.264 -0.898 . . . . 0.0 108.982 178.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.744 ' CD1' HG23 ' A' ' 89' ' ' THR . 5.1 m-30 -64.81 -46.66 81.04 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.889 -1.132 . . . . 0.0 108.87 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -71.78 -22.24 61.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.23 -0.919 . . . . 0.0 109.314 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.442 ' O ' ' OG1' ' A' ' 99' ' ' THR . . . -78.98 -31.02 44.79 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.725 HG11 ' CG ' ' A' ' 29' ' ' PHE . 2.8 t -105.73 6.63 10.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.179 -1.189 . . . . 0.0 109.325 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 93' ' ' PHE . 40.5 mm-40 -105.21 9.13 34.17 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 120.974 -1.079 . . . . 0.0 110.514 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.487 ' CG ' ' O ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER 173.27 -49.69 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.654 -1.278 . . . . 0.0 110.443 179.643 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 100' ' ' GLN . 59.7 p -55.32 -44.53 75.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.608 -1.308 . . . . 0.0 109.297 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 99' ' ' THR . 0.1 OUTLIER 71.41 12.04 6.62 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 110.285 179.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 t -79.63 -7.78 58.77 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.628 ' CB ' HG22 ' A' ' 96' ' ' VAL . 7.7 mm -84.95 73.32 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.12 33.37 3.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.883 . . . . 0.0 109.605 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 107' ' ' ASP . 14.7 p -160.45 133.24 6.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 0.0 110.056 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.532 ' N ' ' HB3' ' A' ' 68' ' ' LEU . . . -50.81 -34.76 28.96 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 31.9 p -61.59 -31.6 71.67 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 104' ' ' SER . 0.2 OUTLIER -70.6 -51.24 29.56 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.731 HD11 HD23 ' A' ' 68' ' ' LEU . 52.5 mt -48.66 -29.94 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.89 -38.54 53.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.485 -0.759 . . . . 0.0 109.551 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -57.18 -44.32 83.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 109.438 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.857 HG11 ' HG ' ' A' ' 92' ' ' LEU . 69.9 t -72.62 -38.17 58.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.095 -1.003 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.63 -42.74 98.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.125 -0.984 . . . . 0.0 109.62 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.5 mt -71.5 -24.29 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.099 -1.001 . . . . 0.0 109.271 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -67.29 -19.65 65.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.362 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.672 ' HB3' HD13 ' A' ' 117' ' ' ILE . . . -91.75 -12.03 35.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.366 -0.834 . . . . 0.0 109.253 179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 112.98 -7.96 25.4 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.823 HG22 ' O ' ' A' ' 117' ' ' ILE . 1.9 mp -76.93 52.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.315 -1.109 . . . . 0.0 109.478 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 117' ' ' ILE . 35.5 mttm -40.46 154.43 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.035 -1.041 . . . . 0.0 109.769 -179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -51.75 -35.7 39.24 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -58.48 -56.27 24.31 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.045 -1.268 . . . . 0.0 110.018 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -46.86 87.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.24 -0.912 . . . . 0.0 109.946 -179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.726 ' CE1' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -62.86 -62.64 1.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.561 -179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 122' ' ' TYR . 13.8 t70 -42.52 -35.08 0.97 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.133 -0.979 . . . . 0.0 109.768 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -78.95 -41.87 28.27 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.242 -0.911 . . . . 0.0 109.698 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . 0.535 ' O ' ' CG2' ' A' ' 131' ' ' VAL . . . -58.57 -48.29 81.43 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.303 -0.873 . . . . 0.0 108.795 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.53 ' CD1' ' C ' ' A' ' 126' ' ' TRP . 2.2 t90 -62.37 -56.85 14.32 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.12 -16.1 0.71 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.552 -0.718 . . . . 0.0 110.559 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.421 ' O ' ' HB2' ' A' ' 132' ' ' LYS . 4.7 t -69.07 -175.59 0.76 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.853 -1.154 . . . . 0.0 110.073 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -90.29 -34.89 15.56 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.299 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -71.4 -46.92 62.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 118.415 -1.314 . . . . 0.0 110.11 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.703 HG22 ' HB1' ' A' ' 81' ' ' ALA . 6.5 t -72.14 -34.14 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.853 -1.154 . . . . 0.0 108.911 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 128' ' ' SER . 1.3 tttm -64.3 -44.04 92.86 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.383 -0.823 . . . . 0.0 109.016 179.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 11.4 t -65.12 -30.87 71.84 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 77' ' ' ALA . 7.7 tp -78.91 -17.59 55.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.19 -47.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . -64.46 -33.36 75.7 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.445 ' OE1' ' OH ' ' A' ' 59' ' ' TYR . 0.8 OUTLIER -66.46 -37.85 86.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.442 -0.786 . . . . 0.0 108.959 179.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.53 ' NE2' ' HB2' ' A' ' 77' ' ' ALA . 8.4 mt-30 -67.46 -67.62 0.44 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.85 . . . . 0.0 108.885 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 138' ' ' GLN . 8.4 tt0 -46.74 -36.85 7.66 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 136' ' ' ALA . 10.2 mmtt -72.52 -29.12 63.31 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.429 -0.794 . . . . 0.0 108.996 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.58 ' O ' HG22 ' A' ' 145' ' ' VAL . . . -61.99 -53.62 53.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.3 -0.875 . . . . 0.0 109.071 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.525 ' O ' ' N ' ' A' ' 146' ' ' GLN . . . -71.77 -35.35 70.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.4 -0.813 . . . . 0.0 109.927 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -76.79 -18.63 58.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.176 -0.952 . . . . 0.0 109.836 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 140' ' ' LYS . 7.5 m-20 -82.82 -45.04 14.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.114 -0.992 . . . . 0.0 108.753 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.989 HG21 ' CE2' ' A' ' 25' ' ' PHE . 20.9 m -97.33 -11.96 8.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.04 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.545 ' CB ' ' O ' ' A' ' 145' ' ' VAL . 3.4 mt-30 82.02 -44.84 0.17 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.57 -0.706 . . . . 0.0 109.75 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.59 HD13 ' CG ' ' A' ' 25' ' ' PHE . 14.6 tp 66.46 133.76 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.347 -0.845 . . . . 0.0 109.144 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.4 37.41 0.17 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.536 -1.353 . . . . 0.0 109.846 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 158.04 109.51 0.28 Allowed Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.435 -1.364 . . . . 0.0 110.291 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.965 ' CG1' HG11 ' A' ' 61' ' ' VAL . 0.0 OUTLIER -93.56 142.59 25.37 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.427 -1.043 . . . . 0.0 109.358 178.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.16 151.76 93.79 Favored 'Cis proline' 0 C--N 1.314 -1.254 0 C-N-CA 123.891 -1.296 . . . . 0.0 110.487 0.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . . . -126.83 153.53 45.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.306 -1.496 . . . . 0.0 109.264 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' MET . . . . . 0.531 ' C ' ' CD1' ' A' ' 154' ' ' PHE . 3.2 ttm -145.32 136.44 24.84 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.118 -0.989 . . . . 0.0 109.818 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.6 ' CE2' ' HG3' ' A' ' 160' ' ' GLN . 3.0 m-85 -135.7 129.18 32.29 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.149 -0.97 . . . . 0.0 110.003 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.781 HG13 ' O ' ' A' ' 21' ' ' GLN . 53.9 t -98.32 132.11 44.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.173 -0.954 . . . . 0.0 109.636 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . 0.735 ' C ' ' HB3' ' A' ' 19' ' ' ALA . 4.3 t30 46.46 22.69 0.18 Allowed 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.219 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.651 ' N ' ' HB3' ' A' ' 19' ' ' ALA . . . 56.36 56.42 24.51 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LYS . . . . . 0.465 ' HG3' ' HB3' ' A' ' 15' ' ' PRO . 10.9 tttt -164.95 -34.16 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.377 -1.073 . . . . 0.0 108.32 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.599 ' CD2' ' HG2' ' A' ' 188' ' ' LYS . 86.1 m-85 -115.27 116.37 28.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.204 -0.935 . . . . 0.0 109.207 179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.6 ' HG3' ' CE2' ' A' ' 154' ' ' PHE . 0.5 OUTLIER -100.67 106.15 17.59 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.386 -0.821 . . . . 0.0 109.958 -179.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.468 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 16.4 mt -61.3 159.7 11.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.838 . . . . 0.0 109.028 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -129.71 117.59 18.52 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.105 -0.997 . . . . 0.0 109.271 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.33 22.48 0.76 Allowed 'Trans proline' 0 C--N 1.313 -1.31 0 C-N-CA 122.561 2.174 . . . . 0.0 111.239 -179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . 0.419 ' OE1' ' CA ' ' A' ' 164' ' ' GLN . 4.2 mm100 -83.96 -0.0 49.74 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.853 -1.154 . . . . 0.0 109.659 -179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -78.23 -1.07 79.72 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.84 -6.46 27.13 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.07 -1.253 . . . . 0.0 109.681 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -85.95 15.9 4.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.157 -0.965 . . . . 0.0 109.576 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.429 ' O ' ' HB2' ' A' ' 169' ' ' SER . 3.7 t -81.43 -19.14 43.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.174 -0.953 . . . . 0.0 109.527 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.429 ' HB2' ' O ' ' A' ' 168' ' ' THR . 4.2 m 70.55 42.75 0.83 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.865 . . . . 0.0 109.544 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -160.44 92.42 0.97 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.243 -0.91 . . . . 0.0 109.104 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' MET . . . . . . . . . . . . . 1.8 mmt -58.4 -16.19 13.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.235 -0.916 . . . . 0.0 109.724 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.33 -61.27 2.06 Favored 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.677 -0.639 . . . . 0.0 109.415 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.4 t -65.9 -23.08 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.205 -0.934 . . . . 0.0 109.034 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -73.44 -42.25 62.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.197 -0.94 . . . . 0.0 109.216 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 55.9 t -73.27 -26.26 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.145 -0.972 . . . . 0.0 109.121 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.48 -61.31 2.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 109.3 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -52.55 -32.54 41.36 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.262 -0.899 . . . . 0.0 109.437 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -74.52 -60.49 2.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 109.524 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -54.27 -20.77 7.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.066 -1.021 . . . . 0.0 108.784 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -82.59 -55.52 4.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.48 -0.763 . . . . 0.0 109.448 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.679 ' O ' HD23 ' A' ' 185' ' ' LEU . 69.6 m -50.73 -27.11 6.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.423 ' HA ' ' HB2' ' A' ' 185' ' ' LEU . 54.0 t -87.86 -37.3 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.034 -1.042 . . . . 0.0 108.911 179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -57.27 -44.23 83.76 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.241 -0.912 . . . . 0.0 108.863 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 184' ' ' TYR . 0.0 OUTLIER -83.43 -35.74 24.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.403 -0.811 . . . . 0.0 109.391 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 181' ' ' THR . 0.9 OUTLIER -58.03 -18.43 24.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.797 -1.189 . . . . 0.0 109.712 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' SER . . . . . 0.528 ' HB3' ' CG1' ' A' ' 54' ' ' VAL . 0.9 OUTLIER -78.7 -5.06 52.09 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.793 -1.192 . . . . 0.0 108.722 178.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -102.22 9.07 40.32 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.327 -0.858 . . . . 0.0 109.481 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.599 ' HG2' ' CD2' ' A' ' 159' ' ' TYR . 2.4 tptp -56.37 -31.48 63.84 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.178 -0.951 . . . . 0.0 109.704 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.563 -179.962 . . . . . . . . 1 1 . 1 stop_ save_